{"pair_id":"BioInfer.d454.s0.p0","sentence":"No significant changes in glomerular @PROTEIN2$, talin, @PROTEIN1$, or total actin expression occurred at any time point during disease development.","label":0}
{"pair_id":"BioInfer.d454.s0.p1","sentence":"No significant changes in glomerular vinculin, talin, @PROTEIN1$, or total @PROTEIN2$ expression occurred at any time point during disease development.","label":0}
{"pair_id":"BioInfer.d454.s0.p2","sentence":"No significant changes in glomerular vinculin, @PROTEIN2$, @PROTEIN1$, or total actin expression occurred at any time point during disease development.","label":0}
{"pair_id":"BioInfer.d454.s0.p3","sentence":"No significant changes in glomerular @PROTEIN1$, talin, beta 1-integrin, or total @PROTEIN2$ expression occurred at any time point during disease development.","label":0}
{"pair_id":"BioInfer.d454.s0.p4","sentence":"No significant changes in glomerular @PROTEIN1$, @PROTEIN2$, beta 1-integrin, or total actin expression occurred at any time point during disease development.","label":0}
{"pair_id":"BioInfer.d454.s0.p5","sentence":"No significant changes in glomerular vinculin, @PROTEIN2$, beta 1-integrin, or total @PROTEIN1$ expression occurred at any time point during disease development.","label":0}
{"pair_id":"BioInfer.d637.s1.p0","sentence":"To our knowledge, @PROTEIN1$ is the only integral component in cell-cell junctions discovered thus far that interacts with @PROTEIN2$ and thus could modulate actin modeling proximal to adhesion complexes.","label":1}
{"pair_id":"BioInfer.d637.s1.p1","sentence":"To our knowledge, @PROTEIN1$ is the only integral component in cell-cell junctions discovered thus far that interacts with profilin and thus could modulate @PROTEIN2$ modeling proximal to adhesion complexes.","label":1}
{"pair_id":"BioInfer.d637.s1.p2","sentence":"To our knowledge, AF-6 is the only integral component in cell-cell junctions discovered thus far that interacts with @PROTEIN1$ and thus could modulate @PROTEIN2$ modeling proximal to adhesion complexes.","label":0}
{"pair_id":"AIMed.d128.s1094.p0","sentence":"The @PROTEIN1$ and @PROTEIN2$ receptors (hGHR and hPRLR, respectively) are single-pass transmembrane receptors from class 1 of the haematopoietic receptor superfamily.","label":0}
{"pair_id":"AIMed.d128.s1094.p1","sentence":"The @PROTEIN1$ and hPRL receptors (@PROTEIN2$ and hPRLR, respectively) are single-pass transmembrane receptors from class 1 of the haematopoietic receptor superfamily.","label":1}
{"pair_id":"AIMed.d128.s1094.p2","sentence":"The @PROTEIN1$ and hPRL receptors (hGHR and @PROTEIN2$, respectively) are single-pass transmembrane receptors from class 1 of the haematopoietic receptor superfamily.","label":0}
{"pair_id":"AIMed.d128.s1094.p3","sentence":"The hGH and @PROTEIN1$ receptors (@PROTEIN2$ and hPRLR, respectively) are single-pass transmembrane receptors from class 1 of the haematopoietic receptor superfamily.","label":0}
{"pair_id":"AIMed.d128.s1094.p4","sentence":"The hGH and @PROTEIN1$ receptors (hGHR and @PROTEIN2$, respectively) are single-pass transmembrane receptors from class 1 of the haematopoietic receptor superfamily.","label":1}
{"pair_id":"AIMed.d128.s1094.p5","sentence":"The hGH and hPRL receptors (@PROTEIN1$ and @PROTEIN2$, respectively) are single-pass transmembrane receptors from class 1 of the haematopoietic receptor superfamily.","label":0}
{"pair_id":"BioInfer.d551.s0.p0","sentence":"Structural studies on the ribbon-to-helix transition in @PROTEIN1$: @PROTEIN2$ crystals.","label":0}
{"pair_id":"BioInfer.d421.s0.p0","sentence":"METHODS: Paraffin-embedded sections of five AVMs, CCMs, and control brain tissues were stained immunohistochemically with antibodies to alpha-smooth muscle actin (@PROTEIN1$), @PROTEIN2$, and smoothelin, a novel marker for contractile VSMC phenotype.","label":0}
{"pair_id":"BioInfer.d421.s0.p1","sentence":"METHODS: Paraffin-embedded sections of five AVMs, CCMs, and control brain tissues were stained immunohistochemically with antibodies to alpha-smooth muscle actin (@PROTEIN1$), myosin heavy chain, and @PROTEIN2$, a novel marker for contractile VSMC phenotype.","label":0}
{"pair_id":"BioInfer.d421.s0.p2","sentence":"METHODS: Paraffin-embedded sections of five AVMs, CCMs, and control brain tissues were stained immunohistochemically with antibodies to @PROTEIN2$ (@PROTEIN1$), myosin heavy chain, and smoothelin, a novel marker for contractile VSMC phenotype.","label":0}
{"pair_id":"BioInfer.d421.s0.p3","sentence":"METHODS: Paraffin-embedded sections of five AVMs, CCMs, and control brain tissues were stained immunohistochemically with antibodies to alpha-smooth muscle actin (alpha-SMA), @PROTEIN1$, and @PROTEIN2$, a novel marker for contractile VSMC phenotype.","label":0}
{"pair_id":"BioInfer.d421.s0.p4","sentence":"METHODS: Paraffin-embedded sections of five AVMs, CCMs, and control brain tissues were stained immunohistochemically with antibodies to @PROTEIN2$ (alpha-SMA), @PROTEIN1$, and smoothelin, a novel marker for contractile VSMC phenotype.","label":0}
{"pair_id":"BioInfer.d421.s0.p5","sentence":"METHODS: Paraffin-embedded sections of five AVMs, CCMs, and control brain tissues were stained immunohistochemically with antibodies to @PROTEIN2$ (alpha-SMA), myosin heavy chain, and @PROTEIN1$, a novel marker for contractile VSMC phenotype.","label":0}
{"pair_id":"BioInfer.d12.s0.p0","sentence":"A core activity associated with the N terminus of the yeast RAD52 protein is revealed by @PROTEIN2$ overexpression suppression of C-terminal @PROTEIN1$ truncation alleles.","label":1}
{"pair_id":"BioInfer.d12.s0.p1","sentence":"A core activity associated with the N terminus of the yeast @PROTEIN2$ protein is revealed by RAD51 overexpression suppression of C-terminal @PROTEIN1$ truncation alleles.","label":0}
{"pair_id":"BioInfer.d12.s0.p2","sentence":"A core activity associated with the N terminus of the yeast @PROTEIN2$ protein is revealed by @PROTEIN1$ overexpression suppression of C-terminal rad52 truncation alleles.","label":0}
{"pair_id":"BioInfer.d575.s0.p0","sentence":"The @PROTEIN1$ binding site on beta-catenin may be discontinuous since neither the carboxyl- nor amino-terminal halves of beta-catenin will independently associate with APC, although the amino-terminal half independently binds @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d575.s0.p1","sentence":"The @PROTEIN1$ binding site on beta-catenin may be discontinuous since neither the carboxyl- nor amino-terminal halves of beta-catenin will independently associate with @PROTEIN2$, although the amino-terminal half independently binds alpha-catenin.","label":0}
{"pair_id":"BioInfer.d575.s0.p2","sentence":"The @PROTEIN1$ binding site on @PROTEIN2$ may be discontinuous since neither the carboxyl- nor amino-terminal halves of beta-catenin will independently associate with APC, although the amino-terminal half independently binds alpha-catenin.","label":1}
{"pair_id":"BioInfer.d575.s0.p3","sentence":"The @PROTEIN1$ binding site on beta-catenin may be discontinuous since neither the carboxyl- nor amino-terminal halves of @PROTEIN2$ will independently associate with APC, although the amino-terminal half independently binds alpha-catenin.","label":0}
{"pair_id":"BioInfer.d575.s0.p4","sentence":"The APC binding site on beta-catenin may be discontinuous since neither the carboxyl- nor amino-terminal halves of beta-catenin will independently associate with @PROTEIN2$, although the amino-terminal half independently binds @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d575.s0.p5","sentence":"The APC binding site on @PROTEIN2$ may be discontinuous since neither the carboxyl- nor amino-terminal halves of beta-catenin will independently associate with APC, although the amino-terminal half independently binds @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d575.s0.p6","sentence":"The APC binding site on beta-catenin may be discontinuous since neither the carboxyl- nor amino-terminal halves of @PROTEIN2$ will independently associate with APC, although the amino-terminal half independently binds @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d575.s0.p7","sentence":"The APC binding site on @PROTEIN2$ may be discontinuous since neither the carboxyl- nor amino-terminal halves of beta-catenin will independently associate with @PROTEIN1$, although the amino-terminal half independently binds alpha-catenin.","label":0}
{"pair_id":"BioInfer.d575.s0.p8","sentence":"The APC binding site on beta-catenin may be discontinuous since neither the carboxyl- nor amino-terminal halves of @PROTEIN2$ will independently associate with @PROTEIN1$, although the amino-terminal half independently binds alpha-catenin.","label":1}
{"pair_id":"BioInfer.d575.s0.p9","sentence":"The APC binding site on @PROTEIN1$ may be discontinuous since neither the carboxyl- nor amino-terminal halves of @PROTEIN2$ will independently associate with APC, although the amino-terminal half independently binds alpha-catenin.","label":0}
{"pair_id":"AIMed.d103.s875.p0","sentence":"These results reveal differences not only in subunit composition, but also in the organization of @PROTEIN1$ and @PROTEIN2$ complexes.","label":0}
{"pair_id":"BioInfer.d296.s3.p0","sentence":"We found that the down-regulation of @PROTEIN2$, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for @PROTEIN1$, the down-regulation of which was associated with c-erbB2 down-regulation.","label":0}
{"pair_id":"BioInfer.d296.s3.p1","sentence":"We found that the down-regulation of E-cad, alpha-catenin, and @PROTEIN2$ expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for @PROTEIN1$, the down-regulation of which was associated with c-erbB2 down-regulation.","label":0}
{"pair_id":"BioInfer.d296.s3.p2","sentence":"We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or @PROTEIN2$ expression, except for @PROTEIN1$, the down-regulation of which was associated with c-erbB2 down-regulation.","label":0}
{"pair_id":"BioInfer.d296.s3.p3","sentence":"We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, @PROTEIN2$ expression, Ki-67 labeling, or c-erbB2 expression, except for @PROTEIN1$, the down-regulation of which was associated with c-erbB2 down-regulation.","label":0}
{"pair_id":"BioInfer.d296.s3.p4","sentence":"We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for @PROTEIN1$, the down-regulation of which was associated with @PROTEIN2$ down-regulation.","label":1}
{"pair_id":"BioInfer.d296.s3.p5","sentence":"We found that the down-regulation of E-cad, @PROTEIN2$, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for @PROTEIN1$, the down-regulation of which was associated with c-erbB2 down-regulation.","label":0}
{"pair_id":"BioInfer.d296.s3.p6","sentence":"We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, @PROTEIN2$ labeling, or c-erbB2 expression, except for @PROTEIN1$, the down-regulation of which was associated with c-erbB2 down-regulation.","label":0}
{"pair_id":"BioInfer.d296.s3.p7","sentence":"We found that the down-regulation of @PROTEIN1$, alpha-catenin, and @PROTEIN2$ expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.","label":0}
{"pair_id":"BioInfer.d296.s3.p8","sentence":"We found that the down-regulation of @PROTEIN1$, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or @PROTEIN2$ expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.","label":1}
{"pair_id":"BioInfer.d296.s3.p9","sentence":"We found that the down-regulation of @PROTEIN1$, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, @PROTEIN2$ expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.","label":1}
{"pair_id":"BioInfer.d296.s3.p10","sentence":"We found that the down-regulation of @PROTEIN1$, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with @PROTEIN2$ down-regulation.","label":0}
{"pair_id":"BioInfer.d296.s3.p11","sentence":"We found that the down-regulation of @PROTEIN1$, @PROTEIN2$, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.","label":0}
{"pair_id":"BioInfer.d296.s3.p12","sentence":"We found that the down-regulation of @PROTEIN1$, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, @PROTEIN2$ labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.","label":0}
{"pair_id":"BioInfer.d296.s3.p13","sentence":"We found that the down-regulation of E-cad, alpha-catenin, and @PROTEIN1$ expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or @PROTEIN2$ expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.","label":1}
{"pair_id":"BioInfer.d296.s3.p14","sentence":"We found that the down-regulation of E-cad, alpha-catenin, and @PROTEIN1$ expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, @PROTEIN2$ expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.","label":1}
{"pair_id":"BioInfer.d296.s3.p15","sentence":"We found that the down-regulation of E-cad, alpha-catenin, and @PROTEIN1$ expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with @PROTEIN2$ down-regulation.","label":0}
{"pair_id":"BioInfer.d296.s3.p16","sentence":"We found that the down-regulation of E-cad, @PROTEIN2$, and @PROTEIN1$ expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.","label":0}
{"pair_id":"BioInfer.d296.s3.p17","sentence":"We found that the down-regulation of E-cad, alpha-catenin, and @PROTEIN1$ expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, @PROTEIN2$ labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.","label":0}
{"pair_id":"BioInfer.d296.s3.p18","sentence":"We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, @PROTEIN2$ expression, Ki-67 labeling, or @PROTEIN1$ expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.","label":0}
{"pair_id":"BioInfer.d296.s3.p19","sentence":"We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or @PROTEIN1$ expression, except for beta-catenin, the down-regulation of which was associated with @PROTEIN2$ down-regulation.","label":0}
{"pair_id":"BioInfer.d296.s3.p20","sentence":"We found that the down-regulation of E-cad, @PROTEIN2$, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or @PROTEIN1$ expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.","label":1}
{"pair_id":"BioInfer.d296.s3.p21","sentence":"We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, @PROTEIN2$ labeling, or @PROTEIN1$ expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.","label":0}
{"pair_id":"BioInfer.d296.s3.p22","sentence":"We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, @PROTEIN1$ expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with @PROTEIN2$ down-regulation.","label":0}
{"pair_id":"BioInfer.d296.s3.p23","sentence":"We found that the down-regulation of E-cad, @PROTEIN2$, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, @PROTEIN1$ expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.","label":1}
{"pair_id":"BioInfer.d296.s3.p24","sentence":"We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, @PROTEIN1$ expression, @PROTEIN2$ labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.","label":0}
{"pair_id":"BioInfer.d296.s3.p25","sentence":"We found that the down-regulation of E-cad, @PROTEIN2$, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with @PROTEIN1$ down-regulation.","label":0}
{"pair_id":"BioInfer.d296.s3.p26","sentence":"We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, @PROTEIN2$ labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with @PROTEIN1$ down-regulation.","label":0}
{"pair_id":"BioInfer.d296.s3.p27","sentence":"We found that the down-regulation of E-cad, @PROTEIN1$, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, @PROTEIN2$ labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.","label":0}
{"pair_id":"AIMed.d35.s292.p0","sentence":"Most familial early-onset Alzheimer's disease cases are caused by mutations in the @PROTEIN1$ (@PROTEIN2$) gene.","label":0}
{"pair_id":"AIMed.d48.s419.p0","sentence":"@PROTEIN1$ induces chemotaxis and adhesion by interacting with @PROTEIN2$ and CCR8.","label":1}
{"pair_id":"AIMed.d48.s419.p1","sentence":"@PROTEIN1$ induces chemotaxis and adhesion by interacting with CCR1 and @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d48.s419.p2","sentence":"LEC induces chemotaxis and adhesion by interacting with @PROTEIN1$ and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d431.s0.p0","sentence":"[Molecular functions of @PROTEIN2$ which regulates reorganization of @PROTEIN1$ cytoskeleton].","label":1}
{"pair_id":"AIMed.d211.s1833.p0","sentence":"Recombinant @PROTEIN1$ induces the tyrosine-phosphorylation of @PROTEIN2$, ErbB3 and ErbB4 in cell lines expressing all of these ErbB-family receptors.","label":1}
{"pair_id":"AIMed.d211.s1833.p1","sentence":"Recombinant @PROTEIN1$ induces the tyrosine-phosphorylation of ErbB2, @PROTEIN2$ and ErbB4 in cell lines expressing all of these ErbB-family receptors.","label":1}
{"pair_id":"AIMed.d211.s1833.p2","sentence":"Recombinant @PROTEIN1$ induces the tyrosine-phosphorylation of ErbB2, ErbB3 and @PROTEIN2$ in cell lines expressing all of these ErbB-family receptors.","label":1}
{"pair_id":"AIMed.d211.s1833.p3","sentence":"Recombinant neuregulin-2beta induces the tyrosine-phosphorylation of @PROTEIN1$, @PROTEIN2$ and ErbB4 in cell lines expressing all of these ErbB-family receptors.","label":0}
{"pair_id":"AIMed.d211.s1833.p4","sentence":"Recombinant neuregulin-2beta induces the tyrosine-phosphorylation of @PROTEIN1$, ErbB3 and @PROTEIN2$ in cell lines expressing all of these ErbB-family receptors.","label":0}
{"pair_id":"AIMed.d211.s1833.p5","sentence":"Recombinant neuregulin-2beta induces the tyrosine-phosphorylation of ErbB2, @PROTEIN1$ and @PROTEIN2$ in cell lines expressing all of these ErbB-family receptors.","label":0}
{"pair_id":"BioInfer.d634.s0.p0","sentence":"The involvement of the death adaptor proteins @PROTEIN2$\/MORT1, TRADD, and @PROTEIN1$ and the apoptosis-initiating caspases-8 and cas in death signaling by the two death-inducing TRAIL receptors 1 and T (TRAIL-R1 and TRAIL-R2) are controversial.","label":0}
{"pair_id":"BioInfer.d634.s0.p1","sentence":"The involvement of the death adaptor proteins FADD\/MORT1, @PROTEIN2$, and @PROTEIN1$ and the apoptosis-initiating caspases-8 and cas in death signaling by the two death-inducing TRAIL receptors 1 and T (TRAIL-R1 and TRAIL-R2) are controversial.","label":0}
{"pair_id":"BioInfer.d634.s0.p2","sentence":"The involvement of the death adaptor proteins FADD\/@PROTEIN2$, TRADD, and @PROTEIN1$ and the apoptosis-initiating caspases-8 and cas in death signaling by the two death-inducing TRAIL receptors 1 and T (TRAIL-R1 and TRAIL-R2) are controversial.","label":0}
{"pair_id":"BioInfer.d634.s0.p3","sentence":"The involvement of the death adaptor proteins FADD\/MORT1, TRADD, and @PROTEIN1$ and the apoptosis-initiating caspases-8 and cas in death signaling by the two death-inducing TRAIL receptors 1 and T (@PROTEIN2$ and TRAIL-R2) are controversial.","label":1}
{"pair_id":"BioInfer.d634.s0.p4","sentence":"The involvement of the death adaptor proteins FADD\/MORT1, TRADD, and @PROTEIN1$ and the apoptosis-initiating @PROTEIN2$-8 and @PROTEIN2$ in death signaling by the two death-inducing TRAIL receptors 1 and T (TRAIL-R1 and TRAIL-R2) are controversial.","label":0}
{"pair_id":"BioInfer.d634.s0.p5","sentence":"The involvement of the death adaptor proteins FADD\/MORT1, TRADD, and @PROTEIN1$ and the apoptosis-initiating @PROTEIN2$ and cas in death signaling by the two death-inducing TRAIL receptors 1 and T (TRAIL-R1 and TRAIL-R2) are controversial.","label":0}
{"pair_id":"BioInfer.d634.s0.p6","sentence":"The involvement of the death adaptor proteins FADD\/MORT1, TRADD, and @PROTEIN1$ and the apoptosis-initiating caspases-8 and cas in death signaling by the two death-inducing @PROTEIN2$ 1 and @PROTEIN2$ (TRAIL-R1 and TRAIL-R2) are controversial.","label":1}
{"pair_id":"BioInfer.d634.s0.p7","sentence":"The involvement of the death adaptor proteins FADD\/MORT1, TRADD, and @PROTEIN1$ and the apoptosis-initiating caspases-8 and cas in death signaling by the two death-inducing @PROTEIN2$ and T (TRAIL-R1 and TRAIL-R2) are controversial.","label":1}
{"pair_id":"BioInfer.d634.s0.p8","sentence":"The involvement of the death adaptor proteins FADD\/MORT1, TRADD, and @PROTEIN1$ and the apoptosis-initiating caspases-8 and cas in death signaling by the two death-inducing TRAIL receptors 1 and T (TRAIL-R1 and @PROTEIN2$) are controversial.","label":1}
{"pair_id":"BioInfer.d634.s0.p9","sentence":"The involvement of the death adaptor proteins @PROTEIN1$\/MORT1, @PROTEIN2$, and RIP and the apoptosis-initiating caspases-8 and cas in death signaling by the two death-inducing TRAIL receptors 1 and T (TRAIL-R1 and TRAIL-R2) are controversial.","label":0}
{"pair_id":"BioInfer.d634.s0.p10","sentence":"The involvement of the death adaptor proteins @PROTEIN1$\/@PROTEIN2$, TRADD, and RIP and the apoptosis-initiating caspases-8 and cas in death signaling by the two death-inducing TRAIL receptors 1 and T (TRAIL-R1 and TRAIL-R2) are controversial.","label":0}
{"pair_id":"BioInfer.d634.s0.p11","sentence":"The involvement of the death adaptor proteins @PROTEIN1$\/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and cas in death signaling by the two death-inducing TRAIL receptors 1 and T (@PROTEIN2$ and TRAIL-R2) are controversial.","label":1}
{"pair_id":"BioInfer.d634.s0.p12","sentence":"The involvement of the death adaptor proteins @PROTEIN1$\/MORT1, TRADD, and RIP and the apoptosis-initiating @PROTEIN2$-8 and @PROTEIN2$ in death signaling by the two death-inducing TRAIL receptors 1 and T (TRAIL-R1 and TRAIL-R2) are controversial.","label":0}
{"pair_id":"BioInfer.d634.s0.p13","sentence":"The involvement of the death adaptor proteins @PROTEIN1$\/MORT1, TRADD, and RIP and the apoptosis-initiating @PROTEIN2$ and cas in death signaling by the two death-inducing TRAIL receptors 1 and T (TRAIL-R1 and TRAIL-R2) are controversial.","label":0}
{"pair_id":"BioInfer.d634.s0.p14","sentence":"The involvement of the death adaptor proteins @PROTEIN1$\/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and cas in death signaling by the two death-inducing @PROTEIN2$ 1 and @PROTEIN2$ (TRAIL-R1 and TRAIL-R2) are controversial.","label":1}
{"pair_id":"BioInfer.d634.s0.p15","sentence":"The involvement of the death adaptor proteins @PROTEIN1$\/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and cas in death signaling by the two death-inducing @PROTEIN2$ and T (TRAIL-R1 and TRAIL-R2) are controversial.","label":1}
{"pair_id":"BioInfer.d634.s0.p16","sentence":"The involvement of the death adaptor proteins @PROTEIN1$\/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and cas in death signaling by the two death-inducing TRAIL receptors 1 and T (TRAIL-R1 and @PROTEIN2$) are controversial.","label":1}
{"pair_id":"BioInfer.d634.s0.p17","sentence":"The involvement of the death adaptor proteins FADD\/@PROTEIN2$, @PROTEIN1$, and RIP and the apoptosis-initiating caspases-8 and cas in death signaling by the two death-inducing TRAIL receptors 1 and T (TRAIL-R1 and TRAIL-R2) are controversial.","label":0}
{"pair_id":"BioInfer.d634.s0.p18","sentence":"The involvement of the death adaptor proteins FADD\/MORT1, @PROTEIN1$, and RIP and the apoptosis-initiating caspases-8 and cas in death signaling by the two death-inducing TRAIL receptors 1 and T (@PROTEIN2$ and TRAIL-R2) are controversial.","label":1}
{"pair_id":"BioInfer.d634.s0.p19","sentence":"The involvement of the death adaptor proteins FADD\/MORT1, @PROTEIN1$, and RIP and the apoptosis-initiating @PROTEIN2$-8 and @PROTEIN2$ in death signaling by the two death-inducing TRAIL receptors 1 and T (TRAIL-R1 and TRAIL-R2) are controversial.","label":0}
{"pair_id":"BioInfer.d634.s0.p20","sentence":"The involvement of the death adaptor proteins FADD\/MORT1, @PROTEIN1$, and RIP and the apoptosis-initiating @PROTEIN2$ and cas in death signaling by the two death-inducing TRAIL receptors 1 and T (TRAIL-R1 and TRAIL-R2) are controversial.","label":0}
{"pair_id":"BioInfer.d634.s0.p21","sentence":"The involvement of the death adaptor proteins FADD\/MORT1, @PROTEIN1$, and RIP and the apoptosis-initiating caspases-8 and cas in death signaling by the two death-inducing @PROTEIN2$ 1 and @PROTEIN2$ (TRAIL-R1 and TRAIL-R2) are controversial.","label":1}
{"pair_id":"BioInfer.d634.s0.p22","sentence":"The involvement of the death adaptor proteins FADD\/MORT1, @PROTEIN1$, and RIP and the apoptosis-initiating caspases-8 and cas in death signaling by the two death-inducing @PROTEIN2$ and T (TRAIL-R1 and TRAIL-R2) are controversial.","label":1}
{"pair_id":"BioInfer.d634.s0.p23","sentence":"The involvement of the death adaptor proteins FADD\/MORT1, @PROTEIN1$, and RIP and the apoptosis-initiating caspases-8 and cas in death signaling by the two death-inducing TRAIL receptors 1 and T (TRAIL-R1 and @PROTEIN2$) are controversial.","label":1}
{"pair_id":"BioInfer.d634.s0.p24","sentence":"The involvement of the death adaptor proteins FADD\/@PROTEIN1$, TRADD, and RIP and the apoptosis-initiating caspases-8 and cas in death signaling by the two death-inducing TRAIL receptors 1 and T (@PROTEIN2$ and TRAIL-R2) are controversial.","label":1}
{"pair_id":"BioInfer.d634.s0.p25","sentence":"The involvement of the death adaptor proteins FADD\/@PROTEIN1$, TRADD, and RIP and the apoptosis-initiating @PROTEIN2$-8 and @PROTEIN2$ in death signaling by the two death-inducing TRAIL receptors 1 and T (TRAIL-R1 and TRAIL-R2) are controversial.","label":0}
{"pair_id":"BioInfer.d634.s0.p26","sentence":"The involvement of the death adaptor proteins FADD\/@PROTEIN1$, TRADD, and RIP and the apoptosis-initiating @PROTEIN2$ and cas in death signaling by the two death-inducing TRAIL receptors 1 and T (TRAIL-R1 and TRAIL-R2) are controversial.","label":0}
{"pair_id":"BioInfer.d634.s0.p27","sentence":"The involvement of the death adaptor proteins FADD\/@PROTEIN1$, TRADD, and RIP and the apoptosis-initiating caspases-8 and cas in death signaling by the two death-inducing @PROTEIN2$ 1 and @PROTEIN2$ (TRAIL-R1 and TRAIL-R2) are controversial.","label":1}
{"pair_id":"BioInfer.d634.s0.p28","sentence":"The involvement of the death adaptor proteins FADD\/@PROTEIN1$, TRADD, and RIP and the apoptosis-initiating caspases-8 and cas in death signaling by the two death-inducing @PROTEIN2$ and T (TRAIL-R1 and TRAIL-R2) are controversial.","label":1}
{"pair_id":"BioInfer.d634.s0.p29","sentence":"The involvement of the death adaptor proteins FADD\/@PROTEIN1$, TRADD, and RIP and the apoptosis-initiating caspases-8 and cas in death signaling by the two death-inducing TRAIL receptors 1 and T (TRAIL-R1 and @PROTEIN2$) are controversial.","label":1}
{"pair_id":"BioInfer.d634.s0.p30","sentence":"The involvement of the death adaptor proteins FADD\/MORT1, TRADD, and RIP and the apoptosis-initiating @PROTEIN2$-8 and @PROTEIN2$ in death signaling by the two death-inducing TRAIL receptors 1 and T (@PROTEIN1$ and TRAIL-R2) are controversial.","label":1}
{"pair_id":"BioInfer.d634.s0.p31","sentence":"The involvement of the death adaptor proteins FADD\/MORT1, TRADD, and RIP and the apoptosis-initiating @PROTEIN2$ and cas in death signaling by the two death-inducing TRAIL receptors 1 and T (@PROTEIN1$ and TRAIL-R2) are controversial.","label":1}
{"pair_id":"BioInfer.d634.s0.p32","sentence":"The involvement of the death adaptor proteins FADD\/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and cas in death signaling by the two death-inducing @PROTEIN2$ 1 and @PROTEIN2$ (@PROTEIN1$ and TRAIL-R2) are controversial.","label":0}
{"pair_id":"BioInfer.d634.s0.p33","sentence":"The involvement of the death adaptor proteins FADD\/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and cas in death signaling by the two death-inducing @PROTEIN2$ and T (@PROTEIN1$ and TRAIL-R2) are controversial.","label":0}
{"pair_id":"BioInfer.d634.s0.p34","sentence":"The involvement of the death adaptor proteins FADD\/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and cas in death signaling by the two death-inducing TRAIL receptors 1 and T (@PROTEIN1$ and @PROTEIN2$) are controversial.","label":0}
{"pair_id":"BioInfer.d634.s0.p35","sentence":"The involvement of the death adaptor proteins FADD\/MORT1, TRADD, and RIP and the apoptosis-initiating @PROTEIN1$@PROTEIN2$ and @PROTEIN1$ in death signaling by the two death-inducing TRAIL receptors 1 and T (TRAIL-R1 and TRAIL-R2) are controversial.","label":0}
{"pair_id":"BioInfer.d634.s0.p36","sentence":"The involvement of the death adaptor proteins FADD\/MORT1, TRADD, and RIP and the apoptosis-initiating @PROTEIN1$-8 and @PROTEIN1$ in death signaling by the two death-inducing @PROTEIN2$ 1 and @PROTEIN2$ (TRAIL-R1 and TRAIL-R2) are controversial.","label":1}
{"pair_id":"BioInfer.d634.s0.p37","sentence":"The involvement of the death adaptor proteins FADD\/MORT1, TRADD, and RIP and the apoptosis-initiating @PROTEIN1$-8 and @PROTEIN1$ in death signaling by the two death-inducing @PROTEIN2$ and T (TRAIL-R1 and TRAIL-R2) are controversial.","label":1}
{"pair_id":"BioInfer.d634.s0.p38","sentence":"The involvement of the death adaptor proteins FADD\/MORT1, TRADD, and RIP and the apoptosis-initiating @PROTEIN1$-8 and @PROTEIN1$ in death signaling by the two death-inducing TRAIL receptors 1 and T (TRAIL-R1 and @PROTEIN2$) are controversial.","label":1}
{"pair_id":"BioInfer.d634.s0.p39","sentence":"The involvement of the death adaptor proteins FADD\/MORT1, TRADD, and RIP and the apoptosis-initiating @PROTEIN1$ and cas in death signaling by the two death-inducing @PROTEIN2$ 1 and @PROTEIN2$ (TRAIL-R1 and TRAIL-R2) are controversial.","label":1}
{"pair_id":"BioInfer.d634.s0.p40","sentence":"The involvement of the death adaptor proteins FADD\/MORT1, TRADD, and RIP and the apoptosis-initiating @PROTEIN1$ and cas in death signaling by the two death-inducing @PROTEIN2$ and T (TRAIL-R1 and TRAIL-R2) are controversial.","label":1}
{"pair_id":"BioInfer.d634.s0.p41","sentence":"The involvement of the death adaptor proteins FADD\/MORT1, TRADD, and RIP and the apoptosis-initiating @PROTEIN1$ and cas in death signaling by the two death-inducing TRAIL receptors 1 and T (TRAIL-R1 and @PROTEIN2$) are controversial.","label":1}
{"pair_id":"BioInfer.d634.s0.p42","sentence":"The involvement of the death adaptor proteins FADD\/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and cas in death signaling by the two death-inducing @PROTEIN1$@PROTEIN2$ and @PROTEIN1$ (TRAIL-R1 and TRAIL-R2) are controversial.","label":0}
{"pair_id":"BioInfer.d634.s0.p43","sentence":"The involvement of the death adaptor proteins FADD\/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and cas in death signaling by the two death-inducing @PROTEIN1$ 1 and @PROTEIN1$ (TRAIL-R1 and @PROTEIN2$) are controversial.","label":0}
{"pair_id":"BioInfer.d634.s0.p44","sentence":"The involvement of the death adaptor proteins FADD\/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and cas in death signaling by the two death-inducing @PROTEIN1$ and T (TRAIL-R1 and @PROTEIN2$) are controversial.","label":0}
{"pair_id":"BioInfer.d193.s0.p0","sentence":"Evaluation of the binding of Acanthamoeba @PROTEIN1$ to pyrene-labeled @PROTEIN2$ by fluorescence enhancement.","label":1}
{"pair_id":"BioInfer.d591.s0.p0","sentence":"The cellular morphological changes were analyzed and correlated with the distribution of cell-substratum contacts viewed by confocal images obtained after immunostaining with antibodies raised against the @PROTEIN2$, talin, @PROTEIN1$ and actin.","label":0}
{"pair_id":"BioInfer.d591.s0.p1","sentence":"The cellular morphological changes were analyzed and correlated with the distribution of cell-substratum contacts viewed by confocal images obtained after immunostaining with antibodies raised against the fibronectin receptor, talin, @PROTEIN1$ and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d591.s0.p2","sentence":"The cellular morphological changes were analyzed and correlated with the distribution of cell-substratum contacts viewed by confocal images obtained after immunostaining with antibodies raised against the fibronectin receptor, @PROTEIN2$, @PROTEIN1$ and actin.","label":0}
{"pair_id":"BioInfer.d591.s0.p3","sentence":"The cellular morphological changes were analyzed and correlated with the distribution of cell-substratum contacts viewed by confocal images obtained after immunostaining with antibodies raised against the @PROTEIN1$, talin, vinculin and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d591.s0.p4","sentence":"The cellular morphological changes were analyzed and correlated with the distribution of cell-substratum contacts viewed by confocal images obtained after immunostaining with antibodies raised against the @PROTEIN1$, @PROTEIN2$, vinculin and actin.","label":0}
{"pair_id":"BioInfer.d591.s0.p5","sentence":"The cellular morphological changes were analyzed and correlated with the distribution of cell-substratum contacts viewed by confocal images obtained after immunostaining with antibodies raised against the fibronectin receptor, @PROTEIN2$, vinculin and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d205.s0.p0","sentence":"Expression of @PROTEIN1$, alpha-catenin and @PROTEIN2$ in normal ovarian surface epithelium and epithelial ovarian cancers.","label":0}
{"pair_id":"BioInfer.d205.s0.p1","sentence":"Expression of @PROTEIN1$, @PROTEIN2$ and beta-catenin in normal ovarian surface epithelium and epithelial ovarian cancers.","label":0}
{"pair_id":"BioInfer.d205.s0.p2","sentence":"Expression of E-cadherin, @PROTEIN2$ and @PROTEIN1$ in normal ovarian surface epithelium and epithelial ovarian cancers.","label":0}
{"pair_id":"AIMed.d109.s918.p0","sentence":"We have determined the X-ray crystal structure of a heterodimer of the bZIP regions of @PROTEIN1$ and @PROTEIN2$ bound to DNA.","label":1}
{"pair_id":"AIMed.d121.s1023.p0","sentence":"Several hydrophobic amino acids in the @PROTEIN1$ amino-terminal domain are required for transcriptional activation, binding to @PROTEIN2$ and the adenovirus 5 E1B 55-kD protein.","label":1}
{"pair_id":"AIMed.d121.s1023.p1","sentence":"Several hydrophobic amino acids in the @PROTEIN1$ amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 @PROTEIN2$ 55-kD protein.","label":0}
{"pair_id":"AIMed.d121.s1023.p2","sentence":"Several hydrophobic amino acids in the @PROTEIN1$ amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus @PROTEIN2$ 55-kD protein.","label":1}
{"pair_id":"AIMed.d121.s1023.p3","sentence":"Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to @PROTEIN1$ and the adenovirus 5 @PROTEIN2$ 55-kD protein.","label":0}
{"pair_id":"AIMed.d121.s1023.p4","sentence":"Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to @PROTEIN1$ and the adenovirus @PROTEIN2$ 55-kD protein.","label":0}
{"pair_id":"AIMed.d121.s1023.p5","sentence":"Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus @PROTEIN2$@PROTEIN1$ 55-kD protein.","label":0}
{"pair_id":"AIMed.d131.s1126.p0","sentence":"Like @PROTEIN1$, @PROTEIN2$ is structurally related to IFNR.","label":0}
{"pair_id":"AIMed.d131.s1126.p1","sentence":"Like @PROTEIN1$, hIL-10R is structurally related to @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d131.s1126.p2","sentence":"Like mIL-10R, @PROTEIN1$ is structurally related to @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d633.s0.p0","sentence":"The intracellular molecules @PROTEIN2$ and @PROTEIN1$ actively regulate actin-based motility and participate in the signaling pathways used to steer growth cones.","label":0}
{"pair_id":"BioInfer.d633.s0.p1","sentence":"The intracellular molecules calmodulin and @PROTEIN1$ actively regulate @PROTEIN2$-based motility and participate in the signaling pathways used to steer growth cones.","label":1}
{"pair_id":"BioInfer.d633.s0.p2","sentence":"The intracellular molecules @PROTEIN1$ and profilin actively regulate @PROTEIN2$-based motility and participate in the signaling pathways used to steer growth cones.","label":1}
{"pair_id":"AIMed.d114.s969.p0","sentence":"We have found a COOH-terminal 37-kD fragment of @PROTEIN1$ sufficient to interact with translated @PROTEIN2$ and its homologues, suggesting that the dystrophin binding site on beta 1-syntrophin occurs on a region that is conserved among the three syntrophin homologues.","label":1}
{"pair_id":"AIMed.d114.s969.p1","sentence":"We have found a COOH-terminal 37-kD fragment of @PROTEIN1$ sufficient to interact with translated dystrophin and its homologues, suggesting that the @PROTEIN2$ binding site on beta 1-syntrophin occurs on a region that is conserved among the three syntrophin homologues.","label":0}
{"pair_id":"AIMed.d114.s969.p2","sentence":"We have found a COOH-terminal 37-kD fragment of @PROTEIN1$ sufficient to interact with translated dystrophin and its homologues, suggesting that the dystrophin binding site on @PROTEIN2$ occurs on a region that is conserved among the three syntrophin homologues.","label":0}
{"pair_id":"AIMed.d114.s969.p3","sentence":"We have found a COOH-terminal 37-kD fragment of beta 1-syntrophin sufficient to interact with translated @PROTEIN1$ and its homologues, suggesting that the @PROTEIN2$ binding site on beta 1-syntrophin occurs on a region that is conserved among the three syntrophin homologues.","label":0}
{"pair_id":"AIMed.d114.s969.p4","sentence":"We have found a COOH-terminal 37-kD fragment of beta 1-syntrophin sufficient to interact with translated @PROTEIN1$ and its homologues, suggesting that the dystrophin binding site on @PROTEIN2$ occurs on a region that is conserved among the three syntrophin homologues.","label":0}
{"pair_id":"AIMed.d114.s969.p5","sentence":"We have found a COOH-terminal 37-kD fragment of beta 1-syntrophin sufficient to interact with translated dystrophin and its homologues, suggesting that the @PROTEIN1$ binding site on @PROTEIN2$ occurs on a region that is conserved among the three syntrophin homologues.","label":1}
{"pair_id":"BioInfer.d184.s0.p0","sentence":"Effects of @PROTEIN2$-annexin I association on some properties of both @PROTEIN1$ and annexin I: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.","label":1}
{"pair_id":"BioInfer.d184.s0.p1","sentence":"Effects of profilin-@PROTEIN2$ association on some properties of both @PROTEIN1$ and annexin I: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.","label":1}
{"pair_id":"BioInfer.d184.s0.p2","sentence":"Effects of profilin-annexin I association on some properties of both @PROTEIN1$ and annexin I: modification of the inhibitory activity of @PROTEIN2$ on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.","label":0}
{"pair_id":"BioInfer.d184.s0.p3","sentence":"Effects of profilin-annexin I association on some properties of both @PROTEIN1$ and annexin I: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of @PROTEIN2$ and its interactions with liposomes.","label":0}
{"pair_id":"BioInfer.d184.s0.p4","sentence":"Effects of profilin-annexin I association on some properties of both @PROTEIN1$ and annexin I: modification of the inhibitory activity of profilin on @PROTEIN2$ polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.","label":0}
{"pair_id":"BioInfer.d184.s0.p5","sentence":"Effects of profilin-annexin I association on some properties of both @PROTEIN1$ and @PROTEIN2$: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.","label":0}
{"pair_id":"BioInfer.d184.s0.p6","sentence":"Effects of @PROTEIN1$-@PROTEIN2$ association on some properties of both profilin and annexin I: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.","label":1}
{"pair_id":"BioInfer.d184.s0.p7","sentence":"Effects of @PROTEIN1$-annexin I association on some properties of both profilin and annexin I: modification of the inhibitory activity of @PROTEIN2$ on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.","label":1}
{"pair_id":"BioInfer.d184.s0.p8","sentence":"Effects of @PROTEIN1$-annexin I association on some properties of both profilin and annexin I: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of @PROTEIN2$ and its interactions with liposomes.","label":1}
{"pair_id":"BioInfer.d184.s0.p9","sentence":"Effects of @PROTEIN1$-annexin I association on some properties of both profilin and annexin I: modification of the inhibitory activity of profilin on @PROTEIN2$ polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.","label":1}
{"pair_id":"BioInfer.d184.s0.p10","sentence":"Effects of @PROTEIN1$-annexin I association on some properties of both profilin and @PROTEIN2$: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.","label":1}
{"pair_id":"BioInfer.d184.s0.p11","sentence":"Effects of profilin-@PROTEIN1$ association on some properties of both profilin and annexin I: modification of the inhibitory activity of @PROTEIN2$ on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.","label":0}
{"pair_id":"BioInfer.d184.s0.p12","sentence":"Effects of profilin-@PROTEIN1$ association on some properties of both profilin and annexin I: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of @PROTEIN2$ and its interactions with liposomes.","label":1}
{"pair_id":"BioInfer.d184.s0.p13","sentence":"Effects of profilin-@PROTEIN1$ association on some properties of both profilin and annexin I: modification of the inhibitory activity of profilin on @PROTEIN2$ polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.","label":1}
{"pair_id":"BioInfer.d184.s0.p14","sentence":"Effects of profilin-@PROTEIN1$ association on some properties of both profilin and @PROTEIN2$: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.","label":1}
{"pair_id":"BioInfer.d184.s0.p15","sentence":"Effects of profilin-annexin I association on some properties of both profilin and annexin I: modification of the inhibitory activity of @PROTEIN1$ on actin polymerization and inhibition of the self-association of @PROTEIN2$ and its interactions with liposomes.","label":0}
{"pair_id":"BioInfer.d184.s0.p16","sentence":"Effects of profilin-annexin I association on some properties of both profilin and annexin I: modification of the inhibitory activity of @PROTEIN1$ on @PROTEIN2$ polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.","label":1}
{"pair_id":"BioInfer.d184.s0.p17","sentence":"Effects of profilin-annexin I association on some properties of both profilin and @PROTEIN2$: modification of the inhibitory activity of @PROTEIN1$ on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.","label":0}
{"pair_id":"BioInfer.d184.s0.p18","sentence":"Effects of profilin-annexin I association on some properties of both profilin and annexin I: modification of the inhibitory activity of profilin on @PROTEIN2$ polymerization and inhibition of the self-association of @PROTEIN1$ and its interactions with liposomes.","label":0}
{"pair_id":"BioInfer.d184.s0.p19","sentence":"Effects of profilin-annexin I association on some properties of both profilin and @PROTEIN2$: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of @PROTEIN1$ and its interactions with liposomes.","label":0}
{"pair_id":"BioInfer.d184.s0.p20","sentence":"Effects of profilin-annexin I association on some properties of both profilin and @PROTEIN2$: modification of the inhibitory activity of profilin on @PROTEIN1$ polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.","label":0}
{"pair_id":"BioInfer.d229.s0.p0","sentence":"Gel electrophoresis was used to measure changes in the relative amounts of @PROTEIN1$ or myosin and of @PROTEIN2$ (MHC) isoforms.","label":0}
{"pair_id":"BioInfer.d229.s0.p1","sentence":"Gel electrophoresis was used to measure changes in the relative amounts of @PROTEIN1$ or @PROTEIN2$ and of myosin heavy chain (MHC) isoforms.","label":0}
{"pair_id":"BioInfer.d229.s0.p2","sentence":"Gel electrophoresis was used to measure changes in the relative amounts of @PROTEIN1$ or myosin and of myosin heavy chain (@PROTEIN2$) isoforms.","label":0}
{"pair_id":"BioInfer.d229.s0.p3","sentence":"Gel electrophoresis was used to measure changes in the relative amounts of actin or @PROTEIN2$ and of @PROTEIN1$ (MHC) isoforms.","label":0}
{"pair_id":"BioInfer.d229.s0.p4","sentence":"Gel electrophoresis was used to measure changes in the relative amounts of actin or myosin and of @PROTEIN1$ (@PROTEIN2$) isoforms.","label":0}
{"pair_id":"BioInfer.d229.s0.p5","sentence":"Gel electrophoresis was used to measure changes in the relative amounts of actin or @PROTEIN1$ and of myosin heavy chain (@PROTEIN2$) isoforms.","label":0}
{"pair_id":"AIMed.d222.s1929.p0","sentence":"The precise function of @PROTEIN1$ in these pathways is not clear, although a genetic analysis in Caenorhabditis elegans suggests that @PROTEIN2$ is a negative regulator of the epidermal growth factor receptor.","label":0}
{"pair_id":"AIMed.d222.s1929.p1","sentence":"The precise function of @PROTEIN1$ in these pathways is not clear, although a genetic analysis in Caenorhabditis elegans suggests that c-Cbl is a negative regulator of the @PROTEIN2$ receptor.","label":0}
{"pair_id":"AIMed.d222.s1929.p2","sentence":"The precise function of @PROTEIN1$ in these pathways is not clear, although a genetic analysis in Caenorhabditis elegans suggests that c-Cbl is a negative regulator of the @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d222.s1929.p3","sentence":"The precise function of c-Cbl in these pathways is not clear, although a genetic analysis in Caenorhabditis elegans suggests that @PROTEIN1$ is a negative regulator of the @PROTEIN2$ receptor.","label":0}
{"pair_id":"AIMed.d222.s1929.p4","sentence":"The precise function of c-Cbl in these pathways is not clear, although a genetic analysis in Caenorhabditis elegans suggests that @PROTEIN1$ is a negative regulator of the @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d222.s1929.p5","sentence":"The precise function of c-Cbl in these pathways is not clear, although a genetic analysis in Caenorhabditis elegans suggests that c-Cbl is a negative regulator of the @PROTEIN1$@PROTEIN2$.","label":0}
{"pair_id":"AIMed.d2.s19.p0","sentence":"DESIGN: We took advantage of previously collected data during a randomised double-blind, placebo-controlled clinical trial to conduct a secondary analysis of the @PROTEIN1$\/@PROTEIN2$ ratio and its relationship to infection and VA status.","label":0}
{"pair_id":"BioInfer.d170.s1.p0","sentence":"The truncated @PROTEIN2$ molecules produced in E. coli were purified and examined for their @PROTEIN1$-binding and PIP2-binding ability.","label":1}
{"pair_id":"AIMed.d39.s336.p0","sentence":"Here we show that @PROTEIN1$\/@PROTEIN2$, a negative regulator of c-Jun, is a candidate to mediate the function of PS1 in the cell.","label":0}
{"pair_id":"AIMed.d39.s336.p1","sentence":"Here we show that @PROTEIN1$\/Jun-interacting factor (Jif)-1, a negative regulator of @PROTEIN2$, is a candidate to mediate the function of PS1 in the cell.","label":1}
{"pair_id":"AIMed.d39.s336.p2","sentence":"Here we show that @PROTEIN1$\/Jun-interacting factor (Jif)-1, a negative regulator of c-Jun, is a candidate to mediate the function of @PROTEIN2$ in the cell.","label":0}
{"pair_id":"AIMed.d39.s336.p3","sentence":"Here we show that QM\/@PROTEIN1$, a negative regulator of @PROTEIN2$, is a candidate to mediate the function of PS1 in the cell.","label":1}
{"pair_id":"AIMed.d39.s336.p4","sentence":"Here we show that QM\/@PROTEIN1$, a negative regulator of c-Jun, is a candidate to mediate the function of @PROTEIN2$ in the cell.","label":0}
{"pair_id":"AIMed.d39.s336.p5","sentence":"Here we show that QM\/Jun-interacting factor (Jif)-1, a negative regulator of @PROTEIN1$, is a candidate to mediate the function of @PROTEIN2$ in the cell.","label":0}
{"pair_id":"BioInfer.d742.s0.p0","sentence":"This novel mutation was predicted to disrupt the binding of @PROTEIN2$ to @PROTEIN1$ and may be related to the diffuse type morphology.","label":1}
{"pair_id":"BioInfer.d558.s1.p0","sentence":"@PROTEIN2$ inhibition also led to the formation of less prominent focal adhesions as revealed by immunofluorescence staining against vinculin, @PROTEIN1$, and beta1-integrin.","label":0}
{"pair_id":"BioInfer.d558.s1.p1","sentence":"alpha-Sm actin inhibition also led to the formation of less prominent focal adhesions as revealed by immunofluorescence staining against vinculin, @PROTEIN1$, and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d558.s1.p2","sentence":"alpha-Sm actin inhibition also led to the formation of less prominent focal adhesions as revealed by immunofluorescence staining against @PROTEIN2$, @PROTEIN1$, and beta1-integrin.","label":0}
{"pair_id":"BioInfer.d558.s1.p3","sentence":"@PROTEIN1$ inhibition also led to the formation of less prominent focal adhesions as revealed by immunofluorescence staining against vinculin, talin, and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d558.s1.p4","sentence":"@PROTEIN1$ inhibition also led to the formation of less prominent focal adhesions as revealed by immunofluorescence staining against @PROTEIN2$, talin, and beta1-integrin.","label":0}
{"pair_id":"BioInfer.d558.s1.p5","sentence":"alpha-Sm actin inhibition also led to the formation of less prominent focal adhesions as revealed by immunofluorescence staining against @PROTEIN2$, talin, and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d695.s0.p0","sentence":"These data suggest that nuclear @PROTEIN2$ can mediate a stimulus-response action on the @PROTEIN1$ cytoskeleton which is somehow linked to a phosphoinositide-signaling cascade.","label":1}
{"pair_id":"BioInfer.d805.s0.p0","sentence":"We found normal levels of @PROTEIN2$ and @PROTEIN1$ in BT549 and HS578t cells; however, low levels of plakoglobin were expressed in these cells compared to those found in weakly invasive MCF-7 cells.","label":0}
{"pair_id":"BioInfer.d805.s0.p1","sentence":"We found normal levels of alpha-catenin and @PROTEIN1$ in BT549 and HS578t cells; however, low levels of @PROTEIN2$ were expressed in these cells compared to those found in weakly invasive MCF-7 cells.","label":0}
{"pair_id":"BioInfer.d805.s0.p2","sentence":"We found normal levels of @PROTEIN1$ and beta-catenin in BT549 and HS578t cells; however, low levels of @PROTEIN2$ were expressed in these cells compared to those found in weakly invasive MCF-7 cells.","label":0}
{"pair_id":"AIMed.d123.s1047.p0","sentence":"We demonstrate that @PROTEIN1$ forms a specific complex with the cytoplasmic domain of the @PROTEIN2$ when both are expressed as hybrid proteins in yeast cells.","label":1}
{"pair_id":"AIMed.d204.s1757.p0","sentence":"Here, we describe the production of @PROTEIN1$ (@PROTEIN2$) and wild-type and mutant human collagenase type I (rMMP-1) proteins in SF9 cells by the baculovirus expression system.","label":0}
{"pair_id":"AIMed.d204.s1757.p1","sentence":"Here, we describe the production of @PROTEIN1$ (rTIMP-1) and wild-type and mutant human @PROTEIN2$ (rMMP-1) proteins in SF9 cells by the baculovirus expression system.","label":0}
{"pair_id":"AIMed.d204.s1757.p2","sentence":"Here, we describe the production of @PROTEIN1$ (rTIMP-1) and wild-type and mutant human collagenase type I (@PROTEIN2$) proteins in SF9 cells by the baculovirus expression system.","label":0}
{"pair_id":"AIMed.d204.s1757.p3","sentence":"Here, we describe the production of recombinant human tissue inhibitor of metalloproteinases-1 (@PROTEIN1$) and wild-type and mutant human @PROTEIN2$ (rMMP-1) proteins in SF9 cells by the baculovirus expression system.","label":0}
{"pair_id":"AIMed.d204.s1757.p4","sentence":"Here, we describe the production of recombinant human tissue inhibitor of metalloproteinases-1 (@PROTEIN1$) and wild-type and mutant human collagenase type I (@PROTEIN2$) proteins in SF9 cells by the baculovirus expression system.","label":0}
{"pair_id":"AIMed.d204.s1757.p5","sentence":"Here, we describe the production of recombinant human tissue inhibitor of metalloproteinases-1 (rTIMP-1) and wild-type and mutant human @PROTEIN1$ (@PROTEIN2$) proteins in SF9 cells by the baculovirus expression system.","label":0}
{"pair_id":"AIMed.d152.s1291.p0","sentence":"@PROTEIN1$-@PROTEIN2$ and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways.","label":1}
{"pair_id":"AIMed.d152.s1291.p1","sentence":"@PROTEIN1$-TRAF2 and @PROTEIN2$-FADD interactions define two distinct TNF receptor 1 signal transduction pathways.","label":0}
{"pair_id":"AIMed.d152.s1291.p2","sentence":"@PROTEIN1$-TRAF2 and TRADD-@PROTEIN2$ interactions define two distinct TNF receptor 1 signal transduction pathways.","label":0}
{"pair_id":"AIMed.d152.s1291.p3","sentence":"@PROTEIN1$-TRAF2 and TRADD-FADD interactions define two distinct @PROTEIN2$ signal transduction pathways.","label":0}
{"pair_id":"AIMed.d152.s1291.p4","sentence":"TRADD-@PROTEIN1$ and @PROTEIN2$-FADD interactions define two distinct TNF receptor 1 signal transduction pathways.","label":0}
{"pair_id":"AIMed.d152.s1291.p5","sentence":"TRADD-@PROTEIN1$ and TRADD-@PROTEIN2$ interactions define two distinct TNF receptor 1 signal transduction pathways.","label":0}
{"pair_id":"AIMed.d152.s1291.p6","sentence":"TRADD-@PROTEIN1$ and TRADD-FADD interactions define two distinct @PROTEIN2$ signal transduction pathways.","label":0}
{"pair_id":"AIMed.d152.s1291.p7","sentence":"TRADD-TRAF2 and @PROTEIN1$-@PROTEIN2$ interactions define two distinct TNF receptor 1 signal transduction pathways.","label":1}
{"pair_id":"AIMed.d152.s1291.p8","sentence":"TRADD-TRAF2 and @PROTEIN1$-FADD interactions define two distinct @PROTEIN2$ signal transduction pathways.","label":0}
{"pair_id":"AIMed.d152.s1291.p9","sentence":"TRADD-TRAF2 and TRADD-@PROTEIN1$ interactions define two distinct @PROTEIN2$ signal transduction pathways.","label":0}
{"pair_id":"AIMed.d160.s1344.p0","sentence":"@PROTEIN1$ (@PROTEIN2$) expression in various cell types is induced by hypoxia and other stimuli.","label":0}
{"pair_id":"BioInfer.d311.s0.p0","sentence":"In addition to their role in mismatch repair (MMR), the @PROTEIN1$ and @PROTEIN2$ gene products are required to remove 3' nonhomologous DNA tails during genetic recombination.","label":0}
{"pair_id":"BioInfer.d437.s1.p0","sentence":"pH control of @PROTEIN2$ polymerization by @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d388.s2.p0","sentence":"The @PROTEIN1$ monomer-binding protein, profilin, influences the dynamics of actin filaments in vitro by suppressing nucleation, enhancing nucleotide exchange on @PROTEIN2$, and promoting barbed-end assembly.","label":0}
{"pair_id":"BioInfer.d388.s2.p1","sentence":"The @PROTEIN1$ monomer-binding protein, profilin, influences the dynamics of @PROTEIN2$ filaments in vitro by suppressing nucleation, enhancing nucleotide exchange on actin, and promoting barbed-end assembly.","label":0}
{"pair_id":"BioInfer.d388.s2.p2","sentence":"The @PROTEIN1$ monomer-binding protein, @PROTEIN2$, influences the dynamics of actin filaments in vitro by suppressing nucleation, enhancing nucleotide exchange on actin, and promoting barbed-end assembly.","label":1}
{"pair_id":"BioInfer.d388.s2.p3","sentence":"The actin monomer-binding protein, profilin, influences the dynamics of @PROTEIN2$ filaments in vitro by suppressing nucleation, enhancing nucleotide exchange on @PROTEIN1$, and promoting barbed-end assembly.","label":1}
{"pair_id":"BioInfer.d388.s2.p4","sentence":"The actin monomer-binding protein, @PROTEIN2$, influences the dynamics of actin filaments in vitro by suppressing nucleation, enhancing nucleotide exchange on @PROTEIN1$, and promoting barbed-end assembly.","label":1}
{"pair_id":"BioInfer.d388.s2.p5","sentence":"The actin monomer-binding protein, @PROTEIN2$, influences the dynamics of @PROTEIN1$ filaments in vitro by suppressing nucleation, enhancing nucleotide exchange on actin, and promoting barbed-end assembly.","label":1}
{"pair_id":"AIMed.d113.s956.p0","sentence":"Using a protein interaction cloning technique, we identified cDNAs that encode a novel @PROTEIN1$@PROTEIN2$, termed BAG-1.","label":0}
{"pair_id":"AIMed.d113.s956.p1","sentence":"Using a protein interaction cloning technique, we identified cDNAs that encode a novel @PROTEIN1$-binding protein, termed @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d113.s956.p2","sentence":"Using a protein interaction cloning technique, we identified cDNAs that encode a novel @PROTEIN1$, termed @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d31.s0.p0","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three @PROTEIN2$ H3 variants and @PROTEIN1$ H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p1","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: @PROTEIN2$ H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and @PROTEIN1$ H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p2","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, @PROTEIN2$ H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and @PROTEIN1$ H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p3","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, @PROTEIN2$ H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and @PROTEIN1$ H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p4","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four @PROTEIN2$ H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and @PROTEIN1$ H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p5","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, @PROTEIN2$ H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and @PROTEIN1$ H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p6","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, @PROTEIN2$ H2B, three histone H3 variants and @PROTEIN1$ H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p7","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, @PROTEIN2$ H2A.Z, histone H2B, three histone H3 variants and @PROTEIN1$ H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p8","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone @PROTEIN2$ variants and @PROTEIN1$ H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p9","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone @PROTEIN2$, three histone H3 variants and @PROTEIN1$ H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p10","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and @PROTEIN1$ @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d31.s0.p11","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized @PROTEIN2$ H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and @PROTEIN1$ H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p12","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone @PROTEIN2$, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and @PROTEIN1$ H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p13","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone @PROTEIN2$ subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and @PROTEIN1$ H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p14","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone @PROTEIN2$, four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and @PROTEIN1$ H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p15","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified @PROTEIN2$ were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and @PROTEIN1$ H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p16","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone @PROTEIN2$, histone H2B, three histone H3 variants and @PROTEIN1$ H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p17","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone @PROTEIN2$, histone H2A.Z, histone H2B, three histone H3 variants and @PROTEIN1$ H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p18","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone @PROTEIN2$, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and @PROTEIN1$ H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p19","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone @PROTEIN2$, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and @PROTEIN1$ H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p20","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: @PROTEIN2$ H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three @PROTEIN1$ H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p21","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, @PROTEIN2$ H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three @PROTEIN1$ H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p22","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, @PROTEIN2$ H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three @PROTEIN1$ H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p23","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four @PROTEIN2$ H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three @PROTEIN1$ H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p24","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, @PROTEIN2$ H2A.X, histone H2A.Z, histone H2B, three @PROTEIN1$ H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p25","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, @PROTEIN2$ H2B, three @PROTEIN1$ H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p26","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, @PROTEIN2$ H2A.Z, histone H2B, three @PROTEIN1$ H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p27","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three @PROTEIN1$ @PROTEIN2$ variants and histone H4.","label":1}
{"pair_id":"BioInfer.d31.s0.p28","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone @PROTEIN2$, three @PROTEIN1$ H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p29","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three @PROTEIN1$ H3 variants and histone @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d31.s0.p30","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized @PROTEIN2$ H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three @PROTEIN1$ H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p31","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone @PROTEIN2$, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three @PROTEIN1$ H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p32","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone @PROTEIN2$ subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three @PROTEIN1$ H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p33","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone @PROTEIN2$, four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three @PROTEIN1$ H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p34","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified @PROTEIN2$ were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three @PROTEIN1$ H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p35","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone @PROTEIN2$, histone H2B, three @PROTEIN1$ H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p36","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone @PROTEIN2$, histone H2A.Z, histone H2B, three @PROTEIN1$ H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p37","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone @PROTEIN2$, histone H2A.X, histone H2A.Z, histone H2B, three @PROTEIN1$ H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p38","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone @PROTEIN2$, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three @PROTEIN1$ H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p39","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: @PROTEIN1$ H1(0), four histone H1 subfractions, histone H2A.1, @PROTEIN2$ H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p40","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: @PROTEIN1$ H1(0), four histone H1 subfractions, @PROTEIN2$ H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p41","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: @PROTEIN1$ H1(0), four @PROTEIN2$ H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p42","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: @PROTEIN1$ H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, @PROTEIN2$ H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p43","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: @PROTEIN1$ H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, @PROTEIN2$ H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p44","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: @PROTEIN1$ H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, @PROTEIN2$ H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p45","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: @PROTEIN1$ H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone @PROTEIN2$ variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p46","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: @PROTEIN1$ H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone @PROTEIN2$, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p47","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: @PROTEIN1$ H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d31.s0.p48","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: @PROTEIN1$ H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized @PROTEIN2$ H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p49","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: @PROTEIN1$ H1(0), four histone H1 subfractions, histone @PROTEIN2$, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p50","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: @PROTEIN1$ H1(0), four histone @PROTEIN2$ subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p51","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: @PROTEIN1$ @PROTEIN2$, four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":1}
{"pair_id":"BioInfer.d31.s0.p52","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified @PROTEIN2$ were identified by HPLC and gel electrophoresis: @PROTEIN1$ H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p53","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: @PROTEIN1$ H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone @PROTEIN2$, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p54","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: @PROTEIN1$ H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone @PROTEIN2$, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p55","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: @PROTEIN1$ H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone @PROTEIN2$, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p56","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: @PROTEIN1$ H1(0), four histone H1 subfractions, histone H2A.1, histone @PROTEIN2$, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p57","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, @PROTEIN2$ H2A.1, @PROTEIN1$ H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p58","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four @PROTEIN2$ H1 subfractions, histone H2A.1, @PROTEIN1$ H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p59","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, @PROTEIN1$ H2A.2, oxidized histone H2A.2, @PROTEIN2$ H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p60","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, @PROTEIN1$ H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, @PROTEIN2$ H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p61","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, @PROTEIN1$ H2A.2, oxidized histone H2A.2, histone H2A.X, @PROTEIN2$ H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p62","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, @PROTEIN1$ H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone @PROTEIN2$ variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p63","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, @PROTEIN1$ H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone @PROTEIN2$, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p64","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, @PROTEIN1$ H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d31.s0.p65","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, @PROTEIN1$ H2A.2, oxidized @PROTEIN2$ H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p66","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone @PROTEIN2$, @PROTEIN1$ H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p67","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone @PROTEIN2$ subfractions, histone H2A.1, @PROTEIN1$ H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p68","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone @PROTEIN2$, four histone H1 subfractions, histone H2A.1, @PROTEIN1$ H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p69","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified @PROTEIN2$ were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, @PROTEIN1$ H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p70","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, @PROTEIN1$ H2A.2, oxidized histone H2A.2, histone H2A.X, histone @PROTEIN2$, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p71","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, @PROTEIN1$ H2A.2, oxidized histone H2A.2, histone @PROTEIN2$, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p72","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, @PROTEIN1$ H2A.2, oxidized histone @PROTEIN2$, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p73","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, @PROTEIN1$ @PROTEIN2$, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":1}
{"pair_id":"BioInfer.d31.s0.p74","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four @PROTEIN2$ H1 subfractions, @PROTEIN1$ H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p75","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, @PROTEIN1$ H2A.1, histone H2A.2, oxidized histone H2A.2, @PROTEIN2$ H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p76","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, @PROTEIN1$ H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, @PROTEIN2$ H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p77","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, @PROTEIN1$ H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, @PROTEIN2$ H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p78","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, @PROTEIN1$ H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone @PROTEIN2$ variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p79","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, @PROTEIN1$ H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone @PROTEIN2$, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p80","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, @PROTEIN1$ H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d31.s0.p81","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, @PROTEIN1$ H2A.1, histone H2A.2, oxidized @PROTEIN2$ H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p82","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, @PROTEIN1$ @PROTEIN2$, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":1}
{"pair_id":"BioInfer.d31.s0.p83","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone @PROTEIN2$ subfractions, @PROTEIN1$ H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p84","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone @PROTEIN2$, four histone H1 subfractions, @PROTEIN1$ H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p85","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified @PROTEIN2$ were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, @PROTEIN1$ H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p86","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, @PROTEIN1$ H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone @PROTEIN2$, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p87","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, @PROTEIN1$ H2A.1, histone H2A.2, oxidized histone H2A.2, histone @PROTEIN2$, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p88","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, @PROTEIN1$ H2A.1, histone H2A.2, oxidized histone @PROTEIN2$, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p89","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, @PROTEIN1$ H2A.1, histone @PROTEIN2$, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p90","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four @PROTEIN1$ H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, @PROTEIN2$ H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p91","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four @PROTEIN1$ H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, @PROTEIN2$ H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p92","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four @PROTEIN1$ H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, @PROTEIN2$ H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p93","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four @PROTEIN1$ H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone @PROTEIN2$ variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p94","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four @PROTEIN1$ H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone @PROTEIN2$, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p95","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four @PROTEIN1$ H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d31.s0.p96","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four @PROTEIN1$ H1 subfractions, histone H2A.1, histone H2A.2, oxidized @PROTEIN2$ H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p97","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four @PROTEIN1$ H1 subfractions, histone @PROTEIN2$, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p98","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four @PROTEIN1$ @PROTEIN2$ subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":1}
{"pair_id":"BioInfer.d31.s0.p99","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone @PROTEIN2$, four @PROTEIN1$ H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p100","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified @PROTEIN2$ were identified by HPLC and gel electrophoresis: histone H1(0), four @PROTEIN1$ H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p101","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four @PROTEIN1$ H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone @PROTEIN2$, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p102","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four @PROTEIN1$ H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone @PROTEIN2$, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p103","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four @PROTEIN1$ H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone @PROTEIN2$, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p104","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four @PROTEIN1$ H1 subfractions, histone H2A.1, histone @PROTEIN2$, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p105","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, @PROTEIN1$ H2A.X, histone H2A.Z, @PROTEIN2$ H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p106","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, @PROTEIN1$ H2A.X, @PROTEIN2$ H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p107","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, @PROTEIN1$ H2A.X, histone H2A.Z, histone H2B, three histone @PROTEIN2$ variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p108","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, @PROTEIN1$ H2A.X, histone H2A.Z, histone @PROTEIN2$, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p109","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, @PROTEIN1$ H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d31.s0.p110","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized @PROTEIN2$ H2A.2, @PROTEIN1$ H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p111","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone @PROTEIN2$, histone H2A.2, oxidized histone H2A.2, @PROTEIN1$ H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p112","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone @PROTEIN2$ subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, @PROTEIN1$ H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p113","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone @PROTEIN2$, four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, @PROTEIN1$ H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p114","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified @PROTEIN2$ were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, @PROTEIN1$ H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p115","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, @PROTEIN1$ H2A.X, histone @PROTEIN2$, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p116","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, @PROTEIN1$ @PROTEIN2$, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":1}
{"pair_id":"BioInfer.d31.s0.p117","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone @PROTEIN2$, @PROTEIN1$ H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p118","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone @PROTEIN2$, oxidized histone H2A.2, @PROTEIN1$ H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p119","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, @PROTEIN2$ H2A.Z, @PROTEIN1$ H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p120","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, @PROTEIN1$ H2B, three histone @PROTEIN2$ variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p121","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, @PROTEIN1$ @PROTEIN2$, three histone H3 variants and histone H4.","label":1}
{"pair_id":"BioInfer.d31.s0.p122","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, @PROTEIN1$ H2B, three histone H3 variants and histone @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d31.s0.p123","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized @PROTEIN2$ H2A.2, histone H2A.X, histone H2A.Z, @PROTEIN1$ H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p124","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone @PROTEIN2$, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, @PROTEIN1$ H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p125","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone @PROTEIN2$ subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, @PROTEIN1$ H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p126","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone @PROTEIN2$, four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, @PROTEIN1$ H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p127","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified @PROTEIN2$ were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, @PROTEIN1$ H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p128","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone @PROTEIN2$, @PROTEIN1$ H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p129","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone @PROTEIN2$, histone H2A.Z, @PROTEIN1$ H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p130","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone @PROTEIN2$, histone H2A.X, histone H2A.Z, @PROTEIN1$ H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p131","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone @PROTEIN2$, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, @PROTEIN1$ H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p132","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, @PROTEIN1$ H2A.Z, histone H2B, three histone @PROTEIN2$ variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p133","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, @PROTEIN1$ H2A.Z, histone @PROTEIN2$, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p134","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, @PROTEIN1$ H2A.Z, histone H2B, three histone H3 variants and histone @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d31.s0.p135","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized @PROTEIN2$ H2A.2, histone H2A.X, @PROTEIN1$ H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p136","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone @PROTEIN2$, histone H2A.2, oxidized histone H2A.2, histone H2A.X, @PROTEIN1$ H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p137","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone @PROTEIN2$ subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, @PROTEIN1$ H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p138","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone @PROTEIN2$, four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, @PROTEIN1$ H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p139","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified @PROTEIN2$ were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, @PROTEIN1$ H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p140","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, @PROTEIN1$ @PROTEIN2$, histone H2B, three histone H3 variants and histone H4.","label":1}
{"pair_id":"BioInfer.d31.s0.p141","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone @PROTEIN2$, @PROTEIN1$ H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p142","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone @PROTEIN2$, histone H2A.X, @PROTEIN1$ H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p143","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone @PROTEIN2$, oxidized histone H2A.2, histone H2A.X, @PROTEIN1$ H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p144","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone @PROTEIN2$, three histone @PROTEIN1$ variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p145","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone @PROTEIN1$ variants and histone @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d31.s0.p146","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized @PROTEIN2$ H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone @PROTEIN1$ variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p147","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone @PROTEIN2$, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone @PROTEIN1$ variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p148","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone @PROTEIN2$ subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone @PROTEIN1$ variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p149","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone @PROTEIN2$, four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone @PROTEIN1$ variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p150","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified @PROTEIN2$ were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone @PROTEIN1$ variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p151","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone @PROTEIN2$, histone H2B, three histone @PROTEIN1$ variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p152","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone @PROTEIN2$, histone H2A.Z, histone H2B, three histone @PROTEIN1$ variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p153","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone @PROTEIN2$, histone H2A.X, histone H2A.Z, histone H2B, three histone @PROTEIN1$ variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p154","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone @PROTEIN2$, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone @PROTEIN1$ variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p155","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone @PROTEIN1$, three histone H3 variants and histone @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d31.s0.p156","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized @PROTEIN2$ H2A.2, histone H2A.X, histone H2A.Z, histone @PROTEIN1$, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p157","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone @PROTEIN2$, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone @PROTEIN1$, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p158","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone @PROTEIN2$ subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone @PROTEIN1$, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p159","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone @PROTEIN2$, four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone @PROTEIN1$, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p160","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified @PROTEIN2$ were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone @PROTEIN1$, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p161","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone @PROTEIN2$, histone @PROTEIN1$, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p162","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone @PROTEIN2$, histone H2A.Z, histone @PROTEIN1$, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p163","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone @PROTEIN2$, histone H2A.X, histone H2A.Z, histone @PROTEIN1$, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p164","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone @PROTEIN2$, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone @PROTEIN1$, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p165","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized @PROTEIN2$ H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d31.s0.p166","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone @PROTEIN2$, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d31.s0.p167","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone @PROTEIN2$ subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d31.s0.p168","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone @PROTEIN2$, four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d31.s0.p169","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified @PROTEIN2$ were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d31.s0.p170","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone @PROTEIN2$, histone H2B, three histone H3 variants and histone @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d31.s0.p171","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone @PROTEIN2$, histone H2A.Z, histone H2B, three histone H3 variants and histone @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d31.s0.p172","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone @PROTEIN2$, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d31.s0.p173","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone @PROTEIN2$, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d31.s0.p174","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone @PROTEIN2$, histone H2A.2, oxidized @PROTEIN1$ H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p175","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone @PROTEIN2$ subfractions, histone H2A.1, histone H2A.2, oxidized @PROTEIN1$ H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p176","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone @PROTEIN2$, four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized @PROTEIN1$ H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p177","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified @PROTEIN2$ were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized @PROTEIN1$ H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p178","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized @PROTEIN1$ H2A.2, histone H2A.X, histone @PROTEIN2$, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p179","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized @PROTEIN1$ H2A.2, histone @PROTEIN2$, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p180","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized @PROTEIN1$ @PROTEIN2$, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":1}
{"pair_id":"BioInfer.d31.s0.p181","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone @PROTEIN2$, oxidized @PROTEIN1$ H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p182","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone @PROTEIN2$ subfractions, histone @PROTEIN1$, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p183","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone @PROTEIN2$, four histone H1 subfractions, histone @PROTEIN1$, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p184","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified @PROTEIN2$ were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone @PROTEIN1$, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p185","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone @PROTEIN1$, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone @PROTEIN2$, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p186","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone @PROTEIN1$, histone H2A.2, oxidized histone H2A.2, histone @PROTEIN2$, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p187","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone @PROTEIN1$, histone H2A.2, oxidized histone @PROTEIN2$, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p188","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone @PROTEIN1$, histone @PROTEIN2$, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p189","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone @PROTEIN2$, four histone @PROTEIN1$ subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p190","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified @PROTEIN2$ were identified by HPLC and gel electrophoresis: histone H1(0), four histone @PROTEIN1$ subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p191","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone @PROTEIN1$ subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone @PROTEIN2$, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p192","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone @PROTEIN1$ subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone @PROTEIN2$, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p193","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone @PROTEIN1$ subfractions, histone H2A.1, histone H2A.2, oxidized histone @PROTEIN2$, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p194","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone @PROTEIN1$ subfractions, histone H2A.1, histone @PROTEIN2$, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p195","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified @PROTEIN2$ were identified by HPLC and gel electrophoresis: histone @PROTEIN1$, four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p196","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone @PROTEIN1$, four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone @PROTEIN2$, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p197","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone @PROTEIN1$, four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone @PROTEIN2$, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p198","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone @PROTEIN1$, four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone @PROTEIN2$, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p199","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone @PROTEIN1$, four histone H1 subfractions, histone H2A.1, histone @PROTEIN2$, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p200","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified @PROTEIN1$ were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone @PROTEIN2$, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p201","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified @PROTEIN1$ were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone @PROTEIN2$, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p202","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified @PROTEIN1$ were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone @PROTEIN2$, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p203","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified @PROTEIN1$ were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone @PROTEIN2$, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p204","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone @PROTEIN2$, histone @PROTEIN1$, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p205","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone @PROTEIN2$, histone H2A.X, histone @PROTEIN1$, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p206","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone @PROTEIN2$, oxidized histone H2A.2, histone H2A.X, histone @PROTEIN1$, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p207","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone @PROTEIN2$, histone @PROTEIN1$, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p208","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone @PROTEIN2$, oxidized histone H2A.2, histone @PROTEIN1$, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p209","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone @PROTEIN2$, oxidized histone @PROTEIN1$, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d597.s0.p0","sentence":"The concentration of @PROTEIN2$ was constant during the follicular phase, whereas the content of @PROTEIN1$ decreased in granulosa cells after treatment with diethylstilboestrol or hCG.","label":0}
{"pair_id":"AIMed.d129.s1101.p0","sentence":"Immunoprecipitation of unactivated avian progesterone receptor results in the copurification of @PROTEIN1$, @PROTEIN2$, and three additional proteins, p54, p50, and p23.","label":0}
{"pair_id":"AIMed.d129.s1101.p1","sentence":"Immunoprecipitation of unactivated avian progesterone receptor results in the copurification of @PROTEIN1$, hsp70, and three additional proteins, @PROTEIN2$, p50, and p23.","label":0}
{"pair_id":"AIMed.d129.s1101.p2","sentence":"Immunoprecipitation of unactivated avian progesterone receptor results in the copurification of @PROTEIN1$, hsp70, and three additional proteins, p54, @PROTEIN2$, and p23.","label":0}
{"pair_id":"AIMed.d129.s1101.p3","sentence":"Immunoprecipitation of unactivated avian progesterone receptor results in the copurification of @PROTEIN1$, hsp70, and three additional proteins, p54, p50, and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d129.s1101.p4","sentence":"Immunoprecipitation of unactivated avian progesterone receptor results in the copurification of hsp90, @PROTEIN1$, and three additional proteins, @PROTEIN2$, p50, and p23.","label":0}
{"pair_id":"AIMed.d129.s1101.p5","sentence":"Immunoprecipitation of unactivated avian progesterone receptor results in the copurification of hsp90, @PROTEIN1$, and three additional proteins, p54, @PROTEIN2$, and p23.","label":0}
{"pair_id":"AIMed.d129.s1101.p6","sentence":"Immunoprecipitation of unactivated avian progesterone receptor results in the copurification of hsp90, @PROTEIN1$, and three additional proteins, p54, p50, and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d129.s1101.p7","sentence":"Immunoprecipitation of unactivated avian progesterone receptor results in the copurification of hsp90, hsp70, and three additional proteins, @PROTEIN1$, @PROTEIN2$, and p23.","label":0}
{"pair_id":"AIMed.d129.s1101.p8","sentence":"Immunoprecipitation of unactivated avian progesterone receptor results in the copurification of hsp90, hsp70, and three additional proteins, @PROTEIN1$, p50, and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d129.s1101.p9","sentence":"Immunoprecipitation of unactivated avian progesterone receptor results in the copurification of hsp90, hsp70, and three additional proteins, p54, @PROTEIN1$, and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d678.s0.p0","sentence":"The radioresistant N10 and parental KB cell lines were examined for the expression of human DNA repair genes which were related to the repair of radiation-induced DNA damage by northern blot analysis using five kinds of DNA probes (@PROTEIN2$, XRCC3, @PROTEIN1$, RAD51, RAD52).","label":0}
{"pair_id":"BioInfer.d678.s0.p1","sentence":"The radioresistant N10 and parental KB cell lines were examined for the expression of human DNA repair genes which were related to the repair of radiation-induced DNA damage by northern blot analysis using five kinds of DNA probes (XRCC1, XRCC3, @PROTEIN1$, RAD51, @PROTEIN2$).","label":0}
{"pair_id":"BioInfer.d678.s0.p2","sentence":"The radioresistant N10 and parental KB cell lines were examined for the expression of human DNA repair genes which were related to the repair of radiation-induced DNA damage by northern blot analysis using five kinds of DNA probes (XRCC1, @PROTEIN2$, @PROTEIN1$, RAD51, RAD52).","label":0}
{"pair_id":"BioInfer.d678.s0.p3","sentence":"The radioresistant N10 and parental KB cell lines were examined for the expression of human DNA repair genes which were related to the repair of radiation-induced DNA damage by northern blot analysis using five kinds of DNA probes (XRCC1, XRCC3, @PROTEIN1$, @PROTEIN2$, RAD52).","label":0}
{"pair_id":"BioInfer.d678.s0.p4","sentence":"The radioresistant N10 and parental KB cell lines were examined for the expression of human DNA repair genes which were related to the repair of radiation-induced DNA damage by northern blot analysis using five kinds of DNA probes (@PROTEIN1$, XRCC3, XRCC5, RAD51, @PROTEIN2$).","label":0}
{"pair_id":"BioInfer.d678.s0.p5","sentence":"The radioresistant N10 and parental KB cell lines were examined for the expression of human DNA repair genes which were related to the repair of radiation-induced DNA damage by northern blot analysis using five kinds of DNA probes (@PROTEIN1$, @PROTEIN2$, XRCC5, RAD51, RAD52).","label":0}
{"pair_id":"BioInfer.d678.s0.p6","sentence":"The radioresistant N10 and parental KB cell lines were examined for the expression of human DNA repair genes which were related to the repair of radiation-induced DNA damage by northern blot analysis using five kinds of DNA probes (@PROTEIN1$, XRCC3, XRCC5, @PROTEIN2$, RAD52).","label":0}
{"pair_id":"BioInfer.d678.s0.p7","sentence":"The radioresistant N10 and parental KB cell lines were examined for the expression of human DNA repair genes which were related to the repair of radiation-induced DNA damage by northern blot analysis using five kinds of DNA probes (XRCC1, @PROTEIN2$, XRCC5, RAD51, @PROTEIN1$).","label":0}
{"pair_id":"BioInfer.d678.s0.p8","sentence":"The radioresistant N10 and parental KB cell lines were examined for the expression of human DNA repair genes which were related to the repair of radiation-induced DNA damage by northern blot analysis using five kinds of DNA probes (XRCC1, XRCC3, XRCC5, @PROTEIN2$, @PROTEIN1$).","label":0}
{"pair_id":"BioInfer.d678.s0.p9","sentence":"The radioresistant N10 and parental KB cell lines were examined for the expression of human DNA repair genes which were related to the repair of radiation-induced DNA damage by northern blot analysis using five kinds of DNA probes (XRCC1, @PROTEIN1$, XRCC5, @PROTEIN2$, RAD52).","label":0}
{"pair_id":"BioInfer.d740.s0.p0","sentence":"This is consistent with @PROTEIN1$ activation being required for @PROTEIN2$ reorganization during exocytosis.","label":1}
{"pair_id":"AIMed.d117.s990.p0","sentence":"@PROTEIN1$ complexes in which an @PROTEIN2$ chain occupies each receptor subunit.","label":0}
{"pair_id":"BioInfer.d543.s0.p0","sentence":"@PROTEIN2$, which consists of a full length myosin heavy chain and a tagged tail, was isolated on the basis of the affinities for Nickel agarose and @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d543.s0.p1","sentence":"Single-headed myosin, which consists of a full length @PROTEIN2$ and a tagged tail, was isolated on the basis of the affinities for Nickel agarose and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d543.s0.p2","sentence":"@PROTEIN1$, which consists of a full length @PROTEIN2$ and a tagged tail, was isolated on the basis of the affinities for Nickel agarose and actin.","label":1}
{"pair_id":"AIMed.d36.s301.p0","sentence":"Molecular determinants of the interaction between the C-terminal domain of Alzheimer's @PROTEIN1$ and @PROTEIN2$ alpha-helices.","label":1}
{"pair_id":"AIMed.d148.s1252.p0","sentence":".Originally identified as a 'mitotic cyclin', @PROTEIN1$ exhibits properties of growth factor sensitivity, susceptibility to viral subversion and association with a tumor-suppressor protein, properties which are indicative of an @PROTEIN2$ (SPF) as well as a candidate proto-oncogene.","label":0}
{"pair_id":"AIMed.d148.s1252.p1","sentence":".Originally identified as a 'mitotic cyclin', @PROTEIN1$ exhibits properties of growth factor sensitivity, susceptibility to viral subversion and association with a tumor-suppressor protein, properties which are indicative of an S-phase-promoting factor (@PROTEIN2$) as well as a candidate proto-oncogene.","label":0}
{"pair_id":"AIMed.d148.s1252.p2","sentence":".Originally identified as a 'mitotic cyclin', cyclin A exhibits properties of growth factor sensitivity, susceptibility to viral subversion and association with a tumor-suppressor protein, properties which are indicative of an @PROTEIN1$ (@PROTEIN2$) as well as a candidate proto-oncogene.","label":0}
{"pair_id":"BioInfer.d662.s0.p0","sentence":"The posttranslational metabolism of @PROTEIN1$ (@PROTEIN2$) and actin was regulated in parallel with the total contractile protein pool.","label":0}
{"pair_id":"BioInfer.d662.s0.p1","sentence":"The posttranslational metabolism of @PROTEIN1$ (MHC) and @PROTEIN2$ was regulated in parallel with the total contractile protein pool.","label":0}
{"pair_id":"BioInfer.d662.s0.p2","sentence":"The posttranslational metabolism of myosin heavy chain (@PROTEIN1$) and @PROTEIN2$ was regulated in parallel with the total contractile protein pool.","label":0}
{"pair_id":"AIMed.d69.s589.p0","sentence":"Activation of @PROTEIN1$ results in rapid, site-specific dephosphorylation of @PROTEIN2$ at one or more of these three sites and is coincident with increased AP-1-binding activity.","label":1}
{"pair_id":"AIMed.d69.s589.p1","sentence":"Activation of @PROTEIN1$ results in rapid, site-specific dephosphorylation of c-Jun at one or more of these three sites and is coincident with increased @PROTEIN2$-binding activity.","label":0}
{"pair_id":"AIMed.d69.s589.p2","sentence":"Activation of protein kinase C results in rapid, site-specific dephosphorylation of @PROTEIN1$ at one or more of these three sites and is coincident with increased @PROTEIN2$-binding activity.","label":0}
{"pair_id":"BioInfer.d264.s0.p0","sentence":"@PROTEIN2$ H3 showed at least seven sites of acetylation, histone H2B.1 had six sites and @PROTEIN1$ H4 had five sites.","label":0}
{"pair_id":"BioInfer.d264.s0.p1","sentence":"Histone H3 showed at least seven sites of acetylation, histone @PROTEIN2$ had six sites and @PROTEIN1$ H4 had five sites.","label":0}
{"pair_id":"BioInfer.d264.s0.p2","sentence":"Histone H3 showed at least seven sites of acetylation, @PROTEIN2$ H2B.1 had six sites and @PROTEIN1$ H4 had five sites.","label":0}
{"pair_id":"BioInfer.d264.s0.p3","sentence":"Histone H3 showed at least seven sites of acetylation, histone H2B.1 had six sites and @PROTEIN1$ @PROTEIN2$ had five sites.","label":1}
{"pair_id":"BioInfer.d264.s0.p4","sentence":"Histone @PROTEIN2$ showed at least seven sites of acetylation, histone H2B.1 had six sites and @PROTEIN1$ H4 had five sites.","label":0}
{"pair_id":"BioInfer.d264.s0.p5","sentence":"@PROTEIN1$ H3 showed at least seven sites of acetylation, histone @PROTEIN2$ had six sites and histone H4 had five sites.","label":0}
{"pair_id":"BioInfer.d264.s0.p6","sentence":"@PROTEIN1$ H3 showed at least seven sites of acetylation, @PROTEIN2$ H2B.1 had six sites and histone H4 had five sites.","label":0}
{"pair_id":"BioInfer.d264.s0.p7","sentence":"@PROTEIN1$ H3 showed at least seven sites of acetylation, histone H2B.1 had six sites and histone @PROTEIN2$ had five sites.","label":0}
{"pair_id":"BioInfer.d264.s0.p8","sentence":"@PROTEIN1$ @PROTEIN2$ showed at least seven sites of acetylation, histone H2B.1 had six sites and histone H4 had five sites.","label":1}
{"pair_id":"BioInfer.d264.s0.p9","sentence":"Histone H3 showed at least seven sites of acetylation, @PROTEIN2$ @PROTEIN1$ had six sites and histone H4 had five sites.","label":1}
{"pair_id":"BioInfer.d264.s0.p10","sentence":"Histone H3 showed at least seven sites of acetylation, histone @PROTEIN1$ had six sites and histone @PROTEIN2$ had five sites.","label":0}
{"pair_id":"BioInfer.d264.s0.p11","sentence":"Histone @PROTEIN2$ showed at least seven sites of acetylation, histone @PROTEIN1$ had six sites and histone H4 had five sites.","label":0}
{"pair_id":"BioInfer.d264.s0.p12","sentence":"Histone H3 showed at least seven sites of acetylation, @PROTEIN1$ H2B.1 had six sites and histone @PROTEIN2$ had five sites.","label":0}
{"pair_id":"BioInfer.d264.s0.p13","sentence":"Histone @PROTEIN2$ showed at least seven sites of acetylation, @PROTEIN1$ H2B.1 had six sites and histone H4 had five sites.","label":0}
{"pair_id":"BioInfer.d264.s0.p14","sentence":"Histone @PROTEIN2$ showed at least seven sites of acetylation, histone H2B.1 had six sites and histone @PROTEIN1$ had five sites.","label":0}
{"pair_id":"AIMed.d176.s1494.p0","sentence":"From these results, it appears that @PROTEIN1$ is a key mediator in the chaperoned assembly and functional maturation of @PROTEIN2$ complexes.","label":0}
{"pair_id":"BioInfer.d8.s1.p0","sentence":"In addition to its presence in cell-cell adhesion sites, we have found @PROTEIN1$, but not @PROTEIN2$, in the Z-discs of heart and skeletal striated muscles.","label":1}
{"pair_id":"AIMed.d115.s974.p0","sentence":"Further, @PROTEIN1$'s central charged cluster domain is required for binding to @PROTEIN2$'s activation domain.","label":0}
{"pair_id":"BioInfer.d282.s0.p0","sentence":"Human @PROTEIN2$, a talin-like @PROTEIN1$, binds selectively to mixed lipid bilayers.","label":1}
{"pair_id":"BioInfer.d282.s0.p1","sentence":"Human platelet P-235, a @PROTEIN2$-like @PROTEIN1$, binds selectively to mixed lipid bilayers.","label":0}
{"pair_id":"BioInfer.d282.s0.p2","sentence":"Human @PROTEIN1$, a @PROTEIN2$-like actin binding protein, binds selectively to mixed lipid bilayers.","label":1}
{"pair_id":"BioInfer.d33.s0.p0","sentence":"A highly significant correlation was observed between the loss of expression of @PROTEIN2$, @PROTEIN1$ and gamma-catenin, but not beta-catenin, with increased TNM stage (p <0.05).","label":1}
{"pair_id":"BioInfer.d33.s0.p1","sentence":"A highly significant correlation was observed between the loss of expression of E-cadherin, @PROTEIN1$ and gamma-catenin, but not @PROTEIN2$, with increased TNM stage (p <0.05).","label":1}
{"pair_id":"BioInfer.d33.s0.p2","sentence":"A highly significant correlation was observed between the loss of expression of E-cadherin, @PROTEIN1$ and @PROTEIN2$, but not beta-catenin, with increased TNM stage (p <0.05).","label":1}
{"pair_id":"BioInfer.d33.s0.p3","sentence":"A highly significant correlation was observed between the loss of expression of @PROTEIN1$, alpha-catenin and gamma-catenin, but not @PROTEIN2$, with increased TNM stage (p <0.05).","label":1}
{"pair_id":"BioInfer.d33.s0.p4","sentence":"A highly significant correlation was observed between the loss of expression of @PROTEIN1$, alpha-catenin and @PROTEIN2$, but not beta-catenin, with increased TNM stage (p <0.05).","label":1}
{"pair_id":"BioInfer.d33.s0.p5","sentence":"A highly significant correlation was observed between the loss of expression of E-cadherin, alpha-catenin and @PROTEIN2$, but not @PROTEIN1$, with increased TNM stage (p <0.05).","label":1}
{"pair_id":"BioInfer.d461.s0.p0","sentence":"One, @PROTEIN2$ (also called FADD), binds to Fas\/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas\/@PROTEIN1$; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p1","sentence":"One, MORT1 (also called FADD), binds to Fas\/APO1 but not to p55-R; another, @PROTEIN2$, binds to the p55 TNF receptor but not to Fas\/@PROTEIN1$; and the third, RIP, binds weakly to both receptors.","label":1}
{"pair_id":"BioInfer.d461.s0.p2","sentence":"One, MORT1 (also called FADD), binds to Fas\/APO1 but not to @PROTEIN2$; another, TRADD, binds to the p55 TNF receptor but not to Fas\/@PROTEIN1$; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p3","sentence":"One, MORT1 (also called @PROTEIN2$), binds to Fas\/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas\/@PROTEIN1$; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p4","sentence":"One, MORT1 (also called FADD), binds to Fas\/@PROTEIN2$ but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas\/@PROTEIN1$; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p5","sentence":"One, MORT1 (also called FADD), binds to @PROTEIN2$\/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas\/@PROTEIN1$; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p6","sentence":"One, MORT1 (also called FADD), binds to Fas\/APO1 but not to p55-R; another, TRADD, binds to the p55 @PROTEIN2$ but not to Fas\/@PROTEIN1$; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p7","sentence":"One, MORT1 (also called FADD), binds to Fas\/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas\/@PROTEIN1$; and the third, @PROTEIN2$, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p8","sentence":"One, MORT1 (also called FADD), binds to Fas\/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to @PROTEIN2$\/@PROTEIN1$; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p9","sentence":"One, MORT1 (also called FADD), binds to Fas\/APO1 but not to p55-R; another, TRADD, binds to the @PROTEIN2$ TNF receptor but not to Fas\/@PROTEIN1$; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p10","sentence":"One, @PROTEIN1$ (also called FADD), binds to Fas\/APO1 but not to p55-R; another, @PROTEIN2$, binds to the p55 TNF receptor but not to Fas\/APO1; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p11","sentence":"One, @PROTEIN1$ (also called FADD), binds to Fas\/APO1 but not to @PROTEIN2$; another, TRADD, binds to the p55 TNF receptor but not to Fas\/APO1; and the third, RIP, binds weakly to both receptors.","label":1}
{"pair_id":"BioInfer.d461.s0.p12","sentence":"One, @PROTEIN1$ (also called @PROTEIN2$), binds to Fas\/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas\/APO1; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p13","sentence":"One, @PROTEIN1$ (also called FADD), binds to Fas\/@PROTEIN2$ but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas\/APO1; and the third, RIP, binds weakly to both receptors.","label":1}
{"pair_id":"BioInfer.d461.s0.p14","sentence":"One, @PROTEIN1$ (also called FADD), binds to @PROTEIN2$\/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas\/APO1; and the third, RIP, binds weakly to both receptors.","label":1}
{"pair_id":"BioInfer.d461.s0.p15","sentence":"One, @PROTEIN1$ (also called FADD), binds to Fas\/APO1 but not to p55-R; another, TRADD, binds to the p55 @PROTEIN2$ but not to Fas\/APO1; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p16","sentence":"One, @PROTEIN1$ (also called FADD), binds to Fas\/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas\/APO1; and the third, @PROTEIN2$, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p17","sentence":"One, @PROTEIN1$ (also called FADD), binds to Fas\/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to @PROTEIN2$\/APO1; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p18","sentence":"One, @PROTEIN1$ (also called FADD), binds to Fas\/APO1 but not to p55-R; another, TRADD, binds to the @PROTEIN2$ TNF receptor but not to Fas\/APO1; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p19","sentence":"One, MORT1 (also called FADD), binds to Fas\/APO1 but not to @PROTEIN2$; another, @PROTEIN1$, binds to the p55 TNF receptor but not to Fas\/APO1; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p20","sentence":"One, MORT1 (also called @PROTEIN2$), binds to Fas\/APO1 but not to p55-R; another, @PROTEIN1$, binds to the p55 TNF receptor but not to Fas\/APO1; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p21","sentence":"One, MORT1 (also called FADD), binds to Fas\/@PROTEIN2$ but not to p55-R; another, @PROTEIN1$, binds to the p55 TNF receptor but not to Fas\/APO1; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p22","sentence":"One, MORT1 (also called FADD), binds to @PROTEIN2$\/APO1 but not to p55-R; another, @PROTEIN1$, binds to the p55 TNF receptor but not to Fas\/APO1; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p23","sentence":"One, MORT1 (also called FADD), binds to Fas\/APO1 but not to p55-R; another, @PROTEIN1$, binds to the p55 @PROTEIN2$ but not to Fas\/APO1; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p24","sentence":"One, MORT1 (also called FADD), binds to Fas\/APO1 but not to p55-R; another, @PROTEIN1$, binds to the p55 TNF receptor but not to Fas\/APO1; and the third, @PROTEIN2$, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p25","sentence":"One, MORT1 (also called FADD), binds to Fas\/APO1 but not to p55-R; another, @PROTEIN1$, binds to the p55 TNF receptor but not to @PROTEIN2$\/APO1; and the third, RIP, binds weakly to both receptors.","label":1}
{"pair_id":"BioInfer.d461.s0.p26","sentence":"One, MORT1 (also called FADD), binds to Fas\/APO1 but not to p55-R; another, @PROTEIN1$, binds to the @PROTEIN2$ TNF receptor but not to Fas\/APO1; and the third, RIP, binds weakly to both receptors.","label":1}
{"pair_id":"BioInfer.d461.s0.p27","sentence":"One, MORT1 (also called @PROTEIN2$), binds to Fas\/APO1 but not to @PROTEIN1$; another, TRADD, binds to the p55 TNF receptor but not to Fas\/APO1; and the third, RIP, binds weakly to both receptors.","label":1}
{"pair_id":"BioInfer.d461.s0.p28","sentence":"One, MORT1 (also called FADD), binds to Fas\/@PROTEIN2$ but not to @PROTEIN1$; another, TRADD, binds to the p55 TNF receptor but not to Fas\/APO1; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p29","sentence":"One, MORT1 (also called FADD), binds to @PROTEIN2$\/APO1 but not to @PROTEIN1$; another, TRADD, binds to the p55 TNF receptor but not to Fas\/APO1; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p30","sentence":"One, MORT1 (also called FADD), binds to Fas\/APO1 but not to @PROTEIN1$; another, TRADD, binds to the p55 @PROTEIN2$ but not to Fas\/APO1; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p31","sentence":"One, MORT1 (also called FADD), binds to Fas\/APO1 but not to @PROTEIN1$; another, TRADD, binds to the p55 TNF receptor but not to Fas\/APO1; and the third, @PROTEIN2$, binds weakly to both receptors.","label":1}
{"pair_id":"BioInfer.d461.s0.p32","sentence":"One, MORT1 (also called FADD), binds to Fas\/APO1 but not to @PROTEIN1$; another, TRADD, binds to the p55 TNF receptor but not to @PROTEIN2$\/APO1; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p33","sentence":"One, MORT1 (also called FADD), binds to Fas\/APO1 but not to @PROTEIN1$; another, TRADD, binds to the @PROTEIN2$ TNF receptor but not to Fas\/APO1; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p34","sentence":"One, MORT1 (also called @PROTEIN1$), binds to Fas\/@PROTEIN2$ but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas\/APO1; and the third, RIP, binds weakly to both receptors.","label":1}
{"pair_id":"BioInfer.d461.s0.p35","sentence":"One, MORT1 (also called @PROTEIN1$), binds to @PROTEIN2$\/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas\/APO1; and the third, RIP, binds weakly to both receptors.","label":1}
{"pair_id":"BioInfer.d461.s0.p36","sentence":"One, MORT1 (also called @PROTEIN1$), binds to Fas\/APO1 but not to p55-R; another, TRADD, binds to the p55 @PROTEIN2$ but not to Fas\/APO1; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p37","sentence":"One, MORT1 (also called @PROTEIN1$), binds to Fas\/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas\/APO1; and the third, @PROTEIN2$, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p38","sentence":"One, MORT1 (also called @PROTEIN1$), binds to Fas\/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to @PROTEIN2$\/APO1; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p39","sentence":"One, MORT1 (also called @PROTEIN1$), binds to Fas\/APO1 but not to p55-R; another, TRADD, binds to the @PROTEIN2$ TNF receptor but not to Fas\/APO1; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p40","sentence":"One, MORT1 (also called FADD), binds to @PROTEIN2$\/@PROTEIN1$ but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas\/APO1; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p41","sentence":"One, MORT1 (also called FADD), binds to Fas\/@PROTEIN1$ but not to p55-R; another, TRADD, binds to the p55 @PROTEIN2$ but not to Fas\/APO1; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p42","sentence":"One, MORT1 (also called FADD), binds to Fas\/@PROTEIN1$ but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas\/APO1; and the third, @PROTEIN2$, binds weakly to both receptors.","label":1}
{"pair_id":"BioInfer.d461.s0.p43","sentence":"One, MORT1 (also called FADD), binds to Fas\/@PROTEIN1$ but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to @PROTEIN2$\/APO1; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p44","sentence":"One, MORT1 (also called FADD), binds to Fas\/@PROTEIN1$ but not to p55-R; another, TRADD, binds to the @PROTEIN2$ TNF receptor but not to Fas\/APO1; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p45","sentence":"One, MORT1 (also called FADD), binds to @PROTEIN1$\/APO1 but not to p55-R; another, TRADD, binds to the p55 @PROTEIN2$ but not to Fas\/APO1; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p46","sentence":"One, MORT1 (also called FADD), binds to @PROTEIN1$\/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas\/APO1; and the third, @PROTEIN2$, binds weakly to both receptors.","label":1}
{"pair_id":"BioInfer.d461.s0.p47","sentence":"One, MORT1 (also called FADD), binds to @PROTEIN1$\/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to @PROTEIN2$\/APO1; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p48","sentence":"One, MORT1 (also called FADD), binds to @PROTEIN1$\/APO1 but not to p55-R; another, TRADD, binds to the @PROTEIN2$ TNF receptor but not to Fas\/APO1; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p49","sentence":"One, MORT1 (also called FADD), binds to Fas\/APO1 but not to p55-R; another, TRADD, binds to the p55 @PROTEIN1$ but not to Fas\/APO1; and the third, @PROTEIN2$, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p50","sentence":"One, MORT1 (also called FADD), binds to Fas\/APO1 but not to p55-R; another, TRADD, binds to the p55 @PROTEIN1$ but not to @PROTEIN2$\/APO1; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p51","sentence":"One, MORT1 (also called FADD), binds to Fas\/APO1 but not to p55-R; another, TRADD, binds to the @PROTEIN2$ @PROTEIN1$ but not to Fas\/APO1; and the third, RIP, binds weakly to both receptors.","label":1}
{"pair_id":"BioInfer.d461.s0.p52","sentence":"One, MORT1 (also called FADD), binds to Fas\/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to @PROTEIN2$\/APO1; and the third, @PROTEIN1$, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p53","sentence":"One, MORT1 (also called FADD), binds to Fas\/APO1 but not to p55-R; another, TRADD, binds to the @PROTEIN2$ TNF receptor but not to Fas\/APO1; and the third, @PROTEIN1$, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p54","sentence":"One, MORT1 (also called FADD), binds to Fas\/APO1 but not to p55-R; another, TRADD, binds to the @PROTEIN2$ TNF receptor but not to @PROTEIN1$\/APO1; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d141.s0.p0","sentence":"Chemical modification of the cysteine residue 374 of actin, both with N-ethylmaleimide and with the fluorescent probe N-(1-pyrenyl)iodoacetamide, is shown to counteract the inhibiting effect of @PROTEIN1$ on @PROTEIN2$ polymerization.","label":1}
{"pair_id":"BioInfer.d141.s0.p1","sentence":"Chemical modification of the cysteine residue 374 of @PROTEIN2$, both with N-ethylmaleimide and with the fluorescent probe N-(1-pyrenyl)iodoacetamide, is shown to counteract the inhibiting effect of @PROTEIN1$ on actin polymerization.","label":1}
{"pair_id":"BioInfer.d141.s0.p2","sentence":"Chemical modification of the cysteine residue 374 of @PROTEIN2$, both with N-ethylmaleimide and with the fluorescent probe N-(1-pyrenyl)iodoacetamide, is shown to counteract the inhibiting effect of profilin on @PROTEIN1$ polymerization.","label":1}
{"pair_id":"AIMed.d143.s1207.p0","sentence":"The similarities in biofunctions and differences in ligand binding proteins between @PROTEIN1$ and @PROTEIN2$ prompted us to investigate whether IL-11 shares common signal transduction mechanisms with IL-6.","label":0}
{"pair_id":"AIMed.d143.s1207.p1","sentence":"The similarities in biofunctions and differences in ligand binding proteins between @PROTEIN1$ and IL-6 prompted us to investigate whether @PROTEIN2$ shares common signal transduction mechanisms with IL-6.","label":0}
{"pair_id":"AIMed.d143.s1207.p2","sentence":"The similarities in biofunctions and differences in ligand binding proteins between @PROTEIN1$ and IL-6 prompted us to investigate whether IL-11 shares common signal transduction mechanisms with @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d143.s1207.p3","sentence":"The similarities in biofunctions and differences in ligand binding proteins between IL-11 and @PROTEIN1$ prompted us to investigate whether @PROTEIN2$ shares common signal transduction mechanisms with IL-6.","label":0}
{"pair_id":"AIMed.d143.s1207.p4","sentence":"The similarities in biofunctions and differences in ligand binding proteins between IL-11 and @PROTEIN1$ prompted us to investigate whether IL-11 shares common signal transduction mechanisms with @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d143.s1207.p5","sentence":"The similarities in biofunctions and differences in ligand binding proteins between IL-11 and IL-6 prompted us to investigate whether @PROTEIN1$ shares common signal transduction mechanisms with @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d597.s1.p0","sentence":"@PROTEIN2$ and @PROTEIN1$@PROTEIN2$ were present in most ovarian cells at all stages of folliculogenesis.","label":0}
{"pair_id":"BioInfer.d343.s0.p0","sentence":"In higher plants, a large number of isoforms for the @PROTEIN1$ monomer-binding protein profilin have been identified, whereas other organisms express only few @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d343.s0.p1","sentence":"In higher plants, a large number of isoforms for the @PROTEIN1$ monomer-binding protein @PROTEIN2$ have been identified, whereas other organisms express only few profilins.","label":1}
{"pair_id":"BioInfer.d343.s0.p2","sentence":"In higher plants, a large number of isoforms for the actin monomer-binding protein @PROTEIN2$ have been identified, whereas other organisms express only few @PROTEIN1$.","label":0}
{"pair_id":"AIMed.d190.s1610.p0","sentence":"Discrete protein interactions with the @PROTEIN1$\/@PROTEIN2$ complex in SCF- and TPO-mediated myeloid cell proliferation.","label":1}
{"pair_id":"AIMed.d190.s1610.p1","sentence":"Discrete protein interactions with the @PROTEIN1$\/c-Cbl complex in @PROTEIN2$- and TPO-mediated myeloid cell proliferation.","label":0}
{"pair_id":"AIMed.d190.s1610.p2","sentence":"Discrete protein interactions with the @PROTEIN1$\/c-Cbl complex in SCF- and @PROTEIN2$-mediated myeloid cell proliferation.","label":0}
{"pair_id":"AIMed.d190.s1610.p3","sentence":"Discrete protein interactions with the Grb2\/@PROTEIN1$ complex in @PROTEIN2$- and TPO-mediated myeloid cell proliferation.","label":0}
{"pair_id":"AIMed.d190.s1610.p4","sentence":"Discrete protein interactions with the Grb2\/@PROTEIN1$ complex in SCF- and @PROTEIN2$-mediated myeloid cell proliferation.","label":0}
{"pair_id":"AIMed.d190.s1610.p5","sentence":"Discrete protein interactions with the Grb2\/c-Cbl complex in @PROTEIN1$- and @PROTEIN2$-mediated myeloid cell proliferation.","label":0}
{"pair_id":"BioInfer.d756.s0.p0","sentence":"Thus, poly-L-proline binding, @PROTEIN1$ binding, and @PROTEIN2$ nucleotide exchange are each independent requirements for profilin function in fission yeast.","label":0}
{"pair_id":"BioInfer.d756.s0.p1","sentence":"Thus, poly-L-proline binding, @PROTEIN1$ binding, and actin nucleotide exchange are each independent requirements for @PROTEIN2$ function in fission yeast.","label":1}
{"pair_id":"BioInfer.d756.s0.p2","sentence":"Thus, poly-L-proline binding, actin binding, and @PROTEIN1$ nucleotide exchange are each independent requirements for @PROTEIN2$ function in fission yeast.","label":1}
{"pair_id":"AIMed.d58.s517.p0","sentence":"These results suggest that @PROTEIN1$\/@PROTEIN2$ plays a crucial role in a highly conserved mechanism for growth factor control of ras signaling.","label":0}
{"pair_id":"BioInfer.d379.s2.p0","sentence":"The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion\/deletion mispairs and requires a combination of either @PROTEIN2$ and MSH6 or @PROTEIN1$ and MSH3.","label":0}
{"pair_id":"BioInfer.d379.s2.p1","sentence":"The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion\/deletion mispairs and requires a combination of either MSH2 and @PROTEIN2$ or @PROTEIN1$ and MSH3.","label":0}
{"pair_id":"BioInfer.d379.s2.p2","sentence":"The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion\/deletion mispairs and requires a combination of either MSH2 and MSH6 or @PROTEIN1$ and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d379.s2.p3","sentence":"The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires @PROTEIN2$ and MSH6, and a second that recognizes insertion\/deletion mispairs and requires a combination of either MSH2 and MSH6 or @PROTEIN1$ and MSH3.","label":0}
{"pair_id":"BioInfer.d379.s2.p4","sentence":"The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and @PROTEIN2$, and a second that recognizes insertion\/deletion mispairs and requires a combination of either MSH2 and MSH6 or @PROTEIN1$ and MSH3.","label":0}
{"pair_id":"BioInfer.d379.s2.p5","sentence":"The results indicate that S. cerevisiae has two pathways of @PROTEIN2$-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion\/deletion mispairs and requires a combination of either MSH2 and MSH6 or @PROTEIN1$ and MSH3.","label":1}
{"pair_id":"BioInfer.d379.s2.p6","sentence":"The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion\/deletion mispairs and requires a combination of either @PROTEIN1$ and @PROTEIN2$ or MSH2 and MSH3.","label":0}
{"pair_id":"BioInfer.d379.s2.p7","sentence":"The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion\/deletion mispairs and requires a combination of either @PROTEIN1$ and MSH6 or MSH2 and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d379.s2.p8","sentence":"The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires @PROTEIN2$ and MSH6, and a second that recognizes insertion\/deletion mispairs and requires a combination of either @PROTEIN1$ and MSH6 or MSH2 and MSH3.","label":0}
{"pair_id":"BioInfer.d379.s2.p9","sentence":"The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and @PROTEIN2$, and a second that recognizes insertion\/deletion mispairs and requires a combination of either @PROTEIN1$ and MSH6 or MSH2 and MSH3.","label":0}
{"pair_id":"BioInfer.d379.s2.p10","sentence":"The results indicate that S. cerevisiae has two pathways of @PROTEIN2$-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion\/deletion mispairs and requires a combination of either @PROTEIN1$ and MSH6 or MSH2 and MSH3.","label":1}
{"pair_id":"BioInfer.d379.s2.p11","sentence":"The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion\/deletion mispairs and requires a combination of either MSH2 and @PROTEIN1$ or MSH2 and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d379.s2.p12","sentence":"The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires @PROTEIN2$ and MSH6, and a second that recognizes insertion\/deletion mispairs and requires a combination of either MSH2 and @PROTEIN1$ or MSH2 and MSH3.","label":0}
{"pair_id":"BioInfer.d379.s2.p13","sentence":"The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and @PROTEIN2$, and a second that recognizes insertion\/deletion mispairs and requires a combination of either MSH2 and @PROTEIN1$ or MSH2 and MSH3.","label":0}
{"pair_id":"BioInfer.d379.s2.p14","sentence":"The results indicate that S. cerevisiae has two pathways of @PROTEIN2$-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion\/deletion mispairs and requires a combination of either MSH2 and @PROTEIN1$ or MSH2 and MSH3.","label":1}
{"pair_id":"BioInfer.d379.s2.p15","sentence":"The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires @PROTEIN2$ and MSH6, and a second that recognizes insertion\/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d379.s2.p16","sentence":"The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and @PROTEIN2$, and a second that recognizes insertion\/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d379.s2.p17","sentence":"The results indicate that S. cerevisiae has two pathways of @PROTEIN2$-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion\/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d379.s2.p18","sentence":"The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires @PROTEIN1$ and @PROTEIN2$, and a second that recognizes insertion\/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and MSH3.","label":0}
{"pair_id":"BioInfer.d379.s2.p19","sentence":"The results indicate that S. cerevisiae has two pathways of @PROTEIN2$-dependent mismatch repair: one that recognized single-base mispairs and requires @PROTEIN1$ and MSH6, and a second that recognizes insertion\/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and MSH3.","label":1}
{"pair_id":"BioInfer.d379.s2.p20","sentence":"The results indicate that S. cerevisiae has two pathways of @PROTEIN2$-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and @PROTEIN1$, and a second that recognizes insertion\/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and MSH3.","label":1}
{"pair_id":"BioInfer.d213.s2.p0","sentence":"To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of @PROTEIN1$ that bound profilin, a protein that interacts with phosphoinositides and @PROTEIN2$-monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled actin (Kd > 30 microM), yet retained the ability to inhibit DNase I.","label":0}
{"pair_id":"BioInfer.d213.s2.p1","sentence":"To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of @PROTEIN1$ that bound @PROTEIN2$, a protein that interacts with phosphoinositides and actin-monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled actin (Kd > 30 microM), yet retained the ability to inhibit DNase I.","label":1}
{"pair_id":"BioInfer.d213.s2.p2","sentence":"To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of @PROTEIN1$ that bound profilin, a protein that interacts with phosphoinositides and actin-monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled actin (Kd > 30 microM), yet retained the ability to inhibit @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d213.s2.p3","sentence":"To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of @PROTEIN1$ that bound profilin, a protein that interacts with phosphoinositides and actin-monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled @PROTEIN2$ (Kd > 30 microM), yet retained the ability to inhibit DNase I.","label":0}
{"pair_id":"BioInfer.d213.s2.p4","sentence":"To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of actin that bound @PROTEIN2$, a protein that interacts with phosphoinositides and @PROTEIN1$-monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled actin (Kd > 30 microM), yet retained the ability to inhibit DNase I.","label":1}
{"pair_id":"BioInfer.d213.s2.p5","sentence":"To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of actin that bound profilin, a protein that interacts with phosphoinositides and @PROTEIN1$-monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled actin (Kd > 30 microM), yet retained the ability to inhibit @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d213.s2.p6","sentence":"To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of actin that bound profilin, a protein that interacts with phosphoinositides and @PROTEIN1$-monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled @PROTEIN2$ (Kd > 30 microM), yet retained the ability to inhibit DNase I.","label":0}
{"pair_id":"BioInfer.d213.s2.p7","sentence":"To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of actin that bound @PROTEIN1$, a protein that interacts with phosphoinositides and actin-monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled actin (Kd > 30 microM), yet retained the ability to inhibit @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d213.s2.p8","sentence":"To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of actin that bound @PROTEIN1$, a protein that interacts with phosphoinositides and actin-monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled @PROTEIN2$ (Kd > 30 microM), yet retained the ability to inhibit DNase I.","label":1}
{"pair_id":"BioInfer.d213.s2.p9","sentence":"To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of actin that bound profilin, a protein that interacts with phosphoinositides and actin-monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled @PROTEIN2$ (Kd > 30 microM), yet retained the ability to inhibit @PROTEIN1$.","label":0}
{"pair_id":"AIMed.d199.s1710.p0","sentence":"In summary, @PROTEIN1$ signaling pathway utilizes two @PROTEIN2$-containing complexes; Shc.","label":0}
{"pair_id":"AIMed.d199.s1710.p1","sentence":"In summary, @PROTEIN1$ signaling pathway utilizes two GRB2-containing complexes; @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d199.s1710.p2","sentence":"In summary, FGFR3 signaling pathway utilizes two @PROTEIN1$-containing complexes; @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d219.s1904.p0","sentence":"However, whether 14-3-3 proteins interact directly with the @PROTEIN1$ and how this interaction may mediate @PROTEIN2$ function has not been determined.","label":0}
{"pair_id":"AIMed.d125.s1069.p0","sentence":"In contrast to LexA\/@PROTEIN1$ fusion proteins, expression of a LexA\/@PROTEIN2$ protein was lethal to yeast.","label":0}
{"pair_id":"BioInfer.d751.s0.p0","sentence":"Thus, actin was found in association with @PROTEIN1$ in the mechanoreceptive region of hair cells, whereas supporting cells, although rich in @PROTEIN2$, did not reveal fimbrin.","label":0}
{"pair_id":"BioInfer.d751.s0.p1","sentence":"Thus, @PROTEIN2$ was found in association with @PROTEIN1$ in the mechanoreceptive region of hair cells, whereas supporting cells, although rich in actin, did not reveal fimbrin.","label":1}
{"pair_id":"BioInfer.d751.s0.p2","sentence":"Thus, actin was found in association with @PROTEIN1$ in the mechanoreceptive region of hair cells, whereas supporting cells, although rich in actin, did not reveal @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d751.s0.p3","sentence":"Thus, @PROTEIN2$ was found in association with fimbrin in the mechanoreceptive region of hair cells, whereas supporting cells, although rich in @PROTEIN1$, did not reveal fimbrin.","label":0}
{"pair_id":"BioInfer.d751.s0.p4","sentence":"Thus, actin was found in association with fimbrin in the mechanoreceptive region of hair cells, whereas supporting cells, although rich in @PROTEIN1$, did not reveal @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d751.s0.p5","sentence":"Thus, @PROTEIN1$ was found in association with fimbrin in the mechanoreceptive region of hair cells, whereas supporting cells, although rich in actin, did not reveal @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d529.s0.p0","sentence":"Semiserial sections were subjected to immunohistochemical staining with antibodies to alpha-smooth muscle actin (@PROTEIN2$), desmin and smooth muscle myosin heavy chain isoforms: SM1, @PROTEIN1$ and SMemb.","label":0}
{"pair_id":"BioInfer.d529.s0.p1","sentence":"Semiserial sections were subjected to immunohistochemical staining with antibodies to alpha-smooth muscle actin (alpha-SMA), desmin and @PROTEIN2$ isoforms: SM1, @PROTEIN1$ and SMemb.","label":1}
{"pair_id":"BioInfer.d529.s0.p2","sentence":"Semiserial sections were subjected to immunohistochemical staining with antibodies to @PROTEIN2$ (alpha-SMA), desmin and smooth muscle myosin heavy chain isoforms: SM1, @PROTEIN1$ and SMemb.","label":0}
{"pair_id":"BioInfer.d529.s0.p3","sentence":"Semiserial sections were subjected to immunohistochemical staining with antibodies to alpha-smooth muscle actin (alpha-SMA), desmin and smooth muscle myosin heavy chain isoforms: @PROTEIN2$, @PROTEIN1$ and SMemb.","label":0}
{"pair_id":"BioInfer.d529.s0.p4","sentence":"Semiserial sections were subjected to immunohistochemical staining with antibodies to alpha-smooth muscle actin (alpha-SMA), @PROTEIN2$ and smooth muscle myosin heavy chain isoforms: SM1, @PROTEIN1$ and SMemb.","label":0}
{"pair_id":"BioInfer.d529.s0.p5","sentence":"Semiserial sections were subjected to immunohistochemical staining with antibodies to alpha-smooth muscle actin (alpha-SMA), desmin and smooth muscle myosin heavy chain isoforms: SM1, @PROTEIN1$ and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d529.s0.p6","sentence":"Semiserial sections were subjected to immunohistochemical staining with antibodies to alpha-smooth muscle actin (@PROTEIN1$), desmin and @PROTEIN2$ isoforms: SM1, SM2 and SMemb.","label":0}
{"pair_id":"BioInfer.d529.s0.p7","sentence":"Semiserial sections were subjected to immunohistochemical staining with antibodies to @PROTEIN2$ (@PROTEIN1$), desmin and smooth muscle myosin heavy chain isoforms: SM1, SM2 and SMemb.","label":0}
{"pair_id":"BioInfer.d529.s0.p8","sentence":"Semiserial sections were subjected to immunohistochemical staining with antibodies to alpha-smooth muscle actin (@PROTEIN1$), desmin and smooth muscle myosin heavy chain isoforms: @PROTEIN2$, SM2 and SMemb.","label":0}
{"pair_id":"BioInfer.d529.s0.p9","sentence":"Semiserial sections were subjected to immunohistochemical staining with antibodies to alpha-smooth muscle actin (@PROTEIN1$), @PROTEIN2$ and smooth muscle myosin heavy chain isoforms: SM1, SM2 and SMemb.","label":0}
{"pair_id":"BioInfer.d529.s0.p10","sentence":"Semiserial sections were subjected to immunohistochemical staining with antibodies to alpha-smooth muscle actin (@PROTEIN1$), desmin and smooth muscle myosin heavy chain isoforms: SM1, SM2 and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d529.s0.p11","sentence":"Semiserial sections were subjected to immunohistochemical staining with antibodies to @PROTEIN2$ (alpha-SMA), desmin and @PROTEIN1$ isoforms: SM1, SM2 and SMemb.","label":0}
{"pair_id":"BioInfer.d529.s0.p12","sentence":"Semiserial sections were subjected to immunohistochemical staining with antibodies to alpha-smooth muscle actin (alpha-SMA), desmin and @PROTEIN1$ isoforms: @PROTEIN2$, SM2 and SMemb.","label":1}
{"pair_id":"BioInfer.d529.s0.p13","sentence":"Semiserial sections were subjected to immunohistochemical staining with antibodies to alpha-smooth muscle actin (alpha-SMA), @PROTEIN2$ and @PROTEIN1$ isoforms: SM1, SM2 and SMemb.","label":0}
{"pair_id":"BioInfer.d529.s0.p14","sentence":"Semiserial sections were subjected to immunohistochemical staining with antibodies to alpha-smooth muscle actin (alpha-SMA), desmin and @PROTEIN1$ isoforms: SM1, SM2 and @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d529.s0.p15","sentence":"Semiserial sections were subjected to immunohistochemical staining with antibodies to @PROTEIN1$ (alpha-SMA), desmin and smooth muscle myosin heavy chain isoforms: @PROTEIN2$, SM2 and SMemb.","label":0}
{"pair_id":"BioInfer.d529.s0.p16","sentence":"Semiserial sections were subjected to immunohistochemical staining with antibodies to @PROTEIN1$ (alpha-SMA), @PROTEIN2$ and smooth muscle myosin heavy chain isoforms: SM1, SM2 and SMemb.","label":0}
{"pair_id":"BioInfer.d529.s0.p17","sentence":"Semiserial sections were subjected to immunohistochemical staining with antibodies to @PROTEIN1$ (alpha-SMA), desmin and smooth muscle myosin heavy chain isoforms: SM1, SM2 and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d529.s0.p18","sentence":"Semiserial sections were subjected to immunohistochemical staining with antibodies to alpha-smooth muscle actin (alpha-SMA), @PROTEIN2$ and smooth muscle myosin heavy chain isoforms: @PROTEIN1$, SM2 and SMemb.","label":0}
{"pair_id":"BioInfer.d529.s0.p19","sentence":"Semiserial sections were subjected to immunohistochemical staining with antibodies to alpha-smooth muscle actin (alpha-SMA), desmin and smooth muscle myosin heavy chain isoforms: @PROTEIN1$, SM2 and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d529.s0.p20","sentence":"Semiserial sections were subjected to immunohistochemical staining with antibodies to alpha-smooth muscle actin (alpha-SMA), @PROTEIN1$ and smooth muscle myosin heavy chain isoforms: SM1, SM2 and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d131.s1121.p0","sentence":"The predicted amino acid sequence of @PROTEIN1$ is 60% identical and 73% similar to mouse @PROTEIN2$ (mIL-10R). rIL-10R expressed in an IL-3-dependent mouse pro-B cell line (Ba\/F3) binds hIL-10 with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to hIL-10.","label":0}
{"pair_id":"AIMed.d131.s1121.p1","sentence":"The predicted amino acid sequence of @PROTEIN1$ is 60% identical and 73% similar to mouse IL-10R (@PROTEIN2$). rIL-10R expressed in an IL-3-dependent mouse pro-B cell line (Ba\/F3) binds hIL-10 with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to hIL-10.","label":0}
{"pair_id":"AIMed.d131.s1121.p2","sentence":"The predicted amino acid sequence of @PROTEIN1$ is 60% identical and 73% similar to mouse IL-10R (mIL-10R). @PROTEIN2$ expressed in an IL-3-dependent mouse pro-B cell line (Ba\/F3) binds hIL-10 with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to hIL-10.","label":0}
{"pair_id":"AIMed.d131.s1121.p3","sentence":"The predicted amino acid sequence of @PROTEIN1$ is 60% identical and 73% similar to mouse IL-10R (mIL-10R). rIL-10R expressed in an @PROTEIN2$-dependent mouse pro-B cell line (Ba\/F3) binds hIL-10 with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to hIL-10.","label":0}
{"pair_id":"AIMed.d131.s1121.p4","sentence":"The predicted amino acid sequence of @PROTEIN1$ is 60% identical and 73% similar to mouse IL-10R (mIL-10R). rIL-10R expressed in an IL-3-dependent mouse pro-B cell line (Ba\/F3) binds @PROTEIN2$ with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to hIL-10.","label":0}
{"pair_id":"AIMed.d131.s1121.p5","sentence":"The predicted amino acid sequence of @PROTEIN1$ is 60% identical and 73% similar to mouse IL-10R (mIL-10R). rIL-10R expressed in an IL-3-dependent mouse pro-B cell line (Ba\/F3) binds hIL-10 with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d131.s1121.p6","sentence":"The predicted amino acid sequence of hIL-10R is 60% identical and 73% similar to mouse @PROTEIN1$ (@PROTEIN2$). rIL-10R expressed in an IL-3-dependent mouse pro-B cell line (Ba\/F3) binds hIL-10 with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to hIL-10.","label":0}
{"pair_id":"AIMed.d131.s1121.p7","sentence":"The predicted amino acid sequence of hIL-10R is 60% identical and 73% similar to mouse @PROTEIN1$ (mIL-10R). @PROTEIN2$ expressed in an IL-3-dependent mouse pro-B cell line (Ba\/F3) binds hIL-10 with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to hIL-10.","label":0}
{"pair_id":"AIMed.d131.s1121.p8","sentence":"The predicted amino acid sequence of hIL-10R is 60% identical and 73% similar to mouse @PROTEIN1$ (mIL-10R). rIL-10R expressed in an @PROTEIN2$-dependent mouse pro-B cell line (Ba\/F3) binds hIL-10 with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to hIL-10.","label":0}
{"pair_id":"AIMed.d131.s1121.p9","sentence":"The predicted amino acid sequence of hIL-10R is 60% identical and 73% similar to mouse @PROTEIN1$ (mIL-10R). rIL-10R expressed in an IL-3-dependent mouse pro-B cell line (Ba\/F3) binds @PROTEIN2$ with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to hIL-10.","label":0}
{"pair_id":"AIMed.d131.s1121.p10","sentence":"The predicted amino acid sequence of hIL-10R is 60% identical and 73% similar to mouse @PROTEIN1$ (mIL-10R). rIL-10R expressed in an IL-3-dependent mouse pro-B cell line (Ba\/F3) binds hIL-10 with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d131.s1121.p11","sentence":"The predicted amino acid sequence of hIL-10R is 60% identical and 73% similar to mouse IL-10R (@PROTEIN1$). @PROTEIN2$ expressed in an IL-3-dependent mouse pro-B cell line (Ba\/F3) binds hIL-10 with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to hIL-10.","label":0}
{"pair_id":"AIMed.d131.s1121.p12","sentence":"The predicted amino acid sequence of hIL-10R is 60% identical and 73% similar to mouse IL-10R (@PROTEIN1$). rIL-10R expressed in an @PROTEIN2$-dependent mouse pro-B cell line (Ba\/F3) binds hIL-10 with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to hIL-10.","label":0}
{"pair_id":"AIMed.d131.s1121.p13","sentence":"The predicted amino acid sequence of hIL-10R is 60% identical and 73% similar to mouse IL-10R (@PROTEIN1$). rIL-10R expressed in an IL-3-dependent mouse pro-B cell line (Ba\/F3) binds @PROTEIN2$ with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to hIL-10.","label":0}
{"pair_id":"AIMed.d131.s1121.p14","sentence":"The predicted amino acid sequence of hIL-10R is 60% identical and 73% similar to mouse IL-10R (@PROTEIN1$). rIL-10R expressed in an IL-3-dependent mouse pro-B cell line (Ba\/F3) binds hIL-10 with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d131.s1121.p15","sentence":"The predicted amino acid sequence of hIL-10R is 60% identical and 73% similar to mouse IL-10R (mIL-10R). @PROTEIN1$ expressed in an @PROTEIN2$-dependent mouse pro-B cell line (Ba\/F3) binds hIL-10 with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to hIL-10.","label":0}
{"pair_id":"AIMed.d131.s1121.p16","sentence":"The predicted amino acid sequence of hIL-10R is 60% identical and 73% similar to mouse IL-10R (mIL-10R). @PROTEIN1$ expressed in an IL-3-dependent mouse pro-B cell line (Ba\/F3) binds @PROTEIN2$ with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to hIL-10.","label":1}
{"pair_id":"AIMed.d131.s1121.p17","sentence":"The predicted amino acid sequence of hIL-10R is 60% identical and 73% similar to mouse IL-10R (mIL-10R). @PROTEIN1$ expressed in an IL-3-dependent mouse pro-B cell line (Ba\/F3) binds hIL-10 with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d131.s1121.p18","sentence":"The predicted amino acid sequence of hIL-10R is 60% identical and 73% similar to mouse IL-10R (mIL-10R). rIL-10R expressed in an @PROTEIN1$-dependent mouse pro-B cell line (Ba\/F3) binds @PROTEIN2$ with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to hIL-10.","label":0}
{"pair_id":"AIMed.d131.s1121.p19","sentence":"The predicted amino acid sequence of hIL-10R is 60% identical and 73% similar to mouse IL-10R (mIL-10R). rIL-10R expressed in an @PROTEIN1$-dependent mouse pro-B cell line (Ba\/F3) binds hIL-10 with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d131.s1121.p20","sentence":"The predicted amino acid sequence of hIL-10R is 60% identical and 73% similar to mouse IL-10R (mIL-10R). rIL-10R expressed in an IL-3-dependent mouse pro-B cell line (Ba\/F3) binds @PROTEIN1$ with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d645.s0.p0","sentence":"The monomeric @PROTEIN1$, profilin, is a key regulator of @PROTEIN2$-filament dynamics in animal cells and it has recently been identified in plants as a pollen allergen.","label":0}
{"pair_id":"BioInfer.d645.s0.p1","sentence":"The monomeric @PROTEIN1$, @PROTEIN2$, is a key regulator of actin-filament dynamics in animal cells and it has recently been identified in plants as a pollen allergen.","label":1}
{"pair_id":"BioInfer.d645.s0.p2","sentence":"The monomeric actin-binding protein, @PROTEIN2$, is a key regulator of @PROTEIN1$-filament dynamics in animal cells and it has recently been identified in plants as a pollen allergen.","label":1}
{"pair_id":"AIMed.d161.s1357.p0","sentence":"Using @PROTEIN1$ as bait and supplying an exogenous tyrosine kinase gene to the yeast cells, we have found that @PROTEIN2$ interacts with another signaling protein, Grb7.","label":0}
{"pair_id":"AIMed.d161.s1357.p1","sentence":"Using @PROTEIN1$ as bait and supplying an exogenous tyrosine kinase gene to the yeast cells, we have found that SHPTP2 interacts with another signaling protein, @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d161.s1357.p2","sentence":"Using SHPTP2 as bait and supplying an exogenous tyrosine kinase gene to the yeast cells, we have found that @PROTEIN1$ interacts with another signaling protein, @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d332.s0.p0","sentence":"Increasing the ionic strength within a relatively narrow range significantly decreased ability of @PROTEIN1$ to bind to @PROTEIN2$, regardless of pH.","label":1}
{"pair_id":"BioInfer.d352.s0.p0","sentence":"In resting leukocytes, @PROTEIN2$ are constitutively linked to the @PROTEIN1$ cytoskeleton via the protein talin.","label":1}
{"pair_id":"BioInfer.d352.s0.p1","sentence":"In resting leukocytes, beta2 integrins are constitutively linked to the @PROTEIN1$ cytoskeleton via the protein @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d352.s0.p2","sentence":"In resting leukocytes, @PROTEIN1$ are constitutively linked to the actin cytoskeleton via the protein @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d218.s1891.p0","sentence":"The @PROTEIN1$-like domain of @PROTEIN2$ (TPO1-153) has been fused to the gIII coat protein of M13 bacteriophage.","label":0}
{"pair_id":"AIMed.d218.s1891.p1","sentence":"The @PROTEIN1$-like domain of TPO (TPO1-153) has been fused to the @PROTEIN2$ coat protein of M13 bacteriophage.","label":0}
{"pair_id":"AIMed.d218.s1891.p2","sentence":"The erythropoietin-like domain of @PROTEIN1$ (TPO1-153) has been fused to the @PROTEIN2$ coat protein of M13 bacteriophage.","label":0}
{"pair_id":"BioInfer.d319.s0.p0","sentence":"In a model system, the interacting proteins recruiting @PROTEIN2$ to DNA were PRP21 and @PROTEIN1$ or PRP21 and PRP11.","label":1}
{"pair_id":"BioInfer.d319.s0.p1","sentence":"In a model system, the interacting proteins recruiting TFIIIC to DNA were PRP21 and @PROTEIN1$ or @PROTEIN2$ and PRP11.","label":0}
{"pair_id":"BioInfer.d319.s0.p2","sentence":"In a model system, the interacting proteins recruiting TFIIIC to DNA were PRP21 and @PROTEIN1$ or PRP21 and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d319.s0.p3","sentence":"In a model system, the interacting proteins recruiting TFIIIC to DNA were @PROTEIN2$ and @PROTEIN1$ or PRP21 and PRP11.","label":1}
{"pair_id":"BioInfer.d319.s0.p4","sentence":"In a model system, the interacting proteins recruiting @PROTEIN1$ to DNA were PRP21 and PRP9 or @PROTEIN2$ and PRP11.","label":1}
{"pair_id":"BioInfer.d319.s0.p5","sentence":"In a model system, the interacting proteins recruiting @PROTEIN1$ to DNA were PRP21 and PRP9 or PRP21 and @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d319.s0.p6","sentence":"In a model system, the interacting proteins recruiting @PROTEIN1$ to DNA were @PROTEIN2$ and PRP9 or PRP21 and PRP11.","label":1}
{"pair_id":"BioInfer.d319.s0.p7","sentence":"In a model system, the interacting proteins recruiting TFIIIC to DNA were PRP21 and PRP9 or @PROTEIN1$ and @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d319.s0.p8","sentence":"In a model system, the interacting proteins recruiting TFIIIC to DNA were @PROTEIN2$ and PRP9 or @PROTEIN1$ and PRP11.","label":0}
{"pair_id":"BioInfer.d319.s0.p9","sentence":"In a model system, the interacting proteins recruiting TFIIIC to DNA were @PROTEIN2$ and PRP9 or PRP21 and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d150.s0.p0","sentence":"CONCLUSIONS: The expression of alpha-catenin, @PROTEIN2$, and gamma-catenin is related to histological type and differentiation in NSCLC, although @PROTEIN1$ have no independent prognostic value.","label":0}
{"pair_id":"BioInfer.d150.s0.p1","sentence":"CONCLUSIONS: The expression of alpha-catenin, beta-catenin, and @PROTEIN2$ is related to histological type and differentiation in NSCLC, although @PROTEIN1$ have no independent prognostic value.","label":0}
{"pair_id":"BioInfer.d150.s0.p2","sentence":"CONCLUSIONS: The expression of @PROTEIN2$, beta-catenin, and gamma-catenin is related to histological type and differentiation in NSCLC, although @PROTEIN1$ have no independent prognostic value.","label":0}
{"pair_id":"BioInfer.d150.s0.p3","sentence":"CONCLUSIONS: The expression of alpha-catenin, @PROTEIN1$, and @PROTEIN2$ is related to histological type and differentiation in NSCLC, although catenins have no independent prognostic value.","label":0}
{"pair_id":"BioInfer.d150.s0.p4","sentence":"CONCLUSIONS: The expression of @PROTEIN2$, @PROTEIN1$, and gamma-catenin is related to histological type and differentiation in NSCLC, although catenins have no independent prognostic value.","label":0}
{"pair_id":"BioInfer.d150.s0.p5","sentence":"CONCLUSIONS: The expression of @PROTEIN2$, beta-catenin, and @PROTEIN1$ is related to histological type and differentiation in NSCLC, although catenins have no independent prognostic value.","label":0}
{"pair_id":"AIMed.d120.s1016.p0","sentence":"However, the function of @PROTEIN1$ and the identity of proteins that interact with @PROTEIN2$ remain unknown.","label":0}
{"pair_id":"AIMed.d168.s1413.p0","sentence":"The @PROTEIN1$@PROTEIN2$ (EPOR) is a member of a family of cytokine and growth factor receptors that share conserved features in their extracellular and cytoplasmic domains.","label":0}
{"pair_id":"AIMed.d168.s1413.p1","sentence":"The @PROTEIN1$ receptor (@PROTEIN2$) is a member of a family of cytokine and growth factor receptors that share conserved features in their extracellular and cytoplasmic domains.","label":1}
{"pair_id":"AIMed.d168.s1413.p2","sentence":"The @PROTEIN1$ (@PROTEIN2$) is a member of a family of cytokine and growth factor receptors that share conserved features in their extracellular and cytoplasmic domains.","label":0}
{"pair_id":"AIMed.d160.s1343.p0","sentence":"Identification of vascular endothelial growth factor determinants for binding @PROTEIN1$ and @PROTEIN2$ receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis.","label":0}
{"pair_id":"AIMed.d160.s1343.p1","sentence":"Identification of vascular endothelial growth factor determinants for binding @PROTEIN1$ and FLT-1 receptors. Generation of receptor-selective @PROTEIN2$ variants by site-directed mutagenesis.","label":0}
{"pair_id":"AIMed.d160.s1343.p2","sentence":"Identification of vascular endothelial growth factor determinants for binding KDR and @PROTEIN1$ receptors. Generation of receptor-selective @PROTEIN2$ variants by site-directed mutagenesis.","label":0}
{"pair_id":"BioInfer.d5.s0.p0","sentence":"Acanthamoeba @PROTEIN1$ and @PROTEIN2$ can be cross-linked between glutamic acid 364 of actin and lysine 115 of profilin.","label":1}
{"pair_id":"BioInfer.d5.s0.p1","sentence":"Acanthamoeba @PROTEIN1$ and profilin can be cross-linked between glutamic acid 364 of @PROTEIN2$ and lysine 115 of profilin.","label":0}
{"pair_id":"BioInfer.d5.s0.p2","sentence":"Acanthamoeba @PROTEIN1$ and profilin can be cross-linked between glutamic acid 364 of actin and lysine 115 of @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d5.s0.p3","sentence":"Acanthamoeba actin and @PROTEIN1$ can be cross-linked between glutamic acid 364 of @PROTEIN2$ and lysine 115 of profilin.","label":0}
{"pair_id":"BioInfer.d5.s0.p4","sentence":"Acanthamoeba actin and @PROTEIN1$ can be cross-linked between glutamic acid 364 of actin and lysine 115 of @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d5.s0.p5","sentence":"Acanthamoeba actin and profilin can be cross-linked between glutamic acid 364 of @PROTEIN1$ and lysine 115 of @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d715.s0.p0","sentence":"These results suggest that @PROTEIN2$ can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, @PROTEIN1$, FADD, and FLICE, and TNF-induced ceramide production may be involved in the pathways.","label":1}
{"pair_id":"BioInfer.d715.s0.p1","sentence":"These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, @PROTEIN1$, FADD, and @PROTEIN2$, and TNF-induced ceramide production may be involved in the pathways.","label":0}
{"pair_id":"BioInfer.d715.s0.p2","sentence":"These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, @PROTEIN1$, @PROTEIN2$, and FLICE, and TNF-induced ceramide production may be involved in the pathways.","label":0}
{"pair_id":"BioInfer.d715.s0.p3","sentence":"These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, @PROTEIN1$, FADD, and FLICE, and @PROTEIN2$-induced ceramide production may be involved in the pathways.","label":0}
{"pair_id":"BioInfer.d715.s0.p4","sentence":"These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through @PROTEIN2$-linked apoptotic factors, @PROTEIN1$, FADD, and FLICE, and TNF-induced ceramide production may be involved in the pathways.","label":1}
{"pair_id":"BioInfer.d715.s0.p5","sentence":"These results suggest that @PROTEIN1$ can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, TRADD, FADD, and @PROTEIN2$, and TNF-induced ceramide production may be involved in the pathways.","label":1}
{"pair_id":"BioInfer.d715.s0.p6","sentence":"These results suggest that @PROTEIN1$ can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, TRADD, @PROTEIN2$, and FLICE, and TNF-induced ceramide production may be involved in the pathways.","label":1}
{"pair_id":"BioInfer.d715.s0.p7","sentence":"These results suggest that @PROTEIN1$ can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, TRADD, FADD, and FLICE, and @PROTEIN2$-induced ceramide production may be involved in the pathways.","label":0}
{"pair_id":"BioInfer.d715.s0.p8","sentence":"These results suggest that @PROTEIN1$ can cause apoptosis in pancreatic beta cells through @PROTEIN2$-linked apoptotic factors, TRADD, FADD, and FLICE, and TNF-induced ceramide production may be involved in the pathways.","label":0}
{"pair_id":"BioInfer.d715.s0.p9","sentence":"These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, TRADD, @PROTEIN2$, and @PROTEIN1$, and TNF-induced ceramide production may be involved in the pathways.","label":0}
{"pair_id":"BioInfer.d715.s0.p10","sentence":"These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, TRADD, FADD, and @PROTEIN1$, and @PROTEIN2$-induced ceramide production may be involved in the pathways.","label":0}
{"pair_id":"BioInfer.d715.s0.p11","sentence":"These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through @PROTEIN2$-linked apoptotic factors, TRADD, FADD, and @PROTEIN1$, and TNF-induced ceramide production may be involved in the pathways.","label":1}
{"pair_id":"BioInfer.d715.s0.p12","sentence":"These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, TRADD, @PROTEIN1$, and FLICE, and @PROTEIN2$-induced ceramide production may be involved in the pathways.","label":0}
{"pair_id":"BioInfer.d715.s0.p13","sentence":"These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through @PROTEIN2$-linked apoptotic factors, TRADD, @PROTEIN1$, and FLICE, and TNF-induced ceramide production may be involved in the pathways.","label":1}
{"pair_id":"BioInfer.d715.s0.p14","sentence":"These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through @PROTEIN2$-linked apoptotic factors, TRADD, FADD, and FLICE, and @PROTEIN1$-induced ceramide production may be involved in the pathways.","label":0}
{"pair_id":"AIMed.d76.s638.p0","sentence":"@PROTEIN1$ is a T-cell-specific antigen which binds to the B-cell antigen @PROTEIN2$ and acts as a coreceptor in the stimulation of T-cell growth.","label":1}
{"pair_id":"AIMed.d14.s117.p0","sentence":"Concentrations of @PROTEIN1$ (@PROTEIN2$) and light subunit neurofilament protein (NFL) in cerebrospinal fluid (CSF) were measured in patients with second-stage Trypanosoma brucei gambiense sleeping sickness.","label":0}
{"pair_id":"AIMed.d14.s117.p1","sentence":"Concentrations of @PROTEIN1$ (GFAp) and @PROTEIN2$ (NFL) in cerebrospinal fluid (CSF) were measured in patients with second-stage Trypanosoma brucei gambiense sleeping sickness.","label":0}
{"pair_id":"AIMed.d14.s117.p2","sentence":"Concentrations of @PROTEIN1$ (GFAp) and light subunit neurofilament protein (@PROTEIN2$) in cerebrospinal fluid (CSF) were measured in patients with second-stage Trypanosoma brucei gambiense sleeping sickness.","label":0}
{"pair_id":"AIMed.d14.s117.p3","sentence":"Concentrations of glial fibrillary acidic protein (@PROTEIN1$) and @PROTEIN2$ (NFL) in cerebrospinal fluid (CSF) were measured in patients with second-stage Trypanosoma brucei gambiense sleeping sickness.","label":0}
{"pair_id":"AIMed.d14.s117.p4","sentence":"Concentrations of glial fibrillary acidic protein (@PROTEIN1$) and light subunit neurofilament protein (@PROTEIN2$) in cerebrospinal fluid (CSF) were measured in patients with second-stage Trypanosoma brucei gambiense sleeping sickness.","label":0}
{"pair_id":"AIMed.d14.s117.p5","sentence":"Concentrations of glial fibrillary acidic protein (GFAp) and @PROTEIN1$ (@PROTEIN2$) in cerebrospinal fluid (CSF) were measured in patients with second-stage Trypanosoma brucei gambiense sleeping sickness.","label":0}
{"pair_id":"AIMed.d80.s683.p0","sentence":"Using the cytoplasmic domain of @PROTEIN1$ in the yeast two-hybrid system, we have identified a novel interacting protein, @PROTEIN2$, which binds Fas and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p1","sentence":"Using the cytoplasmic domain of @PROTEIN1$ in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds @PROTEIN2$ and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p2","sentence":"Using the cytoplasmic domain of @PROTEIN1$ in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and @PROTEIN2$-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p3","sentence":"Using the cytoplasmic domain of @PROTEIN1$ in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-@PROTEIN2$, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p4","sentence":"Using the cytoplasmic domain of @PROTEIN1$ in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-FD5, a mutant of @PROTEIN2$ possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p5","sentence":"Using the cytoplasmic domain of @PROTEIN1$ in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants @PROTEIN2$-LPR and Fas-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p6","sentence":"Using the cytoplasmic domain of @PROTEIN1$ in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-@PROTEIN2$ and Fas-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p7","sentence":"Using the cytoplasmic domain of @PROTEIN1$ in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and @PROTEIN2$-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p8","sentence":"Using the cytoplasmic domain of @PROTEIN1$ in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-@PROTEIN2$.","label":0}
{"pair_id":"AIMed.d80.s683.p9","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, @PROTEIN1$, which binds @PROTEIN2$ and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-FD8.","label":1}
{"pair_id":"AIMed.d80.s683.p10","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, @PROTEIN1$, which binds Fas and @PROTEIN2$-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-FD8.","label":1}
{"pair_id":"AIMed.d80.s683.p11","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, @PROTEIN1$, which binds Fas and Fas-@PROTEIN2$, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-FD8.","label":1}
{"pair_id":"AIMed.d80.s683.p12","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, @PROTEIN1$, which binds Fas and Fas-FD5, a mutant of @PROTEIN2$ possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p13","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, @PROTEIN1$, which binds Fas and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants @PROTEIN2$-LPR and Fas-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p14","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, @PROTEIN1$, which binds Fas and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-@PROTEIN2$ and Fas-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p15","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, @PROTEIN1$, which binds Fas and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and @PROTEIN2$-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p16","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, @PROTEIN1$, which binds Fas and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-@PROTEIN2$.","label":0}
{"pair_id":"AIMed.d80.s683.p17","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds @PROTEIN1$ and @PROTEIN2$-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p18","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds @PROTEIN1$ and Fas-@PROTEIN2$, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p19","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds @PROTEIN1$ and Fas-FD5, a mutant of @PROTEIN2$ possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p20","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds @PROTEIN1$ and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants @PROTEIN2$-LPR and Fas-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p21","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds @PROTEIN1$ and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-@PROTEIN2$ and Fas-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p22","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds @PROTEIN1$ and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and @PROTEIN2$-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p23","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds @PROTEIN1$ and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-@PROTEIN2$.","label":0}
{"pair_id":"AIMed.d80.s683.p24","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and @PROTEIN1$-@PROTEIN2$, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p25","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and @PROTEIN1$-FD5, a mutant of @PROTEIN2$ possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p26","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and @PROTEIN1$-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants @PROTEIN2$-LPR and Fas-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p27","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and @PROTEIN1$-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-@PROTEIN2$ and Fas-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p28","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and @PROTEIN1$-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and @PROTEIN2$-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p29","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and @PROTEIN1$-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-@PROTEIN2$.","label":0}
{"pair_id":"AIMed.d80.s683.p30","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-@PROTEIN1$, a mutant of @PROTEIN2$ possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p31","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-@PROTEIN1$, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants @PROTEIN2$-LPR and Fas-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p32","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-@PROTEIN1$, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-@PROTEIN2$ and Fas-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p33","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-@PROTEIN1$, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and @PROTEIN2$-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p34","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-@PROTEIN1$, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-@PROTEIN2$.","label":0}
{"pair_id":"AIMed.d80.s683.p35","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-FD5, a mutant of @PROTEIN1$ possessing enhanced killing activity, but not the functionally inactive mutants @PROTEIN2$-LPR and Fas-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p36","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-FD5, a mutant of @PROTEIN1$ possessing enhanced killing activity, but not the functionally inactive mutants Fas-@PROTEIN2$ and Fas-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p37","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-FD5, a mutant of @PROTEIN1$ possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and @PROTEIN2$-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p38","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-FD5, a mutant of @PROTEIN1$ possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-@PROTEIN2$.","label":0}
{"pair_id":"AIMed.d80.s683.p39","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants @PROTEIN1$-@PROTEIN2$ and Fas-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p40","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants @PROTEIN1$-LPR and @PROTEIN2$-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p41","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants @PROTEIN1$-LPR and Fas-@PROTEIN2$.","label":0}
{"pair_id":"AIMed.d80.s683.p42","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-@PROTEIN1$ and @PROTEIN2$-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p43","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-@PROTEIN1$ and Fas-@PROTEIN2$.","label":0}
{"pair_id":"AIMed.d80.s683.p44","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and @PROTEIN1$-@PROTEIN2$.","label":0}
{"pair_id":"AIMed.d91.s782.p0","sentence":"Moreover, a partial recombinant @PROTEIN1$ complex containing @PROTEIN2$ was capable of mediating in vitro transcriptional activation by the VP16 activation domain.","label":0}
{"pair_id":"AIMed.d91.s782.p1","sentence":"Moreover, a partial recombinant @PROTEIN1$ complex containing hTAFII32 was capable of mediating in vitro transcriptional activation by the @PROTEIN2$ activation domain.","label":0}
{"pair_id":"AIMed.d91.s782.p2","sentence":"Moreover, a partial recombinant TFIID complex containing @PROTEIN1$ was capable of mediating in vitro transcriptional activation by the @PROTEIN2$ activation domain.","label":0}
{"pair_id":"AIMed.d103.s867.p0","sentence":"Cloning and characterization of @PROTEIN1$, @PROTEIN2$ and hTAFII28: three subunits of the human transcription factor TFIID.","label":1}
{"pair_id":"AIMed.d103.s867.p1","sentence":"Cloning and characterization of @PROTEIN1$, hTAFII20 and @PROTEIN2$: three subunits of the human transcription factor TFIID.","label":1}
{"pair_id":"AIMed.d103.s867.p2","sentence":"Cloning and characterization of @PROTEIN1$, hTAFII20 and hTAFII28: three subunits of the human transcription factor @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d103.s867.p3","sentence":"Cloning and characterization of hTAFII18, @PROTEIN1$ and @PROTEIN2$: three subunits of the human transcription factor TFIID.","label":1}
{"pair_id":"AIMed.d103.s867.p4","sentence":"Cloning and characterization of hTAFII18, @PROTEIN1$ and hTAFII28: three subunits of the human transcription factor @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d103.s867.p5","sentence":"Cloning and characterization of hTAFII18, hTAFII20 and @PROTEIN1$: three subunits of the human transcription factor @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d205.s1766.p0","sentence":"Thymocyte activation induces the association of @PROTEIN1$ and @PROTEIN2$ with CD5.","label":0}
{"pair_id":"AIMed.d205.s1766.p1","sentence":"Thymocyte activation induces the association of @PROTEIN1$ and pp120 with @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d205.s1766.p2","sentence":"Thymocyte activation induces the association of phosphatidylinositol 3-kinase and @PROTEIN1$ with @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d204.s1761.p0","sentence":"In addition to co-immunoprecipitation analysis, we have established a rapid and sensitive ELISA assay using immobilized @PROTEIN1$ to determine the structural requirements of @PROTEIN2$ to form complexes with its inhibitor.","label":0}
{"pair_id":"BioInfer.d724.s0.p0","sentence":"The structure of an @PROTEIN2$-crosslinking domain from human @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d279.s2.p0","sentence":"Stimulus-dependent disorganization of @PROTEIN1$ filaments induced by overexpression of @PROTEIN2$ in C2 myoblasts.","label":1}
{"pair_id":"AIMed.d217.s1881.p0","sentence":"When human soluble @PROTEIN1$ (sFasL, containing the extracellular portion) was expressed in human embryo kidney 293 cells, the three N-linked glycans of each @PROTEIN2$ monomer were found to be essential for efficient secretion.","label":0}
{"pair_id":"BioInfer.d700.s0.p0","sentence":"These increases were specific; DNA, total protein, lactic dehydrogenase, @PROTEIN1$, and @PROTEIN2$ levels were unchanged in the overexpressing cells.","label":0}
{"pair_id":"BioInfer.d700.s0.p1","sentence":"These increases were specific; DNA, total protein, @PROTEIN2$, @PROTEIN1$, and actin depolymerizing factor levels were unchanged in the overexpressing cells.","label":0}
{"pair_id":"BioInfer.d700.s0.p2","sentence":"These increases were specific; DNA, total protein, @PROTEIN2$, profilin, and @PROTEIN1$ levels were unchanged in the overexpressing cells.","label":0}
{"pair_id":"BioInfer.d306.s0.p0","sentence":"In a blot overlay experiment, purified 125I-labeled recombinant @PROTEIN1$ bound not only to plant @PROTEIN2$, but also to mammalian actin, demonstrating that cytoskeletal components from distantly related organisms with divergent primary structures can be compatible.","label":1}
{"pair_id":"BioInfer.d306.s0.p1","sentence":"In a blot overlay experiment, purified 125I-labeled recombinant @PROTEIN1$ bound not only to plant actin, but also to mammalian @PROTEIN2$, demonstrating that cytoskeletal components from distantly related organisms with divergent primary structures can be compatible.","label":1}
{"pair_id":"BioInfer.d306.s0.p2","sentence":"In a blot overlay experiment, purified 125I-labeled recombinant profilin bound not only to plant @PROTEIN1$, but also to mammalian @PROTEIN2$, demonstrating that cytoskeletal components from distantly related organisms with divergent primary structures can be compatible.","label":0}
{"pair_id":"AIMed.d32.s270.p0","sentence":"Remarkably, Phe93 forms extensive contacts with a peptide ligand in the crystal structure of the @PROTEIN1$ bound to an @PROTEIN2$-mimetic peptide (EMP1), suggesting that Phe93 is also important for EMP1 binding.","label":0}
{"pair_id":"AIMed.d32.s270.p1","sentence":"Remarkably, Phe93 forms extensive contacts with a peptide ligand in the crystal structure of the @PROTEIN1$ bound to an @PROTEIN2$ (EMP1), suggesting that Phe93 is also important for EMP1 binding.","label":0}
{"pair_id":"AIMed.d32.s270.p2","sentence":"Remarkably, Phe93 forms extensive contacts with a peptide ligand in the crystal structure of the @PROTEIN1$ bound to an EPO-mimetic peptide (@PROTEIN2$), suggesting that Phe93 is also important for EMP1 binding.","label":1}
{"pair_id":"AIMed.d32.s270.p3","sentence":"Remarkably, Phe93 forms extensive contacts with a peptide ligand in the crystal structure of the @PROTEIN1$ bound to an EPO-mimetic peptide (EMP1), suggesting that Phe93 is also important for @PROTEIN2$ binding.","label":1}
{"pair_id":"AIMed.d32.s270.p4","sentence":"Remarkably, Phe93 forms extensive contacts with a peptide ligand in the crystal structure of the EBP bound to an @PROTEIN1$@PROTEIN2$ (EMP1), suggesting that Phe93 is also important for EMP1 binding.","label":0}
{"pair_id":"AIMed.d32.s270.p5","sentence":"Remarkably, Phe93 forms extensive contacts with a peptide ligand in the crystal structure of the EBP bound to an @PROTEIN1$-mimetic peptide (@PROTEIN2$), suggesting that Phe93 is also important for EMP1 binding.","label":0}
{"pair_id":"AIMed.d32.s270.p6","sentence":"Remarkably, Phe93 forms extensive contacts with a peptide ligand in the crystal structure of the EBP bound to an @PROTEIN1$-mimetic peptide (EMP1), suggesting that Phe93 is also important for @PROTEIN2$ binding.","label":0}
{"pair_id":"AIMed.d32.s270.p7","sentence":"Remarkably, Phe93 forms extensive contacts with a peptide ligand in the crystal structure of the EBP bound to an @PROTEIN1$ (@PROTEIN2$), suggesting that Phe93 is also important for EMP1 binding.","label":0}
{"pair_id":"AIMed.d32.s270.p8","sentence":"Remarkably, Phe93 forms extensive contacts with a peptide ligand in the crystal structure of the EBP bound to an @PROTEIN1$ (EMP1), suggesting that Phe93 is also important for @PROTEIN2$ binding.","label":0}
{"pair_id":"AIMed.d32.s270.p9","sentence":"Remarkably, Phe93 forms extensive contacts with a peptide ligand in the crystal structure of the EBP bound to an EPO-mimetic peptide (@PROTEIN1$), suggesting that Phe93 is also important for @PROTEIN2$ binding.","label":0}
{"pair_id":"AIMed.d171.s1443.p0","sentence":"@PROTEIN1$ binds the complex as an extended structure interacting with both @PROTEIN2$ and Cdk2.","label":1}
{"pair_id":"AIMed.d171.s1443.p1","sentence":"@PROTEIN1$ binds the complex as an extended structure interacting with both cyclin A and @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d171.s1443.p2","sentence":"p27Kip1 binds the complex as an extended structure interacting with both @PROTEIN1$ and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d22.s184.p0","sentence":"In the end we refer to the relations between circulating @PROTEIN1$ of renal origin and the extrarenal @PROTEIN2$ specific to tissue underlying the fact that the two RAS components cooperate and constitute a unitary hormonal system, regulating the major functions of the organism and maintaining the main homeostatic equilibria.","label":0}
{"pair_id":"AIMed.d22.s184.p1","sentence":"In the end we refer to the relations between circulating @PROTEIN1$ of renal origin and the extrarenal RAS specific to tissue underlying the fact that the two @PROTEIN2$ components cooperate and constitute a unitary hormonal system, regulating the major functions of the organism and maintaining the main homeostatic equilibria.","label":0}
{"pair_id":"AIMed.d22.s184.p2","sentence":"In the end we refer to the relations between circulating RAS of renal origin and the extrarenal @PROTEIN1$ specific to tissue underlying the fact that the two @PROTEIN2$ components cooperate and constitute a unitary hormonal system, regulating the major functions of the organism and maintaining the main homeostatic equilibria.","label":0}
{"pair_id":"AIMed.d102.s863.p0","sentence":"These cells contain a temperature-sensitive mutation in the @PROTEIN1$@PROTEIN2$ TAFII250, first identified as the cell cycle regulatory protein CCG1.","label":0}
{"pair_id":"AIMed.d102.s863.p1","sentence":"These cells contain a temperature-sensitive mutation in the @PROTEIN1$-associated factor @PROTEIN2$, first identified as the cell cycle regulatory protein CCG1.","label":0}
{"pair_id":"AIMed.d102.s863.p2","sentence":"These cells contain a temperature-sensitive mutation in the @PROTEIN1$-associated factor TAFII250, first identified as the cell cycle regulatory protein @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d102.s863.p3","sentence":"These cells contain a temperature-sensitive mutation in the @PROTEIN1$ @PROTEIN2$, first identified as the cell cycle regulatory protein CCG1.","label":0}
{"pair_id":"AIMed.d102.s863.p4","sentence":"These cells contain a temperature-sensitive mutation in the @PROTEIN1$ TAFII250, first identified as the cell cycle regulatory protein @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d102.s863.p5","sentence":"These cells contain a temperature-sensitive mutation in the TATA-binding protein-associated factor @PROTEIN1$, first identified as the cell cycle regulatory protein @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d411.s0.p0","sentence":"Mammalian homologues of two important yeast genes involved in DNA double-strand break repair and recombination, @PROTEIN2$ and @PROTEIN1$, have been isolated.","label":0}
{"pair_id":"BioInfer.d99.s0.p0","sentence":"Biochemical analyses revealed a strong induction of @PROTEIN1$ (flk-1\/KDR) tyrosine-autophosphorylation by @PROTEIN2$ which was maximal after 5 minutes and was followed by receptor downregulation.","label":1}
{"pair_id":"BioInfer.d99.s0.p1","sentence":"Biochemical analyses revealed a strong induction of @PROTEIN1$ (flk-1\/@PROTEIN2$) tyrosine-autophosphorylation by VEGF which was maximal after 5 minutes and was followed by receptor downregulation.","label":0}
{"pair_id":"BioInfer.d99.s0.p2","sentence":"Biochemical analyses revealed a strong induction of @PROTEIN1$ (@PROTEIN2$\/KDR) tyrosine-autophosphorylation by VEGF which was maximal after 5 minutes and was followed by receptor downregulation.","label":0}
{"pair_id":"BioInfer.d99.s0.p3","sentence":"Biochemical analyses revealed a strong induction of VEGF-receptor-2 (flk-1\/@PROTEIN2$) tyrosine-autophosphorylation by @PROTEIN1$ which was maximal after 5 minutes and was followed by receptor downregulation.","label":1}
{"pair_id":"BioInfer.d99.s0.p4","sentence":"Biochemical analyses revealed a strong induction of VEGF-receptor-2 (@PROTEIN2$\/KDR) tyrosine-autophosphorylation by @PROTEIN1$ which was maximal after 5 minutes and was followed by receptor downregulation.","label":1}
{"pair_id":"BioInfer.d99.s0.p5","sentence":"Biochemical analyses revealed a strong induction of VEGF-receptor-2 (@PROTEIN2$\/@PROTEIN1$) tyrosine-autophosphorylation by VEGF which was maximal after 5 minutes and was followed by receptor downregulation.","label":0}
{"pair_id":"BioInfer.d637.s0.p0","sentence":"The junctional multidomain protein @PROTEIN1$ is a binding partner of the @PROTEIN2$ GTPase and associates with the actin cytoskeletal regulator profilin.","label":1}
{"pair_id":"BioInfer.d637.s0.p1","sentence":"The junctional multidomain protein @PROTEIN1$ is a binding partner of the Rap1A GTPase and associates with the @PROTEIN2$ cytoskeletal regulator profilin.","label":0}
{"pair_id":"BioInfer.d637.s0.p2","sentence":"The junctional multidomain protein @PROTEIN1$ is a binding partner of the Rap1A @PROTEIN2$ and associates with the actin cytoskeletal regulator profilin.","label":0}
{"pair_id":"BioInfer.d637.s0.p3","sentence":"The junctional multidomain protein @PROTEIN1$ is a binding partner of the Rap1A GTPase and associates with the actin cytoskeletal regulator @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d637.s0.p4","sentence":"The junctional multidomain protein AF-6 is a binding partner of the @PROTEIN1$ GTPase and associates with the @PROTEIN2$ cytoskeletal regulator profilin.","label":0}
{"pair_id":"BioInfer.d637.s0.p5","sentence":"The junctional multidomain protein AF-6 is a binding partner of the @PROTEIN1$ @PROTEIN2$ and associates with the actin cytoskeletal regulator profilin.","label":1}
{"pair_id":"BioInfer.d637.s0.p6","sentence":"The junctional multidomain protein AF-6 is a binding partner of the @PROTEIN1$ GTPase and associates with the actin cytoskeletal regulator @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d637.s0.p7","sentence":"The junctional multidomain protein AF-6 is a binding partner of the Rap1A @PROTEIN2$ and associates with the @PROTEIN1$ cytoskeletal regulator profilin.","label":0}
{"pair_id":"BioInfer.d637.s0.p8","sentence":"The junctional multidomain protein AF-6 is a binding partner of the Rap1A GTPase and associates with the @PROTEIN1$ cytoskeletal regulator @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d637.s0.p9","sentence":"The junctional multidomain protein AF-6 is a binding partner of the Rap1A @PROTEIN1$ and associates with the actin cytoskeletal regulator @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d202.s1740.p0","sentence":"Each of these molecules binds to the @PROTEIN2$@PROTEIN1$ receptor (IL1R).","label":0}
{"pair_id":"AIMed.d202.s1740.p1","sentence":"Each of these molecules binds to the type I @PROTEIN1$ receptor (@PROTEIN2$).","label":0}
{"pair_id":"AIMed.d202.s1740.p2","sentence":"Each of these molecules binds to the @PROTEIN1$ (@PROTEIN2$).","label":0}
{"pair_id":"BioInfer.d242.s0.p0","sentence":"Here we describe the TNF-dependent activation of acid SMase (A-SMase) through the p55 TNF receptor-associated proteins @PROTEIN1$ and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d242.s0.p1","sentence":"Here we describe the @PROTEIN2$-dependent activation of acid SMase (A-SMase) through the p55 TNF receptor-associated proteins @PROTEIN1$ and FADD.","label":0}
{"pair_id":"BioInfer.d242.s0.p2","sentence":"Here we describe the TNF-dependent activation of acid SMase (A-SMase) through the @PROTEIN2$ TNF receptor-associated proteins @PROTEIN1$ and FADD.","label":1}
{"pair_id":"BioInfer.d242.s0.p3","sentence":"Here we describe the TNF-dependent activation of acid SMase (A-SMase) through the p55 @PROTEIN2$-associated proteins @PROTEIN1$ and FADD.","label":0}
{"pair_id":"BioInfer.d242.s0.p4","sentence":"Here we describe the TNF-dependent activation of @PROTEIN2$ (A-SMase) through the p55 TNF receptor-associated proteins @PROTEIN1$ and FADD.","label":1}
{"pair_id":"BioInfer.d242.s0.p5","sentence":"Here we describe the TNF-dependent activation of acid SMase (@PROTEIN2$) through the p55 TNF receptor-associated proteins @PROTEIN1$ and FADD.","label":1}
{"pair_id":"BioInfer.d242.s0.p6","sentence":"Here we describe the @PROTEIN2$-dependent activation of acid SMase (A-SMase) through the p55 TNF receptor-associated proteins TRADD and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d242.s0.p7","sentence":"Here we describe the TNF-dependent activation of acid SMase (A-SMase) through the @PROTEIN2$ TNF receptor-associated proteins TRADD and @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d242.s0.p8","sentence":"Here we describe the TNF-dependent activation of acid SMase (A-SMase) through the p55 @PROTEIN2$-associated proteins TRADD and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d242.s0.p9","sentence":"Here we describe the TNF-dependent activation of @PROTEIN2$ (A-SMase) through the p55 TNF receptor-associated proteins TRADD and @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d242.s0.p10","sentence":"Here we describe the TNF-dependent activation of acid SMase (@PROTEIN2$) through the p55 TNF receptor-associated proteins TRADD and @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d242.s0.p11","sentence":"Here we describe the @PROTEIN1$-dependent activation of acid SMase (A-SMase) through the @PROTEIN2$ TNF receptor-associated proteins TRADD and FADD.","label":0}
{"pair_id":"BioInfer.d242.s0.p12","sentence":"Here we describe the @PROTEIN1$-dependent activation of acid SMase (A-SMase) through the p55 @PROTEIN2$-associated proteins TRADD and FADD.","label":0}
{"pair_id":"BioInfer.d242.s0.p13","sentence":"Here we describe the @PROTEIN1$-dependent activation of @PROTEIN2$ (A-SMase) through the p55 TNF receptor-associated proteins TRADD and FADD.","label":1}
{"pair_id":"BioInfer.d242.s0.p14","sentence":"Here we describe the @PROTEIN1$-dependent activation of acid SMase (@PROTEIN2$) through the p55 TNF receptor-associated proteins TRADD and FADD.","label":1}
{"pair_id":"BioInfer.d242.s0.p15","sentence":"Here we describe the TNF-dependent activation of acid SMase (A-SMase) through the @PROTEIN1$ @PROTEIN2$-associated proteins TRADD and FADD.","label":1}
{"pair_id":"BioInfer.d242.s0.p16","sentence":"Here we describe the TNF-dependent activation of @PROTEIN2$ (A-SMase) through the @PROTEIN1$ TNF receptor-associated proteins TRADD and FADD.","label":0}
{"pair_id":"BioInfer.d242.s0.p17","sentence":"Here we describe the TNF-dependent activation of acid SMase (@PROTEIN2$) through the @PROTEIN1$ TNF receptor-associated proteins TRADD and FADD.","label":0}
{"pair_id":"BioInfer.d242.s0.p18","sentence":"Here we describe the TNF-dependent activation of @PROTEIN2$ (A-SMase) through the p55 @PROTEIN1$-associated proteins TRADD and FADD.","label":0}
{"pair_id":"BioInfer.d242.s0.p19","sentence":"Here we describe the TNF-dependent activation of acid SMase (@PROTEIN2$) through the p55 @PROTEIN1$-associated proteins TRADD and FADD.","label":0}
{"pair_id":"BioInfer.d242.s0.p20","sentence":"Here we describe the TNF-dependent activation of @PROTEIN1$ (@PROTEIN2$) through the p55 TNF receptor-associated proteins TRADD and FADD.","label":0}
{"pair_id":"BioInfer.d762.s0.p0","sentence":"To check its applicability, well characterized, commercially available antibodies (against E-cadherin, @PROTEIN1$, and @PROTEIN2$) were used on sections of human small intestine.","label":0}
{"pair_id":"BioInfer.d762.s0.p1","sentence":"To check its applicability, well characterized, commercially available antibodies (against @PROTEIN2$, @PROTEIN1$, and beta-catenin) were used on sections of human small intestine.","label":0}
{"pair_id":"BioInfer.d762.s0.p2","sentence":"To check its applicability, well characterized, commercially available antibodies (against @PROTEIN2$, alpha-catenin, and @PROTEIN1$) were used on sections of human small intestine.","label":0}
{"pair_id":"AIMed.d39.s334.p0","sentence":"@PROTEIN1$ suppresses the function of @PROTEIN2$ homodimers via interaction with QM\/Jif-1.","label":0}
{"pair_id":"AIMed.d39.s334.p1","sentence":"@PROTEIN1$ suppresses the function of c-Jun homodimers via interaction with @PROTEIN2$\/Jif-1.","label":1}
{"pair_id":"AIMed.d39.s334.p2","sentence":"@PROTEIN1$ suppresses the function of c-Jun homodimers via interaction with QM\/@PROTEIN2$.","label":1}
{"pair_id":"AIMed.d39.s334.p3","sentence":"Presenilin 1 suppresses the function of @PROTEIN1$ homodimers via interaction with @PROTEIN2$\/Jif-1.","label":0}
{"pair_id":"AIMed.d39.s334.p4","sentence":"Presenilin 1 suppresses the function of @PROTEIN1$ homodimers via interaction with QM\/@PROTEIN2$.","label":0}
{"pair_id":"AIMed.d39.s334.p5","sentence":"Presenilin 1 suppresses the function of c-Jun homodimers via interaction with @PROTEIN1$\/@PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d670.s1.p0","sentence":"These results suggest that @PROTEIN1$ and @PROTEIN2$ can function differentially to control homeologous exchanges.","label":0}
{"pair_id":"AIMed.d163.s1376.p0","sentence":"Thus, @PROTEIN1$ is likely to play a role in sorting @PROTEIN2$ to lysosomes.","label":0}
{"pair_id":"BioInfer.d370.s0.p0","sentence":"In the present paper, using indirect immunofluorescence, we found that PMN adhesion to tumor necrosis factor-activated endothelial cells (EC) induced the disappearance from endothelial cell-to-cell contacts of adherens junction (AJ) components: vascular endothelial (VE)-vascular, alpha-catenin, @PROTEIN2$, and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d370.s0.p1","sentence":"In the present paper, using indirect immunofluorescence, we found that PMN adhesion to tumor necrosis factor-activated endothelial cells (EC) induced the disappearance from endothelial cell-to-cell contacts of adherens junction (AJ) components: vascular endothelial (VE)-vascular, @PROTEIN2$, beta-catenin, and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d370.s0.p2","sentence":"In the present paper, using indirect immunofluorescence, we found that PMN adhesion to tumor necrosis factor-activated endothelial cells (EC) induced the disappearance from endothelial cell-to-cell contacts of adherens junction (AJ) components: @PROTEIN2$ (VE)-@PROTEIN2$, alpha-catenin, beta-catenin, and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d370.s0.p3","sentence":"In the present paper, using indirect immunofluorescence, we found that PMN adhesion to @PROTEIN2$-activated endothelial cells (EC) induced the disappearance from endothelial cell-to-cell contacts of adherens junction (AJ) components: vascular endothelial (VE)-vascular, alpha-catenin, beta-catenin, and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d370.s0.p4","sentence":"In the present paper, using indirect immunofluorescence, we found that PMN adhesion to tumor necrosis factor-activated endothelial cells (EC) induced the disappearance from endothelial cell-to-cell contacts of adherens junction (AJ) components: vascular endothelial (VE)-vascular, @PROTEIN2$, @PROTEIN1$, and plakoglobin.","label":0}
{"pair_id":"BioInfer.d370.s0.p5","sentence":"In the present paper, using indirect immunofluorescence, we found that PMN adhesion to tumor necrosis factor-activated endothelial cells (EC) induced the disappearance from endothelial cell-to-cell contacts of adherens junction (AJ) components: @PROTEIN2$ (VE)-@PROTEIN2$, alpha-catenin, @PROTEIN1$, and plakoglobin.","label":0}
{"pair_id":"BioInfer.d370.s0.p6","sentence":"In the present paper, using indirect immunofluorescence, we found that PMN adhesion to @PROTEIN2$-activated endothelial cells (EC) induced the disappearance from endothelial cell-to-cell contacts of adherens junction (AJ) components: vascular endothelial (VE)-vascular, alpha-catenin, @PROTEIN1$, and plakoglobin.","label":0}
{"pair_id":"BioInfer.d370.s0.p7","sentence":"In the present paper, using indirect immunofluorescence, we found that PMN adhesion to tumor necrosis factor-activated endothelial cells (EC) induced the disappearance from endothelial cell-to-cell contacts of adherens junction (AJ) components: @PROTEIN2$ (VE)-@PROTEIN2$, @PROTEIN1$, beta-catenin, and plakoglobin.","label":0}
{"pair_id":"BioInfer.d370.s0.p8","sentence":"In the present paper, using indirect immunofluorescence, we found that PMN adhesion to @PROTEIN2$-activated endothelial cells (EC) induced the disappearance from endothelial cell-to-cell contacts of adherens junction (AJ) components: vascular endothelial (VE)-vascular, @PROTEIN1$, beta-catenin, and plakoglobin.","label":0}
{"pair_id":"BioInfer.d370.s0.p9","sentence":"In the present paper, using indirect immunofluorescence, we found that PMN adhesion to @PROTEIN2$-activated endothelial cells (EC) induced the disappearance from endothelial cell-to-cell contacts of adherens junction (AJ) components: @PROTEIN1$ (VE)-@PROTEIN1$, alpha-catenin, beta-catenin, and plakoglobin.","label":0}
{"pair_id":"AIMed.d199.s1712.p0","sentence":"@PROTEIN1$ and @PROTEIN2$.pp66.","label":0}
{"pair_id":"AIMed.d199.s1712.p1","sentence":"@PROTEIN1$ and 80K-H.@PROTEIN2$.","label":0}
{"pair_id":"AIMed.d199.s1712.p2","sentence":"Sos and @PROTEIN1$.@PROTEIN2$.","label":1}
{"pair_id":"AIMed.d90.s767.p0","sentence":"Using radiolabeled @PROTEIN1$ protein as a probe, we screened a B cell cDNA expression library and isolated a number of clones encoding @PROTEIN2$ interacting proteins.","label":0}
{"pair_id":"AIMed.d14.s119.p0","sentence":"Abnormal levels of @PROTEIN1$ and @PROTEIN2$ were significantly associated with increasing CSF cell number and protein concentration, and with the absence of lymph nodes or the absence of trypanosomes in lymph node aspirate.","label":0}
{"pair_id":"AIMed.d199.s1695.p0","sentence":"Stimulation of @PROTEIN1$ (@PROTEIN2$) results in a variety of functional effects, including regulation of epithelial cell growth and differentiation.","label":0}
{"pair_id":"AIMed.d219.s1908.p0","sentence":"Thus, 14-3-3 interaction with the @PROTEIN1$ may serve in negative regulation of @PROTEIN2$ function by facilitating dissociation of 14-3-3 from the NH2 terminus of Raf-1 to promote subsequent events necessary for full activation of Raf-1.","label":0}
{"pair_id":"AIMed.d219.s1908.p1","sentence":"Thus, 14-3-3 interaction with the @PROTEIN1$ may serve in negative regulation of Raf-1 function by facilitating dissociation of 14-3-3 from the NH2 terminus of @PROTEIN2$ to promote subsequent events necessary for full activation of Raf-1.","label":0}
{"pair_id":"AIMed.d219.s1908.p2","sentence":"Thus, 14-3-3 interaction with the @PROTEIN1$ may serve in negative regulation of Raf-1 function by facilitating dissociation of 14-3-3 from the NH2 terminus of Raf-1 to promote subsequent events necessary for full activation of @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d219.s1908.p3","sentence":"Thus, 14-3-3 interaction with the Raf-CRD may serve in negative regulation of @PROTEIN1$ function by facilitating dissociation of 14-3-3 from the NH2 terminus of @PROTEIN2$ to promote subsequent events necessary for full activation of Raf-1.","label":0}
{"pair_id":"AIMed.d219.s1908.p4","sentence":"Thus, 14-3-3 interaction with the Raf-CRD may serve in negative regulation of @PROTEIN1$ function by facilitating dissociation of 14-3-3 from the NH2 terminus of Raf-1 to promote subsequent events necessary for full activation of @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d219.s1908.p5","sentence":"Thus, 14-3-3 interaction with the Raf-CRD may serve in negative regulation of Raf-1 function by facilitating dissociation of 14-3-3 from the NH2 terminus of @PROTEIN1$ to promote subsequent events necessary for full activation of @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d315.s0.p0","sentence":"In addition, we have demonstrated that increased gene dosage of either SIR1 or @PROTEIN1$, two other factors required for silencing, suppresses the silencing defect of the @PROTEIN2$ mutants.","label":1}
{"pair_id":"BioInfer.d315.s0.p1","sentence":"In addition, we have demonstrated that increased gene dosage of either @PROTEIN2$ or @PROTEIN1$, two other factors required for silencing, suppresses the silencing defect of the rap1 mutants.","label":0}
{"pair_id":"BioInfer.d315.s0.p2","sentence":"In addition, we have demonstrated that increased gene dosage of either @PROTEIN2$ or SIR4, two other factors required for silencing, suppresses the silencing defect of the @PROTEIN1$ mutants.","label":1}
{"pair_id":"BioInfer.d375.s1.p0","sentence":"Quantitative analysis of the effect of Acanthamoeba @PROTEIN1$ on @PROTEIN2$ filament nucleation and elongation.","label":1}
{"pair_id":"AIMed.d70.s597.p0","sentence":"A bacterially expressed 318-amino acid fragment, @PROTEIN1$ (418-736), containing the amphipathic helix region, was able to bind @PROTEIN2$ alpha.","label":0}
{"pair_id":"AIMed.d70.s597.p1","sentence":"A bacterially expressed 318-amino acid fragment, @PROTEIN1$ (418-736), containing the amphipathic helix region, was able to bind @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d70.s597.p2","sentence":"A bacterially expressed 318-amino acid fragment, Ht 31 (418-736), containing the amphipathic helix region, was able to bind @PROTEIN1$@PROTEIN2$.","label":0}
{"pair_id":"AIMed.d108.s912.p0","sentence":"Here, a direct interaction between the activation domain of @PROTEIN1$ and two subunits of the @PROTEIN2$ complex, TAFII40 and TAFII60, is reported.","label":0}
{"pair_id":"AIMed.d108.s912.p1","sentence":"Here, a direct interaction between the activation domain of @PROTEIN1$ and two subunits of the TFIID complex, @PROTEIN2$ and TAFII60, is reported.","label":1}
{"pair_id":"AIMed.d108.s912.p2","sentence":"Here, a direct interaction between the activation domain of @PROTEIN1$ and two subunits of the TFIID complex, TAFII40 and @PROTEIN2$, is reported.","label":1}
{"pair_id":"AIMed.d108.s912.p3","sentence":"Here, a direct interaction between the activation domain of p53 and two subunits of the @PROTEIN1$ complex, @PROTEIN2$ and TAFII60, is reported.","label":0}
{"pair_id":"AIMed.d108.s912.p4","sentence":"Here, a direct interaction between the activation domain of p53 and two subunits of the @PROTEIN1$ complex, TAFII40 and @PROTEIN2$, is reported.","label":0}
{"pair_id":"AIMed.d108.s912.p5","sentence":"Here, a direct interaction between the activation domain of p53 and two subunits of the TFIID complex, @PROTEIN1$ and @PROTEIN2$, is reported.","label":0}
{"pair_id":"BioInfer.d35.s0.p0","sentence":"@PROTEIN1$ interacts with cofilin to disassemble @PROTEIN2$ filaments.","label":1}
{"pair_id":"BioInfer.d35.s0.p1","sentence":"@PROTEIN1$ interacts with @PROTEIN2$ to disassemble actin filaments.","label":1}
{"pair_id":"BioInfer.d35.s0.p2","sentence":"Aip1p interacts with @PROTEIN2$ to disassemble @PROTEIN1$ filaments.","label":1}
{"pair_id":"AIMed.d214.s1857.p0","sentence":"Proto-oncoprotein @PROTEIN1$ interacts with @PROTEIN2$ in activated thymocytes and peripheral T cells.","label":1}
{"pair_id":"BioInfer.d795.s0.p0","sentence":"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as @PROTEIN1$\/@PROTEIN2$-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.","label":0}
{"pair_id":"BioInfer.d795.s0.p1","sentence":"WASp contains a binding motif for the Rho GTPase @PROTEIN2$ as well as @PROTEIN1$\/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.","label":0}
{"pair_id":"BioInfer.d795.s0.p2","sentence":"@PROTEIN2$ contains a binding motif for the Rho GTPase CDC42Hs as well as @PROTEIN1$\/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.","label":1}
{"pair_id":"BioInfer.d795.s0.p3","sentence":"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as @PROTEIN1$\/cofilin-like actin-regulatory domains, but no specific actin structure regulated by @PROTEIN2$-WASp has been identified.","label":0}
{"pair_id":"BioInfer.d795.s0.p4","sentence":"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as @PROTEIN1$\/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-@PROTEIN2$ has been identified.","label":0}
{"pair_id":"BioInfer.d795.s0.p5","sentence":"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as @PROTEIN1$\/cofilin-like @PROTEIN2$-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.","label":0}
{"pair_id":"BioInfer.d795.s0.p6","sentence":"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as @PROTEIN1$\/cofilin-like actin-regulatory domains, but no specific @PROTEIN2$ structure regulated by CDC42Hs-WASp has been identified.","label":0}
{"pair_id":"BioInfer.d795.s0.p7","sentence":"WASp contains a binding motif for the @PROTEIN2$ CDC42Hs as well as @PROTEIN1$\/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.","label":0}
{"pair_id":"BioInfer.d795.s0.p8","sentence":"WASp contains a binding motif for the Rho GTPase @PROTEIN2$ as well as verprolin\/@PROTEIN1$-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.","label":0}
{"pair_id":"BioInfer.d795.s0.p9","sentence":"@PROTEIN2$ contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin\/@PROTEIN1$-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.","label":1}
{"pair_id":"BioInfer.d795.s0.p10","sentence":"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin\/@PROTEIN1$-like actin-regulatory domains, but no specific actin structure regulated by @PROTEIN2$-WASp has been identified.","label":0}
{"pair_id":"BioInfer.d795.s0.p11","sentence":"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin\/@PROTEIN1$-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-@PROTEIN2$ has been identified.","label":0}
{"pair_id":"BioInfer.d795.s0.p12","sentence":"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin\/@PROTEIN1$-like @PROTEIN2$-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.","label":0}
{"pair_id":"BioInfer.d795.s0.p13","sentence":"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin\/@PROTEIN1$-like actin-regulatory domains, but no specific @PROTEIN2$ structure regulated by CDC42Hs-WASp has been identified.","label":0}
{"pair_id":"BioInfer.d795.s0.p14","sentence":"WASp contains a binding motif for the @PROTEIN2$ CDC42Hs as well as verprolin\/@PROTEIN1$-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.","label":0}
{"pair_id":"BioInfer.d795.s0.p15","sentence":"@PROTEIN2$ contains a binding motif for the Rho GTPase @PROTEIN1$ as well as verprolin\/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.","label":1}
{"pair_id":"BioInfer.d795.s0.p16","sentence":"WASp contains a binding motif for the Rho GTPase @PROTEIN1$ as well as verprolin\/cofilin-like actin-regulatory domains, but no specific actin structure regulated by @PROTEIN2$-WASp has been identified.","label":0}
{"pair_id":"BioInfer.d795.s0.p17","sentence":"WASp contains a binding motif for the Rho GTPase @PROTEIN1$ as well as verprolin\/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-@PROTEIN2$ has been identified.","label":0}
{"pair_id":"BioInfer.d795.s0.p18","sentence":"WASp contains a binding motif for the Rho GTPase @PROTEIN1$ as well as verprolin\/cofilin-like @PROTEIN2$-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.","label":0}
{"pair_id":"BioInfer.d795.s0.p19","sentence":"WASp contains a binding motif for the Rho GTPase @PROTEIN1$ as well as verprolin\/cofilin-like actin-regulatory domains, but no specific @PROTEIN2$ structure regulated by CDC42Hs-WASp has been identified.","label":0}
{"pair_id":"BioInfer.d795.s0.p20","sentence":"WASp contains a binding motif for the @PROTEIN2$ @PROTEIN1$ as well as verprolin\/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.","label":1}
{"pair_id":"BioInfer.d795.s0.p21","sentence":"@PROTEIN1$ contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin\/cofilin-like actin-regulatory domains, but no specific actin structure regulated by @PROTEIN2$-WASp has been identified.","label":0}
{"pair_id":"BioInfer.d795.s0.p22","sentence":"@PROTEIN1$ contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin\/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-@PROTEIN2$ has been identified.","label":0}
{"pair_id":"BioInfer.d795.s0.p23","sentence":"@PROTEIN1$ contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin\/cofilin-like @PROTEIN2$-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.","label":1}
{"pair_id":"BioInfer.d795.s0.p24","sentence":"@PROTEIN1$ contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin\/cofilin-like actin-regulatory domains, but no specific @PROTEIN2$ structure regulated by CDC42Hs-WASp has been identified.","label":0}
{"pair_id":"BioInfer.d795.s0.p25","sentence":"@PROTEIN1$ contains a binding motif for the @PROTEIN2$ CDC42Hs as well as verprolin\/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.","label":0}
{"pair_id":"BioInfer.d795.s0.p26","sentence":"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin\/cofilin-like actin-regulatory domains, but no specific actin structure regulated by @PROTEIN1$-@PROTEIN2$ has been identified.","label":1}
{"pair_id":"BioInfer.d795.s0.p27","sentence":"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin\/cofilin-like @PROTEIN2$-regulatory domains, but no specific actin structure regulated by @PROTEIN1$-WASp has been identified.","label":0}
{"pair_id":"BioInfer.d795.s0.p28","sentence":"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin\/cofilin-like actin-regulatory domains, but no specific @PROTEIN2$ structure regulated by @PROTEIN1$-WASp has been identified.","label":1}
{"pair_id":"BioInfer.d795.s0.p29","sentence":"WASp contains a binding motif for the @PROTEIN2$ CDC42Hs as well as verprolin\/cofilin-like actin-regulatory domains, but no specific actin structure regulated by @PROTEIN1$-WASp has been identified.","label":0}
{"pair_id":"BioInfer.d795.s0.p30","sentence":"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin\/cofilin-like @PROTEIN2$-regulatory domains, but no specific actin structure regulated by CDC42Hs-@PROTEIN1$ has been identified.","label":0}
{"pair_id":"BioInfer.d795.s0.p31","sentence":"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin\/cofilin-like actin-regulatory domains, but no specific @PROTEIN2$ structure regulated by CDC42Hs-@PROTEIN1$ has been identified.","label":1}
{"pair_id":"BioInfer.d795.s0.p32","sentence":"WASp contains a binding motif for the @PROTEIN2$ CDC42Hs as well as verprolin\/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-@PROTEIN1$ has been identified.","label":0}
{"pair_id":"BioInfer.d795.s0.p33","sentence":"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin\/cofilin-like @PROTEIN1$-regulatory domains, but no specific @PROTEIN2$ structure regulated by CDC42Hs-WASp has been identified.","label":0}
{"pair_id":"BioInfer.d795.s0.p34","sentence":"WASp contains a binding motif for the @PROTEIN2$ CDC42Hs as well as verprolin\/cofilin-like @PROTEIN1$-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.","label":0}
{"pair_id":"BioInfer.d795.s0.p35","sentence":"WASp contains a binding motif for the @PROTEIN2$ CDC42Hs as well as verprolin\/cofilin-like actin-regulatory domains, but no specific @PROTEIN1$ structure regulated by CDC42Hs-WASp has been identified.","label":0}
{"pair_id":"AIMed.d82.s697.p0","sentence":"Previously, a mammalian protein that directly associates with @PROTEIN1$-rapamycin has been identified and its encoding gene has been cloned from both human (designated @PROTEIN2$) [Brown, E.J., Albers, M.W., Shin, T.B., Ichikawa, K., Keith, C.T., Lane, W.S. & Schreiber, S.L. (1994) Nature (London) 369, 756-758] and rat (designated RAFT) [Sabatini, D.M., Erdjument-Bromage, H., Lui, M., Tempst, P. & Snyder, S.H. (1994) Cell 78, 35-43].","label":1}
{"pair_id":"AIMed.d82.s697.p1","sentence":"Previously, a mammalian protein that directly associates with @PROTEIN1$-rapamycin has been identified and its encoding gene has been cloned from both human (designated FRAP) [Brown, E.J., Albers, M.W., Shin, T.B., Ichikawa, K., Keith, C.T., Lane, W.S. & Schreiber, S.L. (1994) Nature (London) 369, 756-758] and rat (designated @PROTEIN2$) [Sabatini, D.M., Erdjument-Bromage, H., Lui, M., Tempst, P. & Snyder, S.H. (1994) Cell 78, 35-43].","label":0}
{"pair_id":"AIMed.d82.s697.p2","sentence":"Previously, a mammalian protein that directly associates with FKBP12-rapamycin has been identified and its encoding gene has been cloned from both human (designated @PROTEIN1$) [Brown, E.J., Albers, M.W., Shin, T.B., Ichikawa, K., Keith, C.T., Lane, W.S. & Schreiber, S.L. (1994) Nature (London) 369, 756-758] and rat (designated @PROTEIN2$) [Sabatini, D.M., Erdjument-Bromage, H., Lui, M., Tempst, P. & Snyder, S.H. (1994) Cell 78, 35-43].","label":0}
{"pair_id":"BioInfer.d262.s0.p0","sentence":"HGF\/@PROTEIN1$ treatment of LoVo reduced the amount of @PROTEIN2$ complexed with E-cadherin more markedly than in L-10, but in both cell lines this reduction was not accompanied by increased tyrosine phosphorylation of beta-catenin, suggesting the presence of a mechanism other than phosphorylation for release from cell-cell adhesion during cell motility.","label":0}
{"pair_id":"BioInfer.d262.s0.p1","sentence":"HGF\/@PROTEIN1$ treatment of LoVo reduced the amount of alpha-catenin complexed with @PROTEIN2$ more markedly than in L-10, but in both cell lines this reduction was not accompanied by increased tyrosine phosphorylation of beta-catenin, suggesting the presence of a mechanism other than phosphorylation for release from cell-cell adhesion during cell motility.","label":0}
{"pair_id":"BioInfer.d262.s0.p2","sentence":"@PROTEIN2$\/@PROTEIN1$ treatment of LoVo reduced the amount of alpha-catenin complexed with E-cadherin more markedly than in L-10, but in both cell lines this reduction was not accompanied by increased tyrosine phosphorylation of beta-catenin, suggesting the presence of a mechanism other than phosphorylation for release from cell-cell adhesion during cell motility.","label":0}
{"pair_id":"BioInfer.d262.s0.p3","sentence":"HGF\/@PROTEIN1$ treatment of LoVo reduced the amount of alpha-catenin complexed with E-cadherin more markedly than in L-10, but in both cell lines this reduction was not accompanied by increased tyrosine phosphorylation of @PROTEIN2$, suggesting the presence of a mechanism other than phosphorylation for release from cell-cell adhesion during cell motility.","label":0}
{"pair_id":"BioInfer.d262.s0.p4","sentence":"HGF\/SF treatment of LoVo reduced the amount of @PROTEIN1$ complexed with @PROTEIN2$ more markedly than in L-10, but in both cell lines this reduction was not accompanied by increased tyrosine phosphorylation of beta-catenin, suggesting the presence of a mechanism other than phosphorylation for release from cell-cell adhesion during cell motility.","label":1}
{"pair_id":"BioInfer.d262.s0.p5","sentence":"@PROTEIN2$\/SF treatment of LoVo reduced the amount of @PROTEIN1$ complexed with E-cadherin more markedly than in L-10, but in both cell lines this reduction was not accompanied by increased tyrosine phosphorylation of beta-catenin, suggesting the presence of a mechanism other than phosphorylation for release from cell-cell adhesion during cell motility.","label":0}
{"pair_id":"BioInfer.d262.s0.p6","sentence":"HGF\/SF treatment of LoVo reduced the amount of @PROTEIN1$ complexed with E-cadherin more markedly than in L-10, but in both cell lines this reduction was not accompanied by increased tyrosine phosphorylation of @PROTEIN2$, suggesting the presence of a mechanism other than phosphorylation for release from cell-cell adhesion during cell motility.","label":0}
{"pair_id":"BioInfer.d262.s0.p7","sentence":"@PROTEIN2$\/SF treatment of LoVo reduced the amount of alpha-catenin complexed with @PROTEIN1$ more markedly than in L-10, but in both cell lines this reduction was not accompanied by increased tyrosine phosphorylation of beta-catenin, suggesting the presence of a mechanism other than phosphorylation for release from cell-cell adhesion during cell motility.","label":0}
{"pair_id":"BioInfer.d262.s0.p8","sentence":"HGF\/SF treatment of LoVo reduced the amount of alpha-catenin complexed with @PROTEIN1$ more markedly than in L-10, but in both cell lines this reduction was not accompanied by increased tyrosine phosphorylation of @PROTEIN2$, suggesting the presence of a mechanism other than phosphorylation for release from cell-cell adhesion during cell motility.","label":0}
{"pair_id":"BioInfer.d262.s0.p9","sentence":"@PROTEIN1$\/SF treatment of LoVo reduced the amount of alpha-catenin complexed with E-cadherin more markedly than in L-10, but in both cell lines this reduction was not accompanied by increased tyrosine phosphorylation of @PROTEIN2$, suggesting the presence of a mechanism other than phosphorylation for release from cell-cell adhesion during cell motility.","label":0}
{"pair_id":"AIMed.d54.s478.p0","sentence":"@PROTEIN1$ exhibits greater mitogenic potency than @PROTEIN2$ and comparable or greater mitogenic activity than PDGF-AB and PDGF-BB on several mesenchymal cell types.","label":0}
{"pair_id":"AIMed.d54.s478.p1","sentence":"@PROTEIN1$ exhibits greater mitogenic potency than PDGF-AA and comparable or greater mitogenic activity than @PROTEIN2$ and PDGF-BB on several mesenchymal cell types.","label":0}
{"pair_id":"AIMed.d54.s478.p2","sentence":"@PROTEIN1$ exhibits greater mitogenic potency than PDGF-AA and comparable or greater mitogenic activity than PDGF-AB and @PROTEIN2$ on several mesenchymal cell types.","label":0}
{"pair_id":"AIMed.d54.s478.p3","sentence":"PDGF-CC exhibits greater mitogenic potency than @PROTEIN1$ and comparable or greater mitogenic activity than @PROTEIN2$ and PDGF-BB on several mesenchymal cell types.","label":0}
{"pair_id":"AIMed.d54.s478.p4","sentence":"PDGF-CC exhibits greater mitogenic potency than @PROTEIN1$ and comparable or greater mitogenic activity than PDGF-AB and @PROTEIN2$ on several mesenchymal cell types.","label":0}
{"pair_id":"AIMed.d54.s478.p5","sentence":"PDGF-CC exhibits greater mitogenic potency than PDGF-AA and comparable or greater mitogenic activity than @PROTEIN1$ and @PROTEIN2$ on several mesenchymal cell types.","label":0}
{"pair_id":"AIMed.d127.s1085.p0","sentence":"@PROTEIN1$ (@PROTEIN2$) signaling requires the dimerization of the IL-2 receptor beta.(IL-2R beta) and common gamma (gamma c) chains.","label":0}
{"pair_id":"AIMed.d127.s1085.p1","sentence":"@PROTEIN1$ (IL-2) signaling requires the dimerization of the @PROTEIN2$ receptor beta.(IL-2R beta) and common gamma (gamma c) chains.","label":0}
{"pair_id":"AIMed.d127.s1085.p2","sentence":"@PROTEIN1$ (IL-2) signaling requires the dimerization of the @PROTEIN2$.(IL-2R beta) and common gamma (gamma c) chains.","label":0}
{"pair_id":"AIMed.d127.s1085.p3","sentence":"@PROTEIN1$ (IL-2) signaling requires the dimerization of the IL-2 receptor beta.(@PROTEIN2$) and common gamma (gamma c) chains.","label":0}
{"pair_id":"AIMed.d127.s1085.p4","sentence":"Interleukin-2 (@PROTEIN1$) signaling requires the dimerization of the @PROTEIN2$ receptor beta.(IL-2R beta) and common gamma (gamma c) chains.","label":0}
{"pair_id":"AIMed.d127.s1085.p5","sentence":"Interleukin-2 (@PROTEIN1$) signaling requires the dimerization of the @PROTEIN2$.(IL-2R beta) and common gamma (gamma c) chains.","label":0}
{"pair_id":"AIMed.d127.s1085.p6","sentence":"Interleukin-2 (@PROTEIN1$) signaling requires the dimerization of the IL-2 receptor beta.(@PROTEIN2$) and common gamma (gamma c) chains.","label":0}
{"pair_id":"AIMed.d127.s1085.p7","sentence":"Interleukin-2 (IL-2) signaling requires the dimerization of the @PROTEIN1$@PROTEIN2$.(IL-2R beta) and common gamma (gamma c) chains.","label":0}
{"pair_id":"AIMed.d127.s1085.p8","sentence":"Interleukin-2 (IL-2) signaling requires the dimerization of the @PROTEIN1$ receptor beta.(@PROTEIN2$) and common gamma (gamma c) chains.","label":0}
{"pair_id":"AIMed.d127.s1085.p9","sentence":"Interleukin-2 (IL-2) signaling requires the dimerization of the @PROTEIN1$.(@PROTEIN2$) and common gamma (gamma c) chains.","label":0}
{"pair_id":"BioInfer.d60.s1.p0","sentence":"In this study, cell cycle-dependent expression of human and rodent @PROTEIN2$ and @PROTEIN1$ proteins was monitored using two approaches.","label":0}
{"pair_id":"BioInfer.d278.s1.p0","sentence":"This suggests that dephosphorylation of cofilin and destrin\/@PROTEIN1$ by @PROTEIN2$ could be implicated in the disruption of actin-containing stress fibers and in the reorganization of microfilaments induced by this hormone.","label":1}
{"pair_id":"BioInfer.d278.s1.p1","sentence":"This suggests that dephosphorylation of cofilin and destrin\/@PROTEIN1$ by TSH could be implicated in the disruption of @PROTEIN2$-containing stress fibers and in the reorganization of microfilaments induced by this hormone.","label":1}
{"pair_id":"BioInfer.d278.s1.p2","sentence":"This suggests that dephosphorylation of cofilin and @PROTEIN2$\/@PROTEIN1$ by TSH could be implicated in the disruption of actin-containing stress fibers and in the reorganization of microfilaments induced by this hormone.","label":0}
{"pair_id":"BioInfer.d278.s1.p3","sentence":"This suggests that dephosphorylation of @PROTEIN2$ and destrin\/@PROTEIN1$ by TSH could be implicated in the disruption of actin-containing stress fibers and in the reorganization of microfilaments induced by this hormone.","label":0}
{"pair_id":"BioInfer.d278.s1.p4","sentence":"This suggests that dephosphorylation of cofilin and destrin\/ADF by @PROTEIN1$ could be implicated in the disruption of @PROTEIN2$-containing stress fibers and in the reorganization of microfilaments induced by this hormone.","label":1}
{"pair_id":"BioInfer.d278.s1.p5","sentence":"This suggests that dephosphorylation of cofilin and @PROTEIN2$\/ADF by @PROTEIN1$ could be implicated in the disruption of actin-containing stress fibers and in the reorganization of microfilaments induced by this hormone.","label":1}
{"pair_id":"BioInfer.d278.s1.p6","sentence":"This suggests that dephosphorylation of @PROTEIN2$ and destrin\/ADF by @PROTEIN1$ could be implicated in the disruption of actin-containing stress fibers and in the reorganization of microfilaments induced by this hormone.","label":1}
{"pair_id":"BioInfer.d278.s1.p7","sentence":"This suggests that dephosphorylation of cofilin and @PROTEIN2$\/ADF by TSH could be implicated in the disruption of @PROTEIN1$-containing stress fibers and in the reorganization of microfilaments induced by this hormone.","label":1}
{"pair_id":"BioInfer.d278.s1.p8","sentence":"This suggests that dephosphorylation of @PROTEIN2$ and destrin\/ADF by TSH could be implicated in the disruption of @PROTEIN1$-containing stress fibers and in the reorganization of microfilaments induced by this hormone.","label":1}
{"pair_id":"BioInfer.d278.s1.p9","sentence":"This suggests that dephosphorylation of @PROTEIN2$ and @PROTEIN1$\/ADF by TSH could be implicated in the disruption of actin-containing stress fibers and in the reorganization of microfilaments induced by this hormone.","label":0}
{"pair_id":"AIMed.d216.s1873.p0","sentence":"The three-dimensional structure of the complex between human @PROTEIN1$ bound to guanosine diphosphate and the guanosine triphosphatase (GTPase)-activating domain of the human @PROTEIN2$ p120GAP (GAP-334) in the presence of aluminum fluoride was solved at a resolution of 2.5 angstroms.","label":0}
{"pair_id":"AIMed.d216.s1873.p1","sentence":"The three-dimensional structure of the complex between human @PROTEIN1$ bound to guanosine diphosphate and the guanosine triphosphatase (GTPase)-activating domain of the human GTPase-activating protein @PROTEIN2$ (GAP-334) in the presence of aluminum fluoride was solved at a resolution of 2.5 angstroms.","label":1}
{"pair_id":"AIMed.d216.s1873.p2","sentence":"The three-dimensional structure of the complex between human @PROTEIN1$ bound to guanosine diphosphate and the guanosine triphosphatase (GTPase)-activating domain of the human GTPase-activating protein p120GAP (@PROTEIN2$) in the presence of aluminum fluoride was solved at a resolution of 2.5 angstroms.","label":1}
{"pair_id":"AIMed.d216.s1873.p3","sentence":"The three-dimensional structure of the complex between human H-Ras bound to guanosine diphosphate and the guanosine triphosphatase (GTPase)-activating domain of the human @PROTEIN1$ @PROTEIN2$ (GAP-334) in the presence of aluminum fluoride was solved at a resolution of 2.5 angstroms.","label":0}
{"pair_id":"AIMed.d216.s1873.p4","sentence":"The three-dimensional structure of the complex between human H-Ras bound to guanosine diphosphate and the guanosine triphosphatase (GTPase)-activating domain of the human @PROTEIN1$ p120GAP (@PROTEIN2$) in the presence of aluminum fluoride was solved at a resolution of 2.5 angstroms.","label":0}
{"pair_id":"AIMed.d216.s1873.p5","sentence":"The three-dimensional structure of the complex between human H-Ras bound to guanosine diphosphate and the guanosine triphosphatase (GTPase)-activating domain of the human GTPase-activating protein @PROTEIN1$ (@PROTEIN2$) in the presence of aluminum fluoride was solved at a resolution of 2.5 angstroms.","label":0}
{"pair_id":"AIMed.d43.s376.p0","sentence":"In this study, a minimum set of residues in the human @PROTEIN1$ second immunoglobulin-like domain, which does not bind @PROTEIN2$ (NGF), were substituted with those from human TrkA.","label":0}
{"pair_id":"AIMed.d43.s376.p1","sentence":"In this study, a minimum set of residues in the human @PROTEIN1$ second immunoglobulin-like domain, which does not bind nerve growth factor (@PROTEIN2$), were substituted with those from human TrkA.","label":0}
{"pair_id":"AIMed.d43.s376.p2","sentence":"In this study, a minimum set of residues in the human @PROTEIN1$ second immunoglobulin-like domain, which does not bind nerve growth factor (NGF), were substituted with those from human @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d43.s376.p3","sentence":"In this study, a minimum set of residues in the human TrkC second immunoglobulin-like domain, which does not bind @PROTEIN1$ (@PROTEIN2$), were substituted with those from human TrkA.","label":0}
{"pair_id":"AIMed.d43.s376.p4","sentence":"In this study, a minimum set of residues in the human TrkC second immunoglobulin-like domain, which does not bind @PROTEIN1$ (NGF), were substituted with those from human @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d43.s376.p5","sentence":"In this study, a minimum set of residues in the human TrkC second immunoglobulin-like domain, which does not bind nerve growth factor (@PROTEIN1$), were substituted with those from human @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d39.s337.p0","sentence":"We screened for proteins that bind to @PROTEIN1$ from a human embryonic brain cDNA library using the two-hybrid method and isolated one clone encoding the @PROTEIN2$\/Jif-1 gene.","label":1}
{"pair_id":"AIMed.d39.s337.p1","sentence":"We screened for proteins that bind to @PROTEIN1$ from a human embryonic brain cDNA library using the two-hybrid method and isolated one clone encoding the QM\/@PROTEIN2$ gene.","label":1}
{"pair_id":"AIMed.d39.s337.p2","sentence":"We screened for proteins that bind to PS1 from a human embryonic brain cDNA library using the two-hybrid method and isolated one clone encoding the @PROTEIN1$\/@PROTEIN2$ gene.","label":0}
{"pair_id":"BioInfer.d481.s0.p0","sentence":"Particle aggregates associated with this array of @PROTEIN1$ microfilaments also labeled with antibodies to vinculin, @PROTEIN2$ and beta 1-integrin.","label":0}
{"pair_id":"BioInfer.d481.s0.p1","sentence":"Particle aggregates associated with this array of @PROTEIN1$ microfilaments also labeled with antibodies to @PROTEIN2$, talin and beta 1-integrin.","label":0}
{"pair_id":"BioInfer.d481.s0.p2","sentence":"Particle aggregates associated with this array of @PROTEIN1$ microfilaments also labeled with antibodies to vinculin, talin and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d481.s0.p3","sentence":"Particle aggregates associated with this array of actin microfilaments also labeled with antibodies to @PROTEIN2$, @PROTEIN1$ and beta 1-integrin.","label":0}
{"pair_id":"BioInfer.d481.s0.p4","sentence":"Particle aggregates associated with this array of actin microfilaments also labeled with antibodies to vinculin, @PROTEIN1$ and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d481.s0.p5","sentence":"Particle aggregates associated with this array of actin microfilaments also labeled with antibodies to @PROTEIN1$, talin and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d132.s1129.p0","sentence":"The gamma chain of the @PROTEIN1$ (@PROTEIN2$) receptor is shared with the functional IL-4 receptor and is causatively related to X-linked severe combined immunodeficiency (XSCID), which is ascribed to a profound T cell defect.","label":0}
{"pair_id":"AIMed.d132.s1129.p1","sentence":"The gamma chain of the @PROTEIN1$@PROTEIN2$ is shared with the functional IL-4 receptor and is causatively related to X-linked severe combined immunodeficiency (XSCID), which is ascribed to a profound T cell defect.","label":0}
{"pair_id":"AIMed.d132.s1129.p2","sentence":"The gamma chain of the @PROTEIN1$ (IL-2) receptor is shared with the functional @PROTEIN2$ receptor and is causatively related to X-linked severe combined immunodeficiency (XSCID), which is ascribed to a profound T cell defect.","label":0}
{"pair_id":"AIMed.d132.s1129.p3","sentence":"The gamma chain of the @PROTEIN1$ (IL-2) receptor is shared with the functional @PROTEIN2$ and is causatively related to X-linked severe combined immunodeficiency (XSCID), which is ascribed to a profound T cell defect.","label":0}
{"pair_id":"AIMed.d132.s1129.p4","sentence":"The gamma chain of the @PROTEIN2$@PROTEIN1$) receptor is shared with the functional IL-4 receptor and is causatively related to X-linked severe combined immunodeficiency (XSCID), which is ascribed to a profound T cell defect.","label":0}
{"pair_id":"AIMed.d132.s1129.p5","sentence":"The gamma chain of the interleukin-2 (@PROTEIN1$) receptor is shared with the functional @PROTEIN2$ receptor and is causatively related to X-linked severe combined immunodeficiency (XSCID), which is ascribed to a profound T cell defect.","label":0}
{"pair_id":"AIMed.d132.s1129.p6","sentence":"The gamma chain of the interleukin-2 (@PROTEIN1$) receptor is shared with the functional @PROTEIN2$ and is causatively related to X-linked severe combined immunodeficiency (XSCID), which is ascribed to a profound T cell defect.","label":0}
{"pair_id":"AIMed.d132.s1129.p7","sentence":"The gamma chain of the @PROTEIN1$ is shared with the functional @PROTEIN2$ receptor and is causatively related to X-linked severe combined immunodeficiency (XSCID), which is ascribed to a profound T cell defect.","label":0}
{"pair_id":"AIMed.d132.s1129.p8","sentence":"The gamma chain of the @PROTEIN1$ is shared with the functional @PROTEIN2$ and is causatively related to X-linked severe combined immunodeficiency (XSCID), which is ascribed to a profound T cell defect.","label":0}
{"pair_id":"AIMed.d132.s1129.p9","sentence":"The gamma chain of the interleukin-2 (IL-2) receptor is shared with the functional @PROTEIN1$@PROTEIN2$ and is causatively related to X-linked severe combined immunodeficiency (XSCID), which is ascribed to a profound T cell defect.","label":0}
{"pair_id":"BioInfer.d268.s0.p0","sentence":"However, disassembly of the actin cytoskeleton using Latrunculin-A does not alter verprolin's location, indicating that @PROTEIN1$ establishes and maintains its location independent of the @PROTEIN2$ cytoskeleton.","label":1}
{"pair_id":"BioInfer.d268.s0.p1","sentence":"However, disassembly of the actin cytoskeleton using Latrunculin-A does not alter @PROTEIN2$'s location, indicating that @PROTEIN1$ establishes and maintains its location independent of the actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d268.s0.p2","sentence":"However, disassembly of the @PROTEIN2$ cytoskeleton using Latrunculin-A does not alter verprolin's location, indicating that @PROTEIN1$ establishes and maintains its location independent of the actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d268.s0.p3","sentence":"However, disassembly of the actin cytoskeleton using Latrunculin-A does not alter @PROTEIN2$'s location, indicating that verprolin establishes and maintains its location independent of the @PROTEIN1$ cytoskeleton.","label":0}
{"pair_id":"BioInfer.d268.s0.p4","sentence":"However, disassembly of the @PROTEIN2$ cytoskeleton using Latrunculin-A does not alter verprolin's location, indicating that verprolin establishes and maintains its location independent of the @PROTEIN1$ cytoskeleton.","label":0}
{"pair_id":"BioInfer.d268.s0.p5","sentence":"However, disassembly of the @PROTEIN2$ cytoskeleton using Latrunculin-A does not alter @PROTEIN1$'s location, indicating that verprolin establishes and maintains its location independent of the actin cytoskeleton.","label":1}
{"pair_id":"BioInfer.d416.s0.p0","sentence":"Mechanism of inhibition of @PROTEIN1$-dependent DNA synthesis by the cyclin-dependent kinase inhibitor @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d416.s0.p1","sentence":"Mechanism of inhibition of @PROTEIN1$-dependent DNA synthesis by the @PROTEIN2$ p21.","label":0}
{"pair_id":"BioInfer.d416.s0.p2","sentence":"Mechanism of inhibition of proliferating cell nuclear antigen-dependent DNA synthesis by the @PROTEIN2$ @PROTEIN1$.","label":1}
{"pair_id":"AIMed.d209.s1810.p0","sentence":"When expressed in mammalian cells, the @PROTEIN1$ binding domain of @PROTEIN2$ can act as a dominant negative signal transduction blocker.","label":1}
{"pair_id":"AIMed.d60.s528.p0","sentence":"The @PROTEIN1$ proteins purified from cells infected with EC12 or 22W viruses activated @PROTEIN2$ kinase from skeletal muscle in vitro.","label":0}
{"pair_id":"AIMed.d60.s528.p1","sentence":"The @PROTEIN1$ proteins purified from cells infected with EC12 or 22W viruses activated @PROTEIN2$ from skeletal muscle in vitro.","label":1}
{"pair_id":"AIMed.d60.s528.p2","sentence":"The v-Raf proteins purified from cells infected with EC12 or 22W viruses activated @PROTEIN1$@PROTEIN2$ from skeletal muscle in vitro.","label":0}
{"pair_id":"BioInfer.d21.s0.p0","sentence":"Actophorin and @PROTEIN2$ have opposite effects on the rate of exchange of nucleotide bound to @PROTEIN1$ monomers.","label":0}
{"pair_id":"BioInfer.d21.s0.p1","sentence":"@PROTEIN2$ and profilin have opposite effects on the rate of exchange of nucleotide bound to @PROTEIN1$ monomers.","label":0}
{"pair_id":"BioInfer.d21.s0.p2","sentence":"@PROTEIN2$ and @PROTEIN1$ have opposite effects on the rate of exchange of nucleotide bound to actin monomers.","label":0}
{"pair_id":"BioInfer.d812.s0.p0","sentence":"We have examined the level of @PROTEIN2$, a G1 cyclin, and @PROTEIN1$, a cyclin-dependent kinase inhibitor, in BALB\/c 3T3 cells.","label":0}
{"pair_id":"BioInfer.d812.s0.p1","sentence":"We have examined the level of cyclin E, a @PROTEIN2$, and @PROTEIN1$, a cyclin-dependent kinase inhibitor, in BALB\/c 3T3 cells.","label":0}
{"pair_id":"BioInfer.d812.s0.p2","sentence":"We have examined the level of cyclin E, a G1 cyclin, and @PROTEIN1$, a @PROTEIN2$, in BALB\/c 3T3 cells.","label":1}
{"pair_id":"BioInfer.d812.s0.p3","sentence":"We have examined the level of @PROTEIN1$, a @PROTEIN2$, and p27kip, a cyclin-dependent kinase inhibitor, in BALB\/c 3T3 cells.","label":1}
{"pair_id":"BioInfer.d812.s0.p4","sentence":"We have examined the level of @PROTEIN1$, a G1 cyclin, and p27kip, a @PROTEIN2$, in BALB\/c 3T3 cells.","label":0}
{"pair_id":"BioInfer.d812.s0.p5","sentence":"We have examined the level of cyclin E, a @PROTEIN1$, and p27kip, a @PROTEIN2$, in BALB\/c 3T3 cells.","label":0}
{"pair_id":"BioInfer.d257.s0.p0","sentence":"Herpes simplex virus type 1 encodes a heterotrimeric @PROTEIN2$ complex that is composed of the products of the UL5, @PROTEIN1$, and UL8 genes.","label":1}
{"pair_id":"BioInfer.d257.s0.p1","sentence":"Herpes simplex virus type 1 encodes a heterotrimeric helicase-primase complex that is composed of the products of the @PROTEIN2$, @PROTEIN1$, and UL8 genes.","label":1}
{"pair_id":"BioInfer.d257.s0.p2","sentence":"Herpes simplex virus type 1 encodes a heterotrimeric helicase-primase complex that is composed of the products of the UL5, @PROTEIN1$, and @PROTEIN2$ genes.","label":1}
{"pair_id":"BioInfer.d257.s0.p3","sentence":"Herpes simplex virus type 1 encodes a heterotrimeric @PROTEIN1$ complex that is composed of the products of the @PROTEIN2$, UL52, and UL8 genes.","label":1}
{"pair_id":"BioInfer.d257.s0.p4","sentence":"Herpes simplex virus type 1 encodes a heterotrimeric @PROTEIN1$ complex that is composed of the products of the UL5, UL52, and @PROTEIN2$ genes.","label":1}
{"pair_id":"BioInfer.d257.s0.p5","sentence":"Herpes simplex virus type 1 encodes a heterotrimeric helicase-primase complex that is composed of the products of the @PROTEIN1$, UL52, and @PROTEIN2$ genes.","label":1}
{"pair_id":"BioInfer.d144.s1.p0","sentence":"Expression of the A8R and @PROTEIN1$ genes occurred between 1 and 5 h after vaccinia virus infection and was not prevented by an inhibitor of DNA replication, consistent with a role for @PROTEIN2$ in specifically regulating intermediate transcription in vivo.","label":0}
{"pair_id":"BioInfer.d144.s1.p1","sentence":"Expression of the @PROTEIN2$ and @PROTEIN1$ genes occurred between 1 and 5 h after vaccinia virus infection and was not prevented by an inhibitor of DNA replication, consistent with a role for VITF-3 in specifically regulating intermediate transcription in vivo.","label":0}
{"pair_id":"BioInfer.d144.s1.p2","sentence":"Expression of the @PROTEIN2$ and A23R genes occurred between 1 and 5 h after vaccinia virus infection and was not prevented by an inhibitor of DNA replication, consistent with a role for @PROTEIN1$ in specifically regulating intermediate transcription in vivo.","label":0}
{"pair_id":"AIMed.d129.s1110.p0","sentence":"Bacterially overexpressed human @PROTEIN1$ was used to raise several monoclonal antibodies to @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d103.s874.p0","sentence":"As observed with the homologous Drosophila proteins, @PROTEIN1$ interacts directly with @PROTEIN2$; however, additional interactions between hTAFII20 and hTAFII28 or hTAFII30 were detected.","label":1}
{"pair_id":"AIMed.d103.s874.p1","sentence":"As observed with the homologous Drosophila proteins, @PROTEIN1$ interacts directly with TBP; however, additional interactions between @PROTEIN2$ and hTAFII28 or hTAFII30 were detected.","label":0}
{"pair_id":"AIMed.d103.s874.p2","sentence":"As observed with the homologous Drosophila proteins, @PROTEIN1$ interacts directly with TBP; however, additional interactions between hTAFII20 and @PROTEIN2$ or hTAFII30 were detected.","label":0}
{"pair_id":"AIMed.d103.s874.p3","sentence":"As observed with the homologous Drosophila proteins, @PROTEIN1$ interacts directly with TBP; however, additional interactions between hTAFII20 and hTAFII28 or @PROTEIN2$ were detected.","label":0}
{"pair_id":"AIMed.d103.s874.p4","sentence":"As observed with the homologous Drosophila proteins, hTAFII20 interacts directly with @PROTEIN1$; however, additional interactions between @PROTEIN2$ and hTAFII28 or hTAFII30 were detected.","label":0}
{"pair_id":"AIMed.d103.s874.p5","sentence":"As observed with the homologous Drosophila proteins, hTAFII20 interacts directly with @PROTEIN1$; however, additional interactions between hTAFII20 and @PROTEIN2$ or hTAFII30 were detected.","label":0}
{"pair_id":"AIMed.d103.s874.p6","sentence":"As observed with the homologous Drosophila proteins, hTAFII20 interacts directly with @PROTEIN1$; however, additional interactions between hTAFII20 and hTAFII28 or @PROTEIN2$ were detected.","label":0}
{"pair_id":"AIMed.d103.s874.p7","sentence":"As observed with the homologous Drosophila proteins, hTAFII20 interacts directly with TBP; however, additional interactions between @PROTEIN1$ and @PROTEIN2$ or hTAFII30 were detected.","label":1}
{"pair_id":"AIMed.d103.s874.p8","sentence":"As observed with the homologous Drosophila proteins, hTAFII20 interacts directly with TBP; however, additional interactions between @PROTEIN1$ and hTAFII28 or @PROTEIN2$ were detected.","label":1}
{"pair_id":"AIMed.d103.s874.p9","sentence":"As observed with the homologous Drosophila proteins, hTAFII20 interacts directly with TBP; however, additional interactions between hTAFII20 and @PROTEIN1$ or @PROTEIN2$ were detected.","label":0}
{"pair_id":"BioInfer.d496.s1.p0","sentence":"Since functional characteristics for @PROTEIN1$ are lacking, we assayed the @PROTEIN2$, the phosphatidylinositol 4,5-bisphosphate and the poly(L-proline) binding properties of this isoform.","label":1}
{"pair_id":"BioInfer.d391.s1.p0","sentence":"These results indicate that the assembly of cytoskeletal and @PROTEIN2$ is regulated differently by @PROTEIN1$ in the developing skeletal muscle, and that the former may not be involved in myofibril assembly.","label":1}
{"pair_id":"BioInfer.d391.s1.p1","sentence":"These results indicate that the assembly of @PROTEIN2$ and sarcomeric @PROTEIN2$ is regulated differently by @PROTEIN1$ in the developing skeletal muscle, and that the former may not be involved in myofibril assembly.","label":1}
{"pair_id":"BioInfer.d391.s1.p2","sentence":"These results indicate that the assembly of @PROTEIN2$ and @PROTEIN1$@PROTEIN2$ is regulated differently by profilin in the developing skeletal muscle, and that the former may not be involved in myofibril assembly.","label":0}
{"pair_id":"AIMed.d196.s1673.p0","sentence":"Thus @PROTEIN1$ is a cellular oncogene that targets @PROTEIN2$ and PP1, both of which are targets for oncogenic viruses and chemical tumour promoters.","label":1}
{"pair_id":"AIMed.d196.s1673.p1","sentence":"Thus @PROTEIN1$ is a cellular oncogene that targets PP2A and @PROTEIN2$, both of which are targets for oncogenic viruses and chemical tumour promoters.","label":1}
{"pair_id":"AIMed.d196.s1673.p2","sentence":"Thus HOX11 is a cellular oncogene that targets @PROTEIN1$ and @PROTEIN2$, both of which are targets for oncogenic viruses and chemical tumour promoters.","label":0}
{"pair_id":"AIMed.d125.s1070.p0","sentence":"This cytotoxicity could be abrogated by B42 fusion proteins containing @PROTEIN1$, @PROTEIN2$, or Mcl-1 but not those containing Bcl-X-S (an alternatively spliced form of Bcl-X that lacks a well-conserved 63-amino acid region).","label":0}
{"pair_id":"AIMed.d125.s1070.p1","sentence":"This cytotoxicity could be abrogated by B42 fusion proteins containing @PROTEIN1$, Bcl-X-L, or @PROTEIN2$ but not those containing Bcl-X-S (an alternatively spliced form of Bcl-X that lacks a well-conserved 63-amino acid region).","label":0}
{"pair_id":"AIMed.d125.s1070.p2","sentence":"This cytotoxicity could be abrogated by B42 fusion proteins containing @PROTEIN1$, Bcl-X-L, or Mcl-1 but not those containing @PROTEIN2$ (an alternatively spliced form of Bcl-X that lacks a well-conserved 63-amino acid region).","label":0}
{"pair_id":"AIMed.d125.s1070.p3","sentence":"This cytotoxicity could be abrogated by B42 fusion proteins containing @PROTEIN1$, Bcl-X-L, or Mcl-1 but not those containing Bcl-X-S (an alternatively spliced form of @PROTEIN2$ that lacks a well-conserved 63-amino acid region).","label":0}
{"pair_id":"AIMed.d125.s1070.p4","sentence":"This cytotoxicity could be abrogated by B42 fusion proteins containing Bcl-2, @PROTEIN1$, or @PROTEIN2$ but not those containing Bcl-X-S (an alternatively spliced form of Bcl-X that lacks a well-conserved 63-amino acid region).","label":0}
{"pair_id":"AIMed.d125.s1070.p5","sentence":"This cytotoxicity could be abrogated by B42 fusion proteins containing Bcl-2, @PROTEIN1$, or Mcl-1 but not those containing @PROTEIN2$ (an alternatively spliced form of Bcl-X that lacks a well-conserved 63-amino acid region).","label":0}
{"pair_id":"AIMed.d125.s1070.p6","sentence":"This cytotoxicity could be abrogated by B42 fusion proteins containing Bcl-2, @PROTEIN1$, or Mcl-1 but not those containing Bcl-X-S (an alternatively spliced form of @PROTEIN2$ that lacks a well-conserved 63-amino acid region).","label":0}
{"pair_id":"AIMed.d125.s1070.p7","sentence":"This cytotoxicity could be abrogated by B42 fusion proteins containing Bcl-2, Bcl-X-L, or @PROTEIN1$ but not those containing @PROTEIN2$ (an alternatively spliced form of Bcl-X that lacks a well-conserved 63-amino acid region).","label":0}
{"pair_id":"AIMed.d125.s1070.p8","sentence":"This cytotoxicity could be abrogated by B42 fusion proteins containing Bcl-2, Bcl-X-L, or @PROTEIN1$ but not those containing Bcl-X-S (an alternatively spliced form of @PROTEIN2$ that lacks a well-conserved 63-amino acid region).","label":0}
{"pair_id":"AIMed.d125.s1070.p9","sentence":"This cytotoxicity could be abrogated by B42 fusion proteins containing Bcl-2, Bcl-X-L, or Mcl-1 but not those containing @PROTEIN1$ (an alternatively spliced form of @PROTEIN2$ that lacks a well-conserved 63-amino acid region).","label":0}
{"pair_id":"AIMed.d154.s1314.p0","sentence":"Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like @PROTEIN1$, both beta 2- and @PROTEIN2$ interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin\/dystrophin related protein, and the Torpedo 87K protein.","label":0}
{"pair_id":"AIMed.d154.s1314.p1","sentence":"Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like @PROTEIN1$, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of @PROTEIN2$, utrophin\/dystrophin related protein, and the Torpedo 87K protein.","label":1}
{"pair_id":"AIMed.d154.s1314.p2","sentence":"Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like @PROTEIN1$, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, @PROTEIN2$\/dystrophin related protein, and the Torpedo 87K protein.","label":1}
{"pair_id":"AIMed.d154.s1314.p3","sentence":"Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like @PROTEIN1$, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin\/@PROTEIN2$ related protein, and the Torpedo 87K protein.","label":0}
{"pair_id":"AIMed.d154.s1314.p4","sentence":"Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like @PROTEIN1$, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin\/@PROTEIN2$, and the Torpedo 87K protein.","label":1}
{"pair_id":"AIMed.d154.s1314.p5","sentence":"Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like @PROTEIN1$, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin\/dystrophin related protein, and the @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d154.s1314.p6","sentence":"Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and @PROTEIN1$ interact with peptides encoding the syntrophin-binding region of @PROTEIN2$, utrophin\/dystrophin related protein, and the Torpedo 87K protein.","label":1}
{"pair_id":"AIMed.d154.s1314.p7","sentence":"Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and @PROTEIN1$ interact with peptides encoding the syntrophin-binding region of dystrophin, @PROTEIN2$\/dystrophin related protein, and the Torpedo 87K protein.","label":1}
{"pair_id":"AIMed.d154.s1314.p8","sentence":"Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and @PROTEIN1$ interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin\/@PROTEIN2$ related protein, and the Torpedo 87K protein.","label":0}
{"pair_id":"AIMed.d154.s1314.p9","sentence":"Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and @PROTEIN1$ interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin\/@PROTEIN2$, and the Torpedo 87K protein.","label":1}
{"pair_id":"AIMed.d154.s1314.p10","sentence":"Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and @PROTEIN1$ interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin\/dystrophin related protein, and the @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d154.s1314.p11","sentence":"Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of @PROTEIN1$, @PROTEIN2$\/dystrophin related protein, and the Torpedo 87K protein.","label":0}
{"pair_id":"AIMed.d154.s1314.p12","sentence":"Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of @PROTEIN1$, utrophin\/@PROTEIN2$ related protein, and the Torpedo 87K protein.","label":0}
{"pair_id":"AIMed.d154.s1314.p13","sentence":"Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of @PROTEIN1$, utrophin\/@PROTEIN2$, and the Torpedo 87K protein.","label":0}
{"pair_id":"AIMed.d154.s1314.p14","sentence":"Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of @PROTEIN1$, utrophin\/dystrophin related protein, and the @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d154.s1314.p15","sentence":"Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, @PROTEIN1$\/@PROTEIN2$ related protein, and the Torpedo 87K protein.","label":0}
{"pair_id":"AIMed.d154.s1314.p16","sentence":"Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, @PROTEIN1$\/@PROTEIN2$, and the Torpedo 87K protein.","label":0}
{"pair_id":"AIMed.d154.s1314.p17","sentence":"Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, @PROTEIN1$\/dystrophin related protein, and the @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d154.s1314.p18","sentence":"Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin\/@PROTEIN1$@PROTEIN2$, and the Torpedo 87K protein.","label":0}
{"pair_id":"AIMed.d154.s1314.p19","sentence":"Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin\/@PROTEIN1$ related protein, and the @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d154.s1314.p20","sentence":"Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin\/@PROTEIN1$, and the @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d54.s475.p0","sentence":"@PROTEIN1$ is a multidomain protein with the N-terminal region homologous to the extracellular CUB domain of @PROTEIN2$, and the C-terminal region consists of a growth factor domain (GFD) with homology to vascular endothelial growth factor (25%) and PDGF A-chain (23%).","label":0}
{"pair_id":"AIMed.d54.s475.p1","sentence":"@PROTEIN1$ is a multidomain protein with the N-terminal region homologous to the extracellular CUB domain of neuropilin-1, and the C-terminal region consists of a growth factor domain (GFD) with homology to vascular @PROTEIN2$ (25%) and PDGF A-chain (23%).","label":0}
{"pair_id":"AIMed.d54.s475.p2","sentence":"@PROTEIN1$ is a multidomain protein with the N-terminal region homologous to the extracellular CUB domain of neuropilin-1, and the C-terminal region consists of a growth factor domain (GFD) with homology to vascular endothelial growth factor (25%) and @PROTEIN2$-chain (23%).","label":0}
{"pair_id":"AIMed.d54.s475.p3","sentence":"PDGF-C is a multidomain protein with the N-terminal region homologous to the extracellular CUB domain of @PROTEIN1$, and the C-terminal region consists of a growth factor domain (GFD) with homology to vascular @PROTEIN2$ (25%) and PDGF A-chain (23%).","label":0}
{"pair_id":"AIMed.d54.s475.p4","sentence":"PDGF-C is a multidomain protein with the N-terminal region homologous to the extracellular CUB domain of @PROTEIN1$, and the C-terminal region consists of a growth factor domain (GFD) with homology to vascular endothelial growth factor (25%) and @PROTEIN2$-chain (23%).","label":0}
{"pair_id":"AIMed.d54.s475.p5","sentence":"PDGF-C is a multidomain protein with the N-terminal region homologous to the extracellular CUB domain of neuropilin-1, and the C-terminal region consists of a growth factor domain (GFD) with homology to vascular @PROTEIN1$ (25%) and @PROTEIN2$-chain (23%).","label":0}
{"pair_id":"AIMed.d85.s717.p0","sentence":"@PROTEIN1$ physically associates with @PROTEIN2$ through Src homology 3 domains.","label":1}
{"pair_id":"AIMed.d30.s252.p0","sentence":"Yeast two-hybrid assay, GST binding assay and immunoprecipitation demonstrated that @PROTEIN1$ interacted with a hydrophilic loop region in the endoproteolytic C-terminal fragment of @PROTEIN2$, but not with that of PS-2.","label":1}
{"pair_id":"AIMed.d30.s252.p1","sentence":"Yeast two-hybrid assay, GST binding assay and immunoprecipitation demonstrated that @PROTEIN1$ interacted with a hydrophilic loop region in the endoproteolytic C-terminal fragment of PS1, but not with that of @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d30.s252.p2","sentence":"Yeast two-hybrid assay, GST binding assay and immunoprecipitation demonstrated that delta-catenin interacted with a hydrophilic loop region in the endoproteolytic C-terminal fragment of @PROTEIN1$, but not with that of @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d193.s1642.p0","sentence":"We have used an interaction cloning strategy to identify an inhibitory isoform of the @PROTEIN1$ transcription factor, @PROTEIN2$, that interacts with the transcriptional inhibitor Id3\/HLH462.","label":0}
{"pair_id":"AIMed.d193.s1642.p1","sentence":"We have used an interaction cloning strategy to identify an inhibitory isoform of the @PROTEIN1$ transcription factor, ITF-2b, that interacts with the transcriptional inhibitor @PROTEIN2$\/HLH462.","label":0}
{"pair_id":"AIMed.d193.s1642.p2","sentence":"We have used an interaction cloning strategy to identify an inhibitory isoform of the @PROTEIN1$ transcription factor, ITF-2b, that interacts with the transcriptional inhibitor Id3\/@PROTEIN2$.","label":0}
{"pair_id":"AIMed.d193.s1642.p3","sentence":"We have used an interaction cloning strategy to identify an inhibitory isoform of the ITF-2 transcription factor, @PROTEIN1$, that interacts with the transcriptional inhibitor @PROTEIN2$\/HLH462.","label":1}
{"pair_id":"AIMed.d193.s1642.p4","sentence":"We have used an interaction cloning strategy to identify an inhibitory isoform of the ITF-2 transcription factor, @PROTEIN1$, that interacts with the transcriptional inhibitor Id3\/@PROTEIN2$.","label":1}
{"pair_id":"AIMed.d193.s1642.p5","sentence":"We have used an interaction cloning strategy to identify an inhibitory isoform of the ITF-2 transcription factor, ITF-2b, that interacts with the transcriptional inhibitor @PROTEIN1$\/@PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d179.s0.p0","sentence":"Double mutants containing N-terminal domain deletions of both @PROTEIN1$ H3 and histone @PROTEIN2$ were inviable.","label":0}
{"pair_id":"BioInfer.d179.s0.p1","sentence":"Double mutants containing N-terminal domain deletions of both @PROTEIN1$ H3 and @PROTEIN2$ H4 were inviable.","label":0}
{"pair_id":"BioInfer.d179.s0.p2","sentence":"Double mutants containing N-terminal domain deletions of both @PROTEIN1$ @PROTEIN2$ and histone H4 were inviable.","label":1}
{"pair_id":"BioInfer.d179.s0.p3","sentence":"Double mutants containing N-terminal domain deletions of both histone H3 and @PROTEIN2$ @PROTEIN1$ were inviable.","label":1}
{"pair_id":"BioInfer.d179.s0.p4","sentence":"Double mutants containing N-terminal domain deletions of both histone @PROTEIN2$ and histone @PROTEIN1$ were inviable.","label":0}
{"pair_id":"BioInfer.d179.s0.p5","sentence":"Double mutants containing N-terminal domain deletions of both histone @PROTEIN2$ and @PROTEIN1$ H4 were inviable.","label":0}
{"pair_id":"BioInfer.d297.s0.p0","sentence":"Immunoprecipitation of @PROTEIN1$ was increased in response to both doses of CdCl2, while the immunoprecipitation of @PROTEIN2$ was little changed by either cadmium dose.","label":0}
{"pair_id":"BioInfer.d183.s2.p0","sentence":"While parallel @PROTEIN2$ bundles crossing the cells are virtually absent in cells overexpressing profilin, the submembranous @PROTEIN1$ network of these cells is denser than in control cells.","label":0}
{"pair_id":"BioInfer.d183.s2.p1","sentence":"While parallel actin bundles crossing the cells are virtually absent in cells overexpressing @PROTEIN2$, the submembranous @PROTEIN1$ network of these cells is denser than in control cells.","label":0}
{"pair_id":"BioInfer.d183.s2.p2","sentence":"While parallel @PROTEIN1$ bundles crossing the cells are virtually absent in cells overexpressing @PROTEIN2$, the submembranous actin network of these cells is denser than in control cells.","label":0}
{"pair_id":"BioInfer.d590.s0.p0","sentence":"The cardiac myosin heavy chain Arg-403-->Gln mutation that causes hypertrophic cardiomyopathy does not affect the @PROTEIN1$- or ATP-binding capacities of two size-limited recombinant @PROTEIN2$ fragments.","label":1}
{"pair_id":"BioInfer.d590.s0.p1","sentence":"The @PROTEIN2$ Arg-403-->Gln mutation that causes hypertrophic cardiomyopathy does not affect the @PROTEIN1$- or ATP-binding capacities of two size-limited recombinant myosin heavy chain fragments.","label":1}
{"pair_id":"BioInfer.d590.s0.p2","sentence":"The @PROTEIN2$ Arg-403-->Gln mutation that causes hypertrophic cardiomyopathy does not affect the actin- or ATP-binding capacities of two size-limited recombinant @PROTEIN1$ fragments.","label":1}
{"pair_id":"BioInfer.d435.s0.p0","sentence":"Moreover, talin, but not @PROTEIN2$ or tubulin, appears to co-localize with @PROTEIN1$ microfilaments in the membrane ruffles of NK cells that undergo cytoskeleton rearrangement following CD31 cross-linking.","label":1}
{"pair_id":"BioInfer.d435.s0.p1","sentence":"Moreover, talin, but not vinculin or @PROTEIN2$, appears to co-localize with @PROTEIN1$ microfilaments in the membrane ruffles of NK cells that undergo cytoskeleton rearrangement following CD31 cross-linking.","label":1}
{"pair_id":"BioInfer.d435.s0.p2","sentence":"Moreover, @PROTEIN2$, but not vinculin or tubulin, appears to co-localize with @PROTEIN1$ microfilaments in the membrane ruffles of NK cells that undergo cytoskeleton rearrangement following CD31 cross-linking.","label":1}
{"pair_id":"BioInfer.d435.s0.p3","sentence":"Moreover, talin, but not vinculin or tubulin, appears to co-localize with @PROTEIN1$ microfilaments in the membrane ruffles of NK cells that undergo cytoskeleton rearrangement following @PROTEIN2$ cross-linking.","label":0}
{"pair_id":"BioInfer.d435.s0.p4","sentence":"Moreover, talin, but not @PROTEIN1$ or @PROTEIN2$, appears to co-localize with actin microfilaments in the membrane ruffles of NK cells that undergo cytoskeleton rearrangement following CD31 cross-linking.","label":0}
{"pair_id":"BioInfer.d435.s0.p5","sentence":"Moreover, @PROTEIN2$, but not @PROTEIN1$ or tubulin, appears to co-localize with actin microfilaments in the membrane ruffles of NK cells that undergo cytoskeleton rearrangement following CD31 cross-linking.","label":0}
{"pair_id":"BioInfer.d435.s0.p6","sentence":"Moreover, talin, but not @PROTEIN1$ or tubulin, appears to co-localize with actin microfilaments in the membrane ruffles of NK cells that undergo cytoskeleton rearrangement following @PROTEIN2$ cross-linking.","label":0}
{"pair_id":"BioInfer.d435.s0.p7","sentence":"Moreover, @PROTEIN2$, but not vinculin or @PROTEIN1$, appears to co-localize with actin microfilaments in the membrane ruffles of NK cells that undergo cytoskeleton rearrangement following CD31 cross-linking.","label":0}
{"pair_id":"BioInfer.d435.s0.p8","sentence":"Moreover, talin, but not vinculin or @PROTEIN1$, appears to co-localize with actin microfilaments in the membrane ruffles of NK cells that undergo cytoskeleton rearrangement following @PROTEIN2$ cross-linking.","label":0}
{"pair_id":"BioInfer.d435.s0.p9","sentence":"Moreover, @PROTEIN1$, but not vinculin or tubulin, appears to co-localize with actin microfilaments in the membrane ruffles of NK cells that undergo cytoskeleton rearrangement following @PROTEIN2$ cross-linking.","label":0}
{"pair_id":"BioInfer.d665.s0.p0","sentence":"The presence, in varying quantities, of @PROTEIN2$ and @PROTEIN1$ isoforms of smooth muscle type in the different vessels reflected their degree of differentiation.","label":0}
{"pair_id":"AIMed.d211.s1829.p0","sentence":"Through their interaction with the ErbB family of receptors (@PROTEIN1$, @PROTEIN2$ and ErbB4), neuregulins help to regulate cell growth and differentiation in many tissues.","label":0}
{"pair_id":"AIMed.d211.s1829.p1","sentence":"Through their interaction with the ErbB family of receptors (@PROTEIN1$, ErbB3 and @PROTEIN2$), neuregulins help to regulate cell growth and differentiation in many tissues.","label":0}
{"pair_id":"AIMed.d211.s1829.p2","sentence":"Through their interaction with the ErbB family of receptors (ErbB2, @PROTEIN1$ and @PROTEIN2$), neuregulins help to regulate cell growth and differentiation in many tissues.","label":0}
{"pair_id":"AIMed.d135.s1147.p0","sentence":"Tumor necrosis factor (TNF) and @PROTEIN1$ (@PROTEIN2$) are members of a family of secreted and cell surface cytokines that participate in the regulation of immune and inflammatory responses.","label":0}
{"pair_id":"AIMed.d190.s1613.p0","sentence":"By using the growth factor dependent M-07e cell line, we found that both @PROTEIN1$ and @PROTEIN2$ ligands, namely: SCF and TPO, induce c-Cbl tyrosine phosphorylation.","label":0}
{"pair_id":"AIMed.d190.s1613.p1","sentence":"By using the growth factor dependent M-07e cell line, we found that both @PROTEIN1$ and c-Kit ligands, namely: @PROTEIN2$ and TPO, induce c-Cbl tyrosine phosphorylation.","label":0}
{"pair_id":"AIMed.d190.s1613.p2","sentence":"By using the growth factor dependent M-07e cell line, we found that both @PROTEIN1$ and c-Kit ligands, namely: SCF and @PROTEIN2$, induce c-Cbl tyrosine phosphorylation.","label":0}
{"pair_id":"AIMed.d190.s1613.p3","sentence":"By using the growth factor dependent M-07e cell line, we found that both @PROTEIN1$ and c-Kit ligands, namely: SCF and TPO, induce @PROTEIN2$ tyrosine phosphorylation.","label":0}
{"pair_id":"AIMed.d190.s1613.p4","sentence":"By using the growth factor dependent M-07e cell line, we found that both c-Mpl and @PROTEIN1$ ligands, namely: @PROTEIN2$ and TPO, induce c-Cbl tyrosine phosphorylation.","label":0}
{"pair_id":"AIMed.d190.s1613.p5","sentence":"By using the growth factor dependent M-07e cell line, we found that both c-Mpl and @PROTEIN1$ ligands, namely: SCF and @PROTEIN2$, induce c-Cbl tyrosine phosphorylation.","label":0}
{"pair_id":"AIMed.d190.s1613.p6","sentence":"By using the growth factor dependent M-07e cell line, we found that both c-Mpl and @PROTEIN1$ ligands, namely: SCF and TPO, induce @PROTEIN2$ tyrosine phosphorylation.","label":0}
{"pair_id":"AIMed.d190.s1613.p7","sentence":"By using the growth factor dependent M-07e cell line, we found that both c-Mpl and c-Kit ligands, namely: @PROTEIN1$ and @PROTEIN2$, induce c-Cbl tyrosine phosphorylation.","label":0}
{"pair_id":"AIMed.d190.s1613.p8","sentence":"By using the growth factor dependent M-07e cell line, we found that both c-Mpl and c-Kit ligands, namely: @PROTEIN1$ and TPO, induce @PROTEIN2$ tyrosine phosphorylation.","label":1}
{"pair_id":"AIMed.d190.s1613.p9","sentence":"By using the growth factor dependent M-07e cell line, we found that both c-Mpl and c-Kit ligands, namely: SCF and @PROTEIN1$, induce @PROTEIN2$ tyrosine phosphorylation.","label":1}
{"pair_id":"BioInfer.d288.s3.p0","sentence":"We have biochemically identified the Saccharomyces cerevisiae homologue of the mammalian @PROTEIN1$ @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d490.s0.p0","sentence":"Polyacrylamide gels of platelets heated at 45 degrees C for 90 minutes showed an increase in @PROTEIN2$ incorporation into heated platelet cytoskeletons but no increase in filamentous @PROTEIN1$.","label":0}
{"pair_id":"AIMed.d144.s1217.p0","sentence":"The @PROTEIN1$ (@PROTEIN2$) interacts with many cellular proteins in complexes potentially important for its growth-suppressing function.","label":0}
{"pair_id":"BioInfer.d609.s0.p0","sentence":"The effects of two adhesion substrates (serum and @PROTEIN1$) and time in culture on the expression of genes encoding @PROTEIN2$ (MHC) isoforms and alpha-skeletal actin were analysed in myocytes isolated from adult rat heart and maintained in serum-free culture.","label":1}
{"pair_id":"BioInfer.d609.s0.p1","sentence":"The effects of two adhesion substrates (serum and @PROTEIN1$) and time in culture on the expression of genes encoding myosin heavy chain (@PROTEIN2$) isoforms and alpha-skeletal actin were analysed in myocytes isolated from adult rat heart and maintained in serum-free culture.","label":1}
{"pair_id":"BioInfer.d609.s0.p2","sentence":"The effects of two adhesion substrates (serum and @PROTEIN1$) and time in culture on the expression of genes encoding myosin heavy chain (MHC) isoforms and @PROTEIN2$ were analysed in myocytes isolated from adult rat heart and maintained in serum-free culture.","label":1}
{"pair_id":"BioInfer.d609.s0.p3","sentence":"The effects of two adhesion substrates (serum and laminin) and time in culture on the expression of genes encoding @PROTEIN1$ (@PROTEIN2$) isoforms and alpha-skeletal actin were analysed in myocytes isolated from adult rat heart and maintained in serum-free culture.","label":0}
{"pair_id":"BioInfer.d609.s0.p4","sentence":"The effects of two adhesion substrates (serum and laminin) and time in culture on the expression of genes encoding @PROTEIN1$ (MHC) isoforms and @PROTEIN2$ were analysed in myocytes isolated from adult rat heart and maintained in serum-free culture.","label":0}
{"pair_id":"BioInfer.d609.s0.p5","sentence":"The effects of two adhesion substrates (serum and laminin) and time in culture on the expression of genes encoding myosin heavy chain (@PROTEIN1$) isoforms and @PROTEIN2$ were analysed in myocytes isolated from adult rat heart and maintained in serum-free culture.","label":0}
{"pair_id":"BioInfer.d625.s0.p0","sentence":"The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of cyclin D1, the cyclin dependent kinase inhibitor p16ink4a and of p53 and decreased expression of the @PROTEIN1$ @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d625.s0.p1","sentence":"The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of cyclin D1, the cyclin dependent kinase inhibitor p16ink4a and of @PROTEIN2$ and decreased expression of the @PROTEIN1$ p27kip1.","label":0}
{"pair_id":"BioInfer.d625.s0.p2","sentence":"The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of cyclin D1, the cyclin dependent kinase inhibitor @PROTEIN2$ and of p53 and decreased expression of the @PROTEIN1$ p27kip1.","label":0}
{"pair_id":"BioInfer.d625.s0.p3","sentence":"The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of cyclin D1, the @PROTEIN2$ p16ink4a and of p53 and decreased expression of the @PROTEIN1$ p27kip1.","label":0}
{"pair_id":"BioInfer.d625.s0.p4","sentence":"The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of @PROTEIN2$, the cyclin dependent kinase inhibitor p16ink4a and of p53 and decreased expression of the @PROTEIN1$ p27kip1.","label":0}
{"pair_id":"BioInfer.d625.s0.p5","sentence":"The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of cyclin D1, the cyclin dependent kinase inhibitor p16ink4a and of @PROTEIN2$ and decreased expression of the cyclin dependent kinase inhibitor @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d625.s0.p6","sentence":"The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of cyclin D1, the cyclin dependent kinase inhibitor @PROTEIN2$ and of p53 and decreased expression of the cyclin dependent kinase inhibitor @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d625.s0.p7","sentence":"The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of cyclin D1, the @PROTEIN2$ p16ink4a and of p53 and decreased expression of the cyclin dependent kinase inhibitor @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d625.s0.p8","sentence":"The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of @PROTEIN2$, the cyclin dependent kinase inhibitor p16ink4a and of p53 and decreased expression of the cyclin dependent kinase inhibitor @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d625.s0.p9","sentence":"The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of cyclin D1, the cyclin dependent kinase inhibitor @PROTEIN2$ and of @PROTEIN1$ and decreased expression of the cyclin dependent kinase inhibitor p27kip1.","label":0}
{"pair_id":"BioInfer.d625.s0.p10","sentence":"The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of cyclin D1, the @PROTEIN2$ p16ink4a and of @PROTEIN1$ and decreased expression of the cyclin dependent kinase inhibitor p27kip1.","label":0}
{"pair_id":"BioInfer.d625.s0.p11","sentence":"The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of @PROTEIN2$, the cyclin dependent kinase inhibitor p16ink4a and of @PROTEIN1$ and decreased expression of the cyclin dependent kinase inhibitor p27kip1.","label":0}
{"pair_id":"BioInfer.d625.s0.p12","sentence":"The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of cyclin D1, the @PROTEIN2$ @PROTEIN1$ and of p53 and decreased expression of the cyclin dependent kinase inhibitor p27kip1.","label":1}
{"pair_id":"BioInfer.d625.s0.p13","sentence":"The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of @PROTEIN2$, the cyclin dependent kinase inhibitor @PROTEIN1$ and of p53 and decreased expression of the cyclin dependent kinase inhibitor p27kip1.","label":0}
{"pair_id":"BioInfer.d625.s0.p14","sentence":"The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of @PROTEIN2$, the @PROTEIN1$ p16ink4a and of p53 and decreased expression of the cyclin dependent kinase inhibitor p27kip1.","label":0}
{"pair_id":"BioInfer.d444.s0.p0","sentence":"Mutations in RVS161 and @PROTEIN1$, the two yeast @PROTEIN2$ homologs, cause very similar growth phenotypes, a depolarized actin cytoskeleton, and a defect in the internalization step of endocytosis.","label":1}
{"pair_id":"BioInfer.d444.s0.p1","sentence":"Mutations in RVS161 and @PROTEIN1$, the two yeast amphiphysin homologs, cause very similar growth phenotypes, a depolarized @PROTEIN2$ cytoskeleton, and a defect in the internalization step of endocytosis.","label":1}
{"pair_id":"BioInfer.d444.s0.p2","sentence":"Mutations in @PROTEIN2$ and @PROTEIN1$, the two yeast amphiphysin homologs, cause very similar growth phenotypes, a depolarized actin cytoskeleton, and a defect in the internalization step of endocytosis.","label":0}
{"pair_id":"BioInfer.d444.s0.p3","sentence":"Mutations in RVS161 and RVS167, the two yeast @PROTEIN1$ homologs, cause very similar growth phenotypes, a depolarized @PROTEIN2$ cytoskeleton, and a defect in the internalization step of endocytosis.","label":0}
{"pair_id":"BioInfer.d444.s0.p4","sentence":"Mutations in @PROTEIN2$ and RVS167, the two yeast @PROTEIN1$ homologs, cause very similar growth phenotypes, a depolarized actin cytoskeleton, and a defect in the internalization step of endocytosis.","label":1}
{"pair_id":"BioInfer.d444.s0.p5","sentence":"Mutations in @PROTEIN2$ and RVS167, the two yeast amphiphysin homologs, cause very similar growth phenotypes, a depolarized @PROTEIN1$ cytoskeleton, and a defect in the internalization step of endocytosis.","label":1}
{"pair_id":"BioInfer.d635.s0.p0","sentence":"Their abilities to store lipids and express @PROTEIN2$ intermediate filaments, alpha-smooth muscle actin, and @PROTEIN1$ in contractile filaments in vitro illustrate similarities among the pulmonary LF, the hepatic lipocyte, and the contractile interstitial cell, which contribute to the repair reaction in the lung after pulmonary injury.","label":1}
{"pair_id":"BioInfer.d635.s0.p1","sentence":"Their abilities to store lipids and express desmin intermediate filaments, @PROTEIN2$, and @PROTEIN1$ in contractile filaments in vitro illustrate similarities among the pulmonary LF, the hepatic lipocyte, and the contractile interstitial cell, which contribute to the repair reaction in the lung after pulmonary injury.","label":1}
{"pair_id":"BioInfer.d635.s0.p2","sentence":"Their abilities to store lipids and express @PROTEIN1$ intermediate filaments, @PROTEIN2$, and smooth muscle myosin heavy chain in contractile filaments in vitro illustrate similarities among the pulmonary LF, the hepatic lipocyte, and the contractile interstitial cell, which contribute to the repair reaction in the lung after pulmonary injury.","label":1}
{"pair_id":"BioInfer.d1.s2.p0","sentence":"Interaction of plant @PROTEIN1$ with mammalian @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d189.s0.p0","sentence":"Elevation of cAMP induced morphologic alterations indicative of changes in the adhesive status of the macrophage, including cell rounding and disassembly of structures that represent points of contact with substrate containing @PROTEIN1$ and @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d538.s0.p0","sentence":"Significantly, those actin mutants exhibiting the most severe phenotypes in all three processes have altered residues that cluster to a small region of the @PROTEIN1$ crystal structure previously defined as the @PROTEIN2$ (Sac6p)-binding site.","label":1}
{"pair_id":"BioInfer.d538.s0.p1","sentence":"Significantly, those actin mutants exhibiting the most severe phenotypes in all three processes have altered residues that cluster to a small region of the @PROTEIN1$ crystal structure previously defined as the fimbrin (@PROTEIN2$)-binding site.","label":1}
{"pair_id":"BioInfer.d538.s0.p2","sentence":"Significantly, those @PROTEIN2$ mutants exhibiting the most severe phenotypes in all three processes have altered residues that cluster to a small region of the @PROTEIN1$ crystal structure previously defined as the fimbrin (Sac6p)-binding site.","label":0}
{"pair_id":"BioInfer.d538.s0.p3","sentence":"Significantly, those actin mutants exhibiting the most severe phenotypes in all three processes have altered residues that cluster to a small region of the actin crystal structure previously defined as the @PROTEIN1$ (@PROTEIN2$)-binding site.","label":0}
{"pair_id":"BioInfer.d538.s0.p4","sentence":"Significantly, those @PROTEIN2$ mutants exhibiting the most severe phenotypes in all three processes have altered residues that cluster to a small region of the actin crystal structure previously defined as the @PROTEIN1$ (Sac6p)-binding site.","label":0}
{"pair_id":"BioInfer.d538.s0.p5","sentence":"Significantly, those @PROTEIN2$ mutants exhibiting the most severe phenotypes in all three processes have altered residues that cluster to a small region of the actin crystal structure previously defined as the fimbrin (@PROTEIN1$)-binding site.","label":0}
{"pair_id":"BioInfer.d697.s0.p0","sentence":"These findings reveal striking differences between S. cerevisiae and vertebrates in the functions of @PROTEIN1$ and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d143.s1208.p0","sentence":"We have examined early signals triggered by @PROTEIN1$ or @PROTEIN2$ in a multifactor-dependent human erythroleukemic cell line, TF-1.","label":0}
{"pair_id":"BioInfer.d450.s1.p0","sentence":"The resulting profilin II-peptide complex overcomes the combined capacity of thymosin beta4 and @PROTEIN2$ to inhibit @PROTEIN1$ nucleation and restores the extent of filament formation.","label":1}
{"pair_id":"BioInfer.d450.s1.p1","sentence":"The resulting profilin II-peptide complex overcomes the combined capacity of @PROTEIN2$ and profilin II to inhibit @PROTEIN1$ nucleation and restores the extent of filament formation.","label":1}
{"pair_id":"BioInfer.d450.s1.p2","sentence":"The resulting @PROTEIN2$-peptide complex overcomes the combined capacity of thymosin beta4 and profilin II to inhibit @PROTEIN1$ nucleation and restores the extent of filament formation.","label":1}
{"pair_id":"BioInfer.d450.s1.p3","sentence":"The resulting profilin II-peptide complex overcomes the combined capacity of @PROTEIN2$ and @PROTEIN1$ to inhibit actin nucleation and restores the extent of filament formation.","label":0}
{"pair_id":"BioInfer.d450.s1.p4","sentence":"The resulting @PROTEIN2$-peptide complex overcomes the combined capacity of thymosin beta4 and @PROTEIN1$ to inhibit actin nucleation and restores the extent of filament formation.","label":0}
{"pair_id":"BioInfer.d450.s1.p5","sentence":"The resulting @PROTEIN2$-peptide complex overcomes the combined capacity of @PROTEIN1$ and profilin II to inhibit actin nucleation and restores the extent of filament formation.","label":0}
{"pair_id":"AIMed.d10.s81.p0","sentence":"@PROTEIN1$ and @PROTEIN2$ involvement in the osteogenic properties of the HeLa cell line.","label":0}
{"pair_id":"BioInfer.d327.s0.p0","sentence":"In contrast, the @PROTEIN2$ and @PROTEIN1$ genes are essential for homothallic mating-type switching.","label":0}
{"pair_id":"BioInfer.d28.s1.p0","sentence":"Cells were fixed and stained with antibodies to @PROTEIN1$ (VE) @PROTEIN1$, alpha-catenin, @PROTEIN2$, or plakoglobin.","label":0}
{"pair_id":"BioInfer.d28.s1.p1","sentence":"Cells were fixed and stained with antibodies to @PROTEIN1$ (VE) @PROTEIN1$, @PROTEIN2$, beta-catenin, or plakoglobin.","label":0}
{"pair_id":"BioInfer.d28.s1.p2","sentence":"Cells were fixed and stained with antibodies to @PROTEIN1$ (VE) @PROTEIN1$, alpha-catenin, beta-catenin, or @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d28.s1.p3","sentence":"Cells were fixed and stained with antibodies to vascular endothelial (VE) vascular, @PROTEIN2$, @PROTEIN1$, or plakoglobin.","label":0}
{"pair_id":"BioInfer.d28.s1.p4","sentence":"Cells were fixed and stained with antibodies to vascular endothelial (VE) vascular, alpha-catenin, @PROTEIN1$, or @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d28.s1.p5","sentence":"Cells were fixed and stained with antibodies to vascular endothelial (VE) vascular, @PROTEIN1$, beta-catenin, or @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d430.s0.p0","sentence":"Molecular cloning and primary structure analysis demonstrated that alpha-catenin is homologous to vinculin and the beta-catenin is homologous to human @PROTEIN1$ and the Drosophila gene product @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d430.s0.p1","sentence":"Molecular cloning and primary structure analysis demonstrated that alpha-catenin is homologous to @PROTEIN2$ and the beta-catenin is homologous to human @PROTEIN1$ and the Drosophila gene product armadillo.","label":0}
{"pair_id":"BioInfer.d430.s0.p2","sentence":"Molecular cloning and primary structure analysis demonstrated that alpha-catenin is homologous to vinculin and the @PROTEIN2$ is homologous to human @PROTEIN1$ and the Drosophila gene product armadillo.","label":1}
{"pair_id":"BioInfer.d430.s0.p3","sentence":"Molecular cloning and primary structure analysis demonstrated that @PROTEIN2$ is homologous to vinculin and the beta-catenin is homologous to human @PROTEIN1$ and the Drosophila gene product armadillo.","label":0}
{"pair_id":"BioInfer.d430.s0.p4","sentence":"Molecular cloning and primary structure analysis demonstrated that alpha-catenin is homologous to @PROTEIN2$ and the beta-catenin is homologous to human plakoglobin and the Drosophila gene product @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d430.s0.p5","sentence":"Molecular cloning and primary structure analysis demonstrated that alpha-catenin is homologous to vinculin and the @PROTEIN2$ is homologous to human plakoglobin and the Drosophila gene product @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d430.s0.p6","sentence":"Molecular cloning and primary structure analysis demonstrated that @PROTEIN2$ is homologous to vinculin and the beta-catenin is homologous to human plakoglobin and the Drosophila gene product @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d430.s0.p7","sentence":"Molecular cloning and primary structure analysis demonstrated that alpha-catenin is homologous to @PROTEIN1$ and the @PROTEIN2$ is homologous to human plakoglobin and the Drosophila gene product armadillo.","label":0}
{"pair_id":"BioInfer.d430.s0.p8","sentence":"Molecular cloning and primary structure analysis demonstrated that @PROTEIN2$ is homologous to @PROTEIN1$ and the beta-catenin is homologous to human plakoglobin and the Drosophila gene product armadillo.","label":1}
{"pair_id":"BioInfer.d430.s0.p9","sentence":"Molecular cloning and primary structure analysis demonstrated that @PROTEIN2$ is homologous to vinculin and the @PROTEIN1$ is homologous to human plakoglobin and the Drosophila gene product armadillo.","label":0}
{"pair_id":"AIMed.d199.s1706.p0","sentence":"In addition to this unique pathway, @PROTEIN1$ also links to @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d153.s1298.p0","sentence":"Characterization of @PROTEIN1$ binding to human @PROTEIN2$ on T cells and its biologic role in immune response.","label":1}
{"pair_id":"BioInfer.d62.s2.p0","sentence":"The herpes simplex virus type 1 (HSV-1) @PROTEIN1$, an essential component of the viral DNA replication machinery, is a trimeric complex of the virus-coded @PROTEIN2$, UL8, and UL52 proteins.","label":1}
{"pair_id":"BioInfer.d62.s2.p1","sentence":"The herpes simplex virus type 1 (HSV-1) @PROTEIN1$, an essential component of the viral DNA replication machinery, is a trimeric complex of the virus-coded UL5, @PROTEIN2$, and UL52 proteins.","label":1}
{"pair_id":"BioInfer.d62.s2.p2","sentence":"The herpes simplex virus type 1 (HSV-1) @PROTEIN1$, an essential component of the viral DNA replication machinery, is a trimeric complex of the virus-coded UL5, UL8, and @PROTEIN2$ proteins.","label":1}
{"pair_id":"BioInfer.d62.s2.p3","sentence":"The herpes simplex virus type 1 (HSV-1) helicase-primase, an essential component of the viral DNA replication machinery, is a trimeric complex of the virus-coded @PROTEIN1$, @PROTEIN2$, and UL52 proteins.","label":1}
{"pair_id":"BioInfer.d62.s2.p4","sentence":"The herpes simplex virus type 1 (HSV-1) helicase-primase, an essential component of the viral DNA replication machinery, is a trimeric complex of the virus-coded @PROTEIN1$, UL8, and @PROTEIN2$ proteins.","label":1}
{"pair_id":"BioInfer.d62.s2.p5","sentence":"The herpes simplex virus type 1 (HSV-1) helicase-primase, an essential component of the viral DNA replication machinery, is a trimeric complex of the virus-coded UL5, @PROTEIN1$, and @PROTEIN2$ proteins.","label":1}
{"pair_id":"AIMed.d121.s1025.p0","sentence":"The acidic amino terminus of the @PROTEIN1$ protein has been shown to contain this trans-activation activity as well as the domains for @PROTEIN2$ and adenovirus 5 E1B 55-kD protein binding.","label":1}
{"pair_id":"AIMed.d121.s1025.p1","sentence":"The acidic amino terminus of the @PROTEIN1$ protein has been shown to contain this trans-activation activity as well as the domains for mdm-2 and adenovirus 5 @PROTEIN2$ 55-kD protein binding.","label":0}
{"pair_id":"AIMed.d121.s1025.p2","sentence":"The acidic amino terminus of the @PROTEIN1$ protein has been shown to contain this trans-activation activity as well as the domains for mdm-2 and adenovirus @PROTEIN2$ 55-kD protein binding.","label":1}
{"pair_id":"AIMed.d121.s1025.p3","sentence":"The acidic amino terminus of the p53 protein has been shown to contain this trans-activation activity as well as the domains for @PROTEIN1$ and adenovirus 5 @PROTEIN2$ 55-kD protein binding.","label":0}
{"pair_id":"AIMed.d121.s1025.p4","sentence":"The acidic amino terminus of the p53 protein has been shown to contain this trans-activation activity as well as the domains for @PROTEIN1$ and adenovirus @PROTEIN2$ 55-kD protein binding.","label":0}
{"pair_id":"AIMed.d121.s1025.p5","sentence":"The acidic amino terminus of the p53 protein has been shown to contain this trans-activation activity as well as the domains for mdm-2 and adenovirus @PROTEIN2$@PROTEIN1$ 55-kD protein binding.","label":0}
{"pair_id":"BioInfer.d150.s1.p0","sentence":"Reduced expression of @PROTEIN2$, beta-catenin, and @PROTEIN1$ is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer.","label":0}
{"pair_id":"BioInfer.d150.s1.p1","sentence":"Reduced expression of alpha-catenin, @PROTEIN2$, and @PROTEIN1$ is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer.","label":0}
{"pair_id":"BioInfer.d150.s1.p2","sentence":"Reduced expression of @PROTEIN1$, @PROTEIN2$, and gamma-catenin is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer.","label":0}
{"pair_id":"BioInfer.d77.s1.p0","sentence":"By analytical ultracentrifugation, rhodamine-labeled profilin binds Arp2\/A complex with a Kd of 7 microM, an affinity intermediate between the low affinity of @PROTEIN2$ for barbed ends of actin filaments and its high affinity for @PROTEIN1$ monomers.","label":1}
{"pair_id":"BioInfer.d77.s1.p1","sentence":"By analytical ultracentrifugation, rhodamine-labeled profilin binds @PROTEIN2$\/A complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of actin filaments and its high affinity for @PROTEIN1$ monomers.","label":0}
{"pair_id":"BioInfer.d77.s1.p2","sentence":"By analytical ultracentrifugation, rhodamine-labeled @PROTEIN2$ binds Arp2\/A complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of actin filaments and its high affinity for @PROTEIN1$ monomers.","label":0}
{"pair_id":"BioInfer.d77.s1.p3","sentence":"By analytical ultracentrifugation, rhodamine-labeled profilin binds Arp2\/A complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of @PROTEIN2$ filaments and its high affinity for @PROTEIN1$ monomers.","label":0}
{"pair_id":"BioInfer.d77.s1.p4","sentence":"By analytical ultracentrifugation, rhodamine-labeled profilin binds @PROTEIN2$2\/@PROTEIN2$ complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of actin filaments and its high affinity for @PROTEIN1$ monomers.","label":0}
{"pair_id":"BioInfer.d77.s1.p5","sentence":"By analytical ultracentrifugation, rhodamine-labeled profilin binds @PROTEIN2$\/A complex with a Kd of 7 microM, an affinity intermediate between the low affinity of @PROTEIN1$ for barbed ends of actin filaments and its high affinity for actin monomers.","label":0}
{"pair_id":"BioInfer.d77.s1.p6","sentence":"By analytical ultracentrifugation, rhodamine-labeled @PROTEIN2$ binds Arp2\/A complex with a Kd of 7 microM, an affinity intermediate between the low affinity of @PROTEIN1$ for barbed ends of actin filaments and its high affinity for actin monomers.","label":0}
{"pair_id":"BioInfer.d77.s1.p7","sentence":"By analytical ultracentrifugation, rhodamine-labeled profilin binds Arp2\/A complex with a Kd of 7 microM, an affinity intermediate between the low affinity of @PROTEIN1$ for barbed ends of @PROTEIN2$ filaments and its high affinity for actin monomers.","label":1}
{"pair_id":"BioInfer.d77.s1.p8","sentence":"By analytical ultracentrifugation, rhodamine-labeled profilin binds @PROTEIN2$2\/@PROTEIN2$ complex with a Kd of 7 microM, an affinity intermediate between the low affinity of @PROTEIN1$ for barbed ends of actin filaments and its high affinity for actin monomers.","label":0}
{"pair_id":"BioInfer.d77.s1.p9","sentence":"By analytical ultracentrifugation, rhodamine-labeled @PROTEIN2$ binds @PROTEIN1$\/A complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of actin filaments and its high affinity for actin monomers.","label":1}
{"pair_id":"BioInfer.d77.s1.p10","sentence":"By analytical ultracentrifugation, rhodamine-labeled profilin binds @PROTEIN1$\/A complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of @PROTEIN2$ filaments and its high affinity for actin monomers.","label":0}
{"pair_id":"BioInfer.d77.s1.p11","sentence":"By analytical ultracentrifugation, rhodamine-labeled profilin binds @PROTEIN1$@PROTEIN2$2\/@PROTEIN2$ complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of actin filaments and its high affinity for actin monomers.","label":1}
{"pair_id":"BioInfer.d77.s1.p12","sentence":"By analytical ultracentrifugation, rhodamine-labeled @PROTEIN1$ binds Arp2\/A complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of @PROTEIN2$ filaments and its high affinity for actin monomers.","label":0}
{"pair_id":"BioInfer.d77.s1.p13","sentence":"By analytical ultracentrifugation, rhodamine-labeled @PROTEIN1$ binds @PROTEIN2$2\/@PROTEIN2$ complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of actin filaments and its high affinity for actin monomers.","label":1}
{"pair_id":"BioInfer.d77.s1.p14","sentence":"By analytical ultracentrifugation, rhodamine-labeled profilin binds @PROTEIN2$2\/@PROTEIN2$ complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of @PROTEIN1$ filaments and its high affinity for actin monomers.","label":0}
{"pair_id":"AIMed.d196.s1669.p0","sentence":"We observed that the protein @PROTEIN1$ interacted with protein @PROTEIN2$ catalytic subunit (PP2AC), as well as protein phosphatase 1 (PP1C) in mammalian cells.","label":0}
{"pair_id":"AIMed.d196.s1669.p1","sentence":"We observed that the protein @PROTEIN1$ interacted with protein @PROTEIN2$ (PP2AC), as well as protein phosphatase 1 (PP1C) in mammalian cells.","label":1}
{"pair_id":"AIMed.d196.s1669.p2","sentence":"We observed that the protein @PROTEIN1$ interacted with protein serine-threonine phosphatase 2A catalytic subunit (@PROTEIN2$), as well as protein phosphatase 1 (PP1C) in mammalian cells.","label":1}
{"pair_id":"AIMed.d196.s1669.p3","sentence":"We observed that the protein @PROTEIN1$ interacted with protein serine-threonine phosphatase 2A catalytic subunit (PP2AC), as well as @PROTEIN2$ (PP1C) in mammalian cells.","label":1}
{"pair_id":"AIMed.d196.s1669.p4","sentence":"We observed that the protein @PROTEIN1$ interacted with protein serine-threonine phosphatase 2A catalytic subunit (PP2AC), as well as protein phosphatase 1 (@PROTEIN2$) in mammalian cells.","label":1}
{"pair_id":"AIMed.d196.s1669.p5","sentence":"We observed that the protein HOX11 interacted with protein @PROTEIN1$@PROTEIN2$ (PP2AC), as well as protein phosphatase 1 (PP1C) in mammalian cells.","label":0}
{"pair_id":"AIMed.d196.s1669.p6","sentence":"We observed that the protein HOX11 interacted with protein @PROTEIN1$ catalytic subunit (@PROTEIN2$), as well as protein phosphatase 1 (PP1C) in mammalian cells.","label":0}
{"pair_id":"AIMed.d196.s1669.p7","sentence":"We observed that the protein HOX11 interacted with protein @PROTEIN1$ catalytic subunit (PP2AC), as well as @PROTEIN2$ (PP1C) in mammalian cells.","label":0}
{"pair_id":"AIMed.d196.s1669.p8","sentence":"We observed that the protein HOX11 interacted with protein @PROTEIN1$ catalytic subunit (PP2AC), as well as protein phosphatase 1 (@PROTEIN2$) in mammalian cells.","label":0}
{"pair_id":"AIMed.d196.s1669.p9","sentence":"We observed that the protein HOX11 interacted with protein @PROTEIN1$ (@PROTEIN2$), as well as protein phosphatase 1 (PP1C) in mammalian cells.","label":0}
{"pair_id":"AIMed.d196.s1669.p10","sentence":"We observed that the protein HOX11 interacted with protein @PROTEIN1$ (PP2AC), as well as @PROTEIN2$ (PP1C) in mammalian cells.","label":0}
{"pair_id":"AIMed.d196.s1669.p11","sentence":"We observed that the protein HOX11 interacted with protein @PROTEIN1$ (PP2AC), as well as protein phosphatase 1 (@PROTEIN2$) in mammalian cells.","label":0}
{"pair_id":"AIMed.d196.s1669.p12","sentence":"We observed that the protein HOX11 interacted with protein serine-threonine phosphatase 2A catalytic subunit (@PROTEIN1$), as well as @PROTEIN2$ (PP1C) in mammalian cells.","label":0}
{"pair_id":"AIMed.d196.s1669.p13","sentence":"We observed that the protein HOX11 interacted with protein serine-threonine phosphatase 2A catalytic subunit (@PROTEIN1$), as well as protein phosphatase 1 (@PROTEIN2$) in mammalian cells.","label":0}
{"pair_id":"AIMed.d196.s1669.p14","sentence":"We observed that the protein HOX11 interacted with protein serine-threonine phosphatase 2A catalytic subunit (PP2AC), as well as @PROTEIN1$ (@PROTEIN2$) in mammalian cells.","label":0}
{"pair_id":"AIMed.d220.s1910.p0","sentence":"The extracellular domain of the human @PROTEIN2$@PROTEIN1$ receptor expressed in Chinese hamster ovary cells is a highly glycosylated protein, possessing binding ability for brain-derived neurotrophic factor (BDNF).","label":0}
{"pair_id":"AIMed.d220.s1910.p1","sentence":"The extracellular domain of the human neurotrophin @PROTEIN1$ receptor expressed in Chinese hamster ovary cells is a highly glycosylated protein, possessing binding ability for @PROTEIN2$ (BDNF).","label":0}
{"pair_id":"AIMed.d220.s1910.p2","sentence":"The extracellular domain of the human neurotrophin @PROTEIN1$ receptor expressed in Chinese hamster ovary cells is a highly glycosylated protein, possessing binding ability for brain-derived neurotrophic factor (@PROTEIN2$).","label":0}
{"pair_id":"AIMed.d220.s1910.p3","sentence":"The extracellular domain of the human @PROTEIN1$ expressed in Chinese hamster ovary cells is a highly glycosylated protein, possessing binding ability for @PROTEIN2$ (BDNF).","label":1}
{"pair_id":"AIMed.d220.s1910.p4","sentence":"The extracellular domain of the human @PROTEIN1$ expressed in Chinese hamster ovary cells is a highly glycosylated protein, possessing binding ability for brain-derived neurotrophic factor (@PROTEIN2$).","label":1}
{"pair_id":"AIMed.d220.s1910.p5","sentence":"The extracellular domain of the human neurotrophin TRKB receptor expressed in Chinese hamster ovary cells is a highly glycosylated protein, possessing binding ability for @PROTEIN1$ (@PROTEIN2$).","label":0}
{"pair_id":"AIMed.d53.s469.p0","sentence":"Kaposi's sarcoma-associated herpesvirus encodes a functional homolog of human @PROTEIN1$ (@PROTEIN2$) that activates human gp130.","label":0}
{"pair_id":"AIMed.d53.s469.p1","sentence":"Kaposi's sarcoma-associated herpesvirus encodes a functional homolog of human @PROTEIN1$ (IL-6) that activates human @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d53.s469.p2","sentence":"Kaposi's sarcoma-associated herpesvirus encodes a functional homolog of human interleukin-6 (@PROTEIN1$) that activates human @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d505.s0.p0","sentence":"Pyrenyliodoacetamide labeling of cysteine 374 of @PROTEIN1$ reduces the affinity for @PROTEIN2$ 10-fold.","label":1}
{"pair_id":"AIMed.d33.s282.p0","sentence":"Analysis of sedimentation equilibria and also of the fluorescence enhancement of suramin when bound to protein provided evidence for two suramin-binding sites on each @PROTEIN1$ and three on each @PROTEIN2$ in the oligomers.","label":0}
{"pair_id":"AIMed.d9.s73.p0","sentence":"We investigated the mechanism of calcium-stimulated @PROTEIN1$ release from gastrinoma cells in vitro with a particular focus on the @PROTEIN2$ (CaR).","label":0}
{"pair_id":"AIMed.d9.s73.p1","sentence":"We investigated the mechanism of calcium-stimulated @PROTEIN1$ release from gastrinoma cells in vitro with a particular focus on the calcium-sensing receptor (@PROTEIN2$).","label":0}
{"pair_id":"AIMed.d9.s73.p2","sentence":"We investigated the mechanism of calcium-stimulated gastrin release from gastrinoma cells in vitro with a particular focus on the @PROTEIN1$ (@PROTEIN2$).","label":0}
{"pair_id":"AIMed.d94.s797.p0","sentence":"We have isolated a human cDNA encoding the first eosinophil-selective chemokine receptor, designated @PROTEIN1$ (@PROTEIN2$).","label":0}
{"pair_id":"AIMed.d214.s1862.p0","sentence":"@PROTEIN1$\/@PROTEIN2$ interactions are also detectable in freshly isolated T cells from gene-targeted mice that lack the T cell-specific inhibitory receptor CTLA-4, in which c-Cbl is hyperphosphorylated on tyrosine residues.","label":1}
{"pair_id":"AIMed.d214.s1862.p1","sentence":"@PROTEIN1$\/c-Cbl interactions are also detectable in freshly isolated T cells from gene-targeted mice that lack the T cell-specific inhibitory receptor @PROTEIN2$, in which c-Cbl is hyperphosphorylated on tyrosine residues.","label":0}
{"pair_id":"AIMed.d214.s1862.p2","sentence":"@PROTEIN1$\/c-Cbl interactions are also detectable in freshly isolated T cells from gene-targeted mice that lack the T cell-specific inhibitory receptor CTLA-4, in which @PROTEIN2$ is hyperphosphorylated on tyrosine residues.","label":0}
{"pair_id":"AIMed.d214.s1862.p3","sentence":"Vav\/@PROTEIN1$ interactions are also detectable in freshly isolated T cells from gene-targeted mice that lack the T cell-specific inhibitory receptor @PROTEIN2$, in which c-Cbl is hyperphosphorylated on tyrosine residues.","label":0}
{"pair_id":"AIMed.d214.s1862.p4","sentence":"Vav\/@PROTEIN1$ interactions are also detectable in freshly isolated T cells from gene-targeted mice that lack the T cell-specific inhibitory receptor CTLA-4, in which @PROTEIN2$ is hyperphosphorylated on tyrosine residues.","label":0}
{"pair_id":"AIMed.d214.s1862.p5","sentence":"Vav\/c-Cbl interactions are also detectable in freshly isolated T cells from gene-targeted mice that lack the T cell-specific inhibitory receptor @PROTEIN1$, in which @PROTEIN2$ is hyperphosphorylated on tyrosine residues.","label":0}
{"pair_id":"BioInfer.d230.s0.p0","sentence":"Generation of these membrane microparticles was dependent on the presence of extracellular calcium and was accompanied by proteolytic degradation of the cytoskeletal proteins, @PROTEIN1$ (ABP), talin, and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d230.s0.p1","sentence":"Generation of these membrane microparticles was dependent on the presence of extracellular calcium and was accompanied by proteolytic degradation of the cytoskeletal proteins, @PROTEIN1$ (ABP), @PROTEIN2$, and myosin heavy chain.","label":0}
{"pair_id":"BioInfer.d230.s0.p2","sentence":"Generation of these membrane microparticles was dependent on the presence of extracellular calcium and was accompanied by proteolytic degradation of the cytoskeletal proteins, @PROTEIN1$ (@PROTEIN2$), talin, and myosin heavy chain.","label":0}
{"pair_id":"BioInfer.d230.s0.p3","sentence":"Generation of these membrane microparticles was dependent on the presence of extracellular calcium and was accompanied by proteolytic degradation of the cytoskeletal proteins, actin binding protein (ABP), @PROTEIN2$, and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d230.s0.p4","sentence":"Generation of these membrane microparticles was dependent on the presence of extracellular calcium and was accompanied by proteolytic degradation of the cytoskeletal proteins, actin binding protein (@PROTEIN2$), talin, and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d230.s0.p5","sentence":"Generation of these membrane microparticles was dependent on the presence of extracellular calcium and was accompanied by proteolytic degradation of the cytoskeletal proteins, actin binding protein (@PROTEIN2$), @PROTEIN1$, and myosin heavy chain.","label":0}
{"pair_id":"AIMed.d108.s909.p0","sentence":"@PROTEIN1$ transcriptional activation mediated by coactivators @PROTEIN2$ and TAFII60.","label":1}
{"pair_id":"AIMed.d108.s909.p1","sentence":"@PROTEIN1$ transcriptional activation mediated by coactivators TAFII40 and @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d108.s909.p2","sentence":"p53 transcriptional activation mediated by coactivators @PROTEIN1$ and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d91.s780.p0","sentence":"We find that @PROTEIN1$ is the human homologue of Drosophila @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d618.s0.p0","sentence":"The herpes simplex virus @PROTEIN2$ complex, a heterotrimer of the @PROTEIN1$, UL8, and UL52 proteins, displays a single predominant site of primer synthesis on phi X174 virion DNA (Tenney, D. J., Hurlburt, W. W., Micheletti, P. M., Bifano, M., and Hamatake, R. K. (1994) J. Biol. Chem. 269, 5030-5035).","label":1}
{"pair_id":"BioInfer.d618.s0.p1","sentence":"The herpes simplex virus helicase-primase complex, a heterotrimer of the @PROTEIN1$, @PROTEIN2$, and UL52 proteins, displays a single predominant site of primer synthesis on phi X174 virion DNA (Tenney, D. J., Hurlburt, W. W., Micheletti, P. M., Bifano, M., and Hamatake, R. K. (1994) J. Biol. Chem. 269, 5030-5035).","label":1}
{"pair_id":"BioInfer.d618.s0.p2","sentence":"The herpes simplex virus helicase-primase complex, a heterotrimer of the @PROTEIN1$, UL8, and @PROTEIN2$ proteins, displays a single predominant site of primer synthesis on phi X174 virion DNA (Tenney, D. J., Hurlburt, W. W., Micheletti, P. M., Bifano, M., and Hamatake, R. K. (1994) J. Biol. Chem. 269, 5030-5035).","label":1}
{"pair_id":"BioInfer.d618.s0.p3","sentence":"The herpes simplex virus @PROTEIN1$ complex, a heterotrimer of the UL5, @PROTEIN2$, and UL52 proteins, displays a single predominant site of primer synthesis on phi X174 virion DNA (Tenney, D. J., Hurlburt, W. W., Micheletti, P. M., Bifano, M., and Hamatake, R. K. (1994) J. Biol. Chem. 269, 5030-5035).","label":1}
{"pair_id":"BioInfer.d618.s0.p4","sentence":"The herpes simplex virus @PROTEIN1$ complex, a heterotrimer of the UL5, UL8, and @PROTEIN2$ proteins, displays a single predominant site of primer synthesis on phi X174 virion DNA (Tenney, D. J., Hurlburt, W. W., Micheletti, P. M., Bifano, M., and Hamatake, R. K. (1994) J. Biol. Chem. 269, 5030-5035).","label":1}
{"pair_id":"BioInfer.d618.s0.p5","sentence":"The herpes simplex virus helicase-primase complex, a heterotrimer of the UL5, @PROTEIN1$, and @PROTEIN2$ proteins, displays a single predominant site of primer synthesis on phi X174 virion DNA (Tenney, D. J., Hurlburt, W. W., Micheletti, P. M., Bifano, M., and Hamatake, R. K. (1994) J. Biol. Chem. 269, 5030-5035).","label":1}
{"pair_id":"BioInfer.d457.s0.p0","sentence":"Of the five major structural proteins of MV, only @PROTEIN1$ (@PROTEIN2$) @PROTEIN1$ and phosphoprotein (P protein) were consistently detected in diseased brain areas.","label":0}
{"pair_id":"BioInfer.d457.s0.p1","sentence":"Of the five major structural proteins of MV, only @PROTEIN1$ (N) @PROTEIN1$ and @PROTEIN2$ (P protein) were consistently detected in diseased brain areas.","label":0}
{"pair_id":"BioInfer.d457.s0.p2","sentence":"Of the five major structural proteins of MV, only @PROTEIN1$ (N) @PROTEIN1$ and phosphoprotein (@PROTEIN2$) were consistently detected in diseased brain areas.","label":0}
{"pair_id":"BioInfer.d457.s0.p3","sentence":"Of the five major structural proteins of MV, only nucleocapsid (@PROTEIN1$) nucleoc and @PROTEIN2$ (P protein) were consistently detected in diseased brain areas.","label":0}
{"pair_id":"BioInfer.d457.s0.p4","sentence":"Of the five major structural proteins of MV, only nucleocapsid (@PROTEIN1$) nucleoc and phosphoprotein (@PROTEIN2$) were consistently detected in diseased brain areas.","label":0}
{"pair_id":"BioInfer.d457.s0.p5","sentence":"Of the five major structural proteins of MV, only nucleocapsid (N) nucleoc and @PROTEIN1$ (@PROTEIN2$) were consistently detected in diseased brain areas.","label":0}
{"pair_id":"AIMed.d174.s1468.p0","sentence":"Monomeric (@PROTEIN1$) and dimeric (@PROTEIN2$) forms of Escherichia coli-derived human IL-6 and the extracellular (\"soluble\") portions of the IL-6 receptor (sIL-6R) and gp130 have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.","label":0}
{"pair_id":"AIMed.d174.s1468.p1","sentence":"Monomeric (@PROTEIN1$) and dimeric (IL-6D) forms of Escherichia coli-derived human @PROTEIN2$ and the extracellular (\"soluble\") portions of the IL-6 receptor (sIL-6R) and gp130 have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.","label":0}
{"pair_id":"AIMed.d174.s1468.p2","sentence":"Monomeric (@PROTEIN1$) and dimeric (IL-6D) forms of Escherichia coli-derived human IL-6 and the extracellular (\"soluble\") portions of the @PROTEIN2$ receptor (sIL-6R) and gp130 have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.","label":0}
{"pair_id":"AIMed.d174.s1468.p3","sentence":"Monomeric (@PROTEIN1$) and dimeric (IL-6D) forms of Escherichia coli-derived human IL-6 and the extracellular (\"soluble\") portions of the @PROTEIN2$ (sIL-6R) and gp130 have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.","label":0}
{"pair_id":"AIMed.d174.s1468.p4","sentence":"Monomeric (@PROTEIN1$) and dimeric (IL-6D) forms of Escherichia coli-derived human IL-6 and the extracellular (\"soluble\") portions of the IL-6 receptor (@PROTEIN2$) and gp130 have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.","label":0}
{"pair_id":"AIMed.d174.s1468.p5","sentence":"Monomeric (@PROTEIN1$) and dimeric (IL-6D) forms of Escherichia coli-derived human IL-6 and the extracellular (\"soluble\") portions of the IL-6 receptor (sIL-6R) and @PROTEIN2$ have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.","label":0}
{"pair_id":"AIMed.d174.s1468.p6","sentence":"Monomeric (@PROTEIN1$) and dimeric (IL-6D) forms of Escherichia coli-derived human IL-6 and the extracellular (\"soluble\") portions of the IL-6 receptor (sIL-6R) and gp130 have been purified in order to investigate the effect of @PROTEIN2$ dimerization on binding to the receptor complex.","label":0}
{"pair_id":"AIMed.d174.s1468.p7","sentence":"Monomeric (IL-6M) and dimeric (@PROTEIN1$) forms of Escherichia coli-derived human @PROTEIN2$ and the extracellular (\"soluble\") portions of the IL-6 receptor (sIL-6R) and gp130 have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.","label":0}
{"pair_id":"AIMed.d174.s1468.p8","sentence":"Monomeric (IL-6M) and dimeric (@PROTEIN1$) forms of Escherichia coli-derived human IL-6 and the extracellular (\"soluble\") portions of the @PROTEIN2$ receptor (sIL-6R) and gp130 have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.","label":0}
{"pair_id":"AIMed.d174.s1468.p9","sentence":"Monomeric (IL-6M) and dimeric (@PROTEIN1$) forms of Escherichia coli-derived human IL-6 and the extracellular (\"soluble\") portions of the @PROTEIN2$ (sIL-6R) and gp130 have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.","label":0}
{"pair_id":"AIMed.d174.s1468.p10","sentence":"Monomeric (IL-6M) and dimeric (@PROTEIN1$) forms of Escherichia coli-derived human IL-6 and the extracellular (\"soluble\") portions of the IL-6 receptor (@PROTEIN2$) and gp130 have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.","label":0}
{"pair_id":"AIMed.d174.s1468.p11","sentence":"Monomeric (IL-6M) and dimeric (@PROTEIN1$) forms of Escherichia coli-derived human IL-6 and the extracellular (\"soluble\") portions of the IL-6 receptor (sIL-6R) and @PROTEIN2$ have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.","label":0}
{"pair_id":"AIMed.d174.s1468.p12","sentence":"Monomeric (IL-6M) and dimeric (@PROTEIN1$) forms of Escherichia coli-derived human IL-6 and the extracellular (\"soluble\") portions of the IL-6 receptor (sIL-6R) and gp130 have been purified in order to investigate the effect of @PROTEIN2$ dimerization on binding to the receptor complex.","label":0}
{"pair_id":"AIMed.d174.s1468.p13","sentence":"Monomeric (IL-6M) and dimeric (IL-6D) forms of Escherichia coli-derived human @PROTEIN1$ and the extracellular (\"soluble\") portions of the @PROTEIN2$ receptor (sIL-6R) and gp130 have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.","label":0}
{"pair_id":"AIMed.d174.s1468.p14","sentence":"Monomeric (IL-6M) and dimeric (IL-6D) forms of Escherichia coli-derived human @PROTEIN1$ and the extracellular (\"soluble\") portions of the @PROTEIN2$ (sIL-6R) and gp130 have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.","label":0}
{"pair_id":"AIMed.d174.s1468.p15","sentence":"Monomeric (IL-6M) and dimeric (IL-6D) forms of Escherichia coli-derived human @PROTEIN1$ and the extracellular (\"soluble\") portions of the IL-6 receptor (@PROTEIN2$) and gp130 have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.","label":0}
{"pair_id":"AIMed.d174.s1468.p16","sentence":"Monomeric (IL-6M) and dimeric (IL-6D) forms of Escherichia coli-derived human @PROTEIN1$ and the extracellular (\"soluble\") portions of the IL-6 receptor (sIL-6R) and @PROTEIN2$ have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.","label":0}
{"pair_id":"AIMed.d174.s1468.p17","sentence":"Monomeric (IL-6M) and dimeric (IL-6D) forms of Escherichia coli-derived human @PROTEIN1$ and the extracellular (\"soluble\") portions of the IL-6 receptor (sIL-6R) and gp130 have been purified in order to investigate the effect of @PROTEIN2$ dimerization on binding to the receptor complex.","label":0}
{"pair_id":"AIMed.d174.s1468.p18","sentence":"Monomeric (IL-6M) and dimeric (IL-6D) forms of Escherichia coli-derived human IL-6 and the extracellular (\"soluble\") portions of the @PROTEIN1$@PROTEIN2$ (sIL-6R) and gp130 have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.","label":0}
{"pair_id":"AIMed.d174.s1468.p19","sentence":"Monomeric (IL-6M) and dimeric (IL-6D) forms of Escherichia coli-derived human IL-6 and the extracellular (\"soluble\") portions of the @PROTEIN1$ receptor (@PROTEIN2$) and gp130 have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.","label":1}
{"pair_id":"AIMed.d174.s1468.p20","sentence":"Monomeric (IL-6M) and dimeric (IL-6D) forms of Escherichia coli-derived human IL-6 and the extracellular (\"soluble\") portions of the @PROTEIN1$ receptor (sIL-6R) and @PROTEIN2$ have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.","label":0}
{"pair_id":"AIMed.d174.s1468.p21","sentence":"Monomeric (IL-6M) and dimeric (IL-6D) forms of Escherichia coli-derived human IL-6 and the extracellular (\"soluble\") portions of the @PROTEIN1$ receptor (sIL-6R) and gp130 have been purified in order to investigate the effect of @PROTEIN2$ dimerization on binding to the receptor complex.","label":0}
{"pair_id":"AIMed.d174.s1468.p22","sentence":"Monomeric (IL-6M) and dimeric (IL-6D) forms of Escherichia coli-derived human IL-6 and the extracellular (\"soluble\") portions of the @PROTEIN1$ (@PROTEIN2$) and gp130 have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.","label":0}
{"pair_id":"AIMed.d174.s1468.p23","sentence":"Monomeric (IL-6M) and dimeric (IL-6D) forms of Escherichia coli-derived human IL-6 and the extracellular (\"soluble\") portions of the @PROTEIN1$ (sIL-6R) and @PROTEIN2$ have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.","label":0}
{"pair_id":"AIMed.d174.s1468.p24","sentence":"Monomeric (IL-6M) and dimeric (IL-6D) forms of Escherichia coli-derived human IL-6 and the extracellular (\"soluble\") portions of the @PROTEIN1$ (sIL-6R) and gp130 have been purified in order to investigate the effect of @PROTEIN2$ dimerization on binding to the receptor complex.","label":0}
{"pair_id":"AIMed.d174.s1468.p25","sentence":"Monomeric (IL-6M) and dimeric (IL-6D) forms of Escherichia coli-derived human IL-6 and the extracellular (\"soluble\") portions of the IL-6 receptor (@PROTEIN1$) and @PROTEIN2$ have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.","label":0}
{"pair_id":"AIMed.d174.s1468.p26","sentence":"Monomeric (IL-6M) and dimeric (IL-6D) forms of Escherichia coli-derived human IL-6 and the extracellular (\"soluble\") portions of the IL-6 receptor (@PROTEIN1$) and gp130 have been purified in order to investigate the effect of @PROTEIN2$ dimerization on binding to the receptor complex.","label":0}
{"pair_id":"AIMed.d174.s1468.p27","sentence":"Monomeric (IL-6M) and dimeric (IL-6D) forms of Escherichia coli-derived human IL-6 and the extracellular (\"soluble\") portions of the IL-6 receptor (sIL-6R) and @PROTEIN1$ have been purified in order to investigate the effect of @PROTEIN2$ dimerization on binding to the receptor complex.","label":0}
{"pair_id":"AIMed.d49.s431.p0","sentence":"@PROTEIN1$ recognizes one FGFR isoform known as the @PROTEIN2$ isoform or keratinocyte growth factor receptor (KGFR), whereas FGF-2 binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with KGFR.","label":1}
{"pair_id":"AIMed.d49.s431.p1","sentence":"@PROTEIN1$ recognizes one FGFR isoform known as the FGFR2 IIIb isoform or @PROTEIN2$ receptor (KGFR), whereas FGF-2 binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with KGFR.","label":0}
{"pair_id":"AIMed.d49.s431.p2","sentence":"@PROTEIN1$ recognizes one FGFR isoform known as the FGFR2 IIIb isoform or @PROTEIN2$ (KGFR), whereas FGF-2 binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with KGFR.","label":1}
{"pair_id":"AIMed.d49.s431.p3","sentence":"@PROTEIN1$ recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (@PROTEIN2$), whereas FGF-2 binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with KGFR.","label":1}
{"pair_id":"AIMed.d49.s431.p4","sentence":"@PROTEIN1$ recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (KGFR), whereas @PROTEIN2$ binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with KGFR.","label":0}
{"pair_id":"AIMed.d49.s431.p5","sentence":"@PROTEIN1$ recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (KGFR), whereas FGF-2 binds well to @PROTEIN2$, FGFR2, and FGFR4 but interacts poorly with KGFR.","label":0}
{"pair_id":"AIMed.d49.s431.p6","sentence":"@PROTEIN1$ recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (KGFR), whereas FGF-2 binds well to FGFR1, @PROTEIN2$, and FGFR4 but interacts poorly with KGFR.","label":0}
{"pair_id":"AIMed.d49.s431.p7","sentence":"@PROTEIN1$ recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (KGFR), whereas FGF-2 binds well to FGFR1, FGFR2, and @PROTEIN2$ but interacts poorly with KGFR.","label":0}
{"pair_id":"AIMed.d49.s431.p8","sentence":"@PROTEIN1$ recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (KGFR), whereas FGF-2 binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d49.s431.p9","sentence":"FGF-7 recognizes one FGFR isoform known as the @PROTEIN1$ isoform or @PROTEIN2$ receptor (KGFR), whereas FGF-2 binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with KGFR.","label":0}
{"pair_id":"AIMed.d49.s431.p10","sentence":"FGF-7 recognizes one FGFR isoform known as the @PROTEIN1$ isoform or @PROTEIN2$ (KGFR), whereas FGF-2 binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with KGFR.","label":0}
{"pair_id":"AIMed.d49.s431.p11","sentence":"FGF-7 recognizes one FGFR isoform known as the @PROTEIN1$ isoform or keratinocyte growth factor receptor (@PROTEIN2$), whereas FGF-2 binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with KGFR.","label":0}
{"pair_id":"AIMed.d49.s431.p12","sentence":"FGF-7 recognizes one FGFR isoform known as the @PROTEIN1$ isoform or keratinocyte growth factor receptor (KGFR), whereas @PROTEIN2$ binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with KGFR.","label":0}
{"pair_id":"AIMed.d49.s431.p13","sentence":"FGF-7 recognizes one FGFR isoform known as the @PROTEIN1$ isoform or keratinocyte growth factor receptor (KGFR), whereas FGF-2 binds well to @PROTEIN2$, FGFR2, and FGFR4 but interacts poorly with KGFR.","label":0}
{"pair_id":"AIMed.d49.s431.p14","sentence":"FGF-7 recognizes one FGFR isoform known as the @PROTEIN1$ isoform or keratinocyte growth factor receptor (KGFR), whereas FGF-2 binds well to FGFR1, @PROTEIN2$, and FGFR4 but interacts poorly with KGFR.","label":0}
{"pair_id":"AIMed.d49.s431.p15","sentence":"FGF-7 recognizes one FGFR isoform known as the @PROTEIN1$ isoform or keratinocyte growth factor receptor (KGFR), whereas FGF-2 binds well to FGFR1, FGFR2, and @PROTEIN2$ but interacts poorly with KGFR.","label":0}
{"pair_id":"AIMed.d49.s431.p16","sentence":"FGF-7 recognizes one FGFR isoform known as the @PROTEIN1$ isoform or keratinocyte growth factor receptor (KGFR), whereas FGF-2 binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d49.s431.p17","sentence":"FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or @PROTEIN1$@PROTEIN2$ (KGFR), whereas FGF-2 binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with KGFR.","label":0}
{"pair_id":"AIMed.d49.s431.p18","sentence":"FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or @PROTEIN1$ receptor (@PROTEIN2$), whereas FGF-2 binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with KGFR.","label":0}
{"pair_id":"AIMed.d49.s431.p19","sentence":"FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or @PROTEIN1$ receptor (KGFR), whereas @PROTEIN2$ binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with KGFR.","label":0}
{"pair_id":"AIMed.d49.s431.p20","sentence":"FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or @PROTEIN1$ receptor (KGFR), whereas FGF-2 binds well to @PROTEIN2$, FGFR2, and FGFR4 but interacts poorly with KGFR.","label":0}
{"pair_id":"AIMed.d49.s431.p21","sentence":"FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or @PROTEIN1$ receptor (KGFR), whereas FGF-2 binds well to FGFR1, @PROTEIN2$, and FGFR4 but interacts poorly with KGFR.","label":0}
{"pair_id":"AIMed.d49.s431.p22","sentence":"FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or @PROTEIN1$ receptor (KGFR), whereas FGF-2 binds well to FGFR1, FGFR2, and @PROTEIN2$ but interacts poorly with KGFR.","label":0}
{"pair_id":"AIMed.d49.s431.p23","sentence":"FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or @PROTEIN1$ receptor (KGFR), whereas FGF-2 binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d49.s431.p24","sentence":"FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or @PROTEIN1$ (@PROTEIN2$), whereas FGF-2 binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with KGFR.","label":0}
{"pair_id":"AIMed.d49.s431.p25","sentence":"FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or @PROTEIN1$ (KGFR), whereas @PROTEIN2$ binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with KGFR.","label":0}
{"pair_id":"AIMed.d49.s431.p26","sentence":"FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or @PROTEIN1$ (KGFR), whereas FGF-2 binds well to @PROTEIN2$, FGFR2, and FGFR4 but interacts poorly with KGFR.","label":0}
{"pair_id":"AIMed.d49.s431.p27","sentence":"FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or @PROTEIN1$ (KGFR), whereas FGF-2 binds well to FGFR1, @PROTEIN2$, and FGFR4 but interacts poorly with KGFR.","label":0}
{"pair_id":"AIMed.d49.s431.p28","sentence":"FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or @PROTEIN1$ (KGFR), whereas FGF-2 binds well to FGFR1, FGFR2, and @PROTEIN2$ but interacts poorly with KGFR.","label":0}
{"pair_id":"AIMed.d49.s431.p29","sentence":"FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or @PROTEIN1$ (KGFR), whereas FGF-2 binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d49.s431.p30","sentence":"FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (@PROTEIN1$), whereas @PROTEIN2$ binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with KGFR.","label":0}
{"pair_id":"AIMed.d49.s431.p31","sentence":"FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (@PROTEIN1$), whereas FGF-2 binds well to @PROTEIN2$, FGFR2, and FGFR4 but interacts poorly with KGFR.","label":0}
{"pair_id":"AIMed.d49.s431.p32","sentence":"FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (@PROTEIN1$), whereas FGF-2 binds well to FGFR1, @PROTEIN2$, and FGFR4 but interacts poorly with KGFR.","label":0}
{"pair_id":"AIMed.d49.s431.p33","sentence":"FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (@PROTEIN1$), whereas FGF-2 binds well to FGFR1, FGFR2, and @PROTEIN2$ but interacts poorly with KGFR.","label":0}
{"pair_id":"AIMed.d49.s431.p34","sentence":"FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (@PROTEIN1$), whereas FGF-2 binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d49.s431.p35","sentence":"FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (KGFR), whereas @PROTEIN1$ binds well to @PROTEIN2$, FGFR2, and FGFR4 but interacts poorly with KGFR.","label":1}
{"pair_id":"AIMed.d49.s431.p36","sentence":"FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (KGFR), whereas @PROTEIN1$ binds well to FGFR1, @PROTEIN2$, and FGFR4 but interacts poorly with KGFR.","label":1}
{"pair_id":"AIMed.d49.s431.p37","sentence":"FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (KGFR), whereas @PROTEIN1$ binds well to FGFR1, FGFR2, and @PROTEIN2$ but interacts poorly with KGFR.","label":1}
{"pair_id":"AIMed.d49.s431.p38","sentence":"FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (KGFR), whereas @PROTEIN1$ binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d49.s431.p39","sentence":"FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (KGFR), whereas FGF-2 binds well to @PROTEIN1$, @PROTEIN2$, and FGFR4 but interacts poorly with KGFR.","label":0}
{"pair_id":"AIMed.d49.s431.p40","sentence":"FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (KGFR), whereas FGF-2 binds well to @PROTEIN1$, FGFR2, and @PROTEIN2$ but interacts poorly with KGFR.","label":0}
{"pair_id":"AIMed.d49.s431.p41","sentence":"FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (KGFR), whereas FGF-2 binds well to @PROTEIN1$, FGFR2, and FGFR4 but interacts poorly with @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d49.s431.p42","sentence":"FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (KGFR), whereas FGF-2 binds well to FGFR1, @PROTEIN1$, and @PROTEIN2$ but interacts poorly with KGFR.","label":0}
{"pair_id":"AIMed.d49.s431.p43","sentence":"FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (KGFR), whereas FGF-2 binds well to FGFR1, @PROTEIN1$, and FGFR4 but interacts poorly with @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d49.s431.p44","sentence":"FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (KGFR), whereas FGF-2 binds well to FGFR1, FGFR2, and @PROTEIN1$ but interacts poorly with @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d245.s1.p0","sentence":"It is well established that the cytoplasmic domain of E-cadherin binds either beta-catenin or @PROTEIN1$, which both can assemble @PROTEIN2$ into the complex.","label":1}
{"pair_id":"BioInfer.d245.s1.p1","sentence":"It is well established that the cytoplasmic domain of E-cadherin binds either @PROTEIN2$ or @PROTEIN1$, which both can assemble alpha-catenin into the complex.","label":0}
{"pair_id":"BioInfer.d245.s1.p2","sentence":"It is well established that the cytoplasmic domain of @PROTEIN2$ binds either beta-catenin or @PROTEIN1$, which both can assemble alpha-catenin into the complex.","label":1}
{"pair_id":"BioInfer.d245.s1.p3","sentence":"It is well established that the cytoplasmic domain of E-cadherin binds either @PROTEIN2$ or plakoglobin, which both can assemble @PROTEIN1$ into the complex.","label":1}
{"pair_id":"BioInfer.d245.s1.p4","sentence":"It is well established that the cytoplasmic domain of @PROTEIN2$ binds either beta-catenin or plakoglobin, which both can assemble @PROTEIN1$ into the complex.","label":1}
{"pair_id":"BioInfer.d245.s1.p5","sentence":"It is well established that the cytoplasmic domain of @PROTEIN2$ binds either @PROTEIN1$ or plakoglobin, which both can assemble alpha-catenin into the complex.","label":1}
{"pair_id":"BioInfer.d735.s0.p0","sentence":"This activity is independent of FADD-DN's ability to bind to three known interacting proteins, Fas, TRADD or @PROTEIN1$ suggesting that it is distinct from @PROTEIN2$'s functions at activated death receptors.","label":0}
{"pair_id":"BioInfer.d735.s0.p1","sentence":"This activity is independent of FADD-DN's ability to bind to three known interacting proteins, @PROTEIN2$, TRADD or @PROTEIN1$ suggesting that it is distinct from FADD's functions at activated death receptors.","label":1}
{"pair_id":"BioInfer.d735.s0.p2","sentence":"This activity is independent of @PROTEIN2$'s ability to bind to three known interacting proteins, Fas, TRADD or @PROTEIN1$ suggesting that it is distinct from FADD's functions at activated death receptors.","label":1}
{"pair_id":"BioInfer.d735.s0.p3","sentence":"This activity is independent of FADD-DN's ability to bind to three known interacting proteins, Fas, TRADD or @PROTEIN1$ suggesting that it is distinct from FADD's functions at activated @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d735.s0.p4","sentence":"This activity is independent of FADD-DN's ability to bind to three known interacting proteins, Fas, @PROTEIN2$ or @PROTEIN1$ suggesting that it is distinct from FADD's functions at activated death receptors.","label":1}
{"pair_id":"BioInfer.d735.s0.p5","sentence":"This activity is independent of FADD-DN's ability to bind to three known interacting proteins, @PROTEIN2$, TRADD or RIP suggesting that it is distinct from @PROTEIN1$'s functions at activated death receptors.","label":0}
{"pair_id":"BioInfer.d735.s0.p6","sentence":"This activity is independent of @PROTEIN2$'s ability to bind to three known interacting proteins, Fas, TRADD or RIP suggesting that it is distinct from @PROTEIN1$'s functions at activated death receptors.","label":0}
{"pair_id":"BioInfer.d735.s0.p7","sentence":"This activity is independent of FADD-DN's ability to bind to three known interacting proteins, Fas, TRADD or RIP suggesting that it is distinct from @PROTEIN1$'s functions at activated @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d735.s0.p8","sentence":"This activity is independent of FADD-DN's ability to bind to three known interacting proteins, Fas, @PROTEIN2$ or RIP suggesting that it is distinct from @PROTEIN1$'s functions at activated death receptors.","label":0}
{"pair_id":"BioInfer.d735.s0.p9","sentence":"This activity is independent of @PROTEIN2$'s ability to bind to three known interacting proteins, @PROTEIN1$, TRADD or RIP suggesting that it is distinct from FADD's functions at activated death receptors.","label":1}
{"pair_id":"BioInfer.d735.s0.p10","sentence":"This activity is independent of FADD-DN's ability to bind to three known interacting proteins, @PROTEIN1$, TRADD or RIP suggesting that it is distinct from FADD's functions at activated @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d735.s0.p11","sentence":"This activity is independent of FADD-DN's ability to bind to three known interacting proteins, @PROTEIN1$, @PROTEIN2$ or RIP suggesting that it is distinct from FADD's functions at activated death receptors.","label":1}
{"pair_id":"BioInfer.d735.s0.p12","sentence":"This activity is independent of @PROTEIN1$'s ability to bind to three known interacting proteins, Fas, TRADD or RIP suggesting that it is distinct from FADD's functions at activated @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d735.s0.p13","sentence":"This activity is independent of @PROTEIN1$'s ability to bind to three known interacting proteins, Fas, @PROTEIN2$ or RIP suggesting that it is distinct from FADD's functions at activated death receptors.","label":1}
{"pair_id":"BioInfer.d735.s0.p14","sentence":"This activity is independent of FADD-DN's ability to bind to three known interacting proteins, Fas, @PROTEIN2$ or RIP suggesting that it is distinct from FADD's functions at activated @PROTEIN1$.","label":0}
{"pair_id":"AIMed.d151.s1287.p0","sentence":"Immunoprecipitation studies confirm that the four @PROTEIN1$ subunits originally found to copurify during conventional chromatography indeed form a tightly associated complex; they further show that the @PROTEIN2$ so defined, including the gamma and delta subunits specifically, is essential for transcription of both class II and class III snRNA genes.","label":0}
{"pair_id":"BioInfer.d248.s0.p0","sentence":"Here we report that @PROTEIN2$ associates with a complex containing @PROTEIN1$, alpha-catenin, beta-catenin, and plakoglobin.","label":1}
{"pair_id":"BioInfer.d248.s0.p1","sentence":"Here we report that p120 associates with a complex containing @PROTEIN1$, @PROTEIN2$, beta-catenin, and plakoglobin.","label":1}
{"pair_id":"BioInfer.d248.s0.p2","sentence":"Here we report that p120 associates with a complex containing @PROTEIN1$, alpha-catenin, beta-catenin, and @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d248.s0.p3","sentence":"Here we report that p120 associates with a complex containing @PROTEIN1$, alpha-catenin, @PROTEIN2$, and plakoglobin.","label":1}
{"pair_id":"BioInfer.d248.s0.p4","sentence":"Here we report that @PROTEIN1$ associates with a complex containing E-cadherin, @PROTEIN2$, beta-catenin, and plakoglobin.","label":1}
{"pair_id":"BioInfer.d248.s0.p5","sentence":"Here we report that @PROTEIN1$ associates with a complex containing E-cadherin, alpha-catenin, beta-catenin, and @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d248.s0.p6","sentence":"Here we report that @PROTEIN1$ associates with a complex containing E-cadherin, alpha-catenin, @PROTEIN2$, and plakoglobin.","label":1}
{"pair_id":"BioInfer.d248.s0.p7","sentence":"Here we report that p120 associates with a complex containing E-cadherin, @PROTEIN1$, beta-catenin, and @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d248.s0.p8","sentence":"Here we report that p120 associates with a complex containing E-cadherin, @PROTEIN1$, @PROTEIN2$, and plakoglobin.","label":1}
{"pair_id":"BioInfer.d248.s0.p9","sentence":"Here we report that p120 associates with a complex containing E-cadherin, alpha-catenin, @PROTEIN2$, and @PROTEIN1$.","label":1}
{"pair_id":"AIMed.d167.s1405.p0","sentence":"A truncated version of the integral membrane glycoprotein @PROTEIN1$ (@PROTEIN2$) was synthesized in a rabbit reticulocyte translation system in the presence of canine pancreatic microsomes.","label":0}
{"pair_id":"AIMed.d199.s1707.p0","sentence":"@PROTEIN1$ complex via the adapter protein @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d204.s1764.p0","sentence":"This demonstrates that the C-terminal hemopexin domain of @PROTEIN1$, in contrast to the corresponding regions of @PROTEIN2$ and gelatinase B, does not interact with TIMP-1.","label":0}
{"pair_id":"AIMed.d204.s1764.p1","sentence":"This demonstrates that the C-terminal hemopexin domain of @PROTEIN1$, in contrast to the corresponding regions of gelatinase A and @PROTEIN2$, does not interact with TIMP-1.","label":0}
{"pair_id":"AIMed.d204.s1764.p2","sentence":"This demonstrates that the C-terminal hemopexin domain of @PROTEIN1$, in contrast to the corresponding regions of gelatinase A and gelatinase B, does not interact with @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d204.s1764.p3","sentence":"This demonstrates that the C-terminal hemopexin domain of MMP-1, in contrast to the corresponding regions of @PROTEIN1$ and @PROTEIN2$, does not interact with TIMP-1.","label":0}
{"pair_id":"AIMed.d204.s1764.p4","sentence":"This demonstrates that the C-terminal hemopexin domain of MMP-1, in contrast to the corresponding regions of @PROTEIN1$ and gelatinase B, does not interact with @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d204.s1764.p5","sentence":"This demonstrates that the C-terminal hemopexin domain of MMP-1, in contrast to the corresponding regions of gelatinase A and @PROTEIN1$, does not interact with @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d110.s928.p0","sentence":"The @PROTEIN1$-interacting region of @PROTEIN2$ was localized to its DNA-binding domain, which is distinct from the glutamine-rich activation domains previously shown to interact with Drosophila TAFII110.","label":1}
{"pair_id":"AIMed.d110.s928.p1","sentence":"The @PROTEIN1$-interacting region of Sp1 was localized to its DNA-binding domain, which is distinct from the glutamine-rich activation domains previously shown to interact with Drosophila @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d110.s928.p2","sentence":"The TAFII55-interacting region of @PROTEIN1$ was localized to its DNA-binding domain, which is distinct from the glutamine-rich activation domains previously shown to interact with Drosophila @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d56.s495.p0","sentence":"A cDNA clone, designated @PROTEIN1$ (@PROTEIN2$) was isolated from a collection of T cell activation genes.","label":0}
{"pair_id":"AIMed.d77.s657.p0","sentence":"We have identified an 18-amino acid residue stretch in the @PROTEIN1$ head that is conserved only among type II epidermal keratins and that appears to play some role in @PROTEIN2$ tail binding.","label":1}
{"pair_id":"AIMed.d199.s1697.p0","sentence":"Expression of @PROTEIN1$@PROTEIN2$ in stably transfected L6 cells conferred growth responses to several members of the FGF family including FGF-1, -2, -4, and -6, while FGFR3 IIIb-expressing cells responded only to FGF-1.","label":0}
{"pair_id":"AIMed.d199.s1697.p1","sentence":"Expression of @PROTEIN1$ IIIc in stably transfected L6 cells conferred growth responses to several members of the FGF family including @PROTEIN2$, -2, -4, and -6, while FGFR3 IIIb-expressing cells responded only to FGF-1.","label":0}
{"pair_id":"AIMed.d199.s1697.p2","sentence":"Expression of @PROTEIN1$ IIIc in stably transfected L6 cells conferred growth responses to several members of the FGF family including FGF-1, -2, -4, and -6, while @PROTEIN2$ IIIb-expressing cells responded only to FGF-1.","label":0}
{"pair_id":"AIMed.d199.s1697.p3","sentence":"Expression of @PROTEIN1$ IIIc in stably transfected L6 cells conferred growth responses to several members of the FGF family including FGF-1, -2, -4, and -6, while @PROTEIN2$-expressing cells responded only to FGF-1.","label":0}
{"pair_id":"AIMed.d199.s1697.p4","sentence":"Expression of @PROTEIN1$ IIIc in stably transfected L6 cells conferred growth responses to several members of the FGF family including FGF-1, -2, -4, and -6, while FGFR3 IIIb-expressing cells responded only to @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d199.s1697.p5","sentence":"Expression of @PROTEIN1$ in stably transfected L6 cells conferred growth responses to several members of the FGF family including @PROTEIN2$, -2, -4, and -6, while FGFR3 IIIb-expressing cells responded only to FGF-1.","label":0}
{"pair_id":"AIMed.d199.s1697.p6","sentence":"Expression of @PROTEIN1$ in stably transfected L6 cells conferred growth responses to several members of the FGF family including FGF-1, -2, -4, and -6, while @PROTEIN2$ IIIb-expressing cells responded only to FGF-1.","label":0}
{"pair_id":"AIMed.d199.s1697.p7","sentence":"Expression of @PROTEIN1$ in stably transfected L6 cells conferred growth responses to several members of the FGF family including FGF-1, -2, -4, and -6, while @PROTEIN2$-expressing cells responded only to FGF-1.","label":0}
{"pair_id":"AIMed.d199.s1697.p8","sentence":"Expression of @PROTEIN1$ in stably transfected L6 cells conferred growth responses to several members of the FGF family including FGF-1, -2, -4, and -6, while FGFR3 IIIb-expressing cells responded only to @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d199.s1697.p9","sentence":"Expression of FGFR3 IIIc in stably transfected L6 cells conferred growth responses to several members of the FGF family including @PROTEIN1$, -2, -4, and -6, while @PROTEIN2$ IIIb-expressing cells responded only to FGF-1.","label":0}
{"pair_id":"AIMed.d199.s1697.p10","sentence":"Expression of FGFR3 IIIc in stably transfected L6 cells conferred growth responses to several members of the FGF family including @PROTEIN1$, -2, -4, and -6, while @PROTEIN2$-expressing cells responded only to FGF-1.","label":0}
{"pair_id":"AIMed.d199.s1697.p11","sentence":"Expression of FGFR3 IIIc in stably transfected L6 cells conferred growth responses to several members of the FGF family including @PROTEIN1$, -2, -4, and -6, while FGFR3 IIIb-expressing cells responded only to @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d199.s1697.p12","sentence":"Expression of FGFR3 IIIc in stably transfected L6 cells conferred growth responses to several members of the FGF family including FGF-1, -2, -4, and -6, while @PROTEIN1$@PROTEIN2$-expressing cells responded only to FGF-1.","label":0}
{"pair_id":"AIMed.d199.s1697.p13","sentence":"Expression of FGFR3 IIIc in stably transfected L6 cells conferred growth responses to several members of the FGF family including FGF-1, -2, -4, and -6, while @PROTEIN1$ IIIb-expressing cells responded only to @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d199.s1697.p14","sentence":"Expression of FGFR3 IIIc in stably transfected L6 cells conferred growth responses to several members of the FGF family including FGF-1, -2, -4, and -6, while @PROTEIN1$-expressing cells responded only to @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d137.s1164.p0","sentence":"Co-transfection of human @PROTEIN1$ and @PROTEIN2$ expression vectors into B cells resulted in a synergistic activation of an octamer motif containing promoter.","label":0}
{"pair_id":"AIMed.d42.s367.p0","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (@PROTEIN1$\/@PROTEIN2$ and BR-II\/BR-Ib) and homomeric (BR-II\/BR-II, BR-Ia\/ BR-Ia, BR-Ib\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":1}
{"pair_id":"AIMed.d42.s367.p1","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (@PROTEIN1$\/BR-Ia and @PROTEIN2$\/BR-Ib) and homomeric (BR-II\/BR-II, BR-Ia\/ BR-Ia, BR-Ib\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p2","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (@PROTEIN1$\/BR-Ia and BR-II\/@PROTEIN2$) and homomeric (BR-II\/BR-II, BR-Ia\/ BR-Ia, BR-Ib\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p3","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (@PROTEIN1$\/BR-Ia and BR-II\/BR-Ib) and homomeric (@PROTEIN2$\/BR-II, BR-Ia\/ BR-Ia, BR-Ib\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p4","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (@PROTEIN1$\/BR-Ia and BR-II\/BR-Ib) and homomeric (BR-II\/@PROTEIN2$, BR-Ia\/ BR-Ia, BR-Ib\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p5","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (@PROTEIN1$\/BR-Ia and BR-II\/BR-Ib) and homomeric (BR-II\/BR-II, @PROTEIN2$\/ BR-Ia, BR-Ib\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p6","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (@PROTEIN1$\/BR-Ia and BR-II\/BR-Ib) and homomeric (BR-II\/BR-II, BR-Ia\/ @PROTEIN2$, BR-Ib\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p7","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (@PROTEIN1$\/BR-Ia and BR-II\/BR-Ib) and homomeric (BR-II\/BR-II, BR-Ia\/ BR-Ia, @PROTEIN2$\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p8","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (@PROTEIN1$\/BR-Ia and BR-II\/BR-Ib) and homomeric (BR-II\/BR-II, BR-Ia\/ BR-Ia, BR-Ib\/ @PROTEIN2$, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p9","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (@PROTEIN1$\/BR-Ia and BR-II\/BR-Ib) and homomeric (BR-II\/BR-II, BR-Ia\/ BR-Ia, BR-Ib\/ BR-Ib, and also @PROTEIN2$\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p10","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (@PROTEIN1$\/BR-Ia and BR-II\/BR-Ib) and homomeric (BR-II\/BR-II, BR-Ia\/ BR-Ia, BR-Ib\/ BR-Ib, and also BR-Ia\/ @PROTEIN2$) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p11","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/@PROTEIN1$ and @PROTEIN2$\/BR-Ib) and homomeric (BR-II\/BR-II, BR-Ia\/ BR-Ia, BR-Ib\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p12","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/@PROTEIN1$ and BR-II\/@PROTEIN2$) and homomeric (BR-II\/BR-II, BR-Ia\/ BR-Ia, BR-Ib\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p13","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/@PROTEIN1$ and BR-II\/BR-Ib) and homomeric (@PROTEIN2$\/BR-II, BR-Ia\/ BR-Ia, BR-Ib\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p14","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/@PROTEIN1$ and BR-II\/BR-Ib) and homomeric (BR-II\/@PROTEIN2$, BR-Ia\/ BR-Ia, BR-Ib\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p15","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/@PROTEIN1$ and BR-II\/BR-Ib) and homomeric (BR-II\/BR-II, @PROTEIN2$\/ BR-Ia, BR-Ib\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p16","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/@PROTEIN1$ and BR-II\/BR-Ib) and homomeric (BR-II\/BR-II, BR-Ia\/ @PROTEIN2$, BR-Ib\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p17","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/@PROTEIN1$ and BR-II\/BR-Ib) and homomeric (BR-II\/BR-II, BR-Ia\/ BR-Ia, @PROTEIN2$\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p18","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/@PROTEIN1$ and BR-II\/BR-Ib) and homomeric (BR-II\/BR-II, BR-Ia\/ BR-Ia, BR-Ib\/ @PROTEIN2$, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p19","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/@PROTEIN1$ and BR-II\/BR-Ib) and homomeric (BR-II\/BR-II, BR-Ia\/ BR-Ia, BR-Ib\/ BR-Ib, and also @PROTEIN2$\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p20","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/@PROTEIN1$ and BR-II\/BR-Ib) and homomeric (BR-II\/BR-II, BR-Ia\/ BR-Ia, BR-Ib\/ BR-Ib, and also BR-Ia\/ @PROTEIN2$) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p21","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and @PROTEIN1$\/@PROTEIN2$) and homomeric (BR-II\/BR-II, BR-Ia\/ BR-Ia, BR-Ib\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":1}
{"pair_id":"AIMed.d42.s367.p22","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and @PROTEIN1$\/BR-Ib) and homomeric (@PROTEIN2$\/BR-II, BR-Ia\/ BR-Ia, BR-Ib\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p23","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and @PROTEIN1$\/BR-Ib) and homomeric (BR-II\/@PROTEIN2$, BR-Ia\/ BR-Ia, BR-Ib\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p24","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and @PROTEIN1$\/BR-Ib) and homomeric (BR-II\/BR-II, @PROTEIN2$\/ BR-Ia, BR-Ib\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p25","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and @PROTEIN1$\/BR-Ib) and homomeric (BR-II\/BR-II, BR-Ia\/ @PROTEIN2$, BR-Ib\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p26","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and @PROTEIN1$\/BR-Ib) and homomeric (BR-II\/BR-II, BR-Ia\/ BR-Ia, @PROTEIN2$\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p27","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and @PROTEIN1$\/BR-Ib) and homomeric (BR-II\/BR-II, BR-Ia\/ BR-Ia, BR-Ib\/ @PROTEIN2$, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p28","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and @PROTEIN1$\/BR-Ib) and homomeric (BR-II\/BR-II, BR-Ia\/ BR-Ia, BR-Ib\/ BR-Ib, and also @PROTEIN2$\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p29","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and @PROTEIN1$\/BR-Ib) and homomeric (BR-II\/BR-II, BR-Ia\/ BR-Ia, BR-Ib\/ BR-Ib, and also BR-Ia\/ @PROTEIN2$) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p30","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/@PROTEIN1$) and homomeric (@PROTEIN2$\/BR-II, BR-Ia\/ BR-Ia, BR-Ib\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p31","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/@PROTEIN1$) and homomeric (BR-II\/@PROTEIN2$, BR-Ia\/ BR-Ia, BR-Ib\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p32","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/@PROTEIN1$) and homomeric (BR-II\/BR-II, @PROTEIN2$\/ BR-Ia, BR-Ib\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p33","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/@PROTEIN1$) and homomeric (BR-II\/BR-II, BR-Ia\/ @PROTEIN2$, BR-Ib\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p34","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/@PROTEIN1$) and homomeric (BR-II\/BR-II, BR-Ia\/ BR-Ia, @PROTEIN2$\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p35","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/@PROTEIN1$) and homomeric (BR-II\/BR-II, BR-Ia\/ BR-Ia, BR-Ib\/ @PROTEIN2$, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p36","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/@PROTEIN1$) and homomeric (BR-II\/BR-II, BR-Ia\/ BR-Ia, BR-Ib\/ BR-Ib, and also @PROTEIN2$\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p37","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/@PROTEIN1$) and homomeric (BR-II\/BR-II, BR-Ia\/ BR-Ia, BR-Ib\/ BR-Ib, and also BR-Ia\/ @PROTEIN2$) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p38","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/BR-Ib) and homomeric (@PROTEIN1$\/@PROTEIN2$, BR-Ia\/ BR-Ia, BR-Ib\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":1}
{"pair_id":"AIMed.d42.s367.p39","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/BR-Ib) and homomeric (@PROTEIN1$\/BR-II, @PROTEIN2$\/ BR-Ia, BR-Ib\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p40","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/BR-Ib) and homomeric (@PROTEIN1$\/BR-II, BR-Ia\/ @PROTEIN2$, BR-Ib\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p41","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/BR-Ib) and homomeric (@PROTEIN1$\/BR-II, BR-Ia\/ BR-Ia, @PROTEIN2$\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p42","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/BR-Ib) and homomeric (@PROTEIN1$\/BR-II, BR-Ia\/ BR-Ia, BR-Ib\/ @PROTEIN2$, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p43","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/BR-Ib) and homomeric (@PROTEIN1$\/BR-II, BR-Ia\/ BR-Ia, BR-Ib\/ BR-Ib, and also @PROTEIN2$\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p44","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/BR-Ib) and homomeric (@PROTEIN1$\/BR-II, BR-Ia\/ BR-Ia, BR-Ib\/ BR-Ib, and also BR-Ia\/ @PROTEIN2$) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p45","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/BR-Ib) and homomeric (BR-II\/@PROTEIN1$, @PROTEIN2$\/ BR-Ia, BR-Ib\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p46","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/BR-Ib) and homomeric (BR-II\/@PROTEIN1$, BR-Ia\/ @PROTEIN2$, BR-Ib\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p47","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/BR-Ib) and homomeric (BR-II\/@PROTEIN1$, BR-Ia\/ BR-Ia, @PROTEIN2$\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p48","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/BR-Ib) and homomeric (BR-II\/@PROTEIN1$, BR-Ia\/ BR-Ia, BR-Ib\/ @PROTEIN2$, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p49","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/BR-Ib) and homomeric (BR-II\/@PROTEIN1$, BR-Ia\/ BR-Ia, BR-Ib\/ BR-Ib, and also @PROTEIN2$\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p50","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/BR-Ib) and homomeric (BR-II\/@PROTEIN1$, BR-Ia\/ BR-Ia, BR-Ib\/ BR-Ib, and also BR-Ia\/ @PROTEIN2$) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p51","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/BR-Ib) and homomeric (BR-II\/BR-II, @PROTEIN1$\/ @PROTEIN2$, BR-Ib\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":1}
{"pair_id":"AIMed.d42.s367.p52","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/BR-Ib) and homomeric (BR-II\/BR-II, @PROTEIN1$\/ BR-Ia, @PROTEIN2$\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p53","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/BR-Ib) and homomeric (BR-II\/BR-II, @PROTEIN1$\/ BR-Ia, BR-Ib\/ @PROTEIN2$, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p54","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/BR-Ib) and homomeric (BR-II\/BR-II, @PROTEIN1$\/ BR-Ia, BR-Ib\/ BR-Ib, and also @PROTEIN2$\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p55","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/BR-Ib) and homomeric (BR-II\/BR-II, @PROTEIN1$\/ BR-Ia, BR-Ib\/ BR-Ib, and also BR-Ia\/ @PROTEIN2$) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p56","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/BR-Ib) and homomeric (BR-II\/BR-II, BR-Ia\/ @PROTEIN1$, @PROTEIN2$\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p57","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/BR-Ib) and homomeric (BR-II\/BR-II, BR-Ia\/ @PROTEIN1$, BR-Ib\/ @PROTEIN2$, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p58","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/BR-Ib) and homomeric (BR-II\/BR-II, BR-Ia\/ @PROTEIN1$, BR-Ib\/ BR-Ib, and also @PROTEIN2$\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p59","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/BR-Ib) and homomeric (BR-II\/BR-II, BR-Ia\/ @PROTEIN1$, BR-Ib\/ BR-Ib, and also BR-Ia\/ @PROTEIN2$) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p60","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/BR-Ib) and homomeric (BR-II\/BR-II, BR-Ia\/ BR-Ia, @PROTEIN1$\/ @PROTEIN2$, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":1}
{"pair_id":"AIMed.d42.s367.p61","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/BR-Ib) and homomeric (BR-II\/BR-II, BR-Ia\/ BR-Ia, @PROTEIN1$\/ BR-Ib, and also @PROTEIN2$\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p62","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/BR-Ib) and homomeric (BR-II\/BR-II, BR-Ia\/ BR-Ia, @PROTEIN1$\/ BR-Ib, and also BR-Ia\/ @PROTEIN2$) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p63","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/BR-Ib) and homomeric (BR-II\/BR-II, BR-Ia\/ BR-Ia, BR-Ib\/ @PROTEIN1$, and also @PROTEIN2$\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p64","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/BR-Ib) and homomeric (BR-II\/BR-II, BR-Ia\/ BR-Ia, BR-Ib\/ @PROTEIN1$, and also BR-Ia\/ @PROTEIN2$) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p65","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/BR-Ib) and homomeric (BR-II\/BR-II, BR-Ia\/ BR-Ia, BR-Ib\/ BR-Ib, and also @PROTEIN1$\/ @PROTEIN2$) oligomers in the absence of ligand.","label":1}
{"pair_id":"BioInfer.d39.s0.p0","sentence":"Although binding patterns of different sera were not identical, almost all sera caused @PROTEIN1$ binding to platelet components of 87-90 kD, 140 kD (identified as vinculin) and 220-240 kD (tentatively identified as talin and @PROTEIN2$).","label":1}
{"pair_id":"BioInfer.d39.s0.p1","sentence":"Although binding patterns of different sera were not identical, almost all sera caused @PROTEIN1$ binding to platelet components of 87-90 kD, 140 kD (identified as vinculin) and 220-240 kD (tentatively identified as @PROTEIN2$ and actin-binding protein).","label":1}
{"pair_id":"BioInfer.d39.s0.p2","sentence":"Although binding patterns of different sera were not identical, almost all sera caused @PROTEIN1$ binding to platelet components of 87-90 kD, 140 kD (identified as @PROTEIN2$) and 220-240 kD (tentatively identified as talin and actin-binding protein).","label":1}
{"pair_id":"BioInfer.d39.s0.p3","sentence":"Although binding patterns of different sera were not identical, almost all sera caused IgG binding to platelet components of 87-90 kD, 140 kD (identified as vinculin) and 220-240 kD (tentatively identified as @PROTEIN2$ and @PROTEIN1$).","label":0}
{"pair_id":"BioInfer.d39.s0.p4","sentence":"Although binding patterns of different sera were not identical, almost all sera caused IgG binding to platelet components of 87-90 kD, 140 kD (identified as @PROTEIN2$) and 220-240 kD (tentatively identified as talin and @PROTEIN1$).","label":0}
{"pair_id":"BioInfer.d39.s0.p5","sentence":"Although binding patterns of different sera were not identical, almost all sera caused IgG binding to platelet components of 87-90 kD, 140 kD (identified as @PROTEIN2$) and 220-240 kD (tentatively identified as @PROTEIN1$ and actin-binding protein).","label":0}
{"pair_id":"AIMed.d63.s544.p0","sentence":"Coassociation of @PROTEIN1$ (@PROTEIN2$) with CD45 on the surface of human T lymphocytes.","label":0}
{"pair_id":"AIMed.d63.s544.p1","sentence":"Coassociation of @PROTEIN1$ (dipeptidyl peptidase IV) with @PROTEIN2$ on the surface of human T lymphocytes.","label":1}
{"pair_id":"AIMed.d63.s544.p2","sentence":"Coassociation of CD26 (@PROTEIN1$) with @PROTEIN2$ on the surface of human T lymphocytes.","label":1}
{"pair_id":"BioInfer.d165.s0.p0","sentence":"Deletion and overexpression studies demonstrate that @PROTEIN1$, but not SIR1, @PROTEIN2$ or SIR4, is required for this rDNA position effect.","label":0}
{"pair_id":"BioInfer.d165.s0.p1","sentence":"Deletion and overexpression studies demonstrate that @PROTEIN1$, but not @PROTEIN2$, SIR3 or SIR4, is required for this rDNA position effect.","label":0}
{"pair_id":"BioInfer.d165.s0.p2","sentence":"Deletion and overexpression studies demonstrate that @PROTEIN1$, but not SIR1, SIR3 or @PROTEIN2$, is required for this rDNA position effect.","label":0}
{"pair_id":"BioInfer.d165.s0.p3","sentence":"Deletion and overexpression studies demonstrate that SIR2, but not @PROTEIN2$, @PROTEIN1$ or SIR4, is required for this rDNA position effect.","label":0}
{"pair_id":"BioInfer.d165.s0.p4","sentence":"Deletion and overexpression studies demonstrate that SIR2, but not SIR1, @PROTEIN1$ or @PROTEIN2$, is required for this rDNA position effect.","label":0}
{"pair_id":"BioInfer.d165.s0.p5","sentence":"Deletion and overexpression studies demonstrate that SIR2, but not @PROTEIN1$, SIR3 or @PROTEIN2$, is required for this rDNA position effect.","label":0}
{"pair_id":"AIMed.d195.s1662.p0","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of @PROTEIN1$, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. @PROTEIN2$, a member of the spectrin\/dystrophin family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both NR1 and NR2B subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p1","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of @PROTEIN1$, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/@PROTEIN2$ family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both NR1 and NR2B subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p2","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of @PROTEIN1$, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/dystrophin family of @PROTEIN2$-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both NR1 and NR2B subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p3","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of @PROTEIN1$, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/dystrophin family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule @PROTEIN2$. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both NR1 and NR2B subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p4","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of @PROTEIN1$, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/dystrophin family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. @PROTEIN2$ binds by its central rod domain to the cytoplasmic tail of both NR1 and NR2B subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p5","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of @PROTEIN1$, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/dystrophin family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both @PROTEIN2$ and NR2B subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p6","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of @PROTEIN1$, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/dystrophin family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both NR1 and @PROTEIN2$ subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p7","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of @PROTEIN1$, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/dystrophin family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both NR1 and NR2B subunits of the @PROTEIN2$, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p8","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of @PROTEIN1$, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/dystrophin family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both NR1 and NR2B subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and @PROTEIN2$ from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p9","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. @PROTEIN1$, a member of the spectrin\/@PROTEIN2$ family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both NR1 and NR2B subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p10","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. @PROTEIN1$, a member of the spectrin\/dystrophin family of @PROTEIN2$-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both NR1 and NR2B subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p11","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. @PROTEIN1$, a member of the spectrin\/dystrophin family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule @PROTEIN2$. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both NR1 and NR2B subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p12","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. @PROTEIN1$, a member of the spectrin\/dystrophin family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. @PROTEIN2$ binds by its central rod domain to the cytoplasmic tail of both NR1 and NR2B subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p13","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. @PROTEIN1$, a member of the spectrin\/dystrophin family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both @PROTEIN2$ and NR2B subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p14","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. @PROTEIN1$, a member of the spectrin\/dystrophin family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both NR1 and @PROTEIN2$ subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p15","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. @PROTEIN1$, a member of the spectrin\/dystrophin family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both NR1 and NR2B subunits of the @PROTEIN2$, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p16","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. @PROTEIN1$, a member of the spectrin\/dystrophin family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both NR1 and NR2B subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and @PROTEIN2$ from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p17","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/@PROTEIN1$ family of @PROTEIN2$-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both NR1 and NR2B subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p18","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/@PROTEIN1$ family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule @PROTEIN2$. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both NR1 and NR2B subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p19","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/@PROTEIN1$ family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. @PROTEIN2$ binds by its central rod domain to the cytoplasmic tail of both NR1 and NR2B subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p20","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/@PROTEIN1$ family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both @PROTEIN2$ and NR2B subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p21","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/@PROTEIN1$ family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both NR1 and @PROTEIN2$ subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p22","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/@PROTEIN1$ family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both NR1 and NR2B subunits of the @PROTEIN2$, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p23","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/@PROTEIN1$ family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both NR1 and NR2B subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and @PROTEIN2$ from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p24","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/dystrophin family of @PROTEIN1$-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule @PROTEIN2$. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both NR1 and NR2B subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p25","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/dystrophin family of @PROTEIN1$-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. @PROTEIN2$ binds by its central rod domain to the cytoplasmic tail of both NR1 and NR2B subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p26","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/dystrophin family of @PROTEIN1$-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both @PROTEIN2$ and NR2B subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p27","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/dystrophin family of @PROTEIN1$-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both NR1 and @PROTEIN2$ subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p28","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/dystrophin family of @PROTEIN1$-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both NR1 and NR2B subunits of the @PROTEIN2$, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p29","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/dystrophin family of @PROTEIN1$-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both NR1 and NR2B subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and @PROTEIN2$ from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p30","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/dystrophin family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule @PROTEIN1$. @PROTEIN2$ binds by its central rod domain to the cytoplasmic tail of both NR1 and NR2B subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p31","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/dystrophin family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule @PROTEIN1$. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both @PROTEIN2$ and NR2B subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p32","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/dystrophin family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule @PROTEIN1$. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both NR1 and @PROTEIN2$ subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p33","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/dystrophin family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule @PROTEIN1$. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both NR1 and NR2B subunits of the @PROTEIN2$, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p34","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/dystrophin family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule @PROTEIN1$. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both NR1 and NR2B subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and @PROTEIN2$ from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p35","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/dystrophin family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. @PROTEIN1$ binds by its central rod domain to the cytoplasmic tail of both @PROTEIN2$ and NR2B subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p36","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/dystrophin family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. @PROTEIN1$ binds by its central rod domain to the cytoplasmic tail of both NR1 and @PROTEIN2$ subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p37","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/dystrophin family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. @PROTEIN1$ binds by its central rod domain to the cytoplasmic tail of both NR1 and NR2B subunits of the @PROTEIN2$, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":1}
{"pair_id":"AIMed.d195.s1662.p38","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/dystrophin family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. @PROTEIN1$ binds by its central rod domain to the cytoplasmic tail of both NR1 and NR2B subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and @PROTEIN2$ from rat brain.","label":1}
{"pair_id":"AIMed.d195.s1662.p39","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/dystrophin family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both @PROTEIN1$ and @PROTEIN2$ subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p40","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/dystrophin family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both @PROTEIN1$ and NR2B subunits of the @PROTEIN2$, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p41","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/dystrophin family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both @PROTEIN1$ and NR2B subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and @PROTEIN2$ from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p42","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/dystrophin family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both NR1 and @PROTEIN1$ subunits of the @PROTEIN2$, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p43","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/dystrophin family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both NR1 and @PROTEIN1$ subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and @PROTEIN2$ from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p44","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/dystrophin family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both NR1 and NR2B subunits of the @PROTEIN1$, and can be immunoprecipitated with NMDA receptors and @PROTEIN2$ from rat brain.","label":0}
{"pair_id":"BioInfer.d706.s0.p0","sentence":"The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the @PROTEIN2$ alpha-catenin, @PROTEIN1$\/Armadillo, and classical cadherin, respectively.","label":1}
{"pair_id":"BioInfer.d706.s0.p1","sentence":"The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins @PROTEIN2$, @PROTEIN1$\/Armadillo, and classical cadherin, respectively.","label":0}
{"pair_id":"BioInfer.d706.s0.p2","sentence":"The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, @PROTEIN1$\/Armadillo, and @PROTEIN2$, respectively.","label":0}
{"pair_id":"BioInfer.d706.s0.p3","sentence":"The sequences of the predicted HMP-1, @PROTEIN2$, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, @PROTEIN1$\/Armadillo, and classical cadherin, respectively.","label":1}
{"pair_id":"BioInfer.d706.s0.p4","sentence":"The sequences of the predicted HMP-1, HMP-2, and @PROTEIN2$ proteins are related to the cell adhesion proteins alpha-catenin, @PROTEIN1$\/Armadillo, and classical cadherin, respectively.","label":0}
{"pair_id":"BioInfer.d706.s0.p5","sentence":"The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, @PROTEIN1$\/@PROTEIN2$, and classical cadherin, respectively.","label":0}
{"pair_id":"BioInfer.d706.s0.p6","sentence":"The sequences of the predicted @PROTEIN2$, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, @PROTEIN1$\/Armadillo, and classical cadherin, respectively.","label":0}
{"pair_id":"BioInfer.d706.s0.p7","sentence":"The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the @PROTEIN1$ @PROTEIN2$, beta-catenin\/Armadillo, and classical cadherin, respectively.","label":1}
{"pair_id":"BioInfer.d706.s0.p8","sentence":"The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the @PROTEIN1$ alpha-catenin, beta-catenin\/Armadillo, and @PROTEIN2$, respectively.","label":1}
{"pair_id":"BioInfer.d706.s0.p9","sentence":"The sequences of the predicted HMP-1, @PROTEIN2$, and HMR-1 proteins are related to the @PROTEIN1$ alpha-catenin, beta-catenin\/Armadillo, and classical cadherin, respectively.","label":0}
{"pair_id":"BioInfer.d706.s0.p10","sentence":"The sequences of the predicted HMP-1, HMP-2, and @PROTEIN2$ proteins are related to the @PROTEIN1$ alpha-catenin, beta-catenin\/Armadillo, and classical cadherin, respectively.","label":0}
{"pair_id":"BioInfer.d706.s0.p11","sentence":"The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the @PROTEIN1$ alpha-catenin, beta-catenin\/@PROTEIN2$, and classical cadherin, respectively.","label":1}
{"pair_id":"BioInfer.d706.s0.p12","sentence":"The sequences of the predicted @PROTEIN2$, HMP-2, and HMR-1 proteins are related to the @PROTEIN1$ alpha-catenin, beta-catenin\/Armadillo, and classical cadherin, respectively.","label":0}
{"pair_id":"BioInfer.d706.s0.p13","sentence":"The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins @PROTEIN1$, beta-catenin\/Armadillo, and @PROTEIN2$, respectively.","label":0}
{"pair_id":"BioInfer.d706.s0.p14","sentence":"The sequences of the predicted HMP-1, @PROTEIN2$, and HMR-1 proteins are related to the cell adhesion proteins @PROTEIN1$, beta-catenin\/Armadillo, and classical cadherin, respectively.","label":0}
{"pair_id":"BioInfer.d706.s0.p15","sentence":"The sequences of the predicted HMP-1, HMP-2, and @PROTEIN2$ proteins are related to the cell adhesion proteins @PROTEIN1$, beta-catenin\/Armadillo, and classical cadherin, respectively.","label":0}
{"pair_id":"BioInfer.d706.s0.p16","sentence":"The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins @PROTEIN1$, beta-catenin\/@PROTEIN2$, and classical cadherin, respectively.","label":0}
{"pair_id":"BioInfer.d706.s0.p17","sentence":"The sequences of the predicted @PROTEIN2$, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins @PROTEIN1$, beta-catenin\/Armadillo, and classical cadherin, respectively.","label":1}
{"pair_id":"BioInfer.d706.s0.p18","sentence":"The sequences of the predicted HMP-1, @PROTEIN2$, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin\/Armadillo, and @PROTEIN1$, respectively.","label":0}
{"pair_id":"BioInfer.d706.s0.p19","sentence":"The sequences of the predicted HMP-1, HMP-2, and @PROTEIN2$ proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin\/Armadillo, and @PROTEIN1$, respectively.","label":1}
{"pair_id":"BioInfer.d706.s0.p20","sentence":"The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin\/@PROTEIN2$, and @PROTEIN1$, respectively.","label":0}
{"pair_id":"BioInfer.d706.s0.p21","sentence":"The sequences of the predicted @PROTEIN2$, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin\/Armadillo, and @PROTEIN1$, respectively.","label":0}
{"pair_id":"BioInfer.d706.s0.p22","sentence":"The sequences of the predicted HMP-1, @PROTEIN1$, and @PROTEIN2$ proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin\/Armadillo, and classical cadherin, respectively.","label":0}
{"pair_id":"BioInfer.d706.s0.p23","sentence":"The sequences of the predicted HMP-1, @PROTEIN1$, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin\/@PROTEIN2$, and classical cadherin, respectively.","label":1}
{"pair_id":"BioInfer.d706.s0.p24","sentence":"The sequences of the predicted @PROTEIN2$, @PROTEIN1$, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin\/Armadillo, and classical cadherin, respectively.","label":0}
{"pair_id":"BioInfer.d706.s0.p25","sentence":"The sequences of the predicted HMP-1, HMP-2, and @PROTEIN1$ proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin\/@PROTEIN2$, and classical cadherin, respectively.","label":0}
{"pair_id":"BioInfer.d706.s0.p26","sentence":"The sequences of the predicted @PROTEIN2$, HMP-2, and @PROTEIN1$ proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin\/Armadillo, and classical cadherin, respectively.","label":0}
{"pair_id":"BioInfer.d706.s0.p27","sentence":"The sequences of the predicted @PROTEIN2$, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin\/@PROTEIN1$, and classical cadherin, respectively.","label":0}
{"pair_id":"AIMed.d47.s412.p0","sentence":"Bone morphogenetic proteins (BMPs) belong to the large @PROTEIN1$ (@PROTEIN2$) superfamily of multifunctional cytokines.","label":0}
{"pair_id":"AIMed.d118.s1002.p0","sentence":"Furthermore, @PROTEIN1$ blocks the ability of @PROTEIN2$ to activate DNA polymerase delta, the principal replicative DNA polymerase.","label":1}
{"pair_id":"AIMed.d118.s1002.p1","sentence":"Furthermore, @PROTEIN1$ blocks the ability of PCNA to activate @PROTEIN2$, the principal replicative DNA polymerase.","label":0}
{"pair_id":"AIMed.d118.s1002.p2","sentence":"Furthermore, p21 blocks the ability of @PROTEIN1$ to activate @PROTEIN2$, the principal replicative DNA polymerase.","label":1}
{"pair_id":"AIMed.d215.s1868.p0","sentence":"Specific cleavage of @PROTEIN1$ (@PROTEIN2$) by matrix metalloprotease-2 (MMP2) was shown to induce migration of breast epithelial cells.","label":0}
{"pair_id":"AIMed.d215.s1868.p1","sentence":"Specific cleavage of @PROTEIN1$ (Ln-5) by @PROTEIN2$ (MMP2) was shown to induce migration of breast epithelial cells.","label":1}
{"pair_id":"AIMed.d215.s1868.p2","sentence":"Specific cleavage of @PROTEIN1$ (Ln-5) by matrix metalloprotease-2 (@PROTEIN2$) was shown to induce migration of breast epithelial cells.","label":1}
{"pair_id":"AIMed.d215.s1868.p3","sentence":"Specific cleavage of laminin-5 (@PROTEIN1$) by @PROTEIN2$ (MMP2) was shown to induce migration of breast epithelial cells.","label":1}
{"pair_id":"AIMed.d215.s1868.p4","sentence":"Specific cleavage of laminin-5 (@PROTEIN1$) by matrix metalloprotease-2 (@PROTEIN2$) was shown to induce migration of breast epithelial cells.","label":1}
{"pair_id":"AIMed.d215.s1868.p5","sentence":"Specific cleavage of laminin-5 (Ln-5) by @PROTEIN1$ (@PROTEIN2$) was shown to induce migration of breast epithelial cells.","label":0}
{"pair_id":"BioInfer.d562.s0.p0","sentence":"The @PROTEIN1$ bundle formation induced by overexpression of @PROTEIN2$ is accompanied with an increase in cell motility of Dictyostelium cells. 4.","label":1}
{"pair_id":"BioInfer.d115.s0.p0","sentence":"@PROTEIN1$, a new component of the yeast @PROTEIN2$-SWI complex that interacts with a conserved region of SNF2.","label":1}
{"pair_id":"BioInfer.d115.s0.p1","sentence":"@PROTEIN1$, a new component of the yeast SNF-SWI complex that interacts with a conserved region of @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d115.s0.p2","sentence":"@PROTEIN1$, a new component of the yeast SNF-@PROTEIN2$ complex that interacts with a conserved region of SNF2.","label":1}
{"pair_id":"BioInfer.d115.s0.p3","sentence":"SNF11, a new component of the yeast @PROTEIN1$-SWI complex that interacts with a conserved region of @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d115.s0.p4","sentence":"SNF11, a new component of the yeast @PROTEIN1$-@PROTEIN2$ complex that interacts with a conserved region of SNF2.","label":1}
{"pair_id":"BioInfer.d115.s0.p5","sentence":"SNF11, a new component of the yeast SNF-@PROTEIN2$ complex that interacts with a conserved region of @PROTEIN1$.","label":0}
{"pair_id":"AIMed.d213.s1851.p0","sentence":"We show that the physical interaction between @PROTEIN1$ and @PROTEIN2$, a coactivator for CREB, is not sufficient for repression of CREB-mediated transcription.","label":1}
{"pair_id":"AIMed.d213.s1851.p1","sentence":"We show that the physical interaction between @PROTEIN1$ and p300, a coactivator for @PROTEIN2$, is not sufficient for repression of CREB-mediated transcription.","label":0}
{"pair_id":"AIMed.d213.s1851.p2","sentence":"We show that the physical interaction between @PROTEIN1$ and p300, a coactivator for CREB, is not sufficient for repression of @PROTEIN2$-mediated transcription.","label":0}
{"pair_id":"AIMed.d213.s1851.p3","sentence":"We show that the physical interaction between YY1 and @PROTEIN1$, a coactivator for @PROTEIN2$, is not sufficient for repression of CREB-mediated transcription.","label":1}
{"pair_id":"AIMed.d213.s1851.p4","sentence":"We show that the physical interaction between YY1 and @PROTEIN1$, a coactivator for CREB, is not sufficient for repression of @PROTEIN2$-mediated transcription.","label":0}
{"pair_id":"AIMed.d213.s1851.p5","sentence":"We show that the physical interaction between YY1 and p300, a coactivator for @PROTEIN1$, is not sufficient for repression of @PROTEIN2$-mediated transcription.","label":0}
{"pair_id":"BioInfer.d187.s0.p0","sentence":"Effects of single amino acid substitutions in the @PROTEIN1$-binding site on the biological activity of bovine @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d453.s0.p0","sentence":"No evidence for the surface expression of the phosphoprotein (@PROTEIN1$), matrix (M) or nucleocapsid (@PROTEIN2$) matrix p was found.","label":0}
{"pair_id":"BioInfer.d453.s0.p1","sentence":"No evidence for the surface expression of the phosphoprotein (@PROTEIN1$), matrix (M) or @PROTEIN2$ (N) @PROTEIN2$ was found.","label":0}
{"pair_id":"BioInfer.d453.s0.p2","sentence":"No evidence for the surface expression of the @PROTEIN2$ (@PROTEIN1$), matrix (M) or nucleocapsid (N) @PROTEIN2$ was found.","label":0}
{"pair_id":"BioInfer.d453.s0.p3","sentence":"No evidence for the surface expression of the phosphoprotein (@PROTEIN1$), matrix (@PROTEIN2$) or nucleocapsid (N) matrix p was found.","label":0}
{"pair_id":"BioInfer.d453.s0.p4","sentence":"No evidence for the surface expression of the phosphoprotein (@PROTEIN1$), @PROTEIN2$ (M) or nucleocapsid (N) @PROTEIN2$ was found.","label":0}
{"pair_id":"BioInfer.d453.s0.p5","sentence":"No evidence for the surface expression of the phosphoprotein (P), matrix (M) or @PROTEIN2$ (@PROTEIN1$) @PROTEIN2$ was found.","label":0}
{"pair_id":"BioInfer.d453.s0.p6","sentence":"No evidence for the surface expression of the @PROTEIN2$ (P), matrix (M) or nucleocapsid (@PROTEIN1$) @PROTEIN2$ was found.","label":0}
{"pair_id":"BioInfer.d453.s0.p7","sentence":"No evidence for the surface expression of the phosphoprotein (P), matrix (@PROTEIN2$) or nucleocapsid (@PROTEIN1$) matrix p was found.","label":0}
{"pair_id":"BioInfer.d453.s0.p8","sentence":"No evidence for the surface expression of the phosphoprotein (P), @PROTEIN2$ (M) or nucleocapsid (@PROTEIN1$) @PROTEIN2$ was found.","label":0}
{"pair_id":"BioInfer.d453.s0.p9","sentence":"No evidence for the surface expression of the @PROTEIN2$ (P), matrix (M) or @PROTEIN1$ (N) @PROTEIN1$@PROTEIN2$ was found.","label":0}
{"pair_id":"BioInfer.d453.s0.p10","sentence":"No evidence for the surface expression of the phosphoprotein (P), matrix (@PROTEIN2$) or @PROTEIN1$ (N) @PROTEIN1$ was found.","label":0}
{"pair_id":"BioInfer.d453.s0.p11","sentence":"No evidence for the surface expression of the phosphoprotein (P), @PROTEIN2$ (M) or @PROTEIN1$ (N) @PROTEIN1$@PROTEIN2$ was found.","label":0}
{"pair_id":"BioInfer.d453.s0.p12","sentence":"No evidence for the surface expression of the @PROTEIN1$ (P), matrix (@PROTEIN2$) or nucleocapsid (N) @PROTEIN1$ was found.","label":0}
{"pair_id":"BioInfer.d453.s0.p13","sentence":"No evidence for the surface expression of the @PROTEIN1$ (P), @PROTEIN2$ (M) or nucleocapsid (N) @PROTEIN1$@PROTEIN2$ was found.","label":0}
{"pair_id":"BioInfer.d453.s0.p14","sentence":"No evidence for the surface expression of the phosphoprotein (P), @PROTEIN2$ (@PROTEIN1$) or nucleocapsid (N) @PROTEIN2$ was found.","label":0}
{"pair_id":"AIMed.d202.s1744.p0","sentence":"The crystal structure shows that @PROTEIN1$ consists of three immunoglobulin-like domains which wrap around @PROTEIN2$ in a manner distinct from the structures of previously described cytokine-receptor complexes.","label":1}
{"pair_id":"AIMed.d87.s735.p0","sentence":"The experiments were performed with the cytoplasmic beta domain (wild type or mutated) of @PROTEIN1$ and @PROTEIN2$ and p85 or its subdomains (N + C-SH2, N-SH2, C-SH2, SH3 + N-SH2).","label":0}
{"pair_id":"AIMed.d87.s735.p1","sentence":"The experiments were performed with the cytoplasmic beta domain (wild type or mutated) of @PROTEIN1$ and IGF-1R and @PROTEIN2$ or its subdomains (N + C-SH2, N-SH2, C-SH2, SH3 + N-SH2).","label":0}
{"pair_id":"AIMed.d87.s735.p2","sentence":"The experiments were performed with the cytoplasmic beta domain (wild type or mutated) of IR and @PROTEIN1$ and @PROTEIN2$ or its subdomains (N + C-SH2, N-SH2, C-SH2, SH3 + N-SH2).","label":0}
{"pair_id":"BioInfer.d727.s0.p0","sentence":"The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, @PROTEIN1$, FADD and @PROTEIN2$ - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].","label":1}
{"pair_id":"BioInfer.d727.s0.p1","sentence":"The tumor necrosis factor receptor 1 (@PROTEIN2$) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, @PROTEIN1$, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].","label":1}
{"pair_id":"BioInfer.d727.s0.p2","sentence":"The tumor necrosis factor receptor 1 (TNFR1) and the @PROTEIN2$ receptor recruit complexes formed by the interactions between RIP kinase, @PROTEIN1$, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].","label":1}
{"pair_id":"BioInfer.d727.s0.p3","sentence":"The @PROTEIN2$ (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, @PROTEIN1$, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].","label":1}
{"pair_id":"BioInfer.d727.s0.p4","sentence":"The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between @PROTEIN2$, @PROTEIN1$, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].","label":1}
{"pair_id":"BioInfer.d727.s0.p5","sentence":"The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, @PROTEIN1$, @PROTEIN2$ and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].","label":1}
{"pair_id":"BioInfer.d727.s0.p6","sentence":"The tumor necrosis factor receptor 1 (@PROTEIN2$) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and @PROTEIN1$ - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].","label":1}
{"pair_id":"BioInfer.d727.s0.p7","sentence":"The tumor necrosis factor receptor 1 (TNFR1) and the @PROTEIN2$ receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and @PROTEIN1$ - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].","label":1}
{"pair_id":"BioInfer.d727.s0.p8","sentence":"The @PROTEIN2$ (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and @PROTEIN1$ - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].","label":1}
{"pair_id":"BioInfer.d727.s0.p9","sentence":"The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between @PROTEIN2$, TRADD, FADD and @PROTEIN1$ - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].","label":1}
{"pair_id":"BioInfer.d727.s0.p10","sentence":"The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, @PROTEIN2$ and @PROTEIN1$ - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].","label":1}
{"pair_id":"BioInfer.d727.s0.p11","sentence":"The tumor necrosis factor receptor 1 (@PROTEIN1$) and the @PROTEIN2$ receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].","label":0}
{"pair_id":"BioInfer.d727.s0.p12","sentence":"The @PROTEIN2$ (@PROTEIN1$) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].","label":0}
{"pair_id":"BioInfer.d727.s0.p13","sentence":"The tumor necrosis factor receptor 1 (@PROTEIN1$) and the Fas receptor recruit complexes formed by the interactions between @PROTEIN2$, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].","label":1}
{"pair_id":"BioInfer.d727.s0.p14","sentence":"The tumor necrosis factor receptor 1 (@PROTEIN1$) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, @PROTEIN2$ and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].","label":1}
{"pair_id":"BioInfer.d727.s0.p15","sentence":"The @PROTEIN2$ (TNFR1) and the @PROTEIN1$ receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].","label":0}
{"pair_id":"BioInfer.d727.s0.p16","sentence":"The tumor necrosis factor receptor 1 (TNFR1) and the @PROTEIN1$ receptor recruit complexes formed by the interactions between @PROTEIN2$, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].","label":1}
{"pair_id":"BioInfer.d727.s0.p17","sentence":"The tumor necrosis factor receptor 1 (TNFR1) and the @PROTEIN1$ receptor recruit complexes formed by the interactions between RIP kinase, TRADD, @PROTEIN2$ and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].","label":1}
{"pair_id":"BioInfer.d727.s0.p18","sentence":"The @PROTEIN1$ (TNFR1) and the Fas receptor recruit complexes formed by the interactions between @PROTEIN2$, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].","label":1}
{"pair_id":"BioInfer.d727.s0.p19","sentence":"The @PROTEIN1$ (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, @PROTEIN2$ and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].","label":1}
{"pair_id":"BioInfer.d727.s0.p20","sentence":"The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between @PROTEIN1$, TRADD, @PROTEIN2$ and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].","label":1}
{"pair_id":"AIMed.d26.s217.p0","sentence":"Flow cytometric analysis demonstrated high levels of @PROTEIN1$ and @PROTEIN2$ expression by CD3(-) CD16(+) cells in healthy controls.","label":0}
{"pair_id":"AIMed.d26.s217.p1","sentence":"Flow cytometric analysis demonstrated high levels of @PROTEIN1$ and granulysin expression by @PROTEIN2$(-) CD16(+) cells in healthy controls.","label":0}
{"pair_id":"AIMed.d26.s217.p2","sentence":"Flow cytometric analysis demonstrated high levels of @PROTEIN1$ and granulysin expression by CD3(-) @PROTEIN2$(+) cells in healthy controls.","label":0}
{"pair_id":"AIMed.d26.s217.p3","sentence":"Flow cytometric analysis demonstrated high levels of perforin and @PROTEIN1$ expression by @PROTEIN2$(-) CD16(+) cells in healthy controls.","label":0}
{"pair_id":"AIMed.d26.s217.p4","sentence":"Flow cytometric analysis demonstrated high levels of perforin and @PROTEIN1$ expression by CD3(-) @PROTEIN2$(+) cells in healthy controls.","label":0}
{"pair_id":"AIMed.d26.s217.p5","sentence":"Flow cytometric analysis demonstrated high levels of perforin and granulysin expression by @PROTEIN1$(-) @PROTEIN2$(+) cells in healthy controls.","label":0}
{"pair_id":"AIMed.d116.s980.p0","sentence":"Here we report that (1) there is an accumulation of @PROTEIN1$ protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of @PROTEIN2$ to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional Rb pocket; and (4) Rb specifically inhibits the activity of the RNA polymerase I transcription factor UBF (upstream binding factor) in vitro.","label":0}
{"pair_id":"AIMed.d116.s980.p1","sentence":"Here we report that (1) there is an accumulation of @PROTEIN1$ protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of Rb to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional @PROTEIN2$ pocket; and (4) Rb specifically inhibits the activity of the RNA polymerase I transcription factor UBF (upstream binding factor) in vitro.","label":0}
{"pair_id":"AIMed.d116.s980.p2","sentence":"Here we report that (1) there is an accumulation of @PROTEIN1$ protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of Rb to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional Rb pocket; and (4) @PROTEIN2$ specifically inhibits the activity of the RNA polymerase I transcription factor UBF (upstream binding factor) in vitro.","label":0}
{"pair_id":"AIMed.d116.s980.p3","sentence":"Here we report that (1) there is an accumulation of @PROTEIN1$ protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of Rb to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional Rb pocket; and (4) Rb specifically inhibits the activity of the RNA polymerase I transcription factor @PROTEIN2$ (upstream binding factor) in vitro.","label":0}
{"pair_id":"AIMed.d116.s980.p4","sentence":"Here we report that (1) there is an accumulation of @PROTEIN1$ protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of Rb to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional Rb pocket; and (4) Rb specifically inhibits the activity of the RNA polymerase I transcription factor UBF (@PROTEIN2$) in vitro.","label":0}
{"pair_id":"AIMed.d116.s980.p5","sentence":"Here we report that (1) there is an accumulation of Rb protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of @PROTEIN1$ to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional @PROTEIN2$ pocket; and (4) Rb specifically inhibits the activity of the RNA polymerase I transcription factor UBF (upstream binding factor) in vitro.","label":0}
{"pair_id":"AIMed.d116.s980.p6","sentence":"Here we report that (1) there is an accumulation of Rb protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of @PROTEIN1$ to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional Rb pocket; and (4) @PROTEIN2$ specifically inhibits the activity of the RNA polymerase I transcription factor UBF (upstream binding factor) in vitro.","label":0}
{"pair_id":"AIMed.d116.s980.p7","sentence":"Here we report that (1) there is an accumulation of Rb protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of @PROTEIN1$ to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional Rb pocket; and (4) Rb specifically inhibits the activity of the RNA polymerase I transcription factor @PROTEIN2$ (upstream binding factor) in vitro.","label":0}
{"pair_id":"AIMed.d116.s980.p8","sentence":"Here we report that (1) there is an accumulation of Rb protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of @PROTEIN1$ to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional Rb pocket; and (4) Rb specifically inhibits the activity of the RNA polymerase I transcription factor UBF (@PROTEIN2$) in vitro.","label":0}
{"pair_id":"AIMed.d116.s980.p9","sentence":"Here we report that (1) there is an accumulation of Rb protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of Rb to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional @PROTEIN1$ pocket; and (4) @PROTEIN2$ specifically inhibits the activity of the RNA polymerase I transcription factor UBF (upstream binding factor) in vitro.","label":0}
{"pair_id":"AIMed.d116.s980.p10","sentence":"Here we report that (1) there is an accumulation of Rb protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of Rb to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional @PROTEIN1$ pocket; and (4) Rb specifically inhibits the activity of the RNA polymerase I transcription factor @PROTEIN2$ (upstream binding factor) in vitro.","label":0}
{"pair_id":"AIMed.d116.s980.p11","sentence":"Here we report that (1) there is an accumulation of Rb protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of Rb to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional @PROTEIN1$ pocket; and (4) Rb specifically inhibits the activity of the RNA polymerase I transcription factor UBF (@PROTEIN2$) in vitro.","label":0}
{"pair_id":"AIMed.d116.s980.p12","sentence":"Here we report that (1) there is an accumulation of Rb protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of Rb to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional Rb pocket; and (4) @PROTEIN1$ specifically inhibits the activity of the RNA polymerase I transcription factor @PROTEIN2$ (upstream binding factor) in vitro.","label":1}
{"pair_id":"AIMed.d116.s980.p13","sentence":"Here we report that (1) there is an accumulation of Rb protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of Rb to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional Rb pocket; and (4) @PROTEIN1$ specifically inhibits the activity of the RNA polymerase I transcription factor UBF (@PROTEIN2$) in vitro.","label":1}
{"pair_id":"AIMed.d116.s980.p14","sentence":"Here we report that (1) there is an accumulation of Rb protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of Rb to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional Rb pocket; and (4) Rb specifically inhibits the activity of the RNA polymerase I transcription factor @PROTEIN1$ (@PROTEIN2$) in vitro.","label":0}
{"pair_id":"BioInfer.d394.s0.p0","sentence":"It is also possible that PtdIns-4,5-P2 has other roles, such as promoting the release of G actin from @PROTEIN1$ or promoting the cross-linking of @PROTEIN2$ or its anchorage to the plasma membrane.","label":0}
{"pair_id":"BioInfer.d394.s0.p1","sentence":"It is also possible that PtdIns-4,5-P2 has other roles, such as promoting the release of G @PROTEIN2$ from @PROTEIN1$ or promoting the cross-linking of actin or its anchorage to the plasma membrane.","label":1}
{"pair_id":"BioInfer.d394.s0.p2","sentence":"It is also possible that PtdIns-4,5-P2 has other roles, such as promoting the release of G @PROTEIN2$ from profilin or promoting the cross-linking of @PROTEIN1$ or its anchorage to the plasma membrane.","label":0}
{"pair_id":"AIMed.d198.s1690.p0","sentence":"Site-specific mutants were expressed in Escherichia coli as soluble @PROTEIN1$ and analyzed for @PROTEIN2$ binding in several different assay formats.","label":0}
{"pair_id":"BioInfer.d135.s1.p0","sentence":"For example, @PROTEIN2$ with a deletion of the eight C-terminal residues has many of the physical properties of a molten globule, yet remarkably still binds to @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d185.s0.p0","sentence":"Effects of macrophage profilin on @PROTEIN1$ in the presence and absence of @PROTEIN2$ and gelsolin.","label":0}
{"pair_id":"BioInfer.d185.s0.p1","sentence":"Effects of macrophage profilin on @PROTEIN1$ in the presence and absence of acumentin and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d185.s0.p2","sentence":"Effects of @PROTEIN2$ on @PROTEIN1$ in the presence and absence of acumentin and gelsolin.","label":1}
{"pair_id":"BioInfer.d185.s0.p3","sentence":"Effects of macrophage profilin on actin in the presence and absence of @PROTEIN1$ and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d185.s0.p4","sentence":"Effects of @PROTEIN2$ on actin in the presence and absence of @PROTEIN1$ and gelsolin.","label":0}
{"pair_id":"BioInfer.d185.s0.p5","sentence":"Effects of @PROTEIN2$ on actin in the presence and absence of acumentin and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d599.s0.p0","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian @PROTEIN2$ H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; @PROTEIN1$ H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p1","sentence":"The core @PROTEIN2$ from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; @PROTEIN1$ H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p2","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of @PROTEIN2$ H3; @PROTEIN1$ H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p3","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; @PROTEIN2$ H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; @PROTEIN1$ H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p4","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; @PROTEIN1$ H2A and @PROTEIN2$ show less heterogeneity.","label":1}
{"pair_id":"BioInfer.d599.s0.p5","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); @PROTEIN2$ H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; @PROTEIN1$ H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p6","sentence":"The core histones from Physarum, @PROTEIN2$ H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; @PROTEIN1$ H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p7","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone @PROTEIN2$ shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; @PROTEIN1$ H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p8","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and @PROTEIN2$, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; @PROTEIN1$ H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p9","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone @PROTEIN2$ has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; @PROTEIN1$ H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p10","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone @PROTEIN2$ (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; @PROTEIN1$ H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p11","sentence":"The core histones from Physarum, histones @PROTEIN2$, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; @PROTEIN1$ H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p12","sentence":"The core histones from Physarum, histones H2A, H2B, @PROTEIN2$, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; @PROTEIN1$ H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p13","sentence":"The core histones from Physarum, histones H2A, @PROTEIN2$, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; @PROTEIN1$ H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p14","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; @PROTEIN1$ @PROTEIN2$ and H2B show less heterogeneity.","label":1}
{"pair_id":"BioInfer.d599.s0.p15","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone @PROTEIN2$; @PROTEIN1$ H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p16","sentence":"The core @PROTEIN2$ from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian @PROTEIN1$ H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p17","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian @PROTEIN1$ H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of @PROTEIN2$ H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p18","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; @PROTEIN2$ H4 shows five subfractions, analogous to the five subfractions of mammalian @PROTEIN1$ H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p19","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian @PROTEIN1$ H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and @PROTEIN2$ show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p20","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian @PROTEIN1$ H4 (containing zero to four acetyllysine residues per molecule); @PROTEIN2$ H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p21","sentence":"The core histones from Physarum, @PROTEIN2$ H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian @PROTEIN1$ H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p22","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone @PROTEIN2$ shows five subfractions, analogous to the five subfractions of mammalian @PROTEIN1$ H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p23","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and @PROTEIN2$, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian @PROTEIN1$ H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p24","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian @PROTEIN1$ H4 (containing zero to four acetyllysine residues per molecule); histone @PROTEIN2$ has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p25","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian @PROTEIN1$ @PROTEIN2$ (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":1}
{"pair_id":"BioInfer.d599.s0.p26","sentence":"The core histones from Physarum, histones @PROTEIN2$, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian @PROTEIN1$ H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p27","sentence":"The core histones from Physarum, histones H2A, H2B, @PROTEIN2$, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian @PROTEIN1$ H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p28","sentence":"The core histones from Physarum, histones H2A, @PROTEIN2$, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian @PROTEIN1$ H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p29","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian @PROTEIN1$ H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones @PROTEIN2$ and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p30","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian @PROTEIN1$ H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone @PROTEIN2$; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p31","sentence":"The core @PROTEIN1$ from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of @PROTEIN2$ H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p32","sentence":"The core @PROTEIN1$ from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; @PROTEIN2$ H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p33","sentence":"The core @PROTEIN1$ from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and @PROTEIN2$ show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p34","sentence":"The core @PROTEIN1$ from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); @PROTEIN2$ H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p35","sentence":"The core @PROTEIN1$ from Physarum, @PROTEIN2$ H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p36","sentence":"The core @PROTEIN1$ from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone @PROTEIN2$ shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p37","sentence":"The core @PROTEIN1$ from Physarum, histones H2A, H2B, H3, and @PROTEIN2$, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":1}
{"pair_id":"BioInfer.d599.s0.p38","sentence":"The core @PROTEIN1$ from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone @PROTEIN2$ has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p39","sentence":"The core @PROTEIN1$ from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone @PROTEIN2$ (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p40","sentence":"The core @PROTEIN1$ from Physarum, histones @PROTEIN2$, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":1}
{"pair_id":"BioInfer.d599.s0.p41","sentence":"The core @PROTEIN1$ from Physarum, histones H2A, H2B, @PROTEIN2$, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":1}
{"pair_id":"BioInfer.d599.s0.p42","sentence":"The core @PROTEIN1$ from Physarum, histones H2A, @PROTEIN2$, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":1}
{"pair_id":"BioInfer.d599.s0.p43","sentence":"The core @PROTEIN1$ from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones @PROTEIN2$ and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p44","sentence":"The core @PROTEIN1$ from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone @PROTEIN2$; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p45","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; @PROTEIN2$ H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of @PROTEIN1$ H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p46","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of @PROTEIN1$ H3; histones H2A and @PROTEIN2$ show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p47","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); @PROTEIN2$ H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of @PROTEIN1$ H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p48","sentence":"The core histones from Physarum, @PROTEIN2$ H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of @PROTEIN1$ H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p49","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone @PROTEIN2$ shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of @PROTEIN1$ H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p50","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and @PROTEIN2$, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of @PROTEIN1$ H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p51","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone @PROTEIN2$ has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of @PROTEIN1$ H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p52","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone @PROTEIN2$ (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of @PROTEIN1$ H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p53","sentence":"The core histones from Physarum, histones @PROTEIN2$, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of @PROTEIN1$ H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p54","sentence":"The core histones from Physarum, histones H2A, H2B, @PROTEIN2$, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of @PROTEIN1$ H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p55","sentence":"The core histones from Physarum, histones H2A, @PROTEIN2$, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of @PROTEIN1$ H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p56","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of @PROTEIN1$ H3; histones @PROTEIN2$ and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p57","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of @PROTEIN1$ @PROTEIN2$; histones H2A and H2B show less heterogeneity.","label":1}
{"pair_id":"BioInfer.d599.s0.p58","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; @PROTEIN1$ H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and @PROTEIN2$ show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p59","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; @PROTEIN1$ H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); @PROTEIN2$ H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p60","sentence":"The core histones from Physarum, @PROTEIN2$ H2A, H2B, H3, and H4, are rapidly acetylated; @PROTEIN1$ H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p61","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; @PROTEIN1$ @PROTEIN2$ shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":1}
{"pair_id":"BioInfer.d599.s0.p62","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and @PROTEIN2$, are rapidly acetylated; @PROTEIN1$ H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p63","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; @PROTEIN1$ H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone @PROTEIN2$ has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p64","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; @PROTEIN1$ H4 shows five subfractions, analogous to the five subfractions of mammalian histone @PROTEIN2$ (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p65","sentence":"The core histones from Physarum, histones @PROTEIN2$, H2B, H3, and H4, are rapidly acetylated; @PROTEIN1$ H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p66","sentence":"The core histones from Physarum, histones H2A, H2B, @PROTEIN2$, and H4, are rapidly acetylated; @PROTEIN1$ H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p67","sentence":"The core histones from Physarum, histones H2A, @PROTEIN2$, H3, and H4, are rapidly acetylated; @PROTEIN1$ H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p68","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; @PROTEIN1$ H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones @PROTEIN2$ and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p69","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; @PROTEIN1$ H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone @PROTEIN2$; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p70","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); @PROTEIN2$ H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and @PROTEIN1$ show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p71","sentence":"The core histones from Physarum, @PROTEIN2$ H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and @PROTEIN1$ show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p72","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone @PROTEIN2$ shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and @PROTEIN1$ show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p73","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and @PROTEIN2$, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and @PROTEIN1$ show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p74","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone @PROTEIN2$ has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and @PROTEIN1$ show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p75","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone @PROTEIN2$ (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and @PROTEIN1$ show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p76","sentence":"The core histones from Physarum, histones @PROTEIN2$, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and @PROTEIN1$ show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p77","sentence":"The core histones from Physarum, histones H2A, H2B, @PROTEIN2$, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and @PROTEIN1$ show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p78","sentence":"The core histones from Physarum, histones H2A, @PROTEIN2$, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and @PROTEIN1$ show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p79","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones @PROTEIN2$ and @PROTEIN1$ show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p80","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone @PROTEIN2$; histones H2A and @PROTEIN1$ show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p81","sentence":"The core histones from Physarum, @PROTEIN2$ H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); @PROTEIN1$ H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p82","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone @PROTEIN2$ shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); @PROTEIN1$ H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p83","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and @PROTEIN2$, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); @PROTEIN1$ H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p84","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); @PROTEIN1$ @PROTEIN2$ has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":1}
{"pair_id":"BioInfer.d599.s0.p85","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone @PROTEIN2$ (containing zero to four acetyllysine residues per molecule); @PROTEIN1$ H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p86","sentence":"The core histones from Physarum, histones @PROTEIN2$, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); @PROTEIN1$ H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p87","sentence":"The core histones from Physarum, histones H2A, H2B, @PROTEIN2$, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); @PROTEIN1$ H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p88","sentence":"The core histones from Physarum, histones H2A, @PROTEIN2$, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); @PROTEIN1$ H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p89","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); @PROTEIN1$ H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones @PROTEIN2$ and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p90","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); @PROTEIN1$ H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone @PROTEIN2$; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p91","sentence":"The core histones from Physarum, @PROTEIN1$ H2A, H2B, H3, and H4, are rapidly acetylated; histone @PROTEIN2$ shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p92","sentence":"The core histones from Physarum, @PROTEIN1$ H2A, H2B, H3, and @PROTEIN2$, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":1}
{"pair_id":"BioInfer.d599.s0.p93","sentence":"The core histones from Physarum, @PROTEIN1$ H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone @PROTEIN2$ has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p94","sentence":"The core histones from Physarum, @PROTEIN1$ H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone @PROTEIN2$ (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p95","sentence":"The core histones from Physarum, @PROTEIN1$ @PROTEIN2$, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":1}
{"pair_id":"BioInfer.d599.s0.p96","sentence":"The core histones from Physarum, @PROTEIN1$ H2A, H2B, @PROTEIN2$, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":1}
{"pair_id":"BioInfer.d599.s0.p97","sentence":"The core histones from Physarum, @PROTEIN1$ H2A, @PROTEIN2$, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":1}
{"pair_id":"BioInfer.d599.s0.p98","sentence":"The core histones from Physarum, @PROTEIN1$ H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones @PROTEIN2$ and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p99","sentence":"The core histones from Physarum, @PROTEIN1$ H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone @PROTEIN2$; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p100","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and @PROTEIN2$, are rapidly acetylated; histone @PROTEIN1$ shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p101","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone @PROTEIN1$ shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone @PROTEIN2$ has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p102","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone @PROTEIN1$ shows five subfractions, analogous to the five subfractions of mammalian histone @PROTEIN2$ (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p103","sentence":"The core histones from Physarum, histones @PROTEIN2$, H2B, H3, and H4, are rapidly acetylated; histone @PROTEIN1$ shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p104","sentence":"The core histones from Physarum, histones H2A, H2B, @PROTEIN2$, and H4, are rapidly acetylated; histone @PROTEIN1$ shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p105","sentence":"The core histones from Physarum, histones H2A, @PROTEIN2$, H3, and H4, are rapidly acetylated; histone @PROTEIN1$ shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p106","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone @PROTEIN1$ shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones @PROTEIN2$ and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p107","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone @PROTEIN1$ shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone @PROTEIN2$; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p108","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and @PROTEIN1$, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone @PROTEIN2$ has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p109","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and @PROTEIN1$, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone @PROTEIN2$ (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p110","sentence":"The core histones from Physarum, histones @PROTEIN2$, H2B, H3, and @PROTEIN1$, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p111","sentence":"The core histones from Physarum, histones H2A, H2B, @PROTEIN2$, and @PROTEIN1$, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p112","sentence":"The core histones from Physarum, histones H2A, @PROTEIN2$, H3, and @PROTEIN1$, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p113","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and @PROTEIN1$, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones @PROTEIN2$ and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p114","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and @PROTEIN1$, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone @PROTEIN2$; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p115","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone @PROTEIN2$ (containing zero to four acetyllysine residues per molecule); histone @PROTEIN1$ has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p116","sentence":"The core histones from Physarum, histones @PROTEIN2$, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone @PROTEIN1$ has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p117","sentence":"The core histones from Physarum, histones H2A, H2B, @PROTEIN2$, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone @PROTEIN1$ has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p118","sentence":"The core histones from Physarum, histones H2A, @PROTEIN2$, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone @PROTEIN1$ has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p119","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone @PROTEIN1$ has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones @PROTEIN2$ and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p120","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone @PROTEIN1$ has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone @PROTEIN2$; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p121","sentence":"The core histones from Physarum, histones @PROTEIN2$, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone @PROTEIN1$ (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p122","sentence":"The core histones from Physarum, histones H2A, H2B, @PROTEIN2$, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone @PROTEIN1$ (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p123","sentence":"The core histones from Physarum, histones H2A, @PROTEIN2$, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone @PROTEIN1$ (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p124","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone @PROTEIN1$ (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones @PROTEIN2$ and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p125","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone @PROTEIN1$ (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone @PROTEIN2$; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p126","sentence":"The core histones from Physarum, histones @PROTEIN1$, H2B, @PROTEIN2$, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p127","sentence":"The core histones from Physarum, histones @PROTEIN1$, @PROTEIN2$, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p128","sentence":"The core histones from Physarum, histones @PROTEIN1$, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones @PROTEIN2$ and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p129","sentence":"The core histones from Physarum, histones @PROTEIN1$, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone @PROTEIN2$; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p130","sentence":"The core histones from Physarum, histones H2A, @PROTEIN2$, @PROTEIN1$, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p131","sentence":"The core histones from Physarum, histones H2A, H2B, @PROTEIN1$, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones @PROTEIN2$ and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p132","sentence":"The core histones from Physarum, histones H2A, H2B, @PROTEIN1$, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone @PROTEIN2$; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p133","sentence":"The core histones from Physarum, histones H2A, @PROTEIN1$, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones @PROTEIN2$ and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p134","sentence":"The core histones from Physarum, histones H2A, @PROTEIN1$, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone @PROTEIN2$; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p135","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone @PROTEIN2$; histones @PROTEIN1$ and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d567.s0.p0","sentence":"The @PROTEIN2$ binding domain of @PROTEIN1$ is sufficient to contact to c-Jun in vitro.","label":1}
{"pair_id":"BioInfer.d567.s0.p1","sentence":"The CREB binding domain of @PROTEIN1$ is sufficient to contact to @PROTEIN2$ in vitro.","label":1}
{"pair_id":"BioInfer.d567.s0.p2","sentence":"The @PROTEIN1$ binding domain of CBP is sufficient to contact to @PROTEIN2$ in vitro.","label":0}
{"pair_id":"AIMed.d46.s404.p0","sentence":"@PROTEIN1$ is a homodimeric cysteine knot protein that, as a member of the @PROTEIN2$ (TGF-beta) superfamily, signals by oligomerizing type I and type II receptor serine-kinases in the cell membrane.","label":0}
{"pair_id":"AIMed.d46.s404.p1","sentence":"@PROTEIN1$ is a homodimeric cysteine knot protein that, as a member of the transforming growth factor-beta (@PROTEIN2$) superfamily, signals by oligomerizing type I and type II receptor serine-kinases in the cell membrane.","label":0}
{"pair_id":"AIMed.d46.s404.p2","sentence":"BMP-2 is a homodimeric cysteine knot protein that, as a member of the @PROTEIN1$ (@PROTEIN2$) superfamily, signals by oligomerizing type I and type II receptor serine-kinases in the cell membrane.","label":0}
{"pair_id":"AIMed.d138.s1169.p0","sentence":"@PROTEIN1$ interacts with @PROTEIN2$ in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and SF3b in the incorporation of U2 snRNP into the spliceosome.","label":1}
{"pair_id":"AIMed.d138.s1169.p1","sentence":"@PROTEIN1$ interacts with U2 snRNP in the presence of @PROTEIN2$ to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and SF3b in the incorporation of U2 snRNP into the spliceosome.","label":0}
{"pair_id":"AIMed.d138.s1169.p2","sentence":"@PROTEIN1$ interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S @PROTEIN2$, which suggests a function for SF3a and SF3b in the incorporation of U2 snRNP into the spliceosome.","label":0}
{"pair_id":"AIMed.d138.s1169.p3","sentence":"@PROTEIN1$ interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for @PROTEIN2$ and SF3b in the incorporation of U2 snRNP into the spliceosome.","label":0}
{"pair_id":"AIMed.d138.s1169.p4","sentence":"@PROTEIN1$ interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and @PROTEIN2$ in the incorporation of U2 snRNP into the spliceosome.","label":0}
{"pair_id":"AIMed.d138.s1169.p5","sentence":"@PROTEIN1$ interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and SF3b in the incorporation of @PROTEIN2$ into the spliceosome.","label":0}
{"pair_id":"AIMed.d138.s1169.p6","sentence":"SF3a interacts with @PROTEIN1$ in the presence of @PROTEIN2$ to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and SF3b in the incorporation of U2 snRNP into the spliceosome.","label":0}
{"pair_id":"AIMed.d138.s1169.p7","sentence":"SF3a interacts with @PROTEIN1$ in the presence of SF3b to generate a structure similar to 17S @PROTEIN2$, which suggests a function for SF3a and SF3b in the incorporation of U2 snRNP into the spliceosome.","label":0}
{"pair_id":"AIMed.d138.s1169.p8","sentence":"SF3a interacts with @PROTEIN1$ in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for @PROTEIN2$ and SF3b in the incorporation of U2 snRNP into the spliceosome.","label":0}
{"pair_id":"AIMed.d138.s1169.p9","sentence":"SF3a interacts with @PROTEIN1$ in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and @PROTEIN2$ in the incorporation of U2 snRNP into the spliceosome.","label":0}
{"pair_id":"AIMed.d138.s1169.p10","sentence":"SF3a interacts with @PROTEIN1$ in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and SF3b in the incorporation of @PROTEIN2$ into the spliceosome.","label":0}
{"pair_id":"AIMed.d138.s1169.p11","sentence":"SF3a interacts with U2 snRNP in the presence of @PROTEIN1$ to generate a structure similar to 17S @PROTEIN2$, which suggests a function for SF3a and SF3b in the incorporation of U2 snRNP into the spliceosome.","label":0}
{"pair_id":"AIMed.d138.s1169.p12","sentence":"SF3a interacts with U2 snRNP in the presence of @PROTEIN1$ to generate a structure similar to 17S U2 snRNP, which suggests a function for @PROTEIN2$ and SF3b in the incorporation of U2 snRNP into the spliceosome.","label":0}
{"pair_id":"AIMed.d138.s1169.p13","sentence":"SF3a interacts with U2 snRNP in the presence of @PROTEIN1$ to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and @PROTEIN2$ in the incorporation of U2 snRNP into the spliceosome.","label":0}
{"pair_id":"AIMed.d138.s1169.p14","sentence":"SF3a interacts with U2 snRNP in the presence of @PROTEIN1$ to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and SF3b in the incorporation of @PROTEIN2$ into the spliceosome.","label":0}
{"pair_id":"AIMed.d138.s1169.p15","sentence":"SF3a interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S @PROTEIN1$, which suggests a function for @PROTEIN2$ and SF3b in the incorporation of U2 snRNP into the spliceosome.","label":0}
{"pair_id":"AIMed.d138.s1169.p16","sentence":"SF3a interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S @PROTEIN1$, which suggests a function for SF3a and @PROTEIN2$ in the incorporation of U2 snRNP into the spliceosome.","label":0}
{"pair_id":"AIMed.d138.s1169.p17","sentence":"SF3a interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S @PROTEIN1$, which suggests a function for SF3a and SF3b in the incorporation of @PROTEIN2$ into the spliceosome.","label":0}
{"pair_id":"AIMed.d138.s1169.p18","sentence":"SF3a interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for @PROTEIN1$ and @PROTEIN2$ in the incorporation of U2 snRNP into the spliceosome.","label":0}
{"pair_id":"AIMed.d138.s1169.p19","sentence":"SF3a interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for @PROTEIN1$ and SF3b in the incorporation of @PROTEIN2$ into the spliceosome.","label":0}
{"pair_id":"AIMed.d138.s1169.p20","sentence":"SF3a interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and @PROTEIN1$ in the incorporation of @PROTEIN2$ into the spliceosome.","label":0}
{"pair_id":"BioInfer.d336.s1.p0","sentence":"@PROTEIN2$ staining was dimmer and its colocalization with filamentous @PROTEIN1$ bundles in growth cones was less striking than that of myosin heavy chain B.","label":1}
{"pair_id":"BioInfer.d336.s1.p1","sentence":"Myosin heavy chain A staining was dimmer and its colocalization with filamentous @PROTEIN1$ bundles in growth cones was less striking than that of @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d336.s1.p2","sentence":"@PROTEIN1$ staining was dimmer and its colocalization with filamentous actin bundles in growth cones was less striking than that of @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d187.s1.p0","sentence":"However, these mutants displayed a lower affinity for @PROTEIN1$ than wild-type profilin, suggesting that additional putative bonds created this way cannot increase profilin's affinity for @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d187.s1.p1","sentence":"However, these mutants displayed a lower affinity for @PROTEIN1$ than wild-type @PROTEIN2$, suggesting that additional putative bonds created this way cannot increase profilin's affinity for actin.","label":1}
{"pair_id":"BioInfer.d187.s1.p2","sentence":"However, these mutants displayed a lower affinity for @PROTEIN1$ than wild-type profilin, suggesting that additional putative bonds created this way cannot increase @PROTEIN2$'s affinity for actin.","label":0}
{"pair_id":"BioInfer.d187.s1.p3","sentence":"However, these mutants displayed a lower affinity for actin than wild-type @PROTEIN2$, suggesting that additional putative bonds created this way cannot increase profilin's affinity for @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d187.s1.p4","sentence":"However, these mutants displayed a lower affinity for actin than wild-type profilin, suggesting that additional putative bonds created this way cannot increase @PROTEIN2$'s affinity for @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d187.s1.p5","sentence":"However, these mutants displayed a lower affinity for actin than wild-type @PROTEIN1$, suggesting that additional putative bonds created this way cannot increase @PROTEIN2$'s affinity for actin.","label":0}
{"pair_id":"BioInfer.d774.s0.p0","sentence":"Transfection of @PROTEIN2$-deficient colon carcinoma cells recruited E-cadherin and @PROTEIN1$ to cell-cell contacts and functional cadherin-mediated cell-cell adhesion was restored in this way.","label":0}
{"pair_id":"BioInfer.d774.s0.p1","sentence":"Transfection of alpha-catenin-deficient colon carcinoma cells recruited E-cadherin and @PROTEIN1$ to cell-cell contacts and functional @PROTEIN2$-mediated cell-cell adhesion was restored in this way.","label":0}
{"pair_id":"BioInfer.d774.s0.p2","sentence":"Transfection of alpha-catenin-deficient colon carcinoma cells recruited @PROTEIN2$ and @PROTEIN1$ to cell-cell contacts and functional cadherin-mediated cell-cell adhesion was restored in this way.","label":0}
{"pair_id":"BioInfer.d774.s0.p3","sentence":"Transfection of @PROTEIN1$-deficient colon carcinoma cells recruited E-cadherin and beta-catenin to cell-cell contacts and functional @PROTEIN2$-mediated cell-cell adhesion was restored in this way.","label":0}
{"pair_id":"BioInfer.d774.s0.p4","sentence":"Transfection of @PROTEIN1$-deficient colon carcinoma cells recruited @PROTEIN2$ and beta-catenin to cell-cell contacts and functional cadherin-mediated cell-cell adhesion was restored in this way.","label":0}
{"pair_id":"BioInfer.d774.s0.p5","sentence":"Transfection of alpha-catenin-deficient colon carcinoma cells recruited @PROTEIN2$ and beta-catenin to cell-cell contacts and functional @PROTEIN1$-mediated cell-cell adhesion was restored in this way.","label":0}
{"pair_id":"BioInfer.d27.s0.p0","sentence":"ADP-ribosylation of @PROTEIN1$ at Arg 177 by Clostridium perfringens @PROTEIN2$ increased the nucleotide dissociation rate from 2.2 x 10(-3) s-1 to 4.5 x 10(-3) s-1 without affecting the profilin-induced stimulation of nucleotide exchange.","label":1}
{"pair_id":"BioInfer.d27.s0.p1","sentence":"ADP-ribosylation of @PROTEIN1$ at Arg 177 by Clostridium perfringens iota toxin increased the nucleotide dissociation rate from 2.2 x 10(-3) s-1 to 4.5 x 10(-3) s-1 without affecting the @PROTEIN2$-induced stimulation of nucleotide exchange.","label":0}
{"pair_id":"BioInfer.d27.s0.p2","sentence":"ADP-ribosylation of actin at Arg 177 by Clostridium perfringens @PROTEIN1$ increased the nucleotide dissociation rate from 2.2 x 10(-3) s-1 to 4.5 x 10(-3) s-1 without affecting the @PROTEIN2$-induced stimulation of nucleotide exchange.","label":1}
{"pair_id":"AIMed.d139.s1173.p0","sentence":"The self-association site appears to be formed by interactions between helices 1 and 2 of @PROTEIN1$ repeat 17 of one dimer with helix 3 of @PROTEIN2$ repeat 1 of the other dimer to form two combined alpha-beta triple-helical segments.","label":1}
{"pair_id":"BioInfer.d392.s0.p0","sentence":"Isolation of human @PROTEIN2$ and its binding specificity with @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d250.s0.p0","sentence":"Here we show that @PROTEIN1$ is a member of a family of proteins including Drosophila diaphanous, Saccharomyces cerevisiae BNI1, and S. pombe @PROTEIN2$, which are involved in cytokinesis or other actin-mediated processes.","label":0}
{"pair_id":"BioInfer.d250.s0.p1","sentence":"Here we show that @PROTEIN1$ is a member of a family of proteins including Drosophila diaphanous, Saccharomyces cerevisiae BNI1, and S. pombe fus1, which are involved in cytokinesis or other @PROTEIN2$-mediated processes.","label":0}
{"pair_id":"BioInfer.d250.s0.p2","sentence":"Here we show that @PROTEIN1$ is a member of a family of proteins including Drosophila diaphanous, Saccharomyces cerevisiae @PROTEIN2$, and S. pombe fus1, which are involved in cytokinesis or other actin-mediated processes.","label":0}
{"pair_id":"BioInfer.d250.s0.p3","sentence":"Here we show that @PROTEIN1$ is a member of a family of proteins including Drosophila @PROTEIN2$, Saccharomyces cerevisiae BNI1, and S. pombe fus1, which are involved in cytokinesis or other actin-mediated processes.","label":0}
{"pair_id":"BioInfer.d250.s0.p4","sentence":"Here we show that cdc12p is a member of a family of proteins including Drosophila diaphanous, Saccharomyces cerevisiae BNI1, and S. pombe @PROTEIN1$, which are involved in cytokinesis or other @PROTEIN2$-mediated processes.","label":0}
{"pair_id":"BioInfer.d250.s0.p5","sentence":"Here we show that cdc12p is a member of a family of proteins including Drosophila diaphanous, Saccharomyces cerevisiae @PROTEIN2$, and S. pombe @PROTEIN1$, which are involved in cytokinesis or other actin-mediated processes.","label":0}
{"pair_id":"BioInfer.d250.s0.p6","sentence":"Here we show that cdc12p is a member of a family of proteins including Drosophila @PROTEIN2$, Saccharomyces cerevisiae BNI1, and S. pombe @PROTEIN1$, which are involved in cytokinesis or other actin-mediated processes.","label":0}
{"pair_id":"BioInfer.d250.s0.p7","sentence":"Here we show that cdc12p is a member of a family of proteins including Drosophila diaphanous, Saccharomyces cerevisiae @PROTEIN2$, and S. pombe fus1, which are involved in cytokinesis or other @PROTEIN1$-mediated processes.","label":0}
{"pair_id":"BioInfer.d250.s0.p8","sentence":"Here we show that cdc12p is a member of a family of proteins including Drosophila @PROTEIN2$, Saccharomyces cerevisiae BNI1, and S. pombe fus1, which are involved in cytokinesis or other @PROTEIN1$-mediated processes.","label":0}
{"pair_id":"BioInfer.d250.s0.p9","sentence":"Here we show that cdc12p is a member of a family of proteins including Drosophila @PROTEIN2$, Saccharomyces cerevisiae @PROTEIN1$, and S. pombe fus1, which are involved in cytokinesis or other actin-mediated processes.","label":0}
{"pair_id":"BioInfer.d14.s0.p0","sentence":"Actin-binding proteins such as profilin and @PROTEIN1$ bind to phosphatidylinositol (PI) 4,5-bisphosphate (PI 4,5-P2) and regulate the concentration of monomeric @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d14.s0.p1","sentence":"@PROTEIN2$ such as profilin and @PROTEIN1$ bind to phosphatidylinositol (PI) 4,5-bisphosphate (PI 4,5-P2) and regulate the concentration of monomeric actin.","label":1}
{"pair_id":"BioInfer.d14.s0.p2","sentence":"Actin-binding proteins such as @PROTEIN2$ and @PROTEIN1$ bind to phosphatidylinositol (PI) 4,5-bisphosphate (PI 4,5-P2) and regulate the concentration of monomeric actin.","label":0}
{"pair_id":"BioInfer.d14.s0.p3","sentence":"@PROTEIN2$ such as profilin and gelsolin bind to phosphatidylinositol (PI) 4,5-bisphosphate (PI 4,5-P2) and regulate the concentration of monomeric @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d14.s0.p4","sentence":"Actin-binding proteins such as @PROTEIN2$ and gelsolin bind to phosphatidylinositol (PI) 4,5-bisphosphate (PI 4,5-P2) and regulate the concentration of monomeric @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d14.s0.p5","sentence":"@PROTEIN1$ such as @PROTEIN2$ and gelsolin bind to phosphatidylinositol (PI) 4,5-bisphosphate (PI 4,5-P2) and regulate the concentration of monomeric actin.","label":1}
{"pair_id":"BioInfer.d648.s0.p0","sentence":"The multifunctional protein @PROTEIN1$ is one of the most abundant proteins in the cytoplasm and is thought to regulate @PROTEIN2$ assembly and the phosphoinositide signaling pathway.","label":1}
{"pair_id":"BioInfer.d752.s0.p0","sentence":"Thus, @PROTEIN2$, E-cadherin, and @PROTEIN1$ have similar prognostic values.","label":0}
{"pair_id":"BioInfer.d752.s0.p1","sentence":"Thus, beta-catenin, @PROTEIN2$, and @PROTEIN1$ have similar prognostic values.","label":0}
{"pair_id":"BioInfer.d752.s0.p2","sentence":"Thus, @PROTEIN1$, @PROTEIN2$, and alpha-catenin have similar prognostic values.","label":0}
{"pair_id":"BioInfer.d401.s0.p0","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the @PROTEIN1$ @PROTEIN2$ and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p1","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, @PROTEIN2$, and MEC3, indicating that the @PROTEIN1$ rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p2","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions @PROTEIN2$, RAD17, RAD24, and MEC3, indicating that the @PROTEIN1$ rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p3","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and @PROTEIN2$, indicating that the @PROTEIN1$ rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p4","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, @PROTEIN2$, RAD24, and MEC3, indicating that the @PROTEIN1$ rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p5","sentence":"Lethality of the @PROTEIN2$ rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the @PROTEIN1$ rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p6","sentence":"Lethality of the srs2Delta @PROTEIN2$ and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the @PROTEIN1$ rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p7","sentence":"Lethality of the srs2Delta rad54Delta and @PROTEIN2$ rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the @PROTEIN1$ rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p8","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta @PROTEIN2$ double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the @PROTEIN1$ rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p9","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the @PROTEIN1$ rad54 and @PROTEIN2$ rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p10","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the @PROTEIN1$ rad54 and srs2 @PROTEIN2$ mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p11","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, @PROTEIN2$, and MEC3, indicating that the srs2 @PROTEIN1$ and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p12","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions @PROTEIN2$, RAD17, RAD24, and MEC3, indicating that the srs2 @PROTEIN1$ and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p13","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and @PROTEIN2$, indicating that the srs2 @PROTEIN1$ and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p14","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, @PROTEIN2$, RAD24, and MEC3, indicating that the srs2 @PROTEIN1$ and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p15","sentence":"Lethality of the @PROTEIN2$ rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 @PROTEIN1$ and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p16","sentence":"Lethality of the srs2Delta @PROTEIN2$ and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 @PROTEIN1$ and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p17","sentence":"Lethality of the srs2Delta rad54Delta and @PROTEIN2$ rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 @PROTEIN1$ and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p18","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta @PROTEIN2$ double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 @PROTEIN1$ and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p19","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 @PROTEIN1$ and @PROTEIN2$ rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p20","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 @PROTEIN1$ and srs2 @PROTEIN2$ mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p21","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions @PROTEIN2$, RAD17, @PROTEIN1$, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p22","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, @PROTEIN1$, and @PROTEIN2$, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p23","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, @PROTEIN2$, @PROTEIN1$, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p24","sentence":"Lethality of the @PROTEIN2$ rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, @PROTEIN1$, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p25","sentence":"Lethality of the srs2Delta @PROTEIN2$ and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, @PROTEIN1$, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p26","sentence":"Lethality of the srs2Delta rad54Delta and @PROTEIN2$ rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, @PROTEIN1$, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p27","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta @PROTEIN2$ double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, @PROTEIN1$, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p28","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, @PROTEIN1$, and MEC3, indicating that the srs2 rad54 and @PROTEIN2$ rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p29","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, @PROTEIN1$, and MEC3, indicating that the srs2 rad54 and srs2 @PROTEIN2$ mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p30","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions @PROTEIN1$, RAD17, RAD24, and @PROTEIN2$, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p31","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions @PROTEIN1$, @PROTEIN2$, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p32","sentence":"Lethality of the @PROTEIN2$ rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions @PROTEIN1$, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p33","sentence":"Lethality of the srs2Delta @PROTEIN2$ and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions @PROTEIN1$, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p34","sentence":"Lethality of the srs2Delta rad54Delta and @PROTEIN2$ rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions @PROTEIN1$, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p35","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta @PROTEIN2$ double mutants can also be rescued by mutations in the DNA damage checkpoint functions @PROTEIN1$, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p36","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions @PROTEIN1$, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and @PROTEIN2$ rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p37","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions @PROTEIN1$, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 @PROTEIN2$ mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p38","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, @PROTEIN2$, RAD24, and @PROTEIN1$, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p39","sentence":"Lethality of the @PROTEIN2$ rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and @PROTEIN1$, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p40","sentence":"Lethality of the srs2Delta @PROTEIN2$ and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and @PROTEIN1$, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p41","sentence":"Lethality of the srs2Delta rad54Delta and @PROTEIN2$ rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and @PROTEIN1$, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p42","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta @PROTEIN2$ double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and @PROTEIN1$, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p43","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and @PROTEIN1$, indicating that the srs2 rad54 and @PROTEIN2$ rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p44","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and @PROTEIN1$, indicating that the srs2 rad54 and srs2 @PROTEIN2$ mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p45","sentence":"Lethality of the @PROTEIN2$ rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, @PROTEIN1$, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p46","sentence":"Lethality of the srs2Delta @PROTEIN2$ and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, @PROTEIN1$, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p47","sentence":"Lethality of the srs2Delta rad54Delta and @PROTEIN2$ rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, @PROTEIN1$, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p48","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta @PROTEIN2$ double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, @PROTEIN1$, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p49","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, @PROTEIN1$, RAD24, and MEC3, indicating that the srs2 rad54 and @PROTEIN2$ rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p50","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, @PROTEIN1$, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 @PROTEIN2$ mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p51","sentence":"Lethality of the @PROTEIN1$ @PROTEIN2$ and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p52","sentence":"Lethality of the @PROTEIN1$ rad54Delta and @PROTEIN2$ rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p53","sentence":"Lethality of the @PROTEIN1$ rad54Delta and srs2Delta @PROTEIN2$ double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p54","sentence":"Lethality of the @PROTEIN1$ rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and @PROTEIN2$ rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p55","sentence":"Lethality of the @PROTEIN1$ rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 @PROTEIN2$ mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p56","sentence":"Lethality of the srs2Delta @PROTEIN1$ and @PROTEIN2$ rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p57","sentence":"Lethality of the srs2Delta @PROTEIN1$ and srs2Delta @PROTEIN2$ double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p58","sentence":"Lethality of the srs2Delta @PROTEIN1$ and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and @PROTEIN2$ rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p59","sentence":"Lethality of the srs2Delta @PROTEIN1$ and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 @PROTEIN2$ mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p60","sentence":"Lethality of the srs2Delta rad54Delta and @PROTEIN1$ @PROTEIN2$ double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p61","sentence":"Lethality of the srs2Delta rad54Delta and @PROTEIN1$ rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and @PROTEIN2$ rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p62","sentence":"Lethality of the srs2Delta rad54Delta and @PROTEIN1$ rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 @PROTEIN2$ mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p63","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta @PROTEIN1$ double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and @PROTEIN2$ rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p64","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta @PROTEIN1$ double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 @PROTEIN2$ mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p65","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and @PROTEIN1$ @PROTEIN2$ mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"AIMed.d216.s1872.p0","sentence":"The @PROTEIN1$-@PROTEIN2$ complex: structural basis for GTPase activation and its loss in oncogenic Ras mutants.","label":1}
{"pair_id":"AIMed.d216.s1872.p1","sentence":"The @PROTEIN1$-RasGAP complex: structural basis for GTPase activation and its loss in oncogenic @PROTEIN2$ mutants.","label":0}
{"pair_id":"AIMed.d216.s1872.p2","sentence":"The Ras-@PROTEIN1$ complex: structural basis for GTPase activation and its loss in oncogenic @PROTEIN2$ mutants.","label":0}
{"pair_id":"AIMed.d148.s1258.p0","sentence":"In synchronized human osteosarcoma cells, @PROTEIN1$ is induced in early G1 and becomes associated with @PROTEIN2$, a Cdk-binding subunit.","label":1}
{"pair_id":"BioInfer.d702.s0.p0","sentence":"These phenotypes are similar to those of the mutant of @PROTEIN1$, which encodes profilin, an @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d702.s0.p1","sentence":"These phenotypes are similar to those of the mutant of @PROTEIN1$, which encodes @PROTEIN2$, an actin-binding protein.","label":1}
{"pair_id":"BioInfer.d702.s0.p2","sentence":"These phenotypes are similar to those of the mutant of PFY1, which encodes @PROTEIN2$, an @PROTEIN1$.","label":1}
{"pair_id":"AIMed.d50.s441.p0","sentence":"Type I interferons bind to two cell surface receptors, @PROTEIN1$ and @PROTEIN2$, as the first step in the activation of several signal transduction pathways that elicit an anti-viral state and an anti-proliferative response.","label":0}
{"pair_id":"AIMed.d109.s921.p0","sentence":"Comparison of the two crystallographically distinct protein-DNA complexes show that the coiled-coil is flexibly joined to the basic regions and that the @PROTEIN1$-@PROTEIN2$ heterodimer does not recognize the asymmetric 5'-TGAGTCA-3' recognition element in a unique orientation.","label":1}
{"pair_id":"AIMed.d105.s885.p0","sentence":"The helical cytokine @PROTEIN1$ and its specific binding subunit @PROTEIN2$ form a 1:1 complex which, by promoting homodimerization of the signalling subunit gp130 on the surface of target cells, triggers intracellular responses.","label":1}
{"pair_id":"AIMed.d105.s885.p1","sentence":"The helical cytokine @PROTEIN1$ and its specific binding subunit IL-6R alpha form a 1:1 complex which, by promoting homodimerization of the signalling subunit @PROTEIN2$ on the surface of target cells, triggers intracellular responses.","label":0}
{"pair_id":"AIMed.d105.s885.p2","sentence":"The helical cytokine interleukin (IL) 6 and its specific binding subunit @PROTEIN1$ form a 1:1 complex which, by promoting homodimerization of the signalling subunit @PROTEIN2$ on the surface of target cells, triggers intracellular responses.","label":0}
{"pair_id":"BioInfer.d246.s1.p0","sentence":"Our results define a mechanism for the regulation of @PROTEIN2$ and hence of @PROTEIN1$ dynamics in vivo.","label":0}
{"pair_id":"BioInfer.d267.s0.p0","sentence":"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (@PROTEIN2$), mouse RAD51, and the HHR23B\/p58 and HHR23A subunits of @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d267.s0.p1","sentence":"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the @PROTEIN2$\/p58 and HHR23A subunits of @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d267.s0.p2","sentence":"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B\/@PROTEIN2$ and HHR23A subunits of @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d267.s0.p3","sentence":"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B\/p58 and @PROTEIN2$ subunits of @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d267.s0.p4","sentence":"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include @PROTEIN2$, ERCC2 (XPD), mouse RAD51, and the HHR23B\/p58 and HHR23A subunits of @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d267.s0.p5","sentence":"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, @PROTEIN2$ (XPD), mouse RAD51, and the HHR23B\/p58 and HHR23A subunits of @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d267.s0.p6","sentence":"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse @PROTEIN2$, and the HHR23B\/p58 and HHR23A subunits of @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d267.s0.p7","sentence":"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (@PROTEIN1$), mouse RAD51, and the @PROTEIN2$\/p58 and HHR23A subunits of XPC.","label":0}
{"pair_id":"BioInfer.d267.s0.p8","sentence":"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (@PROTEIN1$), mouse RAD51, and the HHR23B\/@PROTEIN2$ and HHR23A subunits of XPC.","label":0}
{"pair_id":"BioInfer.d267.s0.p9","sentence":"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (@PROTEIN1$), mouse RAD51, and the HHR23B\/p58 and @PROTEIN2$ subunits of XPC.","label":0}
{"pair_id":"BioInfer.d267.s0.p10","sentence":"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include @PROTEIN2$, ERCC2 (@PROTEIN1$), mouse RAD51, and the HHR23B\/p58 and HHR23A subunits of XPC.","label":0}
{"pair_id":"BioInfer.d267.s0.p11","sentence":"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, @PROTEIN2$ (@PROTEIN1$), mouse RAD51, and the HHR23B\/p58 and HHR23A subunits of XPC.","label":0}
{"pair_id":"BioInfer.d267.s0.p12","sentence":"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (@PROTEIN1$), mouse @PROTEIN2$, and the HHR23B\/p58 and HHR23A subunits of XPC.","label":0}
{"pair_id":"BioInfer.d267.s0.p13","sentence":"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the @PROTEIN1$\/@PROTEIN2$ and HHR23A subunits of XPC.","label":1}
{"pair_id":"BioInfer.d267.s0.p14","sentence":"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the @PROTEIN1$\/p58 and @PROTEIN2$ subunits of XPC.","label":1}
{"pair_id":"BioInfer.d267.s0.p15","sentence":"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include @PROTEIN2$, ERCC2 (XPD), mouse RAD51, and the @PROTEIN1$\/p58 and HHR23A subunits of XPC.","label":0}
{"pair_id":"BioInfer.d267.s0.p16","sentence":"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, @PROTEIN2$ (XPD), mouse RAD51, and the @PROTEIN1$\/p58 and HHR23A subunits of XPC.","label":0}
{"pair_id":"BioInfer.d267.s0.p17","sentence":"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse @PROTEIN2$, and the @PROTEIN1$\/p58 and HHR23A subunits of XPC.","label":0}
{"pair_id":"BioInfer.d267.s0.p18","sentence":"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B\/@PROTEIN1$ and @PROTEIN2$ subunits of XPC.","label":1}
{"pair_id":"BioInfer.d267.s0.p19","sentence":"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include @PROTEIN2$, ERCC2 (XPD), mouse RAD51, and the HHR23B\/@PROTEIN1$ and HHR23A subunits of XPC.","label":0}
{"pair_id":"BioInfer.d267.s0.p20","sentence":"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, @PROTEIN2$ (XPD), mouse RAD51, and the HHR23B\/@PROTEIN1$ and HHR23A subunits of XPC.","label":0}
{"pair_id":"BioInfer.d267.s0.p21","sentence":"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse @PROTEIN2$, and the HHR23B\/@PROTEIN1$ and HHR23A subunits of XPC.","label":0}
{"pair_id":"BioInfer.d267.s0.p22","sentence":"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include @PROTEIN2$, ERCC2 (XPD), mouse RAD51, and the HHR23B\/p58 and @PROTEIN1$ subunits of XPC.","label":0}
{"pair_id":"BioInfer.d267.s0.p23","sentence":"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, @PROTEIN2$ (XPD), mouse RAD51, and the HHR23B\/p58 and @PROTEIN1$ subunits of XPC.","label":0}
{"pair_id":"BioInfer.d267.s0.p24","sentence":"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse @PROTEIN2$, and the HHR23B\/p58 and @PROTEIN1$ subunits of XPC.","label":0}
{"pair_id":"BioInfer.d267.s0.p25","sentence":"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include @PROTEIN1$, @PROTEIN2$ (XPD), mouse RAD51, and the HHR23B\/p58 and HHR23A subunits of XPC.","label":0}
{"pair_id":"BioInfer.d267.s0.p26","sentence":"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include @PROTEIN1$, ERCC2 (XPD), mouse @PROTEIN2$, and the HHR23B\/p58 and HHR23A subunits of XPC.","label":0}
{"pair_id":"BioInfer.d267.s0.p27","sentence":"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, @PROTEIN1$ (XPD), mouse @PROTEIN2$, and the HHR23B\/p58 and HHR23A subunits of XPC.","label":0}
{"pair_id":"AIMed.d168.s1422.p0","sentence":"These data indicate that Phe93 is a critical @PROTEIN1$ binding determinant of the @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d85.s722.p0","sentence":"In vitro translation studies identified the 66-kDa protein as the protein product of @PROTEIN1$, and subcellular fractionation experiments showed that @PROTEIN2$ is mainly present in the cytosol fraction, although significant amounts are also present in membrane and nuclear fractions.","label":0}
{"pair_id":"AIMed.d204.s1765.p0","sentence":"In summary, we have shown that the integrity of the catalytic domain of @PROTEIN1$ and its ability to bind Zn2+ is absolutely required for complex formation with @PROTEIN2$, which further underlines the importance of this region for proper regulation of enzymatic activity of MMP-1.","label":1}
{"pair_id":"AIMed.d204.s1765.p1","sentence":"In summary, we have shown that the integrity of the catalytic domain of @PROTEIN1$ and its ability to bind Zn2+ is absolutely required for complex formation with TIMP-1, which further underlines the importance of this region for proper regulation of enzymatic activity of @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d204.s1765.p2","sentence":"In summary, we have shown that the integrity of the catalytic domain of MMP-1 and its ability to bind Zn2+ is absolutely required for complex formation with @PROTEIN1$, which further underlines the importance of this region for proper regulation of enzymatic activity of @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d172.s1448.p0","sentence":"@PROTEIN1$ and @PROTEIN2$ have been shown to play key roles in vascular development; these two receptors bind and are activated by vascular endothelial growth factor (VEGF).","label":0}
{"pair_id":"AIMed.d172.s1448.p1","sentence":"@PROTEIN1$ and Flk1 have been shown to play key roles in vascular development; these two receptors bind and are activated by @PROTEIN2$ (VEGF).","label":1}
{"pair_id":"AIMed.d172.s1448.p2","sentence":"@PROTEIN1$ and Flk1 have been shown to play key roles in vascular development; these two receptors bind and are activated by vascular endothelial growth factor (@PROTEIN2$).","label":1}
{"pair_id":"AIMed.d172.s1448.p3","sentence":"Flt1 and @PROTEIN1$ have been shown to play key roles in vascular development; these two receptors bind and are activated by @PROTEIN2$ (VEGF).","label":1}
{"pair_id":"AIMed.d172.s1448.p4","sentence":"Flt1 and @PROTEIN1$ have been shown to play key roles in vascular development; these two receptors bind and are activated by vascular endothelial growth factor (@PROTEIN2$).","label":1}
{"pair_id":"AIMed.d172.s1448.p5","sentence":"Flt1 and Flk1 have been shown to play key roles in vascular development; these two receptors bind and are activated by @PROTEIN1$ (@PROTEIN2$).","label":0}
{"pair_id":"BioInfer.d832.s0.p0","sentence":"While poly(ADP-ribose) effectively competed with DNA for binding of histone H4, it equally competed with DNA for binding of @PROTEIN1$ @PROTEIN2$ and only inefficiently competed with DNA for binding of histone H1.","label":1}
{"pair_id":"BioInfer.d832.s0.p1","sentence":"While poly(ADP-ribose) effectively competed with DNA for binding of histone H4, it equally competed with DNA for binding of @PROTEIN1$ H3 and only inefficiently competed with DNA for binding of @PROTEIN2$ H1.","label":0}
{"pair_id":"BioInfer.d832.s0.p2","sentence":"While poly(ADP-ribose) effectively competed with DNA for binding of @PROTEIN2$ H4, it equally competed with DNA for binding of @PROTEIN1$ H3 and only inefficiently competed with DNA for binding of histone H1.","label":0}
{"pair_id":"BioInfer.d832.s0.p3","sentence":"While poly(ADP-ribose) effectively competed with DNA for binding of histone @PROTEIN2$, it equally competed with DNA for binding of @PROTEIN1$ H3 and only inefficiently competed with DNA for binding of histone H1.","label":0}
{"pair_id":"BioInfer.d832.s0.p4","sentence":"While poly(ADP-ribose) effectively competed with DNA for binding of histone H4, it equally competed with DNA for binding of @PROTEIN1$ H3 and only inefficiently competed with DNA for binding of histone @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d832.s0.p5","sentence":"While poly(ADP-ribose) effectively competed with DNA for binding of histone H4, it equally competed with DNA for binding of histone @PROTEIN1$ and only inefficiently competed with DNA for binding of @PROTEIN2$ H1.","label":0}
{"pair_id":"BioInfer.d832.s0.p6","sentence":"While poly(ADP-ribose) effectively competed with DNA for binding of @PROTEIN2$ H4, it equally competed with DNA for binding of histone @PROTEIN1$ and only inefficiently competed with DNA for binding of histone H1.","label":0}
{"pair_id":"BioInfer.d832.s0.p7","sentence":"While poly(ADP-ribose) effectively competed with DNA for binding of histone @PROTEIN2$, it equally competed with DNA for binding of histone @PROTEIN1$ and only inefficiently competed with DNA for binding of histone H1.","label":0}
{"pair_id":"BioInfer.d832.s0.p8","sentence":"While poly(ADP-ribose) effectively competed with DNA for binding of histone H4, it equally competed with DNA for binding of histone @PROTEIN1$ and only inefficiently competed with DNA for binding of histone @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d832.s0.p9","sentence":"While poly(ADP-ribose) effectively competed with DNA for binding of @PROTEIN2$ H4, it equally competed with DNA for binding of histone H3 and only inefficiently competed with DNA for binding of @PROTEIN1$ H1.","label":0}
{"pair_id":"BioInfer.d832.s0.p10","sentence":"While poly(ADP-ribose) effectively competed with DNA for binding of histone @PROTEIN2$, it equally competed with DNA for binding of histone H3 and only inefficiently competed with DNA for binding of @PROTEIN1$ H1.","label":0}
{"pair_id":"BioInfer.d832.s0.p11","sentence":"While poly(ADP-ribose) effectively competed with DNA for binding of histone H4, it equally competed with DNA for binding of histone H3 and only inefficiently competed with DNA for binding of @PROTEIN1$ @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d832.s0.p12","sentence":"While poly(ADP-ribose) effectively competed with DNA for binding of @PROTEIN1$ @PROTEIN2$, it equally competed with DNA for binding of histone H3 and only inefficiently competed with DNA for binding of histone H1.","label":1}
{"pair_id":"BioInfer.d832.s0.p13","sentence":"While poly(ADP-ribose) effectively competed with DNA for binding of @PROTEIN1$ H4, it equally competed with DNA for binding of histone H3 and only inefficiently competed with DNA for binding of histone @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d832.s0.p14","sentence":"While poly(ADP-ribose) effectively competed with DNA for binding of histone @PROTEIN1$, it equally competed with DNA for binding of histone H3 and only inefficiently competed with DNA for binding of histone @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d141.s1188.p0","sentence":"The @PROTEIN1$ Cdk-interacting protein @PROTEIN2$ is a potent inhibitor of G1 cyclin-dependent kinases.","label":0}
{"pair_id":"AIMed.d150.s1277.p0","sentence":"@PROTEIN1$ binds exclusively to the underphosphorylated form of @PROTEIN2$ and fails to bind to Rb mutants derived from patients with retinoblastoma.","label":0}
{"pair_id":"AIMed.d150.s1277.p1","sentence":"@PROTEIN1$ binds exclusively to the underphosphorylated form of Rb and fails to bind to @PROTEIN2$ mutants derived from patients with retinoblastoma.","label":0}
{"pair_id":"AIMed.d150.s1277.p2","sentence":"Elf-1 binds exclusively to the underphosphorylated form of @PROTEIN1$ and fails to bind to @PROTEIN2$ mutants derived from patients with retinoblastoma.","label":0}
{"pair_id":"BioInfer.d301.s0.p0","sentence":"Immunoreactive @PROTEIN1$, alpha-catenin, @PROTEIN2$, and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival.","label":0}
{"pair_id":"BioInfer.d301.s0.p1","sentence":"Immunoreactive @PROTEIN1$, @PROTEIN2$, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival.","label":0}
{"pair_id":"BioInfer.d301.s0.p2","sentence":"Immunoreactive @PROTEIN1$, alpha-catenin, beta-catenin, and @PROTEIN2$ proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival.","label":0}
{"pair_id":"BioInfer.d301.s0.p3","sentence":"Immunoreactive E-cadherin, @PROTEIN2$, @PROTEIN1$, and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival.","label":0}
{"pair_id":"BioInfer.d301.s0.p4","sentence":"Immunoreactive E-cadherin, alpha-catenin, @PROTEIN1$, and @PROTEIN2$ proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival.","label":0}
{"pair_id":"BioInfer.d301.s0.p5","sentence":"Immunoreactive E-cadherin, @PROTEIN1$, beta-catenin, and @PROTEIN2$ proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival.","label":0}
{"pair_id":"BioInfer.d399.s1.p0","sentence":"The results suggest some cooperativity with respect to @PROTEIN2$ binding to filamentous @PROTEIN1$ which may be pH dependent.","label":1}
{"pair_id":"AIMed.d158.s1335.p0","sentence":"We also show that @PROTEIN1$ is a serine-threonine kinase that is recruited by @PROTEIN2$ to TNFR1 in a TNF-dependent process.","label":0}
{"pair_id":"AIMed.d158.s1335.p1","sentence":"We also show that @PROTEIN1$ is a serine-threonine kinase that is recruited by TRADD to @PROTEIN2$ in a TNF-dependent process.","label":0}
{"pair_id":"AIMed.d158.s1335.p2","sentence":"We also show that RIP is a serine-threonine kinase that is recruited by @PROTEIN1$ to @PROTEIN2$ in a TNF-dependent process.","label":0}
{"pair_id":"BioInfer.d624.s0.p0","sentence":"The high recombination levels seen in rad5 and rad18 mutants is dependent on the RAD1, @PROTEIN2$, RAD52, and @PROTEIN1$ genes.","label":0}
{"pair_id":"BioInfer.d624.s0.p1","sentence":"The high recombination levels seen in rad5 and rad18 mutants is dependent on the RAD1, RAD51, @PROTEIN2$, and @PROTEIN1$ genes.","label":0}
{"pair_id":"BioInfer.d624.s0.p2","sentence":"The high recombination levels seen in rad5 and @PROTEIN2$ mutants is dependent on the RAD1, RAD51, RAD52, and @PROTEIN1$ genes.","label":0}
{"pair_id":"BioInfer.d624.s0.p3","sentence":"The high recombination levels seen in rad5 and rad18 mutants is dependent on the @PROTEIN2$, RAD51, RAD52, and @PROTEIN1$ genes.","label":0}
{"pair_id":"BioInfer.d624.s0.p4","sentence":"The high recombination levels seen in @PROTEIN2$ and rad18 mutants is dependent on the RAD1, RAD51, RAD52, and @PROTEIN1$ genes.","label":0}
{"pair_id":"BioInfer.d624.s0.p5","sentence":"The high recombination levels seen in rad5 and rad18 mutants is dependent on the RAD1, @PROTEIN1$, @PROTEIN2$, and RAD5 genes.","label":0}
{"pair_id":"BioInfer.d624.s0.p6","sentence":"The high recombination levels seen in rad5 and @PROTEIN2$ mutants is dependent on the RAD1, @PROTEIN1$, RAD52, and RAD5 genes.","label":0}
{"pair_id":"BioInfer.d624.s0.p7","sentence":"The high recombination levels seen in rad5 and rad18 mutants is dependent on the @PROTEIN2$, @PROTEIN1$, RAD52, and RAD5 genes.","label":0}
{"pair_id":"BioInfer.d624.s0.p8","sentence":"The high recombination levels seen in @PROTEIN2$ and rad18 mutants is dependent on the RAD1, @PROTEIN1$, RAD52, and RAD5 genes.","label":0}
{"pair_id":"BioInfer.d624.s0.p9","sentence":"The high recombination levels seen in rad5 and @PROTEIN2$ mutants is dependent on the RAD1, RAD51, @PROTEIN1$, and RAD5 genes.","label":0}
{"pair_id":"BioInfer.d624.s0.p10","sentence":"The high recombination levels seen in rad5 and rad18 mutants is dependent on the @PROTEIN2$, RAD51, @PROTEIN1$, and RAD5 genes.","label":0}
{"pair_id":"BioInfer.d624.s0.p11","sentence":"The high recombination levels seen in @PROTEIN2$ and rad18 mutants is dependent on the RAD1, RAD51, @PROTEIN1$, and RAD5 genes.","label":0}
{"pair_id":"BioInfer.d624.s0.p12","sentence":"The high recombination levels seen in rad5 and @PROTEIN1$ mutants is dependent on the @PROTEIN2$, RAD51, RAD52, and RAD5 genes.","label":0}
{"pair_id":"BioInfer.d624.s0.p13","sentence":"The high recombination levels seen in @PROTEIN2$ and @PROTEIN1$ mutants is dependent on the RAD1, RAD51, RAD52, and RAD5 genes.","label":0}
{"pair_id":"BioInfer.d624.s0.p14","sentence":"The high recombination levels seen in @PROTEIN2$ and rad18 mutants is dependent on the @PROTEIN1$, RAD51, RAD52, and RAD5 genes.","label":0}
{"pair_id":"BioInfer.d385.s0.p0","sentence":"Introduction of high concentrations of @PROTEIN1$ (estimated injected intracellular concentration 11-22 microM) into infected PtK2 cells causes a marked slowing of @PROTEIN2$ tail elongation and bacterial migration.","label":1}
{"pair_id":"AIMed.d168.s1412.p0","sentence":"Identification of a critical ligand binding determinant of the human @PROTEIN1$@PROTEIN2$. Evidence for common ligand binding motifs in the cytokine receptor family.","label":0}
{"pair_id":"BioInfer.d140.s0.p0","sentence":"Characterization of the interactions of @PROTEIN2$ with @PROTEIN1$ and beta-catenin\/plakoglobin.","label":1}
{"pair_id":"BioInfer.d140.s0.p1","sentence":"Characterization of the interactions of alpha-catenin with @PROTEIN1$ and beta-catenin\/@PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d140.s0.p2","sentence":"Characterization of the interactions of alpha-catenin with @PROTEIN1$ and @PROTEIN2$\/plakoglobin.","label":0}
{"pair_id":"BioInfer.d140.s0.p3","sentence":"Characterization of the interactions of @PROTEIN1$ with alpha-actinin and beta-catenin\/@PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d140.s0.p4","sentence":"Characterization of the interactions of @PROTEIN1$ with alpha-actinin and @PROTEIN2$\/plakoglobin.","label":1}
{"pair_id":"BioInfer.d140.s0.p5","sentence":"Characterization of the interactions of alpha-catenin with alpha-actinin and @PROTEIN2$\/@PROTEIN1$.","label":1}
{"pair_id":"AIMed.d90.s769.p0","sentence":"We have characterized the physical and functional interactions between @PROTEIN1$ and @PROTEIN2$, a leucine zipper transcription factor implicated in inflammatory responses.","label":1}
{"pair_id":"AIMed.d202.s1737.p0","sentence":"Crystal structure of the @PROTEIN2$@PROTEIN1$ receptor complexed with interleukin-1beta.","label":0}
{"pair_id":"AIMed.d202.s1737.p1","sentence":"Crystal structure of the type-I @PROTEIN1$ receptor complexed with @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d202.s1737.p2","sentence":"Crystal structure of the @PROTEIN1$ complexed with @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d378.s0.p0","sentence":"In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, @PROTEIN1$ and the smooth muscle myosin heavy-chain isoforms of SM1 and @PROTEIN2$) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and\/or by reverse transcription-polymerase chain reaction (RT-PCR).","label":0}
{"pair_id":"BioInfer.d378.s0.p1","sentence":"In this study, the expressions of smooth muscle-specific proteins (@PROTEIN2$, alpha-smooth muscle actin, @PROTEIN1$ and the smooth muscle myosin heavy-chain isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and\/or by reverse transcription-polymerase chain reaction (RT-PCR).","label":0}
{"pair_id":"BioInfer.d378.s0.p2","sentence":"In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, @PROTEIN1$ and the smooth muscle myosin heavy-chain isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and\/or by reverse transcription-@PROTEIN2$ chain reaction (RT-PCR).","label":0}
{"pair_id":"BioInfer.d378.s0.p3","sentence":"In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, @PROTEIN1$ and the @PROTEIN2$ isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and\/or by reverse transcription-polymerase chain reaction (RT-PCR).","label":0}
{"pair_id":"BioInfer.d378.s0.p4","sentence":"In this study, the expressions of smooth muscle-specific proteins (desmin, @PROTEIN2$, @PROTEIN1$ and the smooth muscle myosin heavy-chain isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and\/or by reverse transcription-polymerase chain reaction (RT-PCR).","label":0}
{"pair_id":"BioInfer.d378.s0.p5","sentence":"In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, @PROTEIN1$ and the smooth muscle myosin heavy-chain isoforms of @PROTEIN2$ and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and\/or by reverse transcription-polymerase chain reaction (RT-PCR).","label":0}
{"pair_id":"BioInfer.d378.s0.p6","sentence":"In this study, the expressions of smooth muscle-specific proteins (@PROTEIN2$, alpha-smooth muscle actin, basic calponin and the smooth muscle myosin heavy-chain isoforms of SM1 and @PROTEIN1$) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and\/or by reverse transcription-polymerase chain reaction (RT-PCR).","label":0}
{"pair_id":"BioInfer.d378.s0.p7","sentence":"In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, basic calponin and the smooth muscle myosin heavy-chain isoforms of SM1 and @PROTEIN1$) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and\/or by reverse transcription-@PROTEIN2$ chain reaction (RT-PCR).","label":0}
{"pair_id":"BioInfer.d378.s0.p8","sentence":"In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, basic calponin and the @PROTEIN2$ isoforms of SM1 and @PROTEIN1$) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and\/or by reverse transcription-polymerase chain reaction (RT-PCR).","label":1}
{"pair_id":"BioInfer.d378.s0.p9","sentence":"In this study, the expressions of smooth muscle-specific proteins (desmin, @PROTEIN2$, basic calponin and the smooth muscle myosin heavy-chain isoforms of SM1 and @PROTEIN1$) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and\/or by reverse transcription-polymerase chain reaction (RT-PCR).","label":0}
{"pair_id":"BioInfer.d378.s0.p10","sentence":"In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, basic calponin and the smooth muscle myosin heavy-chain isoforms of @PROTEIN2$ and @PROTEIN1$) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and\/or by reverse transcription-polymerase chain reaction (RT-PCR).","label":0}
{"pair_id":"BioInfer.d378.s0.p11","sentence":"In this study, the expressions of smooth muscle-specific proteins (@PROTEIN1$, alpha-smooth muscle actin, basic calponin and the smooth muscle myosin heavy-chain isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and\/or by reverse transcription-@PROTEIN2$ chain reaction (RT-PCR).","label":0}
{"pair_id":"BioInfer.d378.s0.p12","sentence":"In this study, the expressions of smooth muscle-specific proteins (@PROTEIN1$, alpha-smooth muscle actin, basic calponin and the @PROTEIN2$ isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and\/or by reverse transcription-polymerase chain reaction (RT-PCR).","label":0}
{"pair_id":"BioInfer.d378.s0.p13","sentence":"In this study, the expressions of smooth muscle-specific proteins (@PROTEIN1$, @PROTEIN2$, basic calponin and the smooth muscle myosin heavy-chain isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and\/or by reverse transcription-polymerase chain reaction (RT-PCR).","label":0}
{"pair_id":"BioInfer.d378.s0.p14","sentence":"In this study, the expressions of smooth muscle-specific proteins (@PROTEIN1$, alpha-smooth muscle actin, basic calponin and the smooth muscle myosin heavy-chain isoforms of @PROTEIN2$ and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and\/or by reverse transcription-polymerase chain reaction (RT-PCR).","label":0}
{"pair_id":"BioInfer.d378.s0.p15","sentence":"In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, basic calponin and the @PROTEIN2$ isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and\/or by reverse transcription-@PROTEIN1$ chain reaction (RT-PCR).","label":0}
{"pair_id":"BioInfer.d378.s0.p16","sentence":"In this study, the expressions of smooth muscle-specific proteins (desmin, @PROTEIN2$, basic calponin and the smooth muscle myosin heavy-chain isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and\/or by reverse transcription-@PROTEIN1$ chain reaction (RT-PCR).","label":0}
{"pair_id":"BioInfer.d378.s0.p17","sentence":"In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, basic calponin and the smooth muscle myosin heavy-chain isoforms of @PROTEIN2$ and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and\/or by reverse transcription-@PROTEIN1$ chain reaction (RT-PCR).","label":0}
{"pair_id":"BioInfer.d378.s0.p18","sentence":"In this study, the expressions of smooth muscle-specific proteins (desmin, @PROTEIN2$, basic calponin and the @PROTEIN1$ isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and\/or by reverse transcription-polymerase chain reaction (RT-PCR).","label":0}
{"pair_id":"BioInfer.d378.s0.p19","sentence":"In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, basic calponin and the @PROTEIN1$ isoforms of @PROTEIN2$ and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and\/or by reverse transcription-polymerase chain reaction (RT-PCR).","label":1}
{"pair_id":"BioInfer.d378.s0.p20","sentence":"In this study, the expressions of smooth muscle-specific proteins (desmin, @PROTEIN1$, basic calponin and the smooth muscle myosin heavy-chain isoforms of @PROTEIN2$ and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and\/or by reverse transcription-polymerase chain reaction (RT-PCR).","label":0}
{"pair_id":"BioInfer.d266.s0.p0","sentence":"However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 @PROTEIN1$ (@PROTEIN2$).","label":0}
{"pair_id":"BioInfer.d266.s0.p1","sentence":"However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with @PROTEIN2$ allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 @PROTEIN1$ (CKI).","label":0}
{"pair_id":"BioInfer.d266.s0.p2","sentence":"However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of @PROTEIN2$ with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 @PROTEIN1$ (CKI).","label":0}
{"pair_id":"BioInfer.d266.s0.p3","sentence":"However, although expression of Ras alone will not induce G1 @PROTEIN2$ activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 @PROTEIN1$ (CKI).","label":0}
{"pair_id":"BioInfer.d266.s0.p4","sentence":"However, although expression of @PROTEIN2$ alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 @PROTEIN1$ (CKI).","label":0}
{"pair_id":"BioInfer.d266.s0.p5","sentence":"However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the @PROTEIN2$ @PROTEIN1$ (CKI).","label":1}
{"pair_id":"BioInfer.d266.s0.p6","sentence":"However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of @PROTEIN2$ activity and the induction of S phase, coincident with the loss of the p27 @PROTEIN1$ (CKI).","label":0}
{"pair_id":"BioInfer.d266.s0.p7","sentence":"However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with @PROTEIN2$ allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (@PROTEIN1$).","label":0}
{"pair_id":"BioInfer.d266.s0.p8","sentence":"However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of @PROTEIN2$ with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (@PROTEIN1$).","label":0}
{"pair_id":"BioInfer.d266.s0.p9","sentence":"However, although expression of Ras alone will not induce G1 @PROTEIN2$ activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (@PROTEIN1$).","label":0}
{"pair_id":"BioInfer.d266.s0.p10","sentence":"However, although expression of @PROTEIN2$ alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (@PROTEIN1$).","label":0}
{"pair_id":"BioInfer.d266.s0.p11","sentence":"However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the @PROTEIN2$ cyclin-dependent kinase inhibitor (@PROTEIN1$).","label":1}
{"pair_id":"BioInfer.d266.s0.p12","sentence":"However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of @PROTEIN2$ activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (@PROTEIN1$).","label":0}
{"pair_id":"BioInfer.d266.s0.p13","sentence":"However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of @PROTEIN2$ with @PROTEIN1$ allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).","label":1}
{"pair_id":"BioInfer.d266.s0.p14","sentence":"However, although expression of Ras alone will not induce G1 @PROTEIN2$ activity or S phase, coexpression of Ras with @PROTEIN1$ allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).","label":0}
{"pair_id":"BioInfer.d266.s0.p15","sentence":"However, although expression of @PROTEIN2$ alone will not induce G1 CDK activity or S phase, coexpression of Ras with @PROTEIN1$ allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).","label":0}
{"pair_id":"BioInfer.d266.s0.p16","sentence":"However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with @PROTEIN1$ allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the @PROTEIN2$ cyclin-dependent kinase inhibitor (CKI).","label":0}
{"pair_id":"BioInfer.d266.s0.p17","sentence":"However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with @PROTEIN1$ allows the generation of @PROTEIN2$ activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).","label":1}
{"pair_id":"BioInfer.d266.s0.p18","sentence":"However, although expression of Ras alone will not induce G1 @PROTEIN2$ activity or S phase, coexpression of @PROTEIN1$ with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).","label":0}
{"pair_id":"BioInfer.d266.s0.p19","sentence":"However, although expression of @PROTEIN2$ alone will not induce G1 CDK activity or S phase, coexpression of @PROTEIN1$ with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).","label":0}
{"pair_id":"BioInfer.d266.s0.p20","sentence":"However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of @PROTEIN1$ with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the @PROTEIN2$ cyclin-dependent kinase inhibitor (CKI).","label":0}
{"pair_id":"BioInfer.d266.s0.p21","sentence":"However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of @PROTEIN1$ with Myc allows the generation of @PROTEIN2$ activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).","label":1}
{"pair_id":"BioInfer.d266.s0.p22","sentence":"However, although expression of @PROTEIN2$ alone will not induce G1 @PROTEIN1$ activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).","label":1}
{"pair_id":"BioInfer.d266.s0.p23","sentence":"However, although expression of Ras alone will not induce G1 @PROTEIN1$ activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the @PROTEIN2$ cyclin-dependent kinase inhibitor (CKI).","label":0}
{"pair_id":"BioInfer.d266.s0.p24","sentence":"However, although expression of Ras alone will not induce G1 @PROTEIN1$ activity or S phase, coexpression of Ras with Myc allows the generation of @PROTEIN2$ activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).","label":0}
{"pair_id":"BioInfer.d266.s0.p25","sentence":"However, although expression of @PROTEIN1$ alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the @PROTEIN2$ cyclin-dependent kinase inhibitor (CKI).","label":0}
{"pair_id":"BioInfer.d266.s0.p26","sentence":"However, although expression of @PROTEIN1$ alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of @PROTEIN2$ activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).","label":0}
{"pair_id":"BioInfer.d266.s0.p27","sentence":"However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of @PROTEIN2$ activity and the induction of S phase, coincident with the loss of the @PROTEIN1$ cyclin-dependent kinase inhibitor (CKI).","label":1}
{"pair_id":"BioInfer.d395.s0.p0","sentence":"It is estimated that at optimal levels of transcription, every molecule of viral genomic RNA associates with approximately the following number of protein molecules: 30 molecules of @PROTEIN1$, 120 molecules of phosphoprotein P, and 60 molecules each of @PROTEIN2$ and profilin.","label":0}
{"pair_id":"BioInfer.d395.s0.p1","sentence":"It is estimated that at optimal levels of transcription, every molecule of viral genomic RNA associates with approximately the following number of protein molecules: 30 molecules of @PROTEIN1$, 120 molecules of @PROTEIN2$ P, and 60 molecules each of actin and profilin.","label":0}
{"pair_id":"BioInfer.d395.s0.p2","sentence":"It is estimated that at optimal levels of transcription, every molecule of viral genomic RNA associates with approximately the following number of protein molecules: 30 molecules of @PROTEIN1$, 120 molecules of phosphoprotein @PROTEIN2$, and 60 molecules each of actin and profilin.","label":0}
{"pair_id":"BioInfer.d395.s0.p3","sentence":"It is estimated that at optimal levels of transcription, every molecule of viral genomic RNA associates with approximately the following number of protein molecules: 30 molecules of @PROTEIN1$, 120 molecules of phosphoprotein P, and 60 molecules each of actin and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d395.s0.p4","sentence":"It is estimated that at optimal levels of transcription, every molecule of viral genomic RNA associates with approximately the following number of protein molecules: 30 molecules of L, 120 molecules of @PROTEIN2$ P, and 60 molecules each of @PROTEIN1$ and profilin.","label":0}
{"pair_id":"BioInfer.d395.s0.p5","sentence":"It is estimated that at optimal levels of transcription, every molecule of viral genomic RNA associates with approximately the following number of protein molecules: 30 molecules of L, 120 molecules of phosphoprotein @PROTEIN2$, and 60 molecules each of @PROTEIN1$ and profilin.","label":0}
{"pair_id":"BioInfer.d395.s0.p6","sentence":"It is estimated that at optimal levels of transcription, every molecule of viral genomic RNA associates with approximately the following number of protein molecules: 30 molecules of L, 120 molecules of phosphoprotein P, and 60 molecules each of @PROTEIN1$ and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d395.s0.p7","sentence":"It is estimated that at optimal levels of transcription, every molecule of viral genomic RNA associates with approximately the following number of protein molecules: 30 molecules of L, 120 molecules of @PROTEIN1$ @PROTEIN2$, and 60 molecules each of actin and profilin.","label":1}
{"pair_id":"BioInfer.d395.s0.p8","sentence":"It is estimated that at optimal levels of transcription, every molecule of viral genomic RNA associates with approximately the following number of protein molecules: 30 molecules of L, 120 molecules of @PROTEIN1$ P, and 60 molecules each of actin and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d395.s0.p9","sentence":"It is estimated that at optimal levels of transcription, every molecule of viral genomic RNA associates with approximately the following number of protein molecules: 30 molecules of L, 120 molecules of phosphoprotein @PROTEIN1$, and 60 molecules each of actin and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d581.s0.p0","sentence":"The @PROTEIN1$-binding region is distinct from major anti-CD26 mAb epitopes on the human dipeptidyl peptidase IV(@PROTEIN2$) molecule.","label":0}
{"pair_id":"BioInfer.d581.s0.p1","sentence":"The @PROTEIN1$-binding region is distinct from major anti-@PROTEIN2$ mAb epitopes on the human dipeptidyl peptidase IV(CD26) molecule.","label":0}
{"pair_id":"BioInfer.d581.s0.p2","sentence":"The @PROTEIN1$-binding region is distinct from major anti-CD26 mAb epitopes on the human @PROTEIN2$(CD26) molecule.","label":0}
{"pair_id":"BioInfer.d581.s0.p3","sentence":"The adenosine deaminase-binding region is distinct from major anti-@PROTEIN2$ mAb epitopes on the human dipeptidyl peptidase IV(@PROTEIN1$) molecule.","label":1}
{"pair_id":"BioInfer.d581.s0.p4","sentence":"The adenosine deaminase-binding region is distinct from major anti-CD26 mAb epitopes on the human @PROTEIN2$(@PROTEIN1$) molecule.","label":0}
{"pair_id":"BioInfer.d581.s0.p5","sentence":"The adenosine deaminase-binding region is distinct from major anti-@PROTEIN1$ mAb epitopes on the human @PROTEIN2$(CD26) molecule.","label":1}
{"pair_id":"AIMed.d146.s1237.p0","sentence":"@PROTEIN1$-driven proliferation is mediated via high affinity @PROTEIN2$, and accordingly, Scatchard analysis revealed that, like the p90 IL-7R, the p76 IL-7R bound IL-7 with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.","label":0}
{"pair_id":"AIMed.d146.s1237.p1","sentence":"@PROTEIN1$-driven proliferation is mediated via high affinity IL-7R, and accordingly, Scatchard analysis revealed that, like the @PROTEIN2$ IL-7R, the p76 IL-7R bound IL-7 with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.","label":0}
{"pair_id":"AIMed.d146.s1237.p2","sentence":"@PROTEIN1$-driven proliferation is mediated via high affinity IL-7R, and accordingly, Scatchard analysis revealed that, like the p90 @PROTEIN2$, the p76 IL-7R bound IL-7 with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.","label":0}
{"pair_id":"AIMed.d146.s1237.p3","sentence":"@PROTEIN1$-driven proliferation is mediated via high affinity IL-7R, and accordingly, Scatchard analysis revealed that, like the p90 IL-7R, the @PROTEIN2$ IL-7R bound IL-7 with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.","label":0}
{"pair_id":"AIMed.d146.s1237.p4","sentence":"@PROTEIN1$-driven proliferation is mediated via high affinity IL-7R, and accordingly, Scatchard analysis revealed that, like the p90 IL-7R, the p76 @PROTEIN2$ bound IL-7 with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.","label":0}
{"pair_id":"AIMed.d146.s1237.p5","sentence":"@PROTEIN1$-driven proliferation is mediated via high affinity IL-7R, and accordingly, Scatchard analysis revealed that, like the p90 IL-7R, the p76 IL-7R bound @PROTEIN2$ with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.","label":0}
{"pair_id":"AIMed.d146.s1237.p6","sentence":"IL-7-driven proliferation is mediated via high affinity @PROTEIN1$, and accordingly, Scatchard analysis revealed that, like the @PROTEIN2$ IL-7R, the p76 IL-7R bound IL-7 with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.","label":0}
{"pair_id":"AIMed.d146.s1237.p7","sentence":"IL-7-driven proliferation is mediated via high affinity @PROTEIN1$, and accordingly, Scatchard analysis revealed that, like the p90 @PROTEIN2$, the p76 IL-7R bound IL-7 with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.","label":0}
{"pair_id":"AIMed.d146.s1237.p8","sentence":"IL-7-driven proliferation is mediated via high affinity @PROTEIN1$, and accordingly, Scatchard analysis revealed that, like the p90 IL-7R, the @PROTEIN2$ IL-7R bound IL-7 with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.","label":0}
{"pair_id":"AIMed.d146.s1237.p9","sentence":"IL-7-driven proliferation is mediated via high affinity @PROTEIN1$, and accordingly, Scatchard analysis revealed that, like the p90 IL-7R, the p76 @PROTEIN2$ bound IL-7 with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.","label":0}
{"pair_id":"AIMed.d146.s1237.p10","sentence":"IL-7-driven proliferation is mediated via high affinity @PROTEIN1$, and accordingly, Scatchard analysis revealed that, like the p90 IL-7R, the p76 IL-7R bound @PROTEIN2$ with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.","label":0}
{"pair_id":"AIMed.d146.s1237.p11","sentence":"IL-7-driven proliferation is mediated via high affinity IL-7R, and accordingly, Scatchard analysis revealed that, like the @PROTEIN1$ @PROTEIN2$, the p76 IL-7R bound IL-7 with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.","label":0}
{"pair_id":"AIMed.d146.s1237.p12","sentence":"IL-7-driven proliferation is mediated via high affinity IL-7R, and accordingly, Scatchard analysis revealed that, like the @PROTEIN1$ IL-7R, the @PROTEIN2$ IL-7R bound IL-7 with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.","label":0}
{"pair_id":"AIMed.d146.s1237.p13","sentence":"IL-7-driven proliferation is mediated via high affinity IL-7R, and accordingly, Scatchard analysis revealed that, like the @PROTEIN1$ IL-7R, the p76 @PROTEIN2$ bound IL-7 with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.","label":0}
{"pair_id":"AIMed.d146.s1237.p14","sentence":"IL-7-driven proliferation is mediated via high affinity IL-7R, and accordingly, Scatchard analysis revealed that, like the @PROTEIN1$ IL-7R, the p76 IL-7R bound @PROTEIN2$ with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.","label":0}
{"pair_id":"AIMed.d146.s1237.p15","sentence":"IL-7-driven proliferation is mediated via high affinity IL-7R, and accordingly, Scatchard analysis revealed that, like the p90 @PROTEIN1$, the @PROTEIN2$ IL-7R bound IL-7 with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.","label":0}
{"pair_id":"AIMed.d146.s1237.p16","sentence":"IL-7-driven proliferation is mediated via high affinity IL-7R, and accordingly, Scatchard analysis revealed that, like the p90 @PROTEIN1$, the p76 @PROTEIN2$ bound IL-7 with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.","label":0}
{"pair_id":"AIMed.d146.s1237.p17","sentence":"IL-7-driven proliferation is mediated via high affinity IL-7R, and accordingly, Scatchard analysis revealed that, like the p90 @PROTEIN1$, the p76 IL-7R bound @PROTEIN2$ with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.","label":0}
{"pair_id":"AIMed.d146.s1237.p18","sentence":"IL-7-driven proliferation is mediated via high affinity IL-7R, and accordingly, Scatchard analysis revealed that, like the p90 IL-7R, the @PROTEIN1$ @PROTEIN2$ bound IL-7 with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.","label":0}
{"pair_id":"AIMed.d146.s1237.p19","sentence":"IL-7-driven proliferation is mediated via high affinity IL-7R, and accordingly, Scatchard analysis revealed that, like the p90 IL-7R, the @PROTEIN1$ IL-7R bound @PROTEIN2$ with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.","label":0}
{"pair_id":"AIMed.d146.s1237.p20","sentence":"IL-7-driven proliferation is mediated via high affinity IL-7R, and accordingly, Scatchard analysis revealed that, like the p90 IL-7R, the p76 @PROTEIN1$ bound @PROTEIN2$ with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.","label":0}
{"pair_id":"BioInfer.d659.s0.p0","sentence":"The polycystic kidney disease 1 gene product mediates @PROTEIN1$-dependent and @PROTEIN2$-dependent activation of the transcription factor AP-1.","label":0}
{"pair_id":"BioInfer.d659.s0.p1","sentence":"The @PROTEIN2$ gene product mediates @PROTEIN1$-dependent and c-Jun N-terminal kinase-dependent activation of the transcription factor AP-1.","label":0}
{"pair_id":"BioInfer.d659.s0.p2","sentence":"The polycystic kidney disease 1 gene product mediates @PROTEIN1$-dependent and c-Jun N-terminal kinase-dependent activation of the transcription factor @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d659.s0.p3","sentence":"The @PROTEIN2$ gene product mediates protein kinase C alpha-dependent and @PROTEIN1$-dependent activation of the transcription factor AP-1.","label":0}
{"pair_id":"BioInfer.d659.s0.p4","sentence":"The polycystic kidney disease 1 gene product mediates protein kinase C alpha-dependent and @PROTEIN1$-dependent activation of the transcription factor @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d659.s0.p5","sentence":"The @PROTEIN1$ gene product mediates protein kinase C alpha-dependent and c-Jun N-terminal kinase-dependent activation of the transcription factor @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d113.s1.p0","sentence":"The results suggest that tyrosine phosphorylation of @PROTEIN2$ is achieved by EGFR upon tryptic digestion of cells and concurrent with but independent of dissociation of @PROTEIN1$ from E-cadherin.","label":1}
{"pair_id":"BioInfer.d113.s1.p1","sentence":"The results suggest that tyrosine phosphorylation of beta-catenin is achieved by @PROTEIN2$ upon tryptic digestion of cells and concurrent with but independent of dissociation of @PROTEIN1$ from E-cadherin.","label":0}
{"pair_id":"BioInfer.d113.s1.p2","sentence":"The results suggest that tyrosine phosphorylation of beta-catenin is achieved by EGFR upon tryptic digestion of cells and concurrent with but independent of dissociation of @PROTEIN1$ from @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d113.s1.p3","sentence":"The results suggest that tyrosine phosphorylation of @PROTEIN1$ is achieved by @PROTEIN2$ upon tryptic digestion of cells and concurrent with but independent of dissociation of alpha-catenin from E-cadherin.","label":1}
{"pair_id":"BioInfer.d113.s1.p4","sentence":"The results suggest that tyrosine phosphorylation of @PROTEIN1$ is achieved by EGFR upon tryptic digestion of cells and concurrent with but independent of dissociation of alpha-catenin from @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d113.s1.p5","sentence":"The results suggest that tyrosine phosphorylation of beta-catenin is achieved by @PROTEIN1$ upon tryptic digestion of cells and concurrent with but independent of dissociation of alpha-catenin from @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d18.s156.p0","sentence":"@PROTEIN1$ and sP- and @PROTEIN2$ levels were not related to function of lymphocytes (by MDM data) as seen in both tests; it is probable that another cell-cell communication mechanism had been switched on.","label":0}
{"pair_id":"BioInfer.d33.s3.p0","sentence":"RESULTS: E-cadherin, @PROTEIN1$, beta-catenin and @PROTEIN2$ were expressed in a normal membranous pattern in all normal bladder epithelium specimens.","label":0}
{"pair_id":"BioInfer.d33.s3.p1","sentence":"RESULTS: @PROTEIN2$, @PROTEIN1$, beta-catenin and gamma-catenin were expressed in a normal membranous pattern in all normal bladder epithelium specimens.","label":0}
{"pair_id":"BioInfer.d33.s3.p2","sentence":"RESULTS: E-cadherin, @PROTEIN1$, @PROTEIN2$ and gamma-catenin were expressed in a normal membranous pattern in all normal bladder epithelium specimens.","label":0}
{"pair_id":"BioInfer.d33.s3.p3","sentence":"RESULTS: @PROTEIN2$, alpha-catenin, beta-catenin and @PROTEIN1$ were expressed in a normal membranous pattern in all normal bladder epithelium specimens.","label":0}
{"pair_id":"BioInfer.d33.s3.p4","sentence":"RESULTS: E-cadherin, alpha-catenin, @PROTEIN2$ and @PROTEIN1$ were expressed in a normal membranous pattern in all normal bladder epithelium specimens.","label":0}
{"pair_id":"BioInfer.d33.s3.p5","sentence":"RESULTS: @PROTEIN1$, alpha-catenin, @PROTEIN2$ and gamma-catenin were expressed in a normal membranous pattern in all normal bladder epithelium specimens.","label":0}
{"pair_id":"BioInfer.d35.s2.p0","sentence":"A two-hybrid-based approach using @PROTEIN2$ and @PROTEIN1$ mutants identified residues necessary for the interaction of actin, cofilin, and Aip1p in an apparent ternary complex.","label":0}
{"pair_id":"BioInfer.d35.s2.p1","sentence":"A two-hybrid-based approach using cofilin and @PROTEIN1$ mutants identified residues necessary for the interaction of @PROTEIN2$, cofilin, and Aip1p in an apparent ternary complex.","label":0}
{"pair_id":"BioInfer.d35.s2.p2","sentence":"A two-hybrid-based approach using cofilin and @PROTEIN1$ mutants identified residues necessary for the interaction of actin, @PROTEIN2$, and Aip1p in an apparent ternary complex.","label":0}
{"pair_id":"BioInfer.d35.s2.p3","sentence":"A two-hybrid-based approach using cofilin and @PROTEIN1$ mutants identified residues necessary for the interaction of actin, cofilin, and @PROTEIN2$ in an apparent ternary complex.","label":0}
{"pair_id":"BioInfer.d35.s2.p4","sentence":"A two-hybrid-based approach using @PROTEIN1$ and actin mutants identified residues necessary for the interaction of @PROTEIN2$, cofilin, and Aip1p in an apparent ternary complex.","label":0}
{"pair_id":"BioInfer.d35.s2.p5","sentence":"A two-hybrid-based approach using @PROTEIN1$ and actin mutants identified residues necessary for the interaction of actin, @PROTEIN2$, and Aip1p in an apparent ternary complex.","label":0}
{"pair_id":"BioInfer.d35.s2.p6","sentence":"A two-hybrid-based approach using @PROTEIN1$ and actin mutants identified residues necessary for the interaction of actin, cofilin, and @PROTEIN2$ in an apparent ternary complex.","label":0}
{"pair_id":"BioInfer.d35.s2.p7","sentence":"A two-hybrid-based approach using cofilin and actin mutants identified residues necessary for the interaction of @PROTEIN1$, @PROTEIN2$, and Aip1p in an apparent ternary complex.","label":1}
{"pair_id":"BioInfer.d35.s2.p8","sentence":"A two-hybrid-based approach using cofilin and actin mutants identified residues necessary for the interaction of @PROTEIN1$, cofilin, and @PROTEIN2$ in an apparent ternary complex.","label":1}
{"pair_id":"BioInfer.d35.s2.p9","sentence":"A two-hybrid-based approach using cofilin and actin mutants identified residues necessary for the interaction of actin, @PROTEIN1$, and @PROTEIN2$ in an apparent ternary complex.","label":1}
{"pair_id":"BioInfer.d512.s0.p0","sentence":"Reduced E-cadherin, @PROTEIN2$, beta-catenin and @PROTEIN1$ expression correlated closely with the differentiation grade of the esophageal squamous cell carcinoma (p < 0.05).","label":0}
{"pair_id":"BioInfer.d512.s0.p1","sentence":"Reduced E-cadherin, alpha-catenin, @PROTEIN2$ and @PROTEIN1$ expression correlated closely with the differentiation grade of the esophageal squamous cell carcinoma (p < 0.05).","label":0}
{"pair_id":"BioInfer.d512.s0.p2","sentence":"Reduced @PROTEIN2$, alpha-catenin, beta-catenin and @PROTEIN1$ expression correlated closely with the differentiation grade of the esophageal squamous cell carcinoma (p < 0.05).","label":0}
{"pair_id":"BioInfer.d512.s0.p3","sentence":"Reduced E-cadherin, @PROTEIN1$, @PROTEIN2$ and plakoglobin expression correlated closely with the differentiation grade of the esophageal squamous cell carcinoma (p < 0.05).","label":0}
{"pair_id":"BioInfer.d512.s0.p4","sentence":"Reduced @PROTEIN2$, @PROTEIN1$, beta-catenin and plakoglobin expression correlated closely with the differentiation grade of the esophageal squamous cell carcinoma (p < 0.05).","label":0}
{"pair_id":"BioInfer.d512.s0.p5","sentence":"Reduced @PROTEIN2$, alpha-catenin, @PROTEIN1$ and plakoglobin expression correlated closely with the differentiation grade of the esophageal squamous cell carcinoma (p < 0.05).","label":0}
{"pair_id":"AIMed.d209.s1809.p0","sentence":"The same domain of @PROTEIN1$ that binds @PROTEIN2$ also interacts with 14-3-3 proteins, extending the similarity between RIN1 and other RAS effectors.","label":1}
{"pair_id":"AIMed.d209.s1809.p1","sentence":"The same domain of @PROTEIN1$ that binds RAS also interacts with 14-3-3 proteins, extending the similarity between @PROTEIN2$ and other RAS effectors.","label":0}
{"pair_id":"AIMed.d209.s1809.p2","sentence":"The same domain of @PROTEIN1$ that binds RAS also interacts with 14-3-3 proteins, extending the similarity between RIN1 and other @PROTEIN2$ effectors.","label":0}
{"pair_id":"AIMed.d209.s1809.p3","sentence":"The same domain of RIN1 that binds @PROTEIN1$ also interacts with 14-3-3 proteins, extending the similarity between @PROTEIN2$ and other RAS effectors.","label":0}
{"pair_id":"AIMed.d209.s1809.p4","sentence":"The same domain of RIN1 that binds @PROTEIN1$ also interacts with 14-3-3 proteins, extending the similarity between RIN1 and other @PROTEIN2$ effectors.","label":0}
{"pair_id":"AIMed.d209.s1809.p5","sentence":"The same domain of RIN1 that binds RAS also interacts with 14-3-3 proteins, extending the similarity between @PROTEIN1$ and other @PROTEIN2$ effectors.","label":0}
{"pair_id":"BioInfer.d670.s0.p0","sentence":"The products of the yeast mismatch repair genes @PROTEIN1$ and @PROTEIN2$ participate in the inhibition of genetic recombination between homeologous (divergent) DNA sequences.","label":0}
{"pair_id":"AIMed.d117.s991.p0","sentence":"@PROTEIN1$ also binds to @PROTEIN2$ through its beta subunit, competes with the binding of activin to ActRII, but fails to form the ActRII.","label":1}
{"pair_id":"AIMed.d117.s991.p1","sentence":"@PROTEIN1$ also binds to ActRII through its beta subunit, competes with the binding of activin to @PROTEIN2$, but fails to form the ActRII.","label":0}
{"pair_id":"AIMed.d117.s991.p2","sentence":"@PROTEIN1$ also binds to ActRII through its beta subunit, competes with the binding of activin to ActRII, but fails to form the @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d117.s991.p3","sentence":"Inhibin also binds to @PROTEIN1$ through its beta subunit, competes with the binding of activin to @PROTEIN2$, but fails to form the ActRII.","label":0}
{"pair_id":"AIMed.d117.s991.p4","sentence":"Inhibin also binds to @PROTEIN1$ through its beta subunit, competes with the binding of activin to ActRII, but fails to form the @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d117.s991.p5","sentence":"Inhibin also binds to ActRII through its beta subunit, competes with the binding of activin to @PROTEIN1$, but fails to form the @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d131.s1124.p0","sentence":"In a number of human T cell clones, expression of @PROTEIN1$ mRNA is down-regulated after activation of the cells with anti-@PROTEIN2$ Ab and phorbol ester.","label":0}
{"pair_id":"AIMed.d146.s1234.p0","sentence":"In this study the origin and function of the @PROTEIN1$ and @PROTEIN2$ molecules have been investigated.","label":0}
{"pair_id":"BioInfer.d6.s2.p0","sentence":"We speculate that nonfilamentous @PROTEIN2$ and @PROTEIN1$, both of which form shear-sensitive structures, can be modeled as flocculant materials.","label":0}
{"pair_id":"AIMed.d153.s1300.p0","sentence":"In the present study, we examined both the binding of @PROTEIN1$ and @PROTEIN2$ and the functional consequences of this interaction.","label":1}
{"pair_id":"AIMed.d103.s873.p0","sentence":"The binding of @PROTEIN1$ and @PROTEIN2$ requires distinct domains of hTAFII18.","label":0}
{"pair_id":"AIMed.d103.s873.p1","sentence":"The binding of @PROTEIN1$ and hTAFII30 requires distinct domains of @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d103.s873.p2","sentence":"The binding of hTAFII28 and @PROTEIN1$ requires distinct domains of @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d115.s972.p0","sentence":"Here we show that the general transcription factor @PROTEIN1$ is also a target for a transcriptional activator, namely @PROTEIN2$ (SRF), which binds to the c-fos promoter.","label":0}
{"pair_id":"AIMed.d115.s972.p1","sentence":"Here we show that the general transcription factor @PROTEIN1$ is also a target for a transcriptional activator, namely serum response factor (@PROTEIN2$), which binds to the c-fos promoter.","label":0}
{"pair_id":"AIMed.d115.s972.p2","sentence":"Here we show that the general transcription factor @PROTEIN1$ is also a target for a transcriptional activator, namely serum response factor (SRF), which binds to the @PROTEIN2$ promoter.","label":0}
{"pair_id":"AIMed.d115.s972.p3","sentence":"Here we show that the general transcription factor TFIIF is also a target for a transcriptional activator, namely @PROTEIN1$ (@PROTEIN2$), which binds to the c-fos promoter.","label":0}
{"pair_id":"AIMed.d115.s972.p4","sentence":"Here we show that the general transcription factor TFIIF is also a target for a transcriptional activator, namely @PROTEIN1$ (SRF), which binds to the @PROTEIN2$ promoter.","label":0}
{"pair_id":"AIMed.d115.s972.p5","sentence":"Here we show that the general transcription factor TFIIF is also a target for a transcriptional activator, namely serum response factor (@PROTEIN1$), which binds to the @PROTEIN2$ promoter.","label":0}
{"pair_id":"BioInfer.d500.s0.p0","sentence":"Proteolytic activity was not detected with casein, @PROTEIN1$, or @PROTEIN2$ substrates.","label":0}
{"pair_id":"BioInfer.d500.s0.p1","sentence":"Proteolytic activity was not detected with @PROTEIN2$, @PROTEIN1$, or myosin heavy-chain substrates.","label":0}
{"pair_id":"BioInfer.d500.s0.p2","sentence":"Proteolytic activity was not detected with @PROTEIN2$, actin, or @PROTEIN1$ substrates.","label":0}
{"pair_id":"AIMed.d147.s1248.p0","sentence":"We have now isolated cDNA clones that contain the full-length coding sequence of two other proteins, @PROTEIN1$ and @PROTEIN2$, cloned originally by their interaction with pRB.","label":0}
{"pair_id":"AIMed.d147.s1248.p1","sentence":"We have now isolated cDNA clones that contain the full-length coding sequence of two other proteins, @PROTEIN1$ and RBP2, cloned originally by their interaction with @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d147.s1248.p2","sentence":"We have now isolated cDNA clones that contain the full-length coding sequence of two other proteins, RBP1 and @PROTEIN1$, cloned originally by their interaction with @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d433.s1.p0","sentence":"These results show that the C-terminal actin-binding site is distinct from the region recognized by the anti-functional antibody @PROTEIN2$, raising the possibility that it binds to a novel functionally important ligand-binding site in the @PROTEIN1$ molecule.","label":1}
{"pair_id":"BioInfer.d433.s1.p1","sentence":"These results show that the C-terminal @PROTEIN2$-binding site is distinct from the region recognized by the anti-functional antibody TD77, raising the possibility that it binds to a novel functionally important ligand-binding site in the @PROTEIN1$ molecule.","label":1}
{"pair_id":"BioInfer.d433.s1.p2","sentence":"These results show that the C-terminal @PROTEIN2$-binding site is distinct from the region recognized by the anti-functional antibody @PROTEIN1$, raising the possibility that it binds to a novel functionally important ligand-binding site in the talin molecule.","label":0}
{"pair_id":"BioInfer.d488.s0.p0","sentence":"Photochemical cleavage of @PROTEIN2$ and the effect on the interaction with @PROTEIN1$.","label":1}
{"pair_id":"AIMed.d58.s516.p0","sentence":"While injection of @PROTEIN1$ or @PROTEIN2$ proteins alone into quiescent rat fibroblasts did not have mitogenic effect, microinjection of GRB2 together with H-ras protein stimulated DNA synthesis.","label":0}
{"pair_id":"AIMed.d58.s516.p1","sentence":"While injection of @PROTEIN1$ or H-ras proteins alone into quiescent rat fibroblasts did not have mitogenic effect, microinjection of @PROTEIN2$ together with H-ras protein stimulated DNA synthesis.","label":0}
{"pair_id":"AIMed.d58.s516.p2","sentence":"While injection of @PROTEIN1$ or H-ras proteins alone into quiescent rat fibroblasts did not have mitogenic effect, microinjection of GRB2 together with @PROTEIN2$ protein stimulated DNA synthesis.","label":0}
{"pair_id":"AIMed.d58.s516.p3","sentence":"While injection of GRB2 or @PROTEIN1$ proteins alone into quiescent rat fibroblasts did not have mitogenic effect, microinjection of @PROTEIN2$ together with H-ras protein stimulated DNA synthesis.","label":0}
{"pair_id":"AIMed.d58.s516.p4","sentence":"While injection of GRB2 or @PROTEIN1$ proteins alone into quiescent rat fibroblasts did not have mitogenic effect, microinjection of GRB2 together with @PROTEIN2$ protein stimulated DNA synthesis.","label":0}
{"pair_id":"AIMed.d58.s516.p5","sentence":"While injection of GRB2 or H-ras proteins alone into quiescent rat fibroblasts did not have mitogenic effect, microinjection of @PROTEIN1$ together with @PROTEIN2$ protein stimulated DNA synthesis.","label":0}
{"pair_id":"BioInfer.d143.s2.p0","sentence":"We propose a model in which @PROTEIN1$ alters cellular concentrations of @PROTEIN2$ polymers in response to fluctuations in cytosolic calcium concentration.","label":1}
{"pair_id":"AIMed.d26.s219.p0","sentence":"The tumor-free patients expressed @PROTEIN1$ at levels similar to healthy controls, while the progressive tumor-bearing patients expressed remarkably lower levels of @PROTEIN2$ compared to healthy controls ( P<0.0001).","label":0}
{"pair_id":"AIMed.d35.s299.p0","sentence":"Cell surface @PROTEIN1$ formed complexes in vivo with actin-binding protein @PROTEIN2$ (ABP-280), which is known to form bridges between cell surface receptors and cytoskeleton and mediate cell adhesion and cell motility.","label":1}
{"pair_id":"AIMed.d35.s299.p1","sentence":"Cell surface @PROTEIN1$ formed complexes in vivo with actin-binding protein filamin (@PROTEIN2$), which is known to form bridges between cell surface receptors and cytoskeleton and mediate cell adhesion and cell motility.","label":1}
{"pair_id":"AIMed.d35.s299.p2","sentence":"Cell surface PS1 formed complexes in vivo with actin-binding protein @PROTEIN1$ (@PROTEIN2$), which is known to form bridges between cell surface receptors and cytoskeleton and mediate cell adhesion and cell motility.","label":0}
{"pair_id":"AIMed.d148.s1251.p0","sentence":"Two potentially oncogenic cyclins, @PROTEIN1$ and @PROTEIN2$, share common properties of subunit configuration, tyrosine phosphorylation and physical association with the Rb protein","label":0}
{"pair_id":"AIMed.d148.s1251.p1","sentence":"Two potentially oncogenic cyclins, @PROTEIN1$ and cyclin D1, share common properties of subunit configuration, tyrosine phosphorylation and physical association with the @PROTEIN2$ protein","label":1}
{"pair_id":"AIMed.d148.s1251.p2","sentence":"Two potentially oncogenic cyclins, cyclin A and @PROTEIN1$, share common properties of subunit configuration, tyrosine phosphorylation and physical association with the @PROTEIN2$ protein","label":1}
{"pair_id":"BioInfer.d212.s0.p0","sentence":"First, the C-terminal @PROTEIN2$-@PROTEIN1$-acidic domain was shown to be essential for the regulation of actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d212.s0.p1","sentence":"First, the C-terminal verprolin-@PROTEIN1$-acidic domain was shown to be essential for the regulation of @PROTEIN2$ cytoskeleton.","label":0}
{"pair_id":"BioInfer.d212.s0.p2","sentence":"First, the C-terminal @PROTEIN1$-cofilin-acidic domain was shown to be essential for the regulation of @PROTEIN2$ cytoskeleton.","label":0}
{"pair_id":"AIMed.d153.s1299.p0","sentence":"@PROTEIN1$, a T cell activation Ag, also known as @PROTEIN2$,is directly associated with adenosine deaminase (ADA) on the surface of T cells and T cell lines.","label":0}
{"pair_id":"AIMed.d153.s1299.p1","sentence":"@PROTEIN1$, a T cell activation Ag, also known as dipeptidyl peptidase IV,is directly associated with @PROTEIN2$ (ADA) on the surface of T cells and T cell lines.","label":1}
{"pair_id":"AIMed.d153.s1299.p2","sentence":"@PROTEIN1$, a T cell activation Ag, also known as dipeptidyl peptidase IV,is directly associated with adenosine deaminase (@PROTEIN2$) on the surface of T cells and T cell lines.","label":1}
{"pair_id":"AIMed.d153.s1299.p3","sentence":"CD26, a T cell activation Ag, also known as @PROTEIN1$,is directly associated with @PROTEIN2$ (ADA) on the surface of T cells and T cell lines.","label":1}
{"pair_id":"AIMed.d153.s1299.p4","sentence":"CD26, a T cell activation Ag, also known as @PROTEIN1$,is directly associated with adenosine deaminase (@PROTEIN2$) on the surface of T cells and T cell lines.","label":1}
{"pair_id":"AIMed.d153.s1299.p5","sentence":"CD26, a T cell activation Ag, also known as dipeptidyl peptidase IV,is directly associated with @PROTEIN1$ (@PROTEIN2$) on the surface of T cells and T cell lines.","label":0}
{"pair_id":"BioInfer.d339.s0.p0","sentence":"Inhibition of @PROTEIN2$ polymerization in KCl was stronger than that of the parental @PROTEIN1$, and the Kd value of its interaction with rabbit skeletal muscle actin, as determined by falling ball viscometry, was smaller (mean value 0.5 x 10(-6) M, as compared to 1.9 x 10(-6) M for bovine profilin).","label":1}
{"pair_id":"BioInfer.d339.s0.p1","sentence":"Inhibition of actin polymerization in KCl was stronger than that of the parental @PROTEIN1$, and the Kd value of its interaction with rabbit skeletal muscle actin, as determined by falling ball viscometry, was smaller (mean value 0.5 x 10(-6) M, as compared to 1.9 x 10(-6) M for bovine @PROTEIN2$).","label":0}
{"pair_id":"BioInfer.d339.s0.p2","sentence":"Inhibition of actin polymerization in KCl was stronger than that of the parental @PROTEIN1$, and the Kd value of its interaction with rabbit @PROTEIN2$, as determined by falling ball viscometry, was smaller (mean value 0.5 x 10(-6) M, as compared to 1.9 x 10(-6) M for bovine profilin).","label":0}
{"pair_id":"BioInfer.d339.s0.p3","sentence":"Inhibition of @PROTEIN1$ polymerization in KCl was stronger than that of the parental profilin, and the Kd value of its interaction with rabbit skeletal muscle actin, as determined by falling ball viscometry, was smaller (mean value 0.5 x 10(-6) M, as compared to 1.9 x 10(-6) M for bovine @PROTEIN2$).","label":0}
{"pair_id":"BioInfer.d339.s0.p4","sentence":"Inhibition of @PROTEIN1$ polymerization in KCl was stronger than that of the parental profilin, and the Kd value of its interaction with rabbit @PROTEIN2$, as determined by falling ball viscometry, was smaller (mean value 0.5 x 10(-6) M, as compared to 1.9 x 10(-6) M for bovine profilin).","label":0}
{"pair_id":"BioInfer.d339.s0.p5","sentence":"Inhibition of actin polymerization in KCl was stronger than that of the parental profilin, and the Kd value of its interaction with rabbit @PROTEIN2$, as determined by falling ball viscometry, was smaller (mean value 0.5 x 10(-6) M, as compared to 1.9 x 10(-6) M for bovine @PROTEIN1$).","label":1}
{"pair_id":"AIMed.d114.s961.p0","sentence":"@PROTEIN1$ binds to an alternatively spliced exon of @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d168.s1416.p0","sentence":"Substitution of phenylalanine at position 93 (Phe93) with alanine (F93A mutation) resulted in a drastic reduction in @PROTEIN1$ binding in the @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d647.s0.p0","sentence":"The most striking difference was in the relative preference for acetylation of histone @PROTEIN1$ versus acetylation of histone H3: with the purified acetylase, @PROTEIN2$ H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).","label":0}
{"pair_id":"BioInfer.d647.s0.p1","sentence":"The most striking difference was in the relative preference for acetylation of @PROTEIN2$ @PROTEIN1$ versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).","label":1}
{"pair_id":"BioInfer.d647.s0.p2","sentence":"The most striking difference was in the relative preference for acetylation of histone @PROTEIN1$ versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone @PROTEIN2$, whereas the reverse preference was found with the endogenous acetylase(s).","label":0}
{"pair_id":"BioInfer.d647.s0.p3","sentence":"The most striking difference was in the relative preference for acetylation of histone @PROTEIN1$ versus acetylation of histone @PROTEIN2$: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).","label":0}
{"pair_id":"BioInfer.d647.s0.p4","sentence":"The most striking difference was in the relative preference for acetylation of histone @PROTEIN1$ versus acetylation of histone H3: with the purified @PROTEIN2$, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).","label":0}
{"pair_id":"BioInfer.d647.s0.p5","sentence":"The most striking difference was in the relative preference for acetylation of histone @PROTEIN1$ versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d647.s0.p6","sentence":"The most striking difference was in the relative preference for acetylation of histone @PROTEIN1$ versus acetylation of @PROTEIN2$ H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).","label":0}
{"pair_id":"BioInfer.d647.s0.p7","sentence":"The most striking difference was in the relative preference for acetylation of histone @PROTEIN1$ versus acetylation of histone H3: with the purified acetylase, histone @PROTEIN2$ in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).","label":0}
{"pair_id":"BioInfer.d647.s0.p8","sentence":"The most striking difference was in the relative preference for acetylation of histone @PROTEIN1$ versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was @PROTEIN2$ H3, whereas the reverse preference was found with the endogenous acetylase(s).","label":0}
{"pair_id":"BioInfer.d647.s0.p9","sentence":"The most striking difference was in the relative preference for acetylation of @PROTEIN2$ H4 versus acetylation of histone H3: with the purified acetylase, @PROTEIN1$ H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).","label":0}
{"pair_id":"BioInfer.d647.s0.p10","sentence":"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, @PROTEIN1$ H4 in nucleosomes was acetylated to a much greater extent than was histone @PROTEIN2$, whereas the reverse preference was found with the endogenous acetylase(s).","label":0}
{"pair_id":"BioInfer.d647.s0.p11","sentence":"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone @PROTEIN2$: with the purified acetylase, @PROTEIN1$ H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).","label":0}
{"pair_id":"BioInfer.d647.s0.p12","sentence":"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified @PROTEIN2$, @PROTEIN1$ H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).","label":0}
{"pair_id":"BioInfer.d647.s0.p13","sentence":"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, @PROTEIN1$ H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d647.s0.p14","sentence":"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of @PROTEIN2$ H3: with the purified acetylase, @PROTEIN1$ H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).","label":0}
{"pair_id":"BioInfer.d647.s0.p15","sentence":"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, @PROTEIN1$ @PROTEIN2$ in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).","label":1}
{"pair_id":"BioInfer.d647.s0.p16","sentence":"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, @PROTEIN1$ H4 in nucleosomes was acetylated to a much greater extent than was @PROTEIN2$ H3, whereas the reverse preference was found with the endogenous acetylase(s).","label":0}
{"pair_id":"BioInfer.d647.s0.p17","sentence":"The most striking difference was in the relative preference for acetylation of @PROTEIN1$ H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone @PROTEIN2$, whereas the reverse preference was found with the endogenous acetylase(s).","label":0}
{"pair_id":"BioInfer.d647.s0.p18","sentence":"The most striking difference was in the relative preference for acetylation of @PROTEIN1$ H4 versus acetylation of histone @PROTEIN2$: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).","label":0}
{"pair_id":"BioInfer.d647.s0.p19","sentence":"The most striking difference was in the relative preference for acetylation of @PROTEIN1$ H4 versus acetylation of histone H3: with the purified @PROTEIN2$, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).","label":0}
{"pair_id":"BioInfer.d647.s0.p20","sentence":"The most striking difference was in the relative preference for acetylation of @PROTEIN1$ H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d647.s0.p21","sentence":"The most striking difference was in the relative preference for acetylation of @PROTEIN1$ H4 versus acetylation of @PROTEIN2$ H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).","label":0}
{"pair_id":"BioInfer.d647.s0.p22","sentence":"The most striking difference was in the relative preference for acetylation of @PROTEIN1$ H4 versus acetylation of histone H3: with the purified acetylase, histone @PROTEIN2$ in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).","label":0}
{"pair_id":"BioInfer.d647.s0.p23","sentence":"The most striking difference was in the relative preference for acetylation of @PROTEIN1$ H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was @PROTEIN2$ H3, whereas the reverse preference was found with the endogenous acetylase(s).","label":0}
{"pair_id":"BioInfer.d647.s0.p24","sentence":"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone @PROTEIN2$: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone @PROTEIN1$, whereas the reverse preference was found with the endogenous acetylase(s).","label":0}
{"pair_id":"BioInfer.d647.s0.p25","sentence":"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified @PROTEIN2$, histone H4 in nucleosomes was acetylated to a much greater extent than was histone @PROTEIN1$, whereas the reverse preference was found with the endogenous acetylase(s).","label":1}
{"pair_id":"BioInfer.d647.s0.p26","sentence":"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone @PROTEIN1$, whereas the reverse preference was found with the endogenous @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d647.s0.p27","sentence":"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of @PROTEIN2$ H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone @PROTEIN1$, whereas the reverse preference was found with the endogenous acetylase(s).","label":0}
{"pair_id":"BioInfer.d647.s0.p28","sentence":"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone @PROTEIN2$ in nucleosomes was acetylated to a much greater extent than was histone @PROTEIN1$, whereas the reverse preference was found with the endogenous acetylase(s).","label":0}
{"pair_id":"BioInfer.d647.s0.p29","sentence":"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was @PROTEIN2$ @PROTEIN1$, whereas the reverse preference was found with the endogenous acetylase(s).","label":1}
{"pair_id":"BioInfer.d647.s0.p30","sentence":"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone @PROTEIN1$: with the purified @PROTEIN2$, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).","label":0}
{"pair_id":"BioInfer.d647.s0.p31","sentence":"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone @PROTEIN1$: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d647.s0.p32","sentence":"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of @PROTEIN2$ @PROTEIN1$: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).","label":1}
{"pair_id":"BioInfer.d647.s0.p33","sentence":"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone @PROTEIN1$: with the purified acetylase, histone @PROTEIN2$ in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).","label":0}
{"pair_id":"BioInfer.d647.s0.p34","sentence":"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone @PROTEIN1$: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was @PROTEIN2$ H3, whereas the reverse preference was found with the endogenous acetylase(s).","label":0}
{"pair_id":"BioInfer.d647.s0.p35","sentence":"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified @PROTEIN1$, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d647.s0.p36","sentence":"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of @PROTEIN2$ H3: with the purified @PROTEIN1$, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).","label":0}
{"pair_id":"BioInfer.d647.s0.p37","sentence":"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified @PROTEIN1$, histone @PROTEIN2$ in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).","label":1}
{"pair_id":"BioInfer.d647.s0.p38","sentence":"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified @PROTEIN1$, histone H4 in nucleosomes was acetylated to a much greater extent than was @PROTEIN2$ H3, whereas the reverse preference was found with the endogenous acetylase(s).","label":0}
{"pair_id":"BioInfer.d647.s0.p39","sentence":"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of @PROTEIN2$ H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d647.s0.p40","sentence":"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone @PROTEIN2$ in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d647.s0.p41","sentence":"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was @PROTEIN2$ H3, whereas the reverse preference was found with the endogenous @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d647.s0.p42","sentence":"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of @PROTEIN1$ H3: with the purified acetylase, histone @PROTEIN2$ in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).","label":0}
{"pair_id":"BioInfer.d647.s0.p43","sentence":"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of @PROTEIN1$ H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was @PROTEIN2$ H3, whereas the reverse preference was found with the endogenous acetylase(s).","label":0}
{"pair_id":"BioInfer.d647.s0.p44","sentence":"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone @PROTEIN1$ in nucleosomes was acetylated to a much greater extent than was @PROTEIN2$ H3, whereas the reverse preference was found with the endogenous acetylase(s).","label":0}
{"pair_id":"AIMed.d213.s1846.p0","sentence":"In addition, previous work indicated that @PROTEIN1$ and @PROTEIN2$ might be involved in YY1-mediated repression.","label":0}
{"pair_id":"AIMed.d213.s1846.p1","sentence":"In addition, previous work indicated that @PROTEIN1$ and CBP might be involved in @PROTEIN2$-mediated repression.","label":0}
{"pair_id":"AIMed.d213.s1846.p2","sentence":"In addition, previous work indicated that p300 and @PROTEIN1$ might be involved in @PROTEIN2$-mediated repression.","label":0}
{"pair_id":"BioInfer.d14.s2.p0","sentence":"This effect is specific to @PROTEIN1$ and gelsolin because other cytoskeletal proteins such as tau or actin do not affect @PROTEIN2$ activity.","label":0}
{"pair_id":"BioInfer.d14.s2.p1","sentence":"This effect is specific to @PROTEIN1$ and gelsolin because other cytoskeletal proteins such as @PROTEIN2$ or actin do not affect PI 3-kinase activity.","label":0}
{"pair_id":"BioInfer.d14.s2.p2","sentence":"This effect is specific to @PROTEIN1$ and gelsolin because other cytoskeletal proteins such as tau or @PROTEIN2$ do not affect PI 3-kinase activity.","label":0}
{"pair_id":"BioInfer.d14.s2.p3","sentence":"This effect is specific to @PROTEIN1$ and @PROTEIN2$ because other cytoskeletal proteins such as tau or actin do not affect PI 3-kinase activity.","label":0}
{"pair_id":"BioInfer.d14.s2.p4","sentence":"This effect is specific to profilin and gelsolin because other cytoskeletal proteins such as @PROTEIN2$ or actin do not affect @PROTEIN1$ activity.","label":1}
{"pair_id":"BioInfer.d14.s2.p5","sentence":"This effect is specific to profilin and gelsolin because other cytoskeletal proteins such as tau or @PROTEIN2$ do not affect @PROTEIN1$ activity.","label":1}
{"pair_id":"BioInfer.d14.s2.p6","sentence":"This effect is specific to profilin and @PROTEIN2$ because other cytoskeletal proteins such as tau or actin do not affect @PROTEIN1$ activity.","label":0}
{"pair_id":"BioInfer.d14.s2.p7","sentence":"This effect is specific to profilin and gelsolin because other cytoskeletal proteins such as @PROTEIN1$ or @PROTEIN2$ do not affect PI 3-kinase activity.","label":0}
{"pair_id":"BioInfer.d14.s2.p8","sentence":"This effect is specific to profilin and @PROTEIN2$ because other cytoskeletal proteins such as @PROTEIN1$ or actin do not affect PI 3-kinase activity.","label":0}
{"pair_id":"BioInfer.d14.s2.p9","sentence":"This effect is specific to profilin and @PROTEIN2$ because other cytoskeletal proteins such as tau or @PROTEIN1$ do not affect PI 3-kinase activity.","label":0}
{"pair_id":"AIMed.d32.s273.p0","sentence":"Our results indicate that Phe93 and Phe205 are important for both @PROTEIN1$ and @PROTEIN2$ binding, Met150 is not important for EPO binding but is critical for EMP1 binding, and Thr151 is not important for binding either ligand.","label":0}
{"pair_id":"AIMed.d32.s273.p1","sentence":"Our results indicate that Phe93 and Phe205 are important for both @PROTEIN1$ and EMP1 binding, Met150 is not important for @PROTEIN2$ binding but is critical for EMP1 binding, and Thr151 is not important for binding either ligand.","label":0}
{"pair_id":"AIMed.d32.s273.p2","sentence":"Our results indicate that Phe93 and Phe205 are important for both @PROTEIN1$ and EMP1 binding, Met150 is not important for EPO binding but is critical for @PROTEIN2$ binding, and Thr151 is not important for binding either ligand.","label":0}
{"pair_id":"AIMed.d32.s273.p3","sentence":"Our results indicate that Phe93 and Phe205 are important for both EPO and @PROTEIN1$ binding, Met150 is not important for @PROTEIN2$ binding but is critical for EMP1 binding, and Thr151 is not important for binding either ligand.","label":0}
{"pair_id":"AIMed.d32.s273.p4","sentence":"Our results indicate that Phe93 and Phe205 are important for both EPO and @PROTEIN1$ binding, Met150 is not important for EPO binding but is critical for @PROTEIN2$ binding, and Thr151 is not important for binding either ligand.","label":0}
{"pair_id":"AIMed.d32.s273.p5","sentence":"Our results indicate that Phe93 and Phe205 are important for both EPO and EMP1 binding, Met150 is not important for @PROTEIN1$ binding but is critical for @PROTEIN2$ binding, and Thr151 is not important for binding either ligand.","label":0}
{"pair_id":"BioInfer.d334.s0.p0","sentence":"In extracts from mouse brain, @PROTEIN2$ and profilin II can form complexes with regulators of endocytosis, synaptic vesicle recycling and @PROTEIN1$ assembly.","label":0}
{"pair_id":"BioInfer.d334.s0.p1","sentence":"In extracts from mouse brain, profilin I and @PROTEIN2$ can form complexes with regulators of endocytosis, synaptic vesicle recycling and @PROTEIN1$ assembly.","label":0}
{"pair_id":"BioInfer.d334.s0.p2","sentence":"In extracts from mouse brain, @PROTEIN1$ and @PROTEIN2$ can form complexes with regulators of endocytosis, synaptic vesicle recycling and actin assembly.","label":0}
{"pair_id":"AIMed.d154.s1313.p0","sentence":"Somatic cell hybrids and fluorescent in situ hybridization were both used to determine their chromosomal locations: @PROTEIN1$ to chromosome 16q22-23 and @PROTEIN2$ to chromosome 20q11.2.","label":0}
{"pair_id":"BioInfer.d322.s0.p0","sentence":"In cell extracts, we found that complementary strand synthesis was inhibited by the @PROTEIN1$ p21(@PROTEIN2$\/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (Pol) DNA p in the conversion reaction.","label":1}
{"pair_id":"BioInfer.d322.s0.p1","sentence":"In cell extracts, we found that complementary strand synthesis was inhibited by the @PROTEIN1$ p21(WAF1\/CIP1) and rescued by the addition of @PROTEIN2$, arguing for the involvement of DNA polymerase (Pol) DNA p in the conversion reaction.","label":0}
{"pair_id":"BioInfer.d322.s0.p2","sentence":"In cell extracts, we found that complementary strand synthesis was inhibited by the @PROTEIN1$ p21(WAF1\/@PROTEIN2$) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (Pol) DNA p in the conversion reaction.","label":1}
{"pair_id":"BioInfer.d322.s0.p3","sentence":"In cell extracts, we found that complementary strand synthesis was inhibited by the @PROTEIN1$ @PROTEIN2$(WAF1\/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (Pol) DNA p in the conversion reaction.","label":1}
{"pair_id":"BioInfer.d322.s0.p4","sentence":"In cell extracts, we found that complementary strand synthesis was inhibited by the @PROTEIN1$ p21(WAF1\/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of @PROTEIN2$ (Pol) @PROTEIN2$ in the conversion reaction.","label":0}
{"pair_id":"BioInfer.d322.s0.p5","sentence":"In cell extracts, we found that complementary strand synthesis was inhibited by the @PROTEIN1$ p21(WAF1\/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (@PROTEIN2$) DNA p in the conversion reaction.","label":0}
{"pair_id":"BioInfer.d322.s0.p6","sentence":"In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(@PROTEIN1$\/CIP1) and rescued by the addition of @PROTEIN2$, arguing for the involvement of DNA polymerase (Pol) DNA p in the conversion reaction.","label":0}
{"pair_id":"BioInfer.d322.s0.p7","sentence":"In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(@PROTEIN1$\/@PROTEIN2$) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (Pol) DNA p in the conversion reaction.","label":0}
{"pair_id":"BioInfer.d322.s0.p8","sentence":"In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor @PROTEIN2$(@PROTEIN1$\/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (Pol) DNA p in the conversion reaction.","label":0}
{"pair_id":"BioInfer.d322.s0.p9","sentence":"In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(@PROTEIN1$\/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of @PROTEIN2$ (Pol) @PROTEIN2$ in the conversion reaction.","label":0}
{"pair_id":"BioInfer.d322.s0.p10","sentence":"In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(@PROTEIN1$\/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (@PROTEIN2$) DNA p in the conversion reaction.","label":0}
{"pair_id":"BioInfer.d322.s0.p11","sentence":"In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(WAF1\/@PROTEIN2$) and rescued by the addition of @PROTEIN1$, arguing for the involvement of DNA polymerase (Pol) DNA p in the conversion reaction.","label":0}
{"pair_id":"BioInfer.d322.s0.p12","sentence":"In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor @PROTEIN2$(WAF1\/CIP1) and rescued by the addition of @PROTEIN1$, arguing for the involvement of DNA polymerase (Pol) DNA p in the conversion reaction.","label":0}
{"pair_id":"BioInfer.d322.s0.p13","sentence":"In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(WAF1\/CIP1) and rescued by the addition of @PROTEIN1$, arguing for the involvement of @PROTEIN2$ (Pol) @PROTEIN2$ in the conversion reaction.","label":0}
{"pair_id":"BioInfer.d322.s0.p14","sentence":"In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(WAF1\/CIP1) and rescued by the addition of @PROTEIN1$, arguing for the involvement of DNA polymerase (@PROTEIN2$) DNA p in the conversion reaction.","label":0}
{"pair_id":"BioInfer.d322.s0.p15","sentence":"In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor @PROTEIN2$(WAF1\/@PROTEIN1$) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (Pol) DNA p in the conversion reaction.","label":0}
{"pair_id":"BioInfer.d322.s0.p16","sentence":"In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(WAF1\/@PROTEIN1$) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of @PROTEIN2$ (Pol) @PROTEIN2$ in the conversion reaction.","label":0}
{"pair_id":"BioInfer.d322.s0.p17","sentence":"In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(WAF1\/@PROTEIN1$) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (@PROTEIN2$) DNA p in the conversion reaction.","label":0}
{"pair_id":"BioInfer.d322.s0.p18","sentence":"In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor @PROTEIN1$(WAF1\/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of @PROTEIN2$ (Pol) @PROTEIN2$ in the conversion reaction.","label":0}
{"pair_id":"BioInfer.d322.s0.p19","sentence":"In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor @PROTEIN1$(WAF1\/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (@PROTEIN2$) DNA p in the conversion reaction.","label":0}
{"pair_id":"BioInfer.d322.s0.p20","sentence":"In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(WAF1\/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of @PROTEIN1$ (@PROTEIN2$) @PROTEIN1$ in the conversion reaction.","label":0}
{"pair_id":"BioInfer.d465.s0.p0","sentence":"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and @PROTEIN1$), the origin-binding protein (@PROTEIN2$), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.","label":1}
{"pair_id":"BioInfer.d465.s0.p1","sentence":"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and @PROTEIN1$), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (@PROTEIN2$) assemble together to initiate the process.","label":1}
{"pair_id":"BioInfer.d465.s0.p2","sentence":"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the @PROTEIN2$ components (UL5, UL8, and @PROTEIN1$), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.","label":1}
{"pair_id":"BioInfer.d465.s0.p3","sentence":"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and @PROTEIN1$), the origin-binding protein (UL9), and the viral @PROTEIN2$ (ICP8) assemble together to initiate the process.","label":1}
{"pair_id":"BioInfer.d465.s0.p4","sentence":"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (@PROTEIN2$, UL8, and @PROTEIN1$), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.","label":1}
{"pair_id":"BioInfer.d465.s0.p5","sentence":"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, @PROTEIN2$, and @PROTEIN1$), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.","label":1}
{"pair_id":"BioInfer.d465.s0.p6","sentence":"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and @PROTEIN1$), the @PROTEIN2$ (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.","label":1}
{"pair_id":"BioInfer.d465.s0.p7","sentence":"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the origin-binding protein (@PROTEIN1$), and the viral single-stranded DNA-binding protein (@PROTEIN2$) assemble together to initiate the process.","label":1}
{"pair_id":"BioInfer.d465.s0.p8","sentence":"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the @PROTEIN2$ components (UL5, UL8, and UL52), the origin-binding protein (@PROTEIN1$), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.","label":0}
{"pair_id":"BioInfer.d465.s0.p9","sentence":"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the origin-binding protein (@PROTEIN1$), and the viral @PROTEIN2$ (ICP8) assemble together to initiate the process.","label":1}
{"pair_id":"BioInfer.d465.s0.p10","sentence":"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (@PROTEIN2$, UL8, and UL52), the origin-binding protein (@PROTEIN1$), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.","label":1}
{"pair_id":"BioInfer.d465.s0.p11","sentence":"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, @PROTEIN2$, and UL52), the origin-binding protein (@PROTEIN1$), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.","label":1}
{"pair_id":"BioInfer.d465.s0.p12","sentence":"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the @PROTEIN2$ (@PROTEIN1$), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.","label":0}
{"pair_id":"BioInfer.d465.s0.p13","sentence":"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the @PROTEIN2$ components (UL5, UL8, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (@PROTEIN1$) assemble together to initiate the process.","label":0}
{"pair_id":"BioInfer.d465.s0.p14","sentence":"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the origin-binding protein (UL9), and the viral @PROTEIN2$ (@PROTEIN1$) assemble together to initiate the process.","label":0}
{"pair_id":"BioInfer.d465.s0.p15","sentence":"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (@PROTEIN2$, UL8, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (@PROTEIN1$) assemble together to initiate the process.","label":1}
{"pair_id":"BioInfer.d465.s0.p16","sentence":"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, @PROTEIN2$, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (@PROTEIN1$) assemble together to initiate the process.","label":1}
{"pair_id":"BioInfer.d465.s0.p17","sentence":"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the @PROTEIN2$ (UL9), and the viral single-stranded DNA-binding protein (@PROTEIN1$) assemble together to initiate the process.","label":1}
{"pair_id":"BioInfer.d465.s0.p18","sentence":"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the @PROTEIN1$ components (UL5, UL8, and UL52), the origin-binding protein (UL9), and the viral @PROTEIN2$ (ICP8) assemble together to initiate the process.","label":0}
{"pair_id":"BioInfer.d465.s0.p19","sentence":"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the @PROTEIN1$ components (@PROTEIN2$, UL8, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.","label":1}
{"pair_id":"BioInfer.d465.s0.p20","sentence":"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the @PROTEIN1$ components (UL5, @PROTEIN2$, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.","label":1}
{"pair_id":"BioInfer.d465.s0.p21","sentence":"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the @PROTEIN1$ components (UL5, UL8, and UL52), the @PROTEIN2$ (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.","label":0}
{"pair_id":"BioInfer.d465.s0.p22","sentence":"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (@PROTEIN2$, UL8, and UL52), the origin-binding protein (UL9), and the viral @PROTEIN1$ (ICP8) assemble together to initiate the process.","label":1}
{"pair_id":"BioInfer.d465.s0.p23","sentence":"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, @PROTEIN2$, and UL52), the origin-binding protein (UL9), and the viral @PROTEIN1$ (ICP8) assemble together to initiate the process.","label":1}
{"pair_id":"BioInfer.d465.s0.p24","sentence":"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the @PROTEIN2$ (UL9), and the viral @PROTEIN1$ (ICP8) assemble together to initiate the process.","label":1}
{"pair_id":"BioInfer.d465.s0.p25","sentence":"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (@PROTEIN1$, @PROTEIN2$, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.","label":1}
{"pair_id":"BioInfer.d465.s0.p26","sentence":"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (@PROTEIN1$, UL8, and UL52), the @PROTEIN2$ (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.","label":1}
{"pair_id":"BioInfer.d465.s0.p27","sentence":"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, @PROTEIN1$, and UL52), the @PROTEIN2$ (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.","label":1}
{"pair_id":"BioInfer.d283.s0.p0","sentence":"Human platelets contain @PROTEIN2$, a potential regulator of @PROTEIN1$ polymerisability.","label":1}
{"pair_id":"BioInfer.d530.s0.p0","sentence":"Sequence analysis of the genes encoding the @PROTEIN1$ and phosphoprotein (P) of phocid distemper virus, and editing of the @PROTEIN2$ gene transcript.","label":0}
{"pair_id":"BioInfer.d530.s0.p1","sentence":"Sequence analysis of the genes encoding the @PROTEIN1$ and @PROTEIN2$ (P) of phocid distemper virus, and editing of the P gene transcript.","label":0}
{"pair_id":"BioInfer.d530.s0.p2","sentence":"Sequence analysis of the genes encoding the @PROTEIN1$ and phosphoprotein (@PROTEIN2$) of phocid distemper virus, and editing of the P gene transcript.","label":0}
{"pair_id":"BioInfer.d530.s0.p3","sentence":"Sequence analysis of the genes encoding the nucleocapsid protein and @PROTEIN2$ (P) of phocid distemper virus, and editing of the @PROTEIN1$ gene transcript.","label":0}
{"pair_id":"BioInfer.d530.s0.p4","sentence":"Sequence analysis of the genes encoding the nucleocapsid protein and phosphoprotein (@PROTEIN2$) of phocid distemper virus, and editing of the @PROTEIN1$ gene transcript.","label":0}
{"pair_id":"BioInfer.d530.s0.p5","sentence":"Sequence analysis of the genes encoding the nucleocapsid protein and @PROTEIN1$ (@PROTEIN2$) of phocid distemper virus, and editing of the P gene transcript.","label":0}
{"pair_id":"AIMed.d99.s838.p0","sentence":"The cloned @PROTEIN1$ gene encodes a member of a protein family that includes the yeast @PROTEIN2$ protein, a component of the transcriptional regulator Swi\/Snf.","label":0}
{"pair_id":"AIMed.d99.s838.p1","sentence":"The cloned @PROTEIN1$ gene encodes a member of a protein family that includes the yeast Snf2 protein, a component of the transcriptional regulator @PROTEIN2$\/Snf.","label":0}
{"pair_id":"AIMed.d99.s838.p2","sentence":"The cloned @PROTEIN1$ gene encodes a member of a protein family that includes the yeast Snf2 protein, a component of the transcriptional regulator Swi\/@PROTEIN2$.","label":0}
{"pair_id":"AIMed.d99.s838.p3","sentence":"The cloned CSB gene encodes a member of a protein family that includes the yeast @PROTEIN1$ protein, a component of the transcriptional regulator @PROTEIN2$\/Snf.","label":0}
{"pair_id":"AIMed.d99.s838.p4","sentence":"The cloned CSB gene encodes a member of a protein family that includes the yeast @PROTEIN1$ protein, a component of the transcriptional regulator Swi\/@PROTEIN2$.","label":0}
{"pair_id":"AIMed.d99.s838.p5","sentence":"The cloned CSB gene encodes a member of a protein family that includes the yeast Snf2 protein, a component of the transcriptional regulator @PROTEIN1$\/@PROTEIN2$.","label":0}
{"pair_id":"AIMed.d47.s415.p0","sentence":"Here we report the crystal structure of human dimeric @PROTEIN1$ in complex with two high affinity @PROTEIN2$ extracellular domains(BRIAec).","label":0}
{"pair_id":"AIMed.d47.s415.p1","sentence":"Here we report the crystal structure of human dimeric @PROTEIN1$ in complex with two high affinity @PROTEIN2$s(BRIAec).","label":1}
{"pair_id":"AIMed.d47.s415.p2","sentence":"Here we report the crystal structure of human dimeric @PROTEIN1$ in complex with two high affinity BMP receptor IA extracellular domains(@PROTEIN2$).","label":1}
{"pair_id":"AIMed.d47.s415.p3","sentence":"Here we report the crystal structure of human dimeric BMP-2 in complex with two high affinity @PROTEIN1$@PROTEIN2$s(BRIAec).","label":0}
{"pair_id":"AIMed.d47.s415.p4","sentence":"Here we report the crystal structure of human dimeric BMP-2 in complex with two high affinity @PROTEIN1$ extracellular domains(@PROTEIN2$).","label":0}
{"pair_id":"AIMed.d47.s415.p5","sentence":"Here we report the crystal structure of human dimeric BMP-2 in complex with two high affinity @PROTEIN1$s(@PROTEIN2$).","label":0}
{"pair_id":"AIMed.d60.s530.p0","sentence":"These findings suggest that one function of @PROTEIN1$ in mitogenic signaling is to phosphorylate and activate @PROTEIN2$ kinase.","label":0}
{"pair_id":"AIMed.d60.s530.p1","sentence":"These findings suggest that one function of @PROTEIN1$ in mitogenic signaling is to phosphorylate and activate @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d60.s530.p2","sentence":"These findings suggest that one function of c-Raf-1 in mitogenic signaling is to phosphorylate and activate @PROTEIN1$@PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d294.s0.p0","sentence":"Immunohistochemistry for a variety of @PROTEIN1$@PROTEIN2$ (CKs) (@PROTEIN2$\/cy, @PROTEIN1$\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p1","sentence":"Immunohistochemistry for a variety of @PROTEIN1$ (CKs) (c\/cy, @PROTEIN1$\/cy, c, and cy), epithelial membrane antigen (EMA), @PROTEIN2$ protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p2","sentence":"Immunohistochemistry for a variety of @PROTEIN1$ (CKs) (c\/cy, @PROTEIN1$\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and @PROTEIN2$ was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p3","sentence":"Immunohistochemistry for a variety of @PROTEIN1$ (CKs) (c\/cy, @PROTEIN1$\/cy, c, and cy), epithelial membrane antigen (@PROTEIN2$), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p4","sentence":"Immunohistochemistry for a variety of @PROTEIN1$ (CKs) (c\/cy, @PROTEIN1$\/cy, c, and cy), @PROTEIN2$ (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p5","sentence":"Immunohistochemistry for a variety of @PROTEIN1$ (CKs) (c\/cy, @PROTEIN1$\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, @PROTEIN2$, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p6","sentence":"Immunohistochemistry for a variety of @PROTEIN1$ (CKs) (c\/cy, @PROTEIN1$\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, @PROTEIN2$ CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p7","sentence":"Immunohistochemistry for a variety of @PROTEIN1$ (CKs) (c\/cy, @PROTEIN1$\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, @PROTEIN2$, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p8","sentence":"Immunohistochemistry for a variety of @PROTEIN1$ (CKs) (c\/cy, @PROTEIN1$\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, @PROTEIN2$, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p9","sentence":"Immunohistochemistry for a variety of @PROTEIN1$ (CKs) (c\/cy, @PROTEIN1$\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin @PROTEIN2$, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p10","sentence":"Immunohistochemistry for a variety of @PROTEIN1$@PROTEIN2$ (CKs) (c\/cy, @PROTEIN1$\/cy, c, and @PROTEIN2$), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p11","sentence":"Immunohistochemistry for a variety of @PROTEIN1$@PROTEIN2$ (CKs) (c\/cy, @PROTEIN1$\/cy, @PROTEIN2$, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p12","sentence":"Immunohistochemistry for a variety of @PROTEIN1$ (CKs) (c\/cy, @PROTEIN1$\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, @PROTEIN2$, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p13","sentence":"Immunohistochemistry for a variety of @PROTEIN1$ (@PROTEIN2$) (c\/cy, @PROTEIN1$\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p14","sentence":"Immunohistochemistry for a variety of @PROTEIN1$@PROTEIN2$ (CKs) (c\/cy, @PROTEIN1$\/@PROTEIN2$, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":1}
{"pair_id":"BioInfer.d294.s0.p15","sentence":"Immunohistochemistry for a variety of @PROTEIN1$@PROTEIN2$ (CKs) (c\/@PROTEIN2$, @PROTEIN1$\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p16","sentence":"Immunohistochemistry for a variety of @PROTEIN1$ (CKs) (@PROTEIN1$\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), @PROTEIN2$ protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p17","sentence":"Immunohistochemistry for a variety of @PROTEIN1$ (CKs) (@PROTEIN1$\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and @PROTEIN2$ was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p18","sentence":"Immunohistochemistry for a variety of @PROTEIN1$ (CKs) (@PROTEIN1$\/cy, c\/cy, c, and cy), epithelial membrane antigen (@PROTEIN2$), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p19","sentence":"Immunohistochemistry for a variety of @PROTEIN1$ (CKs) (@PROTEIN1$\/cy, c\/cy, c, and cy), @PROTEIN2$ (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p20","sentence":"Immunohistochemistry for a variety of @PROTEIN1$ (CKs) (@PROTEIN1$\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, @PROTEIN2$, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p21","sentence":"Immunohistochemistry for a variety of @PROTEIN1$ (CKs) (@PROTEIN1$\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, @PROTEIN2$ CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p22","sentence":"Immunohistochemistry for a variety of @PROTEIN1$ (CKs) (@PROTEIN1$\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, @PROTEIN2$, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p23","sentence":"Immunohistochemistry for a variety of @PROTEIN1$ (CKs) (@PROTEIN1$\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, @PROTEIN2$, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p24","sentence":"Immunohistochemistry for a variety of @PROTEIN1$ (CKs) (@PROTEIN1$\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin @PROTEIN2$, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p25","sentence":"Immunohistochemistry for a variety of @PROTEIN1$@PROTEIN2$ (CKs) (@PROTEIN1$\/cy, c\/cy, c, and @PROTEIN2$), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p26","sentence":"Immunohistochemistry for a variety of @PROTEIN1$@PROTEIN2$ (CKs) (@PROTEIN1$\/cy, c\/cy, @PROTEIN2$, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p27","sentence":"Immunohistochemistry for a variety of @PROTEIN1$ (CKs) (@PROTEIN1$\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, @PROTEIN2$, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p28","sentence":"Immunohistochemistry for a variety of @PROTEIN1$ (@PROTEIN2$) (@PROTEIN1$\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p29","sentence":"Immunohistochemistry for a variety of @PROTEIN1$@PROTEIN2$ (CKs) (@PROTEIN1$\/cy, c\/@PROTEIN2$, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p30","sentence":"Immunohistochemistry for a variety of @PROTEIN1$@PROTEIN2$ (CKs) (@PROTEIN1$\/@PROTEIN2$, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":1}
{"pair_id":"BioInfer.d294.s0.p31","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), @PROTEIN1$ protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and @PROTEIN2$ was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p32","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (@PROTEIN2$), @PROTEIN1$ protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p33","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), @PROTEIN2$ (EMA), @PROTEIN1$ protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p34","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), @PROTEIN1$ protein, vimentin CD34, @PROTEIN2$, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p35","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), @PROTEIN1$ protein, @PROTEIN2$ CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p36","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), @PROTEIN1$ protein, vimentin CD34, type IV collagen, smooth muscle actin, @PROTEIN2$, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p37","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), @PROTEIN1$ protein, vimentin CD34, type IV collagen, @PROTEIN2$, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p38","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), @PROTEIN1$ protein, vimentin @PROTEIN2$, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p39","sentence":"Immunohistochemistry for a variety of @PROTEIN2$ (CKs) (c\/cy, c\/cy, c, and @PROTEIN2$), epithelial membrane antigen (EMA), @PROTEIN1$ protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p40","sentence":"Immunohistochemistry for a variety of @PROTEIN2$ (CKs) (c\/cy, c\/cy, @PROTEIN2$, and cy), epithelial membrane antigen (EMA), @PROTEIN1$ protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p41","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), @PROTEIN1$ protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, @PROTEIN2$, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p42","sentence":"Immunohistochemistry for a variety of cytokeratins (@PROTEIN2$) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), @PROTEIN1$ protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p43","sentence":"Immunohistochemistry for a variety of @PROTEIN2$ (CKs) (c\/cy, c\/@PROTEIN2$, c, and cy), epithelial membrane antigen (EMA), @PROTEIN1$ protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p44","sentence":"Immunohistochemistry for a variety of @PROTEIN2$ (CKs) (c\/@PROTEIN2$, c\/cy, c, and cy), epithelial membrane antigen (EMA), @PROTEIN1$ protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p45","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (@PROTEIN2$), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and @PROTEIN1$ was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p46","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), @PROTEIN2$ (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and @PROTEIN1$ was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p47","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, @PROTEIN2$, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and @PROTEIN1$ was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p48","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, @PROTEIN2$ CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and @PROTEIN1$ was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p49","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, @PROTEIN2$, calponin, and @PROTEIN1$ was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p50","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, @PROTEIN2$, smooth muscle myosin heavy chain, calponin, and @PROTEIN1$ was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p51","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin @PROTEIN2$, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and @PROTEIN1$ was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p52","sentence":"Immunohistochemistry for a variety of @PROTEIN2$ (CKs) (c\/cy, c\/cy, c, and @PROTEIN2$), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and @PROTEIN1$ was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p53","sentence":"Immunohistochemistry for a variety of @PROTEIN2$ (CKs) (c\/cy, c\/cy, @PROTEIN2$, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and @PROTEIN1$ was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p54","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, @PROTEIN2$, and @PROTEIN1$ was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p55","sentence":"Immunohistochemistry for a variety of cytokeratins (@PROTEIN2$) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and @PROTEIN1$ was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p56","sentence":"Immunohistochemistry for a variety of @PROTEIN2$ (CKs) (c\/cy, c\/@PROTEIN2$, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and @PROTEIN1$ was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p57","sentence":"Immunohistochemistry for a variety of @PROTEIN2$ (CKs) (c\/@PROTEIN2$, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and @PROTEIN1$ was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p58","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), @PROTEIN2$ (@PROTEIN1$), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p59","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (@PROTEIN1$), S-100 protein, vimentin CD34, @PROTEIN2$, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p60","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (@PROTEIN1$), S-100 protein, @PROTEIN2$ CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p61","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (@PROTEIN1$), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, @PROTEIN2$, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p62","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (@PROTEIN1$), S-100 protein, vimentin CD34, type IV collagen, @PROTEIN2$, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p63","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (@PROTEIN1$), S-100 protein, vimentin @PROTEIN2$, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p64","sentence":"Immunohistochemistry for a variety of @PROTEIN2$ (CKs) (c\/cy, c\/cy, c, and @PROTEIN2$), epithelial membrane antigen (@PROTEIN1$), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p65","sentence":"Immunohistochemistry for a variety of @PROTEIN2$ (CKs) (c\/cy, c\/cy, @PROTEIN2$, and cy), epithelial membrane antigen (@PROTEIN1$), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p66","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (@PROTEIN1$), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, @PROTEIN2$, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p67","sentence":"Immunohistochemistry for a variety of cytokeratins (@PROTEIN2$) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (@PROTEIN1$), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p68","sentence":"Immunohistochemistry for a variety of @PROTEIN2$ (CKs) (c\/cy, c\/@PROTEIN2$, c, and cy), epithelial membrane antigen (@PROTEIN1$), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p69","sentence":"Immunohistochemistry for a variety of @PROTEIN2$ (CKs) (c\/@PROTEIN2$, c\/cy, c, and cy), epithelial membrane antigen (@PROTEIN1$), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p70","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), @PROTEIN1$ (EMA), S-100 protein, vimentin CD34, @PROTEIN2$, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p71","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), @PROTEIN1$ (EMA), S-100 protein, @PROTEIN2$ CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p72","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), @PROTEIN1$ (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, @PROTEIN2$, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p73","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), @PROTEIN1$ (EMA), S-100 protein, vimentin CD34, type IV collagen, @PROTEIN2$, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p74","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), @PROTEIN1$ (EMA), S-100 protein, vimentin @PROTEIN2$, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p75","sentence":"Immunohistochemistry for a variety of @PROTEIN2$ (CKs) (c\/cy, c\/cy, c, and @PROTEIN2$), @PROTEIN1$ (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p76","sentence":"Immunohistochemistry for a variety of @PROTEIN2$ (CKs) (c\/cy, c\/cy, @PROTEIN2$, and cy), @PROTEIN1$ (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p77","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), @PROTEIN1$ (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, @PROTEIN2$, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p78","sentence":"Immunohistochemistry for a variety of cytokeratins (@PROTEIN2$) (c\/cy, c\/cy, c, and cy), @PROTEIN1$ (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p79","sentence":"Immunohistochemistry for a variety of @PROTEIN2$ (CKs) (c\/cy, c\/@PROTEIN2$, c, and cy), @PROTEIN1$ (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p80","sentence":"Immunohistochemistry for a variety of @PROTEIN2$ (CKs) (c\/@PROTEIN2$, c\/cy, c, and cy), @PROTEIN1$ (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p81","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, @PROTEIN2$ CD34, @PROTEIN1$, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p82","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, @PROTEIN1$, smooth muscle actin, @PROTEIN2$, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p83","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, @PROTEIN1$, @PROTEIN2$, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p84","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin @PROTEIN2$, @PROTEIN1$, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p85","sentence":"Immunohistochemistry for a variety of @PROTEIN2$ (CKs) (c\/cy, c\/cy, c, and @PROTEIN2$), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, @PROTEIN1$, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p86","sentence":"Immunohistochemistry for a variety of @PROTEIN2$ (CKs) (c\/cy, c\/cy, @PROTEIN2$, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, @PROTEIN1$, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p87","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, @PROTEIN1$, smooth muscle actin, smooth muscle myosin heavy chain, @PROTEIN2$, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p88","sentence":"Immunohistochemistry for a variety of cytokeratins (@PROTEIN2$) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, @PROTEIN1$, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p89","sentence":"Immunohistochemistry for a variety of @PROTEIN2$ (CKs) (c\/cy, c\/@PROTEIN2$, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, @PROTEIN1$, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p90","sentence":"Immunohistochemistry for a variety of @PROTEIN2$ (CKs) (c\/@PROTEIN2$, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, @PROTEIN1$, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p91","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, @PROTEIN1$ CD34, type IV collagen, smooth muscle actin, @PROTEIN2$, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p92","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, @PROTEIN1$ CD34, type IV collagen, @PROTEIN2$, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p93","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, @PROTEIN1$ @PROTEIN2$, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p94","sentence":"Immunohistochemistry for a variety of @PROTEIN2$ (CKs) (c\/cy, c\/cy, c, and @PROTEIN2$), epithelial membrane antigen (EMA), S-100 protein, @PROTEIN1$ CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p95","sentence":"Immunohistochemistry for a variety of @PROTEIN2$ (CKs) (c\/cy, c\/cy, @PROTEIN2$, and cy), epithelial membrane antigen (EMA), S-100 protein, @PROTEIN1$ CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p96","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, @PROTEIN1$ CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, @PROTEIN2$, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p97","sentence":"Immunohistochemistry for a variety of cytokeratins (@PROTEIN2$) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, @PROTEIN1$ CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p98","sentence":"Immunohistochemistry for a variety of @PROTEIN2$ (CKs) (c\/cy, c\/@PROTEIN2$, c, and cy), epithelial membrane antigen (EMA), S-100 protein, @PROTEIN1$ CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p99","sentence":"Immunohistochemistry for a variety of @PROTEIN2$ (CKs) (c\/@PROTEIN2$, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, @PROTEIN1$ CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p100","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, @PROTEIN2$, @PROTEIN1$, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p101","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin @PROTEIN2$, type IV collagen, smooth muscle actin, @PROTEIN1$, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p102","sentence":"Immunohistochemistry for a variety of @PROTEIN2$ (CKs) (c\/cy, c\/cy, c, and @PROTEIN2$), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, @PROTEIN1$, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p103","sentence":"Immunohistochemistry for a variety of @PROTEIN2$ (CKs) (c\/cy, c\/cy, @PROTEIN2$, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, @PROTEIN1$, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p104","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, @PROTEIN1$, @PROTEIN2$, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p105","sentence":"Immunohistochemistry for a variety of cytokeratins (@PROTEIN2$) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, @PROTEIN1$, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p106","sentence":"Immunohistochemistry for a variety of @PROTEIN2$ (CKs) (c\/cy, c\/@PROTEIN2$, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, @PROTEIN1$, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p107","sentence":"Immunohistochemistry for a variety of @PROTEIN2$ (CKs) (c\/@PROTEIN2$, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, @PROTEIN1$, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p108","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin @PROTEIN2$, type IV collagen, @PROTEIN1$, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p109","sentence":"Immunohistochemistry for a variety of @PROTEIN2$ (CKs) (c\/cy, c\/cy, c, and @PROTEIN2$), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, @PROTEIN1$, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p110","sentence":"Immunohistochemistry for a variety of @PROTEIN2$ (CKs) (c\/cy, c\/cy, @PROTEIN2$, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, @PROTEIN1$, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p111","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, @PROTEIN1$, smooth muscle myosin heavy chain, @PROTEIN2$, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p112","sentence":"Immunohistochemistry for a variety of cytokeratins (@PROTEIN2$) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, @PROTEIN1$, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p113","sentence":"Immunohistochemistry for a variety of @PROTEIN2$ (CKs) (c\/cy, c\/@PROTEIN2$, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, @PROTEIN1$, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p114","sentence":"Immunohistochemistry for a variety of @PROTEIN2$ (CKs) (c\/@PROTEIN2$, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, @PROTEIN1$, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p115","sentence":"Immunohistochemistry for a variety of @PROTEIN2$ (CKs) (c\/cy, c\/cy, c, and @PROTEIN2$), epithelial membrane antigen (EMA), S-100 protein, vimentin @PROTEIN1$, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p116","sentence":"Immunohistochemistry for a variety of @PROTEIN2$ (CKs) (c\/cy, c\/cy, @PROTEIN2$, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin @PROTEIN1$, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p117","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin @PROTEIN1$, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, @PROTEIN2$, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p118","sentence":"Immunohistochemistry for a variety of cytokeratins (@PROTEIN2$) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin @PROTEIN1$, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p119","sentence":"Immunohistochemistry for a variety of @PROTEIN2$ (CKs) (c\/cy, c\/@PROTEIN2$, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin @PROTEIN1$, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p120","sentence":"Immunohistochemistry for a variety of @PROTEIN2$ (CKs) (c\/@PROTEIN2$, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin @PROTEIN1$, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p121","sentence":"Immunohistochemistry for a variety of @PROTEIN1$@PROTEIN2$ (CKs) (c\/cy, c\/cy, @PROTEIN2$, and @PROTEIN1$), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p122","sentence":"Immunohistochemistry for a variety of @PROTEIN1$ (CKs) (c\/cy, c\/cy, c, and @PROTEIN1$), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, @PROTEIN2$, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p123","sentence":"Immunohistochemistry for a variety of @PROTEIN1$ (@PROTEIN2$) (c\/cy, c\/cy, c, and @PROTEIN1$), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p124","sentence":"Immunohistochemistry for a variety of @PROTEIN1$@PROTEIN2$ (CKs) (c\/cy, c\/@PROTEIN2$, c, and @PROTEIN1$), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p125","sentence":"Immunohistochemistry for a variety of @PROTEIN1$@PROTEIN2$ (CKs) (c\/@PROTEIN2$, c\/cy, c, and @PROTEIN1$), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p126","sentence":"Immunohistochemistry for a variety of @PROTEIN1$ (CKs) (c\/cy, c\/cy, @PROTEIN1$, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, @PROTEIN2$, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p127","sentence":"Immunohistochemistry for a variety of @PROTEIN1$ (@PROTEIN2$) (c\/cy, c\/cy, @PROTEIN1$, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p128","sentence":"Immunohistochemistry for a variety of @PROTEIN1$@PROTEIN2$ (CKs) (c\/cy, c\/@PROTEIN2$, @PROTEIN1$, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p129","sentence":"Immunohistochemistry for a variety of @PROTEIN1$@PROTEIN2$ (CKs) (c\/@PROTEIN2$, c\/cy, @PROTEIN1$, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p130","sentence":"Immunohistochemistry for a variety of cytokeratins (@PROTEIN2$) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, @PROTEIN1$, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p131","sentence":"Immunohistochemistry for a variety of @PROTEIN2$ (CKs) (c\/cy, c\/@PROTEIN2$, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, @PROTEIN1$, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p132","sentence":"Immunohistochemistry for a variety of @PROTEIN2$ (CKs) (c\/@PROTEIN2$, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, @PROTEIN1$, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p133","sentence":"Immunohistochemistry for a variety of @PROTEIN2$ (@PROTEIN1$) (c\/cy, c\/@PROTEIN2$, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p134","sentence":"Immunohistochemistry for a variety of @PROTEIN2$ (@PROTEIN1$) (c\/@PROTEIN2$, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p135","sentence":"Immunohistochemistry for a variety of @PROTEIN1$@PROTEIN2$ (CKs) (c\/@PROTEIN2$, c\/@PROTEIN1$, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d162.s0.p0","sentence":"Data is presented to suggest that the G1 @PROTEIN1$ and the cyclin-dependent kinase inhibitor @PROTEIN2$ may be involved in subversion of the G1\/S traverse by signaling pathways activated by HER-2 function.","label":0}
{"pair_id":"BioInfer.d162.s0.p1","sentence":"Data is presented to suggest that the G1 @PROTEIN1$ and the cyclin-dependent kinase inhibitor p27KIP1 may be involved in subversion of the G1\/S traverse by signaling pathways activated by @PROTEIN2$ function.","label":1}
{"pair_id":"BioInfer.d162.s0.p2","sentence":"Data is presented to suggest that the G1 @PROTEIN1$ and the @PROTEIN2$ p27KIP1 may be involved in subversion of the G1\/S traverse by signaling pathways activated by HER-2 function.","label":0}
{"pair_id":"BioInfer.d162.s0.p3","sentence":"Data is presented to suggest that the G1 cyclin D1 and the cyclin-dependent kinase inhibitor @PROTEIN1$ may be involved in subversion of the G1\/S traverse by signaling pathways activated by @PROTEIN2$ function.","label":1}
{"pair_id":"BioInfer.d162.s0.p4","sentence":"Data is presented to suggest that the G1 cyclin D1 and the @PROTEIN2$ @PROTEIN1$ may be involved in subversion of the G1\/S traverse by signaling pathways activated by HER-2 function.","label":1}
{"pair_id":"BioInfer.d162.s0.p5","sentence":"Data is presented to suggest that the G1 cyclin D1 and the @PROTEIN2$ p27KIP1 may be involved in subversion of the G1\/S traverse by signaling pathways activated by @PROTEIN1$ function.","label":0}
{"pair_id":"BioInfer.d731.s0.p0","sentence":"The vaccinia virus @PROTEIN1$ gene product, pE3, is a dsRNA binding protein that prevents activation of the interferon-induced, dsRNA-activated @PROTEIN2$, PKR.","label":0}
{"pair_id":"BioInfer.d731.s0.p1","sentence":"The vaccinia virus @PROTEIN1$ gene product, @PROTEIN2$, is a dsRNA binding protein that prevents activation of the interferon-induced, dsRNA-activated protein kinase, PKR.","label":0}
{"pair_id":"BioInfer.d731.s0.p2","sentence":"The vaccinia virus @PROTEIN1$ gene product, pE3, is a dsRNA binding protein that prevents activation of the @PROTEIN2$-induced, dsRNA-activated protein kinase, PKR.","label":0}
{"pair_id":"BioInfer.d731.s0.p3","sentence":"The vaccinia virus @PROTEIN1$ gene product, pE3, is a dsRNA binding protein that prevents activation of the interferon-induced, dsRNA-activated protein kinase, @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d731.s0.p4","sentence":"The vaccinia virus E3L gene product, @PROTEIN2$, is a dsRNA binding protein that prevents activation of the interferon-induced, dsRNA-activated @PROTEIN1$, PKR.","label":0}
{"pair_id":"BioInfer.d731.s0.p5","sentence":"The vaccinia virus E3L gene product, pE3, is a dsRNA binding protein that prevents activation of the @PROTEIN2$-induced, dsRNA-activated @PROTEIN1$, PKR.","label":0}
{"pair_id":"BioInfer.d731.s0.p6","sentence":"The vaccinia virus E3L gene product, pE3, is a dsRNA binding protein that prevents activation of the interferon-induced, dsRNA-activated @PROTEIN1$, @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d731.s0.p7","sentence":"The vaccinia virus E3L gene product, @PROTEIN1$, is a dsRNA binding protein that prevents activation of the @PROTEIN2$-induced, dsRNA-activated protein kinase, PKR.","label":0}
{"pair_id":"BioInfer.d731.s0.p8","sentence":"The vaccinia virus E3L gene product, @PROTEIN1$, is a dsRNA binding protein that prevents activation of the interferon-induced, dsRNA-activated protein kinase, @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d731.s0.p9","sentence":"The vaccinia virus E3L gene product, pE3, is a dsRNA binding protein that prevents activation of the @PROTEIN1$-induced, dsRNA-activated protein kinase, @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d57.s509.p0","sentence":"As previously shown with reticulocyte lysate-reconstituted steroid receptor heteroprotein complexes, the reconstituted @PROTEIN1$ multiprotein complex contains @PROTEIN2$, which is a major candidate for providing the protein unfoldase activity required for hsp90 association.","label":1}
{"pair_id":"AIMed.d57.s509.p1","sentence":"As previously shown with reticulocyte lysate-reconstituted steroid receptor heteroprotein complexes, the reconstituted @PROTEIN1$ multiprotein complex contains hsp70, which is a major candidate for providing the protein unfoldase activity required for @PROTEIN2$ association.","label":0}
{"pair_id":"AIMed.d57.s509.p2","sentence":"As previously shown with reticulocyte lysate-reconstituted steroid receptor heteroprotein complexes, the reconstituted pp60src multiprotein complex contains @PROTEIN1$, which is a major candidate for providing the protein unfoldase activity required for @PROTEIN2$ association.","label":0}
{"pair_id":"AIMed.d41.s357.p0","sentence":"The structures of @PROTEIN1$ alone and complexed with @PROTEIN2$ differ in their domain arrangement and dimer interfaces, providing a mechanism for communicating binding events between TfR chains.","label":1}
{"pair_id":"AIMed.d41.s357.p1","sentence":"The structures of @PROTEIN1$ alone and complexed with HFE differ in their domain arrangement and dimer interfaces, providing a mechanism for communicating binding events between @PROTEIN2$ chains.","label":0}
{"pair_id":"AIMed.d41.s357.p2","sentence":"The structures of TfR alone and complexed with @PROTEIN1$ differ in their domain arrangement and dimer interfaces, providing a mechanism for communicating binding events between @PROTEIN2$ chains.","label":0}
{"pair_id":"BioInfer.d49.s4.p0","sentence":"When barbed ends are capped, @PROTEIN1$ simply sequesters globular @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d135.s1148.p0","sentence":"The cell surface form of @PROTEIN1$ is assembled during biosynthesis as a heteromeric complex with @PROTEIN2$ (LT-beta), a type II transmembrane protein that is another member of the TNF ligand family.","label":1}
{"pair_id":"AIMed.d135.s1148.p1","sentence":"The cell surface form of @PROTEIN1$ is assembled during biosynthesis as a heteromeric complex with lymphotoxin-beta (@PROTEIN2$), a type II transmembrane protein that is another member of the TNF ligand family.","label":1}
{"pair_id":"AIMed.d135.s1148.p2","sentence":"The cell surface form of LT-alpha is assembled during biosynthesis as a heteromeric complex with @PROTEIN1$ (@PROTEIN2$), a type II transmembrane protein that is another member of the TNF ligand family.","label":0}
{"pair_id":"AIMed.d39.s335.p0","sentence":"@PROTEIN1$ (@PROTEIN2$) is the causative gene for an autosomal dominant familial Alzheimer's disease (AD) mapped to chromosome 14.","label":0}
{"pair_id":"AIMed.d112.s948.p0","sentence":"This @PROTEIN1$-@PROTEIN2$ interaction may be dependent on the stage of B-cell differentiation, since Syk-Lyn associations were not detected in pre-B and myeloma cell lines and Syk from an immature B-cell line did not reassociate with Lyn in vitro.","label":1}
{"pair_id":"AIMed.d112.s948.p1","sentence":"This @PROTEIN1$-Lyn interaction may be dependent on the stage of B-cell differentiation, since @PROTEIN2$-Lyn associations were not detected in pre-B and myeloma cell lines and Syk from an immature B-cell line did not reassociate with Lyn in vitro.","label":0}
{"pair_id":"AIMed.d112.s948.p2","sentence":"This @PROTEIN1$-Lyn interaction may be dependent on the stage of B-cell differentiation, since Syk-@PROTEIN2$ associations were not detected in pre-B and myeloma cell lines and Syk from an immature B-cell line did not reassociate with Lyn in vitro.","label":0}
{"pair_id":"AIMed.d112.s948.p3","sentence":"This @PROTEIN1$-Lyn interaction may be dependent on the stage of B-cell differentiation, since Syk-Lyn associations were not detected in pre-B and myeloma cell lines and @PROTEIN2$ from an immature B-cell line did not reassociate with Lyn in vitro.","label":0}
{"pair_id":"AIMed.d112.s948.p4","sentence":"This @PROTEIN1$-Lyn interaction may be dependent on the stage of B-cell differentiation, since Syk-Lyn associations were not detected in pre-B and myeloma cell lines and Syk from an immature B-cell line did not reassociate with @PROTEIN2$ in vitro.","label":0}
{"pair_id":"AIMed.d112.s948.p5","sentence":"This Syk-@PROTEIN1$ interaction may be dependent on the stage of B-cell differentiation, since @PROTEIN2$-Lyn associations were not detected in pre-B and myeloma cell lines and Syk from an immature B-cell line did not reassociate with Lyn in vitro.","label":0}
{"pair_id":"AIMed.d112.s948.p6","sentence":"This Syk-@PROTEIN1$ interaction may be dependent on the stage of B-cell differentiation, since Syk-@PROTEIN2$ associations were not detected in pre-B and myeloma cell lines and Syk from an immature B-cell line did not reassociate with Lyn in vitro.","label":0}
{"pair_id":"AIMed.d112.s948.p7","sentence":"This Syk-@PROTEIN1$ interaction may be dependent on the stage of B-cell differentiation, since Syk-Lyn associations were not detected in pre-B and myeloma cell lines and @PROTEIN2$ from an immature B-cell line did not reassociate with Lyn in vitro.","label":0}
{"pair_id":"AIMed.d112.s948.p8","sentence":"This Syk-@PROTEIN1$ interaction may be dependent on the stage of B-cell differentiation, since Syk-Lyn associations were not detected in pre-B and myeloma cell lines and Syk from an immature B-cell line did not reassociate with @PROTEIN2$ in vitro.","label":0}
{"pair_id":"AIMed.d112.s948.p9","sentence":"This Syk-Lyn interaction may be dependent on the stage of B-cell differentiation, since @PROTEIN1$-@PROTEIN2$ associations were not detected in pre-B and myeloma cell lines and Syk from an immature B-cell line did not reassociate with Lyn in vitro.","label":1}
{"pair_id":"AIMed.d112.s948.p10","sentence":"This Syk-Lyn interaction may be dependent on the stage of B-cell differentiation, since @PROTEIN1$-Lyn associations were not detected in pre-B and myeloma cell lines and @PROTEIN2$ from an immature B-cell line did not reassociate with Lyn in vitro.","label":0}
{"pair_id":"AIMed.d112.s948.p11","sentence":"This Syk-Lyn interaction may be dependent on the stage of B-cell differentiation, since @PROTEIN1$-Lyn associations were not detected in pre-B and myeloma cell lines and Syk from an immature B-cell line did not reassociate with @PROTEIN2$ in vitro.","label":0}
{"pair_id":"AIMed.d112.s948.p12","sentence":"This Syk-Lyn interaction may be dependent on the stage of B-cell differentiation, since Syk-@PROTEIN1$ associations were not detected in pre-B and myeloma cell lines and @PROTEIN2$ from an immature B-cell line did not reassociate with Lyn in vitro.","label":0}
{"pair_id":"AIMed.d112.s948.p13","sentence":"This Syk-Lyn interaction may be dependent on the stage of B-cell differentiation, since Syk-@PROTEIN1$ associations were not detected in pre-B and myeloma cell lines and Syk from an immature B-cell line did not reassociate with @PROTEIN2$ in vitro.","label":0}
{"pair_id":"AIMed.d112.s948.p14","sentence":"This Syk-Lyn interaction may be dependent on the stage of B-cell differentiation, since Syk-Lyn associations were not detected in pre-B and myeloma cell lines and @PROTEIN1$ from an immature B-cell line did not reassociate with @PROTEIN2$ in vitro.","label":0}
{"pair_id":"AIMed.d97.s821.p0","sentence":"In transfected COS-1 cells, @PROTEIN1$\/@PROTEIN2$, and less efficiently BMP-4, bound to BMPR-II.","label":0}
{"pair_id":"AIMed.d97.s821.p1","sentence":"In transfected COS-1 cells, @PROTEIN1$\/BMP-7, and less efficiently @PROTEIN2$, bound to BMPR-II.","label":0}
{"pair_id":"AIMed.d97.s821.p2","sentence":"In transfected COS-1 cells, @PROTEIN1$\/BMP-7, and less efficiently BMP-4, bound to @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d97.s821.p3","sentence":"In transfected COS-1 cells, osteogenic protein (OP)-1\/@PROTEIN1$, and less efficiently @PROTEIN2$, bound to BMPR-II.","label":0}
{"pair_id":"AIMed.d97.s821.p4","sentence":"In transfected COS-1 cells, osteogenic protein (OP)-1\/@PROTEIN1$, and less efficiently BMP-4, bound to @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d97.s821.p5","sentence":"In transfected COS-1 cells, osteogenic protein (OP)-1\/BMP-7, and less efficiently @PROTEIN1$, bound to @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d207.s1796.p0","sentence":"Our data indicate that, in differentiating myocytes, one mechanism through which @PROTEIN1$ induces permanent cell cycle arrest involves @PROTEIN2$ upregulation and suppression of the proliferation-associated cdks-containing E2F complexes formation.","label":0}
{"pair_id":"AIMed.d207.s1796.p1","sentence":"Our data indicate that, in differentiating myocytes, one mechanism through which @PROTEIN1$ induces permanent cell cycle arrest involves p21 upregulation and suppression of the proliferation-associated cdks-containing @PROTEIN2$ complexes formation.","label":0}
{"pair_id":"AIMed.d207.s1796.p2","sentence":"Our data indicate that, in differentiating myocytes, one mechanism through which MyoD induces permanent cell cycle arrest involves @PROTEIN1$ upregulation and suppression of the proliferation-associated cdks-containing @PROTEIN2$ complexes formation.","label":0}
{"pair_id":"BioInfer.d122.s1.p0","sentence":"Our results provide support for both physical and functional interactions between three subunits, TIF34, @PROTEIN1$ and @PROTEIN2$, in the eIF3 complex.","label":1}
{"pair_id":"BioInfer.d122.s1.p1","sentence":"Our results provide support for both physical and functional interactions between three subunits, TIF34, @PROTEIN1$ and p33, in the @PROTEIN2$ complex.","label":1}
{"pair_id":"BioInfer.d122.s1.p2","sentence":"Our results provide support for both physical and functional interactions between three subunits, @PROTEIN2$, @PROTEIN1$ and p33, in the eIF3 complex.","label":1}
{"pair_id":"BioInfer.d122.s1.p3","sentence":"Our results provide support for both physical and functional interactions between three subunits, TIF34, PRT1 and @PROTEIN1$, in the @PROTEIN2$ complex.","label":1}
{"pair_id":"BioInfer.d122.s1.p4","sentence":"Our results provide support for both physical and functional interactions between three subunits, @PROTEIN2$, PRT1 and @PROTEIN1$, in the eIF3 complex.","label":1}
{"pair_id":"BioInfer.d122.s1.p5","sentence":"Our results provide support for both physical and functional interactions between three subunits, @PROTEIN2$, PRT1 and p33, in the @PROTEIN1$ complex.","label":1}
{"pair_id":"AIMed.d164.s1382.p0","sentence":"In vitro protein-RNA interaction studies with pre-mRNAs containing either a constitutive or regulated splicing enhancer revealed that @PROTEIN1$ directly mediates interactions between @PROTEIN2$ and proteins bound to the enhancers.","label":0}
{"pair_id":"AIMed.d162.s1367.p0","sentence":"We found that the human @PROTEIN1$ (@PROTEIN2$) physically interacted with p53 via its DNA binding domain.","label":0}
{"pair_id":"AIMed.d162.s1367.p1","sentence":"We found that the human @PROTEIN1$ (h-TR beta 1) physically interacted with @PROTEIN2$ via its DNA binding domain.","label":1}
{"pair_id":"AIMed.d162.s1367.p2","sentence":"We found that the human TR subtype beta 1 (@PROTEIN1$) physically interacted with @PROTEIN2$ via its DNA binding domain.","label":1}
{"pair_id":"AIMed.d137.s1161.p0","sentence":"We show that the POU homeodomain of @PROTEIN1$ and the evolutionarily conserved C-terminal core domain of @PROTEIN2$ are both required and sufficient for the interaction.","label":1}
{"pair_id":"AIMed.d110.s926.p0","sentence":"The cloning of a complementary DNA encoding a human @PROTEIN1$ TAF, @PROTEIN2$, that has no known homolog in Drosophila TFIID is now described.","label":0}
{"pair_id":"AIMed.d110.s926.p1","sentence":"The cloning of a complementary DNA encoding a human @PROTEIN1$ TAF, TAFII55, that has no known homolog in Drosophila @PROTEIN2$ is now described.","label":0}
{"pair_id":"AIMed.d110.s926.p2","sentence":"The cloning of a complementary DNA encoding a human TFIID TAF, @PROTEIN1$, that has no known homolog in Drosophila @PROTEIN2$ is now described.","label":0}
{"pair_id":"BioInfer.d549.s0.p0","sentence":"Spontaneous and mitomycin C-induced SCE levels were significantly reduced for chicken DT40 B cells lacking the key HR genes @PROTEIN1$ and @PROTEIN2$ but not for nonhomologous DNA end-joining (NHEJ)-defective KU70(-\/-) cells.","label":0}
{"pair_id":"BioInfer.d728.s0.p0","sentence":"The two cardiac myosin heavy chain isoforms, cardi and card, differ functionally, alpha Myosin exhibits higher actin-activated @PROTEIN1$ than does @PROTEIN2$, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.","label":1}
{"pair_id":"BioInfer.d728.s0.p1","sentence":"The two cardiac myosin heavy chain isoforms, cardi and card, differ functionally, @PROTEIN2$ exhibits higher actin-activated @PROTEIN1$ than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.","label":1}
{"pair_id":"BioInfer.d728.s0.p2","sentence":"The two cardiac myosin heavy chain isoforms, cardi and card, differ functionally, alpha Myosin exhibits higher actin-activated @PROTEIN1$ than does beta myosin, and hearts expressing @PROTEIN2$ exhibit increased contractility relative to hearts expressing beta myosin.","label":0}
{"pair_id":"BioInfer.d728.s0.p3","sentence":"The two cardiac myosin heavy chain isoforms, cardi and card, differ functionally, alpha Myosin exhibits higher actin-activated @PROTEIN1$ than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d728.s0.p4","sentence":"The two @PROTEIN2$ isoforms, @PROTEIN2$ and card, differ functionally, alpha Myosin exhibits higher actin-activated @PROTEIN1$ than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.","label":0}
{"pair_id":"BioInfer.d728.s0.p5","sentence":"The two cardiac myosin heavy chain isoforms, cardi and card, differ functionally, alpha Myosin exhibits higher @PROTEIN2$-activated @PROTEIN1$ than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.","label":1}
{"pair_id":"BioInfer.d728.s0.p6","sentence":"The two @PROTEIN2$ isoforms, cardi and @PROTEIN2$, differ functionally, alpha Myosin exhibits higher actin-activated @PROTEIN1$ than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.","label":0}
{"pair_id":"BioInfer.d728.s0.p7","sentence":"The two cardiac myosin heavy chain isoforms, cardi and card, differ functionally, @PROTEIN2$ exhibits higher actin-activated ATPase than does @PROTEIN1$, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.","label":0}
{"pair_id":"BioInfer.d728.s0.p8","sentence":"The two cardiac myosin heavy chain isoforms, cardi and card, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does @PROTEIN1$, and hearts expressing @PROTEIN2$ exhibit increased contractility relative to hearts expressing beta myosin.","label":0}
{"pair_id":"BioInfer.d728.s0.p9","sentence":"The two cardiac myosin heavy chain isoforms, cardi and card, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does @PROTEIN1$, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d728.s0.p10","sentence":"The two @PROTEIN2$ isoforms, @PROTEIN2$ and card, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does @PROTEIN1$, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.","label":0}
{"pair_id":"BioInfer.d728.s0.p11","sentence":"The two cardiac myosin heavy chain isoforms, cardi and card, differ functionally, alpha Myosin exhibits higher @PROTEIN2$-activated ATPase than does @PROTEIN1$, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.","label":0}
{"pair_id":"BioInfer.d728.s0.p12","sentence":"The two @PROTEIN2$ isoforms, cardi and @PROTEIN2$, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does @PROTEIN1$, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.","label":0}
{"pair_id":"BioInfer.d728.s0.p13","sentence":"The two cardiac myosin heavy chain isoforms, cardi and card, differ functionally, @PROTEIN1$ exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing @PROTEIN2$ exhibit increased contractility relative to hearts expressing beta myosin.","label":0}
{"pair_id":"BioInfer.d728.s0.p14","sentence":"The two cardiac myosin heavy chain isoforms, cardi and card, differ functionally, @PROTEIN1$ exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d728.s0.p15","sentence":"The two @PROTEIN2$ isoforms, @PROTEIN2$ and card, differ functionally, @PROTEIN1$ exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.","label":0}
{"pair_id":"BioInfer.d728.s0.p16","sentence":"The two cardiac myosin heavy chain isoforms, cardi and card, differ functionally, @PROTEIN1$ exhibits higher @PROTEIN2$-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.","label":0}
{"pair_id":"BioInfer.d728.s0.p17","sentence":"The two @PROTEIN2$ isoforms, cardi and @PROTEIN2$, differ functionally, @PROTEIN1$ exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.","label":0}
{"pair_id":"BioInfer.d728.s0.p18","sentence":"The two cardiac myosin heavy chain isoforms, cardi and card, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing @PROTEIN1$ exhibit increased contractility relative to hearts expressing @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d728.s0.p19","sentence":"The two @PROTEIN2$ isoforms, @PROTEIN2$ and card, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing @PROTEIN1$ exhibit increased contractility relative to hearts expressing beta myosin.","label":0}
{"pair_id":"BioInfer.d728.s0.p20","sentence":"The two cardiac myosin heavy chain isoforms, cardi and card, differ functionally, alpha Myosin exhibits higher @PROTEIN2$-activated ATPase than does beta myosin, and hearts expressing @PROTEIN1$ exhibit increased contractility relative to hearts expressing beta myosin.","label":0}
{"pair_id":"BioInfer.d728.s0.p21","sentence":"The two @PROTEIN2$ isoforms, cardi and @PROTEIN2$, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing @PROTEIN1$ exhibit increased contractility relative to hearts expressing beta myosin.","label":0}
{"pair_id":"BioInfer.d728.s0.p22","sentence":"The two @PROTEIN2$ isoforms, @PROTEIN2$ and card, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d728.s0.p23","sentence":"The two cardiac myosin heavy chain isoforms, cardi and card, differ functionally, alpha Myosin exhibits higher @PROTEIN2$-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d728.s0.p24","sentence":"The two @PROTEIN2$ isoforms, cardi and @PROTEIN2$, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d728.s0.p25","sentence":"The two @PROTEIN1$ isoforms, @PROTEIN1$ and card, differ functionally, alpha Myosin exhibits higher @PROTEIN2$-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.","label":0}
{"pair_id":"BioInfer.d728.s0.p26","sentence":"The two @PROTEIN1$@PROTEIN2$ isoforms, @PROTEIN1$ and @PROTEIN2$, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.","label":1}
{"pair_id":"BioInfer.d728.s0.p27","sentence":"The two @PROTEIN2$ isoforms, cardi and @PROTEIN2$, differ functionally, alpha Myosin exhibits higher @PROTEIN1$-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.","label":0}
{"pair_id":"BioInfer.d246.s2.p0","sentence":"Phosphorylation by LIM-kinase 1 inactivates @PROTEIN2$, leading to accumulation of @PROTEIN1$ filaments.","label":1}
{"pair_id":"BioInfer.d246.s2.p1","sentence":"Phosphorylation by @PROTEIN2$ inactivates cofilin, leading to accumulation of @PROTEIN1$ filaments.","label":1}
{"pair_id":"BioInfer.d246.s2.p2","sentence":"Phosphorylation by @PROTEIN2$ inactivates @PROTEIN1$, leading to accumulation of actin filaments.","label":1}
{"pair_id":"AIMed.d143.s1210.p0","sentence":"These findings imply that @PROTEIN1$ and @PROTEIN2$ share similar early signaling events with the possibility of using the same signal transducer, gp130.","label":0}
{"pair_id":"AIMed.d143.s1210.p1","sentence":"These findings imply that @PROTEIN1$ and IL-6 share similar early signaling events with the possibility of using the same signal transducer, @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d143.s1210.p2","sentence":"These findings imply that IL-11 and @PROTEIN1$ share similar early signaling events with the possibility of using the same signal transducer, @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d8.s63.p0","sentence":"These cell lines showed mutations in @PROTEIN1$ and @PROTEIN2$ at frequencies of 91% and 95%, respectively.","label":0}
{"pair_id":"BioInfer.d202.s0.p0","sentence":"Expression of @PROTEIN2$ was generally weak and did not correlate with the expression of either beta-catenin or @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d202.s0.p1","sentence":"Expression of alpha-catenin was generally weak and did not correlate with the expression of either @PROTEIN2$ or @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d202.s0.p2","sentence":"Expression of @PROTEIN1$ was generally weak and did not correlate with the expression of either @PROTEIN2$ or E-cadherin.","label":1}
{"pair_id":"AIMed.d83.s707.p0","sentence":"Superposition of the @PROTEIN1$ and growth hormone structures showed that the location of these epitopes on @PROTEIN2$ is analogous to the location of the first and second receptor epitopes on the surface of growth hormone.","label":0}
{"pair_id":"BioInfer.d1.s3.p0","sentence":"In viscometric assays, the birch protein was seen to modulate @PROTEIN1$ filament formation analogous to animal @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d224.s0.p0","sentence":"Furthermore, this inactivating effect of @PROTEIN1$ can be prevented by coexpressing a region of the cytoskeletal protein @PROTEIN2$ known to interact with the CO region of NR1.","label":1}
{"pair_id":"BioInfer.d224.s0.p1","sentence":"Furthermore, this inactivating effect of @PROTEIN1$ can be prevented by coexpressing a region of the cytoskeletal protein alpha-actinin2 known to interact with the CO region of @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d224.s0.p2","sentence":"Furthermore, this inactivating effect of calmodulin can be prevented by coexpressing a region of the cytoskeletal protein @PROTEIN1$ known to interact with the CO region of @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d89.s761.p0","sentence":"Immunoprecipitation experiments employing a polyclonal anti-@PROTEIN1$ antibody provided further evidence that the 60-kDa protein isolated in this study was @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d104.s881.p0","sentence":"Here we demonstrate that DP is also a family of polypeptides with at least two members (@PROTEIN1$ and @PROTEIN2$).","label":0}
{"pair_id":"BioInfer.d36.s0.p0","sentence":"A LIMK2 mutant with replacement of threonine 505 by valine abolished LIMK2 activities for cofilin phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the @PROTEIN1$ activity and stress fiber formation by @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d36.s0.p1","sentence":"A LIMK2 mutant with replacement of threonine 505 by valine abolished LIMK2 activities for @PROTEIN2$ phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the @PROTEIN1$ activity and stress fiber formation by LIMK2.","label":0}
{"pair_id":"BioInfer.d36.s0.p2","sentence":"A @PROTEIN2$ mutant with replacement of threonine 505 by valine abolished LIMK2 activities for cofilin phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the @PROTEIN1$ activity and stress fiber formation by LIMK2.","label":0}
{"pair_id":"BioInfer.d36.s0.p3","sentence":"A LIMK2 mutant with replacement of threonine 505 by valine abolished LIMK2 activities for cofilin phosphorylation and @PROTEIN2$ cytoskeletal changes, whereas replacement by glutamate enhanced the @PROTEIN1$ activity and stress fiber formation by LIMK2.","label":0}
{"pair_id":"BioInfer.d36.s0.p4","sentence":"A LIMK2 mutant with replacement of threonine 505 by valine abolished @PROTEIN2$ activities for cofilin phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the @PROTEIN1$ activity and stress fiber formation by LIMK2.","label":0}
{"pair_id":"BioInfer.d36.s0.p5","sentence":"A LIMK2 mutant with replacement of threonine 505 by valine abolished LIMK2 activities for @PROTEIN2$ phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d36.s0.p6","sentence":"A @PROTEIN2$ mutant with replacement of threonine 505 by valine abolished LIMK2 activities for cofilin phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d36.s0.p7","sentence":"A LIMK2 mutant with replacement of threonine 505 by valine abolished LIMK2 activities for cofilin phosphorylation and @PROTEIN2$ cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d36.s0.p8","sentence":"A LIMK2 mutant with replacement of threonine 505 by valine abolished @PROTEIN2$ activities for cofilin phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d36.s0.p9","sentence":"A @PROTEIN2$ mutant with replacement of threonine 505 by valine abolished LIMK2 activities for @PROTEIN1$ phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by LIMK2.","label":1}
{"pair_id":"BioInfer.d36.s0.p10","sentence":"A LIMK2 mutant with replacement of threonine 505 by valine abolished LIMK2 activities for @PROTEIN1$ phosphorylation and @PROTEIN2$ cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by LIMK2.","label":0}
{"pair_id":"BioInfer.d36.s0.p11","sentence":"A LIMK2 mutant with replacement of threonine 505 by valine abolished @PROTEIN2$ activities for @PROTEIN1$ phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by LIMK2.","label":1}
{"pair_id":"BioInfer.d36.s0.p12","sentence":"A @PROTEIN1$ mutant with replacement of threonine 505 by valine abolished LIMK2 activities for cofilin phosphorylation and @PROTEIN2$ cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by LIMK2.","label":1}
{"pair_id":"BioInfer.d36.s0.p13","sentence":"A @PROTEIN1$ mutant with replacement of threonine 505 by valine abolished @PROTEIN2$ activities for cofilin phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by LIMK2.","label":0}
{"pair_id":"BioInfer.d36.s0.p14","sentence":"A LIMK2 mutant with replacement of threonine 505 by valine abolished @PROTEIN2$ activities for cofilin phosphorylation and @PROTEIN1$ cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by LIMK2.","label":1}
{"pair_id":"AIMed.d169.s1424.p0","sentence":"Cloning and characterization of a specific @PROTEIN1$ binding protein structurally related to the @PROTEIN2$ receptor alpha chain.","label":0}
{"pair_id":"AIMed.d169.s1424.p1","sentence":"Cloning and characterization of a specific @PROTEIN1$ binding protein structurally related to the @PROTEIN2$ alpha chain.","label":0}
{"pair_id":"AIMed.d169.s1424.p2","sentence":"Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the @PROTEIN1$@PROTEIN2$ alpha chain.","label":0}
{"pair_id":"AIMed.d112.s952.p0","sentence":"Sequential immunoprecipitation identified the 72-kDa protein associated with @PROTEIN1$ as @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d146.s1240.p0","sentence":"These antibodies also immunoprecipitated the cloned @PROTEIN1$ as a 90-kDa species from both 125-I-surface-labeled resting and activated T cells, but were unable to precipitate the 76-kDa @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d70.s0.p0","sentence":"Aprotinin inhibited platelet aggregation induced by thrombin (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by @PROTEIN2$ (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of actin and @PROTEIN1$ associated with cytoskeletons.","label":0}
{"pair_id":"BioInfer.d70.s0.p1","sentence":"@PROTEIN2$ inhibited platelet aggregation induced by thrombin (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by thrombin (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of actin and @PROTEIN1$ associated with cytoskeletons.","label":1}
{"pair_id":"BioInfer.d70.s0.p2","sentence":"Aprotinin inhibited platelet aggregation induced by @PROTEIN2$ (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by thrombin (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of actin and @PROTEIN1$ associated with cytoskeletons.","label":0}
{"pair_id":"BioInfer.d70.s0.p3","sentence":"Aprotinin inhibited platelet aggregation induced by thrombin (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by thrombin (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of @PROTEIN2$ and @PROTEIN1$ associated with cytoskeletons.","label":0}
{"pair_id":"BioInfer.d70.s0.p4","sentence":"@PROTEIN2$ inhibited platelet aggregation induced by thrombin (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by @PROTEIN1$ (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of actin and myosin heavy chain associated with cytoskeletons.","label":1}
{"pair_id":"BioInfer.d70.s0.p5","sentence":"Aprotinin inhibited platelet aggregation induced by @PROTEIN2$ (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by @PROTEIN1$ (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of actin and myosin heavy chain associated with cytoskeletons.","label":0}
{"pair_id":"BioInfer.d70.s0.p6","sentence":"Aprotinin inhibited platelet aggregation induced by thrombin (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by @PROTEIN1$ (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of @PROTEIN2$ and myosin heavy chain associated with cytoskeletons.","label":0}
{"pair_id":"BioInfer.d70.s0.p7","sentence":"@PROTEIN1$ inhibited platelet aggregation induced by @PROTEIN2$ (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by thrombin (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of actin and myosin heavy chain associated with cytoskeletons.","label":0}
{"pair_id":"BioInfer.d70.s0.p8","sentence":"@PROTEIN1$ inhibited platelet aggregation induced by thrombin (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by thrombin (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of @PROTEIN2$ and myosin heavy chain associated with cytoskeletons.","label":1}
{"pair_id":"BioInfer.d70.s0.p9","sentence":"Aprotinin inhibited platelet aggregation induced by @PROTEIN1$ (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by thrombin (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of @PROTEIN2$ and myosin heavy chain associated with cytoskeletons.","label":0}
{"pair_id":"BioInfer.d783.s0.p0","sentence":"Unlike @PROTEIN2$, @PROTEIN1$'s actin-bundling action was strictly calcium-dependent: the bundles were formed at pCa 7, but not at pCa 6.","label":0}
{"pair_id":"BioInfer.d783.s0.p1","sentence":"Unlike fimbrin, @PROTEIN1$'s @PROTEIN2$-bundling action was strictly calcium-dependent: the bundles were formed at pCa 7, but not at pCa 6.","label":1}
{"pair_id":"BioInfer.d783.s0.p2","sentence":"Unlike @PROTEIN1$, L-plastin's @PROTEIN2$-bundling action was strictly calcium-dependent: the bundles were formed at pCa 7, but not at pCa 6.","label":1}
{"pair_id":"AIMed.d128.s1092.p0","sentence":"The human pituitary hormones, @PROTEIN1$ (@PROTEIN2$) and prolactin (hPRL), regulate a large variety of physiological processes, among which are growth and differentiation of muscle, bone and cartilage cells, and lactation.","label":0}
{"pair_id":"AIMed.d128.s1092.p1","sentence":"The human pituitary hormones, @PROTEIN1$ (hGH) and @PROTEIN2$ (hPRL), regulate a large variety of physiological processes, among which are growth and differentiation of muscle, bone and cartilage cells, and lactation.","label":0}
{"pair_id":"AIMed.d128.s1092.p2","sentence":"The human pituitary hormones, @PROTEIN1$ (hGH) and prolactin (@PROTEIN2$), regulate a large variety of physiological processes, among which are growth and differentiation of muscle, bone and cartilage cells, and lactation.","label":0}
{"pair_id":"AIMed.d128.s1092.p3","sentence":"The human pituitary hormones, growth hormone (@PROTEIN1$) and @PROTEIN2$ (hPRL), regulate a large variety of physiological processes, among which are growth and differentiation of muscle, bone and cartilage cells, and lactation.","label":0}
{"pair_id":"AIMed.d128.s1092.p4","sentence":"The human pituitary hormones, growth hormone (@PROTEIN1$) and prolactin (@PROTEIN2$), regulate a large variety of physiological processes, among which are growth and differentiation of muscle, bone and cartilage cells, and lactation.","label":0}
{"pair_id":"AIMed.d128.s1092.p5","sentence":"The human pituitary hormones, growth hormone (hGH) and @PROTEIN1$ (@PROTEIN2$), regulate a large variety of physiological processes, among which are growth and differentiation of muscle, bone and cartilage cells, and lactation.","label":0}
{"pair_id":"BioInfer.d561.s0.p0","sentence":"The @PROTEIN1$ @PROTEIN2$ was isolated from Tetrahymena thermophila by affinity chromatography, and the peptide sequence was determined for part of the protein.","label":1}
{"pair_id":"AIMed.d48.s420.p0","sentence":"@PROTEIN1$ (@PROTEIN2$) is an unusually large CC chemokine, which is also known as LMC, HCC-4, NCC-4, and CCL16.","label":0}
{"pair_id":"AIMed.d48.s420.p1","sentence":"@PROTEIN1$ (LEC) is an unusually large CC chemokine, which is also known as @PROTEIN2$, HCC-4, NCC-4, and CCL16.","label":0}
{"pair_id":"AIMed.d48.s420.p2","sentence":"@PROTEIN1$ (LEC) is an unusually large CC chemokine, which is also known as LMC, @PROTEIN2$, NCC-4, and CCL16.","label":0}
{"pair_id":"AIMed.d48.s420.p3","sentence":"@PROTEIN1$ (LEC) is an unusually large CC chemokine, which is also known as LMC, HCC-4, @PROTEIN2$, and CCL16.","label":0}
{"pair_id":"AIMed.d48.s420.p4","sentence":"@PROTEIN1$ (LEC) is an unusually large CC chemokine, which is also known as LMC, HCC-4, NCC-4, and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d48.s420.p5","sentence":"Liver-expressed chemokine (@PROTEIN1$) is an unusually large CC chemokine, which is also known as @PROTEIN2$, HCC-4, NCC-4, and CCL16.","label":0}
{"pair_id":"AIMed.d48.s420.p6","sentence":"Liver-expressed chemokine (@PROTEIN1$) is an unusually large CC chemokine, which is also known as LMC, @PROTEIN2$, NCC-4, and CCL16.","label":0}
{"pair_id":"AIMed.d48.s420.p7","sentence":"Liver-expressed chemokine (@PROTEIN1$) is an unusually large CC chemokine, which is also known as LMC, HCC-4, @PROTEIN2$, and CCL16.","label":0}
{"pair_id":"AIMed.d48.s420.p8","sentence":"Liver-expressed chemokine (@PROTEIN1$) is an unusually large CC chemokine, which is also known as LMC, HCC-4, NCC-4, and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d48.s420.p9","sentence":"Liver-expressed chemokine (LEC) is an unusually large CC chemokine, which is also known as @PROTEIN1$, @PROTEIN2$, NCC-4, and CCL16.","label":0}
{"pair_id":"AIMed.d48.s420.p10","sentence":"Liver-expressed chemokine (LEC) is an unusually large CC chemokine, which is also known as @PROTEIN1$, HCC-4, @PROTEIN2$, and CCL16.","label":0}
{"pair_id":"AIMed.d48.s420.p11","sentence":"Liver-expressed chemokine (LEC) is an unusually large CC chemokine, which is also known as @PROTEIN1$, HCC-4, NCC-4, and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d48.s420.p12","sentence":"Liver-expressed chemokine (LEC) is an unusually large CC chemokine, which is also known as LMC, @PROTEIN1$, @PROTEIN2$, and CCL16.","label":0}
{"pair_id":"AIMed.d48.s420.p13","sentence":"Liver-expressed chemokine (LEC) is an unusually large CC chemokine, which is also known as LMC, @PROTEIN1$, NCC-4, and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d48.s420.p14","sentence":"Liver-expressed chemokine (LEC) is an unusually large CC chemokine, which is also known as LMC, HCC-4, @PROTEIN1$, and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d199.s1696.p0","sentence":"In order to characterize the signaling pathway through which @PROTEIN1$ regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, @PROTEIN2$ IIIb and FGFR3 IIIc, that result from alternative splicing of exon III of the FGFR3 gene encoding the ligand binding domain.","label":0}
{"pair_id":"AIMed.d199.s1696.p1","sentence":"In order to characterize the signaling pathway through which @PROTEIN1$ regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, @PROTEIN2$ and FGFR3 IIIc, that result from alternative splicing of exon III of the FGFR3 gene encoding the ligand binding domain.","label":0}
{"pair_id":"AIMed.d199.s1696.p2","sentence":"In order to characterize the signaling pathway through which @PROTEIN1$ regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, FGFR3 IIIb and @PROTEIN2$ IIIc, that result from alternative splicing of exon III of the FGFR3 gene encoding the ligand binding domain.","label":0}
{"pair_id":"AIMed.d199.s1696.p3","sentence":"In order to characterize the signaling pathway through which @PROTEIN1$ regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, FGFR3 IIIb and @PROTEIN2$, that result from alternative splicing of exon III of the FGFR3 gene encoding the ligand binding domain.","label":0}
{"pair_id":"AIMed.d199.s1696.p4","sentence":"In order to characterize the signaling pathway through which @PROTEIN1$ regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, FGFR3 IIIb and FGFR3 IIIc, that result from alternative splicing of exon III of the @PROTEIN2$ gene encoding the ligand binding domain.","label":0}
{"pair_id":"AIMed.d199.s1696.p5","sentence":"In order to characterize the signaling pathway through which FGFR3 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, @PROTEIN1$@PROTEIN2$ and FGFR3 IIIc, that result from alternative splicing of exon III of the FGFR3 gene encoding the ligand binding domain.","label":0}
{"pair_id":"AIMed.d199.s1696.p6","sentence":"In order to characterize the signaling pathway through which FGFR3 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, @PROTEIN1$ IIIb and @PROTEIN2$ IIIc, that result from alternative splicing of exon III of the FGFR3 gene encoding the ligand binding domain.","label":0}
{"pair_id":"AIMed.d199.s1696.p7","sentence":"In order to characterize the signaling pathway through which FGFR3 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, @PROTEIN1$ IIIb and @PROTEIN2$, that result from alternative splicing of exon III of the FGFR3 gene encoding the ligand binding domain.","label":0}
{"pair_id":"AIMed.d199.s1696.p8","sentence":"In order to characterize the signaling pathway through which FGFR3 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, @PROTEIN1$ IIIb and FGFR3 IIIc, that result from alternative splicing of exon III of the @PROTEIN2$ gene encoding the ligand binding domain.","label":0}
{"pair_id":"AIMed.d199.s1696.p9","sentence":"In order to characterize the signaling pathway through which FGFR3 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, @PROTEIN1$ and @PROTEIN2$ IIIc, that result from alternative splicing of exon III of the FGFR3 gene encoding the ligand binding domain.","label":0}
{"pair_id":"AIMed.d199.s1696.p10","sentence":"In order to characterize the signaling pathway through which FGFR3 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, @PROTEIN1$ and @PROTEIN2$, that result from alternative splicing of exon III of the FGFR3 gene encoding the ligand binding domain.","label":0}
{"pair_id":"AIMed.d199.s1696.p11","sentence":"In order to characterize the signaling pathway through which FGFR3 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, @PROTEIN1$ and FGFR3 IIIc, that result from alternative splicing of exon III of the @PROTEIN2$ gene encoding the ligand binding domain.","label":0}
{"pair_id":"AIMed.d199.s1696.p12","sentence":"In order to characterize the signaling pathway through which FGFR3 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, FGFR3 IIIb and @PROTEIN1$@PROTEIN2$, that result from alternative splicing of exon III of the FGFR3 gene encoding the ligand binding domain.","label":0}
{"pair_id":"AIMed.d199.s1696.p13","sentence":"In order to characterize the signaling pathway through which FGFR3 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, FGFR3 IIIb and @PROTEIN1$ IIIc, that result from alternative splicing of exon III of the @PROTEIN2$ gene encoding the ligand binding domain.","label":0}
{"pair_id":"AIMed.d199.s1696.p14","sentence":"In order to characterize the signaling pathway through which FGFR3 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, FGFR3 IIIb and @PROTEIN1$, that result from alternative splicing of exon III of the @PROTEIN2$ gene encoding the ligand binding domain.","label":0}
{"pair_id":"BioInfer.d449.s1.p0","sentence":"@PROTEIN1$ and @PROTEIN2$ mRNAs were detected precociously, before the young myotube stage.","label":0}
{"pair_id":"AIMed.d172.s1451.p0","sentence":"This protein, designated @PROTEIN1$@PROTEIN2$ (VRP), specifically binds to the extracellular domain of Flt4, stimulates the tyrosine phosphorylation of Flt4 expressed in mammalian cells, and promotes the mitogenesis of human lung endothelial cells.","label":0}
{"pair_id":"AIMed.d172.s1451.p1","sentence":"This protein, designated @PROTEIN1$-related protein (@PROTEIN2$), specifically binds to the extracellular domain of Flt4, stimulates the tyrosine phosphorylation of Flt4 expressed in mammalian cells, and promotes the mitogenesis of human lung endothelial cells.","label":0}
{"pair_id":"AIMed.d172.s1451.p2","sentence":"This protein, designated @PROTEIN1$-related protein (VRP), specifically binds to the extracellular domain of @PROTEIN2$, stimulates the tyrosine phosphorylation of Flt4 expressed in mammalian cells, and promotes the mitogenesis of human lung endothelial cells.","label":0}
{"pair_id":"AIMed.d172.s1451.p3","sentence":"This protein, designated @PROTEIN1$-related protein (VRP), specifically binds to the extracellular domain of Flt4, stimulates the tyrosine phosphorylation of @PROTEIN2$ expressed in mammalian cells, and promotes the mitogenesis of human lung endothelial cells.","label":0}
{"pair_id":"AIMed.d172.s1451.p4","sentence":"This protein, designated @PROTEIN1$ (@PROTEIN2$), specifically binds to the extracellular domain of Flt4, stimulates the tyrosine phosphorylation of Flt4 expressed in mammalian cells, and promotes the mitogenesis of human lung endothelial cells.","label":0}
{"pair_id":"AIMed.d172.s1451.p5","sentence":"This protein, designated @PROTEIN1$ (VRP), specifically binds to the extracellular domain of @PROTEIN2$, stimulates the tyrosine phosphorylation of Flt4 expressed in mammalian cells, and promotes the mitogenesis of human lung endothelial cells.","label":1}
{"pair_id":"AIMed.d172.s1451.p6","sentence":"This protein, designated @PROTEIN1$ (VRP), specifically binds to the extracellular domain of Flt4, stimulates the tyrosine phosphorylation of @PROTEIN2$ expressed in mammalian cells, and promotes the mitogenesis of human lung endothelial cells.","label":0}
{"pair_id":"AIMed.d172.s1451.p7","sentence":"This protein, designated VEGF-related protein (@PROTEIN1$), specifically binds to the extracellular domain of @PROTEIN2$, stimulates the tyrosine phosphorylation of Flt4 expressed in mammalian cells, and promotes the mitogenesis of human lung endothelial cells.","label":1}
{"pair_id":"AIMed.d172.s1451.p8","sentence":"This protein, designated VEGF-related protein (@PROTEIN1$), specifically binds to the extracellular domain of Flt4, stimulates the tyrosine phosphorylation of @PROTEIN2$ expressed in mammalian cells, and promotes the mitogenesis of human lung endothelial cells.","label":0}
{"pair_id":"AIMed.d172.s1451.p9","sentence":"This protein, designated VEGF-related protein (VRP), specifically binds to the extracellular domain of @PROTEIN1$, stimulates the tyrosine phosphorylation of @PROTEIN2$ expressed in mammalian cells, and promotes the mitogenesis of human lung endothelial cells.","label":0}
{"pair_id":"BioInfer.d563.s0.p0","sentence":"The @PROTEIN1$ cytoskeleton-associated protein @PROTEIN2$ binds to integrins, vinculin, and actin.","label":1}
{"pair_id":"BioInfer.d563.s0.p1","sentence":"The @PROTEIN1$ cytoskeleton-associated protein talin binds to @PROTEIN2$, vinculin, and actin.","label":0}
{"pair_id":"BioInfer.d563.s0.p2","sentence":"The @PROTEIN1$ cytoskeleton-associated protein talin binds to integrins, @PROTEIN2$, and actin.","label":0}
{"pair_id":"BioInfer.d563.s0.p3","sentence":"The @PROTEIN1$ cytoskeleton-associated protein talin binds to integrins, vinculin, and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d563.s0.p4","sentence":"The actin cytoskeleton-associated protein @PROTEIN1$ binds to @PROTEIN2$, vinculin, and actin.","label":1}
{"pair_id":"BioInfer.d563.s0.p5","sentence":"The actin cytoskeleton-associated protein @PROTEIN1$ binds to integrins, @PROTEIN2$, and actin.","label":1}
{"pair_id":"BioInfer.d563.s0.p6","sentence":"The actin cytoskeleton-associated protein @PROTEIN1$ binds to integrins, vinculin, and @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d563.s0.p7","sentence":"The actin cytoskeleton-associated protein talin binds to @PROTEIN1$, @PROTEIN2$, and actin.","label":0}
{"pair_id":"BioInfer.d563.s0.p8","sentence":"The actin cytoskeleton-associated protein talin binds to @PROTEIN1$, vinculin, and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d563.s0.p9","sentence":"The actin cytoskeleton-associated protein talin binds to integrins, @PROTEIN1$, and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d629.s0.p0","sentence":"The interaction between the human respiratory syncytial virus phosphoprotein (P) and @PROTEIN1$ (@PROTEIN2$) @PROTEIN1$ has been investigated using the two hybrid system in yeast and in tissue culture cells.","label":0}
{"pair_id":"BioInfer.d629.s0.p1","sentence":"The interaction between the human respiratory syncytial virus phosphoprotein (@PROTEIN2$) and @PROTEIN1$ (N) @PROTEIN1$ has been investigated using the two hybrid system in yeast and in tissue culture cells.","label":1}
{"pair_id":"BioInfer.d629.s0.p2","sentence":"The interaction between the human respiratory syncytial virus @PROTEIN2$ (P) and @PROTEIN1$ (N) @PROTEIN1$@PROTEIN2$ has been investigated using the two hybrid system in yeast and in tissue culture cells.","label":1}
{"pair_id":"BioInfer.d629.s0.p3","sentence":"The interaction between the human respiratory syncytial virus phosphoprotein (@PROTEIN2$) and nucleocapsid (@PROTEIN1$) phospho has been investigated using the two hybrid system in yeast and in tissue culture cells.","label":1}
{"pair_id":"BioInfer.d629.s0.p4","sentence":"The interaction between the human respiratory syncytial virus @PROTEIN2$ (P) and nucleocapsid (@PROTEIN1$) @PROTEIN2$ has been investigated using the two hybrid system in yeast and in tissue culture cells.","label":1}
{"pair_id":"BioInfer.d629.s0.p5","sentence":"The interaction between the human respiratory syncytial virus @PROTEIN2$ (@PROTEIN1$) and nucleocapsid (N) @PROTEIN2$ has been investigated using the two hybrid system in yeast and in tissue culture cells.","label":0}
{"pair_id":"AIMed.d91.s781.p0","sentence":"In vitro protein-protein interaction assays reveal that as observed with Drosophila @PROTEIN1$, @PROTEIN2$ interacts with the C-terminal 39-amino acid activation domain of the acidic transactivator viral protein 16 (VP16) as well as with the general transcription factor TFIIB.","label":0}
{"pair_id":"AIMed.d91.s781.p1","sentence":"In vitro protein-protein interaction assays reveal that as observed with Drosophila @PROTEIN1$, hTAFII32 interacts with the C-terminal 39-amino acid activation domain of the acidic transactivator @PROTEIN2$ (VP16) as well as with the general transcription factor TFIIB.","label":0}
{"pair_id":"AIMed.d91.s781.p2","sentence":"In vitro protein-protein interaction assays reveal that as observed with Drosophila @PROTEIN1$, hTAFII32 interacts with the C-terminal 39-amino acid activation domain of the acidic transactivator viral protein 16 (@PROTEIN2$) as well as with the general transcription factor TFIIB.","label":0}
{"pair_id":"AIMed.d91.s781.p3","sentence":"In vitro protein-protein interaction assays reveal that as observed with Drosophila @PROTEIN1$, hTAFII32 interacts with the C-terminal 39-amino acid activation domain of the acidic transactivator viral protein 16 (VP16) as well as with the general transcription factor @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d91.s781.p4","sentence":"In vitro protein-protein interaction assays reveal that as observed with Drosophila TAFII40, @PROTEIN1$ interacts with the C-terminal 39-amino acid activation domain of the acidic transactivator @PROTEIN2$ (VP16) as well as with the general transcription factor TFIIB.","label":1}
{"pair_id":"AIMed.d91.s781.p5","sentence":"In vitro protein-protein interaction assays reveal that as observed with Drosophila TAFII40, @PROTEIN1$ interacts with the C-terminal 39-amino acid activation domain of the acidic transactivator viral protein 16 (@PROTEIN2$) as well as with the general transcription factor TFIIB.","label":1}
{"pair_id":"AIMed.d91.s781.p6","sentence":"In vitro protein-protein interaction assays reveal that as observed with Drosophila TAFII40, @PROTEIN1$ interacts with the C-terminal 39-amino acid activation domain of the acidic transactivator viral protein 16 (VP16) as well as with the general transcription factor @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d91.s781.p7","sentence":"In vitro protein-protein interaction assays reveal that as observed with Drosophila TAFII40, hTAFII32 interacts with the C-terminal 39-amino acid activation domain of the acidic transactivator @PROTEIN1$ (@PROTEIN2$) as well as with the general transcription factor TFIIB.","label":0}
{"pair_id":"AIMed.d91.s781.p8","sentence":"In vitro protein-protein interaction assays reveal that as observed with Drosophila TAFII40, hTAFII32 interacts with the C-terminal 39-amino acid activation domain of the acidic transactivator @PROTEIN1$ (VP16) as well as with the general transcription factor @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d91.s781.p9","sentence":"In vitro protein-protein interaction assays reveal that as observed with Drosophila TAFII40, hTAFII32 interacts with the C-terminal 39-amino acid activation domain of the acidic transactivator viral protein 16 (@PROTEIN1$) as well as with the general transcription factor @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d803.s0.p0","sentence":"We find that @PROTEIN2$ and @PROTEIN1$ regulate actin-filament formation throughout the cell cortex.","label":0}
{"pair_id":"BioInfer.d803.s0.p1","sentence":"We find that profilin and @PROTEIN1$ regulate @PROTEIN2$-filament formation throughout the cell cortex.","label":1}
{"pair_id":"BioInfer.d803.s0.p2","sentence":"We find that @PROTEIN1$ and cofilin regulate @PROTEIN2$-filament formation throughout the cell cortex.","label":1}
{"pair_id":"AIMed.d151.s1284.p0","sentence":"The @PROTEIN1$ (@PROTEIN2$) specifically recognizes the PSEs of both RNA polymerase II- and RNA polymerase III-transcribed small nuclear RNA (snRNA) genes.","label":0}
{"pair_id":"BioInfer.d89.s0.p0","sentence":"BACKGROUND: Although @PROTEIN2$ is believed to be an essential regulator of the @PROTEIN1$ cytoskeleton in most cells, its precise role in mammalian cells remains unknown.","label":1}
{"pair_id":"BioInfer.d797.s0.p0","sentence":"We believe that this complex may mediate the cortical functions of @PROTEIN1$ at @PROTEIN2$ patches in S. pombe.","label":1}
{"pair_id":"AIMed.d125.s1067.p0","sentence":"@PROTEIN1$ displayed the same pattern of combinatorial interactions with @PROTEIN2$ family proteins as Bcl-2.","label":0}
{"pair_id":"AIMed.d125.s1067.p1","sentence":"@PROTEIN1$ displayed the same pattern of combinatorial interactions with Bcl-2 family proteins as @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d125.s1067.p2","sentence":"Bcl-X-L displayed the same pattern of combinatorial interactions with @PROTEIN1$ family proteins as @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d185.s1569.p0","sentence":"@PROTEIN1$ recruitment by two distinct ligand-induced, tyrosine-phosphorylated docking sites in the @PROTEIN2$ receptor intracellular domain.","label":0}
{"pair_id":"AIMed.d185.s1569.p1","sentence":"@PROTEIN1$ recruitment by two distinct ligand-induced, tyrosine-phosphorylated docking sites in the @PROTEIN2$ intracellular domain.","label":1}
{"pair_id":"AIMed.d185.s1569.p2","sentence":"Stat3 recruitment by two distinct ligand-induced, tyrosine-phosphorylated docking sites in the @PROTEIN1$@PROTEIN2$ intracellular domain.","label":0}
{"pair_id":"AIMed.d180.s1534.p0","sentence":"@PROTEIN1$ phosphorylates @PROTEIN2$ on serine 41.","label":1}
{"pair_id":"AIMed.d2.s23.p0","sentence":"MAIN OUTCOME MEASURES: @PROTEIN1$\/@PROTEIN2$ molar ratio after 7 days hospitalisation.","label":0}
{"pair_id":"BioInfer.d375.s3.p0","sentence":"This model includes two different Kd's--one for @PROTEIN1$ bound to actin monomers and one for @PROTEIN2$ bound to an actin molecule at the barbed end of a filament.","label":0}
{"pair_id":"BioInfer.d375.s3.p1","sentence":"This model includes two different Kd's--one for @PROTEIN1$ bound to @PROTEIN2$ monomers and one for profilin bound to an actin molecule at the barbed end of a filament.","label":1}
{"pair_id":"BioInfer.d375.s3.p2","sentence":"This model includes two different Kd's--one for @PROTEIN1$ bound to actin monomers and one for profilin bound to an @PROTEIN2$ molecule at the barbed end of a filament.","label":0}
{"pair_id":"BioInfer.d375.s3.p3","sentence":"This model includes two different Kd's--one for profilin bound to @PROTEIN2$ monomers and one for @PROTEIN1$ bound to an actin molecule at the barbed end of a filament.","label":0}
{"pair_id":"BioInfer.d375.s3.p4","sentence":"This model includes two different Kd's--one for profilin bound to actin monomers and one for @PROTEIN1$ bound to an @PROTEIN2$ molecule at the barbed end of a filament.","label":1}
{"pair_id":"BioInfer.d375.s3.p5","sentence":"This model includes two different Kd's--one for profilin bound to @PROTEIN1$ monomers and one for profilin bound to an @PROTEIN2$ molecule at the barbed end of a filament.","label":0}
{"pair_id":"AIMed.d167.s1406.p0","sentence":"Following immunoprecipitation with an anticalnexin antiserum, a cross-linker-independent association was observed between @PROTEIN1$ and @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d606.s0.p0","sentence":"The domains in CBP that are involved in CREB binding and transcriptional activation are highly related to the adenoviral @PROTEIN1$-associated cellular protein p300 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, R10E11.1 and @PROTEIN2$ (refs 4 and 5, respectively), whose functions are unknown.","label":0}
{"pair_id":"BioInfer.d606.s0.p1","sentence":"The domains in CBP that are involved in CREB binding and transcriptional activation are highly related to the adenoviral @PROTEIN1$-associated cellular protein @PROTEIN2$ (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, R10E11.1 and K03H1.10 (refs 4 and 5, respectively), whose functions are unknown.","label":1}
{"pair_id":"BioInfer.d606.s0.p2","sentence":"The domains in CBP that are involved in CREB binding and transcriptional activation are highly related to the adenoviral @PROTEIN1$-associated cellular protein p300 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, @PROTEIN2$ and K03H1.10 (refs 4 and 5, respectively), whose functions are unknown.","label":0}
{"pair_id":"BioInfer.d606.s0.p3","sentence":"The domains in CBP that are involved in @PROTEIN2$ binding and transcriptional activation are highly related to the adenoviral @PROTEIN1$-associated cellular protein p300 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, R10E11.1 and K03H1.10 (refs 4 and 5, respectively), whose functions are unknown.","label":0}
{"pair_id":"BioInfer.d606.s0.p4","sentence":"The domains in @PROTEIN2$ that are involved in CREB binding and transcriptional activation are highly related to the adenoviral @PROTEIN1$-associated cellular protein p300 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, R10E11.1 and K03H1.10 (refs 4 and 5, respectively), whose functions are unknown.","label":0}
{"pair_id":"BioInfer.d606.s0.p5","sentence":"The domains in CBP that are involved in CREB binding and transcriptional activation are highly related to the adenoviral E1A-associated cellular protein @PROTEIN2$ (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, R10E11.1 and @PROTEIN1$ (refs 4 and 5, respectively), whose functions are unknown.","label":0}
{"pair_id":"BioInfer.d606.s0.p6","sentence":"The domains in CBP that are involved in CREB binding and transcriptional activation are highly related to the adenoviral E1A-associated cellular protein p300 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, @PROTEIN2$ and @PROTEIN1$ (refs 4 and 5, respectively), whose functions are unknown.","label":0}
{"pair_id":"BioInfer.d606.s0.p7","sentence":"The domains in CBP that are involved in @PROTEIN2$ binding and transcriptional activation are highly related to the adenoviral E1A-associated cellular protein p300 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, R10E11.1 and @PROTEIN1$ (refs 4 and 5, respectively), whose functions are unknown.","label":0}
{"pair_id":"BioInfer.d606.s0.p8","sentence":"The domains in @PROTEIN2$ that are involved in CREB binding and transcriptional activation are highly related to the adenoviral E1A-associated cellular protein p300 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, R10E11.1 and @PROTEIN1$ (refs 4 and 5, respectively), whose functions are unknown.","label":1}
{"pair_id":"BioInfer.d606.s0.p9","sentence":"The domains in CBP that are involved in CREB binding and transcriptional activation are highly related to the adenoviral E1A-associated cellular protein @PROTEIN1$ (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, @PROTEIN2$ and K03H1.10 (refs 4 and 5, respectively), whose functions are unknown.","label":0}
{"pair_id":"BioInfer.d606.s0.p10","sentence":"The domains in CBP that are involved in @PROTEIN2$ binding and transcriptional activation are highly related to the adenoviral E1A-associated cellular protein @PROTEIN1$ (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, R10E11.1 and K03H1.10 (refs 4 and 5, respectively), whose functions are unknown.","label":0}
{"pair_id":"BioInfer.d606.s0.p11","sentence":"The domains in @PROTEIN2$ that are involved in CREB binding and transcriptional activation are highly related to the adenoviral E1A-associated cellular protein @PROTEIN1$ (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, R10E11.1 and K03H1.10 (refs 4 and 5, respectively), whose functions are unknown.","label":1}
{"pair_id":"BioInfer.d606.s0.p12","sentence":"The domains in CBP that are involved in @PROTEIN2$ binding and transcriptional activation are highly related to the adenoviral E1A-associated cellular protein p300 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, @PROTEIN1$ and K03H1.10 (refs 4 and 5, respectively), whose functions are unknown.","label":0}
{"pair_id":"BioInfer.d606.s0.p13","sentence":"The domains in @PROTEIN2$ that are involved in CREB binding and transcriptional activation are highly related to the adenoviral E1A-associated cellular protein p300 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, @PROTEIN1$ and K03H1.10 (refs 4 and 5, respectively), whose functions are unknown.","label":1}
{"pair_id":"BioInfer.d606.s0.p14","sentence":"The domains in @PROTEIN2$ that are involved in @PROTEIN1$ binding and transcriptional activation are highly related to the adenoviral E1A-associated cellular protein p300 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, R10E11.1 and K03H1.10 (refs 4 and 5, respectively), whose functions are unknown.","label":1}
{"pair_id":"AIMed.d153.s1303.p0","sentence":"In keeping with this observation, we showed that human @PROTEIN1$-transfected murine pre-B cell lines lacking human @PROTEIN2$ acquired ADA from an extracellular source.","label":0}
{"pair_id":"AIMed.d153.s1303.p1","sentence":"In keeping with this observation, we showed that human @PROTEIN1$-transfected murine pre-B cell lines lacking human ADA acquired @PROTEIN2$ from an extracellular source.","label":0}
{"pair_id":"AIMed.d153.s1303.p2","sentence":"In keeping with this observation, we showed that human CD26-transfected murine pre-B cell lines lacking human @PROTEIN1$ acquired @PROTEIN2$ from an extracellular source.","label":0}
{"pair_id":"BioInfer.d354.s0.p0","sentence":"@PROTEIN2$, @PROTEIN1$, and myosin heavy chain messenger RNAs in skeletal muscle after an injection of growth hormone in subjects over 60 years old.","label":0}
{"pair_id":"BioInfer.d354.s0.p1","sentence":"Insulin-like growth factor-I, @PROTEIN1$, and @PROTEIN2$ messenger RNAs in skeletal muscle after an injection of growth hormone in subjects over 60 years old.","label":0}
{"pair_id":"BioInfer.d354.s0.p2","sentence":"@PROTEIN1$, actin, and @PROTEIN2$ messenger RNAs in skeletal muscle after an injection of growth hormone in subjects over 60 years old.","label":0}
{"pair_id":"AIMed.d92.s784.p0","sentence":"A potential interaction of @PROTEIN1$ and @PROTEIN2$ NGF receptors revealed by affinity crosslinking and immunoprecipitation.","label":0}
{"pair_id":"AIMed.d92.s784.p1","sentence":"A potential interaction of @PROTEIN1$ and trkA @PROTEIN2$ receptors revealed by affinity crosslinking and immunoprecipitation.","label":0}
{"pair_id":"AIMed.d92.s784.p2","sentence":"A potential interaction of p75 and @PROTEIN1$ @PROTEIN2$ receptors revealed by affinity crosslinking and immunoprecipitation.","label":0}
{"pair_id":"BioInfer.d517.s0.p0","sentence":"Removal of one nonhomologous DNA end during gene conversion by a @PROTEIN1$- and @PROTEIN2$-independent pathway.","label":0}
{"pair_id":"AIMed.d168.s1419.p0","sentence":"Furthermore, the F93A mutation in full-length @PROTEIN1$ expressed in COS cells abolished detectable @PROTEIN2$ binding.","label":1}
{"pair_id":"BioInfer.d287.s1.p0","sentence":"We attribute the detection of @PROTEIN1$ and @PROTEIN2$ to the applied cryomethods which yield a much better preservation of ultrastructure and antigenicity of delicate cytoskeletal constituents than conventional fixation techniques.","label":0}
{"pair_id":"BioInfer.d97.s1.p0","sentence":"@PROTEIN1$ binds to @PROTEIN2$ in vitro and hence is an actin binding protein.","label":1}
{"pair_id":"BioInfer.d97.s1.p1","sentence":"@PROTEIN1$ binds to actin in vitro and hence is an @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d97.s1.p2","sentence":"Platelet talin binds to @PROTEIN1$ in vitro and hence is an @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d143.s1204.p0","sentence":"Involvement of @PROTEIN1$ signal transducer @PROTEIN2$ in IL-11-mediated signal transduction.","label":0}
{"pair_id":"AIMed.d143.s1204.p1","sentence":"Involvement of @PROTEIN1$ signal transducer gp130 in @PROTEIN2$-mediated signal transduction.","label":0}
{"pair_id":"AIMed.d143.s1204.p2","sentence":"Involvement of IL-6 signal transducer @PROTEIN1$ in @PROTEIN2$-mediated signal transduction.","label":0}
{"pair_id":"AIMed.d52.s464.p0","sentence":"We show that the S252W mutation allows the mesenchymal splice form of @PROTEIN1$ (@PROTEIN2$) to bind and to be activated by the mesenchymally expressed ligands FGF7 or FGF10 and the epithelial splice form of FGFR2 (FGFR2b) to be activated by FGF2, FGF6, and FGF9.","label":0}
{"pair_id":"AIMed.d52.s464.p1","sentence":"We show that the S252W mutation allows the mesenchymal splice form of @PROTEIN1$ (FGFR2c) to bind and to be activated by the mesenchymally expressed ligands @PROTEIN2$ or FGF10 and the epithelial splice form of FGFR2 (FGFR2b) to be activated by FGF2, FGF6, and FGF9.","label":0}
{"pair_id":"AIMed.d52.s464.p2","sentence":"We show that the S252W mutation allows the mesenchymal splice form of @PROTEIN1$ (FGFR2c) to bind and to be activated by the mesenchymally expressed ligands FGF7 or @PROTEIN2$ and the epithelial splice form of FGFR2 (FGFR2b) to be activated by FGF2, FGF6, and FGF9.","label":0}
{"pair_id":"AIMed.d52.s464.p3","sentence":"We show that the S252W mutation allows the mesenchymal splice form of @PROTEIN1$ (FGFR2c) to bind and to be activated by the mesenchymally expressed ligands FGF7 or FGF10 and the epithelial splice form of @PROTEIN2$ (FGFR2b) to be activated by FGF2, FGF6, and FGF9.","label":0}
{"pair_id":"AIMed.d52.s464.p4","sentence":"We show that the S252W mutation allows the mesenchymal splice form of @PROTEIN1$ (FGFR2c) to bind and to be activated by the mesenchymally expressed ligands FGF7 or FGF10 and the epithelial splice form of FGFR2 (@PROTEIN2$) to be activated by FGF2, FGF6, and FGF9.","label":0}
{"pair_id":"AIMed.d52.s464.p5","sentence":"We show that the S252W mutation allows the mesenchymal splice form of @PROTEIN1$ (FGFR2c) to bind and to be activated by the mesenchymally expressed ligands FGF7 or FGF10 and the epithelial splice form of FGFR2 (FGFR2b) to be activated by @PROTEIN2$, FGF6, and FGF9.","label":0}
{"pair_id":"AIMed.d52.s464.p6","sentence":"We show that the S252W mutation allows the mesenchymal splice form of @PROTEIN1$ (FGFR2c) to bind and to be activated by the mesenchymally expressed ligands FGF7 or FGF10 and the epithelial splice form of FGFR2 (FGFR2b) to be activated by FGF2, @PROTEIN2$, and FGF9.","label":0}
{"pair_id":"AIMed.d52.s464.p7","sentence":"We show that the S252W mutation allows the mesenchymal splice form of @PROTEIN1$ (FGFR2c) to bind and to be activated by the mesenchymally expressed ligands FGF7 or FGF10 and the epithelial splice form of FGFR2 (FGFR2b) to be activated by FGF2, FGF6, and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d52.s464.p8","sentence":"We show that the S252W mutation allows the mesenchymal splice form of FGFR2 (@PROTEIN1$) to bind and to be activated by the mesenchymally expressed ligands @PROTEIN2$ or FGF10 and the epithelial splice form of FGFR2 (FGFR2b) to be activated by FGF2, FGF6, and FGF9.","label":1}
{"pair_id":"AIMed.d52.s464.p9","sentence":"We show that the S252W mutation allows the mesenchymal splice form of FGFR2 (@PROTEIN1$) to bind and to be activated by the mesenchymally expressed ligands FGF7 or @PROTEIN2$ and the epithelial splice form of FGFR2 (FGFR2b) to be activated by FGF2, FGF6, and FGF9.","label":1}
{"pair_id":"AIMed.d52.s464.p10","sentence":"We show that the S252W mutation allows the mesenchymal splice form of FGFR2 (@PROTEIN1$) to bind and to be activated by the mesenchymally expressed ligands FGF7 or FGF10 and the epithelial splice form of @PROTEIN2$ (FGFR2b) to be activated by FGF2, FGF6, and FGF9.","label":0}
{"pair_id":"AIMed.d52.s464.p11","sentence":"We show that the S252W mutation allows the mesenchymal splice form of FGFR2 (@PROTEIN1$) to bind and to be activated by the mesenchymally expressed ligands FGF7 or FGF10 and the epithelial splice form of FGFR2 (@PROTEIN2$) to be activated by FGF2, FGF6, and FGF9.","label":0}
{"pair_id":"AIMed.d52.s464.p12","sentence":"We show that the S252W mutation allows the mesenchymal splice form of FGFR2 (@PROTEIN1$) to bind and to be activated by the mesenchymally expressed ligands FGF7 or FGF10 and the epithelial splice form of FGFR2 (FGFR2b) to be activated by @PROTEIN2$, FGF6, and FGF9.","label":0}
{"pair_id":"AIMed.d52.s464.p13","sentence":"We show that the S252W mutation allows the mesenchymal splice form of FGFR2 (@PROTEIN1$) to bind and to be activated by the mesenchymally expressed ligands FGF7 or FGF10 and the epithelial splice form of FGFR2 (FGFR2b) to be activated by FGF2, @PROTEIN2$, and FGF9.","label":0}
{"pair_id":"AIMed.d52.s464.p14","sentence":"We show that the S252W mutation allows the mesenchymal splice form of FGFR2 (@PROTEIN1$) to bind and to be activated by the mesenchymally expressed ligands FGF7 or FGF10 and the epithelial splice form of FGFR2 (FGFR2b) to be activated by FGF2, FGF6, and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d52.s464.p15","sentence":"We show that the S252W mutation allows the mesenchymal splice form of FGFR2 (FGFR2c) to bind and to be activated by the mesenchymally expressed ligands @PROTEIN1$ or @PROTEIN2$ and the epithelial splice form of FGFR2 (FGFR2b) to be activated by FGF2, FGF6, and FGF9.","label":0}
{"pair_id":"AIMed.d52.s464.p16","sentence":"We show that the S252W mutation allows the mesenchymal splice form of FGFR2 (FGFR2c) to bind and to be activated by the mesenchymally expressed ligands @PROTEIN1$ or FGF10 and the epithelial splice form of @PROTEIN2$ (FGFR2b) to be activated by FGF2, FGF6, and FGF9.","label":0}
{"pair_id":"AIMed.d52.s464.p17","sentence":"We show that the S252W mutation allows the mesenchymal splice form of FGFR2 (FGFR2c) to bind and to be activated by the mesenchymally expressed ligands @PROTEIN1$ or FGF10 and the epithelial splice form of FGFR2 (@PROTEIN2$) to be activated by FGF2, FGF6, and FGF9.","label":0}
{"pair_id":"AIMed.d52.s464.p18","sentence":"We show that the S252W mutation allows the mesenchymal splice form of FGFR2 (FGFR2c) to bind and to be activated by the mesenchymally expressed ligands @PROTEIN1$ or FGF10 and the epithelial splice form of FGFR2 (FGFR2b) to be activated by @PROTEIN2$, FGF6, and FGF9.","label":0}
{"pair_id":"AIMed.d52.s464.p19","sentence":"We show that the S252W mutation allows the mesenchymal splice form of FGFR2 (FGFR2c) to bind and to be activated by the mesenchymally expressed ligands @PROTEIN1$ or FGF10 and the epithelial splice form of FGFR2 (FGFR2b) to be activated by FGF2, @PROTEIN2$, and FGF9.","label":0}
{"pair_id":"AIMed.d52.s464.p20","sentence":"We show that the S252W mutation allows the mesenchymal splice form of FGFR2 (FGFR2c) to bind and to be activated by the mesenchymally expressed ligands @PROTEIN1$ or FGF10 and the epithelial splice form of FGFR2 (FGFR2b) to be activated by FGF2, FGF6, and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d52.s464.p21","sentence":"We show that the S252W mutation allows the mesenchymal splice form of FGFR2 (FGFR2c) to bind and to be activated by the mesenchymally expressed ligands FGF7 or @PROTEIN1$ and the epithelial splice form of @PROTEIN2$ (FGFR2b) to be activated by FGF2, FGF6, and FGF9.","label":0}
{"pair_id":"AIMed.d52.s464.p22","sentence":"We show that the S252W mutation allows the mesenchymal splice form of FGFR2 (FGFR2c) to bind and to be activated by the mesenchymally expressed ligands FGF7 or @PROTEIN1$ and the epithelial splice form of FGFR2 (@PROTEIN2$) to be activated by FGF2, FGF6, and FGF9.","label":0}
{"pair_id":"AIMed.d52.s464.p23","sentence":"We show that the S252W mutation allows the mesenchymal splice form of FGFR2 (FGFR2c) to bind and to be activated by the mesenchymally expressed ligands FGF7 or @PROTEIN1$ and the epithelial splice form of FGFR2 (FGFR2b) to be activated by @PROTEIN2$, FGF6, and FGF9.","label":0}
{"pair_id":"AIMed.d52.s464.p24","sentence":"We show that the S252W mutation allows the mesenchymal splice form of FGFR2 (FGFR2c) to bind and to be activated by the mesenchymally expressed ligands FGF7 or @PROTEIN1$ and the epithelial splice form of FGFR2 (FGFR2b) to be activated by FGF2, @PROTEIN2$, and FGF9.","label":0}
{"pair_id":"AIMed.d52.s464.p25","sentence":"We show that the S252W mutation allows the mesenchymal splice form of FGFR2 (FGFR2c) to bind and to be activated by the mesenchymally expressed ligands FGF7 or @PROTEIN1$ and the epithelial splice form of FGFR2 (FGFR2b) to be activated by FGF2, FGF6, and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d52.s464.p26","sentence":"We show that the S252W mutation allows the mesenchymal splice form of FGFR2 (FGFR2c) to bind and to be activated by the mesenchymally expressed ligands FGF7 or FGF10 and the epithelial splice form of @PROTEIN1$ (@PROTEIN2$) to be activated by FGF2, FGF6, and FGF9.","label":0}
{"pair_id":"AIMed.d52.s464.p27","sentence":"We show that the S252W mutation allows the mesenchymal splice form of FGFR2 (FGFR2c) to bind and to be activated by the mesenchymally expressed ligands FGF7 or FGF10 and the epithelial splice form of @PROTEIN1$ (FGFR2b) to be activated by @PROTEIN2$, FGF6, and FGF9.","label":0}
{"pair_id":"AIMed.d52.s464.p28","sentence":"We show that the S252W mutation allows the mesenchymal splice form of FGFR2 (FGFR2c) to bind and to be activated by the mesenchymally expressed ligands FGF7 or FGF10 and the epithelial splice form of @PROTEIN1$ (FGFR2b) to be activated by FGF2, @PROTEIN2$, and FGF9.","label":0}
{"pair_id":"AIMed.d52.s464.p29","sentence":"We show that the S252W mutation allows the mesenchymal splice form of FGFR2 (FGFR2c) to bind and to be activated by the mesenchymally expressed ligands FGF7 or FGF10 and the epithelial splice form of @PROTEIN1$ (FGFR2b) to be activated by FGF2, FGF6, and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d52.s464.p30","sentence":"We show that the S252W mutation allows the mesenchymal splice form of FGFR2 (FGFR2c) to bind and to be activated by the mesenchymally expressed ligands FGF7 or FGF10 and the epithelial splice form of FGFR2 (@PROTEIN1$) to be activated by @PROTEIN2$, FGF6, and FGF9.","label":1}
{"pair_id":"AIMed.d52.s464.p31","sentence":"We show that the S252W mutation allows the mesenchymal splice form of FGFR2 (FGFR2c) to bind and to be activated by the mesenchymally expressed ligands FGF7 or FGF10 and the epithelial splice form of FGFR2 (@PROTEIN1$) to be activated by FGF2, @PROTEIN2$, and FGF9.","label":1}
{"pair_id":"AIMed.d52.s464.p32","sentence":"We show that the S252W mutation allows the mesenchymal splice form of FGFR2 (FGFR2c) to bind and to be activated by the mesenchymally expressed ligands FGF7 or FGF10 and the epithelial splice form of FGFR2 (@PROTEIN1$) to be activated by FGF2, FGF6, and @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d52.s464.p33","sentence":"We show that the S252W mutation allows the mesenchymal splice form of FGFR2 (FGFR2c) to bind and to be activated by the mesenchymally expressed ligands FGF7 or FGF10 and the epithelial splice form of FGFR2 (FGFR2b) to be activated by @PROTEIN1$, @PROTEIN2$, and FGF9.","label":0}
{"pair_id":"AIMed.d52.s464.p34","sentence":"We show that the S252W mutation allows the mesenchymal splice form of FGFR2 (FGFR2c) to bind and to be activated by the mesenchymally expressed ligands FGF7 or FGF10 and the epithelial splice form of FGFR2 (FGFR2b) to be activated by @PROTEIN1$, FGF6, and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d52.s464.p35","sentence":"We show that the S252W mutation allows the mesenchymal splice form of FGFR2 (FGFR2c) to bind and to be activated by the mesenchymally expressed ligands FGF7 or FGF10 and the epithelial splice form of FGFR2 (FGFR2b) to be activated by FGF2, @PROTEIN1$, and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d76.s0.p0","sentence":"Armadillo (@PROTEIN2$) repeat 10 to the COOH terminus of beta-catenin is involved in binding to @PROTEIN1$, whereas beta-catenin interacts directly with the CREB-binding domain of CBP.","label":1}
{"pair_id":"BioInfer.d76.s0.p1","sentence":"Armadillo (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to @PROTEIN1$, whereas @PROTEIN2$ interacts directly with the CREB-binding domain of CBP.","label":0}
{"pair_id":"BioInfer.d76.s0.p2","sentence":"Armadillo (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to @PROTEIN1$, whereas beta-catenin interacts directly with the @PROTEIN2$-binding domain of CBP.","label":0}
{"pair_id":"BioInfer.d76.s0.p3","sentence":"@PROTEIN2$ (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to @PROTEIN1$, whereas beta-catenin interacts directly with the CREB-binding domain of CBP.","label":1}
{"pair_id":"BioInfer.d76.s0.p4","sentence":"Armadillo (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to @PROTEIN1$, whereas beta-catenin interacts directly with the CREB-binding domain of @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d76.s0.p5","sentence":"Armadillo (Arm) repeat 10 to the COOH terminus of @PROTEIN2$ is involved in binding to @PROTEIN1$, whereas beta-catenin interacts directly with the CREB-binding domain of CBP.","label":1}
{"pair_id":"BioInfer.d76.s0.p6","sentence":"Armadillo (@PROTEIN1$) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas @PROTEIN2$ interacts directly with the CREB-binding domain of CBP.","label":0}
{"pair_id":"BioInfer.d76.s0.p7","sentence":"Armadillo (@PROTEIN1$) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas beta-catenin interacts directly with the @PROTEIN2$-binding domain of CBP.","label":0}
{"pair_id":"BioInfer.d76.s0.p8","sentence":"@PROTEIN2$ (@PROTEIN1$) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas beta-catenin interacts directly with the CREB-binding domain of CBP.","label":0}
{"pair_id":"BioInfer.d76.s0.p9","sentence":"Armadillo (@PROTEIN1$) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas beta-catenin interacts directly with the CREB-binding domain of @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d76.s0.p10","sentence":"Armadillo (@PROTEIN1$) repeat 10 to the COOH terminus of @PROTEIN2$ is involved in binding to CBP, whereas beta-catenin interacts directly with the CREB-binding domain of CBP.","label":1}
{"pair_id":"BioInfer.d76.s0.p11","sentence":"Armadillo (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas @PROTEIN1$ interacts directly with the @PROTEIN2$-binding domain of CBP.","label":0}
{"pair_id":"BioInfer.d76.s0.p12","sentence":"@PROTEIN2$ (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas @PROTEIN1$ interacts directly with the CREB-binding domain of CBP.","label":0}
{"pair_id":"BioInfer.d76.s0.p13","sentence":"Armadillo (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas @PROTEIN1$ interacts directly with the CREB-binding domain of @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d76.s0.p14","sentence":"Armadillo (Arm) repeat 10 to the COOH terminus of @PROTEIN2$ is involved in binding to CBP, whereas @PROTEIN1$ interacts directly with the CREB-binding domain of CBP.","label":0}
{"pair_id":"BioInfer.d76.s0.p15","sentence":"@PROTEIN2$ (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas beta-catenin interacts directly with the @PROTEIN1$-binding domain of CBP.","label":0}
{"pair_id":"BioInfer.d76.s0.p16","sentence":"Armadillo (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas beta-catenin interacts directly with the @PROTEIN1$-binding domain of @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d76.s0.p17","sentence":"Armadillo (Arm) repeat 10 to the COOH terminus of @PROTEIN2$ is involved in binding to CBP, whereas beta-catenin interacts directly with the @PROTEIN1$-binding domain of CBP.","label":0}
{"pair_id":"BioInfer.d76.s0.p18","sentence":"@PROTEIN1$ (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas beta-catenin interacts directly with the CREB-binding domain of @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d76.s0.p19","sentence":"@PROTEIN1$ (Arm) repeat 10 to the COOH terminus of @PROTEIN2$ is involved in binding to CBP, whereas beta-catenin interacts directly with the CREB-binding domain of CBP.","label":1}
{"pair_id":"BioInfer.d76.s0.p20","sentence":"Armadillo (Arm) repeat 10 to the COOH terminus of @PROTEIN2$ is involved in binding to CBP, whereas beta-catenin interacts directly with the CREB-binding domain of @PROTEIN1$.","label":0}
{"pair_id":"AIMed.d92.s787.p0","sentence":"Here we have utilized affinity crosslinking agents with 125I-NGF to detect an association of @PROTEIN1$ and @PROTEIN2$ receptors in embryonic spinal cord and brain tissues enriched in the two receptors.","label":0}
{"pair_id":"AIMed.d100.s850.p0","sentence":"Recombinant @PROTEIN1$ binds directly to @PROTEIN2$ both in vitro and in yeast, and participates in the formation of the TFIID complex.","label":1}
{"pair_id":"AIMed.d100.s850.p1","sentence":"Recombinant @PROTEIN1$ binds directly to TBP both in vitro and in yeast, and participates in the formation of the @PROTEIN2$ complex.","label":0}
{"pair_id":"AIMed.d100.s850.p2","sentence":"Recombinant hTAFII250 binds directly to @PROTEIN1$ both in vitro and in yeast, and participates in the formation of the @PROTEIN2$ complex.","label":0}
{"pair_id":"AIMed.d95.s803.p0","sentence":"The crystal structure of the human @PROTEIN1$-@PROTEIN2$ (CDK2)-ATP complex has been determined at 2.3 A resolution.","label":1}
{"pair_id":"AIMed.d95.s803.p1","sentence":"The crystal structure of the human @PROTEIN1$-cyclin-dependent kinase2 (@PROTEIN2$)-ATP complex has been determined at 2.3 A resolution.","label":1}
{"pair_id":"AIMed.d95.s803.p2","sentence":"The crystal structure of the human cyclinA-@PROTEIN1$ (@PROTEIN2$)-ATP complex has been determined at 2.3 A resolution.","label":0}
{"pair_id":"BioInfer.d817.s0.p0","sentence":"We previously showed that @PROTEIN1$ is transported in an unassembled form with its associated proteins actin depolymerizing factor, @PROTEIN2$, and profilin.","label":1}
{"pair_id":"BioInfer.d817.s0.p1","sentence":"We previously showed that @PROTEIN1$ is transported in an unassembled form with its associated proteins actin depolymerizing factor, cofilin, and @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d817.s0.p2","sentence":"We previously showed that @PROTEIN1$ is transported in an unassembled form with its associated proteins @PROTEIN2$, cofilin, and profilin.","label":1}
{"pair_id":"BioInfer.d817.s0.p3","sentence":"We previously showed that actin is transported in an unassembled form with its associated proteins actin depolymerizing factor, @PROTEIN1$, and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d817.s0.p4","sentence":"We previously showed that actin is transported in an unassembled form with its associated proteins @PROTEIN2$, @PROTEIN1$, and profilin.","label":0}
{"pair_id":"BioInfer.d817.s0.p5","sentence":"We previously showed that actin is transported in an unassembled form with its associated proteins @PROTEIN2$, cofilin, and @PROTEIN1$.","label":0}
{"pair_id":"AIMed.d184.s1564.p0","sentence":"The apparent affinity of the interaction between @PROTEIN1$ and @PROTEIN2$ was dramatically lower in the absence of soluble CD4.","label":1}
{"pair_id":"AIMed.d184.s1564.p1","sentence":"The apparent affinity of the interaction between @PROTEIN1$ and CCR-5 was dramatically lower in the absence of soluble @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d184.s1564.p2","sentence":"The apparent affinity of the interaction between gp120 and @PROTEIN1$ was dramatically lower in the absence of soluble @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d218.s1893.p0","sentence":"Phage enzyme-linked immunosorbent assay was used to determine affinities for binding to both the @PROTEIN1$ receptor and five anti-@PROTEIN2$-153 monoclonal antibodies.","label":0}
{"pair_id":"AIMed.d39.s339.p0","sentence":"Immunoelectronmicroscopic analysis showed that @PROTEIN1$\/@PROTEIN2$ and PS1 are colocalized at the endoplasmic reticulum, and the nuclear matrix in human brain neurons.","label":0}
{"pair_id":"AIMed.d39.s339.p1","sentence":"Immunoelectronmicroscopic analysis showed that @PROTEIN1$\/Jif-1 and @PROTEIN2$ are colocalized at the endoplasmic reticulum, and the nuclear matrix in human brain neurons.","label":0}
{"pair_id":"AIMed.d39.s339.p2","sentence":"Immunoelectronmicroscopic analysis showed that QM\/@PROTEIN1$ and @PROTEIN2$ are colocalized at the endoplasmic reticulum, and the nuclear matrix in human brain neurons.","label":0}
{"pair_id":"BioInfer.d822.s0.p0","sentence":"We speculate that @PROTEIN1$ may help maintain the parallel growth of @PROTEIN2$ filaments within the stereocilia.","label":1}
{"pair_id":"AIMed.d29.s249.p0","sentence":"This study demonstrates that @PROTEIN1$ recognizes and activates @PROTEIN2$, CXCR2, and the Duffy antigen by distinct mechanisms.","label":1}
{"pair_id":"AIMed.d29.s249.p1","sentence":"This study demonstrates that @PROTEIN1$ recognizes and activates CXCR1, @PROTEIN2$, and the Duffy antigen by distinct mechanisms.","label":1}
{"pair_id":"AIMed.d29.s249.p2","sentence":"This study demonstrates that @PROTEIN1$ recognizes and activates CXCR1, CXCR2, and the @PROTEIN2$ by distinct mechanisms.","label":1}
{"pair_id":"AIMed.d29.s249.p3","sentence":"This study demonstrates that IL-8 recognizes and activates @PROTEIN1$, @PROTEIN2$, and the Duffy antigen by distinct mechanisms.","label":0}
{"pair_id":"AIMed.d29.s249.p4","sentence":"This study demonstrates that IL-8 recognizes and activates @PROTEIN1$, CXCR2, and the @PROTEIN2$ by distinct mechanisms.","label":0}
{"pair_id":"AIMed.d29.s249.p5","sentence":"This study demonstrates that IL-8 recognizes and activates CXCR1, @PROTEIN1$, and the @PROTEIN2$ by distinct mechanisms.","label":0}
{"pair_id":"AIMed.d160.s1350.p0","sentence":"Endothelial cell mitogenesis was abolished in mutants lacking @PROTEIN1$ affinity; however, @PROTEIN2$ deficient mutants induced normal proliferation.","label":0}
{"pair_id":"BioInfer.d405.s0.p0","sentence":"LIM-kinase 1 (LIMK1) phosphorylates cofilin, an @PROTEIN2$, and regulates @PROTEIN1$ cytoskeletal reorganization.","label":0}
{"pair_id":"BioInfer.d405.s0.p1","sentence":"LIM-kinase 1 (LIMK1) phosphorylates @PROTEIN2$, an actin-depolymerizing factor, and regulates @PROTEIN1$ cytoskeletal reorganization.","label":0}
{"pair_id":"BioInfer.d405.s0.p2","sentence":"LIM-kinase 1 (@PROTEIN2$) phosphorylates cofilin, an actin-depolymerizing factor, and regulates @PROTEIN1$ cytoskeletal reorganization.","label":1}
{"pair_id":"BioInfer.d405.s0.p3","sentence":"@PROTEIN2$ (LIMK1) phosphorylates cofilin, an actin-depolymerizing factor, and regulates @PROTEIN1$ cytoskeletal reorganization.","label":1}
{"pair_id":"BioInfer.d405.s0.p4","sentence":"LIM-kinase 1 (LIMK1) phosphorylates @PROTEIN2$, an @PROTEIN1$, and regulates actin cytoskeletal reorganization.","label":1}
{"pair_id":"BioInfer.d405.s0.p5","sentence":"LIM-kinase 1 (@PROTEIN2$) phosphorylates cofilin, an @PROTEIN1$, and regulates actin cytoskeletal reorganization.","label":0}
{"pair_id":"BioInfer.d405.s0.p6","sentence":"@PROTEIN2$ (LIMK1) phosphorylates cofilin, an @PROTEIN1$, and regulates actin cytoskeletal reorganization.","label":0}
{"pair_id":"BioInfer.d405.s0.p7","sentence":"LIM-kinase 1 (@PROTEIN2$) phosphorylates @PROTEIN1$, an actin-depolymerizing factor, and regulates actin cytoskeletal reorganization.","label":1}
{"pair_id":"BioInfer.d405.s0.p8","sentence":"@PROTEIN2$ (LIMK1) phosphorylates @PROTEIN1$, an actin-depolymerizing factor, and regulates actin cytoskeletal reorganization.","label":1}
{"pair_id":"BioInfer.d405.s0.p9","sentence":"@PROTEIN2$ (@PROTEIN1$) phosphorylates cofilin, an actin-depolymerizing factor, and regulates actin cytoskeletal reorganization.","label":0}
{"pair_id":"BioInfer.d471.s2.p0","sentence":"Selective monoclonal antibodies confirm that most of the @PROTEIN1$ is bound to @PROTEIN2$: 65% in extract immunoadsorption assays and 74-89% by fluorescent antibody staining.","label":1}
{"pair_id":"AIMed.d70.s600.p0","sentence":"Mutation of Ala-522 to proline, which is located outside the predicted amphipathic helix region, had no effect on @PROTEIN1$@PROTEIN2$ binding.","label":0}
{"pair_id":"BioInfer.d447.s1.p0","sentence":"Recombinant @PROTEIN2$ protein has a general RNA-binding activity that does not require @PROTEIN1$.","label":1}
{"pair_id":"AIMed.d150.s1273.p0","sentence":"Regulation of the @PROTEIN1$-related transcription factor @PROTEIN2$ by binding to the retinoblastoma protein.","label":0}
{"pair_id":"AIMed.d150.s1273.p1","sentence":"Regulation of the @PROTEIN1$-related transcription factor Elf-1 by binding to the @PROTEIN2$ protein.","label":0}
{"pair_id":"AIMed.d150.s1273.p2","sentence":"Regulation of the Ets-related transcription factor @PROTEIN1$ by binding to the @PROTEIN2$ protein.","label":1}
{"pair_id":"BioInfer.d602.s0.p0","sentence":"The C-terminal region of ORC3 was, however, necessary to bring @PROTEIN1$ and @PROTEIN2$ into the core complex.","label":1}
{"pair_id":"BioInfer.d602.s0.p1","sentence":"The C-terminal region of @PROTEIN2$ was, however, necessary to bring @PROTEIN1$ and ORC5 into the core complex.","label":1}
{"pair_id":"BioInfer.d602.s0.p2","sentence":"The C-terminal region of @PROTEIN2$ was, however, necessary to bring ORC4 and @PROTEIN1$ into the core complex.","label":1}
{"pair_id":"AIMed.d224.s1949.p0","sentence":"We demonstrate that @PROTEIN1$ surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d80.s686.p0","sentence":"Overexpression of @PROTEIN1$ in MCF7 and BJAB cells induces apoptosis, which, like @PROTEIN2$-induced apoptosis, is blocked by CrmA, a specific inhibitor of the interleukin-1 beta-converting enzyme.","label":0}
{"pair_id":"AIMed.d80.s686.p1","sentence":"Overexpression of @PROTEIN1$ in MCF7 and BJAB cells induces apoptosis, which, like Fas-induced apoptosis, is blocked by @PROTEIN2$, a specific inhibitor of the interleukin-1 beta-converting enzyme.","label":0}
{"pair_id":"AIMed.d80.s686.p2","sentence":"Overexpression of @PROTEIN1$ in MCF7 and BJAB cells induces apoptosis, which, like Fas-induced apoptosis, is blocked by CrmA, a specific inhibitor of the @PROTEIN2$-converting enzyme.","label":0}
{"pair_id":"AIMed.d80.s686.p3","sentence":"Overexpression of @PROTEIN1$ in MCF7 and BJAB cells induces apoptosis, which, like Fas-induced apoptosis, is blocked by CrmA, a specific inhibitor of the @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d80.s686.p4","sentence":"Overexpression of FADD in MCF7 and BJAB cells induces apoptosis, which, like @PROTEIN1$-induced apoptosis, is blocked by @PROTEIN2$, a specific inhibitor of the interleukin-1 beta-converting enzyme.","label":0}
{"pair_id":"AIMed.d80.s686.p5","sentence":"Overexpression of FADD in MCF7 and BJAB cells induces apoptosis, which, like @PROTEIN1$-induced apoptosis, is blocked by CrmA, a specific inhibitor of the @PROTEIN2$-converting enzyme.","label":0}
{"pair_id":"AIMed.d80.s686.p6","sentence":"Overexpression of FADD in MCF7 and BJAB cells induces apoptosis, which, like @PROTEIN1$-induced apoptosis, is blocked by CrmA, a specific inhibitor of the @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d80.s686.p7","sentence":"Overexpression of FADD in MCF7 and BJAB cells induces apoptosis, which, like Fas-induced apoptosis, is blocked by @PROTEIN1$, a specific inhibitor of the @PROTEIN2$-converting enzyme.","label":0}
{"pair_id":"AIMed.d80.s686.p8","sentence":"Overexpression of FADD in MCF7 and BJAB cells induces apoptosis, which, like Fas-induced apoptosis, is blocked by @PROTEIN1$, a specific inhibitor of the @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d80.s686.p9","sentence":"Overexpression of FADD in MCF7 and BJAB cells induces apoptosis, which, like Fas-induced apoptosis, is blocked by CrmA, a specific inhibitor of the @PROTEIN1$@PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d620.s0.p0","sentence":"The herpes simplex virus type-1 DNA helicase-primase is a heterotrimer encoded by the UL5, @PROTEIN1$, and @PROTEIN2$ genes.","label":0}
{"pair_id":"BioInfer.d620.s0.p1","sentence":"The herpes simplex virus type-1 @PROTEIN2$ is a heterotrimer encoded by the UL5, @PROTEIN1$, and UL52 genes.","label":1}
{"pair_id":"BioInfer.d620.s0.p2","sentence":"The herpes simplex virus type-1 DNA helicase-primase is a heterotrimer encoded by the @PROTEIN2$, @PROTEIN1$, and UL52 genes.","label":0}
{"pair_id":"BioInfer.d620.s0.p3","sentence":"The herpes simplex virus type-1 @PROTEIN2$ is a heterotrimer encoded by the UL5, UL8, and @PROTEIN1$ genes.","label":1}
{"pair_id":"BioInfer.d620.s0.p4","sentence":"The herpes simplex virus type-1 DNA helicase-primase is a heterotrimer encoded by the @PROTEIN2$, UL8, and @PROTEIN1$ genes.","label":0}
{"pair_id":"BioInfer.d620.s0.p5","sentence":"The herpes simplex virus type-1 @PROTEIN1$ is a heterotrimer encoded by the @PROTEIN2$, UL8, and UL52 genes.","label":1}
{"pair_id":"AIMed.d157.s1330.p0","sentence":"The subcellular distributions of @PROTEIN1$ and @PROTEIN2$ were similar in neurons.","label":0}
{"pair_id":"AIMed.d30.s253.p0","sentence":"These results suggest that @PROTEIN1$ and @PROTEIN2$ partly differ in function.","label":0}
{"pair_id":"BioInfer.d216.s0.p0","sentence":"From an analysis of profilin mutants, whose actin cytoskeleton is disrupted, we found that @PROTEIN2$ also requires @PROTEIN1$ filaments to associate with adhesive cell membranes in the ovary.","label":1}
{"pair_id":"BioInfer.d216.s0.p1","sentence":"From an analysis of @PROTEIN2$ mutants, whose actin cytoskeleton is disrupted, we found that E-APC also requires @PROTEIN1$ filaments to associate with adhesive cell membranes in the ovary.","label":0}
{"pair_id":"BioInfer.d216.s0.p2","sentence":"From an analysis of profilin mutants, whose @PROTEIN2$ cytoskeleton is disrupted, we found that E-APC also requires @PROTEIN1$ filaments to associate with adhesive cell membranes in the ovary.","label":0}
{"pair_id":"BioInfer.d216.s0.p3","sentence":"From an analysis of @PROTEIN2$ mutants, whose actin cytoskeleton is disrupted, we found that @PROTEIN1$ also requires actin filaments to associate with adhesive cell membranes in the ovary.","label":0}
{"pair_id":"BioInfer.d216.s0.p4","sentence":"From an analysis of profilin mutants, whose @PROTEIN2$ cytoskeleton is disrupted, we found that @PROTEIN1$ also requires actin filaments to associate with adhesive cell membranes in the ovary.","label":0}
{"pair_id":"BioInfer.d216.s0.p5","sentence":"From an analysis of @PROTEIN1$ mutants, whose @PROTEIN2$ cytoskeleton is disrupted, we found that E-APC also requires actin filaments to associate with adhesive cell membranes in the ovary.","label":0}
{"pair_id":"AIMed.d164.s1383.p0","sentence":"Thus, @PROTEIN1$ functions as a bridge between @PROTEIN2$ and the enhancer complex to recruit U2AF65 to the adjacent intron.","label":0}
{"pair_id":"AIMed.d164.s1383.p1","sentence":"Thus, @PROTEIN1$ functions as a bridge between U2AF65 and the enhancer complex to recruit @PROTEIN2$ to the adjacent intron.","label":0}
{"pair_id":"AIMed.d164.s1383.p2","sentence":"Thus, U2AF35 functions as a bridge between @PROTEIN1$ and the enhancer complex to recruit @PROTEIN2$ to the adjacent intron.","label":0}
{"pair_id":"BioInfer.d448.s0.p0","sentence":"@PROTEIN2$ shows homology to the head domains and the coiledcoil tail of the conventional type II myosin heavy chain and carries putative binding sites for ATP and @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d448.s0.p1","sentence":"Myo2p shows homology to the head domains and the coiledcoil tail of the conventional @PROTEIN2$ and carries putative binding sites for ATP and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d448.s0.p2","sentence":"@PROTEIN1$ shows homology to the head domains and the coiledcoil tail of the conventional @PROTEIN2$ and carries putative binding sites for ATP and actin.","label":1}
{"pair_id":"BioInfer.d139.s0.p0","sentence":"Characterization of the action of porcine @PROTEIN1$ on @PROTEIN2$ polymerization.","label":1}
{"pair_id":"AIMed.d41.s355.p0","sentence":"The 2.8 A crystal structure of a complex between the extracellular portions of @PROTEIN1$ and @PROTEIN2$ shows two HFE molecules which grasp each side of a twofold symmetric TfR dimer.","label":1}
{"pair_id":"AIMed.d41.s355.p1","sentence":"The 2.8 A crystal structure of a complex between the extracellular portions of @PROTEIN1$ and TfR shows two @PROTEIN2$ molecules which grasp each side of a twofold symmetric TfR dimer.","label":0}
{"pair_id":"AIMed.d41.s355.p2","sentence":"The 2.8 A crystal structure of a complex between the extracellular portions of @PROTEIN1$ and TfR shows two HFE molecules which grasp each side of a twofold symmetric @PROTEIN2$ dimer.","label":0}
{"pair_id":"AIMed.d41.s355.p3","sentence":"The 2.8 A crystal structure of a complex between the extracellular portions of HFE and @PROTEIN1$ shows two @PROTEIN2$ molecules which grasp each side of a twofold symmetric TfR dimer.","label":0}
{"pair_id":"AIMed.d41.s355.p4","sentence":"The 2.8 A crystal structure of a complex between the extracellular portions of HFE and @PROTEIN1$ shows two HFE molecules which grasp each side of a twofold symmetric @PROTEIN2$ dimer.","label":0}
{"pair_id":"AIMed.d41.s355.p5","sentence":"The 2.8 A crystal structure of a complex between the extracellular portions of HFE and TfR shows two @PROTEIN1$ molecules which grasp each side of a twofold symmetric @PROTEIN2$ dimer.","label":1}
{"pair_id":"BioInfer.d103.s0.p0","sentence":"Bistratene A causes phosphorylation of @PROTEIN2$ and redistribution of @PROTEIN1$ microfilaments in fibroblasts: possible role for PKC-delta.","label":0}
{"pair_id":"BioInfer.d103.s0.p1","sentence":"Bistratene A causes phosphorylation of talin and redistribution of @PROTEIN1$ microfilaments in fibroblasts: possible role for @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d103.s0.p2","sentence":"Bistratene A causes phosphorylation of @PROTEIN1$ and redistribution of actin microfilaments in fibroblasts: possible role for @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d94.s798.p0","sentence":"@PROTEIN1$ is a seven-transmembrane domain G protein-coupled receptor most closely related to the previously reported monocyte- and neutrophil-selective receptor @PROTEIN2$ (also known as the MIP-1 alpha\/RANTES receptor).","label":0}
{"pair_id":"AIMed.d94.s798.p1","sentence":"@PROTEIN1$ is a seven-transmembrane domain G protein-coupled receptor most closely related to the previously reported monocyte- and neutrophil-selective receptor CC CKR1 (also known as the @PROTEIN2$\/RANTES receptor).","label":0}
{"pair_id":"AIMed.d94.s798.p2","sentence":"@PROTEIN1$ is a seven-transmembrane domain G protein-coupled receptor most closely related to the previously reported monocyte- and neutrophil-selective receptor CC CKR1 (also known as the MIP-1 alpha\/@PROTEIN2$ receptor).","label":0}
{"pair_id":"AIMed.d94.s798.p3","sentence":"CC CKR3 is a seven-transmembrane domain G protein-coupled receptor most closely related to the previously reported monocyte- and neutrophil-selective receptor @PROTEIN1$ (also known as the @PROTEIN2$\/RANTES receptor).","label":0}
{"pair_id":"AIMed.d94.s798.p4","sentence":"CC CKR3 is a seven-transmembrane domain G protein-coupled receptor most closely related to the previously reported monocyte- and neutrophil-selective receptor @PROTEIN1$ (also known as the MIP-1 alpha\/@PROTEIN2$ receptor).","label":0}
{"pair_id":"AIMed.d94.s798.p5","sentence":"CC CKR3 is a seven-transmembrane domain G protein-coupled receptor most closely related to the previously reported monocyte- and neutrophil-selective receptor CC CKR1 (also known as the @PROTEIN1$\/@PROTEIN2$ receptor).","label":0}
{"pair_id":"AIMed.d10.s84.p0","sentence":"We postulate that the mechanism of bone induction is based on the secretion of bone morphogenetic proteins @PROTEIN1$ and @PROTEIN2$ by the grafted HeLa cells.","label":0}
{"pair_id":"AIMed.d144.s1216.p0","sentence":"The @PROTEIN1$ associates with the @PROTEIN2$ catalytic subunit.","label":1}
{"pair_id":"BioInfer.d270.s0.p0","sentence":"However, increases were also selective in nature, with increases in certain individual proteins, including @PROTEIN1$ (twofold to threefold), vimentin (2.5-fold to sevenfold), @PROTEIN2$ (threefold to sixfold), and myosin heavy chain, far exceeding overall increases in cellular protein content (20-40%).","label":0}
{"pair_id":"BioInfer.d270.s0.p1","sentence":"However, increases were also selective in nature, with increases in certain individual proteins, including @PROTEIN1$ (twofold to threefold), @PROTEIN2$ (2.5-fold to sevenfold), tropomyosin (threefold to sixfold), and myosin heavy chain, far exceeding overall increases in cellular protein content (20-40%).","label":0}
{"pair_id":"BioInfer.d270.s0.p2","sentence":"However, increases were also selective in nature, with increases in certain individual proteins, including @PROTEIN1$ (twofold to threefold), vimentin (2.5-fold to sevenfold), tropomyosin (threefold to sixfold), and @PROTEIN2$, far exceeding overall increases in cellular protein content (20-40%).","label":0}
{"pair_id":"BioInfer.d270.s0.p3","sentence":"However, increases were also selective in nature, with increases in certain individual proteins, including actin (twofold to threefold), @PROTEIN2$ (2.5-fold to sevenfold), @PROTEIN1$ (threefold to sixfold), and myosin heavy chain, far exceeding overall increases in cellular protein content (20-40%).","label":0}
{"pair_id":"BioInfer.d270.s0.p4","sentence":"However, increases were also selective in nature, with increases in certain individual proteins, including actin (twofold to threefold), vimentin (2.5-fold to sevenfold), @PROTEIN1$ (threefold to sixfold), and @PROTEIN2$, far exceeding overall increases in cellular protein content (20-40%).","label":0}
{"pair_id":"BioInfer.d270.s0.p5","sentence":"However, increases were also selective in nature, with increases in certain individual proteins, including actin (twofold to threefold), @PROTEIN1$ (2.5-fold to sevenfold), tropomyosin (threefold to sixfold), and @PROTEIN2$, far exceeding overall increases in cellular protein content (20-40%).","label":0}
{"pair_id":"BioInfer.d663.s0.p0","sentence":"The potentiating effect of insulin appears to involve increases in the expression of cyclin E and decreases in the expression of the @PROTEIN1$ p27(@PROTEIN2$).","label":1}
{"pair_id":"BioInfer.d663.s0.p1","sentence":"The potentiating effect of insulin appears to involve increases in the expression of @PROTEIN2$ and decreases in the expression of the @PROTEIN1$ p27(Kip1).","label":0}
{"pair_id":"BioInfer.d663.s0.p2","sentence":"The potentiating effect of @PROTEIN2$ appears to involve increases in the expression of cyclin E and decreases in the expression of the @PROTEIN1$ p27(Kip1).","label":0}
{"pair_id":"BioInfer.d663.s0.p3","sentence":"The potentiating effect of insulin appears to involve increases in the expression of cyclin E and decreases in the expression of the @PROTEIN1$ @PROTEIN2$(Kip1).","label":1}
{"pair_id":"BioInfer.d663.s0.p4","sentence":"The potentiating effect of insulin appears to involve increases in the expression of @PROTEIN2$ and decreases in the expression of the cyclin-dependent kinase inhibitor p27(@PROTEIN1$).","label":0}
{"pair_id":"BioInfer.d663.s0.p5","sentence":"The potentiating effect of @PROTEIN2$ appears to involve increases in the expression of cyclin E and decreases in the expression of the cyclin-dependent kinase inhibitor p27(@PROTEIN1$).","label":1}
{"pair_id":"BioInfer.d663.s0.p6","sentence":"The potentiating effect of insulin appears to involve increases in the expression of cyclin E and decreases in the expression of the cyclin-dependent kinase inhibitor @PROTEIN2$(@PROTEIN1$).","label":0}
{"pair_id":"BioInfer.d663.s0.p7","sentence":"The potentiating effect of @PROTEIN2$ appears to involve increases in the expression of @PROTEIN1$ and decreases in the expression of the cyclin-dependent kinase inhibitor p27(Kip1).","label":1}
{"pair_id":"BioInfer.d663.s0.p8","sentence":"The potentiating effect of insulin appears to involve increases in the expression of @PROTEIN1$ and decreases in the expression of the cyclin-dependent kinase inhibitor @PROTEIN2$(Kip1).","label":0}
{"pair_id":"BioInfer.d663.s0.p9","sentence":"The potentiating effect of @PROTEIN1$ appears to involve increases in the expression of cyclin E and decreases in the expression of the cyclin-dependent kinase inhibitor @PROTEIN2$(Kip1).","label":1}
{"pair_id":"AIMed.d220.s1911.p0","sentence":"Two distinct ligand binding domains of @PROTEIN1$ were isolated from proteolytic digests of the receptor by affinity separation on immobilized @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d112.s950.p0","sentence":"Crosslinking of cell surface IgM led to rapid activation of both tyrosine and serine\/threonine protein kinase activities that resulted in phosphorylation in vitro of proteins coprecipitating with @PROTEIN1$--in particular, a serine\/threonine phosphorylated protein 120 kDa in size (@PROTEIN2$).","label":0}
{"pair_id":"AIMed.d59.s523.p0","sentence":"The results show that @PROTEIN1$ heterodimerizes with @PROTEIN2$ and E47 in vivo, but it does not homodimerize to a measurable extent.","label":1}
{"pair_id":"AIMed.d59.s523.p1","sentence":"The results show that @PROTEIN1$ heterodimerizes with E12 and @PROTEIN2$ in vivo, but it does not homodimerize to a measurable extent.","label":1}
{"pair_id":"AIMed.d59.s523.p2","sentence":"The results show that myogenin heterodimerizes with @PROTEIN1$ and @PROTEIN2$ in vivo, but it does not homodimerize to a measurable extent.","label":0}
{"pair_id":"BioInfer.d167.s0.p0","sentence":"Deletion of @PROTEIN2$ enhanced @PROTEIN1$ and MET15 silencing, but deletion of SIR1 or SIR3 did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.","label":1}
{"pair_id":"BioInfer.d167.s0.p1","sentence":"Deletion of SIR4 enhanced @PROTEIN1$ and MET15 silencing, but deletion of SIR1 or @PROTEIN2$ did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.","label":1}
{"pair_id":"BioInfer.d167.s0.p2","sentence":"Deletion of SIR4 enhanced @PROTEIN1$ and MET15 silencing, but deletion of @PROTEIN2$ or SIR3 did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.","label":1}
{"pair_id":"BioInfer.d167.s0.p3","sentence":"Deletion of SIR4 enhanced @PROTEIN1$ and @PROTEIN2$ silencing, but deletion of SIR1 or SIR3 did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.","label":0}
{"pair_id":"BioInfer.d167.s0.p4","sentence":"Deletion of @PROTEIN1$ enhanced mURA3 and MET15 silencing, but deletion of SIR1 or @PROTEIN2$ did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.","label":0}
{"pair_id":"BioInfer.d167.s0.p5","sentence":"Deletion of @PROTEIN1$ enhanced mURA3 and MET15 silencing, but deletion of @PROTEIN2$ or SIR3 did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.","label":0}
{"pair_id":"BioInfer.d167.s0.p6","sentence":"Deletion of @PROTEIN1$ enhanced mURA3 and @PROTEIN2$ silencing, but deletion of SIR1 or SIR3 did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.","label":1}
{"pair_id":"BioInfer.d167.s0.p7","sentence":"Deletion of SIR4 enhanced mURA3 and MET15 silencing, but deletion of @PROTEIN2$ or @PROTEIN1$ did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.","label":0}
{"pair_id":"BioInfer.d167.s0.p8","sentence":"Deletion of SIR4 enhanced mURA3 and @PROTEIN2$ silencing, but deletion of SIR1 or @PROTEIN1$ did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.","label":1}
{"pair_id":"BioInfer.d167.s0.p9","sentence":"Deletion of SIR4 enhanced mURA3 and @PROTEIN2$ silencing, but deletion of @PROTEIN1$ or SIR3 did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.","label":1}
{"pair_id":"AIMed.d160.s1347.p0","sentence":"Arg82, Lys84 and His86, located in a hairpin loop, were found to be critical for binding @PROTEIN1$\/@PROTEIN2$, while negatively charged residues, Asp63, Glu64, and Glu67, were associated with FLT-1 binding.","label":0}
{"pair_id":"AIMed.d160.s1347.p1","sentence":"Arg82, Lys84 and His86, located in a hairpin loop, were found to be critical for binding @PROTEIN1$\/Flk-1, while negatively charged residues, Asp63, Glu64, and Glu67, were associated with @PROTEIN2$ binding.","label":0}
{"pair_id":"AIMed.d160.s1347.p2","sentence":"Arg82, Lys84 and His86, located in a hairpin loop, were found to be critical for binding KDR\/@PROTEIN1$, while negatively charged residues, Asp63, Glu64, and Glu67, were associated with @PROTEIN2$ binding.","label":0}
{"pair_id":"BioInfer.d584.s0.p0","sentence":"The @PROTEIN1$ (@PROTEIN2$) contains the actin- and ATP-binding sites and represents the molecular motor of muscle contraction.","label":0}
{"pair_id":"BioInfer.d584.s0.p1","sentence":"The @PROTEIN1$ (MHC) contains the @PROTEIN2$- and ATP-binding sites and represents the molecular motor of muscle contraction.","label":1}
{"pair_id":"BioInfer.d584.s0.p2","sentence":"The myosin heavy chain (@PROTEIN1$) contains the @PROTEIN2$- and ATP-binding sites and represents the molecular motor of muscle contraction.","label":1}
{"pair_id":"BioInfer.d97.s0.p0","sentence":"Binding of @PROTEIN2$ to @PROTEIN1$ occurs at a maximal molar ratio of 1:3 as determined by fluorescencetitration under G-buffer conditions.","label":1}
{"pair_id":"AIMed.d187.s1589.p0","sentence":"@PROTEIN1$ (@PROTEIN2$), a second major CSF protein, formed SDS-stable complexes with A beta and significantly decreased the rate of A beta fibril formation.","label":0}
{"pair_id":"AIMed.d187.s1589.p1","sentence":"@PROTEIN1$ (TTR), a second major CSF protein, formed SDS-stable complexes with @PROTEIN2$ and significantly decreased the rate of A beta fibril formation.","label":1}
{"pair_id":"AIMed.d187.s1589.p2","sentence":"@PROTEIN1$ (TTR), a second major CSF protein, formed SDS-stable complexes with A beta and significantly decreased the rate of @PROTEIN2$ fibril formation.","label":0}
{"pair_id":"AIMed.d187.s1589.p3","sentence":"Transthyretin (@PROTEIN1$), a second major CSF protein, formed SDS-stable complexes with @PROTEIN2$ and significantly decreased the rate of A beta fibril formation.","label":1}
{"pair_id":"AIMed.d187.s1589.p4","sentence":"Transthyretin (@PROTEIN1$), a second major CSF protein, formed SDS-stable complexes with A beta and significantly decreased the rate of @PROTEIN2$ fibril formation.","label":0}
{"pair_id":"AIMed.d187.s1589.p5","sentence":"Transthyretin (TTR), a second major CSF protein, formed SDS-stable complexes with @PROTEIN1$ and significantly decreased the rate of @PROTEIN2$ fibril formation.","label":0}
{"pair_id":"BioInfer.d397.s1.p0","sentence":"Regulation of @PROTEIN2$ and @PROTEIN1$ isogenes expression during cardiac growth.","label":0}
{"pair_id":"BioInfer.d33.s1.p0","sentence":"Loss of normal surface @PROTEIN2$, alpha-catenin, @PROTEIN1$ and gamma-catenin expression was found in 52\/68 (76.4%) tumors, 57\/68 (83.8%) tumors, 54\/68 (79.4%) tumors and 54\/68 (79.4%) tumors (p <0.001).","label":0}
{"pair_id":"BioInfer.d33.s1.p1","sentence":"Loss of normal surface E-cadherin, alpha-catenin, @PROTEIN1$ and @PROTEIN2$ expression was found in 52\/68 (76.4%) tumors, 57\/68 (83.8%) tumors, 54\/68 (79.4%) tumors and 54\/68 (79.4%) tumors (p <0.001).","label":0}
{"pair_id":"BioInfer.d33.s1.p2","sentence":"Loss of normal surface E-cadherin, @PROTEIN2$, @PROTEIN1$ and gamma-catenin expression was found in 52\/68 (76.4%) tumors, 57\/68 (83.8%) tumors, 54\/68 (79.4%) tumors and 54\/68 (79.4%) tumors (p <0.001).","label":0}
{"pair_id":"BioInfer.d33.s1.p3","sentence":"Loss of normal surface @PROTEIN1$, alpha-catenin, beta-catenin and @PROTEIN2$ expression was found in 52\/68 (76.4%) tumors, 57\/68 (83.8%) tumors, 54\/68 (79.4%) tumors and 54\/68 (79.4%) tumors (p <0.001).","label":0}
{"pair_id":"BioInfer.d33.s1.p4","sentence":"Loss of normal surface @PROTEIN1$, @PROTEIN2$, beta-catenin and gamma-catenin expression was found in 52\/68 (76.4%) tumors, 57\/68 (83.8%) tumors, 54\/68 (79.4%) tumors and 54\/68 (79.4%) tumors (p <0.001).","label":0}
{"pair_id":"BioInfer.d33.s1.p5","sentence":"Loss of normal surface E-cadherin, @PROTEIN2$, beta-catenin and @PROTEIN1$ expression was found in 52\/68 (76.4%) tumors, 57\/68 (83.8%) tumors, 54\/68 (79.4%) tumors and 54\/68 (79.4%) tumors (p <0.001).","label":0}
{"pair_id":"BioInfer.d143.s1.p0","sentence":"The @PROTEIN2$-sequestering activity of both maize @PROTEIN1$ classes was found to be dependent on the concentration of free calcium.","label":1}
{"pair_id":"BioInfer.d574.s0.p0","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (@PROTEIN2$), phosphoprotein (P), H, nucleocapsid (N) and matrix (@PROTEIN1$) phosphop.","label":0}
{"pair_id":"BioInfer.d574.s0.p1","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, @PROTEIN2$ (N) and matrix (@PROTEIN1$) @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d574.s0.p2","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (@PROTEIN2$), H, nucleocapsid (N) and matrix (@PROTEIN1$) phosphop.","label":0}
{"pair_id":"BioInfer.d574.s0.p3","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (@PROTEIN2$) and matrix (@PROTEIN1$) phosphop.","label":0}
{"pair_id":"BioInfer.d574.s0.p4","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), @PROTEIN2$, nucleocapsid (N) and matrix (@PROTEIN1$) @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d574.s0.p5","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the @PROTEIN2$ (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (@PROTEIN1$) @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d574.s0.p6","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and @PROTEIN2$ (@PROTEIN1$) @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d574.s0.p7","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), @PROTEIN2$ (P), H, nucleocapsid (N) and matrix (@PROTEIN1$) @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d574.s0.p8","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (@PROTEIN1$), phosphoprotein (P), H, @PROTEIN2$ (N) and matrix (M) @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d574.s0.p9","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (@PROTEIN1$), phosphoprotein (@PROTEIN2$), H, nucleocapsid (N) and matrix (M) phosphop.","label":0}
{"pair_id":"BioInfer.d574.s0.p10","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (@PROTEIN1$), phosphoprotein (P), H, nucleocapsid (@PROTEIN2$) and matrix (M) phosphop.","label":0}
{"pair_id":"BioInfer.d574.s0.p11","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (@PROTEIN1$), phosphoprotein (P), @PROTEIN2$, nucleocapsid (N) and matrix (M) @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d574.s0.p12","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the @PROTEIN2$ (@PROTEIN1$), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d574.s0.p13","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (@PROTEIN1$), phosphoprotein (P), H, nucleocapsid (N) and @PROTEIN2$ (M) @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d574.s0.p14","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (@PROTEIN1$), @PROTEIN2$ (P), H, nucleocapsid (N) and matrix (M) @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d574.s0.p15","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (@PROTEIN2$), H, @PROTEIN1$ (N) and matrix (M) @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d574.s0.p16","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, @PROTEIN1$ (@PROTEIN2$) and matrix (M) @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d574.s0.p17","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), @PROTEIN2$, @PROTEIN1$ (N) and matrix (M) @PROTEIN1$@PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d574.s0.p18","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the @PROTEIN2$ (F), phosphoprotein (P), H, @PROTEIN1$ (N) and matrix (M) @PROTEIN1$@PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d574.s0.p19","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, @PROTEIN1$ (N) and @PROTEIN2$ (M) @PROTEIN1$@PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d574.s0.p20","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), @PROTEIN2$ (P), H, @PROTEIN1$ (N) and matrix (M) @PROTEIN1$@PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d574.s0.p21","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (@PROTEIN1$), H, nucleocapsid (@PROTEIN2$) and matrix (M) phosphop.","label":0}
{"pair_id":"BioInfer.d574.s0.p22","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (@PROTEIN1$), @PROTEIN2$, nucleocapsid (N) and matrix (M) @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d574.s0.p23","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the @PROTEIN2$ (F), phosphoprotein (@PROTEIN1$), H, nucleocapsid (N) and matrix (M) @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d574.s0.p24","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (@PROTEIN1$), H, nucleocapsid (N) and @PROTEIN2$ (M) @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d574.s0.p25","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), @PROTEIN2$ (@PROTEIN1$), H, nucleocapsid (N) and matrix (M) @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d574.s0.p26","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), @PROTEIN2$, nucleocapsid (@PROTEIN1$) and matrix (M) @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d574.s0.p27","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the @PROTEIN2$ (F), phosphoprotein (P), H, nucleocapsid (@PROTEIN1$) and matrix (M) @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d574.s0.p28","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (@PROTEIN1$) and @PROTEIN2$ (M) @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d574.s0.p29","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), @PROTEIN2$ (P), H, nucleocapsid (@PROTEIN1$) and matrix (M) @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d574.s0.p30","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the @PROTEIN2$ (F), phosphoprotein (P), @PROTEIN1$, nucleocapsid (N) and matrix (M) @PROTEIN1$@PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d574.s0.p31","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), @PROTEIN1$, nucleocapsid (N) and @PROTEIN2$ (M) @PROTEIN1$@PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d574.s0.p32","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), @PROTEIN2$ (P), @PROTEIN1$, nucleocapsid (N) and matrix (M) @PROTEIN1$@PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d574.s0.p33","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the @PROTEIN1$ (F), phosphoprotein (P), H, nucleocapsid (N) and @PROTEIN2$ (M) @PROTEIN1$@PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d574.s0.p34","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the @PROTEIN1$ (F), @PROTEIN2$ (P), H, nucleocapsid (N) and matrix (M) @PROTEIN1$@PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d574.s0.p35","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), @PROTEIN2$ (P), H, nucleocapsid (N) and @PROTEIN1$ (M) @PROTEIN1$@PROTEIN2$.","label":0}
{"pair_id":"AIMed.d48.s426.p0","sentence":"A neutralizing polyclonal antibody to @PROTEIN1$ was developed to demonstrate that the unusually high concentration of @PROTEIN2$ required to induce chemotaxis was a property of LEC and not as a result of an irrelevant protein contamination.","label":0}
{"pair_id":"AIMed.d48.s426.p1","sentence":"A neutralizing polyclonal antibody to @PROTEIN1$ was developed to demonstrate that the unusually high concentration of LEC required to induce chemotaxis was a property of @PROTEIN2$ and not as a result of an irrelevant protein contamination.","label":0}
{"pair_id":"AIMed.d48.s426.p2","sentence":"A neutralizing polyclonal antibody to LEC was developed to demonstrate that the unusually high concentration of @PROTEIN1$ required to induce chemotaxis was a property of @PROTEIN2$ and not as a result of an irrelevant protein contamination.","label":0}
{"pair_id":"BioInfer.d479.s0.p0","sentence":"@PROTEIN1$ (p21WAF1\/Cip1), a cyclin-dependent kinase inhibitor, induces G1 arrest and can inhibit the activity of the proliferating cell nuclear antigen (@PROTEIN2$).","label":1}
{"pair_id":"BioInfer.d479.s0.p1","sentence":"@PROTEIN1$ (p21WAF1\/@PROTEIN2$), a cyclin-dependent kinase inhibitor, induces G1 arrest and can inhibit the activity of the proliferating cell nuclear antigen (PCNA).","label":0}
{"pair_id":"BioInfer.d479.s0.p2","sentence":"@PROTEIN1$ (@PROTEIN2$\/Cip1), a cyclin-dependent kinase inhibitor, induces G1 arrest and can inhibit the activity of the proliferating cell nuclear antigen (PCNA).","label":0}
{"pair_id":"BioInfer.d479.s0.p3","sentence":"@PROTEIN1$ (p21WAF1\/Cip1), a cyclin-dependent kinase inhibitor, induces G1 arrest and can inhibit the activity of the @PROTEIN2$ (PCNA).","label":1}
{"pair_id":"BioInfer.d479.s0.p4","sentence":"@PROTEIN1$ (p21WAF1\/Cip1), a @PROTEIN2$, induces G1 arrest and can inhibit the activity of the proliferating cell nuclear antigen (PCNA).","label":1}
{"pair_id":"BioInfer.d479.s0.p5","sentence":"p21 (p21WAF1\/@PROTEIN2$), a cyclin-dependent kinase inhibitor, induces G1 arrest and can inhibit the activity of the proliferating cell nuclear antigen (@PROTEIN1$).","label":1}
{"pair_id":"BioInfer.d479.s0.p6","sentence":"p21 (@PROTEIN2$\/Cip1), a cyclin-dependent kinase inhibitor, induces G1 arrest and can inhibit the activity of the proliferating cell nuclear antigen (@PROTEIN1$).","label":1}
{"pair_id":"BioInfer.d479.s0.p7","sentence":"p21 (p21WAF1\/Cip1), a cyclin-dependent kinase inhibitor, induces G1 arrest and can inhibit the activity of the @PROTEIN2$ (@PROTEIN1$).","label":0}
{"pair_id":"BioInfer.d479.s0.p8","sentence":"p21 (p21WAF1\/Cip1), a @PROTEIN2$, induces G1 arrest and can inhibit the activity of the proliferating cell nuclear antigen (@PROTEIN1$).","label":0}
{"pair_id":"BioInfer.d479.s0.p9","sentence":"p21 (@PROTEIN2$\/@PROTEIN1$), a cyclin-dependent kinase inhibitor, induces G1 arrest and can inhibit the activity of the proliferating cell nuclear antigen (PCNA).","label":0}
{"pair_id":"BioInfer.d479.s0.p10","sentence":"p21 (p21WAF1\/@PROTEIN1$), a cyclin-dependent kinase inhibitor, induces G1 arrest and can inhibit the activity of the @PROTEIN2$ (PCNA).","label":1}
{"pair_id":"BioInfer.d479.s0.p11","sentence":"p21 (p21WAF1\/@PROTEIN1$), a @PROTEIN2$, induces G1 arrest and can inhibit the activity of the proliferating cell nuclear antigen (PCNA).","label":1}
{"pair_id":"BioInfer.d479.s0.p12","sentence":"p21 (@PROTEIN1$\/Cip1), a cyclin-dependent kinase inhibitor, induces G1 arrest and can inhibit the activity of the @PROTEIN2$ (PCNA).","label":1}
{"pair_id":"BioInfer.d479.s0.p13","sentence":"p21 (@PROTEIN1$\/Cip1), a @PROTEIN2$, induces G1 arrest and can inhibit the activity of the proliferating cell nuclear antigen (PCNA).","label":1}
{"pair_id":"BioInfer.d479.s0.p14","sentence":"p21 (p21WAF1\/Cip1), a @PROTEIN2$, induces G1 arrest and can inhibit the activity of the @PROTEIN1$ (PCNA).","label":0}
{"pair_id":"BioInfer.d113.s2.p0","sentence":"Tyrosine phosphorylation of beta-catenin was concomitantly induced with association of beta-catenin with EGF receptor (@PROTEIN2$) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of alpha-catenin from @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d113.s2.p1","sentence":"Tyrosine phosphorylation of beta-catenin was concomitantly induced with association of @PROTEIN2$ with EGF receptor (EGFR) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of alpha-catenin from @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d113.s2.p2","sentence":"Tyrosine phosphorylation of @PROTEIN2$ was concomitantly induced with association of beta-catenin with EGF receptor (EGFR) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of alpha-catenin from @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d113.s2.p3","sentence":"Tyrosine phosphorylation of beta-catenin was concomitantly induced with association of beta-catenin with @PROTEIN2$ (EGFR) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of alpha-catenin from @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d113.s2.p4","sentence":"Tyrosine phosphorylation of beta-catenin was concomitantly induced with association of beta-catenin with EGF receptor (EGFR) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of @PROTEIN2$ from @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d113.s2.p5","sentence":"Tyrosine phosphorylation of beta-catenin was concomitantly induced with association of @PROTEIN2$ with EGF receptor (@PROTEIN1$) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of alpha-catenin from E-cadherin.","label":1}
{"pair_id":"BioInfer.d113.s2.p6","sentence":"Tyrosine phosphorylation of @PROTEIN2$ was concomitantly induced with association of beta-catenin with EGF receptor (@PROTEIN1$) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of alpha-catenin from E-cadherin.","label":1}
{"pair_id":"BioInfer.d113.s2.p7","sentence":"Tyrosine phosphorylation of beta-catenin was concomitantly induced with association of beta-catenin with @PROTEIN2$ (@PROTEIN1$) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of alpha-catenin from E-cadherin.","label":0}
{"pair_id":"BioInfer.d113.s2.p8","sentence":"Tyrosine phosphorylation of beta-catenin was concomitantly induced with association of beta-catenin with EGF receptor (@PROTEIN1$) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of @PROTEIN2$ from E-cadherin.","label":0}
{"pair_id":"BioInfer.d113.s2.p9","sentence":"Tyrosine phosphorylation of @PROTEIN2$ was concomitantly induced with association of @PROTEIN1$ with EGF receptor (EGFR) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of alpha-catenin from E-cadherin.","label":1}
{"pair_id":"BioInfer.d113.s2.p10","sentence":"Tyrosine phosphorylation of beta-catenin was concomitantly induced with association of @PROTEIN1$ with @PROTEIN2$ (EGFR) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of alpha-catenin from E-cadherin.","label":1}
{"pair_id":"BioInfer.d113.s2.p11","sentence":"Tyrosine phosphorylation of beta-catenin was concomitantly induced with association of @PROTEIN1$ with EGF receptor (EGFR) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of @PROTEIN2$ from E-cadherin.","label":0}
{"pair_id":"BioInfer.d113.s2.p12","sentence":"Tyrosine phosphorylation of @PROTEIN1$ was concomitantly induced with association of beta-catenin with @PROTEIN2$ (EGFR) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of alpha-catenin from E-cadherin.","label":1}
{"pair_id":"BioInfer.d113.s2.p13","sentence":"Tyrosine phosphorylation of @PROTEIN1$ was concomitantly induced with association of beta-catenin with EGF receptor (EGFR) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of @PROTEIN2$ from E-cadherin.","label":0}
{"pair_id":"BioInfer.d113.s2.p14","sentence":"Tyrosine phosphorylation of beta-catenin was concomitantly induced with association of beta-catenin with @PROTEIN1$ (EGFR) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of @PROTEIN2$ from E-cadherin.","label":0}
{"pair_id":"AIMed.d131.s1120.p0","sentence":"cDNA clones encoding a human @PROTEIN1$ (@PROTEIN2$) from a Burkitt lymphoma cell line, BJAB, express a 90 to 110 kDa polypeptide in COS7 cells that binds hIL-10 specifically.","label":0}
{"pair_id":"AIMed.d131.s1120.p1","sentence":"cDNA clones encoding a human @PROTEIN1$ (hIL-10R) from a Burkitt lymphoma cell line, BJAB, express a 90 to 110 kDa polypeptide in COS7 cells that binds @PROTEIN2$ specifically.","label":1}
{"pair_id":"AIMed.d131.s1120.p2","sentence":"cDNA clones encoding a human IL-10R (@PROTEIN1$) from a Burkitt lymphoma cell line, BJAB, express a 90 to 110 kDa polypeptide in COS7 cells that binds @PROTEIN2$ specifically.","label":1}
{"pair_id":"BioInfer.d66.s0.p0","sentence":"Another @PROTEIN2$, p27KIP1, and cyclin D increased slightly, whereas @PROTEIN1$ and p130 remained unchanged.","label":0}
{"pair_id":"BioInfer.d66.s0.p1","sentence":"Another cyclin-dependent kinase inhibitor, p27KIP1, and cyclin D increased slightly, whereas @PROTEIN1$ and @PROTEIN2$ remained unchanged.","label":0}
{"pair_id":"BioInfer.d66.s0.p2","sentence":"Another cyclin-dependent kinase inhibitor, @PROTEIN2$, and cyclin D increased slightly, whereas @PROTEIN1$ and p130 remained unchanged.","label":0}
{"pair_id":"BioInfer.d66.s0.p3","sentence":"Another cyclin-dependent kinase inhibitor, p27KIP1, and @PROTEIN2$ increased slightly, whereas @PROTEIN1$ and p130 remained unchanged.","label":0}
{"pair_id":"BioInfer.d66.s0.p4","sentence":"Another @PROTEIN1$, p27KIP1, and cyclin D increased slightly, whereas proliferating cell nuclear antigen and @PROTEIN2$ remained unchanged.","label":0}
{"pair_id":"BioInfer.d66.s0.p5","sentence":"Another @PROTEIN1$, @PROTEIN2$, and cyclin D increased slightly, whereas proliferating cell nuclear antigen and p130 remained unchanged.","label":1}
{"pair_id":"BioInfer.d66.s0.p6","sentence":"Another @PROTEIN1$, p27KIP1, and @PROTEIN2$ increased slightly, whereas proliferating cell nuclear antigen and p130 remained unchanged.","label":0}
{"pair_id":"BioInfer.d66.s0.p7","sentence":"Another cyclin-dependent kinase inhibitor, @PROTEIN2$, and cyclin D increased slightly, whereas proliferating cell nuclear antigen and @PROTEIN1$ remained unchanged.","label":0}
{"pair_id":"BioInfer.d66.s0.p8","sentence":"Another cyclin-dependent kinase inhibitor, p27KIP1, and @PROTEIN2$ increased slightly, whereas proliferating cell nuclear antigen and @PROTEIN1$ remained unchanged.","label":0}
{"pair_id":"BioInfer.d66.s0.p9","sentence":"Another cyclin-dependent kinase inhibitor, @PROTEIN1$, and @PROTEIN2$ increased slightly, whereas proliferating cell nuclear antigen and p130 remained unchanged.","label":0}
{"pair_id":"BioInfer.d814.s0.p0","sentence":"We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the @PROTEIN2$ family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the @PROTEIN1$ cytoskeleton in the yeast Saccharomyces cerevisiae.","label":0}
{"pair_id":"BioInfer.d814.s0.p1","sentence":"We have shown that the FH proteins Bni1p and @PROTEIN2$ are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the @PROTEIN1$ cytoskeleton in the yeast Saccharomyces cerevisiae.","label":1}
{"pair_id":"BioInfer.d814.s0.p2","sentence":"We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family @PROTEIN2$ and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the @PROTEIN1$ cytoskeleton in the yeast Saccharomyces cerevisiae.","label":0}
{"pair_id":"BioInfer.d814.s0.p3","sentence":"We have shown that the FH proteins @PROTEIN2$ and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the @PROTEIN1$ cytoskeleton in the yeast Saccharomyces cerevisiae.","label":1}
{"pair_id":"BioInfer.d814.s0.p4","sentence":"We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, @PROTEIN2$, at their proline-rich FH1 domains to regulate reorganization of the @PROTEIN1$ cytoskeleton in the yeast Saccharomyces cerevisiae.","label":1}
{"pair_id":"BioInfer.d814.s0.p5","sentence":"We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an @PROTEIN2$, profilin, at their proline-rich FH1 domains to regulate reorganization of the @PROTEIN1$ cytoskeleton in the yeast Saccharomyces cerevisiae.","label":0}
{"pair_id":"BioInfer.d814.s0.p6","sentence":"We have shown that the @PROTEIN2$ Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the @PROTEIN1$ cytoskeleton in the yeast Saccharomyces cerevisiae.","label":0}
{"pair_id":"BioInfer.d814.s0.p7","sentence":"We have shown that the FH proteins Bni1p and @PROTEIN2$ are potential targets of the @PROTEIN1$ family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.","label":1}
{"pair_id":"BioInfer.d814.s0.p8","sentence":"We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the @PROTEIN1$ family @PROTEIN2$ and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.","label":1}
{"pair_id":"BioInfer.d814.s0.p9","sentence":"We have shown that the FH proteins @PROTEIN2$ and Bnr1p are potential targets of the @PROTEIN1$ family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.","label":1}
{"pair_id":"BioInfer.d814.s0.p10","sentence":"We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the @PROTEIN1$ family small GTP-binding proteins and bind to an actin-binding protein, @PROTEIN2$, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.","label":0}
{"pair_id":"BioInfer.d814.s0.p11","sentence":"We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the @PROTEIN1$ family small GTP-binding proteins and bind to an @PROTEIN2$, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.","label":0}
{"pair_id":"BioInfer.d814.s0.p12","sentence":"We have shown that the @PROTEIN2$ Bni1p and Bnr1p are potential targets of the @PROTEIN1$ family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.","label":0}
{"pair_id":"BioInfer.d814.s0.p13","sentence":"We have shown that the FH proteins Bni1p and @PROTEIN1$ are potential targets of the Rho family @PROTEIN2$ and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.","label":1}
{"pair_id":"BioInfer.d814.s0.p14","sentence":"We have shown that the FH proteins @PROTEIN2$ and @PROTEIN1$ are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.","label":0}
{"pair_id":"BioInfer.d814.s0.p15","sentence":"We have shown that the FH proteins Bni1p and @PROTEIN1$ are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, @PROTEIN2$, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.","label":1}
{"pair_id":"BioInfer.d814.s0.p16","sentence":"We have shown that the FH proteins Bni1p and @PROTEIN1$ are potential targets of the Rho family small GTP-binding proteins and bind to an @PROTEIN2$, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.","label":0}
{"pair_id":"BioInfer.d814.s0.p17","sentence":"We have shown that the @PROTEIN2$ Bni1p and @PROTEIN1$ are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.","label":1}
{"pair_id":"BioInfer.d814.s0.p18","sentence":"We have shown that the FH proteins @PROTEIN2$ and Bnr1p are potential targets of the Rho family @PROTEIN1$ and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.","label":1}
{"pair_id":"BioInfer.d814.s0.p19","sentence":"We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family @PROTEIN1$ and bind to an actin-binding protein, @PROTEIN2$, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.","label":0}
{"pair_id":"BioInfer.d814.s0.p20","sentence":"We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family @PROTEIN1$ and bind to an @PROTEIN2$, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.","label":0}
{"pair_id":"BioInfer.d814.s0.p21","sentence":"We have shown that the @PROTEIN2$ Bni1p and Bnr1p are potential targets of the Rho family @PROTEIN1$ and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.","label":0}
{"pair_id":"BioInfer.d814.s0.p22","sentence":"We have shown that the FH proteins @PROTEIN1$ and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, @PROTEIN2$, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.","label":1}
{"pair_id":"BioInfer.d814.s0.p23","sentence":"We have shown that the FH proteins @PROTEIN1$ and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an @PROTEIN2$, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.","label":0}
{"pair_id":"BioInfer.d814.s0.p24","sentence":"We have shown that the @PROTEIN2$ @PROTEIN1$ and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.","label":1}
{"pair_id":"BioInfer.d814.s0.p25","sentence":"We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an @PROTEIN2$, @PROTEIN1$, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.","label":1}
{"pair_id":"BioInfer.d814.s0.p26","sentence":"We have shown that the @PROTEIN2$ Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, @PROTEIN1$, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.","label":0}
{"pair_id":"BioInfer.d814.s0.p27","sentence":"We have shown that the @PROTEIN2$ Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an @PROTEIN1$, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.","label":0}
{"pair_id":"AIMed.d211.s1831.p0","sentence":"The encoded product of the @PROTEIN1$ gene has a motif structure similar to that of neuregulins and an alternative splicing site in the @PROTEIN2$(EGF)-like domain gives rise to two isoforms (alpha and beta).","label":0}
{"pair_id":"AIMed.d211.s1831.p1","sentence":"The encoded product of the @PROTEIN1$ gene has a motif structure similar to that of neuregulins and an alternative splicing site in the epidermal growth factor(@PROTEIN2$)-like domain gives rise to two isoforms (alpha and beta).","label":0}
{"pair_id":"AIMed.d211.s1831.p2","sentence":"The encoded product of the neuregulin-2 gene has a motif structure similar to that of neuregulins and an alternative splicing site in the @PROTEIN1$(@PROTEIN2$)-like domain gives rise to two isoforms (alpha and beta).","label":0}
{"pair_id":"BioInfer.d651.s0.p0","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, @PROTEIN1$, collagen type IV, laminin and @PROTEIN2$ protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p1","sentence":"The neoplastic cells were positive for @PROTEIN2$, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, @PROTEIN1$, collagen type IV, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p2","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, @PROTEIN2$ and CD34, but negative for desmin, calponin, high molecular weight caldesmon, @PROTEIN1$, collagen type IV, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p3","sentence":"The neoplastic cells were positive for vimentin, @PROTEIN2$, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, @PROTEIN1$, collagen type IV, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p4","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for @PROTEIN2$, calponin, high molecular weight caldesmon, @PROTEIN1$, collagen type IV, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p5","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and @PROTEIN2$, but negative for desmin, calponin, high molecular weight caldesmon, @PROTEIN1$, collagen type IV, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p6","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, @PROTEIN2$, @PROTEIN1$, collagen type IV, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p7","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, @PROTEIN2$, high molecular weight caldesmon, @PROTEIN1$, collagen type IV, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p8","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, @PROTEIN1$, @PROTEIN2$, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p9","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, @PROTEIN1$, collagen type IV, @PROTEIN2$ and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p10","sentence":"The neoplastic cells were positive for @PROTEIN2$, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and @PROTEIN1$ protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p11","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, @PROTEIN2$ and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and @PROTEIN1$ protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p12","sentence":"The neoplastic cells were positive for vimentin, @PROTEIN2$, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and @PROTEIN1$ protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p13","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for @PROTEIN2$, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and @PROTEIN1$ protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p14","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and @PROTEIN2$, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and @PROTEIN1$ protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p15","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, @PROTEIN2$, smooth muscle myosin heavy chain, collagen type IV, laminin and @PROTEIN1$ protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p16","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, @PROTEIN2$, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and @PROTEIN1$ protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p17","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, @PROTEIN2$, laminin and @PROTEIN1$ protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p18","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, @PROTEIN2$ and @PROTEIN1$ protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p19","sentence":"The neoplastic cells were positive for @PROTEIN1$, Factor-XIIIa, @PROTEIN2$ and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p20","sentence":"The neoplastic cells were positive for @PROTEIN1$, @PROTEIN2$, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p21","sentence":"The neoplastic cells were positive for @PROTEIN1$, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for @PROTEIN2$, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p22","sentence":"The neoplastic cells were positive for @PROTEIN1$, Factor-XIIIa, alpha-smooth muscle actin and @PROTEIN2$, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p23","sentence":"The neoplastic cells were positive for @PROTEIN1$, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, @PROTEIN2$, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p24","sentence":"The neoplastic cells were positive for @PROTEIN1$, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, @PROTEIN2$, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p25","sentence":"The neoplastic cells were positive for @PROTEIN1$, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, @PROTEIN2$, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p26","sentence":"The neoplastic cells were positive for @PROTEIN1$, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, @PROTEIN2$ and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p27","sentence":"The neoplastic cells were positive for vimentin, @PROTEIN2$, @PROTEIN1$ and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p28","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, @PROTEIN1$ and CD34, but negative for @PROTEIN2$, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p29","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, @PROTEIN1$ and @PROTEIN2$, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p30","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, @PROTEIN1$ and CD34, but negative for desmin, calponin, @PROTEIN2$, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p31","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, @PROTEIN1$ and CD34, but negative for desmin, @PROTEIN2$, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p32","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, @PROTEIN1$ and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, @PROTEIN2$, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p33","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, @PROTEIN1$ and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, @PROTEIN2$ and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p34","sentence":"The neoplastic cells were positive for vimentin, @PROTEIN1$, alpha-smooth muscle actin and CD34, but negative for @PROTEIN2$, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p35","sentence":"The neoplastic cells were positive for vimentin, @PROTEIN1$, alpha-smooth muscle actin and @PROTEIN2$, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p36","sentence":"The neoplastic cells were positive for vimentin, @PROTEIN1$, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, @PROTEIN2$, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p37","sentence":"The neoplastic cells were positive for vimentin, @PROTEIN1$, alpha-smooth muscle actin and CD34, but negative for desmin, @PROTEIN2$, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p38","sentence":"The neoplastic cells were positive for vimentin, @PROTEIN1$, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, @PROTEIN2$, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p39","sentence":"The neoplastic cells were positive for vimentin, @PROTEIN1$, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, @PROTEIN2$ and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p40","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and @PROTEIN2$, but negative for @PROTEIN1$, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p41","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for @PROTEIN1$, calponin, @PROTEIN2$, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p42","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for @PROTEIN1$, @PROTEIN2$, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p43","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for @PROTEIN1$, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, @PROTEIN2$, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p44","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for @PROTEIN1$, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, @PROTEIN2$ and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p45","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and @PROTEIN1$, but negative for desmin, calponin, @PROTEIN2$, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p46","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and @PROTEIN1$, but negative for desmin, @PROTEIN2$, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p47","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and @PROTEIN1$, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, @PROTEIN2$, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p48","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and @PROTEIN1$, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, @PROTEIN2$ and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p49","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, @PROTEIN2$, @PROTEIN1$, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p50","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, @PROTEIN1$, smooth muscle myosin heavy chain, @PROTEIN2$, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p51","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, @PROTEIN1$, smooth muscle myosin heavy chain, collagen type IV, @PROTEIN2$ and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p52","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, @PROTEIN1$, high molecular weight caldesmon, smooth muscle myosin heavy chain, @PROTEIN2$, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p53","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, @PROTEIN1$, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, @PROTEIN2$ and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p54","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, @PROTEIN1$, @PROTEIN2$ and S-100 protein.","label":0}
{"pair_id":"AIMed.d139.s1171.p0","sentence":"@PROTEIN1$. an Ala-->Gly substitution in helix 1 of @PROTEIN2$ repeat 17 that severely disrupts the structure and self-association of the erythrocyte spectrin heterodimer.","label":0}
{"pair_id":"BioInfer.d769.s1.p0","sentence":"Various immunological assays suggest that four of these proteins (UL5, @PROTEIN2$, UL9, and @PROTEIN1$) are made in infected cells in very low abundance relative to the other three.","label":0}
{"pair_id":"BioInfer.d769.s1.p1","sentence":"Various immunological assays suggest that four of these proteins (UL5, UL8, @PROTEIN2$, and @PROTEIN1$) are made in infected cells in very low abundance relative to the other three.","label":0}
{"pair_id":"BioInfer.d769.s1.p2","sentence":"Various immunological assays suggest that four of these proteins (@PROTEIN2$, UL8, UL9, and @PROTEIN1$) are made in infected cells in very low abundance relative to the other three.","label":0}
{"pair_id":"BioInfer.d769.s1.p3","sentence":"Various immunological assays suggest that four of these proteins (UL5, @PROTEIN1$, @PROTEIN2$, and UL52) are made in infected cells in very low abundance relative to the other three.","label":0}
{"pair_id":"BioInfer.d769.s1.p4","sentence":"Various immunological assays suggest that four of these proteins (@PROTEIN2$, @PROTEIN1$, UL9, and UL52) are made in infected cells in very low abundance relative to the other three.","label":0}
{"pair_id":"BioInfer.d769.s1.p5","sentence":"Various immunological assays suggest that four of these proteins (@PROTEIN2$, UL8, @PROTEIN1$, and UL52) are made in infected cells in very low abundance relative to the other three.","label":0}
{"pair_id":"BioInfer.d827.s0.p0","sentence":"We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in @PROTEIN1$ or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of @PROTEIN2$, MSH6, BAX, and TGFbeta RII.","label":0}
{"pair_id":"BioInfer.d827.s0.p1","sentence":"We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in @PROTEIN1$ or @PROTEIN2$ to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, BAX, and TGFbeta RII.","label":0}
{"pair_id":"BioInfer.d827.s0.p2","sentence":"We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in @PROTEIN1$ or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, @PROTEIN2$, and TGFbeta RII.","label":0}
{"pair_id":"BioInfer.d827.s0.p3","sentence":"We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in @PROTEIN1$ or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, @PROTEIN2$, BAX, and TGFbeta RII.","label":0}
{"pair_id":"BioInfer.d827.s0.p4","sentence":"We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in @PROTEIN1$ or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, BAX, and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d827.s0.p5","sentence":"We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or @PROTEIN2$ to assess the involvement of mononucleotide repeats contained in the coding regions of @PROTEIN1$, MSH6, BAX, and TGFbeta RII.","label":0}
{"pair_id":"BioInfer.d827.s0.p6","sentence":"We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of @PROTEIN1$, MSH6, @PROTEIN2$, and TGFbeta RII.","label":0}
{"pair_id":"BioInfer.d827.s0.p7","sentence":"We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of @PROTEIN1$, @PROTEIN2$, BAX, and TGFbeta RII.","label":0}
{"pair_id":"BioInfer.d827.s0.p8","sentence":"We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of @PROTEIN1$, MSH6, BAX, and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d827.s0.p9","sentence":"We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or @PROTEIN1$ to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, @PROTEIN2$, and TGFbeta RII.","label":0}
{"pair_id":"BioInfer.d827.s0.p10","sentence":"We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or @PROTEIN1$ to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, @PROTEIN2$, BAX, and TGFbeta RII.","label":0}
{"pair_id":"BioInfer.d827.s0.p11","sentence":"We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or @PROTEIN1$ to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, BAX, and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d827.s0.p12","sentence":"We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, @PROTEIN2$, @PROTEIN1$, and TGFbeta RII.","label":0}
{"pair_id":"BioInfer.d827.s0.p13","sentence":"We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, @PROTEIN1$, and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d827.s0.p14","sentence":"We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, @PROTEIN1$, BAX, and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d49.s0.p0","sentence":"A model is proposed for the function of @PROTEIN2$ in @PROTEIN1$-based motility.","label":1}
{"pair_id":"AIMed.d12.s96.p0","sentence":"Soluble @PROTEIN1$@PROTEIN2$ and interleukin 1alpha in toxic epidermal necrolysis: a comparative analysis of serum and blister fluid samples.","label":0}
{"pair_id":"AIMed.d12.s96.p1","sentence":"Soluble @PROTEIN1$ receptor and @PROTEIN2$ in toxic epidermal necrolysis: a comparative analysis of serum and blister fluid samples.","label":0}
{"pair_id":"AIMed.d12.s96.p2","sentence":"Soluble @PROTEIN1$ and @PROTEIN2$ in toxic epidermal necrolysis: a comparative analysis of serum and blister fluid samples.","label":0}
{"pair_id":"AIMed.d101.s855.p0","sentence":"The ability of @PROTEIN1$ and @PROTEIN2$ proteins to interact directly with the TATA box-binding protein (TBP), the general transcription factor required for initiating the assembly of transcription complexes, was investigated.","label":0}
{"pair_id":"AIMed.d101.s855.p1","sentence":"The ability of @PROTEIN1$ and c-Jun proteins to interact directly with the @PROTEIN2$ (TBP), the general transcription factor required for initiating the assembly of transcription complexes, was investigated.","label":1}
{"pair_id":"AIMed.d101.s855.p2","sentence":"The ability of @PROTEIN1$ and c-Jun proteins to interact directly with the TATA box-binding protein (@PROTEIN2$), the general transcription factor required for initiating the assembly of transcription complexes, was investigated.","label":1}
{"pair_id":"AIMed.d101.s855.p3","sentence":"The ability of c-Fos and @PROTEIN1$ proteins to interact directly with the @PROTEIN2$ (TBP), the general transcription factor required for initiating the assembly of transcription complexes, was investigated.","label":1}
{"pair_id":"AIMed.d101.s855.p4","sentence":"The ability of c-Fos and @PROTEIN1$ proteins to interact directly with the TATA box-binding protein (@PROTEIN2$), the general transcription factor required for initiating the assembly of transcription complexes, was investigated.","label":1}
{"pair_id":"AIMed.d101.s855.p5","sentence":"The ability of c-Fos and c-Jun proteins to interact directly with the @PROTEIN1$ (@PROTEIN2$), the general transcription factor required for initiating the assembly of transcription complexes, was investigated.","label":0}
{"pair_id":"AIMed.d219.s1905.p0","sentence":"In the present study, we demonstrate that @PROTEIN1$ binds directly to the isolated @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d169.s2.p0","sentence":"Recombinant plant (birch) @PROTEIN2$ was analyzed for its ability to promote actin polymerization from the actin:@PROTEIN1$ beta4 and @PROTEIN1$ complex.","label":0}
{"pair_id":"BioInfer.d169.s2.p1","sentence":"Recombinant plant (birch) profilin was analyzed for its ability to promote actin polymerization from the actin:@PROTEIN1$@PROTEIN2$ and @PROTEIN1$ complex.","label":1}
{"pair_id":"BioInfer.d169.s2.p2","sentence":"Recombinant plant (birch) profilin was analyzed for its ability to promote @PROTEIN2$ polymerization from the actin:@PROTEIN1$ beta4 and @PROTEIN1$ complex.","label":1}
{"pair_id":"BioInfer.d169.s2.p3","sentence":"Recombinant plant (birch) profilin was analyzed for its ability to promote actin polymerization from the @PROTEIN2$:@PROTEIN1$ beta4 and @PROTEIN1$ complex.","label":1}
{"pair_id":"BioInfer.d169.s2.p4","sentence":"Recombinant plant (birch) @PROTEIN1$ was analyzed for its ability to promote actin polymerization from the actin:@PROTEIN2$ and thymo complex.","label":0}
{"pair_id":"BioInfer.d169.s2.p5","sentence":"Recombinant plant (birch) @PROTEIN1$ was analyzed for its ability to promote @PROTEIN2$ polymerization from the actin:thymosin beta4 and thymo complex.","label":1}
{"pair_id":"BioInfer.d169.s2.p6","sentence":"Recombinant plant (birch) @PROTEIN1$ was analyzed for its ability to promote actin polymerization from the @PROTEIN2$:thymosin beta4 and thymo complex.","label":0}
{"pair_id":"BioInfer.d169.s2.p7","sentence":"Recombinant plant (birch) profilin was analyzed for its ability to promote @PROTEIN2$ polymerization from the actin:@PROTEIN1$ and thymo complex.","label":1}
{"pair_id":"BioInfer.d169.s2.p8","sentence":"Recombinant plant (birch) profilin was analyzed for its ability to promote actin polymerization from the @PROTEIN2$:@PROTEIN1$ and thymo complex.","label":1}
{"pair_id":"BioInfer.d169.s2.p9","sentence":"Recombinant plant (birch) profilin was analyzed for its ability to promote @PROTEIN1$ polymerization from the @PROTEIN2$:thymosin beta4 and thymo complex.","label":1}
{"pair_id":"AIMed.d119.s1010.p0","sentence":"We have used fluorescence anisotropy measurements to define the equilibrium binding parameters of the @PROTEIN1$:@PROTEIN2$ interaction and report here that CBP can activate transcription through a region in its carboxy terminus.","label":1}
{"pair_id":"AIMed.d119.s1010.p1","sentence":"We have used fluorescence anisotropy measurements to define the equilibrium binding parameters of the @PROTEIN1$:CBP interaction and report here that @PROTEIN2$ can activate transcription through a region in its carboxy terminus.","label":0}
{"pair_id":"AIMed.d119.s1010.p2","sentence":"We have used fluorescence anisotropy measurements to define the equilibrium binding parameters of the phosphoCREB:@PROTEIN1$ interaction and report here that @PROTEIN2$ can activate transcription through a region in its carboxy terminus.","label":0}
{"pair_id":"AIMed.d25.s206.p0","sentence":"@PROTEIN1$, @PROTEIN2$, and complement factors C3 and C4 concentrations were measured simultaneously in blood and serous effusion using commercially available methods.","label":0}
{"pair_id":"AIMed.d25.s206.p1","sentence":"@PROTEIN1$, alpha1AT, and complement factors @PROTEIN2$ and C4 concentrations were measured simultaneously in blood and serous effusion using commercially available methods.","label":0}
{"pair_id":"AIMed.d25.s206.p2","sentence":"@PROTEIN1$, alpha1AT, and complement factors C3 and @PROTEIN2$ concentrations were measured simultaneously in blood and serous effusion using commercially available methods.","label":0}
{"pair_id":"AIMed.d25.s206.p3","sentence":"TNFalpha, @PROTEIN1$, and complement factors @PROTEIN2$ and C4 concentrations were measured simultaneously in blood and serous effusion using commercially available methods.","label":0}
{"pair_id":"AIMed.d25.s206.p4","sentence":"TNFalpha, @PROTEIN1$, and complement factors C3 and @PROTEIN2$ concentrations were measured simultaneously in blood and serous effusion using commercially available methods.","label":0}
{"pair_id":"AIMed.d25.s206.p5","sentence":"TNFalpha, alpha1AT, and complement factors @PROTEIN1$ and @PROTEIN2$ concentrations were measured simultaneously in blood and serous effusion using commercially available methods.","label":0}
{"pair_id":"BioInfer.d505.s2.p0","sentence":"Three methods, fluorescence anisotropy of rhodamine-labeled @PROTEIN2$, intrinsic fluorescence and nucleotide exchange, give the same affinity, Kd = 0.1 microM, for Acanthamoeba profilins binding amoeba @PROTEIN1$ monomers with bound Mg-ATP.","label":0}
{"pair_id":"BioInfer.d505.s2.p1","sentence":"Three methods, fluorescence anisotropy of rhodamine-labeled profilin, intrinsic fluorescence and nucleotide exchange, give the same affinity, Kd = 0.1 microM, for Acanthamoeba @PROTEIN2$ binding amoeba @PROTEIN1$ monomers with bound Mg-ATP.","label":1}
{"pair_id":"BioInfer.d505.s2.p2","sentence":"Three methods, fluorescence anisotropy of rhodamine-labeled @PROTEIN1$, intrinsic fluorescence and nucleotide exchange, give the same affinity, Kd = 0.1 microM, for Acanthamoeba @PROTEIN2$ binding amoeba actin monomers with bound Mg-ATP.","label":0}
{"pair_id":"BioInfer.d605.s0.p0","sentence":"The domain consists of a mixed alpha-helical\/beta-sheet fold that resembles a circular permutation of the @PROTEIN1$\/poly-proline binding protein, profilin, and the @PROTEIN2$ family of regulatory modules.","label":0}
{"pair_id":"BioInfer.d605.s0.p1","sentence":"The domain consists of a mixed alpha-helical\/beta-sheet fold that resembles a circular permutation of the @PROTEIN1$\/poly-proline binding protein, @PROTEIN2$, and the GAF\/PAS family of regulatory modules.","label":1}
{"pair_id":"BioInfer.d605.s0.p2","sentence":"The domain consists of a mixed alpha-helical\/beta-sheet fold that resembles a circular permutation of the actin\/poly-proline binding protein, @PROTEIN2$, and the @PROTEIN1$ family of regulatory modules.","label":0}
{"pair_id":"BioInfer.d623.s0.p0","sentence":"The higher affinity of vaccinia profilin for polyphosphoinositides (Kd = 0.2-8.5 microM) than for actin or poly(L-proline) and the concentration of vaccinia @PROTEIN2$ expressed in infected HeLa cells (approximately 20 microM) suggest that vaccinia @PROTEIN1$ binds preferentially to PIP and PIP2 in vivo.","label":0}
{"pair_id":"BioInfer.d623.s0.p1","sentence":"The higher affinity of vaccinia profilin for polyphosphoinositides (Kd = 0.2-8.5 microM) than for @PROTEIN2$ or poly(L-proline) and the concentration of vaccinia profilin expressed in infected HeLa cells (approximately 20 microM) suggest that vaccinia @PROTEIN1$ binds preferentially to PIP and PIP2 in vivo.","label":0}
{"pair_id":"BioInfer.d623.s0.p2","sentence":"The higher affinity of vaccinia @PROTEIN2$ for polyphosphoinositides (Kd = 0.2-8.5 microM) than for actin or poly(L-proline) and the concentration of vaccinia profilin expressed in infected HeLa cells (approximately 20 microM) suggest that vaccinia @PROTEIN1$ binds preferentially to PIP and PIP2 in vivo.","label":0}
{"pair_id":"BioInfer.d623.s0.p3","sentence":"The higher affinity of vaccinia profilin for polyphosphoinositides (Kd = 0.2-8.5 microM) than for @PROTEIN2$ or poly(L-proline) and the concentration of vaccinia @PROTEIN1$ expressed in infected HeLa cells (approximately 20 microM) suggest that vaccinia profilin binds preferentially to PIP and PIP2 in vivo.","label":0}
{"pair_id":"BioInfer.d623.s0.p4","sentence":"The higher affinity of vaccinia @PROTEIN2$ for polyphosphoinositides (Kd = 0.2-8.5 microM) than for actin or poly(L-proline) and the concentration of vaccinia @PROTEIN1$ expressed in infected HeLa cells (approximately 20 microM) suggest that vaccinia profilin binds preferentially to PIP and PIP2 in vivo.","label":0}
{"pair_id":"BioInfer.d623.s0.p5","sentence":"The higher affinity of vaccinia @PROTEIN2$ for polyphosphoinositides (Kd = 0.2-8.5 microM) than for @PROTEIN1$ or poly(L-proline) and the concentration of vaccinia profilin expressed in infected HeLa cells (approximately 20 microM) suggest that vaccinia profilin binds preferentially to PIP and PIP2 in vivo.","label":1}
{"pair_id":"AIMed.d172.s1452.p0","sentence":"@PROTEIN1$ fails to bind appreciably to the extracellular domain of @PROTEIN2$ or Flk1.","label":0}
{"pair_id":"AIMed.d172.s1452.p1","sentence":"@PROTEIN1$ fails to bind appreciably to the extracellular domain of Flt1 or @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d172.s1452.p2","sentence":"VRP fails to bind appreciably to the extracellular domain of @PROTEIN1$ or @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d173.s0.p0","sentence":"Digestion of isolated myofibrils with alkaline proteinase resulted in the degradation of @PROTEIN1$ and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d173.s0.p1","sentence":"Digestion of isolated myofibrils with @PROTEIN2$ resulted in the degradation of @PROTEIN1$ and actin.","label":1}
{"pair_id":"BioInfer.d173.s0.p2","sentence":"Digestion of isolated myofibrils with @PROTEIN2$ resulted in the degradation of myosin heavy chain and @PROTEIN1$.","label":1}
{"pair_id":"AIMed.d197.s1681.p0","sentence":"Following this hypothesis, we altered in @PROTEIN1$ and @PROTEIN2$ residues predicted to reside in the contact region and to interact with each other.","label":1}
{"pair_id":"AIMed.d115.s970.p0","sentence":"Interaction with @PROTEIN1$ subunit of @PROTEIN2$ is required for transcriptional activation by serum response factor.","label":0}
{"pair_id":"AIMed.d115.s970.p1","sentence":"Interaction with @PROTEIN1$ subunit of TFIIF is required for transcriptional activation by @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d115.s970.p2","sentence":"Interaction with RAP74 subunit of @PROTEIN1$ is required for transcriptional activation by @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d7.s2.p0","sentence":"Addition of @PROTEIN1$ to polymerized @PROTEIN2$ causes it to depolymerize until a new steady-state, dependent on profilin concentration, is achieved.","label":1}
{"pair_id":"BioInfer.d7.s2.p1","sentence":"Addition of @PROTEIN1$ to polymerized actin causes it to depolymerize until a new steady-state, dependent on @PROTEIN2$ concentration, is achieved.","label":0}
{"pair_id":"BioInfer.d7.s2.p2","sentence":"Addition of profilin to polymerized @PROTEIN1$ causes it to depolymerize until a new steady-state, dependent on @PROTEIN2$ concentration, is achieved.","label":0}
{"pair_id":"AIMed.d37.s310.p0","sentence":"@PROTEIN1$ binds multiple CC-chemokines: @PROTEIN2$ acts as a natural antagonist.","label":0}
{"pair_id":"AIMed.d197.s1678.p0","sentence":"We studied the human @PROTEIN1$ (@PROTEIN2$)\/hIL-6R binding interface by a combination of molecular modelling and site-directed mutagenesis.","label":0}
{"pair_id":"AIMed.d197.s1678.p1","sentence":"We studied the human @PROTEIN1$ (hIL-6)\/@PROTEIN2$ binding interface by a combination of molecular modelling and site-directed mutagenesis.","label":1}
{"pair_id":"AIMed.d197.s1678.p2","sentence":"We studied the human IL-6 (@PROTEIN1$)\/@PROTEIN2$ binding interface by a combination of molecular modelling and site-directed mutagenesis.","label":1}
{"pair_id":"BioInfer.d96.s0.p0","sentence":"Between day 1 and day 3 in culture, the specific synthetic activities of total proteins and of electrophoretically purified @PROTEIN1$ and @PROTEIN2$ ([14C] phenylalanine incorporation into protein, in disintegrations per minute per microgram protein) decreased (-19%,-32%, and -73%, respectively).","label":0}
{"pair_id":"BioInfer.d91.s0.p0","sentence":"BACKGROUND: @PROTEIN1$(Kip1), a cyclin-dependent kinase inhibitor, negatively regulates the G1 phase progression of the cell cycle by binding to the @PROTEIN2$\/cyclin-dependent kinase 2 complex.","label":1}
{"pair_id":"BioInfer.d91.s0.p1","sentence":"BACKGROUND: @PROTEIN1$(@PROTEIN2$), a cyclin-dependent kinase inhibitor, negatively regulates the G1 phase progression of the cell cycle by binding to the cyclin E\/cyclin-dependent kinase 2 complex.","label":0}
{"pair_id":"BioInfer.d91.s0.p2","sentence":"BACKGROUND: @PROTEIN1$(Kip1), a cyclin-dependent kinase inhibitor, negatively regulates the G1 phase progression of the cell cycle by binding to the cyclin E\/@PROTEIN2$ complex.","label":1}
{"pair_id":"BioInfer.d91.s0.p3","sentence":"BACKGROUND: @PROTEIN1$(Kip1), a @PROTEIN2$, negatively regulates the G1 phase progression of the cell cycle by binding to the cyclin E\/cyclin-dependent kinase 2 complex.","label":1}
{"pair_id":"BioInfer.d91.s0.p4","sentence":"BACKGROUND: p27(@PROTEIN2$), a cyclin-dependent kinase inhibitor, negatively regulates the G1 phase progression of the cell cycle by binding to the @PROTEIN1$\/cyclin-dependent kinase 2 complex.","label":1}
{"pair_id":"BioInfer.d91.s0.p5","sentence":"BACKGROUND: p27(Kip1), a cyclin-dependent kinase inhibitor, negatively regulates the G1 phase progression of the cell cycle by binding to the @PROTEIN1$\/@PROTEIN2$ complex.","label":1}
{"pair_id":"BioInfer.d91.s0.p6","sentence":"BACKGROUND: p27(Kip1), a @PROTEIN2$, negatively regulates the G1 phase progression of the cell cycle by binding to the @PROTEIN1$\/cyclin-dependent kinase 2 complex.","label":0}
{"pair_id":"BioInfer.d91.s0.p7","sentence":"BACKGROUND: p27(@PROTEIN1$), a cyclin-dependent kinase inhibitor, negatively regulates the G1 phase progression of the cell cycle by binding to the cyclin E\/@PROTEIN2$ complex.","label":1}
{"pair_id":"BioInfer.d91.s0.p8","sentence":"BACKGROUND: p27(@PROTEIN1$), a @PROTEIN2$, negatively regulates the G1 phase progression of the cell cycle by binding to the cyclin E\/cyclin-dependent kinase 2 complex.","label":1}
{"pair_id":"BioInfer.d91.s0.p9","sentence":"BACKGROUND: p27(Kip1), a @PROTEIN2$, negatively regulates the G1 phase progression of the cell cycle by binding to the cyclin E\/@PROTEIN1$ complex.","label":0}
{"pair_id":"BioInfer.d108.s0.p0","sentence":"@PROTEIN2$ (@PROTEIN1$) is a receptor for vascular endothelial growth factor (VEGF) vas (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).","label":0}
{"pair_id":"BioInfer.d108.s0.p1","sentence":"Neuropilin 1 (@PROTEIN1$) is a receptor for vascular endothelial growth factor (VEGF) vas (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (@PROTEIN2$).","label":1}
{"pair_id":"BioInfer.d108.s0.p2","sentence":"Neuropilin 1 (@PROTEIN1$) is a receptor for @PROTEIN2$ (VEGF) @PROTEIN2$ (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).","label":1}
{"pair_id":"BioInfer.d108.s0.p3","sentence":"Neuropilin 1 (@PROTEIN1$) is a receptor for vascular endothelial growth factor (VEGF) vas (@PROTEIN2$) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).","label":1}
{"pair_id":"BioInfer.d108.s0.p4","sentence":"Neuropilin 1 (@PROTEIN1$) is a receptor for vascular endothelial growth factor (VEGF) vas (VEGF165) and acts as a coreceptor that enhances @PROTEIN2$ function through tyrosine kinase VEGF receptor 2 (VEGFR-2).","label":1}
{"pair_id":"BioInfer.d108.s0.p5","sentence":"Neuropilin 1 (@PROTEIN1$) is a receptor for vascular endothelial growth factor (@PROTEIN2$) vas (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).","label":0}
{"pair_id":"BioInfer.d108.s0.p6","sentence":"Neuropilin 1 (@PROTEIN1$) is a receptor for vascular endothelial growth factor (VEGF) vas (VEGF165) and acts as a coreceptor that enhances VEGF165 function through @PROTEIN2$ VEGF receptor 2 (VEGFR-2).","label":0}
{"pair_id":"BioInfer.d108.s0.p7","sentence":"Neuropilin 1 (@PROTEIN1$) is a receptor for vascular endothelial growth factor (VEGF) vas (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase @PROTEIN2$ (VEGFR-2).","label":1}
{"pair_id":"BioInfer.d108.s0.p8","sentence":"@PROTEIN1$ (NP-1) is a receptor for vascular endothelial growth factor (VEGF) vas (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (@PROTEIN2$).","label":1}
{"pair_id":"BioInfer.d108.s0.p9","sentence":"@PROTEIN1$ (NP-1) is a receptor for @PROTEIN2$ (VEGF) @PROTEIN2$ (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).","label":1}
{"pair_id":"BioInfer.d108.s0.p10","sentence":"@PROTEIN1$ (NP-1) is a receptor for vascular endothelial growth factor (VEGF) vas (@PROTEIN2$) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).","label":1}
{"pair_id":"BioInfer.d108.s0.p11","sentence":"@PROTEIN1$ (NP-1) is a receptor for vascular endothelial growth factor (VEGF) vas (VEGF165) and acts as a coreceptor that enhances @PROTEIN2$ function through tyrosine kinase VEGF receptor 2 (VEGFR-2).","label":1}
{"pair_id":"BioInfer.d108.s0.p12","sentence":"@PROTEIN1$ (NP-1) is a receptor for vascular endothelial growth factor (@PROTEIN2$) vas (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).","label":0}
{"pair_id":"BioInfer.d108.s0.p13","sentence":"@PROTEIN1$ (NP-1) is a receptor for vascular endothelial growth factor (VEGF) vas (VEGF165) and acts as a coreceptor that enhances VEGF165 function through @PROTEIN2$ VEGF receptor 2 (VEGFR-2).","label":0}
{"pair_id":"BioInfer.d108.s0.p14","sentence":"@PROTEIN1$ (NP-1) is a receptor for vascular endothelial growth factor (VEGF) vas (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase @PROTEIN2$ (VEGFR-2).","label":1}
{"pair_id":"BioInfer.d108.s0.p15","sentence":"Neuropilin 1 (NP-1) is a receptor for @PROTEIN2$ (VEGF) @PROTEIN2$ (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (@PROTEIN1$).","label":0}
{"pair_id":"BioInfer.d108.s0.p16","sentence":"Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) vas (@PROTEIN2$) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (@PROTEIN1$).","label":0}
{"pair_id":"BioInfer.d108.s0.p17","sentence":"Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) vas (VEGF165) and acts as a coreceptor that enhances @PROTEIN2$ function through tyrosine kinase VEGF receptor 2 (@PROTEIN1$).","label":1}
{"pair_id":"BioInfer.d108.s0.p18","sentence":"Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (@PROTEIN2$) vas (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (@PROTEIN1$).","label":0}
{"pair_id":"BioInfer.d108.s0.p19","sentence":"Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) vas (VEGF165) and acts as a coreceptor that enhances VEGF165 function through @PROTEIN2$ VEGF receptor 2 (@PROTEIN1$).","label":1}
{"pair_id":"BioInfer.d108.s0.p20","sentence":"Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) vas (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase @PROTEIN2$ (@PROTEIN1$).","label":0}
{"pair_id":"BioInfer.d108.s0.p21","sentence":"Neuropilin 1 (NP-1) is a receptor for @PROTEIN1$ (VEGF) @PROTEIN1$ (@PROTEIN2$) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).","label":0}
{"pair_id":"BioInfer.d108.s0.p22","sentence":"Neuropilin 1 (NP-1) is a receptor for @PROTEIN1$ (VEGF) @PROTEIN1$ (VEGF165) and acts as a coreceptor that enhances @PROTEIN2$ function through tyrosine kinase VEGF receptor 2 (VEGFR-2).","label":0}
{"pair_id":"BioInfer.d108.s0.p23","sentence":"Neuropilin 1 (NP-1) is a receptor for @PROTEIN1$ (@PROTEIN2$) @PROTEIN1$ (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).","label":0}
{"pair_id":"BioInfer.d108.s0.p24","sentence":"Neuropilin 1 (NP-1) is a receptor for @PROTEIN1$ (VEGF) @PROTEIN1$ (VEGF165) and acts as a coreceptor that enhances VEGF165 function through @PROTEIN2$ VEGF receptor 2 (VEGFR-2).","label":0}
{"pair_id":"BioInfer.d108.s0.p25","sentence":"Neuropilin 1 (NP-1) is a receptor for @PROTEIN1$ (VEGF) @PROTEIN1$ (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase @PROTEIN2$ (VEGFR-2).","label":0}
{"pair_id":"BioInfer.d108.s0.p26","sentence":"Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) vas (@PROTEIN1$) and acts as a coreceptor that enhances @PROTEIN2$ function through tyrosine kinase VEGF receptor 2 (VEGFR-2).","label":0}
{"pair_id":"BioInfer.d108.s0.p27","sentence":"Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (@PROTEIN2$) vas (@PROTEIN1$) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).","label":0}
{"pair_id":"BioInfer.d108.s0.p28","sentence":"Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) vas (@PROTEIN1$) and acts as a coreceptor that enhances VEGF165 function through @PROTEIN2$ VEGF receptor 2 (VEGFR-2).","label":0}
{"pair_id":"BioInfer.d108.s0.p29","sentence":"Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) vas (@PROTEIN1$) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase @PROTEIN2$ (VEGFR-2).","label":0}
{"pair_id":"BioInfer.d108.s0.p30","sentence":"Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (@PROTEIN2$) vas (VEGF165) and acts as a coreceptor that enhances @PROTEIN1$ function through tyrosine kinase VEGF receptor 2 (VEGFR-2).","label":0}
{"pair_id":"BioInfer.d108.s0.p31","sentence":"Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) vas (VEGF165) and acts as a coreceptor that enhances @PROTEIN1$ function through @PROTEIN2$ VEGF receptor 2 (VEGFR-2).","label":0}
{"pair_id":"BioInfer.d108.s0.p32","sentence":"Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) vas (VEGF165) and acts as a coreceptor that enhances @PROTEIN1$ function through tyrosine kinase @PROTEIN2$ (VEGFR-2).","label":1}
{"pair_id":"BioInfer.d108.s0.p33","sentence":"Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (@PROTEIN1$) vas (VEGF165) and acts as a coreceptor that enhances VEGF165 function through @PROTEIN2$ VEGF receptor 2 (VEGFR-2).","label":0}
{"pair_id":"BioInfer.d108.s0.p34","sentence":"Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (@PROTEIN1$) vas (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase @PROTEIN2$ (VEGFR-2).","label":0}
{"pair_id":"BioInfer.d108.s0.p35","sentence":"Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) vas (VEGF165) and acts as a coreceptor that enhances VEGF165 function through @PROTEIN1$ @PROTEIN2$ (VEGFR-2).","label":1}
{"pair_id":"AIMed.d215.s1869.p0","sentence":"@PROTEIN1$ cleaved the @PROTEIN2$ gamma2 subunit at residue 587, exposing a putative cryptic promigratory site on Ln-5 that triggers cell motility.","label":1}
{"pair_id":"AIMed.d215.s1869.p1","sentence":"@PROTEIN1$ cleaved the @PROTEIN2$ subunit at residue 587, exposing a putative cryptic promigratory site on Ln-5 that triggers cell motility.","label":0}
{"pair_id":"AIMed.d215.s1869.p2","sentence":"@PROTEIN1$ cleaved the Ln-5 gamma2 subunit at residue 587, exposing a putative cryptic promigratory site on @PROTEIN2$ that triggers cell motility.","label":0}
{"pair_id":"AIMed.d215.s1869.p3","sentence":"MMP2 cleaved the @PROTEIN1$@PROTEIN2$ subunit at residue 587, exposing a putative cryptic promigratory site on Ln-5 that triggers cell motility.","label":0}
{"pair_id":"AIMed.d215.s1869.p4","sentence":"MMP2 cleaved the @PROTEIN1$ gamma2 subunit at residue 587, exposing a putative cryptic promigratory site on @PROTEIN2$ that triggers cell motility.","label":0}
{"pair_id":"AIMed.d215.s1869.p5","sentence":"MMP2 cleaved the @PROTEIN1$ subunit at residue 587, exposing a putative cryptic promigratory site on @PROTEIN2$ that triggers cell motility.","label":0}
{"pair_id":"AIMed.d54.s473.p0","sentence":"@PROTEIN1$ (@PROTEIN2$), a novel growth factor that binds to PDGF alpha and beta receptor.","label":0}
{"pair_id":"AIMed.d54.s473.p1","sentence":"@PROTEIN1$ (PDGF-C), a novel growth factor that binds to @PROTEIN2$ and beta receptor.","label":1}
{"pair_id":"AIMed.d54.s473.p2","sentence":"Platelet-derived growth factor C (@PROTEIN1$), a novel growth factor that binds to @PROTEIN2$ and beta receptor.","label":1}
{"pair_id":"BioInfer.d78.s2.p0","sentence":"In most cases, @PROTEIN2$ and cofilin colocalized in the same nuclear actin rods, but ADF appeared to predominate in mononucleated cells, while @PROTEIN1$ was present in multinucleated myotubes.","label":0}
{"pair_id":"BioInfer.d78.s2.p1","sentence":"In most cases, ADF and cofilin colocalized in the same nuclear actin rods, but @PROTEIN2$ appeared to predominate in mononucleated cells, while @PROTEIN1$ was present in multinucleated myotubes.","label":0}
{"pair_id":"BioInfer.d78.s2.p2","sentence":"In most cases, ADF and cofilin colocalized in the same nuclear @PROTEIN2$ rods, but ADF appeared to predominate in mononucleated cells, while @PROTEIN1$ was present in multinucleated myotubes.","label":0}
{"pair_id":"BioInfer.d78.s2.p3","sentence":"In most cases, ADF and @PROTEIN2$ colocalized in the same nuclear actin rods, but ADF appeared to predominate in mononucleated cells, while @PROTEIN1$ was present in multinucleated myotubes.","label":0}
{"pair_id":"BioInfer.d78.s2.p4","sentence":"In most cases, @PROTEIN1$ and cofilin colocalized in the same nuclear actin rods, but @PROTEIN2$ appeared to predominate in mononucleated cells, while cofilin was present in multinucleated myotubes.","label":0}
{"pair_id":"BioInfer.d78.s2.p5","sentence":"In most cases, @PROTEIN1$ and cofilin colocalized in the same nuclear @PROTEIN2$ rods, but ADF appeared to predominate in mononucleated cells, while cofilin was present in multinucleated myotubes.","label":1}
{"pair_id":"BioInfer.d78.s2.p6","sentence":"In most cases, @PROTEIN1$ and @PROTEIN2$ colocalized in the same nuclear actin rods, but ADF appeared to predominate in mononucleated cells, while cofilin was present in multinucleated myotubes.","label":1}
{"pair_id":"BioInfer.d78.s2.p7","sentence":"In most cases, ADF and cofilin colocalized in the same nuclear @PROTEIN2$ rods, but @PROTEIN1$ appeared to predominate in mononucleated cells, while cofilin was present in multinucleated myotubes.","label":0}
{"pair_id":"BioInfer.d78.s2.p8","sentence":"In most cases, ADF and @PROTEIN2$ colocalized in the same nuclear actin rods, but @PROTEIN1$ appeared to predominate in mononucleated cells, while cofilin was present in multinucleated myotubes.","label":0}
{"pair_id":"BioInfer.d78.s2.p9","sentence":"In most cases, ADF and @PROTEIN2$ colocalized in the same nuclear @PROTEIN1$ rods, but ADF appeared to predominate in mononucleated cells, while cofilin was present in multinucleated myotubes.","label":1}
{"pair_id":"AIMed.d54.s477.p0","sentence":"Competition binding and immunoprecipitation studies on cells bearing both @PROTEIN1$ and beta receptors reveal a high affinity binding of recombinant GFD (@PROTEIN2$) to PDGF receptor-alpha homodimers and PDGF receptor-alpha\/beta heterodimers.","label":0}
{"pair_id":"AIMed.d54.s477.p1","sentence":"Competition binding and immunoprecipitation studies on cells bearing both @PROTEIN1$ and beta receptors reveal a high affinity binding of recombinant GFD (PDGF-CC) to @PROTEIN2$ homodimers and PDGF receptor-alpha\/beta heterodimers.","label":0}
{"pair_id":"AIMed.d54.s477.p2","sentence":"Competition binding and immunoprecipitation studies on cells bearing both @PROTEIN1$ and beta receptors reveal a high affinity binding of recombinant GFD (PDGF-CC) to PDGF receptor-alpha homodimers and @PROTEIN2$\/beta heterodimers.","label":0}
{"pair_id":"AIMed.d54.s477.p3","sentence":"Competition binding and immunoprecipitation studies on cells bearing both PDGF alpha and beta receptors reveal a high affinity binding of recombinant GFD (@PROTEIN1$) to @PROTEIN2$ homodimers and PDGF receptor-alpha\/beta heterodimers.","label":1}
{"pair_id":"AIMed.d54.s477.p4","sentence":"Competition binding and immunoprecipitation studies on cells bearing both PDGF alpha and beta receptors reveal a high affinity binding of recombinant GFD (@PROTEIN1$) to PDGF receptor-alpha homodimers and @PROTEIN2$\/beta heterodimers.","label":1}
{"pair_id":"AIMed.d54.s477.p5","sentence":"Competition binding and immunoprecipitation studies on cells bearing both PDGF alpha and beta receptors reveal a high affinity binding of recombinant GFD (PDGF-CC) to @PROTEIN1$ homodimers and @PROTEIN2$\/beta heterodimers.","label":0}
{"pair_id":"AIMed.d80.s682.p0","sentence":"@PROTEIN1$, a novel death domain-containing protein, interacts with the death domain of @PROTEIN2$ and initiates apoptosis.","label":1}
{"pair_id":"BioInfer.d245.s2.p0","sentence":"Recently we have identified an @PROTEIN1$ binding site in @PROTEIN2$ and plakoglobin and postulated, based on sequence analysis, that these protein-protein interactions are mediated by a hydrophobic interaction mechanism.","label":1}
{"pair_id":"BioInfer.d245.s2.p1","sentence":"Recently we have identified an @PROTEIN1$ binding site in beta-catenin and @PROTEIN2$ and postulated, based on sequence analysis, that these protein-protein interactions are mediated by a hydrophobic interaction mechanism.","label":1}
{"pair_id":"BioInfer.d245.s2.p2","sentence":"Recently we have identified an alpha-catenin binding site in @PROTEIN1$ and @PROTEIN2$ and postulated, based on sequence analysis, that these protein-protein interactions are mediated by a hydrophobic interaction mechanism.","label":0}
{"pair_id":"BioInfer.d233.s0.p0","sentence":"Germline mutations in several members of these families, MSH2, @PROTEIN2$, MLH1, and PMS2, but not @PROTEIN1$, are responsible for hereditary non-polyposis colorectal cancer.","label":0}
{"pair_id":"BioInfer.d233.s0.p1","sentence":"Germline mutations in several members of these families, MSH2, MSH6, @PROTEIN2$, and PMS2, but not @PROTEIN1$, are responsible for hereditary non-polyposis colorectal cancer.","label":0}
{"pair_id":"BioInfer.d233.s0.p2","sentence":"Germline mutations in several members of these families, @PROTEIN2$, MSH6, MLH1, and PMS2, but not @PROTEIN1$, are responsible for hereditary non-polyposis colorectal cancer.","label":0}
{"pair_id":"BioInfer.d233.s0.p3","sentence":"Germline mutations in several members of these families, MSH2, MSH6, MLH1, and @PROTEIN2$, but not @PROTEIN1$, are responsible for hereditary non-polyposis colorectal cancer.","label":0}
{"pair_id":"BioInfer.d233.s0.p4","sentence":"Germline mutations in several members of these families, MSH2, @PROTEIN1$, @PROTEIN2$, and PMS2, but not MSH3, are responsible for hereditary non-polyposis colorectal cancer.","label":0}
{"pair_id":"BioInfer.d233.s0.p5","sentence":"Germline mutations in several members of these families, @PROTEIN2$, @PROTEIN1$, MLH1, and PMS2, but not MSH3, are responsible for hereditary non-polyposis colorectal cancer.","label":0}
{"pair_id":"BioInfer.d233.s0.p6","sentence":"Germline mutations in several members of these families, MSH2, @PROTEIN1$, MLH1, and @PROTEIN2$, but not MSH3, are responsible for hereditary non-polyposis colorectal cancer.","label":0}
{"pair_id":"BioInfer.d233.s0.p7","sentence":"Germline mutations in several members of these families, @PROTEIN2$, MSH6, @PROTEIN1$, and PMS2, but not MSH3, are responsible for hereditary non-polyposis colorectal cancer.","label":0}
{"pair_id":"BioInfer.d233.s0.p8","sentence":"Germline mutations in several members of these families, MSH2, MSH6, @PROTEIN1$, and @PROTEIN2$, but not MSH3, are responsible for hereditary non-polyposis colorectal cancer.","label":0}
{"pair_id":"BioInfer.d233.s0.p9","sentence":"Germline mutations in several members of these families, @PROTEIN1$, MSH6, MLH1, and @PROTEIN2$, but not MSH3, are responsible for hereditary non-polyposis colorectal cancer.","label":0}
{"pair_id":"BioInfer.d88.s0.p0","sentence":"At the light microscope level, brush cells can be identified by antibodies against the actin filament crosslinking proteins @PROTEIN1$ and @PROTEIN2$ that not only stain the apical tuft of microvilli and their rootlets, but also label projections emanating from the basolateral surface of these cells.","label":0}
{"pair_id":"BioInfer.d88.s0.p1","sentence":"At the light microscope level, brush cells can be identified by antibodies against the @PROTEIN2$ filament crosslinking proteins @PROTEIN1$ and fimbrin that not only stain the apical tuft of microvilli and their rootlets, but also label projections emanating from the basolateral surface of these cells.","label":1}
{"pair_id":"BioInfer.d88.s0.p2","sentence":"At the light microscope level, brush cells can be identified by antibodies against the @PROTEIN2$ filament crosslinking proteins villin and @PROTEIN1$ that not only stain the apical tuft of microvilli and their rootlets, but also label projections emanating from the basolateral surface of these cells.","label":1}
{"pair_id":"BioInfer.d222.s0.p0","sentence":"Furthermore, a simultaneous expression of profilin, @PROTEIN2$ and @PROTEIN1$ was observed during the regeneration of rat liver, that is, all mRNAs of these proteins showed biphasic peaks around 6 h and 48 h after partial hepatectomy.","label":1}
{"pair_id":"BioInfer.d222.s0.p1","sentence":"Furthermore, a simultaneous expression of @PROTEIN2$, actin and @PROTEIN1$ was observed during the regeneration of rat liver, that is, all mRNAs of these proteins showed biphasic peaks around 6 h and 48 h after partial hepatectomy.","label":1}
{"pair_id":"BioInfer.d222.s0.p2","sentence":"Furthermore, a simultaneous expression of @PROTEIN2$, @PROTEIN1$ and extracellular matrix proteins was observed during the regeneration of rat liver, that is, all mRNAs of these proteins showed biphasic peaks around 6 h and 48 h after partial hepatectomy.","label":1}
{"pair_id":"AIMed.d183.s1555.p0","sentence":"In the baculovirus coexpression system, @PROTEIN1$ was activated by @PROTEIN2$ in the presence of p21ras.","label":1}
{"pair_id":"AIMed.d183.s1555.p1","sentence":"In the baculovirus coexpression system, @PROTEIN1$ was activated by JAK2 in the presence of @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d183.s1555.p2","sentence":"In the baculovirus coexpression system, Raf-1 was activated by @PROTEIN1$ in the presence of @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d153.s1305.p0","sentence":"On the other hand, cells expressing @PROTEIN1$ and @PROTEIN2$ on the surface were much more resistant to the inhibitory effect of adenosine.","label":0}
{"pair_id":"AIMed.d50.s447.p0","sentence":"Relating the anti-viral and anti-proliferative activity of the various interferon mutants with their affinity toward @PROTEIN1$ results in linear function over the whole range of affinities investigated, suggesting that @PROTEIN2$ binding is the rate-determining step in cellular activation.","label":0}
{"pair_id":"AIMed.d109.s917.p0","sentence":"The @PROTEIN1$ and @PROTEIN2$ families of eukaryotic transcription factors heterodimerize to form complexes capable of binding 5'-TGAGTCA-3' DNA elements.","label":1}
{"pair_id":"BioInfer.d148.s0.p0","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, @PROTEIN2$, TRADD, RIP, and @PROTEIN1$, and an up to twofold increase for FADD and FAP, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p1","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and @PROTEIN1$, and an up to twofold increase for FADD and @PROTEIN2$, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p2","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, @PROTEIN2$, and @PROTEIN1$, and an up to twofold increase for FADD and FAP, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p3","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, @PROTEIN2$, TRAIL, TRADD, RIP, and @PROTEIN1$, and an up to twofold increase for FADD and FAP, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p4","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for @PROTEIN2$, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and @PROTEIN1$, and an up to twofold increase for FADD and FAP, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p5","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, @PROTEIN2$, RIP, and @PROTEIN1$, and an up to twofold increase for FADD and FAP, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p6","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, @PROTEIN2$, TNF-R1, TRAIL, TRADD, RIP, and @PROTEIN1$, and an up to twofold increase for FADD and FAP, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p7","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and @PROTEIN1$, and an up to twofold increase for FADD and FAP, but there was little change for @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d148.s0.p8","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and @PROTEIN1$, and an up to twofold increase for @PROTEIN2$ and FAP, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p9","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, @PROTEIN1$, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and @PROTEIN2$, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p10","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, @PROTEIN1$, TRADD, @PROTEIN2$, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p11","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, @PROTEIN2$, @PROTEIN1$, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p12","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for @PROTEIN2$, Fas ligand, TNF-R1, @PROTEIN1$, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p13","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, @PROTEIN1$, @PROTEIN2$, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p14","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, @PROTEIN2$, TNF-R1, @PROTEIN1$, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p15","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, @PROTEIN1$, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d148.s0.p16","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, @PROTEIN1$, TRADD, RIP, and caspase-8, and an up to twofold increase for @PROTEIN2$ and FAP, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p17","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, @PROTEIN2$, and caspase-8, and an up to twofold increase for FADD and @PROTEIN1$, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p18","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, @PROTEIN2$, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and @PROTEIN1$, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p19","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for @PROTEIN2$, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and @PROTEIN1$, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p20","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, @PROTEIN2$, RIP, and caspase-8, and an up to twofold increase for FADD and @PROTEIN1$, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p21","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, @PROTEIN2$, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and @PROTEIN1$, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p22","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and @PROTEIN1$, but there was little change for @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d148.s0.p23","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for @PROTEIN2$ and @PROTEIN1$, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p24","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, @PROTEIN2$, TRAIL, TRADD, @PROTEIN1$, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p25","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for @PROTEIN2$, Fas ligand, TNF-R1, TRAIL, TRADD, @PROTEIN1$, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p26","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, @PROTEIN2$, @PROTEIN1$, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p27","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, @PROTEIN2$, TNF-R1, TRAIL, TRADD, @PROTEIN1$, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p28","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, @PROTEIN1$, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d148.s0.p29","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, @PROTEIN1$, and caspase-8, and an up to twofold increase for @PROTEIN2$ and FAP, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p30","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for @PROTEIN2$, Fas ligand, @PROTEIN1$, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p31","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, @PROTEIN1$, TRAIL, @PROTEIN2$, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p32","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, @PROTEIN2$, @PROTEIN1$, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p33","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, @PROTEIN1$, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d148.s0.p34","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, @PROTEIN1$, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for @PROTEIN2$ and FAP, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p35","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for @PROTEIN1$, Fas ligand, TNF-R1, TRAIL, @PROTEIN2$, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p36","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for @PROTEIN1$, @PROTEIN2$, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p37","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for @PROTEIN1$, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d148.s0.p38","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for @PROTEIN1$, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for @PROTEIN2$ and FAP, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p39","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, @PROTEIN2$, TNF-R1, TRAIL, @PROTEIN1$, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p40","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, @PROTEIN1$, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d148.s0.p41","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, @PROTEIN1$, RIP, and caspase-8, and an up to twofold increase for @PROTEIN2$ and FAP, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p42","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, @PROTEIN1$, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d148.s0.p43","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, @PROTEIN1$, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for @PROTEIN2$ and FAP, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p44","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for @PROTEIN2$ and FAP, but there was little change for @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d171.s2.p0","sentence":"We investigate allelic losses in microsatellites of the RAD51, RAD52, @PROTEIN2$, @PROTEIN1$ and BRCA2 regions, and their correlations with nine pathologic parameters in 127 breast carcinomas.","label":0}
{"pair_id":"BioInfer.d171.s2.p1","sentence":"We investigate allelic losses in microsatellites of the @PROTEIN2$, RAD52, RAD54, @PROTEIN1$ and BRCA2 regions, and their correlations with nine pathologic parameters in 127 breast carcinomas.","label":0}
{"pair_id":"BioInfer.d171.s2.p2","sentence":"We investigate allelic losses in microsatellites of the RAD51, RAD52, RAD54, @PROTEIN1$ and @PROTEIN2$ regions, and their correlations with nine pathologic parameters in 127 breast carcinomas.","label":0}
{"pair_id":"BioInfer.d171.s2.p3","sentence":"We investigate allelic losses in microsatellites of the RAD51, @PROTEIN2$, RAD54, @PROTEIN1$ and BRCA2 regions, and their correlations with nine pathologic parameters in 127 breast carcinomas.","label":0}
{"pair_id":"BioInfer.d171.s2.p4","sentence":"We investigate allelic losses in microsatellites of the @PROTEIN2$, RAD52, @PROTEIN1$, BRCA1 and BRCA2 regions, and their correlations with nine pathologic parameters in 127 breast carcinomas.","label":0}
{"pair_id":"BioInfer.d171.s2.p5","sentence":"We investigate allelic losses in microsatellites of the RAD51, RAD52, @PROTEIN1$, BRCA1 and @PROTEIN2$ regions, and their correlations with nine pathologic parameters in 127 breast carcinomas.","label":0}
{"pair_id":"BioInfer.d171.s2.p6","sentence":"We investigate allelic losses in microsatellites of the RAD51, @PROTEIN2$, @PROTEIN1$, BRCA1 and BRCA2 regions, and their correlations with nine pathologic parameters in 127 breast carcinomas.","label":0}
{"pair_id":"BioInfer.d171.s2.p7","sentence":"We investigate allelic losses in microsatellites of the @PROTEIN1$, RAD52, RAD54, BRCA1 and @PROTEIN2$ regions, and their correlations with nine pathologic parameters in 127 breast carcinomas.","label":0}
{"pair_id":"BioInfer.d171.s2.p8","sentence":"We investigate allelic losses in microsatellites of the @PROTEIN1$, @PROTEIN2$, RAD54, BRCA1 and BRCA2 regions, and their correlations with nine pathologic parameters in 127 breast carcinomas.","label":0}
{"pair_id":"BioInfer.d171.s2.p9","sentence":"We investigate allelic losses in microsatellites of the RAD51, @PROTEIN2$, RAD54, BRCA1 and @PROTEIN1$ regions, and their correlations with nine pathologic parameters in 127 breast carcinomas.","label":0}
{"pair_id":"BioInfer.d526.s0.p0","sentence":"Saccharomyces cerevisiae @PROTEIN1$ functions with @PROTEIN2$, C and C in a pathway leading to normal microtubule stability.","label":1}
{"pair_id":"BioInfer.d526.s0.p1","sentence":"Saccharomyces cerevisiae @PROTEIN1$ functions with @PROTEIN2$1, C and @PROTEIN2$ in a pathway leading to normal microtubule stability.","label":1}
{"pair_id":"BioInfer.d526.s0.p2","sentence":"Saccharomyces cerevisiae @PROTEIN1$ functions with @PROTEIN2$1, @PROTEIN2$ and C in a pathway leading to normal microtubule stability.","label":1}
{"pair_id":"BioInfer.d526.s0.p3","sentence":"Saccharomyces cerevisiae PAC2 functions with @PROTEIN1$@PROTEIN2$1, C and @PROTEIN2$ in a pathway leading to normal microtubule stability.","label":0}
{"pair_id":"BioInfer.d526.s0.p4","sentence":"Saccharomyces cerevisiae PAC2 functions with @PROTEIN1$@PROTEIN2$1, @PROTEIN2$ and C in a pathway leading to normal microtubule stability.","label":0}
{"pair_id":"BioInfer.d526.s0.p5","sentence":"Saccharomyces cerevisiae PAC2 functions with @PROTEIN1$@PROTEIN2$1, @PROTEIN2$ and @PROTEIN1$ in a pathway leading to normal microtubule stability.","label":0}
{"pair_id":"AIMed.d219.s1901.p0","sentence":"We recently reported that @PROTEIN1$ interaction with the @PROTEIN2$ cysteine-rich domain (Raf-CRD, residues 139-184) may be required for Raf-1 activation.","label":0}
{"pair_id":"AIMed.d219.s1901.p1","sentence":"We recently reported that @PROTEIN1$ interaction with the @PROTEIN2$ (Raf-CRD, residues 139-184) may be required for Raf-1 activation.","label":1}
{"pair_id":"AIMed.d219.s1901.p2","sentence":"We recently reported that @PROTEIN1$ interaction with the Raf-1 cysteine-rich domain (@PROTEIN2$, residues 139-184) may be required for Raf-1 activation.","label":1}
{"pair_id":"AIMed.d219.s1901.p3","sentence":"We recently reported that @PROTEIN1$ interaction with the Raf-1 cysteine-rich domain (Raf-CRD, residues 139-184) may be required for @PROTEIN2$ activation.","label":0}
{"pair_id":"AIMed.d219.s1901.p4","sentence":"We recently reported that Ras interaction with the @PROTEIN1$@PROTEIN2$ (Raf-CRD, residues 139-184) may be required for Raf-1 activation.","label":0}
{"pair_id":"AIMed.d219.s1901.p5","sentence":"We recently reported that Ras interaction with the @PROTEIN1$ cysteine-rich domain (@PROTEIN2$, residues 139-184) may be required for Raf-1 activation.","label":0}
{"pair_id":"AIMed.d219.s1901.p6","sentence":"We recently reported that Ras interaction with the @PROTEIN1$ cysteine-rich domain (Raf-CRD, residues 139-184) may be required for @PROTEIN2$ activation.","label":0}
{"pair_id":"AIMed.d219.s1901.p7","sentence":"We recently reported that Ras interaction with the @PROTEIN1$ (@PROTEIN2$, residues 139-184) may be required for Raf-1 activation.","label":0}
{"pair_id":"AIMed.d219.s1901.p8","sentence":"We recently reported that Ras interaction with the @PROTEIN1$ (Raf-CRD, residues 139-184) may be required for @PROTEIN2$ activation.","label":0}
{"pair_id":"AIMed.d219.s1901.p9","sentence":"We recently reported that Ras interaction with the Raf-1 cysteine-rich domain (@PROTEIN1$, residues 139-184) may be required for @PROTEIN2$ activation.","label":0}
{"pair_id":"BioInfer.d267.s1.p0","sentence":"NLS-less S.cerevisiae proteins include both RAD51 and @PROTEIN2$ that function in the recombination and in the repair of double-strand breaks as well as the RAD23 and @PROTEIN1$ molecules.","label":0}
{"pair_id":"BioInfer.d267.s1.p1","sentence":"NLS-less S.cerevisiae proteins include both RAD51 and RAD52 that function in the recombination and in the repair of double-strand breaks as well as the @PROTEIN2$ and @PROTEIN1$ molecules.","label":0}
{"pair_id":"BioInfer.d267.s1.p2","sentence":"NLS-less S.cerevisiae proteins include both @PROTEIN2$ and RAD52 that function in the recombination and in the repair of double-strand breaks as well as the RAD23 and @PROTEIN1$ molecules.","label":0}
{"pair_id":"BioInfer.d267.s1.p3","sentence":"NLS-less S.cerevisiae proteins include both RAD51 and @PROTEIN1$ that function in the recombination and in the repair of double-strand breaks as well as the @PROTEIN2$ and HRR25 molecules.","label":0}
{"pair_id":"BioInfer.d267.s1.p4","sentence":"NLS-less S.cerevisiae proteins include both @PROTEIN2$ and @PROTEIN1$ that function in the recombination and in the repair of double-strand breaks as well as the RAD23 and HRR25 molecules.","label":0}
{"pair_id":"BioInfer.d267.s1.p5","sentence":"NLS-less S.cerevisiae proteins include both @PROTEIN2$ and RAD52 that function in the recombination and in the repair of double-strand breaks as well as the @PROTEIN1$ and HRR25 molecules.","label":0}
{"pair_id":"AIMed.d112.s945.p0","sentence":"The 72-kDa spleen tyrosine kinase (@PROTEIN1$) and Src-family kinase @PROTEIN2$\/56Lyn (Lyn) contribute to signaling via the B-cell antigen receptor complex.","label":0}
{"pair_id":"AIMed.d112.s945.p1","sentence":"The 72-kDa spleen tyrosine kinase (@PROTEIN1$) and Src-family kinase p53\/@PROTEIN2$ (Lyn) contribute to signaling via the B-cell antigen receptor complex.","label":0}
{"pair_id":"AIMed.d112.s945.p2","sentence":"The 72-kDa spleen tyrosine kinase (@PROTEIN1$) and Src-family kinase p53\/56Lyn (@PROTEIN2$) contribute to signaling via the B-cell antigen receptor complex.","label":0}
{"pair_id":"AIMed.d112.s945.p3","sentence":"The 72-kDa spleen tyrosine kinase (Syk) and Src-family kinase @PROTEIN1$\/@PROTEIN2$ (Lyn) contribute to signaling via the B-cell antigen receptor complex.","label":0}
{"pair_id":"AIMed.d112.s945.p4","sentence":"The 72-kDa spleen tyrosine kinase (Syk) and Src-family kinase @PROTEIN1$\/56Lyn (@PROTEIN2$) contribute to signaling via the B-cell antigen receptor complex.","label":0}
{"pair_id":"AIMed.d112.s945.p5","sentence":"The 72-kDa spleen tyrosine kinase (Syk) and Src-family kinase p53\/@PROTEIN1$ (@PROTEIN2$) contribute to signaling via the B-cell antigen receptor complex.","label":0}
{"pair_id":"BioInfer.d736.s1.p0","sentence":"21 @PROTEIN2$ mutations were analyzed in budding yeast, and specific regions of @PROTEIN1$ subdomain 1 were implicated in the interaction with fimbrin, an actin filament-bundling protein.","label":0}
{"pair_id":"BioInfer.d736.s1.p1","sentence":"21 actin mutations were analyzed in budding yeast, and specific regions of @PROTEIN1$ subdomain 1 were implicated in the interaction with fimbrin, an @PROTEIN2$ filament-bundling protein.","label":0}
{"pair_id":"BioInfer.d736.s1.p2","sentence":"21 actin mutations were analyzed in budding yeast, and specific regions of @PROTEIN1$ subdomain 1 were implicated in the interaction with @PROTEIN2$, an actin filament-bundling protein.","label":1}
{"pair_id":"BioInfer.d736.s1.p3","sentence":"21 @PROTEIN1$ mutations were analyzed in budding yeast, and specific regions of actin subdomain 1 were implicated in the interaction with fimbrin, an @PROTEIN2$ filament-bundling protein.","label":0}
{"pair_id":"BioInfer.d736.s1.p4","sentence":"21 @PROTEIN1$ mutations were analyzed in budding yeast, and specific regions of actin subdomain 1 were implicated in the interaction with @PROTEIN2$, an actin filament-bundling protein.","label":0}
{"pair_id":"BioInfer.d736.s1.p5","sentence":"21 actin mutations were analyzed in budding yeast, and specific regions of actin subdomain 1 were implicated in the interaction with @PROTEIN2$, an @PROTEIN1$ filament-bundling protein.","label":1}
{"pair_id":"BioInfer.d102.s2.p0","sentence":"The binding of 125I-labeled recombinant birch pollen profilin to plant and animal actins can be blocked by @PROTEIN1$-specific antibodies that react with different epitopes of birch @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d102.s2.p1","sentence":"The binding of 125I-labeled recombinant birch pollen profilin to plant and animal @PROTEIN2$ can be blocked by @PROTEIN1$-specific antibodies that react with different epitopes of birch profilin.","label":1}
{"pair_id":"BioInfer.d102.s2.p2","sentence":"The binding of 125I-labeled recombinant birch pollen @PROTEIN2$ to plant and animal actins can be blocked by @PROTEIN1$-specific antibodies that react with different epitopes of birch profilin.","label":1}
{"pair_id":"BioInfer.d102.s2.p3","sentence":"The binding of 125I-labeled recombinant birch pollen profilin to plant and animal @PROTEIN2$ can be blocked by profilin-specific antibodies that react with different epitopes of birch @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d102.s2.p4","sentence":"The binding of 125I-labeled recombinant birch pollen @PROTEIN2$ to plant and animal actins can be blocked by profilin-specific antibodies that react with different epitopes of birch @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d102.s2.p5","sentence":"The binding of 125I-labeled recombinant birch pollen @PROTEIN2$ to plant and animal @PROTEIN1$ can be blocked by profilin-specific antibodies that react with different epitopes of birch profilin.","label":1}
{"pair_id":"AIMed.d169.s1427.p0","sentence":"Two proteins have been described as constituents of the @PROTEIN1$ receptor, a approximately 140-kDa glycoprotein (@PROTEIN2$) and the gamma chain (gammac) of the IL-2 receptor, but neither of these proteins binds IL-13.","label":0}
{"pair_id":"AIMed.d169.s1427.p1","sentence":"Two proteins have been described as constituents of the @PROTEIN1$ receptor, a approximately 140-kDa glycoprotein (IL-4R) and the gamma chain (gammac) of the @PROTEIN2$ receptor, but neither of these proteins binds IL-13.","label":0}
{"pair_id":"AIMed.d169.s1427.p2","sentence":"Two proteins have been described as constituents of the @PROTEIN1$ receptor, a approximately 140-kDa glycoprotein (IL-4R) and the gamma chain (gammac) of the @PROTEIN2$, but neither of these proteins binds IL-13.","label":0}
{"pair_id":"AIMed.d169.s1427.p3","sentence":"Two proteins have been described as constituents of the @PROTEIN1$ receptor, a approximately 140-kDa glycoprotein (IL-4R) and the gamma chain (gammac) of the IL-2 receptor, but neither of these proteins binds @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d169.s1427.p4","sentence":"Two proteins have been described as constituents of the IL-4 receptor, a approximately 140-kDa glycoprotein (@PROTEIN1$) and the gamma chain (gammac) of the @PROTEIN2$ receptor, but neither of these proteins binds IL-13.","label":0}
{"pair_id":"AIMed.d169.s1427.p5","sentence":"Two proteins have been described as constituents of the IL-4 receptor, a approximately 140-kDa glycoprotein (@PROTEIN1$) and the gamma chain (gammac) of the @PROTEIN2$, but neither of these proteins binds IL-13.","label":0}
{"pair_id":"AIMed.d169.s1427.p6","sentence":"Two proteins have been described as constituents of the IL-4 receptor, a approximately 140-kDa glycoprotein (@PROTEIN1$) and the gamma chain (gammac) of the IL-2 receptor, but neither of these proteins binds @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d169.s1427.p7","sentence":"Two proteins have been described as constituents of the IL-4 receptor, a approximately 140-kDa glycoprotein (IL-4R) and the gamma chain (gammac) of the @PROTEIN1$@PROTEIN2$, but neither of these proteins binds IL-13.","label":0}
{"pair_id":"AIMed.d169.s1427.p8","sentence":"Two proteins have been described as constituents of the IL-4 receptor, a approximately 140-kDa glycoprotein (IL-4R) and the gamma chain (gammac) of the @PROTEIN1$ receptor, but neither of these proteins binds @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d169.s1427.p9","sentence":"Two proteins have been described as constituents of the IL-4 receptor, a approximately 140-kDa glycoprotein (IL-4R) and the gamma chain (gammac) of the @PROTEIN1$, but neither of these proteins binds @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d583.s1.p0","sentence":"This review describes three structures of @PROTEIN1$ complexed with different monomer-binding proteins, namely with @PROTEIN2$, gelsolin segment 1, and profilin.","label":1}
{"pair_id":"BioInfer.d583.s1.p1","sentence":"This review describes three structures of @PROTEIN1$ complexed with different monomer-binding proteins, namely with DNase I, gelsolin segment 1, and @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d583.s1.p2","sentence":"This review describes three structures of @PROTEIN1$ complexed with different monomer-binding proteins, namely with DNase I, @PROTEIN2$ segment 1, and profilin.","label":1}
{"pair_id":"BioInfer.d583.s1.p3","sentence":"This review describes three structures of actin complexed with different monomer-binding proteins, namely with @PROTEIN1$, gelsolin segment 1, and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d583.s1.p4","sentence":"This review describes three structures of actin complexed with different monomer-binding proteins, namely with @PROTEIN1$, @PROTEIN2$ segment 1, and profilin.","label":0}
{"pair_id":"BioInfer.d583.s1.p5","sentence":"This review describes three structures of actin complexed with different monomer-binding proteins, namely with DNase I, @PROTEIN2$ segment 1, and @PROTEIN1$.","label":0}
{"pair_id":"AIMed.d176.s1487.p0","sentence":"This observation supports a model in which @PROTEIN1$ functions at an intermediate stage of @PROTEIN2$ assembly to facilitate formation of subsequent PR complexes lacking p60.","label":0}
{"pair_id":"AIMed.d176.s1487.p1","sentence":"This observation supports a model in which @PROTEIN1$ functions at an intermediate stage of PR assembly to facilitate formation of subsequent @PROTEIN2$ complexes lacking p60.","label":0}
{"pair_id":"AIMed.d176.s1487.p2","sentence":"This observation supports a model in which @PROTEIN1$ functions at an intermediate stage of PR assembly to facilitate formation of subsequent PR complexes lacking @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d176.s1487.p3","sentence":"This observation supports a model in which p60 functions at an intermediate stage of @PROTEIN1$ assembly to facilitate formation of subsequent @PROTEIN2$ complexes lacking p60.","label":0}
{"pair_id":"AIMed.d176.s1487.p4","sentence":"This observation supports a model in which p60 functions at an intermediate stage of @PROTEIN1$ assembly to facilitate formation of subsequent PR complexes lacking @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d176.s1487.p5","sentence":"This observation supports a model in which p60 functions at an intermediate stage of PR assembly to facilitate formation of subsequent @PROTEIN1$ complexes lacking @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d757.s0.p0","sentence":"Thus, the @PROTEIN1$-binding dodecapeptide sequence of @PROTEIN2$ may constitute a multifunctional domain in cofilin.","label":1}
{"pair_id":"BioInfer.d757.s0.p1","sentence":"Thus, the @PROTEIN1$-binding dodecapeptide sequence of cofilin may constitute a multifunctional domain in @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d757.s0.p2","sentence":"Thus, the actin-binding dodecapeptide sequence of @PROTEIN1$ may constitute a multifunctional domain in @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d182.s1549.p0","sentence":"The interface relies on the steric complementarity between the @PROTEIN1$ cleft and the hydrophobic face of the @PROTEIN2$ alpha helix and, in particular, on a triad of p53 amino acids-Phe19, Trp23, and Leu26-which insert deep into the MDM2 cleft.","label":0}
{"pair_id":"AIMed.d182.s1549.p1","sentence":"The interface relies on the steric complementarity between the @PROTEIN1$ cleft and the hydrophobic face of the p53 alpha helix and, in particular, on a triad of @PROTEIN2$ amino acids-Phe19, Trp23, and Leu26-which insert deep into the MDM2 cleft.","label":0}
{"pair_id":"AIMed.d182.s1549.p2","sentence":"The interface relies on the steric complementarity between the @PROTEIN1$ cleft and the hydrophobic face of the p53 alpha helix and, in particular, on a triad of p53 amino acids-Phe19, Trp23, and Leu26-which insert deep into the @PROTEIN2$ cleft.","label":0}
{"pair_id":"AIMed.d182.s1549.p3","sentence":"The interface relies on the steric complementarity between the MDM2 cleft and the hydrophobic face of the @PROTEIN1$ alpha helix and, in particular, on a triad of @PROTEIN2$ amino acids-Phe19, Trp23, and Leu26-which insert deep into the MDM2 cleft.","label":0}
{"pair_id":"AIMed.d182.s1549.p4","sentence":"The interface relies on the steric complementarity between the MDM2 cleft and the hydrophobic face of the @PROTEIN1$ alpha helix and, in particular, on a triad of p53 amino acids-Phe19, Trp23, and Leu26-which insert deep into the @PROTEIN2$ cleft.","label":0}
{"pair_id":"AIMed.d182.s1549.p5","sentence":"The interface relies on the steric complementarity between the MDM2 cleft and the hydrophobic face of the p53 alpha helix and, in particular, on a triad of @PROTEIN1$ amino acids-Phe19, Trp23, and Leu26-which insert deep into the @PROTEIN2$ cleft.","label":1}
{"pair_id":"AIMed.d153.s1302.p0","sentence":"Moreover, using immunoelectron microscopy, we demonstrated that @PROTEIN1$ and @PROTEIN2$ co-localized on the cell surface, but not inside cells, suggesting that CD26 did not transport ADA to the surface.","label":0}
{"pair_id":"AIMed.d153.s1302.p1","sentence":"Moreover, using immunoelectron microscopy, we demonstrated that @PROTEIN1$ and ADA co-localized on the cell surface, but not inside cells, suggesting that @PROTEIN2$ did not transport ADA to the surface.","label":0}
{"pair_id":"AIMed.d153.s1302.p2","sentence":"Moreover, using immunoelectron microscopy, we demonstrated that @PROTEIN1$ and ADA co-localized on the cell surface, but not inside cells, suggesting that CD26 did not transport @PROTEIN2$ to the surface.","label":0}
{"pair_id":"AIMed.d153.s1302.p3","sentence":"Moreover, using immunoelectron microscopy, we demonstrated that CD26 and @PROTEIN1$ co-localized on the cell surface, but not inside cells, suggesting that @PROTEIN2$ did not transport ADA to the surface.","label":0}
{"pair_id":"AIMed.d153.s1302.p4","sentence":"Moreover, using immunoelectron microscopy, we demonstrated that CD26 and @PROTEIN1$ co-localized on the cell surface, but not inside cells, suggesting that CD26 did not transport @PROTEIN2$ to the surface.","label":0}
{"pair_id":"AIMed.d153.s1302.p5","sentence":"Moreover, using immunoelectron microscopy, we demonstrated that CD26 and ADA co-localized on the cell surface, but not inside cells, suggesting that @PROTEIN1$ did not transport @PROTEIN2$ to the surface.","label":0}
{"pair_id":"AIMed.d146.s1230.p0","sentence":"Characterization of a novel high affinity human @PROTEIN1$@PROTEIN2$. Expression on T cells and association with IL-7 driven proliferation.","label":0}
{"pair_id":"AIMed.d146.s1230.p1","sentence":"Characterization of a novel high affinity human @PROTEIN1$ receptor. Expression on T cells and association with @PROTEIN2$ driven proliferation.","label":0}
{"pair_id":"AIMed.d146.s1230.p2","sentence":"Characterization of a novel high affinity human @PROTEIN1$. Expression on T cells and association with @PROTEIN2$ driven proliferation.","label":0}
{"pair_id":"AIMed.d195.s1663.p0","sentence":"Intriguingly, @PROTEIN1$-@PROTEIN2$ binding is directly antagonized by Ca2+\/calmodulin.","label":0}
{"pair_id":"AIMed.d195.s1663.p1","sentence":"Intriguingly, @PROTEIN1$-alpha-actinin binding is directly antagonized by Ca2+\/@PROTEIN2$.","label":0}
{"pair_id":"AIMed.d195.s1663.p2","sentence":"Intriguingly, NR1-@PROTEIN1$ binding is directly antagonized by Ca2+\/@PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d51.s0.p0","sentence":"@PROTEIN1$ plays a fundamental role in mispair recognition whereas MSH3 and @PROTEIN2$ appear to modify the specificity of this recognition.","label":0}
{"pair_id":"BioInfer.d51.s0.p1","sentence":"@PROTEIN1$ plays a fundamental role in mispair recognition whereas @PROTEIN2$ and MSH6 appear to modify the specificity of this recognition.","label":0}
{"pair_id":"BioInfer.d51.s0.p2","sentence":"MSH2 plays a fundamental role in mispair recognition whereas @PROTEIN2$ and @PROTEIN1$ appear to modify the specificity of this recognition.","label":0}
{"pair_id":"AIMed.d126.s1074.p0","sentence":"Using immunoprecipitation techniques, we have determined the rates at which @PROTEIN1$ and @PROTEIN2$ (GS) are released from groEL in a form committed to refold to active enzyme.","label":0}
{"pair_id":"AIMed.d126.s1074.p1","sentence":"Using immunoprecipitation techniques, we have determined the rates at which @PROTEIN1$ and glutamine synthetase (@PROTEIN2$) are released from groEL in a form committed to refold to active enzyme.","label":0}
{"pair_id":"AIMed.d126.s1074.p2","sentence":"Using immunoprecipitation techniques, we have determined the rates at which @PROTEIN1$ and glutamine synthetase (GS) are released from @PROTEIN2$ in a form committed to refold to active enzyme.","label":1}
{"pair_id":"AIMed.d126.s1074.p3","sentence":"Using immunoprecipitation techniques, we have determined the rates at which rhodanese and @PROTEIN1$ (@PROTEIN2$) are released from groEL in a form committed to refold to active enzyme.","label":0}
{"pair_id":"AIMed.d126.s1074.p4","sentence":"Using immunoprecipitation techniques, we have determined the rates at which rhodanese and @PROTEIN1$ (GS) are released from @PROTEIN2$ in a form committed to refold to active enzyme.","label":1}
{"pair_id":"AIMed.d126.s1074.p5","sentence":"Using immunoprecipitation techniques, we have determined the rates at which rhodanese and glutamine synthetase (@PROTEIN1$) are released from @PROTEIN2$ in a form committed to refold to active enzyme.","label":1}
{"pair_id":"BioInfer.d240.s0.p0","sentence":"Here we demonstrate that @PROTEIN1$ is concentrated in cultured skin fibroblasts and several other human mesenchymal cell lines in the focal adhesions at the ends of actin stress fibers, co-localizing with the known focal adhesion components @PROTEIN2$ and vinculin.","label":1}
{"pair_id":"BioInfer.d240.s0.p1","sentence":"Here we demonstrate that @PROTEIN1$ is concentrated in cultured skin fibroblasts and several other human mesenchymal cell lines in the focal adhesions at the ends of actin stress fibers, co-localizing with the known focal adhesion components talin and @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d240.s0.p2","sentence":"Here we demonstrate that @PROTEIN1$ is concentrated in cultured skin fibroblasts and several other human mesenchymal cell lines in the focal adhesions at the ends of @PROTEIN2$ stress fibers, co-localizing with the known focal adhesion components talin and vinculin.","label":1}
{"pair_id":"BioInfer.d240.s0.p3","sentence":"Here we demonstrate that type XIII collagen is concentrated in cultured skin fibroblasts and several other human mesenchymal cell lines in the focal adhesions at the ends of actin stress fibers, co-localizing with the known focal adhesion components @PROTEIN1$ and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d240.s0.p4","sentence":"Here we demonstrate that type XIII collagen is concentrated in cultured skin fibroblasts and several other human mesenchymal cell lines in the focal adhesions at the ends of @PROTEIN2$ stress fibers, co-localizing with the known focal adhesion components @PROTEIN1$ and vinculin.","label":0}
{"pair_id":"BioInfer.d240.s0.p5","sentence":"Here we demonstrate that type XIII collagen is concentrated in cultured skin fibroblasts and several other human mesenchymal cell lines in the focal adhesions at the ends of @PROTEIN2$ stress fibers, co-localizing with the known focal adhesion components talin and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d692.s0.p0","sentence":"The Schizosaccharomyces pombe rhp51+, rad22+ and @PROTEIN1$ genes are homologous to RAD51, RAD52 and @PROTEIN2$ respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.","label":1}
{"pair_id":"BioInfer.d692.s0.p1","sentence":"The Schizosaccharomyces pombe rhp51+, rad22+ and @PROTEIN1$ genes are homologous to @PROTEIN2$, RAD52 and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.","label":0}
{"pair_id":"BioInfer.d692.s0.p2","sentence":"The Schizosaccharomyces pombe rhp51+, @PROTEIN2$ and @PROTEIN1$ genes are homologous to RAD51, RAD52 and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.","label":0}
{"pair_id":"BioInfer.d692.s0.p3","sentence":"The Schizosaccharomyces pombe @PROTEIN2$, rad22+ and @PROTEIN1$ genes are homologous to RAD51, RAD52 and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.","label":0}
{"pair_id":"BioInfer.d692.s0.p4","sentence":"The Schizosaccharomyces pombe rhp51+, rad22+ and @PROTEIN1$ genes are homologous to RAD51, @PROTEIN2$ and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.","label":0}
{"pair_id":"BioInfer.d692.s0.p5","sentence":"The Schizosaccharomyces pombe rhp51+, rad22+ and rhp54+ genes are homologous to @PROTEIN2$, RAD52 and @PROTEIN1$ respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.","label":0}
{"pair_id":"BioInfer.d692.s0.p6","sentence":"The Schizosaccharomyces pombe rhp51+, @PROTEIN2$ and rhp54+ genes are homologous to RAD51, RAD52 and @PROTEIN1$ respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.","label":0}
{"pair_id":"BioInfer.d692.s0.p7","sentence":"The Schizosaccharomyces pombe @PROTEIN2$, rad22+ and rhp54+ genes are homologous to RAD51, RAD52 and @PROTEIN1$ respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.","label":0}
{"pair_id":"BioInfer.d692.s0.p8","sentence":"The Schizosaccharomyces pombe rhp51+, rad22+ and rhp54+ genes are homologous to RAD51, @PROTEIN2$ and @PROTEIN1$ respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.","label":0}
{"pair_id":"BioInfer.d692.s0.p9","sentence":"The Schizosaccharomyces pombe rhp51+, @PROTEIN2$ and rhp54+ genes are homologous to @PROTEIN1$, RAD52 and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.","label":0}
{"pair_id":"BioInfer.d692.s0.p10","sentence":"The Schizosaccharomyces pombe @PROTEIN2$, rad22+ and rhp54+ genes are homologous to @PROTEIN1$, RAD52 and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.","label":1}
{"pair_id":"BioInfer.d692.s0.p11","sentence":"The Schizosaccharomyces pombe rhp51+, rad22+ and rhp54+ genes are homologous to @PROTEIN1$, @PROTEIN2$ and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.","label":0}
{"pair_id":"BioInfer.d692.s0.p12","sentence":"The Schizosaccharomyces pombe @PROTEIN2$, @PROTEIN1$ and rhp54+ genes are homologous to RAD51, RAD52 and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.","label":0}
{"pair_id":"BioInfer.d692.s0.p13","sentence":"The Schizosaccharomyces pombe rhp51+, @PROTEIN1$ and rhp54+ genes are homologous to RAD51, @PROTEIN2$ and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.","label":1}
{"pair_id":"BioInfer.d692.s0.p14","sentence":"The Schizosaccharomyces pombe @PROTEIN1$, rad22+ and rhp54+ genes are homologous to RAD51, @PROTEIN2$ and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.","label":0}
{"pair_id":"BioInfer.d255.s0.p0","sentence":"@PROTEIN2$ binds to predicted alpha-helical coiled-coil regions of @PROTEIN1$ and SNAP-25, shown previously to be engaged in their direct interaction.","label":1}
{"pair_id":"BioInfer.d255.s0.p1","sentence":"alpha-SNAP binds to predicted alpha-helical coiled-coil regions of @PROTEIN1$ and @PROTEIN2$, shown previously to be engaged in their direct interaction.","label":1}
{"pair_id":"BioInfer.d255.s0.p2","sentence":"@PROTEIN1$ binds to predicted alpha-helical coiled-coil regions of syntaxin and @PROTEIN2$, shown previously to be engaged in their direct interaction.","label":1}
{"pair_id":"AIMed.d120.s1017.p0","sentence":"To identify specific @PROTEIN1$-protein interactions, a recombinant fusion protein affinity reagent was constructed and used to identify proteins associating with @PROTEIN2$ from human platelet lysates and erythroleukemia cells.","label":0}
{"pair_id":"BioInfer.d119.s1.p0","sentence":"The @PROTEIN1$ exhibited a profound decrease in its ability to interact with @PROTEIN2$, whereas binding to poly-(L)-proline was essentially unchanged.","label":1}
{"pair_id":"AIMed.d175.s1481.p0","sentence":"A physical interaction between @PROTEIN1$ and @PROTEIN2$ suggests that CDC37 may regulate the mammalian cell cycle through a direct effect on CDK4.","label":1}
{"pair_id":"AIMed.d175.s1481.p1","sentence":"A physical interaction between @PROTEIN1$ and CDK4 suggests that @PROTEIN2$ may regulate the mammalian cell cycle through a direct effect on CDK4.","label":0}
{"pair_id":"AIMed.d175.s1481.p2","sentence":"A physical interaction between @PROTEIN1$ and CDK4 suggests that CDC37 may regulate the mammalian cell cycle through a direct effect on @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d175.s1481.p3","sentence":"A physical interaction between CDC37 and @PROTEIN1$ suggests that @PROTEIN2$ may regulate the mammalian cell cycle through a direct effect on CDK4.","label":0}
{"pair_id":"AIMed.d175.s1481.p4","sentence":"A physical interaction between CDC37 and @PROTEIN1$ suggests that CDC37 may regulate the mammalian cell cycle through a direct effect on @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d175.s1481.p5","sentence":"A physical interaction between CDC37 and CDK4 suggests that @PROTEIN1$ may regulate the mammalian cell cycle through a direct effect on @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d348.s1.p0","sentence":"The exogeneous @PROTEIN1$, but not @PROTEIN2$, caused quick disassembly of actin filaments and accumulated in furrow region of dividing cells.","label":0}
{"pair_id":"BioInfer.d348.s1.p1","sentence":"The exogeneous @PROTEIN1$, but not ADF, caused quick disassembly of @PROTEIN2$ filaments and accumulated in furrow region of dividing cells.","label":1}
{"pair_id":"BioInfer.d348.s1.p2","sentence":"The exogeneous cofilin, but not @PROTEIN1$, caused quick disassembly of @PROTEIN2$ filaments and accumulated in furrow region of dividing cells.","label":1}
{"pair_id":"AIMed.d42.s364.p0","sentence":"Using several complementary approaches, we investigated the formation of homomeric and heteromeric complexes between the two known BMP type I receptors (@PROTEIN1$ and @PROTEIN2$) and the BMP type II receptor (BR-II).","label":0}
{"pair_id":"AIMed.d42.s364.p1","sentence":"Using several complementary approaches, we investigated the formation of homomeric and heteromeric complexes between the two known BMP type I receptors (@PROTEIN1$ and BR-Ib) and the @PROTEIN2$ (BR-II).","label":0}
{"pair_id":"AIMed.d42.s364.p2","sentence":"Using several complementary approaches, we investigated the formation of homomeric and heteromeric complexes between the two known BMP type I receptors (@PROTEIN1$ and BR-Ib) and the BMP type II receptor (@PROTEIN2$).","label":0}
{"pair_id":"AIMed.d42.s364.p3","sentence":"Using several complementary approaches, we investigated the formation of homomeric and heteromeric complexes between the two known BMP type I receptors (BR-Ia and @PROTEIN1$) and the @PROTEIN2$ (BR-II).","label":0}
{"pair_id":"AIMed.d42.s364.p4","sentence":"Using several complementary approaches, we investigated the formation of homomeric and heteromeric complexes between the two known BMP type I receptors (BR-Ia and @PROTEIN1$) and the BMP type II receptor (@PROTEIN2$).","label":0}
{"pair_id":"AIMed.d42.s364.p5","sentence":"Using several complementary approaches, we investigated the formation of homomeric and heteromeric complexes between the two known BMP type I receptors (BR-Ia and BR-Ib) and the @PROTEIN1$ (@PROTEIN2$).","label":0}
{"pair_id":"BioInfer.d234.s0.p0","sentence":"Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in @PROTEIN2$ critical for binding CBP\/@PROTEIN1$ to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.","label":1}
{"pair_id":"BioInfer.d234.s0.p1","sentence":"Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding @PROTEIN2$\/@PROTEIN1$ to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.","label":0}
{"pair_id":"BioInfer.d234.s0.p2","sentence":"Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding CBP\/@PROTEIN1$ to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for @PROTEIN2$ binding and Tax subunit dimerization.","label":0}
{"pair_id":"BioInfer.d234.s0.p3","sentence":"@PROTEIN2$ pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding CBP\/@PROTEIN1$ to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.","label":0}
{"pair_id":"BioInfer.d234.s0.p4","sentence":"Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding CBP\/@PROTEIN1$ to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and @PROTEIN2$ subunit dimerization.","label":0}
{"pair_id":"BioInfer.d234.s0.p5","sentence":"Glutathione S-transferase pull-down performed with @PROTEIN2$ deletion mutants and peptide competition have localized the site in Tax critical for binding CBP\/@PROTEIN1$ to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.","label":0}
{"pair_id":"BioInfer.d234.s0.p6","sentence":"Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in @PROTEIN1$ critical for binding @PROTEIN2$\/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.","label":1}
{"pair_id":"BioInfer.d234.s0.p7","sentence":"Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in @PROTEIN1$ critical for binding CBP\/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for @PROTEIN2$ binding and Tax subunit dimerization.","label":1}
{"pair_id":"BioInfer.d234.s0.p8","sentence":"@PROTEIN2$ pull-down performed with Tax deletion mutants and peptide competition have localized the site in @PROTEIN1$ critical for binding CBP\/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.","label":0}
{"pair_id":"BioInfer.d234.s0.p9","sentence":"Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in @PROTEIN1$ critical for binding CBP\/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and @PROTEIN2$ subunit dimerization.","label":1}
{"pair_id":"BioInfer.d234.s0.p10","sentence":"Glutathione S-transferase pull-down performed with @PROTEIN2$ deletion mutants and peptide competition have localized the site in @PROTEIN1$ critical for binding CBP\/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.","label":0}
{"pair_id":"BioInfer.d234.s0.p11","sentence":"Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding @PROTEIN1$\/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for @PROTEIN2$ binding and Tax subunit dimerization.","label":0}
{"pair_id":"BioInfer.d234.s0.p12","sentence":"@PROTEIN2$ pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding @PROTEIN1$\/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.","label":0}
{"pair_id":"BioInfer.d234.s0.p13","sentence":"Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding @PROTEIN1$\/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and @PROTEIN2$ subunit dimerization.","label":0}
{"pair_id":"BioInfer.d234.s0.p14","sentence":"Glutathione S-transferase pull-down performed with @PROTEIN2$ deletion mutants and peptide competition have localized the site in Tax critical for binding @PROTEIN1$\/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.","label":0}
{"pair_id":"BioInfer.d234.s0.p15","sentence":"@PROTEIN2$ pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding CBP\/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for @PROTEIN1$ binding and Tax subunit dimerization.","label":0}
{"pair_id":"BioInfer.d234.s0.p16","sentence":"Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding CBP\/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for @PROTEIN1$ binding and @PROTEIN2$ subunit dimerization.","label":0}
{"pair_id":"BioInfer.d234.s0.p17","sentence":"Glutathione S-transferase pull-down performed with @PROTEIN2$ deletion mutants and peptide competition have localized the site in Tax critical for binding CBP\/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for @PROTEIN1$ binding and Tax subunit dimerization.","label":0}
{"pair_id":"BioInfer.d234.s0.p18","sentence":"@PROTEIN1$ pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding CBP\/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and @PROTEIN2$ subunit dimerization.","label":0}
{"pair_id":"BioInfer.d234.s0.p19","sentence":"@PROTEIN1$ pull-down performed with @PROTEIN2$ deletion mutants and peptide competition have localized the site in Tax critical for binding CBP\/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.","label":0}
{"pair_id":"BioInfer.d234.s0.p20","sentence":"Glutathione S-transferase pull-down performed with @PROTEIN2$ deletion mutants and peptide competition have localized the site in Tax critical for binding CBP\/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and @PROTEIN1$ subunit dimerization.","label":0}
{"pair_id":"BioInfer.d246.s3.p0","sentence":"Regulation of @PROTEIN1$ dynamics through phosphorylation of @PROTEIN2$ by LIM-kinase.","label":1}
{"pair_id":"BioInfer.d246.s3.p1","sentence":"Regulation of @PROTEIN1$ dynamics through phosphorylation of cofilin by @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d246.s3.p2","sentence":"Regulation of actin dynamics through phosphorylation of @PROTEIN1$ by @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d296.s1.p0","sentence":"In CC, membranous expression of @PROTEIN1$, alpha-catenin, and @PROTEIN2$ was the same or reduced when compared with non-cancerous bile ducts in the majority of CC.","label":0}
{"pair_id":"BioInfer.d296.s1.p1","sentence":"In CC, membranous expression of @PROTEIN1$, @PROTEIN2$, and beta-catenin was the same or reduced when compared with non-cancerous bile ducts in the majority of CC.","label":0}
{"pair_id":"BioInfer.d296.s1.p2","sentence":"In CC, membranous expression of E-cad, @PROTEIN2$, and @PROTEIN1$ was the same or reduced when compared with non-cancerous bile ducts in the majority of CC.","label":0}
{"pair_id":"BioInfer.d321.s0.p0","sentence":"In cancerous tissues, the frequency of reduced expression of beta-catenin (28 of 86, 33%) was similar to that of @PROTEIN1$ (19 of 86, 22%), but less than that of @PROTEIN2$ (47 of 86, 55%).","label":0}
{"pair_id":"BioInfer.d321.s0.p1","sentence":"In cancerous tissues, the frequency of reduced expression of @PROTEIN2$ (28 of 86, 33%) was similar to that of @PROTEIN1$ (19 of 86, 22%), but less than that of alpha-catenin (47 of 86, 55%).","label":0}
{"pair_id":"BioInfer.d321.s0.p2","sentence":"In cancerous tissues, the frequency of reduced expression of @PROTEIN2$ (28 of 86, 33%) was similar to that of E-cadherin (19 of 86, 22%), but less than that of @PROTEIN1$ (47 of 86, 55%).","label":0}
{"pair_id":"AIMed.d96.s808.p0","sentence":"It binds homophilically, i.e., @PROTEIN1$ on the surface of one cell binds to @PROTEIN2$ on an apposing cell, and the binding site lies within the immunoglobulin domain.","label":1}
{"pair_id":"AIMed.d205.s1773.p0","sentence":"Cellular @PROTEIN1$ as well as the recombinant Src homology 2 (SH2) domains of @PROTEIN2$ bound a tyrosine-phosphorylated peptide encompassing Y463 with approximately threefold greater affinity than a doubly tyrosine-phosphorylated Y429-Y441 peptide.","label":0}
{"pair_id":"AIMed.d119.s1005.p0","sentence":"Nuclear protein @PROTEIN1$ is a coactivator for the transcription factor @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d94.s800.p0","sentence":"However, @PROTEIN1$ was also an agonist for @PROTEIN2$ but not CC CKR1; MCP-3 was an agonist for CC CKR1 but not CC CKR3.","label":1}
{"pair_id":"AIMed.d94.s800.p1","sentence":"However, @PROTEIN1$ was also an agonist for CC CKR3 but not @PROTEIN2$; MCP-3 was an agonist for CC CKR1 but not CC CKR3.","label":0}
{"pair_id":"AIMed.d94.s800.p2","sentence":"However, @PROTEIN1$ was also an agonist for CC CKR3 but not CC CKR1; @PROTEIN2$ was an agonist for CC CKR1 but not CC CKR3.","label":0}
{"pair_id":"AIMed.d94.s800.p3","sentence":"However, @PROTEIN1$ was also an agonist for CC CKR3 but not CC CKR1; MCP-3 was an agonist for @PROTEIN2$ but not CC CKR3.","label":0}
{"pair_id":"AIMed.d94.s800.p4","sentence":"However, @PROTEIN1$ was also an agonist for CC CKR3 but not CC CKR1; MCP-3 was an agonist for CC CKR1 but not @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d94.s800.p5","sentence":"However, MIP-1 beta was also an agonist for @PROTEIN1$ but not @PROTEIN2$; MCP-3 was an agonist for CC CKR1 but not CC CKR3.","label":0}
{"pair_id":"AIMed.d94.s800.p6","sentence":"However, MIP-1 beta was also an agonist for @PROTEIN1$ but not CC CKR1; @PROTEIN2$ was an agonist for CC CKR1 but not CC CKR3.","label":0}
{"pair_id":"AIMed.d94.s800.p7","sentence":"However, MIP-1 beta was also an agonist for @PROTEIN1$ but not CC CKR1; MCP-3 was an agonist for @PROTEIN2$ but not CC CKR3.","label":0}
{"pair_id":"AIMed.d94.s800.p8","sentence":"However, MIP-1 beta was also an agonist for @PROTEIN1$ but not CC CKR1; MCP-3 was an agonist for CC CKR1 but not @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d94.s800.p9","sentence":"However, MIP-1 beta was also an agonist for CC CKR3 but not @PROTEIN1$; @PROTEIN2$ was an agonist for CC CKR1 but not CC CKR3.","label":0}
{"pair_id":"AIMed.d94.s800.p10","sentence":"However, MIP-1 beta was also an agonist for CC CKR3 but not @PROTEIN1$; MCP-3 was an agonist for @PROTEIN2$ but not CC CKR3.","label":0}
{"pair_id":"AIMed.d94.s800.p11","sentence":"However, MIP-1 beta was also an agonist for CC CKR3 but not @PROTEIN1$; MCP-3 was an agonist for CC CKR1 but not @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d94.s800.p12","sentence":"However, MIP-1 beta was also an agonist for CC CKR3 but not CC CKR1; @PROTEIN1$ was an agonist for @PROTEIN2$ but not CC CKR3.","label":1}
{"pair_id":"AIMed.d94.s800.p13","sentence":"However, MIP-1 beta was also an agonist for CC CKR3 but not CC CKR1; @PROTEIN1$ was an agonist for CC CKR1 but not @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d94.s800.p14","sentence":"However, MIP-1 beta was also an agonist for CC CKR3 but not CC CKR1; MCP-3 was an agonist for @PROTEIN1$ but not @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d480.s0.p0","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (@PROTEIN2$), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) phosphop of MV and the H, F, @PROTEIN1$ and P @PROTEIN1$ of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p1","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), @PROTEIN2$ (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) @PROTEIN2$ of MV and the H, F, @PROTEIN1$ and P @PROTEIN1$ of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p2","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and @PROTEIN2$ (M) @PROTEIN2$ of MV and the H, F, @PROTEIN1$ and P @PROTEIN1$ of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p3","sentence":"Panels of six to 31 MAbs against the @PROTEIN2$ (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) @PROTEIN2$ of MV and the H, F, @PROTEIN1$ and P @PROTEIN1$ of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p4","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), @PROTEIN2$ (NP), phosphoprotein (P) and matrix (M) @PROTEIN2$ of MV and the H, F, @PROTEIN1$ and P @PROTEIN1$ of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p5","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) phosphop of MV and the @PROTEIN2$, F, @PROTEIN1$ and P @PROTEIN1$@PROTEIN2$ of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p6","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) phosphop of MV and the H, F, @PROTEIN1$ and @PROTEIN2$@PROTEIN1$ of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p7","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), @PROTEIN2$ (P) and matrix (M) @PROTEIN2$ of MV and the H, F, @PROTEIN1$ and P @PROTEIN1$ of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p8","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) phosphop of MV and the H, @PROTEIN2$, @PROTEIN1$ and P @PROTEIN1$@PROTEIN2$ of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p9","sentence":"Panels of six to 31 MAbs against the haemagglutinin (@PROTEIN2$), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) phosphop of MV and the H, F, @PROTEIN1$ and P @PROTEIN1$ of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p10","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (@PROTEIN2$) and matrix (M) phosphop of MV and the H, F, @PROTEIN1$ and P @PROTEIN1$ of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p11","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (@PROTEIN2$), phosphoprotein (P) and matrix (M) phosphop of MV and the H, F, @PROTEIN1$ and P @PROTEIN1$ of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p12","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (@PROTEIN2$) phosphop of MV and the H, F, @PROTEIN1$ and P @PROTEIN1$ of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p13","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), @PROTEIN2$ (@PROTEIN1$), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) @PROTEIN2$ of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p14","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (@PROTEIN1$), nucleocapsid protein (NP), phosphoprotein (P) and @PROTEIN2$ (M) @PROTEIN2$ of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p15","sentence":"Panels of six to 31 MAbs against the @PROTEIN2$ (H), fusion (@PROTEIN1$), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) @PROTEIN2$ of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p16","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (@PROTEIN1$), @PROTEIN2$ (NP), phosphoprotein (P) and matrix (M) @PROTEIN2$ of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p17","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (@PROTEIN1$), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) phosphop of MV and the @PROTEIN2$, F, NP and P @PROTEIN2$ of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p18","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (@PROTEIN1$), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) phosphop of MV and the H, F, NP and @PROTEIN2$ of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p19","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (@PROTEIN1$), nucleocapsid protein (NP), @PROTEIN2$ (P) and matrix (M) @PROTEIN2$ of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p20","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (@PROTEIN1$), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) phosphop of MV and the H, @PROTEIN2$, NP and P @PROTEIN2$ of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p21","sentence":"Panels of six to 31 MAbs against the haemagglutinin (@PROTEIN2$), fusion (@PROTEIN1$), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) phosphop of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p22","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (@PROTEIN1$), nucleocapsid protein (NP), phosphoprotein (@PROTEIN2$) and matrix (M) phosphop of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p23","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (@PROTEIN1$), nucleocapsid protein (@PROTEIN2$), phosphoprotein (P) and matrix (M) phosphop of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p24","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (@PROTEIN1$), nucleocapsid protein (NP), phosphoprotein (P) and matrix (@PROTEIN2$) phosphop of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p25","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), @PROTEIN1$ (F), nucleocapsid protein (NP), phosphoprotein (P) and @PROTEIN2$ (M) @PROTEIN1$@PROTEIN2$ of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p26","sentence":"Panels of six to 31 MAbs against the @PROTEIN2$ (H), @PROTEIN1$ (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) @PROTEIN1$@PROTEIN2$ of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p27","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), @PROTEIN1$ (F), @PROTEIN2$ (NP), phosphoprotein (P) and matrix (M) @PROTEIN1$@PROTEIN2$ of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p28","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), @PROTEIN1$ (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) @PROTEIN1$ of MV and the @PROTEIN2$, F, NP and P @PROTEIN2$ of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p29","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), @PROTEIN1$ (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) @PROTEIN1$ of MV and the H, F, NP and @PROTEIN2$ of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p30","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), @PROTEIN1$ (F), nucleocapsid protein (NP), @PROTEIN2$ (P) and matrix (M) @PROTEIN1$@PROTEIN2$ of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p31","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), @PROTEIN1$ (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) @PROTEIN1$ of MV and the H, @PROTEIN2$, NP and P @PROTEIN2$ of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p32","sentence":"Panels of six to 31 MAbs against the haemagglutinin (@PROTEIN2$), @PROTEIN1$ (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) @PROTEIN1$ of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p33","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), @PROTEIN1$ (F), nucleocapsid protein (NP), phosphoprotein (@PROTEIN2$) and matrix (M) @PROTEIN1$ of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p34","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), @PROTEIN1$ (F), nucleocapsid protein (@PROTEIN2$), phosphoprotein (P) and matrix (M) @PROTEIN1$ of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p35","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), @PROTEIN1$ (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (@PROTEIN2$) @PROTEIN1$ of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p36","sentence":"Panels of six to 31 MAbs against the @PROTEIN2$ (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and @PROTEIN1$ (M) @PROTEIN1$@PROTEIN2$ of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p37","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), @PROTEIN2$ (NP), phosphoprotein (P) and @PROTEIN1$ (M) @PROTEIN1$@PROTEIN2$ of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p38","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and @PROTEIN1$ (M) @PROTEIN1$ of MV and the @PROTEIN2$, F, NP and P @PROTEIN2$ of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p39","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and @PROTEIN1$ (M) @PROTEIN1$ of MV and the H, F, NP and @PROTEIN2$ of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p40","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), @PROTEIN2$ (P) and @PROTEIN1$ (M) @PROTEIN1$@PROTEIN2$ of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p41","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and @PROTEIN1$ (M) @PROTEIN1$ of MV and the H, @PROTEIN2$, NP and P @PROTEIN2$ of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p42","sentence":"Panels of six to 31 MAbs against the haemagglutinin (@PROTEIN2$), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and @PROTEIN1$ (M) @PROTEIN1$ of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p43","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (@PROTEIN2$) and @PROTEIN1$ (M) @PROTEIN1$ of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p44","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (@PROTEIN2$), phosphoprotein (P) and @PROTEIN1$ (M) @PROTEIN1$ of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p45","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and @PROTEIN1$ (@PROTEIN2$) @PROTEIN1$ of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p46","sentence":"Panels of six to 31 MAbs against the @PROTEIN1$ (H), fusion (F), @PROTEIN2$ (NP), phosphoprotein (P) and matrix (M) @PROTEIN1$@PROTEIN2$ of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p47","sentence":"Panels of six to 31 MAbs against the @PROTEIN1$ (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) @PROTEIN1$ of MV and the @PROTEIN2$, F, NP and P @PROTEIN2$ of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p48","sentence":"Panels of six to 31 MAbs against the @PROTEIN1$ (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) @PROTEIN1$ of MV and the H, F, NP and @PROTEIN2$ of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p49","sentence":"Panels of six to 31 MAbs against the @PROTEIN1$ (H), fusion (F), nucleocapsid protein (NP), @PROTEIN2$ (P) and matrix (M) @PROTEIN1$@PROTEIN2$ of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p50","sentence":"Panels of six to 31 MAbs against the @PROTEIN1$ (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) @PROTEIN1$ of MV and the H, @PROTEIN2$, NP and P @PROTEIN2$ of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p51","sentence":"Panels of six to 31 MAbs against the @PROTEIN1$ (@PROTEIN2$), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) @PROTEIN1$ of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p52","sentence":"Panels of six to 31 MAbs against the @PROTEIN1$ (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (@PROTEIN2$) and matrix (M) @PROTEIN1$ of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p53","sentence":"Panels of six to 31 MAbs against the @PROTEIN1$ (H), fusion (F), nucleocapsid protein (@PROTEIN2$), phosphoprotein (P) and matrix (M) @PROTEIN1$ of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p54","sentence":"Panels of six to 31 MAbs against the @PROTEIN1$ (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (@PROTEIN2$) @PROTEIN1$ of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p55","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), @PROTEIN1$ (NP), phosphoprotein (P) and matrix (M) @PROTEIN1$ of MV and the @PROTEIN2$, F, NP and P @PROTEIN2$ of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p56","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), @PROTEIN1$ (NP), phosphoprotein (P) and matrix (M) @PROTEIN1$ of MV and the H, F, NP and @PROTEIN2$ of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p57","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), @PROTEIN1$ (NP), @PROTEIN2$ (P) and matrix (M) @PROTEIN1$@PROTEIN2$ of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p58","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), @PROTEIN1$ (NP), phosphoprotein (P) and matrix (M) @PROTEIN1$ of MV and the H, @PROTEIN2$, NP and P @PROTEIN2$ of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p59","sentence":"Panels of six to 31 MAbs against the haemagglutinin (@PROTEIN2$), fusion (F), @PROTEIN1$ (NP), phosphoprotein (P) and matrix (M) @PROTEIN1$ of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p60","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), @PROTEIN1$ (NP), phosphoprotein (@PROTEIN2$) and matrix (M) @PROTEIN1$ of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p61","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), @PROTEIN1$ (@PROTEIN2$), phosphoprotein (P) and matrix (M) @PROTEIN1$ of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p62","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), @PROTEIN1$ (NP), phosphoprotein (P) and matrix (@PROTEIN2$) @PROTEIN1$ of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p63","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) phosphop of MV and the @PROTEIN1$, F, NP and @PROTEIN2$@PROTEIN1$ of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p64","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), @PROTEIN2$ (P) and matrix (M) @PROTEIN2$ of MV and the @PROTEIN1$, F, NP and P @PROTEIN1$ of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p65","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) phosphop of MV and the @PROTEIN1$, @PROTEIN2$, NP and P @PROTEIN1$@PROTEIN2$ of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p66","sentence":"Panels of six to 31 MAbs against the haemagglutinin (@PROTEIN2$), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) phosphop of MV and the @PROTEIN1$, F, NP and P @PROTEIN1$ of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p67","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (@PROTEIN2$) and matrix (M) phosphop of MV and the @PROTEIN1$, F, NP and P @PROTEIN1$ of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p68","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (@PROTEIN2$), phosphoprotein (P) and matrix (M) phosphop of MV and the @PROTEIN1$, F, NP and P @PROTEIN1$ of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p69","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (@PROTEIN2$) phosphop of MV and the @PROTEIN1$, F, NP and P @PROTEIN1$ of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p70","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), @PROTEIN2$ (P) and matrix (M) @PROTEIN2$ of MV and the H, F, NP and @PROTEIN1$ of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p71","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) phosphop of MV and the H, @PROTEIN2$, NP and @PROTEIN1$@PROTEIN2$ of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p72","sentence":"Panels of six to 31 MAbs against the haemagglutinin (@PROTEIN2$), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) phosphop of MV and the H, F, NP and @PROTEIN1$ of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p73","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (@PROTEIN2$) and matrix (M) phosphop of MV and the H, F, NP and @PROTEIN1$ of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p74","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (@PROTEIN2$), phosphoprotein (P) and matrix (M) phosphop of MV and the H, F, NP and @PROTEIN1$ of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p75","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (@PROTEIN2$) phosphop of MV and the H, F, NP and @PROTEIN1$ of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p76","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), @PROTEIN1$ (P) and matrix (M) @PROTEIN1$ of MV and the H, @PROTEIN2$, NP and P @PROTEIN2$ of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p77","sentence":"Panels of six to 31 MAbs against the haemagglutinin (@PROTEIN2$), fusion (F), nucleocapsid protein (NP), @PROTEIN1$ (P) and matrix (M) @PROTEIN1$ of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p78","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), @PROTEIN1$ (@PROTEIN2$) and matrix (M) @PROTEIN1$ of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p79","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (@PROTEIN2$), @PROTEIN1$ (P) and matrix (M) @PROTEIN1$ of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p80","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), @PROTEIN1$ (P) and matrix (@PROTEIN2$) @PROTEIN1$ of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p81","sentence":"Panels of six to 31 MAbs against the haemagglutinin (@PROTEIN2$), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) phosphop of MV and the H, @PROTEIN1$, NP and P @PROTEIN1$ of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p82","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (@PROTEIN2$) and matrix (M) phosphop of MV and the H, @PROTEIN1$, NP and P @PROTEIN1$ of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p83","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (@PROTEIN2$), phosphoprotein (P) and matrix (M) phosphop of MV and the H, @PROTEIN1$, NP and P @PROTEIN1$ of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p84","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (@PROTEIN2$) phosphop of MV and the H, @PROTEIN1$, NP and P @PROTEIN1$ of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p85","sentence":"Panels of six to 31 MAbs against the haemagglutinin (@PROTEIN1$), fusion (F), nucleocapsid protein (NP), phosphoprotein (@PROTEIN2$) and matrix (M) phosphop of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p86","sentence":"Panels of six to 31 MAbs against the haemagglutinin (@PROTEIN1$), fusion (F), nucleocapsid protein (@PROTEIN2$), phosphoprotein (P) and matrix (M) phosphop of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p87","sentence":"Panels of six to 31 MAbs against the haemagglutinin (@PROTEIN1$), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (@PROTEIN2$) phosphop of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p88","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (@PROTEIN2$), phosphoprotein (@PROTEIN1$) and matrix (M) phosphop of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p89","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (@PROTEIN1$) and matrix (@PROTEIN2$) phosphop of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p90","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (@PROTEIN1$), phosphoprotein (P) and matrix (@PROTEIN2$) phosphop of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"AIMed.d202.s1742.p0","sentence":"Here we report the three-dimensional structure of @PROTEIN1$ bound to the extracellular domain of @PROTEIN2$ (s-IL1R) at 2.5 A resolution.","label":1}
{"pair_id":"AIMed.d202.s1742.p1","sentence":"Here we report the three-dimensional structure of @PROTEIN1$ bound to the extracellular domain of IL1R (@PROTEIN2$) at 2.5 A resolution.","label":1}
{"pair_id":"AIMed.d202.s1742.p2","sentence":"Here we report the three-dimensional structure of IL-1beta bound to the extracellular domain of @PROTEIN1$ (@PROTEIN2$) at 2.5 A resolution.","label":0}
{"pair_id":"BioInfer.d247.s3.p0","sentence":"This mutant @PROTEIN1$ suppresses actin polymerization in microspike formation induced by @PROTEIN2$, the essential factor in microspike formation.","label":1}
{"pair_id":"BioInfer.d247.s3.p1","sentence":"This mutant @PROTEIN1$ suppresses @PROTEIN2$ polymerization in microspike formation induced by N-WASP, the essential factor in microspike formation.","label":1}
{"pair_id":"BioInfer.d247.s3.p2","sentence":"This mutant profilin I suppresses @PROTEIN2$ polymerization in microspike formation induced by @PROTEIN1$, the essential factor in microspike formation.","label":1}
{"pair_id":"BioInfer.d312.s0.p0","sentence":"In addition to the TNF-alpha-induced increase in the general protein synthesis, stimulation with TNF-alpha led to a 2.4-fold increase in net @PROTEIN2$ protein synthesis and a 3.3-fold increase in net @PROTEIN1$ synthesis.","label":0}
{"pair_id":"BioInfer.d312.s0.p1","sentence":"In addition to the @PROTEIN2$-induced increase in the general protein synthesis, stimulation with TNF-alpha led to a 2.4-fold increase in net actin protein synthesis and a 3.3-fold increase in net @PROTEIN1$ synthesis.","label":0}
{"pair_id":"BioInfer.d312.s0.p2","sentence":"In addition to the TNF-alpha-induced increase in the general protein synthesis, stimulation with @PROTEIN2$ led to a 2.4-fold increase in net actin protein synthesis and a 3.3-fold increase in net @PROTEIN1$ synthesis.","label":1}
{"pair_id":"BioInfer.d312.s0.p3","sentence":"In addition to the @PROTEIN2$-induced increase in the general protein synthesis, stimulation with TNF-alpha led to a 2.4-fold increase in net @PROTEIN1$ protein synthesis and a 3.3-fold increase in net myosin heavy chain synthesis.","label":0}
{"pair_id":"BioInfer.d312.s0.p4","sentence":"In addition to the TNF-alpha-induced increase in the general protein synthesis, stimulation with @PROTEIN2$ led to a 2.4-fold increase in net @PROTEIN1$ protein synthesis and a 3.3-fold increase in net myosin heavy chain synthesis.","label":1}
{"pair_id":"BioInfer.d312.s0.p5","sentence":"In addition to the @PROTEIN1$-induced increase in the general protein synthesis, stimulation with @PROTEIN2$ led to a 2.4-fold increase in net actin protein synthesis and a 3.3-fold increase in net myosin heavy chain synthesis.","label":0}
{"pair_id":"AIMed.d60.s529.p0","sentence":"Furthermore, a bacterially expressed @PROTEIN1$ fusion protein (glutathione S-transferase-p3722W) also activated @PROTEIN2$ kinase in vitro.","label":0}
{"pair_id":"AIMed.d60.s529.p1","sentence":"Furthermore, a bacterially expressed @PROTEIN1$ fusion protein (glutathione S-transferase-p3722W) also activated @PROTEIN2$ in vitro.","label":0}
{"pair_id":"AIMed.d60.s529.p2","sentence":"Furthermore, a bacterially expressed v-Raf fusion protein (glutathione S-transferase-p3722W) also activated @PROTEIN1$@PROTEIN2$ in vitro.","label":0}
{"pair_id":"AIMed.d165.s1388.p0","sentence":"At least two of the subunits of @PROTEIN1$ (@PROTEIN2$ and XPD proteins) are implicated in the disease xeroderma pigmentosum (XP).","label":0}
{"pair_id":"AIMed.d165.s1388.p1","sentence":"At least two of the subunits of @PROTEIN1$ (XPB and @PROTEIN2$ proteins) are implicated in the disease xeroderma pigmentosum (XP).","label":0}
{"pair_id":"AIMed.d165.s1388.p2","sentence":"At least two of the subunits of TFIIH (@PROTEIN1$ and @PROTEIN2$ proteins) are implicated in the disease xeroderma pigmentosum (XP).","label":0}
{"pair_id":"BioInfer.d638.s0.p0","sentence":"The long repeats, which are interdigitated between the PRRs, increased the frequency with which @PROTEIN1$-based motility occurred by a mechanism independent of the PRRs, VASP, and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d638.s0.p1","sentence":"The long repeats, which are interdigitated between the PRRs, increased the frequency with which @PROTEIN1$-based motility occurred by a mechanism independent of the PRRs, @PROTEIN2$, and profilin.","label":0}
{"pair_id":"BioInfer.d638.s0.p2","sentence":"The long repeats, which are interdigitated between the PRRs, increased the frequency with which actin-based motility occurred by a mechanism independent of the PRRs, @PROTEIN2$, and @PROTEIN1$.","label":0}
{"pair_id":"AIMed.d190.s1617.p0","sentence":"In vitro and in vivo experiments support the hypothesis that @PROTEIN1$ mediates the association of @PROTEIN2$ with c-Cbl.","label":0}
{"pair_id":"AIMed.d190.s1617.p1","sentence":"In vitro and in vivo experiments support the hypothesis that @PROTEIN1$ mediates the association of c-Kit with @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d190.s1617.p2","sentence":"In vitro and in vivo experiments support the hypothesis that Grb2 mediates the association of @PROTEIN1$ with @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d147.s0.p0","sentence":"@PROTEIN1$ was identified by peptide sequencing, and @PROTEIN2$ recruitment and Listeria tail length were found to be pH-dependent, in agreement with its recently reported role in enhancing actin filament turnover.","label":0}
{"pair_id":"BioInfer.d147.s0.p1","sentence":"@PROTEIN1$ was identified by peptide sequencing, and cofilin recruitment and Listeria tail length were found to be pH-dependent, in agreement with its recently reported role in enhancing @PROTEIN2$ filament turnover.","label":1}
{"pair_id":"BioInfer.d147.s0.p2","sentence":"Cofilin was identified by peptide sequencing, and @PROTEIN1$ recruitment and Listeria tail length were found to be pH-dependent, in agreement with its recently reported role in enhancing @PROTEIN2$ filament turnover.","label":0}
{"pair_id":"BioInfer.d355.s1.p0","sentence":"To determine the effect of insulin-like growth factor I (IGF-I) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into @PROTEIN2$ and @PROTEIN1$ during intravenous infusions (4 h) of either saline or IGF-I (1 microgram. kg-1. min-1) in awake rats.","label":0}
{"pair_id":"BioInfer.d355.s1.p1","sentence":"To determine the effect of @PROTEIN2$ (IGF-I) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into myosin heavy chain and @PROTEIN1$ during intravenous infusions (4 h) of either saline or IGF-I (1 microgram. kg-1. min-1) in awake rats.","label":0}
{"pair_id":"BioInfer.d355.s1.p2","sentence":"To determine the effect of insulin-like growth factor I (IGF-I) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into myosin heavy chain and @PROTEIN1$ during intravenous infusions (4 h) of either saline or @PROTEIN2$ (1 microgram. kg-1. min-1) in awake rats.","label":0}
{"pair_id":"BioInfer.d355.s1.p3","sentence":"To determine the effect of insulin-like growth factor I (@PROTEIN2$) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into myosin heavy chain and @PROTEIN1$ during intravenous infusions (4 h) of either saline or IGF-I (1 microgram. kg-1. min-1) in awake rats.","label":0}
{"pair_id":"BioInfer.d355.s1.p4","sentence":"To determine the effect of @PROTEIN2$ (IGF-I) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into @PROTEIN1$ and actin during intravenous infusions (4 h) of either saline or IGF-I (1 microgram. kg-1. min-1) in awake rats.","label":0}
{"pair_id":"BioInfer.d355.s1.p5","sentence":"To determine the effect of insulin-like growth factor I (IGF-I) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into @PROTEIN1$ and actin during intravenous infusions (4 h) of either saline or @PROTEIN2$ (1 microgram. kg-1. min-1) in awake rats.","label":0}
{"pair_id":"BioInfer.d355.s1.p6","sentence":"To determine the effect of insulin-like growth factor I (@PROTEIN2$) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into @PROTEIN1$ and actin during intravenous infusions (4 h) of either saline or IGF-I (1 microgram. kg-1. min-1) in awake rats.","label":0}
{"pair_id":"BioInfer.d355.s1.p7","sentence":"To determine the effect of @PROTEIN1$ (IGF-I) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into myosin heavy chain and actin during intravenous infusions (4 h) of either saline or @PROTEIN2$ (1 microgram. kg-1. min-1) in awake rats.","label":0}
{"pair_id":"BioInfer.d355.s1.p8","sentence":"To determine the effect of @PROTEIN1$ (@PROTEIN2$) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into myosin heavy chain and actin during intravenous infusions (4 h) of either saline or IGF-I (1 microgram. kg-1. min-1) in awake rats.","label":0}
{"pair_id":"BioInfer.d355.s1.p9","sentence":"To determine the effect of insulin-like growth factor I (@PROTEIN2$) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into myosin heavy chain and actin during intravenous infusions (4 h) of either saline or @PROTEIN1$ (1 microgram. kg-1. min-1) in awake rats.","label":0}
{"pair_id":"BioInfer.d604.s0.p0","sentence":"The deduced peptide sequence contained a nuclear localization signal and a putative @PROTEIN2$-binding sequence as reported in @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d7.s1.p0","sentence":"Acanthamoeba @PROTEIN2$ strongly inhibits in a concentration-dependent fashion the rate and extent of Acanthamoeba @PROTEIN1$ polymerization in 50 mM KCl.","label":1}
{"pair_id":"BioInfer.d469.s0.p0","sentence":"Other mammalian actin-binding proteins such as profilin and @PROTEIN1$ but also @PROTEIN2$ from Physarum polycephalum are similar targets for PIP2-stimulated pp60(c-src) phosphorylation.","label":0}
{"pair_id":"BioInfer.d469.s0.p1","sentence":"Other mammalian actin-binding proteins such as profilin and @PROTEIN1$ but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated @PROTEIN2$(c-src) phosphorylation.","label":1}
{"pair_id":"BioInfer.d469.s0.p2","sentence":"Other mammalian actin-binding proteins such as profilin and @PROTEIN1$ but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated pp60(@PROTEIN2$) phosphorylation.","label":1}
{"pair_id":"BioInfer.d469.s0.p3","sentence":"Other mammalian @PROTEIN2$ such as profilin and @PROTEIN1$ but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated pp60(c-src) phosphorylation.","label":1}
{"pair_id":"BioInfer.d469.s0.p4","sentence":"Other mammalian actin-binding proteins such as @PROTEIN2$ and @PROTEIN1$ but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated pp60(c-src) phosphorylation.","label":0}
{"pair_id":"BioInfer.d469.s0.p5","sentence":"Other mammalian actin-binding proteins such as profilin and CapG but also @PROTEIN1$ from Physarum polycephalum are similar targets for PIP2-stimulated @PROTEIN2$(c-src) phosphorylation.","label":1}
{"pair_id":"BioInfer.d469.s0.p6","sentence":"Other mammalian actin-binding proteins such as profilin and CapG but also @PROTEIN1$ from Physarum polycephalum are similar targets for PIP2-stimulated pp60(@PROTEIN2$) phosphorylation.","label":1}
{"pair_id":"BioInfer.d469.s0.p7","sentence":"Other mammalian @PROTEIN2$ such as profilin and CapG but also @PROTEIN1$ from Physarum polycephalum are similar targets for PIP2-stimulated pp60(c-src) phosphorylation.","label":1}
{"pair_id":"BioInfer.d469.s0.p8","sentence":"Other mammalian actin-binding proteins such as @PROTEIN2$ and CapG but also @PROTEIN1$ from Physarum polycephalum are similar targets for PIP2-stimulated pp60(c-src) phosphorylation.","label":0}
{"pair_id":"BioInfer.d469.s0.p9","sentence":"Other mammalian actin-binding proteins such as profilin and CapG but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated @PROTEIN1$(@PROTEIN2$) phosphorylation.","label":0}
{"pair_id":"BioInfer.d469.s0.p10","sentence":"Other mammalian @PROTEIN2$ such as profilin and CapG but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated @PROTEIN1$(c-src) phosphorylation.","label":0}
{"pair_id":"BioInfer.d469.s0.p11","sentence":"Other mammalian actin-binding proteins such as @PROTEIN2$ and CapG but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated @PROTEIN1$(c-src) phosphorylation.","label":1}
{"pair_id":"BioInfer.d469.s0.p12","sentence":"Other mammalian @PROTEIN2$ such as profilin and CapG but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated pp60(@PROTEIN1$) phosphorylation.","label":0}
{"pair_id":"BioInfer.d469.s0.p13","sentence":"Other mammalian actin-binding proteins such as @PROTEIN2$ and CapG but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated pp60(@PROTEIN1$) phosphorylation.","label":1}
{"pair_id":"BioInfer.d469.s0.p14","sentence":"Other mammalian @PROTEIN1$ such as @PROTEIN2$ and CapG but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated pp60(c-src) phosphorylation.","label":1}
{"pair_id":"AIMed.d176.s1489.p0","sentence":"@PROTEIN1$ can bind either @PROTEIN2$ or hsp90 independently and in an ATP-independent manner.","label":1}
{"pair_id":"AIMed.d176.s1489.p1","sentence":"@PROTEIN1$ can bind either hsp70 or @PROTEIN2$ independently and in an ATP-independent manner.","label":1}
{"pair_id":"AIMed.d176.s1489.p2","sentence":"P60 can bind either @PROTEIN1$ or @PROTEIN2$ independently and in an ATP-independent manner.","label":0}
{"pair_id":"BioInfer.d768.s0.p0","sentence":"Together these results indicate that @PROTEIN1$ regulates @PROTEIN2$ gene expression through an AP-1 site and its cognate transcription factor AP-1, and requires the involvement of protein kinase C.","label":1}
{"pair_id":"BioInfer.d768.s0.p1","sentence":"Together these results indicate that @PROTEIN1$ regulates clusterin gene expression through an AP-1 site and its cognate transcription factor @PROTEIN2$, and requires the involvement of protein kinase C.","label":1}
{"pair_id":"BioInfer.d768.s0.p2","sentence":"Together these results indicate that @PROTEIN1$ regulates clusterin gene expression through an @PROTEIN2$ site and its cognate transcription factor AP-1, and requires the involvement of protein kinase C.","label":1}
{"pair_id":"BioInfer.d768.s0.p3","sentence":"Together these results indicate that @PROTEIN1$ regulates clusterin gene expression through an AP-1 site and its cognate transcription factor AP-1, and requires the involvement of @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d768.s0.p4","sentence":"Together these results indicate that TGFbeta regulates @PROTEIN1$ gene expression through an AP-1 site and its cognate transcription factor @PROTEIN2$, and requires the involvement of protein kinase C.","label":1}
{"pair_id":"BioInfer.d768.s0.p5","sentence":"Together these results indicate that TGFbeta regulates @PROTEIN1$ gene expression through an @PROTEIN2$ site and its cognate transcription factor AP-1, and requires the involvement of protein kinase C.","label":1}
{"pair_id":"BioInfer.d768.s0.p6","sentence":"Together these results indicate that TGFbeta regulates @PROTEIN1$ gene expression through an AP-1 site and its cognate transcription factor AP-1, and requires the involvement of @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d768.s0.p7","sentence":"Together these results indicate that TGFbeta regulates clusterin gene expression through an @PROTEIN2$ site and its cognate transcription factor @PROTEIN1$, and requires the involvement of protein kinase C.","label":1}
{"pair_id":"BioInfer.d768.s0.p8","sentence":"Together these results indicate that TGFbeta regulates clusterin gene expression through an AP-1 site and its cognate transcription factor @PROTEIN1$, and requires the involvement of @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d768.s0.p9","sentence":"Together these results indicate that TGFbeta regulates clusterin gene expression through an @PROTEIN1$ site and its cognate transcription factor AP-1, and requires the involvement of @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d641.s0.p0","sentence":"The majority of the aromatic residues in @PROTEIN1$ are exposed to solvent and lie in either of two hydrophobic patches, neither of which takes part in an interface with @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d296.s0.p0","sentence":"Immunolocalization of @PROTEIN2$ (E-cad), alpha-catenin, @PROTEIN1$, and CD44 has rarely been investigated in human cholangiocarcinoma (CC).","label":0}
{"pair_id":"BioInfer.d296.s0.p1","sentence":"Immunolocalization of E-cadherin (@PROTEIN2$), alpha-catenin, @PROTEIN1$, and CD44 has rarely been investigated in human cholangiocarcinoma (CC).","label":0}
{"pair_id":"BioInfer.d296.s0.p2","sentence":"Immunolocalization of E-cadherin (E-cad), @PROTEIN2$, @PROTEIN1$, and CD44 has rarely been investigated in human cholangiocarcinoma (CC).","label":0}
{"pair_id":"BioInfer.d296.s0.p3","sentence":"Immunolocalization of E-cadherin (E-cad), alpha-catenin, @PROTEIN1$, and @PROTEIN2$ has rarely been investigated in human cholangiocarcinoma (CC).","label":0}
{"pair_id":"BioInfer.d296.s0.p4","sentence":"Immunolocalization of @PROTEIN1$ (@PROTEIN2$), alpha-catenin, beta-catenin, and CD44 has rarely been investigated in human cholangiocarcinoma (CC).","label":0}
{"pair_id":"BioInfer.d296.s0.p5","sentence":"Immunolocalization of @PROTEIN1$ (E-cad), @PROTEIN2$, beta-catenin, and CD44 has rarely been investigated in human cholangiocarcinoma (CC).","label":0}
{"pair_id":"BioInfer.d296.s0.p6","sentence":"Immunolocalization of @PROTEIN1$ (E-cad), alpha-catenin, beta-catenin, and @PROTEIN2$ has rarely been investigated in human cholangiocarcinoma (CC).","label":0}
{"pair_id":"BioInfer.d296.s0.p7","sentence":"Immunolocalization of E-cadherin (@PROTEIN1$), @PROTEIN2$, beta-catenin, and CD44 has rarely been investigated in human cholangiocarcinoma (CC).","label":0}
{"pair_id":"BioInfer.d296.s0.p8","sentence":"Immunolocalization of E-cadherin (@PROTEIN1$), alpha-catenin, beta-catenin, and @PROTEIN2$ has rarely been investigated in human cholangiocarcinoma (CC).","label":0}
{"pair_id":"BioInfer.d296.s0.p9","sentence":"Immunolocalization of E-cadherin (E-cad), @PROTEIN1$, beta-catenin, and @PROTEIN2$ has rarely been investigated in human cholangiocarcinoma (CC).","label":0}
{"pair_id":"BioInfer.d332.s1.p0","sentence":"Interaction of @PROTEIN1$ with @PROTEIN2$: sensitive modulation of filament crosslinking activity.","label":1}
{"pair_id":"BioInfer.d82.s0.p0","sentence":"A similar phenotype was seen in testes treated with cytochalasin B and has been noted previously in mutants at the twinstar locus, a gene that encodes a Drosophila member of the @PROTEIN2$ family of @PROTEIN1$-severing proteins.","label":1}
{"pair_id":"BioInfer.d82.s0.p1","sentence":"A similar phenotype was seen in testes treated with cytochalasin B and has been noted previously in mutants at the @PROTEIN2$ locus, a gene that encodes a Drosophila member of the cofilin\/ADF family of @PROTEIN1$-severing proteins.","label":0}
{"pair_id":"BioInfer.d82.s0.p2","sentence":"A similar phenotype was seen in testes treated with cytochalasin B and has been noted previously in mutants at the @PROTEIN2$ locus, a gene that encodes a Drosophila member of the @PROTEIN1$ family of actin-severing proteins.","label":1}
{"pair_id":"AIMed.d126.s1078.p0","sentence":"At 25 degrees C, the rate profiles indicate the release and commitment to folding of @PROTEIN1$ to its native state occurs far earlier (t1\/2 < 1 min) than for @PROTEIN2$ (t1\/2 = 5 min).","label":0}
{"pair_id":"BioInfer.d502.s1.p0","sentence":"The presence of filamin in the cleavage furrows also suggests the possibility of an overlapping mechanism in addition to that of a @PROTEIN2$ mediated mechanism for the attachment of @PROTEIN1$ filaments to the cell surfaces in the cleavage furrow.","label":1}
{"pair_id":"BioInfer.d502.s1.p1","sentence":"The presence of @PROTEIN2$ in the cleavage furrows also suggests the possibility of an overlapping mechanism in addition to that of a talin mediated mechanism for the attachment of @PROTEIN1$ filaments to the cell surfaces in the cleavage furrow.","label":0}
{"pair_id":"BioInfer.d502.s1.p2","sentence":"The presence of @PROTEIN2$ in the cleavage furrows also suggests the possibility of an overlapping mechanism in addition to that of a @PROTEIN1$ mediated mechanism for the attachment of actin filaments to the cell surfaces in the cleavage furrow.","label":0}
{"pair_id":"BioInfer.d554.s0.p0","sentence":"Study of mutated yeast profilins and profilins from Acanthamoeba suggests that the ability of @PROTEIN2$ to suppress @PROTEIN1$ cells is dependent upon a property other than, or in addition to, its ability to bind actin.","label":0}
{"pair_id":"BioInfer.d554.s0.p1","sentence":"Study of mutated yeast profilins and profilins from Acanthamoeba suggests that the ability of profilin to suppress @PROTEIN1$ cells is dependent upon a property other than, or in addition to, its ability to bind @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d554.s0.p2","sentence":"Study of mutated yeast @PROTEIN2$ and profilins from Acanthamoeba suggests that the ability of profilin to suppress @PROTEIN1$ cells is dependent upon a property other than, or in addition to, its ability to bind actin.","label":0}
{"pair_id":"BioInfer.d554.s0.p3","sentence":"Study of mutated yeast profilins and @PROTEIN2$ from Acanthamoeba suggests that the ability of profilin to suppress @PROTEIN1$ cells is dependent upon a property other than, or in addition to, its ability to bind actin.","label":0}
{"pair_id":"BioInfer.d554.s0.p4","sentence":"Study of mutated yeast profilins and profilins from Acanthamoeba suggests that the ability of @PROTEIN1$ to suppress cap- cells is dependent upon a property other than, or in addition to, its ability to bind @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d554.s0.p5","sentence":"Study of mutated yeast @PROTEIN2$ and profilins from Acanthamoeba suggests that the ability of @PROTEIN1$ to suppress cap- cells is dependent upon a property other than, or in addition to, its ability to bind actin.","label":0}
{"pair_id":"BioInfer.d554.s0.p6","sentence":"Study of mutated yeast profilins and @PROTEIN2$ from Acanthamoeba suggests that the ability of @PROTEIN1$ to suppress cap- cells is dependent upon a property other than, or in addition to, its ability to bind actin.","label":0}
{"pair_id":"BioInfer.d554.s0.p7","sentence":"Study of mutated yeast @PROTEIN2$ and profilins from Acanthamoeba suggests that the ability of profilin to suppress cap- cells is dependent upon a property other than, or in addition to, its ability to bind @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d554.s0.p8","sentence":"Study of mutated yeast profilins and @PROTEIN2$ from Acanthamoeba suggests that the ability of profilin to suppress cap- cells is dependent upon a property other than, or in addition to, its ability to bind @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d554.s0.p9","sentence":"Study of mutated yeast @PROTEIN1$ and @PROTEIN2$ from Acanthamoeba suggests that the ability of profilin to suppress cap- cells is dependent upon a property other than, or in addition to, its ability to bind actin.","label":0}
{"pair_id":"BioInfer.d552.s0.p0","sentence":"Studies on cultured cells have suggested that both @PROTEIN2$ and plakoglobin are important for the adhesive function of @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d552.s0.p1","sentence":"Studies on cultured cells have suggested that both alpha-catenin and @PROTEIN2$ are important for the adhesive function of @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d552.s0.p2","sentence":"Studies on cultured cells have suggested that both @PROTEIN1$ and @PROTEIN2$ are important for the adhesive function of cadherins.","label":0}
{"pair_id":"BioInfer.d464.s0.p0","sentence":"Only the unphosphorylated form of cofilin is an active form that binds @PROTEIN2$, whereas the regulatory mechanisms of @PROTEIN1$ have not been elucidated.","label":0}
{"pair_id":"BioInfer.d464.s0.p1","sentence":"Only the unphosphorylated form of @PROTEIN2$ is an active form that binds actin, whereas the regulatory mechanisms of @PROTEIN1$ have not been elucidated.","label":0}
{"pair_id":"BioInfer.d464.s0.p2","sentence":"Only the unphosphorylated form of @PROTEIN2$ is an active form that binds @PROTEIN1$, whereas the regulatory mechanisms of cofilin have not been elucidated.","label":1}
{"pair_id":"AIMed.d69.s592.p0","sentence":"We propose that @PROTEIN1$ is present in resting cells in a latent, phosphorylated form that can be activated by site-specific dephosphorylation in response to @PROTEIN2$ activation.","label":1}
{"pair_id":"BioInfer.d644.s0.p0","sentence":"The microvillus cytoskeleton, isolated from chicken intestinal epithelial cell brush borders, is known to contain five major protein components, the 110,000-dalton polypeptide, @PROTEIN1$ (95,000 daltons), fimbrin (68,000 daltons), actin (43,000 daltons), and @PROTEIN2$ (17,000 daltons).","label":1}
{"pair_id":"BioInfer.d644.s0.p1","sentence":"The microvillus cytoskeleton, isolated from chicken intestinal epithelial cell brush borders, is known to contain five major protein components, the 110,000-dalton polypeptide, @PROTEIN1$ (95,000 daltons), @PROTEIN2$ (68,000 daltons), actin (43,000 daltons), and calmodulin (17,000 daltons).","label":1}
{"pair_id":"BioInfer.d644.s0.p2","sentence":"The microvillus cytoskeleton, isolated from chicken intestinal epithelial cell brush borders, is known to contain five major protein components, the 110,000-dalton polypeptide, @PROTEIN1$ (95,000 daltons), fimbrin (68,000 daltons), @PROTEIN2$ (43,000 daltons), and calmodulin (17,000 daltons).","label":1}
{"pair_id":"BioInfer.d644.s0.p3","sentence":"The microvillus cytoskeleton, isolated from chicken intestinal epithelial cell brush borders, is known to contain five major protein components, the 110,000-dalton polypeptide, villin (95,000 daltons), @PROTEIN2$ (68,000 daltons), actin (43,000 daltons), and @PROTEIN1$ (17,000 daltons).","label":1}
{"pair_id":"BioInfer.d644.s0.p4","sentence":"The microvillus cytoskeleton, isolated from chicken intestinal epithelial cell brush borders, is known to contain five major protein components, the 110,000-dalton polypeptide, villin (95,000 daltons), fimbrin (68,000 daltons), @PROTEIN2$ (43,000 daltons), and @PROTEIN1$ (17,000 daltons).","label":1}
{"pair_id":"BioInfer.d644.s0.p5","sentence":"The microvillus cytoskeleton, isolated from chicken intestinal epithelial cell brush borders, is known to contain five major protein components, the 110,000-dalton polypeptide, villin (95,000 daltons), @PROTEIN1$ (68,000 daltons), @PROTEIN2$ (43,000 daltons), and calmodulin (17,000 daltons).","label":1}
{"pair_id":"AIMed.d59.s524.p0","sentence":"Peptide growth factors, as well as the immediate early gene products @PROTEIN1$, @PROTEIN2$, and c-Myc, inhibit the activity of myogenin through a mechanism independent of its association with E2A products.","label":0}
{"pair_id":"AIMed.d59.s524.p1","sentence":"Peptide growth factors, as well as the immediate early gene products @PROTEIN1$, v-Fos, and @PROTEIN2$, inhibit the activity of myogenin through a mechanism independent of its association with E2A products.","label":0}
{"pair_id":"AIMed.d59.s524.p2","sentence":"Peptide growth factors, as well as the immediate early gene products @PROTEIN1$, v-Fos, and c-Myc, inhibit the activity of myogenin through a mechanism independent of its association with @PROTEIN2$ products.","label":0}
{"pair_id":"AIMed.d59.s524.p3","sentence":"Peptide growth factors, as well as the immediate early gene products c-Jun, @PROTEIN1$, and @PROTEIN2$, inhibit the activity of myogenin through a mechanism independent of its association with E2A products.","label":0}
{"pair_id":"AIMed.d59.s524.p4","sentence":"Peptide growth factors, as well as the immediate early gene products c-Jun, @PROTEIN1$, and c-Myc, inhibit the activity of myogenin through a mechanism independent of its association with @PROTEIN2$ products.","label":0}
{"pair_id":"AIMed.d59.s524.p5","sentence":"Peptide growth factors, as well as the immediate early gene products c-Jun, v-Fos, and @PROTEIN1$, inhibit the activity of myogenin through a mechanism independent of its association with @PROTEIN2$ products.","label":0}
{"pair_id":"AIMed.d152.s1293.p0","sentence":"@PROTEIN1$ is a @PROTEIN2$-associated signal transducer that is involved in activating both pathways.","label":0}
{"pair_id":"BioInfer.d83.s0.p0","sentence":"As previous studies indicated that the @PROTEIN1$ and @PROTEIN2$ gene products of Saccharomyces cerevisiae seem to be involved in the same cellular function, we considered the possibility of a complex between the proteins encoded by these two genes.","label":1}
{"pair_id":"AIMed.d112.s946.p0","sentence":"Here we show that @PROTEIN1$ and @PROTEIN2$ from human B lymphocytes can interact directly.","label":1}
{"pair_id":"BioInfer.d187.s2.p0","sentence":"These results emphasize the highly conserved biological function of @PROTEIN1$ with low sequence homology, and correlate specifically their @PROTEIN2$-binding capacity with cell motility and proliferation.","label":1}
{"pair_id":"AIMed.d115.s973.p0","sentence":"Using a yeast interaction assay, we find that @PROTEIN1$ binds the @PROTEIN2$ subunit of TFIIF and that SRF's transcriptional activation domain is the region involved in this binding.","label":1}
{"pair_id":"AIMed.d115.s973.p1","sentence":"Using a yeast interaction assay, we find that @PROTEIN1$ binds the RAP74 subunit of @PROTEIN2$ and that SRF's transcriptional activation domain is the region involved in this binding.","label":0}
{"pair_id":"AIMed.d115.s973.p2","sentence":"Using a yeast interaction assay, we find that @PROTEIN1$ binds the RAP74 subunit of TFIIF and that @PROTEIN2$'s transcriptional activation domain is the region involved in this binding.","label":0}
{"pair_id":"AIMed.d115.s973.p3","sentence":"Using a yeast interaction assay, we find that SRF binds the @PROTEIN1$ subunit of @PROTEIN2$ and that SRF's transcriptional activation domain is the region involved in this binding.","label":0}
{"pair_id":"AIMed.d115.s973.p4","sentence":"Using a yeast interaction assay, we find that SRF binds the @PROTEIN1$ subunit of TFIIF and that @PROTEIN2$'s transcriptional activation domain is the region involved in this binding.","label":0}
{"pair_id":"AIMed.d115.s973.p5","sentence":"Using a yeast interaction assay, we find that SRF binds the RAP74 subunit of @PROTEIN1$ and that @PROTEIN2$'s transcriptional activation domain is the region involved in this binding.","label":0}
{"pair_id":"AIMed.d127.s1084.p0","sentence":"Interaction of @PROTEIN1$ and gamma c chains with @PROTEIN2$ and Jak3: implications for XSCID and XCID.","label":1}
{"pair_id":"AIMed.d127.s1084.p1","sentence":"Interaction of @PROTEIN1$ and gamma c chains with Jak1 and @PROTEIN2$: implications for XSCID and XCID.","label":1}
{"pair_id":"AIMed.d127.s1084.p2","sentence":"Interaction of IL-2R beta and gamma c chains with @PROTEIN1$ and @PROTEIN2$: implications for XSCID and XCID.","label":0}
{"pair_id":"BioInfer.d2.s0.p0","sentence":"Abnormal immunoreactivity in the tumor tissue was observed in 18 patients (34.0%) for E-cadherin, in 35 (66.0%) for @PROTEIN1$, in 20 (37.7%) for beta-catenin, and in 37 (69.8%) for @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d2.s0.p1","sentence":"Abnormal immunoreactivity in the tumor tissue was observed in 18 patients (34.0%) for @PROTEIN2$, in 35 (66.0%) for @PROTEIN1$, in 20 (37.7%) for beta-catenin, and in 37 (69.8%) for gamma-catenin.","label":0}
{"pair_id":"BioInfer.d2.s0.p2","sentence":"Abnormal immunoreactivity in the tumor tissue was observed in 18 patients (34.0%) for E-cadherin, in 35 (66.0%) for @PROTEIN1$, in 20 (37.7%) for @PROTEIN2$, and in 37 (69.8%) for gamma-catenin.","label":0}
{"pair_id":"BioInfer.d2.s0.p3","sentence":"Abnormal immunoreactivity in the tumor tissue was observed in 18 patients (34.0%) for @PROTEIN2$, in 35 (66.0%) for alpha-catenin, in 20 (37.7%) for beta-catenin, and in 37 (69.8%) for @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d2.s0.p4","sentence":"Abnormal immunoreactivity in the tumor tissue was observed in 18 patients (34.0%) for E-cadherin, in 35 (66.0%) for alpha-catenin, in 20 (37.7%) for @PROTEIN2$, and in 37 (69.8%) for @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d2.s0.p5","sentence":"Abnormal immunoreactivity in the tumor tissue was observed in 18 patients (34.0%) for @PROTEIN1$, in 35 (66.0%) for alpha-catenin, in 20 (37.7%) for @PROTEIN2$, and in 37 (69.8%) for gamma-catenin.","label":0}
{"pair_id":"BioInfer.d237.s4.p0","sentence":"These results suggest that @PROTEIN1$ may modulate the catalytic activities of @PROTEIN2$ protein such as homologous pairing and strand exchange through a direct physical interaction.","label":1}
{"pair_id":"BioInfer.d16.s0.p0","sentence":"@PROTEIN2$ (@PROTEIN1$) and cofilin define a family of actin-binding proteins essential for the rapid turnover of filamentous actin in vivo.","label":0}
{"pair_id":"BioInfer.d16.s0.p1","sentence":"Actin-depolymerizing factor (@PROTEIN1$) and @PROTEIN2$ define a family of actin-binding proteins essential for the rapid turnover of filamentous actin in vivo.","label":0}
{"pair_id":"BioInfer.d16.s0.p2","sentence":"Actin-depolymerizing factor (@PROTEIN1$) and cofilin define a family of actin-binding proteins essential for the rapid turnover of filamentous @PROTEIN2$ in vivo.","label":0}
{"pair_id":"BioInfer.d16.s0.p3","sentence":"Actin-depolymerizing factor (@PROTEIN1$) and cofilin define a family of @PROTEIN2$ essential for the rapid turnover of filamentous actin in vivo.","label":1}
{"pair_id":"BioInfer.d16.s0.p4","sentence":"@PROTEIN1$ (ADF) and @PROTEIN2$ define a family of actin-binding proteins essential for the rapid turnover of filamentous actin in vivo.","label":0}
{"pair_id":"BioInfer.d16.s0.p5","sentence":"@PROTEIN1$ (ADF) and cofilin define a family of actin-binding proteins essential for the rapid turnover of filamentous @PROTEIN2$ in vivo.","label":0}
{"pair_id":"BioInfer.d16.s0.p6","sentence":"@PROTEIN1$ (ADF) and cofilin define a family of @PROTEIN2$ essential for the rapid turnover of filamentous actin in vivo.","label":1}
{"pair_id":"BioInfer.d16.s0.p7","sentence":"Actin-depolymerizing factor (ADF) and @PROTEIN1$ define a family of actin-binding proteins essential for the rapid turnover of filamentous @PROTEIN2$ in vivo.","label":0}
{"pair_id":"BioInfer.d16.s0.p8","sentence":"Actin-depolymerizing factor (ADF) and @PROTEIN1$ define a family of @PROTEIN2$ essential for the rapid turnover of filamentous actin in vivo.","label":1}
{"pair_id":"BioInfer.d16.s0.p9","sentence":"Actin-depolymerizing factor (ADF) and cofilin define a family of @PROTEIN2$ essential for the rapid turnover of filamentous @PROTEIN1$ in vivo.","label":1}
{"pair_id":"BioInfer.d166.s1.p0","sentence":"@PROTEIN1$ mutations completely abolished the ability to generate type II survivors, while @PROTEIN2$ mutations decreased the growth viability of type II survivors but did not completely eliminate their appearance.","label":0}
{"pair_id":"AIMed.d64.s550.p0","sentence":"Transient expression in COS-1 cells and immunoprecipitation using an antiserum raised against a C-terminal peptide, gave rise to two components, representing mature (130 kDa) and precursor (115 kDa) forms of the @PROTEIN1$ encoded polypeptide, which was denoted @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d577.s0.p0","sentence":"The Arp2\/A complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the @PROTEIN1$ monomer-binding protein @PROTEIN2$, giving active nucleation over a low background of spontaneous nucleation.","label":1}
{"pair_id":"BioInfer.d577.s0.p1","sentence":"The Arp2\/A complex with full-length @PROTEIN2$, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the @PROTEIN1$ monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.","label":0}
{"pair_id":"BioInfer.d577.s0.p2","sentence":"The @PROTEIN2$2\/@PROTEIN2$ complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the @PROTEIN1$ monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.","label":0}
{"pair_id":"BioInfer.d577.s0.p3","sentence":"The Arp2\/A complex with full-length Scar, @PROTEIN2$ containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the @PROTEIN1$ monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.","label":0}
{"pair_id":"BioInfer.d577.s0.p4","sentence":"The Arp2\/A complex with full-length Scar, Scar containing P, W, and A domains, or @PROTEIN2$ containing W and A domains overcomes inhibition of nucleation by the @PROTEIN1$ monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.","label":0}
{"pair_id":"BioInfer.d577.s0.p5","sentence":"The @PROTEIN2$\/A complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the @PROTEIN1$ monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.","label":0}
{"pair_id":"BioInfer.d577.s0.p6","sentence":"The Arp2\/A complex with full-length @PROTEIN2$, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein @PROTEIN1$, giving active nucleation over a low background of spontaneous nucleation.","label":0}
{"pair_id":"BioInfer.d577.s0.p7","sentence":"The @PROTEIN2$2\/@PROTEIN2$ complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein @PROTEIN1$, giving active nucleation over a low background of spontaneous nucleation.","label":1}
{"pair_id":"BioInfer.d577.s0.p8","sentence":"The Arp2\/A complex with full-length Scar, @PROTEIN2$ containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein @PROTEIN1$, giving active nucleation over a low background of spontaneous nucleation.","label":0}
{"pair_id":"BioInfer.d577.s0.p9","sentence":"The Arp2\/A complex with full-length Scar, Scar containing P, W, and A domains, or @PROTEIN2$ containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein @PROTEIN1$, giving active nucleation over a low background of spontaneous nucleation.","label":0}
{"pair_id":"BioInfer.d577.s0.p10","sentence":"The @PROTEIN2$\/A complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein @PROTEIN1$, giving active nucleation over a low background of spontaneous nucleation.","label":1}
{"pair_id":"BioInfer.d577.s0.p11","sentence":"The @PROTEIN2$2\/@PROTEIN2$ complex with full-length @PROTEIN1$, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.","label":0}
{"pair_id":"BioInfer.d577.s0.p12","sentence":"The Arp2\/A complex with full-length @PROTEIN1$, @PROTEIN2$ containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.","label":0}
{"pair_id":"BioInfer.d577.s0.p13","sentence":"The Arp2\/A complex with full-length @PROTEIN1$, Scar containing P, W, and A domains, or @PROTEIN2$ containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.","label":0}
{"pair_id":"BioInfer.d577.s0.p14","sentence":"The @PROTEIN2$\/A complex with full-length @PROTEIN1$, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.","label":0}
{"pair_id":"BioInfer.d577.s0.p15","sentence":"The @PROTEIN1$2\/@PROTEIN1$ complex with full-length Scar, @PROTEIN2$ containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.","label":0}
{"pair_id":"BioInfer.d577.s0.p16","sentence":"The @PROTEIN1$2\/@PROTEIN1$ complex with full-length Scar, Scar containing P, W, and A domains, or @PROTEIN2$ containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.","label":0}
{"pair_id":"BioInfer.d577.s0.p17","sentence":"The @PROTEIN1$@PROTEIN2$\/@PROTEIN1$ complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.","label":1}
{"pair_id":"BioInfer.d577.s0.p18","sentence":"The Arp2\/A complex with full-length Scar, @PROTEIN1$ containing P, W, and A domains, or @PROTEIN2$ containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.","label":0}
{"pair_id":"BioInfer.d577.s0.p19","sentence":"The @PROTEIN2$\/A complex with full-length Scar, @PROTEIN1$ containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.","label":0}
{"pair_id":"BioInfer.d577.s0.p20","sentence":"The @PROTEIN2$\/A complex with full-length Scar, Scar containing P, W, and A domains, or @PROTEIN1$ containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.","label":0}
{"pair_id":"BioInfer.d802.s0.p0","sentence":"We examined whether levels of @PROTEIN2$ or @PROTEIN1$ correlated with myosin heavy-chain levels in the glomeruli of rats with puromycin aminonucleoside nephrosis.","label":0}
{"pair_id":"BioInfer.d802.s0.p1","sentence":"We examined whether levels of alpha-smooth-muscle actin or @PROTEIN1$ correlated with @PROTEIN2$ levels in the glomeruli of rats with puromycin aminonucleoside nephrosis.","label":1}
{"pair_id":"BioInfer.d802.s0.p2","sentence":"We examined whether levels of @PROTEIN1$ or proliferating cell nuclear antigen correlated with @PROTEIN2$ levels in the glomeruli of rats with puromycin aminonucleoside nephrosis.","label":1}
{"pair_id":"AIMed.d144.s1219.p0","sentence":"One clone encodes a novel @PROTEIN1$ catalytic subunit (@PROTEIN2$), which differs from the originally defined PP-1 alpha by an amino-terminal 11-amino-acid insert.","label":0}
{"pair_id":"AIMed.d144.s1219.p1","sentence":"One clone encodes a novel @PROTEIN1$ catalytic subunit (PP-1 alpha 2), which differs from the originally defined @PROTEIN2$ by an amino-terminal 11-amino-acid insert.","label":0}
{"pair_id":"AIMed.d144.s1219.p2","sentence":"One clone encodes a novel type 1 protein phosphatase catalytic subunit (@PROTEIN1$), which differs from the originally defined @PROTEIN2$ by an amino-terminal 11-amino-acid insert.","label":0}
{"pair_id":"BioInfer.d441.s0.p0","sentence":"Motile areas of leech neurites are rich in microfilaments and two actin-binding proteins: @PROTEIN1$ and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d441.s0.p1","sentence":"Motile areas of leech neurites are rich in microfilaments and two @PROTEIN2$: @PROTEIN1$ and profilin.","label":1}
{"pair_id":"BioInfer.d441.s0.p2","sentence":"Motile areas of leech neurites are rich in microfilaments and two @PROTEIN2$: gelsolin and @PROTEIN1$.","label":1}
{"pair_id":"AIMed.d174.s1473.p0","sentence":"These data imply that @PROTEIN1$-induced dimerization of @PROTEIN2$ is not the driving force in promoting formation of the hexameric (IL-6 IL-6R gp130)2 complex.","label":0}
{"pair_id":"AIMed.d174.s1473.p1","sentence":"These data imply that @PROTEIN1$-induced dimerization of sIL-6R is not the driving force in promoting formation of the hexameric (@PROTEIN2$ IL-6R gp130)2 complex.","label":0}
{"pair_id":"AIMed.d174.s1473.p2","sentence":"These data imply that @PROTEIN1$-induced dimerization of sIL-6R is not the driving force in promoting formation of the hexameric (IL-6 @PROTEIN2$ gp130)2 complex.","label":0}
{"pair_id":"AIMed.d174.s1473.p3","sentence":"These data imply that @PROTEIN1$-induced dimerization of sIL-6R is not the driving force in promoting formation of the hexameric (IL-6 IL-6R @PROTEIN2$)2 complex.","label":0}
{"pair_id":"AIMed.d174.s1473.p4","sentence":"These data imply that IL-6-induced dimerization of @PROTEIN1$ is not the driving force in promoting formation of the hexameric (@PROTEIN2$ IL-6R gp130)2 complex.","label":0}
{"pair_id":"AIMed.d174.s1473.p5","sentence":"These data imply that IL-6-induced dimerization of @PROTEIN1$ is not the driving force in promoting formation of the hexameric (IL-6 @PROTEIN2$ gp130)2 complex.","label":0}
{"pair_id":"AIMed.d174.s1473.p6","sentence":"These data imply that IL-6-induced dimerization of @PROTEIN1$ is not the driving force in promoting formation of the hexameric (IL-6 IL-6R @PROTEIN2$)2 complex.","label":0}
{"pair_id":"AIMed.d174.s1473.p7","sentence":"These data imply that IL-6-induced dimerization of sIL-6R is not the driving force in promoting formation of the hexameric (@PROTEIN1$ @PROTEIN2$ gp130)2 complex.","label":1}
{"pair_id":"AIMed.d174.s1473.p8","sentence":"These data imply that IL-6-induced dimerization of sIL-6R is not the driving force in promoting formation of the hexameric (@PROTEIN1$ IL-6R @PROTEIN2$)2 complex.","label":0}
{"pair_id":"AIMed.d174.s1473.p9","sentence":"These data imply that IL-6-induced dimerization of sIL-6R is not the driving force in promoting formation of the hexameric (IL-6 @PROTEIN1$ @PROTEIN2$)2 complex.","label":0}
{"pair_id":"AIMed.d152.s1296.p0","sentence":"Conversely, a @PROTEIN1$ mutant lacking its N-terminal 79 amino acids is a dominant-negative inhibitor of TNF-induced apoptosis, but does not inhibit @PROTEIN2$ activation.","label":0}
{"pair_id":"BioInfer.d365.s0.p0","sentence":"In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to @PROTEIN2$, alpha-catenin, or with pan-desmocollin and @PROTEIN1$ antibodies.","label":0}
{"pair_id":"BioInfer.d365.s0.p1","sentence":"In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with @PROTEIN2$ and @PROTEIN1$ antibodies.","label":0}
{"pair_id":"BioInfer.d365.s0.p2","sentence":"In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and @PROTEIN2$, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and @PROTEIN1$ antibodies.","label":0}
{"pair_id":"BioInfer.d365.s0.p3","sentence":"In the basal layer, patches of brightly labeled cells were detected with antibodies to @PROTEIN2$, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and @PROTEIN1$ antibodies.","label":0}
{"pair_id":"BioInfer.d365.s0.p4","sentence":"In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, @PROTEIN2$, or with pan-desmocollin and @PROTEIN1$ antibodies.","label":0}
{"pair_id":"BioInfer.d365.s0.p5","sentence":"In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, @PROTEIN2$, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and @PROTEIN1$ antibodies.","label":0}
{"pair_id":"BioInfer.d365.s0.p6","sentence":"In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to @PROTEIN1$, alpha-catenin, or with @PROTEIN2$ and pan-desmoglein antibodies.","label":0}
{"pair_id":"BioInfer.d365.s0.p7","sentence":"In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and @PROTEIN2$, but not with antibodies to @PROTEIN1$, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.","label":0}
{"pair_id":"BioInfer.d365.s0.p8","sentence":"In the basal layer, patches of brightly labeled cells were detected with antibodies to @PROTEIN2$, beta-catenin, and gamma-catenin, but not with antibodies to @PROTEIN1$, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.","label":0}
{"pair_id":"BioInfer.d365.s0.p9","sentence":"In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to @PROTEIN1$, @PROTEIN2$, or with pan-desmocollin and pan-desmoglein antibodies.","label":0}
{"pair_id":"BioInfer.d365.s0.p10","sentence":"In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, @PROTEIN2$, and gamma-catenin, but not with antibodies to @PROTEIN1$, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.","label":0}
{"pair_id":"BioInfer.d365.s0.p11","sentence":"In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and @PROTEIN2$, but not with antibodies to P-cadherin, alpha-catenin, or with @PROTEIN1$ and pan-desmoglein antibodies.","label":0}
{"pair_id":"BioInfer.d365.s0.p12","sentence":"In the basal layer, patches of brightly labeled cells were detected with antibodies to @PROTEIN2$, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with @PROTEIN1$ and pan-desmoglein antibodies.","label":0}
{"pair_id":"BioInfer.d365.s0.p13","sentence":"In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, @PROTEIN2$, or with @PROTEIN1$ and pan-desmoglein antibodies.","label":0}
{"pair_id":"BioInfer.d365.s0.p14","sentence":"In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, @PROTEIN2$, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with @PROTEIN1$ and pan-desmoglein antibodies.","label":0}
{"pair_id":"BioInfer.d365.s0.p15","sentence":"In the basal layer, patches of brightly labeled cells were detected with antibodies to @PROTEIN2$, beta-catenin, and @PROTEIN1$, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.","label":0}
{"pair_id":"BioInfer.d365.s0.p16","sentence":"In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and @PROTEIN1$, but not with antibodies to P-cadherin, @PROTEIN2$, or with pan-desmocollin and pan-desmoglein antibodies.","label":0}
{"pair_id":"BioInfer.d365.s0.p17","sentence":"In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, @PROTEIN2$, and @PROTEIN1$, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.","label":0}
{"pair_id":"BioInfer.d365.s0.p18","sentence":"In the basal layer, patches of brightly labeled cells were detected with antibodies to @PROTEIN1$, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, @PROTEIN2$, or with pan-desmocollin and pan-desmoglein antibodies.","label":0}
{"pair_id":"BioInfer.d365.s0.p19","sentence":"In the basal layer, patches of brightly labeled cells were detected with antibodies to @PROTEIN1$, @PROTEIN2$, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.","label":0}
{"pair_id":"BioInfer.d365.s0.p20","sentence":"In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, @PROTEIN2$, and gamma-catenin, but not with antibodies to P-cadherin, @PROTEIN1$, or with pan-desmocollin and pan-desmoglein antibodies.","label":0}
{"pair_id":"AIMed.d122.s1036.p0","sentence":"In previous studies (Scott, J. D., Stofko, R. E., McDonald, J. R., Comer, J. D., Vitalis, E. A., and Mangili J. (1990) J. Biol. Chem. 265, 21561-21566) we have shown that dimerization of @PROTEIN1$ was required for interaction with the cytoskeletal component @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d57.s506.p0","sentence":"In addition, @PROTEIN1$ in the lysate complexes with wild-type @PROTEIN2$, of which only a small portion is normally recovered in cytosol in the native multiprotein complex, and with the cellular homolog, pp60c-src, which has never been recovered in cytosol in the form of a native multiprotein complex with hsp90.","label":1}
{"pair_id":"AIMed.d57.s506.p1","sentence":"In addition, @PROTEIN1$ in the lysate complexes with wild-type pp60v-src, of which only a small portion is normally recovered in cytosol in the native multiprotein complex, and with the cellular homolog, @PROTEIN2$, which has never been recovered in cytosol in the form of a native multiprotein complex with hsp90.","label":1}
{"pair_id":"AIMed.d57.s506.p2","sentence":"In addition, @PROTEIN1$ in the lysate complexes with wild-type pp60v-src, of which only a small portion is normally recovered in cytosol in the native multiprotein complex, and with the cellular homolog, pp60c-src, which has never been recovered in cytosol in the form of a native multiprotein complex with @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d57.s506.p3","sentence":"In addition, hsp90 in the lysate complexes with wild-type @PROTEIN1$, of which only a small portion is normally recovered in cytosol in the native multiprotein complex, and with the cellular homolog, @PROTEIN2$, which has never been recovered in cytosol in the form of a native multiprotein complex with hsp90.","label":0}
{"pair_id":"AIMed.d57.s506.p4","sentence":"In addition, hsp90 in the lysate complexes with wild-type @PROTEIN1$, of which only a small portion is normally recovered in cytosol in the native multiprotein complex, and with the cellular homolog, pp60c-src, which has never been recovered in cytosol in the form of a native multiprotein complex with @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d57.s506.p5","sentence":"In addition, hsp90 in the lysate complexes with wild-type pp60v-src, of which only a small portion is normally recovered in cytosol in the native multiprotein complex, and with the cellular homolog, @PROTEIN1$, which has never been recovered in cytosol in the form of a native multiprotein complex with @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d199.s1709.p0","sentence":"@PROTEIN1$ complex following @PROTEIN2$ phosphorylation.","label":0}
{"pair_id":"BioInfer.d631.s0.p0","sentence":"The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with nucleocapsid (@PROTEIN2$) and @PROTEIN1$ (L) @PROTEIN1$ was investigated using an intracellular BRSV-CAT minigenome replication system.","label":0}
{"pair_id":"BioInfer.d631.s0.p1","sentence":"The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with @PROTEIN2$ (N) and @PROTEIN1$ (L) @PROTEIN1$@PROTEIN2$ was investigated using an intracellular BRSV-CAT minigenome replication system.","label":0}
{"pair_id":"BioInfer.d631.s0.p2","sentence":"The interaction of bovine respiratory syncytial virus (BRSV) @PROTEIN2$ (P) with nucleocapsid (N) and @PROTEIN1$ (L) @PROTEIN1$ was investigated using an intracellular BRSV-CAT minigenome replication system.","label":1}
{"pair_id":"BioInfer.d631.s0.p3","sentence":"The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (@PROTEIN2$) with nucleocapsid (N) and @PROTEIN1$ (L) @PROTEIN1$ was investigated using an intracellular BRSV-CAT minigenome replication system.","label":1}
{"pair_id":"BioInfer.d631.s0.p4","sentence":"The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with nucleocapsid (N) and @PROTEIN1$ (L) @PROTEIN1$ was investigated using an intracellular BRSV-@PROTEIN2$ minigenome replication system.","label":0}
{"pair_id":"BioInfer.d631.s0.p5","sentence":"The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with nucleocapsid (N) and @PROTEIN1$ (@PROTEIN2$) @PROTEIN1$ was investigated using an intracellular BRSV-CAT minigenome replication system.","label":0}
{"pair_id":"BioInfer.d631.s0.p6","sentence":"The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with @PROTEIN2$ (@PROTEIN1$) and large polymerase (L) @PROTEIN2$ was investigated using an intracellular BRSV-CAT minigenome replication system.","label":0}
{"pair_id":"BioInfer.d631.s0.p7","sentence":"The interaction of bovine respiratory syncytial virus (BRSV) @PROTEIN2$ (P) with nucleocapsid (@PROTEIN1$) and large polymerase (L) nucleoca was investigated using an intracellular BRSV-CAT minigenome replication system.","label":1}
{"pair_id":"BioInfer.d631.s0.p8","sentence":"The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (@PROTEIN2$) with nucleocapsid (@PROTEIN1$) and large polymerase (L) nucleoca was investigated using an intracellular BRSV-CAT minigenome replication system.","label":1}
{"pair_id":"BioInfer.d631.s0.p9","sentence":"The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with nucleocapsid (@PROTEIN1$) and large polymerase (L) nucleoca was investigated using an intracellular BRSV-@PROTEIN2$ minigenome replication system.","label":0}
{"pair_id":"BioInfer.d631.s0.p10","sentence":"The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with nucleocapsid (@PROTEIN1$) and large polymerase (@PROTEIN2$) nucleoca was investigated using an intracellular BRSV-CAT minigenome replication system.","label":0}
{"pair_id":"BioInfer.d631.s0.p11","sentence":"The interaction of bovine respiratory syncytial virus (BRSV) @PROTEIN2$ (P) with @PROTEIN1$ (N) and large polymerase (L) @PROTEIN1$ was investigated using an intracellular BRSV-CAT minigenome replication system.","label":1}
{"pair_id":"BioInfer.d631.s0.p12","sentence":"The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (@PROTEIN2$) with @PROTEIN1$ (N) and large polymerase (L) @PROTEIN1$ was investigated using an intracellular BRSV-CAT minigenome replication system.","label":1}
{"pair_id":"BioInfer.d631.s0.p13","sentence":"The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with @PROTEIN1$ (N) and large polymerase (L) @PROTEIN1$ was investigated using an intracellular BRSV-@PROTEIN2$ minigenome replication system.","label":0}
{"pair_id":"BioInfer.d631.s0.p14","sentence":"The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with @PROTEIN1$ (N) and large polymerase (@PROTEIN2$) @PROTEIN1$ was investigated using an intracellular BRSV-CAT minigenome replication system.","label":0}
{"pair_id":"BioInfer.d631.s0.p15","sentence":"The interaction of bovine respiratory syncytial virus (BRSV) @PROTEIN1$ (@PROTEIN2$) with nucleocapsid (N) and large polymerase (L) nucleoca was investigated using an intracellular BRSV-CAT minigenome replication system.","label":0}
{"pair_id":"BioInfer.d631.s0.p16","sentence":"The interaction of bovine respiratory syncytial virus (BRSV) @PROTEIN1$ (P) with nucleocapsid (N) and large polymerase (L) nucleoca was investigated using an intracellular BRSV-@PROTEIN2$ minigenome replication system.","label":0}
{"pair_id":"BioInfer.d631.s0.p17","sentence":"The interaction of bovine respiratory syncytial virus (BRSV) @PROTEIN1$ (P) with nucleocapsid (N) and large polymerase (@PROTEIN2$) nucleoca was investigated using an intracellular BRSV-CAT minigenome replication system.","label":1}
{"pair_id":"BioInfer.d631.s0.p18","sentence":"The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (@PROTEIN1$) with nucleocapsid (N) and large polymerase (L) nucleoca was investigated using an intracellular BRSV-@PROTEIN2$ minigenome replication system.","label":0}
{"pair_id":"BioInfer.d631.s0.p19","sentence":"The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (@PROTEIN1$) with nucleocapsid (N) and large polymerase (@PROTEIN2$) nucleoca was investigated using an intracellular BRSV-CAT minigenome replication system.","label":1}
{"pair_id":"BioInfer.d631.s0.p20","sentence":"The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with nucleocapsid (N) and large polymerase (@PROTEIN2$) nucleoca was investigated using an intracellular BRSV-@PROTEIN1$ minigenome replication system.","label":0}
{"pair_id":"AIMed.d61.s534.p0","sentence":"Cross-linking of 125I-@PROTEIN1$ and 125I-@PROTEIN2$ to 293\/TNF-R2 cells yielded predominant complexes with apparent molecular weights of 211,000 for TNF-alpha and 205,000 and 244,000 for TNF-beta, suggesting these complexes contain two or three TNF-R2 molecules.","label":0}
{"pair_id":"AIMed.d61.s534.p1","sentence":"Cross-linking of 125I-@PROTEIN1$ and 125I-TNF-beta to 293\/@PROTEIN2$ cells yielded predominant complexes with apparent molecular weights of 211,000 for TNF-alpha and 205,000 and 244,000 for TNF-beta, suggesting these complexes contain two or three TNF-R2 molecules.","label":0}
{"pair_id":"AIMed.d61.s534.p2","sentence":"Cross-linking of 125I-@PROTEIN1$ and 125I-TNF-beta to 293\/TNF-R2 cells yielded predominant complexes with apparent molecular weights of 211,000 for @PROTEIN2$ and 205,000 and 244,000 for TNF-beta, suggesting these complexes contain two or three TNF-R2 molecules.","label":0}
{"pair_id":"AIMed.d61.s534.p3","sentence":"Cross-linking of 125I-@PROTEIN1$ and 125I-TNF-beta to 293\/TNF-R2 cells yielded predominant complexes with apparent molecular weights of 211,000 for TNF-alpha and 205,000 and 244,000 for @PROTEIN2$, suggesting these complexes contain two or three TNF-R2 molecules.","label":0}
{"pair_id":"AIMed.d61.s534.p4","sentence":"Cross-linking of 125I-@PROTEIN1$ and 125I-TNF-beta to 293\/TNF-R2 cells yielded predominant complexes with apparent molecular weights of 211,000 for TNF-alpha and 205,000 and 244,000 for TNF-beta, suggesting these complexes contain two or three @PROTEIN2$ molecules.","label":0}
{"pair_id":"AIMed.d61.s534.p5","sentence":"Cross-linking of 125I-TNF-alpha and 125I-@PROTEIN1$ to 293\/@PROTEIN2$ cells yielded predominant complexes with apparent molecular weights of 211,000 for TNF-alpha and 205,000 and 244,000 for TNF-beta, suggesting these complexes contain two or three TNF-R2 molecules.","label":0}
{"pair_id":"AIMed.d61.s534.p6","sentence":"Cross-linking of 125I-TNF-alpha and 125I-@PROTEIN1$ to 293\/TNF-R2 cells yielded predominant complexes with apparent molecular weights of 211,000 for @PROTEIN2$ and 205,000 and 244,000 for TNF-beta, suggesting these complexes contain two or three TNF-R2 molecules.","label":0}
{"pair_id":"AIMed.d61.s534.p7","sentence":"Cross-linking of 125I-TNF-alpha and 125I-@PROTEIN1$ to 293\/TNF-R2 cells yielded predominant complexes with apparent molecular weights of 211,000 for TNF-alpha and 205,000 and 244,000 for @PROTEIN2$, suggesting these complexes contain two or three TNF-R2 molecules.","label":0}
{"pair_id":"AIMed.d61.s534.p8","sentence":"Cross-linking of 125I-TNF-alpha and 125I-@PROTEIN1$ to 293\/TNF-R2 cells yielded predominant complexes with apparent molecular weights of 211,000 for TNF-alpha and 205,000 and 244,000 for TNF-beta, suggesting these complexes contain two or three @PROTEIN2$ molecules.","label":0}
{"pair_id":"AIMed.d61.s534.p9","sentence":"Cross-linking of 125I-TNF-alpha and 125I-TNF-beta to 293\/@PROTEIN1$ cells yielded predominant complexes with apparent molecular weights of 211,000 for @PROTEIN2$ and 205,000 and 244,000 for TNF-beta, suggesting these complexes contain two or three TNF-R2 molecules.","label":0}
{"pair_id":"AIMed.d61.s534.p10","sentence":"Cross-linking of 125I-TNF-alpha and 125I-TNF-beta to 293\/@PROTEIN1$ cells yielded predominant complexes with apparent molecular weights of 211,000 for TNF-alpha and 205,000 and 244,000 for @PROTEIN2$, suggesting these complexes contain two or three TNF-R2 molecules.","label":0}
{"pair_id":"AIMed.d61.s534.p11","sentence":"Cross-linking of 125I-TNF-alpha and 125I-TNF-beta to 293\/@PROTEIN1$ cells yielded predominant complexes with apparent molecular weights of 211,000 for TNF-alpha and 205,000 and 244,000 for TNF-beta, suggesting these complexes contain two or three @PROTEIN2$ molecules.","label":0}
{"pair_id":"AIMed.d61.s534.p12","sentence":"Cross-linking of 125I-TNF-alpha and 125I-TNF-beta to 293\/TNF-R2 cells yielded predominant complexes with apparent molecular weights of 211,000 for @PROTEIN1$ and 205,000 and 244,000 for @PROTEIN2$, suggesting these complexes contain two or three TNF-R2 molecules.","label":0}
{"pair_id":"AIMed.d61.s534.p13","sentence":"Cross-linking of 125I-TNF-alpha and 125I-TNF-beta to 293\/TNF-R2 cells yielded predominant complexes with apparent molecular weights of 211,000 for @PROTEIN1$ and 205,000 and 244,000 for TNF-beta, suggesting these complexes contain two or three @PROTEIN2$ molecules.","label":0}
{"pair_id":"AIMed.d61.s534.p14","sentence":"Cross-linking of 125I-TNF-alpha and 125I-TNF-beta to 293\/TNF-R2 cells yielded predominant complexes with apparent molecular weights of 211,000 for TNF-alpha and 205,000 and 244,000 for @PROTEIN1$, suggesting these complexes contain two or three @PROTEIN2$ molecules.","label":0}
{"pair_id":"BioInfer.d470.s0.p0","sentence":"@PROTEIN1$-mediated cell injury exhibited proteolysis of the @PROTEIN2$ protein substrate lamin B without appreciable breakdown of TnI.","label":0}
{"pair_id":"BioInfer.d470.s0.p1","sentence":"@PROTEIN1$-mediated cell injury exhibited proteolysis of the caspase protein substrate lamin B without appreciable breakdown of @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d470.s0.p2","sentence":"@PROTEIN1$-mediated cell injury exhibited proteolysis of the caspase protein substrate @PROTEIN2$ without appreciable breakdown of TnI.","label":0}
{"pair_id":"BioInfer.d470.s0.p3","sentence":"p53-mediated cell injury exhibited proteolysis of the @PROTEIN1$ protein substrate lamin B without appreciable breakdown of @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d470.s0.p4","sentence":"p53-mediated cell injury exhibited proteolysis of the @PROTEIN1$ protein substrate @PROTEIN2$ without appreciable breakdown of TnI.","label":0}
{"pair_id":"BioInfer.d470.s0.p5","sentence":"p53-mediated cell injury exhibited proteolysis of the caspase protein substrate @PROTEIN2$ without appreciable breakdown of @PROTEIN1$.","label":0}
{"pair_id":"AIMed.d165.s1384.p0","sentence":"Interactions involving the human RNA polymerase II transcription\/nucleotide excision repair complex @PROTEIN1$, the nucleotide excision repair protein @PROTEIN2$, and Cockayne syndrome group B (CSB) protein.","label":0}
{"pair_id":"AIMed.d165.s1384.p1","sentence":"Interactions involving the human RNA polymerase II transcription\/nucleotide excision repair complex @PROTEIN1$, the nucleotide excision repair protein XPG, and Cockayne syndrome group B (@PROTEIN2$) protein.","label":0}
{"pair_id":"AIMed.d165.s1384.p2","sentence":"Interactions involving the human RNA polymerase II transcription\/nucleotide excision repair complex @PROTEIN1$, the nucleotide excision repair protein XPG, and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d165.s1384.p3","sentence":"Interactions involving the human RNA polymerase II transcription\/nucleotide excision repair complex TFIIH, the nucleotide excision repair protein @PROTEIN1$, and Cockayne syndrome group B (@PROTEIN2$) protein.","label":1}
{"pair_id":"AIMed.d165.s1384.p4","sentence":"Interactions involving the human RNA polymerase II transcription\/nucleotide excision repair complex TFIIH, the nucleotide excision repair protein @PROTEIN1$, and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d165.s1384.p5","sentence":"Interactions involving the human RNA polymerase II transcription\/nucleotide excision repair complex TFIIH, the nucleotide excision repair protein XPG, and @PROTEIN2$@PROTEIN1$) protein.","label":0}
{"pair_id":"BioInfer.d658.s0.p0","sentence":"The phosphoprotein was identified as @PROTEIN2$, an @PROTEIN1$, and the activation-induced changes in its intracellular distribution have been described elsewhere (Suzuki et al., 1995, J Biol Chem 270:19551-19556).","label":1}
{"pair_id":"BioInfer.d148.s1.p0","sentence":"To detect the expression of apoptosis-related molecules, @PROTEIN2$ protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, @PROTEIN1$, FADD, TRADD, RIP, FAF, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p1","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, @PROTEIN1$, FADD, TRADD, RIP, @PROTEIN2$, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p2","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, @PROTEIN1$, FADD, TRADD, RIP, FAF, @PROTEIN2$, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p3","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, @PROTEIN1$, FADD, @PROTEIN2$, RIP, FAF, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p4","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, @PROTEIN1$, FADD, TRADD, @PROTEIN2$, FAF, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p5","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, @PROTEIN1$, FADD, TRADD, RIP, FAF, FAP, and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d148.s1.p6","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, @PROTEIN1$, @PROTEIN2$, TRADD, RIP, FAF, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p7","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, @PROTEIN2$, TNFR-1, @PROTEIN1$, FADD, TRADD, RIP, FAF, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p8","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, @PROTEIN2$, @PROTEIN1$, FADD, TRADD, RIP, FAF, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p9","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for @PROTEIN2$, Fas ligand, TNFR-1, @PROTEIN1$, FADD, TRADD, RIP, FAF, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p10","sentence":"To detect the expression of apoptosis-related molecules, @PROTEIN1$ protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, @PROTEIN2$, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p11","sentence":"To detect the expression of apoptosis-related molecules, @PROTEIN1$ protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, @PROTEIN2$, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p12","sentence":"To detect the expression of apoptosis-related molecules, @PROTEIN1$ protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, @PROTEIN2$, RIP, FAF, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p13","sentence":"To detect the expression of apoptosis-related molecules, @PROTEIN1$ protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, @PROTEIN2$, FAF, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p14","sentence":"To detect the expression of apoptosis-related molecules, @PROTEIN1$ protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d148.s1.p15","sentence":"To detect the expression of apoptosis-related molecules, @PROTEIN1$ protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, @PROTEIN2$, TRADD, RIP, FAF, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p16","sentence":"To detect the expression of apoptosis-related molecules, @PROTEIN1$ protection assay was used with specific antisense RNA probes for Fas, @PROTEIN2$, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p17","sentence":"To detect the expression of apoptosis-related molecules, @PROTEIN1$ protection assay was used with specific antisense RNA probes for Fas, Fas ligand, @PROTEIN2$, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p18","sentence":"To detect the expression of apoptosis-related molecules, @PROTEIN1$ protection assay was used with specific antisense RNA probes for @PROTEIN2$, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p19","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, @PROTEIN1$, @PROTEIN2$, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p20","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, @PROTEIN2$, RIP, @PROTEIN1$, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p21","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, @PROTEIN2$, @PROTEIN1$, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p22","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, @PROTEIN1$, FAP, and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d148.s1.p23","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, @PROTEIN2$, TRADD, RIP, @PROTEIN1$, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p24","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, @PROTEIN2$, TNFR-1, TRAIL, FADD, TRADD, RIP, @PROTEIN1$, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p25","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, @PROTEIN2$, TRAIL, FADD, TRADD, RIP, @PROTEIN1$, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p26","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for @PROTEIN2$, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, @PROTEIN1$, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p27","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, @PROTEIN2$, RIP, FAF, @PROTEIN1$, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p28","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, @PROTEIN2$, FAF, @PROTEIN1$, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p29","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, @PROTEIN1$, and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d148.s1.p30","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, @PROTEIN2$, TRADD, RIP, FAF, @PROTEIN1$, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p31","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, @PROTEIN2$, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, @PROTEIN1$, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p32","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, @PROTEIN2$, TRAIL, FADD, TRADD, RIP, FAF, @PROTEIN1$, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p33","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for @PROTEIN2$, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, @PROTEIN1$, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p34","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, @PROTEIN1$, @PROTEIN2$, FAF, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p35","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, @PROTEIN1$, RIP, FAF, FAP, and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d148.s1.p36","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, @PROTEIN2$, @PROTEIN1$, RIP, FAF, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p37","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, @PROTEIN2$, TNFR-1, TRAIL, FADD, @PROTEIN1$, RIP, FAF, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p38","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, @PROTEIN2$, TRAIL, FADD, @PROTEIN1$, RIP, FAF, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p39","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for @PROTEIN2$, Fas ligand, TNFR-1, TRAIL, FADD, @PROTEIN1$, RIP, FAF, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p40","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, @PROTEIN1$, FAF, FAP, and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d148.s1.p41","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, @PROTEIN2$, TRADD, @PROTEIN1$, FAF, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p42","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, @PROTEIN2$, TNFR-1, TRAIL, FADD, TRADD, @PROTEIN1$, FAF, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p43","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, @PROTEIN2$, TRAIL, FADD, TRADD, @PROTEIN1$, FAF, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p44","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for @PROTEIN2$, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, @PROTEIN1$, FAF, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p45","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, @PROTEIN2$, TRADD, RIP, FAF, FAP, and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d148.s1.p46","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, @PROTEIN2$, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d148.s1.p47","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, @PROTEIN2$, TRAIL, FADD, TRADD, RIP, FAF, FAP, and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d148.s1.p48","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for @PROTEIN2$, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d148.s1.p49","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, @PROTEIN2$, TNFR-1, TRAIL, @PROTEIN1$, TRADD, RIP, FAF, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p50","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, @PROTEIN2$, TRAIL, @PROTEIN1$, TRADD, RIP, FAF, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p51","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for @PROTEIN2$, Fas ligand, TNFR-1, TRAIL, @PROTEIN1$, TRADD, RIP, FAF, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p52","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, @PROTEIN1$, @PROTEIN2$, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p53","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for @PROTEIN2$, @PROTEIN1$, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p54","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for @PROTEIN2$, Fas ligand, @PROTEIN1$, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.","label":0}
{"pair_id":"AIMed.d76.s649.p0","sentence":"@PROTEIN1$ interaction w@PROTEIN2$ p56lck represents a novel variant of a receptor-kinase complex in which receptor can also serve as substrate. ( ABSTRACT TRUNCATED AT 250 WORDS )","label":0}
{"pair_id":"AIMed.d76.s649.p1","sentence":"@PROTEIN1$ interaction with @PROTEIN2$ represents a novel variant of a receptor-kinase complex in which receptor can also serve as substrate. ( ABSTRACT TRUNCATED AT 250 WORDS )","label":1}
{"pair_id":"AIMed.d76.s649.p2","sentence":"@PROTEIN1$ interaction with p56lck represents a novel variant of a receptor-kinas@PROTEIN2$ex in which receptor can also serve as substrate. ( ABSTRACT TRUNCATED AT 250 WORDS )","label":0}
{"pair_id":"AIMed.d76.s649.p3","sentence":"CD5 interaction w@PROTEIN1$ @PROTEIN2$ represents a novel variant of a receptor-kinase complex in which receptor can also serve as substrate. ( ABSTRACT TRUNCATED AT 250 WORDS )","label":0}
{"pair_id":"AIMed.d76.s649.p4","sentence":"CD5 interaction w@PROTEIN1$ p56lck represents a novel variant of a receptor-kinas@PROTEIN2$ex in which receptor can also serve as substrate. ( ABSTRACT TRUNCATED AT 250 WORDS )","label":0}
{"pair_id":"AIMed.d76.s649.p5","sentence":"CD5 interaction with @PROTEIN1$ represents a novel variant of a receptor-kinas@PROTEIN2$ex in which receptor can also serve as substrate. ( ABSTRACT TRUNCATED AT 250 WORDS )","label":0}
{"pair_id":"AIMed.d61.s537.p0","sentence":"@PROTEIN1$ treatment of 293\/@PROTEIN2$ cells did not significantly affect the degree or pattern of phosphorylation.","label":0}
{"pair_id":"AIMed.d217.s1879.p0","sentence":"Characterization of @PROTEIN1$ (@PROTEIN2$, CD95)-Fas ligand interaction.","label":0}
{"pair_id":"AIMed.d217.s1879.p1","sentence":"Characterization of @PROTEIN1$ (Apo-1, @PROTEIN2$)-Fas ligand interaction.","label":0}
{"pair_id":"AIMed.d217.s1879.p2","sentence":"Characterization of @PROTEIN1$ (Apo-1, CD95)-@PROTEIN2$ ligand interaction.","label":0}
{"pair_id":"AIMed.d217.s1879.p3","sentence":"Characterization of @PROTEIN1$ (Apo-1, CD95)-@PROTEIN2$ interaction.","label":1}
{"pair_id":"AIMed.d217.s1879.p4","sentence":"Characterization of Fas (@PROTEIN1$, @PROTEIN2$)-Fas ligand interaction.","label":0}
{"pair_id":"AIMed.d217.s1879.p5","sentence":"Characterization of Fas (@PROTEIN1$, CD95)-@PROTEIN2$ ligand interaction.","label":0}
{"pair_id":"AIMed.d217.s1879.p6","sentence":"Characterization of Fas (@PROTEIN1$, CD95)-@PROTEIN2$ interaction.","label":1}
{"pair_id":"AIMed.d217.s1879.p7","sentence":"Characterization of Fas (Apo-1, @PROTEIN1$)-@PROTEIN2$ ligand interaction.","label":0}
{"pair_id":"AIMed.d217.s1879.p8","sentence":"Characterization of Fas (Apo-1, @PROTEIN1$)-@PROTEIN2$ interaction.","label":1}
{"pair_id":"AIMed.d217.s1879.p9","sentence":"Characterization of Fas (Apo-1, CD95)-@PROTEIN1$@PROTEIN2$ interaction.","label":0}
{"pair_id":"AIMed.d217.s1880.p0","sentence":"The death-inducing receptor @PROTEIN1$ is activated when cross-linked by the type II membrane protein @PROTEIN2$ ligand (FasL).","label":0}
{"pair_id":"AIMed.d217.s1880.p1","sentence":"The death-inducing receptor @PROTEIN1$ is activated when cross-linked by the type II membrane protein @PROTEIN2$ (FasL).","label":1}
{"pair_id":"AIMed.d217.s1880.p2","sentence":"The death-inducing receptor @PROTEIN1$ is activated when cross-linked by the type II membrane protein Fas ligand (@PROTEIN2$).","label":1}
{"pair_id":"AIMed.d217.s1880.p3","sentence":"The death-inducing receptor Fas is activated when cross-linked by the type II membrane protein @PROTEIN1$@PROTEIN2$ (FasL).","label":0}
{"pair_id":"AIMed.d217.s1880.p4","sentence":"The death-inducing receptor Fas is activated when cross-linked by the type II membrane protein @PROTEIN1$ ligand (@PROTEIN2$).","label":1}
{"pair_id":"AIMed.d217.s1880.p5","sentence":"The death-inducing receptor Fas is activated when cross-linked by the type II membrane protein @PROTEIN1$ (@PROTEIN2$).","label":0}
{"pair_id":"BioInfer.d137.s0.p0","sentence":"Characterization of gelsolin truncates that inhibit @PROTEIN2$ depolymerization by severing activity of gelsolin and @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d137.s0.p1","sentence":"Characterization of gelsolin truncates that inhibit actin depolymerization by severing activity of @PROTEIN2$ and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d137.s0.p2","sentence":"Characterization of @PROTEIN2$ truncates that inhibit actin depolymerization by severing activity of gelsolin and @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d137.s0.p3","sentence":"Characterization of gelsolin truncates that inhibit @PROTEIN1$ depolymerization by severing activity of @PROTEIN2$ and cofilin.","label":1}
{"pair_id":"BioInfer.d137.s0.p4","sentence":"Characterization of @PROTEIN2$ truncates that inhibit @PROTEIN1$ depolymerization by severing activity of gelsolin and cofilin.","label":1}
{"pair_id":"BioInfer.d137.s0.p5","sentence":"Characterization of @PROTEIN2$ truncates that inhibit actin depolymerization by severing activity of @PROTEIN1$ and cofilin.","label":1}
{"pair_id":"BioInfer.d84.s1.p0","sentence":"In contrast, @PROTEIN2$ and @PROTEIN1$ mRNA accumulation was not enhanced in hybrid embryos.","label":0}
{"pair_id":"BioInfer.d463.s0.p0","sentence":"One such protein is the yeast @PROTEIN1$ @PROTEIN2$, which is homologous to vertebrate fimbrin (Adams, A. E. M., D. Botstein, and D. G. Drubin. 1991. Nature (Lond.). 354:404-408.).","label":1}
{"pair_id":"BioInfer.d463.s0.p1","sentence":"One such protein is the yeast @PROTEIN1$ Sac6p, which is homologous to vertebrate @PROTEIN2$ (Adams, A. E. M., D. Botstein, and D. G. Drubin. 1991. Nature (Lond.). 354:404-408.).","label":0}
{"pair_id":"BioInfer.d463.s0.p2","sentence":"One such protein is the yeast actin-binding protein @PROTEIN1$, which is homologous to vertebrate @PROTEIN2$ (Adams, A. E. M., D. Botstein, and D. G. Drubin. 1991. Nature (Lond.). 354:404-408.).","label":1}
{"pair_id":"BioInfer.d334.s1.p0","sentence":"In mouse brain profilin I and @PROTEIN1$ associate with regulators of the endocytic pathway and @PROTEIN2$ assembly.","label":0}
{"pair_id":"BioInfer.d334.s1.p1","sentence":"In mouse brain @PROTEIN2$ and @PROTEIN1$ associate with regulators of the endocytic pathway and actin assembly.","label":0}
{"pair_id":"BioInfer.d334.s1.p2","sentence":"In mouse brain @PROTEIN2$ and profilin II associate with regulators of the endocytic pathway and @PROTEIN1$ assembly.","label":0}
{"pair_id":"AIMed.d160.s1352.p0","sentence":"Furthermore, this mutational analysis implicates @PROTEIN1$, but not @PROTEIN2$, in VEGF induction of endothelial cell proliferation.","label":0}
{"pair_id":"AIMed.d160.s1352.p1","sentence":"Furthermore, this mutational analysis implicates @PROTEIN1$, but not FLT-1, in @PROTEIN2$ induction of endothelial cell proliferation.","label":0}
{"pair_id":"AIMed.d160.s1352.p2","sentence":"Furthermore, this mutational analysis implicates KDR, but not @PROTEIN1$, in @PROTEIN2$ induction of endothelial cell proliferation.","label":0}
{"pair_id":"AIMed.d68.s580.p0","sentence":"Microinjection of anti-@PROTEIN1$ antibodies into HeLa cells causes their arrest in mitosis. @PROTEIN2$ and cdc25B display endogenous tyrosine phosphatase activity that is stimulated several-fold, in the absence of cdc2, by stoichiometric addition of either cyclin B1 or B2 but not A or D1.","label":0}
{"pair_id":"AIMed.d68.s580.p1","sentence":"Microinjection of anti-@PROTEIN1$ antibodies into HeLa cells causes their arrest in mitosis. cdc25A and @PROTEIN2$ display endogenous tyrosine phosphatase activity that is stimulated several-fold, in the absence of cdc2, by stoichiometric addition of either cyclin B1 or B2 but not A or D1.","label":0}
{"pair_id":"AIMed.d68.s580.p2","sentence":"Microinjection of anti-@PROTEIN1$ antibodies into HeLa cells causes their arrest in mitosis. cdc25A and cdc25B display endogenous tyrosine phosphatase activity that is stimulated several-fold, in the absence of cdc2, by stoichiometric addition of either @PROTEIN2$ or B2 but not A or D1.","label":0}
{"pair_id":"AIMed.d68.s580.p3","sentence":"Microinjection of anti-cdc25A antibodies into HeLa cells causes their arrest in mitosis. @PROTEIN1$ and @PROTEIN2$ display endogenous tyrosine phosphatase activity that is stimulated several-fold, in the absence of cdc2, by stoichiometric addition of either cyclin B1 or B2 but not A or D1.","label":0}
{"pair_id":"AIMed.d68.s580.p4","sentence":"Microinjection of anti-cdc25A antibodies into HeLa cells causes their arrest in mitosis. @PROTEIN1$ and cdc25B display endogenous tyrosine phosphatase activity that is stimulated several-fold, in the absence of cdc2, by stoichiometric addition of either @PROTEIN2$ or B2 but not A or D1.","label":0}
{"pair_id":"AIMed.d68.s580.p5","sentence":"Microinjection of anti-cdc25A antibodies into HeLa cells causes their arrest in mitosis. cdc25A and @PROTEIN1$ display endogenous tyrosine phosphatase activity that is stimulated several-fold, in the absence of cdc2, by stoichiometric addition of either @PROTEIN2$ or B2 but not A or D1.","label":0}
{"pair_id":"BioInfer.d547.s0.p0","sentence":"Specific interaction between the nucleocapsid protein (N) and the @PROTEIN2$ (@PROTEIN1$) of vesicular stomatitis virus (VSV), an important step in the life-cycle of the virus, was studied by using a two-hybrid system.","label":0}
{"pair_id":"BioInfer.d547.s0.p1","sentence":"Specific interaction between the @PROTEIN2$ (N) and the phosphoprotein (@PROTEIN1$) of vesicular stomatitis virus (VSV), an important step in the life-cycle of the virus, was studied by using a two-hybrid system.","label":1}
{"pair_id":"BioInfer.d547.s0.p2","sentence":"Specific interaction between the nucleocapsid protein (@PROTEIN2$) and the phosphoprotein (@PROTEIN1$) of vesicular stomatitis virus (VSV), an important step in the life-cycle of the virus, was studied by using a two-hybrid system.","label":1}
{"pair_id":"BioInfer.d547.s0.p3","sentence":"Specific interaction between the @PROTEIN2$ (N) and the @PROTEIN1$ (P) of vesicular stomatitis virus (VSV), an important step in the life-cycle of the virus, was studied by using a two-hybrid system.","label":1}
{"pair_id":"BioInfer.d547.s0.p4","sentence":"Specific interaction between the nucleocapsid protein (@PROTEIN2$) and the @PROTEIN1$ (P) of vesicular stomatitis virus (VSV), an important step in the life-cycle of the virus, was studied by using a two-hybrid system.","label":1}
{"pair_id":"BioInfer.d547.s0.p5","sentence":"Specific interaction between the @PROTEIN1$ (@PROTEIN2$) and the phosphoprotein (P) of vesicular stomatitis virus (VSV), an important step in the life-cycle of the virus, was studied by using a two-hybrid system.","label":0}
{"pair_id":"BioInfer.d170.s0.p0","sentence":"Detection of a sequence involved in @PROTEIN1$-binding and phosphoinositide-binding in the N-terminal side of @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d275.s0.p0","sentence":"However, smooth muscle contents of @PROTEIN2$ (26.0 +\/- 1.8 vs. 19.1 +\/- 2.2 micrograms\/mg wet wt) and @PROTEIN1$ (5.5 +\/- 0.4 vs. 2.0 +\/- 0.3 microgram\/mg wet wt) were greater (P < 0.04) in myometrium from late-pregnant vs. nonpregnant ewes.","label":0}
{"pair_id":"AIMed.d219.s1899.p0","sentence":"@PROTEIN1$ negatively regulates @PROTEIN2$ activity by interactions with the Raf-1 cysteine-rich domain.","label":1}
{"pair_id":"AIMed.d219.s1899.p1","sentence":"@PROTEIN1$ negatively regulates raf-1 activity by interactions with the @PROTEIN2$ cysteine-rich domain.","label":1}
{"pair_id":"AIMed.d219.s1899.p2","sentence":"14-3-3 zeta negatively regulates @PROTEIN1$ activity by interactions with the @PROTEIN2$ cysteine-rich domain.","label":0}
{"pair_id":"AIMed.d216.s1878.p0","sentence":"Glycine-12 in the transition state mimic is within van der Waals distance of both arginine-789 of @PROTEIN1$ and glutamine-61 of @PROTEIN2$, and even its mutation to alanine would disturb the arrangements of residues in the transition state.","label":0}
{"pair_id":"BioInfer.d55.s0.p0","sentence":"Analysis of @PROTEIN1$: actin crystals reveals an extensive intermolecular network, rather than a discrete \"monomeric complex\", comprising stacked actin ribbons held in place by columns of @PROTEIN2$ molecules, wedged in between neighboring actin subunits and running perpendicular to the ribbons.","label":0}
{"pair_id":"BioInfer.d55.s0.p1","sentence":"Analysis of @PROTEIN1$: actin crystals reveals an extensive intermolecular network, rather than a discrete \"monomeric complex\", comprising stacked @PROTEIN2$ ribbons held in place by columns of profilin molecules, wedged in between neighboring actin subunits and running perpendicular to the ribbons.","label":0}
{"pair_id":"BioInfer.d55.s0.p2","sentence":"Analysis of @PROTEIN1$: @PROTEIN2$ crystals reveals an extensive intermolecular network, rather than a discrete \"monomeric complex\", comprising stacked actin ribbons held in place by columns of profilin molecules, wedged in between neighboring actin subunits and running perpendicular to the ribbons.","label":0}
{"pair_id":"BioInfer.d55.s0.p3","sentence":"Analysis of @PROTEIN1$: actin crystals reveals an extensive intermolecular network, rather than a discrete \"monomeric complex\", comprising stacked actin ribbons held in place by columns of profilin molecules, wedged in between neighboring @PROTEIN2$ subunits and running perpendicular to the ribbons.","label":0}
{"pair_id":"BioInfer.d55.s0.p4","sentence":"Analysis of profilin: actin crystals reveals an extensive intermolecular network, rather than a discrete \"monomeric complex\", comprising stacked @PROTEIN2$ ribbons held in place by columns of @PROTEIN1$ molecules, wedged in between neighboring actin subunits and running perpendicular to the ribbons.","label":0}
{"pair_id":"BioInfer.d55.s0.p5","sentence":"Analysis of profilin: @PROTEIN2$ crystals reveals an extensive intermolecular network, rather than a discrete \"monomeric complex\", comprising stacked actin ribbons held in place by columns of @PROTEIN1$ molecules, wedged in between neighboring actin subunits and running perpendicular to the ribbons.","label":0}
{"pair_id":"BioInfer.d55.s0.p6","sentence":"Analysis of profilin: actin crystals reveals an extensive intermolecular network, rather than a discrete \"monomeric complex\", comprising stacked actin ribbons held in place by columns of @PROTEIN1$ molecules, wedged in between neighboring @PROTEIN2$ subunits and running perpendicular to the ribbons.","label":0}
{"pair_id":"BioInfer.d55.s0.p7","sentence":"Analysis of profilin: @PROTEIN2$ crystals reveals an extensive intermolecular network, rather than a discrete \"monomeric complex\", comprising stacked @PROTEIN1$ ribbons held in place by columns of profilin molecules, wedged in between neighboring actin subunits and running perpendicular to the ribbons.","label":0}
{"pair_id":"BioInfer.d55.s0.p8","sentence":"Analysis of profilin: actin crystals reveals an extensive intermolecular network, rather than a discrete \"monomeric complex\", comprising stacked @PROTEIN1$ ribbons held in place by columns of profilin molecules, wedged in between neighboring @PROTEIN2$ subunits and running perpendicular to the ribbons.","label":0}
{"pair_id":"BioInfer.d55.s0.p9","sentence":"Analysis of profilin: @PROTEIN1$ crystals reveals an extensive intermolecular network, rather than a discrete \"monomeric complex\", comprising stacked actin ribbons held in place by columns of profilin molecules, wedged in between neighboring @PROTEIN2$ subunits and running perpendicular to the ribbons.","label":0}
{"pair_id":"BioInfer.d359.s0.p0","sentence":"Interaction between nucleocapsid protein (@PROTEIN1$) and phosphoprotein (P) of human parainfluenza virus type 2: one of the two @PROTEIN2$ binding sites on P is essential for granule formation.","label":0}
{"pair_id":"BioInfer.d359.s0.p1","sentence":"Interaction between nucleocapsid protein (@PROTEIN1$) and phosphoprotein (@PROTEIN2$) of human parainfluenza virus type 2: one of the two NP binding sites on P is essential for granule formation.","label":1}
{"pair_id":"BioInfer.d359.s0.p2","sentence":"Interaction between nucleocapsid protein (@PROTEIN1$) and @PROTEIN2$ (P) of human parainfluenza virus type 2: one of the two NP binding sites on P is essential for granule formation.","label":1}
{"pair_id":"BioInfer.d359.s0.p3","sentence":"Interaction between @PROTEIN2$ (@PROTEIN1$) and phosphoprotein (P) of human parainfluenza virus type 2: one of the two NP binding sites on P is essential for granule formation.","label":0}
{"pair_id":"BioInfer.d359.s0.p4","sentence":"Interaction between nucleocapsid protein (@PROTEIN1$) and phosphoprotein (P) of human parainfluenza virus type 2: one of the two NP binding sites on @PROTEIN2$ is essential for granule formation.","label":0}
{"pair_id":"BioInfer.d359.s0.p5","sentence":"Interaction between nucleocapsid protein (NP) and phosphoprotein (@PROTEIN2$) of human parainfluenza virus type 2: one of the two @PROTEIN1$ binding sites on P is essential for granule formation.","label":0}
{"pair_id":"BioInfer.d359.s0.p6","sentence":"Interaction between nucleocapsid protein (NP) and @PROTEIN2$ (P) of human parainfluenza virus type 2: one of the two @PROTEIN1$ binding sites on P is essential for granule formation.","label":0}
{"pair_id":"BioInfer.d359.s0.p7","sentence":"Interaction between @PROTEIN2$ (NP) and phosphoprotein (P) of human parainfluenza virus type 2: one of the two @PROTEIN1$ binding sites on P is essential for granule formation.","label":0}
{"pair_id":"BioInfer.d359.s0.p8","sentence":"Interaction between nucleocapsid protein (NP) and phosphoprotein (P) of human parainfluenza virus type 2: one of the two @PROTEIN1$ binding sites on @PROTEIN2$ is essential for granule formation.","label":1}
{"pair_id":"BioInfer.d359.s0.p9","sentence":"Interaction between nucleocapsid protein (NP) and @PROTEIN2$ (@PROTEIN1$) of human parainfluenza virus type 2: one of the two NP binding sites on P is essential for granule formation.","label":0}
{"pair_id":"BioInfer.d359.s0.p10","sentence":"Interaction between @PROTEIN2$ (NP) and phosphoprotein (@PROTEIN1$) of human parainfluenza virus type 2: one of the two NP binding sites on P is essential for granule formation.","label":1}
{"pair_id":"BioInfer.d359.s0.p11","sentence":"Interaction between nucleocapsid protein (NP) and phosphoprotein (@PROTEIN1$) of human parainfluenza virus type 2: one of the two NP binding sites on @PROTEIN2$ is essential for granule formation.","label":0}
{"pair_id":"BioInfer.d359.s0.p12","sentence":"Interaction between @PROTEIN2$ (NP) and @PROTEIN1$ (P) of human parainfluenza virus type 2: one of the two NP binding sites on P is essential for granule formation.","label":1}
{"pair_id":"BioInfer.d359.s0.p13","sentence":"Interaction between nucleocapsid protein (NP) and @PROTEIN1$ (P) of human parainfluenza virus type 2: one of the two NP binding sites on @PROTEIN2$ is essential for granule formation.","label":0}
{"pair_id":"BioInfer.d359.s0.p14","sentence":"Interaction between @PROTEIN1$ (NP) and phosphoprotein (P) of human parainfluenza virus type 2: one of the two NP binding sites on @PROTEIN2$ is essential for granule formation.","label":0}
{"pair_id":"AIMed.d91.s776.p0","sentence":"Molecular cloning and expression of the 32-kDa subunit of human @PROTEIN1$ reveals interactions with @PROTEIN2$ and TFIIB that mediate transcriptional activation.","label":0}
{"pair_id":"AIMed.d91.s776.p1","sentence":"Molecular cloning and expression of the 32-kDa subunit of human @PROTEIN1$ reveals interactions with VP16 and @PROTEIN2$ that mediate transcriptional activation.","label":0}
{"pair_id":"AIMed.d91.s776.p2","sentence":"Molecular cloning and expression of the 32-kDa subunit of human TFIID reveals interactions with @PROTEIN1$ and @PROTEIN2$ that mediate transcriptional activation.","label":0}
{"pair_id":"AIMed.d15.s126.p0","sentence":"We investigated whether the chronic inflammation and pain experienced by patients may be caused by an imbalance of proinflammatory versus anti-inflammatory cytokines within the prostate, namely @PROTEIN1$, @PROTEIN2$ and IL-2 versus IL-10.","label":0}
{"pair_id":"AIMed.d15.s126.p1","sentence":"We investigated whether the chronic inflammation and pain experienced by patients may be caused by an imbalance of proinflammatory versus anti-inflammatory cytokines within the prostate, namely @PROTEIN1$, interferon-gamma and @PROTEIN2$ versus IL-10.","label":0}
{"pair_id":"AIMed.d15.s126.p2","sentence":"We investigated whether the chronic inflammation and pain experienced by patients may be caused by an imbalance of proinflammatory versus anti-inflammatory cytokines within the prostate, namely @PROTEIN1$, interferon-gamma and IL-2 versus @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d15.s126.p3","sentence":"We investigated whether the chronic inflammation and pain experienced by patients may be caused by an imbalance of proinflammatory versus anti-inflammatory cytokines within the prostate, namely interleukin (IL)-8, @PROTEIN1$ and @PROTEIN2$ versus IL-10.","label":0}
{"pair_id":"AIMed.d15.s126.p4","sentence":"We investigated whether the chronic inflammation and pain experienced by patients may be caused by an imbalance of proinflammatory versus anti-inflammatory cytokines within the prostate, namely interleukin (IL)-8, @PROTEIN1$ and IL-2 versus @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d15.s126.p5","sentence":"We investigated whether the chronic inflammation and pain experienced by patients may be caused by an imbalance of proinflammatory versus anti-inflammatory cytokines within the prostate, namely interleukin (IL)-8, interferon-gamma and @PROTEIN1$ versus @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d195.s1660.p0","sentence":"Competitive binding of @PROTEIN1$ and @PROTEIN2$ to the NMDA receptor.","label":0}
{"pair_id":"AIMed.d195.s1660.p1","sentence":"Competitive binding of @PROTEIN1$ and calmodulin to the @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d195.s1660.p2","sentence":"Competitive binding of alpha-actinin and @PROTEIN1$ to the @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d214.s0.p0","sentence":"Fluorographic analysis showed that the specific activity of soluble actin was two to three times that of its particulate form and that soluble actin, cofilin, @PROTEIN1$, and @PROTEIN2$ were transported at similar rates in slow component b of axonal flow.","label":0}
{"pair_id":"BioInfer.d214.s0.p1","sentence":"Fluorographic analysis showed that the specific activity of soluble actin was two to three times that of its particulate form and that soluble @PROTEIN2$, cofilin, @PROTEIN1$, and profilin were transported at similar rates in slow component b of axonal flow.","label":0}
{"pair_id":"BioInfer.d214.s0.p2","sentence":"Fluorographic analysis showed that the specific activity of soluble actin was two to three times that of its particulate form and that soluble actin, @PROTEIN2$, @PROTEIN1$, and profilin were transported at similar rates in slow component b of axonal flow.","label":0}
{"pair_id":"BioInfer.d214.s0.p3","sentence":"Fluorographic analysis showed that the specific activity of soluble @PROTEIN2$ was two to three times that of its particulate form and that soluble actin, cofilin, @PROTEIN1$, and profilin were transported at similar rates in slow component b of axonal flow.","label":0}
{"pair_id":"BioInfer.d214.s0.p4","sentence":"Fluorographic analysis showed that the specific activity of soluble actin was two to three times that of its particulate form and that soluble @PROTEIN2$, cofilin, actin depolymerizing factor, and @PROTEIN1$ were transported at similar rates in slow component b of axonal flow.","label":0}
{"pair_id":"BioInfer.d214.s0.p5","sentence":"Fluorographic analysis showed that the specific activity of soluble actin was two to three times that of its particulate form and that soluble actin, @PROTEIN2$, actin depolymerizing factor, and @PROTEIN1$ were transported at similar rates in slow component b of axonal flow.","label":0}
{"pair_id":"BioInfer.d214.s0.p6","sentence":"Fluorographic analysis showed that the specific activity of soluble @PROTEIN2$ was two to three times that of its particulate form and that soluble actin, cofilin, actin depolymerizing factor, and @PROTEIN1$ were transported at similar rates in slow component b of axonal flow.","label":0}
{"pair_id":"BioInfer.d214.s0.p7","sentence":"Fluorographic analysis showed that the specific activity of soluble actin was two to three times that of its particulate form and that soluble @PROTEIN1$, @PROTEIN2$, actin depolymerizing factor, and profilin were transported at similar rates in slow component b of axonal flow.","label":0}
{"pair_id":"BioInfer.d214.s0.p8","sentence":"Fluorographic analysis showed that the specific activity of soluble @PROTEIN2$ was two to three times that of its particulate form and that soluble @PROTEIN1$, cofilin, actin depolymerizing factor, and profilin were transported at similar rates in slow component b of axonal flow.","label":0}
{"pair_id":"BioInfer.d214.s0.p9","sentence":"Fluorographic analysis showed that the specific activity of soluble @PROTEIN2$ was two to three times that of its particulate form and that soluble actin, @PROTEIN1$, actin depolymerizing factor, and profilin were transported at similar rates in slow component b of axonal flow.","label":0}
{"pair_id":"AIMed.d164.s1381.p0","sentence":"Nuclear extracts deficient in @PROTEIN1$ were inactive; however, both constitutive and enhancer-dependent splicing could be restored by the addition of purified recombinant @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d0.s7.p0","sentence":"In patients with a complete response to @PROTEIN1$, the levels of @PROTEIN2$ were higher at 24 weeks following IFN-alpha treatment than that of pre-treatment (P = 0.04), and the levels of IL-4 decreased markedly at 12 and 24 weeks (P = 0.02, 0.03, respectively). mRNA expression positively correlated with the level of Th1\/Th2 type cytokines in the supernatant.","label":0}
{"pair_id":"AIMed.d0.s7.p1","sentence":"In patients with a complete response to @PROTEIN1$, the levels of IFN-gamma were higher at 24 weeks following @PROTEIN2$ treatment than that of pre-treatment (P = 0.04), and the levels of IL-4 decreased markedly at 12 and 24 weeks (P = 0.02, 0.03, respectively). mRNA expression positively correlated with the level of Th1\/Th2 type cytokines in the supernatant.","label":0}
{"pair_id":"AIMed.d0.s7.p2","sentence":"In patients with a complete response to @PROTEIN1$, the levels of IFN-gamma were higher at 24 weeks following IFN-alpha treatment than that of pre-treatment (P = 0.04), and the levels of @PROTEIN2$ decreased markedly at 12 and 24 weeks (P = 0.02, 0.03, respectively). mRNA expression positively correlated with the level of Th1\/Th2 type cytokines in the supernatant.","label":0}
{"pair_id":"AIMed.d0.s7.p3","sentence":"In patients with a complete response to IFN-alpha, the levels of @PROTEIN1$ were higher at 24 weeks following @PROTEIN2$ treatment than that of pre-treatment (P = 0.04), and the levels of IL-4 decreased markedly at 12 and 24 weeks (P = 0.02, 0.03, respectively). mRNA expression positively correlated with the level of Th1\/Th2 type cytokines in the supernatant.","label":0}
{"pair_id":"AIMed.d0.s7.p4","sentence":"In patients with a complete response to IFN-alpha, the levels of @PROTEIN1$ were higher at 24 weeks following IFN-alpha treatment than that of pre-treatment (P = 0.04), and the levels of @PROTEIN2$ decreased markedly at 12 and 24 weeks (P = 0.02, 0.03, respectively). mRNA expression positively correlated with the level of Th1\/Th2 type cytokines in the supernatant.","label":0}
{"pair_id":"AIMed.d0.s7.p5","sentence":"In patients with a complete response to IFN-alpha, the levels of IFN-gamma were higher at 24 weeks following @PROTEIN1$ treatment than that of pre-treatment (P = 0.04), and the levels of @PROTEIN2$ decreased markedly at 12 and 24 weeks (P = 0.02, 0.03, respectively). mRNA expression positively correlated with the level of Th1\/Th2 type cytokines in the supernatant.","label":0}
{"pair_id":"BioInfer.d492.s0.p0","sentence":"Previously, we have shown that in the absence of @PROTEIN1$, repair is nearly absent and diploid cells lose the broken chromosome; however, in cells lacking @PROTEIN2$, gene conversion is absent but cells can repair the DSB by BIR.","label":0}
{"pair_id":"AIMed.d113.s955.p0","sentence":"Cloning and functional analysis of @PROTEIN1$: a novel @PROTEIN2$-binding protein with anti-cell death activity.","label":1}
{"pair_id":"AIMed.d113.s955.p1","sentence":"Cloning and functional analysis of @PROTEIN1$: a novel @PROTEIN2$ with anti-cell death activity.","label":0}
{"pair_id":"AIMed.d113.s955.p2","sentence":"Cloning and functional analysis of BAG-1: a novel @PROTEIN1$@PROTEIN2$ with anti-cell death activity.","label":0}
{"pair_id":"BioInfer.d139.s1.p0","sentence":"Moreover, addition of @PROTEIN1$ to steady-state @PROTEIN2$ filaments causes slow depolymerization.","label":1}
{"pair_id":"BioInfer.d761.s0.p0","sentence":"To characterize the phenotypic alteration in mesangial cells in human glomerulonephritis, we investigated the expression of nonmuscle-type myosin heavy chain, SMemb, and @PROTEIN2$ (alpha-SM actin) in @PROTEIN1$ nephropathy.","label":0}
{"pair_id":"BioInfer.d761.s0.p1","sentence":"To characterize the phenotypic alteration in mesangial cells in human glomerulonephritis, we investigated the expression of @PROTEIN2$, SMemb, and alpha-smooth muscle actin (alpha-SM actin) in @PROTEIN1$ nephropathy.","label":0}
{"pair_id":"BioInfer.d761.s0.p2","sentence":"To characterize the phenotypic alteration in mesangial cells in human glomerulonephritis, we investigated the expression of nonmuscle-type myosin heavy chain, SMemb, and alpha-smooth muscle actin (@PROTEIN2$) in @PROTEIN1$ nephropathy.","label":0}
{"pair_id":"BioInfer.d761.s0.p3","sentence":"To characterize the phenotypic alteration in mesangial cells in human glomerulonephritis, we investigated the expression of nonmuscle-type myosin heavy chain, @PROTEIN2$, and alpha-smooth muscle actin (alpha-SM actin) in @PROTEIN1$ nephropathy.","label":0}
{"pair_id":"BioInfer.d761.s0.p4","sentence":"To characterize the phenotypic alteration in mesangial cells in human glomerulonephritis, we investigated the expression of @PROTEIN2$, SMemb, and @PROTEIN1$ (alpha-SM actin) in IgA nephropathy.","label":0}
{"pair_id":"BioInfer.d761.s0.p5","sentence":"To characterize the phenotypic alteration in mesangial cells in human glomerulonephritis, we investigated the expression of nonmuscle-type myosin heavy chain, SMemb, and @PROTEIN1$ (@PROTEIN2$) in IgA nephropathy.","label":0}
{"pair_id":"BioInfer.d761.s0.p6","sentence":"To characterize the phenotypic alteration in mesangial cells in human glomerulonephritis, we investigated the expression of nonmuscle-type myosin heavy chain, @PROTEIN2$, and @PROTEIN1$ (alpha-SM actin) in IgA nephropathy.","label":0}
{"pair_id":"BioInfer.d761.s0.p7","sentence":"To characterize the phenotypic alteration in mesangial cells in human glomerulonephritis, we investigated the expression of @PROTEIN1$, SMemb, and alpha-smooth muscle actin (@PROTEIN2$) in IgA nephropathy.","label":0}
{"pair_id":"BioInfer.d761.s0.p8","sentence":"To characterize the phenotypic alteration in mesangial cells in human glomerulonephritis, we investigated the expression of @PROTEIN1$, @PROTEIN2$, and alpha-smooth muscle actin (alpha-SM actin) in IgA nephropathy.","label":0}
{"pair_id":"BioInfer.d761.s0.p9","sentence":"To characterize the phenotypic alteration in mesangial cells in human glomerulonephritis, we investigated the expression of nonmuscle-type myosin heavy chain, @PROTEIN2$, and alpha-smooth muscle actin (@PROTEIN1$) in IgA nephropathy.","label":0}
{"pair_id":"BioInfer.d799.s0.p0","sentence":"We constructed recombinant viruses based on the herpes simplex virus type 1 mutant tsK which individually were able to express the products of four viral DNA replication genes (@PROTEIN1$, UL8, @PROTEIN2$ and UL52) in the absence of any of the other proteins required for viral DNA synthesis.","label":0}
{"pair_id":"BioInfer.d799.s0.p1","sentence":"We constructed recombinant viruses based on the herpes simplex virus type 1 mutant tsK which individually were able to express the products of four viral DNA replication genes (@PROTEIN1$, @PROTEIN2$, UL9 and UL52) in the absence of any of the other proteins required for viral DNA synthesis.","label":0}
{"pair_id":"BioInfer.d799.s0.p2","sentence":"We constructed recombinant viruses based on the herpes simplex virus type 1 mutant tsK which individually were able to express the products of four viral DNA replication genes (@PROTEIN1$, UL8, UL9 and @PROTEIN2$) in the absence of any of the other proteins required for viral DNA synthesis.","label":0}
{"pair_id":"BioInfer.d799.s0.p3","sentence":"We constructed recombinant viruses based on the herpes simplex virus type 1 mutant tsK which individually were able to express the products of four viral DNA replication genes (UL5, @PROTEIN2$, @PROTEIN1$ and UL52) in the absence of any of the other proteins required for viral DNA synthesis.","label":0}
{"pair_id":"BioInfer.d799.s0.p4","sentence":"We constructed recombinant viruses based on the herpes simplex virus type 1 mutant tsK which individually were able to express the products of four viral DNA replication genes (UL5, UL8, @PROTEIN1$ and @PROTEIN2$) in the absence of any of the other proteins required for viral DNA synthesis.","label":0}
{"pair_id":"BioInfer.d799.s0.p5","sentence":"We constructed recombinant viruses based on the herpes simplex virus type 1 mutant tsK which individually were able to express the products of four viral DNA replication genes (UL5, @PROTEIN1$, UL9 and @PROTEIN2$) in the absence of any of the other proteins required for viral DNA synthesis.","label":0}
{"pair_id":"AIMed.d182.s1546.p0","sentence":"The @PROTEIN1$ oncoprotein is a cellular inhibitor of the @PROTEIN2$ tumor suppressor in that it can bind the transactivation domain of p53 and downregulate its ability to activate transcription.","label":1}
{"pair_id":"AIMed.d182.s1546.p1","sentence":"The @PROTEIN1$ oncoprotein is a cellular inhibitor of the p53 tumor suppressor in that it can bind the transactivation domain of @PROTEIN2$ and downregulate its ability to activate transcription.","label":1}
{"pair_id":"AIMed.d182.s1546.p2","sentence":"The MDM2 oncoprotein is a cellular inhibitor of the @PROTEIN1$ tumor suppressor in that it can bind the transactivation domain of @PROTEIN2$ and downregulate its ability to activate transcription.","label":0}
{"pair_id":"AIMed.d82.s699.p0","sentence":"Using an in vitro transcription\/translation assay method coupled with proteolysis studies, we have identified an 11-kDa @PROTEIN1$-rapamycin-binding domain within @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d166.s1401.p0","sentence":"Abolition of the @PROTEIN1$ binding site in @PROTEIN2$ created antagonists of LIF action.","label":1}
{"pair_id":"AIMed.d166.s1401.p1","sentence":"Abolition of the @PROTEIN1$ binding site in hLIF created antagonists of @PROTEIN2$ action.","label":0}
{"pair_id":"AIMed.d166.s1401.p2","sentence":"Abolition of the gp130 binding site in @PROTEIN1$ created antagonists of @PROTEIN2$ action.","label":0}
{"pair_id":"BioInfer.d408.s0.p0","sentence":"Localization of VASP to the leading edge of a migrating cell can lead to local accumulation of @PROTEIN1$, which in turn can supply @PROTEIN2$ monomers to growing filament ends.","label":1}
{"pair_id":"BioInfer.d408.s0.p1","sentence":"Localization of @PROTEIN2$ to the leading edge of a migrating cell can lead to local accumulation of @PROTEIN1$, which in turn can supply actin monomers to growing filament ends.","label":1}
{"pair_id":"BioInfer.d408.s0.p2","sentence":"Localization of @PROTEIN2$ to the leading edge of a migrating cell can lead to local accumulation of profilin, which in turn can supply @PROTEIN1$ monomers to growing filament ends.","label":0}
{"pair_id":"AIMed.d125.s1066.p0","sentence":"@PROTEIN1$ also interacted with @PROTEIN2$ and Mcl-1 and with the dominant inhibitors Bax and Bcl-X-S.","label":1}
{"pair_id":"AIMed.d125.s1066.p1","sentence":"@PROTEIN1$ also interacted with Bcl-X-L and @PROTEIN2$ and with the dominant inhibitors Bax and Bcl-X-S.","label":1}
{"pair_id":"AIMed.d125.s1066.p2","sentence":"@PROTEIN1$ also interacted with Bcl-X-L and Mcl-1 and with the dominant inhibitors @PROTEIN2$ and Bcl-X-S.","label":1}
{"pair_id":"AIMed.d125.s1066.p3","sentence":"@PROTEIN1$ also interacted with Bcl-X-L and Mcl-1 and with the dominant inhibitors Bax and @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d125.s1066.p4","sentence":"Bcl-2 also interacted with @PROTEIN1$ and @PROTEIN2$ and with the dominant inhibitors Bax and Bcl-X-S.","label":0}
{"pair_id":"AIMed.d125.s1066.p5","sentence":"Bcl-2 also interacted with @PROTEIN1$ and Mcl-1 and with the dominant inhibitors @PROTEIN2$ and Bcl-X-S.","label":0}
{"pair_id":"AIMed.d125.s1066.p6","sentence":"Bcl-2 also interacted with @PROTEIN1$ and Mcl-1 and with the dominant inhibitors Bax and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d125.s1066.p7","sentence":"Bcl-2 also interacted with Bcl-X-L and @PROTEIN1$ and with the dominant inhibitors @PROTEIN2$ and Bcl-X-S.","label":0}
{"pair_id":"AIMed.d125.s1066.p8","sentence":"Bcl-2 also interacted with Bcl-X-L and @PROTEIN1$ and with the dominant inhibitors Bax and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d125.s1066.p9","sentence":"Bcl-2 also interacted with Bcl-X-L and Mcl-1 and with the dominant inhibitors @PROTEIN1$ and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d172.s0.p0","sentence":"Developmental changes in @PROTEIN2$ and @PROTEIN1$ isoform expression in smooth muscle.","label":0}
{"pair_id":"AIMed.d121.s1028.p0","sentence":"Rather, the hydrophobic amino acid residues Leu-22 and Trp-23 of human @PROTEIN1$ are both required for trans-activation activity, binding to the adenovirus @PROTEIN2$ 55-kD protein and the human mdm-2-p53 protein in vitro.","label":1}
{"pair_id":"AIMed.d121.s1028.p1","sentence":"Rather, the hydrophobic amino acid residues Leu-22 and Trp-23 of human @PROTEIN1$ are both required for trans-activation activity, binding to the adenovirus E1B 55-kD protein and the human @PROTEIN2$-p53 protein in vitro.","label":0}
{"pair_id":"AIMed.d121.s1028.p2","sentence":"Rather, the hydrophobic amino acid residues Leu-22 and Trp-23 of human @PROTEIN1$ are both required for trans-activation activity, binding to the adenovirus E1B 55-kD protein and the human mdm-2-@PROTEIN2$ protein in vitro.","label":0}
{"pair_id":"AIMed.d121.s1028.p3","sentence":"Rather, the hydrophobic amino acid residues Leu-22 and Trp-23 of human p53 are both required for trans-activation activity, binding to the adenovirus @PROTEIN1$ 55-kD protein and the human @PROTEIN2$-p53 protein in vitro.","label":0}
{"pair_id":"AIMed.d121.s1028.p4","sentence":"Rather, the hydrophobic amino acid residues Leu-22 and Trp-23 of human p53 are both required for trans-activation activity, binding to the adenovirus @PROTEIN1$ 55-kD protein and the human mdm-2-@PROTEIN2$ protein in vitro.","label":0}
{"pair_id":"AIMed.d121.s1028.p5","sentence":"Rather, the hydrophobic amino acid residues Leu-22 and Trp-23 of human p53 are both required for trans-activation activity, binding to the adenovirus E1B 55-kD protein and the human @PROTEIN1$-@PROTEIN2$ protein in vitro.","label":1}
{"pair_id":"BioInfer.d583.s0.p0","sentence":"The binding surfaces for segment 1 and @PROTEIN2$ are different, although they peripherally overlap on @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d682.s0.p0","sentence":"The recombinant material is similar to authentic profilin from Acanthamoeba-based on fluorescence monitored urea denaturation, circular dichroism, @PROTEIN2$-nucleotide exchange rate and the Kd for rabbit @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d682.s0.p1","sentence":"The recombinant material is similar to authentic @PROTEIN2$ from Acanthamoeba-based on fluorescence monitored urea denaturation, circular dichroism, actin-nucleotide exchange rate and the Kd for rabbit @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d682.s0.p2","sentence":"The recombinant material is similar to authentic @PROTEIN2$ from Acanthamoeba-based on fluorescence monitored urea denaturation, circular dichroism, @PROTEIN1$-nucleotide exchange rate and the Kd for rabbit skeletal actin.","label":0}
{"pair_id":"BioInfer.d69.s0.p0","sentence":"A pre-treatment of cells with SGE from partially fed ticks in amounts corresponding to 1 or 3 salivary glands increased the level of both viral nucleocapsid (N) nucleoc and @PROTEIN1$ (@PROTEIN2$) in a dose-dependent manner.","label":0}
{"pair_id":"BioInfer.d69.s0.p1","sentence":"A pre-treatment of cells with SGE from partially fed ticks in amounts corresponding to 1 or 3 salivary glands increased the level of both viral @PROTEIN2$ (N) @PROTEIN2$ and @PROTEIN1$ (P) in a dose-dependent manner.","label":0}
{"pair_id":"BioInfer.d69.s0.p2","sentence":"A pre-treatment of cells with SGE from partially fed ticks in amounts corresponding to 1 or 3 salivary glands increased the level of both viral nucleocapsid (@PROTEIN2$) nucleoc and @PROTEIN1$ (P) in a dose-dependent manner.","label":0}
{"pair_id":"BioInfer.d69.s0.p3","sentence":"A pre-treatment of cells with SGE from partially fed ticks in amounts corresponding to 1 or 3 salivary glands increased the level of both viral @PROTEIN2$ (N) @PROTEIN2$ and phosphoprotein (@PROTEIN1$) in a dose-dependent manner.","label":0}
{"pair_id":"BioInfer.d69.s0.p4","sentence":"A pre-treatment of cells with SGE from partially fed ticks in amounts corresponding to 1 or 3 salivary glands increased the level of both viral nucleocapsid (@PROTEIN2$) nucleoc and phosphoprotein (@PROTEIN1$) in a dose-dependent manner.","label":0}
{"pair_id":"BioInfer.d69.s0.p5","sentence":"A pre-treatment of cells with SGE from partially fed ticks in amounts corresponding to 1 or 3 salivary glands increased the level of both viral @PROTEIN1$ (@PROTEIN2$) @PROTEIN1$ and phosphoprotein (P) in a dose-dependent manner.","label":0}
{"pair_id":"BioInfer.d360.s1.p0","sentence":"The quantity of the complex is reduced by treatment of Caco-2 cells with the alkylating agent N-ethylmaleimide which also has an inhibitory effect on the ability of @PROTEIN1$ to associate with @PROTEIN2$ in vitro.","label":1}
{"pair_id":"BioInfer.d308.s0.p0","sentence":"In Acanthamoeba, the two isoforms of @PROTEIN2$ may have specialized functions on the basis of their identical (approximately 10 microM) affinities for @PROTEIN1$ monomers and different affinities for PIP2.","label":1}
{"pair_id":"BioInfer.d676.s0.p0","sentence":"The proximity of the semi-conserved @PROTEIN1$-binding site and the binding pocket characteristic of plant @PROTEIN2$ suggests that epitopes encompassing both features are responsible for the cross-reactivity of antibodies between human and plant profilins thought to be responsible for type I allergies.","label":0}
{"pair_id":"BioInfer.d676.s0.p1","sentence":"The proximity of the semi-conserved @PROTEIN1$-binding site and the binding pocket characteristic of plant profilins suggests that epitopes encompassing both features are responsible for the cross-reactivity of antibodies between human and plant @PROTEIN2$ thought to be responsible for type I allergies.","label":0}
{"pair_id":"BioInfer.d676.s0.p2","sentence":"The proximity of the semi-conserved actin-binding site and the binding pocket characteristic of plant @PROTEIN1$ suggests that epitopes encompassing both features are responsible for the cross-reactivity of antibodies between human and plant @PROTEIN2$ thought to be responsible for type I allergies.","label":0}
{"pair_id":"BioInfer.d732.s0.p0","sentence":"The yeast two-hybrid system was used to identify domains involved in specific in vivo interactions between the Rinderpest virus (RPV) @PROTEIN2$ (P) and @PROTEIN1$ (N).","label":1}
{"pair_id":"BioInfer.d732.s0.p1","sentence":"The yeast two-hybrid system was used to identify domains involved in specific in vivo interactions between the Rinderpest virus (RPV) phosphoprotein (@PROTEIN2$) and @PROTEIN1$ (N).","label":1}
{"pair_id":"BioInfer.d732.s0.p2","sentence":"The yeast two-hybrid system was used to identify domains involved in specific in vivo interactions between the Rinderpest virus (RPV) phosphoprotein (P) and @PROTEIN1$ (@PROTEIN2$).","label":0}
{"pair_id":"BioInfer.d732.s0.p3","sentence":"The yeast two-hybrid system was used to identify domains involved in specific in vivo interactions between the Rinderpest virus (RPV) @PROTEIN1$ (@PROTEIN2$) and nucleocapsid protein (N).","label":0}
{"pair_id":"BioInfer.d732.s0.p4","sentence":"The yeast two-hybrid system was used to identify domains involved in specific in vivo interactions between the Rinderpest virus (RPV) @PROTEIN1$ (P) and nucleocapsid protein (@PROTEIN2$).","label":1}
{"pair_id":"BioInfer.d732.s0.p5","sentence":"The yeast two-hybrid system was used to identify domains involved in specific in vivo interactions between the Rinderpest virus (RPV) phosphoprotein (@PROTEIN1$) and nucleocapsid protein (@PROTEIN2$).","label":1}
{"pair_id":"AIMed.d9.s80.p0","sentence":"Our results demonstrated that @PROTEIN1$ was expressed in human gastrinoma cells and could be involved in the mechanism of calcium-evoked @PROTEIN2$ release.","label":0}
{"pair_id":"BioInfer.d49.s1.p0","sentence":"As a consequence, in the presence of thymosin beta 4 (T beta 4), low amounts of @PROTEIN1$ promote extensive @PROTEIN2$ assembly off of the pool of actin-T beta 4 complex.","label":1}
{"pair_id":"BioInfer.d49.s1.p1","sentence":"As a consequence, in the presence of thymosin beta 4 (T beta 4), low amounts of @PROTEIN1$ promote extensive actin assembly off of the pool of @PROTEIN2$-T beta 4 complex.","label":0}
{"pair_id":"BioInfer.d49.s1.p2","sentence":"As a consequence, in the presence of @PROTEIN2$ (T beta 4), low amounts of @PROTEIN1$ promote extensive actin assembly off of the pool of actin-T beta 4 complex.","label":0}
{"pair_id":"BioInfer.d49.s1.p3","sentence":"As a consequence, in the presence of thymosin beta 4 (T beta 4), low amounts of @PROTEIN1$ promote extensive actin assembly off of the pool of actin-@PROTEIN2$ complex.","label":0}
{"pair_id":"BioInfer.d49.s1.p4","sentence":"As a consequence, in the presence of thymosin beta 4 (@PROTEIN2$), low amounts of @PROTEIN1$ promote extensive actin assembly off of the pool of actin-T beta 4 complex.","label":0}
{"pair_id":"BioInfer.d49.s1.p5","sentence":"As a consequence, in the presence of thymosin beta 4 (T beta 4), low amounts of profilin promote extensive @PROTEIN1$ assembly off of the pool of @PROTEIN2$-T beta 4 complex.","label":1}
{"pair_id":"BioInfer.d49.s1.p6","sentence":"As a consequence, in the presence of @PROTEIN2$ (T beta 4), low amounts of profilin promote extensive @PROTEIN1$ assembly off of the pool of actin-T beta 4 complex.","label":0}
{"pair_id":"BioInfer.d49.s1.p7","sentence":"As a consequence, in the presence of thymosin beta 4 (T beta 4), low amounts of profilin promote extensive @PROTEIN1$ assembly off of the pool of actin-@PROTEIN2$ complex.","label":1}
{"pair_id":"BioInfer.d49.s1.p8","sentence":"As a consequence, in the presence of thymosin beta 4 (@PROTEIN2$), low amounts of profilin promote extensive @PROTEIN1$ assembly off of the pool of actin-T beta 4 complex.","label":0}
{"pair_id":"BioInfer.d49.s1.p9","sentence":"As a consequence, in the presence of @PROTEIN2$ (T beta 4), low amounts of profilin promote extensive actin assembly off of the pool of @PROTEIN1$-T beta 4 complex.","label":0}
{"pair_id":"BioInfer.d49.s1.p10","sentence":"As a consequence, in the presence of thymosin beta 4 (T beta 4), low amounts of profilin promote extensive actin assembly off of the pool of @PROTEIN1$-@PROTEIN2$ complex.","label":1}
{"pair_id":"BioInfer.d49.s1.p11","sentence":"As a consequence, in the presence of thymosin beta 4 (@PROTEIN2$), low amounts of profilin promote extensive actin assembly off of the pool of @PROTEIN1$-T beta 4 complex.","label":0}
{"pair_id":"BioInfer.d49.s1.p12","sentence":"As a consequence, in the presence of @PROTEIN1$ (T beta 4), low amounts of profilin promote extensive actin assembly off of the pool of actin-@PROTEIN2$ complex.","label":0}
{"pair_id":"BioInfer.d49.s1.p13","sentence":"As a consequence, in the presence of @PROTEIN1$ (@PROTEIN2$), low amounts of profilin promote extensive actin assembly off of the pool of actin-T beta 4 complex.","label":0}
{"pair_id":"BioInfer.d49.s1.p14","sentence":"As a consequence, in the presence of thymosin beta 4 (@PROTEIN2$), low amounts of profilin promote extensive actin assembly off of the pool of actin-@PROTEIN1$ complex.","label":0}
{"pair_id":"AIMed.d139.s1177.p0","sentence":"Following linkage studies which were most consistent with a @PROTEIN1$ gene mutation, a nucleotide change was identified in codon 2018, resulting in an Ala-->Gly substitution in the first helical domain of @PROTEIN2$ repeat 17.","label":0}
{"pair_id":"BioInfer.d367.s0.p0","sentence":"In the cytoplasm, HBx was shown to stimulate the @PROTEIN1$-Raf-mitogen-activated protein kinase (@PROTEIN2$) cascade, which is essential for activation of transcription factor AP-1.","label":1}
{"pair_id":"BioInfer.d367.s0.p1","sentence":"In the cytoplasm, @PROTEIN2$ was shown to stimulate the @PROTEIN1$-Raf-mitogen-activated protein kinase (MAP kinase) cascade, which is essential for activation of transcription factor AP-1.","label":0}
{"pair_id":"BioInfer.d367.s0.p2","sentence":"In the cytoplasm, HBx was shown to stimulate the @PROTEIN1$-Raf-mitogen-activated protein kinase (MAP kinase) cascade, which is essential for activation of transcription factor @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d367.s0.p3","sentence":"In the cytoplasm, HBx was shown to stimulate the @PROTEIN1$-Raf-@PROTEIN2$ (MAP kinase) cascade, which is essential for activation of transcription factor AP-1.","label":1}
{"pair_id":"BioInfer.d367.s0.p4","sentence":"In the cytoplasm, HBx was shown to stimulate the @PROTEIN1$-@PROTEIN2$-mitogen-activated protein kinase (MAP kinase) cascade, which is essential for activation of transcription factor AP-1.","label":1}
{"pair_id":"BioInfer.d367.s0.p5","sentence":"In the cytoplasm, @PROTEIN2$ was shown to stimulate the Ras-Raf-mitogen-activated protein kinase (@PROTEIN1$) cascade, which is essential for activation of transcription factor AP-1.","label":0}
{"pair_id":"BioInfer.d367.s0.p6","sentence":"In the cytoplasm, HBx was shown to stimulate the Ras-Raf-mitogen-activated protein kinase (@PROTEIN1$) cascade, which is essential for activation of transcription factor @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d367.s0.p7","sentence":"In the cytoplasm, HBx was shown to stimulate the Ras-Raf-@PROTEIN2$ (@PROTEIN1$) cascade, which is essential for activation of transcription factor AP-1.","label":1}
{"pair_id":"BioInfer.d367.s0.p8","sentence":"In the cytoplasm, HBx was shown to stimulate the Ras-@PROTEIN2$-mitogen-activated protein kinase (@PROTEIN1$) cascade, which is essential for activation of transcription factor AP-1.","label":1}
{"pair_id":"BioInfer.d367.s0.p9","sentence":"In the cytoplasm, @PROTEIN1$ was shown to stimulate the Ras-Raf-mitogen-activated protein kinase (MAP kinase) cascade, which is essential for activation of transcription factor @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d367.s0.p10","sentence":"In the cytoplasm, @PROTEIN1$ was shown to stimulate the Ras-Raf-@PROTEIN2$ (MAP kinase) cascade, which is essential for activation of transcription factor AP-1.","label":0}
{"pair_id":"BioInfer.d367.s0.p11","sentence":"In the cytoplasm, @PROTEIN1$ was shown to stimulate the Ras-@PROTEIN2$-mitogen-activated protein kinase (MAP kinase) cascade, which is essential for activation of transcription factor AP-1.","label":0}
{"pair_id":"BioInfer.d367.s0.p12","sentence":"In the cytoplasm, HBx was shown to stimulate the Ras-Raf-@PROTEIN2$ (MAP kinase) cascade, which is essential for activation of transcription factor @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d367.s0.p13","sentence":"In the cytoplasm, HBx was shown to stimulate the Ras-@PROTEIN2$-mitogen-activated protein kinase (MAP kinase) cascade, which is essential for activation of transcription factor @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d367.s0.p14","sentence":"In the cytoplasm, HBx was shown to stimulate the Ras-@PROTEIN2$-@PROTEIN1$ (MAP kinase) cascade, which is essential for activation of transcription factor AP-1.","label":1}
{"pair_id":"BioInfer.d669.s0.p0","sentence":"The product of @PROTEIN1$ has been shown to be essential for capsid assembly, but no role has previously been assigned to the product of @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d44.s379.p0","sentence":"Characterization of the @PROTEIN1$ binding domain on the human @PROTEIN2$ molecule using anti-CD30 antibodies.","label":1}
{"pair_id":"AIMed.d44.s379.p1","sentence":"Characterization of the @PROTEIN1$ binding domain on the human CD30 molecule using anti-@PROTEIN2$ antibodies.","label":0}
{"pair_id":"AIMed.d44.s379.p2","sentence":"Characterization of the CD30L binding domain on the human @PROTEIN1$ molecule using anti-@PROTEIN2$ antibodies.","label":0}
{"pair_id":"BioInfer.d657.s0.p0","sentence":"p27 binds to and inhibits complexes formed by @PROTEIN1$-cdk2, @PROTEIN2$-cdk2, and cyclin D-cdk4.","label":0}
{"pair_id":"BioInfer.d657.s0.p1","sentence":"p27 binds to and inhibits complexes formed by @PROTEIN1$-cdk2, cyclin A-cdk2, and @PROTEIN2$-cdk4.","label":0}
{"pair_id":"BioInfer.d657.s0.p2","sentence":"p27 binds to and inhibits complexes formed by @PROTEIN1$-cdk2, cyclin A-@PROTEIN2$, and cyclin D-cdk4.","label":0}
{"pair_id":"BioInfer.d657.s0.p3","sentence":"p27 binds to and inhibits complexes formed by @PROTEIN1$-cdk2, cyclin A-cdk2, and cyclin D-@PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d657.s0.p4","sentence":"p27 binds to and inhibits complexes formed by @PROTEIN1$-@PROTEIN2$, cyclin A-cdk2, and cyclin D-cdk4.","label":1}
{"pair_id":"BioInfer.d657.s0.p5","sentence":"@PROTEIN2$ binds to and inhibits complexes formed by @PROTEIN1$-cdk2, cyclin A-cdk2, and cyclin D-cdk4.","label":1}
{"pair_id":"BioInfer.d657.s0.p6","sentence":"p27 binds to and inhibits complexes formed by cyclin E-cdk2, @PROTEIN1$-cdk2, and @PROTEIN2$-cdk4.","label":0}
{"pair_id":"BioInfer.d657.s0.p7","sentence":"p27 binds to and inhibits complexes formed by cyclin E-cdk2, @PROTEIN1$-@PROTEIN2$, and cyclin D-cdk4.","label":1}
{"pair_id":"BioInfer.d657.s0.p8","sentence":"p27 binds to and inhibits complexes formed by cyclin E-cdk2, @PROTEIN1$-cdk2, and cyclin D-@PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d657.s0.p9","sentence":"p27 binds to and inhibits complexes formed by cyclin E-@PROTEIN2$, @PROTEIN1$-cdk2, and cyclin D-cdk4.","label":0}
{"pair_id":"BioInfer.d657.s0.p10","sentence":"@PROTEIN2$ binds to and inhibits complexes formed by cyclin E-cdk2, @PROTEIN1$-cdk2, and cyclin D-cdk4.","label":1}
{"pair_id":"BioInfer.d657.s0.p11","sentence":"p27 binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-@PROTEIN2$, and @PROTEIN1$-cdk4.","label":0}
{"pair_id":"BioInfer.d657.s0.p12","sentence":"p27 binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-cdk2, and @PROTEIN1$-@PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d657.s0.p13","sentence":"p27 binds to and inhibits complexes formed by cyclin E-@PROTEIN2$, cyclin A-cdk2, and @PROTEIN1$-cdk4.","label":0}
{"pair_id":"BioInfer.d657.s0.p14","sentence":"@PROTEIN2$ binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-cdk2, and @PROTEIN1$-cdk4.","label":1}
{"pair_id":"BioInfer.d657.s0.p15","sentence":"p27 binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-@PROTEIN1$, and cyclin D-@PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d657.s0.p16","sentence":"p27 binds to and inhibits complexes formed by cyclin E-@PROTEIN2$, cyclin A-@PROTEIN1$, and cyclin D-cdk4.","label":0}
{"pair_id":"BioInfer.d657.s0.p17","sentence":"@PROTEIN2$ binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-@PROTEIN1$, and cyclin D-cdk4.","label":1}
{"pair_id":"BioInfer.d657.s0.p18","sentence":"p27 binds to and inhibits complexes formed by cyclin E-@PROTEIN2$, cyclin A-cdk2, and cyclin D-@PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d657.s0.p19","sentence":"@PROTEIN2$ binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-cdk2, and cyclin D-@PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d657.s0.p20","sentence":"@PROTEIN2$ binds to and inhibits complexes formed by cyclin E-@PROTEIN1$, cyclin A-cdk2, and cyclin D-cdk4.","label":1}
{"pair_id":"BioInfer.d8.s0.p0","sentence":"Accordingly, @PROTEIN2$ is also found in these structures, again in the absence of @PROTEIN1$.","label":0}
{"pair_id":"AIMed.d176.s1492.p0","sentence":"The @PROTEIN1$-@PROTEIN2$-hsp70 multichaperone complex is highly dynamic and does not appear to be affected by the hsp90-binding drug geldanamycin.","label":1}
{"pair_id":"AIMed.d176.s1492.p1","sentence":"The @PROTEIN1$-p60-@PROTEIN2$ multichaperone complex is highly dynamic and does not appear to be affected by the hsp90-binding drug geldanamycin.","label":0}
{"pair_id":"AIMed.d176.s1492.p2","sentence":"The @PROTEIN1$-p60-hsp70 multichaperone complex is highly dynamic and does not appear to be affected by the @PROTEIN2$-binding drug geldanamycin.","label":0}
{"pair_id":"AIMed.d176.s1492.p3","sentence":"The hsp90-@PROTEIN1$-@PROTEIN2$ multichaperone complex is highly dynamic and does not appear to be affected by the hsp90-binding drug geldanamycin.","label":0}
{"pair_id":"AIMed.d176.s1492.p4","sentence":"The hsp90-@PROTEIN1$-hsp70 multichaperone complex is highly dynamic and does not appear to be affected by the @PROTEIN2$-binding drug geldanamycin.","label":0}
{"pair_id":"AIMed.d176.s1492.p5","sentence":"The hsp90-p60-@PROTEIN1$ multichaperone complex is highly dynamic and does not appear to be affected by the @PROTEIN2$-binding drug geldanamycin.","label":0}
{"pair_id":"BioInfer.d163.s1.p0","sentence":"Selective repression of @PROTEIN2$ and @PROTEIN1$ expression during the programmed death of insect skeletal muscle.","label":0}
{"pair_id":"BioInfer.d447.s0.p0","sentence":"Mutations that alter putative RNA-binding residues of either HSH49 RRM are lethal in vivo, but do not prevent binding to CUS1 in vitro, suggesting that the predicted RNA-binding surfaces of @PROTEIN2$ are not required for interaction with @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d447.s0.p1","sentence":"Mutations that alter putative RNA-binding residues of either HSH49 RRM are lethal in vivo, but do not prevent binding to @PROTEIN2$ in vitro, suggesting that the predicted RNA-binding surfaces of HSH49 are not required for interaction with @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d447.s0.p2","sentence":"Mutations that alter putative RNA-binding residues of either @PROTEIN2$ RRM are lethal in vivo, but do not prevent binding to CUS1 in vitro, suggesting that the predicted RNA-binding surfaces of HSH49 are not required for interaction with @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d447.s0.p3","sentence":"Mutations that alter putative RNA-binding residues of either HSH49 RRM are lethal in vivo, but do not prevent binding to @PROTEIN2$ in vitro, suggesting that the predicted RNA-binding surfaces of @PROTEIN1$ are not required for interaction with CUS1.","label":0}
{"pair_id":"BioInfer.d447.s0.p4","sentence":"Mutations that alter putative RNA-binding residues of either @PROTEIN2$ RRM are lethal in vivo, but do not prevent binding to CUS1 in vitro, suggesting that the predicted RNA-binding surfaces of @PROTEIN1$ are not required for interaction with CUS1.","label":0}
{"pair_id":"BioInfer.d447.s0.p5","sentence":"Mutations that alter putative RNA-binding residues of either @PROTEIN2$ RRM are lethal in vivo, but do not prevent binding to @PROTEIN1$ in vitro, suggesting that the predicted RNA-binding surfaces of HSH49 are not required for interaction with CUS1.","label":1}
{"pair_id":"AIMed.d115.s976.p0","sentence":"The correlation of @PROTEIN1$-@PROTEIN2$ binding with transcriptional activation suggests that RAP74 is a critical target for SRF-activated transcription.","label":1}
{"pair_id":"AIMed.d115.s976.p1","sentence":"The correlation of @PROTEIN1$-RAP74 binding with transcriptional activation suggests that @PROTEIN2$ is a critical target for SRF-activated transcription.","label":0}
{"pair_id":"AIMed.d115.s976.p2","sentence":"The correlation of @PROTEIN1$-RAP74 binding with transcriptional activation suggests that RAP74 is a critical target for @PROTEIN2$-activated transcription.","label":0}
{"pair_id":"AIMed.d115.s976.p3","sentence":"The correlation of SRF-@PROTEIN1$ binding with transcriptional activation suggests that @PROTEIN2$ is a critical target for SRF-activated transcription.","label":0}
{"pair_id":"AIMed.d115.s976.p4","sentence":"The correlation of SRF-@PROTEIN1$ binding with transcriptional activation suggests that RAP74 is a critical target for @PROTEIN2$-activated transcription.","label":0}
{"pair_id":"AIMed.d115.s976.p5","sentence":"The correlation of SRF-RAP74 binding with transcriptional activation suggests that @PROTEIN1$ is a critical target for @PROTEIN2$-activated transcription.","label":1}
{"pair_id":"AIMed.d123.s1043.p0","sentence":"Characterization of an interaction between @PROTEIN1$ and the @PROTEIN2$ by using the two-hybrid system.","label":1}
{"pair_id":"BioInfer.d335.s1.p0","sentence":"These results suggest that @PROTEIN2$ may be involved in dynamic reorganization of membranous @PROTEIN1$ cytoskeletons.","label":1}
{"pair_id":"AIMed.d43.s375.p0","sentence":"Although the individual amino acids in @PROTEIN1$ involved in binding to @PROTEIN2$ (NGF) and those in TrkC involved in binding to neurotrophin-3 have been mapped in this domain, the Trk amino acids that provide specificity remained unclear.","label":1}
{"pair_id":"AIMed.d43.s375.p1","sentence":"Although the individual amino acids in @PROTEIN1$ involved in binding to nerve growth factor (@PROTEIN2$) and those in TrkC involved in binding to neurotrophin-3 have been mapped in this domain, the Trk amino acids that provide specificity remained unclear.","label":1}
{"pair_id":"AIMed.d43.s375.p2","sentence":"Although the individual amino acids in @PROTEIN1$ involved in binding to nerve growth factor (NGF) and those in @PROTEIN2$ involved in binding to neurotrophin-3 have been mapped in this domain, the Trk amino acids that provide specificity remained unclear.","label":0}
{"pair_id":"AIMed.d43.s375.p3","sentence":"Although the individual amino acids in @PROTEIN1$ involved in binding to nerve growth factor (NGF) and those in TrkC involved in binding to @PROTEIN2$ have been mapped in this domain, the Trk amino acids that provide specificity remained unclear.","label":0}
{"pair_id":"AIMed.d43.s375.p4","sentence":"Although the individual amino acids in TrkA involved in binding to @PROTEIN1$ (@PROTEIN2$) and those in TrkC involved in binding to neurotrophin-3 have been mapped in this domain, the Trk amino acids that provide specificity remained unclear.","label":0}
{"pair_id":"AIMed.d43.s375.p5","sentence":"Although the individual amino acids in TrkA involved in binding to @PROTEIN1$ (NGF) and those in @PROTEIN2$ involved in binding to neurotrophin-3 have been mapped in this domain, the Trk amino acids that provide specificity remained unclear.","label":0}
{"pair_id":"AIMed.d43.s375.p6","sentence":"Although the individual amino acids in TrkA involved in binding to @PROTEIN1$ (NGF) and those in TrkC involved in binding to @PROTEIN2$ have been mapped in this domain, the Trk amino acids that provide specificity remained unclear.","label":0}
{"pair_id":"AIMed.d43.s375.p7","sentence":"Although the individual amino acids in TrkA involved in binding to nerve growth factor (@PROTEIN1$) and those in @PROTEIN2$ involved in binding to neurotrophin-3 have been mapped in this domain, the Trk amino acids that provide specificity remained unclear.","label":0}
{"pair_id":"AIMed.d43.s375.p8","sentence":"Although the individual amino acids in TrkA involved in binding to nerve growth factor (@PROTEIN1$) and those in TrkC involved in binding to @PROTEIN2$ have been mapped in this domain, the Trk amino acids that provide specificity remained unclear.","label":0}
{"pair_id":"AIMed.d43.s375.p9","sentence":"Although the individual amino acids in TrkA involved in binding to nerve growth factor (NGF) and those in @PROTEIN1$ involved in binding to @PROTEIN2$ have been mapped in this domain, the Trk amino acids that provide specificity remained unclear.","label":1}
{"pair_id":"BioInfer.d710.s0.p0","sentence":"These results show that @PROTEIN1$\/@PROTEIN2$ is an important regulator of actin-based cell motility during Drosophila development.","label":0}
{"pair_id":"BioInfer.d710.s0.p1","sentence":"These results show that @PROTEIN1$\/ADF is an important regulator of @PROTEIN2$-based cell motility during Drosophila development.","label":1}
{"pair_id":"BioInfer.d710.s0.p2","sentence":"These results show that cofilin\/@PROTEIN1$ is an important regulator of @PROTEIN2$-based cell motility during Drosophila development.","label":1}
{"pair_id":"AIMed.d179.s1523.p0","sentence":"The @PROTEIN1$-induced phosphorylation of @PROTEIN2$ was rapid and transient, occurring within 30 s of treatment and diminishing thereafter.","label":1}
{"pair_id":"AIMed.d169.s1432.p0","sentence":"COS-7 cells co-transfected with the cloned @PROTEIN1$ cDNA and @PROTEIN2$ cDNA resulted in the reconstitution of a small number of receptors that recognized both IL-4 and IL-13.","label":0}
{"pair_id":"AIMed.d169.s1432.p1","sentence":"COS-7 cells co-transfected with the cloned @PROTEIN1$ cDNA and IL-4R cDNA resulted in the reconstitution of a small number of receptors that recognized both @PROTEIN2$ and IL-13.","label":0}
{"pair_id":"AIMed.d169.s1432.p2","sentence":"COS-7 cells co-transfected with the cloned @PROTEIN1$ cDNA and IL-4R cDNA resulted in the reconstitution of a small number of receptors that recognized both IL-4 and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d169.s1432.p3","sentence":"COS-7 cells co-transfected with the cloned IL-13R cDNA and @PROTEIN1$ cDNA resulted in the reconstitution of a small number of receptors that recognized both @PROTEIN2$ and IL-13.","label":0}
{"pair_id":"AIMed.d169.s1432.p4","sentence":"COS-7 cells co-transfected with the cloned IL-13R cDNA and @PROTEIN1$ cDNA resulted in the reconstitution of a small number of receptors that recognized both IL-4 and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d169.s1432.p5","sentence":"COS-7 cells co-transfected with the cloned IL-13R cDNA and IL-4R cDNA resulted in the reconstitution of a small number of receptors that recognized both @PROTEIN1$ and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d25.s0.p0","sentence":"Adherens junction proteins (N-cadherin, @PROTEIN2$, alpha-catenin, beta-catenin, @PROTEIN1$, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.","label":0}
{"pair_id":"BioInfer.d25.s0.p1","sentence":"Adherens junction proteins (N-cadherin, E-cadherin, @PROTEIN2$, beta-catenin, @PROTEIN1$, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.","label":0}
{"pair_id":"BioInfer.d25.s0.p2","sentence":"Adherens junction proteins (@PROTEIN2$, E-cadherin, alpha-catenin, beta-catenin, @PROTEIN1$, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.","label":0}
{"pair_id":"BioInfer.d25.s0.p3","sentence":"Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, @PROTEIN1$, and actin) and the proliferation marker @PROTEIN2$ were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.","label":0}
{"pair_id":"BioInfer.d25.s0.p4","sentence":"Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, @PROTEIN1$, and @PROTEIN2$) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.","label":0}
{"pair_id":"BioInfer.d25.s0.p5","sentence":"Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, @PROTEIN2$, @PROTEIN1$, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.","label":0}
{"pair_id":"BioInfer.d25.s0.p6","sentence":"Adherens junction proteins (N-cadherin, @PROTEIN1$, @PROTEIN2$, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.","label":0}
{"pair_id":"BioInfer.d25.s0.p7","sentence":"Adherens junction proteins (@PROTEIN2$, @PROTEIN1$, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.","label":0}
{"pair_id":"BioInfer.d25.s0.p8","sentence":"Adherens junction proteins (N-cadherin, @PROTEIN1$, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker @PROTEIN2$ were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.","label":0}
{"pair_id":"BioInfer.d25.s0.p9","sentence":"Adherens junction proteins (N-cadherin, @PROTEIN1$, alpha-catenin, beta-catenin, plakoglobin, and @PROTEIN2$) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.","label":0}
{"pair_id":"BioInfer.d25.s0.p10","sentence":"Adherens junction proteins (N-cadherin, @PROTEIN1$, alpha-catenin, @PROTEIN2$, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.","label":0}
{"pair_id":"BioInfer.d25.s0.p11","sentence":"Adherens junction proteins (@PROTEIN2$, E-cadherin, @PROTEIN1$, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.","label":0}
{"pair_id":"BioInfer.d25.s0.p12","sentence":"Adherens junction proteins (N-cadherin, E-cadherin, @PROTEIN1$, beta-catenin, plakoglobin, and actin) and the proliferation marker @PROTEIN2$ were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.","label":0}
{"pair_id":"BioInfer.d25.s0.p13","sentence":"Adherens junction proteins (N-cadherin, E-cadherin, @PROTEIN1$, beta-catenin, plakoglobin, and @PROTEIN2$) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.","label":0}
{"pair_id":"BioInfer.d25.s0.p14","sentence":"Adherens junction proteins (N-cadherin, E-cadherin, @PROTEIN1$, @PROTEIN2$, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.","label":0}
{"pair_id":"BioInfer.d25.s0.p15","sentence":"Adherens junction proteins (@PROTEIN1$, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker @PROTEIN2$ were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.","label":0}
{"pair_id":"BioInfer.d25.s0.p16","sentence":"Adherens junction proteins (@PROTEIN1$, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and @PROTEIN2$) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.","label":0}
{"pair_id":"BioInfer.d25.s0.p17","sentence":"Adherens junction proteins (@PROTEIN1$, E-cadherin, alpha-catenin, @PROTEIN2$, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.","label":0}
{"pair_id":"BioInfer.d25.s0.p18","sentence":"Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and @PROTEIN2$) and the proliferation marker @PROTEIN1$ were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.","label":0}
{"pair_id":"BioInfer.d25.s0.p19","sentence":"Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, @PROTEIN2$, plakoglobin, and actin) and the proliferation marker @PROTEIN1$ were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.","label":0}
{"pair_id":"BioInfer.d25.s0.p20","sentence":"Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, @PROTEIN2$, plakoglobin, and @PROTEIN1$) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.","label":0}
{"pair_id":"AIMed.d152.s1295.p0","sentence":"A @PROTEIN1$ mutant lacking its N-terminal RING finger domain is a dominant-negative inhibitor of TNF-mediated @PROTEIN2$ activation, but does not affect TNF-induced apoptosis.","label":0}
{"pair_id":"BioInfer.d149.s0.p0","sentence":"Complete gene sequences for the nucleocapsid protein (@PROTEIN1$) and phosphoprotein (P\/@PROTEIN2$) have been determined and recombinant N and V proteins produced in baculovirus.","label":0}
{"pair_id":"BioInfer.d149.s0.p1","sentence":"Complete gene sequences for the nucleocapsid protein (@PROTEIN1$) and phosphoprotein (P\/V) have been determined and recombinant N and @PROTEIN2$ proteins produced in baculovirus.","label":0}
{"pair_id":"BioInfer.d149.s0.p2","sentence":"Complete gene sequences for the nucleocapsid protein (@PROTEIN1$) and phosphoprotein (@PROTEIN2$\/V) have been determined and recombinant N and V proteins produced in baculovirus.","label":0}
{"pair_id":"BioInfer.d149.s0.p3","sentence":"Complete gene sequences for the nucleocapsid protein (@PROTEIN1$) and phosphoprotein (P\/V) have been determined and recombinant @PROTEIN2$ and V proteins produced in baculovirus.","label":0}
{"pair_id":"BioInfer.d149.s0.p4","sentence":"Complete gene sequences for the nucleocapsid protein (@PROTEIN1$) and @PROTEIN2$ (P\/V) have been determined and recombinant N and V proteins produced in baculovirus.","label":0}
{"pair_id":"BioInfer.d149.s0.p5","sentence":"Complete gene sequences for the @PROTEIN2$ (@PROTEIN1$) and phosphoprotein (P\/V) have been determined and recombinant N and V proteins produced in baculovirus.","label":0}
{"pair_id":"BioInfer.d149.s0.p6","sentence":"Complete gene sequences for the nucleocapsid protein (N) and phosphoprotein (P\/@PROTEIN1$) have been determined and recombinant N and @PROTEIN2$ proteins produced in baculovirus.","label":0}
{"pair_id":"BioInfer.d149.s0.p7","sentence":"Complete gene sequences for the nucleocapsid protein (N) and phosphoprotein (@PROTEIN2$\/@PROTEIN1$) have been determined and recombinant N and V proteins produced in baculovirus.","label":0}
{"pair_id":"BioInfer.d149.s0.p8","sentence":"Complete gene sequences for the nucleocapsid protein (N) and phosphoprotein (P\/@PROTEIN1$) have been determined and recombinant @PROTEIN2$ and V proteins produced in baculovirus.","label":0}
{"pair_id":"BioInfer.d149.s0.p9","sentence":"Complete gene sequences for the nucleocapsid protein (N) and @PROTEIN2$ (P\/@PROTEIN1$) have been determined and recombinant N and V proteins produced in baculovirus.","label":1}
{"pair_id":"BioInfer.d149.s0.p10","sentence":"Complete gene sequences for the @PROTEIN2$ (N) and phosphoprotein (P\/@PROTEIN1$) have been determined and recombinant N and V proteins produced in baculovirus.","label":0}
{"pair_id":"BioInfer.d149.s0.p11","sentence":"Complete gene sequences for the nucleocapsid protein (N) and phosphoprotein (@PROTEIN2$\/V) have been determined and recombinant N and @PROTEIN1$ proteins produced in baculovirus.","label":0}
{"pair_id":"BioInfer.d149.s0.p12","sentence":"Complete gene sequences for the nucleocapsid protein (N) and phosphoprotein (P\/V) have been determined and recombinant @PROTEIN2$ and @PROTEIN1$ proteins produced in baculovirus.","label":0}
{"pair_id":"BioInfer.d149.s0.p13","sentence":"Complete gene sequences for the nucleocapsid protein (N) and @PROTEIN2$ (P\/V) have been determined and recombinant N and @PROTEIN1$ proteins produced in baculovirus.","label":0}
{"pair_id":"BioInfer.d149.s0.p14","sentence":"Complete gene sequences for the @PROTEIN2$ (N) and phosphoprotein (P\/V) have been determined and recombinant N and @PROTEIN1$ proteins produced in baculovirus.","label":0}
{"pair_id":"BioInfer.d149.s0.p15","sentence":"Complete gene sequences for the nucleocapsid protein (N) and phosphoprotein (@PROTEIN1$\/V) have been determined and recombinant @PROTEIN2$ and V proteins produced in baculovirus.","label":0}
{"pair_id":"BioInfer.d149.s0.p16","sentence":"Complete gene sequences for the nucleocapsid protein (N) and @PROTEIN2$ (@PROTEIN1$\/V) have been determined and recombinant N and V proteins produced in baculovirus.","label":1}
{"pair_id":"BioInfer.d149.s0.p17","sentence":"Complete gene sequences for the @PROTEIN2$ (N) and phosphoprotein (@PROTEIN1$\/V) have been determined and recombinant N and V proteins produced in baculovirus.","label":0}
{"pair_id":"BioInfer.d149.s0.p18","sentence":"Complete gene sequences for the nucleocapsid protein (N) and @PROTEIN2$ (P\/V) have been determined and recombinant @PROTEIN1$ and V proteins produced in baculovirus.","label":0}
{"pair_id":"BioInfer.d149.s0.p19","sentence":"Complete gene sequences for the @PROTEIN2$ (N) and phosphoprotein (P\/V) have been determined and recombinant @PROTEIN1$ and V proteins produced in baculovirus.","label":0}
{"pair_id":"BioInfer.d149.s0.p20","sentence":"Complete gene sequences for the @PROTEIN2$ (N) and @PROTEIN1$ (P\/V) have been determined and recombinant N and V proteins produced in baculovirus.","label":0}
{"pair_id":"BioInfer.d429.s0.p0","sentence":"Molecular analysis of the @PROTEIN2$-catenin complex elucidated the central role of @PROTEIN1$ in this adhesion complex, as it binds to the cytoplasmic domain of E-cadherin and to alpha-catenin.","label":1}
{"pair_id":"BioInfer.d429.s0.p1","sentence":"Molecular analysis of the cadherin-@PROTEIN2$ complex elucidated the central role of @PROTEIN1$ in this adhesion complex, as it binds to the cytoplasmic domain of E-cadherin and to alpha-catenin.","label":1}
{"pair_id":"BioInfer.d429.s0.p2","sentence":"Molecular analysis of the cadherin-catenin complex elucidated the central role of @PROTEIN1$ in this adhesion complex, as it binds to the cytoplasmic domain of E-cadherin and to @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d429.s0.p3","sentence":"Molecular analysis of the cadherin-catenin complex elucidated the central role of @PROTEIN1$ in this adhesion complex, as it binds to the cytoplasmic domain of @PROTEIN2$ and to alpha-catenin.","label":1}
{"pair_id":"BioInfer.d429.s0.p4","sentence":"Molecular analysis of the @PROTEIN1$-@PROTEIN2$ complex elucidated the central role of beta-catenin in this adhesion complex, as it binds to the cytoplasmic domain of E-cadherin and to alpha-catenin.","label":1}
{"pair_id":"BioInfer.d429.s0.p5","sentence":"Molecular analysis of the @PROTEIN1$-catenin complex elucidated the central role of beta-catenin in this adhesion complex, as it binds to the cytoplasmic domain of E-cadherin and to @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d429.s0.p6","sentence":"Molecular analysis of the @PROTEIN1$-catenin complex elucidated the central role of beta-catenin in this adhesion complex, as it binds to the cytoplasmic domain of @PROTEIN2$ and to alpha-catenin.","label":0}
{"pair_id":"BioInfer.d429.s0.p7","sentence":"Molecular analysis of the cadherin-@PROTEIN1$ complex elucidated the central role of beta-catenin in this adhesion complex, as it binds to the cytoplasmic domain of E-cadherin and to @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d429.s0.p8","sentence":"Molecular analysis of the cadherin-@PROTEIN1$ complex elucidated the central role of beta-catenin in this adhesion complex, as it binds to the cytoplasmic domain of @PROTEIN2$ and to alpha-catenin.","label":0}
{"pair_id":"BioInfer.d429.s0.p9","sentence":"Molecular analysis of the cadherin-catenin complex elucidated the central role of beta-catenin in this adhesion complex, as it binds to the cytoplasmic domain of @PROTEIN2$ and to @PROTEIN1$.","label":0}
{"pair_id":"AIMed.d147.s1244.p0","sentence":"Characterization of the @PROTEIN1$ binding proteins @PROTEIN2$ and RBP2.","label":1}
{"pair_id":"AIMed.d147.s1244.p1","sentence":"Characterization of the @PROTEIN1$ binding proteins RBP1 and @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d147.s1244.p2","sentence":"Characterization of the retinoblastoma binding proteins @PROTEIN1$ and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d118.s1003.p0","sentence":"This regulation results from a direct interaction between @PROTEIN1$ and @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d97.s820.p0","sentence":"Here we report the cDNA cloning and characterization of a human type II receptor for BMPs (@PROTEIN1$), which is distantly related to @PROTEIN2$, a BMP type II receptor from Caenorhabditis elegans.","label":0}
{"pair_id":"AIMed.d97.s820.p1","sentence":"Here we report the cDNA cloning and characterization of a human type II receptor for BMPs (@PROTEIN1$), which is distantly related to DAF-4, a @PROTEIN2$ from Caenorhabditis elegans.","label":0}
{"pair_id":"AIMed.d97.s820.p2","sentence":"Here we report the cDNA cloning and characterization of a human type II receptor for BMPs (BMPR-II), which is distantly related to @PROTEIN1$, a @PROTEIN2$ from Caenorhabditis elegans.","label":0}
{"pair_id":"BioInfer.d442.s0.p0","sentence":"Mutants of @PROTEIN2$ and cdc8, which encode profilin and @PROTEIN1$ respectively, display disorganized actin patches in all cells.","label":0}
{"pair_id":"BioInfer.d442.s0.p1","sentence":"Mutants of cdc3 and cdc8, which encode @PROTEIN2$ and @PROTEIN1$ respectively, display disorganized actin patches in all cells.","label":0}
{"pair_id":"BioInfer.d442.s0.p2","sentence":"Mutants of cdc3 and @PROTEIN2$, which encode profilin and @PROTEIN1$ respectively, display disorganized actin patches in all cells.","label":1}
{"pair_id":"BioInfer.d442.s0.p3","sentence":"Mutants of cdc3 and cdc8, which encode profilin and @PROTEIN1$ respectively, display disorganized @PROTEIN2$ patches in all cells.","label":0}
{"pair_id":"BioInfer.d442.s0.p4","sentence":"Mutants of @PROTEIN1$ and cdc8, which encode @PROTEIN2$ and tropomyosin respectively, display disorganized actin patches in all cells.","label":1}
{"pair_id":"BioInfer.d442.s0.p5","sentence":"Mutants of @PROTEIN1$ and @PROTEIN2$, which encode profilin and tropomyosin respectively, display disorganized actin patches in all cells.","label":0}
{"pair_id":"BioInfer.d442.s0.p6","sentence":"Mutants of @PROTEIN1$ and cdc8, which encode profilin and tropomyosin respectively, display disorganized @PROTEIN2$ patches in all cells.","label":0}
{"pair_id":"BioInfer.d442.s0.p7","sentence":"Mutants of cdc3 and @PROTEIN2$, which encode @PROTEIN1$ and tropomyosin respectively, display disorganized actin patches in all cells.","label":0}
{"pair_id":"BioInfer.d442.s0.p8","sentence":"Mutants of cdc3 and cdc8, which encode @PROTEIN1$ and tropomyosin respectively, display disorganized @PROTEIN2$ patches in all cells.","label":0}
{"pair_id":"BioInfer.d442.s0.p9","sentence":"Mutants of cdc3 and @PROTEIN1$, which encode profilin and tropomyosin respectively, display disorganized @PROTEIN2$ patches in all cells.","label":0}
{"pair_id":"AIMed.d42.s368.p0","sentence":"@PROTEIN1$ binding significantly increased hetero- and homo-oligomerization (except for the @PROTEIN2$ homo-oligomer, which binds ligand poorly in the absence of BR-I).","label":1}
{"pair_id":"AIMed.d42.s368.p1","sentence":"@PROTEIN1$ binding significantly increased hetero- and homo-oligomerization (except for the BR-II homo-oligomer, which binds ligand poorly in the absence of @PROTEIN2$).","label":0}
{"pair_id":"AIMed.d42.s368.p2","sentence":"BMP-2 binding significantly increased hetero- and homo-oligomerization (except for the @PROTEIN1$ homo-oligomer, which binds ligand poorly in the absence of @PROTEIN2$).","label":1}
{"pair_id":"BioInfer.d374.s0.p0","sentence":"In this case, efficient repair does not require @PROTEIN2$ and @PROTEIN1$, consistent with our previous observations.","label":0}
{"pair_id":"BioInfer.d1.s1.p0","sentence":"Birch @PROTEIN2$ increased the critical concentration required for muscle and @PROTEIN1$ polymerization in a concentration-dependent manner, supporting the notion of the formation of a heterologous complex between the plant protein and animal actin.","label":1}
{"pair_id":"BioInfer.d1.s1.p1","sentence":"Birch profilin increased the critical concentration required for @PROTEIN2$ and @PROTEIN1$@PROTEIN2$ polymerization in a concentration-dependent manner, supporting the notion of the formation of a heterologous complex between the plant protein and animal actin.","label":0}
{"pair_id":"BioInfer.d1.s1.p2","sentence":"Birch profilin increased the critical concentration required for muscle and @PROTEIN1$ polymerization in a concentration-dependent manner, supporting the notion of the formation of a heterologous complex between the plant protein and animal @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d1.s1.p3","sentence":"Birch @PROTEIN1$ increased the critical concentration required for @PROTEIN2$ and brain @PROTEIN2$ polymerization in a concentration-dependent manner, supporting the notion of the formation of a heterologous complex between the plant protein and animal actin.","label":1}
{"pair_id":"BioInfer.d1.s1.p4","sentence":"Birch @PROTEIN1$ increased the critical concentration required for muscle and brain actin polymerization in a concentration-dependent manner, supporting the notion of the formation of a heterologous complex between the plant protein and animal @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d1.s1.p5","sentence":"Birch profilin increased the critical concentration required for @PROTEIN1$ and brain @PROTEIN1$ polymerization in a concentration-dependent manner, supporting the notion of the formation of a heterologous complex between the plant protein and animal @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d502.s0.p0","sentence":"PtK2 cells of exceptionally large size were microinjected with fluorescently labeled probes for @PROTEIN2$, myosin, @PROTEIN1$, and talin in order to follow the assembly of the contractile proteins into the cleavage furrows.","label":0}
{"pair_id":"BioInfer.d502.s0.p1","sentence":"PtK2 cells of exceptionally large size were microinjected with fluorescently labeled probes for actin, myosin, @PROTEIN1$, and @PROTEIN2$ in order to follow the assembly of the contractile proteins into the cleavage furrows.","label":0}
{"pair_id":"BioInfer.d502.s0.p2","sentence":"PtK2 cells of exceptionally large size were microinjected with fluorescently labeled probes for actin, @PROTEIN2$, @PROTEIN1$, and talin in order to follow the assembly of the contractile proteins into the cleavage furrows.","label":0}
{"pair_id":"BioInfer.d502.s0.p3","sentence":"PtK2 cells of exceptionally large size were microinjected with fluorescently labeled probes for @PROTEIN1$, myosin, filamin, and @PROTEIN2$ in order to follow the assembly of the contractile proteins into the cleavage furrows.","label":0}
{"pair_id":"BioInfer.d502.s0.p4","sentence":"PtK2 cells of exceptionally large size were microinjected with fluorescently labeled probes for @PROTEIN1$, @PROTEIN2$, filamin, and talin in order to follow the assembly of the contractile proteins into the cleavage furrows.","label":0}
{"pair_id":"BioInfer.d502.s0.p5","sentence":"PtK2 cells of exceptionally large size were microinjected with fluorescently labeled probes for actin, @PROTEIN2$, filamin, and @PROTEIN1$ in order to follow the assembly of the contractile proteins into the cleavage furrows.","label":0}
{"pair_id":"AIMed.d148.s1259.p0","sentence":"Immunoprecipitation experiments with human osteosarcoma cells and Ewing's sarcoma cells demonstrated that @PROTEIN1$ is associated with both @PROTEIN2$ and p33cdk2, and that cyclin D1 immune complexes exhibit appreciable histone H1 kinase activity.","label":1}
{"pair_id":"AIMed.d148.s1259.p1","sentence":"Immunoprecipitation experiments with human osteosarcoma cells and Ewing's sarcoma cells demonstrated that @PROTEIN1$ is associated with both p34cdc2 and @PROTEIN2$, and that cyclin D1 immune complexes exhibit appreciable histone H1 kinase activity.","label":1}
{"pair_id":"AIMed.d148.s1259.p2","sentence":"Immunoprecipitation experiments with human osteosarcoma cells and Ewing's sarcoma cells demonstrated that @PROTEIN1$ is associated with both p34cdc2 and p33cdk2, and that @PROTEIN2$ immune complexes exhibit appreciable histone H1 kinase activity.","label":0}
{"pair_id":"AIMed.d148.s1259.p3","sentence":"Immunoprecipitation experiments with human osteosarcoma cells and Ewing's sarcoma cells demonstrated that cyclin D1 is associated with both @PROTEIN1$ and @PROTEIN2$, and that cyclin D1 immune complexes exhibit appreciable histone H1 kinase activity.","label":0}
{"pair_id":"AIMed.d148.s1259.p4","sentence":"Immunoprecipitation experiments with human osteosarcoma cells and Ewing's sarcoma cells demonstrated that cyclin D1 is associated with both @PROTEIN1$ and p33cdk2, and that @PROTEIN2$ immune complexes exhibit appreciable histone H1 kinase activity.","label":0}
{"pair_id":"AIMed.d148.s1259.p5","sentence":"Immunoprecipitation experiments with human osteosarcoma cells and Ewing's sarcoma cells demonstrated that cyclin D1 is associated with both p34cdc2 and @PROTEIN1$, and that @PROTEIN2$ immune complexes exhibit appreciable histone H1 kinase activity.","label":0}
{"pair_id":"AIMed.d196.s1665.p0","sentence":"@PROTEIN1$ interacts with protein phosphatases @PROTEIN2$ and PP1 and disrupts a G2\/M cell-cycle checkpoint.","label":1}
{"pair_id":"AIMed.d196.s1665.p1","sentence":"@PROTEIN1$ interacts with protein phosphatases PP2A and @PROTEIN2$ and disrupts a G2\/M cell-cycle checkpoint.","label":1}
{"pair_id":"AIMed.d196.s1665.p2","sentence":"HOX11 interacts with protein phosphatases @PROTEIN1$ and @PROTEIN2$ and disrupts a G2\/M cell-cycle checkpoint.","label":0}
{"pair_id":"AIMed.d71.s606.p0","sentence":"We present evidence that @PROTEIN1$ (@PROTEIN2$ and pp42\/44) specifically phosphorylate these sites and that their phosphorylation positively regulates the transacting activity of c-jun.","label":0}
{"pair_id":"AIMed.d71.s606.p1","sentence":"We present evidence that @PROTEIN1$ (pp54 and @PROTEIN2$\/44) specifically phosphorylate these sites and that their phosphorylation positively regulates the transacting activity of c-jun.","label":0}
{"pair_id":"AIMed.d71.s606.p2","sentence":"We present evidence that @PROTEIN1$ (pp54 and pp42\/44) specifically phosphorylate these sites and that their phosphorylation positively regulates the transacting activity of @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d71.s606.p3","sentence":"We present evidence that mitogen-activated protein-serine (MAP) kinases (@PROTEIN1$ and @PROTEIN2$\/44) specifically phosphorylate these sites and that their phosphorylation positively regulates the transacting activity of c-jun.","label":0}
{"pair_id":"AIMed.d71.s606.p4","sentence":"We present evidence that mitogen-activated protein-serine (MAP) kinases (@PROTEIN1$ and pp42\/44) specifically phosphorylate these sites and that their phosphorylation positively regulates the transacting activity of @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d71.s606.p5","sentence":"We present evidence that mitogen-activated protein-serine (MAP) kinases (pp54 and @PROTEIN1$\/44) specifically phosphorylate these sites and that their phosphorylation positively regulates the transacting activity of @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d52.s1.p0","sentence":"Even the Munc18-2 mutants that do not detectably bind syntaxin 3 were membrane associated in Caco-2 cells, suggesting that the @PROTEIN1$ interaction is not the sole determinant of @PROTEIN2$ protein membrane attachment.","label":1}
{"pair_id":"BioInfer.d52.s1.p1","sentence":"Even the Munc18-2 mutants that do not detectably bind @PROTEIN2$ were membrane associated in Caco-2 cells, suggesting that the @PROTEIN1$ interaction is not the sole determinant of Sec1 protein membrane attachment.","label":0}
{"pair_id":"BioInfer.d52.s1.p2","sentence":"Even the @PROTEIN2$ mutants that do not detectably bind syntaxin 3 were membrane associated in Caco-2 cells, suggesting that the @PROTEIN1$ interaction is not the sole determinant of Sec1 protein membrane attachment.","label":0}
{"pair_id":"BioInfer.d52.s1.p3","sentence":"Even the Munc18-2 mutants that do not detectably bind @PROTEIN2$ were membrane associated in Caco-2 cells, suggesting that the syntaxin interaction is not the sole determinant of @PROTEIN1$ protein membrane attachment.","label":0}
{"pair_id":"BioInfer.d52.s1.p4","sentence":"Even the @PROTEIN2$ mutants that do not detectably bind syntaxin 3 were membrane associated in Caco-2 cells, suggesting that the syntaxin interaction is not the sole determinant of @PROTEIN1$ protein membrane attachment.","label":0}
{"pair_id":"BioInfer.d52.s1.p5","sentence":"Even the @PROTEIN2$ mutants that do not detectably bind @PROTEIN1$ were membrane associated in Caco-2 cells, suggesting that the syntaxin interaction is not the sole determinant of Sec1 protein membrane attachment.","label":1}
{"pair_id":"AIMed.d176.s1485.p0","sentence":"One of these proteins, @PROTEIN1$, appears transiently during assembly and is not a component of functionally mature @PROTEIN2$ complexes.","label":0}
{"pair_id":"AIMed.d192.s1637.p0","sentence":"@PROTEIN1$ was also shown to cleave the precursor of @PROTEIN2$ inducing factor (IGIF) at the authentic processing site with high efficiency, thereby activating IGIF and facilitating its export.","label":0}
{"pair_id":"AIMed.d192.s1637.p1","sentence":"@PROTEIN1$ was also shown to cleave the precursor of @PROTEIN2$ (IGIF) at the authentic processing site with high efficiency, thereby activating IGIF and facilitating its export.","label":1}
{"pair_id":"AIMed.d192.s1637.p2","sentence":"@PROTEIN1$ was also shown to cleave the precursor of interferon-gamma inducing factor (@PROTEIN2$) at the authentic processing site with high efficiency, thereby activating IGIF and facilitating its export.","label":1}
{"pair_id":"AIMed.d192.s1637.p3","sentence":"@PROTEIN1$ was also shown to cleave the precursor of interferon-gamma inducing factor (IGIF) at the authentic processing site with high efficiency, thereby activating @PROTEIN2$ and facilitating its export.","label":1}
{"pair_id":"AIMed.d192.s1637.p4","sentence":"ICE was also shown to cleave the precursor of @PROTEIN1$@PROTEIN2$ (IGIF) at the authentic processing site with high efficiency, thereby activating IGIF and facilitating its export.","label":0}
{"pair_id":"AIMed.d192.s1637.p5","sentence":"ICE was also shown to cleave the precursor of @PROTEIN1$ inducing factor (@PROTEIN2$) at the authentic processing site with high efficiency, thereby activating IGIF and facilitating its export.","label":0}
{"pair_id":"AIMed.d192.s1637.p6","sentence":"ICE was also shown to cleave the precursor of @PROTEIN1$ inducing factor (IGIF) at the authentic processing site with high efficiency, thereby activating @PROTEIN2$ and facilitating its export.","label":0}
{"pair_id":"AIMed.d192.s1637.p7","sentence":"ICE was also shown to cleave the precursor of @PROTEIN1$ (@PROTEIN2$) at the authentic processing site with high efficiency, thereby activating IGIF and facilitating its export.","label":0}
{"pair_id":"AIMed.d192.s1637.p8","sentence":"ICE was also shown to cleave the precursor of @PROTEIN1$ (IGIF) at the authentic processing site with high efficiency, thereby activating @PROTEIN2$ and facilitating its export.","label":0}
{"pair_id":"AIMed.d192.s1637.p9","sentence":"ICE was also shown to cleave the precursor of interferon-gamma inducing factor (@PROTEIN1$) at the authentic processing site with high efficiency, thereby activating @PROTEIN2$ and facilitating its export.","label":0}
{"pair_id":"AIMed.d167.s1407.p0","sentence":"In addition, the anti-calnexin antiserum immunoprecipitated a UV-dependent cross-linking product consisting of @PROTEIN1$ and a protein of approximately 60 kDa designated @PROTEIN2$ (calnexin-associated protein of 60 kDa).","label":1}
{"pair_id":"AIMed.d167.s1407.p1","sentence":"In addition, the anti-calnexin antiserum immunoprecipitated a UV-dependent cross-linking product consisting of @PROTEIN1$ and a protein of approximately 60 kDa designated CAP-60 (@PROTEIN2$ of 60 kDa).","label":1}
{"pair_id":"AIMed.d167.s1407.p2","sentence":"In addition, the anti-calnexin antiserum immunoprecipitated a UV-dependent cross-linking product consisting of GT155 and a protein of approximately 60 kDa designated @PROTEIN1$ (@PROTEIN2$ of 60 kDa).","label":0}
{"pair_id":"AIMed.d79.s676.p0","sentence":"It contains an @PROTEIN1$-binding motif that shares an antigenic epitope with the C terminus of @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d152.s1297.p0","sentence":"Thus, these two @PROTEIN1$-@PROTEIN2$ signaling cascades appear to bifurcate at TRADD.","label":0}
{"pair_id":"AIMed.d152.s1297.p1","sentence":"Thus, these two @PROTEIN1$-TRADD signaling cascades appear to bifurcate at @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d152.s1297.p2","sentence":"Thus, these two TNFR1-@PROTEIN1$ signaling cascades appear to bifurcate at @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d289.s0.p0","sentence":"Immunofluorescence microscopy of monolayers between 2 and 3 h post-@PROTEIN1$ showed that beta-catenin, @PROTEIN2$, alpha-catenin, and cadherin-5 were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.","label":0}
{"pair_id":"BioInfer.d289.s0.p1","sentence":"Immunofluorescence microscopy of monolayers between 2 and 3 h post-@PROTEIN1$ showed that @PROTEIN2$, plakoglobin, alpha-catenin, and cadherin-5 were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.","label":0}
{"pair_id":"BioInfer.d289.s0.p2","sentence":"Immunofluorescence microscopy of monolayers between 2 and 3 h post-@PROTEIN1$ showed that beta-catenin, plakoglobin, alpha-catenin, and @PROTEIN2$ were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.","label":0}
{"pair_id":"BioInfer.d289.s0.p3","sentence":"Immunofluorescence microscopy of monolayers between 2 and 3 h post-@PROTEIN1$ showed that beta-catenin, plakoglobin, @PROTEIN2$, and cadherin-5 were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.","label":0}
{"pair_id":"BioInfer.d289.s0.p4","sentence":"Immunofluorescence microscopy of monolayers between 2 and 3 h post-TGF-beta1 showed that @PROTEIN2$, @PROTEIN1$, alpha-catenin, and cadherin-5 were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.","label":1}
{"pair_id":"BioInfer.d289.s0.p5","sentence":"Immunofluorescence microscopy of monolayers between 2 and 3 h post-TGF-beta1 showed that beta-catenin, @PROTEIN1$, alpha-catenin, and @PROTEIN2$ were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.","label":1}
{"pair_id":"BioInfer.d289.s0.p6","sentence":"Immunofluorescence microscopy of monolayers between 2 and 3 h post-TGF-beta1 showed that beta-catenin, @PROTEIN1$, @PROTEIN2$, and cadherin-5 were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.","label":1}
{"pair_id":"BioInfer.d289.s0.p7","sentence":"Immunofluorescence microscopy of monolayers between 2 and 3 h post-TGF-beta1 showed that @PROTEIN1$, plakoglobin, alpha-catenin, and @PROTEIN2$ were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.","label":1}
{"pair_id":"BioInfer.d289.s0.p8","sentence":"Immunofluorescence microscopy of monolayers between 2 and 3 h post-TGF-beta1 showed that @PROTEIN1$, plakoglobin, @PROTEIN2$, and cadherin-5 were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.","label":1}
{"pair_id":"BioInfer.d289.s0.p9","sentence":"Immunofluorescence microscopy of monolayers between 2 and 3 h post-TGF-beta1 showed that beta-catenin, plakoglobin, @PROTEIN2$, and @PROTEIN1$ were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.","label":1}
{"pair_id":"AIMed.d190.s1616.p0","sentence":"By contrast stimulation with @PROTEIN1$ leads to the formation of a @PROTEIN2$ complex containing JAK2.","label":0}
{"pair_id":"AIMed.d190.s1616.p1","sentence":"By contrast stimulation with @PROTEIN1$ leads to the formation of a Grb2 complex containing @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d190.s1616.p2","sentence":"By contrast stimulation with TPO leads to the formation of a @PROTEIN1$ complex containing @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d202.s1738.p0","sentence":"@PROTEIN1$ (@PROTEIN2$) is an important mediator of inflammatory disease.","label":0}
{"pair_id":"BioInfer.d34.s0.p0","sentence":"AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of @PROTEIN1$ (E-cad), alpha-catenin (alpha-cat) and @PROTEIN2$ (beta-cat) in ACC, and compared it with that in the normal labial gland.","label":0}
{"pair_id":"BioInfer.d34.s0.p1","sentence":"AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of @PROTEIN1$ (E-cad), @PROTEIN2$ (alpha-cat) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.","label":0}
{"pair_id":"BioInfer.d34.s0.p2","sentence":"AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of @PROTEIN1$ (E-cad), alpha-catenin (alpha-cat) and beta-catenin (@PROTEIN2$) in ACC, and compared it with that in the normal labial gland.","label":0}
{"pair_id":"BioInfer.d34.s0.p3","sentence":"AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of @PROTEIN1$ (E-cad), alpha-catenin (@PROTEIN2$) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.","label":0}
{"pair_id":"BioInfer.d34.s0.p4","sentence":"AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of @PROTEIN1$ (@PROTEIN2$), alpha-catenin (alpha-cat) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.","label":0}
{"pair_id":"BioInfer.d34.s0.p5","sentence":"AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), @PROTEIN2$ (alpha-cat) and @PROTEIN1$ (beta-cat) in ACC, and compared it with that in the normal labial gland.","label":0}
{"pair_id":"BioInfer.d34.s0.p6","sentence":"AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), alpha-catenin (alpha-cat) and @PROTEIN1$ (@PROTEIN2$) in ACC, and compared it with that in the normal labial gland.","label":0}
{"pair_id":"BioInfer.d34.s0.p7","sentence":"AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), alpha-catenin (@PROTEIN2$) and @PROTEIN1$ (beta-cat) in ACC, and compared it with that in the normal labial gland.","label":0}
{"pair_id":"BioInfer.d34.s0.p8","sentence":"AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (@PROTEIN2$), alpha-catenin (alpha-cat) and @PROTEIN1$ (beta-cat) in ACC, and compared it with that in the normal labial gland.","label":0}
{"pair_id":"BioInfer.d34.s0.p9","sentence":"AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), @PROTEIN1$ (alpha-cat) and beta-catenin (@PROTEIN2$) in ACC, and compared it with that in the normal labial gland.","label":0}
{"pair_id":"BioInfer.d34.s0.p10","sentence":"AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), @PROTEIN1$ (@PROTEIN2$) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.","label":0}
{"pair_id":"BioInfer.d34.s0.p11","sentence":"AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (@PROTEIN2$), @PROTEIN1$ (alpha-cat) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.","label":0}
{"pair_id":"BioInfer.d34.s0.p12","sentence":"AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), alpha-catenin (@PROTEIN2$) and beta-catenin (@PROTEIN1$) in ACC, and compared it with that in the normal labial gland.","label":0}
{"pair_id":"BioInfer.d34.s0.p13","sentence":"AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (@PROTEIN2$), alpha-catenin (alpha-cat) and beta-catenin (@PROTEIN1$) in ACC, and compared it with that in the normal labial gland.","label":0}
{"pair_id":"BioInfer.d34.s0.p14","sentence":"AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (@PROTEIN2$), alpha-catenin (@PROTEIN1$) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.","label":0}
{"pair_id":"BioInfer.d284.s0.p0","sentence":"Hypertonicity provoked Fyn-dependent tyrosine phosphorylation in @PROTEIN2$, alpha-catenin, and p120(@PROTEIN1$) and caused the dissociation of beta-catenin from the contacts.","label":0}
{"pair_id":"BioInfer.d284.s0.p1","sentence":"Hypertonicity provoked Fyn-dependent tyrosine phosphorylation in beta-catenin, alpha-catenin, and @PROTEIN2$(@PROTEIN1$) and caused the dissociation of beta-catenin from the contacts.","label":0}
{"pair_id":"BioInfer.d284.s0.p2","sentence":"Hypertonicity provoked @PROTEIN2$-dependent tyrosine phosphorylation in beta-catenin, alpha-catenin, and p120(@PROTEIN1$) and caused the dissociation of beta-catenin from the contacts.","label":1}
{"pair_id":"BioInfer.d284.s0.p3","sentence":"Hypertonicity provoked Fyn-dependent tyrosine phosphorylation in beta-catenin, @PROTEIN2$, and p120(@PROTEIN1$) and caused the dissociation of beta-catenin from the contacts.","label":0}
{"pair_id":"BioInfer.d284.s0.p4","sentence":"Hypertonicity provoked Fyn-dependent tyrosine phosphorylation in beta-catenin, alpha-catenin, and p120(@PROTEIN1$) and caused the dissociation of @PROTEIN2$ from the contacts.","label":0}
{"pair_id":"BioInfer.d284.s0.p5","sentence":"Hypertonicity provoked Fyn-dependent tyrosine phosphorylation in @PROTEIN1$, alpha-catenin, and @PROTEIN2$(Cas) and caused the dissociation of beta-catenin from the contacts.","label":0}
{"pair_id":"BioInfer.d284.s0.p6","sentence":"Hypertonicity provoked @PROTEIN2$-dependent tyrosine phosphorylation in @PROTEIN1$, alpha-catenin, and p120(Cas) and caused the dissociation of beta-catenin from the contacts.","label":1}
{"pair_id":"BioInfer.d284.s0.p7","sentence":"Hypertonicity provoked Fyn-dependent tyrosine phosphorylation in @PROTEIN1$, @PROTEIN2$, and p120(Cas) and caused the dissociation of beta-catenin from the contacts.","label":0}
{"pair_id":"BioInfer.d284.s0.p8","sentence":"Hypertonicity provoked Fyn-dependent tyrosine phosphorylation in @PROTEIN1$, alpha-catenin, and p120(Cas) and caused the dissociation of @PROTEIN2$ from the contacts.","label":0}
{"pair_id":"BioInfer.d284.s0.p9","sentence":"Hypertonicity provoked @PROTEIN2$-dependent tyrosine phosphorylation in beta-catenin, alpha-catenin, and @PROTEIN1$(Cas) and caused the dissociation of beta-catenin from the contacts.","label":1}
{"pair_id":"BioInfer.d284.s0.p10","sentence":"Hypertonicity provoked Fyn-dependent tyrosine phosphorylation in beta-catenin, @PROTEIN2$, and @PROTEIN1$(Cas) and caused the dissociation of beta-catenin from the contacts.","label":0}
{"pair_id":"BioInfer.d284.s0.p11","sentence":"Hypertonicity provoked Fyn-dependent tyrosine phosphorylation in beta-catenin, alpha-catenin, and @PROTEIN1$(Cas) and caused the dissociation of @PROTEIN2$ from the contacts.","label":0}
{"pair_id":"BioInfer.d284.s0.p12","sentence":"Hypertonicity provoked @PROTEIN1$-dependent tyrosine phosphorylation in beta-catenin, @PROTEIN2$, and p120(Cas) and caused the dissociation of beta-catenin from the contacts.","label":1}
{"pair_id":"BioInfer.d284.s0.p13","sentence":"Hypertonicity provoked @PROTEIN1$-dependent tyrosine phosphorylation in beta-catenin, alpha-catenin, and p120(Cas) and caused the dissociation of @PROTEIN2$ from the contacts.","label":0}
{"pair_id":"BioInfer.d284.s0.p14","sentence":"Hypertonicity provoked Fyn-dependent tyrosine phosphorylation in beta-catenin, @PROTEIN1$, and p120(Cas) and caused the dissociation of @PROTEIN2$ from the contacts.","label":0}
{"pair_id":"AIMed.d37.s315.p0","sentence":"We found that in addition to @PROTEIN1$, @PROTEIN2$, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, MCP-3, MCP-4, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":0}
{"pair_id":"AIMed.d37.s315.p1","sentence":"We found that in addition to @PROTEIN1$, MIP-1alpha, and @PROTEIN2$, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, MCP-3, MCP-4, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":0}
{"pair_id":"AIMed.d37.s315.p2","sentence":"We found that in addition to @PROTEIN1$, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-@PROTEIN2$ binding: MCP-2, MCP-3, MCP-4, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":1}
{"pair_id":"AIMed.d37.s315.p3","sentence":"We found that in addition to @PROTEIN1$, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: @PROTEIN2$, MCP-3, MCP-4, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":0}
{"pair_id":"AIMed.d37.s315.p4","sentence":"We found that in addition to @PROTEIN1$, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, @PROTEIN2$, MCP-4, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":0}
{"pair_id":"AIMed.d37.s315.p5","sentence":"We found that in addition to @PROTEIN1$, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, MCP-3, @PROTEIN2$, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":0}
{"pair_id":"AIMed.d37.s315.p6","sentence":"We found that in addition to @PROTEIN1$, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, MCP-3, MCP-4, @PROTEIN2$, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":0}
{"pair_id":"AIMed.d37.s315.p7","sentence":"We found that in addition to @PROTEIN1$, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, MCP-3, MCP-4, MCP-1, and @PROTEIN2$ binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":0}
{"pair_id":"AIMed.d37.s315.p8","sentence":"We found that in addition to MIP-1beta, @PROTEIN1$, and @PROTEIN2$, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, MCP-3, MCP-4, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":0}
{"pair_id":"AIMed.d37.s315.p9","sentence":"We found that in addition to MIP-1beta, @PROTEIN1$, and RANTES, five other CC-chemokines could compete for [(125)I]-@PROTEIN2$ binding: MCP-2, MCP-3, MCP-4, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":1}
{"pair_id":"AIMed.d37.s315.p10","sentence":"We found that in addition to MIP-1beta, @PROTEIN1$, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: @PROTEIN2$, MCP-3, MCP-4, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":0}
{"pair_id":"AIMed.d37.s315.p11","sentence":"We found that in addition to MIP-1beta, @PROTEIN1$, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, @PROTEIN2$, MCP-4, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":0}
{"pair_id":"AIMed.d37.s315.p12","sentence":"We found that in addition to MIP-1beta, @PROTEIN1$, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, MCP-3, @PROTEIN2$, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":0}
{"pair_id":"AIMed.d37.s315.p13","sentence":"We found that in addition to MIP-1beta, @PROTEIN1$, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, MCP-3, MCP-4, @PROTEIN2$, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":0}
{"pair_id":"AIMed.d37.s315.p14","sentence":"We found that in addition to MIP-1beta, @PROTEIN1$, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, MCP-3, MCP-4, MCP-1, and @PROTEIN2$ binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":0}
{"pair_id":"AIMed.d37.s315.p15","sentence":"We found that in addition to MIP-1beta, MIP-1alpha, and @PROTEIN1$, five other CC-chemokines could compete for [(125)I]-@PROTEIN2$ binding: MCP-2, MCP-3, MCP-4, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":1}
{"pair_id":"AIMed.d37.s315.p16","sentence":"We found that in addition to MIP-1beta, MIP-1alpha, and @PROTEIN1$, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: @PROTEIN2$, MCP-3, MCP-4, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":0}
{"pair_id":"AIMed.d37.s315.p17","sentence":"We found that in addition to MIP-1beta, MIP-1alpha, and @PROTEIN1$, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, @PROTEIN2$, MCP-4, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":0}
{"pair_id":"AIMed.d37.s315.p18","sentence":"We found that in addition to MIP-1beta, MIP-1alpha, and @PROTEIN1$, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, MCP-3, @PROTEIN2$, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":0}
{"pair_id":"AIMed.d37.s315.p19","sentence":"We found that in addition to MIP-1beta, MIP-1alpha, and @PROTEIN1$, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, MCP-3, MCP-4, @PROTEIN2$, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":0}
{"pair_id":"AIMed.d37.s315.p20","sentence":"We found that in addition to MIP-1beta, MIP-1alpha, and @PROTEIN1$, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, MCP-3, MCP-4, MCP-1, and @PROTEIN2$ binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":0}
{"pair_id":"AIMed.d37.s315.p21","sentence":"We found that in addition to MIP-1beta, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-@PROTEIN1$ binding: @PROTEIN2$, MCP-3, MCP-4, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":1}
{"pair_id":"AIMed.d37.s315.p22","sentence":"We found that in addition to MIP-1beta, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-@PROTEIN1$ binding: MCP-2, @PROTEIN2$, MCP-4, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":1}
{"pair_id":"AIMed.d37.s315.p23","sentence":"We found that in addition to MIP-1beta, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-@PROTEIN1$ binding: MCP-2, MCP-3, @PROTEIN2$, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":1}
{"pair_id":"AIMed.d37.s315.p24","sentence":"We found that in addition to MIP-1beta, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-@PROTEIN1$ binding: MCP-2, MCP-3, MCP-4, @PROTEIN2$, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":1}
{"pair_id":"AIMed.d37.s315.p25","sentence":"We found that in addition to MIP-1beta, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-@PROTEIN1$ binding: MCP-2, MCP-3, MCP-4, MCP-1, and @PROTEIN2$ binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":1}
{"pair_id":"AIMed.d37.s315.p26","sentence":"We found that in addition to MIP-1beta, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: @PROTEIN1$, @PROTEIN2$, MCP-4, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":0}
{"pair_id":"AIMed.d37.s315.p27","sentence":"We found that in addition to MIP-1beta, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: @PROTEIN1$, MCP-3, @PROTEIN2$, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":0}
{"pair_id":"AIMed.d37.s315.p28","sentence":"We found that in addition to MIP-1beta, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: @PROTEIN1$, MCP-3, MCP-4, @PROTEIN2$, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":0}
{"pair_id":"AIMed.d37.s315.p29","sentence":"We found that in addition to MIP-1beta, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: @PROTEIN1$, MCP-3, MCP-4, MCP-1, and @PROTEIN2$ binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":0}
{"pair_id":"AIMed.d37.s315.p30","sentence":"We found that in addition to MIP-1beta, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, @PROTEIN1$, @PROTEIN2$, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":0}
{"pair_id":"AIMed.d37.s315.p31","sentence":"We found that in addition to MIP-1beta, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, @PROTEIN1$, MCP-4, @PROTEIN2$, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":0}
{"pair_id":"AIMed.d37.s315.p32","sentence":"We found that in addition to MIP-1beta, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, @PROTEIN1$, MCP-4, MCP-1, and @PROTEIN2$ binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":0}
{"pair_id":"AIMed.d37.s315.p33","sentence":"We found that in addition to MIP-1beta, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, MCP-3, @PROTEIN1$, @PROTEIN2$, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":0}
{"pair_id":"AIMed.d37.s315.p34","sentence":"We found that in addition to MIP-1beta, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, MCP-3, @PROTEIN1$, MCP-1, and @PROTEIN2$ binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":0}
{"pair_id":"AIMed.d37.s315.p35","sentence":"We found that in addition to MIP-1beta, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, MCP-3, MCP-4, @PROTEIN1$, and @PROTEIN2$ binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":0}
{"pair_id":"BioInfer.d443.s0.p0","sentence":"Mutations in BUD3, @PROTEIN1$, and @PROTEIN2$ cause a and alpha cells to exhibit the bipolar pattern, indicating that these genes are necessary to specify the axial budding pattern (Chant, J., and I. Herskowitz. 1991. Cell. 65:1203-1212; Fujita, A., C. Oka, Y. Arikawa, T. Katagi, A. Tonouchi, S. Kuhara, and Y. Misumi. 1994. Nature (Lond.). 372:567-570).","label":0}
{"pair_id":"BioInfer.d443.s0.p1","sentence":"Mutations in @PROTEIN2$, @PROTEIN1$, and AXL1 cause a and alpha cells to exhibit the bipolar pattern, indicating that these genes are necessary to specify the axial budding pattern (Chant, J., and I. Herskowitz. 1991. Cell. 65:1203-1212; Fujita, A., C. Oka, Y. Arikawa, T. Katagi, A. Tonouchi, S. Kuhara, and Y. Misumi. 1994. Nature (Lond.). 372:567-570).","label":0}
{"pair_id":"BioInfer.d443.s0.p2","sentence":"Mutations in @PROTEIN2$, BUD4, and @PROTEIN1$ cause a and alpha cells to exhibit the bipolar pattern, indicating that these genes are necessary to specify the axial budding pattern (Chant, J., and I. Herskowitz. 1991. Cell. 65:1203-1212; Fujita, A., C. Oka, Y. Arikawa, T. Katagi, A. Tonouchi, S. Kuhara, and Y. Misumi. 1994. Nature (Lond.). 372:567-570).","label":0}
{"pair_id":"BioInfer.d835.s0.p0","sentence":"YACs containing @PROTEIN2$ gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the RAD1, RAD6, RAD51, or @PROTEIN1$ loci.","label":0}
{"pair_id":"BioInfer.d835.s0.p1","sentence":"YACs containing color vision red pigment gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the RAD1, @PROTEIN2$, RAD51, or @PROTEIN1$ loci.","label":0}
{"pair_id":"BioInfer.d835.s0.p2","sentence":"YACs containing color vision red pigment gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the RAD1, RAD6, @PROTEIN2$, or @PROTEIN1$ loci.","label":0}
{"pair_id":"BioInfer.d835.s0.p3","sentence":"YACs containing color vision red pigment gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the @PROTEIN2$, RAD6, RAD51, or @PROTEIN1$ loci.","label":0}
{"pair_id":"BioInfer.d835.s0.p4","sentence":"YACs containing @PROTEIN1$ gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the RAD1, @PROTEIN2$, RAD51, or RAD52 loci.","label":0}
{"pair_id":"BioInfer.d835.s0.p5","sentence":"YACs containing @PROTEIN1$ gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the RAD1, RAD6, @PROTEIN2$, or RAD52 loci.","label":0}
{"pair_id":"BioInfer.d835.s0.p6","sentence":"YACs containing @PROTEIN1$ gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the @PROTEIN2$, RAD6, RAD51, or RAD52 loci.","label":0}
{"pair_id":"BioInfer.d835.s0.p7","sentence":"YACs containing color vision red pigment gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the RAD1, @PROTEIN1$, @PROTEIN2$, or RAD52 loci.","label":0}
{"pair_id":"BioInfer.d835.s0.p8","sentence":"YACs containing color vision red pigment gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the @PROTEIN2$, @PROTEIN1$, RAD51, or RAD52 loci.","label":0}
{"pair_id":"BioInfer.d835.s0.p9","sentence":"YACs containing color vision red pigment gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the @PROTEIN2$, RAD6, @PROTEIN1$, or RAD52 loci.","label":0}
{"pair_id":"BioInfer.d613.s0.p0","sentence":"The findings suggest that @PROTEIN2$ muscarinic receptors are involved in muscarinic receptor-mediated enhancement of @PROTEIN1$ production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":1}
{"pair_id":"BioInfer.d613.s0.p1","sentence":"The findings suggest that M1 @PROTEIN2$ are involved in muscarinic receptor-mediated enhancement of @PROTEIN1$ production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p2","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of @PROTEIN1$ production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and @PROTEIN2$, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p3","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of @PROTEIN1$ production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of @PROTEIN2$ production.","label":0}
{"pair_id":"BioInfer.d613.s0.p4","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of @PROTEIN1$ production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the @PROTEIN2$-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p5","sentence":"The findings suggest that M1 muscarinic receptors are involved in @PROTEIN2$-mediated enhancement of @PROTEIN1$ production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":1}
{"pair_id":"BioInfer.d613.s0.p6","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of @PROTEIN1$ production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 @PROTEIN2$, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p7","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of @PROTEIN1$ production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/@PROTEIN2$ and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p8","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of @PROTEIN1$ production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (@PROTEIN2$)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p9","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of @PROTEIN1$ production in Jurkat cells and that the transcription factor @PROTEIN2$ and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p10","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of @PROTEIN1$ production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via @PROTEIN2$ MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p11","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of @PROTEIN1$ production in Jurkat cells and that the transcription factor AP-1 and pathways via @PROTEIN2$ (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p12","sentence":"The findings suggest that @PROTEIN1$ @PROTEIN2$ are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":1}
{"pair_id":"BioInfer.d613.s0.p13","sentence":"The findings suggest that @PROTEIN1$ muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and @PROTEIN2$, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p14","sentence":"The findings suggest that @PROTEIN1$ muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of @PROTEIN2$ production.","label":0}
{"pair_id":"BioInfer.d613.s0.p15","sentence":"The findings suggest that @PROTEIN1$ muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the @PROTEIN2$-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p16","sentence":"The findings suggest that @PROTEIN1$ muscarinic receptors are involved in @PROTEIN2$-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p17","sentence":"The findings suggest that @PROTEIN1$ muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 @PROTEIN2$, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p18","sentence":"The findings suggest that @PROTEIN1$ muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/@PROTEIN2$ and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p19","sentence":"The findings suggest that @PROTEIN1$ muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (@PROTEIN2$)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p20","sentence":"The findings suggest that @PROTEIN1$ muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor @PROTEIN2$ and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p21","sentence":"The findings suggest that @PROTEIN1$ muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via @PROTEIN2$ MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p22","sentence":"The findings suggest that @PROTEIN1$ muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via @PROTEIN2$ (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p23","sentence":"The findings suggest that M1 @PROTEIN1$ are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and @PROTEIN2$, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p24","sentence":"The findings suggest that M1 @PROTEIN1$ are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of @PROTEIN2$ production.","label":0}
{"pair_id":"BioInfer.d613.s0.p25","sentence":"The findings suggest that M1 @PROTEIN1$ are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the @PROTEIN2$-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p26","sentence":"The findings suggest that M1 @PROTEIN1$ are involved in @PROTEIN2$-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p27","sentence":"The findings suggest that M1 @PROTEIN1$ are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 @PROTEIN2$, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p28","sentence":"The findings suggest that M1 @PROTEIN1$ are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/@PROTEIN2$ and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p29","sentence":"The findings suggest that M1 @PROTEIN1$ are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (@PROTEIN2$)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p30","sentence":"The findings suggest that M1 @PROTEIN1$ are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor @PROTEIN2$ and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p31","sentence":"The findings suggest that M1 @PROTEIN1$ are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via @PROTEIN2$ MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p32","sentence":"The findings suggest that M1 @PROTEIN1$ are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via @PROTEIN2$ (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p33","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and @PROTEIN1$, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of @PROTEIN2$ production.","label":1}
{"pair_id":"BioInfer.d613.s0.p34","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and @PROTEIN1$, but not via p38 MAPK, may be involved in the @PROTEIN2$-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p35","sentence":"The findings suggest that M1 muscarinic receptors are involved in @PROTEIN2$-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and @PROTEIN1$, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p36","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and @PROTEIN1$, but not via p38 @PROTEIN2$, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p37","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/@PROTEIN2$ and @PROTEIN1$, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p38","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (@PROTEIN2$)\/extracellular signal regulated protein kinase and @PROTEIN1$, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p39","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor @PROTEIN2$ and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and @PROTEIN1$, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p40","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and @PROTEIN1$, but not via @PROTEIN2$ MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p41","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via @PROTEIN2$ (MAPK)\/extracellular signal regulated protein kinase and @PROTEIN1$, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p42","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the @PROTEIN2$-mediated enhancement of @PROTEIN1$ production.","label":1}
{"pair_id":"BioInfer.d613.s0.p43","sentence":"The findings suggest that M1 muscarinic receptors are involved in @PROTEIN2$-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of @PROTEIN1$ production.","label":0}
{"pair_id":"BioInfer.d613.s0.p44","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 @PROTEIN2$, may be involved in the muscarinic receptor-mediated enhancement of @PROTEIN1$ production.","label":0}
{"pair_id":"BioInfer.d613.s0.p45","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/@PROTEIN2$ and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of @PROTEIN1$ production.","label":1}
{"pair_id":"BioInfer.d613.s0.p46","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (@PROTEIN2$)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of @PROTEIN1$ production.","label":1}
{"pair_id":"BioInfer.d613.s0.p47","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor @PROTEIN2$ and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of @PROTEIN1$ production.","label":1}
{"pair_id":"BioInfer.d613.s0.p48","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via @PROTEIN2$ MAPK, may be involved in the muscarinic receptor-mediated enhancement of @PROTEIN1$ production.","label":1}
{"pair_id":"BioInfer.d613.s0.p49","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via @PROTEIN2$ (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of @PROTEIN1$ production.","label":1}
{"pair_id":"BioInfer.d613.s0.p50","sentence":"The findings suggest that M1 muscarinic receptors are involved in @PROTEIN2$-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the @PROTEIN1$-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p51","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 @PROTEIN2$, may be involved in the @PROTEIN1$-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p52","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/@PROTEIN2$ and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the @PROTEIN1$-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p53","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (@PROTEIN2$)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the @PROTEIN1$-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p54","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor @PROTEIN2$ and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the @PROTEIN1$-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p55","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via @PROTEIN2$ MAPK, may be involved in the @PROTEIN1$-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p56","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via @PROTEIN2$ (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the @PROTEIN1$-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p57","sentence":"The findings suggest that M1 muscarinic receptors are involved in @PROTEIN1$-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 @PROTEIN2$, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p58","sentence":"The findings suggest that M1 muscarinic receptors are involved in @PROTEIN1$-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/@PROTEIN2$ and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p59","sentence":"The findings suggest that M1 muscarinic receptors are involved in @PROTEIN1$-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (@PROTEIN2$)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p60","sentence":"The findings suggest that M1 muscarinic receptors are involved in @PROTEIN1$-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor @PROTEIN2$ and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p61","sentence":"The findings suggest that M1 muscarinic receptors are involved in @PROTEIN1$-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via @PROTEIN2$ MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p62","sentence":"The findings suggest that M1 muscarinic receptors are involved in @PROTEIN1$-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via @PROTEIN2$ (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p63","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/@PROTEIN2$ and c-Jun N-terminal kinase, but not via p38 @PROTEIN1$, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p64","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (@PROTEIN2$)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 @PROTEIN1$, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p65","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor @PROTEIN2$ and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 @PROTEIN1$, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p66","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via @PROTEIN2$ @PROTEIN1$, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":1}
{"pair_id":"BioInfer.d613.s0.p67","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via @PROTEIN2$ (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 @PROTEIN1$, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p68","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (@PROTEIN2$)\/@PROTEIN1$ and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p69","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor @PROTEIN2$ and pathways via mitogen-activated protein kinase (MAPK)\/@PROTEIN1$ and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p70","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/@PROTEIN1$ and c-Jun N-terminal kinase, but not via @PROTEIN2$ MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p71","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via @PROTEIN2$ (MAPK)\/@PROTEIN1$ and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p72","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor @PROTEIN2$ and pathways via mitogen-activated protein kinase (@PROTEIN1$)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p73","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (@PROTEIN1$)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via @PROTEIN2$ MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p74","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via @PROTEIN2$ (@PROTEIN1$)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p75","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor @PROTEIN1$ and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via @PROTEIN2$ MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p76","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor @PROTEIN1$ and pathways via @PROTEIN2$ (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p77","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via @PROTEIN2$ (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via @PROTEIN1$ MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"AIMed.d63.s547.p0","sentence":"These findings strongly suggest that @PROTEIN1$ may be closely associated with the @PROTEIN2$ protein tyrosine phosphatase on T cell surface and further support the notion that the interaction of CD26 with CD45 results in enhanced tyrosine kinase activity, zeta chain phosphorylation, and T cell activation.","label":0}
{"pair_id":"AIMed.d63.s547.p1","sentence":"These findings strongly suggest that @PROTEIN1$ may be closely associated with the CD45 protein tyrosine phosphatase on T cell surface and further support the notion that the interaction of @PROTEIN2$ with CD45 results in enhanced tyrosine kinase activity, zeta chain phosphorylation, and T cell activation.","label":0}
{"pair_id":"AIMed.d63.s547.p2","sentence":"These findings strongly suggest that @PROTEIN1$ may be closely associated with the CD45 protein tyrosine phosphatase on T cell surface and further support the notion that the interaction of CD26 with @PROTEIN2$ results in enhanced tyrosine kinase activity, zeta chain phosphorylation, and T cell activation.","label":0}
{"pair_id":"AIMed.d63.s547.p3","sentence":"These findings strongly suggest that CD26 may be closely associated with the @PROTEIN1$ protein tyrosine phosphatase on T cell surface and further support the notion that the interaction of @PROTEIN2$ with CD45 results in enhanced tyrosine kinase activity, zeta chain phosphorylation, and T cell activation.","label":0}
{"pair_id":"AIMed.d63.s547.p4","sentence":"These findings strongly suggest that CD26 may be closely associated with the @PROTEIN1$ protein tyrosine phosphatase on T cell surface and further support the notion that the interaction of CD26 with @PROTEIN2$ results in enhanced tyrosine kinase activity, zeta chain phosphorylation, and T cell activation.","label":0}
{"pair_id":"AIMed.d63.s547.p5","sentence":"These findings strongly suggest that CD26 may be closely associated with the CD45 protein tyrosine phosphatase on T cell surface and further support the notion that the interaction of @PROTEIN1$ with @PROTEIN2$ results in enhanced tyrosine kinase activity, zeta chain phosphorylation, and T cell activation.","label":1}
{"pair_id":"AIMed.d16.s141.p0","sentence":"CONCLUSION: The triple transduction of @PROTEIN1$, @PROTEIN2$ and GCH genes with separate AAV vectors is effective, which might be important to gene therapy for Parkinson's disease.","label":0}
{"pair_id":"AIMed.d16.s141.p1","sentence":"CONCLUSION: The triple transduction of @PROTEIN1$, AADC and @PROTEIN2$ genes with separate AAV vectors is effective, which might be important to gene therapy for Parkinson's disease.","label":0}
{"pair_id":"AIMed.d16.s141.p2","sentence":"CONCLUSION: The triple transduction of TH, @PROTEIN1$ and @PROTEIN2$ genes with separate AAV vectors is effective, which might be important to gene therapy for Parkinson's disease.","label":0}
{"pair_id":"BioInfer.d330.s0.p0","sentence":"In COS-7 cells overexpressing a N-WASP mutant lacking the proline-rich domain (N-WASP) unable to interact with @PROTEIN2$, the @PROTEIN1$ tail formation of intracellular Shigella was inhibited.","label":0}
{"pair_id":"BioInfer.d330.s0.p1","sentence":"In COS-7 cells overexpressing a @PROTEIN2$ mutant lacking the proline-rich domain (@PROTEIN2$) unable to interact with profilin, the @PROTEIN1$ tail formation of intracellular Shigella was inhibited.","label":0}
{"pair_id":"BioInfer.d330.s0.p2","sentence":"In COS-7 cells overexpressing a @PROTEIN2$ mutant lacking the proline-rich domain (@PROTEIN2$) unable to interact with @PROTEIN1$, the actin tail formation of intracellular Shigella was inhibited.","label":1}
{"pair_id":"AIMed.d26.s216.p0","sentence":"The aim of the present study was to elucidate whether intracellular expression of @PROTEIN1$ and @PROTEIN2$ by NK cells might be associated with progression of cancer.","label":0}
{"pair_id":"AIMed.d160.s1348.p0","sentence":"A @PROTEIN1$ model based on @PROTEIN2$ indicated these positively and negatively charged regions are distal in the monomer but are spatially close in the dimer.","label":0}
{"pair_id":"BioInfer.d180.s0.p0","sentence":"@PROTEIN2$ signal transduction is mediated by a complex of intracellular signaling molecules including @PROTEIN1$, TRAF2, FADD, and FLICE.","label":0}
{"pair_id":"BioInfer.d180.s0.p1","sentence":"DR3 signal transduction is mediated by a complex of intracellular signaling molecules including @PROTEIN1$, TRAF2, FADD, and @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d180.s0.p2","sentence":"DR3 signal transduction is mediated by a complex of intracellular signaling molecules including @PROTEIN1$, TRAF2, @PROTEIN2$, and FLICE.","label":1}
{"pair_id":"BioInfer.d180.s0.p3","sentence":"DR3 signal transduction is mediated by a complex of intracellular signaling molecules including @PROTEIN1$, @PROTEIN2$, FADD, and FLICE.","label":1}
{"pair_id":"BioInfer.d180.s0.p4","sentence":"@PROTEIN1$ signal transduction is mediated by a complex of intracellular signaling molecules including TRADD, TRAF2, FADD, and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d180.s0.p5","sentence":"@PROTEIN1$ signal transduction is mediated by a complex of intracellular signaling molecules including TRADD, TRAF2, @PROTEIN2$, and FLICE.","label":0}
{"pair_id":"BioInfer.d180.s0.p6","sentence":"@PROTEIN1$ signal transduction is mediated by a complex of intracellular signaling molecules including TRADD, @PROTEIN2$, FADD, and FLICE.","label":0}
{"pair_id":"BioInfer.d180.s0.p7","sentence":"DR3 signal transduction is mediated by a complex of intracellular signaling molecules including TRADD, TRAF2, @PROTEIN2$, and @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d180.s0.p8","sentence":"DR3 signal transduction is mediated by a complex of intracellular signaling molecules including TRADD, @PROTEIN2$, FADD, and @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d180.s0.p9","sentence":"DR3 signal transduction is mediated by a complex of intracellular signaling molecules including TRADD, @PROTEIN2$, @PROTEIN1$, and FLICE.","label":1}
{"pair_id":"BioInfer.d638.s1.p0","sentence":"The tandem repeat domain in the Listeria monocytogenes @PROTEIN2$ protein controls the rate of actin-based motility, the percentage of moving bacteria, and the localization of vasodilator-stimulated phosphoprotein and @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d638.s1.p1","sentence":"The tandem repeat domain in the Listeria monocytogenes ActA protein controls the rate of @PROTEIN2$-based motility, the percentage of moving bacteria, and the localization of vasodilator-stimulated phosphoprotein and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d638.s1.p2","sentence":"The tandem repeat domain in the Listeria monocytogenes ActA protein controls the rate of actin-based motility, the percentage of moving bacteria, and the localization of @PROTEIN2$ and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d638.s1.p3","sentence":"The tandem repeat domain in the Listeria monocytogenes @PROTEIN1$ protein controls the rate of @PROTEIN2$-based motility, the percentage of moving bacteria, and the localization of vasodilator-stimulated phosphoprotein and profilin.","label":1}
{"pair_id":"BioInfer.d638.s1.p4","sentence":"The tandem repeat domain in the Listeria monocytogenes @PROTEIN1$ protein controls the rate of actin-based motility, the percentage of moving bacteria, and the localization of @PROTEIN2$ and profilin.","label":1}
{"pair_id":"BioInfer.d638.s1.p5","sentence":"The tandem repeat domain in the Listeria monocytogenes ActA protein controls the rate of @PROTEIN1$-based motility, the percentage of moving bacteria, and the localization of @PROTEIN2$ and profilin.","label":0}
{"pair_id":"BioInfer.d201.s0.p0","sentence":"Expression of @PROTEIN1$ and @PROTEIN2$ genes in skeletal, cardiac and uterine muscles of young and old rats.","label":0}
{"pair_id":"AIMed.d115.s971.p0","sentence":"A few general transcription factors, in particular @PROTEIN1$ and @PROTEIN2$, have been found to bind transcriptional activators.","label":0}
{"pair_id":"AIMed.d127.s1088.p0","sentence":"@PROTEIN1$ and @PROTEIN2$ associated with IL-2R beta and gamma c, respectively; IL-2 induced Jak3-IL-2R beta and increased Jak3-gamma c associations.","label":0}
{"pair_id":"AIMed.d127.s1088.p1","sentence":"@PROTEIN1$ and Jak3 associated with @PROTEIN2$ and gamma c, respectively; IL-2 induced Jak3-IL-2R beta and increased Jak3-gamma c associations.","label":1}
{"pair_id":"AIMed.d127.s1088.p2","sentence":"@PROTEIN1$ and Jak3 associated with IL-2R beta and gamma c, respectively; @PROTEIN2$ induced Jak3-IL-2R beta and increased Jak3-gamma c associations.","label":0}
{"pair_id":"AIMed.d127.s1088.p3","sentence":"@PROTEIN1$ and Jak3 associated with IL-2R beta and gamma c, respectively; IL-2 induced @PROTEIN2$-IL-2R beta and increased Jak3-gamma c associations.","label":0}
{"pair_id":"AIMed.d127.s1088.p4","sentence":"@PROTEIN1$ and Jak3 associated with IL-2R beta and gamma c, respectively; IL-2 induced Jak3-@PROTEIN2$ and increased Jak3-gamma c associations.","label":0}
{"pair_id":"AIMed.d127.s1088.p5","sentence":"@PROTEIN1$ and Jak3 associated with IL-2R beta and gamma c, respectively; IL-2 induced Jak3-IL-2R beta and increased @PROTEIN2$-gamma c associations.","label":0}
{"pair_id":"AIMed.d127.s1088.p6","sentence":"Jak1 and @PROTEIN1$ associated with @PROTEIN2$ and gamma c, respectively; IL-2 induced Jak3-IL-2R beta and increased Jak3-gamma c associations.","label":1}
{"pair_id":"AIMed.d127.s1088.p7","sentence":"Jak1 and @PROTEIN1$ associated with IL-2R beta and gamma c, respectively; @PROTEIN2$ induced Jak3-IL-2R beta and increased Jak3-gamma c associations.","label":0}
{"pair_id":"AIMed.d127.s1088.p8","sentence":"Jak1 and @PROTEIN1$ associated with IL-2R beta and gamma c, respectively; IL-2 induced @PROTEIN2$-IL-2R beta and increased Jak3-gamma c associations.","label":0}
{"pair_id":"AIMed.d127.s1088.p9","sentence":"Jak1 and @PROTEIN1$ associated with IL-2R beta and gamma c, respectively; IL-2 induced Jak3-@PROTEIN2$ and increased Jak3-gamma c associations.","label":0}
{"pair_id":"AIMed.d127.s1088.p10","sentence":"Jak1 and @PROTEIN1$ associated with IL-2R beta and gamma c, respectively; IL-2 induced Jak3-IL-2R beta and increased @PROTEIN2$-gamma c associations.","label":0}
{"pair_id":"AIMed.d127.s1088.p11","sentence":"Jak1 and Jak3 associated with @PROTEIN1$ and gamma c, respectively; @PROTEIN2$ induced Jak3-IL-2R beta and increased Jak3-gamma c associations.","label":0}
{"pair_id":"AIMed.d127.s1088.p12","sentence":"Jak1 and Jak3 associated with @PROTEIN1$ and gamma c, respectively; IL-2 induced @PROTEIN2$-IL-2R beta and increased Jak3-gamma c associations.","label":0}
{"pair_id":"AIMed.d127.s1088.p13","sentence":"Jak1 and Jak3 associated with @PROTEIN1$ and gamma c, respectively; IL-2 induced Jak3-@PROTEIN2$ and increased Jak3-gamma c associations.","label":0}
{"pair_id":"AIMed.d127.s1088.p14","sentence":"Jak1 and Jak3 associated with @PROTEIN1$ and gamma c, respectively; IL-2 induced Jak3-IL-2R beta and increased @PROTEIN2$-gamma c associations.","label":0}
{"pair_id":"AIMed.d127.s1088.p15","sentence":"Jak1 and Jak3 associated with IL-2R beta and gamma c, respectively; @PROTEIN1$ induced @PROTEIN2$-IL-2R beta and increased Jak3-gamma c associations.","label":0}
{"pair_id":"AIMed.d127.s1088.p16","sentence":"Jak1 and Jak3 associated with IL-2R beta and gamma c, respectively; @PROTEIN1$ induced Jak3-@PROTEIN2$ and increased Jak3-gamma c associations.","label":0}
{"pair_id":"AIMed.d127.s1088.p17","sentence":"Jak1 and Jak3 associated with IL-2R beta and gamma c, respectively; @PROTEIN1$ induced Jak3-IL-2R beta and increased @PROTEIN2$-gamma c associations.","label":0}
{"pair_id":"AIMed.d127.s1088.p18","sentence":"Jak1 and Jak3 associated with IL-2R beta and gamma c, respectively; IL-2 induced @PROTEIN1$-@PROTEIN2$ and increased Jak3-gamma c associations.","label":1}
{"pair_id":"AIMed.d127.s1088.p19","sentence":"Jak1 and Jak3 associated with IL-2R beta and gamma c, respectively; IL-2 induced @PROTEIN1$-IL-2R beta and increased @PROTEIN2$-gamma c associations.","label":0}
{"pair_id":"AIMed.d127.s1088.p20","sentence":"Jak1 and Jak3 associated with IL-2R beta and gamma c, respectively; IL-2 induced Jak3-@PROTEIN1$ and increased @PROTEIN2$-gamma c associations.","label":0}
{"pair_id":"AIMed.d160.s1345.p0","sentence":"@PROTEIN1$ mediates endothelial cell proliferation, angiogenesis, vascular growth, and vascular permeability via the endothelial cell receptors, @PROTEIN2$ (KDR)\/fetal liver kinase 1 (Flk-1) and FLT-1.","label":0}
{"pair_id":"AIMed.d160.s1345.p1","sentence":"@PROTEIN1$ mediates endothelial cell proliferation, angiogenesis, vascular growth, and vascular permeability via the endothelial cell receptors, kinase insert domain-containing receptor (@PROTEIN2$)\/fetal liver kinase 1 (Flk-1) and FLT-1.","label":0}
{"pair_id":"AIMed.d160.s1345.p2","sentence":"@PROTEIN1$ mediates endothelial cell proliferation, angiogenesis, vascular growth, and vascular permeability via the endothelial cell receptors, kinase insert domain-containing receptor (KDR)\/@PROTEIN2$ (Flk-1) and FLT-1.","label":0}
{"pair_id":"AIMed.d160.s1345.p3","sentence":"@PROTEIN1$ mediates endothelial cell proliferation, angiogenesis, vascular growth, and vascular permeability via the endothelial cell receptors, kinase insert domain-containing receptor (KDR)\/fetal liver kinase 1 (@PROTEIN2$) and FLT-1.","label":0}
{"pair_id":"AIMed.d160.s1345.p4","sentence":"@PROTEIN1$ mediates endothelial cell proliferation, angiogenesis, vascular growth, and vascular permeability via the endothelial cell receptors, kinase insert domain-containing receptor (KDR)\/fetal liver kinase 1 (Flk-1) and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d160.s1345.p5","sentence":"VEGF mediates endothelial cell proliferation, angiogenesis, vascular growth, and vascular permeability via the endothelial cell receptors, @PROTEIN1$ (@PROTEIN2$)\/fetal liver kinase 1 (Flk-1) and FLT-1.","label":0}
{"pair_id":"AIMed.d160.s1345.p6","sentence":"VEGF mediates endothelial cell proliferation, angiogenesis, vascular growth, and vascular permeability via the endothelial cell receptors, @PROTEIN1$ (KDR)\/@PROTEIN2$ (Flk-1) and FLT-1.","label":0}
{"pair_id":"AIMed.d160.s1345.p7","sentence":"VEGF mediates endothelial cell proliferation, angiogenesis, vascular growth, and vascular permeability via the endothelial cell receptors, @PROTEIN1$ (KDR)\/fetal liver kinase 1 (@PROTEIN2$) and FLT-1.","label":0}
{"pair_id":"AIMed.d160.s1345.p8","sentence":"VEGF mediates endothelial cell proliferation, angiogenesis, vascular growth, and vascular permeability via the endothelial cell receptors, @PROTEIN1$ (KDR)\/fetal liver kinase 1 (Flk-1) and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d160.s1345.p9","sentence":"VEGF mediates endothelial cell proliferation, angiogenesis, vascular growth, and vascular permeability via the endothelial cell receptors, kinase insert domain-containing receptor (@PROTEIN1$)\/@PROTEIN2$ (Flk-1) and FLT-1.","label":0}
{"pair_id":"AIMed.d160.s1345.p10","sentence":"VEGF mediates endothelial cell proliferation, angiogenesis, vascular growth, and vascular permeability via the endothelial cell receptors, kinase insert domain-containing receptor (@PROTEIN1$)\/fetal liver kinase 1 (@PROTEIN2$) and FLT-1.","label":0}
{"pair_id":"AIMed.d160.s1345.p11","sentence":"VEGF mediates endothelial cell proliferation, angiogenesis, vascular growth, and vascular permeability via the endothelial cell receptors, kinase insert domain-containing receptor (@PROTEIN1$)\/fetal liver kinase 1 (Flk-1) and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d160.s1345.p12","sentence":"VEGF mediates endothelial cell proliferation, angiogenesis, vascular growth, and vascular permeability via the endothelial cell receptors, kinase insert domain-containing receptor (KDR)\/@PROTEIN1$ (@PROTEIN2$) and FLT-1.","label":0}
{"pair_id":"AIMed.d160.s1345.p13","sentence":"VEGF mediates endothelial cell proliferation, angiogenesis, vascular growth, and vascular permeability via the endothelial cell receptors, kinase insert domain-containing receptor (KDR)\/@PROTEIN1$ (Flk-1) and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d160.s1345.p14","sentence":"VEGF mediates endothelial cell proliferation, angiogenesis, vascular growth, and vascular permeability via the endothelial cell receptors, kinase insert domain-containing receptor (KDR)\/fetal liver kinase 1 (@PROTEIN1$) and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d188.s0.p0","sentence":"Electrical stimulation of cardiocyte contraction did not enhance alpha-cardiac actin or @PROTEIN1$@PROTEIN2$ (@PROTEIN2$+@PROTEIN1$) mRNA transcript levels relative to 28S rRNA during the period of rapid growth that occurred over the first 48 hours.","label":0}
{"pair_id":"BioInfer.d188.s0.p1","sentence":"Electrical stimulation of cardiocyte contraction did not enhance @PROTEIN2$ or @PROTEIN1$ (myosi+@PROTEIN1$) mRNA transcript levels relative to 28S rRNA during the period of rapid growth that occurred over the first 48 hours.","label":0}
{"pair_id":"BioInfer.d188.s0.p2","sentence":"Electrical stimulation of cardiocyte contraction did not enhance alpha-cardiac actin or @PROTEIN1$ (myosi+@PROTEIN1$) mRNA transcript levels relative to @PROTEIN2$ during the period of rapid growth that occurred over the first 48 hours.","label":0}
{"pair_id":"BioInfer.d188.s0.p3","sentence":"Electrical stimulation of cardiocyte contraction did not enhance @PROTEIN2$ or @PROTEIN1$ (@PROTEIN1$+myos) mRNA transcript levels relative to 28S rRNA during the period of rapid growth that occurred over the first 48 hours.","label":0}
{"pair_id":"BioInfer.d188.s0.p4","sentence":"Electrical stimulation of cardiocyte contraction did not enhance alpha-cardiac actin or @PROTEIN1$ (@PROTEIN1$+myos) mRNA transcript levels relative to @PROTEIN2$ during the period of rapid growth that occurred over the first 48 hours.","label":0}
{"pair_id":"BioInfer.d188.s0.p5","sentence":"Electrical stimulation of cardiocyte contraction did not enhance @PROTEIN1$ or myosin heavy chain (myosi+myos) mRNA transcript levels relative to @PROTEIN2$ during the period of rapid growth that occurred over the first 48 hours.","label":0}
{"pair_id":"BioInfer.d718.s0.p0","sentence":"These two proteins were identified as the phosphorylated and non-phosphorylated forms of the pH-sensitive actin-depolymerizing protein, @PROTEIN2$, by sequencing of peptide fragments and immunoblotting with a monoclonal antibody specific for @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d718.s0.p1","sentence":"These two proteins were identified as the phosphorylated and non-phosphorylated forms of the pH-sensitive @PROTEIN2$-depolymerizing protein, cofilin, by sequencing of peptide fragments and immunoblotting with a monoclonal antibody specific for @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d718.s0.p2","sentence":"These two proteins were identified as the phosphorylated and non-phosphorylated forms of the pH-sensitive @PROTEIN2$-depolymerizing protein, @PROTEIN1$, by sequencing of peptide fragments and immunoblotting with a monoclonal antibody specific for cofilin.","label":1}
{"pair_id":"BioInfer.d140.s2.p0","sentence":"beta-catenin or @PROTEIN2$ is associated directly with the @PROTEIN1$; alpha-catenin binds to beta-catenin\/plakoglobin and serves to link the cadherin\/catenin complex to the actin cytoskeleton.","label":1}
{"pair_id":"BioInfer.d140.s2.p1","sentence":"@PROTEIN2$ or plakoglobin is associated directly with the @PROTEIN1$; alpha-catenin binds to beta-catenin\/plakoglobin and serves to link the cadherin\/catenin complex to the actin cytoskeleton.","label":1}
{"pair_id":"BioInfer.d140.s2.p2","sentence":"beta-catenin or plakoglobin is associated directly with the @PROTEIN1$; alpha-catenin binds to beta-catenin\/plakoglobin and serves to link the @PROTEIN2$\/catenin complex to the actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d140.s2.p3","sentence":"beta-catenin or plakoglobin is associated directly with the @PROTEIN1$; alpha-catenin binds to beta-catenin\/plakoglobin and serves to link the cadherin\/@PROTEIN2$ complex to the actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d140.s2.p4","sentence":"beta-catenin or plakoglobin is associated directly with the @PROTEIN1$; @PROTEIN2$ binds to beta-catenin\/plakoglobin and serves to link the cadherin\/catenin complex to the actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d140.s2.p5","sentence":"beta-catenin or plakoglobin is associated directly with the @PROTEIN1$; alpha-catenin binds to beta-catenin\/@PROTEIN2$ and serves to link the cadherin\/catenin complex to the actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d140.s2.p6","sentence":"beta-catenin or plakoglobin is associated directly with the @PROTEIN1$; alpha-catenin binds to beta-catenin\/plakoglobin and serves to link the cadherin\/catenin complex to the @PROTEIN2$ cytoskeleton.","label":0}
{"pair_id":"BioInfer.d140.s2.p7","sentence":"beta-catenin or plakoglobin is associated directly with the @PROTEIN1$; alpha-catenin binds to @PROTEIN2$\/plakoglobin and serves to link the cadherin\/catenin complex to the actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d140.s2.p8","sentence":"@PROTEIN2$ or @PROTEIN1$ is associated directly with the cadherin; alpha-catenin binds to beta-catenin\/plakoglobin and serves to link the cadherin\/catenin complex to the actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d140.s2.p9","sentence":"beta-catenin or @PROTEIN1$ is associated directly with the cadherin; alpha-catenin binds to beta-catenin\/plakoglobin and serves to link the @PROTEIN2$\/catenin complex to the actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d140.s2.p10","sentence":"beta-catenin or @PROTEIN1$ is associated directly with the cadherin; alpha-catenin binds to beta-catenin\/plakoglobin and serves to link the cadherin\/@PROTEIN2$ complex to the actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d140.s2.p11","sentence":"beta-catenin or @PROTEIN1$ is associated directly with the cadherin; @PROTEIN2$ binds to beta-catenin\/plakoglobin and serves to link the cadherin\/catenin complex to the actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d140.s2.p12","sentence":"beta-catenin or @PROTEIN1$ is associated directly with the cadherin; alpha-catenin binds to beta-catenin\/@PROTEIN2$ and serves to link the cadherin\/catenin complex to the actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d140.s2.p13","sentence":"beta-catenin or @PROTEIN1$ is associated directly with the cadherin; alpha-catenin binds to beta-catenin\/plakoglobin and serves to link the cadherin\/catenin complex to the @PROTEIN2$ cytoskeleton.","label":0}
{"pair_id":"BioInfer.d140.s2.p14","sentence":"beta-catenin or @PROTEIN1$ is associated directly with the cadherin; alpha-catenin binds to @PROTEIN2$\/plakoglobin and serves to link the cadherin\/catenin complex to the actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d140.s2.p15","sentence":"@PROTEIN1$ or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin\/plakoglobin and serves to link the @PROTEIN2$\/catenin complex to the actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d140.s2.p16","sentence":"@PROTEIN1$ or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin\/plakoglobin and serves to link the cadherin\/@PROTEIN2$ complex to the actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d140.s2.p17","sentence":"@PROTEIN1$ or plakoglobin is associated directly with the cadherin; @PROTEIN2$ binds to beta-catenin\/plakoglobin and serves to link the cadherin\/catenin complex to the actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d140.s2.p18","sentence":"@PROTEIN1$ or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin\/@PROTEIN2$ and serves to link the cadherin\/catenin complex to the actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d140.s2.p19","sentence":"@PROTEIN1$ or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin\/plakoglobin and serves to link the cadherin\/catenin complex to the @PROTEIN2$ cytoskeleton.","label":0}
{"pair_id":"BioInfer.d140.s2.p20","sentence":"@PROTEIN1$ or plakoglobin is associated directly with the cadherin; alpha-catenin binds to @PROTEIN2$\/plakoglobin and serves to link the cadherin\/catenin complex to the actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d140.s2.p21","sentence":"beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin\/plakoglobin and serves to link the @PROTEIN1$\/@PROTEIN2$ complex to the actin cytoskeleton.","label":1}
{"pair_id":"BioInfer.d140.s2.p22","sentence":"beta-catenin or plakoglobin is associated directly with the cadherin; @PROTEIN2$ binds to beta-catenin\/plakoglobin and serves to link the @PROTEIN1$\/catenin complex to the actin cytoskeleton.","label":1}
{"pair_id":"BioInfer.d140.s2.p23","sentence":"beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin\/@PROTEIN2$ and serves to link the @PROTEIN1$\/catenin complex to the actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d140.s2.p24","sentence":"beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin\/plakoglobin and serves to link the @PROTEIN1$\/catenin complex to the @PROTEIN2$ cytoskeleton.","label":1}
{"pair_id":"BioInfer.d140.s2.p25","sentence":"beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to @PROTEIN2$\/plakoglobin and serves to link the @PROTEIN1$\/catenin complex to the actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d140.s2.p26","sentence":"beta-catenin or plakoglobin is associated directly with the cadherin; @PROTEIN2$ binds to beta-catenin\/plakoglobin and serves to link the cadherin\/@PROTEIN1$ complex to the actin cytoskeleton.","label":1}
{"pair_id":"BioInfer.d140.s2.p27","sentence":"beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin\/@PROTEIN2$ and serves to link the cadherin\/@PROTEIN1$ complex to the actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d140.s2.p28","sentence":"beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin\/plakoglobin and serves to link the cadherin\/@PROTEIN1$ complex to the @PROTEIN2$ cytoskeleton.","label":1}
{"pair_id":"BioInfer.d140.s2.p29","sentence":"beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to @PROTEIN2$\/plakoglobin and serves to link the cadherin\/@PROTEIN1$ complex to the actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d140.s2.p30","sentence":"beta-catenin or plakoglobin is associated directly with the cadherin; @PROTEIN1$ binds to beta-catenin\/@PROTEIN2$ and serves to link the cadherin\/catenin complex to the actin cytoskeleton.","label":1}
{"pair_id":"BioInfer.d140.s2.p31","sentence":"beta-catenin or plakoglobin is associated directly with the cadherin; @PROTEIN1$ binds to beta-catenin\/plakoglobin and serves to link the cadherin\/catenin complex to the @PROTEIN2$ cytoskeleton.","label":1}
{"pair_id":"BioInfer.d140.s2.p32","sentence":"beta-catenin or plakoglobin is associated directly with the cadherin; @PROTEIN1$ binds to @PROTEIN2$\/plakoglobin and serves to link the cadherin\/catenin complex to the actin cytoskeleton.","label":1}
{"pair_id":"BioInfer.d140.s2.p33","sentence":"beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin\/@PROTEIN1$ and serves to link the cadherin\/catenin complex to the @PROTEIN2$ cytoskeleton.","label":0}
{"pair_id":"BioInfer.d140.s2.p34","sentence":"beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to @PROTEIN2$\/@PROTEIN1$ and serves to link the cadherin\/catenin complex to the actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d140.s2.p35","sentence":"beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to @PROTEIN2$\/plakoglobin and serves to link the cadherin\/catenin complex to the @PROTEIN1$ cytoskeleton.","label":0}
{"pair_id":"BioInfer.d35.s1.p0","sentence":"Aip1p localizes to cortical @PROTEIN1$ patches in yeast cells, and this localization is disrupted by specific @PROTEIN2$ and cofilin mutations.","label":1}
{"pair_id":"BioInfer.d35.s1.p1","sentence":"@PROTEIN2$ localizes to cortical @PROTEIN1$ patches in yeast cells, and this localization is disrupted by specific actin and cofilin mutations.","label":1}
{"pair_id":"BioInfer.d35.s1.p2","sentence":"Aip1p localizes to cortical @PROTEIN1$ patches in yeast cells, and this localization is disrupted by specific actin and @PROTEIN2$ mutations.","label":1}
{"pair_id":"BioInfer.d35.s1.p3","sentence":"@PROTEIN2$ localizes to cortical actin patches in yeast cells, and this localization is disrupted by specific @PROTEIN1$ and cofilin mutations.","label":0}
{"pair_id":"BioInfer.d35.s1.p4","sentence":"Aip1p localizes to cortical actin patches in yeast cells, and this localization is disrupted by specific @PROTEIN1$ and @PROTEIN2$ mutations.","label":0}
{"pair_id":"BioInfer.d35.s1.p5","sentence":"@PROTEIN1$ localizes to cortical actin patches in yeast cells, and this localization is disrupted by specific actin and @PROTEIN2$ mutations.","label":0}
{"pair_id":"AIMed.d153.s1301.p0","sentence":"We found that @PROTEIN1$ was associated with @PROTEIN2$ on T cell lines lacking either ADA or dipeptidyl peptidase IV enzymatic activity, indicating that the association between dipeptidyl peptidase IV and ADA did not require enzymatic activity.","label":1}
{"pair_id":"AIMed.d153.s1301.p1","sentence":"We found that @PROTEIN1$ was associated with CD26 on T cell lines lacking either @PROTEIN2$ or dipeptidyl peptidase IV enzymatic activity, indicating that the association between dipeptidyl peptidase IV and ADA did not require enzymatic activity.","label":0}
{"pair_id":"AIMed.d153.s1301.p2","sentence":"We found that @PROTEIN1$ was associated with CD26 on T cell lines lacking either ADA or @PROTEIN2$ enzymatic activity, indicating that the association between dipeptidyl peptidase IV and ADA did not require enzymatic activity.","label":0}
{"pair_id":"AIMed.d153.s1301.p3","sentence":"We found that @PROTEIN1$ was associated with CD26 on T cell lines lacking either ADA or dipeptidyl peptidase IV enzymatic activity, indicating that the association between @PROTEIN2$ and ADA did not require enzymatic activity.","label":0}
{"pair_id":"AIMed.d153.s1301.p4","sentence":"We found that @PROTEIN1$ was associated with CD26 on T cell lines lacking either ADA or dipeptidyl peptidase IV enzymatic activity, indicating that the association between dipeptidyl peptidase IV and @PROTEIN2$ did not require enzymatic activity.","label":0}
{"pair_id":"AIMed.d153.s1301.p5","sentence":"We found that ADA was associated with @PROTEIN1$ on T cell lines lacking either @PROTEIN2$ or dipeptidyl peptidase IV enzymatic activity, indicating that the association between dipeptidyl peptidase IV and ADA did not require enzymatic activity.","label":0}
{"pair_id":"AIMed.d153.s1301.p6","sentence":"We found that ADA was associated with @PROTEIN1$ on T cell lines lacking either ADA or @PROTEIN2$ enzymatic activity, indicating that the association between dipeptidyl peptidase IV and ADA did not require enzymatic activity.","label":0}
{"pair_id":"AIMed.d153.s1301.p7","sentence":"We found that ADA was associated with @PROTEIN1$ on T cell lines lacking either ADA or dipeptidyl peptidase IV enzymatic activity, indicating that the association between @PROTEIN2$ and ADA did not require enzymatic activity.","label":0}
{"pair_id":"AIMed.d153.s1301.p8","sentence":"We found that ADA was associated with @PROTEIN1$ on T cell lines lacking either ADA or dipeptidyl peptidase IV enzymatic activity, indicating that the association between dipeptidyl peptidase IV and @PROTEIN2$ did not require enzymatic activity.","label":0}
{"pair_id":"AIMed.d153.s1301.p9","sentence":"We found that ADA was associated with CD26 on T cell lines lacking either @PROTEIN1$ or @PROTEIN2$ enzymatic activity, indicating that the association between dipeptidyl peptidase IV and ADA did not require enzymatic activity.","label":0}
{"pair_id":"AIMed.d153.s1301.p10","sentence":"We found that ADA was associated with CD26 on T cell lines lacking either @PROTEIN1$ or dipeptidyl peptidase IV enzymatic activity, indicating that the association between @PROTEIN2$ and ADA did not require enzymatic activity.","label":0}
{"pair_id":"AIMed.d153.s1301.p11","sentence":"We found that ADA was associated with CD26 on T cell lines lacking either @PROTEIN1$ or dipeptidyl peptidase IV enzymatic activity, indicating that the association between dipeptidyl peptidase IV and @PROTEIN2$ did not require enzymatic activity.","label":0}
{"pair_id":"AIMed.d153.s1301.p12","sentence":"We found that ADA was associated with CD26 on T cell lines lacking either ADA or @PROTEIN1$ enzymatic activity, indicating that the association between @PROTEIN2$ and ADA did not require enzymatic activity.","label":0}
{"pair_id":"AIMed.d153.s1301.p13","sentence":"We found that ADA was associated with CD26 on T cell lines lacking either ADA or @PROTEIN1$ enzymatic activity, indicating that the association between dipeptidyl peptidase IV and @PROTEIN2$ did not require enzymatic activity.","label":0}
{"pair_id":"AIMed.d153.s1301.p14","sentence":"We found that ADA was associated with CD26 on T cell lines lacking either ADA or dipeptidyl peptidase IV enzymatic activity, indicating that the association between @PROTEIN1$ and @PROTEIN2$ did not require enzymatic activity.","label":1}
{"pair_id":"AIMed.d53.s472.p0","sentence":"The cross-reactivity of @PROTEIN1$ is apparently due to a chemical plasticity evident in the amphipathic @PROTEIN2$ cytokine-binding sites.","label":0}
{"pair_id":"AIMed.d187.s1592.p0","sentence":"Using site-directed mutagenesis and computer-assisted modelling, we identified amino acid residues on the surface of the @PROTEIN1$ monomer that interact with @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d716.s0.p0","sentence":"The serine phosphatases PP1 and PP2A associate with and activate the @PROTEIN1$ @PROTEIN2$ in human T lymphocytes.","label":1}
{"pair_id":"BioInfer.d716.s0.p1","sentence":"The serine phosphatases @PROTEIN2$ and PP2A associate with and activate the @PROTEIN1$ cofilin in human T lymphocytes.","label":0}
{"pair_id":"BioInfer.d716.s0.p2","sentence":"The serine phosphatases PP1 and @PROTEIN2$ associate with and activate the @PROTEIN1$ cofilin in human T lymphocytes.","label":0}
{"pair_id":"BioInfer.d716.s0.p3","sentence":"The @PROTEIN2$ PP1 and PP2A associate with and activate the @PROTEIN1$ cofilin in human T lymphocytes.","label":0}
{"pair_id":"BioInfer.d716.s0.p4","sentence":"The serine phosphatases @PROTEIN2$ and PP2A associate with and activate the actin-binding protein @PROTEIN1$ in human T lymphocytes.","label":1}
{"pair_id":"BioInfer.d716.s0.p5","sentence":"The serine phosphatases PP1 and @PROTEIN2$ associate with and activate the actin-binding protein @PROTEIN1$ in human T lymphocytes.","label":1}
{"pair_id":"BioInfer.d716.s0.p6","sentence":"The @PROTEIN2$ PP1 and PP2A associate with and activate the actin-binding protein @PROTEIN1$ in human T lymphocytes.","label":0}
{"pair_id":"BioInfer.d716.s0.p7","sentence":"The serine phosphatases @PROTEIN1$ and @PROTEIN2$ associate with and activate the actin-binding protein cofilin in human T lymphocytes.","label":0}
{"pair_id":"BioInfer.d716.s0.p8","sentence":"The @PROTEIN2$ @PROTEIN1$ and PP2A associate with and activate the actin-binding protein cofilin in human T lymphocytes.","label":1}
{"pair_id":"BioInfer.d716.s0.p9","sentence":"The @PROTEIN2$ PP1 and @PROTEIN1$ associate with and activate the actin-binding protein cofilin in human T lymphocytes.","label":1}
{"pair_id":"AIMed.d224.s1953.p0","sentence":"The correlation between @PROTEIN1$ and MHC class I surface expression might be relevant to the function of @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d87.s733.p0","sentence":"Interaction of @PROTEIN1$ subunit of @PROTEIN2$ with insulin and IGF-1 receptors analysed by using the two-hybrid system.","label":0}
{"pair_id":"AIMed.d87.s733.p1","sentence":"Interaction of @PROTEIN1$ subunit of PI 3-kinase with @PROTEIN2$ and IGF-1 receptors analysed by using the two-hybrid system.","label":0}
{"pair_id":"AIMed.d87.s733.p2","sentence":"Interaction of @PROTEIN1$ subunit of PI 3-kinase with insulin and @PROTEIN2$ receptors analysed by using the two-hybrid system.","label":0}
{"pair_id":"AIMed.d87.s733.p3","sentence":"Interaction of p85 subunit of @PROTEIN1$ with @PROTEIN2$ and IGF-1 receptors analysed by using the two-hybrid system.","label":0}
{"pair_id":"AIMed.d87.s733.p4","sentence":"Interaction of p85 subunit of @PROTEIN1$ with insulin and @PROTEIN2$ receptors analysed by using the two-hybrid system.","label":0}
{"pair_id":"AIMed.d87.s733.p5","sentence":"Interaction of p85 subunit of PI 3-kinase with @PROTEIN1$ and @PROTEIN2$ receptors analysed by using the two-hybrid system.","label":0}
{"pair_id":"AIMed.d120.s1021.p0","sentence":"@PROTEIN1$ also was shown to coprecipitate with @PROTEIN2$ in immunoprecipitation studies and to colocalize with HSP27 in immunofluorescence studies of intact glass-activated platelets.","label":1}
{"pair_id":"AIMed.d120.s1021.p1","sentence":"@PROTEIN1$ also was shown to coprecipitate with HSP27 in immunoprecipitation studies and to colocalize with @PROTEIN2$ in immunofluorescence studies of intact glass-activated platelets.","label":0}
{"pair_id":"AIMed.d120.s1021.p2","sentence":"FXIII also was shown to coprecipitate with @PROTEIN1$ in immunoprecipitation studies and to colocalize with @PROTEIN2$ in immunofluorescence studies of intact glass-activated platelets.","label":0}
{"pair_id":"AIMed.d126.s1082.p0","sentence":"If current models of chaperonin mechanism are correct, @PROTEIN1$ undergoes more rebinding and release cycles than does @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d118.s1000.p0","sentence":"@PROTEIN1$ controls CDK activity, thereby affecting cell-cycle control, whereas @PROTEIN2$ functions in both DNA replication and repair.","label":0}
{"pair_id":"AIMed.d37.s319.p0","sentence":"@PROTEIN1$ could compete efficiently for @PROTEIN2$ binding but was, however, found to be a weak inhibitor of HIV infection, probably as a consequence of its inability to downregulate the receptor.","label":1}
{"pair_id":"AIMed.d117.s984.p0","sentence":"The beta:@PROTEIN1$ homodimer and alpha:@PROTEIN2$ heterodimer are mutual antagonists which share a common beta subunit.","label":0}
{"pair_id":"AIMed.d126.s1080.p0","sentence":"In contrast, the renaturation rate for @PROTEIN1$ with the groE chaperonins mirrored the committed renaturation rates following @PROTEIN2$ depletion.","label":0}
{"pair_id":"BioInfer.d314.s0.p0","sentence":"In addition, we demonstrate that @PROTEIN2$ and its @PROTEIN1$ binding peptide compete with gelsolin segments 2-3 for binding to actin filaments.","label":1}
{"pair_id":"BioInfer.d314.s0.p1","sentence":"In addition, we demonstrate that cofilin and its @PROTEIN1$ binding peptide compete with gelsolin segments 2-3 for binding to @PROTEIN2$ filaments.","label":0}
{"pair_id":"BioInfer.d314.s0.p2","sentence":"In addition, we demonstrate that cofilin and its @PROTEIN1$ binding peptide compete with @PROTEIN2$ segments 2-3 for binding to actin filaments.","label":0}
{"pair_id":"BioInfer.d314.s0.p3","sentence":"In addition, we demonstrate that @PROTEIN1$ and its actin binding peptide compete with gelsolin segments 2-3 for binding to @PROTEIN2$ filaments.","label":1}
{"pair_id":"BioInfer.d314.s0.p4","sentence":"In addition, we demonstrate that @PROTEIN1$ and its actin binding peptide compete with @PROTEIN2$ segments 2-3 for binding to actin filaments.","label":0}
{"pair_id":"BioInfer.d314.s0.p5","sentence":"In addition, we demonstrate that cofilin and its actin binding peptide compete with @PROTEIN2$ segments 2-3 for binding to @PROTEIN1$ filaments.","label":1}
{"pair_id":"AIMed.d69.s586.p0","sentence":"Activation of @PROTEIN1$ decreases phosphorylation of @PROTEIN2$ at sites that negatively regulate its DNA-binding activity.","label":1}
{"pair_id":"BioInfer.d673.s0.p0","sentence":"The protein @PROTEIN2$ binds to both @PROTEIN1$ and the head groups of poly)phosphoinositide)s and may regulate both actin assembly and the phosphoinositide signaling pathway.","label":1}
{"pair_id":"BioInfer.d673.s0.p1","sentence":"The protein profilin binds to both @PROTEIN1$ and the head groups of poly)phosphoinositide)s and may regulate both @PROTEIN2$ assembly and the phosphoinositide signaling pathway.","label":0}
{"pair_id":"BioInfer.d673.s0.p2","sentence":"The protein @PROTEIN1$ binds to both actin and the head groups of poly)phosphoinositide)s and may regulate both @PROTEIN2$ assembly and the phosphoinositide signaling pathway.","label":1}
{"pair_id":"AIMed.d65.s555.p0","sentence":"The @PROTEIN1$\/@PROTEIN2$ and ATF\/CREB families of transcription factors function in coupling extracellular signals to alterations in expression of specific target genes.","label":0}
{"pair_id":"AIMed.d65.s555.p1","sentence":"The @PROTEIN1$\/Jun and @PROTEIN2$\/CREB families of transcription factors function in coupling extracellular signals to alterations in expression of specific target genes.","label":0}
{"pair_id":"AIMed.d65.s555.p2","sentence":"The @PROTEIN1$\/Jun and ATF\/@PROTEIN2$ families of transcription factors function in coupling extracellular signals to alterations in expression of specific target genes.","label":0}
{"pair_id":"AIMed.d65.s555.p3","sentence":"The Fos\/@PROTEIN1$ and @PROTEIN2$\/CREB families of transcription factors function in coupling extracellular signals to alterations in expression of specific target genes.","label":0}
{"pair_id":"AIMed.d65.s555.p4","sentence":"The Fos\/@PROTEIN1$ and ATF\/@PROTEIN2$ families of transcription factors function in coupling extracellular signals to alterations in expression of specific target genes.","label":0}
{"pair_id":"AIMed.d65.s555.p5","sentence":"The Fos\/Jun and @PROTEIN1$\/@PROTEIN2$ families of transcription factors function in coupling extracellular signals to alterations in expression of specific target genes.","label":0}
{"pair_id":"AIMed.d30.s250.p0","sentence":"Isolation of human @PROTEIN1$ and its binding specificity with @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d519.s1.p0","sentence":"Results from epistasis analyses indicate that @PROTEIN2$ functions in mismatch repair in conjunction with MSH3 or @PROTEIN1$ and that MSH3 and MSH6 constitute alternate pathways of MSH2-dependent mismatch repair.","label":1}
{"pair_id":"BioInfer.d519.s1.p1","sentence":"Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with MSH3 or @PROTEIN1$ and that MSH3 and @PROTEIN2$ constitute alternate pathways of MSH2-dependent mismatch repair.","label":0}
{"pair_id":"BioInfer.d519.s1.p2","sentence":"Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with @PROTEIN2$ or @PROTEIN1$ and that MSH3 and MSH6 constitute alternate pathways of MSH2-dependent mismatch repair.","label":0}
{"pair_id":"BioInfer.d519.s1.p3","sentence":"Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with MSH3 or @PROTEIN1$ and that MSH3 and MSH6 constitute alternate pathways of @PROTEIN2$-dependent mismatch repair.","label":0}
{"pair_id":"BioInfer.d519.s1.p4","sentence":"Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with MSH3 or @PROTEIN1$ and that @PROTEIN2$ and MSH6 constitute alternate pathways of MSH2-dependent mismatch repair.","label":0}
{"pair_id":"BioInfer.d519.s1.p5","sentence":"Results from epistasis analyses indicate that @PROTEIN1$ functions in mismatch repair in conjunction with MSH3 or MSH6 and that MSH3 and @PROTEIN2$ constitute alternate pathways of MSH2-dependent mismatch repair.","label":0}
{"pair_id":"BioInfer.d519.s1.p6","sentence":"Results from epistasis analyses indicate that @PROTEIN1$ functions in mismatch repair in conjunction with @PROTEIN2$ or MSH6 and that MSH3 and MSH6 constitute alternate pathways of MSH2-dependent mismatch repair.","label":1}
{"pair_id":"BioInfer.d519.s1.p7","sentence":"Results from epistasis analyses indicate that @PROTEIN1$ functions in mismatch repair in conjunction with MSH3 or MSH6 and that MSH3 and MSH6 constitute alternate pathways of @PROTEIN2$-dependent mismatch repair.","label":0}
{"pair_id":"BioInfer.d519.s1.p8","sentence":"Results from epistasis analyses indicate that @PROTEIN1$ functions in mismatch repair in conjunction with MSH3 or MSH6 and that @PROTEIN2$ and MSH6 constitute alternate pathways of MSH2-dependent mismatch repair.","label":0}
{"pair_id":"BioInfer.d519.s1.p9","sentence":"Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with @PROTEIN2$ or MSH6 and that MSH3 and @PROTEIN1$ constitute alternate pathways of MSH2-dependent mismatch repair.","label":0}
{"pair_id":"BioInfer.d519.s1.p10","sentence":"Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with MSH3 or MSH6 and that MSH3 and @PROTEIN1$ constitute alternate pathways of @PROTEIN2$-dependent mismatch repair.","label":1}
{"pair_id":"BioInfer.d519.s1.p11","sentence":"Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with MSH3 or MSH6 and that @PROTEIN2$ and @PROTEIN1$ constitute alternate pathways of MSH2-dependent mismatch repair.","label":0}
{"pair_id":"BioInfer.d519.s1.p12","sentence":"Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with @PROTEIN1$ or MSH6 and that MSH3 and MSH6 constitute alternate pathways of @PROTEIN2$-dependent mismatch repair.","label":0}
{"pair_id":"BioInfer.d519.s1.p13","sentence":"Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with @PROTEIN1$ or MSH6 and that @PROTEIN2$ and MSH6 constitute alternate pathways of MSH2-dependent mismatch repair.","label":0}
{"pair_id":"BioInfer.d519.s1.p14","sentence":"Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with MSH3 or MSH6 and that @PROTEIN2$ and MSH6 constitute alternate pathways of @PROTEIN1$-dependent mismatch repair.","label":1}
{"pair_id":"BioInfer.d288.s1.p0","sentence":"In this study, we demonstrate using viscosity, sedimentation, and @PROTEIN2$ assembly rate assays that yeast @PROTEIN1$ (16 kD) possesses all of these properties.","label":0}
{"pair_id":"BioInfer.d41.s0.p0","sentence":"Although @PROTEIN1$ released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of @PROTEIN2$ released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.","label":0}
{"pair_id":"BioInfer.d41.s0.p1","sentence":"Although @PROTEIN1$ released actin at the appropriate time to stimulate @PROTEIN2$ assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.","label":1}
{"pair_id":"BioInfer.d41.s0.p2","sentence":"Although @PROTEIN1$ released @PROTEIN2$ at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.","label":1}
{"pair_id":"BioInfer.d41.s0.p3","sentence":"Although @PROTEIN1$ released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized @PROTEIN2$ content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.","label":0}
{"pair_id":"BioInfer.d41.s0.p4","sentence":"Although @PROTEIN1$ released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of @PROTEIN2$ in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.","label":0}
{"pair_id":"BioInfer.d41.s0.p5","sentence":"Although @PROTEIN1$ released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized @PROTEIN2$ associated with maximal chemoattractant stimulation.","label":0}
{"pair_id":"BioInfer.d41.s0.p6","sentence":"Although @PROTEIN1$ released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from @PROTEIN2$ too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.","label":0}
{"pair_id":"BioInfer.d41.s0.p7","sentence":"Although profilin released actin at the appropriate time to stimulate @PROTEIN2$ assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of @PROTEIN1$ released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.","label":0}
{"pair_id":"BioInfer.d41.s0.p8","sentence":"Although profilin released @PROTEIN2$ at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of @PROTEIN1$ released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.","label":0}
{"pair_id":"BioInfer.d41.s0.p9","sentence":"Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized @PROTEIN2$ content in unstimulated PMN and the quantity of @PROTEIN1$ released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.","label":0}
{"pair_id":"BioInfer.d41.s0.p10","sentence":"Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of @PROTEIN2$ in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of @PROTEIN1$ released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.","label":0}
{"pair_id":"BioInfer.d41.s0.p11","sentence":"Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of @PROTEIN1$ released from profilin too small to account for the large shifts from unpolymerized to polymerized @PROTEIN2$ associated with maximal chemoattractant stimulation.","label":1}
{"pair_id":"BioInfer.d41.s0.p12","sentence":"Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of @PROTEIN1$ released from @PROTEIN2$ too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.","label":1}
{"pair_id":"BioInfer.d41.s0.p13","sentence":"Although profilin released @PROTEIN2$ at the appropriate time to stimulate @PROTEIN1$ assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.","label":1}
{"pair_id":"BioInfer.d41.s0.p14","sentence":"Although profilin released actin at the appropriate time to stimulate @PROTEIN1$ assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized @PROTEIN2$ content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.","label":0}
{"pair_id":"BioInfer.d41.s0.p15","sentence":"Although profilin released actin at the appropriate time to stimulate @PROTEIN1$ assembly during exposure to chemoattractants, the concentration of @PROTEIN2$ in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.","label":0}
{"pair_id":"BioInfer.d41.s0.p16","sentence":"Although profilin released actin at the appropriate time to stimulate @PROTEIN1$ assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized @PROTEIN2$ associated with maximal chemoattractant stimulation.","label":0}
{"pair_id":"BioInfer.d41.s0.p17","sentence":"Although profilin released actin at the appropriate time to stimulate @PROTEIN1$ assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from @PROTEIN2$ too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.","label":0}
{"pair_id":"BioInfer.d41.s0.p18","sentence":"Although profilin released @PROTEIN1$ at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized @PROTEIN2$ content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.","label":0}
{"pair_id":"BioInfer.d41.s0.p19","sentence":"Although profilin released @PROTEIN1$ at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of @PROTEIN2$ in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.","label":0}
{"pair_id":"BioInfer.d41.s0.p20","sentence":"Although profilin released @PROTEIN1$ at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized @PROTEIN2$ associated with maximal chemoattractant stimulation.","label":0}
{"pair_id":"BioInfer.d41.s0.p21","sentence":"Although profilin released @PROTEIN1$ at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from @PROTEIN2$ too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.","label":0}
{"pair_id":"BioInfer.d41.s0.p22","sentence":"Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of @PROTEIN2$ in PMN was insufficient to explain the high unpolymerized @PROTEIN1$ content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.","label":1}
{"pair_id":"BioInfer.d41.s0.p23","sentence":"Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized @PROTEIN1$ content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized @PROTEIN2$ associated with maximal chemoattractant stimulation.","label":0}
{"pair_id":"BioInfer.d41.s0.p24","sentence":"Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized @PROTEIN1$ content in unstimulated PMN and the quantity of actin released from @PROTEIN2$ too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.","label":0}
{"pair_id":"BioInfer.d41.s0.p25","sentence":"Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of @PROTEIN1$ in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized @PROTEIN2$ associated with maximal chemoattractant stimulation.","label":0}
{"pair_id":"BioInfer.d41.s0.p26","sentence":"Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of @PROTEIN1$ in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from @PROTEIN2$ too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.","label":0}
{"pair_id":"BioInfer.d41.s0.p27","sentence":"Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from @PROTEIN2$ too small to account for the large shifts from unpolymerized to polymerized @PROTEIN1$ associated with maximal chemoattractant stimulation.","label":0}
{"pair_id":"BioInfer.d711.s0.p0","sentence":"These results suggest that activation of PKC precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with @PROTEIN2$ such as gelsolin and @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d711.s0.p1","sentence":"These results suggest that activation of PKC precedes the activation of @PROTEIN2$ and PIP @PROTEIN2$ and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d711.s0.p2","sentence":"These results suggest that activation of @PROTEIN2$ precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d711.s0.p3","sentence":"These results suggest that activation of PKC precedes the activation of PI and @PROTEIN2$ and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d711.s0.p4","sentence":"These results suggest that activation of PKC precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of @PROTEIN2$ in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d711.s0.p5","sentence":"These results suggest that activation of PKC precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as @PROTEIN2$ and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d711.s0.p6","sentence":"These results suggest that activation of PKC precedes the activation of @PROTEIN2$ and PIP @PROTEIN2$ and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with @PROTEIN1$ such as gelsolin and profilin.","label":1}
{"pair_id":"BioInfer.d711.s0.p7","sentence":"These results suggest that activation of @PROTEIN2$ precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with @PROTEIN1$ such as gelsolin and profilin.","label":1}
{"pair_id":"BioInfer.d711.s0.p8","sentence":"These results suggest that activation of PKC precedes the activation of PI and @PROTEIN2$ and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with @PROTEIN1$ such as gelsolin and profilin.","label":1}
{"pair_id":"BioInfer.d711.s0.p9","sentence":"These results suggest that activation of PKC precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of @PROTEIN2$ in RBL cells, possibly through the interaction of the polyphosphoinositides with @PROTEIN1$ such as gelsolin and profilin.","label":1}
{"pair_id":"BioInfer.d711.s0.p10","sentence":"These results suggest that activation of PKC precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with @PROTEIN1$ such as @PROTEIN2$ and profilin.","label":1}
{"pair_id":"BioInfer.d711.s0.p11","sentence":"These results suggest that activation of @PROTEIN2$ precedes the activation of @PROTEIN1$ and PIP @PROTEIN1$ and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and profilin.","label":1}
{"pair_id":"BioInfer.d711.s0.p12","sentence":"These results suggest that activation of PKC precedes the activation of @PROTEIN1$ and @PROTEIN2$@PROTEIN1$ and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and profilin.","label":0}
{"pair_id":"BioInfer.d711.s0.p13","sentence":"These results suggest that activation of PKC precedes the activation of @PROTEIN1$ and PIP @PROTEIN1$ and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of @PROTEIN2$ in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and profilin.","label":1}
{"pair_id":"BioInfer.d711.s0.p14","sentence":"These results suggest that activation of PKC precedes the activation of @PROTEIN1$ and PIP @PROTEIN1$ and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as @PROTEIN2$ and profilin.","label":0}
{"pair_id":"BioInfer.d711.s0.p15","sentence":"These results suggest that activation of @PROTEIN1$ precedes the activation of PI and @PROTEIN2$ and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and profilin.","label":1}
{"pair_id":"BioInfer.d711.s0.p16","sentence":"These results suggest that activation of @PROTEIN1$ precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of @PROTEIN2$ in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and profilin.","label":1}
{"pair_id":"BioInfer.d711.s0.p17","sentence":"These results suggest that activation of @PROTEIN1$ precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as @PROTEIN2$ and profilin.","label":0}
{"pair_id":"BioInfer.d711.s0.p18","sentence":"These results suggest that activation of PKC precedes the activation of PI and @PROTEIN1$ and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of @PROTEIN2$ in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and profilin.","label":1}
{"pair_id":"BioInfer.d711.s0.p19","sentence":"These results suggest that activation of PKC precedes the activation of PI and @PROTEIN1$ and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as @PROTEIN2$ and profilin.","label":0}
{"pair_id":"BioInfer.d711.s0.p20","sentence":"These results suggest that activation of PKC precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of @PROTEIN1$ in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as @PROTEIN2$ and profilin.","label":0}
{"pair_id":"AIMed.d32.s269.p0","sentence":"We have shown previously that Phe93 in the extracellular domain of the @PROTEIN1$ (@PROTEIN2$) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p1","sentence":"We have shown previously that Phe93 in the extracellular domain of the @PROTEIN1$@PROTEIN2$ (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p2","sentence":"We have shown previously that Phe93 in the extracellular domain of the @PROTEIN1$ (EPO) receptor (@PROTEIN2$) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":1}
{"pair_id":"AIMed.d32.s269.p3","sentence":"We have shown previously that Phe93 in the extracellular domain of the @PROTEIN1$ (EPO) receptor (EPOR) is crucial for binding @PROTEIN2$.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p4","sentence":"We have shown previously that Phe93 in the extracellular domain of the @PROTEIN1$ (EPO) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in @PROTEIN2$ binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p5","sentence":"We have shown previously that Phe93 in the extracellular domain of the @PROTEIN1$ (EPO) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the @PROTEIN2$ (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p6","sentence":"We have shown previously that Phe93 in the extracellular domain of the @PROTEIN1$ (EPO) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (@PROTEIN2$-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p7","sentence":"We have shown previously that Phe93 in the extracellular domain of the @PROTEIN1$ (EPO) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (@PROTEIN2$ or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p8","sentence":"We have shown previously that Phe93 in the extracellular domain of the @PROTEIN1$ (EPO) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or @PROTEIN2$) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p9","sentence":"We have shown previously that Phe93 in the extracellular domain of the @PROTEIN2$@PROTEIN1$) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p10","sentence":"We have shown previously that Phe93 in the extracellular domain of the erythropoietin (@PROTEIN1$) receptor (@PROTEIN2$) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":1}
{"pair_id":"AIMed.d32.s269.p11","sentence":"We have shown previously that Phe93 in the extracellular domain of the erythropoietin (@PROTEIN1$) receptor (EPOR) is crucial for binding @PROTEIN2$.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p12","sentence":"We have shown previously that Phe93 in the extracellular domain of the erythropoietin (@PROTEIN1$) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in @PROTEIN2$ binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p13","sentence":"We have shown previously that Phe93 in the extracellular domain of the erythropoietin (@PROTEIN1$) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the @PROTEIN2$ (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p14","sentence":"We have shown previously that Phe93 in the extracellular domain of the erythropoietin (@PROTEIN1$) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (@PROTEIN2$-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p15","sentence":"We have shown previously that Phe93 in the extracellular domain of the erythropoietin (@PROTEIN1$) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (@PROTEIN2$ or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p16","sentence":"We have shown previously that Phe93 in the extracellular domain of the erythropoietin (@PROTEIN1$) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or @PROTEIN2$) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p17","sentence":"We have shown previously that Phe93 in the extracellular domain of the @PROTEIN1$ (@PROTEIN2$) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p18","sentence":"We have shown previously that Phe93 in the extracellular domain of the @PROTEIN1$ (EPOR) is crucial for binding @PROTEIN2$.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":1}
{"pair_id":"AIMed.d32.s269.p19","sentence":"We have shown previously that Phe93 in the extracellular domain of the @PROTEIN1$ (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in @PROTEIN2$ binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p20","sentence":"We have shown previously that Phe93 in the extracellular domain of the @PROTEIN1$ (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the @PROTEIN2$ (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p21","sentence":"We have shown previously that Phe93 in the extracellular domain of the @PROTEIN1$ (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (@PROTEIN2$-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p22","sentence":"We have shown previously that Phe93 in the extracellular domain of the @PROTEIN1$ (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (@PROTEIN2$ or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p23","sentence":"We have shown previously that Phe93 in the extracellular domain of the @PROTEIN1$ (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or @PROTEIN2$) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p24","sentence":"We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor (@PROTEIN1$) is crucial for binding @PROTEIN2$.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":1}
{"pair_id":"AIMed.d32.s269.p25","sentence":"We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor (@PROTEIN1$) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in @PROTEIN2$ binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p26","sentence":"We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor (@PROTEIN1$) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the @PROTEIN2$ (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p27","sentence":"We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor (@PROTEIN1$) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (@PROTEIN2$-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p28","sentence":"We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor (@PROTEIN1$) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (@PROTEIN2$ or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p29","sentence":"We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor (@PROTEIN1$) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or @PROTEIN2$) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p30","sentence":"We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor (EPOR) is crucial for binding @PROTEIN1$.Substitution of Phe93 with alanine resulted in a dramatic decrease in @PROTEIN2$ binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p31","sentence":"We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor (EPOR) is crucial for binding @PROTEIN1$.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the @PROTEIN2$ (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p32","sentence":"We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor (EPOR) is crucial for binding @PROTEIN1$.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (@PROTEIN2$-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p33","sentence":"We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor (EPOR) is crucial for binding @PROTEIN1$.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (@PROTEIN2$ or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p34","sentence":"We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor (EPOR) is crucial for binding @PROTEIN1$.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or @PROTEIN2$) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p35","sentence":"We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in @PROTEIN1$ binding to the Escherichia coli-expressed extracellular domain of the @PROTEIN2$ (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":1}
{"pair_id":"AIMed.d32.s269.p36","sentence":"We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in @PROTEIN1$ binding to the Escherichia coli-expressed extracellular domain of the EPOR (@PROTEIN2$-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p37","sentence":"We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in @PROTEIN1$ binding to the Escherichia coli-expressed extracellular domain of the EPOR (@PROTEIN2$ or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":1}
{"pair_id":"AIMed.d32.s269.p38","sentence":"We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in @PROTEIN1$ binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or @PROTEIN2$) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":1}
{"pair_id":"AIMed.d32.s269.p39","sentence":"We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the @PROTEIN1$ (@PROTEIN2$-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p40","sentence":"We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the @PROTEIN1$ (@PROTEIN2$ or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p41","sentence":"We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the @PROTEIN1$ (EPO-binding protein or @PROTEIN2$) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p42","sentence":"We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (@PROTEIN1$@PROTEIN2$ or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p43","sentence":"We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (@PROTEIN1$-binding protein or @PROTEIN2$) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p44","sentence":"We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (@PROTEIN1$ or @PROTEIN2$) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d81.s689.p0","sentence":"Ligation of the extracellular domain of the cell surface receptor @PROTEIN1$\/@PROTEIN2$ (CD95) elicits a characteristic programmed death response in susceptible cells.","label":0}
{"pair_id":"AIMed.d81.s689.p1","sentence":"Ligation of the extracellular domain of the cell surface receptor @PROTEIN1$\/APO-1 (@PROTEIN2$) elicits a characteristic programmed death response in susceptible cells.","label":0}
{"pair_id":"AIMed.d81.s689.p2","sentence":"Ligation of the extracellular domain of the cell surface receptor Fas\/@PROTEIN1$ (@PROTEIN2$) elicits a characteristic programmed death response in susceptible cells.","label":0}
{"pair_id":"BioInfer.d557.s0.p0","sentence":"Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, Myf5, the @PROTEIN2$, or the @PROTEIN1$ genes.","label":0}
{"pair_id":"BioInfer.d557.s0.p1","sentence":"Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, @PROTEIN2$, the skeletal muscle actin, or the @PROTEIN1$ genes.","label":0}
{"pair_id":"BioInfer.d557.s0.p2","sentence":"Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, @PROTEIN2$, Myf5, the skeletal muscle actin, or the @PROTEIN1$ genes.","label":0}
{"pair_id":"BioInfer.d557.s0.p3","sentence":"Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous @PROTEIN2$, MRF4, Myf5, the skeletal muscle actin, or the @PROTEIN1$ genes.","label":0}
{"pair_id":"BioInfer.d557.s0.p4","sentence":"Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and @PROTEIN2$ gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the @PROTEIN1$ genes.","label":0}
{"pair_id":"BioInfer.d557.s0.p5","sentence":"Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous @PROTEIN2$ and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the @PROTEIN1$ genes.","label":0}
{"pair_id":"BioInfer.d557.s0.p6","sentence":"Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, @PROTEIN2$, the @PROTEIN1$, or the myosin heavy chain genes.","label":0}
{"pair_id":"BioInfer.d557.s0.p7","sentence":"Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, @PROTEIN2$, Myf5, the @PROTEIN1$, or the myosin heavy chain genes.","label":0}
{"pair_id":"BioInfer.d557.s0.p8","sentence":"Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous @PROTEIN2$, MRF4, Myf5, the @PROTEIN1$, or the myosin heavy chain genes.","label":0}
{"pair_id":"BioInfer.d557.s0.p9","sentence":"Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and @PROTEIN2$ gene but not the endogenous MyoD1, MRF4, Myf5, the @PROTEIN1$, or the myosin heavy chain genes.","label":0}
{"pair_id":"BioInfer.d557.s0.p10","sentence":"Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous @PROTEIN2$ and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, Myf5, the @PROTEIN1$, or the myosin heavy chain genes.","label":0}
{"pair_id":"BioInfer.d557.s0.p11","sentence":"Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, @PROTEIN2$, @PROTEIN1$, the skeletal muscle actin, or the myosin heavy chain genes.","label":0}
{"pair_id":"BioInfer.d557.s0.p12","sentence":"Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous @PROTEIN2$, MRF4, @PROTEIN1$, the skeletal muscle actin, or the myosin heavy chain genes.","label":0}
{"pair_id":"BioInfer.d557.s0.p13","sentence":"Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and @PROTEIN2$ gene but not the endogenous MyoD1, MRF4, @PROTEIN1$, the skeletal muscle actin, or the myosin heavy chain genes.","label":0}
{"pair_id":"BioInfer.d557.s0.p14","sentence":"Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous @PROTEIN2$ and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, @PROTEIN1$, the skeletal muscle actin, or the myosin heavy chain genes.","label":0}
{"pair_id":"BioInfer.d557.s0.p15","sentence":"Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous @PROTEIN2$, @PROTEIN1$, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.","label":0}
{"pair_id":"BioInfer.d557.s0.p16","sentence":"Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and @PROTEIN2$ gene but not the endogenous MyoD1, @PROTEIN1$, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.","label":0}
{"pair_id":"BioInfer.d557.s0.p17","sentence":"Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous @PROTEIN2$ and myosin light chain 2 gene but not the endogenous MyoD1, @PROTEIN1$, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.","label":0}
{"pair_id":"BioInfer.d557.s0.p18","sentence":"Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and @PROTEIN2$ gene but not the endogenous @PROTEIN1$, MRF4, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.","label":0}
{"pair_id":"BioInfer.d557.s0.p19","sentence":"Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous @PROTEIN2$ and myosin light chain 2 gene but not the endogenous @PROTEIN1$, MRF4, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.","label":0}
{"pair_id":"BioInfer.d557.s0.p20","sentence":"Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous @PROTEIN2$ and @PROTEIN1$ gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.","label":0}
{"pair_id":"BioInfer.d621.s0.p0","sentence":"The Herpes simplex virus type 1 @PROTEIN2$ consists of three subunits that are the products of the @PROTEIN1$, UL8, and UL52 genes.","label":1}
{"pair_id":"BioInfer.d621.s0.p1","sentence":"The Herpes simplex virus type 1 primosome consists of three subunits that are the products of the @PROTEIN1$, @PROTEIN2$, and UL52 genes.","label":1}
{"pair_id":"BioInfer.d621.s0.p2","sentence":"The Herpes simplex virus type 1 primosome consists of three subunits that are the products of the @PROTEIN1$, UL8, and @PROTEIN2$ genes.","label":1}
{"pair_id":"BioInfer.d621.s0.p3","sentence":"The Herpes simplex virus type 1 @PROTEIN1$ consists of three subunits that are the products of the UL5, @PROTEIN2$, and UL52 genes.","label":1}
{"pair_id":"BioInfer.d621.s0.p4","sentence":"The Herpes simplex virus type 1 @PROTEIN1$ consists of three subunits that are the products of the UL5, UL8, and @PROTEIN2$ genes.","label":1}
{"pair_id":"BioInfer.d621.s0.p5","sentence":"The Herpes simplex virus type 1 primosome consists of three subunits that are the products of the UL5, @PROTEIN1$, and @PROTEIN2$ genes.","label":1}
{"pair_id":"BioInfer.d199.s0.p0","sentence":"Exposure of the cells to tumor promoter did, however, result in a loss of @PROTEIN1$ and @PROTEIN2$-rich cell surface elaborations that resemble focal contact precursor structures.","label":0}
{"pair_id":"AIMed.d180.s1533.p0","sentence":"In the yeast-based cloning system, the only strong interaction that was detected between @PROTEIN1$ and the @PROTEIN2$, calmodulin (CaM).","label":0}
{"pair_id":"AIMed.d180.s1533.p1","sentence":"In the yeast-based cloning system, the only strong interaction that was detected between @PROTEIN1$ and the calcium effector protein, @PROTEIN2$ (CaM).","label":1}
{"pair_id":"AIMed.d180.s1533.p2","sentence":"In the yeast-based cloning system, the only strong interaction that was detected between @PROTEIN1$ and the calcium effector protein, calmodulin (@PROTEIN2$).","label":1}
{"pair_id":"AIMed.d180.s1533.p3","sentence":"In the yeast-based cloning system, the only strong interaction that was detected between GAP-43 and the @PROTEIN1$, @PROTEIN2$ (CaM).","label":0}
{"pair_id":"AIMed.d180.s1533.p4","sentence":"In the yeast-based cloning system, the only strong interaction that was detected between GAP-43 and the @PROTEIN1$, calmodulin (@PROTEIN2$).","label":0}
{"pair_id":"AIMed.d180.s1533.p5","sentence":"In the yeast-based cloning system, the only strong interaction that was detected between GAP-43 and the calcium effector protein, @PROTEIN1$ (@PROTEIN2$).","label":0}
{"pair_id":"AIMed.d187.s1586.p0","sentence":"Aggregated @PROTEIN1$ (@PROTEIN2$) is a key component of the amyloid depositions found in the brains of patients with Alzheimer's disease.","label":0}
{"pair_id":"AIMed.d179.s1519.p0","sentence":"@PROTEIN1$ stimulates tyrosine phosphorylation of @PROTEIN2$ receptor substrate 1 and its association with Grb2 and the phosphatidylinositol 3-kinase.","label":0}
{"pair_id":"AIMed.d179.s1519.p1","sentence":"@PROTEIN1$ stimulates tyrosine phosphorylation of @PROTEIN2$ substrate 1 and its association with Grb2 and the phosphatidylinositol 3-kinase.","label":0}
{"pair_id":"AIMed.d179.s1519.p2","sentence":"@PROTEIN1$ stimulates tyrosine phosphorylation of @PROTEIN2$ and its association with Grb2 and the phosphatidylinositol 3-kinase.","label":1}
{"pair_id":"AIMed.d179.s1519.p3","sentence":"@PROTEIN1$ stimulates tyrosine phosphorylation of insulin receptor substrate 1 and its association with @PROTEIN2$ and the phosphatidylinositol 3-kinase.","label":0}
{"pair_id":"AIMed.d179.s1519.p4","sentence":"@PROTEIN1$ stimulates tyrosine phosphorylation of insulin receptor substrate 1 and its association with Grb2 and the @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d179.s1519.p5","sentence":"Gastrin stimulates tyrosine phosphorylation of @PROTEIN1$@PROTEIN2$ substrate 1 and its association with Grb2 and the phosphatidylinositol 3-kinase.","label":0}
{"pair_id":"AIMed.d179.s1519.p6","sentence":"Gastrin stimulates tyrosine phosphorylation of @PROTEIN1$@PROTEIN2$ and its association with Grb2 and the phosphatidylinositol 3-kinase.","label":0}
{"pair_id":"AIMed.d179.s1519.p7","sentence":"Gastrin stimulates tyrosine phosphorylation of @PROTEIN1$ receptor substrate 1 and its association with @PROTEIN2$ and the phosphatidylinositol 3-kinase.","label":0}
{"pair_id":"AIMed.d179.s1519.p8","sentence":"Gastrin stimulates tyrosine phosphorylation of @PROTEIN1$ receptor substrate 1 and its association with Grb2 and the @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d179.s1519.p9","sentence":"Gastrin stimulates tyrosine phosphorylation of @PROTEIN1$@PROTEIN2$ and its association with Grb2 and the phosphatidylinositol 3-kinase.","label":0}
{"pair_id":"AIMed.d179.s1519.p10","sentence":"Gastrin stimulates tyrosine phosphorylation of @PROTEIN1$ substrate 1 and its association with @PROTEIN2$ and the phosphatidylinositol 3-kinase.","label":0}
{"pair_id":"AIMed.d179.s1519.p11","sentence":"Gastrin stimulates tyrosine phosphorylation of @PROTEIN1$ substrate 1 and its association with Grb2 and the @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d179.s1519.p12","sentence":"Gastrin stimulates tyrosine phosphorylation of @PROTEIN1$ and its association with @PROTEIN2$ and the phosphatidylinositol 3-kinase.","label":1}
{"pair_id":"AIMed.d179.s1519.p13","sentence":"Gastrin stimulates tyrosine phosphorylation of @PROTEIN1$ and its association with Grb2 and the @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d179.s1519.p14","sentence":"Gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 and its association with @PROTEIN1$ and the @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d757.s1.p0","sentence":"We have previously shown that the synthetic dodecapeptide corresponding to Trp104-Met115 of @PROTEIN1$ is a potent inhibitor of @PROTEIN2$ polymerization (Yonezawa, N., Nishida, E., Iida, K., Kumagai, H., Yahara, I., and Sakai, H. (1991) J. Biol. Chem. 266, 10485-10489).","label":1}
{"pair_id":"BioInfer.d124.s1.p0","sentence":"@PROTEIN1$ links @PROTEIN2$ to the actin-based cytoskeleton.","label":1}
{"pair_id":"BioInfer.d124.s1.p1","sentence":"@PROTEIN1$ links beta-catenin to the @PROTEIN2$-based cytoskeleton.","label":1}
{"pair_id":"BioInfer.d124.s1.p2","sentence":"alpha-catenin links @PROTEIN1$ to the @PROTEIN2$-based cytoskeleton.","label":1}
{"pair_id":"AIMed.d61.s539.p0","sentence":"Shedding of the extracellular domain of @PROTEIN1$ was induced by 4 beta-phorbol 12-myristate 13-acetate but not by @PROTEIN2$ or TNF-beta.","label":0}
{"pair_id":"AIMed.d61.s539.p1","sentence":"Shedding of the extracellular domain of @PROTEIN1$ was induced by 4 beta-phorbol 12-myristate 13-acetate but not by TNF-alpha or @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d61.s539.p2","sentence":"Shedding of the extracellular domain of TNF-R2 was induced by 4 beta-phorbol 12-myristate 13-acetate but not by @PROTEIN1$ or @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d70.s599.p0","sentence":"Specifically, substitution of proline for Ala-498 significantly diminished @PROTEIN1$@PROTEIN2$ binding, and similar mutation of Ile-502 or Ile-507 abolished interaction.","label":0}
{"pair_id":"BioInfer.d434.s0.p0","sentence":"Monocytes and in vitro differentiated U937 cells induce focal loss in the staining of VE-cadherin, @PROTEIN2$, beta-catenin, and @PROTEIN1$ during transendothelial migration under physiological flow conditions.","label":0}
{"pair_id":"BioInfer.d434.s0.p1","sentence":"Monocytes and in vitro differentiated U937 cells induce focal loss in the staining of VE-cadherin, alpha-catenin, @PROTEIN2$, and @PROTEIN1$ during transendothelial migration under physiological flow conditions.","label":0}
{"pair_id":"BioInfer.d434.s0.p2","sentence":"Monocytes and in vitro differentiated U937 cells induce focal loss in the staining of @PROTEIN2$, alpha-catenin, beta-catenin, and @PROTEIN1$ during transendothelial migration under physiological flow conditions.","label":0}
{"pair_id":"BioInfer.d434.s0.p3","sentence":"Monocytes and in vitro differentiated U937 cells induce focal loss in the staining of VE-cadherin, @PROTEIN1$, @PROTEIN2$, and plakoglobin during transendothelial migration under physiological flow conditions.","label":0}
{"pair_id":"BioInfer.d434.s0.p4","sentence":"Monocytes and in vitro differentiated U937 cells induce focal loss in the staining of @PROTEIN2$, @PROTEIN1$, beta-catenin, and plakoglobin during transendothelial migration under physiological flow conditions.","label":0}
{"pair_id":"BioInfer.d434.s0.p5","sentence":"Monocytes and in vitro differentiated U937 cells induce focal loss in the staining of @PROTEIN2$, alpha-catenin, @PROTEIN1$, and plakoglobin during transendothelial migration under physiological flow conditions.","label":0}
{"pair_id":"BioInfer.d388.s1.p0","sentence":"@PROTEIN2$, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of @PROTEIN1$, a profilin mutant defective in actin binding.","label":1}
{"pair_id":"BioInfer.d388.s1.p1","sentence":"act1-157, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of @PROTEIN1$, a @PROTEIN2$ mutant defective in actin binding.","label":0}
{"pair_id":"BioInfer.d388.s1.p2","sentence":"act1-157, an @PROTEIN2$ mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of @PROTEIN1$, a profilin mutant defective in actin binding.","label":1}
{"pair_id":"BioInfer.d388.s1.p3","sentence":"act1-157, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in @PROTEIN2$ organization, cell growth, and fluid-phase endocytosis of @PROTEIN1$, a profilin mutant defective in actin binding.","label":0}
{"pair_id":"BioInfer.d388.s1.p4","sentence":"act1-157, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of @PROTEIN1$, a profilin mutant defective in @PROTEIN2$ binding.","label":1}
{"pair_id":"BioInfer.d388.s1.p5","sentence":"@PROTEIN1$, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of pfy1-4, a @PROTEIN2$ mutant defective in actin binding.","label":1}
{"pair_id":"BioInfer.d388.s1.p6","sentence":"@PROTEIN1$, an @PROTEIN2$ mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of pfy1-4, a profilin mutant defective in actin binding.","label":0}
{"pair_id":"BioInfer.d388.s1.p7","sentence":"@PROTEIN1$, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in @PROTEIN2$ organization, cell growth, and fluid-phase endocytosis of pfy1-4, a profilin mutant defective in actin binding.","label":1}
{"pair_id":"BioInfer.d388.s1.p8","sentence":"@PROTEIN1$, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of pfy1-4, a profilin mutant defective in @PROTEIN2$ binding.","label":0}
{"pair_id":"BioInfer.d388.s1.p9","sentence":"act1-157, an @PROTEIN2$ mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of pfy1-4, a @PROTEIN1$ mutant defective in actin binding.","label":1}
{"pair_id":"BioInfer.d388.s1.p10","sentence":"act1-157, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in @PROTEIN2$ organization, cell growth, and fluid-phase endocytosis of pfy1-4, a @PROTEIN1$ mutant defective in actin binding.","label":0}
{"pair_id":"BioInfer.d388.s1.p11","sentence":"act1-157, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of pfy1-4, a @PROTEIN1$ mutant defective in @PROTEIN2$ binding.","label":1}
{"pair_id":"BioInfer.d388.s1.p12","sentence":"act1-157, an @PROTEIN1$ mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in @PROTEIN2$ organization, cell growth, and fluid-phase endocytosis of pfy1-4, a profilin mutant defective in actin binding.","label":1}
{"pair_id":"BioInfer.d388.s1.p13","sentence":"act1-157, an @PROTEIN1$ mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of pfy1-4, a profilin mutant defective in @PROTEIN2$ binding.","label":0}
{"pair_id":"BioInfer.d388.s1.p14","sentence":"act1-157, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in @PROTEIN1$ organization, cell growth, and fluid-phase endocytosis of pfy1-4, a profilin mutant defective in @PROTEIN2$ binding.","label":0}
{"pair_id":"BioInfer.d81.s0.p0","sentence":"As expected from immunofluorescence experiments, Abp1p, @PROTEIN1$, and @PROTEIN2$ colocalized in immuno-EM to the dense patchlike structures but not to the cables.","label":1}
{"pair_id":"BioInfer.d81.s0.p1","sentence":"As expected from immunofluorescence experiments, @PROTEIN2$, @PROTEIN1$, and actin colocalized in immuno-EM to the dense patchlike structures but not to the cables.","label":1}
{"pair_id":"BioInfer.d81.s0.p2","sentence":"As expected from immunofluorescence experiments, @PROTEIN2$, cofilin, and @PROTEIN1$ colocalized in immuno-EM to the dense patchlike structures but not to the cables.","label":1}
{"pair_id":"BioInfer.d20.s0.p0","sentence":"Active, Ser133-phosphorylated CREB effects transcription of CRE-dependent genes via interaction with the 265-kDa co-activator protein @PROTEIN1$, CBP, which bridges the CRE\/@PROTEIN2$ complex to components of the basal transcriptional apparatus.","label":1}
{"pair_id":"BioInfer.d20.s0.p1","sentence":"Active, Ser133-phosphorylated @PROTEIN2$ effects transcription of CRE-dependent genes via interaction with the 265-kDa co-activator protein @PROTEIN1$, CBP, which bridges the CRE\/CREB complex to components of the basal transcriptional apparatus.","label":1}
{"pair_id":"BioInfer.d20.s0.p2","sentence":"Active, Ser133-phosphorylated CREB effects transcription of CRE-dependent genes via interaction with the 265-kDa co-activator protein @PROTEIN1$, @PROTEIN2$, which bridges the CRE\/CREB complex to components of the basal transcriptional apparatus.","label":0}
{"pair_id":"BioInfer.d20.s0.p3","sentence":"Active, Ser133-phosphorylated @PROTEIN2$ effects transcription of CRE-dependent genes via interaction with the 265-kDa co-activator protein CREB-binding-protein, CBP, which bridges the CRE\/@PROTEIN1$ complex to components of the basal transcriptional apparatus.","label":0}
{"pair_id":"BioInfer.d20.s0.p4","sentence":"Active, Ser133-phosphorylated CREB effects transcription of CRE-dependent genes via interaction with the 265-kDa co-activator protein CREB-binding-protein, @PROTEIN2$, which bridges the CRE\/@PROTEIN1$ complex to components of the basal transcriptional apparatus.","label":1}
{"pair_id":"BioInfer.d20.s0.p5","sentence":"Active, Ser133-phosphorylated @PROTEIN1$ effects transcription of CRE-dependent genes via interaction with the 265-kDa co-activator protein CREB-binding-protein, @PROTEIN2$, which bridges the CRE\/CREB complex to components of the basal transcriptional apparatus.","label":1}
{"pair_id":"AIMed.d100.s849.p0","sentence":"The @PROTEIN1$ gene is identical to a gene, @PROTEIN2$, (ref 7,8), implicated in cell-cycle progression.","label":0}
{"pair_id":"AIMed.d87.s737.p0","sentence":"Interaction of @PROTEIN1$ and N+C-SH2 with @PROTEIN2$ (delta C-43) or IGF-1R beta(delta C-43) in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.","label":1}
{"pair_id":"AIMed.d87.s737.p1","sentence":"Interaction of @PROTEIN1$ and N+C-SH2 with IR beta (@PROTEIN2$) or IGF-1R beta(delta C-43) in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.","label":0}
{"pair_id":"AIMed.d87.s737.p2","sentence":"Interaction of @PROTEIN1$ and N+C-SH2 with IR beta (delta C-43) or @PROTEIN2$ beta(delta C-43) in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.","label":0}
{"pair_id":"AIMed.d87.s737.p3","sentence":"Interaction of @PROTEIN1$ and N+C-SH2 with IR beta (delta C-43) or @PROTEIN2$(delta C-43) in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.","label":1}
{"pair_id":"AIMed.d87.s737.p4","sentence":"Interaction of @PROTEIN1$ and N+C-SH2 with IR beta (delta C-43) or IGF-1R beta(@PROTEIN2$) in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.","label":0}
{"pair_id":"AIMed.d87.s737.p5","sentence":"Interaction of p85 and N+C-SH2 with @PROTEIN1$ (@PROTEIN2$) or IGF-1R beta(delta C-43) in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.","label":0}
{"pair_id":"AIMed.d87.s737.p6","sentence":"Interaction of p85 and N+C-SH2 with @PROTEIN1$ (delta C-43) or @PROTEIN2$ beta(delta C-43) in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.","label":0}
{"pair_id":"AIMed.d87.s737.p7","sentence":"Interaction of p85 and N+C-SH2 with @PROTEIN1$ (delta C-43) or @PROTEIN2$(delta C-43) in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.","label":0}
{"pair_id":"AIMed.d87.s737.p8","sentence":"Interaction of p85 and N+C-SH2 with @PROTEIN1$ (delta C-43) or IGF-1R beta(@PROTEIN2$) in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.","label":0}
{"pair_id":"AIMed.d87.s737.p9","sentence":"Interaction of p85 and N+C-SH2 with IR beta (@PROTEIN1$) or @PROTEIN2$ beta(delta C-43) in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.","label":0}
{"pair_id":"AIMed.d87.s737.p10","sentence":"Interaction of p85 and N+C-SH2 with IR beta (@PROTEIN1$) or @PROTEIN2$(delta C-43) in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.","label":0}
{"pair_id":"AIMed.d87.s737.p11","sentence":"Interaction of p85 and N+C-SH2 with IR beta (@PROTEIN1$) or IGF-1R beta(@PROTEIN2$) in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.","label":0}
{"pair_id":"AIMed.d87.s737.p12","sentence":"Interaction of p85 and N+C-SH2 with IR beta (delta C-43) or @PROTEIN1$@PROTEIN2$(delta C-43) in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.","label":0}
{"pair_id":"AIMed.d87.s737.p13","sentence":"Interaction of p85 and N+C-SH2 with IR beta (delta C-43) or @PROTEIN1$ beta(@PROTEIN2$) in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.","label":0}
{"pair_id":"AIMed.d87.s737.p14","sentence":"Interaction of p85 and N+C-SH2 with IR beta (delta C-43) or @PROTEIN1$(@PROTEIN2$) in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.","label":0}
{"pair_id":"AIMed.d187.s1588.p0","sentence":"The analysis of complexes of @PROTEIN1$ with CSF proteins in a KBr gradient revealed an association of @PROTEIN2$ only with free proteins and not with lipoprotein particles.","label":0}
{"pair_id":"BioInfer.d227.s0.p0","sentence":"Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, plakoglobin, p120, @PROTEIN1$ and @PROTEIN2$ that were equivalent to epithelioid cells.","label":0}
{"pair_id":"BioInfer.d227.s0.p1","sentence":"Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, @PROTEIN2$, p120, @PROTEIN1$ and vinculin that were equivalent to epithelioid cells.","label":0}
{"pair_id":"BioInfer.d227.s0.p2","sentence":"Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, plakoglobin, @PROTEIN2$, @PROTEIN1$ and vinculin that were equivalent to epithelioid cells.","label":0}
{"pair_id":"BioInfer.d227.s0.p3","sentence":"Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, @PROTEIN2$, beta-catenin, plakoglobin, p120, @PROTEIN1$ and vinculin that were equivalent to epithelioid cells.","label":0}
{"pair_id":"BioInfer.d227.s0.p4","sentence":"Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, @PROTEIN2$, plakoglobin, p120, @PROTEIN1$ and vinculin that were equivalent to epithelioid cells.","label":0}
{"pair_id":"BioInfer.d227.s0.p5","sentence":"Fusiform RPE, however, were not deficient in these proteins, expressing amounts of @PROTEIN2$, alpha-catenin, beta-catenin, plakoglobin, p120, @PROTEIN1$ and vinculin that were equivalent to epithelioid cells.","label":0}
{"pair_id":"BioInfer.d227.s0.p6","sentence":"Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, @PROTEIN2$, p120, alpha-actinin and @PROTEIN1$ that were equivalent to epithelioid cells.","label":0}
{"pair_id":"BioInfer.d227.s0.p7","sentence":"Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, plakoglobin, @PROTEIN2$, alpha-actinin and @PROTEIN1$ that were equivalent to epithelioid cells.","label":0}
{"pair_id":"BioInfer.d227.s0.p8","sentence":"Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, @PROTEIN2$, beta-catenin, plakoglobin, p120, alpha-actinin and @PROTEIN1$ that were equivalent to epithelioid cells.","label":0}
{"pair_id":"BioInfer.d227.s0.p9","sentence":"Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, @PROTEIN2$, plakoglobin, p120, alpha-actinin and @PROTEIN1$ that were equivalent to epithelioid cells.","label":0}
{"pair_id":"BioInfer.d227.s0.p10","sentence":"Fusiform RPE, however, were not deficient in these proteins, expressing amounts of @PROTEIN2$, alpha-catenin, beta-catenin, plakoglobin, p120, alpha-actinin and @PROTEIN1$ that were equivalent to epithelioid cells.","label":0}
{"pair_id":"BioInfer.d227.s0.p11","sentence":"Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, @PROTEIN1$, @PROTEIN2$, alpha-actinin and vinculin that were equivalent to epithelioid cells.","label":0}
{"pair_id":"BioInfer.d227.s0.p12","sentence":"Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, @PROTEIN2$, beta-catenin, @PROTEIN1$, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.","label":0}
{"pair_id":"BioInfer.d227.s0.p13","sentence":"Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, @PROTEIN2$, @PROTEIN1$, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.","label":0}
{"pair_id":"BioInfer.d227.s0.p14","sentence":"Fusiform RPE, however, were not deficient in these proteins, expressing amounts of @PROTEIN2$, alpha-catenin, beta-catenin, @PROTEIN1$, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.","label":0}
{"pair_id":"BioInfer.d227.s0.p15","sentence":"Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, @PROTEIN2$, beta-catenin, plakoglobin, @PROTEIN1$, alpha-actinin and vinculin that were equivalent to epithelioid cells.","label":0}
{"pair_id":"BioInfer.d227.s0.p16","sentence":"Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, @PROTEIN2$, plakoglobin, @PROTEIN1$, alpha-actinin and vinculin that were equivalent to epithelioid cells.","label":0}
{"pair_id":"BioInfer.d227.s0.p17","sentence":"Fusiform RPE, however, were not deficient in these proteins, expressing amounts of @PROTEIN2$, alpha-catenin, beta-catenin, plakoglobin, @PROTEIN1$, alpha-actinin and vinculin that were equivalent to epithelioid cells.","label":0}
{"pair_id":"BioInfer.d227.s0.p18","sentence":"Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, @PROTEIN1$, @PROTEIN2$, plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.","label":0}
{"pair_id":"BioInfer.d227.s0.p19","sentence":"Fusiform RPE, however, were not deficient in these proteins, expressing amounts of @PROTEIN2$, @PROTEIN1$, beta-catenin, plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.","label":0}
{"pair_id":"BioInfer.d227.s0.p20","sentence":"Fusiform RPE, however, were not deficient in these proteins, expressing amounts of @PROTEIN2$, alpha-catenin, @PROTEIN1$, plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.","label":0}
{"pair_id":"AIMed.d164.s1379.p0","sentence":"@PROTEIN1$ binds specifically to 3' splice sites, but previous studies failed to demonstrate a function for @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d124.s1055.p0","sentence":"The protein @PROTEIN1$, a key mediator of mitogenesis and differentiation, associates with @PROTEIN2$ (refs 1-3).","label":1}
{"pair_id":"BioInfer.d169.s3.p0","sentence":"These data indicated a negative co-operativity between the @PROTEIN2$ and @PROTEIN1$ binding sites on actin.","label":1}
{"pair_id":"BioInfer.d169.s3.p1","sentence":"These data indicated a negative co-operativity between the profilin and @PROTEIN1$ binding sites on @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d169.s3.p2","sentence":"These data indicated a negative co-operativity between the @PROTEIN1$ and DNase I binding sites on @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d204.s1760.p0","sentence":"Deletion of the complete active-site [des-(161-228)-@PROTEIN1$] within the catalytic domain, or mutation of a single His residue of the Zn2+ binding domain (His199), generates stable forms of @PROTEIN2$ proteins which are unable to digest collagen type I or beta-casein.","label":0}
{"pair_id":"AIMed.d204.s1760.p1","sentence":"Deletion of the complete active-site [des-(161-228)-@PROTEIN1$] within the catalytic domain, or mutation of a single His residue of the Zn2+ binding domain (His199), generates stable forms of MMP-1 proteins which are unable to digest @PROTEIN2$ or beta-casein.","label":0}
{"pair_id":"AIMed.d204.s1760.p2","sentence":"Deletion of the complete active-site [des-(161-228)-@PROTEIN1$] within the catalytic domain, or mutation of a single His residue of the Zn2+ binding domain (His199), generates stable forms of MMP-1 proteins which are unable to digest collagen type I or @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d204.s1760.p3","sentence":"Deletion of the complete active-site [des-(161-228)-MMP-1] within the catalytic domain, or mutation of a single His residue of the Zn2+ binding domain (His199), generates stable forms of @PROTEIN1$ proteins which are unable to digest @PROTEIN2$ or beta-casein.","label":0}
{"pair_id":"AIMed.d204.s1760.p4","sentence":"Deletion of the complete active-site [des-(161-228)-MMP-1] within the catalytic domain, or mutation of a single His residue of the Zn2+ binding domain (His199), generates stable forms of @PROTEIN1$ proteins which are unable to digest collagen type I or @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d204.s1760.p5","sentence":"Deletion of the complete active-site [des-(161-228)-MMP-1] within the catalytic domain, or mutation of a single His residue of the Zn2+ binding domain (His199), generates stable forms of MMP-1 proteins which are unable to digest @PROTEIN1$ or @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d41.s1.p0","sentence":"Determination of the total profilin and @PROTEIN1$ concentrations in PMN revealed that the molar ratio of profilin to @PROTEIN2$ was 1 to 5.2.","label":0}
{"pair_id":"BioInfer.d41.s1.p1","sentence":"Determination of the total @PROTEIN2$ and @PROTEIN1$ concentrations in PMN revealed that the molar ratio of profilin to actin was 1 to 5.2.","label":0}
{"pair_id":"BioInfer.d41.s1.p2","sentence":"Determination of the total profilin and @PROTEIN1$ concentrations in PMN revealed that the molar ratio of @PROTEIN2$ to actin was 1 to 5.2.","label":0}
{"pair_id":"BioInfer.d41.s1.p3","sentence":"Determination of the total @PROTEIN2$ and actin concentrations in PMN revealed that the molar ratio of profilin to @PROTEIN1$ was 1 to 5.2.","label":0}
{"pair_id":"BioInfer.d41.s1.p4","sentence":"Determination of the total profilin and actin concentrations in PMN revealed that the molar ratio of @PROTEIN2$ to @PROTEIN1$ was 1 to 5.2.","label":0}
{"pair_id":"BioInfer.d41.s1.p5","sentence":"Determination of the total @PROTEIN1$ and actin concentrations in PMN revealed that the molar ratio of @PROTEIN2$ to actin was 1 to 5.2.","label":0}
{"pair_id":"BioInfer.d159.s0.p0","sentence":"CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (@PROTEIN1$), phosphoprotein (P), and nucleocapsid protein (@PROTEIN2$), alone or together, for the expression of biologically active proteins.","label":0}
{"pair_id":"BioInfer.d159.s0.p1","sentence":"CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (@PROTEIN1$), phosphoprotein (P), and @PROTEIN2$ (NP), alone or together, for the expression of biologically active proteins.","label":0}
{"pair_id":"BioInfer.d159.s0.p2","sentence":"CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the @PROTEIN2$ (@PROTEIN1$), phosphoprotein (P), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.","label":0}
{"pair_id":"BioInfer.d159.s0.p3","sentence":"CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (@PROTEIN1$), phosphoprotein (@PROTEIN2$), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.","label":0}
{"pair_id":"BioInfer.d159.s0.p4","sentence":"CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (@PROTEIN1$), @PROTEIN2$ (P), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.","label":0}
{"pair_id":"BioInfer.d159.s0.p5","sentence":"CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), phosphoprotein (P), and @PROTEIN2$ (@PROTEIN1$), alone or together, for the expression of biologically active proteins.","label":0}
{"pair_id":"BioInfer.d159.s0.p6","sentence":"CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the @PROTEIN2$ (L), phosphoprotein (P), and nucleocapsid protein (@PROTEIN1$), alone or together, for the expression of biologically active proteins.","label":0}
{"pair_id":"BioInfer.d159.s0.p7","sentence":"CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), phosphoprotein (@PROTEIN2$), and nucleocapsid protein (@PROTEIN1$), alone or together, for the expression of biologically active proteins.","label":0}
{"pair_id":"BioInfer.d159.s0.p8","sentence":"CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), @PROTEIN2$ (P), and nucleocapsid protein (@PROTEIN1$), alone or together, for the expression of biologically active proteins.","label":0}
{"pair_id":"BioInfer.d159.s0.p9","sentence":"CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the @PROTEIN2$ (L), phosphoprotein (P), and @PROTEIN1$ (NP), alone or together, for the expression of biologically active proteins.","label":0}
{"pair_id":"BioInfer.d159.s0.p10","sentence":"CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), phosphoprotein (@PROTEIN2$), and @PROTEIN1$ (NP), alone or together, for the expression of biologically active proteins.","label":0}
{"pair_id":"BioInfer.d159.s0.p11","sentence":"CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), @PROTEIN2$ (P), and @PROTEIN1$ (NP), alone or together, for the expression of biologically active proteins.","label":0}
{"pair_id":"BioInfer.d159.s0.p12","sentence":"CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the @PROTEIN1$ (L), phosphoprotein (@PROTEIN2$), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.","label":0}
{"pair_id":"BioInfer.d159.s0.p13","sentence":"CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the @PROTEIN1$ (L), @PROTEIN2$ (P), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.","label":0}
{"pair_id":"BioInfer.d159.s0.p14","sentence":"CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), @PROTEIN2$ (@PROTEIN1$), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.","label":0}
{"pair_id":"BioInfer.d329.s0.p0","sentence":"In contrast to the model of actin binding proposed for @PROTEIN2$, the utrophin actin-binding domain appears to associate with @PROTEIN1$ in an extended conformation.","label":0}
{"pair_id":"BioInfer.d329.s0.p1","sentence":"In contrast to the model of actin binding proposed for fimbrin, the utrophin @PROTEIN2$-binding domain appears to associate with @PROTEIN1$ in an extended conformation.","label":0}
{"pair_id":"BioInfer.d329.s0.p2","sentence":"In contrast to the model of actin binding proposed for fimbrin, the @PROTEIN2$ actin-binding domain appears to associate with @PROTEIN1$ in an extended conformation.","label":1}
{"pair_id":"BioInfer.d329.s0.p3","sentence":"In contrast to the model of @PROTEIN2$ binding proposed for fimbrin, the utrophin actin-binding domain appears to associate with @PROTEIN1$ in an extended conformation.","label":0}
{"pair_id":"BioInfer.d329.s0.p4","sentence":"In contrast to the model of actin binding proposed for @PROTEIN1$, the utrophin @PROTEIN2$-binding domain appears to associate with actin in an extended conformation.","label":0}
{"pair_id":"BioInfer.d329.s0.p5","sentence":"In contrast to the model of actin binding proposed for @PROTEIN1$, the @PROTEIN2$ actin-binding domain appears to associate with actin in an extended conformation.","label":0}
{"pair_id":"BioInfer.d329.s0.p6","sentence":"In contrast to the model of @PROTEIN2$ binding proposed for @PROTEIN1$, the utrophin actin-binding domain appears to associate with actin in an extended conformation.","label":1}
{"pair_id":"BioInfer.d329.s0.p7","sentence":"In contrast to the model of actin binding proposed for fimbrin, the @PROTEIN2$ @PROTEIN1$-binding domain appears to associate with actin in an extended conformation.","label":1}
{"pair_id":"BioInfer.d329.s0.p8","sentence":"In contrast to the model of @PROTEIN2$ binding proposed for fimbrin, the utrophin @PROTEIN1$-binding domain appears to associate with actin in an extended conformation.","label":0}
{"pair_id":"BioInfer.d329.s0.p9","sentence":"In contrast to the model of @PROTEIN2$ binding proposed for fimbrin, the @PROTEIN1$ actin-binding domain appears to associate with actin in an extended conformation.","label":0}
{"pair_id":"BioInfer.d151.s1.p0","sentence":"Immunofluorescence staining of a wild-type strain using anti-Aip1 antibodies revealed that Aip1 was distributed in cortical @PROTEIN1$ patches where @PROTEIN2$ was also co-localized.","label":1}
{"pair_id":"BioInfer.d151.s1.p1","sentence":"Immunofluorescence staining of a wild-type strain using anti-Aip1 antibodies revealed that @PROTEIN2$ was distributed in cortical @PROTEIN1$ patches where cofilin was also co-localized.","label":1}
{"pair_id":"BioInfer.d151.s1.p2","sentence":"Immunofluorescence staining of a wild-type strain using anti-@PROTEIN2$ antibodies revealed that Aip1 was distributed in cortical @PROTEIN1$ patches where cofilin was also co-localized.","label":0}
{"pair_id":"BioInfer.d151.s1.p3","sentence":"Immunofluorescence staining of a wild-type strain using anti-Aip1 antibodies revealed that @PROTEIN2$ was distributed in cortical actin patches where @PROTEIN1$ was also co-localized.","label":0}
{"pair_id":"BioInfer.d151.s1.p4","sentence":"Immunofluorescence staining of a wild-type strain using anti-@PROTEIN2$ antibodies revealed that Aip1 was distributed in cortical actin patches where @PROTEIN1$ was also co-localized.","label":0}
{"pair_id":"BioInfer.d151.s1.p5","sentence":"Immunofluorescence staining of a wild-type strain using anti-@PROTEIN2$ antibodies revealed that @PROTEIN1$ was distributed in cortical actin patches where cofilin was also co-localized.","label":0}
{"pair_id":"AIMed.d214.s1861.p0","sentence":"Here we show that @PROTEIN1$ and @PROTEIN2$ form inducible molecular complexes in TCR-activated murine thymocytes and peripheral T cells as well as pervanadate-treated T cells.","label":1}
{"pair_id":"AIMed.d214.s1861.p1","sentence":"Here we show that @PROTEIN1$ and c-Cbl form inducible molecular complexes in @PROTEIN2$-activated murine thymocytes and peripheral T cells as well as pervanadate-treated T cells.","label":0}
{"pair_id":"AIMed.d214.s1861.p2","sentence":"Here we show that Vav and @PROTEIN1$ form inducible molecular complexes in @PROTEIN2$-activated murine thymocytes and peripheral T cells as well as pervanadate-treated T cells.","label":0}
{"pair_id":"AIMed.d25.s210.p0","sentence":"Their order of selection was @PROTEIN1$ effusion, @PROTEIN2$ serum, TNFalpha-effusion, and C3 effusion.","label":0}
{"pair_id":"AIMed.d25.s210.p1","sentence":"Their order of selection was @PROTEIN1$ effusion, C4 serum, @PROTEIN2$-effusion, and C3 effusion.","label":0}
{"pair_id":"AIMed.d25.s210.p2","sentence":"Their order of selection was @PROTEIN1$ effusion, C4 serum, TNFalpha-effusion, and @PROTEIN2$ effusion.","label":0}
{"pair_id":"AIMed.d25.s210.p3","sentence":"Their order of selection was alpha1AT effusion, @PROTEIN1$ serum, @PROTEIN2$-effusion, and C3 effusion.","label":0}
{"pair_id":"AIMed.d25.s210.p4","sentence":"Their order of selection was alpha1AT effusion, @PROTEIN1$ serum, TNFalpha-effusion, and @PROTEIN2$ effusion.","label":0}
{"pair_id":"AIMed.d25.s210.p5","sentence":"Their order of selection was alpha1AT effusion, C4 serum, @PROTEIN1$-effusion, and @PROTEIN2$ effusion.","label":0}
{"pair_id":"BioInfer.d87.s1.p0","sentence":"However, the recombinant fusion protein containing wild-type @PROTEIN1$ precipitated @PROTEIN2$ from these cells.","label":0}
{"pair_id":"AIMed.d114.s966.p0","sentence":"We demonstrate that the 53 amino acids encoded on exon 74 of @PROTEIN1$, an alternatively spliced exon, are necessary and sufficient for interaction with translated @PROTEIN2$ in our assay.","label":1}
{"pair_id":"BioInfer.d130.s0.p0","sentence":"@PROTEIN1$ is a T cell activation antigen known to bind @PROTEIN2$ and have dipeptidyl peptidase IV activity.","label":1}
{"pair_id":"BioInfer.d130.s0.p1","sentence":"@PROTEIN1$ is a T cell activation antigen known to bind adenosine deaminase and have @PROTEIN2$ activity.","label":1}
{"pair_id":"BioInfer.d130.s0.p2","sentence":"CD26 is a T cell activation antigen known to bind @PROTEIN1$ and have @PROTEIN2$ activity.","label":0}
{"pair_id":"BioInfer.d243.s0.p0","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, @PROTEIN2$, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, @PROTEIN1$ and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p1","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, @PROTEIN2$, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, @PROTEIN1$ and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p2","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, @PROTEIN2$, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, @PROTEIN1$ and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p3","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, @PROTEIN2$, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, @PROTEIN1$ and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p4","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, @PROTEIN2$, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, @PROTEIN1$ and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p5","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, @PROTEIN2$, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, @PROTEIN1$ and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p6","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, @PROTEIN2$, SPA2, BNI1, DFG5, DFG9, DFG10, @PROTEIN1$ and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p7","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, @PROTEIN2$, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, @PROTEIN1$ and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p8","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, @PROTEIN2$, DFG5, DFG9, DFG10, @PROTEIN1$ and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p9","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, @PROTEIN2$, @PROTEIN1$ and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p10","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, @PROTEIN1$ and @PROTEIN2$, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p11","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, @PROTEIN2$, DFG10, @PROTEIN1$ and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p12","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, @PROTEIN2$, BNI1, DFG5, DFG9, DFG10, @PROTEIN1$ and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p13","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, @PROTEIN2$, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, @PROTEIN1$ and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p14","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, @PROTEIN2$, DFG9, DFG10, @PROTEIN1$ and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p15","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, @PROTEIN2$, STE12, @PROTEIN1$, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p16","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, @PROTEIN1$, WHI3, @PROTEIN2$, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p17","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, @PROTEIN2$, @PROTEIN1$, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p18","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, @PROTEIN1$, WHI3, NAB1, DBR1, @PROTEIN2$, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p19","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, @PROTEIN1$, @PROTEIN2$, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p20","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, @PROTEIN1$, WHI3, NAB1, DBR1, CDC55, SRV2, @PROTEIN2$, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p21","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, @PROTEIN1$, WHI3, NAB1, @PROTEIN2$, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p22","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, @PROTEIN1$, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, @PROTEIN2$, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p23","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, @PROTEIN1$, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, @PROTEIN2$, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p24","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, @PROTEIN1$, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and @PROTEIN2$, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p25","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, @PROTEIN1$, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, @PROTEIN2$, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p26","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, @PROTEIN1$, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, @PROTEIN2$, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p27","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, @PROTEIN1$, WHI3, NAB1, DBR1, CDC55, @PROTEIN2$, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p28","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, @PROTEIN1$, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, @PROTEIN2$, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p29","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, @PROTEIN1$, STE12, TEC1, WHI3, @PROTEIN2$, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p30","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, @PROTEIN1$, @PROTEIN2$, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p31","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, @PROTEIN1$, STE12, TEC1, WHI3, NAB1, DBR1, @PROTEIN2$, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p32","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, @PROTEIN1$, STE12, TEC1, @PROTEIN2$, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p33","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, @PROTEIN1$, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, @PROTEIN2$, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p34","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, @PROTEIN1$, STE12, TEC1, WHI3, NAB1, @PROTEIN2$, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p35","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, @PROTEIN1$, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, @PROTEIN2$, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p36","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, @PROTEIN1$, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, @PROTEIN2$, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p37","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, @PROTEIN1$, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and @PROTEIN2$, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p38","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, @PROTEIN1$, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, @PROTEIN2$, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p39","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, @PROTEIN1$, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, @PROTEIN2$, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p40","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, @PROTEIN1$, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, @PROTEIN2$, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p41","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, @PROTEIN1$, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, @PROTEIN2$, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p42","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, @PROTEIN2$, TEC1, WHI3, @PROTEIN1$, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p43","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, @PROTEIN1$, DBR1, @PROTEIN2$, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p44","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, @PROTEIN2$, @PROTEIN1$, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p45","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, @PROTEIN1$, DBR1, CDC55, SRV2, @PROTEIN2$, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p46","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, @PROTEIN1$, @PROTEIN2$, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p47","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, @PROTEIN1$, DBR1, CDC55, SRV2, TPM1, SPA2, @PROTEIN2$, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p48","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, @PROTEIN1$, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, @PROTEIN2$, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p49","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, @PROTEIN1$, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and @PROTEIN2$, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p50","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, @PROTEIN1$, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, @PROTEIN2$, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p51","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, @PROTEIN1$, DBR1, CDC55, SRV2, TPM1, @PROTEIN2$, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p52","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, @PROTEIN1$, DBR1, CDC55, @PROTEIN2$, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p53","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, @PROTEIN1$, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, @PROTEIN2$, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p54","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, @PROTEIN1$, TEC1, WHI3, NAB1, DBR1, @PROTEIN2$, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p55","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, @PROTEIN1$, TEC1, @PROTEIN2$, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p56","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, @PROTEIN1$, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, @PROTEIN2$, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p57","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, @PROTEIN1$, TEC1, WHI3, NAB1, @PROTEIN2$, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p58","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, @PROTEIN1$, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, @PROTEIN2$, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p59","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, @PROTEIN1$, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, @PROTEIN2$, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p60","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, @PROTEIN1$, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and @PROTEIN2$, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p61","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, @PROTEIN1$, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, @PROTEIN2$, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p62","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, @PROTEIN1$, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, @PROTEIN2$, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p63","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, @PROTEIN1$, TEC1, WHI3, NAB1, DBR1, CDC55, @PROTEIN2$, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p64","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, @PROTEIN1$, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, @PROTEIN2$, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p65","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, @PROTEIN2$, NAB1, DBR1, @PROTEIN1$, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p66","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, @PROTEIN1$, SRV2, @PROTEIN2$, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p67","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, @PROTEIN2$, @PROTEIN1$, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p68","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, @PROTEIN1$, SRV2, TPM1, SPA2, @PROTEIN2$, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p69","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, @PROTEIN1$, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, @PROTEIN2$, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p70","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, @PROTEIN1$, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and @PROTEIN2$, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p71","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, @PROTEIN1$, SRV2, TPM1, SPA2, BNI1, DFG5, @PROTEIN2$, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p72","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, @PROTEIN1$, SRV2, TPM1, @PROTEIN2$, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p73","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, @PROTEIN1$, @PROTEIN2$, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p74","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, @PROTEIN1$, SRV2, TPM1, SPA2, BNI1, @PROTEIN2$, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p75","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, @PROTEIN1$, NAB1, DBR1, CDC55, SRV2, @PROTEIN2$, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p76","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, @PROTEIN1$, NAB1, @PROTEIN2$, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p77","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, @PROTEIN1$, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, @PROTEIN2$, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p78","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, @PROTEIN1$, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, @PROTEIN2$, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p79","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, @PROTEIN1$, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and @PROTEIN2$, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p80","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, @PROTEIN1$, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, @PROTEIN2$, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p81","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, @PROTEIN1$, NAB1, DBR1, CDC55, SRV2, TPM1, @PROTEIN2$, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p82","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, @PROTEIN1$, NAB1, DBR1, CDC55, @PROTEIN2$, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p83","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, @PROTEIN1$, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, @PROTEIN2$, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p84","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, @PROTEIN2$, CDC55, SRV2, @PROTEIN1$, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p85","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, @PROTEIN1$, SPA2, @PROTEIN2$, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p86","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, @PROTEIN1$, SPA2, BNI1, DFG5, DFG9, @PROTEIN2$, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p87","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, @PROTEIN1$, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and @PROTEIN2$, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p88","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, @PROTEIN1$, SPA2, BNI1, DFG5, @PROTEIN2$, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p89","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, @PROTEIN1$, @PROTEIN2$, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p90","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, @PROTEIN2$, @PROTEIN1$, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p91","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, @PROTEIN1$, SPA2, BNI1, @PROTEIN2$, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p92","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, @PROTEIN1$, CDC55, SRV2, TPM1, SPA2, @PROTEIN2$, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p93","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, @PROTEIN1$, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, @PROTEIN2$, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p94","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, @PROTEIN1$, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and @PROTEIN2$, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p95","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, @PROTEIN1$, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, @PROTEIN2$, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p96","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, @PROTEIN1$, CDC55, SRV2, TPM1, @PROTEIN2$, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p97","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, @PROTEIN1$, CDC55, @PROTEIN2$, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p98","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, @PROTEIN1$, CDC55, SRV2, TPM1, SPA2, BNI1, @PROTEIN2$, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p99","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, @PROTEIN1$, DFG5, DFG9, @PROTEIN2$, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p100","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, @PROTEIN1$, DFG5, DFG9, DFG10, BUD8 and @PROTEIN2$, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p101","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, @PROTEIN1$, DFG5, @PROTEIN2$, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p102","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, @PROTEIN2$, @PROTEIN1$, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p103","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, @PROTEIN2$, TPM1, SPA2, @PROTEIN1$, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p104","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, @PROTEIN1$, @PROTEIN2$, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p105","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, @PROTEIN1$, BUD8 and @PROTEIN2$, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p106","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, @PROTEIN2$, @PROTEIN1$, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p107","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, @PROTEIN2$, BNI1, DFG5, DFG9, @PROTEIN1$, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p108","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, @PROTEIN2$, TPM1, SPA2, BNI1, DFG5, DFG9, @PROTEIN1$, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p109","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, @PROTEIN2$, DFG9, @PROTEIN1$, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p110","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, @PROTEIN2$, DFG10, BUD8 and @PROTEIN1$, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p111","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, @PROTEIN2$, BNI1, DFG5, DFG9, DFG10, BUD8 and @PROTEIN1$, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p112","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, @PROTEIN2$, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and @PROTEIN1$, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p113","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, @PROTEIN2$, DFG9, DFG10, BUD8 and @PROTEIN1$, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p114","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, @PROTEIN2$, BNI1, DFG5, @PROTEIN1$, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p115","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, @PROTEIN2$, TPM1, SPA2, BNI1, DFG5, @PROTEIN1$, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p116","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, @PROTEIN2$, @PROTEIN1$, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p117","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, @PROTEIN2$, TPM1, @PROTEIN1$, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p118","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, @PROTEIN1$, BNI1, @PROTEIN2$, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p119","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, @PROTEIN1$, TPM1, SPA2, BNI1, @PROTEIN2$, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d588.s0.p0","sentence":"The C374S mutation had the most pronounced effect; it reduced the polymerizability of the @PROTEIN1$, abolished its binding to @PROTEIN2$, and filaments containing this mutation moved at reduced rates in the in vitro 'motility assay'.","label":1}
{"pair_id":"BioInfer.d636.s0.p0","sentence":"The isolated intestinal microvillus cytoskeleton (core) consists of four major proteins: @PROTEIN1$, villin, fimbrin and @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d636.s0.p1","sentence":"The isolated intestinal microvillus cytoskeleton (core) consists of four major proteins: @PROTEIN1$, @PROTEIN2$, fimbrin and brush border myosin-I.","label":1}
{"pair_id":"BioInfer.d636.s0.p2","sentence":"The isolated intestinal microvillus cytoskeleton (core) consists of four major proteins: @PROTEIN1$, villin, @PROTEIN2$ and brush border myosin-I.","label":1}
{"pair_id":"BioInfer.d636.s0.p3","sentence":"The isolated intestinal microvillus cytoskeleton (core) consists of four major proteins: actin, @PROTEIN2$, fimbrin and @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d636.s0.p4","sentence":"The isolated intestinal microvillus cytoskeleton (core) consists of four major proteins: actin, villin, @PROTEIN2$ and @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d636.s0.p5","sentence":"The isolated intestinal microvillus cytoskeleton (core) consists of four major proteins: actin, @PROTEIN1$, @PROTEIN2$ and brush border myosin-I.","label":1}
{"pair_id":"AIMed.d29.s246.p0","sentence":"Single Asp or Ser substitutions, H18D, F21D, F21S, and double substitutions, H18A\/F21D, H18A\/F21S, and H18D\/F21D, reduced up to 431-fold the binding affinity to @PROTEIN1$, @PROTEIN2$, and the Duffy antigen.","label":0}
{"pair_id":"AIMed.d29.s246.p1","sentence":"Single Asp or Ser substitutions, H18D, F21D, F21S, and double substitutions, H18A\/F21D, H18A\/F21S, and H18D\/F21D, reduced up to 431-fold the binding affinity to @PROTEIN1$, CXCR2, and the @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d29.s246.p2","sentence":"Single Asp or Ser substitutions, H18D, F21D, F21S, and double substitutions, H18A\/F21D, H18A\/F21S, and H18D\/F21D, reduced up to 431-fold the binding affinity to CXCR1, @PROTEIN1$, and the @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d409.s0.p0","sentence":"Location of @PROTEIN1$ at presynaptic sites in the cerebellar cortex; implication for the regulation of the @PROTEIN2$-polymerization state during axonal elongation and synaptogenesis.","label":0}
{"pair_id":"AIMed.d39.s343.p0","sentence":"Collectively, the novel function of @PROTEIN1$ via @PROTEIN2$\/Jif-1 influences c-jun-mediated transcription and apoptosis.","label":0}
{"pair_id":"AIMed.d39.s343.p1","sentence":"Collectively, the novel function of @PROTEIN1$ via QM\/@PROTEIN2$ influences c-jun-mediated transcription and apoptosis.","label":0}
{"pair_id":"AIMed.d39.s343.p2","sentence":"Collectively, the novel function of @PROTEIN1$ via QM\/Jif-1 influences @PROTEIN2$-mediated transcription and apoptosis.","label":0}
{"pair_id":"AIMed.d39.s343.p3","sentence":"Collectively, the novel function of PS1 via @PROTEIN1$\/@PROTEIN2$ influences c-jun-mediated transcription and apoptosis.","label":0}
{"pair_id":"AIMed.d39.s343.p4","sentence":"Collectively, the novel function of PS1 via @PROTEIN1$\/Jif-1 influences @PROTEIN2$-mediated transcription and apoptosis.","label":0}
{"pair_id":"AIMed.d39.s343.p5","sentence":"Collectively, the novel function of PS1 via QM\/@PROTEIN1$ influences @PROTEIN2$-mediated transcription and apoptosis.","label":0}
{"pair_id":"AIMed.d44.s385.p0","sentence":"Cluster Group B antibodies, including M67 and Ki-1, do not affect @PROTEIN1$ binding to @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d214.s1858.p0","sentence":"The molecular adapter @PROTEIN1$ is rapidly tyrosine phosphorylated following stimulation through the @PROTEIN2$ and associates with Src homology domain-2 (SH2)\/SH3 domain-containing adapters such as Grb2, Crk, and Crk-L, which interact with guanine nucleotide exchange factors specific for the Ras family.","label":0}
{"pair_id":"AIMed.d214.s1858.p1","sentence":"The molecular adapter @PROTEIN1$ is rapidly tyrosine phosphorylated following stimulation through the TCR and associates with @PROTEIN2$ homology domain-2 (SH2)\/SH3 domain-containing adapters such as Grb2, Crk, and Crk-L, which interact with guanine nucleotide exchange factors specific for the Ras family.","label":0}
{"pair_id":"AIMed.d214.s1858.p2","sentence":"The molecular adapter @PROTEIN1$ is rapidly tyrosine phosphorylated following stimulation through the TCR and associates with Src homology domain-2 (SH2)\/SH3 domain-containing adapters such as @PROTEIN2$, Crk, and Crk-L, which interact with guanine nucleotide exchange factors specific for the Ras family.","label":1}
{"pair_id":"AIMed.d214.s1858.p3","sentence":"The molecular adapter @PROTEIN1$ is rapidly tyrosine phosphorylated following stimulation through the TCR and associates with Src homology domain-2 (SH2)\/SH3 domain-containing adapters such as Grb2, @PROTEIN2$, and Crk-L, which interact with guanine nucleotide exchange factors specific for the Ras family.","label":1}
{"pair_id":"AIMed.d214.s1858.p4","sentence":"The molecular adapter @PROTEIN1$ is rapidly tyrosine phosphorylated following stimulation through the TCR and associates with Src homology domain-2 (SH2)\/SH3 domain-containing adapters such as Grb2, Crk, and @PROTEIN2$, which interact with guanine nucleotide exchange factors specific for the Ras family.","label":1}
{"pair_id":"AIMed.d214.s1858.p5","sentence":"The molecular adapter c-Cbl is rapidly tyrosine phosphorylated following stimulation through the @PROTEIN1$ and associates with @PROTEIN2$ homology domain-2 (SH2)\/SH3 domain-containing adapters such as Grb2, Crk, and Crk-L, which interact with guanine nucleotide exchange factors specific for the Ras family.","label":0}
{"pair_id":"AIMed.d214.s1858.p6","sentence":"The molecular adapter c-Cbl is rapidly tyrosine phosphorylated following stimulation through the @PROTEIN1$ and associates with Src homology domain-2 (SH2)\/SH3 domain-containing adapters such as @PROTEIN2$, Crk, and Crk-L, which interact with guanine nucleotide exchange factors specific for the Ras family.","label":0}
{"pair_id":"AIMed.d214.s1858.p7","sentence":"The molecular adapter c-Cbl is rapidly tyrosine phosphorylated following stimulation through the @PROTEIN1$ and associates with Src homology domain-2 (SH2)\/SH3 domain-containing adapters such as Grb2, @PROTEIN2$, and Crk-L, which interact with guanine nucleotide exchange factors specific for the Ras family.","label":0}
{"pair_id":"AIMed.d214.s1858.p8","sentence":"The molecular adapter c-Cbl is rapidly tyrosine phosphorylated following stimulation through the @PROTEIN1$ and associates with Src homology domain-2 (SH2)\/SH3 domain-containing adapters such as Grb2, Crk, and @PROTEIN2$, which interact with guanine nucleotide exchange factors specific for the Ras family.","label":0}
{"pair_id":"AIMed.d214.s1858.p9","sentence":"The molecular adapter c-Cbl is rapidly tyrosine phosphorylated following stimulation through the TCR and associates with @PROTEIN1$ homology domain-2 (SH2)\/SH3 domain-containing adapters such as @PROTEIN2$, Crk, and Crk-L, which interact with guanine nucleotide exchange factors specific for the Ras family.","label":0}
{"pair_id":"AIMed.d214.s1858.p10","sentence":"The molecular adapter c-Cbl is rapidly tyrosine phosphorylated following stimulation through the TCR and associates with @PROTEIN1$ homology domain-2 (SH2)\/SH3 domain-containing adapters such as Grb2, @PROTEIN2$, and Crk-L, which interact with guanine nucleotide exchange factors specific for the Ras family.","label":0}
{"pair_id":"AIMed.d214.s1858.p11","sentence":"The molecular adapter c-Cbl is rapidly tyrosine phosphorylated following stimulation through the TCR and associates with @PROTEIN1$ homology domain-2 (SH2)\/SH3 domain-containing adapters such as Grb2, Crk, and @PROTEIN2$, which interact with guanine nucleotide exchange factors specific for the Ras family.","label":0}
{"pair_id":"AIMed.d214.s1858.p12","sentence":"The molecular adapter c-Cbl is rapidly tyrosine phosphorylated following stimulation through the TCR and associates with Src homology domain-2 (SH2)\/SH3 domain-containing adapters such as @PROTEIN1$, @PROTEIN2$, and Crk-L, which interact with guanine nucleotide exchange factors specific for the Ras family.","label":0}
{"pair_id":"AIMed.d214.s1858.p13","sentence":"The molecular adapter c-Cbl is rapidly tyrosine phosphorylated following stimulation through the TCR and associates with Src homology domain-2 (SH2)\/SH3 domain-containing adapters such as @PROTEIN1$, Crk, and @PROTEIN2$, which interact with guanine nucleotide exchange factors specific for the Ras family.","label":0}
{"pair_id":"AIMed.d214.s1858.p14","sentence":"The molecular adapter c-Cbl is rapidly tyrosine phosphorylated following stimulation through the TCR and associates with Src homology domain-2 (SH2)\/SH3 domain-containing adapters such as Grb2, @PROTEIN1$, and @PROTEIN2$, which interact with guanine nucleotide exchange factors specific for the Ras family.","label":0}
{"pair_id":"AIMed.d161.s1359.p0","sentence":"We demonstrate that @PROTEIN1$ binds to @PROTEIN2$ in vitro under conditions where the latter is tyrosine-phosphorylated.","label":1}
{"pair_id":"BioInfer.d107.s0.p0","sentence":"Neuropilin-1 mediates @PROTEIN1$\/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d107.s0.p1","sentence":"Neuropilin-1 mediates @PROTEIN1$\/@PROTEIN2$ inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165.","label":0}
{"pair_id":"BioInfer.d107.s0.p2","sentence":"@PROTEIN2$ mediates @PROTEIN1$\/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165.","label":1}
{"pair_id":"BioInfer.d107.s0.p3","sentence":"Neuropilin-1 mediates @PROTEIN1$\/semaphorin III inhibition of endothelial cell motility: functional competition of @PROTEIN2$ and vascular endothelial growth factor-165.","label":0}
{"pair_id":"BioInfer.d107.s0.p4","sentence":"Neuropilin-1 mediates collapsin-1\/@PROTEIN2$ inhibition of endothelial cell motility: functional competition of collapsin-1 and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d107.s0.p5","sentence":"@PROTEIN2$ mediates collapsin-1\/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d107.s0.p6","sentence":"Neuropilin-1 mediates collapsin-1\/semaphorin III inhibition of endothelial cell motility: functional competition of @PROTEIN2$ and @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d107.s0.p7","sentence":"@PROTEIN2$ mediates collapsin-1\/@PROTEIN1$ inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165.","label":1}
{"pair_id":"BioInfer.d107.s0.p8","sentence":"Neuropilin-1 mediates collapsin-1\/@PROTEIN1$ inhibition of endothelial cell motility: functional competition of @PROTEIN2$ and vascular endothelial growth factor-165.","label":0}
{"pair_id":"BioInfer.d107.s0.p9","sentence":"@PROTEIN1$ mediates collapsin-1\/semaphorin III inhibition of endothelial cell motility: functional competition of @PROTEIN2$ and vascular endothelial growth factor-165.","label":0}
{"pair_id":"BioInfer.d388.s0.p0","sentence":"In vivo importance of @PROTEIN1$ nucleotide exchange catalyzed by @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d162.s1370.p0","sentence":"In contrast, mutant @PROTEIN1$ either had no effect or activated the transcriptional activity of @PROTEIN2$ depending on the type of hormone response elements.","label":0}
{"pair_id":"BioInfer.d763.s0.p0","sentence":"To clarify the relation between alteration of expression of cell adhesion molecules and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for E-cadherin, alpha-catenin, beta-catenin, and @PROTEIN1$, with additional reverse transcription-@PROTEIN2$ chain reaction and Southern blotting hybridization (RT-PCR\/SBH) assays.","label":0}
{"pair_id":"BioInfer.d763.s0.p1","sentence":"To clarify the relation between alteration of expression of cell adhesion molecules and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for E-cadherin, @PROTEIN2$, beta-catenin, and @PROTEIN1$, with additional reverse transcription-polymerase chain reaction and Southern blotting hybridization (RT-PCR\/SBH) assays.","label":0}
{"pair_id":"BioInfer.d763.s0.p2","sentence":"To clarify the relation between alteration of expression of @PROTEIN2$ and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for E-cadherin, alpha-catenin, beta-catenin, and @PROTEIN1$, with additional reverse transcription-polymerase chain reaction and Southern blotting hybridization (RT-PCR\/SBH) assays.","label":0}
{"pair_id":"BioInfer.d763.s0.p3","sentence":"To clarify the relation between alteration of expression of cell adhesion molecules and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for @PROTEIN2$, alpha-catenin, beta-catenin, and @PROTEIN1$, with additional reverse transcription-polymerase chain reaction and Southern blotting hybridization (RT-PCR\/SBH) assays.","label":0}
{"pair_id":"BioInfer.d763.s0.p4","sentence":"To clarify the relation between alteration of expression of cell adhesion molecules and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for E-cadherin, alpha-catenin, @PROTEIN2$, and @PROTEIN1$, with additional reverse transcription-polymerase chain reaction and Southern blotting hybridization (RT-PCR\/SBH) assays.","label":0}
{"pair_id":"BioInfer.d763.s0.p5","sentence":"To clarify the relation between alteration of expression of cell adhesion molecules and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for E-cadherin, @PROTEIN2$, beta-catenin, and CD44, with additional reverse transcription-@PROTEIN1$ chain reaction and Southern blotting hybridization (RT-PCR\/SBH) assays.","label":0}
{"pair_id":"BioInfer.d763.s0.p6","sentence":"To clarify the relation between alteration of expression of @PROTEIN2$ and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for E-cadherin, alpha-catenin, beta-catenin, and CD44, with additional reverse transcription-@PROTEIN1$ chain reaction and Southern blotting hybridization (RT-PCR\/SBH) assays.","label":0}
{"pair_id":"BioInfer.d763.s0.p7","sentence":"To clarify the relation between alteration of expression of cell adhesion molecules and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for @PROTEIN2$, alpha-catenin, beta-catenin, and CD44, with additional reverse transcription-@PROTEIN1$ chain reaction and Southern blotting hybridization (RT-PCR\/SBH) assays.","label":0}
{"pair_id":"BioInfer.d763.s0.p8","sentence":"To clarify the relation between alteration of expression of cell adhesion molecules and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for E-cadherin, alpha-catenin, @PROTEIN2$, and CD44, with additional reverse transcription-@PROTEIN1$ chain reaction and Southern blotting hybridization (RT-PCR\/SBH) assays.","label":0}
{"pair_id":"BioInfer.d763.s0.p9","sentence":"To clarify the relation between alteration of expression of @PROTEIN2$ and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for E-cadherin, @PROTEIN1$, beta-catenin, and CD44, with additional reverse transcription-polymerase chain reaction and Southern blotting hybridization (RT-PCR\/SBH) assays.","label":0}
{"pair_id":"BioInfer.d763.s0.p10","sentence":"To clarify the relation between alteration of expression of cell adhesion molecules and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for @PROTEIN2$, @PROTEIN1$, beta-catenin, and CD44, with additional reverse transcription-polymerase chain reaction and Southern blotting hybridization (RT-PCR\/SBH) assays.","label":0}
{"pair_id":"BioInfer.d763.s0.p11","sentence":"To clarify the relation between alteration of expression of cell adhesion molecules and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for E-cadherin, @PROTEIN1$, @PROTEIN2$, and CD44, with additional reverse transcription-polymerase chain reaction and Southern blotting hybridization (RT-PCR\/SBH) assays.","label":0}
{"pair_id":"BioInfer.d763.s0.p12","sentence":"To clarify the relation between alteration of expression of @PROTEIN1$ and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for @PROTEIN2$, alpha-catenin, beta-catenin, and CD44, with additional reverse transcription-polymerase chain reaction and Southern blotting hybridization (RT-PCR\/SBH) assays.","label":0}
{"pair_id":"BioInfer.d763.s0.p13","sentence":"To clarify the relation between alteration of expression of @PROTEIN1$ and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for E-cadherin, alpha-catenin, @PROTEIN2$, and CD44, with additional reverse transcription-polymerase chain reaction and Southern blotting hybridization (RT-PCR\/SBH) assays.","label":0}
{"pair_id":"BioInfer.d763.s0.p14","sentence":"To clarify the relation between alteration of expression of cell adhesion molecules and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for @PROTEIN1$, alpha-catenin, @PROTEIN2$, and CD44, with additional reverse transcription-polymerase chain reaction and Southern blotting hybridization (RT-PCR\/SBH) assays.","label":0}
{"pair_id":"AIMed.d158.s1333.p0","sentence":"The death domain of @PROTEIN1$ (@PROTEIN2$) triggers distinct signaling pathways leading to apoptosis and NF-kappa B activation through its interaction with the death domain protein TRADD.","label":0}
{"pair_id":"AIMed.d158.s1333.p1","sentence":"The death domain of @PROTEIN1$ (TNFR1) triggers distinct signaling pathways leading to apoptosis and @PROTEIN2$ activation through its interaction with the death domain protein TRADD.","label":0}
{"pair_id":"AIMed.d158.s1333.p2","sentence":"The death domain of @PROTEIN1$ (TNFR1) triggers distinct signaling pathways leading to apoptosis and NF-kappa B activation through its interaction with the death domain protein @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d158.s1333.p3","sentence":"The death domain of tumor necrosis factor (TNF) receptor-1 (@PROTEIN1$) triggers distinct signaling pathways leading to apoptosis and @PROTEIN2$ activation through its interaction with the death domain protein TRADD.","label":0}
{"pair_id":"AIMed.d158.s1333.p4","sentence":"The death domain of tumor necrosis factor (TNF) receptor-1 (@PROTEIN1$) triggers distinct signaling pathways leading to apoptosis and NF-kappa B activation through its interaction with the death domain protein @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d158.s1333.p5","sentence":"The death domain of tumor necrosis factor (TNF) receptor-1 (TNFR1) triggers distinct signaling pathways leading to apoptosis and @PROTEIN1$ activation through its interaction with the death domain protein @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d137.s1156.p0","sentence":"We had previously shown that the ubiquitous @PROTEIN1$ and the lymphoid-specific @PROTEIN2$ transcription factors stimulate transcription at the level of stable preinitiation complex formation.","label":0}
{"pair_id":"AIMed.d104.s878.p0","sentence":"This transcriptional activity is inhibited by association with the @PROTEIN1$ (@PROTEIN2$) or its relatives p107 and p103.","label":0}
{"pair_id":"AIMed.d104.s878.p1","sentence":"This transcriptional activity is inhibited by association with the @PROTEIN1$ (pRB) or its relatives @PROTEIN2$ and p103.","label":0}
{"pair_id":"AIMed.d104.s878.p2","sentence":"This transcriptional activity is inhibited by association with the @PROTEIN1$ (pRB) or its relatives p107 and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d104.s878.p3","sentence":"This transcriptional activity is inhibited by association with the retinoblastoma tumor suppressor protein (@PROTEIN1$) or its relatives @PROTEIN2$ and p103.","label":0}
{"pair_id":"AIMed.d104.s878.p4","sentence":"This transcriptional activity is inhibited by association with the retinoblastoma tumor suppressor protein (@PROTEIN1$) or its relatives p107 and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d104.s878.p5","sentence":"This transcriptional activity is inhibited by association with the retinoblastoma tumor suppressor protein (pRB) or its relatives @PROTEIN1$ and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d49.s434.p0","sentence":"The sequences that confer on @PROTEIN1$ its specific binding to @PROTEIN2$ have not been identified.","label":1}
{"pair_id":"AIMed.d12.s105.p0","sentence":"In TEN we also found significantly higher levels of @PROTEIN1$ in the blister fluid compared with serum samples, pointing to a predominantly local production contrasting with the low concentration of @PROTEIN2$ in the blister fluid of burned patients.","label":0}
{"pair_id":"BioInfer.d791.s0.p0","sentence":"Vascular endothelial cadherin (@PROTEIN1$) clusters were co-localized with beta-catenin, an important signal transduction ligand, and with alpha-catenin, which is thought to link the complex to the peri-junctional @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d791.s0.p1","sentence":"@PROTEIN2$ (@PROTEIN1$) clusters were co-localized with beta-catenin, an important signal transduction ligand, and with alpha-catenin, which is thought to link the complex to the peri-junctional actin.","label":0}
{"pair_id":"BioInfer.d791.s0.p2","sentence":"Vascular endothelial cadherin (@PROTEIN1$) clusters were co-localized with beta-catenin, an important signal transduction ligand, and with @PROTEIN2$, which is thought to link the complex to the peri-junctional actin.","label":1}
{"pair_id":"BioInfer.d791.s0.p3","sentence":"Vascular endothelial cadherin (@PROTEIN1$) clusters were co-localized with @PROTEIN2$, an important signal transduction ligand, and with alpha-catenin, which is thought to link the complex to the peri-junctional actin.","label":1}
{"pair_id":"BioInfer.d791.s0.p4","sentence":"@PROTEIN2$ (VE-cadherin) clusters were co-localized with beta-catenin, an important signal transduction ligand, and with alpha-catenin, which is thought to link the complex to the peri-junctional @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d791.s0.p5","sentence":"Vascular endothelial cadherin (VE-cadherin) clusters were co-localized with beta-catenin, an important signal transduction ligand, and with @PROTEIN2$, which is thought to link the complex to the peri-junctional @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d791.s0.p6","sentence":"Vascular endothelial cadherin (VE-cadherin) clusters were co-localized with @PROTEIN2$, an important signal transduction ligand, and with alpha-catenin, which is thought to link the complex to the peri-junctional @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d791.s0.p7","sentence":"@PROTEIN1$ (VE-cadherin) clusters were co-localized with beta-catenin, an important signal transduction ligand, and with @PROTEIN2$, which is thought to link the complex to the peri-junctional actin.","label":1}
{"pair_id":"BioInfer.d791.s0.p8","sentence":"@PROTEIN1$ (VE-cadherin) clusters were co-localized with @PROTEIN2$, an important signal transduction ligand, and with alpha-catenin, which is thought to link the complex to the peri-junctional actin.","label":1}
{"pair_id":"BioInfer.d791.s0.p9","sentence":"Vascular endothelial cadherin (VE-cadherin) clusters were co-localized with @PROTEIN2$, an important signal transduction ligand, and with @PROTEIN1$, which is thought to link the complex to the peri-junctional actin.","label":0}
{"pair_id":"BioInfer.d360.s0.p0","sentence":"Interaction of @PROTEIN1$ with @PROTEIN2$ controls the association of apical SNAREs in epithelial cells.","label":1}
{"pair_id":"BioInfer.d360.s0.p1","sentence":"Interaction of @PROTEIN1$ with syntaxin 3 controls the association of apical @PROTEIN2$ in epithelial cells.","label":1}
{"pair_id":"BioInfer.d360.s0.p2","sentence":"Interaction of Munc-18-2 with @PROTEIN1$ controls the association of apical @PROTEIN2$ in epithelial cells.","label":1}
{"pair_id":"BioInfer.d48.s1.p0","sentence":"The viscoelasticity of entangled @PROTEIN1$ networks: the influence of defects and modulation by @PROTEIN2$ and vinculin.","label":1}
{"pair_id":"BioInfer.d48.s1.p1","sentence":"The viscoelasticity of entangled @PROTEIN1$ networks: the influence of defects and modulation by talin and @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d48.s1.p2","sentence":"The viscoelasticity of entangled actin networks: the influence of defects and modulation by @PROTEIN1$ and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d391.s0.p0","sentence":"Isolation of @PROTEIN2$ from embryonic chicken skeletal muscle and evaluation of its interaction with different @PROTEIN1$ isoforms.","label":1}
{"pair_id":"AIMed.d69.s590.p0","sentence":"Phosphorylation of recombinant human @PROTEIN1$ proteins in vitro by @PROTEIN2$ decreases their DNA-binding activity.","label":1}
{"pair_id":"BioInfer.d151.s0.p0","sentence":"CONCLUSIONS: These results suggest the cooperative modulation of the actin cytoskeleton by @PROTEIN2$ and @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d151.s0.p1","sentence":"CONCLUSIONS: These results suggest the cooperative modulation of the @PROTEIN2$ cytoskeleton by cofilin and @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d151.s0.p2","sentence":"CONCLUSIONS: These results suggest the cooperative modulation of the @PROTEIN2$ cytoskeleton by @PROTEIN1$ and Aip1.","label":1}
{"pair_id":"BioInfer.d300.s0.p0","sentence":"Immunoprecipitation with an @PROTEIN1$ mAb, which is known to co-precipitate the catenins, demonstrated that the three poorly differentiated cell lines expressing E-cadherin did not co-precipitate alpha-catenin, although all of the moderately-well differentiated cell lines expressed both alpha- and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d300.s0.p1","sentence":"Immunoprecipitation with an @PROTEIN1$ mAb, which is known to co-precipitate the catenins, demonstrated that the three poorly differentiated cell lines expressing E-cadherin did not co-precipitate @PROTEIN2$, although all of the moderately-well differentiated cell lines expressed both alpha- and beta-alpha- .","label":0}
{"pair_id":"BioInfer.d300.s0.p2","sentence":"Immunoprecipitation with an @PROTEIN1$ mAb, which is known to co-precipitate the catenins, demonstrated that the three poorly differentiated cell lines expressing E-cadherin did not co-precipitate alpha-catenin, although all of the moderately-well differentiated cell lines expressed both @PROTEIN2$ and beta-@PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d300.s0.p3","sentence":"Immunoprecipitation with an @PROTEIN1$ mAb, which is known to co-precipitate the @PROTEIN2$, demonstrated that the three poorly differentiated cell lines expressing E-cadherin did not co-precipitate alpha-catenin, although all of the moderately-well differentiated cell lines expressed both alpha- and beta-alpha- .","label":1}
{"pair_id":"BioInfer.d300.s0.p4","sentence":"Immunoprecipitation with an @PROTEIN1$ mAb, which is known to co-precipitate the catenins, demonstrated that the three poorly differentiated cell lines expressing @PROTEIN2$ did not co-precipitate alpha-catenin, although all of the moderately-well differentiated cell lines expressed both alpha- and beta-alpha- .","label":0}
{"pair_id":"BioInfer.d300.s0.p5","sentence":"Immunoprecipitation with an E-cadherin mAb, which is known to co-precipitate the catenins, demonstrated that the three poorly differentiated cell lines expressing E-cadherin did not co-precipitate @PROTEIN2$, although all of the moderately-well differentiated cell lines expressed both alpha- and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d300.s0.p6","sentence":"Immunoprecipitation with an E-cadherin mAb, which is known to co-precipitate the catenins, demonstrated that the three poorly differentiated cell lines expressing E-cadherin did not co-precipitate alpha-catenin, although all of the moderately-well differentiated cell lines expressed both @PROTEIN2$ and @PROTEIN1$@PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d300.s0.p7","sentence":"Immunoprecipitation with an E-cadherin mAb, which is known to co-precipitate the @PROTEIN2$, demonstrated that the three poorly differentiated cell lines expressing E-cadherin did not co-precipitate alpha-catenin, although all of the moderately-well differentiated cell lines expressed both alpha- and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d300.s0.p8","sentence":"Immunoprecipitation with an E-cadherin mAb, which is known to co-precipitate the catenins, demonstrated that the three poorly differentiated cell lines expressing @PROTEIN2$ did not co-precipitate alpha-catenin, although all of the moderately-well differentiated cell lines expressed both alpha- and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d300.s0.p9","sentence":"Immunoprecipitation with an E-cadherin mAb, which is known to co-precipitate the catenins, demonstrated that the three poorly differentiated cell lines expressing E-cadherin did not co-precipitate @PROTEIN1$, although all of the moderately-well differentiated cell lines expressed both @PROTEIN2$ and beta-@PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d300.s0.p10","sentence":"Immunoprecipitation with an E-cadherin mAb, which is known to co-precipitate the @PROTEIN2$, demonstrated that the three poorly differentiated cell lines expressing E-cadherin did not co-precipitate @PROTEIN1$, although all of the moderately-well differentiated cell lines expressed both alpha- and beta-alpha- .","label":0}
{"pair_id":"BioInfer.d300.s0.p11","sentence":"Immunoprecipitation with an E-cadherin mAb, which is known to co-precipitate the catenins, demonstrated that the three poorly differentiated cell lines expressing @PROTEIN2$ did not co-precipitate @PROTEIN1$, although all of the moderately-well differentiated cell lines expressed both alpha- and beta-alpha- .","label":1}
{"pair_id":"BioInfer.d300.s0.p12","sentence":"Immunoprecipitation with an E-cadherin mAb, which is known to co-precipitate the @PROTEIN2$, demonstrated that the three poorly differentiated cell lines expressing E-cadherin did not co-precipitate alpha-catenin, although all of the moderately-well differentiated cell lines expressed both @PROTEIN1$ and beta-@PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d300.s0.p13","sentence":"Immunoprecipitation with an E-cadherin mAb, which is known to co-precipitate the catenins, demonstrated that the three poorly differentiated cell lines expressing @PROTEIN2$ did not co-precipitate alpha-catenin, although all of the moderately-well differentiated cell lines expressed both @PROTEIN1$ and beta-@PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d300.s0.p14","sentence":"Immunoprecipitation with an E-cadherin mAb, which is known to co-precipitate the @PROTEIN1$, demonstrated that the three poorly differentiated cell lines expressing @PROTEIN2$ did not co-precipitate alpha-catenin, although all of the moderately-well differentiated cell lines expressed both alpha- and beta-alpha- .","label":0}
{"pair_id":"AIMed.d98.s832.p0","sentence":"@PROTEIN1$, which is known to bind 14-3-3 proteins, has recently been shown to associate with @PROTEIN2$ and to stimulate its phosphatase activity.","label":1}
{"pair_id":"AIMed.d59.s518.p0","sentence":"Analysis of the oligomerization of @PROTEIN1$ and @PROTEIN2$ products in vivo using a two-hybrid assay system.","label":0}
{"pair_id":"BioInfer.d741.s0.p0","sentence":"This is the first report describing the coexistence of profilin with @PROTEIN1$ filaments in the division furrow, implying the possible involvement of @PROTEIN2$ in assembly and disassembly of contractile ring microfilaments in the process of cytokinesis.","label":0}
{"pair_id":"BioInfer.d741.s0.p1","sentence":"This is the first report describing the coexistence of @PROTEIN2$ with @PROTEIN1$ filaments in the division furrow, implying the possible involvement of profilin in assembly and disassembly of contractile ring microfilaments in the process of cytokinesis.","label":1}
{"pair_id":"BioInfer.d741.s0.p2","sentence":"This is the first report describing the coexistence of @PROTEIN2$ with actin filaments in the division furrow, implying the possible involvement of @PROTEIN1$ in assembly and disassembly of contractile ring microfilaments in the process of cytokinesis.","label":0}
{"pair_id":"AIMed.d173.s1456.p0","sentence":"The kinetics of amyloid fibril formation by @PROTEIN1$ (@PROTEIN2$) are typical of a nucleation-dependent polymerization mechanism.","label":0}
{"pair_id":"BioInfer.d61.s2.p0","sentence":"Using an in vitro assay system involving bacterially expressed proteins, we localized a region in alpha-catenin required for molecular interaction with @PROTEIN1$ and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d61.s2.p1","sentence":"Using an in vitro assay system involving bacterially expressed proteins, we localized a region in @PROTEIN2$ required for molecular interaction with @PROTEIN1$ and plakoglobin.","label":1}
{"pair_id":"BioInfer.d61.s2.p2","sentence":"Using an in vitro assay system involving bacterially expressed proteins, we localized a region in @PROTEIN2$ required for molecular interaction with beta-catenin and @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d280.s0.p0","sentence":"However, when all of the four proteins (@PROTEIN2$, alpha-catenin, @PROTEIN1$, and gamma-catenin) were analysed as one group, a significant association was seen between reduction in immunoreactivity of at least one of these four proteins and the presence of metastases.","label":0}
{"pair_id":"BioInfer.d280.s0.p1","sentence":"However, when all of the four proteins (E-cadherin, alpha-catenin, @PROTEIN1$, and @PROTEIN2$) were analysed as one group, a significant association was seen between reduction in immunoreactivity of at least one of these four proteins and the presence of metastases.","label":0}
{"pair_id":"BioInfer.d280.s0.p2","sentence":"However, when all of the four proteins (E-cadherin, @PROTEIN2$, @PROTEIN1$, and gamma-catenin) were analysed as one group, a significant association was seen between reduction in immunoreactivity of at least one of these four proteins and the presence of metastases.","label":0}
{"pair_id":"BioInfer.d280.s0.p3","sentence":"However, when all of the four proteins (@PROTEIN1$, alpha-catenin, beta-catenin, and @PROTEIN2$) were analysed as one group, a significant association was seen between reduction in immunoreactivity of at least one of these four proteins and the presence of metastases.","label":0}
{"pair_id":"BioInfer.d280.s0.p4","sentence":"However, when all of the four proteins (@PROTEIN1$, @PROTEIN2$, beta-catenin, and gamma-catenin) were analysed as one group, a significant association was seen between reduction in immunoreactivity of at least one of these four proteins and the presence of metastases.","label":0}
{"pair_id":"BioInfer.d280.s0.p5","sentence":"However, when all of the four proteins (E-cadherin, @PROTEIN2$, beta-catenin, and @PROTEIN1$) were analysed as one group, a significant association was seen between reduction in immunoreactivity of at least one of these four proteins and the presence of metastases.","label":0}
{"pair_id":"AIMed.d121.s1033.p0","sentence":"These very same hydrophobic residues contact the @PROTEIN1$ and Ad5 @PROTEIN2$ 55-kD oncogene products.","label":0}
{"pair_id":"AIMed.d127.s1090.p0","sentence":"Thus, gamma c mutations in at least some XSCID and XCID patients prevent normal @PROTEIN1$ activation, suggesting that mutations of @PROTEIN2$ may result in an XSCID-like phenotype.","label":0}
{"pair_id":"AIMed.d185.s1573.p0","sentence":"@PROTEIN1$ also activated @PROTEIN2$ in Ba\/F3 cells that stably expressed the murine IL-10 receptor.","label":1}
{"pair_id":"AIMed.d185.s1573.p1","sentence":"@PROTEIN1$ also activated Stat5 in Ba\/F3 cells that stably expressed the murine @PROTEIN2$ receptor.","label":0}
{"pair_id":"AIMed.d185.s1573.p2","sentence":"@PROTEIN1$ also activated Stat5 in Ba\/F3 cells that stably expressed the murine @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d185.s1573.p3","sentence":"IL-10 also activated @PROTEIN1$ in Ba\/F3 cells that stably expressed the murine @PROTEIN2$ receptor.","label":0}
{"pair_id":"AIMed.d185.s1573.p4","sentence":"IL-10 also activated @PROTEIN1$ in Ba\/F3 cells that stably expressed the murine @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d185.s1573.p5","sentence":"IL-10 also activated Stat5 in Ba\/F3 cells that stably expressed the murine @PROTEIN1$@PROTEIN2$.","label":0}
{"pair_id":"AIMed.d192.s1638.p0","sentence":"Lipopolysaccharide-activated @PROTEIN1$-deficient (ICE-\/-) Kupffer cells synthesized the @PROTEIN2$ precursor but failed to process it into the active form.","label":0}
{"pair_id":"AIMed.d137.s1158.p0","sentence":"By using several different experimental systems we show that @PROTEIN1$ efficiently associates with @PROTEIN2$ and Oct2.","label":1}
{"pair_id":"AIMed.d137.s1158.p1","sentence":"By using several different experimental systems we show that @PROTEIN1$ efficiently associates with Oct1 and @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d137.s1158.p2","sentence":"By using several different experimental systems we show that TBP efficiently associates with @PROTEIN1$ and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d35.s294.p0","sentence":"Although numerous studies revealed predominant localization of @PROTEIN1$ to endoplasmic reticulum and Golgi, there are conflicting reports on the localization of @PROTEIN2$ to the cell surface.","label":0}
{"pair_id":"AIMed.d206.s1782.p0","sentence":"@PROTEIN1$ was detected in beta 1 integrin immunoprecipitates and also in immunoprecipitates of @PROTEIN2$ and syndecan, but not of cadherins.","label":0}
{"pair_id":"AIMed.d206.s1782.p1","sentence":"@PROTEIN1$ was detected in beta 1 integrin immunoprecipitates and also in immunoprecipitates of CD44 and @PROTEIN2$, but not of cadherins.","label":0}
{"pair_id":"AIMed.d206.s1782.p2","sentence":"CD9 was detected in beta 1 integrin immunoprecipitates and also in immunoprecipitates of @PROTEIN1$ and @PROTEIN2$, but not of cadherins.","label":0}
{"pair_id":"AIMed.d192.s1635.p0","sentence":"Activation of @PROTEIN1$@PROTEIN2$ mediated by interleukin-1beta converting enzyme.","label":0}
{"pair_id":"AIMed.d192.s1635.p1","sentence":"Activation of @PROTEIN1$ inducing factor mediated by @PROTEIN2$ converting enzyme.","label":0}
{"pair_id":"AIMed.d192.s1635.p2","sentence":"Activation of @PROTEIN1$ inducing factor mediated by @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d192.s1635.p3","sentence":"Activation of @PROTEIN1$ mediated by @PROTEIN2$ converting enzyme.","label":0}
{"pair_id":"AIMed.d192.s1635.p4","sentence":"Activation of @PROTEIN1$ mediated by @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d192.s1635.p5","sentence":"Activation of interferon-gamma inducing factor mediated by @PROTEIN1$@PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d207.s0.p0","sentence":"Features studied were @PROTEIN2$, microtubules, vinculin, and @PROTEIN1$, using immunofluorescence, sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and immunoblotting; permeability of the cell sheet; wound healing; and phagocytic capacity.","label":0}
{"pair_id":"BioInfer.d207.s0.p1","sentence":"Features studied were actin, microtubules, @PROTEIN2$, and @PROTEIN1$, using immunofluorescence, sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and immunoblotting; permeability of the cell sheet; wound healing; and phagocytic capacity.","label":0}
{"pair_id":"BioInfer.d207.s0.p2","sentence":"Features studied were @PROTEIN1$, microtubules, @PROTEIN2$, and talin, using immunofluorescence, sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and immunoblotting; permeability of the cell sheet; wound healing; and phagocytic capacity.","label":0}
{"pair_id":"BioInfer.d168.s0.p0","sentence":"Demembranated stereociliary cores consisted primarily of protein bands corresponding to @PROTEIN2$ and @PROTEIN1$ and several proteins ranging from 43 to 63 kDa.","label":1}
{"pair_id":"BioInfer.d685.s0.p0","sentence":"The resulting @PROTEIN1$ product is unable to bind @PROTEIN2$ that is responsible for actin filament binding and organization.","label":1}
{"pair_id":"BioInfer.d685.s0.p1","sentence":"The resulting @PROTEIN1$ product is unable to bind alpha-catenin that is responsible for @PROTEIN2$ filament binding and organization.","label":0}
{"pair_id":"BioInfer.d685.s0.p2","sentence":"The resulting beta-catenin product is unable to bind @PROTEIN1$ that is responsible for @PROTEIN2$ filament binding and organization.","label":1}
{"pair_id":"BioInfer.d821.s0.p0","sentence":"We show that the HSV-1 UL5, UL8, @PROTEIN2$, @PROTEIN1$, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.","label":0}
{"pair_id":"BioInfer.d821.s0.p1","sentence":"We show that the HSV-1 UL5, @PROTEIN2$, UL29, @PROTEIN1$, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.","label":0}
{"pair_id":"BioInfer.d821.s0.p2","sentence":"We show that the HSV-1 @PROTEIN2$, UL8, UL29, @PROTEIN1$, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.","label":0}
{"pair_id":"BioInfer.d821.s0.p3","sentence":"We show that the HSV-1 UL5, UL8, UL29, @PROTEIN1$, UL42, and UL52 gene products along with the AAV @PROTEIN2$ protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.","label":0}
{"pair_id":"BioInfer.d821.s0.p4","sentence":"We show that the HSV-1 UL5, UL8, UL29, @PROTEIN1$, UL42, and @PROTEIN2$ gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.","label":0}
{"pair_id":"BioInfer.d821.s0.p5","sentence":"We show that the HSV-1 UL5, UL8, UL29, @PROTEIN1$, @PROTEIN2$, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.","label":0}
{"pair_id":"BioInfer.d821.s0.p6","sentence":"We show that the HSV-1 UL5, @PROTEIN2$, @PROTEIN1$, UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.","label":0}
{"pair_id":"BioInfer.d821.s0.p7","sentence":"We show that the HSV-1 @PROTEIN2$, UL8, @PROTEIN1$, UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.","label":0}
{"pair_id":"BioInfer.d821.s0.p8","sentence":"We show that the HSV-1 UL5, UL8, @PROTEIN1$, UL30, UL42, and UL52 gene products along with the AAV @PROTEIN2$ protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.","label":0}
{"pair_id":"BioInfer.d821.s0.p9","sentence":"We show that the HSV-1 UL5, UL8, @PROTEIN1$, UL30, UL42, and @PROTEIN2$ gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.","label":0}
{"pair_id":"BioInfer.d821.s0.p10","sentence":"We show that the HSV-1 UL5, UL8, @PROTEIN1$, UL30, @PROTEIN2$, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.","label":0}
{"pair_id":"BioInfer.d821.s0.p11","sentence":"We show that the HSV-1 @PROTEIN2$, @PROTEIN1$, UL29, UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.","label":0}
{"pair_id":"BioInfer.d821.s0.p12","sentence":"We show that the HSV-1 UL5, @PROTEIN1$, UL29, UL30, UL42, and UL52 gene products along with the AAV @PROTEIN2$ protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.","label":0}
{"pair_id":"BioInfer.d821.s0.p13","sentence":"We show that the HSV-1 UL5, @PROTEIN1$, UL29, UL30, UL42, and @PROTEIN2$ gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.","label":0}
{"pair_id":"BioInfer.d821.s0.p14","sentence":"We show that the HSV-1 UL5, @PROTEIN1$, UL29, UL30, @PROTEIN2$, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.","label":0}
{"pair_id":"BioInfer.d821.s0.p15","sentence":"We show that the HSV-1 @PROTEIN1$, UL8, UL29, UL30, UL42, and UL52 gene products along with the AAV @PROTEIN2$ protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.","label":0}
{"pair_id":"BioInfer.d821.s0.p16","sentence":"We show that the HSV-1 @PROTEIN1$, UL8, UL29, UL30, UL42, and @PROTEIN2$ gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.","label":0}
{"pair_id":"BioInfer.d821.s0.p17","sentence":"We show that the HSV-1 @PROTEIN1$, UL8, UL29, UL30, @PROTEIN2$, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.","label":0}
{"pair_id":"BioInfer.d821.s0.p18","sentence":"We show that the HSV-1 UL5, UL8, UL29, UL30, UL42, and @PROTEIN2$ gene products along with the AAV @PROTEIN1$ protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.","label":0}
{"pair_id":"BioInfer.d821.s0.p19","sentence":"We show that the HSV-1 UL5, UL8, UL29, UL30, @PROTEIN2$, and UL52 gene products along with the AAV @PROTEIN1$ protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.","label":0}
{"pair_id":"BioInfer.d821.s0.p20","sentence":"We show that the HSV-1 UL5, UL8, UL29, UL30, @PROTEIN2$, and @PROTEIN1$ gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.","label":0}
{"pair_id":"AIMed.d137.s1162.p0","sentence":"The @PROTEIN1$ POU domain, which is highly homologous to the @PROTEIN2$ POU domain, likewise mediates interaction with TBP.","label":0}
{"pair_id":"AIMed.d137.s1162.p1","sentence":"The @PROTEIN1$ POU domain, which is highly homologous to the Oct2 POU domain, likewise mediates interaction with @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d137.s1162.p2","sentence":"The Oct1 POU domain, which is highly homologous to the @PROTEIN1$ POU domain, likewise mediates interaction with @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d247.s2.p0","sentence":"These findings provide the first evidence that @PROTEIN2$ is a key molecule linking a signaling network to rapid @PROTEIN1$ polymerization in microspike formation.","label":1}
{"pair_id":"AIMed.d110.s927.p0","sentence":"@PROTEIN1$ is shown to interact with the largest subunit (@PROTEIN2$) of human TFIID through its central region and with multiple activators--including Sp1, YY1, USF, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.","label":1}
{"pair_id":"AIMed.d110.s927.p1","sentence":"@PROTEIN1$ is shown to interact with the largest subunit (TAFII230) of human @PROTEIN2$ through its central region and with multiple activators--including Sp1, YY1, USF, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.","label":0}
{"pair_id":"AIMed.d110.s927.p2","sentence":"@PROTEIN1$ is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including @PROTEIN2$, YY1, USF, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.","label":1}
{"pair_id":"AIMed.d110.s927.p3","sentence":"@PROTEIN1$ is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including Sp1, @PROTEIN2$, USF, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.","label":1}
{"pair_id":"AIMed.d110.s927.p4","sentence":"@PROTEIN1$ is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including Sp1, YY1, @PROTEIN2$, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.","label":1}
{"pair_id":"AIMed.d110.s927.p5","sentence":"@PROTEIN1$ is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including Sp1, YY1, USF, @PROTEIN2$, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.","label":1}
{"pair_id":"AIMed.d110.s927.p6","sentence":"@PROTEIN1$ is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including Sp1, YY1, USF, CTF, adenoviral @PROTEIN2$, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.","label":1}
{"pair_id":"AIMed.d110.s927.p7","sentence":"@PROTEIN1$ is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including Sp1, YY1, USF, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 @PROTEIN2$ proteins--through a distinct amino-terminal domain.","label":0}
{"pair_id":"AIMed.d110.s927.p8","sentence":"TAFII55 is shown to interact with the largest subunit (@PROTEIN1$) of human @PROTEIN2$ through its central region and with multiple activators--including Sp1, YY1, USF, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.","label":0}
{"pair_id":"AIMed.d110.s927.p9","sentence":"TAFII55 is shown to interact with the largest subunit (@PROTEIN1$) of human TFIID through its central region and with multiple activators--including @PROTEIN2$, YY1, USF, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.","label":0}
{"pair_id":"AIMed.d110.s927.p10","sentence":"TAFII55 is shown to interact with the largest subunit (@PROTEIN1$) of human TFIID through its central region and with multiple activators--including Sp1, @PROTEIN2$, USF, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.","label":0}
{"pair_id":"AIMed.d110.s927.p11","sentence":"TAFII55 is shown to interact with the largest subunit (@PROTEIN1$) of human TFIID through its central region and with multiple activators--including Sp1, YY1, @PROTEIN2$, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.","label":0}
{"pair_id":"AIMed.d110.s927.p12","sentence":"TAFII55 is shown to interact with the largest subunit (@PROTEIN1$) of human TFIID through its central region and with multiple activators--including Sp1, YY1, USF, @PROTEIN2$, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.","label":0}
{"pair_id":"AIMed.d110.s927.p13","sentence":"TAFII55 is shown to interact with the largest subunit (@PROTEIN1$) of human TFIID through its central region and with multiple activators--including Sp1, YY1, USF, CTF, adenoviral @PROTEIN2$, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.","label":0}
{"pair_id":"AIMed.d110.s927.p14","sentence":"TAFII55 is shown to interact with the largest subunit (@PROTEIN1$) of human TFIID through its central region and with multiple activators--including Sp1, YY1, USF, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 @PROTEIN2$ proteins--through a distinct amino-terminal domain.","label":0}
{"pair_id":"AIMed.d110.s927.p15","sentence":"TAFII55 is shown to interact with the largest subunit (TAFII230) of human @PROTEIN1$ through its central region and with multiple activators--including @PROTEIN2$, YY1, USF, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.","label":0}
{"pair_id":"AIMed.d110.s927.p16","sentence":"TAFII55 is shown to interact with the largest subunit (TAFII230) of human @PROTEIN1$ through its central region and with multiple activators--including Sp1, @PROTEIN2$, USF, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.","label":0}
{"pair_id":"AIMed.d110.s927.p17","sentence":"TAFII55 is shown to interact with the largest subunit (TAFII230) of human @PROTEIN1$ through its central region and with multiple activators--including Sp1, YY1, @PROTEIN2$, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.","label":0}
{"pair_id":"AIMed.d110.s927.p18","sentence":"TAFII55 is shown to interact with the largest subunit (TAFII230) of human @PROTEIN1$ through its central region and with multiple activators--including Sp1, YY1, USF, @PROTEIN2$, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.","label":0}
{"pair_id":"AIMed.d110.s927.p19","sentence":"TAFII55 is shown to interact with the largest subunit (TAFII230) of human @PROTEIN1$ through its central region and with multiple activators--including Sp1, YY1, USF, CTF, adenoviral @PROTEIN2$, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.","label":0}
{"pair_id":"AIMed.d110.s927.p20","sentence":"TAFII55 is shown to interact with the largest subunit (TAFII230) of human @PROTEIN1$ through its central region and with multiple activators--including Sp1, YY1, USF, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 @PROTEIN2$ proteins--through a distinct amino-terminal domain.","label":0}
{"pair_id":"AIMed.d110.s927.p21","sentence":"TAFII55 is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including @PROTEIN1$, @PROTEIN2$, USF, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.","label":0}
{"pair_id":"AIMed.d110.s927.p22","sentence":"TAFII55 is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including @PROTEIN1$, YY1, @PROTEIN2$, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.","label":0}
{"pair_id":"AIMed.d110.s927.p23","sentence":"TAFII55 is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including @PROTEIN1$, YY1, USF, @PROTEIN2$, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.","label":0}
{"pair_id":"AIMed.d110.s927.p24","sentence":"TAFII55 is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including @PROTEIN1$, YY1, USF, CTF, adenoviral @PROTEIN2$, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.","label":0}
{"pair_id":"AIMed.d110.s927.p25","sentence":"TAFII55 is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including @PROTEIN1$, YY1, USF, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 @PROTEIN2$ proteins--through a distinct amino-terminal domain.","label":0}
{"pair_id":"AIMed.d110.s927.p26","sentence":"TAFII55 is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including Sp1, @PROTEIN1$, @PROTEIN2$, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.","label":0}
{"pair_id":"AIMed.d110.s927.p27","sentence":"TAFII55 is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including Sp1, @PROTEIN1$, USF, @PROTEIN2$, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.","label":0}
{"pair_id":"AIMed.d110.s927.p28","sentence":"TAFII55 is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including Sp1, @PROTEIN1$, USF, CTF, adenoviral @PROTEIN2$, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.","label":0}
{"pair_id":"AIMed.d110.s927.p29","sentence":"TAFII55 is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including Sp1, @PROTEIN1$, USF, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 @PROTEIN2$ proteins--through a distinct amino-terminal domain.","label":0}
{"pair_id":"AIMed.d110.s927.p30","sentence":"TAFII55 is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including Sp1, YY1, @PROTEIN1$, @PROTEIN2$, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.","label":0}
{"pair_id":"AIMed.d110.s927.p31","sentence":"TAFII55 is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including Sp1, YY1, @PROTEIN1$, CTF, adenoviral @PROTEIN2$, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.","label":0}
{"pair_id":"AIMed.d110.s927.p32","sentence":"TAFII55 is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including Sp1, YY1, @PROTEIN1$, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 @PROTEIN2$ proteins--through a distinct amino-terminal domain.","label":0}
{"pair_id":"AIMed.d110.s927.p33","sentence":"TAFII55 is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including Sp1, YY1, USF, @PROTEIN1$, adenoviral @PROTEIN2$, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.","label":0}
{"pair_id":"AIMed.d110.s927.p34","sentence":"TAFII55 is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including Sp1, YY1, USF, @PROTEIN1$, adenoviral E1A, and human immunodeficiency virus-type 1 @PROTEIN2$ proteins--through a distinct amino-terminal domain.","label":0}
{"pair_id":"AIMed.d110.s927.p35","sentence":"TAFII55 is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including Sp1, YY1, USF, CTF, adenoviral @PROTEIN1$, and human immunodeficiency virus-type 1 @PROTEIN2$ proteins--through a distinct amino-terminal domain.","label":0}
{"pair_id":"BioInfer.d208.s1.p0","sentence":"Thus, both DR5 and @PROTEIN1$ use FADD, TRADD, and @PROTEIN2$ in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.","label":1}
{"pair_id":"BioInfer.d208.s1.p1","sentence":"Thus, both DR5 and @PROTEIN1$ use FADD, @PROTEIN2$, and RIP in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.","label":1}
{"pair_id":"BioInfer.d208.s1.p2","sentence":"Thus, both @PROTEIN2$ and @PROTEIN1$ use FADD, TRADD, and RIP in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.","label":0}
{"pair_id":"BioInfer.d208.s1.p3","sentence":"Thus, both DR5 and @PROTEIN1$ use @PROTEIN2$, TRADD, and RIP in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.","label":1}
{"pair_id":"BioInfer.d208.s1.p4","sentence":"Thus, both DR5 and @PROTEIN1$ use FADD, TRADD, and RIP in their signal transduction pathways, and @PROTEIN2$ is the common mediator of apoptosis by all known death domain-containing receptors.","label":0}
{"pair_id":"BioInfer.d208.s1.p5","sentence":"Thus, both DR5 and DR4 use FADD, @PROTEIN2$, and @PROTEIN1$ in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.","label":0}
{"pair_id":"BioInfer.d208.s1.p6","sentence":"Thus, both @PROTEIN2$ and DR4 use FADD, TRADD, and @PROTEIN1$ in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.","label":1}
{"pair_id":"BioInfer.d208.s1.p7","sentence":"Thus, both DR5 and DR4 use @PROTEIN2$, TRADD, and @PROTEIN1$ in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.","label":0}
{"pair_id":"BioInfer.d208.s1.p8","sentence":"Thus, both DR5 and DR4 use FADD, TRADD, and @PROTEIN1$ in their signal transduction pathways, and @PROTEIN2$ is the common mediator of apoptosis by all known death domain-containing receptors.","label":0}
{"pair_id":"BioInfer.d208.s1.p9","sentence":"Thus, both @PROTEIN2$ and DR4 use FADD, @PROTEIN1$, and RIP in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.","label":1}
{"pair_id":"BioInfer.d208.s1.p10","sentence":"Thus, both DR5 and DR4 use @PROTEIN2$, @PROTEIN1$, and RIP in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.","label":0}
{"pair_id":"BioInfer.d208.s1.p11","sentence":"Thus, both DR5 and DR4 use FADD, @PROTEIN1$, and RIP in their signal transduction pathways, and @PROTEIN2$ is the common mediator of apoptosis by all known death domain-containing receptors.","label":0}
{"pair_id":"BioInfer.d208.s1.p12","sentence":"Thus, both @PROTEIN1$ and DR4 use @PROTEIN2$, TRADD, and RIP in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.","label":1}
{"pair_id":"BioInfer.d208.s1.p13","sentence":"Thus, both @PROTEIN1$ and DR4 use FADD, TRADD, and RIP in their signal transduction pathways, and @PROTEIN2$ is the common mediator of apoptosis by all known death domain-containing receptors.","label":0}
{"pair_id":"BioInfer.d208.s1.p14","sentence":"Thus, both DR5 and DR4 use @PROTEIN1$, TRADD, and RIP in their signal transduction pathways, and @PROTEIN2$ is the common mediator of apoptosis by all known death domain-containing receptors.","label":0}
{"pair_id":"AIMed.d163.s1372.p0","sentence":"Enhanced degradation of @PROTEIN1$ receptors by a sorting @PROTEIN2$, SNX1.","label":0}
{"pair_id":"AIMed.d163.s1372.p1","sentence":"Enhanced degradation of @PROTEIN1$ receptors by a sorting nexin, @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d163.s1372.p2","sentence":"Enhanced degradation of EGF receptors by a sorting @PROTEIN1$, @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d142.s1202.p0","sentence":"In addition, we identified domains within @PROTEIN1$ and @PROTEIN2$ that mediate their interactions with each other.","label":1}
{"pair_id":"BioInfer.d237.s0.p0","sentence":"Here, specific interactions between human RAD51 and RAD52 proteins are demonstrated both in vivo, using the yeast two-hybrid system and immunoprecipitation of insect cells co-infected with @PROTEIN2$ and @PROTEIN1$ recombinant viruses, and in vitro, using affinity chromatography with purified recombinant proteins.","label":0}
{"pair_id":"BioInfer.d237.s0.p1","sentence":"Here, specific interactions between human RAD51 and @PROTEIN2$ proteins are demonstrated both in vivo, using the yeast two-hybrid system and immunoprecipitation of insect cells co-infected with RAD51 and @PROTEIN1$ recombinant viruses, and in vitro, using affinity chromatography with purified recombinant proteins.","label":0}
{"pair_id":"BioInfer.d237.s0.p2","sentence":"Here, specific interactions between human @PROTEIN2$ and RAD52 proteins are demonstrated both in vivo, using the yeast two-hybrid system and immunoprecipitation of insect cells co-infected with RAD51 and @PROTEIN1$ recombinant viruses, and in vitro, using affinity chromatography with purified recombinant proteins.","label":0}
{"pair_id":"BioInfer.d237.s0.p3","sentence":"Here, specific interactions between human RAD51 and @PROTEIN2$ proteins are demonstrated both in vivo, using the yeast two-hybrid system and immunoprecipitation of insect cells co-infected with @PROTEIN1$ and RAD52 recombinant viruses, and in vitro, using affinity chromatography with purified recombinant proteins.","label":0}
{"pair_id":"BioInfer.d237.s0.p4","sentence":"Here, specific interactions between human @PROTEIN2$ and RAD52 proteins are demonstrated both in vivo, using the yeast two-hybrid system and immunoprecipitation of insect cells co-infected with @PROTEIN1$ and RAD52 recombinant viruses, and in vitro, using affinity chromatography with purified recombinant proteins.","label":0}
{"pair_id":"BioInfer.d237.s0.p5","sentence":"Here, specific interactions between human @PROTEIN2$ and @PROTEIN1$ proteins are demonstrated both in vivo, using the yeast two-hybrid system and immunoprecipitation of insect cells co-infected with RAD51 and RAD52 recombinant viruses, and in vitro, using affinity chromatography with purified recombinant proteins.","label":1}
{"pair_id":"BioInfer.d122.s0.p0","sentence":"By two-hybrid screening we have identified two partners that directly associate with TIF34: PRT1, a previously characterized eIF3 subunit, and a novel protein of 33 kDa (@PROTEIN2$) which is part of the @PROTEIN1$ complex and has an RNA binding domain.","label":1}
{"pair_id":"BioInfer.d122.s0.p1","sentence":"By two-hybrid screening we have identified two partners that directly associate with TIF34: PRT1, a previously characterized @PROTEIN2$ subunit, and a novel protein of 33 kDa (eIF3-p33) which is part of the @PROTEIN1$ complex and has an RNA binding domain.","label":0}
{"pair_id":"BioInfer.d122.s0.p2","sentence":"By two-hybrid screening we have identified two partners that directly associate with TIF34: @PROTEIN2$, a previously characterized eIF3 subunit, and a novel protein of 33 kDa (eIF3-p33) which is part of the @PROTEIN1$ complex and has an RNA binding domain.","label":0}
{"pair_id":"BioInfer.d122.s0.p3","sentence":"By two-hybrid screening we have identified two partners that directly associate with @PROTEIN2$: PRT1, a previously characterized eIF3 subunit, and a novel protein of 33 kDa (eIF3-p33) which is part of the @PROTEIN1$ complex and has an RNA binding domain.","label":0}
{"pair_id":"BioInfer.d122.s0.p4","sentence":"By two-hybrid screening we have identified two partners that directly associate with TIF34: PRT1, a previously characterized @PROTEIN2$ subunit, and a novel protein of 33 kDa (@PROTEIN1$) which is part of the eIF3 complex and has an RNA binding domain.","label":0}
{"pair_id":"BioInfer.d122.s0.p5","sentence":"By two-hybrid screening we have identified two partners that directly associate with TIF34: @PROTEIN2$, a previously characterized eIF3 subunit, and a novel protein of 33 kDa (@PROTEIN1$) which is part of the eIF3 complex and has an RNA binding domain.","label":0}
{"pair_id":"BioInfer.d122.s0.p6","sentence":"By two-hybrid screening we have identified two partners that directly associate with @PROTEIN2$: PRT1, a previously characterized eIF3 subunit, and a novel protein of 33 kDa (@PROTEIN1$) which is part of the eIF3 complex and has an RNA binding domain.","label":1}
{"pair_id":"BioInfer.d122.s0.p7","sentence":"By two-hybrid screening we have identified two partners that directly associate with TIF34: @PROTEIN2$, a previously characterized @PROTEIN1$ subunit, and a novel protein of 33 kDa (eIF3-p33) which is part of the eIF3 complex and has an RNA binding domain.","label":1}
{"pair_id":"BioInfer.d122.s0.p8","sentence":"By two-hybrid screening we have identified two partners that directly associate with @PROTEIN2$: PRT1, a previously characterized @PROTEIN1$ subunit, and a novel protein of 33 kDa (eIF3-p33) which is part of the eIF3 complex and has an RNA binding domain.","label":0}
{"pair_id":"BioInfer.d122.s0.p9","sentence":"By two-hybrid screening we have identified two partners that directly associate with @PROTEIN2$: @PROTEIN1$, a previously characterized eIF3 subunit, and a novel protein of 33 kDa (eIF3-p33) which is part of the eIF3 complex and has an RNA binding domain.","label":1}
{"pair_id":"AIMed.d90.s770.p0","sentence":"We found that deletion of the carboxyl-terminal 28 amino acids of @PROTEIN1$ disrupted @PROTEIN2$-NF-IL6 beta physical interaction.","label":0}
{"pair_id":"AIMed.d90.s770.p1","sentence":"We found that deletion of the carboxyl-terminal 28 amino acids of @PROTEIN1$ disrupted PU.1-@PROTEIN2$ physical interaction.","label":0}
{"pair_id":"AIMed.d90.s770.p2","sentence":"We found that deletion of the carboxyl-terminal 28 amino acids of PU.1 disrupted @PROTEIN1$-@PROTEIN2$ physical interaction.","label":1}
{"pair_id":"BioInfer.d622.s0.p0","sentence":"The herpes simplex virus type-1 @PROTEIN2$, @PROTEIN1$, and UL52 genes encode an essential heterotrimeric DNA helicase-primase that is responsible for concomitant DNA unwinding and primer synthesis at the viral DNA replication fork.","label":0}
{"pair_id":"BioInfer.d622.s0.p1","sentence":"The herpes simplex virus type-1 UL5, @PROTEIN1$, and @PROTEIN2$ genes encode an essential heterotrimeric DNA helicase-primase that is responsible for concomitant DNA unwinding and primer synthesis at the viral DNA replication fork.","label":0}
{"pair_id":"BioInfer.d622.s0.p2","sentence":"The herpes simplex virus type-1 UL5, @PROTEIN1$, and UL52 genes encode an essential heterotrimeric @PROTEIN2$ that is responsible for concomitant DNA unwinding and primer synthesis at the viral DNA replication fork.","label":1}
{"pair_id":"BioInfer.d622.s0.p3","sentence":"The herpes simplex virus type-1 @PROTEIN1$, UL8, and @PROTEIN2$ genes encode an essential heterotrimeric DNA helicase-primase that is responsible for concomitant DNA unwinding and primer synthesis at the viral DNA replication fork.","label":0}
{"pair_id":"BioInfer.d622.s0.p4","sentence":"The herpes simplex virus type-1 @PROTEIN1$, UL8, and UL52 genes encode an essential heterotrimeric @PROTEIN2$ that is responsible for concomitant DNA unwinding and primer synthesis at the viral DNA replication fork.","label":1}
{"pair_id":"BioInfer.d622.s0.p5","sentence":"The herpes simplex virus type-1 UL5, UL8, and @PROTEIN1$ genes encode an essential heterotrimeric @PROTEIN2$ that is responsible for concomitant DNA unwinding and primer synthesis at the viral DNA replication fork.","label":1}
{"pair_id":"AIMed.d37.s318.p0","sentence":"Chemokines that could compete with high affinity for @PROTEIN1$ binding could also compete for monomeric @PROTEIN2$ binding, although with variable potencies; maximal gp120 binding inhibition was 80% for MCP-2, but only 30% for MIP-1beta.","label":0}
{"pair_id":"AIMed.d37.s318.p1","sentence":"Chemokines that could compete with high affinity for @PROTEIN1$ binding could also compete for monomeric gp120 binding, although with variable potencies; maximal @PROTEIN2$ binding inhibition was 80% for MCP-2, but only 30% for MIP-1beta.","label":0}
{"pair_id":"AIMed.d37.s318.p2","sentence":"Chemokines that could compete with high affinity for @PROTEIN1$ binding could also compete for monomeric gp120 binding, although with variable potencies; maximal gp120 binding inhibition was 80% for @PROTEIN2$, but only 30% for MIP-1beta.","label":0}
{"pair_id":"AIMed.d37.s318.p3","sentence":"Chemokines that could compete with high affinity for @PROTEIN1$ binding could also compete for monomeric gp120 binding, although with variable potencies; maximal gp120 binding inhibition was 80% for MCP-2, but only 30% for @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d37.s318.p4","sentence":"Chemokines that could compete with high affinity for MIP-1beta binding could also compete for monomeric @PROTEIN1$ binding, although with variable potencies; maximal @PROTEIN2$ binding inhibition was 80% for MCP-2, but only 30% for MIP-1beta.","label":0}
{"pair_id":"AIMed.d37.s318.p5","sentence":"Chemokines that could compete with high affinity for MIP-1beta binding could also compete for monomeric @PROTEIN1$ binding, although with variable potencies; maximal gp120 binding inhibition was 80% for @PROTEIN2$, but only 30% for MIP-1beta.","label":0}
{"pair_id":"AIMed.d37.s318.p6","sentence":"Chemokines that could compete with high affinity for MIP-1beta binding could also compete for monomeric @PROTEIN1$ binding, although with variable potencies; maximal gp120 binding inhibition was 80% for MCP-2, but only 30% for @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d37.s318.p7","sentence":"Chemokines that could compete with high affinity for MIP-1beta binding could also compete for monomeric gp120 binding, although with variable potencies; maximal @PROTEIN1$ binding inhibition was 80% for @PROTEIN2$, but only 30% for MIP-1beta.","label":1}
{"pair_id":"AIMed.d37.s318.p8","sentence":"Chemokines that could compete with high affinity for MIP-1beta binding could also compete for monomeric gp120 binding, although with variable potencies; maximal @PROTEIN1$ binding inhibition was 80% for MCP-2, but only 30% for @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d37.s318.p9","sentence":"Chemokines that could compete with high affinity for MIP-1beta binding could also compete for monomeric gp120 binding, although with variable potencies; maximal gp120 binding inhibition was 80% for @PROTEIN1$, but only 30% for @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d258.s1.p0","sentence":"The interactions of the UL52 protein with the @PROTEIN2$ and @PROTEIN1$ proteins were analysed by using the yeast two-hybrid system.","label":0}
{"pair_id":"BioInfer.d258.s1.p1","sentence":"The interactions of the @PROTEIN2$ protein with the UL8 and @PROTEIN1$ proteins were analysed by using the yeast two-hybrid system.","label":1}
{"pair_id":"BioInfer.d258.s1.p2","sentence":"The interactions of the @PROTEIN2$ protein with the @PROTEIN1$ and UL5 proteins were analysed by using the yeast two-hybrid system.","label":1}
{"pair_id":"BioInfer.d281.s0.p0","sentence":"Human @PROTEIN2$ are multifunctional, single-domain proteins which directly link the @PROTEIN1$ microfilament system to a variety of signalling pathways via two spatially distinct binding sites.","label":1}
{"pair_id":"BioInfer.d546.s0.p0","sentence":"Specific antibodies to myosin heavy chain isoforms (@PROTEIN1$, SM2, SMemb), caldesmon, and @PROTEIN2$ and cDNAs for SMemb were used.","label":0}
{"pair_id":"BioInfer.d546.s0.p1","sentence":"Specific antibodies to myosin heavy chain isoforms (@PROTEIN1$, SM2, SMemb), @PROTEIN2$, and alpha-smooth muscle actin and cDNAs for SMemb were used.","label":0}
{"pair_id":"BioInfer.d546.s0.p2","sentence":"Specific antibodies to myosin heavy chain isoforms (@PROTEIN1$, @PROTEIN2$, SMemb), caldesmon, and alpha-smooth muscle actin and cDNAs for SMemb were used.","label":0}
{"pair_id":"BioInfer.d546.s0.p3","sentence":"Specific antibodies to myosin heavy chain isoforms (@PROTEIN1$, SM2, SMemb), caldesmon, and alpha-smooth muscle actin and cDNAs for @PROTEIN2$ were used.","label":0}
{"pair_id":"BioInfer.d546.s0.p4","sentence":"Specific antibodies to myosin heavy chain isoforms (@PROTEIN1$, SM2, @PROTEIN2$), caldesmon, and alpha-smooth muscle actin and cDNAs for SMemb were used.","label":0}
{"pair_id":"BioInfer.d546.s0.p5","sentence":"Specific antibodies to @PROTEIN2$ isoforms (@PROTEIN1$, SM2, SMemb), caldesmon, and alpha-smooth muscle actin and cDNAs for SMemb were used.","label":1}
{"pair_id":"BioInfer.d546.s0.p6","sentence":"Specific antibodies to myosin heavy chain isoforms (SM1, SM2, SMemb), @PROTEIN2$, and @PROTEIN1$ and cDNAs for SMemb were used.","label":0}
{"pair_id":"BioInfer.d546.s0.p7","sentence":"Specific antibodies to myosin heavy chain isoforms (SM1, @PROTEIN2$, SMemb), caldesmon, and @PROTEIN1$ and cDNAs for SMemb were used.","label":0}
{"pair_id":"BioInfer.d546.s0.p8","sentence":"Specific antibodies to myosin heavy chain isoforms (SM1, SM2, SMemb), caldesmon, and @PROTEIN1$ and cDNAs for @PROTEIN2$ were used.","label":0}
{"pair_id":"BioInfer.d546.s0.p9","sentence":"Specific antibodies to myosin heavy chain isoforms (SM1, SM2, @PROTEIN2$), caldesmon, and @PROTEIN1$ and cDNAs for SMemb were used.","label":0}
{"pair_id":"BioInfer.d546.s0.p10","sentence":"Specific antibodies to @PROTEIN2$ isoforms (SM1, SM2, SMemb), caldesmon, and @PROTEIN1$ and cDNAs for SMemb were used.","label":0}
{"pair_id":"BioInfer.d546.s0.p11","sentence":"Specific antibodies to myosin heavy chain isoforms (SM1, @PROTEIN2$, SMemb), @PROTEIN1$, and alpha-smooth muscle actin and cDNAs for SMemb were used.","label":0}
{"pair_id":"BioInfer.d546.s0.p12","sentence":"Specific antibodies to myosin heavy chain isoforms (SM1, SM2, SMemb), @PROTEIN1$, and alpha-smooth muscle actin and cDNAs for @PROTEIN2$ were used.","label":0}
{"pair_id":"BioInfer.d546.s0.p13","sentence":"Specific antibodies to myosin heavy chain isoforms (SM1, SM2, @PROTEIN2$), @PROTEIN1$, and alpha-smooth muscle actin and cDNAs for SMemb were used.","label":0}
{"pair_id":"BioInfer.d546.s0.p14","sentence":"Specific antibodies to @PROTEIN2$ isoforms (SM1, SM2, SMemb), @PROTEIN1$, and alpha-smooth muscle actin and cDNAs for SMemb were used.","label":0}
{"pair_id":"BioInfer.d546.s0.p15","sentence":"Specific antibodies to myosin heavy chain isoforms (SM1, @PROTEIN1$, SMemb), caldesmon, and alpha-smooth muscle actin and cDNAs for @PROTEIN2$ were used.","label":0}
{"pair_id":"BioInfer.d546.s0.p16","sentence":"Specific antibodies to myosin heavy chain isoforms (SM1, @PROTEIN1$, @PROTEIN2$), caldesmon, and alpha-smooth muscle actin and cDNAs for SMemb were used.","label":0}
{"pair_id":"BioInfer.d546.s0.p17","sentence":"Specific antibodies to @PROTEIN2$ isoforms (SM1, @PROTEIN1$, SMemb), caldesmon, and alpha-smooth muscle actin and cDNAs for SMemb were used.","label":1}
{"pair_id":"BioInfer.d546.s0.p18","sentence":"Specific antibodies to myosin heavy chain isoforms (SM1, SM2, @PROTEIN2$), caldesmon, and alpha-smooth muscle actin and cDNAs for @PROTEIN1$ were used.","label":0}
{"pair_id":"BioInfer.d546.s0.p19","sentence":"Specific antibodies to @PROTEIN2$ isoforms (SM1, SM2, SMemb), caldesmon, and alpha-smooth muscle actin and cDNAs for @PROTEIN1$ were used.","label":0}
{"pair_id":"BioInfer.d546.s0.p20","sentence":"Specific antibodies to @PROTEIN2$ isoforms (SM1, SM2, @PROTEIN1$), caldesmon, and alpha-smooth muscle actin and cDNAs for SMemb were used.","label":1}
{"pair_id":"BioInfer.d412.s0.p0","sentence":"Mammalian LIM-kinases (@PROTEIN2$) phosphorylate cofilin and induce @PROTEIN1$ cytoskeletal reorganization.","label":1}
{"pair_id":"BioInfer.d412.s0.p1","sentence":"Mammalian @PROTEIN2$ (LIMKs) phosphorylate cofilin and induce @PROTEIN1$ cytoskeletal reorganization.","label":1}
{"pair_id":"BioInfer.d412.s0.p2","sentence":"Mammalian LIM-kinases (LIMKs) phosphorylate @PROTEIN2$ and induce @PROTEIN1$ cytoskeletal reorganization.","label":0}
{"pair_id":"BioInfer.d412.s0.p3","sentence":"Mammalian @PROTEIN2$ (@PROTEIN1$) phosphorylate cofilin and induce actin cytoskeletal reorganization.","label":0}
{"pair_id":"BioInfer.d412.s0.p4","sentence":"Mammalian LIM-kinases (@PROTEIN1$) phosphorylate @PROTEIN2$ and induce actin cytoskeletal reorganization.","label":1}
{"pair_id":"BioInfer.d412.s0.p5","sentence":"Mammalian @PROTEIN1$ (LIMKs) phosphorylate @PROTEIN2$ and induce actin cytoskeletal reorganization.","label":1}
{"pair_id":"BioInfer.d62.s0.p0","sentence":"An assembly of the @PROTEIN2$ and @PROTEIN1$ subunits retains both enzymic activities, and the UL8 protein has been implicated in modulating these functions, facilitating efficient nuclear uptake of the complex and interacting with other viral DNA replication proteins.","label":1}
{"pair_id":"BioInfer.d62.s0.p1","sentence":"An assembly of the UL5 and @PROTEIN1$ subunits retains both enzymic activities, and the @PROTEIN2$ protein has been implicated in modulating these functions, facilitating efficient nuclear uptake of the complex and interacting with other viral DNA replication proteins.","label":1}
{"pair_id":"BioInfer.d62.s0.p2","sentence":"An assembly of the @PROTEIN1$ and UL52 subunits retains both enzymic activities, and the @PROTEIN2$ protein has been implicated in modulating these functions, facilitating efficient nuclear uptake of the complex and interacting with other viral DNA replication proteins.","label":1}
{"pair_id":"AIMed.d190.s1615.p0","sentence":"In vitro experiments showed that the stable @PROTEIN1$\/@PROTEIN2$ complex interacts, through the Grb2 SH2 domain, with the SCF-activated c-Kit.","label":1}
{"pair_id":"AIMed.d190.s1615.p1","sentence":"In vitro experiments showed that the stable @PROTEIN1$\/c-Cbl complex interacts, through the @PROTEIN2$ SH2 domain, with the SCF-activated c-Kit.","label":0}
{"pair_id":"AIMed.d190.s1615.p2","sentence":"In vitro experiments showed that the stable @PROTEIN1$\/c-Cbl complex interacts, through the Grb2 SH2 domain, with the @PROTEIN2$-activated c-Kit.","label":0}
{"pair_id":"AIMed.d190.s1615.p3","sentence":"In vitro experiments showed that the stable @PROTEIN1$\/c-Cbl complex interacts, through the Grb2 SH2 domain, with the SCF-activated @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d190.s1615.p4","sentence":"In vitro experiments showed that the stable Grb2\/@PROTEIN1$ complex interacts, through the @PROTEIN2$ SH2 domain, with the SCF-activated c-Kit.","label":0}
{"pair_id":"AIMed.d190.s1615.p5","sentence":"In vitro experiments showed that the stable Grb2\/@PROTEIN1$ complex interacts, through the Grb2 SH2 domain, with the @PROTEIN2$-activated c-Kit.","label":0}
{"pair_id":"AIMed.d190.s1615.p6","sentence":"In vitro experiments showed that the stable Grb2\/@PROTEIN1$ complex interacts, through the Grb2 SH2 domain, with the SCF-activated @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d190.s1615.p7","sentence":"In vitro experiments showed that the stable Grb2\/c-Cbl complex interacts, through the @PROTEIN1$ SH2 domain, with the @PROTEIN2$-activated c-Kit.","label":0}
{"pair_id":"AIMed.d190.s1615.p8","sentence":"In vitro experiments showed that the stable Grb2\/c-Cbl complex interacts, through the @PROTEIN1$ SH2 domain, with the SCF-activated @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d190.s1615.p9","sentence":"In vitro experiments showed that the stable Grb2\/c-Cbl complex interacts, through the Grb2 SH2 domain, with the @PROTEIN1$-activated @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d450.s0.p0","sentence":"Neither can @PROTEIN1$, in the presence of the peptide, promote @PROTEIN2$ polymerization during its early phase consistent with a lower affinity.","label":1}
{"pair_id":"BioInfer.d190.s0.p0","sentence":"END5 encodes a proline-rich protein (@PROTEIN1$ or @PROTEIN2$) required for a polarised cortical actin cytoskeleton and endocytosis [2,3].","label":0}
{"pair_id":"BioInfer.d190.s0.p1","sentence":"@PROTEIN2$ encodes a proline-rich protein (@PROTEIN1$ or verprolin) required for a polarised cortical actin cytoskeleton and endocytosis [2,3].","label":1}
{"pair_id":"BioInfer.d190.s0.p2","sentence":"END5 encodes a proline-rich protein (@PROTEIN1$ or verprolin) required for a polarised cortical @PROTEIN2$ cytoskeleton and endocytosis [2,3].","label":1}
{"pair_id":"BioInfer.d190.s0.p3","sentence":"@PROTEIN2$ encodes a proline-rich protein (End5p or @PROTEIN1$) required for a polarised cortical actin cytoskeleton and endocytosis [2,3].","label":1}
{"pair_id":"BioInfer.d190.s0.p4","sentence":"END5 encodes a proline-rich protein (End5p or @PROTEIN1$) required for a polarised cortical @PROTEIN2$ cytoskeleton and endocytosis [2,3].","label":1}
{"pair_id":"BioInfer.d190.s0.p5","sentence":"@PROTEIN1$ encodes a proline-rich protein (End5p or verprolin) required for a polarised cortical @PROTEIN2$ cytoskeleton and endocytosis [2,3].","label":0}
{"pair_id":"AIMed.d76.s639.p0","sentence":"@PROTEIN1$ associates with the @PROTEIN2$ (TcR zeta)\/CD3 complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta\/CD3 ligation.","label":0}
{"pair_id":"AIMed.d76.s639.p1","sentence":"@PROTEIN1$ associates with the T-cell receptor zeta chain (@PROTEIN2$)\/CD3 complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta\/CD3 ligation.","label":0}
{"pair_id":"AIMed.d76.s639.p2","sentence":"@PROTEIN1$ associates with the T-cell receptor zeta chain (TcR zeta)\/@PROTEIN2$ complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta\/CD3 ligation.","label":0}
{"pair_id":"AIMed.d76.s639.p3","sentence":"@PROTEIN1$ associates with the @PROTEIN2$ complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta\/CD3 ligation.","label":1}
{"pair_id":"AIMed.d76.s639.p4","sentence":"@PROTEIN1$ associates with the T-cell receptor zeta chain (TcR zeta)\/CD3 complex and is rapidly phosphosphorylated on tyrosine residues as a result of @PROTEIN2$\/CD3 ligation.","label":0}
{"pair_id":"AIMed.d76.s639.p5","sentence":"@PROTEIN1$ associates with the T-cell receptor zeta chain (TcR zeta)\/CD3 complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta\/@PROTEIN2$ ligation.","label":0}
{"pair_id":"AIMed.d76.s639.p6","sentence":"CD5 associates with the @PROTEIN1$ (@PROTEIN2$)\/CD3 complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta\/CD3 ligation.","label":0}
{"pair_id":"AIMed.d76.s639.p7","sentence":"CD5 associates with the @PROTEIN1$ (TcR zeta)\/@PROTEIN2$ complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta\/CD3 ligation.","label":1}
{"pair_id":"AIMed.d76.s639.p8","sentence":"CD5 associates with the @PROTEIN1$@PROTEIN2$ complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta\/CD3 ligation.","label":0}
{"pair_id":"AIMed.d76.s639.p9","sentence":"CD5 associates with the @PROTEIN1$ (TcR zeta)\/CD3 complex and is rapidly phosphosphorylated on tyrosine residues as a result of @PROTEIN2$\/CD3 ligation.","label":0}
{"pair_id":"AIMed.d76.s639.p10","sentence":"CD5 associates with the @PROTEIN1$ (TcR zeta)\/CD3 complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta\/@PROTEIN2$ ligation.","label":0}
{"pair_id":"AIMed.d76.s639.p11","sentence":"CD5 associates with the T-cell receptor zeta chain (@PROTEIN1$)\/@PROTEIN2$ complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta\/CD3 ligation.","label":1}
{"pair_id":"AIMed.d76.s639.p12","sentence":"CD5 associates with the @PROTEIN2$@PROTEIN1$)\/CD3 complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta\/CD3 ligation.","label":0}
{"pair_id":"AIMed.d76.s639.p13","sentence":"CD5 associates with the T-cell receptor zeta chain (@PROTEIN1$)\/CD3 complex and is rapidly phosphosphorylated on tyrosine residues as a result of @PROTEIN2$\/CD3 ligation.","label":0}
{"pair_id":"AIMed.d76.s639.p14","sentence":"CD5 associates with the T-cell receptor zeta chain (@PROTEIN1$)\/CD3 complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta\/@PROTEIN2$ ligation.","label":0}
{"pair_id":"AIMed.d76.s639.p15","sentence":"CD5 associates with the @PROTEIN2$@PROTEIN1$ complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta\/CD3 ligation.","label":0}
{"pair_id":"AIMed.d76.s639.p16","sentence":"CD5 associates with the T-cell receptor zeta chain (TcR zeta)\/@PROTEIN1$ complex and is rapidly phosphosphorylated on tyrosine residues as a result of @PROTEIN2$\/CD3 ligation.","label":0}
{"pair_id":"AIMed.d76.s639.p17","sentence":"CD5 associates with the T-cell receptor zeta chain (TcR zeta)\/@PROTEIN1$ complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta\/@PROTEIN2$ ligation.","label":0}
{"pair_id":"AIMed.d76.s639.p18","sentence":"CD5 associates with the @PROTEIN1$ complex and is rapidly phosphosphorylated on tyrosine residues as a result of @PROTEIN2$\/CD3 ligation.","label":0}
{"pair_id":"AIMed.d76.s639.p19","sentence":"CD5 associates with the @PROTEIN1$ complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta\/@PROTEIN2$ ligation.","label":0}
{"pair_id":"AIMed.d76.s639.p20","sentence":"CD5 associates with the T-cell receptor zeta chain (TcR zeta)\/CD3 complex and is rapidly phosphosphorylated on tyrosine residues as a result of @PROTEIN1$\/@PROTEIN2$ ligation.","label":0}
{"pair_id":"AIMed.d70.s594.p0","sentence":"The @PROTEIN1$ is localized to specific subcellular environments through the binding of the regulatory subunit (@PROTEIN2$) dimer to RII-anchoring proteins.","label":0}
{"pair_id":"AIMed.d70.s594.p1","sentence":"The @PROTEIN1$ is localized to specific subcellular environments through the binding of the regulatory subunit (RII) dimer to @PROTEIN2$-anchoring proteins.","label":0}
{"pair_id":"AIMed.d70.s594.p2","sentence":"The type II cAMP-dependent protein kinase is localized to specific subcellular environments through the binding of the regulatory subunit (@PROTEIN1$) dimer to @PROTEIN2$-anchoring proteins.","label":0}
{"pair_id":"BioInfer.d136.s0.p0","sentence":"Characterization of a mutant @PROTEIN1$ with reduced @PROTEIN2$-binding capacity: effects in vitro and in vivo.","label":1}
{"pair_id":"BioInfer.d347.s0.p0","sentence":"In localization studies with mammalian cells, all fusion proteins showed the localization expected for @PROTEIN1$ in areas of high actin dynamics, such as leading lamellae and ruffles induced by @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d347.s0.p1","sentence":"In localization studies with mammalian cells, all fusion proteins showed the localization expected for @PROTEIN1$ in areas of high @PROTEIN2$ dynamics, such as leading lamellae and ruffles induced by epidermal growth factor.","label":0}
{"pair_id":"BioInfer.d347.s0.p2","sentence":"In localization studies with mammalian cells, all fusion proteins showed the localization expected for profilin in areas of high @PROTEIN2$ dynamics, such as leading lamellae and ruffles induced by @PROTEIN1$.","label":0}
{"pair_id":"AIMed.d77.s655.p0","sentence":"We have engineered and purified recombinant @PROTEIN1$ head and @PROTEIN2$ tail, and we demonstrate direct interaction in vitro by solution-binding assays and by ligand blot assays.","label":1}
{"pair_id":"AIMed.d82.s695.p0","sentence":"Identification of an 11-kDa @PROTEIN1$-rapamycin-binding domain within the 289-kDa @PROTEIN2$ and characterization of a critical serine residue.","label":0}
{"pair_id":"AIMed.d116.s977.p0","sentence":"Activity of RNA polymerase I transcription factor @PROTEIN1$ blocked by @PROTEIN2$ gene product.","label":1}
{"pair_id":"AIMed.d205.s1775.p0","sentence":"A @PROTEIN1$ (@PROTEIN2$) associated with CD5 and specifically with the Y429-Y441 phosphopeptide in stimulated thymocytes.","label":0}
{"pair_id":"AIMed.d205.s1775.p1","sentence":"A @PROTEIN1$ (pp120) associated with @PROTEIN2$ and specifically with the Y429-Y441 phosphopeptide in stimulated thymocytes.","label":1}
{"pair_id":"AIMed.d205.s1775.p2","sentence":"A 120-kDa phosphoprotein (@PROTEIN1$) associated with @PROTEIN2$ and specifically with the Y429-Y441 phosphopeptide in stimulated thymocytes.","label":1}
{"pair_id":"BioInfer.d258.s0.p0","sentence":"Herpes simplex virus type 1 expresses a heterotrimeric helicase-primase, the subunits of which are encoded by the viral @PROTEIN2$, @PROTEIN1$ and UL52 genes.","label":0}
{"pair_id":"BioInfer.d258.s0.p1","sentence":"Herpes simplex virus type 1 expresses a heterotrimeric @PROTEIN2$, the subunits of which are encoded by the viral UL5, @PROTEIN1$ and UL52 genes.","label":1}
{"pair_id":"BioInfer.d258.s0.p2","sentence":"Herpes simplex virus type 1 expresses a heterotrimeric helicase-primase, the subunits of which are encoded by the viral UL5, @PROTEIN1$ and @PROTEIN2$ genes.","label":0}
{"pair_id":"BioInfer.d258.s0.p3","sentence":"Herpes simplex virus type 1 expresses a heterotrimeric @PROTEIN2$, the subunits of which are encoded by the viral @PROTEIN1$, UL8 and UL52 genes.","label":1}
{"pair_id":"BioInfer.d258.s0.p4","sentence":"Herpes simplex virus type 1 expresses a heterotrimeric helicase-primase, the subunits of which are encoded by the viral @PROTEIN1$, UL8 and @PROTEIN2$ genes.","label":0}
{"pair_id":"BioInfer.d258.s0.p5","sentence":"Herpes simplex virus type 1 expresses a heterotrimeric @PROTEIN1$, the subunits of which are encoded by the viral UL5, UL8 and @PROTEIN2$ genes.","label":1}
{"pair_id":"BioInfer.d41.s2.p0","sentence":"We examined the role of the @PROTEIN2$ monomer sequestering protein, @PROTEIN1$, in the regulation of PMN actin filament assembly during chemoattractant stimulation using a Triton extraction method.","label":1}
{"pair_id":"BioInfer.d41.s2.p1","sentence":"We examined the role of the actin monomer sequestering protein, @PROTEIN1$, in the regulation of @PROTEIN2$ filament assembly during chemoattractant stimulation using a Triton extraction method.","label":1}
{"pair_id":"BioInfer.d41.s2.p2","sentence":"We examined the role of the @PROTEIN1$ monomer sequestering protein, profilin, in the regulation of @PROTEIN2$ filament assembly during chemoattractant stimulation using a Triton extraction method.","label":0}
{"pair_id":"AIMed.d179.s1528.p0","sentence":"We report here that @PROTEIN1$ also interacts with tyrosine-phosphorylated @PROTEIN2$ in response to gastrin.","label":1}
{"pair_id":"AIMed.d179.s1528.p1","sentence":"We report here that @PROTEIN1$ also interacts with tyrosine-phosphorylated IRS-1 in response to @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d179.s1528.p2","sentence":"We report here that Grb2 also interacts with tyrosine-phosphorylated @PROTEIN1$ in response to @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d100.s851.p0","sentence":"This largest TAF may therefore play a central role in @PROTEIN1$ assembly by interacting with both @PROTEIN2$ and other TAFs, as well as serving to link the control of transcription to the cell cycle.","label":0}
{"pair_id":"AIMed.d198.s1691.p0","sentence":"In addition, selected mutant proteins were expressed as full-length @PROTEIN1$ on the surface of COS cells and analyzed for 125I-@PROTEIN2$ binding in receptor binding assays.","label":0}
{"pair_id":"AIMed.d48.s424.p0","sentence":"The molar concentration of @PROTEIN1$ required to induce maximum cell migration is 20- to 200-fold greater than that required for @PROTEIN2$ or I309, respectively.","label":0}
{"pair_id":"AIMed.d48.s424.p1","sentence":"The molar concentration of @PROTEIN1$ required to induce maximum cell migration is 20- to 200-fold greater than that required for RANTES or @PROTEIN2$, respectively.","label":0}
{"pair_id":"AIMed.d48.s424.p2","sentence":"The molar concentration of LEC required to induce maximum cell migration is 20- to 200-fold greater than that required for @PROTEIN1$ or @PROTEIN2$, respectively.","label":0}
{"pair_id":"AIMed.d174.s1466.p0","sentence":"Influence of @PROTEIN1$ (@PROTEIN2$) dimerization on formation of the high affinity hexameric IL-6.receptor complex.","label":0}
{"pair_id":"AIMed.d174.s1466.p1","sentence":"Influence of @PROTEIN1$ (IL-6) dimerization on formation of the high affinity hexameric @PROTEIN2$.receptor complex.","label":0}
{"pair_id":"AIMed.d174.s1466.p2","sentence":"Influence of @PROTEIN1$ (IL-6) dimerization on formation of the high affinity hexameric @PROTEIN2$ complex.","label":0}
{"pair_id":"AIMed.d174.s1466.p3","sentence":"Influence of interleukin-6 (@PROTEIN1$) dimerization on formation of the high affinity hexameric @PROTEIN2$.receptor complex.","label":0}
{"pair_id":"AIMed.d174.s1466.p4","sentence":"Influence of interleukin-6 (@PROTEIN1$) dimerization on formation of the high affinity hexameric @PROTEIN2$ complex.","label":0}
{"pair_id":"AIMed.d174.s1466.p5","sentence":"Influence of interleukin-6 (IL-6) dimerization on formation of the high affinity hexameric @PROTEIN1$@PROTEIN2$ complex.","label":0}
{"pair_id":"AIMed.d102.s860.p0","sentence":"@PROTEIN1$, the protein product of the @PROTEIN2$ tumor-suppressor gene, regulates the activity of specific transcription factors.","label":0}
{"pair_id":"AIMed.d146.s1238.p0","sentence":"Deglycosylation studies showed that the @PROTEIN1$ and @PROTEIN2$ IL-7R are not simply differently glycosylated isoforms of a single receptor.","label":0}
{"pair_id":"AIMed.d146.s1238.p1","sentence":"Deglycosylation studies showed that the @PROTEIN1$ and p76 @PROTEIN2$ are not simply differently glycosylated isoforms of a single receptor.","label":0}
{"pair_id":"AIMed.d146.s1238.p2","sentence":"Deglycosylation studies showed that the p90 and @PROTEIN1$ @PROTEIN2$ are not simply differently glycosylated isoforms of a single receptor.","label":0}
{"pair_id":"BioInfer.d61.s1.p0","sentence":"Consistent with the observation that beta-catenin and plakoglobin bind to the same region of @PROTEIN1$, beta-catenin competed with the binding of plakoglobin to @PROTEIN2$ and vice versa.","label":0}
{"pair_id":"BioInfer.d61.s1.p1","sentence":"Consistent with the observation that beta-catenin and plakoglobin bind to the same region of @PROTEIN1$, @PROTEIN2$ competed with the binding of plakoglobin to alpha-catenin and vice versa.","label":0}
{"pair_id":"BioInfer.d61.s1.p2","sentence":"Consistent with the observation that beta-catenin and plakoglobin bind to the same region of @PROTEIN1$, beta-catenin competed with the binding of @PROTEIN2$ to alpha-catenin and vice versa.","label":0}
{"pair_id":"BioInfer.d61.s1.p3","sentence":"Consistent with the observation that beta-catenin and @PROTEIN2$ bind to the same region of @PROTEIN1$, beta-catenin competed with the binding of plakoglobin to alpha-catenin and vice versa.","label":1}
{"pair_id":"BioInfer.d61.s1.p4","sentence":"Consistent with the observation that @PROTEIN2$ and plakoglobin bind to the same region of @PROTEIN1$, beta-catenin competed with the binding of plakoglobin to alpha-catenin and vice versa.","label":1}
{"pair_id":"BioInfer.d61.s1.p5","sentence":"Consistent with the observation that beta-catenin and plakoglobin bind to the same region of alpha-catenin, @PROTEIN2$ competed with the binding of plakoglobin to @PROTEIN1$ and vice versa.","label":1}
{"pair_id":"BioInfer.d61.s1.p6","sentence":"Consistent with the observation that beta-catenin and plakoglobin bind to the same region of alpha-catenin, beta-catenin competed with the binding of @PROTEIN2$ to @PROTEIN1$ and vice versa.","label":1}
{"pair_id":"BioInfer.d61.s1.p7","sentence":"Consistent with the observation that beta-catenin and @PROTEIN2$ bind to the same region of alpha-catenin, beta-catenin competed with the binding of plakoglobin to @PROTEIN1$ and vice versa.","label":0}
{"pair_id":"BioInfer.d61.s1.p8","sentence":"Consistent with the observation that @PROTEIN2$ and plakoglobin bind to the same region of alpha-catenin, beta-catenin competed with the binding of plakoglobin to @PROTEIN1$ and vice versa.","label":0}
{"pair_id":"BioInfer.d61.s1.p9","sentence":"Consistent with the observation that beta-catenin and plakoglobin bind to the same region of alpha-catenin, @PROTEIN1$ competed with the binding of @PROTEIN2$ to alpha-catenin and vice versa.","label":0}
{"pair_id":"BioInfer.d61.s1.p10","sentence":"Consistent with the observation that beta-catenin and @PROTEIN2$ bind to the same region of alpha-catenin, @PROTEIN1$ competed with the binding of plakoglobin to alpha-catenin and vice versa.","label":0}
{"pair_id":"BioInfer.d61.s1.p11","sentence":"Consistent with the observation that @PROTEIN2$ and plakoglobin bind to the same region of alpha-catenin, @PROTEIN1$ competed with the binding of plakoglobin to alpha-catenin and vice versa.","label":0}
{"pair_id":"BioInfer.d61.s1.p12","sentence":"Consistent with the observation that beta-catenin and @PROTEIN2$ bind to the same region of alpha-catenin, beta-catenin competed with the binding of @PROTEIN1$ to alpha-catenin and vice versa.","label":0}
{"pair_id":"BioInfer.d61.s1.p13","sentence":"Consistent with the observation that @PROTEIN2$ and plakoglobin bind to the same region of alpha-catenin, beta-catenin competed with the binding of @PROTEIN1$ to alpha-catenin and vice versa.","label":0}
{"pair_id":"BioInfer.d61.s1.p14","sentence":"Consistent with the observation that @PROTEIN2$ and @PROTEIN1$ bind to the same region of alpha-catenin, beta-catenin competed with the binding of plakoglobin to alpha-catenin and vice versa.","label":0}
{"pair_id":"AIMed.d171.s1441.p0","sentence":"Crystal structure of the @PROTEIN1$ cyclin-dependent-kinase inhibitor bound to the @PROTEIN2$-Cdk2 complex.","label":1}
{"pair_id":"AIMed.d171.s1441.p1","sentence":"Crystal structure of the @PROTEIN1$ cyclin-dependent-kinase inhibitor bound to the cyclin A-@PROTEIN2$ complex.","label":1}
{"pair_id":"AIMed.d171.s1441.p2","sentence":"Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the @PROTEIN1$-@PROTEIN2$ complex.","label":1}
{"pair_id":"BioInfer.d135.s0.p0","sentence":"Characterization of @PROTEIN1$ and poly-L-proline binding sites of Acanthamoeba @PROTEIN2$ with monoclonal antibodies and by mutagenesis.","label":1}
{"pair_id":"AIMed.d87.s736.p0","sentence":"The results of his3 activation indicated that @PROTEIN1$, N + C-SH2 and C-SH2 interact with both @PROTEIN2$ beta and IGF-1R beta, whereas N-SH2 and SH3 + N-SH2 interact only with IR beta.","label":0}
{"pair_id":"AIMed.d87.s736.p1","sentence":"The results of his3 activation indicated that @PROTEIN1$, N + C-SH2 and C-SH2 interact with both @PROTEIN2$ and IGF-1R beta, whereas N-SH2 and SH3 + N-SH2 interact only with IR beta.","label":1}
{"pair_id":"AIMed.d87.s736.p2","sentence":"The results of his3 activation indicated that @PROTEIN1$, N + C-SH2 and C-SH2 interact with both IR beta and @PROTEIN2$ beta, whereas N-SH2 and SH3 + N-SH2 interact only with IR beta.","label":0}
{"pair_id":"AIMed.d87.s736.p3","sentence":"The results of his3 activation indicated that @PROTEIN1$, N + C-SH2 and C-SH2 interact with both IR beta and @PROTEIN2$, whereas N-SH2 and SH3 + N-SH2 interact only with IR beta.","label":1}
{"pair_id":"AIMed.d87.s736.p4","sentence":"The results of his3 activation indicated that @PROTEIN1$, N + C-SH2 and C-SH2 interact with both IR beta and IGF-1R beta, whereas N-SH2 and SH3 + N-SH2 interact only with @PROTEIN2$ beta.","label":0}
{"pair_id":"AIMed.d87.s736.p5","sentence":"The results of his3 activation indicated that @PROTEIN1$, N + C-SH2 and C-SH2 interact with both IR beta and IGF-1R beta, whereas N-SH2 and SH3 + N-SH2 interact only with @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d87.s736.p6","sentence":"The results of his3 activation indicated that p85, N + C-SH2 and C-SH2 interact with both @PROTEIN1$@PROTEIN2$ and IGF-1R beta, whereas N-SH2 and SH3 + N-SH2 interact only with IR beta.","label":0}
{"pair_id":"AIMed.d87.s736.p7","sentence":"The results of his3 activation indicated that p85, N + C-SH2 and C-SH2 interact with both @PROTEIN1$ beta and @PROTEIN2$ beta, whereas N-SH2 and SH3 + N-SH2 interact only with IR beta.","label":0}
{"pair_id":"AIMed.d87.s736.p8","sentence":"The results of his3 activation indicated that p85, N + C-SH2 and C-SH2 interact with both @PROTEIN1$ beta and @PROTEIN2$, whereas N-SH2 and SH3 + N-SH2 interact only with IR beta.","label":0}
{"pair_id":"AIMed.d87.s736.p9","sentence":"The results of his3 activation indicated that p85, N + C-SH2 and C-SH2 interact with both @PROTEIN1$ beta and IGF-1R beta, whereas N-SH2 and SH3 + N-SH2 interact only with @PROTEIN2$ beta.","label":0}
{"pair_id":"AIMed.d87.s736.p10","sentence":"The results of his3 activation indicated that p85, N + C-SH2 and C-SH2 interact with both @PROTEIN1$ beta and IGF-1R beta, whereas N-SH2 and SH3 + N-SH2 interact only with @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d87.s736.p11","sentence":"The results of his3 activation indicated that p85, N + C-SH2 and C-SH2 interact with both @PROTEIN1$ and @PROTEIN2$ beta, whereas N-SH2 and SH3 + N-SH2 interact only with IR beta.","label":0}
{"pair_id":"AIMed.d87.s736.p12","sentence":"The results of his3 activation indicated that p85, N + C-SH2 and C-SH2 interact with both @PROTEIN1$ and @PROTEIN2$, whereas N-SH2 and SH3 + N-SH2 interact only with IR beta.","label":0}
{"pair_id":"AIMed.d87.s736.p13","sentence":"The results of his3 activation indicated that p85, N + C-SH2 and C-SH2 interact with both @PROTEIN1$ and IGF-1R beta, whereas N-SH2 and SH3 + N-SH2 interact only with @PROTEIN2$ beta.","label":0}
{"pair_id":"AIMed.d87.s736.p14","sentence":"The results of his3 activation indicated that p85, N + C-SH2 and C-SH2 interact with both @PROTEIN1$ and IGF-1R beta, whereas N-SH2 and SH3 + N-SH2 interact only with @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d87.s736.p15","sentence":"The results of his3 activation indicated that p85, N + C-SH2 and C-SH2 interact with both IR beta and @PROTEIN1$@PROTEIN2$, whereas N-SH2 and SH3 + N-SH2 interact only with IR beta.","label":0}
{"pair_id":"AIMed.d87.s736.p16","sentence":"The results of his3 activation indicated that p85, N + C-SH2 and C-SH2 interact with both IR beta and @PROTEIN1$ beta, whereas N-SH2 and SH3 + N-SH2 interact only with @PROTEIN2$ beta.","label":0}
{"pair_id":"AIMed.d87.s736.p17","sentence":"The results of his3 activation indicated that p85, N + C-SH2 and C-SH2 interact with both IR beta and @PROTEIN1$ beta, whereas N-SH2 and SH3 + N-SH2 interact only with @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d87.s736.p18","sentence":"The results of his3 activation indicated that p85, N + C-SH2 and C-SH2 interact with both IR beta and @PROTEIN1$, whereas N-SH2 and SH3 + N-SH2 interact only with @PROTEIN2$ beta.","label":0}
{"pair_id":"AIMed.d87.s736.p19","sentence":"The results of his3 activation indicated that p85, N + C-SH2 and C-SH2 interact with both IR beta and @PROTEIN1$, whereas N-SH2 and SH3 + N-SH2 interact only with @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d87.s736.p20","sentence":"The results of his3 activation indicated that p85, N + C-SH2 and C-SH2 interact with both IR beta and IGF-1R beta, whereas N-SH2 and SH3 + N-SH2 interact only with @PROTEIN1$@PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d532.s0.p0","sentence":"Ser-133 phosphorylation enhances @PROTEIN2$ activity by promoting interaction with a 265-kDa CREB binding protein referred to as @PROTEIN1$ (Arias, J., Alberts, A., Brindle, P., Claret, F., Smeal, T., Karin, M., Feramisco, J., and Montminy, M. (1994) Nature 370, 226-228; Chrivia, J. C., Kwok, R. P., Lamb, N., Hagiwara, M., Montminy, M. R., and Goodman, R. H. (1993) Nature 365, 855-859).","label":1}
{"pair_id":"BioInfer.d532.s0.p1","sentence":"Ser-133 phosphorylation enhances CREB activity by promoting interaction with a 265-kDa @PROTEIN2$ referred to as @PROTEIN1$ (Arias, J., Alberts, A., Brindle, P., Claret, F., Smeal, T., Karin, M., Feramisco, J., and Montminy, M. (1994) Nature 370, 226-228; Chrivia, J. C., Kwok, R. P., Lamb, N., Hagiwara, M., Montminy, M. R., and Goodman, R. H. (1993) Nature 365, 855-859).","label":0}
{"pair_id":"BioInfer.d532.s0.p2","sentence":"Ser-133 phosphorylation enhances @PROTEIN1$ activity by promoting interaction with a 265-kDa @PROTEIN2$ referred to as CBP (Arias, J., Alberts, A., Brindle, P., Claret, F., Smeal, T., Karin, M., Feramisco, J., and Montminy, M. (1994) Nature 370, 226-228; Chrivia, J. C., Kwok, R. P., Lamb, N., Hagiwara, M., Montminy, M. R., and Goodman, R. H. (1993) Nature 365, 855-859).","label":1}
{"pair_id":"BioInfer.d425.s0.p0","sentence":"Microinjection or stable expression of V12Ras into keratinocytes promotes the loss of @PROTEIN2$ and alpha-catenin and relocalization of @PROTEIN1$ to the cytoplasm and nucleus.","label":0}
{"pair_id":"BioInfer.d425.s0.p1","sentence":"Microinjection or stable expression of V12Ras into keratinocytes promotes the loss of E-cadherin and @PROTEIN2$ and relocalization of @PROTEIN1$ to the cytoplasm and nucleus.","label":0}
{"pair_id":"BioInfer.d425.s0.p2","sentence":"Microinjection or stable expression of @PROTEIN2$ into keratinocytes promotes the loss of E-cadherin and alpha-catenin and relocalization of @PROTEIN1$ to the cytoplasm and nucleus.","label":1}
{"pair_id":"BioInfer.d425.s0.p3","sentence":"Microinjection or stable expression of V12Ras into keratinocytes promotes the loss of @PROTEIN1$ and @PROTEIN2$ and relocalization of beta-catenin to the cytoplasm and nucleus.","label":0}
{"pair_id":"BioInfer.d425.s0.p4","sentence":"Microinjection or stable expression of @PROTEIN2$ into keratinocytes promotes the loss of @PROTEIN1$ and alpha-catenin and relocalization of beta-catenin to the cytoplasm and nucleus.","label":1}
{"pair_id":"BioInfer.d425.s0.p5","sentence":"Microinjection or stable expression of @PROTEIN2$ into keratinocytes promotes the loss of E-cadherin and @PROTEIN1$ and relocalization of beta-catenin to the cytoplasm and nucleus.","label":1}
{"pair_id":"BioInfer.d356.s0.p0","sentence":"Integrating the @PROTEIN2$ and @PROTEIN1$ cytoskeletons.","label":1}
{"pair_id":"BioInfer.d28.s0.p0","sentence":"After 24 or 48 hours of shear, staining for @PROTEIN2$, alpha-catenin, and @PROTEIN1$ was intense and peripheral, forming a band of \"dashes\" (adherens plaques) that colocalized with the ends of stress fibers that inserted along the lateral membranes of cells.","label":0}
{"pair_id":"BioInfer.d28.s0.p1","sentence":"After 24 or 48 hours of shear, staining for VE-cadherin, @PROTEIN2$, and @PROTEIN1$ was intense and peripheral, forming a band of \"dashes\" (adherens plaques) that colocalized with the ends of stress fibers that inserted along the lateral membranes of cells.","label":0}
{"pair_id":"BioInfer.d28.s0.p2","sentence":"After 24 or 48 hours of shear, staining for @PROTEIN1$, @PROTEIN2$, and beta-catenin was intense and peripheral, forming a band of \"dashes\" (adherens plaques) that colocalized with the ends of stress fibers that inserted along the lateral membranes of cells.","label":0}
{"pair_id":"AIMed.d33.s277.p0","sentence":"Native @PROTEIN1$ and @PROTEIN2$ formed a heterodimer in solution of physiological ionic strength with a free-energy change DeltaG degrees of -8.3 kcal\/mol and a dissociation constant Kd of 0.6 microM (at 20 degrees C) that was ionic strength- and temperature-dependent.","label":1}
{"pair_id":"AIMed.d219.s1902.p0","sentence":"The @PROTEIN1$ is located in the NH2-terminal negative regulatory domain of @PROTEIN2$ and is highly homologous to cysteine-rich domains found in protein kinase C family members.","label":0}
{"pair_id":"AIMed.d206.s1785.p0","sentence":"Like antibodies to the @PROTEIN1$ subunit, anti-@PROTEIN2$ inhibited suspension-induced terminal differentiation.","label":0}
{"pair_id":"BioInfer.d704.s0.p0","sentence":"These proteins each have a @PROTEIN1$-homology (V) domain, cofilin-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the @PROTEIN2$\/A complex, leading to rapid actin polymerization.","label":0}
{"pair_id":"BioInfer.d704.s0.p1","sentence":"These proteins each have a @PROTEIN1$-homology (V) domain, cofilin-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the Arp2\/A complex, leading to rapid @PROTEIN2$ polymerization.","label":0}
{"pair_id":"BioInfer.d704.s0.p2","sentence":"These proteins each have a @PROTEIN1$-homology (V) domain, @PROTEIN2$-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the Arp2\/A complex, leading to rapid actin polymerization.","label":0}
{"pair_id":"BioInfer.d704.s0.p3","sentence":"These proteins each have a @PROTEIN1$-homology (V) domain, cofilin-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the @PROTEIN2$2\/@PROTEIN2$ complex, leading to rapid actin polymerization.","label":0}
{"pair_id":"BioInfer.d704.s0.p4","sentence":"These proteins each have a verprolin-homology (V) domain, cofilin-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the @PROTEIN1$\/A complex, leading to rapid @PROTEIN2$ polymerization.","label":1}
{"pair_id":"BioInfer.d704.s0.p5","sentence":"These proteins each have a verprolin-homology (V) domain, @PROTEIN2$-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the @PROTEIN1$\/A complex, leading to rapid actin polymerization.","label":0}
{"pair_id":"BioInfer.d704.s0.p6","sentence":"These proteins each have a verprolin-homology (V) domain, cofilin-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the @PROTEIN1$@PROTEIN2$2\/@PROTEIN2$ complex, leading to rapid actin polymerization.","label":1}
{"pair_id":"BioInfer.d704.s0.p7","sentence":"These proteins each have a verprolin-homology (V) domain, @PROTEIN2$-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the Arp2\/A complex, leading to rapid @PROTEIN1$ polymerization.","label":0}
{"pair_id":"BioInfer.d704.s0.p8","sentence":"These proteins each have a verprolin-homology (V) domain, cofilin-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the @PROTEIN2$2\/@PROTEIN2$ complex, leading to rapid @PROTEIN1$ polymerization.","label":1}
{"pair_id":"BioInfer.d704.s0.p9","sentence":"These proteins each have a verprolin-homology (V) domain, @PROTEIN1$-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the @PROTEIN2$2\/@PROTEIN2$ complex, leading to rapid actin polymerization.","label":0}
{"pair_id":"BioInfer.d208.s0.p0","sentence":"Finally, both receptors can interact with FADD, @PROTEIN1$, and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d208.s0.p1","sentence":"Finally, both receptors can interact with @PROTEIN2$, @PROTEIN1$, and RIP.","label":0}
{"pair_id":"BioInfer.d208.s0.p2","sentence":"Finally, both receptors can interact with @PROTEIN2$, TRADD, and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d35.s4.p0","sentence":"We conclude that Aip1p is a cofilin-associated protein that enhances the filament disassembly activity of @PROTEIN1$ and restricts cofilin localization to cortical @PROTEIN2$ patches.","label":0}
{"pair_id":"BioInfer.d35.s4.p1","sentence":"We conclude that @PROTEIN2$ is a cofilin-associated protein that enhances the filament disassembly activity of @PROTEIN1$ and restricts cofilin localization to cortical actin patches.","label":1}
{"pair_id":"BioInfer.d35.s4.p2","sentence":"We conclude that Aip1p is a cofilin-associated protein that enhances the filament disassembly activity of @PROTEIN1$ and restricts @PROTEIN2$ localization to cortical actin patches.","label":0}
{"pair_id":"BioInfer.d35.s4.p3","sentence":"We conclude that Aip1p is a @PROTEIN2$-associated protein that enhances the filament disassembly activity of @PROTEIN1$ and restricts cofilin localization to cortical actin patches.","label":0}
{"pair_id":"BioInfer.d35.s4.p4","sentence":"We conclude that @PROTEIN2$ is a cofilin-associated protein that enhances the filament disassembly activity of cofilin and restricts cofilin localization to cortical @PROTEIN1$ patches.","label":1}
{"pair_id":"BioInfer.d35.s4.p5","sentence":"We conclude that Aip1p is a cofilin-associated protein that enhances the filament disassembly activity of cofilin and restricts @PROTEIN2$ localization to cortical @PROTEIN1$ patches.","label":1}
{"pair_id":"BioInfer.d35.s4.p6","sentence":"We conclude that Aip1p is a @PROTEIN2$-associated protein that enhances the filament disassembly activity of cofilin and restricts cofilin localization to cortical @PROTEIN1$ patches.","label":0}
{"pair_id":"BioInfer.d35.s4.p7","sentence":"We conclude that @PROTEIN1$ is a cofilin-associated protein that enhances the filament disassembly activity of cofilin and restricts @PROTEIN2$ localization to cortical actin patches.","label":0}
{"pair_id":"BioInfer.d35.s4.p8","sentence":"We conclude that @PROTEIN1$ is a @PROTEIN2$-associated protein that enhances the filament disassembly activity of cofilin and restricts cofilin localization to cortical actin patches.","label":1}
{"pair_id":"BioInfer.d35.s4.p9","sentence":"We conclude that Aip1p is a @PROTEIN2$-associated protein that enhances the filament disassembly activity of cofilin and restricts @PROTEIN1$ localization to cortical actin patches.","label":0}
{"pair_id":"BioInfer.d135.s2.p0","sentence":"The results provide two independent lines of evidence about the binding sites for @PROTEIN1$ and poly-L-proline on the @PROTEIN2$ molecule.","label":1}
{"pair_id":"AIMed.d79.s671.p0","sentence":"The @PROTEIN1$ protein binds to @PROTEIN2$, a zinc-finger protein that shares an epitope with the adenovirus E1A protein.","label":1}
{"pair_id":"AIMed.d79.s671.p1","sentence":"The @PROTEIN1$ protein binds to RIZ, a zinc-finger protein that shares an epitope with the adenovirus @PROTEIN2$ protein.","label":0}
{"pair_id":"AIMed.d79.s671.p2","sentence":"The retinoblastoma protein binds to @PROTEIN1$, a zinc-finger protein that shares an epitope with the adenovirus @PROTEIN2$ protein.","label":0}
{"pair_id":"AIMed.d168.s1415.p0","sentence":"Mutant proteins were expressed in bacteria as soluble @PROTEIN1$ binding proteins (@PROTEIN2$) and characterized for EPO binding activity in a number of different assays.","label":1}
{"pair_id":"AIMed.d168.s1415.p1","sentence":"Mutant proteins were expressed in bacteria as soluble @PROTEIN1$ binding proteins (EBP) and characterized for @PROTEIN2$ binding activity in a number of different assays.","label":0}
{"pair_id":"AIMed.d168.s1415.p2","sentence":"Mutant proteins were expressed in bacteria as soluble EPO binding proteins (@PROTEIN1$) and characterized for @PROTEIN2$ binding activity in a number of different assays.","label":0}
{"pair_id":"AIMed.d46.s402.p0","sentence":"@PROTEIN1$ antagonists emerge from alterations in the low-affinity binding epitope for receptor @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d184.s1562.p0","sentence":"For efficient entry into target cells, primary macrophage-tropic and laboratory-adapted human immunodeficiency viruses type 1 (HIV-1) require particular chemokine receptors, @PROTEIN1$ and @PROTEIN2$, respectively, as well as the primary receptor CD4 (refs 1-6).","label":0}
{"pair_id":"AIMed.d184.s1562.p1","sentence":"For efficient entry into target cells, primary macrophage-tropic and laboratory-adapted human immunodeficiency viruses type 1 (HIV-1) require particular chemokine receptors, @PROTEIN1$ and CXCR-4, respectively, as well as the primary receptor @PROTEIN2$ (refs 1-6).","label":0}
{"pair_id":"AIMed.d184.s1562.p2","sentence":"For efficient entry into target cells, primary macrophage-tropic and laboratory-adapted human immunodeficiency viruses type 1 (HIV-1) require particular chemokine receptors, CCR-5 and @PROTEIN1$, respectively, as well as the primary receptor @PROTEIN2$ (refs 1-6).","label":0}
{"pair_id":"BioInfer.d55.s1.p0","sentence":"Molecular packing in @PROTEIN1$: @PROTEIN2$ crystals and its implications.","label":0}
{"pair_id":"AIMed.d215.s1871.p0","sentence":"Cleavage of @PROTEIN1$ by @PROTEIN2$ and the resulting activation of the Ln-5 cryptic site may provide new targets for modulation of tumor cell invasion and tissue remodeling.","label":1}
{"pair_id":"AIMed.d215.s1871.p1","sentence":"Cleavage of @PROTEIN1$ by MMP2 and the resulting activation of the @PROTEIN2$ cryptic site may provide new targets for modulation of tumor cell invasion and tissue remodeling.","label":0}
{"pair_id":"AIMed.d215.s1871.p2","sentence":"Cleavage of Ln-5 by @PROTEIN1$ and the resulting activation of the @PROTEIN2$ cryptic site may provide new targets for modulation of tumor cell invasion and tissue remodeling.","label":0}
{"pair_id":"AIMed.d92.s788.p0","sentence":"Although multimeric complexes of @PROTEIN1$ and @PROTEIN2$ were not detected by affinity crosslinking, immunoprecipitation of cross-linked NGF-receptor complexes with trk-specific antibodies resulted in selective immunoprecipitation of crosslinked p75.","label":0}
{"pair_id":"AIMed.d92.s788.p1","sentence":"Although multimeric complexes of @PROTEIN1$ and p75 were not detected by affinity crosslinking, immunoprecipitation of cross-linked @PROTEIN2$-receptor complexes with trk-specific antibodies resulted in selective immunoprecipitation of crosslinked p75.","label":0}
{"pair_id":"AIMed.d92.s788.p2","sentence":"Although multimeric complexes of @PROTEIN1$ and p75 were not detected by affinity crosslinking, immunoprecipitation of cross-linked @PROTEIN2$ complexes with trk-specific antibodies resulted in selective immunoprecipitation of crosslinked p75.","label":0}
{"pair_id":"AIMed.d92.s788.p3","sentence":"Although multimeric complexes of @PROTEIN1$ and p75 were not detected by affinity crosslinking, immunoprecipitation of cross-linked NGF-receptor complexes with @PROTEIN2$-specific antibodies resulted in selective immunoprecipitation of crosslinked p75.","label":0}
{"pair_id":"AIMed.d92.s788.p4","sentence":"Although multimeric complexes of @PROTEIN1$ and p75 were not detected by affinity crosslinking, immunoprecipitation of cross-linked NGF-receptor complexes with trk-specific antibodies resulted in selective immunoprecipitation of crosslinked @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d92.s788.p5","sentence":"Although multimeric complexes of trkA and @PROTEIN1$ were not detected by affinity crosslinking, immunoprecipitation of cross-linked @PROTEIN2$-receptor complexes with trk-specific antibodies resulted in selective immunoprecipitation of crosslinked p75.","label":0}
{"pair_id":"AIMed.d92.s788.p6","sentence":"Although multimeric complexes of trkA and @PROTEIN1$ were not detected by affinity crosslinking, immunoprecipitation of cross-linked @PROTEIN2$ complexes with trk-specific antibodies resulted in selective immunoprecipitation of crosslinked p75.","label":0}
{"pair_id":"AIMed.d92.s788.p7","sentence":"Although multimeric complexes of trkA and @PROTEIN1$ were not detected by affinity crosslinking, immunoprecipitation of cross-linked NGF-receptor complexes with @PROTEIN2$-specific antibodies resulted in selective immunoprecipitation of crosslinked p75.","label":0}
{"pair_id":"AIMed.d92.s788.p8","sentence":"Although multimeric complexes of trkA and @PROTEIN1$ were not detected by affinity crosslinking, immunoprecipitation of cross-linked NGF-receptor complexes with trk-specific antibodies resulted in selective immunoprecipitation of crosslinked @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d92.s788.p9","sentence":"Although multimeric complexes of trkA and p75 were not detected by affinity crosslinking, immunoprecipitation of cross-linked @PROTEIN1$@PROTEIN2$ complexes with trk-specific antibodies resulted in selective immunoprecipitation of crosslinked p75.","label":0}
{"pair_id":"AIMed.d92.s788.p10","sentence":"Although multimeric complexes of trkA and p75 were not detected by affinity crosslinking, immunoprecipitation of cross-linked @PROTEIN1$-receptor complexes with @PROTEIN2$-specific antibodies resulted in selective immunoprecipitation of crosslinked p75.","label":0}
{"pair_id":"AIMed.d92.s788.p11","sentence":"Although multimeric complexes of trkA and p75 were not detected by affinity crosslinking, immunoprecipitation of cross-linked @PROTEIN1$-receptor complexes with trk-specific antibodies resulted in selective immunoprecipitation of crosslinked @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d92.s788.p12","sentence":"Although multimeric complexes of trkA and p75 were not detected by affinity crosslinking, immunoprecipitation of cross-linked @PROTEIN1$ complexes with @PROTEIN2$-specific antibodies resulted in selective immunoprecipitation of crosslinked p75.","label":0}
{"pair_id":"AIMed.d92.s788.p13","sentence":"Although multimeric complexes of trkA and p75 were not detected by affinity crosslinking, immunoprecipitation of cross-linked @PROTEIN1$ complexes with trk-specific antibodies resulted in selective immunoprecipitation of crosslinked @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d92.s788.p14","sentence":"Although multimeric complexes of trkA and p75 were not detected by affinity crosslinking, immunoprecipitation of cross-linked NGF-receptor complexes with @PROTEIN1$-specific antibodies resulted in selective immunoprecipitation of crosslinked @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d776.s0.p0","sentence":"Treatment of cells with gamma linolenic acid (GLA) increased alpha catenin expression in most cell lines, while @PROTEIN1$ levels were reduced, and @PROTEIN2$ expression was unchanged.","label":0}
{"pair_id":"BioInfer.d776.s0.p1","sentence":"Treatment of cells with gamma linolenic acid (GLA) increased @PROTEIN2$ expression in most cell lines, while @PROTEIN1$ levels were reduced, and gamma catenin expression was unchanged.","label":0}
{"pair_id":"BioInfer.d776.s0.p2","sentence":"Treatment of cells with gamma linolenic acid (GLA) increased @PROTEIN2$ expression in most cell lines, while beta catenin levels were reduced, and @PROTEIN1$ expression was unchanged.","label":0}
{"pair_id":"BioInfer.d521.s0.p0","sentence":"Resonance energy transfer determination of the following distances, using a hybrid @PROTEIN2$: those between Cys-55 on the Mercenaria regulatory light chain, SH-1 on the Aequipecten @PROTEIN1$, and Cys-374 of actin.","label":0}
{"pair_id":"BioInfer.d521.s0.p1","sentence":"Resonance energy transfer determination of the following distances, using a hybrid myosin: those between Cys-55 on the Mercenaria regulatory light chain, SH-1 on the Aequipecten @PROTEIN1$, and Cys-374 of @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d521.s0.p2","sentence":"Resonance energy transfer determination of the following distances, using a hybrid myosin: those between Cys-55 on the Mercenaria @PROTEIN2$, SH-1 on the Aequipecten @PROTEIN1$, and Cys-374 of actin.","label":0}
{"pair_id":"BioInfer.d521.s0.p3","sentence":"Resonance energy transfer determination of the following distances, using a hybrid @PROTEIN1$: those between Cys-55 on the Mercenaria regulatory light chain, SH-1 on the Aequipecten myosin heavy chain, and Cys-374 of @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d521.s0.p4","sentence":"Resonance energy transfer determination of the following distances, using a hybrid @PROTEIN1$: those between Cys-55 on the Mercenaria @PROTEIN2$, SH-1 on the Aequipecten myosin heavy chain, and Cys-374 of actin.","label":0}
{"pair_id":"BioInfer.d521.s0.p5","sentence":"Resonance energy transfer determination of the following distances, using a hybrid myosin: those between Cys-55 on the Mercenaria @PROTEIN2$, SH-1 on the Aequipecten myosin heavy chain, and Cys-374 of @PROTEIN1$.","label":0}
{"pair_id":"AIMed.d190.s1619.p0","sentence":"By contrast the @PROTEIN1$ exchanger factor (@PROTEIN2$) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2\/Sos1 and Grb2\/c-Cbl are present in different complexes.","label":1}
{"pair_id":"AIMed.d190.s1619.p1","sentence":"By contrast the @PROTEIN1$ exchanger factor (Sos1) was not detected in anti-@PROTEIN2$ immunoprecipitates suggesting that Grb2\/Sos1 and Grb2\/c-Cbl are present in different complexes.","label":0}
{"pair_id":"AIMed.d190.s1619.p2","sentence":"By contrast the @PROTEIN1$ exchanger factor (Sos1) was not detected in anti-c-Cbl immunoprecipitates suggesting that @PROTEIN2$\/Sos1 and Grb2\/c-Cbl are present in different complexes.","label":0}
{"pair_id":"AIMed.d190.s1619.p3","sentence":"By contrast the @PROTEIN1$ exchanger factor (Sos1) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2\/@PROTEIN2$ and Grb2\/c-Cbl are present in different complexes.","label":0}
{"pair_id":"AIMed.d190.s1619.p4","sentence":"By contrast the @PROTEIN1$ exchanger factor (Sos1) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2\/Sos1 and @PROTEIN2$\/c-Cbl are present in different complexes.","label":0}
{"pair_id":"AIMed.d190.s1619.p5","sentence":"By contrast the @PROTEIN1$ exchanger factor (Sos1) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2\/Sos1 and Grb2\/@PROTEIN2$ are present in different complexes.","label":0}
{"pair_id":"AIMed.d190.s1619.p6","sentence":"By contrast the Ras exchanger factor (@PROTEIN1$) was not detected in anti-@PROTEIN2$ immunoprecipitates suggesting that Grb2\/Sos1 and Grb2\/c-Cbl are present in different complexes.","label":0}
{"pair_id":"AIMed.d190.s1619.p7","sentence":"By contrast the Ras exchanger factor (@PROTEIN1$) was not detected in anti-c-Cbl immunoprecipitates suggesting that @PROTEIN2$\/Sos1 and Grb2\/c-Cbl are present in different complexes.","label":0}
{"pair_id":"AIMed.d190.s1619.p8","sentence":"By contrast the Ras exchanger factor (@PROTEIN1$) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2\/@PROTEIN2$ and Grb2\/c-Cbl are present in different complexes.","label":0}
{"pair_id":"AIMed.d190.s1619.p9","sentence":"By contrast the Ras exchanger factor (@PROTEIN1$) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2\/Sos1 and @PROTEIN2$\/c-Cbl are present in different complexes.","label":0}
{"pair_id":"AIMed.d190.s1619.p10","sentence":"By contrast the Ras exchanger factor (@PROTEIN1$) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2\/Sos1 and Grb2\/@PROTEIN2$ are present in different complexes.","label":0}
{"pair_id":"AIMed.d190.s1619.p11","sentence":"By contrast the Ras exchanger factor (Sos1) was not detected in anti-@PROTEIN1$ immunoprecipitates suggesting that @PROTEIN2$\/Sos1 and Grb2\/c-Cbl are present in different complexes.","label":0}
{"pair_id":"AIMed.d190.s1619.p12","sentence":"By contrast the Ras exchanger factor (Sos1) was not detected in anti-@PROTEIN1$ immunoprecipitates suggesting that Grb2\/@PROTEIN2$ and Grb2\/c-Cbl are present in different complexes.","label":0}
{"pair_id":"AIMed.d190.s1619.p13","sentence":"By contrast the Ras exchanger factor (Sos1) was not detected in anti-@PROTEIN1$ immunoprecipitates suggesting that Grb2\/Sos1 and @PROTEIN2$\/c-Cbl are present in different complexes.","label":0}
{"pair_id":"AIMed.d190.s1619.p14","sentence":"By contrast the Ras exchanger factor (Sos1) was not detected in anti-@PROTEIN1$ immunoprecipitates suggesting that Grb2\/Sos1 and Grb2\/@PROTEIN2$ are present in different complexes.","label":0}
{"pair_id":"AIMed.d190.s1619.p15","sentence":"By contrast the Ras exchanger factor (Sos1) was not detected in anti-c-Cbl immunoprecipitates suggesting that @PROTEIN1$\/@PROTEIN2$ and Grb2\/c-Cbl are present in different complexes.","label":0}
{"pair_id":"AIMed.d190.s1619.p16","sentence":"By contrast the Ras exchanger factor (Sos1) was not detected in anti-c-Cbl immunoprecipitates suggesting that @PROTEIN1$\/Sos1 and @PROTEIN2$\/c-Cbl are present in different complexes.","label":0}
{"pair_id":"AIMed.d190.s1619.p17","sentence":"By contrast the Ras exchanger factor (Sos1) was not detected in anti-c-Cbl immunoprecipitates suggesting that @PROTEIN1$\/Sos1 and Grb2\/@PROTEIN2$ are present in different complexes.","label":0}
{"pair_id":"AIMed.d190.s1619.p18","sentence":"By contrast the Ras exchanger factor (Sos1) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2\/@PROTEIN1$ and @PROTEIN2$\/c-Cbl are present in different complexes.","label":0}
{"pair_id":"AIMed.d190.s1619.p19","sentence":"By contrast the Ras exchanger factor (Sos1) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2\/@PROTEIN1$ and Grb2\/@PROTEIN2$ are present in different complexes.","label":0}
{"pair_id":"AIMed.d190.s1619.p20","sentence":"By contrast the Ras exchanger factor (Sos1) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2\/Sos1 and @PROTEIN1$\/@PROTEIN2$ are present in different complexes.","label":0}
{"pair_id":"AIMed.d42.s361.p0","sentence":"The BMP receptors belong to the family of serine\/threonine kinase receptors, whose activation has been investigated intensively for the @PROTEIN1$ (@PROTEIN2$) receptor subfamily.","label":0}
{"pair_id":"AIMed.d180.s1537.p0","sentence":"These results, along with other recent findings, suggest a novel role for the interaction between @PROTEIN1$ and @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d56.s494.p0","sentence":"Cloning of @PROTEIN1$, a ligand for @PROTEIN2$ on human T cells.","label":1}
{"pair_id":"AIMed.d112.s951.p0","sentence":"Several phosphoproteins, including one of 72 kDa and one of 120 kDa, coprecipitated with @PROTEIN1$ (@PROTEIN2$).","label":0}
{"pair_id":"AIMed.d184.s1566.p0","sentence":"A @PROTEIN1$ fragment retaining the @PROTEIN2$-binding site and overlapping epitopes was able to interact with CCR-5 only if the V3 loop, which can specify HIV-1 tropism and chemokine receptor choice, was also present on the molecule.","label":1}
{"pair_id":"AIMed.d184.s1566.p1","sentence":"A @PROTEIN1$ fragment retaining the CD4-binding site and overlapping epitopes was able to interact with @PROTEIN2$ only if the V3 loop, which can specify HIV-1 tropism and chemokine receptor choice, was also present on the molecule.","label":1}
{"pair_id":"AIMed.d184.s1566.p2","sentence":"A gp120 fragment retaining the @PROTEIN1$-binding site and overlapping epitopes was able to interact with @PROTEIN2$ only if the V3 loop, which can specify HIV-1 tropism and chemokine receptor choice, was also present on the molecule.","label":0}
{"pair_id":"AIMed.d192.s1636.p0","sentence":"The @PROTEIN1$ (@PROTEIN2$) converting enzyme (ICE) processes the inactive IL-1beta precursor to the proinflammatory cytokine.","label":0}
{"pair_id":"AIMed.d192.s1636.p1","sentence":"The @PROTEIN1$@PROTEIN2$ (ICE) processes the inactive IL-1beta precursor to the proinflammatory cytokine.","label":0}
{"pair_id":"AIMed.d192.s1636.p2","sentence":"The @PROTEIN1$ (IL-1beta) converting enzyme (@PROTEIN2$) processes the inactive IL-1beta precursor to the proinflammatory cytokine.","label":1}
{"pair_id":"AIMed.d192.s1636.p3","sentence":"The @PROTEIN1$ (IL-1beta) converting enzyme (ICE) processes the inactive @PROTEIN2$ precursor to the proinflammatory cytokine.","label":0}
{"pair_id":"AIMed.d192.s1636.p4","sentence":"The @PROTEIN2$@PROTEIN1$) converting enzyme (ICE) processes the inactive IL-1beta precursor to the proinflammatory cytokine.","label":0}
{"pair_id":"AIMed.d192.s1636.p5","sentence":"The interleukin-1beta (@PROTEIN1$) converting enzyme (@PROTEIN2$) processes the inactive IL-1beta precursor to the proinflammatory cytokine.","label":1}
{"pair_id":"AIMed.d192.s1636.p6","sentence":"The interleukin-1beta (@PROTEIN1$) converting enzyme (ICE) processes the inactive @PROTEIN2$ precursor to the proinflammatory cytokine.","label":0}
{"pair_id":"AIMed.d192.s1636.p7","sentence":"The @PROTEIN1$ (@PROTEIN2$) processes the inactive IL-1beta precursor to the proinflammatory cytokine.","label":0}
{"pair_id":"AIMed.d192.s1636.p8","sentence":"The @PROTEIN1$ (ICE) processes the inactive @PROTEIN2$ precursor to the proinflammatory cytokine.","label":0}
{"pair_id":"AIMed.d192.s1636.p9","sentence":"The interleukin-1beta (IL-1beta) converting enzyme (@PROTEIN1$) processes the inactive @PROTEIN2$ precursor to the proinflammatory cytokine.","label":0}
{"pair_id":"AIMed.d119.s1012.p0","sentence":"Consistent with its role as a coactivator, @PROTEIN1$ augments the activity of phosphorylated @PROTEIN2$ to activate transcription of cAMP-responsive genes.","label":1}
{"pair_id":"AIMed.d208.s1803.p0","sentence":"The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (@PROTEIN1$, @PROTEIN2$\/MORT, RIP, FLICE\/MACH, and TRAFs) associated with both of the p60 and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.","label":0}
{"pair_id":"AIMed.d208.s1803.p1","sentence":"The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (@PROTEIN1$, FADD\/@PROTEIN2$, RIP, FLICE\/MACH, and TRAFs) associated with both of the p60 and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.","label":0}
{"pair_id":"AIMed.d208.s1803.p2","sentence":"The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (@PROTEIN1$, FADD\/MORT, @PROTEIN2$, FLICE\/MACH, and TRAFs) associated with both of the p60 and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.","label":0}
{"pair_id":"AIMed.d208.s1803.p3","sentence":"The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (@PROTEIN1$, FADD\/MORT, RIP, @PROTEIN2$\/MACH, and TRAFs) associated with both of the p60 and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.","label":0}
{"pair_id":"AIMed.d208.s1803.p4","sentence":"The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (@PROTEIN1$, FADD\/MORT, RIP, FLICE\/@PROTEIN2$, and TRAFs) associated with both of the p60 and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.","label":0}
{"pair_id":"AIMed.d208.s1803.p5","sentence":"The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (@PROTEIN1$, FADD\/MORT, RIP, FLICE\/MACH, and TRAFs) associated with both of the @PROTEIN2$ and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.","label":1}
{"pair_id":"AIMed.d208.s1803.p6","sentence":"The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (@PROTEIN1$, FADD\/MORT, RIP, FLICE\/MACH, and TRAFs) associated with both of the p60 and @PROTEIN2$ forms of the TNF receptor and with other members of the TNF receptor superfamily.","label":1}
{"pair_id":"AIMed.d208.s1803.p7","sentence":"The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, @PROTEIN1$\/@PROTEIN2$, RIP, FLICE\/MACH, and TRAFs) associated with both of the p60 and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.","label":0}
{"pair_id":"AIMed.d208.s1803.p8","sentence":"The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, @PROTEIN1$\/MORT, @PROTEIN2$, FLICE\/MACH, and TRAFs) associated with both of the p60 and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.","label":0}
{"pair_id":"AIMed.d208.s1803.p9","sentence":"The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, @PROTEIN1$\/MORT, RIP, @PROTEIN2$\/MACH, and TRAFs) associated with both of the p60 and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.","label":0}
{"pair_id":"AIMed.d208.s1803.p10","sentence":"The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, @PROTEIN1$\/MORT, RIP, FLICE\/@PROTEIN2$, and TRAFs) associated with both of the p60 and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.","label":0}
{"pair_id":"AIMed.d208.s1803.p11","sentence":"The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, @PROTEIN1$\/MORT, RIP, FLICE\/MACH, and TRAFs) associated with both of the @PROTEIN2$ and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.","label":1}
{"pair_id":"AIMed.d208.s1803.p12","sentence":"The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, @PROTEIN1$\/MORT, RIP, FLICE\/MACH, and TRAFs) associated with both of the p60 and @PROTEIN2$ forms of the TNF receptor and with other members of the TNF receptor superfamily.","label":0}
{"pair_id":"AIMed.d208.s1803.p13","sentence":"The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, FADD\/@PROTEIN1$, @PROTEIN2$, FLICE\/MACH, and TRAFs) associated with both of the p60 and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.","label":0}
{"pair_id":"AIMed.d208.s1803.p14","sentence":"The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, FADD\/@PROTEIN1$, RIP, @PROTEIN2$\/MACH, and TRAFs) associated with both of the p60 and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.","label":0}
{"pair_id":"AIMed.d208.s1803.p15","sentence":"The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, FADD\/@PROTEIN1$, RIP, FLICE\/@PROTEIN2$, and TRAFs) associated with both of the p60 and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.","label":0}
{"pair_id":"AIMed.d208.s1803.p16","sentence":"The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, FADD\/@PROTEIN1$, RIP, FLICE\/MACH, and TRAFs) associated with both of the @PROTEIN2$ and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.","label":1}
{"pair_id":"AIMed.d208.s1803.p17","sentence":"The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, FADD\/@PROTEIN1$, RIP, FLICE\/MACH, and TRAFs) associated with both of the p60 and @PROTEIN2$ forms of the TNF receptor and with other members of the TNF receptor superfamily.","label":1}
{"pair_id":"AIMed.d208.s1803.p18","sentence":"The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, FADD\/MORT, @PROTEIN1$, @PROTEIN2$\/MACH, and TRAFs) associated with both of the p60 and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.","label":0}
{"pair_id":"AIMed.d208.s1803.p19","sentence":"The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, FADD\/MORT, @PROTEIN1$, FLICE\/@PROTEIN2$, and TRAFs) associated with both of the p60 and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.","label":0}
{"pair_id":"AIMed.d208.s1803.p20","sentence":"The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, FADD\/MORT, @PROTEIN1$, FLICE\/MACH, and TRAFs) associated with both of the @PROTEIN2$ and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.","label":0}
{"pair_id":"AIMed.d208.s1803.p21","sentence":"The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, FADD\/MORT, @PROTEIN1$, FLICE\/MACH, and TRAFs) associated with both of the p60 and @PROTEIN2$ forms of the TNF receptor and with other members of the TNF receptor superfamily.","label":0}
{"pair_id":"AIMed.d208.s1803.p22","sentence":"The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, FADD\/MORT, RIP, @PROTEIN1$\/@PROTEIN2$, and TRAFs) associated with both of the p60 and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.","label":0}
{"pair_id":"AIMed.d208.s1803.p23","sentence":"The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, FADD\/MORT, RIP, @PROTEIN1$\/MACH, and TRAFs) associated with both of the @PROTEIN2$ and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.","label":1}
{"pair_id":"AIMed.d208.s1803.p24","sentence":"The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, FADD\/MORT, RIP, @PROTEIN1$\/MACH, and TRAFs) associated with both of the p60 and @PROTEIN2$ forms of the TNF receptor and with other members of the TNF receptor superfamily.","label":1}
{"pair_id":"AIMed.d208.s1803.p25","sentence":"The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, FADD\/MORT, RIP, FLICE\/@PROTEIN1$, and TRAFs) associated with both of the @PROTEIN2$ and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.","label":1}
{"pair_id":"AIMed.d208.s1803.p26","sentence":"The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, FADD\/MORT, RIP, FLICE\/@PROTEIN1$, and TRAFs) associated with both of the p60 and @PROTEIN2$ forms of the TNF receptor and with other members of the TNF receptor superfamily.","label":1}
{"pair_id":"AIMed.d208.s1803.p27","sentence":"The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, FADD\/MORT, RIP, FLICE\/MACH, and TRAFs) associated with both of the @PROTEIN1$ and @PROTEIN2$ forms of the TNF receptor and with other members of the TNF receptor superfamily.","label":0}
{"pair_id":"BioInfer.d336.s0.p0","sentence":"In growth cones, @PROTEIN1$ was most concentrated in the margin bordering the thickened, organelle-rich central region and the thin, @PROTEIN2$-rich peripheral region.","label":0}
{"pair_id":"AIMed.d27.s226.p0","sentence":"@PROTEIN1$, a member of the @PROTEIN2$ superfamily, has various effects on diverse biological systems, including cell growth inhibition in many cell types.","label":0}
{"pair_id":"BioInfer.d43.s1.p0","sentence":"A portion of @PROTEIN1$ appeared to be co-localized with @PROTEIN2$ filaments in the cytoplasm of cultured rat hepatocytes incubated with 25 mM glucose.","label":1}
{"pair_id":"AIMed.d206.s1779.p0","sentence":"As @PROTEIN1$ forms complexes with beta 1 integrins and the integrins are known to regulate keratinocyte behaviour, we investigated @PROTEIN2$ expression and function in human epidermal keratinocytes.","label":0}
{"pair_id":"BioInfer.d79.s0.p0","sentence":"A series of truncations was carried out at the C terminus of @PROTEIN2$, a region that has been implicated in @PROTEIN1$ binding.","label":1}
{"pair_id":"BioInfer.d338.s0.p0","sentence":"Inhibition of @PROTEIN1$ polymerization by a synthetic dodecapeptide patterned on the sequence around the @PROTEIN2$-binding site of cofilin.","label":0}
{"pair_id":"BioInfer.d338.s0.p1","sentence":"Inhibition of @PROTEIN1$ polymerization by a synthetic dodecapeptide patterned on the sequence around the actin-binding site of @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d338.s0.p2","sentence":"Inhibition of actin polymerization by a synthetic dodecapeptide patterned on the sequence around the @PROTEIN1$-binding site of @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d100.s2.p0","sentence":"Here, we show that @PROTEIN2$ (a DEAD box helicase-like protein), @PROTEIN1$, and PRP11 are each required for the U2 snRNP to bind to the pre-spliceosome during spliceosome assembly in vitro.","label":0}
{"pair_id":"BioInfer.d100.s2.p1","sentence":"Here, we show that PRP5 (a DEAD box helicase-like protein), @PROTEIN1$, and @PROTEIN2$ are each required for the U2 snRNP to bind to the pre-spliceosome during spliceosome assembly in vitro.","label":0}
{"pair_id":"BioInfer.d100.s2.p2","sentence":"Here, we show that PRP5 (a DEAD box helicase-like protein), @PROTEIN1$, and PRP11 are each required for the @PROTEIN2$ to bind to the pre-spliceosome during spliceosome assembly in vitro.","label":1}
{"pair_id":"BioInfer.d100.s2.p3","sentence":"Here, we show that PRP5 (a @PROTEIN2$-like protein), @PROTEIN1$, and PRP11 are each required for the U2 snRNP to bind to the pre-spliceosome during spliceosome assembly in vitro.","label":0}
{"pair_id":"BioInfer.d100.s2.p4","sentence":"Here, we show that @PROTEIN1$ (a DEAD box helicase-like protein), PRP9, and @PROTEIN2$ are each required for the U2 snRNP to bind to the pre-spliceosome during spliceosome assembly in vitro.","label":0}
{"pair_id":"BioInfer.d100.s2.p5","sentence":"Here, we show that @PROTEIN1$ (a DEAD box helicase-like protein), PRP9, and PRP11 are each required for the @PROTEIN2$ to bind to the pre-spliceosome during spliceosome assembly in vitro.","label":1}
{"pair_id":"BioInfer.d100.s2.p6","sentence":"Here, we show that @PROTEIN1$ (a @PROTEIN2$-like protein), PRP9, and PRP11 are each required for the U2 snRNP to bind to the pre-spliceosome during spliceosome assembly in vitro.","label":1}
{"pair_id":"BioInfer.d100.s2.p7","sentence":"Here, we show that PRP5 (a DEAD box helicase-like protein), PRP9, and @PROTEIN1$ are each required for the @PROTEIN2$ to bind to the pre-spliceosome during spliceosome assembly in vitro.","label":1}
{"pair_id":"BioInfer.d100.s2.p8","sentence":"Here, we show that PRP5 (a @PROTEIN2$-like protein), PRP9, and @PROTEIN1$ are each required for the U2 snRNP to bind to the pre-spliceosome during spliceosome assembly in vitro.","label":0}
{"pair_id":"BioInfer.d100.s2.p9","sentence":"Here, we show that PRP5 (a @PROTEIN2$-like protein), PRP9, and PRP11 are each required for the @PROTEIN1$ to bind to the pre-spliceosome during spliceosome assembly in vitro.","label":0}
{"pair_id":"BioInfer.d823.s0.p0","sentence":"Western analysis of gel-purified USF-nucleosome and GAL4-AH-@PROTEIN2$ complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d823.s0.p1","sentence":"Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated @PROTEIN2$ @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d823.s0.p2","sentence":"Western analysis of gel-purified USF-@PROTEIN2$ and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d823.s0.p3","sentence":"Western analysis of gel-purified USF-nucleosome and GAL4-@PROTEIN2$-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d823.s0.p4","sentence":"Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated @PROTEIN2$ H4 relative to acetylated histone @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d823.s0.p5","sentence":"Western analysis of gel-purified @PROTEIN2$-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d823.s0.p6","sentence":"Western analysis of gel-purified USF-nucleosome and @PROTEIN2$-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d823.s0.p7","sentence":"Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone @PROTEIN2$ relative to acetylated histone @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d823.s0.p8","sentence":"Western analysis of gel-purified USF-nucleosome and GAL4-AH-@PROTEIN1$ complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated @PROTEIN2$ H3.","label":0}
{"pair_id":"BioInfer.d823.s0.p9","sentence":"Western analysis of gel-purified USF-@PROTEIN2$ and GAL4-AH-@PROTEIN1$ complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.","label":0}
{"pair_id":"BioInfer.d823.s0.p10","sentence":"Western analysis of gel-purified USF-nucleosome and GAL4-@PROTEIN2$-@PROTEIN1$ complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.","label":1}
{"pair_id":"BioInfer.d823.s0.p11","sentence":"Western analysis of gel-purified USF-nucleosome and GAL4-AH-@PROTEIN1$ complexes demonstrated the predominant presence of acetylated @PROTEIN2$ H4 relative to acetylated histone H3.","label":0}
{"pair_id":"BioInfer.d823.s0.p12","sentence":"Western analysis of gel-purified @PROTEIN2$-nucleosome and GAL4-AH-@PROTEIN1$ complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.","label":0}
{"pair_id":"BioInfer.d823.s0.p13","sentence":"Western analysis of gel-purified USF-nucleosome and @PROTEIN2$-AH-@PROTEIN1$ complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.","label":1}
{"pair_id":"BioInfer.d823.s0.p14","sentence":"Western analysis of gel-purified USF-nucleosome and GAL4-AH-@PROTEIN1$ complexes demonstrated the predominant presence of acetylated histone @PROTEIN2$ relative to acetylated histone H3.","label":1}
{"pair_id":"BioInfer.d823.s0.p15","sentence":"Western analysis of gel-purified USF-@PROTEIN2$ and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated @PROTEIN1$ H3.","label":0}
{"pair_id":"BioInfer.d823.s0.p16","sentence":"Western analysis of gel-purified USF-nucleosome and GAL4-@PROTEIN2$-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated @PROTEIN1$ H3.","label":0}
{"pair_id":"BioInfer.d823.s0.p17","sentence":"Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated @PROTEIN2$ H4 relative to acetylated @PROTEIN1$ H3.","label":0}
{"pair_id":"BioInfer.d823.s0.p18","sentence":"Western analysis of gel-purified @PROTEIN2$-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated @PROTEIN1$ H3.","label":0}
{"pair_id":"BioInfer.d823.s0.p19","sentence":"Western analysis of gel-purified USF-nucleosome and @PROTEIN2$-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated @PROTEIN1$ H3.","label":0}
{"pair_id":"BioInfer.d823.s0.p20","sentence":"Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone @PROTEIN2$ relative to acetylated @PROTEIN1$ H3.","label":0}
{"pair_id":"BioInfer.d823.s0.p21","sentence":"Western analysis of gel-purified USF-@PROTEIN1$ and GAL4-@PROTEIN2$-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.","label":0}
{"pair_id":"BioInfer.d823.s0.p22","sentence":"Western analysis of gel-purified USF-@PROTEIN1$ and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated @PROTEIN2$ H4 relative to acetylated histone H3.","label":0}
{"pair_id":"BioInfer.d823.s0.p23","sentence":"Western analysis of gel-purified @PROTEIN2$-@PROTEIN1$ and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.","label":1}
{"pair_id":"BioInfer.d823.s0.p24","sentence":"Western analysis of gel-purified USF-@PROTEIN1$ and @PROTEIN2$-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.","label":0}
{"pair_id":"BioInfer.d823.s0.p25","sentence":"Western analysis of gel-purified USF-@PROTEIN1$ and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone @PROTEIN2$ relative to acetylated histone H3.","label":1}
{"pair_id":"BioInfer.d823.s0.p26","sentence":"Western analysis of gel-purified USF-nucleosome and GAL4-@PROTEIN1$-nucleosome complexes demonstrated the predominant presence of acetylated @PROTEIN2$ H4 relative to acetylated histone H3.","label":0}
{"pair_id":"BioInfer.d823.s0.p27","sentence":"Western analysis of gel-purified @PROTEIN2$-nucleosome and GAL4-@PROTEIN1$-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.","label":0}
{"pair_id":"BioInfer.d823.s0.p28","sentence":"Western analysis of gel-purified USF-nucleosome and @PROTEIN2$-@PROTEIN1$-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.","label":1}
{"pair_id":"BioInfer.d823.s0.p29","sentence":"Western analysis of gel-purified USF-nucleosome and GAL4-@PROTEIN1$-nucleosome complexes demonstrated the predominant presence of acetylated histone @PROTEIN2$ relative to acetylated histone H3.","label":1}
{"pair_id":"BioInfer.d823.s0.p30","sentence":"Western analysis of gel-purified @PROTEIN2$-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated @PROTEIN1$ H4 relative to acetylated histone H3.","label":0}
{"pair_id":"BioInfer.d823.s0.p31","sentence":"Western analysis of gel-purified USF-nucleosome and @PROTEIN2$-AH-nucleosome complexes demonstrated the predominant presence of acetylated @PROTEIN1$ H4 relative to acetylated histone H3.","label":0}
{"pair_id":"BioInfer.d823.s0.p32","sentence":"Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated @PROTEIN1$ @PROTEIN2$ relative to acetylated histone H3.","label":1}
{"pair_id":"BioInfer.d823.s0.p33","sentence":"Western analysis of gel-purified @PROTEIN1$-nucleosome and @PROTEIN2$-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.","label":0}
{"pair_id":"BioInfer.d823.s0.p34","sentence":"Western analysis of gel-purified @PROTEIN1$-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone @PROTEIN2$ relative to acetylated histone H3.","label":1}
{"pair_id":"BioInfer.d823.s0.p35","sentence":"Western analysis of gel-purified USF-nucleosome and @PROTEIN1$-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone @PROTEIN2$ relative to acetylated histone H3.","label":1}
{"pair_id":"BioInfer.d705.s0.p0","sentence":"The sequence of the inhibitory region is similar to that of a beta-hairpin region of the @PROTEIN1$ @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d37.s0.p0","sentence":"All of the experimental data were quantitatively accounted for on the basis of a 1:1 complex between @PROTEIN1$ and monomeric @PROTEIN2$ with a Kr between 4 and 9 microM, the same value obtained previously in the absence of MgCl2.","label":1}
{"pair_id":"AIMed.d217.s1886.p0","sentence":"Although the cytotoxic activity of mutant Y218D was unaltered, mutant Y218R was inactive, correlating with the prediction that Tyr-218 of @PROTEIN1$ interacts with a cluster of three basic amino acid side chains of @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d0.s6.p0","sentence":"Levels of @PROTEIN1$ were slightly increased following @PROTEIN2$ treatment (P = 0.09).","label":0}
{"pair_id":"AIMed.d101.s856.p0","sentence":"Using co-immunoprecipitation and protein-protein association assays, we show that both @PROTEIN1$ and @PROTEIN2$ bind specifically and stably to TBP.Mutational analysis demonstrates that both the basic region and leucine zipper domains of c-Fos and c-Jun are necessary and sufficient for stable association with TBP.","label":0}
{"pair_id":"AIMed.d101.s856.p1","sentence":"Using co-immunoprecipitation and protein-protein association assays, we show that both @PROTEIN1$ and c-Jun bind specifically and stably to @PROTEIN2$.Mutational analysis demonstrates that both the basic region and leucine zipper domains of c-Fos and c-Jun are necessary and sufficient for stable association with TBP.","label":1}
{"pair_id":"AIMed.d101.s856.p2","sentence":"Using co-immunoprecipitation and protein-protein association assays, we show that both @PROTEIN1$ and c-Jun bind specifically and stably to TBP.Mutational analysis demonstrates that both the basic region and leucine zipper domains of @PROTEIN2$ and c-Jun are necessary and sufficient for stable association with TBP.","label":0}
{"pair_id":"AIMed.d101.s856.p3","sentence":"Using co-immunoprecipitation and protein-protein association assays, we show that both @PROTEIN1$ and c-Jun bind specifically and stably to TBP.Mutational analysis demonstrates that both the basic region and leucine zipper domains of c-Fos and @PROTEIN2$ are necessary and sufficient for stable association with TBP.","label":0}
{"pair_id":"AIMed.d101.s856.p4","sentence":"Using co-immunoprecipitation and protein-protein association assays, we show that both @PROTEIN1$ and c-Jun bind specifically and stably to TBP.Mutational analysis demonstrates that both the basic region and leucine zipper domains of c-Fos and c-Jun are necessary and sufficient for stable association with @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d101.s856.p5","sentence":"Using co-immunoprecipitation and protein-protein association assays, we show that both c-Fos and @PROTEIN1$ bind specifically and stably to @PROTEIN2$.Mutational analysis demonstrates that both the basic region and leucine zipper domains of c-Fos and c-Jun are necessary and sufficient for stable association with TBP.","label":1}
{"pair_id":"AIMed.d101.s856.p6","sentence":"Using co-immunoprecipitation and protein-protein association assays, we show that both c-Fos and @PROTEIN1$ bind specifically and stably to TBP.Mutational analysis demonstrates that both the basic region and leucine zipper domains of @PROTEIN2$ and c-Jun are necessary and sufficient for stable association with TBP.","label":0}
{"pair_id":"AIMed.d101.s856.p7","sentence":"Using co-immunoprecipitation and protein-protein association assays, we show that both c-Fos and @PROTEIN1$ bind specifically and stably to TBP.Mutational analysis demonstrates that both the basic region and leucine zipper domains of c-Fos and @PROTEIN2$ are necessary and sufficient for stable association with TBP.","label":0}
{"pair_id":"AIMed.d101.s856.p8","sentence":"Using co-immunoprecipitation and protein-protein association assays, we show that both c-Fos and @PROTEIN1$ bind specifically and stably to TBP.Mutational analysis demonstrates that both the basic region and leucine zipper domains of c-Fos and c-Jun are necessary and sufficient for stable association with @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d101.s856.p9","sentence":"Using co-immunoprecipitation and protein-protein association assays, we show that both c-Fos and c-Jun bind specifically and stably to @PROTEIN1$.Mutational analysis demonstrates that both the basic region and leucine zipper domains of @PROTEIN2$ and c-Jun are necessary and sufficient for stable association with TBP.","label":0}
{"pair_id":"AIMed.d101.s856.p10","sentence":"Using co-immunoprecipitation and protein-protein association assays, we show that both c-Fos and c-Jun bind specifically and stably to @PROTEIN1$.Mutational analysis demonstrates that both the basic region and leucine zipper domains of c-Fos and @PROTEIN2$ are necessary and sufficient for stable association with TBP.","label":0}
{"pair_id":"AIMed.d101.s856.p11","sentence":"Using co-immunoprecipitation and protein-protein association assays, we show that both c-Fos and c-Jun bind specifically and stably to @PROTEIN1$.Mutational analysis demonstrates that both the basic region and leucine zipper domains of c-Fos and c-Jun are necessary and sufficient for stable association with @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d101.s856.p12","sentence":"Using co-immunoprecipitation and protein-protein association assays, we show that both c-Fos and c-Jun bind specifically and stably to TBP.Mutational analysis demonstrates that both the basic region and leucine zipper domains of @PROTEIN1$ and @PROTEIN2$ are necessary and sufficient for stable association with TBP.","label":0}
{"pair_id":"AIMed.d101.s856.p13","sentence":"Using co-immunoprecipitation and protein-protein association assays, we show that both c-Fos and c-Jun bind specifically and stably to TBP.Mutational analysis demonstrates that both the basic region and leucine zipper domains of @PROTEIN1$ and c-Jun are necessary and sufficient for stable association with @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d101.s856.p14","sentence":"Using co-immunoprecipitation and protein-protein association assays, we show that both c-Fos and c-Jun bind specifically and stably to TBP.Mutational analysis demonstrates that both the basic region and leucine zipper domains of c-Fos and @PROTEIN1$ are necessary and sufficient for stable association with @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d136.s1153.p0","sentence":"The cytokine, designated @PROTEIN1$ (@PROTEIN2$), is produced by a wide variety of cells and tissues and shares many biological properties with IL-2.","label":0}
{"pair_id":"AIMed.d136.s1153.p1","sentence":"The cytokine, designated @PROTEIN1$ (IL-15), is produced by a wide variety of cells and tissues and shares many biological properties with @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d136.s1153.p2","sentence":"The cytokine, designated interleukin-15 (@PROTEIN1$), is produced by a wide variety of cells and tissues and shares many biological properties with @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d105.s890.p0","sentence":"The binding properties of these variants in vitro, and the result of using a neutralizing monoclonal antibody directed against site 3, lead to the conclusion that @PROTEIN1$ dimer is formed through direct binding at two independent and differently oriented sites on @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d218.s1898.p0","sentence":"These results suggest that @PROTEIN1$ has two distinct receptor-binding sites that function to dimerize @PROTEIN2$ receptors in a sequential fashion.","label":0}
{"pair_id":"AIMed.d118.s1004.p0","sentence":"Thus, during @PROTEIN1$-mediated suppression of cell proliferation, @PROTEIN2$ and PCNA may be important for coordinating cell-cycle progression, DNA replication and repair of damaged DNA.","label":0}
{"pair_id":"AIMed.d118.s1004.p1","sentence":"Thus, during @PROTEIN1$-mediated suppression of cell proliferation, p21 and @PROTEIN2$ may be important for coordinating cell-cycle progression, DNA replication and repair of damaged DNA.","label":0}
{"pair_id":"AIMed.d118.s1004.p2","sentence":"Thus, during p53-mediated suppression of cell proliferation, @PROTEIN1$ and @PROTEIN2$ may be important for coordinating cell-cycle progression, DNA replication and repair of damaged DNA.","label":0}
{"pair_id":"BioInfer.d81.s1.p0","sentence":"Immuno-EM double-labeling experiments were conducted with antibodies to actin together with antibodies to the @PROTEIN2$ Abp1p and @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d81.s1.p1","sentence":"Immuno-EM double-labeling experiments were conducted with antibodies to actin together with antibodies to the actin binding proteins @PROTEIN2$ and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d81.s1.p2","sentence":"Immuno-EM double-labeling experiments were conducted with antibodies to @PROTEIN2$ together with antibodies to the actin binding proteins Abp1p and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d81.s1.p3","sentence":"Immuno-EM double-labeling experiments were conducted with antibodies to actin together with antibodies to the @PROTEIN1$ @PROTEIN2$ and cofilin.","label":1}
{"pair_id":"BioInfer.d81.s1.p4","sentence":"Immuno-EM double-labeling experiments were conducted with antibodies to @PROTEIN2$ together with antibodies to the @PROTEIN1$ Abp1p and cofilin.","label":0}
{"pair_id":"BioInfer.d81.s1.p5","sentence":"Immuno-EM double-labeling experiments were conducted with antibodies to @PROTEIN2$ together with antibodies to the actin binding proteins @PROTEIN1$ and cofilin.","label":0}
{"pair_id":"BioInfer.d237.s2.p0","sentence":"Specific interactions between the human @PROTEIN2$ and @PROTEIN1$ proteins.","label":1}
{"pair_id":"BioInfer.d831.s0.p0","sentence":"While levels of most of these proteins decrease, accumulation of cyclin D1 and the cyclin-dependent kinase inhibitor @PROTEIN2$ Cip1\/@PROTEIN1$ is observed.","label":0}
{"pair_id":"BioInfer.d831.s0.p1","sentence":"While levels of most of these proteins decrease, accumulation of @PROTEIN2$ and the cyclin-dependent kinase inhibitor p21 Cip1\/@PROTEIN1$ is observed.","label":0}
{"pair_id":"BioInfer.d831.s0.p2","sentence":"While levels of most of these proteins decrease, accumulation of cyclin D1 and the @PROTEIN2$ p21 Cip1\/@PROTEIN1$ is observed.","label":1}
{"pair_id":"BioInfer.d831.s0.p3","sentence":"While levels of most of these proteins decrease, accumulation of cyclin D1 and the cyclin-dependent kinase inhibitor p21 @PROTEIN2$\/@PROTEIN1$ is observed.","label":0}
{"pair_id":"BioInfer.d831.s0.p4","sentence":"While levels of most of these proteins decrease, accumulation of @PROTEIN2$ and the cyclin-dependent kinase inhibitor @PROTEIN1$ Cip1\/WAF1 is observed.","label":0}
{"pair_id":"BioInfer.d831.s0.p5","sentence":"While levels of most of these proteins decrease, accumulation of cyclin D1 and the @PROTEIN2$ @PROTEIN1$ Cip1\/WAF1 is observed.","label":1}
{"pair_id":"BioInfer.d831.s0.p6","sentence":"While levels of most of these proteins decrease, accumulation of cyclin D1 and the cyclin-dependent kinase inhibitor @PROTEIN1$ @PROTEIN2$\/WAF1 is observed.","label":0}
{"pair_id":"BioInfer.d831.s0.p7","sentence":"While levels of most of these proteins decrease, accumulation of @PROTEIN1$ and the @PROTEIN2$ p21 Cip1\/WAF1 is observed.","label":0}
{"pair_id":"BioInfer.d831.s0.p8","sentence":"While levels of most of these proteins decrease, accumulation of @PROTEIN1$ and the cyclin-dependent kinase inhibitor p21 @PROTEIN2$\/WAF1 is observed.","label":0}
{"pair_id":"BioInfer.d831.s0.p9","sentence":"While levels of most of these proteins decrease, accumulation of cyclin D1 and the @PROTEIN1$ p21 @PROTEIN2$\/WAF1 is observed.","label":1}
{"pair_id":"AIMed.d148.s1257.p0","sentence":"Moreover, @PROTEIN1$ was found to be phosphorylated on tyrosine residues in vivo and, like @PROTEIN2$, was readily phosphorylated by pp60c-src in vitro.","label":0}
{"pair_id":"AIMed.d148.s1257.p1","sentence":"Moreover, @PROTEIN1$ was found to be phosphorylated on tyrosine residues in vivo and, like cyclin A, was readily phosphorylated by @PROTEIN2$ in vitro.","label":1}
{"pair_id":"AIMed.d148.s1257.p2","sentence":"Moreover, cyclin D1 was found to be phosphorylated on tyrosine residues in vivo and, like @PROTEIN1$, was readily phosphorylated by @PROTEIN2$ in vitro.","label":1}
{"pair_id":"BioInfer.d573.s0.p0","sentence":"The amount of unassembled @PROTEIN2$ (12 microM) is accounted for by the sequestering functions of T beta 4Xen (20 microM) and @PROTEIN1$ (5 microM), the barbed ends being capped.","label":1}
{"pair_id":"BioInfer.d573.s0.p1","sentence":"The amount of unassembled actin (12 microM) is accounted for by the sequestering functions of @PROTEIN2$ (20 microM) and @PROTEIN1$ (5 microM), the barbed ends being capped.","label":0}
{"pair_id":"BioInfer.d573.s0.p2","sentence":"The amount of unassembled @PROTEIN1$ (12 microM) is accounted for by the sequestering functions of @PROTEIN2$ (20 microM) and profilin (5 microM), the barbed ends being capped.","label":1}
{"pair_id":"BioInfer.d680.s0.p0","sentence":"There are only 14 non-conservative substitutions in the two @PROTEIN1$, three of which are located in the secondary @PROTEIN2$-binding loop and flanking regions and others correspond to residues so far not assigned a functional role, including two residues in the proximal S2 domain.","label":1}
{"pair_id":"BioInfer.d280.s1.p0","sentence":"Reduced or absent immunoreactivity in the tumour tissue was seen in 63 (70.0 per cent) for alpha-catenin, in 50 (55.6 per cent) for @PROTEIN1$, and in 50 (55.6 per cent) for @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d280.s1.p1","sentence":"Reduced or absent immunoreactivity in the tumour tissue was seen in 63 (70.0 per cent) for @PROTEIN2$, in 50 (55.6 per cent) for @PROTEIN1$, and in 50 (55.6 per cent) for gamma-catenin.","label":0}
{"pair_id":"BioInfer.d280.s1.p2","sentence":"Reduced or absent immunoreactivity in the tumour tissue was seen in 63 (70.0 per cent) for @PROTEIN2$, in 50 (55.6 per cent) for beta-catenin, and in 50 (55.6 per cent) for @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d830.s0.p0","sentence":"When the actin monomer pool in untransfected myoblasts is increased 70% by treatment with latrunculin A, synthesis of @PROTEIN1$ and actin are down-regulated compared with @PROTEIN2$ and 19 other proteins selected at random.","label":0}
{"pair_id":"BioInfer.d830.s0.p1","sentence":"When the @PROTEIN2$ monomer pool in untransfected myoblasts is increased 70% by treatment with latrunculin A, synthesis of @PROTEIN1$ and actin are down-regulated compared with cofilin and 19 other proteins selected at random.","label":0}
{"pair_id":"BioInfer.d830.s0.p2","sentence":"When the actin monomer pool in untransfected myoblasts is increased 70% by treatment with latrunculin A, synthesis of @PROTEIN1$ and @PROTEIN2$ are down-regulated compared with cofilin and 19 other proteins selected at random.","label":0}
{"pair_id":"BioInfer.d830.s0.p3","sentence":"When the @PROTEIN2$ monomer pool in untransfected myoblasts is increased 70% by treatment with latrunculin A, synthesis of ADF and actin are down-regulated compared with @PROTEIN1$ and 19 other proteins selected at random.","label":0}
{"pair_id":"BioInfer.d830.s0.p4","sentence":"When the actin monomer pool in untransfected myoblasts is increased 70% by treatment with latrunculin A, synthesis of ADF and @PROTEIN2$ are down-regulated compared with @PROTEIN1$ and 19 other proteins selected at random.","label":0}
{"pair_id":"BioInfer.d830.s0.p5","sentence":"When the @PROTEIN1$ monomer pool in untransfected myoblasts is increased 70% by treatment with latrunculin A, synthesis of ADF and @PROTEIN2$ are down-regulated compared with cofilin and 19 other proteins selected at random.","label":0}
{"pair_id":"AIMed.d15.s128.p0","sentence":"MATERIALS AND METHODS: We measured levels of @PROTEIN1$, @PROTEIN2$, IL-2 and IL-10 in the seminal plasma of 31 patients with chronic prostatitis-chronic pelvic pain syndrome and 14 controls using enzyme-linked immunosorbent assay.","label":0}
{"pair_id":"AIMed.d15.s128.p1","sentence":"MATERIALS AND METHODS: We measured levels of @PROTEIN1$, interferon-gamma, @PROTEIN2$ and IL-10 in the seminal plasma of 31 patients with chronic prostatitis-chronic pelvic pain syndrome and 14 controls using enzyme-linked immunosorbent assay.","label":0}
{"pair_id":"AIMed.d15.s128.p2","sentence":"MATERIALS AND METHODS: We measured levels of @PROTEIN1$, interferon-gamma, IL-2 and @PROTEIN2$ in the seminal plasma of 31 patients with chronic prostatitis-chronic pelvic pain syndrome and 14 controls using enzyme-linked immunosorbent assay.","label":0}
{"pair_id":"AIMed.d15.s128.p3","sentence":"MATERIALS AND METHODS: We measured levels of IL-8, @PROTEIN1$, @PROTEIN2$ and IL-10 in the seminal plasma of 31 patients with chronic prostatitis-chronic pelvic pain syndrome and 14 controls using enzyme-linked immunosorbent assay.","label":0}
{"pair_id":"AIMed.d15.s128.p4","sentence":"MATERIALS AND METHODS: We measured levels of IL-8, @PROTEIN1$, IL-2 and @PROTEIN2$ in the seminal plasma of 31 patients with chronic prostatitis-chronic pelvic pain syndrome and 14 controls using enzyme-linked immunosorbent assay.","label":0}
{"pair_id":"AIMed.d15.s128.p5","sentence":"MATERIALS AND METHODS: We measured levels of IL-8, interferon-gamma, @PROTEIN1$ and @PROTEIN2$ in the seminal plasma of 31 patients with chronic prostatitis-chronic pelvic pain syndrome and 14 controls using enzyme-linked immunosorbent assay.","label":0}
{"pair_id":"BioInfer.d95.s0.p0","sentence":"Because other researchers have shown that the RAD51 and RAD52 proteins interact, @PROTEIN1$ on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but @PROTEIN2$, RA and RA did not suppress.","label":1}
{"pair_id":"BioInfer.d95.s0.p1","sentence":"Because other researchers have shown that the RAD51 and RAD52 proteins interact, @PROTEIN1$ on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but @PROTEIN2$ 54, RA and @PROTEIN2$ did not suppress.","label":1}
{"pair_id":"BioInfer.d95.s0.p2","sentence":"Because other researchers have shown that the RAD51 and RAD52 proteins interact, @PROTEIN1$ on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but @PROTEIN2$ 54, @PROTEIN2$ and RA did not suppress.","label":1}
{"pair_id":"BioInfer.d95.s0.p3","sentence":"Because other researchers have shown that the @PROTEIN2$ and RAD52 proteins interact, @PROTEIN1$ on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but RAD 54, RA and RA did not suppress.","label":0}
{"pair_id":"BioInfer.d95.s0.p4","sentence":"Because other researchers have shown that the RAD51 and @PROTEIN2$ proteins interact, @PROTEIN1$ on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but RAD 54, RA and RA did not suppress.","label":0}
{"pair_id":"BioInfer.d95.s0.p5","sentence":"Because other researchers have shown that the RAD51 and RAD52 proteins interact, @PROTEIN1$ on a high copy number plasmid was tested and found to suppress the @PROTEIN2$ allele, but RAD 54, RA and RA did not suppress.","label":1}
{"pair_id":"BioInfer.d95.s0.p6","sentence":"Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but @PROTEIN1$@PROTEIN2$ 54, RA and @PROTEIN2$ did not suppress.","label":0}
{"pair_id":"BioInfer.d95.s0.p7","sentence":"Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but @PROTEIN1$@PROTEIN2$ 54, @PROTEIN2$ and RA did not suppress.","label":0}
{"pair_id":"BioInfer.d95.s0.p8","sentence":"Because other researchers have shown that the @PROTEIN2$ and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but @PROTEIN1$, RA and RA did not suppress.","label":0}
{"pair_id":"BioInfer.d95.s0.p9","sentence":"Because other researchers have shown that the RAD51 and @PROTEIN2$ proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but @PROTEIN1$, RA and RA did not suppress.","label":0}
{"pair_id":"BioInfer.d95.s0.p10","sentence":"Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the @PROTEIN2$ allele, but @PROTEIN1$, RA and RA did not suppress.","label":0}
{"pair_id":"BioInfer.d95.s0.p11","sentence":"Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but @PROTEIN1$@PROTEIN2$ 54, @PROTEIN2$ and @PROTEIN1$ did not suppress.","label":0}
{"pair_id":"BioInfer.d95.s0.p12","sentence":"Because other researchers have shown that the @PROTEIN2$ and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but @PROTEIN1$ 54, RA and @PROTEIN1$ did not suppress.","label":0}
{"pair_id":"BioInfer.d95.s0.p13","sentence":"Because other researchers have shown that the RAD51 and @PROTEIN2$ proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but @PROTEIN1$ 54, RA and @PROTEIN1$ did not suppress.","label":0}
{"pair_id":"BioInfer.d95.s0.p14","sentence":"Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the @PROTEIN2$ allele, but @PROTEIN1$ 54, RA and @PROTEIN1$ did not suppress.","label":0}
{"pair_id":"BioInfer.d95.s0.p15","sentence":"Because other researchers have shown that the @PROTEIN2$ and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but @PROTEIN1$ 54, @PROTEIN1$ and RA did not suppress.","label":0}
{"pair_id":"BioInfer.d95.s0.p16","sentence":"Because other researchers have shown that the RAD51 and @PROTEIN2$ proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but @PROTEIN1$ 54, @PROTEIN1$ and RA did not suppress.","label":0}
{"pair_id":"BioInfer.d95.s0.p17","sentence":"Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the @PROTEIN2$ allele, but @PROTEIN1$ 54, @PROTEIN1$ and RA did not suppress.","label":0}
{"pair_id":"BioInfer.d95.s0.p18","sentence":"Because other researchers have shown that the @PROTEIN1$ and @PROTEIN2$ proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but RAD 54, RA and RA did not suppress.","label":1}
{"pair_id":"BioInfer.d95.s0.p19","sentence":"Because other researchers have shown that the @PROTEIN1$ and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the @PROTEIN2$ allele, but RAD 54, RA and RA did not suppress.","label":0}
{"pair_id":"BioInfer.d95.s0.p20","sentence":"Because other researchers have shown that the RAD51 and @PROTEIN1$ proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the @PROTEIN2$ allele, but RAD 54, RA and RA did not suppress.","label":0}
{"pair_id":"AIMed.d184.s1563.p0","sentence":"Here we show that a complex of @PROTEIN1$, the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble @PROTEIN2$ interacts specifically with CCR-5 and inhibits the binding of the natural CCR-5 ligands, macrophage inflammatory protein (MIP)-1alpha and MIP-1beta (refs 7, 8).","label":1}
{"pair_id":"AIMed.d184.s1563.p1","sentence":"Here we show that a complex of @PROTEIN1$, the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble CD4 interacts specifically with @PROTEIN2$ and inhibits the binding of the natural CCR-5 ligands, macrophage inflammatory protein (MIP)-1alpha and MIP-1beta (refs 7, 8).","label":1}
{"pair_id":"AIMed.d184.s1563.p2","sentence":"Here we show that a complex of @PROTEIN1$, the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble CD4 interacts specifically with CCR-5 and inhibits the binding of the natural @PROTEIN2$ ligands, macrophage inflammatory protein (MIP)-1alpha and MIP-1beta (refs 7, 8).","label":0}
{"pair_id":"AIMed.d184.s1563.p3","sentence":"Here we show that a complex of @PROTEIN1$, the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble CD4 interacts specifically with CCR-5 and inhibits the binding of the natural CCR-5 ligands, @PROTEIN2$ and MIP-1beta (refs 7, 8).","label":0}
{"pair_id":"AIMed.d184.s1563.p4","sentence":"Here we show that a complex of @PROTEIN1$, the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble CD4 interacts specifically with CCR-5 and inhibits the binding of the natural CCR-5 ligands, macrophage inflammatory protein (MIP)-1alpha and @PROTEIN2$ (refs 7, 8).","label":0}
{"pair_id":"AIMed.d184.s1563.p5","sentence":"Here we show that a complex of gp120, the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble @PROTEIN1$ interacts specifically with @PROTEIN2$ and inhibits the binding of the natural CCR-5 ligands, macrophage inflammatory protein (MIP)-1alpha and MIP-1beta (refs 7, 8).","label":1}
{"pair_id":"AIMed.d184.s1563.p6","sentence":"Here we show that a complex of gp120, the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble @PROTEIN1$ interacts specifically with CCR-5 and inhibits the binding of the natural @PROTEIN2$ ligands, macrophage inflammatory protein (MIP)-1alpha and MIP-1beta (refs 7, 8).","label":0}
{"pair_id":"AIMed.d184.s1563.p7","sentence":"Here we show that a complex of gp120, the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble @PROTEIN1$ interacts specifically with CCR-5 and inhibits the binding of the natural CCR-5 ligands, @PROTEIN2$ and MIP-1beta (refs 7, 8).","label":0}
{"pair_id":"AIMed.d184.s1563.p8","sentence":"Here we show that a complex of gp120, the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble @PROTEIN1$ interacts specifically with CCR-5 and inhibits the binding of the natural CCR-5 ligands, macrophage inflammatory protein (MIP)-1alpha and @PROTEIN2$ (refs 7, 8).","label":0}
{"pair_id":"AIMed.d184.s1563.p9","sentence":"Here we show that a complex of gp120, the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble CD4 interacts specifically with @PROTEIN1$ and inhibits the binding of the natural @PROTEIN2$ ligands, macrophage inflammatory protein (MIP)-1alpha and MIP-1beta (refs 7, 8).","label":0}
{"pair_id":"AIMed.d184.s1563.p10","sentence":"Here we show that a complex of gp120, the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble CD4 interacts specifically with @PROTEIN1$ and inhibits the binding of the natural CCR-5 ligands, @PROTEIN2$ and MIP-1beta (refs 7, 8).","label":0}
{"pair_id":"AIMed.d184.s1563.p11","sentence":"Here we show that a complex of gp120, the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble CD4 interacts specifically with @PROTEIN1$ and inhibits the binding of the natural CCR-5 ligands, macrophage inflammatory protein (MIP)-1alpha and @PROTEIN2$ (refs 7, 8).","label":0}
{"pair_id":"AIMed.d184.s1563.p12","sentence":"Here we show that a complex of gp120, the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble CD4 interacts specifically with CCR-5 and inhibits the binding of the natural @PROTEIN1$ ligands, @PROTEIN2$ and MIP-1beta (refs 7, 8).","label":0}
{"pair_id":"AIMed.d184.s1563.p13","sentence":"Here we show that a complex of gp120, the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble CD4 interacts specifically with CCR-5 and inhibits the binding of the natural @PROTEIN1$ ligands, macrophage inflammatory protein (MIP)-1alpha and @PROTEIN2$ (refs 7, 8).","label":0}
{"pair_id":"AIMed.d184.s1563.p14","sentence":"Here we show that a complex of gp120, the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble CD4 interacts specifically with CCR-5 and inhibits the binding of the natural CCR-5 ligands, @PROTEIN1$ and @PROTEIN2$ (refs 7, 8).","label":0}
{"pair_id":"BioInfer.d701.s0.p0","sentence":"These observations demonstrate that cardiac development in man, in contrast to rodent heart, is characterized by an up-regulation of the @PROTEIN1$ gene, the expression of which does not change in hypertrophied and failing hearts, and suggest that the @PROTEIN2$ and myosin heavy chain families are independently regulated in human heart.","label":0}
{"pair_id":"BioInfer.d701.s0.p1","sentence":"These observations demonstrate that cardiac development in man, in contrast to rodent heart, is characterized by an up-regulation of the @PROTEIN1$ gene, the expression of which does not change in hypertrophied and failing hearts, and suggest that the actin and @PROTEIN2$ families are independently regulated in human heart.","label":0}
{"pair_id":"BioInfer.d701.s0.p2","sentence":"These observations demonstrate that cardiac development in man, in contrast to rodent heart, is characterized by an up-regulation of the skeletal actin gene, the expression of which does not change in hypertrophied and failing hearts, and suggest that the @PROTEIN1$ and @PROTEIN2$ families are independently regulated in human heart.","label":1}
{"pair_id":"AIMed.d68.s578.p0","sentence":"Two previously unidentified human @PROTEIN1$ genes have been isolated, @PROTEIN2$ and cdc25B.","label":0}
{"pair_id":"AIMed.d68.s578.p1","sentence":"Two previously unidentified human @PROTEIN1$ genes have been isolated, cdc25A and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d68.s578.p2","sentence":"Two previously unidentified human cdc25 genes have been isolated, @PROTEIN1$ and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d124.s1058.p0","sentence":"These proteins, @PROTEIN1$ (@PROTEIN2$) and 14-3-3 beta (HS1), are members of the 14-3-3 family of proteins.","label":0}
{"pair_id":"AIMed.d124.s1058.p1","sentence":"These proteins, @PROTEIN1$ (PLA2) and @PROTEIN2$ (HS1), are members of the 14-3-3 family of proteins.","label":0}
{"pair_id":"AIMed.d124.s1058.p2","sentence":"These proteins, @PROTEIN1$ (PLA2) and 14-3-3 beta (@PROTEIN2$), are members of the 14-3-3 family of proteins.","label":0}
{"pair_id":"AIMed.d124.s1058.p3","sentence":"These proteins, 14-3-3 zeta (@PROTEIN1$) and @PROTEIN2$ (HS1), are members of the 14-3-3 family of proteins.","label":0}
{"pair_id":"AIMed.d124.s1058.p4","sentence":"These proteins, 14-3-3 zeta (@PROTEIN1$) and 14-3-3 beta (@PROTEIN2$), are members of the 14-3-3 family of proteins.","label":0}
{"pair_id":"AIMed.d124.s1058.p5","sentence":"These proteins, 14-3-3 zeta (PLA2) and @PROTEIN1$ (@PROTEIN2$), are members of the 14-3-3 family of proteins.","label":0}
{"pair_id":"AIMed.d101.s853.p0","sentence":"@PROTEIN1$ and @PROTEIN2$ oncoproteins form a complex that regulates transcription from promoters containing AP-1 binding sites.","label":1}
{"pair_id":"AIMed.d183.s1557.p0","sentence":"In contrast, in the absence of @PROTEIN1$, coexpression of @PROTEIN2$ and Raf-1 resulted in an overall decrease in the Raf-1 kinase activity.","label":0}
{"pair_id":"AIMed.d183.s1557.p1","sentence":"In contrast, in the absence of @PROTEIN1$, coexpression of JAK2 and @PROTEIN2$ resulted in an overall decrease in the Raf-1 kinase activity.","label":0}
{"pair_id":"AIMed.d183.s1557.p2","sentence":"In contrast, in the absence of @PROTEIN1$, coexpression of JAK2 and Raf-1 resulted in an overall decrease in the @PROTEIN2$ kinase activity.","label":0}
{"pair_id":"AIMed.d183.s1557.p3","sentence":"In contrast, in the absence of p21ras, coexpression of @PROTEIN1$ and @PROTEIN2$ resulted in an overall decrease in the Raf-1 kinase activity.","label":0}
{"pair_id":"AIMed.d183.s1557.p4","sentence":"In contrast, in the absence of p21ras, coexpression of @PROTEIN1$ and Raf-1 resulted in an overall decrease in the @PROTEIN2$ kinase activity.","label":0}
{"pair_id":"AIMed.d183.s1557.p5","sentence":"In contrast, in the absence of p21ras, coexpression of JAK2 and @PROTEIN1$ resulted in an overall decrease in the @PROTEIN2$ kinase activity.","label":0}
{"pair_id":"AIMed.d147.s1250.p0","sentence":"In addition we have been able to identify complexes of @PROTEIN1$ and @PROTEIN2$ in vivo that are dissociated in the presence of purified human papillomavirus E7 protein.","label":1}
{"pair_id":"AIMed.d147.s1250.p1","sentence":"In addition we have been able to identify complexes of @PROTEIN1$ and RBP1 in vivo that are dissociated in the presence of purified human papillomavirus @PROTEIN2$ protein.","label":0}
{"pair_id":"AIMed.d147.s1250.p2","sentence":"In addition we have been able to identify complexes of pRB and @PROTEIN1$ in vivo that are dissociated in the presence of purified human papillomavirus @PROTEIN2$ protein.","label":0}
{"pair_id":"AIMed.d117.s989.p0","sentence":"Here we show that beta:@PROTEIN1$ binds to the @PROTEIN2$ (ActRII) which induces activin binding to the type I receptor kinase SKR2 to form ActRII.beta:beta.","label":1}
{"pair_id":"AIMed.d117.s989.p1","sentence":"Here we show that beta:@PROTEIN1$ binds to the activin type II receptor kinase (@PROTEIN2$) which induces activin binding to the type I receptor kinase SKR2 to form ActRII.beta:beta.","label":1}
{"pair_id":"AIMed.d117.s989.p2","sentence":"Here we show that beta:@PROTEIN1$ binds to the activin type II receptor kinase (ActRII) which induces activin binding to the type I receptor kinase @PROTEIN2$ to form ActRII.beta:beta.","label":0}
{"pair_id":"AIMed.d117.s989.p3","sentence":"Here we show that beta:@PROTEIN1$ binds to the activin type II receptor kinase (ActRII) which induces activin binding to the type I receptor kinase SKR2 to form @PROTEIN2$.beta:beta.","label":0}
{"pair_id":"AIMed.d117.s989.p4","sentence":"Here we show that beta:beta activin binds to the @PROTEIN1$ (@PROTEIN2$) which induces activin binding to the type I receptor kinase SKR2 to form ActRII.beta:beta.","label":0}
{"pair_id":"AIMed.d117.s989.p5","sentence":"Here we show that beta:beta activin binds to the @PROTEIN1$ (ActRII) which induces activin binding to the type I receptor kinase @PROTEIN2$ to form ActRII.beta:beta.","label":0}
{"pair_id":"AIMed.d117.s989.p6","sentence":"Here we show that beta:beta activin binds to the @PROTEIN1$ (ActRII) which induces activin binding to the type I receptor kinase SKR2 to form @PROTEIN2$.beta:beta.","label":0}
{"pair_id":"AIMed.d117.s989.p7","sentence":"Here we show that beta:beta activin binds to the activin type II receptor kinase (@PROTEIN1$) which induces activin binding to the type I receptor kinase @PROTEIN2$ to form ActRII.beta:beta.","label":0}
{"pair_id":"AIMed.d117.s989.p8","sentence":"Here we show that beta:beta activin binds to the activin type II receptor kinase (@PROTEIN1$) which induces activin binding to the type I receptor kinase SKR2 to form @PROTEIN2$.beta:beta.","label":0}
{"pair_id":"AIMed.d117.s989.p9","sentence":"Here we show that beta:beta activin binds to the activin type II receptor kinase (ActRII) which induces activin binding to the type I receptor kinase @PROTEIN1$ to form @PROTEIN2$.beta:beta.","label":0}
{"pair_id":"AIMed.d179.s1527.p0","sentence":"We have previously reported that tyrosine phosphorylation of @PROTEIN1$ and its association with the @PROTEIN2$-Sos complex may contribute to the activation of the mitogen-activated protein kinase pathway by gastrin.","label":1}
{"pair_id":"AIMed.d179.s1527.p1","sentence":"We have previously reported that tyrosine phosphorylation of @PROTEIN1$ and its association with the Grb2-@PROTEIN2$ complex may contribute to the activation of the mitogen-activated protein kinase pathway by gastrin.","label":1}
{"pair_id":"AIMed.d179.s1527.p2","sentence":"We have previously reported that tyrosine phosphorylation of @PROTEIN1$ and its association with the Grb2-Sos complex may contribute to the activation of the @PROTEIN2$ pathway by gastrin.","label":0}
{"pair_id":"AIMed.d179.s1527.p3","sentence":"We have previously reported that tyrosine phosphorylation of @PROTEIN1$ and its association with the Grb2-Sos complex may contribute to the activation of the mitogen-activated protein kinase pathway by @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d179.s1527.p4","sentence":"We have previously reported that tyrosine phosphorylation of Shc and its association with the @PROTEIN1$-@PROTEIN2$ complex may contribute to the activation of the mitogen-activated protein kinase pathway by gastrin.","label":1}
{"pair_id":"AIMed.d179.s1527.p5","sentence":"We have previously reported that tyrosine phosphorylation of Shc and its association with the @PROTEIN1$-Sos complex may contribute to the activation of the @PROTEIN2$ pathway by gastrin.","label":0}
{"pair_id":"AIMed.d179.s1527.p6","sentence":"We have previously reported that tyrosine phosphorylation of Shc and its association with the @PROTEIN1$-Sos complex may contribute to the activation of the mitogen-activated protein kinase pathway by @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d179.s1527.p7","sentence":"We have previously reported that tyrosine phosphorylation of Shc and its association with the Grb2-@PROTEIN1$ complex may contribute to the activation of the @PROTEIN2$ pathway by gastrin.","label":0}
{"pair_id":"AIMed.d179.s1527.p8","sentence":"We have previously reported that tyrosine phosphorylation of Shc and its association with the Grb2-@PROTEIN1$ complex may contribute to the activation of the mitogen-activated protein kinase pathway by @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d179.s1527.p9","sentence":"We have previously reported that tyrosine phosphorylation of Shc and its association with the Grb2-Sos complex may contribute to the activation of the @PROTEIN1$ pathway by @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d206.s1783.p0","sentence":"@PROTEIN1$ was associated with alpha 3 beta 1 but not alpha 5 beta 1; small amounts of @PROTEIN2$ also co-immunoprecipitated with antibodies to alpha 2 beta 1 and alpha 6 beta 4.","label":0}
{"pair_id":"BioInfer.d586.s0.p0","sentence":"The @PROTEIN1$ and @PROTEIN2$ genes are involved in genetic recombination and double-strand break repair in the yeast Saccharomyces cerevisiae.","label":0}
{"pair_id":"AIMed.d95.s802.p0","sentence":"Mechanism of CDK activation revealed by the structure of a @PROTEIN1$-@PROTEIN2$ complex.","label":1}
{"pair_id":"BioInfer.d612.s0.p0","sentence":"The expression of @PROTEIN1$, alpha-catenin and @PROTEIN2$ also was decreased in HT29 cells, with a translocation of APC into the nucleus.","label":0}
{"pair_id":"BioInfer.d612.s0.p1","sentence":"The expression of @PROTEIN1$, @PROTEIN2$ and beta-catenin also was decreased in HT29 cells, with a translocation of APC into the nucleus.","label":0}
{"pair_id":"BioInfer.d612.s0.p2","sentence":"The expression of @PROTEIN1$, alpha-catenin and beta-catenin also was decreased in HT29 cells, with a translocation of @PROTEIN2$ into the nucleus.","label":0}
{"pair_id":"BioInfer.d612.s0.p3","sentence":"The expression of APC, @PROTEIN2$ and @PROTEIN1$ also was decreased in HT29 cells, with a translocation of APC into the nucleus.","label":0}
{"pair_id":"BioInfer.d612.s0.p4","sentence":"The expression of APC, alpha-catenin and @PROTEIN1$ also was decreased in HT29 cells, with a translocation of @PROTEIN2$ into the nucleus.","label":0}
{"pair_id":"BioInfer.d612.s0.p5","sentence":"The expression of APC, @PROTEIN1$ and beta-catenin also was decreased in HT29 cells, with a translocation of @PROTEIN2$ into the nucleus.","label":0}
{"pair_id":"BioInfer.d6.s1.p0","sentence":"In contrast, @PROTEIN1$ had little effect on the rigidity and viscosity of @PROTEIN2$ filaments.","label":1}
{"pair_id":"AIMed.d64.s551.p0","sentence":"Crosslinking of iodinated @PROTEIN1$ (@PROTEIN2$) and basic FGF (bFGF) to transiently expressing COS-1 cells revealed a major band of 95 kDa, which was competed for by both aFGF and bFGF.","label":0}
{"pair_id":"AIMed.d64.s551.p1","sentence":"Crosslinking of iodinated @PROTEIN1$ (aFGF) and @PROTEIN2$ (bFGF) to transiently expressing COS-1 cells revealed a major band of 95 kDa, which was competed for by both aFGF and bFGF.","label":0}
{"pair_id":"AIMed.d64.s551.p2","sentence":"Crosslinking of iodinated @PROTEIN1$ (aFGF) and basic FGF (@PROTEIN2$) to transiently expressing COS-1 cells revealed a major band of 95 kDa, which was competed for by both aFGF and bFGF.","label":0}
{"pair_id":"AIMed.d64.s551.p3","sentence":"Crosslinking of iodinated @PROTEIN1$ (aFGF) and basic FGF (bFGF) to transiently expressing COS-1 cells revealed a major band of 95 kDa, which was competed for by both @PROTEIN2$ and bFGF.","label":0}
{"pair_id":"AIMed.d64.s551.p4","sentence":"Crosslinking of iodinated @PROTEIN1$ (aFGF) and basic FGF (bFGF) to transiently expressing COS-1 cells revealed a major band of 95 kDa, which was competed for by both aFGF and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d64.s551.p5","sentence":"Crosslinking of iodinated acidic FGF (@PROTEIN1$) and @PROTEIN2$ (bFGF) to transiently expressing COS-1 cells revealed a major band of 95 kDa, which was competed for by both aFGF and bFGF.","label":0}
{"pair_id":"AIMed.d64.s551.p6","sentence":"Crosslinking of iodinated acidic FGF (@PROTEIN1$) and basic FGF (@PROTEIN2$) to transiently expressing COS-1 cells revealed a major band of 95 kDa, which was competed for by both aFGF and bFGF.","label":0}
{"pair_id":"AIMed.d64.s551.p7","sentence":"Crosslinking of iodinated acidic FGF (@PROTEIN1$) and basic FGF (bFGF) to transiently expressing COS-1 cells revealed a major band of 95 kDa, which was competed for by both @PROTEIN2$ and bFGF.","label":0}
{"pair_id":"AIMed.d64.s551.p8","sentence":"Crosslinking of iodinated acidic FGF (@PROTEIN1$) and basic FGF (bFGF) to transiently expressing COS-1 cells revealed a major band of 95 kDa, which was competed for by both aFGF and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d64.s551.p9","sentence":"Crosslinking of iodinated acidic FGF (aFGF) and @PROTEIN1$ (@PROTEIN2$) to transiently expressing COS-1 cells revealed a major band of 95 kDa, which was competed for by both aFGF and bFGF.","label":0}
{"pair_id":"AIMed.d64.s551.p10","sentence":"Crosslinking of iodinated acidic FGF (aFGF) and @PROTEIN1$ (bFGF) to transiently expressing COS-1 cells revealed a major band of 95 kDa, which was competed for by both @PROTEIN2$ and bFGF.","label":0}
{"pair_id":"AIMed.d64.s551.p11","sentence":"Crosslinking of iodinated acidic FGF (aFGF) and @PROTEIN1$ (bFGF) to transiently expressing COS-1 cells revealed a major band of 95 kDa, which was competed for by both aFGF and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d64.s551.p12","sentence":"Crosslinking of iodinated acidic FGF (aFGF) and basic FGF (@PROTEIN1$) to transiently expressing COS-1 cells revealed a major band of 95 kDa, which was competed for by both @PROTEIN2$ and bFGF.","label":0}
{"pair_id":"AIMed.d64.s551.p13","sentence":"Crosslinking of iodinated acidic FGF (aFGF) and basic FGF (@PROTEIN1$) to transiently expressing COS-1 cells revealed a major band of 95 kDa, which was competed for by both aFGF and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d64.s551.p14","sentence":"Crosslinking of iodinated acidic FGF (aFGF) and basic FGF (bFGF) to transiently expressing COS-1 cells revealed a major band of 95 kDa, which was competed for by both @PROTEIN1$ and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d247.s1.p0","sentence":"The essential role of @PROTEIN2$ in the assembly of @PROTEIN1$ for microspike formation.","label":1}
{"pair_id":"AIMed.d79.s677.p0","sentence":"A domain is conserved between @PROTEIN1$ and the @PROTEIN2$\/Blimp-1 differentiation factor.","label":0}
{"pair_id":"AIMed.d79.s677.p1","sentence":"A domain is conserved between @PROTEIN1$ and the PRDI-BF1\/@PROTEIN2$ differentiation factor.","label":0}
{"pair_id":"AIMed.d79.s677.p2","sentence":"A domain is conserved between RIZ and the @PROTEIN1$\/@PROTEIN2$ differentiation factor.","label":0}
{"pair_id":"AIMed.d172.s1446.p0","sentence":"@PROTEIN1$@PROTEIN2$: a ligand and specific activator of the tyrosine kinase receptor Flt4.","label":0}
{"pair_id":"AIMed.d172.s1446.p1","sentence":"@PROTEIN1$-related protein: a ligand and specific activator of the tyrosine kinase receptor @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d172.s1446.p2","sentence":"@PROTEIN1$: a ligand and specific activator of the tyrosine kinase receptor @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d185.s1571.p0","sentence":"To define the mechanism underlying signal transducer and activator of transcription (STAT) protein recruitment to the @PROTEIN1$ (@PROTEIN2$) receptor, the STAT proteins activated by IL-10 in different cell populations were first defined using electrophoretic mobility shift assays.","label":0}
{"pair_id":"AIMed.d185.s1571.p1","sentence":"To define the mechanism underlying signal transducer and activator of transcription (STAT) protein recruitment to the @PROTEIN1$@PROTEIN2$, the STAT proteins activated by IL-10 in different cell populations were first defined using electrophoretic mobility shift assays.","label":0}
{"pair_id":"AIMed.d185.s1571.p2","sentence":"To define the mechanism underlying signal transducer and activator of transcription (STAT) protein recruitment to the @PROTEIN1$ (IL-10) receptor, the STAT proteins activated by @PROTEIN2$ in different cell populations were first defined using electrophoretic mobility shift assays.","label":0}
{"pair_id":"AIMed.d185.s1571.p3","sentence":"To define the mechanism underlying signal transducer and activator of transcription (STAT) protein recruitment to the @PROTEIN2$@PROTEIN1$) receptor, the STAT proteins activated by IL-10 in different cell populations were first defined using electrophoretic mobility shift assays.","label":0}
{"pair_id":"AIMed.d185.s1571.p4","sentence":"To define the mechanism underlying signal transducer and activator of transcription (STAT) protein recruitment to the interleukin 10 (@PROTEIN1$) receptor, the STAT proteins activated by @PROTEIN2$ in different cell populations were first defined using electrophoretic mobility shift assays.","label":0}
{"pair_id":"AIMed.d185.s1571.p5","sentence":"To define the mechanism underlying signal transducer and activator of transcription (STAT) protein recruitment to the @PROTEIN1$, the STAT proteins activated by @PROTEIN2$ in different cell populations were first defined using electrophoretic mobility shift assays.","label":0}
{"pair_id":"AIMed.d183.s1552.p0","sentence":"The cytokine-activated tyrosine kinase @PROTEIN1$ activates @PROTEIN2$ in a p21ras-dependent manner.","label":1}
{"pair_id":"AIMed.d183.s1552.p1","sentence":"The cytokine-activated tyrosine kinase @PROTEIN1$ activates Raf-1 in a @PROTEIN2$-dependent manner.","label":0}
{"pair_id":"AIMed.d183.s1552.p2","sentence":"The cytokine-activated tyrosine kinase JAK2 activates @PROTEIN1$ in a @PROTEIN2$-dependent manner.","label":0}
{"pair_id":"BioInfer.d729.s0.p0","sentence":"The two proteins were found to differ in their interaction with actin, like @PROTEIN2$ and @PROTEIN1$ isolated from porcine brain.","label":1}
{"pair_id":"BioInfer.d729.s0.p1","sentence":"The two proteins were found to differ in their interaction with @PROTEIN2$, like destrin and @PROTEIN1$ isolated from porcine brain.","label":1}
{"pair_id":"BioInfer.d729.s0.p2","sentence":"The two proteins were found to differ in their interaction with @PROTEIN2$, like @PROTEIN1$ and cofilin isolated from porcine brain.","label":1}
{"pair_id":"AIMed.d215.s1866.p0","sentence":"Induction of cell migration by @PROTEIN1$ cleavage of @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d81.s690.p0","sentence":"Using a genetic selection based on protein-protein interaction in yeast, we have identified two gene products that associate with the intracellular domain of @PROTEIN1$: @PROTEIN2$ itself, and a novel 74 kDa protein we have named RIP, for receptor interacting protein.","label":1}
{"pair_id":"AIMed.d81.s690.p1","sentence":"Using a genetic selection based on protein-protein interaction in yeast, we have identified two gene products that associate with the intracellular domain of @PROTEIN1$: Fas itself, and a novel 74 kDa protein we have named @PROTEIN2$, for receptor interacting protein.","label":1}
{"pair_id":"AIMed.d81.s690.p2","sentence":"Using a genetic selection based on protein-protein interaction in yeast, we have identified two gene products that associate with the intracellular domain of @PROTEIN1$: Fas itself, and a novel 74 kDa protein we have named RIP, for @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d81.s690.p3","sentence":"Using a genetic selection based on protein-protein interaction in yeast, we have identified two gene products that associate with the intracellular domain of Fas: @PROTEIN1$ itself, and a novel 74 kDa protein we have named @PROTEIN2$, for receptor interacting protein.","label":0}
{"pair_id":"AIMed.d81.s690.p4","sentence":"Using a genetic selection based on protein-protein interaction in yeast, we have identified two gene products that associate with the intracellular domain of Fas: @PROTEIN1$ itself, and a novel 74 kDa protein we have named RIP, for @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d81.s690.p5","sentence":"Using a genetic selection based on protein-protein interaction in yeast, we have identified two gene products that associate with the intracellular domain of Fas: Fas itself, and a novel 74 kDa protein we have named @PROTEIN1$, for @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d150.s1280.p0","sentence":"Overexpression of a phosphorylation-defective form of @PROTEIN1$ inhibited @PROTEIN2$-dependent transcription during T cell activation.","label":0}
{"pair_id":"BioInfer.d497.s0.p0","sentence":"@PROTEIN2$ is generally thought to regulate actin polymerization, but the observation that acidic phospholipids dissociate the complex of profilin and @PROTEIN1$ raised the possibility that profilin might also regulate lipid metabolism.","label":0}
{"pair_id":"BioInfer.d497.s0.p1","sentence":"Profilin is generally thought to regulate actin polymerization, but the observation that acidic phospholipids dissociate the complex of @PROTEIN2$ and @PROTEIN1$ raised the possibility that profilin might also regulate lipid metabolism.","label":1}
{"pair_id":"BioInfer.d497.s0.p2","sentence":"Profilin is generally thought to regulate @PROTEIN2$ polymerization, but the observation that acidic phospholipids dissociate the complex of profilin and @PROTEIN1$ raised the possibility that profilin might also regulate lipid metabolism.","label":0}
{"pair_id":"BioInfer.d497.s0.p3","sentence":"Profilin is generally thought to regulate actin polymerization, but the observation that acidic phospholipids dissociate the complex of profilin and @PROTEIN1$ raised the possibility that @PROTEIN2$ might also regulate lipid metabolism.","label":0}
{"pair_id":"BioInfer.d497.s0.p4","sentence":"@PROTEIN1$ is generally thought to regulate actin polymerization, but the observation that acidic phospholipids dissociate the complex of @PROTEIN2$ and actin raised the possibility that profilin might also regulate lipid metabolism.","label":0}
{"pair_id":"BioInfer.d497.s0.p5","sentence":"@PROTEIN1$ is generally thought to regulate @PROTEIN2$ polymerization, but the observation that acidic phospholipids dissociate the complex of profilin and actin raised the possibility that profilin might also regulate lipid metabolism.","label":1}
{"pair_id":"BioInfer.d497.s0.p6","sentence":"@PROTEIN1$ is generally thought to regulate actin polymerization, but the observation that acidic phospholipids dissociate the complex of profilin and actin raised the possibility that @PROTEIN2$ might also regulate lipid metabolism.","label":0}
{"pair_id":"BioInfer.d497.s0.p7","sentence":"Profilin is generally thought to regulate @PROTEIN2$ polymerization, but the observation that acidic phospholipids dissociate the complex of @PROTEIN1$ and actin raised the possibility that profilin might also regulate lipid metabolism.","label":0}
{"pair_id":"BioInfer.d497.s0.p8","sentence":"Profilin is generally thought to regulate actin polymerization, but the observation that acidic phospholipids dissociate the complex of @PROTEIN1$ and actin raised the possibility that @PROTEIN2$ might also regulate lipid metabolism.","label":0}
{"pair_id":"BioInfer.d497.s0.p9","sentence":"Profilin is generally thought to regulate @PROTEIN1$ polymerization, but the observation that acidic phospholipids dissociate the complex of profilin and actin raised the possibility that @PROTEIN2$ might also regulate lipid metabolism.","label":0}
{"pair_id":"BioInfer.d747.s0.p0","sentence":"This technique was employed to quantify changes caused by the lack of talin, a protein that couples the actin network to the plasma membrane, or by the lack of @PROTEIN2$ or co, two isoforms of the actin-bundling protein @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d747.s0.p1","sentence":"This technique was employed to quantify changes caused by the lack of @PROTEIN2$, a protein that couples the actin network to the plasma membrane, or by the lack of cortexillin I or co, two isoforms of the actin-bundling protein @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d747.s0.p2","sentence":"This technique was employed to quantify changes caused by the lack of talin, a protein that couples the actin network to the plasma membrane, or by the lack of @PROTEIN2$ I or @PROTEIN2$, two isoforms of the actin-bundling protein @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d747.s0.p3","sentence":"This technique was employed to quantify changes caused by the lack of talin, a protein that couples the actin network to the plasma membrane, or by the lack of cortexillin I or co, two isoforms of the @PROTEIN2$-bundling protein @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d747.s0.p4","sentence":"This technique was employed to quantify changes caused by the lack of talin, a protein that couples the @PROTEIN2$ network to the plasma membrane, or by the lack of cortexillin I or co, two isoforms of the actin-bundling protein @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d747.s0.p5","sentence":"This technique was employed to quantify changes caused by the lack of @PROTEIN2$, a protein that couples the actin network to the plasma membrane, or by the lack of @PROTEIN1$ or co, two isoforms of the actin-bundling protein cortexillin.","label":0}
{"pair_id":"BioInfer.d747.s0.p6","sentence":"This technique was employed to quantify changes caused by the lack of talin, a protein that couples the actin network to the plasma membrane, or by the lack of @PROTEIN1$@PROTEIN2$ I or @PROTEIN2$, two isoforms of the actin-bundling protein cortexillin.","label":0}
{"pair_id":"BioInfer.d747.s0.p7","sentence":"This technique was employed to quantify changes caused by the lack of talin, a protein that couples the actin network to the plasma membrane, or by the lack of @PROTEIN1$ or co, two isoforms of the @PROTEIN2$-bundling protein cortexillin.","label":0}
{"pair_id":"BioInfer.d747.s0.p8","sentence":"This technique was employed to quantify changes caused by the lack of talin, a protein that couples the @PROTEIN2$ network to the plasma membrane, or by the lack of @PROTEIN1$ or co, two isoforms of the actin-bundling protein cortexillin.","label":0}
{"pair_id":"BioInfer.d747.s0.p9","sentence":"This technique was employed to quantify changes caused by the lack of @PROTEIN1$, a protein that couples the actin network to the plasma membrane, or by the lack of @PROTEIN2$ I or @PROTEIN2$, two isoforms of the actin-bundling protein cortexillin.","label":0}
{"pair_id":"BioInfer.d747.s0.p10","sentence":"This technique was employed to quantify changes caused by the lack of @PROTEIN1$, a protein that couples the actin network to the plasma membrane, or by the lack of cortexillin I or co, two isoforms of the @PROTEIN2$-bundling protein cortexillin.","label":0}
{"pair_id":"BioInfer.d747.s0.p11","sentence":"This technique was employed to quantify changes caused by the lack of @PROTEIN1$, a protein that couples the @PROTEIN2$ network to the plasma membrane, or by the lack of cortexillin I or co, two isoforms of the actin-bundling protein cortexillin.","label":1}
{"pair_id":"BioInfer.d747.s0.p12","sentence":"This technique was employed to quantify changes caused by the lack of talin, a protein that couples the actin network to the plasma membrane, or by the lack of @PROTEIN1$ I or @PROTEIN1$, two isoforms of the @PROTEIN2$-bundling protein cortexillin.","label":0}
{"pair_id":"BioInfer.d747.s0.p13","sentence":"This technique was employed to quantify changes caused by the lack of talin, a protein that couples the @PROTEIN2$ network to the plasma membrane, or by the lack of @PROTEIN1$ I or @PROTEIN1$, two isoforms of the actin-bundling protein cortexillin.","label":0}
{"pair_id":"BioInfer.d747.s0.p14","sentence":"This technique was employed to quantify changes caused by the lack of talin, a protein that couples the @PROTEIN2$ network to the plasma membrane, or by the lack of cortexillin I or co, two isoforms of the @PROTEIN1$-bundling protein cortexillin.","label":0}
{"pair_id":"AIMed.d22.s181.p0","sentence":"Present data concerning the @PROTEIN1$-@PROTEIN2$ system of extrarenal origin.","label":0}
{"pair_id":"BioInfer.d143.s0.p0","sentence":"Class II profilins had higher affinity for poly-l-proline and sequestered more monomeric @PROTEIN2$ than did @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d143.s0.p1","sentence":"@PROTEIN2$ had higher affinity for poly-l-proline and sequestered more monomeric actin than did @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d143.s0.p2","sentence":"@PROTEIN2$ had higher affinity for poly-l-proline and sequestered more monomeric @PROTEIN1$ than did class I profilins.","label":1}
{"pair_id":"BioInfer.d471.s1.p0","sentence":"Our results show that the major pool of polymerizable @PROTEIN2$ monomers is complexed with @PROTEIN1$ and spread throughout the cytoplasm.","label":1}
{"pair_id":"AIMed.d183.s1554.p0","sentence":"@PROTEIN1$ and several other cytokines that are known to activate @PROTEIN2$ kinase were also found to stimulate Raf-1 kinase activity toward MEK-1 in mammalian cells.","label":0}
{"pair_id":"AIMed.d183.s1554.p1","sentence":"@PROTEIN1$ and several other cytokines that are known to activate @PROTEIN2$ were also found to stimulate Raf-1 kinase activity toward MEK-1 in mammalian cells.","label":1}
{"pair_id":"AIMed.d183.s1554.p2","sentence":"@PROTEIN1$ and several other cytokines that are known to activate JAK2 kinase were also found to stimulate @PROTEIN2$ kinase activity toward MEK-1 in mammalian cells.","label":0}
{"pair_id":"AIMed.d183.s1554.p3","sentence":"@PROTEIN1$ and several other cytokines that are known to activate JAK2 kinase were also found to stimulate @PROTEIN2$ activity toward MEK-1 in mammalian cells.","label":0}
{"pair_id":"AIMed.d183.s1554.p4","sentence":"@PROTEIN1$ and several other cytokines that are known to activate JAK2 kinase were also found to stimulate Raf-1 kinase activity toward @PROTEIN2$ in mammalian cells.","label":0}
{"pair_id":"AIMed.d183.s1554.p5","sentence":"Interferon-gamma and several other cytokines that are known to activate @PROTEIN1$@PROTEIN2$ were also found to stimulate Raf-1 kinase activity toward MEK-1 in mammalian cells.","label":0}
{"pair_id":"AIMed.d183.s1554.p6","sentence":"Interferon-gamma and several other cytokines that are known to activate @PROTEIN1$ kinase were also found to stimulate @PROTEIN2$ kinase activity toward MEK-1 in mammalian cells.","label":0}
{"pair_id":"AIMed.d183.s1554.p7","sentence":"Interferon-gamma and several other cytokines that are known to activate @PROTEIN1$ kinase were also found to stimulate @PROTEIN2$ activity toward MEK-1 in mammalian cells.","label":0}
{"pair_id":"AIMed.d183.s1554.p8","sentence":"Interferon-gamma and several other cytokines that are known to activate @PROTEIN1$ kinase were also found to stimulate Raf-1 kinase activity toward @PROTEIN2$ in mammalian cells.","label":0}
{"pair_id":"AIMed.d183.s1554.p9","sentence":"Interferon-gamma and several other cytokines that are known to activate @PROTEIN1$ were also found to stimulate @PROTEIN2$ kinase activity toward MEK-1 in mammalian cells.","label":0}
{"pair_id":"AIMed.d183.s1554.p10","sentence":"Interferon-gamma and several other cytokines that are known to activate @PROTEIN1$ were also found to stimulate @PROTEIN2$ activity toward MEK-1 in mammalian cells.","label":0}
{"pair_id":"AIMed.d183.s1554.p11","sentence":"Interferon-gamma and several other cytokines that are known to activate @PROTEIN1$ were also found to stimulate Raf-1 kinase activity toward @PROTEIN2$ in mammalian cells.","label":0}
{"pair_id":"AIMed.d183.s1554.p12","sentence":"Interferon-gamma and several other cytokines that are known to activate JAK2 kinase were also found to stimulate @PROTEIN1$@PROTEIN2$ activity toward MEK-1 in mammalian cells.","label":0}
{"pair_id":"AIMed.d183.s1554.p13","sentence":"Interferon-gamma and several other cytokines that are known to activate JAK2 kinase were also found to stimulate @PROTEIN1$ kinase activity toward @PROTEIN2$ in mammalian cells.","label":0}
{"pair_id":"AIMed.d183.s1554.p14","sentence":"Interferon-gamma and several other cytokines that are known to activate JAK2 kinase were also found to stimulate @PROTEIN1$ activity toward @PROTEIN2$ in mammalian cells.","label":1}
{"pair_id":"BioInfer.d59.s0.p0","sentence":"Analysis of this product by peptide mapping (Sutoh (1982) Biochemistry 21, 3654-3661) showed that @PROTEIN2$ was cross-linked with the N-terminal segment of @PROTEIN1$ containing residues 1-12.","label":1}
{"pair_id":"BioInfer.d459.s0.p0","sentence":"Once the actin monomer is bound to the filament, the @PROTEIN2$ is released, and is available to bind to additional @PROTEIN1$ monomers.","label":1}
{"pair_id":"BioInfer.d459.s0.p1","sentence":"Once the @PROTEIN2$ monomer is bound to the filament, the profilin is released, and is available to bind to additional @PROTEIN1$ monomers.","label":0}
{"pair_id":"BioInfer.d459.s0.p2","sentence":"Once the @PROTEIN2$ monomer is bound to the filament, the @PROTEIN1$ is released, and is available to bind to additional actin monomers.","label":0}
{"pair_id":"AIMed.d167.s1408.p0","sentence":"Both the @PROTEIN1$-@PROTEIN2$ and the GT155-CAP-60 interactions were dependent on the presence of a correctly modified oligosaccharide group on GT155, a characteristic of many calnexin interactions.","label":1}
{"pair_id":"AIMed.d167.s1408.p1","sentence":"Both the @PROTEIN1$-calnexin and the @PROTEIN2$-CAP-60 interactions were dependent on the presence of a correctly modified oligosaccharide group on GT155, a characteristic of many calnexin interactions.","label":0}
{"pair_id":"AIMed.d167.s1408.p2","sentence":"Both the @PROTEIN1$-calnexin and the GT155-@PROTEIN2$ interactions were dependent on the presence of a correctly modified oligosaccharide group on GT155, a characteristic of many calnexin interactions.","label":0}
{"pair_id":"AIMed.d167.s1408.p3","sentence":"Both the @PROTEIN1$-calnexin and the GT155-CAP-60 interactions were dependent on the presence of a correctly modified oligosaccharide group on @PROTEIN2$, a characteristic of many calnexin interactions.","label":0}
{"pair_id":"AIMed.d167.s1408.p4","sentence":"Both the @PROTEIN1$-calnexin and the GT155-CAP-60 interactions were dependent on the presence of a correctly modified oligosaccharide group on GT155, a characteristic of many @PROTEIN2$ interactions.","label":0}
{"pair_id":"AIMed.d167.s1408.p5","sentence":"Both the GT155-@PROTEIN1$ and the @PROTEIN2$-CAP-60 interactions were dependent on the presence of a correctly modified oligosaccharide group on GT155, a characteristic of many calnexin interactions.","label":0}
{"pair_id":"AIMed.d167.s1408.p6","sentence":"Both the GT155-@PROTEIN1$ and the GT155-@PROTEIN2$ interactions were dependent on the presence of a correctly modified oligosaccharide group on GT155, a characteristic of many calnexin interactions.","label":0}
{"pair_id":"AIMed.d167.s1408.p7","sentence":"Both the GT155-@PROTEIN1$ and the GT155-CAP-60 interactions were dependent on the presence of a correctly modified oligosaccharide group on @PROTEIN2$, a characteristic of many calnexin interactions.","label":0}
{"pair_id":"AIMed.d167.s1408.p8","sentence":"Both the GT155-@PROTEIN1$ and the GT155-CAP-60 interactions were dependent on the presence of a correctly modified oligosaccharide group on GT155, a characteristic of many @PROTEIN2$ interactions.","label":0}
{"pair_id":"AIMed.d167.s1408.p9","sentence":"Both the GT155-calnexin and the @PROTEIN1$-@PROTEIN2$ interactions were dependent on the presence of a correctly modified oligosaccharide group on GT155, a characteristic of many calnexin interactions.","label":1}
{"pair_id":"AIMed.d167.s1408.p10","sentence":"Both the GT155-calnexin and the @PROTEIN1$-CAP-60 interactions were dependent on the presence of a correctly modified oligosaccharide group on @PROTEIN2$, a characteristic of many calnexin interactions.","label":0}
{"pair_id":"AIMed.d167.s1408.p11","sentence":"Both the GT155-calnexin and the @PROTEIN1$-CAP-60 interactions were dependent on the presence of a correctly modified oligosaccharide group on GT155, a characteristic of many @PROTEIN2$ interactions.","label":0}
{"pair_id":"AIMed.d167.s1408.p12","sentence":"Both the GT155-calnexin and the GT155-@PROTEIN1$ interactions were dependent on the presence of a correctly modified oligosaccharide group on @PROTEIN2$, a characteristic of many calnexin interactions.","label":0}
{"pair_id":"AIMed.d167.s1408.p13","sentence":"Both the GT155-calnexin and the GT155-@PROTEIN1$ interactions were dependent on the presence of a correctly modified oligosaccharide group on GT155, a characteristic of many @PROTEIN2$ interactions.","label":0}
{"pair_id":"AIMed.d167.s1408.p14","sentence":"Both the GT155-calnexin and the GT155-CAP-60 interactions were dependent on the presence of a correctly modified oligosaccharide group on @PROTEIN1$, a characteristic of many @PROTEIN2$ interactions.","label":0}
{"pair_id":"AIMed.d48.s423.p0","sentence":"@PROTEIN1$ induced maximal migration of @PROTEIN2$ and CCR8 transfected cells at 89.3 nmol\/L and cell adhesion at 5.6 nmol\/L.","label":0}
{"pair_id":"AIMed.d48.s423.p1","sentence":"@PROTEIN1$ induced maximal migration of CCR1 and @PROTEIN2$ transfected cells at 89.3 nmol\/L and cell adhesion at 5.6 nmol\/L.","label":0}
{"pair_id":"AIMed.d48.s423.p2","sentence":"LEC induced maximal migration of @PROTEIN1$ and @PROTEIN2$ transfected cells at 89.3 nmol\/L and cell adhesion at 5.6 nmol\/L.","label":0}
{"pair_id":"BioInfer.d6.s0.p0","sentence":"Acanthamoeba @PROTEIN2$ affects the mechanical properties of nonfilamentous @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d14.s1.p0","sentence":"These studies suggest that @PROTEIN1$ and gelsolin may control the generation of 3-OH phosphorylated phosphoinositides, which in turn may regulate the @PROTEIN2$ polymerization.","label":0}
{"pair_id":"BioInfer.d14.s1.p1","sentence":"These studies suggest that @PROTEIN1$ and @PROTEIN2$ may control the generation of 3-OH phosphorylated phosphoinositides, which in turn may regulate the actin polymerization.","label":0}
{"pair_id":"BioInfer.d14.s1.p2","sentence":"These studies suggest that profilin and @PROTEIN2$ may control the generation of 3-OH phosphorylated phosphoinositides, which in turn may regulate the @PROTEIN1$ polymerization.","label":0}
{"pair_id":"BioInfer.d779.s0.p0","sentence":"Two cDNAs, isolated from a Xenopus laevis embryonic library, encode proteins of 168 amino acids, both of which are 77% identical to chick cofilin and 66% identical to chick @PROTEIN1$ (@PROTEIN2$), two structurally and functionally related proteins.","label":0}
{"pair_id":"BioInfer.d779.s0.p1","sentence":"Two cDNAs, isolated from a Xenopus laevis embryonic library, encode proteins of 168 amino acids, both of which are 77% identical to chick @PROTEIN2$ and 66% identical to chick @PROTEIN1$ (ADF), two structurally and functionally related proteins.","label":1}
{"pair_id":"BioInfer.d779.s0.p2","sentence":"Two cDNAs, isolated from a Xenopus laevis embryonic library, encode proteins of 168 amino acids, both of which are 77% identical to chick @PROTEIN2$ and 66% identical to chick actin-depolymerizing factor (@PROTEIN1$), two structurally and functionally related proteins.","label":1}
{"pair_id":"AIMed.d152.s1294.p0","sentence":"Here we show that @PROTEIN1$ directly interacts with @PROTEIN2$ and FADD, signal transducers that activate NF-kappa B and induce apoptosis, respectively.","label":1}
{"pair_id":"AIMed.d152.s1294.p1","sentence":"Here we show that @PROTEIN1$ directly interacts with TRAF2 and @PROTEIN2$, signal transducers that activate NF-kappa B and induce apoptosis, respectively.","label":1}
{"pair_id":"AIMed.d152.s1294.p2","sentence":"Here we show that @PROTEIN1$ directly interacts with TRAF2 and FADD, signal transducers that activate @PROTEIN2$ and induce apoptosis, respectively.","label":0}
{"pair_id":"AIMed.d152.s1294.p3","sentence":"Here we show that TRADD directly interacts with @PROTEIN1$ and @PROTEIN2$, signal transducers that activate NF-kappa B and induce apoptosis, respectively.","label":0}
{"pair_id":"AIMed.d152.s1294.p4","sentence":"Here we show that TRADD directly interacts with @PROTEIN1$ and FADD, signal transducers that activate @PROTEIN2$ and induce apoptosis, respectively.","label":1}
{"pair_id":"AIMed.d152.s1294.p5","sentence":"Here we show that TRADD directly interacts with TRAF2 and @PROTEIN1$, signal transducers that activate @PROTEIN2$ and induce apoptosis, respectively.","label":1}
{"pair_id":"BioInfer.d3.s0.p0","sentence":"Absence of @PROTEIN2$ leads to structurally aberrant neuromuscular synapses deficient in @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d608.s0.p0","sentence":"The E-cadherin-associated proteins @PROTEIN1$ and @PROTEIN2$ were not significantly affected by treatment with TPA.","label":0}
{"pair_id":"BioInfer.d608.s0.p1","sentence":"The E-cadherin-associated proteins @PROTEIN1$ and beta-catenin were not significantly affected by treatment with @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d608.s0.p2","sentence":"The @PROTEIN2$-associated proteins @PROTEIN1$ and beta-catenin were not significantly affected by treatment with TPA.","label":1}
{"pair_id":"BioInfer.d608.s0.p3","sentence":"The E-cadherin-associated proteins alpha-catenin and @PROTEIN1$ were not significantly affected by treatment with @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d608.s0.p4","sentence":"The @PROTEIN2$-associated proteins alpha-catenin and @PROTEIN1$ were not significantly affected by treatment with TPA.","label":1}
{"pair_id":"BioInfer.d608.s0.p5","sentence":"The @PROTEIN2$-associated proteins alpha-catenin and beta-catenin were not significantly affected by treatment with @PROTEIN1$.","label":0}
{"pair_id":"AIMed.d99.s842.p0","sentence":"These observations suggest that the products of the @PROTEIN1$ and @PROTEIN2$ genes are involved in transcription.","label":0}
{"pair_id":"AIMed.d76.s647.p0","sentence":"In vivo labelling with 32P(i) also showed a four- to fivefold increase in Y-394 occupancy in @PROTEIN1$ when associated with @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d39.s342.p0","sentence":"@PROTEIN1$ suppressed @PROTEIN2$-associated apoptosis by retinoic acid in F9 embryonic carcinoma cells, whereas this suppression of apoptosis is attenuated by mutation in PS1.","label":0}
{"pair_id":"AIMed.d39.s342.p1","sentence":"@PROTEIN1$ suppressed c-jun-associated apoptosis by retinoic acid in F9 embryonic carcinoma cells, whereas this suppression of apoptosis is attenuated by mutation in @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d39.s342.p2","sentence":"PS1 suppressed @PROTEIN1$-associated apoptosis by retinoic acid in F9 embryonic carcinoma cells, whereas this suppression of apoptosis is attenuated by mutation in @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d173.s1459.p0","sentence":"Fusion proteins were created by linking the @PROTEIN1$ fragment to a @PROTEIN2$ DNA-binding domain (bait) and also to a B42 transactivation domain (prey).","label":0}
{"pair_id":"AIMed.d173.s1459.p1","sentence":"Fusion proteins were created by linking the @PROTEIN1$ fragment to a LexA DNA-binding domain (bait) and also to a @PROTEIN2$ transactivation domain (prey).","label":0}
{"pair_id":"AIMed.d173.s1459.p2","sentence":"Fusion proteins were created by linking the Abeta fragment to a @PROTEIN1$ DNA-binding domain (bait) and also to a @PROTEIN2$ transactivation domain (prey).","label":0}
{"pair_id":"AIMed.d97.s823.p0","sentence":"Binding of @PROTEIN1$\/@PROTEIN2$ to BMPR-II was also observed in nontransfected cell lines.","label":0}
{"pair_id":"AIMed.d97.s823.p1","sentence":"Binding of @PROTEIN1$\/BMP-7 to @PROTEIN2$ was also observed in nontransfected cell lines.","label":1}
{"pair_id":"AIMed.d97.s823.p2","sentence":"Binding of OP-1\/@PROTEIN1$ to @PROTEIN2$ was also observed in nontransfected cell lines.","label":1}
{"pair_id":"BioInfer.d388.s3.p0","sentence":"To study @PROTEIN2$ function, we extensively mutagenized the Saccharomyces cerevisiae profilin gene (PFY1) and examined the consequences of specific point mutations on growth and @PROTEIN1$ organization.","label":0}
{"pair_id":"BioInfer.d388.s3.p1","sentence":"To study profilin function, we extensively mutagenized the Saccharomyces cerevisiae @PROTEIN2$ gene (PFY1) and examined the consequences of specific point mutations on growth and @PROTEIN1$ organization.","label":1}
{"pair_id":"BioInfer.d388.s3.p2","sentence":"To study profilin function, we extensively mutagenized the Saccharomyces cerevisiae profilin gene (@PROTEIN2$) and examined the consequences of specific point mutations on growth and @PROTEIN1$ organization.","label":1}
{"pair_id":"BioInfer.d388.s3.p3","sentence":"To study @PROTEIN1$ function, we extensively mutagenized the Saccharomyces cerevisiae @PROTEIN2$ gene (PFY1) and examined the consequences of specific point mutations on growth and actin organization.","label":0}
{"pair_id":"BioInfer.d388.s3.p4","sentence":"To study @PROTEIN1$ function, we extensively mutagenized the Saccharomyces cerevisiae profilin gene (@PROTEIN2$) and examined the consequences of specific point mutations on growth and actin organization.","label":0}
{"pair_id":"BioInfer.d388.s3.p5","sentence":"To study profilin function, we extensively mutagenized the Saccharomyces cerevisiae @PROTEIN1$ gene (@PROTEIN2$) and examined the consequences of specific point mutations on growth and actin organization.","label":0}
{"pair_id":"BioInfer.d9.s0.p0","sentence":"A chimera consisting of the alpha-catenin-binding region of @PROTEIN1$ linked to the amino terminus of alpha-catenin 57-264 behaves as a monomer in solution, as expected, since @PROTEIN2$ binding disrupts the alpha-catenin dimer.","label":0}
{"pair_id":"BioInfer.d9.s0.p1","sentence":"A chimera consisting of the alpha-catenin-binding region of @PROTEIN1$ linked to the amino terminus of @PROTEIN2$ behaves as a monomer in solution, as expected, since beta-catenin binding disrupts the alpha-catenin dimer.","label":1}
{"pair_id":"BioInfer.d9.s0.p2","sentence":"A chimera consisting of the alpha-catenin-binding region of @PROTEIN1$ linked to the amino terminus of alpha-catenin 57-264 behaves as a monomer in solution, as expected, since beta-catenin binding disrupts the @PROTEIN2$ dimer.","label":0}
{"pair_id":"BioInfer.d9.s0.p3","sentence":"A chimera consisting of the @PROTEIN2$-binding region of @PROTEIN1$ linked to the amino terminus of alpha-catenin 57-264 behaves as a monomer in solution, as expected, since beta-catenin binding disrupts the alpha-catenin dimer.","label":1}
{"pair_id":"BioInfer.d9.s0.p4","sentence":"A chimera consisting of the alpha-catenin-binding region of beta-catenin linked to the amino terminus of @PROTEIN2$ behaves as a monomer in solution, as expected, since @PROTEIN1$ binding disrupts the alpha-catenin dimer.","label":0}
{"pair_id":"BioInfer.d9.s0.p5","sentence":"A chimera consisting of the alpha-catenin-binding region of beta-catenin linked to the amino terminus of alpha-catenin 57-264 behaves as a monomer in solution, as expected, since @PROTEIN1$ binding disrupts the @PROTEIN2$ dimer.","label":1}
{"pair_id":"BioInfer.d9.s0.p6","sentence":"A chimera consisting of the @PROTEIN2$-binding region of beta-catenin linked to the amino terminus of alpha-catenin 57-264 behaves as a monomer in solution, as expected, since @PROTEIN1$ binding disrupts the alpha-catenin dimer.","label":0}
{"pair_id":"BioInfer.d9.s0.p7","sentence":"A chimera consisting of the alpha-catenin-binding region of beta-catenin linked to the amino terminus of @PROTEIN1$ behaves as a monomer in solution, as expected, since beta-catenin binding disrupts the @PROTEIN2$ dimer.","label":0}
{"pair_id":"BioInfer.d9.s0.p8","sentence":"A chimera consisting of the @PROTEIN2$-binding region of beta-catenin linked to the amino terminus of @PROTEIN1$ behaves as a monomer in solution, as expected, since beta-catenin binding disrupts the alpha-catenin dimer.","label":0}
{"pair_id":"BioInfer.d9.s0.p9","sentence":"A chimera consisting of the @PROTEIN2$-binding region of beta-catenin linked to the amino terminus of alpha-catenin 57-264 behaves as a monomer in solution, as expected, since beta-catenin binding disrupts the @PROTEIN1$ dimer.","label":0}
{"pair_id":"BioInfer.d455.s0.p0","sentence":"Notably, the two pro-apoptotic adapter proteins @PROTEIN2$ and @PROTEIN1$ are also involved in the activation of A-SMase.","label":0}
{"pair_id":"BioInfer.d455.s0.p1","sentence":"Notably, the two pro-apoptotic adapter proteins TRADD and @PROTEIN1$ are also involved in the activation of @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d455.s0.p2","sentence":"Notably, the two pro-apoptotic adapter proteins @PROTEIN1$ and FADD are also involved in the activation of @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d18.s151.p0","sentence":"Cytokines @PROTEIN1$, @PROTEIN2$, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p1","sentence":"Cytokines @PROTEIN1$, IL-1beta, @PROTEIN2$, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p2","sentence":"Cytokines @PROTEIN1$, IL-1beta, IL-6, @PROTEIN2$, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p3","sentence":"Cytokines @PROTEIN1$, IL-1beta, IL-6, IL-8, @PROTEIN2$ (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p4","sentence":"Cytokines @PROTEIN1$, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), @PROTEIN2$, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p5","sentence":"Cytokines @PROTEIN1$, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and @PROTEIN2$ (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p6","sentence":"Cytokines @PROTEIN1$, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (@PROTEIN2$) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p7","sentence":"Cytokines @PROTEIN1$, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and @PROTEIN2$, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p8","sentence":"Cytokines @PROTEIN1$, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, @PROTEIN2$, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p9","sentence":"Cytokines @PROTEIN1$, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and @PROTEIN2$ (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p10","sentence":"Cytokines IL-1alpha, @PROTEIN1$, @PROTEIN2$, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p11","sentence":"Cytokines IL-1alpha, @PROTEIN1$, IL-6, @PROTEIN2$, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p12","sentence":"Cytokines IL-1alpha, @PROTEIN1$, IL-6, IL-8, @PROTEIN2$ (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p13","sentence":"Cytokines IL-1alpha, @PROTEIN1$, IL-6, IL-8, IL-10 (Immunotech, France), @PROTEIN2$, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p14","sentence":"Cytokines IL-1alpha, @PROTEIN1$, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and @PROTEIN2$ (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p15","sentence":"Cytokines IL-1alpha, @PROTEIN1$, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (@PROTEIN2$) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p16","sentence":"Cytokines IL-1alpha, @PROTEIN1$, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and @PROTEIN2$, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p17","sentence":"Cytokines IL-1alpha, @PROTEIN1$, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, @PROTEIN2$, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p18","sentence":"Cytokines IL-1alpha, @PROTEIN1$, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and @PROTEIN2$ (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p19","sentence":"Cytokines IL-1alpha, IL-1beta, @PROTEIN1$, @PROTEIN2$, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p20","sentence":"Cytokines IL-1alpha, IL-1beta, @PROTEIN1$, IL-8, @PROTEIN2$ (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p21","sentence":"Cytokines IL-1alpha, IL-1beta, @PROTEIN1$, IL-8, IL-10 (Immunotech, France), @PROTEIN2$, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p22","sentence":"Cytokines IL-1alpha, IL-1beta, @PROTEIN1$, IL-8, IL-10 (Immunotech, France), endothelin-1, and @PROTEIN2$ (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p23","sentence":"Cytokines IL-1alpha, IL-1beta, @PROTEIN1$, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (@PROTEIN2$) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p24","sentence":"Cytokines IL-1alpha, IL-1beta, @PROTEIN1$, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and @PROTEIN2$, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p25","sentence":"Cytokines IL-1alpha, IL-1beta, @PROTEIN1$, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, @PROTEIN2$, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p26","sentence":"Cytokines IL-1alpha, IL-1beta, @PROTEIN1$, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and @PROTEIN2$ (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p27","sentence":"Cytokines IL-1alpha, IL-1beta, IL-6, @PROTEIN1$, @PROTEIN2$ (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p28","sentence":"Cytokines IL-1alpha, IL-1beta, IL-6, @PROTEIN1$, IL-10 (Immunotech, France), @PROTEIN2$, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p29","sentence":"Cytokines IL-1alpha, IL-1beta, IL-6, @PROTEIN1$, IL-10 (Immunotech, France), endothelin-1, and @PROTEIN2$ (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p30","sentence":"Cytokines IL-1alpha, IL-1beta, IL-6, @PROTEIN1$, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (@PROTEIN2$) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p31","sentence":"Cytokines IL-1alpha, IL-1beta, IL-6, @PROTEIN1$, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and @PROTEIN2$, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p32","sentence":"Cytokines IL-1alpha, IL-1beta, IL-6, @PROTEIN1$, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, @PROTEIN2$, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p33","sentence":"Cytokines IL-1alpha, IL-1beta, IL-6, @PROTEIN1$, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and @PROTEIN2$ (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p34","sentence":"Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, @PROTEIN1$ (Immunotech, France), @PROTEIN2$, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p35","sentence":"Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, @PROTEIN1$ (Immunotech, France), endothelin-1, and @PROTEIN2$ (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p36","sentence":"Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, @PROTEIN1$ (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (@PROTEIN2$) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p37","sentence":"Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, @PROTEIN1$ (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and @PROTEIN2$, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p38","sentence":"Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, @PROTEIN1$ (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, @PROTEIN2$, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p39","sentence":"Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, @PROTEIN1$ (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and @PROTEIN2$ (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p40","sentence":"Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), @PROTEIN1$, and @PROTEIN2$ (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p41","sentence":"Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), @PROTEIN1$, and soluble cell adhesion molecules (@PROTEIN2$) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p42","sentence":"Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), @PROTEIN1$, and soluble cell adhesion molecules (sCAM) sP- and @PROTEIN2$, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p43","sentence":"Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), @PROTEIN1$, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, @PROTEIN2$, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p44","sentence":"Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), @PROTEIN1$, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and @PROTEIN2$ (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p45","sentence":"Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and @PROTEIN1$ (@PROTEIN2$) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p46","sentence":"Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and @PROTEIN1$ (sCAM) sP- and @PROTEIN2$, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p47","sentence":"Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and @PROTEIN1$ (sCAM) sP- and sE-selectin, @PROTEIN2$, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p48","sentence":"Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and @PROTEIN1$ (sCAM) sP- and sE-selectin, sICAM-1, and @PROTEIN2$ (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p49","sentence":"Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (@PROTEIN1$) sP- and @PROTEIN2$, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p50","sentence":"Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (@PROTEIN1$) sP- and sE-selectin, @PROTEIN2$, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p51","sentence":"Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (@PROTEIN1$) sP- and sE-selectin, sICAM-1, and @PROTEIN2$ (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p52","sentence":"Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and @PROTEIN1$, @PROTEIN2$, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p53","sentence":"Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and @PROTEIN1$, sICAM-1, and @PROTEIN2$ (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p54","sentence":"Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, @PROTEIN1$, and @PROTEIN2$ (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d153.s1304.p0","sentence":"More importantly, adenosine in the absence of cell surface @PROTEIN1$ inhibited T cell proliferation and @PROTEIN2$ production induced by various stimuli.","label":0}
{"pair_id":"BioInfer.d781.s0.p0","sentence":"Under all conditions, platelets retained 40-50% of their total actin and greater than 70% of their actin-binding protein (@PROTEIN2$) but lost greater than 80% of talin and @PROTEIN1$ to the supernatant.","label":0}
{"pair_id":"BioInfer.d781.s0.p1","sentence":"Under all conditions, platelets retained 40-50% of their total actin and greater than 70% of their @PROTEIN2$ (ABP) but lost greater than 80% of talin and @PROTEIN1$ to the supernatant.","label":0}
{"pair_id":"BioInfer.d781.s0.p2","sentence":"Under all conditions, platelets retained 40-50% of their total actin and greater than 70% of their actin-binding protein (ABP) but lost greater than 80% of @PROTEIN2$ and @PROTEIN1$ to the supernatant.","label":0}
{"pair_id":"BioInfer.d781.s0.p3","sentence":"Under all conditions, platelets retained 40-50% of their total @PROTEIN2$ and greater than 70% of their actin-binding protein (ABP) but lost greater than 80% of talin and @PROTEIN1$ to the supernatant.","label":0}
{"pair_id":"BioInfer.d781.s0.p4","sentence":"Under all conditions, platelets retained 40-50% of their total actin and greater than 70% of their @PROTEIN2$ (@PROTEIN1$) but lost greater than 80% of talin and myosin to the supernatant.","label":0}
{"pair_id":"BioInfer.d781.s0.p5","sentence":"Under all conditions, platelets retained 40-50% of their total actin and greater than 70% of their actin-binding protein (@PROTEIN1$) but lost greater than 80% of @PROTEIN2$ and myosin to the supernatant.","label":0}
{"pair_id":"BioInfer.d781.s0.p6","sentence":"Under all conditions, platelets retained 40-50% of their total @PROTEIN2$ and greater than 70% of their actin-binding protein (@PROTEIN1$) but lost greater than 80% of talin and myosin to the supernatant.","label":0}
{"pair_id":"BioInfer.d781.s0.p7","sentence":"Under all conditions, platelets retained 40-50% of their total actin and greater than 70% of their @PROTEIN1$ (ABP) but lost greater than 80% of @PROTEIN2$ and myosin to the supernatant.","label":0}
{"pair_id":"BioInfer.d781.s0.p8","sentence":"Under all conditions, platelets retained 40-50% of their total @PROTEIN2$ and greater than 70% of their @PROTEIN1$ (ABP) but lost greater than 80% of talin and myosin to the supernatant.","label":0}
{"pair_id":"BioInfer.d781.s0.p9","sentence":"Under all conditions, platelets retained 40-50% of their total @PROTEIN2$ and greater than 70% of their actin-binding protein (ABP) but lost greater than 80% of @PROTEIN1$ and myosin to the supernatant.","label":0}
{"pair_id":"BioInfer.d393.s0.p0","sentence":"Isolation of human @PROTEIN2$ and @PROTEIN1$ for measurement of fractional synthesis rates.","label":0}
{"pair_id":"AIMed.d92.s789.p0","sentence":"Our results indicate that the @PROTEIN1$ and @PROTEIN2$ receptors can potentially interact, and that such an association may be responsible for the generation of high affinity NGF binding sites.","label":0}
{"pair_id":"AIMed.d92.s789.p1","sentence":"Our results indicate that the @PROTEIN1$ and p75 receptors can potentially interact, and that such an association may be responsible for the generation of high affinity @PROTEIN2$ binding sites.","label":0}
{"pair_id":"AIMed.d92.s789.p2","sentence":"Our results indicate that the trkA and @PROTEIN1$ receptors can potentially interact, and that such an association may be responsible for the generation of high affinity @PROTEIN2$ binding sites.","label":0}
{"pair_id":"AIMed.d166.s1397.p0","sentence":"The two residues of @PROTEIN1$ that contribute the majority of free energy for @PROTEIN2$ binding, Phe-156 and Lys-159 are surrounded by other residues which have only a moderate impact.","label":1}
{"pair_id":"BioInfer.d252.s0.p0","sentence":"Here we show that the N-terminal domain of ActA binds one actin monomer, in a @PROTEIN1$-like fashion, and @PROTEIN2$\/A complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2\/A complex.","label":0}
{"pair_id":"BioInfer.d252.s0.p1","sentence":"Here we show that the N-terminal domain of ActA binds one actin monomer, in a @PROTEIN1$-like fashion, and Arp2\/A complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by @PROTEIN2$\/A complex.","label":0}
{"pair_id":"BioInfer.d252.s0.p2","sentence":"Here we show that the N-terminal domain of ActA binds one @PROTEIN2$ monomer, in a @PROTEIN1$-like fashion, and Arp2\/A complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2\/A complex.","label":0}
{"pair_id":"BioInfer.d252.s0.p3","sentence":"Here we show that the N-terminal domain of ActA binds one actin monomer, in a @PROTEIN1$-like fashion, and @PROTEIN2$2\/@PROTEIN2$ complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2\/A complex.","label":0}
{"pair_id":"BioInfer.d252.s0.p4","sentence":"Here we show that the N-terminal domain of ActA binds one actin monomer, in a @PROTEIN1$-like fashion, and Arp2\/A complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by @PROTEIN2$2\/@PROTEIN2$ complex.","label":0}
{"pair_id":"BioInfer.d252.s0.p5","sentence":"Here we show that the N-terminal domain of ActA binds one actin monomer, in a @PROTEIN1$-like fashion, and Arp2\/A complex and mimics the C-terminal domain of @PROTEIN2$ family proteins in catalyzing filament barbed end branching by Arp2\/A complex.","label":0}
{"pair_id":"BioInfer.d252.s0.p6","sentence":"Here we show that the N-terminal domain of @PROTEIN2$ binds one actin monomer, in a @PROTEIN1$-like fashion, and Arp2\/A complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2\/A complex.","label":1}
{"pair_id":"BioInfer.d252.s0.p7","sentence":"Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and @PROTEIN1$\/A complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by @PROTEIN2$\/A complex.","label":0}
{"pair_id":"BioInfer.d252.s0.p8","sentence":"Here we show that the N-terminal domain of ActA binds one @PROTEIN2$ monomer, in a profilin-like fashion, and @PROTEIN1$\/A complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2\/A complex.","label":0}
{"pair_id":"BioInfer.d252.s0.p9","sentence":"Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and @PROTEIN1$@PROTEIN2$2\/@PROTEIN2$ complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2\/A complex.","label":1}
{"pair_id":"BioInfer.d252.s0.p10","sentence":"Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and @PROTEIN1$\/A complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by @PROTEIN2$2\/@PROTEIN2$ complex.","label":0}
{"pair_id":"BioInfer.d252.s0.p11","sentence":"Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and @PROTEIN1$\/A complex and mimics the C-terminal domain of @PROTEIN2$ family proteins in catalyzing filament barbed end branching by Arp2\/A complex.","label":0}
{"pair_id":"BioInfer.d252.s0.p12","sentence":"Here we show that the N-terminal domain of @PROTEIN2$ binds one actin monomer, in a profilin-like fashion, and @PROTEIN1$\/A complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2\/A complex.","label":1}
{"pair_id":"BioInfer.d252.s0.p13","sentence":"Here we show that the N-terminal domain of ActA binds one @PROTEIN2$ monomer, in a profilin-like fashion, and Arp2\/A complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by @PROTEIN1$\/A complex.","label":0}
{"pair_id":"BioInfer.d252.s0.p14","sentence":"Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and @PROTEIN2$2\/@PROTEIN2$ complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by @PROTEIN1$\/A complex.","label":0}
{"pair_id":"BioInfer.d252.s0.p15","sentence":"Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and Arp2\/A complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by @PROTEIN1$@PROTEIN2$2\/@PROTEIN2$ complex.","label":1}
{"pair_id":"BioInfer.d252.s0.p16","sentence":"Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and Arp2\/A complex and mimics the C-terminal domain of @PROTEIN2$ family proteins in catalyzing filament barbed end branching by @PROTEIN1$\/A complex.","label":0}
{"pair_id":"BioInfer.d252.s0.p17","sentence":"Here we show that the N-terminal domain of @PROTEIN2$ binds one actin monomer, in a profilin-like fashion, and Arp2\/A complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by @PROTEIN1$\/A complex.","label":0}
{"pair_id":"BioInfer.d252.s0.p18","sentence":"Here we show that the N-terminal domain of ActA binds one @PROTEIN1$ monomer, in a profilin-like fashion, and @PROTEIN2$2\/@PROTEIN2$ complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2\/A complex.","label":0}
{"pair_id":"BioInfer.d252.s0.p19","sentence":"Here we show that the N-terminal domain of ActA binds one @PROTEIN1$ monomer, in a profilin-like fashion, and Arp2\/A complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by @PROTEIN2$2\/@PROTEIN2$ complex.","label":0}
{"pair_id":"BioInfer.d252.s0.p20","sentence":"Here we show that the N-terminal domain of ActA binds one @PROTEIN1$ monomer, in a profilin-like fashion, and Arp2\/A complex and mimics the C-terminal domain of @PROTEIN2$ family proteins in catalyzing filament barbed end branching by Arp2\/A complex.","label":0}
{"pair_id":"BioInfer.d252.s0.p21","sentence":"Here we show that the N-terminal domain of @PROTEIN2$ binds one @PROTEIN1$ monomer, in a profilin-like fashion, and Arp2\/A complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2\/A complex.","label":1}
{"pair_id":"BioInfer.d252.s0.p22","sentence":"Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and @PROTEIN1$2\/@PROTEIN1$ complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by @PROTEIN2$2\/@PROTEIN2$ complex.","label":0}
{"pair_id":"BioInfer.d252.s0.p23","sentence":"Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and @PROTEIN1$2\/@PROTEIN1$ complex and mimics the C-terminal domain of @PROTEIN2$ family proteins in catalyzing filament barbed end branching by Arp2\/A complex.","label":0}
{"pair_id":"BioInfer.d252.s0.p24","sentence":"Here we show that the N-terminal domain of @PROTEIN2$ binds one actin monomer, in a profilin-like fashion, and @PROTEIN1$2\/@PROTEIN1$ complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2\/A complex.","label":1}
{"pair_id":"BioInfer.d252.s0.p25","sentence":"Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and Arp2\/A complex and mimics the C-terminal domain of @PROTEIN2$ family proteins in catalyzing filament barbed end branching by @PROTEIN1$2\/@PROTEIN1$ complex.","label":0}
{"pair_id":"BioInfer.d252.s0.p26","sentence":"Here we show that the N-terminal domain of @PROTEIN2$ binds one actin monomer, in a profilin-like fashion, and Arp2\/A complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by @PROTEIN1$2\/@PROTEIN1$ complex.","label":0}
{"pair_id":"BioInfer.d252.s0.p27","sentence":"Here we show that the N-terminal domain of @PROTEIN2$ binds one actin monomer, in a profilin-like fashion, and Arp2\/A complex and mimics the C-terminal domain of @PROTEIN1$ family proteins in catalyzing filament barbed end branching by Arp2\/A complex.","label":0}
{"pair_id":"AIMed.d190.s1614.p0","sentence":"In these cells the adaptor protein @PROTEIN1$ constitutively binds a substantial fraction of @PROTEIN2$ through the N-terminal SH3 domain.","label":1}
{"pair_id":"AIMed.d199.s1705.p0","sentence":"Tyrosine phophorylation of the 66-kDa protein was dependent on ligand activation of @PROTEIN1$, suggesting that the 66-kDa protein may play an important role in @PROTEIN2$-specific signaling.","label":0}
{"pair_id":"BioInfer.d649.s0.p0","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, @PROTEIN2$, calmodulin, calponin, @PROTEIN1$, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p1","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, @PROTEIN2$, calponin, @PROTEIN1$, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p2","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, @PROTEIN2$, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, @PROTEIN1$, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p3","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, @PROTEIN2$, myosin heavy chain, calmodulin, calponin, @PROTEIN1$, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p4","sentence":"The muscle-related genes included actin, @PROTEIN2$, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, @PROTEIN1$, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p5","sentence":"The muscle-related genes included actin, tropomyosin, @PROTEIN2$, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, @PROTEIN1$, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p6","sentence":"The muscle-related genes included @PROTEIN2$, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, @PROTEIN1$, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p7","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, @PROTEIN1$, creatine kinase, @PROTEIN2$ protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p8","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, @PROTEIN2$, @PROTEIN1$, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p9","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, @PROTEIN1$, creatine kinase, muscle LIM protein, and @PROTEIN2$, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p10","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, @PROTEIN1$, @PROTEIN2$, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p11","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, @PROTEIN1$, @PROTEIN2$, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p12","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, @PROTEIN2$, myosin light chain kinase, @PROTEIN1$, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p13","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, @PROTEIN2$, @PROTEIN1$, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p14","sentence":"The muscle-related genes included actin, @PROTEIN2$, troponin I, myosin regulatory light chain, myosin light chain kinase, @PROTEIN1$, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p15","sentence":"The muscle-related genes included actin, tropomyosin, @PROTEIN2$, myosin regulatory light chain, myosin light chain kinase, @PROTEIN1$, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p16","sentence":"The muscle-related genes included @PROTEIN2$, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, @PROTEIN1$, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p17","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, @PROTEIN1$, calmodulin, calponin, calcium vector protein, creatine kinase, @PROTEIN2$ protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p18","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, @PROTEIN1$, calmodulin, @PROTEIN2$, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p19","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, @PROTEIN1$, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and @PROTEIN2$, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p20","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, @PROTEIN1$, calmodulin, calponin, calcium vector protein, @PROTEIN2$, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p21","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, @PROTEIN2$, myosin light chain kinase, myosin heavy chain, @PROTEIN1$, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p22","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, @PROTEIN2$, myosin heavy chain, @PROTEIN1$, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p23","sentence":"The muscle-related genes included actin, @PROTEIN2$, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, @PROTEIN1$, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p24","sentence":"The muscle-related genes included actin, tropomyosin, @PROTEIN2$, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, @PROTEIN1$, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p25","sentence":"The muscle-related genes included @PROTEIN2$, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, @PROTEIN1$, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p26","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, @PROTEIN1$, calponin, calcium vector protein, creatine kinase, @PROTEIN2$ protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p27","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, @PROTEIN1$, @PROTEIN2$, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p28","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, @PROTEIN1$, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and @PROTEIN2$, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p29","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, @PROTEIN1$, calponin, calcium vector protein, @PROTEIN2$, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p30","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, @PROTEIN1$, @PROTEIN2$, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p31","sentence":"The muscle-related genes included actin, @PROTEIN2$, troponin I, @PROTEIN1$, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p32","sentence":"The muscle-related genes included actin, tropomyosin, @PROTEIN2$, @PROTEIN1$, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p33","sentence":"The muscle-related genes included @PROTEIN2$, tropomyosin, troponin I, @PROTEIN1$, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p34","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, @PROTEIN1$, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, @PROTEIN2$ protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p35","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, @PROTEIN1$, myosin light chain kinase, myosin heavy chain, calmodulin, @PROTEIN2$, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p36","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, @PROTEIN1$, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and @PROTEIN2$, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p37","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, @PROTEIN1$, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, @PROTEIN2$, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p38","sentence":"The muscle-related genes included actin, @PROTEIN2$, troponin I, myosin regulatory light chain, @PROTEIN1$, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p39","sentence":"The muscle-related genes included actin, tropomyosin, @PROTEIN2$, myosin regulatory light chain, @PROTEIN1$, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p40","sentence":"The muscle-related genes included @PROTEIN2$, tropomyosin, troponin I, myosin regulatory light chain, @PROTEIN1$, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p41","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, @PROTEIN1$, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, @PROTEIN2$ protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p42","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, @PROTEIN1$, myosin heavy chain, calmodulin, @PROTEIN2$, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p43","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, @PROTEIN1$, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and @PROTEIN2$, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p44","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, @PROTEIN1$, myosin heavy chain, calmodulin, calponin, calcium vector protein, @PROTEIN2$, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p45","sentence":"The muscle-related genes included actin, @PROTEIN1$, @PROTEIN2$, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p46","sentence":"The muscle-related genes included @PROTEIN2$, @PROTEIN1$, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p47","sentence":"The muscle-related genes included actin, @PROTEIN1$, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, @PROTEIN2$ protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p48","sentence":"The muscle-related genes included actin, @PROTEIN1$, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, @PROTEIN2$, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p49","sentence":"The muscle-related genes included actin, @PROTEIN1$, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and @PROTEIN2$, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p50","sentence":"The muscle-related genes included actin, @PROTEIN1$, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, @PROTEIN2$, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p51","sentence":"The muscle-related genes included @PROTEIN2$, tropomyosin, @PROTEIN1$, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p52","sentence":"The muscle-related genes included actin, tropomyosin, @PROTEIN1$, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, @PROTEIN2$ protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p53","sentence":"The muscle-related genes included actin, tropomyosin, @PROTEIN1$, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, @PROTEIN2$, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p54","sentence":"The muscle-related genes included actin, tropomyosin, @PROTEIN1$, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and @PROTEIN2$, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p55","sentence":"The muscle-related genes included actin, tropomyosin, @PROTEIN1$, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, @PROTEIN2$, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p56","sentence":"The muscle-related genes included @PROTEIN1$, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, @PROTEIN2$ protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p57","sentence":"The muscle-related genes included @PROTEIN1$, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, @PROTEIN2$, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p58","sentence":"The muscle-related genes included @PROTEIN1$, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and @PROTEIN2$, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p59","sentence":"The muscle-related genes included @PROTEIN1$, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, @PROTEIN2$, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p60","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, @PROTEIN2$, calcium vector protein, creatine kinase, @PROTEIN1$ protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p61","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, @PROTEIN1$ protein, and @PROTEIN2$, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p62","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, @PROTEIN2$, @PROTEIN1$ protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p63","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, @PROTEIN1$, calcium vector protein, creatine kinase, muscle LIM protein, and @PROTEIN2$, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p64","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, @PROTEIN1$, calcium vector protein, @PROTEIN2$, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p65","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, @PROTEIN2$, muscle LIM protein, and @PROTEIN1$, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d672.s0.p0","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-@PROTEIN2$-L-5', where N is the nucleocapsid protein gene; 4a and @PROTEIN1$ are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p1","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-@PROTEIN2$-5', where N is the nucleocapsid protein gene; 4a and @PROTEIN1$ are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p2","sentence":"The proposed LNYV genomic map is 3'-N-4a-@PROTEIN2$-M-G-L-5', where N is the nucleocapsid protein gene; 4a and @PROTEIN1$ are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p3","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-@PROTEIN2$-G-L-5', where N is the nucleocapsid protein gene; 4a and @PROTEIN1$ are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p4","sentence":"The proposed LNYV genomic map is 3'-@PROTEIN2$-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and @PROTEIN1$ are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p5","sentence":"The proposed LNYV genomic map is 3'-N-@PROTEIN2$-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and @PROTEIN1$ are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p6","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and @PROTEIN1$ are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; @PROTEIN2$ is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p7","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and @PROTEIN1$ are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and @PROTEIN2$ is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p8","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where @PROTEIN2$ is the nucleocapsid protein gene; 4a and @PROTEIN1$ are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p9","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and @PROTEIN1$ are two genes, one of which codes for the proposed phosphoprotein @PROTEIN2$ and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":1}
{"pair_id":"BioInfer.d672.s0.p10","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and @PROTEIN1$ are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; @PROTEIN2$ is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p11","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and @PROTEIN1$ are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed @PROTEIN2$ gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p12","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and @PROTEIN1$ are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed @PROTEIN2$ gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p13","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the @PROTEIN2$ gene; 4a and @PROTEIN1$ are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p14","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and @PROTEIN1$ are two genes, one of which codes for the proposed @PROTEIN2$ P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p15","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; @PROTEIN2$ and @PROTEIN1$ are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p16","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and @PROTEIN1$ are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed @PROTEIN2$ gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p17","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-@PROTEIN1$-@PROTEIN2$-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p18","sentence":"The proposed LNYV genomic map is 3'-N-4a-@PROTEIN2$-M-@PROTEIN1$-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p19","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-@PROTEIN2$-@PROTEIN1$-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p20","sentence":"The proposed LNYV genomic map is 3'-@PROTEIN2$-4a-4b-M-@PROTEIN1$-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p21","sentence":"The proposed LNYV genomic map is 3'-N-@PROTEIN2$-4b-M-@PROTEIN1$-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p22","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-@PROTEIN1$-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; @PROTEIN2$ is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p23","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-@PROTEIN1$-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and @PROTEIN2$ is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p24","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-@PROTEIN1$-L-5', where @PROTEIN2$ is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p25","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-@PROTEIN1$-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein @PROTEIN2$ and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p26","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-@PROTEIN1$-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; @PROTEIN2$ is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p27","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-@PROTEIN1$-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed @PROTEIN2$ gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p28","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-@PROTEIN1$-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed @PROTEIN2$ gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p29","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-@PROTEIN1$-L-5', where N is the @PROTEIN2$ gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p30","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-@PROTEIN1$-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed @PROTEIN2$ P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p31","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-@PROTEIN1$-L-5', where N is the nucleocapsid protein gene; @PROTEIN2$ and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p32","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-@PROTEIN1$-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed @PROTEIN2$ gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p33","sentence":"The proposed LNYV genomic map is 3'-N-4a-@PROTEIN2$-M-G-@PROTEIN1$-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p34","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-@PROTEIN2$-G-@PROTEIN1$-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p35","sentence":"The proposed LNYV genomic map is 3'-@PROTEIN2$-4a-4b-M-G-@PROTEIN1$-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p36","sentence":"The proposed LNYV genomic map is 3'-N-@PROTEIN2$-4b-M-G-@PROTEIN1$-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p37","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-@PROTEIN1$-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; @PROTEIN2$ is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p38","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-@PROTEIN1$-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and @PROTEIN2$ is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p39","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-@PROTEIN1$-5', where @PROTEIN2$ is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p40","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-@PROTEIN1$-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein @PROTEIN2$ and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p41","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-@PROTEIN1$-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; @PROTEIN2$ is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p42","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-@PROTEIN1$-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed @PROTEIN2$ gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p43","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-@PROTEIN1$-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed @PROTEIN2$ gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p44","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-@PROTEIN1$-5', where N is the @PROTEIN2$ gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p45","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-@PROTEIN1$-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed @PROTEIN2$ P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p46","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-@PROTEIN1$-5', where N is the nucleocapsid protein gene; @PROTEIN2$ and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p47","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-@PROTEIN1$-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed @PROTEIN2$ gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p48","sentence":"The proposed LNYV genomic map is 3'-N-4a-@PROTEIN1$-@PROTEIN2$-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p49","sentence":"The proposed LNYV genomic map is 3'-@PROTEIN2$-4a-@PROTEIN1$-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p50","sentence":"The proposed LNYV genomic map is 3'-N-@PROTEIN2$-@PROTEIN1$-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p51","sentence":"The proposed LNYV genomic map is 3'-N-4a-@PROTEIN1$-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; @PROTEIN2$ is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p52","sentence":"The proposed LNYV genomic map is 3'-N-4a-@PROTEIN1$-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and @PROTEIN2$ is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p53","sentence":"The proposed LNYV genomic map is 3'-N-4a-@PROTEIN1$-M-G-L-5', where @PROTEIN2$ is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p54","sentence":"The proposed LNYV genomic map is 3'-N-4a-@PROTEIN1$-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein @PROTEIN2$ and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p55","sentence":"The proposed LNYV genomic map is 3'-N-4a-@PROTEIN1$-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; @PROTEIN2$ is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p56","sentence":"The proposed LNYV genomic map is 3'-N-4a-@PROTEIN1$-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed @PROTEIN2$ gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p57","sentence":"The proposed LNYV genomic map is 3'-N-4a-@PROTEIN1$-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed @PROTEIN2$ gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p58","sentence":"The proposed LNYV genomic map is 3'-N-4a-@PROTEIN1$-M-G-L-5', where N is the @PROTEIN2$ gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p59","sentence":"The proposed LNYV genomic map is 3'-N-4a-@PROTEIN1$-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed @PROTEIN2$ P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p60","sentence":"The proposed LNYV genomic map is 3'-N-4a-@PROTEIN1$-M-G-L-5', where N is the nucleocapsid protein gene; @PROTEIN2$ and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p61","sentence":"The proposed LNYV genomic map is 3'-N-4a-@PROTEIN1$-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed @PROTEIN2$ gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p62","sentence":"The proposed LNYV genomic map is 3'-@PROTEIN2$-4a-4b-@PROTEIN1$-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p63","sentence":"The proposed LNYV genomic map is 3'-N-@PROTEIN2$-4b-@PROTEIN1$-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p64","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-@PROTEIN1$-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; @PROTEIN2$ is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p65","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-@PROTEIN1$-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and @PROTEIN2$ is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p66","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-@PROTEIN1$-G-L-5', where @PROTEIN2$ is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p67","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-@PROTEIN1$-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein @PROTEIN2$ and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p68","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-@PROTEIN1$-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; @PROTEIN2$ is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p69","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-@PROTEIN1$-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed @PROTEIN2$ gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p70","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-@PROTEIN1$-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed @PROTEIN2$ gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p71","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-@PROTEIN1$-G-L-5', where N is the @PROTEIN2$ gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p72","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-@PROTEIN1$-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed @PROTEIN2$ P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p73","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-@PROTEIN1$-G-L-5', where N is the nucleocapsid protein gene; @PROTEIN2$ and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p74","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-@PROTEIN1$-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed @PROTEIN2$ gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p75","sentence":"The proposed LNYV genomic map is 3'-@PROTEIN1$-@PROTEIN2$-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p76","sentence":"The proposed LNYV genomic map is 3'-@PROTEIN1$-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; @PROTEIN2$ is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p77","sentence":"The proposed LNYV genomic map is 3'-@PROTEIN1$-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and @PROTEIN2$ is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p78","sentence":"The proposed LNYV genomic map is 3'-@PROTEIN1$-4a-4b-M-G-L-5', where @PROTEIN2$ is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p79","sentence":"The proposed LNYV genomic map is 3'-@PROTEIN1$-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein @PROTEIN2$ and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p80","sentence":"The proposed LNYV genomic map is 3'-@PROTEIN1$-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; @PROTEIN2$ is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p81","sentence":"The proposed LNYV genomic map is 3'-@PROTEIN1$-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed @PROTEIN2$ gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p82","sentence":"The proposed LNYV genomic map is 3'-@PROTEIN1$-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed @PROTEIN2$ gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p83","sentence":"The proposed LNYV genomic map is 3'-@PROTEIN1$-4a-4b-M-G-L-5', where N is the @PROTEIN2$ gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p84","sentence":"The proposed LNYV genomic map is 3'-@PROTEIN1$-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed @PROTEIN2$ P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p85","sentence":"The proposed LNYV genomic map is 3'-@PROTEIN1$-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; @PROTEIN2$ and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p86","sentence":"The proposed LNYV genomic map is 3'-@PROTEIN1$-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed @PROTEIN2$ gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p87","sentence":"The proposed LNYV genomic map is 3'-N-@PROTEIN1$-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; @PROTEIN2$ is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p88","sentence":"The proposed LNYV genomic map is 3'-N-@PROTEIN1$-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and @PROTEIN2$ is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p89","sentence":"The proposed LNYV genomic map is 3'-N-@PROTEIN1$-4b-M-G-L-5', where @PROTEIN2$ is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p90","sentence":"The proposed LNYV genomic map is 3'-N-@PROTEIN1$-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein @PROTEIN2$ and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p91","sentence":"The proposed LNYV genomic map is 3'-N-@PROTEIN1$-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; @PROTEIN2$ is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p92","sentence":"The proposed LNYV genomic map is 3'-N-@PROTEIN1$-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed @PROTEIN2$ gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p93","sentence":"The proposed LNYV genomic map is 3'-N-@PROTEIN1$-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed @PROTEIN2$ gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p94","sentence":"The proposed LNYV genomic map is 3'-N-@PROTEIN1$-4b-M-G-L-5', where N is the @PROTEIN2$ gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p95","sentence":"The proposed LNYV genomic map is 3'-N-@PROTEIN1$-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed @PROTEIN2$ P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p96","sentence":"The proposed LNYV genomic map is 3'-N-@PROTEIN1$-4b-M-G-L-5', where N is the nucleocapsid protein gene; @PROTEIN2$ and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p97","sentence":"The proposed LNYV genomic map is 3'-N-@PROTEIN1$-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed @PROTEIN2$ gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p98","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; @PROTEIN1$ is the proposed glycoprotein gene; and @PROTEIN2$ is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p99","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where @PROTEIN2$ is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; @PROTEIN1$ is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p100","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein @PROTEIN2$ and the other for a putative protein of unknown function; M is the proposed matrix protein gene; @PROTEIN1$ is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p101","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; @PROTEIN2$ is the proposed matrix protein gene; @PROTEIN1$ is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p102","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; @PROTEIN1$ is the proposed glycoprotein gene; and L is the proposed @PROTEIN2$ gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p103","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; @PROTEIN1$ is the proposed @PROTEIN2$ gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p104","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the @PROTEIN2$ gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; @PROTEIN1$ is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p105","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed @PROTEIN2$ P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; @PROTEIN1$ is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p106","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; @PROTEIN2$ and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; @PROTEIN1$ is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p107","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed @PROTEIN2$ gene; @PROTEIN1$ is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p108","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where @PROTEIN2$ is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and @PROTEIN1$ is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p109","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein @PROTEIN2$ and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and @PROTEIN1$ is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p110","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; @PROTEIN2$ is the proposed matrix protein gene; G is the proposed glycoprotein gene; and @PROTEIN1$ is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p111","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and @PROTEIN1$ is the proposed @PROTEIN2$ gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p112","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed @PROTEIN2$ gene; and @PROTEIN1$ is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p113","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the @PROTEIN2$ gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and @PROTEIN1$ is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p114","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed @PROTEIN2$ P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and @PROTEIN1$ is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p115","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; @PROTEIN2$ and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and @PROTEIN1$ is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p116","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed @PROTEIN2$ gene; G is the proposed glycoprotein gene; and @PROTEIN1$ is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p117","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where @PROTEIN1$ is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein @PROTEIN2$ and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p118","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where @PROTEIN1$ is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; @PROTEIN2$ is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p119","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where @PROTEIN1$ is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed @PROTEIN2$ gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p120","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where @PROTEIN1$ is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed @PROTEIN2$ gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p121","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where @PROTEIN1$ is the @PROTEIN2$ gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p122","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where @PROTEIN1$ is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed @PROTEIN2$ P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p123","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where @PROTEIN1$ is the nucleocapsid protein gene; @PROTEIN2$ and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p124","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where @PROTEIN1$ is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed @PROTEIN2$ gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p125","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein @PROTEIN1$ and the other for a putative protein of unknown function; @PROTEIN2$ is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p126","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein @PROTEIN1$ and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed @PROTEIN2$ gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p127","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein @PROTEIN1$ and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed @PROTEIN2$ gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p128","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the @PROTEIN2$ gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein @PROTEIN1$ and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p129","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed @PROTEIN2$ @PROTEIN1$ and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":1}
{"pair_id":"BioInfer.d672.s0.p130","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; @PROTEIN2$ and 4b are two genes, one of which codes for the proposed phosphoprotein @PROTEIN1$ and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":1}
{"pair_id":"BioInfer.d672.s0.p131","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein @PROTEIN1$ and the other for a putative protein of unknown function; M is the proposed @PROTEIN2$ gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p132","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; @PROTEIN1$ is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed @PROTEIN2$ gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p133","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; @PROTEIN1$ is the proposed matrix protein gene; G is the proposed @PROTEIN2$ gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p134","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the @PROTEIN2$ gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; @PROTEIN1$ is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p135","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed @PROTEIN2$ P and the other for a putative protein of unknown function; @PROTEIN1$ is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p136","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; @PROTEIN2$ and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; @PROTEIN1$ is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p137","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; @PROTEIN1$ is the proposed @PROTEIN2$ gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p138","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed @PROTEIN2$ gene; and L is the proposed @PROTEIN1$ gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p139","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the @PROTEIN2$ gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed @PROTEIN1$ gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p140","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed @PROTEIN2$ P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed @PROTEIN1$ gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p141","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; @PROTEIN2$ and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed @PROTEIN1$ gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p142","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed @PROTEIN2$ gene; G is the proposed glycoprotein gene; and L is the proposed @PROTEIN1$ gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p143","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the @PROTEIN2$ gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed @PROTEIN1$ gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p144","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed @PROTEIN2$ P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed @PROTEIN1$ gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p145","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; @PROTEIN2$ and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed @PROTEIN1$ gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p146","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed @PROTEIN2$ gene; G is the proposed @PROTEIN1$ gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p147","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the @PROTEIN1$ gene; 4a and 4b are two genes, one of which codes for the proposed @PROTEIN2$ P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p148","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the @PROTEIN1$ gene; @PROTEIN2$ and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p149","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the @PROTEIN1$ gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed @PROTEIN2$ gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p150","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; @PROTEIN2$ and 4b are two genes, one of which codes for the proposed @PROTEIN1$ P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p151","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed @PROTEIN1$ P and the other for a putative protein of unknown function; M is the proposed @PROTEIN2$ gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p152","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; @PROTEIN1$ and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed @PROTEIN2$ gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"AIMed.d197.s1682.p0","sentence":"We studied the capacity of these mutants to form an @PROTEIN1$\/@PROTEIN2$ complex and their ability to transduce the signal.","label":1}
{"pair_id":"AIMed.d146.s1242.p0","sentence":"These data demonstrate that the @PROTEIN1$ @PROTEIN2$ is the T-cell homologue of the cloned IL-7R, and imply that the p90 and p76 IL-7R have different extracellular domains.","label":0}
{"pair_id":"AIMed.d146.s1242.p1","sentence":"These data demonstrate that the @PROTEIN1$ IL-7R is the T-cell homologue of the cloned @PROTEIN2$, and imply that the p90 and p76 IL-7R have different extracellular domains.","label":0}
{"pair_id":"AIMed.d146.s1242.p2","sentence":"These data demonstrate that the @PROTEIN1$ IL-7R is the T-cell homologue of the cloned IL-7R, and imply that the @PROTEIN2$ and p76 IL-7R have different extracellular domains.","label":0}
{"pair_id":"AIMed.d146.s1242.p3","sentence":"These data demonstrate that the @PROTEIN1$ IL-7R is the T-cell homologue of the cloned IL-7R, and imply that the p90 and @PROTEIN2$ IL-7R have different extracellular domains.","label":0}
{"pair_id":"AIMed.d146.s1242.p4","sentence":"These data demonstrate that the @PROTEIN1$ IL-7R is the T-cell homologue of the cloned IL-7R, and imply that the p90 and p76 @PROTEIN2$ have different extracellular domains.","label":0}
{"pair_id":"AIMed.d146.s1242.p5","sentence":"These data demonstrate that the p90 @PROTEIN1$ is the T-cell homologue of the cloned @PROTEIN2$, and imply that the p90 and p76 IL-7R have different extracellular domains.","label":0}
{"pair_id":"AIMed.d146.s1242.p6","sentence":"These data demonstrate that the p90 @PROTEIN1$ is the T-cell homologue of the cloned IL-7R, and imply that the @PROTEIN2$ and p76 IL-7R have different extracellular domains.","label":0}
{"pair_id":"AIMed.d146.s1242.p7","sentence":"These data demonstrate that the p90 @PROTEIN1$ is the T-cell homologue of the cloned IL-7R, and imply that the p90 and @PROTEIN2$ IL-7R have different extracellular domains.","label":0}
{"pair_id":"AIMed.d146.s1242.p8","sentence":"These data demonstrate that the p90 @PROTEIN1$ is the T-cell homologue of the cloned IL-7R, and imply that the p90 and p76 @PROTEIN2$ have different extracellular domains.","label":0}
{"pair_id":"AIMed.d146.s1242.p9","sentence":"These data demonstrate that the p90 IL-7R is the T-cell homologue of the cloned @PROTEIN1$, and imply that the @PROTEIN2$ and p76 IL-7R have different extracellular domains.","label":0}
{"pair_id":"AIMed.d146.s1242.p10","sentence":"These data demonstrate that the p90 IL-7R is the T-cell homologue of the cloned @PROTEIN1$, and imply that the p90 and @PROTEIN2$ IL-7R have different extracellular domains.","label":0}
{"pair_id":"AIMed.d146.s1242.p11","sentence":"These data demonstrate that the p90 IL-7R is the T-cell homologue of the cloned @PROTEIN1$, and imply that the p90 and p76 @PROTEIN2$ have different extracellular domains.","label":0}
{"pair_id":"AIMed.d146.s1242.p12","sentence":"These data demonstrate that the p90 IL-7R is the T-cell homologue of the cloned IL-7R, and imply that the @PROTEIN1$ and @PROTEIN2$ IL-7R have different extracellular domains.","label":0}
{"pair_id":"AIMed.d146.s1242.p13","sentence":"These data demonstrate that the p90 IL-7R is the T-cell homologue of the cloned IL-7R, and imply that the @PROTEIN1$ and p76 @PROTEIN2$ have different extracellular domains.","label":0}
{"pair_id":"AIMed.d146.s1242.p14","sentence":"These data demonstrate that the p90 IL-7R is the T-cell homologue of the cloned IL-7R, and imply that the p90 and @PROTEIN1$ @PROTEIN2$ have different extracellular domains.","label":0}
{"pair_id":"BioInfer.d296.s2.p0","sentence":"In normal livers, E-cad, alpha-catenin and @PROTEIN1$, but not @PROTEIN2$, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.","label":1}
{"pair_id":"BioInfer.d296.s2.p1","sentence":"In normal livers, E-cad, alpha-catenin and @PROTEIN1$, but not CD44s, CD44v5, CD44v6, CD44v7-8, and @PROTEIN2$, were expressed at the cell membrane of normal intrahepatic bile ducts.","label":1}
{"pair_id":"BioInfer.d296.s2.p2","sentence":"In normal livers, E-cad, alpha-catenin and @PROTEIN1$, but not CD44s, CD44v5, @PROTEIN2$, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.","label":1}
{"pair_id":"BioInfer.d296.s2.p3","sentence":"In normal livers, @PROTEIN2$, alpha-catenin and @PROTEIN1$, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.","label":1}
{"pair_id":"BioInfer.d296.s2.p4","sentence":"In normal livers, E-cad, alpha-catenin and @PROTEIN1$, but not CD44s, @PROTEIN2$, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.","label":1}
{"pair_id":"BioInfer.d296.s2.p5","sentence":"In normal livers, E-cad, @PROTEIN2$ and @PROTEIN1$, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.","label":1}
{"pair_id":"BioInfer.d296.s2.p6","sentence":"In normal livers, E-cad, alpha-catenin and @PROTEIN1$, but not CD44s, CD44v5, CD44v6, @PROTEIN2$, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.","label":1}
{"pair_id":"BioInfer.d296.s2.p7","sentence":"In normal livers, E-cad, alpha-catenin and beta-catenin, but not @PROTEIN1$, CD44v5, CD44v6, CD44v7-8, and @PROTEIN2$, were expressed at the cell membrane of normal intrahepatic bile ducts.","label":0}
{"pair_id":"BioInfer.d296.s2.p8","sentence":"In normal livers, E-cad, alpha-catenin and beta-catenin, but not @PROTEIN1$, CD44v5, @PROTEIN2$, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.","label":0}
{"pair_id":"BioInfer.d296.s2.p9","sentence":"In normal livers, @PROTEIN2$, alpha-catenin and beta-catenin, but not @PROTEIN1$, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.","label":1}
{"pair_id":"BioInfer.d296.s2.p10","sentence":"In normal livers, E-cad, alpha-catenin and beta-catenin, but not @PROTEIN1$, @PROTEIN2$, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.","label":0}
{"pair_id":"BioInfer.d296.s2.p11","sentence":"In normal livers, E-cad, @PROTEIN2$ and beta-catenin, but not @PROTEIN1$, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.","label":1}
{"pair_id":"BioInfer.d296.s2.p12","sentence":"In normal livers, E-cad, alpha-catenin and beta-catenin, but not @PROTEIN1$, CD44v5, CD44v6, @PROTEIN2$, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.","label":0}
{"pair_id":"BioInfer.d296.s2.p13","sentence":"In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, @PROTEIN2$, CD44v7-8, and @PROTEIN1$, were expressed at the cell membrane of normal intrahepatic bile ducts.","label":0}
{"pair_id":"BioInfer.d296.s2.p14","sentence":"In normal livers, @PROTEIN2$, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and @PROTEIN1$, were expressed at the cell membrane of normal intrahepatic bile ducts.","label":1}
{"pair_id":"BioInfer.d296.s2.p15","sentence":"In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, @PROTEIN2$, CD44v6, CD44v7-8, and @PROTEIN1$, were expressed at the cell membrane of normal intrahepatic bile ducts.","label":0}
{"pair_id":"BioInfer.d296.s2.p16","sentence":"In normal livers, E-cad, @PROTEIN2$ and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and @PROTEIN1$, were expressed at the cell membrane of normal intrahepatic bile ducts.","label":1}
{"pair_id":"BioInfer.d296.s2.p17","sentence":"In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, @PROTEIN2$, and @PROTEIN1$, were expressed at the cell membrane of normal intrahepatic bile ducts.","label":0}
{"pair_id":"BioInfer.d296.s2.p18","sentence":"In normal livers, @PROTEIN2$, alpha-catenin and beta-catenin, but not CD44s, CD44v5, @PROTEIN1$, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.","label":1}
{"pair_id":"BioInfer.d296.s2.p19","sentence":"In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, @PROTEIN2$, @PROTEIN1$, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.","label":0}
{"pair_id":"BioInfer.d296.s2.p20","sentence":"In normal livers, E-cad, @PROTEIN2$ and beta-catenin, but not CD44s, CD44v5, @PROTEIN1$, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.","label":1}
{"pair_id":"BioInfer.d296.s2.p21","sentence":"In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, @PROTEIN1$, @PROTEIN2$, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.","label":0}
{"pair_id":"BioInfer.d296.s2.p22","sentence":"In normal livers, @PROTEIN1$, alpha-catenin and beta-catenin, but not CD44s, @PROTEIN2$, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.","label":1}
{"pair_id":"BioInfer.d296.s2.p23","sentence":"In normal livers, @PROTEIN1$, @PROTEIN2$ and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.","label":1}
{"pair_id":"BioInfer.d296.s2.p24","sentence":"In normal livers, @PROTEIN1$, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, @PROTEIN2$, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.","label":1}
{"pair_id":"BioInfer.d296.s2.p25","sentence":"In normal livers, E-cad, @PROTEIN2$ and beta-catenin, but not CD44s, @PROTEIN1$, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.","label":1}
{"pair_id":"BioInfer.d296.s2.p26","sentence":"In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, @PROTEIN1$, CD44v6, @PROTEIN2$, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.","label":0}
{"pair_id":"BioInfer.d296.s2.p27","sentence":"In normal livers, E-cad, @PROTEIN1$ and beta-catenin, but not CD44s, CD44v5, CD44v6, @PROTEIN2$, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.","label":1}
{"pair_id":"AIMed.d29.s244.p0","sentence":"This work shows that single and double Ala substitutions of His18 and Phe21 in @PROTEIN1$ reduced up to 77-fold the binding affinity to @PROTEIN2$ receptor subtypes A (CXCR1) and B (CXCR2) and to the Duffy antigen.","label":0}
{"pair_id":"AIMed.d29.s244.p1","sentence":"This work shows that single and double Ala substitutions of His18 and Phe21 in @PROTEIN1$ reduced up to 77-fold the binding affinity to @PROTEIN2$ (CXCR1) and B (CXCR2) and to the Duffy antigen.","label":0}
{"pair_id":"AIMed.d29.s244.p2","sentence":"This work shows that single and double Ala substitutions of His18 and Phe21 in @PROTEIN1$ reduced up to 77-fold the binding affinity to IL-8 receptor subtypes A (@PROTEIN2$) and B (CXCR2) and to the Duffy antigen.","label":0}
{"pair_id":"AIMed.d29.s244.p3","sentence":"This work shows that single and double Ala substitutions of His18 and Phe21 in @PROTEIN1$ reduced up to 77-fold the binding affinity to IL-8 receptor subtypes A (CXCR1) and B (@PROTEIN2$) and to the Duffy antigen.","label":0}
{"pair_id":"AIMed.d29.s244.p4","sentence":"This work shows that single and double Ala substitutions of His18 and Phe21 in @PROTEIN1$ reduced up to 77-fold the binding affinity to IL-8 receptor subtypes A (CXCR1) and B (CXCR2) and to the @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d29.s244.p5","sentence":"This work shows that single and double Ala substitutions of His18 and Phe21 in IL-8 reduced up to 77-fold the binding affinity to @PROTEIN1$@PROTEIN2$ (CXCR1) and B (CXCR2) and to the Duffy antigen.","label":0}
{"pair_id":"AIMed.d29.s244.p6","sentence":"This work shows that single and double Ala substitutions of His18 and Phe21 in IL-8 reduced up to 77-fold the binding affinity to @PROTEIN1$ receptor subtypes A (@PROTEIN2$) and B (CXCR2) and to the Duffy antigen.","label":1}
{"pair_id":"AIMed.d29.s244.p7","sentence":"This work shows that single and double Ala substitutions of His18 and Phe21 in IL-8 reduced up to 77-fold the binding affinity to @PROTEIN1$ receptor subtypes A (CXCR1) and B (@PROTEIN2$) and to the Duffy antigen.","label":1}
{"pair_id":"AIMed.d29.s244.p8","sentence":"This work shows that single and double Ala substitutions of His18 and Phe21 in IL-8 reduced up to 77-fold the binding affinity to @PROTEIN1$ receptor subtypes A (CXCR1) and B (CXCR2) and to the @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d29.s244.p9","sentence":"This work shows that single and double Ala substitutions of His18 and Phe21 in IL-8 reduced up to 77-fold the binding affinity to @PROTEIN1$ (@PROTEIN2$) and B (CXCR2) and to the Duffy antigen.","label":0}
{"pair_id":"AIMed.d29.s244.p10","sentence":"This work shows that single and double Ala substitutions of His18 and Phe21 in IL-8 reduced up to 77-fold the binding affinity to @PROTEIN1$ (CXCR1) and B (@PROTEIN2$) and to the Duffy antigen.","label":0}
{"pair_id":"AIMed.d29.s244.p11","sentence":"This work shows that single and double Ala substitutions of His18 and Phe21 in IL-8 reduced up to 77-fold the binding affinity to @PROTEIN1$ (CXCR1) and B (CXCR2) and to the @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d29.s244.p12","sentence":"This work shows that single and double Ala substitutions of His18 and Phe21 in IL-8 reduced up to 77-fold the binding affinity to IL-8 receptor subtypes A (@PROTEIN1$) and B (@PROTEIN2$) and to the Duffy antigen.","label":0}
{"pair_id":"AIMed.d29.s244.p13","sentence":"This work shows that single and double Ala substitutions of His18 and Phe21 in IL-8 reduced up to 77-fold the binding affinity to IL-8 receptor subtypes A (@PROTEIN1$) and B (CXCR2) and to the @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d29.s244.p14","sentence":"This work shows that single and double Ala substitutions of His18 and Phe21 in IL-8 reduced up to 77-fold the binding affinity to IL-8 receptor subtypes A (CXCR1) and B (@PROTEIN1$) and to the @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d50.s445.p0","sentence":"Interestingly, the @PROTEIN1$ binding site overlaps the largest continuous hydrophobic patch on @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d39.s338.p0","sentence":"The binding of @PROTEIN1$\/@PROTEIN2$ to full-length PS1 was confirmed in vitro by pull-down assay, and in vivo by immunoprecipitation assays with human samples, including AD brains.","label":0}
{"pair_id":"AIMed.d39.s338.p1","sentence":"The binding of @PROTEIN1$\/Jif-1 to full-length @PROTEIN2$ was confirmed in vitro by pull-down assay, and in vivo by immunoprecipitation assays with human samples, including AD brains.","label":1}
{"pair_id":"AIMed.d39.s338.p2","sentence":"The binding of QM\/@PROTEIN1$ to full-length @PROTEIN2$ was confirmed in vitro by pull-down assay, and in vivo by immunoprecipitation assays with human samples, including AD brains.","label":1}
{"pair_id":"BioInfer.d610.s0.p0","sentence":"The enzyme showed hardly any activity below 50 degrees C but considerable activity at around 60 degrees C against myofibrils, digesting myosin heavy chain, @PROTEIN1$ and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d610.s0.p1","sentence":"The enzyme showed hardly any activity below 50 degrees C but considerable activity at around 60 degrees C against myofibrils, digesting @PROTEIN2$, @PROTEIN1$ and tropomyosin.","label":0}
{"pair_id":"BioInfer.d610.s0.p2","sentence":"The enzyme showed hardly any activity below 50 degrees C but considerable activity at around 60 degrees C against myofibrils, digesting @PROTEIN2$, actin and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d213.s1.p0","sentence":"Three-dimensional fluorescence microscopy of the fluorescent analog of @PROTEIN1$ with a high affinity for @PROTEIN2$ revealed that it incorporated into cortical cytoplasmic fibers and was also distributed diffusely in the non-cortical cytoplasm consistent with a bias of actin assembly near the surface of the cell.","label":1}
{"pair_id":"BioInfer.d213.s1.p1","sentence":"Three-dimensional fluorescence microscopy of the fluorescent analog of @PROTEIN1$ with a high affinity for profilin revealed that it incorporated into cortical cytoplasmic fibers and was also distributed diffusely in the non-cortical cytoplasm consistent with a bias of @PROTEIN2$ assembly near the surface of the cell.","label":0}
{"pair_id":"BioInfer.d213.s1.p2","sentence":"Three-dimensional fluorescence microscopy of the fluorescent analog of actin with a high affinity for @PROTEIN1$ revealed that it incorporated into cortical cytoplasmic fibers and was also distributed diffusely in the non-cortical cytoplasm consistent with a bias of @PROTEIN2$ assembly near the surface of the cell.","label":0}
{"pair_id":"BioInfer.d654.s0.p0","sentence":"The observed in vivo expression patterns of @PROTEIN2$, @PROTEIN1$, and plakoglobin suggest that these proteins are directly linked with the developmental regulation of cell junctions, as cardiac cells become stably committed and phenotypically differentiated to eventually form a mature myocardium.","label":0}
{"pair_id":"BioInfer.d654.s0.p1","sentence":"The observed in vivo expression patterns of alpha-catenin, @PROTEIN1$, and @PROTEIN2$ suggest that these proteins are directly linked with the developmental regulation of cell junctions, as cardiac cells become stably committed and phenotypically differentiated to eventually form a mature myocardium.","label":0}
{"pair_id":"BioInfer.d654.s0.p2","sentence":"The observed in vivo expression patterns of @PROTEIN1$, beta-catenin, and @PROTEIN2$ suggest that these proteins are directly linked with the developmental regulation of cell junctions, as cardiac cells become stably committed and phenotypically differentiated to eventually form a mature myocardium.","label":0}
{"pair_id":"AIMed.d26.s215.p0","sentence":"@PROTEIN1$ has been identified as an effector molecule co-localized with @PROTEIN2$ in the cytotoxic granules of cytotoxic T lymphocytes and natural killer (NK) cells, and has been reported to kill intracellular pathogens in infected cells in the presence of perforin and to induce a cytotoxic effect against tumor cells.","label":0}
{"pair_id":"AIMed.d26.s215.p1","sentence":"@PROTEIN1$ has been identified as an effector molecule co-localized with perforin in the cytotoxic granules of cytotoxic T lymphocytes and natural killer (NK) cells, and has been reported to kill intracellular pathogens in infected cells in the presence of @PROTEIN2$ and to induce a cytotoxic effect against tumor cells.","label":0}
{"pair_id":"AIMed.d26.s215.p2","sentence":"Granulysin has been identified as an effector molecule co-localized with @PROTEIN1$ in the cytotoxic granules of cytotoxic T lymphocytes and natural killer (NK) cells, and has been reported to kill intracellular pathogens in infected cells in the presence of @PROTEIN2$ and to induce a cytotoxic effect against tumor cells.","label":0}
{"pair_id":"AIMed.d187.s1594.p0","sentence":"We propose that @PROTEIN1$ binding proteins play a key role in the modulation of @PROTEIN2$ aggregation and normally prevent amyloid formation in biological fluids and in the brain.","label":0}
{"pair_id":"AIMed.d132.s1130.p0","sentence":"Studies with monoclonal antibodies specific for the @PROTEIN1$ receptor gamma chain showed that the gamma chain participates in the functional high-affinity receptor complexes for @PROTEIN2$ that are involved in the differentiation of T and B cells.","label":0}
{"pair_id":"BioInfer.d686.s0.p0","sentence":"The results clearly showed that the mutated @PROTEIN2$ possessing KTLKK instead of KKRKK did not translocate into the nuclei in response to heat shock whereas a recombinant @PROTEIN1$ with the unaltered sequence of KKRKK responded to heat shock and formed intranuclear rods together with actin.","label":0}
{"pair_id":"BioInfer.d686.s0.p1","sentence":"The results clearly showed that the mutated cofilin possessing KTLKK instead of KKRKK did not translocate into the nuclei in response to heat shock whereas a recombinant @PROTEIN1$ with the unaltered sequence of KKRKK responded to heat shock and formed intranuclear rods together with @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d686.s0.p2","sentence":"The results clearly showed that the mutated @PROTEIN1$ possessing KTLKK instead of KKRKK did not translocate into the nuclei in response to heat shock whereas a recombinant cofilin with the unaltered sequence of KKRKK responded to heat shock and formed intranuclear rods together with @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d316.s0.p0","sentence":"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, @PROTEIN1$ and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d316.s0.p1","sentence":"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, @PROTEIN2$, Myf-5, @PROTEIN1$ and myogenin.","label":0}
{"pair_id":"BioInfer.d316.s0.p2","sentence":"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, @PROTEIN2$, @PROTEIN1$ and myogenin.","label":0}
{"pair_id":"BioInfer.d316.s0.p3","sentence":"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, @PROTEIN2$, myosin heavy chain, sarcomeric actin, Myf-5, @PROTEIN1$ and myogenin.","label":0}
{"pair_id":"BioInfer.d316.s0.p4","sentence":"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, @PROTEIN2$, sarcomeric actin, Myf-5, @PROTEIN1$ and myogenin.","label":0}
{"pair_id":"BioInfer.d316.s0.p5","sentence":"In addition, we performed immunohistochemistry on sectioned Myf-5 and @PROTEIN2$ mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, @PROTEIN1$ and myogenin.","label":0}
{"pair_id":"BioInfer.d316.s0.p6","sentence":"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with @PROTEIN2$, nestin, myosin heavy chain, sarcomeric actin, Myf-5, @PROTEIN1$ and myogenin.","label":0}
{"pair_id":"BioInfer.d316.s0.p7","sentence":"In addition, we performed immunohistochemistry on sectioned @PROTEIN2$ and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, @PROTEIN1$ and myogenin.","label":0}
{"pair_id":"BioInfer.d316.s0.p8","sentence":"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, @PROTEIN2$, Myf-5, MyoD and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d316.s0.p9","sentence":"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, @PROTEIN2$, MyoD and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d316.s0.p10","sentence":"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, @PROTEIN2$, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d316.s0.p11","sentence":"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, @PROTEIN2$, sarcomeric actin, Myf-5, MyoD and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d316.s0.p12","sentence":"In addition, we performed immunohistochemistry on sectioned Myf-5 and @PROTEIN2$ mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d316.s0.p13","sentence":"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with @PROTEIN2$, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d316.s0.p14","sentence":"In addition, we performed immunohistochemistry on sectioned @PROTEIN2$ and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d316.s0.p15","sentence":"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, @PROTEIN1$, @PROTEIN2$, MyoD and myogenin.","label":0}
{"pair_id":"BioInfer.d316.s0.p16","sentence":"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, @PROTEIN2$, myosin heavy chain, @PROTEIN1$, Myf-5, MyoD and myogenin.","label":0}
{"pair_id":"BioInfer.d316.s0.p17","sentence":"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, @PROTEIN2$, @PROTEIN1$, Myf-5, MyoD and myogenin.","label":0}
{"pair_id":"BioInfer.d316.s0.p18","sentence":"In addition, we performed immunohistochemistry on sectioned Myf-5 and @PROTEIN2$ mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, @PROTEIN1$, Myf-5, MyoD and myogenin.","label":0}
{"pair_id":"BioInfer.d316.s0.p19","sentence":"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with @PROTEIN2$, nestin, myosin heavy chain, @PROTEIN1$, Myf-5, MyoD and myogenin.","label":0}
{"pair_id":"BioInfer.d316.s0.p20","sentence":"In addition, we performed immunohistochemistry on sectioned @PROTEIN2$ and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, @PROTEIN1$, Myf-5, MyoD and myogenin.","label":0}
{"pair_id":"BioInfer.d316.s0.p21","sentence":"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, @PROTEIN2$, myosin heavy chain, sarcomeric actin, @PROTEIN1$, MyoD and myogenin.","label":0}
{"pair_id":"BioInfer.d316.s0.p22","sentence":"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, @PROTEIN2$, sarcomeric actin, @PROTEIN1$, MyoD and myogenin.","label":0}
{"pair_id":"BioInfer.d316.s0.p23","sentence":"In addition, we performed immunohistochemistry on sectioned Myf-5 and @PROTEIN2$ mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, @PROTEIN1$, MyoD and myogenin.","label":0}
{"pair_id":"BioInfer.d316.s0.p24","sentence":"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with @PROTEIN2$, nestin, myosin heavy chain, sarcomeric actin, @PROTEIN1$, MyoD and myogenin.","label":0}
{"pair_id":"BioInfer.d316.s0.p25","sentence":"In addition, we performed immunohistochemistry on sectioned @PROTEIN2$ and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, @PROTEIN1$, MyoD and myogenin.","label":0}
{"pair_id":"BioInfer.d316.s0.p26","sentence":"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, @PROTEIN1$, @PROTEIN2$, sarcomeric actin, Myf-5, MyoD and myogenin.","label":0}
{"pair_id":"BioInfer.d316.s0.p27","sentence":"In addition, we performed immunohistochemistry on sectioned Myf-5 and @PROTEIN2$ mutant embryos with antibodies reactive with desmin, @PROTEIN1$, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.","label":0}
{"pair_id":"BioInfer.d316.s0.p28","sentence":"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with @PROTEIN2$, @PROTEIN1$, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.","label":0}
{"pair_id":"BioInfer.d316.s0.p29","sentence":"In addition, we performed immunohistochemistry on sectioned @PROTEIN2$ and MyoD mutant embryos with antibodies reactive with desmin, @PROTEIN1$, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.","label":0}
{"pair_id":"BioInfer.d316.s0.p30","sentence":"In addition, we performed immunohistochemistry on sectioned Myf-5 and @PROTEIN2$ mutant embryos with antibodies reactive with desmin, nestin, @PROTEIN1$, sarcomeric actin, Myf-5, MyoD and myogenin.","label":0}
{"pair_id":"BioInfer.d316.s0.p31","sentence":"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with @PROTEIN2$, nestin, @PROTEIN1$, sarcomeric actin, Myf-5, MyoD and myogenin.","label":0}
{"pair_id":"BioInfer.d316.s0.p32","sentence":"In addition, we performed immunohistochemistry on sectioned @PROTEIN2$ and MyoD mutant embryos with antibodies reactive with desmin, nestin, @PROTEIN1$, sarcomeric actin, Myf-5, MyoD and myogenin.","label":0}
{"pair_id":"BioInfer.d316.s0.p33","sentence":"In addition, we performed immunohistochemistry on sectioned Myf-5 and @PROTEIN1$ mutant embryos with antibodies reactive with @PROTEIN2$, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.","label":0}
{"pair_id":"BioInfer.d316.s0.p34","sentence":"In addition, we performed immunohistochemistry on sectioned @PROTEIN2$ and @PROTEIN1$ mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.","label":0}
{"pair_id":"BioInfer.d316.s0.p35","sentence":"In addition, we performed immunohistochemistry on sectioned @PROTEIN2$ and MyoD mutant embryos with antibodies reactive with @PROTEIN1$, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.","label":0}
{"pair_id":"AIMed.d85.s720.p0","sentence":"Studies in vivo and in vitro demonstrated a highly specific interaction between the SH3 domains of @PROTEIN1$ and @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d324.s0.p0","sentence":"In contrast, act1-159 partially suppresses the temperature sensitivity of a @PROTEIN1$ mutant, and the loss of cytoplasmic cables seen in fimbrin, @PROTEIN2$, and tropomyosin null mutants, suggesting filament stabilizing functions for these actin-binding proteins.","label":0}
{"pair_id":"BioInfer.d324.s0.p1","sentence":"In contrast, act1-159 partially suppresses the temperature sensitivity of a @PROTEIN1$ mutant, and the loss of cytoplasmic cables seen in @PROTEIN2$, Mdm20p, and tropomyosin null mutants, suggesting filament stabilizing functions for these actin-binding proteins.","label":0}
{"pair_id":"BioInfer.d324.s0.p2","sentence":"In contrast, @PROTEIN2$ partially suppresses the temperature sensitivity of a @PROTEIN1$ mutant, and the loss of cytoplasmic cables seen in fimbrin, Mdm20p, and tropomyosin null mutants, suggesting filament stabilizing functions for these actin-binding proteins.","label":1}
{"pair_id":"BioInfer.d324.s0.p3","sentence":"In contrast, act1-159 partially suppresses the temperature sensitivity of a @PROTEIN1$ mutant, and the loss of cytoplasmic cables seen in fimbrin, Mdm20p, and tropomyosin null mutants, suggesting filament stabilizing functions for these @PROTEIN2$-binding proteins.","label":1}
{"pair_id":"BioInfer.d324.s0.p4","sentence":"In contrast, act1-159 partially suppresses the temperature sensitivity of a @PROTEIN1$ mutant, and the loss of cytoplasmic cables seen in fimbrin, Mdm20p, and @PROTEIN2$ null mutants, suggesting filament stabilizing functions for these actin-binding proteins.","label":0}
{"pair_id":"BioInfer.d324.s0.p5","sentence":"In contrast, act1-159 partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in @PROTEIN2$, @PROTEIN1$, and tropomyosin null mutants, suggesting filament stabilizing functions for these actin-binding proteins.","label":0}
{"pair_id":"BioInfer.d324.s0.p6","sentence":"In contrast, @PROTEIN2$ partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in fimbrin, @PROTEIN1$, and tropomyosin null mutants, suggesting filament stabilizing functions for these actin-binding proteins.","label":1}
{"pair_id":"BioInfer.d324.s0.p7","sentence":"In contrast, act1-159 partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in fimbrin, @PROTEIN1$, and tropomyosin null mutants, suggesting filament stabilizing functions for these @PROTEIN2$-binding proteins.","label":1}
{"pair_id":"BioInfer.d324.s0.p8","sentence":"In contrast, act1-159 partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in fimbrin, @PROTEIN1$, and @PROTEIN2$ null mutants, suggesting filament stabilizing functions for these actin-binding proteins.","label":0}
{"pair_id":"BioInfer.d324.s0.p9","sentence":"In contrast, @PROTEIN2$ partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in @PROTEIN1$, Mdm20p, and tropomyosin null mutants, suggesting filament stabilizing functions for these actin-binding proteins.","label":1}
{"pair_id":"BioInfer.d324.s0.p10","sentence":"In contrast, act1-159 partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in @PROTEIN1$, Mdm20p, and tropomyosin null mutants, suggesting filament stabilizing functions for these @PROTEIN2$-binding proteins.","label":1}
{"pair_id":"BioInfer.d324.s0.p11","sentence":"In contrast, act1-159 partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in @PROTEIN1$, Mdm20p, and @PROTEIN2$ null mutants, suggesting filament stabilizing functions for these actin-binding proteins.","label":0}
{"pair_id":"BioInfer.d324.s0.p12","sentence":"In contrast, @PROTEIN1$ partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in fimbrin, Mdm20p, and tropomyosin null mutants, suggesting filament stabilizing functions for these @PROTEIN2$-binding proteins.","label":0}
{"pair_id":"BioInfer.d324.s0.p13","sentence":"In contrast, @PROTEIN1$ partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in fimbrin, Mdm20p, and @PROTEIN2$ null mutants, suggesting filament stabilizing functions for these actin-binding proteins.","label":1}
{"pair_id":"BioInfer.d324.s0.p14","sentence":"In contrast, act1-159 partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in fimbrin, Mdm20p, and @PROTEIN2$ null mutants, suggesting filament stabilizing functions for these @PROTEIN1$-binding proteins.","label":1}
{"pair_id":"AIMed.d87.s739.p0","sentence":"Activation of lacZ upon interaction of @PROTEIN1$ with @PROTEIN2$(delta C-43) was 4-fold less as compared to IR beta.","label":1}
{"pair_id":"AIMed.d87.s739.p1","sentence":"Activation of lacZ upon interaction of @PROTEIN1$ with IR beta(@PROTEIN2$) was 4-fold less as compared to IR beta.","label":0}
{"pair_id":"AIMed.d87.s739.p2","sentence":"Activation of lacZ upon interaction of @PROTEIN1$ with IR beta(delta C-43) was 4-fold less as compared to @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d87.s739.p3","sentence":"Activation of lacZ upon interaction of p85 with @PROTEIN1$(@PROTEIN2$) was 4-fold less as compared to IR beta.","label":0}
{"pair_id":"AIMed.d87.s739.p4","sentence":"Activation of lacZ upon interaction of p85 with @PROTEIN1$(delta C-43) was 4-fold less as compared to @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d87.s739.p5","sentence":"Activation of lacZ upon interaction of p85 with IR beta(@PROTEIN1$) was 4-fold less as compared to @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d173.s1460.p0","sentence":"Protein-protein interactions were measured by expression of these fusion proteins in Saccharomyces cerevisiae harboring @PROTEIN1$ (@PROTEIN2$) and LEU2 (leucine utilization) genes under the control of LexA-dependent operators.","label":0}
{"pair_id":"AIMed.d173.s1460.p1","sentence":"Protein-protein interactions were measured by expression of these fusion proteins in Saccharomyces cerevisiae harboring @PROTEIN1$ (beta-galactosidase) and @PROTEIN2$ (leucine utilization) genes under the control of LexA-dependent operators.","label":0}
{"pair_id":"AIMed.d173.s1460.p2","sentence":"Protein-protein interactions were measured by expression of these fusion proteins in Saccharomyces cerevisiae harboring @PROTEIN1$ (beta-galactosidase) and LEU2 (@PROTEIN2$) genes under the control of LexA-dependent operators.","label":0}
{"pair_id":"AIMed.d173.s1460.p3","sentence":"Protein-protein interactions were measured by expression of these fusion proteins in Saccharomyces cerevisiae harboring lacZ (@PROTEIN1$) and @PROTEIN2$ (leucine utilization) genes under the control of LexA-dependent operators.","label":0}
{"pair_id":"AIMed.d173.s1460.p4","sentence":"Protein-protein interactions were measured by expression of these fusion proteins in Saccharomyces cerevisiae harboring lacZ (@PROTEIN1$) and LEU2 (@PROTEIN2$) genes under the control of LexA-dependent operators.","label":0}
{"pair_id":"AIMed.d173.s1460.p5","sentence":"Protein-protein interactions were measured by expression of these fusion proteins in Saccharomyces cerevisiae harboring lacZ (beta-galactosidase) and @PROTEIN1$ (@PROTEIN2$) genes under the control of LexA-dependent operators.","label":0}
{"pair_id":"AIMed.d90.s773.p0","sentence":"In transient expression assays, we found that @PROTEIN1$ and @PROTEIN2$ can functionally cooperate to synergistically activate transcription.","label":0}
{"pair_id":"AIMed.d12.s102.p0","sentence":"MAIN OUTCOME MEASURES: Measurement of soluble @PROTEIN1$ (@PROTEIN2$) and IL-1alpha in serum samples and fluid of recent blisters.","label":0}
{"pair_id":"AIMed.d12.s102.p1","sentence":"MAIN OUTCOME MEASURES: Measurement of soluble @PROTEIN1$ (sIL-2R) and @PROTEIN2$ in serum samples and fluid of recent blisters.","label":0}
{"pair_id":"AIMed.d12.s102.p2","sentence":"MAIN OUTCOME MEASURES: Measurement of soluble interleukin (IL) 2 receptor (@PROTEIN1$) and @PROTEIN2$ in serum samples and fluid of recent blisters.","label":0}
{"pair_id":"BioInfer.d238.s0.p0","sentence":"Here we demonstrate that accessory receptor triggering induces the transient association of @PROTEIN2$ with the @PROTEIN1$ cytoskeleton.","label":1}
{"pair_id":"BioInfer.d346.s0.p0","sentence":"In isolated hearts, PD 81,723 alone produced only a small stimulus to His bundle (S-H) interval prolongation of 1.5 to 4 msec, which was completely reversed by the @PROTEIN2$ antagonist 8-cyclopentyltheophylline and @PROTEIN1$.","label":0}
{"pair_id":"AIMed.d26.s223.p0","sentence":"In conclusion, impaired expression of @PROTEIN1$ by NK cells correlates with progression of cancer, and determination of @PROTEIN2$ expression might prove informative for assessing the immunological condition of cancer patients.","label":0}
{"pair_id":"BioInfer.d376.s0.p0","sentence":"In this recombinant expression system, the dystrophin relatives, human @PROTEIN2$ (@PROTEIN1$ or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.","label":0}
{"pair_id":"BioInfer.d376.s0.p1","sentence":"In this recombinant expression system, the dystrophin relatives, human dystrophin related protein (@PROTEIN1$ or utrophin) and the @PROTEIN2$ from Torpedo electric organ, also bind to translated beta 1-syntrophin.","label":0}
{"pair_id":"BioInfer.d376.s0.p2","sentence":"In this recombinant expression system, the dystrophin relatives, human dystrophin related protein (@PROTEIN1$ or @PROTEIN2$) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.","label":0}
{"pair_id":"BioInfer.d376.s0.p3","sentence":"In this recombinant expression system, the dystrophin relatives, human dystrophin related protein (@PROTEIN1$ or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d376.s0.p4","sentence":"In this recombinant expression system, the @PROTEIN2$ relatives, human dystrophin related protein (@PROTEIN1$ or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.","label":1}
{"pair_id":"BioInfer.d376.s0.p5","sentence":"In this recombinant expression system, the dystrophin relatives, human @PROTEIN1$ (DRP or utrophin) and the @PROTEIN2$ from Torpedo electric organ, also bind to translated beta 1-syntrophin.","label":0}
{"pair_id":"BioInfer.d376.s0.p6","sentence":"In this recombinant expression system, the dystrophin relatives, human @PROTEIN1$ (DRP or @PROTEIN2$) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.","label":0}
{"pair_id":"BioInfer.d376.s0.p7","sentence":"In this recombinant expression system, the dystrophin relatives, human @PROTEIN1$ (DRP or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d376.s0.p8","sentence":"In this recombinant expression system, the @PROTEIN2$ relatives, human @PROTEIN1$ (DRP or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.","label":1}
{"pair_id":"BioInfer.d376.s0.p9","sentence":"In this recombinant expression system, the dystrophin relatives, human dystrophin related protein (DRP or @PROTEIN2$) and the @PROTEIN1$ from Torpedo electric organ, also bind to translated beta 1-syntrophin.","label":0}
{"pair_id":"BioInfer.d376.s0.p10","sentence":"In this recombinant expression system, the dystrophin relatives, human dystrophin related protein (DRP or utrophin) and the @PROTEIN1$ from Torpedo electric organ, also bind to translated @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d376.s0.p11","sentence":"In this recombinant expression system, the @PROTEIN2$ relatives, human dystrophin related protein (DRP or utrophin) and the @PROTEIN1$ from Torpedo electric organ, also bind to translated beta 1-syntrophin.","label":1}
{"pair_id":"BioInfer.d376.s0.p12","sentence":"In this recombinant expression system, the dystrophin relatives, human dystrophin related protein (DRP or @PROTEIN1$) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d376.s0.p13","sentence":"In this recombinant expression system, the @PROTEIN2$ relatives, human dystrophin related protein (DRP or @PROTEIN1$) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.","label":1}
{"pair_id":"BioInfer.d376.s0.p14","sentence":"In this recombinant expression system, the @PROTEIN2$ relatives, human dystrophin related protein (DRP or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d522.s1.p0","sentence":"Sepharose beads coupled to either monoclonal anti-gelsolin antibodies or to polyproline were used to extract gelsolin and @PROTEIN2$, respectively, from EGTA-containing platelet extracts and determine the proportion of these molecules bound to @PROTEIN1$ with sufficient affinity to withstand dilution (high-affinity complexes).","label":1}
{"pair_id":"BioInfer.d522.s1.p1","sentence":"Sepharose beads coupled to either monoclonal anti-gelsolin antibodies or to polyproline were used to extract @PROTEIN2$ and profilin, respectively, from EGTA-containing platelet extracts and determine the proportion of these molecules bound to @PROTEIN1$ with sufficient affinity to withstand dilution (high-affinity complexes).","label":1}
{"pair_id":"BioInfer.d522.s1.p2","sentence":"Sepharose beads coupled to either monoclonal anti-@PROTEIN2$ antibodies or to polyproline were used to extract gelsolin and profilin, respectively, from EGTA-containing platelet extracts and determine the proportion of these molecules bound to @PROTEIN1$ with sufficient affinity to withstand dilution (high-affinity complexes).","label":0}
{"pair_id":"BioInfer.d522.s1.p3","sentence":"Sepharose beads coupled to either monoclonal anti-gelsolin antibodies or to polyproline were used to extract @PROTEIN2$ and @PROTEIN1$, respectively, from EGTA-containing platelet extracts and determine the proportion of these molecules bound to actin with sufficient affinity to withstand dilution (high-affinity complexes).","label":0}
{"pair_id":"BioInfer.d522.s1.p4","sentence":"Sepharose beads coupled to either monoclonal anti-@PROTEIN2$ antibodies or to polyproline were used to extract gelsolin and @PROTEIN1$, respectively, from EGTA-containing platelet extracts and determine the proportion of these molecules bound to actin with sufficient affinity to withstand dilution (high-affinity complexes).","label":0}
{"pair_id":"BioInfer.d522.s1.p5","sentence":"Sepharose beads coupled to either monoclonal anti-@PROTEIN2$ antibodies or to polyproline were used to extract @PROTEIN1$ and profilin, respectively, from EGTA-containing platelet extracts and determine the proportion of these molecules bound to actin with sufficient affinity to withstand dilution (high-affinity complexes).","label":0}
{"pair_id":"BioInfer.d124.s0.p0","sentence":"@PROTEIN2$ are essential for embryonic morphogenesis since they mediate calcium-dependent cell-cell adhesion and can modulate @PROTEIN1$ signaling.","label":1}
{"pair_id":"AIMed.d76.s646.p0","sentence":"The binding of @PROTEIN1$ to @PROTEIN2$ induced a 10- to 15-fold increase in p56lck catalytic activity, as measured by in vitro kinase analysis.","label":1}
{"pair_id":"AIMed.d76.s646.p1","sentence":"The binding of @PROTEIN1$ to CD5 induced a 10- to 15-fold increase in @PROTEIN2$ catalytic activity, as measured by in vitro kinase analysis.","label":0}
{"pair_id":"AIMed.d76.s646.p2","sentence":"The binding of p56lck to @PROTEIN1$ induced a 10- to 15-fold increase in @PROTEIN2$ catalytic activity, as measured by in vitro kinase analysis.","label":0}
{"pair_id":"AIMed.d32.s268.p0","sentence":"Shared and unique determinants of the @PROTEIN1$ (@PROTEIN2$) receptor are important for binding EPO and EPO mimetic peptide.","label":0}
{"pair_id":"AIMed.d32.s268.p1","sentence":"Shared and unique determinants of the @PROTEIN1$@PROTEIN2$ are important for binding EPO and EPO mimetic peptide.","label":0}
{"pair_id":"AIMed.d32.s268.p2","sentence":"Shared and unique determinants of the @PROTEIN1$ (EPO) receptor are important for binding @PROTEIN2$ and EPO mimetic peptide.","label":0}
{"pair_id":"AIMed.d32.s268.p3","sentence":"Shared and unique determinants of the @PROTEIN1$ (EPO) receptor are important for binding EPO and @PROTEIN2$ mimetic peptide.","label":0}
{"pair_id":"AIMed.d32.s268.p4","sentence":"Shared and unique determinants of the @PROTEIN1$ (EPO) receptor are important for binding EPO and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d32.s268.p5","sentence":"Shared and unique determinants of the @PROTEIN2$@PROTEIN1$) receptor are important for binding EPO and EPO mimetic peptide.","label":0}
{"pair_id":"AIMed.d32.s268.p6","sentence":"Shared and unique determinants of the erythropoietin (@PROTEIN1$) receptor are important for binding @PROTEIN2$ and EPO mimetic peptide.","label":0}
{"pair_id":"AIMed.d32.s268.p7","sentence":"Shared and unique determinants of the erythropoietin (@PROTEIN1$) receptor are important for binding EPO and @PROTEIN2$ mimetic peptide.","label":0}
{"pair_id":"AIMed.d32.s268.p8","sentence":"Shared and unique determinants of the erythropoietin (@PROTEIN1$) receptor are important for binding EPO and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d32.s268.p9","sentence":"Shared and unique determinants of the @PROTEIN1$ are important for binding @PROTEIN2$ and EPO mimetic peptide.","label":1}
{"pair_id":"AIMed.d32.s268.p10","sentence":"Shared and unique determinants of the @PROTEIN1$ are important for binding EPO and @PROTEIN2$ mimetic peptide.","label":0}
{"pair_id":"AIMed.d32.s268.p11","sentence":"Shared and unique determinants of the @PROTEIN1$ are important for binding EPO and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d32.s268.p12","sentence":"Shared and unique determinants of the erythropoietin (EPO) receptor are important for binding @PROTEIN1$ and @PROTEIN2$ mimetic peptide.","label":0}
{"pair_id":"AIMed.d32.s268.p13","sentence":"Shared and unique determinants of the erythropoietin (EPO) receptor are important for binding @PROTEIN1$ and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d32.s268.p14","sentence":"Shared and unique determinants of the erythropoietin (EPO) receptor are important for binding EPO and @PROTEIN1$@PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d441.s1.p0","sentence":"The colocalization of gelsolin and @PROTEIN1$ in motile, microfilament-rich areas supports the hypothesis that they synergistically regulate the @PROTEIN2$ dynamics that underlie neurite growth.","label":1}
{"pair_id":"BioInfer.d441.s1.p1","sentence":"The colocalization of @PROTEIN2$ and @PROTEIN1$ in motile, microfilament-rich areas supports the hypothesis that they synergistically regulate the actin dynamics that underlie neurite growth.","label":1}
{"pair_id":"BioInfer.d441.s1.p2","sentence":"The colocalization of @PROTEIN2$ and profilin in motile, microfilament-rich areas supports the hypothesis that they synergistically regulate the @PROTEIN1$ dynamics that underlie neurite growth.","label":1}
{"pair_id":"BioInfer.d587.s0.p0","sentence":"The @PROTEIN2$-like central (vc) region of Wiskott-Aldrich syndrome protein induces Arp2\/A complex-dependent @PROTEIN1$ nucleation.","label":0}
{"pair_id":"BioInfer.d587.s0.p1","sentence":"The verprolin-like central (vc) region of Wiskott-Aldrich syndrome protein induces @PROTEIN2$2\/@PROTEIN2$ complex-dependent @PROTEIN1$ nucleation.","label":1}
{"pair_id":"BioInfer.d587.s0.p2","sentence":"The verprolin-like central (vc) region of Wiskott-Aldrich syndrome protein induces @PROTEIN2$\/A complex-dependent @PROTEIN1$ nucleation.","label":1}
{"pair_id":"BioInfer.d587.s0.p3","sentence":"The verprolin-like central (vc) region of @PROTEIN2$ induces Arp2\/A complex-dependent @PROTEIN1$ nucleation.","label":1}
{"pair_id":"BioInfer.d587.s0.p4","sentence":"The @PROTEIN1$-like central (vc) region of Wiskott-Aldrich syndrome protein induces @PROTEIN2$2\/@PROTEIN2$ complex-dependent actin nucleation.","label":0}
{"pair_id":"BioInfer.d587.s0.p5","sentence":"The @PROTEIN1$-like central (vc) region of Wiskott-Aldrich syndrome protein induces @PROTEIN2$\/A complex-dependent actin nucleation.","label":0}
{"pair_id":"BioInfer.d587.s0.p6","sentence":"The @PROTEIN1$-like central (vc) region of @PROTEIN2$ induces Arp2\/A complex-dependent actin nucleation.","label":1}
{"pair_id":"BioInfer.d587.s0.p7","sentence":"The verprolin-like central (vc) region of Wiskott-Aldrich syndrome protein induces @PROTEIN1$@PROTEIN2$\/@PROTEIN1$ complex-dependent actin nucleation.","label":1}
{"pair_id":"BioInfer.d587.s0.p8","sentence":"The verprolin-like central (vc) region of @PROTEIN2$ induces @PROTEIN1$2\/@PROTEIN1$ complex-dependent actin nucleation.","label":0}
{"pair_id":"BioInfer.d587.s0.p9","sentence":"The verprolin-like central (vc) region of @PROTEIN2$ induces @PROTEIN1$\/A complex-dependent actin nucleation.","label":0}
{"pair_id":"BioInfer.d393.s1.p0","sentence":"Using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), we have developed a simple method to isolate @PROTEIN2$ (MHC) and @PROTEIN1$ from small (60-80 mg) human skeletal muscle samples for the determination of their fractional synthesis rates.","label":0}
{"pair_id":"BioInfer.d393.s1.p1","sentence":"Using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), we have developed a simple method to isolate myosin heavy chain (@PROTEIN2$) and @PROTEIN1$ from small (60-80 mg) human skeletal muscle samples for the determination of their fractional synthesis rates.","label":0}
{"pair_id":"BioInfer.d393.s1.p2","sentence":"Using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), we have developed a simple method to isolate @PROTEIN1$ (@PROTEIN2$) and actin from small (60-80 mg) human skeletal muscle samples for the determination of their fractional synthesis rates.","label":0}
{"pair_id":"AIMed.d128.s1097.p0","sentence":"In the case of @PROTEIN1$, activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. @PROTEIN2$ does not bind to the hGH receptor, but hGH binds to both the hGHR and hPRLR, and mutagenesis studies have shown that the receptor-binding sites on hGH overlap.","label":0}
{"pair_id":"AIMed.d128.s1097.p1","sentence":"In the case of @PROTEIN1$, activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. hPRL does not bind to the @PROTEIN2$ receptor, but hGH binds to both the hGHR and hPRLR, and mutagenesis studies have shown that the receptor-binding sites on hGH overlap.","label":0}
{"pair_id":"AIMed.d128.s1097.p2","sentence":"In the case of @PROTEIN1$, activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. hPRL does not bind to the hGH receptor, but @PROTEIN2$ binds to both the hGHR and hPRLR, and mutagenesis studies have shown that the receptor-binding sites on hGH overlap.","label":0}
{"pair_id":"AIMed.d128.s1097.p3","sentence":"In the case of @PROTEIN1$, activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. hPRL does not bind to the hGH receptor, but hGH binds to both the @PROTEIN2$ and hPRLR, and mutagenesis studies have shown that the receptor-binding sites on hGH overlap.","label":0}
{"pair_id":"AIMed.d128.s1097.p4","sentence":"In the case of @PROTEIN1$, activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. hPRL does not bind to the hGH receptor, but hGH binds to both the hGHR and @PROTEIN2$, and mutagenesis studies have shown that the receptor-binding sites on hGH overlap.","label":0}
{"pair_id":"AIMed.d128.s1097.p5","sentence":"In the case of @PROTEIN1$, activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. hPRL does not bind to the hGH receptor, but hGH binds to both the hGHR and hPRLR, and mutagenesis studies have shown that the receptor-binding sites on @PROTEIN2$ overlap.","label":0}
{"pair_id":"AIMed.d128.s1097.p6","sentence":"In the case of hGH, activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. @PROTEIN1$ does not bind to the @PROTEIN2$ receptor, but hGH binds to both the hGHR and hPRLR, and mutagenesis studies have shown that the receptor-binding sites on hGH overlap.","label":0}
{"pair_id":"AIMed.d128.s1097.p7","sentence":"In the case of hGH, activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. @PROTEIN1$ does not bind to the hGH receptor, but @PROTEIN2$ binds to both the hGHR and hPRLR, and mutagenesis studies have shown that the receptor-binding sites on hGH overlap.","label":0}
{"pair_id":"AIMed.d128.s1097.p8","sentence":"In the case of hGH, activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. @PROTEIN1$ does not bind to the hGH receptor, but hGH binds to both the @PROTEIN2$ and hPRLR, and mutagenesis studies have shown that the receptor-binding sites on hGH overlap.","label":0}
{"pair_id":"AIMed.d128.s1097.p9","sentence":"In the case of hGH, activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. @PROTEIN1$ does not bind to the hGH receptor, but hGH binds to both the hGHR and @PROTEIN2$, and mutagenesis studies have shown that the receptor-binding sites on hGH overlap.","label":0}
{"pair_id":"AIMed.d128.s1097.p10","sentence":"In the case of hGH, activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. @PROTEIN1$ does not bind to the hGH receptor, but hGH binds to both the hGHR and hPRLR, and mutagenesis studies have shown that the receptor-binding sites on @PROTEIN2$ overlap.","label":0}
{"pair_id":"AIMed.d128.s1097.p11","sentence":"In the case of hGH, activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. hPRL does not bind to the @PROTEIN1$ receptor, but @PROTEIN2$ binds to both the hGHR and hPRLR, and mutagenesis studies have shown that the receptor-binding sites on hGH overlap.","label":0}
{"pair_id":"AIMed.d128.s1097.p12","sentence":"In the case of hGH, activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. hPRL does not bind to the @PROTEIN1$ receptor, but hGH binds to both the @PROTEIN2$ and hPRLR, and mutagenesis studies have shown that the receptor-binding sites on hGH overlap.","label":0}
{"pair_id":"AIMed.d128.s1097.p13","sentence":"In the case of hGH, activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. hPRL does not bind to the @PROTEIN1$ receptor, but hGH binds to both the hGHR and @PROTEIN2$, and mutagenesis studies have shown that the receptor-binding sites on hGH overlap.","label":0}
{"pair_id":"AIMed.d128.s1097.p14","sentence":"In the case of hGH, activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. hPRL does not bind to the @PROTEIN1$ receptor, but hGH binds to both the hGHR and hPRLR, and mutagenesis studies have shown that the receptor-binding sites on @PROTEIN2$ overlap.","label":0}
{"pair_id":"AIMed.d128.s1097.p15","sentence":"In the case of hGH, activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. hPRL does not bind to the hGH receptor, but @PROTEIN1$ binds to both the @PROTEIN2$ and hPRLR, and mutagenesis studies have shown that the receptor-binding sites on hGH overlap.","label":1}
{"pair_id":"AIMed.d128.s1097.p16","sentence":"In the case of hGH, activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. hPRL does not bind to the hGH receptor, but @PROTEIN1$ binds to both the hGHR and @PROTEIN2$, and mutagenesis studies have shown that the receptor-binding sites on hGH overlap.","label":1}
{"pair_id":"AIMed.d128.s1097.p17","sentence":"In the case of hGH, activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. hPRL does not bind to the hGH receptor, but @PROTEIN1$ binds to both the hGHR and hPRLR, and mutagenesis studies have shown that the receptor-binding sites on @PROTEIN2$ overlap.","label":0}
{"pair_id":"AIMed.d128.s1097.p18","sentence":"In the case of hGH, activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. hPRL does not bind to the hGH receptor, but hGH binds to both the @PROTEIN1$ and @PROTEIN2$, and mutagenesis studies have shown that the receptor-binding sites on hGH overlap.","label":0}
{"pair_id":"AIMed.d128.s1097.p19","sentence":"In the case of hGH, activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. hPRL does not bind to the hGH receptor, but hGH binds to both the @PROTEIN1$ and hPRLR, and mutagenesis studies have shown that the receptor-binding sites on @PROTEIN2$ overlap.","label":0}
{"pair_id":"AIMed.d128.s1097.p20","sentence":"In the case of hGH, activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. hPRL does not bind to the hGH receptor, but hGH binds to both the hGHR and @PROTEIN1$, and mutagenesis studies have shown that the receptor-binding sites on @PROTEIN2$ overlap.","label":0}
{"pair_id":"BioInfer.d77.s2.p0","sentence":"Here we show that the @PROTEIN2$ subunit of the complex can be chemically cross-linked to the @PROTEIN1$-binding site of profilin.","label":0}
{"pair_id":"BioInfer.d77.s2.p1","sentence":"Here we show that the Arp2 subunit of the complex can be chemically cross-linked to the @PROTEIN1$-binding site of @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d77.s2.p2","sentence":"Here we show that the @PROTEIN1$ subunit of the complex can be chemically cross-linked to the actin-binding site of @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d116.s982.p0","sentence":"These results indicate that there is an additional mechanism by which @PROTEIN1$ suppresses cell growth, namely that @PROTEIN2$ directly represses transcription of the rRNA genes.","label":0}
{"pair_id":"BioInfer.d423.s0.p0","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (@PROTEIN1$), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (@PROTEIN2$), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p1","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (@PROTEIN1$), troponin I (TnI) isoforms, connexin 43 (@PROTEIN2$), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p2","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (@PROTEIN1$), troponin I (TnI) isoforms, @PROTEIN2$ (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p3","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (@PROTEIN2$), myosin light chain (@PROTEIN1$), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p4","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (@PROTEIN1$), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and @PROTEIN2$ (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p5","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (@PROTEIN1$), troponin I (@PROTEIN2$) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p6","sentence":"METHODS: We have performed a detailed study of the pattern of expression of @PROTEIN2$ (MHC), myosin light chain (@PROTEIN1$), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p7","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (@PROTEIN1$), @PROTEIN2$ (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p8","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), @PROTEIN2$ (@PROTEIN1$), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p9","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (@PROTEIN1$), troponin I (TnI) isoforms, connexin 43 (Cx43), @PROTEIN2$ and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p10","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (@PROTEIN2$), desmin and alpha-smooth muscle actin (@PROTEIN1$), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p11","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, @PROTEIN2$ (Cx43), desmin and alpha-smooth muscle actin (@PROTEIN1$), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p12","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (@PROTEIN2$), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (@PROTEIN1$), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p13","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and @PROTEIN2$ (@PROTEIN1$), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p14","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (@PROTEIN2$) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (@PROTEIN1$), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p15","sentence":"METHODS: We have performed a detailed study of the pattern of expression of @PROTEIN2$ (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (@PROTEIN1$), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p16","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), @PROTEIN2$ (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (@PROTEIN1$), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p17","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), @PROTEIN2$ (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (@PROTEIN1$), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p18","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), @PROTEIN2$ and alpha-smooth muscle actin (@PROTEIN1$), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p19","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, @PROTEIN2$ (@PROTEIN1$), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p20","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (@PROTEIN2$), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (@PROTEIN1$), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p21","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (@PROTEIN1$), desmin and @PROTEIN2$ (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p22","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (@PROTEIN2$) isoforms, connexin 43 (@PROTEIN1$), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p23","sentence":"METHODS: We have performed a detailed study of the pattern of expression of @PROTEIN2$ (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (@PROTEIN1$), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p24","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), @PROTEIN2$ (TnI) isoforms, connexin 43 (@PROTEIN1$), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p25","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), @PROTEIN2$ (MLC), troponin I (TnI) isoforms, connexin 43 (@PROTEIN1$), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p26","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (@PROTEIN1$), @PROTEIN2$ and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p27","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (@PROTEIN2$), myosin light chain (MLC), troponin I (TnI) isoforms, @PROTEIN1$ (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p28","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, @PROTEIN1$ (Cx43), desmin and @PROTEIN2$ (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p29","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (@PROTEIN2$) isoforms, @PROTEIN1$ (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p30","sentence":"METHODS: We have performed a detailed study of the pattern of expression of @PROTEIN2$ (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, @PROTEIN1$ (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p31","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), @PROTEIN2$ (TnI) isoforms, @PROTEIN1$ (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p32","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), @PROTEIN2$ (MLC), troponin I (TnI) isoforms, @PROTEIN1$ (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p33","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, @PROTEIN1$ (Cx43), @PROTEIN2$ and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p34","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (@PROTEIN1$), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and @PROTEIN2$ (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p35","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (@PROTEIN1$), myosin light chain (MLC), troponin I (@PROTEIN2$) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p36","sentence":"METHODS: We have performed a detailed study of the pattern of expression of @PROTEIN2$ (@PROTEIN1$), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p37","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (@PROTEIN1$), myosin light chain (MLC), @PROTEIN2$ (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p38","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (@PROTEIN1$), @PROTEIN2$ (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p39","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (@PROTEIN1$), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), @PROTEIN2$ and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p40","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (@PROTEIN2$) isoforms, connexin 43 (Cx43), desmin and @PROTEIN1$ (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p41","sentence":"METHODS: We have performed a detailed study of the pattern of expression of @PROTEIN2$ (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and @PROTEIN1$ (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p42","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), @PROTEIN2$ (TnI) isoforms, connexin 43 (Cx43), desmin and @PROTEIN1$ (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p43","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), @PROTEIN2$ (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and @PROTEIN1$ (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p44","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), @PROTEIN2$ and @PROTEIN1$ (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p45","sentence":"METHODS: We have performed a detailed study of the pattern of expression of @PROTEIN2$ (MHC), myosin light chain (MLC), troponin I (@PROTEIN1$) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p46","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), @PROTEIN2$ (@PROTEIN1$) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p47","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), @PROTEIN2$ (MLC), troponin I (@PROTEIN1$) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p48","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (@PROTEIN1$) isoforms, connexin 43 (Cx43), @PROTEIN2$ and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p49","sentence":"METHODS: We have performed a detailed study of the pattern of expression of @PROTEIN1$ (MHC), myosin light chain (MLC), @PROTEIN2$ (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p50","sentence":"METHODS: We have performed a detailed study of the pattern of expression of @PROTEIN1$ (MHC), @PROTEIN2$ (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p51","sentence":"METHODS: We have performed a detailed study of the pattern of expression of @PROTEIN1$ (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), @PROTEIN2$ and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p52","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), @PROTEIN2$ (MLC), @PROTEIN1$ (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p53","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), @PROTEIN1$ (TnI) isoforms, connexin 43 (Cx43), @PROTEIN2$ and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p54","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), @PROTEIN1$ (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), @PROTEIN2$ and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"AIMed.d101.s852.p0","sentence":"The bZIP domains of @PROTEIN1$ and @PROTEIN2$ mediate a physical association with the TATA box-binding protein.","label":0}
{"pair_id":"AIMed.d101.s852.p1","sentence":"The bZIP domains of @PROTEIN1$ and Jun mediate a physical association with the @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d101.s852.p2","sentence":"The bZIP domains of Fos and @PROTEIN1$ mediate a physical association with the @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d693.s0.p0","sentence":"These cells have both @PROTEIN2$ and @PROTEIN1$, display unusual expression of N-cadherin, and have the typical fibroblastic phenotype of transformed cells.","label":0}
{"pair_id":"BioInfer.d693.s0.p1","sentence":"These cells have both alpha-catenin and @PROTEIN1$, display unusual expression of @PROTEIN2$, and have the typical fibroblastic phenotype of transformed cells.","label":0}
{"pair_id":"BioInfer.d693.s0.p2","sentence":"These cells have both @PROTEIN1$ and beta-catenin, display unusual expression of @PROTEIN2$, and have the typical fibroblastic phenotype of transformed cells.","label":0}
{"pair_id":"AIMed.d138.s1165.p0","sentence":"Interaction of mammalian splicing factor @PROTEIN1$ with @PROTEIN2$ and relation of its 60-kD subunit to yeast PRP9.","label":1}
{"pair_id":"AIMed.d138.s1165.p1","sentence":"Interaction of mammalian splicing factor @PROTEIN1$ with U2 snRNP and relation of its 60-kD subunit to yeast @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d138.s1165.p2","sentence":"Interaction of mammalian splicing factor SF3a with @PROTEIN1$ and relation of its 60-kD subunit to yeast @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d766.s0.p0","sentence":"To determine the relative importance of protein degradation in the development of starvation-induced cardiac atrophy, in vivo fractional synthetic rates of total cardiac protein, @PROTEIN1$ heavy chain, @PROTEIN2$, myosin light , and @PROTEIN1$ were measured in fed and fasted rabbits by continuous infusion of [3H] leucine.","label":0}
{"pair_id":"BioInfer.d766.s0.p1","sentence":"To determine the relative importance of protein degradation in the development of starvation-induced cardiac atrophy, in vivo fractional synthetic rates of total cardiac protein, @PROTEIN1$@PROTEIN2$ heavy chain, actin, @PROTEIN2$, and @PROTEIN1$ were measured in fed and fasted rabbits by continuous infusion of [3H] leucine.","label":0}
{"pair_id":"BioInfer.d766.s0.p2","sentence":"To determine the relative importance of protein degradation in the development of starvation-induced cardiac atrophy, in vivo fractional synthetic rates of total cardiac protein, @PROTEIN1$@PROTEIN2$, actin, myosin light , and @PROTEIN1$ were measured in fed and fasted rabbits by continuous infusion of [3H] leucine.","label":0}
{"pair_id":"BioInfer.d766.s0.p3","sentence":"To determine the relative importance of protein degradation in the development of starvation-induced cardiac atrophy, in vivo fractional synthetic rates of total cardiac protein, @PROTEIN2$ heavy chain, @PROTEIN1$, @PROTEIN2$, and myosin light  were measured in fed and fasted rabbits by continuous infusion of [3H] leucine.","label":0}
{"pair_id":"BioInfer.d766.s0.p4","sentence":"To determine the relative importance of protein degradation in the development of starvation-induced cardiac atrophy, in vivo fractional synthetic rates of total cardiac protein, @PROTEIN2$, @PROTEIN1$, myosin light , and myosin light  were measured in fed and fasted rabbits by continuous infusion of [3H] leucine.","label":0}
{"pair_id":"BioInfer.d766.s0.p5","sentence":"To determine the relative importance of protein degradation in the development of starvation-induced cardiac atrophy, in vivo fractional synthetic rates of total cardiac protein, @PROTEIN1$@PROTEIN2$, actin, @PROTEIN1$, and myosin light  were measured in fed and fasted rabbits by continuous infusion of [3H] leucine.","label":0}
{"pair_id":"AIMed.d64.s553.p0","sentence":"Thus, @PROTEIN1$ encodes a human FGF receptor with high affinity for both @PROTEIN2$ and bFGF.","label":1}
{"pair_id":"AIMed.d64.s553.p1","sentence":"Thus, @PROTEIN1$ encodes a human FGF receptor with high affinity for both aFGF and @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d64.s553.p2","sentence":"Thus, phFGFR encodes a human FGF receptor with high affinity for both @PROTEIN1$ and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d8.s61.p0","sentence":"The @PROTEIN1$, @PROTEIN2$, p16 and DPC4 genes are among those most frequently altered in pancreatic ductal carcinoma.","label":0}
{"pair_id":"AIMed.d8.s61.p1","sentence":"The @PROTEIN1$, p53, @PROTEIN2$ and DPC4 genes are among those most frequently altered in pancreatic ductal carcinoma.","label":0}
{"pair_id":"AIMed.d8.s61.p2","sentence":"The @PROTEIN1$, p53, p16 and @PROTEIN2$ genes are among those most frequently altered in pancreatic ductal carcinoma.","label":0}
{"pair_id":"AIMed.d8.s61.p3","sentence":"The K-ras, @PROTEIN1$, @PROTEIN2$ and DPC4 genes are among those most frequently altered in pancreatic ductal carcinoma.","label":0}
{"pair_id":"AIMed.d8.s61.p4","sentence":"The K-ras, @PROTEIN1$, p16 and @PROTEIN2$ genes are among those most frequently altered in pancreatic ductal carcinoma.","label":0}
{"pair_id":"AIMed.d8.s61.p5","sentence":"The K-ras, p53, @PROTEIN1$ and @PROTEIN2$ genes are among those most frequently altered in pancreatic ductal carcinoma.","label":0}
{"pair_id":"AIMed.d1.s12.p0","sentence":"This study describes the distributions of @PROTEIN1$ as well as mRNAs for @PROTEIN2$ (BMPRIB). collagen types II (Col II) and III (Col III) in a growing \"cartilage cap\" of osteochondroma.","label":0}
{"pair_id":"AIMed.d1.s12.p1","sentence":"This study describes the distributions of @PROTEIN1$ as well as mRNAs for BMP receptor type IB (@PROTEIN2$). collagen types II (Col II) and III (Col III) in a growing \"cartilage cap\" of osteochondroma.","label":0}
{"pair_id":"AIMed.d1.s12.p2","sentence":"This study describes the distributions of @PROTEIN1$ as well as mRNAs for BMP receptor type IB (BMPRIB). collagen types II (@PROTEIN2$) and III (Col III) in a growing \"cartilage cap\" of osteochondroma.","label":0}
{"pair_id":"AIMed.d1.s12.p3","sentence":"This study describes the distributions of @PROTEIN1$ as well as mRNAs for BMP receptor type IB (BMPRIB). collagen types II (Col II) and III (@PROTEIN2$) in a growing \"cartilage cap\" of osteochondroma.","label":0}
{"pair_id":"AIMed.d1.s12.p4","sentence":"This study describes the distributions of bone morphogenetic protein (BMP)-2 as well as mRNAs for @PROTEIN1$ (@PROTEIN2$). collagen types II (Col II) and III (Col III) in a growing \"cartilage cap\" of osteochondroma.","label":0}
{"pair_id":"AIMed.d1.s12.p5","sentence":"This study describes the distributions of bone morphogenetic protein (BMP)-2 as well as mRNAs for @PROTEIN1$ (BMPRIB). collagen types II (@PROTEIN2$) and III (Col III) in a growing \"cartilage cap\" of osteochondroma.","label":0}
{"pair_id":"AIMed.d1.s12.p6","sentence":"This study describes the distributions of bone morphogenetic protein (BMP)-2 as well as mRNAs for @PROTEIN1$ (BMPRIB). collagen types II (Col II) and III (@PROTEIN2$) in a growing \"cartilage cap\" of osteochondroma.","label":0}
{"pair_id":"AIMed.d1.s12.p7","sentence":"This study describes the distributions of bone morphogenetic protein (BMP)-2 as well as mRNAs for BMP receptor type IB (@PROTEIN1$). collagen types II (@PROTEIN2$) and III (Col III) in a growing \"cartilage cap\" of osteochondroma.","label":0}
{"pair_id":"AIMed.d1.s12.p8","sentence":"This study describes the distributions of bone morphogenetic protein (BMP)-2 as well as mRNAs for BMP receptor type IB (@PROTEIN1$). collagen types II (Col II) and III (@PROTEIN2$) in a growing \"cartilage cap\" of osteochondroma.","label":0}
{"pair_id":"AIMed.d1.s12.p9","sentence":"This study describes the distributions of bone morphogenetic protein (BMP)-2 as well as mRNAs for BMP receptor type IB (BMPRIB). collagen types II (@PROTEIN1$) and III (@PROTEIN2$) in a growing \"cartilage cap\" of osteochondroma.","label":0}
{"pair_id":"AIMed.d108.s913.p0","sentence":"A double point mutation in the activation domain of @PROTEIN1$ impaired the ability of this domain to activate transcription and, simultaneously, its ability to interact with both @PROTEIN2$ and TAFII60.","label":1}
{"pair_id":"AIMed.d108.s913.p1","sentence":"A double point mutation in the activation domain of @PROTEIN1$ impaired the ability of this domain to activate transcription and, simultaneously, its ability to interact with both TAFII40 and @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d108.s913.p2","sentence":"A double point mutation in the activation domain of p53 impaired the ability of this domain to activate transcription and, simultaneously, its ability to interact with both @PROTEIN1$ and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d398.s0.p0","sentence":"Kinetic measurements indicate that @PROTEIN2$ binding to actin weakens the affinity of @PROTEIN1$ for nucleotides primarily due to an increased nucleotide dissociation rate constant, but the nucleotide association rate constant is also increased about 2-fold.","label":1}
{"pair_id":"BioInfer.d398.s0.p1","sentence":"Kinetic measurements indicate that profilin binding to @PROTEIN2$ weakens the affinity of @PROTEIN1$ for nucleotides primarily due to an increased nucleotide dissociation rate constant, but the nucleotide association rate constant is also increased about 2-fold.","label":1}
{"pair_id":"BioInfer.d398.s0.p2","sentence":"Kinetic measurements indicate that @PROTEIN1$ binding to @PROTEIN2$ weakens the affinity of actin for nucleotides primarily due to an increased nucleotide dissociation rate constant, but the nucleotide association rate constant is also increased about 2-fold.","label":1}
{"pair_id":"AIMed.d163.s1375.p0","sentence":"@PROTEIN1$ contains a region of homology to a yeast vacuolar sorting protein, and overexpression of @PROTEIN2$ decreased the amount of EGFR on the cell surface as a result of enhanced rates of constitutive and ligand-induced degradation.","label":0}
{"pair_id":"AIMed.d163.s1375.p1","sentence":"@PROTEIN1$ contains a region of homology to a yeast vacuolar sorting protein, and overexpression of SNX1 decreased the amount of @PROTEIN2$ on the cell surface as a result of enhanced rates of constitutive and ligand-induced degradation.","label":0}
{"pair_id":"AIMed.d163.s1375.p2","sentence":"SNX1 contains a region of homology to a yeast vacuolar sorting protein, and overexpression of @PROTEIN1$ decreased the amount of @PROTEIN2$ on the cell surface as a result of enhanced rates of constitutive and ligand-induced degradation.","label":0}
{"pair_id":"AIMed.d60.s527.p0","sentence":"@PROTEIN1$ and the protein kinase that activates it (@PROTEIN2$) were constitutively activated in NIH 3T3 cells infected with viruses containing either of two oncogenic forms (p35EC12, p3722W) of the c-Raf-1 protein kinase.","label":1}
{"pair_id":"AIMed.d60.s527.p1","sentence":"@PROTEIN1$ and the protein kinase that activates it (MAP kinase kinase) were constitutively activated in NIH 3T3 cells infected with viruses containing either of two oncogenic forms (p35EC12, p3722W) of the @PROTEIN2$ protein kinase.","label":1}
{"pair_id":"AIMed.d60.s527.p2","sentence":"MAP kinase and the protein kinase that activates it (@PROTEIN1$) were constitutively activated in NIH 3T3 cells infected with viruses containing either of two oncogenic forms (p35EC12, p3722W) of the @PROTEIN2$ protein kinase.","label":1}
{"pair_id":"BioInfer.d364.s0.p0","sentence":"In the ADE2 assay system, silencing depends completely upon the function of the SIR genes, known trans-acting regulators of the silent loci, and is sensitive to the gene dosage of two SIR genes, @PROTEIN2$ and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d364.s0.p1","sentence":"In the ADE2 assay system, silencing depends completely upon the function of the @PROTEIN2$ genes, known trans-acting regulators of the silent loci, and is sensitive to the gene dosage of two SIR genes, SIR1 and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d364.s0.p2","sentence":"In the @PROTEIN2$ assay system, silencing depends completely upon the function of the SIR genes, known trans-acting regulators of the silent loci, and is sensitive to the gene dosage of two SIR genes, SIR1 and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d364.s0.p3","sentence":"In the ADE2 assay system, silencing depends completely upon the function of the SIR genes, known trans-acting regulators of the silent loci, and is sensitive to the gene dosage of two @PROTEIN2$ genes, SIR1 and @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d364.s0.p4","sentence":"In the ADE2 assay system, silencing depends completely upon the function of the @PROTEIN2$ genes, known trans-acting regulators of the silent loci, and is sensitive to the gene dosage of two SIR genes, @PROTEIN1$ and SIR4.","label":0}
{"pair_id":"BioInfer.d364.s0.p5","sentence":"In the @PROTEIN2$ assay system, silencing depends completely upon the function of the SIR genes, known trans-acting regulators of the silent loci, and is sensitive to the gene dosage of two SIR genes, @PROTEIN1$ and SIR4.","label":0}
{"pair_id":"BioInfer.d364.s0.p6","sentence":"In the ADE2 assay system, silencing depends completely upon the function of the SIR genes, known trans-acting regulators of the silent loci, and is sensitive to the gene dosage of two @PROTEIN2$ genes, @PROTEIN1$ and SIR4.","label":1}
{"pair_id":"BioInfer.d364.s0.p7","sentence":"In the @PROTEIN2$ assay system, silencing depends completely upon the function of the @PROTEIN1$ genes, known trans-acting regulators of the silent loci, and is sensitive to the gene dosage of two SIR genes, SIR1 and SIR4.","label":0}
{"pair_id":"BioInfer.d364.s0.p8","sentence":"In the ADE2 assay system, silencing depends completely upon the function of the @PROTEIN1$ genes, known trans-acting regulators of the silent loci, and is sensitive to the gene dosage of two @PROTEIN2$ genes, SIR1 and SIR4.","label":0}
{"pair_id":"BioInfer.d364.s0.p9","sentence":"In the @PROTEIN1$ assay system, silencing depends completely upon the function of the SIR genes, known trans-acting regulators of the silent loci, and is sensitive to the gene dosage of two @PROTEIN2$ genes, SIR1 and SIR4.","label":0}
{"pair_id":"AIMed.d57.s503.p0","sentence":"Reconstitution of the multiprotein complex of @PROTEIN1$, @PROTEIN2$, and p50 in a cell-free system.","label":1}
{"pair_id":"AIMed.d57.s503.p1","sentence":"Reconstitution of the multiprotein complex of @PROTEIN1$, hsp90, and @PROTEIN2$ in a cell-free system.","label":0}
{"pair_id":"AIMed.d57.s503.p2","sentence":"Reconstitution of the multiprotein complex of pp60src, @PROTEIN1$, and @PROTEIN2$ in a cell-free system.","label":0}
{"pair_id":"BioInfer.d429.s1.p0","sentence":"@PROTEIN2$ may also function in signalling pathways, given its homology to the gene product of the Drosophila segment polarity gene @PROTEIN1$, which is known to be involved in the wingless signalling cascade.","label":1}
{"pair_id":"BioInfer.d556.s0.p0","sentence":"Suppression of cell transformation by the cyclin-dependent kinase inhibitor @PROTEIN2$ requires binding to @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d556.s0.p1","sentence":"Suppression of cell transformation by the @PROTEIN2$ p57KIP2 requires binding to @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d556.s0.p2","sentence":"Suppression of cell transformation by the @PROTEIN2$ @PROTEIN1$ requires binding to proliferating cell nuclear antigen.","label":1}
{"pair_id":"AIMed.d105.s884.p0","sentence":"Two distinct and independent sites on @PROTEIN1$ trigger @PROTEIN2$ dimer formation and signalling.","label":1}
{"pair_id":"BioInfer.d52.s2.p0","sentence":"The in vitro and in vivo binding patterns were highly similar, and the association of the @PROTEIN1$ variants with syntaxin 3 correlated well with their ability to displace SNAP-23 from @PROTEIN2$ complexes when overexpressed in Caco-2 cells.","label":1}
{"pair_id":"BioInfer.d52.s2.p1","sentence":"The in vitro and in vivo binding patterns were highly similar, and the association of the @PROTEIN1$ variants with syntaxin 3 correlated well with their ability to displace @PROTEIN2$ from syntaxin 3 complexes when overexpressed in Caco-2 cells.","label":1}
{"pair_id":"BioInfer.d52.s2.p2","sentence":"The in vitro and in vivo binding patterns were highly similar, and the association of the @PROTEIN1$ variants with @PROTEIN2$ correlated well with their ability to displace SNAP-23 from syntaxin 3 complexes when overexpressed in Caco-2 cells.","label":1}
{"pair_id":"BioInfer.d52.s2.p3","sentence":"The in vitro and in vivo binding patterns were highly similar, and the association of the Munc18-2 variants with syntaxin 3 correlated well with their ability to displace @PROTEIN2$ from @PROTEIN1$ complexes when overexpressed in Caco-2 cells.","label":1}
{"pair_id":"BioInfer.d52.s2.p4","sentence":"The in vitro and in vivo binding patterns were highly similar, and the association of the Munc18-2 variants with @PROTEIN2$ correlated well with their ability to displace SNAP-23 from @PROTEIN1$ complexes when overexpressed in Caco-2 cells.","label":1}
{"pair_id":"BioInfer.d52.s2.p5","sentence":"The in vitro and in vivo binding patterns were highly similar, and the association of the Munc18-2 variants with @PROTEIN2$ correlated well with their ability to displace @PROTEIN1$ from syntaxin 3 complexes when overexpressed in Caco-2 cells.","label":1}
{"pair_id":"AIMed.d2.s24.p0","sentence":"RESULTS: After 7 days hospitalisation, molar @PROTEIN1$:@PROTEIN2$ ratio (mean+\/-s.d.) of infected children (C-reactive proteins>10 mg\/l) was 0.67+\/-0.31 in the high-dose group (n=81), 0.74+\/-0.44 in the low dose group (n=71) and 0.73+\/-0.39 in the placebo group (n=81). These values did not differ significantly (one-way ANOVA P=0.472). In patients with baseline serum retinol concentrations<0.70 micromol\/l, changes in RBP:TTR ratio between admission and day 7 were not statistically different in the three groups (one-way ANOVA P=0.548). CONCLUSIONS: In this population of malnourished hospitalised children, molar RBP:TTR ratio does not appear to be useful to assess VA status during infection. SPONSORSHIP: Our research was partially supported by a grant from the Fonds de la Recherche Scientifique et Medicale (contract 3.4505.94) and the David and Alice Van Buuren Foundation.","label":0}
{"pair_id":"AIMed.d2.s24.p1","sentence":"RESULTS: After 7 days hospitalisation, molar @PROTEIN1$:TTR ratio (mean+\/-s.d.) of infected children (C-reactive proteins>10 mg\/l) was 0.67+\/-0.31 in the high-dose group (n=81), 0.74+\/-0.44 in the low dose group (n=71) and 0.73+\/-0.39 in the placebo group (n=81). These values did not differ significantly (one-way ANOVA P=0.472). In patients with baseline serum retinol concentrations<0.70 micromol\/l, changes in @PROTEIN2$:TTR ratio between admission and day 7 were not statistically different in the three groups (one-way ANOVA P=0.548). CONCLUSIONS: In this population of malnourished hospitalised children, molar RBP:TTR ratio does not appear to be useful to assess VA status during infection. SPONSORSHIP: Our research was partially supported by a grant from the Fonds de la Recherche Scientifique et Medicale (contract 3.4505.94) and the David and Alice Van Buuren Foundation.","label":0}
{"pair_id":"AIMed.d2.s24.p2","sentence":"RESULTS: After 7 days hospitalisation, molar @PROTEIN1$:TTR ratio (mean+\/-s.d.) of infected children (C-reactive proteins>10 mg\/l) was 0.67+\/-0.31 in the high-dose group (n=81), 0.74+\/-0.44 in the low dose group (n=71) and 0.73+\/-0.39 in the placebo group (n=81). These values did not differ significantly (one-way ANOVA P=0.472). In patients with baseline serum retinol concentrations<0.70 micromol\/l, changes in RBP:@PROTEIN2$ ratio between admission and day 7 were not statistically different in the three groups (one-way ANOVA P=0.548). CONCLUSIONS: In this population of malnourished hospitalised children, molar RBP:TTR ratio does not appear to be useful to assess VA status during infection. SPONSORSHIP: Our research was partially supported by a grant from the Fonds de la Recherche Scientifique et Medicale (contract 3.4505.94) and the David and Alice Van Buuren Foundation.","label":0}
{"pair_id":"AIMed.d2.s24.p3","sentence":"RESULTS: After 7 days hospitalisation, molar @PROTEIN1$:TTR ratio (mean+\/-s.d.) of infected children (C-reactive proteins>10 mg\/l) was 0.67+\/-0.31 in the high-dose group (n=81), 0.74+\/-0.44 in the low dose group (n=71) and 0.73+\/-0.39 in the placebo group (n=81). These values did not differ significantly (one-way ANOVA P=0.472). In patients with baseline serum retinol concentrations<0.70 micromol\/l, changes in RBP:TTR ratio between admission and day 7 were not statistically different in the three groups (one-way ANOVA P=0.548). CONCLUSIONS: In this population of malnourished hospitalised children, molar @PROTEIN2$:TTR ratio does not appear to be useful to assess VA status during infection. SPONSORSHIP: Our research was partially supported by a grant from the Fonds de la Recherche Scientifique et Medicale (contract 3.4505.94) and the David and Alice Van Buuren Foundation.","label":0}
{"pair_id":"AIMed.d2.s24.p4","sentence":"RESULTS: After 7 days hospitalisation, molar @PROTEIN1$:TTR ratio (mean+\/-s.d.) of infected children (C-reactive proteins>10 mg\/l) was 0.67+\/-0.31 in the high-dose group (n=81), 0.74+\/-0.44 in the low dose group (n=71) and 0.73+\/-0.39 in the placebo group (n=81). These values did not differ significantly (one-way ANOVA P=0.472). In patients with baseline serum retinol concentrations<0.70 micromol\/l, changes in RBP:TTR ratio between admission and day 7 were not statistically different in the three groups (one-way ANOVA P=0.548). CONCLUSIONS: In this population of malnourished hospitalised children, molar RBP:@PROTEIN2$ ratio does not appear to be useful to assess VA status during infection. SPONSORSHIP: Our research was partially supported by a grant from the Fonds de la Recherche Scientifique et Medicale (contract 3.4505.94) and the David and Alice Van Buuren Foundation.","label":0}
{"pair_id":"AIMed.d2.s24.p5","sentence":"RESULTS: After 7 days hospitalisation, molar RBP:@PROTEIN1$ ratio (mean+\/-s.d.) of infected children (C-reactive proteins>10 mg\/l) was 0.67+\/-0.31 in the high-dose group (n=81), 0.74+\/-0.44 in the low dose group (n=71) and 0.73+\/-0.39 in the placebo group (n=81). These values did not differ significantly (one-way ANOVA P=0.472). In patients with baseline serum retinol concentrations<0.70 micromol\/l, changes in @PROTEIN2$:TTR ratio between admission and day 7 were not statistically different in the three groups (one-way ANOVA P=0.548). CONCLUSIONS: In this population of malnourished hospitalised children, molar RBP:TTR ratio does not appear to be useful to assess VA status during infection. SPONSORSHIP: Our research was partially supported by a grant from the Fonds de la Recherche Scientifique et Medicale (contract 3.4505.94) and the David and Alice Van Buuren Foundation.","label":0}
{"pair_id":"AIMed.d2.s24.p6","sentence":"RESULTS: After 7 days hospitalisation, molar RBP:@PROTEIN1$ ratio (mean+\/-s.d.) of infected children (C-reactive proteins>10 mg\/l) was 0.67+\/-0.31 in the high-dose group (n=81), 0.74+\/-0.44 in the low dose group (n=71) and 0.73+\/-0.39 in the placebo group (n=81). These values did not differ significantly (one-way ANOVA P=0.472). In patients with baseline serum retinol concentrations<0.70 micromol\/l, changes in RBP:@PROTEIN2$ ratio between admission and day 7 were not statistically different in the three groups (one-way ANOVA P=0.548). CONCLUSIONS: In this population of malnourished hospitalised children, molar RBP:TTR ratio does not appear to be useful to assess VA status during infection. SPONSORSHIP: Our research was partially supported by a grant from the Fonds de la Recherche Scientifique et Medicale (contract 3.4505.94) and the David and Alice Van Buuren Foundation.","label":0}
{"pair_id":"AIMed.d2.s24.p7","sentence":"RESULTS: After 7 days hospitalisation, molar RBP:@PROTEIN1$ ratio (mean+\/-s.d.) of infected children (C-reactive proteins>10 mg\/l) was 0.67+\/-0.31 in the high-dose group (n=81), 0.74+\/-0.44 in the low dose group (n=71) and 0.73+\/-0.39 in the placebo group (n=81). These values did not differ significantly (one-way ANOVA P=0.472). In patients with baseline serum retinol concentrations<0.70 micromol\/l, changes in RBP:TTR ratio between admission and day 7 were not statistically different in the three groups (one-way ANOVA P=0.548). CONCLUSIONS: In this population of malnourished hospitalised children, molar @PROTEIN2$:TTR ratio does not appear to be useful to assess VA status during infection. SPONSORSHIP: Our research was partially supported by a grant from the Fonds de la Recherche Scientifique et Medicale (contract 3.4505.94) and the David and Alice Van Buuren Foundation.","label":0}
{"pair_id":"AIMed.d2.s24.p8","sentence":"RESULTS: After 7 days hospitalisation, molar RBP:@PROTEIN1$ ratio (mean+\/-s.d.) of infected children (C-reactive proteins>10 mg\/l) was 0.67+\/-0.31 in the high-dose group (n=81), 0.74+\/-0.44 in the low dose group (n=71) and 0.73+\/-0.39 in the placebo group (n=81). These values did not differ significantly (one-way ANOVA P=0.472). In patients with baseline serum retinol concentrations<0.70 micromol\/l, changes in RBP:TTR ratio between admission and day 7 were not statistically different in the three groups (one-way ANOVA P=0.548). CONCLUSIONS: In this population of malnourished hospitalised children, molar RBP:@PROTEIN2$ ratio does not appear to be useful to assess VA status during infection. SPONSORSHIP: Our research was partially supported by a grant from the Fonds de la Recherche Scientifique et Medicale (contract 3.4505.94) and the David and Alice Van Buuren Foundation.","label":0}
{"pair_id":"AIMed.d2.s24.p9","sentence":"RESULTS: After 7 days hospitalisation, molar RBP:TTR ratio (mean+\/-s.d.) of infected children (C-reactive proteins>10 mg\/l) was 0.67+\/-0.31 in the high-dose group (n=81), 0.74+\/-0.44 in the low dose group (n=71) and 0.73+\/-0.39 in the placebo group (n=81). These values did not differ significantly (one-way ANOVA P=0.472). In patients with baseline serum retinol concentrations<0.70 micromol\/l, changes in @PROTEIN1$:@PROTEIN2$ ratio between admission and day 7 were not statistically different in the three groups (one-way ANOVA P=0.548). CONCLUSIONS: In this population of malnourished hospitalised children, molar RBP:TTR ratio does not appear to be useful to assess VA status during infection. SPONSORSHIP: Our research was partially supported by a grant from the Fonds de la Recherche Scientifique et Medicale (contract 3.4505.94) and the David and Alice Van Buuren Foundation.","label":0}
{"pair_id":"AIMed.d2.s24.p10","sentence":"RESULTS: After 7 days hospitalisation, molar RBP:TTR ratio (mean+\/-s.d.) of infected children (C-reactive proteins>10 mg\/l) was 0.67+\/-0.31 in the high-dose group (n=81), 0.74+\/-0.44 in the low dose group (n=71) and 0.73+\/-0.39 in the placebo group (n=81). These values did not differ significantly (one-way ANOVA P=0.472). In patients with baseline serum retinol concentrations<0.70 micromol\/l, changes in @PROTEIN1$:TTR ratio between admission and day 7 were not statistically different in the three groups (one-way ANOVA P=0.548). CONCLUSIONS: In this population of malnourished hospitalised children, molar @PROTEIN2$:TTR ratio does not appear to be useful to assess VA status during infection. SPONSORSHIP: Our research was partially supported by a grant from the Fonds de la Recherche Scientifique et Medicale (contract 3.4505.94) and the David and Alice Van Buuren Foundation.","label":0}
{"pair_id":"AIMed.d2.s24.p11","sentence":"RESULTS: After 7 days hospitalisation, molar RBP:TTR ratio (mean+\/-s.d.) of infected children (C-reactive proteins>10 mg\/l) was 0.67+\/-0.31 in the high-dose group (n=81), 0.74+\/-0.44 in the low dose group (n=71) and 0.73+\/-0.39 in the placebo group (n=81). These values did not differ significantly (one-way ANOVA P=0.472). In patients with baseline serum retinol concentrations<0.70 micromol\/l, changes in @PROTEIN1$:TTR ratio between admission and day 7 were not statistically different in the three groups (one-way ANOVA P=0.548). CONCLUSIONS: In this population of malnourished hospitalised children, molar RBP:@PROTEIN2$ ratio does not appear to be useful to assess VA status during infection. SPONSORSHIP: Our research was partially supported by a grant from the Fonds de la Recherche Scientifique et Medicale (contract 3.4505.94) and the David and Alice Van Buuren Foundation.","label":0}
{"pair_id":"AIMed.d2.s24.p12","sentence":"RESULTS: After 7 days hospitalisation, molar RBP:TTR ratio (mean+\/-s.d.) of infected children (C-reactive proteins>10 mg\/l) was 0.67+\/-0.31 in the high-dose group (n=81), 0.74+\/-0.44 in the low dose group (n=71) and 0.73+\/-0.39 in the placebo group (n=81). These values did not differ significantly (one-way ANOVA P=0.472). In patients with baseline serum retinol concentrations<0.70 micromol\/l, changes in RBP:@PROTEIN1$ ratio between admission and day 7 were not statistically different in the three groups (one-way ANOVA P=0.548). CONCLUSIONS: In this population of malnourished hospitalised children, molar @PROTEIN2$:TTR ratio does not appear to be useful to assess VA status during infection. SPONSORSHIP: Our research was partially supported by a grant from the Fonds de la Recherche Scientifique et Medicale (contract 3.4505.94) and the David and Alice Van Buuren Foundation.","label":0}
{"pair_id":"AIMed.d2.s24.p13","sentence":"RESULTS: After 7 days hospitalisation, molar RBP:TTR ratio (mean+\/-s.d.) of infected children (C-reactive proteins>10 mg\/l) was 0.67+\/-0.31 in the high-dose group (n=81), 0.74+\/-0.44 in the low dose group (n=71) and 0.73+\/-0.39 in the placebo group (n=81). These values did not differ significantly (one-way ANOVA P=0.472). In patients with baseline serum retinol concentrations<0.70 micromol\/l, changes in RBP:@PROTEIN1$ ratio between admission and day 7 were not statistically different in the three groups (one-way ANOVA P=0.548). CONCLUSIONS: In this population of malnourished hospitalised children, molar RBP:@PROTEIN2$ ratio does not appear to be useful to assess VA status during infection. SPONSORSHIP: Our research was partially supported by a grant from the Fonds de la Recherche Scientifique et Medicale (contract 3.4505.94) and the David and Alice Van Buuren Foundation.","label":0}
{"pair_id":"AIMed.d2.s24.p14","sentence":"RESULTS: After 7 days hospitalisation, molar RBP:TTR ratio (mean+\/-s.d.) of infected children (C-reactive proteins>10 mg\/l) was 0.67+\/-0.31 in the high-dose group (n=81), 0.74+\/-0.44 in the low dose group (n=71) and 0.73+\/-0.39 in the placebo group (n=81). These values did not differ significantly (one-way ANOVA P=0.472). In patients with baseline serum retinol concentrations<0.70 micromol\/l, changes in RBP:TTR ratio between admission and day 7 were not statistically different in the three groups (one-way ANOVA P=0.548). CONCLUSIONS: In this population of malnourished hospitalised children, molar @PROTEIN1$:@PROTEIN2$ ratio does not appear to be useful to assess VA status during infection. SPONSORSHIP: Our research was partially supported by a grant from the Fonds de la Recherche Scientifique et Medicale (contract 3.4505.94) and the David and Alice Van Buuren Foundation.","label":0}
{"pair_id":"BioInfer.d158.s0.p0","sentence":"Crystallization and preliminary crystallographic analysis of the N-terminal @PROTEIN2$ binding domain of human @PROTEIN1$.","label":1}
{"pair_id":"AIMed.d125.s1068.p0","sentence":"Use of deletion mutants of @PROTEIN1$ suggested that @PROTEIN2$ homodimerization involves interactions between two distinct regions within the Bcl-2 protein, since a LexA protein containing Bcl-2 amino acids 83-218 mediated functional interactions with a B42 fusion protein containing Bcl-2 amino acids 1-81 but did not complement a B42 fusion protein containing Bcl-2 amino acids 83-218.","label":0}
{"pair_id":"AIMed.d125.s1068.p1","sentence":"Use of deletion mutants of @PROTEIN1$ suggested that Bcl-2 homodimerization involves interactions between two distinct regions within the @PROTEIN2$ protein, since a LexA protein containing Bcl-2 amino acids 83-218 mediated functional interactions with a B42 fusion protein containing Bcl-2 amino acids 1-81 but did not complement a B42 fusion protein containing Bcl-2 amino acids 83-218.","label":0}
{"pair_id":"AIMed.d125.s1068.p2","sentence":"Use of deletion mutants of @PROTEIN1$ suggested that Bcl-2 homodimerization involves interactions between two distinct regions within the Bcl-2 protein, since a LexA protein containing @PROTEIN2$ amino acids 83-218 mediated functional interactions with a B42 fusion protein containing Bcl-2 amino acids 1-81 but did not complement a B42 fusion protein containing Bcl-2 amino acids 83-218.","label":0}
{"pair_id":"AIMed.d125.s1068.p3","sentence":"Use of deletion mutants of @PROTEIN1$ suggested that Bcl-2 homodimerization involves interactions between two distinct regions within the Bcl-2 protein, since a LexA protein containing Bcl-2 amino acids 83-218 mediated functional interactions with a B42 fusion protein containing @PROTEIN2$ amino acids 1-81 but did not complement a B42 fusion protein containing Bcl-2 amino acids 83-218.","label":0}
{"pair_id":"AIMed.d125.s1068.p4","sentence":"Use of deletion mutants of @PROTEIN1$ suggested that Bcl-2 homodimerization involves interactions between two distinct regions within the Bcl-2 protein, since a LexA protein containing Bcl-2 amino acids 83-218 mediated functional interactions with a B42 fusion protein containing Bcl-2 amino acids 1-81 but did not complement a B42 fusion protein containing @PROTEIN2$ amino acids 83-218.","label":0}
{"pair_id":"AIMed.d125.s1068.p5","sentence":"Use of deletion mutants of Bcl-2 suggested that @PROTEIN1$ homodimerization involves interactions between two distinct regions within the @PROTEIN2$ protein, since a LexA protein containing Bcl-2 amino acids 83-218 mediated functional interactions with a B42 fusion protein containing Bcl-2 amino acids 1-81 but did not complement a B42 fusion protein containing Bcl-2 amino acids 83-218.","label":0}
{"pair_id":"AIMed.d125.s1068.p6","sentence":"Use of deletion mutants of Bcl-2 suggested that @PROTEIN1$ homodimerization involves interactions between two distinct regions within the Bcl-2 protein, since a LexA protein containing @PROTEIN2$ amino acids 83-218 mediated functional interactions with a B42 fusion protein containing Bcl-2 amino acids 1-81 but did not complement a B42 fusion protein containing Bcl-2 amino acids 83-218.","label":0}
{"pair_id":"AIMed.d125.s1068.p7","sentence":"Use of deletion mutants of Bcl-2 suggested that @PROTEIN1$ homodimerization involves interactions between two distinct regions within the Bcl-2 protein, since a LexA protein containing Bcl-2 amino acids 83-218 mediated functional interactions with a B42 fusion protein containing @PROTEIN2$ amino acids 1-81 but did not complement a B42 fusion protein containing Bcl-2 amino acids 83-218.","label":0}
{"pair_id":"AIMed.d125.s1068.p8","sentence":"Use of deletion mutants of Bcl-2 suggested that @PROTEIN1$ homodimerization involves interactions between two distinct regions within the Bcl-2 protein, since a LexA protein containing Bcl-2 amino acids 83-218 mediated functional interactions with a B42 fusion protein containing Bcl-2 amino acids 1-81 but did not complement a B42 fusion protein containing @PROTEIN2$ amino acids 83-218.","label":0}
{"pair_id":"AIMed.d125.s1068.p9","sentence":"Use of deletion mutants of Bcl-2 suggested that Bcl-2 homodimerization involves interactions between two distinct regions within the @PROTEIN1$ protein, since a LexA protein containing @PROTEIN2$ amino acids 83-218 mediated functional interactions with a B42 fusion protein containing Bcl-2 amino acids 1-81 but did not complement a B42 fusion protein containing Bcl-2 amino acids 83-218.","label":0}
{"pair_id":"AIMed.d125.s1068.p10","sentence":"Use of deletion mutants of Bcl-2 suggested that Bcl-2 homodimerization involves interactions between two distinct regions within the @PROTEIN1$ protein, since a LexA protein containing Bcl-2 amino acids 83-218 mediated functional interactions with a B42 fusion protein containing @PROTEIN2$ amino acids 1-81 but did not complement a B42 fusion protein containing Bcl-2 amino acids 83-218.","label":0}
{"pair_id":"AIMed.d125.s1068.p11","sentence":"Use of deletion mutants of Bcl-2 suggested that Bcl-2 homodimerization involves interactions between two distinct regions within the @PROTEIN1$ protein, since a LexA protein containing Bcl-2 amino acids 83-218 mediated functional interactions with a B42 fusion protein containing Bcl-2 amino acids 1-81 but did not complement a B42 fusion protein containing @PROTEIN2$ amino acids 83-218.","label":0}
{"pair_id":"AIMed.d125.s1068.p12","sentence":"Use of deletion mutants of Bcl-2 suggested that Bcl-2 homodimerization involves interactions between two distinct regions within the Bcl-2 protein, since a LexA protein containing @PROTEIN1$ amino acids 83-218 mediated functional interactions with a B42 fusion protein containing @PROTEIN2$ amino acids 1-81 but did not complement a B42 fusion protein containing Bcl-2 amino acids 83-218.","label":0}
{"pair_id":"AIMed.d125.s1068.p13","sentence":"Use of deletion mutants of Bcl-2 suggested that Bcl-2 homodimerization involves interactions between two distinct regions within the Bcl-2 protein, since a LexA protein containing @PROTEIN1$ amino acids 83-218 mediated functional interactions with a B42 fusion protein containing Bcl-2 amino acids 1-81 but did not complement a B42 fusion protein containing @PROTEIN2$ amino acids 83-218.","label":0}
{"pair_id":"AIMed.d125.s1068.p14","sentence":"Use of deletion mutants of Bcl-2 suggested that Bcl-2 homodimerization involves interactions between two distinct regions within the Bcl-2 protein, since a LexA protein containing Bcl-2 amino acids 83-218 mediated functional interactions with a B42 fusion protein containing @PROTEIN1$ amino acids 1-81 but did not complement a B42 fusion protein containing @PROTEIN2$ amino acids 83-218.","label":0}
{"pair_id":"AIMed.d119.s1011.p0","sentence":"The activation domain of @PROTEIN1$ interacts with the basal transcription factor @PROTEIN2$ through a domain that is conserved in the yeast coactivator ADA-1 (ref. 8).","label":0}
{"pair_id":"AIMed.d119.s1011.p1","sentence":"The activation domain of @PROTEIN1$ interacts with the basal transcription factor TFIIB through a domain that is conserved in the yeast coactivator @PROTEIN2$ (ref. 8).","label":1}
{"pair_id":"AIMed.d119.s1011.p2","sentence":"The activation domain of CBP interacts with the basal transcription factor @PROTEIN1$ through a domain that is conserved in the yeast coactivator @PROTEIN2$ (ref. 8).","label":0}
{"pair_id":"BioInfer.d487.s0.p0","sentence":"Phosphorylation of the headpiece domain could regulate the @PROTEIN1$ binding and bundling properties of @PROTEIN2$, or it could regulate the interaction of fimbrin with other proteins.","label":1}
{"pair_id":"BioInfer.d487.s0.p1","sentence":"Phosphorylation of the headpiece domain could regulate the @PROTEIN1$ binding and bundling properties of fimbrin, or it could regulate the interaction of @PROTEIN2$ with other proteins.","label":0}
{"pair_id":"BioInfer.d487.s0.p2","sentence":"Phosphorylation of the headpiece domain could regulate the actin binding and bundling properties of @PROTEIN1$, or it could regulate the interaction of @PROTEIN2$ with other proteins.","label":1}
{"pair_id":"AIMed.d123.s1052.p0","sentence":"Lastly, in agreement with our findings for yeast cells, we show that the @PROTEIN1$ is unable to phosphorylate an @PROTEIN2$ protein containing a deletion of amino acids 45 to 516 when expressed in COS cells.","label":0}
{"pair_id":"BioInfer.d337.s0.p0","sentence":"Inhibition of 12P-CRE binding was also observed in the presence of an antibody to @PROTEIN1$ (265-kDa @PROTEIN2$), an integrator and coactivator of cAMP-responsive genes.","label":0}
{"pair_id":"BioInfer.d707.s0.p0","sentence":"These regions also interact with the physiologically relevant ligands of @PROTEIN2$, @PROTEIN1$ and proline-rich peptides.","label":1}
{"pair_id":"BioInfer.d375.s2.p0","sentence":"The current view of the mechanism of action of Acanthamoeba @PROTEIN2$ is that it binds to @PROTEIN1$ monomers, forming a complex that cannot polymerize [Tobacman, L. S., & Korn, E. D. (1982) J. Biol. Chem. 257, 4166-4170; Tseng, P., & Pollard, T. D. (1982) J. Cell Biol. 94, 213-218; Tobacman, L. S., Brenner, S. L., & Korn, E. D. (1983) J. Biol. Chem. 258, 8806-8812].","label":1}
{"pair_id":"BioInfer.d758.s0.p0","sentence":"@PROTEIN1$ also inhibited muscle differentiation as measured by several parameters, including cell fusion and the expression of other muscle-specific genes, such as alpha-skeletal actin and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d758.s0.p1","sentence":"@PROTEIN1$ also inhibited muscle differentiation as measured by several parameters, including cell fusion and the expression of other muscle-specific genes, such as @PROTEIN2$ and myosin heavy chain.","label":0}
{"pair_id":"BioInfer.d758.s0.p2","sentence":"TNF also inhibited muscle differentiation as measured by several parameters, including cell fusion and the expression of other muscle-specific genes, such as @PROTEIN2$ and @PROTEIN1$.","label":0}
{"pair_id":"AIMed.d218.s1897.p0","sentence":"In contrast, the other three monoclonal antibodies, which were effective at blocking @PROTEIN1$ activity but did not block initial binding of @PROTEIN2$ to its receptor, had epitopes predominantly on helix or 3.","label":0}
{"pair_id":"BioInfer.d335.s0.p0","sentence":"In flattened cells under starvation stress, @PROTEIN2$ localized at dramatically reorganizing actin-cytoskeletons in ruffling membranes of the leading edge, but not at rigid @PROTEIN1$ meshwork in focal adhesion plaques.","label":1}
{"pair_id":"BioInfer.d335.s0.p1","sentence":"In flattened cells under starvation stress, cofilin localized at dramatically reorganizing @PROTEIN2$-cytoskeletons in ruffling membranes of the leading edge, but not at rigid @PROTEIN1$ meshwork in focal adhesion plaques.","label":0}
{"pair_id":"BioInfer.d335.s0.p2","sentence":"In flattened cells under starvation stress, @PROTEIN1$ localized at dramatically reorganizing @PROTEIN2$-cytoskeletons in ruffling membranes of the leading edge, but not at rigid actin meshwork in focal adhesion plaques.","label":1}
{"pair_id":"AIMed.d129.s1111.p0","sentence":"These antibodies specifically immunoprecipitate @PROTEIN1$ in complex with @PROTEIN2$ in all tissues tested and can be used to immunoaffinity isolate progesterone receptor complexes from chicken oviduct cytosol.","label":1}
{"pair_id":"BioInfer.d566.s0.p0","sentence":"The ability of WIP to replace verprolin is dependent on its WH2 @PROTEIN2$ binding domain and a putative @PROTEIN1$ binding domain.","label":0}
{"pair_id":"BioInfer.d566.s0.p1","sentence":"The ability of @PROTEIN2$ to replace verprolin is dependent on its WH2 actin binding domain and a putative @PROTEIN1$ binding domain.","label":1}
{"pair_id":"BioInfer.d566.s0.p2","sentence":"The ability of WIP to replace @PROTEIN2$ is dependent on its WH2 actin binding domain and a putative @PROTEIN1$ binding domain.","label":0}
{"pair_id":"BioInfer.d566.s0.p3","sentence":"The ability of @PROTEIN2$ to replace verprolin is dependent on its WH2 @PROTEIN1$ binding domain and a putative profilin binding domain.","label":1}
{"pair_id":"BioInfer.d566.s0.p4","sentence":"The ability of WIP to replace @PROTEIN2$ is dependent on its WH2 @PROTEIN1$ binding domain and a putative profilin binding domain.","label":0}
{"pair_id":"BioInfer.d566.s0.p5","sentence":"The ability of @PROTEIN1$ to replace @PROTEIN2$ is dependent on its WH2 actin binding domain and a putative profilin binding domain.","label":1}
{"pair_id":"AIMed.d179.s1529.p0","sentence":"Taken together, our results suggest that @PROTEIN1$ may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the @PROTEIN2$\/CCKB G protein-coupled receptor and the insulin receptor.","label":0}
{"pair_id":"AIMed.d179.s1529.p1","sentence":"Taken together, our results suggest that @PROTEIN1$ may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin\/@PROTEIN2$ G protein-coupled receptor and the insulin receptor.","label":0}
{"pair_id":"AIMed.d179.s1529.p2","sentence":"Taken together, our results suggest that @PROTEIN1$ may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin\/@PROTEIN2$ and the insulin receptor.","label":0}
{"pair_id":"AIMed.d179.s1529.p3","sentence":"Taken together, our results suggest that @PROTEIN1$ may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin\/CCKB G protein-coupled receptor and the @PROTEIN2$ receptor.","label":0}
{"pair_id":"AIMed.d179.s1529.p4","sentence":"Taken together, our results suggest that @PROTEIN1$ may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin\/CCKB G protein-coupled receptor and the @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d179.s1529.p5","sentence":"Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the @PROTEIN1$\/@PROTEIN2$ G protein-coupled receptor and the insulin receptor.","label":0}
{"pair_id":"AIMed.d179.s1529.p6","sentence":"Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the @PROTEIN1$\/@PROTEIN2$ and the insulin receptor.","label":0}
{"pair_id":"AIMed.d179.s1529.p7","sentence":"Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the @PROTEIN1$\/CCKB G protein-coupled receptor and the @PROTEIN2$ receptor.","label":0}
{"pair_id":"AIMed.d179.s1529.p8","sentence":"Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the @PROTEIN1$\/CCKB G protein-coupled receptor and the @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d179.s1529.p9","sentence":"Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin\/@PROTEIN1$@PROTEIN2$ and the insulin receptor.","label":0}
{"pair_id":"AIMed.d179.s1529.p10","sentence":"Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin\/@PROTEIN1$ G protein-coupled receptor and the @PROTEIN2$ receptor.","label":0}
{"pair_id":"AIMed.d179.s1529.p11","sentence":"Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin\/@PROTEIN1$ G protein-coupled receptor and the @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d179.s1529.p12","sentence":"Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin\/@PROTEIN1$ and the @PROTEIN2$ receptor.","label":0}
{"pair_id":"AIMed.d179.s1529.p13","sentence":"Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin\/@PROTEIN1$ and the @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d179.s1529.p14","sentence":"Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin\/CCKB G protein-coupled receptor and the @PROTEIN1$@PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d144.s0.p0","sentence":"Coexpression of the @PROTEIN2$ and @PROTEIN1$ genes in Escherichia coli was required for in vitro activity.","label":1}
{"pair_id":"BioInfer.d497.s2.p0","sentence":"The cellular concentrations and binding characteristics of these molecules are consistent with @PROTEIN2$ being a negative regulator of the phosphoinositide signaling pathway in addition to its established function as an inhibitor of @PROTEIN1$ polymerization.","label":1}
{"pair_id":"BioInfer.d263.s2.p0","sentence":"Interestingly, profilin overproduction can compensate for the deleterious effects of too much @PROTEIN1$ in a @PROTEIN2$ concentration-dependent manner.","label":1}
{"pair_id":"BioInfer.d263.s2.p1","sentence":"Interestingly, @PROTEIN2$ overproduction can compensate for the deleterious effects of too much @PROTEIN1$ in a profilin concentration-dependent manner.","label":1}
{"pair_id":"BioInfer.d263.s2.p2","sentence":"Interestingly, @PROTEIN2$ overproduction can compensate for the deleterious effects of too much actin in a @PROTEIN1$ concentration-dependent manner.","label":0}
{"pair_id":"AIMed.d89.s763.p0","sentence":"The present study has shown that cell surface @PROTEIN1$ binds to the @PROTEIN2$ mediating its mitogenic activity.","label":1}
{"pair_id":"BioInfer.d410.s1.p0","sentence":"There was a trend towards an association between advanced tumour stage and loss of membranous expression of @PROTEIN1$ or @PROTEIN2$, although these associations were not statistically significant.","label":0}
{"pair_id":"AIMed.d76.s644.p0","sentence":"Anti-@PROTEIN1$ also precipitated the kinase from various T cells irrespective of the expression of @PROTEIN2$\/CD3 or CD4.","label":0}
{"pair_id":"AIMed.d76.s644.p1","sentence":"Anti-@PROTEIN1$ also precipitated the kinase from various T cells irrespective of the expression of TcR zeta\/@PROTEIN2$ or CD4.","label":0}
{"pair_id":"AIMed.d76.s644.p2","sentence":"Anti-@PROTEIN1$ also precipitated the kinase from various T cells irrespective of the expression of TcR zeta\/CD3 or @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d76.s644.p3","sentence":"Anti-CD5 also precipitated the kinase from various T cells irrespective of the expression of @PROTEIN1$\/@PROTEIN2$ or CD4.","label":0}
{"pair_id":"AIMed.d76.s644.p4","sentence":"Anti-CD5 also precipitated the kinase from various T cells irrespective of the expression of @PROTEIN1$\/CD3 or @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d76.s644.p5","sentence":"Anti-CD5 also precipitated the kinase from various T cells irrespective of the expression of TcR zeta\/@PROTEIN1$ or @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d192.s1639.p0","sentence":"@PROTEIN1$ and @PROTEIN2$ were diminished in the sera of ICE-\/- mice exposed to Propionibacterium acnes and lipopolysaccharide.","label":0}
{"pair_id":"AIMed.d192.s1639.p1","sentence":"@PROTEIN1$ and IGIF were diminished in the sera of @PROTEIN2$-\/- mice exposed to Propionibacterium acnes and lipopolysaccharide.","label":0}
{"pair_id":"AIMed.d192.s1639.p2","sentence":"Interferon-gamma and @PROTEIN1$ were diminished in the sera of @PROTEIN2$-\/- mice exposed to Propionibacterium acnes and lipopolysaccharide.","label":0}
{"pair_id":"BioInfer.d699.s0.p0","sentence":"These genes were designated @PROTEIN1$, UL8, @PROTEIN2$, UL42, and UL52 and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.","label":0}
{"pair_id":"BioInfer.d699.s0.p1","sentence":"These genes were designated @PROTEIN1$, @PROTEIN2$, UL9, UL42, and UL52 and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.","label":0}
{"pair_id":"BioInfer.d699.s0.p2","sentence":"These genes were designated @PROTEIN1$, UL8, UL9, UL42, and @PROTEIN2$ and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.","label":0}
{"pair_id":"BioInfer.d699.s0.p3","sentence":"These genes were designated @PROTEIN1$, UL8, UL9, @PROTEIN2$, and UL52 and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.","label":0}
{"pair_id":"BioInfer.d699.s0.p4","sentence":"These genes were designated UL5, @PROTEIN2$, @PROTEIN1$, UL42, and UL52 and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.","label":0}
{"pair_id":"BioInfer.d699.s0.p5","sentence":"These genes were designated UL5, UL8, @PROTEIN1$, UL42, and @PROTEIN2$ and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.","label":0}
{"pair_id":"BioInfer.d699.s0.p6","sentence":"These genes were designated UL5, UL8, @PROTEIN1$, @PROTEIN2$, and UL52 and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.","label":0}
{"pair_id":"BioInfer.d699.s0.p7","sentence":"These genes were designated UL5, @PROTEIN1$, UL9, UL42, and @PROTEIN2$ and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.","label":0}
{"pair_id":"BioInfer.d699.s0.p8","sentence":"These genes were designated UL5, @PROTEIN1$, UL9, @PROTEIN2$, and UL52 and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.","label":0}
{"pair_id":"BioInfer.d699.s0.p9","sentence":"These genes were designated UL5, UL8, UL9, @PROTEIN2$, and @PROTEIN1$ and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.","label":0}
{"pair_id":"BioInfer.d238.s1.p0","sentence":"Recently, we have shown that the small @PROTEIN2$-depolymerizing protein @PROTEIN1$ represents a component of a co-stimulatory signaling pathway in human T cells.","label":1}
{"pair_id":"BioInfer.d247.s0.p0","sentence":"Here, we prepared a @PROTEIN1$ mutant (@PROTEIN1$) defective in @PROTEIN2$ binding, but retaining the ability to bind to other proteins.","label":1}
{"pair_id":"AIMed.d96.s815.p0","sentence":"After pervanadate treatment of MvLu cells, which inhibits cellular tyrosine phosphatase activity including @PROTEIN1$, the cadherins associated with @PROTEIN2$ are now found in a tyrosine-phosphorylated form, indicating that the cadherins may be an endogenous substrate for PTPmu.","label":0}
{"pair_id":"AIMed.d96.s815.p1","sentence":"After pervanadate treatment of MvLu cells, which inhibits cellular tyrosine phosphatase activity including @PROTEIN1$, the cadherins associated with PTPmu are now found in a tyrosine-phosphorylated form, indicating that the cadherins may be an endogenous substrate for @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d96.s815.p2","sentence":"After pervanadate treatment of MvLu cells, which inhibits cellular tyrosine phosphatase activity including PTPmu, the cadherins associated with @PROTEIN1$ are now found in a tyrosine-phosphorylated form, indicating that the cadherins may be an endogenous substrate for @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d44.s387.p0","sentence":"Finally, we demonstrate that the anti-@PROTEIN1$ MAb M81 also completely inhibits @PROTEIN2$\/CD30L interaction.","label":0}
{"pair_id":"AIMed.d44.s387.p1","sentence":"Finally, we demonstrate that the anti-@PROTEIN1$ MAb M81 also completely inhibits CD30\/@PROTEIN2$ interaction.","label":0}
{"pair_id":"AIMed.d44.s387.p2","sentence":"Finally, we demonstrate that the anti-CD30L MAb M81 also completely inhibits @PROTEIN1$\/@PROTEIN2$ interaction.","label":1}
{"pair_id":"AIMed.d113.s958.p0","sentence":"In gene transfer experiments using a human lymphoid cell line, Jurkat, coexpression of @PROTEIN1$ and @PROTEIN2$ provided markedly increased protection from cell death induced by several stimuli, including staurosporine, anti-Fas antibody, and cytolytic T cells, relative to cells that contained gene transfer-mediated elevations in either BAG-1 or Bcl-2 protein alone.","label":0}
{"pair_id":"AIMed.d113.s958.p1","sentence":"In gene transfer experiments using a human lymphoid cell line, Jurkat, coexpression of @PROTEIN1$ and Bcl-2 provided markedly increased protection from cell death induced by several stimuli, including staurosporine, anti-Fas antibody, and cytolytic T cells, relative to cells that contained gene transfer-mediated elevations in either @PROTEIN2$ or Bcl-2 protein alone.","label":0}
{"pair_id":"AIMed.d113.s958.p2","sentence":"In gene transfer experiments using a human lymphoid cell line, Jurkat, coexpression of @PROTEIN1$ and Bcl-2 provided markedly increased protection from cell death induced by several stimuli, including staurosporine, anti-Fas antibody, and cytolytic T cells, relative to cells that contained gene transfer-mediated elevations in either BAG-1 or @PROTEIN2$ protein alone.","label":0}
{"pair_id":"AIMed.d113.s958.p3","sentence":"In gene transfer experiments using a human lymphoid cell line, Jurkat, coexpression of BAG-1 and @PROTEIN1$ provided markedly increased protection from cell death induced by several stimuli, including staurosporine, anti-Fas antibody, and cytolytic T cells, relative to cells that contained gene transfer-mediated elevations in either @PROTEIN2$ or Bcl-2 protein alone.","label":0}
{"pair_id":"AIMed.d113.s958.p4","sentence":"In gene transfer experiments using a human lymphoid cell line, Jurkat, coexpression of BAG-1 and @PROTEIN1$ provided markedly increased protection from cell death induced by several stimuli, including staurosporine, anti-Fas antibody, and cytolytic T cells, relative to cells that contained gene transfer-mediated elevations in either BAG-1 or @PROTEIN2$ protein alone.","label":0}
{"pair_id":"AIMed.d113.s958.p5","sentence":"In gene transfer experiments using a human lymphoid cell line, Jurkat, coexpression of BAG-1 and Bcl-2 provided markedly increased protection from cell death induced by several stimuli, including staurosporine, anti-Fas antibody, and cytolytic T cells, relative to cells that contained gene transfer-mediated elevations in either @PROTEIN1$ or @PROTEIN2$ protein alone.","label":0}
{"pair_id":"AIMed.d33.s279.p0","sentence":"Native @PROTEIN1$ also formed a heterodimer with @PROTEIN2$,and low concentrations of polyionic ligands such as protamine and suramin inhibited the interaction.","label":1}
{"pair_id":"BioInfer.d68.s0.p0","sentence":"@PROTEIN2$, @PROTEIN1$ and Cdc6 were stable (T1\/2 >2 h) and associated with a chromatin-containing fraction throughout the cell cycle.","label":1}
{"pair_id":"BioInfer.d68.s0.p1","sentence":"ORC1, @PROTEIN1$ and @PROTEIN2$ were stable (T1\/2 >2 h) and associated with a chromatin-containing fraction throughout the cell cycle.","label":1}
{"pair_id":"BioInfer.d68.s0.p2","sentence":"@PROTEIN1$, ORC4 and @PROTEIN2$ were stable (T1\/2 >2 h) and associated with a chromatin-containing fraction throughout the cell cycle.","label":1}
{"pair_id":"AIMed.d216.s1876.p0","sentence":"The switch II region of @PROTEIN1$ is stabilized by @PROTEIN2$, thus allowing glutamine-61 of Ras, mutation of which activates the oncogenic potential, to participate in catalysis.","label":1}
{"pair_id":"AIMed.d216.s1876.p1","sentence":"The switch II region of @PROTEIN1$ is stabilized by GAP-334, thus allowing glutamine-61 of @PROTEIN2$, mutation of which activates the oncogenic potential, to participate in catalysis.","label":0}
{"pair_id":"AIMed.d216.s1876.p2","sentence":"The switch II region of Ras is stabilized by @PROTEIN1$, thus allowing glutamine-61 of @PROTEIN2$, mutation of which activates the oncogenic potential, to participate in catalysis.","label":0}
{"pair_id":"BioInfer.d288.s0.p0","sentence":"Immunofluorescence experiments showed that, like @PROTEIN1$, cofilin is associated with the membrane @PROTEIN2$ cytoskeleton.","label":1}
{"pair_id":"BioInfer.d288.s0.p1","sentence":"Immunofluorescence experiments showed that, like @PROTEIN1$, @PROTEIN2$ is associated with the membrane actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d288.s0.p2","sentence":"Immunofluorescence experiments showed that, like Abp1p, @PROTEIN2$ is associated with the membrane @PROTEIN1$ cytoskeleton.","label":1}
{"pair_id":"BioInfer.d204.s0.p0","sentence":"Expression of c-Myc or @PROTEIN1$ was sufficient to activate cyclin E-@PROTEIN2$ by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor p21, as has been described, following estrogen treatment.","label":1}
{"pair_id":"BioInfer.d204.s0.p1","sentence":"Expression of c-Myc or @PROTEIN1$ was sufficient to activate @PROTEIN2$-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor p21, as has been described, following estrogen treatment.","label":1}
{"pair_id":"BioInfer.d204.s0.p2","sentence":"Expression of c-Myc or @PROTEIN1$ was sufficient to activate cyclin E-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the @PROTEIN2$ p21, as has been described, following estrogen treatment.","label":0}
{"pair_id":"BioInfer.d204.s0.p3","sentence":"Expression of @PROTEIN2$ or @PROTEIN1$ was sufficient to activate cyclin E-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor p21, as has been described, following estrogen treatment.","label":0}
{"pair_id":"BioInfer.d204.s0.p4","sentence":"Expression of c-Myc or @PROTEIN1$ was sufficient to activate cyclin E-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor @PROTEIN2$, as has been described, following estrogen treatment.","label":0}
{"pair_id":"BioInfer.d204.s0.p5","sentence":"Expression of c-Myc or cyclin D1 was sufficient to activate @PROTEIN2$-@PROTEIN1$ by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor p21, as has been described, following estrogen treatment.","label":1}
{"pair_id":"BioInfer.d204.s0.p6","sentence":"Expression of c-Myc or cyclin D1 was sufficient to activate cyclin E-@PROTEIN1$ by promoting the formation of high-molecular-weight complexes lacking the @PROTEIN2$ p21, as has been described, following estrogen treatment.","label":0}
{"pair_id":"BioInfer.d204.s0.p7","sentence":"Expression of @PROTEIN2$ or cyclin D1 was sufficient to activate cyclin E-@PROTEIN1$ by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor p21, as has been described, following estrogen treatment.","label":1}
{"pair_id":"BioInfer.d204.s0.p8","sentence":"Expression of c-Myc or cyclin D1 was sufficient to activate cyclin E-@PROTEIN1$ by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor @PROTEIN2$, as has been described, following estrogen treatment.","label":0}
{"pair_id":"BioInfer.d204.s0.p9","sentence":"Expression of c-Myc or cyclin D1 was sufficient to activate @PROTEIN1$-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the @PROTEIN2$ p21, as has been described, following estrogen treatment.","label":0}
{"pair_id":"BioInfer.d204.s0.p10","sentence":"Expression of @PROTEIN2$ or cyclin D1 was sufficient to activate @PROTEIN1$-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor p21, as has been described, following estrogen treatment.","label":1}
{"pair_id":"BioInfer.d204.s0.p11","sentence":"Expression of c-Myc or cyclin D1 was sufficient to activate @PROTEIN1$-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor @PROTEIN2$, as has been described, following estrogen treatment.","label":0}
{"pair_id":"BioInfer.d204.s0.p12","sentence":"Expression of @PROTEIN2$ or cyclin D1 was sufficient to activate cyclin E-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the @PROTEIN1$ p21, as has been described, following estrogen treatment.","label":0}
{"pair_id":"BioInfer.d204.s0.p13","sentence":"Expression of c-Myc or cyclin D1 was sufficient to activate cyclin E-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the @PROTEIN1$ @PROTEIN2$, as has been described, following estrogen treatment.","label":1}
{"pair_id":"BioInfer.d204.s0.p14","sentence":"Expression of @PROTEIN1$ or cyclin D1 was sufficient to activate cyclin E-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor @PROTEIN2$, as has been described, following estrogen treatment.","label":0}
{"pair_id":"BioInfer.d17.s0.p0","sentence":"@PROTEIN1$ expression was reduced by 25-50%, relative to that of myosin heavy chain, in smooth muscle of KO mice, without any change in the relative distribution of the @PROTEIN2$ isoforms.","label":0}
{"pair_id":"BioInfer.d17.s0.p1","sentence":"@PROTEIN1$ expression was reduced by 25-50%, relative to that of @PROTEIN2$, in smooth muscle of KO mice, without any change in the relative distribution of the actin isoforms.","label":0}
{"pair_id":"BioInfer.d17.s0.p2","sentence":"Actin expression was reduced by 25-50%, relative to that of @PROTEIN2$, in smooth muscle of KO mice, without any change in the relative distribution of the @PROTEIN1$ isoforms.","label":0}
{"pair_id":"BioInfer.d696.s0.p0","sentence":"These differences in contractile protein profiles between single and cultured cells were collaborated with the observation of cells using immunofluorescence microscope with responsible antibodies to isoforms of @PROTEIN2$, actin and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d696.s0.p1","sentence":"These differences in contractile protein profiles between single and cultured cells were collaborated with the observation of cells using immunofluorescence microscope with responsible antibodies to isoforms of myosin heavy chain, @PROTEIN2$ and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d696.s0.p2","sentence":"These differences in contractile protein profiles between single and cultured cells were collaborated with the observation of cells using immunofluorescence microscope with responsible antibodies to isoforms of @PROTEIN1$, @PROTEIN2$ and tropomyosin.","label":0}
{"pair_id":"AIMed.d150.s1275.p0","sentence":"@PROTEIN1$ is a lymphoid-specific @PROTEIN2$ transcription factor that regulates inducible gene expression during T cell activation.","label":0}
{"pair_id":"AIMed.d25.s203.p0","sentence":"Assaying of @PROTEIN1$, complement factors, and @PROTEIN2$ in the diagnosis of malignant serous effusions.","label":0}
{"pair_id":"AIMed.d169.s1425.p0","sentence":"@PROTEIN1$ (@PROTEIN2$) is a cytokine secreted by activated T lymphocytes that shares many, but not all, biological activities with IL-4.","label":0}
{"pair_id":"AIMed.d169.s1425.p1","sentence":"@PROTEIN1$ (IL-13) is a cytokine secreted by activated T lymphocytes that shares many, but not all, biological activities with @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d169.s1425.p2","sentence":"Interleukin-13 (@PROTEIN1$) is a cytokine secreted by activated T lymphocytes that shares many, but not all, biological activities with @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d162.s1369.p0","sentence":"In transfected cells, wild-type @PROTEIN1$ repressed the hormone-dependent transcriptional activation of @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d721.s0.p0","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (@PROTEIN1$; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (@PROTEIN2$; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) phosphop.","label":0}
{"pair_id":"BioInfer.d721.s0.p1","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (@PROTEIN1$; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), @PROTEIN2$ (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d721.s0.p2","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (@PROTEIN1$; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and @PROTEIN2$ (V; 35 kDa) @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d721.s0.p3","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (@PROTEIN1$; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), @PROTEIN2$ (M; 43 kDa) and non-structural (V; 35 kDa) @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d721.s0.p4","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (@PROTEIN1$; 190 kDa), haemagglutinin neuraminidase (@PROTEIN2$; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) phosphop.","label":0}
{"pair_id":"BioInfer.d721.s0.p5","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the @PROTEIN2$ (@PROTEIN1$; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d721.s0.p6","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (@PROTEIN1$; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), @PROTEIN2$ (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d721.s0.p7","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (@PROTEIN1$; 190 kDa), @PROTEIN2$ (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d721.s0.p8","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (@PROTEIN1$; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), @PROTEIN2$ (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d721.s0.p9","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (@PROTEIN1$; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (@PROTEIN2$; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) phosphop.","label":0}
{"pair_id":"BioInfer.d721.s0.p10","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (@PROTEIN1$; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (@PROTEIN2$; 35 kDa) phosphop.","label":0}
{"pair_id":"BioInfer.d721.s0.p11","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (@PROTEIN1$; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (@PROTEIN2$; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) phosphop.","label":0}
{"pair_id":"BioInfer.d721.s0.p12","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (@PROTEIN1$; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (@PROTEIN2$; 43 kDa) and non-structural (V; 35 kDa) phosphop.","label":0}
{"pair_id":"BioInfer.d721.s0.p13","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), @PROTEIN2$ (@PROTEIN1$; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d721.s0.p14","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (@PROTEIN1$; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and @PROTEIN2$ (V; 35 kDa) @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d721.s0.p15","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (@PROTEIN1$; 63 kDa), phosphoprotein (P; 49 kDa), @PROTEIN2$ (M; 43 kDa) and non-structural (V; 35 kDa) @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d721.s0.p16","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (@PROTEIN2$; 74 kDa), nucleocapsid (N; 66 kDa), fusion (@PROTEIN1$; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) phosphop.","label":0}
{"pair_id":"BioInfer.d721.s0.p17","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the @PROTEIN2$ (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (@PROTEIN1$; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d721.s0.p18","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), @PROTEIN2$ (N; 66 kDa), fusion (@PROTEIN1$; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d721.s0.p19","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), @PROTEIN2$ (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (@PROTEIN1$; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d721.s0.p20","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (@PROTEIN1$; 63 kDa), @PROTEIN2$ (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d721.s0.p21","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (@PROTEIN1$; 63 kDa), phosphoprotein (@PROTEIN2$; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) phosphop.","label":0}
{"pair_id":"BioInfer.d721.s0.p22","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (@PROTEIN1$; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (@PROTEIN2$; 35 kDa) phosphop.","label":0}
{"pair_id":"BioInfer.d721.s0.p23","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (@PROTEIN2$; 66 kDa), fusion (@PROTEIN1$; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) phosphop.","label":0}
{"pair_id":"BioInfer.d721.s0.p24","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (@PROTEIN1$; 63 kDa), phosphoprotein (P; 49 kDa), matrix (@PROTEIN2$; 43 kDa) and non-structural (V; 35 kDa) phosphop.","label":0}
{"pair_id":"BioInfer.d721.s0.p25","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), @PROTEIN1$ (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and @PROTEIN2$ (V; 35 kDa) @PROTEIN1$@PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d721.s0.p26","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), @PROTEIN1$ (F0; 63 kDa), phosphoprotein (P; 49 kDa), @PROTEIN2$ (M; 43 kDa) and non-structural (V; 35 kDa) @PROTEIN1$@PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d721.s0.p27","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (@PROTEIN2$; 74 kDa), nucleocapsid (N; 66 kDa), @PROTEIN1$ (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d721.s0.p28","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the @PROTEIN2$ (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), @PROTEIN1$ (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) @PROTEIN1$@PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d721.s0.p29","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), @PROTEIN2$ (N; 66 kDa), @PROTEIN1$ (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) @PROTEIN1$@PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d721.s0.p30","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), @PROTEIN2$ (HN; 74 kDa), nucleocapsid (N; 66 kDa), @PROTEIN1$ (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) @PROTEIN1$@PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d721.s0.p31","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), @PROTEIN1$ (F0; 63 kDa), @PROTEIN2$ (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) @PROTEIN1$@PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d721.s0.p32","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), @PROTEIN1$ (F0; 63 kDa), phosphoprotein (@PROTEIN2$; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d721.s0.p33","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), @PROTEIN1$ (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (@PROTEIN2$; 35 kDa) @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d721.s0.p34","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (@PROTEIN2$; 66 kDa), @PROTEIN1$ (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d721.s0.p35","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), @PROTEIN1$ (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (@PROTEIN2$; 43 kDa) and non-structural (V; 35 kDa) @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d721.s0.p36","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), @PROTEIN2$ (M; 43 kDa) and @PROTEIN1$ (V; 35 kDa) @PROTEIN1$@PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d721.s0.p37","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (@PROTEIN2$; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and @PROTEIN1$ (V; 35 kDa) @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d721.s0.p38","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the @PROTEIN2$ (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and @PROTEIN1$ (V; 35 kDa) @PROTEIN1$@PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d721.s0.p39","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), @PROTEIN2$ (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and @PROTEIN1$ (V; 35 kDa) @PROTEIN1$@PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d721.s0.p40","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), @PROTEIN2$ (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and @PROTEIN1$ (V; 35 kDa) @PROTEIN1$@PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d721.s0.p41","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), @PROTEIN2$ (P; 49 kDa), matrix (M; 43 kDa) and @PROTEIN1$ (V; 35 kDa) @PROTEIN1$@PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d721.s0.p42","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (@PROTEIN2$; 49 kDa), matrix (M; 43 kDa) and @PROTEIN1$ (V; 35 kDa) @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d721.s0.p43","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and @PROTEIN1$ (@PROTEIN2$; 35 kDa) @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d721.s0.p44","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (@PROTEIN2$; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and @PROTEIN1$ (V; 35 kDa) @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d721.s0.p45","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (@PROTEIN2$; 43 kDa) and @PROTEIN1$ (V; 35 kDa) @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d721.s0.p46","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (@PROTEIN2$; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), @PROTEIN1$ (M; 43 kDa) and non-structural (V; 35 kDa) @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d721.s0.p47","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the @PROTEIN2$ (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), @PROTEIN1$ (M; 43 kDa) and non-structural (V; 35 kDa) @PROTEIN1$@PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d721.s0.p48","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), @PROTEIN2$ (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), @PROTEIN1$ (M; 43 kDa) and non-structural (V; 35 kDa) @PROTEIN1$@PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d721.s0.p49","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), @PROTEIN2$ (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), @PROTEIN1$ (M; 43 kDa) and non-structural (V; 35 kDa) @PROTEIN1$@PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d721.s0.p50","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), @PROTEIN2$ (P; 49 kDa), @PROTEIN1$ (M; 43 kDa) and non-structural (V; 35 kDa) @PROTEIN1$@PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d721.s0.p51","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (@PROTEIN2$; 49 kDa), @PROTEIN1$ (M; 43 kDa) and non-structural (V; 35 kDa) @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d721.s0.p52","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), @PROTEIN1$ (M; 43 kDa) and non-structural (@PROTEIN2$; 35 kDa) @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d721.s0.p53","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (@PROTEIN2$; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), @PROTEIN1$ (M; 43 kDa) and non-structural (V; 35 kDa) @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d721.s0.p54","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), @PROTEIN1$ (@PROTEIN2$; 43 kDa) and non-structural (V; 35 kDa) @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d721.s0.p55","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the @PROTEIN2$ (L; 190 kDa), haemagglutinin neuraminidase (@PROTEIN1$; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d721.s0.p56","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (@PROTEIN1$; 74 kDa), @PROTEIN2$ (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d721.s0.p57","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), @PROTEIN2$ (@PROTEIN1$; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d721.s0.p58","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (@PROTEIN1$; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), @PROTEIN2$ (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d721.s0.p59","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (@PROTEIN1$; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (@PROTEIN2$; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) phosphop.","label":0}
{"pair_id":"BioInfer.d721.s0.p60","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (@PROTEIN1$; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (@PROTEIN2$; 35 kDa) phosphop.","label":0}
{"pair_id":"BioInfer.d721.s0.p61","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (@PROTEIN1$; 74 kDa), nucleocapsid (@PROTEIN2$; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) phosphop.","label":0}
{"pair_id":"BioInfer.d721.s0.p62","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (@PROTEIN1$; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (@PROTEIN2$; 43 kDa) and non-structural (V; 35 kDa) phosphop.","label":0}
{"pair_id":"BioInfer.d721.s0.p63","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the @PROTEIN1$ (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), @PROTEIN2$ (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) @PROTEIN1$@PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d721.s0.p64","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the @PROTEIN1$ (L; 190 kDa), @PROTEIN2$ (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) @PROTEIN1$@PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d721.s0.p65","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the @PROTEIN1$ (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), @PROTEIN2$ (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) @PROTEIN1$@PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d721.s0.p66","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the @PROTEIN1$ (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (@PROTEIN2$; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d721.s0.p67","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the @PROTEIN1$ (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (@PROTEIN2$; 35 kDa) @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d721.s0.p68","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the @PROTEIN1$ (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (@PROTEIN2$; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d721.s0.p69","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the @PROTEIN1$ (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (@PROTEIN2$; 43 kDa) and non-structural (V; 35 kDa) @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d721.s0.p70","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), @PROTEIN2$ (HN; 74 kDa), @PROTEIN1$ (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) @PROTEIN1$@PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d721.s0.p71","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), @PROTEIN1$ (N; 66 kDa), fusion (F0; 63 kDa), @PROTEIN2$ (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) @PROTEIN1$@PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d721.s0.p72","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), @PROTEIN1$ (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (@PROTEIN2$; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d721.s0.p73","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), @PROTEIN1$ (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (@PROTEIN2$; 35 kDa) @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d721.s0.p74","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), @PROTEIN1$ (@PROTEIN2$; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d721.s0.p75","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), @PROTEIN1$ (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (@PROTEIN2$; 43 kDa) and non-structural (V; 35 kDa) @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d721.s0.p76","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), @PROTEIN1$ (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), @PROTEIN2$ (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) @PROTEIN1$@PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d721.s0.p77","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), @PROTEIN1$ (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (@PROTEIN2$; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d721.s0.p78","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), @PROTEIN1$ (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (@PROTEIN2$; 35 kDa) @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d721.s0.p79","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), @PROTEIN1$ (HN; 74 kDa), nucleocapsid (@PROTEIN2$; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d721.s0.p80","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), @PROTEIN1$ (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (@PROTEIN2$; 43 kDa) and non-structural (V; 35 kDa) @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d721.s0.p81","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), @PROTEIN1$ (@PROTEIN2$; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d721.s0.p82","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), @PROTEIN1$ (P; 49 kDa), matrix (M; 43 kDa) and non-structural (@PROTEIN2$; 35 kDa) @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d721.s0.p83","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (@PROTEIN2$; 66 kDa), fusion (F0; 63 kDa), @PROTEIN1$ (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d721.s0.p84","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), @PROTEIN1$ (P; 49 kDa), matrix (@PROTEIN2$; 43 kDa) and non-structural (V; 35 kDa) @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d721.s0.p85","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (@PROTEIN1$; 49 kDa), matrix (M; 43 kDa) and non-structural (@PROTEIN2$; 35 kDa) phosphop.","label":0}
{"pair_id":"BioInfer.d721.s0.p86","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (@PROTEIN2$; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (@PROTEIN1$; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) phosphop.","label":0}
{"pair_id":"BioInfer.d721.s0.p87","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (@PROTEIN1$; 49 kDa), matrix (@PROTEIN2$; 43 kDa) and non-structural (V; 35 kDa) phosphop.","label":0}
{"pair_id":"BioInfer.d721.s0.p88","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (@PROTEIN2$; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (@PROTEIN1$; 35 kDa) phosphop.","label":0}
{"pair_id":"BioInfer.d721.s0.p89","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (@PROTEIN2$; 43 kDa) and non-structural (@PROTEIN1$; 35 kDa) phosphop.","label":0}
{"pair_id":"BioInfer.d721.s0.p90","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (@PROTEIN1$; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (@PROTEIN2$; 43 kDa) and non-structural (V; 35 kDa) phosphop.","label":0}
{"pair_id":"BioInfer.d191.s0.p0","sentence":"Equine satellite cell clone SE-11 and ovine satellite cell clone I(1)were evaluated for expression of myosin heavy chain, @PROTEIN2$, desmin, and @PROTEIN1$ over a 240 h period in culture.","label":0}
{"pair_id":"BioInfer.d191.s0.p1","sentence":"Equine satellite cell clone SE-11 and ovine satellite cell clone I(1)were evaluated for expression of myosin heavy chain, myogenin, @PROTEIN2$, and @PROTEIN1$ over a 240 h period in culture.","label":0}
{"pair_id":"BioInfer.d191.s0.p2","sentence":"Equine satellite cell clone SE-11 and ovine satellite cell clone I(1)were evaluated for expression of @PROTEIN2$, myogenin, desmin, and @PROTEIN1$ over a 240 h period in culture.","label":0}
{"pair_id":"BioInfer.d191.s0.p3","sentence":"Equine satellite cell clone SE-11 and ovine satellite cell clone I(1)were evaluated for expression of myosin heavy chain, @PROTEIN1$, @PROTEIN2$, and muscle-specific actin over a 240 h period in culture.","label":0}
{"pair_id":"BioInfer.d191.s0.p4","sentence":"Equine satellite cell clone SE-11 and ovine satellite cell clone I(1)were evaluated for expression of @PROTEIN2$, @PROTEIN1$, desmin, and muscle-specific actin over a 240 h period in culture.","label":0}
{"pair_id":"BioInfer.d191.s0.p5","sentence":"Equine satellite cell clone SE-11 and ovine satellite cell clone I(1)were evaluated for expression of @PROTEIN2$, myogenin, @PROTEIN1$, and muscle-specific actin over a 240 h period in culture.","label":0}
{"pair_id":"AIMed.d204.s1762.p0","sentence":"Only the activated and not the latent forms of wild-type and C-terminal mutant des-(248-450)-@PROTEIN1$ proteins are able to form complexes with @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d440.s0.p0","sentence":"Most previous studies have focused on @PROTEIN1$ itself rather than its complex with @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d30.s251.p0","sentence":"We screened proteins for interaction with @PROTEIN1$, and cloned the full-length cDNA of human @PROTEIN2$, which encoded 1225 amino acids.","label":1}
{"pair_id":"AIMed.d112.s947.p0","sentence":"@PROTEIN1$ and @PROTEIN2$ coimmunoprecipitated from mature and activated B-cell lines, and gel-purified Syk and Lyn reassociated in vitro, demonstrating their direct interaction.","label":1}
{"pair_id":"AIMed.d112.s947.p1","sentence":"@PROTEIN1$ and Lyn coimmunoprecipitated from mature and activated B-cell lines, and gel-purified @PROTEIN2$ and Lyn reassociated in vitro, demonstrating their direct interaction.","label":0}
{"pair_id":"AIMed.d112.s947.p2","sentence":"@PROTEIN1$ and Lyn coimmunoprecipitated from mature and activated B-cell lines, and gel-purified Syk and @PROTEIN2$ reassociated in vitro, demonstrating their direct interaction.","label":0}
{"pair_id":"AIMed.d112.s947.p3","sentence":"Syk and @PROTEIN1$ coimmunoprecipitated from mature and activated B-cell lines, and gel-purified @PROTEIN2$ and Lyn reassociated in vitro, demonstrating their direct interaction.","label":0}
{"pair_id":"AIMed.d112.s947.p4","sentence":"Syk and @PROTEIN1$ coimmunoprecipitated from mature and activated B-cell lines, and gel-purified Syk and @PROTEIN2$ reassociated in vitro, demonstrating their direct interaction.","label":0}
{"pair_id":"AIMed.d112.s947.p5","sentence":"Syk and Lyn coimmunoprecipitated from mature and activated B-cell lines, and gel-purified @PROTEIN1$ and @PROTEIN2$ reassociated in vitro, demonstrating their direct interaction.","label":1}
{"pair_id":"BioInfer.d410.s0.p0","sentence":"Loss of memberanous expression of @PROTEIN1$, alpha-catenin and @PROTEIN2$ was demonstrated in 52%, 85% and 40% of tumours respectively.","label":0}
{"pair_id":"BioInfer.d410.s0.p1","sentence":"Loss of memberanous expression of @PROTEIN1$, @PROTEIN2$ and beta-catenin was demonstrated in 52%, 85% and 40% of tumours respectively.","label":0}
{"pair_id":"BioInfer.d410.s0.p2","sentence":"Loss of memberanous expression of E-cadherin, @PROTEIN2$ and @PROTEIN1$ was demonstrated in 52%, 85% and 40% of tumours respectively.","label":0}
{"pair_id":"AIMed.d214.s1863.p0","sentence":"The interaction between @PROTEIN1$ and @PROTEIN2$ is directly mediated via the SH2 domain of Vav and is dependent on tyrosine phosphorylation of c-Cbl.","label":1}
{"pair_id":"AIMed.d214.s1863.p1","sentence":"The interaction between @PROTEIN1$ and c-Cbl is directly mediated via the SH2 domain of @PROTEIN2$ and is dependent on tyrosine phosphorylation of c-Cbl.","label":0}
{"pair_id":"AIMed.d214.s1863.p2","sentence":"The interaction between @PROTEIN1$ and c-Cbl is directly mediated via the SH2 domain of Vav and is dependent on tyrosine phosphorylation of @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d214.s1863.p3","sentence":"The interaction between Vav and @PROTEIN1$ is directly mediated via the SH2 domain of @PROTEIN2$ and is dependent on tyrosine phosphorylation of c-Cbl.","label":0}
{"pair_id":"AIMed.d214.s1863.p4","sentence":"The interaction between Vav and @PROTEIN1$ is directly mediated via the SH2 domain of Vav and is dependent on tyrosine phosphorylation of @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d214.s1863.p5","sentence":"The interaction between Vav and c-Cbl is directly mediated via the SH2 domain of @PROTEIN1$ and is dependent on tyrosine phosphorylation of @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d213.s1854.p0","sentence":"In contrast, physical interaction is not necessary for @PROTEIN1$ to repress @PROTEIN2$- and CREB-mediated transcription.","label":0}
{"pair_id":"AIMed.d213.s1854.p1","sentence":"In contrast, physical interaction is not necessary for @PROTEIN1$ to repress Sp1- and @PROTEIN2$-mediated transcription.","label":0}
{"pair_id":"AIMed.d213.s1854.p2","sentence":"In contrast, physical interaction is not necessary for YY1 to repress @PROTEIN1$- and @PROTEIN2$-mediated transcription.","label":0}
{"pair_id":"BioInfer.d59.s1.p0","sentence":"Purification of cofilin, a 21,000 molecular weight actin-binding protein, from porcine kidney and identification of the @PROTEIN2$-binding site in the @PROTEIN1$ sequence.","label":1}
{"pair_id":"BioInfer.d59.s1.p1","sentence":"Purification of cofilin, a 21,000 molecular weight @PROTEIN2$, from porcine kidney and identification of the cofilin-binding site in the @PROTEIN1$ sequence.","label":0}
{"pair_id":"BioInfer.d59.s1.p2","sentence":"Purification of @PROTEIN2$, a 21,000 molecular weight actin-binding protein, from porcine kidney and identification of the cofilin-binding site in the @PROTEIN1$ sequence.","label":0}
{"pair_id":"BioInfer.d59.s1.p3","sentence":"Purification of cofilin, a 21,000 molecular weight @PROTEIN2$, from porcine kidney and identification of the @PROTEIN1$-binding site in the actin sequence.","label":0}
{"pair_id":"BioInfer.d59.s1.p4","sentence":"Purification of @PROTEIN2$, a 21,000 molecular weight actin-binding protein, from porcine kidney and identification of the @PROTEIN1$-binding site in the actin sequence.","label":0}
{"pair_id":"BioInfer.d59.s1.p5","sentence":"Purification of @PROTEIN2$, a 21,000 molecular weight @PROTEIN1$, from porcine kidney and identification of the cofilin-binding site in the actin sequence.","label":1}
{"pair_id":"AIMed.d175.s1482.p0","sentence":"Association of @PROTEIN1$ with both @PROTEIN2$ and HSP90 may also imply a mechanistic link between the functions of CDC37 and HSP90.","label":1}
{"pair_id":"AIMed.d175.s1482.p1","sentence":"Association of @PROTEIN1$ with both CDC37 and @PROTEIN2$ may also imply a mechanistic link between the functions of CDC37 and HSP90.","label":1}
{"pair_id":"AIMed.d175.s1482.p2","sentence":"Association of @PROTEIN1$ with both CDC37 and HSP90 may also imply a mechanistic link between the functions of @PROTEIN2$ and HSP90.","label":0}
{"pair_id":"AIMed.d175.s1482.p3","sentence":"Association of @PROTEIN1$ with both CDC37 and HSP90 may also imply a mechanistic link between the functions of CDC37 and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d175.s1482.p4","sentence":"Association of CDK4 with both @PROTEIN1$ and @PROTEIN2$ may also imply a mechanistic link between the functions of CDC37 and HSP90.","label":0}
{"pair_id":"AIMed.d175.s1482.p5","sentence":"Association of CDK4 with both @PROTEIN1$ and HSP90 may also imply a mechanistic link between the functions of @PROTEIN2$ and HSP90.","label":0}
{"pair_id":"AIMed.d175.s1482.p6","sentence":"Association of CDK4 with both @PROTEIN1$ and HSP90 may also imply a mechanistic link between the functions of CDC37 and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d175.s1482.p7","sentence":"Association of CDK4 with both CDC37 and @PROTEIN1$ may also imply a mechanistic link between the functions of @PROTEIN2$ and HSP90.","label":0}
{"pair_id":"AIMed.d175.s1482.p8","sentence":"Association of CDK4 with both CDC37 and @PROTEIN1$ may also imply a mechanistic link between the functions of CDC37 and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d175.s1482.p9","sentence":"Association of CDK4 with both CDC37 and HSP90 may also imply a mechanistic link between the functions of @PROTEIN1$ and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d366.s0.p0","sentence":"In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, @PROTEIN2$, RAD24, MEC1, @PROTEIN1$ and MEC3.","label":0}
{"pair_id":"BioInfer.d366.s0.p1","sentence":"In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, @PROTEIN2$, MEC1, @PROTEIN1$ and MEC3.","label":0}
{"pair_id":"BioInfer.d366.s0.p2","sentence":"In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes @PROTEIN2$, RAD17, RAD24, MEC1, @PROTEIN1$ and MEC3.","label":0}
{"pair_id":"BioInfer.d366.s0.p3","sentence":"In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, RAD24, MEC1, @PROTEIN1$ and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d366.s0.p4","sentence":"In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, RAD24, @PROTEIN2$, @PROTEIN1$ and MEC3.","label":0}
{"pair_id":"BioInfer.d366.s0.p5","sentence":"In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, @PROTEIN1$, @PROTEIN2$, MEC1, MEC2 and MEC3.","label":0}
{"pair_id":"BioInfer.d366.s0.p6","sentence":"In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes @PROTEIN2$, @PROTEIN1$, RAD24, MEC1, MEC2 and MEC3.","label":0}
{"pair_id":"BioInfer.d366.s0.p7","sentence":"In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, @PROTEIN1$, RAD24, MEC1, MEC2 and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d366.s0.p8","sentence":"In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, @PROTEIN1$, RAD24, @PROTEIN2$, MEC2 and MEC3.","label":0}
{"pair_id":"BioInfer.d366.s0.p9","sentence":"In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes @PROTEIN2$, RAD17, @PROTEIN1$, MEC1, MEC2 and MEC3.","label":0}
{"pair_id":"BioInfer.d366.s0.p10","sentence":"In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, @PROTEIN1$, MEC1, MEC2 and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d366.s0.p11","sentence":"In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, @PROTEIN1$, @PROTEIN2$, MEC2 and MEC3.","label":0}
{"pair_id":"BioInfer.d366.s0.p12","sentence":"In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes @PROTEIN1$, RAD17, RAD24, MEC1, MEC2 and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d366.s0.p13","sentence":"In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes @PROTEIN1$, RAD17, RAD24, @PROTEIN2$, MEC2 and MEC3.","label":0}
{"pair_id":"BioInfer.d366.s0.p14","sentence":"In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, RAD24, @PROTEIN2$, MEC2 and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d433.s2.p0","sentence":"To investigate the possibility that @PROTEIN2$ disrupts actin stress fibers by binding directly to the C-terminal actin binding site, additional @PROTEIN1$ fusion proteins were generated and analyzed for TD77 and actin binding.","label":1}
{"pair_id":"BioInfer.d433.s2.p1","sentence":"To investigate the possibility that TD77 disrupts actin stress fibers by binding directly to the C-terminal @PROTEIN2$ binding site, additional @PROTEIN1$ fusion proteins were generated and analyzed for TD77 and actin binding.","label":1}
{"pair_id":"BioInfer.d433.s2.p2","sentence":"To investigate the possibility that TD77 disrupts actin stress fibers by binding directly to the C-terminal actin binding site, additional @PROTEIN1$ fusion proteins were generated and analyzed for TD77 and @PROTEIN2$ binding.","label":1}
{"pair_id":"BioInfer.d433.s2.p3","sentence":"To investigate the possibility that TD77 disrupts actin stress fibers by binding directly to the C-terminal actin binding site, additional @PROTEIN1$ fusion proteins were generated and analyzed for @PROTEIN2$ and actin binding.","label":1}
{"pair_id":"BioInfer.d433.s2.p4","sentence":"To investigate the possibility that TD77 disrupts @PROTEIN2$ stress fibers by binding directly to the C-terminal actin binding site, additional @PROTEIN1$ fusion proteins were generated and analyzed for TD77 and actin binding.","label":1}
{"pair_id":"BioInfer.d433.s2.p5","sentence":"To investigate the possibility that @PROTEIN1$ disrupts actin stress fibers by binding directly to the C-terminal @PROTEIN2$ binding site, additional talin fusion proteins were generated and analyzed for TD77 and actin binding.","label":0}
{"pair_id":"BioInfer.d433.s2.p6","sentence":"To investigate the possibility that @PROTEIN1$ disrupts actin stress fibers by binding directly to the C-terminal actin binding site, additional talin fusion proteins were generated and analyzed for TD77 and @PROTEIN2$ binding.","label":0}
{"pair_id":"BioInfer.d433.s2.p7","sentence":"To investigate the possibility that @PROTEIN1$ disrupts actin stress fibers by binding directly to the C-terminal actin binding site, additional talin fusion proteins were generated and analyzed for @PROTEIN2$ and actin binding.","label":0}
{"pair_id":"BioInfer.d433.s2.p8","sentence":"To investigate the possibility that @PROTEIN1$ disrupts @PROTEIN2$ stress fibers by binding directly to the C-terminal actin binding site, additional talin fusion proteins were generated and analyzed for TD77 and actin binding.","label":1}
{"pair_id":"BioInfer.d433.s2.p9","sentence":"To investigate the possibility that TD77 disrupts actin stress fibers by binding directly to the C-terminal @PROTEIN1$ binding site, additional talin fusion proteins were generated and analyzed for TD77 and @PROTEIN2$ binding.","label":0}
{"pair_id":"BioInfer.d433.s2.p10","sentence":"To investigate the possibility that TD77 disrupts actin stress fibers by binding directly to the C-terminal @PROTEIN1$ binding site, additional talin fusion proteins were generated and analyzed for @PROTEIN2$ and actin binding.","label":0}
{"pair_id":"BioInfer.d433.s2.p11","sentence":"To investigate the possibility that TD77 disrupts @PROTEIN2$ stress fibers by binding directly to the C-terminal @PROTEIN1$ binding site, additional talin fusion proteins were generated and analyzed for TD77 and actin binding.","label":0}
{"pair_id":"BioInfer.d433.s2.p12","sentence":"To investigate the possibility that TD77 disrupts actin stress fibers by binding directly to the C-terminal actin binding site, additional talin fusion proteins were generated and analyzed for @PROTEIN2$ and @PROTEIN1$ binding.","label":0}
{"pair_id":"BioInfer.d433.s2.p13","sentence":"To investigate the possibility that TD77 disrupts @PROTEIN2$ stress fibers by binding directly to the C-terminal actin binding site, additional talin fusion proteins were generated and analyzed for TD77 and @PROTEIN1$ binding.","label":0}
{"pair_id":"BioInfer.d433.s2.p14","sentence":"To investigate the possibility that TD77 disrupts @PROTEIN2$ stress fibers by binding directly to the C-terminal actin binding site, additional talin fusion proteins were generated and analyzed for @PROTEIN1$ and actin binding.","label":0}
{"pair_id":"BioInfer.d505.s1.p0","sentence":"Replacement of serine 38 with cysteine created a unique site where labeling with rhodamine did not alter the affinity of @PROTEIN2$ for @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d580.s1.p0","sentence":"The herpes simplex virus type 1 (HSV) UL5, @PROTEIN2$, and @PROTEIN1$ proteins form a helicase-primase complex in infected cells.","label":1}
{"pair_id":"BioInfer.d580.s1.p1","sentence":"The herpes simplex virus type 1 (HSV) @PROTEIN2$, UL8, and @PROTEIN1$ proteins form a helicase-primase complex in infected cells.","label":1}
{"pair_id":"BioInfer.d580.s1.p2","sentence":"The herpes simplex virus type 1 (HSV) @PROTEIN2$, @PROTEIN1$, and UL52 proteins form a helicase-primase complex in infected cells.","label":1}
{"pair_id":"BioInfer.d4.s0.p0","sentence":"Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and @PROTEIN1$ is not affected by the differential @PROTEIN2$ expression.","label":1}
{"pair_id":"BioInfer.d4.s0.p1","sentence":"Abundance of @PROTEIN2$, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and @PROTEIN1$ is not affected by the differential calreticulin expression.","label":0}
{"pair_id":"BioInfer.d4.s0.p2","sentence":"Abundance of actin, talin, @PROTEIN2$ and beta 1 @PROTEIN2$, pp125 focal adhesion kinase, and @PROTEIN1$ is not affected by the differential calreticulin expression.","label":0}
{"pair_id":"BioInfer.d4.s0.p3","sentence":"Abundance of actin, talin, alpha 5 and beta 1 integrins, @PROTEIN2$ focal adhesion kinase, and @PROTEIN1$ is not affected by the differential calreticulin expression.","label":0}
{"pair_id":"BioInfer.d4.s0.p4","sentence":"Abundance of actin, talin, alpha 5 and @PROTEIN2$, pp125 focal adhesion kinase, and @PROTEIN1$ is not affected by the differential calreticulin expression.","label":0}
{"pair_id":"BioInfer.d4.s0.p5","sentence":"Abundance of actin, @PROTEIN2$, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and @PROTEIN1$ is not affected by the differential calreticulin expression.","label":0}
{"pair_id":"BioInfer.d4.s0.p6","sentence":"Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 @PROTEIN2$, and @PROTEIN1$ is not affected by the differential calreticulin expression.","label":0}
{"pair_id":"BioInfer.d4.s0.p7","sentence":"Abundance of @PROTEIN2$, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential @PROTEIN1$ expression.","label":1}
{"pair_id":"BioInfer.d4.s0.p8","sentence":"Abundance of actin, talin, @PROTEIN2$ and beta 1 @PROTEIN2$, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential @PROTEIN1$ expression.","label":1}
{"pair_id":"BioInfer.d4.s0.p9","sentence":"Abundance of actin, talin, alpha 5 and beta 1 integrins, @PROTEIN2$ focal adhesion kinase, and alpha-catenin is not affected by the differential @PROTEIN1$ expression.","label":1}
{"pair_id":"BioInfer.d4.s0.p10","sentence":"Abundance of actin, talin, alpha 5 and @PROTEIN2$, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential @PROTEIN1$ expression.","label":1}
{"pair_id":"BioInfer.d4.s0.p11","sentence":"Abundance of actin, @PROTEIN2$, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential @PROTEIN1$ expression.","label":1}
{"pair_id":"BioInfer.d4.s0.p12","sentence":"Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 @PROTEIN2$, and alpha-catenin is not affected by the differential @PROTEIN1$ expression.","label":0}
{"pair_id":"BioInfer.d4.s0.p13","sentence":"Abundance of @PROTEIN1$, talin, @PROTEIN2$ and beta 1 @PROTEIN2$, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.","label":0}
{"pair_id":"BioInfer.d4.s0.p14","sentence":"Abundance of @PROTEIN1$, talin, alpha 5 and beta 1 integrins, @PROTEIN2$ focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.","label":0}
{"pair_id":"BioInfer.d4.s0.p15","sentence":"Abundance of @PROTEIN1$, talin, alpha 5 and @PROTEIN2$, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.","label":0}
{"pair_id":"BioInfer.d4.s0.p16","sentence":"Abundance of @PROTEIN1$, @PROTEIN2$, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.","label":0}
{"pair_id":"BioInfer.d4.s0.p17","sentence":"Abundance of @PROTEIN1$, talin, alpha 5 and beta 1 integrins, pp125 @PROTEIN2$, and alpha-catenin is not affected by the differential calreticulin expression.","label":0}
{"pair_id":"BioInfer.d4.s0.p18","sentence":"Abundance of actin, talin, @PROTEIN1$ and beta 1 @PROTEIN1$, @PROTEIN2$ focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.","label":0}
{"pair_id":"BioInfer.d4.s0.p19","sentence":"Abundance of actin, talin, @PROTEIN1$ and @PROTEIN2$@PROTEIN1$, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.","label":0}
{"pair_id":"BioInfer.d4.s0.p20","sentence":"Abundance of actin, @PROTEIN2$, @PROTEIN1$ and beta 1 @PROTEIN1$, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.","label":0}
{"pair_id":"BioInfer.d4.s0.p21","sentence":"Abundance of actin, talin, @PROTEIN1$ and beta 1 @PROTEIN1$, pp125 @PROTEIN2$, and alpha-catenin is not affected by the differential calreticulin expression.","label":0}
{"pair_id":"BioInfer.d4.s0.p22","sentence":"Abundance of actin, talin, alpha 5 and @PROTEIN2$, @PROTEIN1$ focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.","label":0}
{"pair_id":"BioInfer.d4.s0.p23","sentence":"Abundance of actin, @PROTEIN2$, alpha 5 and beta 1 integrins, @PROTEIN1$ focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.","label":0}
{"pair_id":"BioInfer.d4.s0.p24","sentence":"Abundance of actin, talin, alpha 5 and beta 1 integrins, @PROTEIN1$ @PROTEIN2$, and alpha-catenin is not affected by the differential calreticulin expression.","label":1}
{"pair_id":"BioInfer.d4.s0.p25","sentence":"Abundance of actin, @PROTEIN2$, alpha 5 and @PROTEIN1$, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.","label":0}
{"pair_id":"BioInfer.d4.s0.p26","sentence":"Abundance of actin, talin, alpha 5 and @PROTEIN1$, pp125 @PROTEIN2$, and alpha-catenin is not affected by the differential calreticulin expression.","label":0}
{"pair_id":"BioInfer.d4.s0.p27","sentence":"Abundance of actin, @PROTEIN1$, alpha 5 and beta 1 integrins, pp125 @PROTEIN2$, and alpha-catenin is not affected by the differential calreticulin expression.","label":0}
{"pair_id":"BioInfer.d460.s0.p0","sentence":"One involves @PROTEIN1$, which has recently been shown to bind @PROTEIN2$ directly.","label":1}
{"pair_id":"AIMed.d167.s1411.p0","sentence":"Thus, our data show that both @PROTEIN1$ and @PROTEIN2$ interact with Glut 1 in a glycosylation-dependent manner.","label":0}
{"pair_id":"AIMed.d167.s1411.p1","sentence":"Thus, our data show that both @PROTEIN1$ and calreticulin interact with @PROTEIN2$ in a glycosylation-dependent manner.","label":1}
{"pair_id":"AIMed.d167.s1411.p2","sentence":"Thus, our data show that both calnexin and @PROTEIN1$ interact with @PROTEIN2$ in a glycosylation-dependent manner.","label":1}
{"pair_id":"BioInfer.d49.s3.p0","sentence":"The role of @PROTEIN2$ in the regulation of @PROTEIN1$ assembly has been reexamined.","label":1}
{"pair_id":"AIMed.d89.s762.p0","sentence":"Further, polyclonal antibodies to human @PROTEIN1$ significantly inhibited the mitogenic activity of @PROTEIN2$ on human fibroblasts.","label":0}
{"pair_id":"AIMed.d53.s470.p0","sentence":"In the 2.4 angstrom crystal structure of the extracellular signaling assembly between viral @PROTEIN1$ and human @PROTEIN2$, two complexes are cross-linked into a tetramer through direct interactions between the immunoglobulin domain of gp130 and site III of viral IL-6, which is necessary for receptor activation.","label":1}
{"pair_id":"AIMed.d53.s470.p1","sentence":"In the 2.4 angstrom crystal structure of the extracellular signaling assembly between viral @PROTEIN1$ and human gp130, two complexes are cross-linked into a tetramer through direct interactions between the immunoglobulin domain of @PROTEIN2$ and site III of viral IL-6, which is necessary for receptor activation.","label":0}
{"pair_id":"AIMed.d53.s470.p2","sentence":"In the 2.4 angstrom crystal structure of the extracellular signaling assembly between viral @PROTEIN1$ and human gp130, two complexes are cross-linked into a tetramer through direct interactions between the immunoglobulin domain of gp130 and site III of viral @PROTEIN2$, which is necessary for receptor activation.","label":0}
{"pair_id":"AIMed.d53.s470.p3","sentence":"In the 2.4 angstrom crystal structure of the extracellular signaling assembly between viral IL-6 and human @PROTEIN1$, two complexes are cross-linked into a tetramer through direct interactions between the immunoglobulin domain of @PROTEIN2$ and site III of viral IL-6, which is necessary for receptor activation.","label":0}
{"pair_id":"AIMed.d53.s470.p4","sentence":"In the 2.4 angstrom crystal structure of the extracellular signaling assembly between viral IL-6 and human @PROTEIN1$, two complexes are cross-linked into a tetramer through direct interactions between the immunoglobulin domain of gp130 and site III of viral @PROTEIN2$, which is necessary for receptor activation.","label":0}
{"pair_id":"AIMed.d53.s470.p5","sentence":"In the 2.4 angstrom crystal structure of the extracellular signaling assembly between viral IL-6 and human gp130, two complexes are cross-linked into a tetramer through direct interactions between the immunoglobulin domain of @PROTEIN1$ and site III of viral @PROTEIN2$, which is necessary for receptor activation.","label":1}
{"pair_id":"BioInfer.d73.s1.p0","sentence":"@PROTEIN2$, RAD54, @PROTEIN1$ and RAD57 are still required when the same transcribed donor is on the chromosome.","label":0}
{"pair_id":"BioInfer.d73.s1.p1","sentence":"RAD51, RAD54, @PROTEIN1$ and @PROTEIN2$ are still required when the same transcribed donor is on the chromosome.","label":0}
{"pair_id":"BioInfer.d73.s1.p2","sentence":"RAD51, @PROTEIN2$, @PROTEIN1$ and RAD57 are still required when the same transcribed donor is on the chromosome.","label":0}
{"pair_id":"BioInfer.d73.s1.p3","sentence":"@PROTEIN1$, RAD54, RAD55 and @PROTEIN2$ are still required when the same transcribed donor is on the chromosome.","label":0}
{"pair_id":"BioInfer.d73.s1.p4","sentence":"@PROTEIN1$, @PROTEIN2$, RAD55 and RAD57 are still required when the same transcribed donor is on the chromosome.","label":0}
{"pair_id":"BioInfer.d73.s1.p5","sentence":"RAD51, @PROTEIN2$, RAD55 and @PROTEIN1$ are still required when the same transcribed donor is on the chromosome.","label":0}
{"pair_id":"AIMed.d198.s1687.p0","sentence":"Mutagenesis of the @PROTEIN1$@PROTEIN2$ (EPOR) permits analysis of the contribution that individual amino acid residues make to erythropoietin (EPO) binding.","label":0}
{"pair_id":"AIMed.d198.s1687.p1","sentence":"Mutagenesis of the @PROTEIN1$ receptor (@PROTEIN2$) permits analysis of the contribution that individual amino acid residues make to erythropoietin (EPO) binding.","label":1}
{"pair_id":"AIMed.d198.s1687.p2","sentence":"Mutagenesis of the @PROTEIN1$ receptor (EPOR) permits analysis of the contribution that individual amino acid residues make to @PROTEIN2$ (EPO) binding.","label":0}
{"pair_id":"AIMed.d198.s1687.p3","sentence":"Mutagenesis of the @PROTEIN1$ receptor (EPOR) permits analysis of the contribution that individual amino acid residues make to erythropoietin (@PROTEIN2$) binding.","label":0}
{"pair_id":"AIMed.d198.s1687.p4","sentence":"Mutagenesis of the @PROTEIN1$ (@PROTEIN2$) permits analysis of the contribution that individual amino acid residues make to erythropoietin (EPO) binding.","label":0}
{"pair_id":"AIMed.d198.s1687.p5","sentence":"Mutagenesis of the @PROTEIN1$ (EPOR) permits analysis of the contribution that individual amino acid residues make to @PROTEIN2$ (EPO) binding.","label":0}
{"pair_id":"AIMed.d198.s1687.p6","sentence":"Mutagenesis of the @PROTEIN1$ (EPOR) permits analysis of the contribution that individual amino acid residues make to erythropoietin (@PROTEIN2$) binding.","label":0}
{"pair_id":"AIMed.d198.s1687.p7","sentence":"Mutagenesis of the erythropoietin receptor (@PROTEIN1$) permits analysis of the contribution that individual amino acid residues make to @PROTEIN2$ (EPO) binding.","label":0}
{"pair_id":"AIMed.d198.s1687.p8","sentence":"Mutagenesis of the erythropoietin receptor (@PROTEIN1$) permits analysis of the contribution that individual amino acid residues make to erythropoietin (@PROTEIN2$) binding.","label":0}
{"pair_id":"AIMed.d198.s1687.p9","sentence":"Mutagenesis of the erythropoietin receptor (EPOR) permits analysis of the contribution that individual amino acid residues make to @PROTEIN1$ (@PROTEIN2$) binding.","label":0}
{"pair_id":"AIMed.d148.s1253.p0","sentence":"Other recent studies have identified human @PROTEIN1$ (@PROTEIN2$) as a putative G1 cyclin and candidate proto-oncogene.","label":0}
{"pair_id":"BioInfer.d48.s0.p0","sentence":"A major point of interest was to clarify whether rheological, high precision measurements can yield quantitative information about the influence of talin and @PROTEIN1$ on the structure, chain dynamics, elasticity and viscoelasticity of @PROTEIN2$ filaments with time.","label":1}
{"pair_id":"BioInfer.d48.s0.p1","sentence":"A major point of interest was to clarify whether rheological, high precision measurements can yield quantitative information about the influence of @PROTEIN2$ and @PROTEIN1$ on the structure, chain dynamics, elasticity and viscoelasticity of actin filaments with time.","label":0}
{"pair_id":"BioInfer.d48.s0.p2","sentence":"A major point of interest was to clarify whether rheological, high precision measurements can yield quantitative information about the influence of @PROTEIN2$ and vinculin on the structure, chain dynamics, elasticity and viscoelasticity of @PROTEIN1$ filaments with time.","label":1}
{"pair_id":"BioInfer.d537.s0.p0","sentence":"Signaling pathways involved in dephosphorylation and localization of the @PROTEIN1$ @PROTEIN2$ in stimulated human neutrophils.","label":1}
{"pair_id":"BioInfer.d793.s0.p0","sentence":"Villin and @PROTEIN2$ are two actin-binding proteins that bundle @PROTEIN1$ filaments in the intestine and kidney brush border epithelium.","label":1}
{"pair_id":"BioInfer.d793.s0.p1","sentence":"@PROTEIN2$ and fimbrin are two actin-binding proteins that bundle @PROTEIN1$ filaments in the intestine and kidney brush border epithelium.","label":1}
{"pair_id":"BioInfer.d793.s0.p2","sentence":"Villin and fimbrin are two @PROTEIN2$ that bundle @PROTEIN1$ filaments in the intestine and kidney brush border epithelium.","label":0}
{"pair_id":"BioInfer.d793.s0.p3","sentence":"@PROTEIN2$ and @PROTEIN1$ are two actin-binding proteins that bundle actin filaments in the intestine and kidney brush border epithelium.","label":0}
{"pair_id":"BioInfer.d793.s0.p4","sentence":"Villin and @PROTEIN1$ are two @PROTEIN2$ that bundle actin filaments in the intestine and kidney brush border epithelium.","label":1}
{"pair_id":"BioInfer.d793.s0.p5","sentence":"@PROTEIN1$ and fimbrin are two @PROTEIN2$ that bundle actin filaments in the intestine and kidney brush border epithelium.","label":1}
{"pair_id":"AIMed.d64.s552.p0","sentence":"From Scatchard analyses, the Kd:s for binding of @PROTEIN1$ and @PROTEIN2$ to hFGFR-1 were estimated to 25 pM and 41 pM, respectively.","label":0}
{"pair_id":"AIMed.d64.s552.p1","sentence":"From Scatchard analyses, the Kd:s for binding of @PROTEIN1$ and bFGF to @PROTEIN2$ were estimated to 25 pM and 41 pM, respectively.","label":1}
{"pair_id":"AIMed.d64.s552.p2","sentence":"From Scatchard analyses, the Kd:s for binding of aFGF and @PROTEIN1$ to @PROTEIN2$ were estimated to 25 pM and 41 pM, respectively.","label":1}
{"pair_id":"AIMed.d8.s60.p0","sentence":"Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of @PROTEIN1$, @PROTEIN2$, p16 and DPC4\/Smad4.","label":0}
{"pair_id":"AIMed.d8.s60.p1","sentence":"Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of @PROTEIN1$, p53, @PROTEIN2$ and DPC4\/Smad4.","label":0}
{"pair_id":"AIMed.d8.s60.p2","sentence":"Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of @PROTEIN1$, p53, p16 and @PROTEIN2$\/Smad4.","label":0}
{"pair_id":"AIMed.d8.s60.p3","sentence":"Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of @PROTEIN1$, p53, p16 and DPC4\/@PROTEIN2$.","label":0}
{"pair_id":"AIMed.d8.s60.p4","sentence":"Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, @PROTEIN1$, @PROTEIN2$ and DPC4\/Smad4.","label":0}
{"pair_id":"AIMed.d8.s60.p5","sentence":"Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, @PROTEIN1$, p16 and @PROTEIN2$\/Smad4.","label":0}
{"pair_id":"AIMed.d8.s60.p6","sentence":"Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, @PROTEIN1$, p16 and DPC4\/@PROTEIN2$.","label":0}
{"pair_id":"AIMed.d8.s60.p7","sentence":"Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, p53, @PROTEIN1$ and @PROTEIN2$\/Smad4.","label":0}
{"pair_id":"AIMed.d8.s60.p8","sentence":"Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, p53, @PROTEIN1$ and DPC4\/@PROTEIN2$.","label":0}
{"pair_id":"AIMed.d8.s60.p9","sentence":"Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, p53, p16 and @PROTEIN1$\/@PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d27.s1.p0","sentence":"In contrast, ADP-ribosylation of actin at Arg95\/Arg372 induced by turkey @PROTEIN2$ decreased the nucleotide dissociation rate to 1.5 x 10(3) s-1 and inhibited the @PROTEIN1$-induced stimulation of nucleotide exchange.","label":0}
{"pair_id":"BioInfer.d27.s1.p1","sentence":"In contrast, ADP-ribosylation of @PROTEIN2$ at Arg95\/Arg372 induced by turkey erythrocyte transferase decreased the nucleotide dissociation rate to 1.5 x 10(3) s-1 and inhibited the @PROTEIN1$-induced stimulation of nucleotide exchange.","label":0}
{"pair_id":"BioInfer.d27.s1.p2","sentence":"In contrast, ADP-ribosylation of @PROTEIN2$ at Arg95\/Arg372 induced by turkey @PROTEIN1$ decreased the nucleotide dissociation rate to 1.5 x 10(3) s-1 and inhibited the profilin-induced stimulation of nucleotide exchange.","label":1}
{"pair_id":"AIMed.d87.s741.p0","sentence":"Thus, the C-terminal domain in @PROTEIN1$ appears to exert a negative control on binding of @PROTEIN2$ thereby providing a possible regulatory mechanism for direct activation of the PI 3-kinase pathway.","label":1}
{"pair_id":"AIMed.d87.s741.p1","sentence":"Thus, the C-terminal domain in @PROTEIN1$ appears to exert a negative control on binding of p85 thereby providing a possible regulatory mechanism for direct activation of the @PROTEIN2$ pathway.","label":0}
{"pair_id":"AIMed.d87.s741.p2","sentence":"Thus, the C-terminal domain in IGF-1R appears to exert a negative control on binding of @PROTEIN1$ thereby providing a possible regulatory mechanism for direct activation of the @PROTEIN2$ pathway.","label":0}
{"pair_id":"AIMed.d218.s1889.p0","sentence":"@PROTEIN1$ (@PROTEIN2$) is a hematopoietin important for megakaryocyte proliferation and production of blood platelets.","label":0}
{"pair_id":"AIMed.d167.s1410.p0","sentence":"@PROTEIN1$, the soluble homologue of @PROTEIN2$, was also shown to interact with GT155 only when the protein bore a correctly modified oligosaccharide group.","label":0}
{"pair_id":"AIMed.d167.s1410.p1","sentence":"@PROTEIN1$, the soluble homologue of calnexin, was also shown to interact with @PROTEIN2$ only when the protein bore a correctly modified oligosaccharide group.","label":1}
{"pair_id":"AIMed.d167.s1410.p2","sentence":"Calreticulin, the soluble homologue of @PROTEIN1$, was also shown to interact with @PROTEIN2$ only when the protein bore a correctly modified oligosaccharide group.","label":0}
{"pair_id":"BioInfer.d274.s1.p0","sentence":"Identification of @PROTEIN1$ binding to syntrophin triplet, @PROTEIN2$, and utrophin.","label":1}
{"pair_id":"BioInfer.d274.s1.p1","sentence":"Identification of @PROTEIN1$ binding to @PROTEIN2$, dystrophin, and utrophin.","label":1}
{"pair_id":"BioInfer.d274.s1.p2","sentence":"Identification of @PROTEIN1$ binding to syntrophin triplet, dystrophin, and @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d274.s1.p3","sentence":"Identification of alpha-syntrophin binding to @PROTEIN2$, @PROTEIN1$, and utrophin.","label":0}
{"pair_id":"BioInfer.d274.s1.p4","sentence":"Identification of alpha-syntrophin binding to syntrophin triplet, @PROTEIN1$, and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d274.s1.p5","sentence":"Identification of alpha-syntrophin binding to @PROTEIN1$, dystrophin, and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d550.s0.p0","sentence":"Stable transfection of mutant plakoglobin molecules showed that deletion of the @PROTEIN1$ binding domain, but not the @PROTEIN2$ binding domain, abolished beta-catenin downregulation.","label":0}
{"pair_id":"BioInfer.d550.s0.p1","sentence":"Stable transfection of mutant plakoglobin molecules showed that deletion of the @PROTEIN1$ binding domain, but not the alpha-catenin binding domain, abolished @PROTEIN2$ downregulation.","label":0}
{"pair_id":"BioInfer.d550.s0.p2","sentence":"Stable transfection of mutant @PROTEIN2$ molecules showed that deletion of the @PROTEIN1$ binding domain, but not the alpha-catenin binding domain, abolished beta-catenin downregulation.","label":1}
{"pair_id":"BioInfer.d550.s0.p3","sentence":"Stable transfection of mutant plakoglobin molecules showed that deletion of the N-cadherin binding domain, but not the @PROTEIN1$ binding domain, abolished @PROTEIN2$ downregulation.","label":0}
{"pair_id":"BioInfer.d550.s0.p4","sentence":"Stable transfection of mutant @PROTEIN2$ molecules showed that deletion of the N-cadherin binding domain, but not the @PROTEIN1$ binding domain, abolished beta-catenin downregulation.","label":1}
{"pair_id":"BioInfer.d550.s0.p5","sentence":"Stable transfection of mutant @PROTEIN2$ molecules showed that deletion of the N-cadherin binding domain, but not the alpha-catenin binding domain, abolished @PROTEIN1$ downregulation.","label":1}
{"pair_id":"AIMed.d154.s1311.p0","sentence":"The deduced amino acid sequences of human alpha 1- and @PROTEIN1$ are nearly identical to their homologues in mouse, suggesting a strong functional conservation among the individual isoforms, Much like @PROTEIN2$, human beta 2-syntrophin has multiple transcript classes and is expressed widely, although in a distinct pattern of relative abundance.","label":0}
{"pair_id":"AIMed.d154.s1311.p1","sentence":"The deduced amino acid sequences of human alpha 1- and @PROTEIN1$ are nearly identical to their homologues in mouse, suggesting a strong functional conservation among the individual isoforms, Much like beta 1-syntrophin, human @PROTEIN2$ has multiple transcript classes and is expressed widely, although in a distinct pattern of relative abundance.","label":0}
{"pair_id":"AIMed.d154.s1311.p2","sentence":"The deduced amino acid sequences of human alpha 1- and beta 2-syntrophin are nearly identical to their homologues in mouse, suggesting a strong functional conservation among the individual isoforms, Much like @PROTEIN1$, human @PROTEIN2$ has multiple transcript classes and is expressed widely, although in a distinct pattern of relative abundance.","label":0}
{"pair_id":"AIMed.d118.s1001.p0","sentence":"Here we use simian virus 40 DNA replication in vitro to show than @PROTEIN1$ directly inhibits @PROTEIN2$-dependent DNA replication in the absence of a cyclin\/CDK.","label":1}
{"pair_id":"BioInfer.d595.s0.p0","sentence":"The common denominator is impaired @PROTEIN1$ association with either @PROTEIN2$ (PaTuII) or alpha-catenin (BxPc3 and T3M4).","label":1}
{"pair_id":"BioInfer.d595.s0.p1","sentence":"The common denominator is impaired @PROTEIN1$ association with either E-cadherin (PaTuII) or @PROTEIN2$ (BxPc3 and T3M4).","label":1}
{"pair_id":"BioInfer.d595.s0.p2","sentence":"The common denominator is impaired beta-catenin association with either @PROTEIN1$ (PaTuII) or @PROTEIN2$ (BxPc3 and T3M4).","label":0}
{"pair_id":"AIMed.d76.s637.p0","sentence":"The T-cell antigen @PROTEIN1$ acts as a receptor and substrate for the protein-tyrosine kinase @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d76.s642.p0","sentence":"Coexpression of @PROTEIN1$ with @PROTEIN2$ in the baculovirus expression system resulted in the phosphorylation of CD5 on tyrosine residues.","label":0}
{"pair_id":"AIMed.d76.s642.p1","sentence":"Coexpression of @PROTEIN1$ with p56lck in the baculovirus expression system resulted in the phosphorylation of @PROTEIN2$ on tyrosine residues.","label":0}
{"pair_id":"AIMed.d76.s642.p2","sentence":"Coexpression of CD5 with @PROTEIN1$ in the baculovirus expression system resulted in the phosphorylation of @PROTEIN2$ on tyrosine residues.","label":0}
{"pair_id":"AIMed.d151.s1285.p0","sentence":"We previously have shown that @PROTEIN1$ purified from human HeLa cells is a multisubunit complex of four polypeptides designated @PROTEIN2$ alpha, -beta, -gamma, and -delta.","label":0}
{"pair_id":"AIMed.d151.s1285.p1","sentence":"We previously have shown that @PROTEIN1$ purified from human HeLa cells is a multisubunit complex of four polypeptides designated @PROTEIN2$, -beta, -gamma, and -delta.","label":0}
{"pair_id":"AIMed.d151.s1285.p2","sentence":"We previously have shown that PTF purified from human HeLa cells is a multisubunit complex of four polypeptides designated @PROTEIN1$@PROTEIN2$, -beta, -gamma, and -delta.","label":0}
{"pair_id":"BioInfer.d236.s1.p0","sentence":"The @PROTEIN1$ dimer, which is crucial for @PROTEIN2$ and lipid binding, is built of a backbone containing the 200 kDa rod portions, at both ends of which a 47 kDa globular domain is attached.","label":1}
{"pair_id":"BioInfer.d438.s0.p0","sentence":"Moreover, the virus-encoded @PROTEIN1$ homolog was not required for @PROTEIN2$-associated events, including intracellular virus movement to the periphery of the cell, formation of specialized microvilli, or release of mature virions, as shown by electron microscopy and yields of infectious intra- and extracellular virus.","label":0}
{"pair_id":"AIMed.d179.s1520.p0","sentence":"The growth-promoting effects of @PROTEIN1$ on normal and neoplastic gastrointestinal tissues have been shown to be mediated by the @PROTEIN2$\/CCKB receptor, which belongs to the family of G protein-coupled receptors.","label":0}
{"pair_id":"AIMed.d179.s1520.p1","sentence":"The growth-promoting effects of @PROTEIN1$ on normal and neoplastic gastrointestinal tissues have been shown to be mediated by the gastrin\/@PROTEIN2$, which belongs to the family of G protein-coupled receptors.","label":0}
{"pair_id":"AIMed.d179.s1520.p2","sentence":"The growth-promoting effects of gastrin on normal and neoplastic gastrointestinal tissues have been shown to be mediated by the @PROTEIN1$\/@PROTEIN2$, which belongs to the family of G protein-coupled receptors.","label":0}
{"pair_id":"BioInfer.d323.s0.p0","sentence":"In cells lacking the @PROTEIN1$, the bundles, which were induced by an over-expression of @PROTEIN2$, shortened and became straight following hyperosmotic stress, forming a polygonal structure.","label":0}
{"pair_id":"BioInfer.d580.s0.p0","sentence":"The UL8 component of the herpes simplex virus @PROTEIN2$ complex stimulates primer synthesis by a subassembly of the UL5 and @PROTEIN1$ components.","label":0}
{"pair_id":"BioInfer.d580.s0.p1","sentence":"The @PROTEIN2$ component of the herpes simplex virus helicase-primase complex stimulates primer synthesis by a subassembly of the UL5 and @PROTEIN1$ components.","label":1}
{"pair_id":"BioInfer.d580.s0.p2","sentence":"The UL8 component of the herpes simplex virus helicase-primase complex stimulates primer synthesis by a subassembly of the @PROTEIN2$ and @PROTEIN1$ components.","label":1}
{"pair_id":"BioInfer.d580.s0.p3","sentence":"The @PROTEIN2$ component of the herpes simplex virus @PROTEIN1$ complex stimulates primer synthesis by a subassembly of the UL5 and UL52 components.","label":1}
{"pair_id":"BioInfer.d580.s0.p4","sentence":"The UL8 component of the herpes simplex virus @PROTEIN1$ complex stimulates primer synthesis by a subassembly of the @PROTEIN2$ and UL52 components.","label":0}
{"pair_id":"BioInfer.d580.s0.p5","sentence":"The @PROTEIN1$ component of the herpes simplex virus helicase-primase complex stimulates primer synthesis by a subassembly of the @PROTEIN2$ and UL52 components.","label":1}
{"pair_id":"BioInfer.d357.s0.p0","sentence":"@PROTEIN1$ (@PROTEIN1$) @PROTEIN1$, for example, interact with @PROTEIN2$ (e.g. talin and filamin), which form mechanical links to the cytoskeleton.","label":1}
{"pair_id":"BioInfer.d357.s0.p1","sentence":"@PROTEIN1$ (@PROTEIN1$) @PROTEIN1$, for example, interact with actin-binding proteins (e.g. @PROTEIN2$ and filamin), which form mechanical links to the cytoskeleton.","label":0}
{"pair_id":"BioInfer.d357.s0.p2","sentence":"@PROTEIN1$ (@PROTEIN1$) @PROTEIN1$, for example, interact with actin-binding proteins (e.g. talin and @PROTEIN2$), which form mechanical links to the cytoskeleton.","label":0}
{"pair_id":"BioInfer.d357.s0.p3","sentence":"Integrin (Inte) Integr, for example, interact with @PROTEIN1$ (e.g. @PROTEIN2$ and filamin), which form mechanical links to the cytoskeleton.","label":1}
{"pair_id":"BioInfer.d357.s0.p4","sentence":"Integrin (Inte) Integr, for example, interact with @PROTEIN1$ (e.g. talin and @PROTEIN2$), which form mechanical links to the cytoskeleton.","label":1}
{"pair_id":"BioInfer.d357.s0.p5","sentence":"Integrin (Inte) Integr, for example, interact with actin-binding proteins (e.g. @PROTEIN1$ and @PROTEIN2$), which form mechanical links to the cytoskeleton.","label":0}
{"pair_id":"BioInfer.d154.s0.p0","sentence":"Conversely, inhibition of @PROTEIN2$'s activity by expressing a dominant negative construct, LIMK1-, or expression of the constitutively active S3A cofilin mutant induces loss of @PROTEIN1$ filaments at the phagocytic cup and also inhibits phagocytosis.","label":1}
{"pair_id":"BioInfer.d154.s0.p1","sentence":"Conversely, inhibition of LIMK's activity by expressing a dominant negative construct, LIMK1-, or expression of the constitutively active S3A @PROTEIN2$ mutant induces loss of @PROTEIN1$ filaments at the phagocytic cup and also inhibits phagocytosis.","label":1}
{"pair_id":"BioInfer.d154.s0.p2","sentence":"Conversely, inhibition of LIMK's activity by expressing a dominant negative construct, @PROTEIN2$, or expression of the constitutively active S3A cofilin mutant induces loss of @PROTEIN1$ filaments at the phagocytic cup and also inhibits phagocytosis.","label":1}
{"pair_id":"BioInfer.d154.s0.p3","sentence":"Conversely, inhibition of @PROTEIN1$'s activity by expressing a dominant negative construct, LIMK1-, or expression of the constitutively active S3A @PROTEIN2$ mutant induces loss of actin filaments at the phagocytic cup and also inhibits phagocytosis.","label":0}
{"pair_id":"BioInfer.d154.s0.p4","sentence":"Conversely, inhibition of @PROTEIN1$'s activity by expressing a dominant negative construct, @PROTEIN2$, or expression of the constitutively active S3A cofilin mutant induces loss of actin filaments at the phagocytic cup and also inhibits phagocytosis.","label":1}
{"pair_id":"BioInfer.d154.s0.p5","sentence":"Conversely, inhibition of LIMK's activity by expressing a dominant negative construct, @PROTEIN2$, or expression of the constitutively active S3A @PROTEIN1$ mutant induces loss of actin filaments at the phagocytic cup and also inhibits phagocytosis.","label":0}
{"pair_id":"AIMed.d207.s1795.p0","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing @PROTEIN1$-@PROTEIN2$ (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA\/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p1","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing @PROTEIN1$-MyoD (@PROTEIN2$-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA\/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p2","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing @PROTEIN1$-MyoD (ER-@PROTEIN2$) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA\/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p3","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing @PROTEIN1$-MyoD (ER-MyoD) chimerae, we found that estrogen directed @PROTEIN2$ activation prevents the reassociation of cyclinA\/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p4","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing @PROTEIN1$-MyoD (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of @PROTEIN2$\/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p5","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing @PROTEIN1$-MyoD (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA\/@PROTEIN2$ to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p6","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing @PROTEIN1$-MyoD (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA\/cdk2 to the @PROTEIN2$ containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p7","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing @PROTEIN1$-MyoD (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA\/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of @PROTEIN2$ activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p8","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing Estrogen Receptor-@PROTEIN1$ (@PROTEIN2$-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA\/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p9","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing Estrogen Receptor-@PROTEIN1$ (ER-@PROTEIN2$) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA\/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p10","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing Estrogen Receptor-@PROTEIN1$ (ER-MyoD) chimerae, we found that estrogen directed @PROTEIN2$ activation prevents the reassociation of cyclinA\/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p11","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing Estrogen Receptor-@PROTEIN1$ (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of @PROTEIN2$\/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p12","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing Estrogen Receptor-@PROTEIN1$ (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA\/@PROTEIN2$ to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p13","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing Estrogen Receptor-@PROTEIN1$ (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA\/cdk2 to the @PROTEIN2$ containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p14","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing Estrogen Receptor-@PROTEIN1$ (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA\/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of @PROTEIN2$ activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p15","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (@PROTEIN1$-@PROTEIN2$) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA\/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p16","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (@PROTEIN1$-MyoD) chimerae, we found that estrogen directed @PROTEIN2$ activation prevents the reassociation of cyclinA\/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p17","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (@PROTEIN1$-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of @PROTEIN2$\/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p18","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (@PROTEIN1$-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA\/@PROTEIN2$ to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p19","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (@PROTEIN1$-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA\/cdk2 to the @PROTEIN2$ containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p20","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (@PROTEIN1$-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA\/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of @PROTEIN2$ activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p21","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ER-@PROTEIN1$) chimerae, we found that estrogen directed @PROTEIN2$ activation prevents the reassociation of cyclinA\/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p22","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ER-@PROTEIN1$) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of @PROTEIN2$\/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p23","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ER-@PROTEIN1$) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA\/@PROTEIN2$ to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p24","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ER-@PROTEIN1$) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA\/cdk2 to the @PROTEIN2$ containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p25","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ER-@PROTEIN1$) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA\/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of @PROTEIN2$ activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p26","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ER-MyoD) chimerae, we found that estrogen directed @PROTEIN1$ activation prevents the reassociation of @PROTEIN2$\/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p27","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ER-MyoD) chimerae, we found that estrogen directed @PROTEIN1$ activation prevents the reassociation of cyclinA\/@PROTEIN2$ to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p28","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ER-MyoD) chimerae, we found that estrogen directed @PROTEIN1$ activation prevents the reassociation of cyclinA\/cdk2 to the @PROTEIN2$ containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p29","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ER-MyoD) chimerae, we found that estrogen directed @PROTEIN1$ activation prevents the reassociation of cyclinA\/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of @PROTEIN2$ activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p30","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of @PROTEIN1$\/@PROTEIN2$ to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.","label":1}
{"pair_id":"AIMed.d207.s1795.p31","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of @PROTEIN1$\/cdk2 to the @PROTEIN2$ containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p32","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of @PROTEIN1$\/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of @PROTEIN2$ activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p33","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA\/@PROTEIN1$ to the @PROTEIN2$ containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p34","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA\/@PROTEIN1$ to the E2F4 containing complex following serum stimulation and this correlates with suppression of @PROTEIN2$ activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p35","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA\/cdk2 to the @PROTEIN1$ containing complex following serum stimulation and this correlates with suppression of @PROTEIN2$ activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d43.s377.p0","sentence":"The resulting Trk variant recruited binding of @PROTEIN1$ equivalent to @PROTEIN2$, maintained neurotrophin-3 binding equivalent to TrkC, and also bound brain-derived neurotrophin, although with lower affinity compared with TrkB.","label":1}
{"pair_id":"AIMed.d43.s377.p1","sentence":"The resulting Trk variant recruited binding of @PROTEIN1$ equivalent to TrkA, maintained @PROTEIN2$ binding equivalent to TrkC, and also bound brain-derived neurotrophin, although with lower affinity compared with TrkB.","label":0}
{"pair_id":"AIMed.d43.s377.p2","sentence":"The resulting Trk variant recruited binding of @PROTEIN1$ equivalent to TrkA, maintained neurotrophin-3 binding equivalent to @PROTEIN2$, and also bound brain-derived neurotrophin, although with lower affinity compared with TrkB.","label":0}
{"pair_id":"AIMed.d43.s377.p3","sentence":"The resulting Trk variant recruited binding of @PROTEIN1$ equivalent to TrkA, maintained neurotrophin-3 binding equivalent to TrkC, and also bound @PROTEIN2$, although with lower affinity compared with TrkB.","label":0}
{"pair_id":"AIMed.d43.s377.p4","sentence":"The resulting Trk variant recruited binding of @PROTEIN1$ equivalent to TrkA, maintained neurotrophin-3 binding equivalent to TrkC, and also bound brain-derived neurotrophin, although with lower affinity compared with @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d43.s377.p5","sentence":"The resulting Trk variant recruited binding of NGF equivalent to @PROTEIN1$, maintained @PROTEIN2$ binding equivalent to TrkC, and also bound brain-derived neurotrophin, although with lower affinity compared with TrkB.","label":0}
{"pair_id":"AIMed.d43.s377.p6","sentence":"The resulting Trk variant recruited binding of NGF equivalent to @PROTEIN1$, maintained neurotrophin-3 binding equivalent to @PROTEIN2$, and also bound brain-derived neurotrophin, although with lower affinity compared with TrkB.","label":0}
{"pair_id":"AIMed.d43.s377.p7","sentence":"The resulting Trk variant recruited binding of NGF equivalent to @PROTEIN1$, maintained neurotrophin-3 binding equivalent to TrkC, and also bound @PROTEIN2$, although with lower affinity compared with TrkB.","label":0}
{"pair_id":"AIMed.d43.s377.p8","sentence":"The resulting Trk variant recruited binding of NGF equivalent to @PROTEIN1$, maintained neurotrophin-3 binding equivalent to TrkC, and also bound brain-derived neurotrophin, although with lower affinity compared with @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d43.s377.p9","sentence":"The resulting Trk variant recruited binding of NGF equivalent to TrkA, maintained @PROTEIN1$ binding equivalent to @PROTEIN2$, and also bound brain-derived neurotrophin, although with lower affinity compared with TrkB.","label":1}
{"pair_id":"AIMed.d43.s377.p10","sentence":"The resulting Trk variant recruited binding of NGF equivalent to TrkA, maintained @PROTEIN1$ binding equivalent to TrkC, and also bound @PROTEIN2$, although with lower affinity compared with TrkB.","label":0}
{"pair_id":"AIMed.d43.s377.p11","sentence":"The resulting Trk variant recruited binding of NGF equivalent to TrkA, maintained @PROTEIN1$ binding equivalent to TrkC, and also bound brain-derived neurotrophin, although with lower affinity compared with @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d43.s377.p12","sentence":"The resulting Trk variant recruited binding of NGF equivalent to TrkA, maintained neurotrophin-3 binding equivalent to @PROTEIN1$, and also bound @PROTEIN2$, although with lower affinity compared with TrkB.","label":0}
{"pair_id":"AIMed.d43.s377.p13","sentence":"The resulting Trk variant recruited binding of NGF equivalent to TrkA, maintained neurotrophin-3 binding equivalent to @PROTEIN1$, and also bound brain-derived neurotrophin, although with lower affinity compared with @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d43.s377.p14","sentence":"The resulting Trk variant recruited binding of NGF equivalent to TrkA, maintained neurotrophin-3 binding equivalent to TrkC, and also bound @PROTEIN1$, although with lower affinity compared with @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d520.s0.p0","sentence":"Requirement of yeast @PROTEIN2$ for @PROTEIN1$ organization and morphogenesis in vivo.","label":1}
{"pair_id":"BioInfer.d197.s0.p0","sentence":"Exclusion of @PROTEIN2$ and @PROTEIN1$ gene involvement in hypertrophic cardiomyopathy of several French families.","label":0}
{"pair_id":"AIMed.d204.s1763.p0","sentence":"Neither mutation of His199, nor deletion mutants des-(161-228)-@PROTEIN1$ and des-(161-228\/248-450)-@PROTEIN2$, interact with TIMP.","label":0}
{"pair_id":"AIMed.d204.s1763.p1","sentence":"Neither mutation of His199, nor deletion mutants des-(161-228)-@PROTEIN1$ and des-(161-228\/248-450)-MMP-1, interact with @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d204.s1763.p2","sentence":"Neither mutation of His199, nor deletion mutants des-(161-228)-MMP-1 and des-(161-228\/248-450)-@PROTEIN1$, interact with @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d796.s0.p0","sentence":"We also analysed NHEJ in other DNA damage response mutants and showed that the checkpoint mutant rad3-d and two recombination mutants defective in rhp51 and rhp54 (homologues of S.cerevisiae @PROTEIN1$ and @PROTEIN2$, respectively) are not affected.","label":0}
{"pair_id":"BioInfer.d796.s0.p1","sentence":"We also analysed NHEJ in other DNA damage response mutants and showed that the checkpoint mutant rad3-d and two recombination mutants defective in @PROTEIN2$ and rhp54 (homologues of S.cerevisiae @PROTEIN1$ and RAD54, respectively) are not affected.","label":1}
{"pair_id":"BioInfer.d796.s0.p2","sentence":"We also analysed NHEJ in other DNA damage response mutants and showed that the checkpoint mutant rad3-d and two recombination mutants defective in rhp51 and @PROTEIN2$ (homologues of S.cerevisiae @PROTEIN1$ and RAD54, respectively) are not affected.","label":0}
{"pair_id":"BioInfer.d796.s0.p3","sentence":"We also analysed NHEJ in other DNA damage response mutants and showed that the checkpoint mutant @PROTEIN2$-d and two recombination mutants defective in rhp51 and rhp54 (homologues of S.cerevisiae @PROTEIN1$ and RAD54, respectively) are not affected.","label":0}
{"pair_id":"BioInfer.d796.s0.p4","sentence":"We also analysed NHEJ in other DNA damage response mutants and showed that the checkpoint mutant rad3-d and two recombination mutants defective in @PROTEIN2$ and rhp54 (homologues of S.cerevisiae RAD51 and @PROTEIN1$, respectively) are not affected.","label":0}
{"pair_id":"BioInfer.d796.s0.p5","sentence":"We also analysed NHEJ in other DNA damage response mutants and showed that the checkpoint mutant rad3-d and two recombination mutants defective in rhp51 and @PROTEIN2$ (homologues of S.cerevisiae RAD51 and @PROTEIN1$, respectively) are not affected.","label":1}
{"pair_id":"BioInfer.d796.s0.p6","sentence":"We also analysed NHEJ in other DNA damage response mutants and showed that the checkpoint mutant @PROTEIN2$-d and two recombination mutants defective in rhp51 and rhp54 (homologues of S.cerevisiae RAD51 and @PROTEIN1$, respectively) are not affected.","label":0}
{"pair_id":"BioInfer.d796.s0.p7","sentence":"We also analysed NHEJ in other DNA damage response mutants and showed that the checkpoint mutant rad3-d and two recombination mutants defective in @PROTEIN1$ and @PROTEIN2$ (homologues of S.cerevisiae RAD51 and RAD54, respectively) are not affected.","label":0}
{"pair_id":"BioInfer.d796.s0.p8","sentence":"We also analysed NHEJ in other DNA damage response mutants and showed that the checkpoint mutant @PROTEIN2$-d and two recombination mutants defective in @PROTEIN1$ and rhp54 (homologues of S.cerevisiae RAD51 and RAD54, respectively) are not affected.","label":0}
{"pair_id":"BioInfer.d796.s0.p9","sentence":"We also analysed NHEJ in other DNA damage response mutants and showed that the checkpoint mutant @PROTEIN2$-d and two recombination mutants defective in rhp51 and @PROTEIN1$ (homologues of S.cerevisiae RAD51 and RAD54, respectively) are not affected.","label":0}
{"pair_id":"BioInfer.d118.s0.p0","sentence":"By indirect immunofluorescence, both R. rickettsii and Listeria monocytogenes @PROTEIN1$ tails were shown to contain the cytoskeletal proteins vasodilator-stimulated phosphoprotein profilin, vinculin, and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d118.s0.p1","sentence":"By indirect immunofluorescence, both R. rickettsii and Listeria monocytogenes @PROTEIN1$ tails were shown to contain the cytoskeletal proteins vasodilator-stimulated phosphoprotein profilin, @PROTEIN2$, and filamin.","label":0}
{"pair_id":"BioInfer.d118.s0.p2","sentence":"By indirect immunofluorescence, both R. rickettsii and Listeria monocytogenes @PROTEIN1$ tails were shown to contain the cytoskeletal proteins @PROTEIN2$ profilin, vinculin, and filamin.","label":0}
{"pair_id":"BioInfer.d118.s0.p3","sentence":"By indirect immunofluorescence, both R. rickettsii and Listeria monocytogenes @PROTEIN1$ tails were shown to contain the cytoskeletal proteins vasodilator-stimulated phosphoprotein @PROTEIN2$, vinculin, and filamin.","label":0}
{"pair_id":"BioInfer.d118.s0.p4","sentence":"By indirect immunofluorescence, both R. rickettsii and Listeria monocytogenes actin tails were shown to contain the cytoskeletal proteins vasodilator-stimulated phosphoprotein profilin, @PROTEIN2$, and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d118.s0.p5","sentence":"By indirect immunofluorescence, both R. rickettsii and Listeria monocytogenes actin tails were shown to contain the cytoskeletal proteins @PROTEIN2$ profilin, vinculin, and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d118.s0.p6","sentence":"By indirect immunofluorescence, both R. rickettsii and Listeria monocytogenes actin tails were shown to contain the cytoskeletal proteins vasodilator-stimulated phosphoprotein @PROTEIN2$, vinculin, and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d118.s0.p7","sentence":"By indirect immunofluorescence, both R. rickettsii and Listeria monocytogenes actin tails were shown to contain the cytoskeletal proteins @PROTEIN2$ profilin, @PROTEIN1$, and filamin.","label":0}
{"pair_id":"BioInfer.d118.s0.p8","sentence":"By indirect immunofluorescence, both R. rickettsii and Listeria monocytogenes actin tails were shown to contain the cytoskeletal proteins vasodilator-stimulated phosphoprotein @PROTEIN2$, @PROTEIN1$, and filamin.","label":0}
{"pair_id":"BioInfer.d118.s0.p9","sentence":"By indirect immunofluorescence, both R. rickettsii and Listeria monocytogenes actin tails were shown to contain the cytoskeletal proteins @PROTEIN1$ @PROTEIN2$, vinculin, and filamin.","label":0}
{"pair_id":"AIMed.d112.s954.p0","sentence":"Thus, @PROTEIN1$ may serve as a link between @PROTEIN2$ and PLC gamma 1, coupling the B-cell antigen receptor to the phosphatidylinositol pathway.","label":1}
{"pair_id":"AIMed.d112.s954.p1","sentence":"Thus, @PROTEIN1$ may serve as a link between Syk and @PROTEIN2$, coupling the B-cell antigen receptor to the phosphatidylinositol pathway.","label":1}
{"pair_id":"AIMed.d112.s954.p2","sentence":"Thus, pp120 may serve as a link between @PROTEIN1$ and @PROTEIN2$, coupling the B-cell antigen receptor to the phosphatidylinositol pathway.","label":1}
{"pair_id":"BioInfer.d671.s0.p0","sentence":"The prominent 125 A transverse stripping pattern characteristic of the @PROTEIN1$ cross-bridges in a bundle is also absent in hair borders suggesting @PROTEIN2$ as the component that gives rise to the transverse stripes.","label":0}
{"pair_id":"BioInfer.d177.s0.p0","sentence":"Disruption of the RVS167 gene, which is homologous to @PROTEIN2$\/RVS161 and which is also required for correct @PROTEIN1$ localization, also blocks endocytosis.","label":0}
{"pair_id":"BioInfer.d177.s0.p1","sentence":"Disruption of the RVS167 gene, which is homologous to END6\/@PROTEIN2$ and which is also required for correct @PROTEIN1$ localization, also blocks endocytosis.","label":0}
{"pair_id":"BioInfer.d177.s0.p2","sentence":"Disruption of the @PROTEIN2$ gene, which is homologous to END6\/RVS161 and which is also required for correct @PROTEIN1$ localization, also blocks endocytosis.","label":1}
{"pair_id":"BioInfer.d177.s0.p3","sentence":"Disruption of the RVS167 gene, which is homologous to @PROTEIN1$\/@PROTEIN2$ and which is also required for correct actin localization, also blocks endocytosis.","label":0}
{"pair_id":"BioInfer.d177.s0.p4","sentence":"Disruption of the @PROTEIN2$ gene, which is homologous to @PROTEIN1$\/RVS161 and which is also required for correct actin localization, also blocks endocytosis.","label":1}
{"pair_id":"BioInfer.d177.s0.p5","sentence":"Disruption of the @PROTEIN2$ gene, which is homologous to END6\/@PROTEIN1$ and which is also required for correct actin localization, also blocks endocytosis.","label":1}
{"pair_id":"BioInfer.d782.s0.p0","sentence":"Unexpectedly, treatment with the actin-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the actin-binding proteins @PROTEIN2$ and @PROTEIN1$ also did not exhibit medial GFP-Cdc42p staining.","label":0}
{"pair_id":"BioInfer.d782.s0.p1","sentence":"Unexpectedly, treatment with the actin-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the actin-binding proteins tropomyosin and @PROTEIN1$ also did not exhibit medial GFP-@PROTEIN2$ staining.","label":0}
{"pair_id":"BioInfer.d782.s0.p2","sentence":"Unexpectedly, treatment with the @PROTEIN2$-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the actin-binding proteins tropomyosin and @PROTEIN1$ also did not exhibit medial GFP-Cdc42p staining.","label":0}
{"pair_id":"BioInfer.d782.s0.p3","sentence":"Unexpectedly, treatment with the actin-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the actin-binding proteins tropomyosin and @PROTEIN1$ also did not exhibit medial @PROTEIN2$-Cdc42p staining.","label":0}
{"pair_id":"BioInfer.d782.s0.p4","sentence":"Unexpectedly, treatment with the actin-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the @PROTEIN2$ tropomyosin and @PROTEIN1$ also did not exhibit medial GFP-Cdc42p staining.","label":1}
{"pair_id":"BioInfer.d782.s0.p5","sentence":"Unexpectedly, treatment with the actin-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the actin-binding proteins @PROTEIN1$ and profilin also did not exhibit medial GFP-@PROTEIN2$ staining.","label":0}
{"pair_id":"BioInfer.d782.s0.p6","sentence":"Unexpectedly, treatment with the @PROTEIN2$-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the actin-binding proteins @PROTEIN1$ and profilin also did not exhibit medial GFP-Cdc42p staining.","label":0}
{"pair_id":"BioInfer.d782.s0.p7","sentence":"Unexpectedly, treatment with the actin-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the actin-binding proteins @PROTEIN1$ and profilin also did not exhibit medial @PROTEIN2$-Cdc42p staining.","label":0}
{"pair_id":"BioInfer.d782.s0.p8","sentence":"Unexpectedly, treatment with the actin-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the @PROTEIN2$ @PROTEIN1$ and profilin also did not exhibit medial GFP-Cdc42p staining.","label":1}
{"pair_id":"BioInfer.d782.s0.p9","sentence":"Unexpectedly, treatment with the @PROTEIN2$-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the actin-binding proteins tropomyosin and profilin also did not exhibit medial GFP-@PROTEIN1$ staining.","label":0}
{"pair_id":"BioInfer.d782.s0.p10","sentence":"Unexpectedly, treatment with the actin-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the actin-binding proteins tropomyosin and profilin also did not exhibit medial @PROTEIN2$-@PROTEIN1$ staining.","label":1}
{"pair_id":"BioInfer.d782.s0.p11","sentence":"Unexpectedly, treatment with the actin-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the @PROTEIN2$ tropomyosin and profilin also did not exhibit medial GFP-@PROTEIN1$ staining.","label":0}
{"pair_id":"BioInfer.d782.s0.p12","sentence":"Unexpectedly, treatment with the @PROTEIN1$-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the actin-binding proteins tropomyosin and profilin also did not exhibit medial @PROTEIN2$-Cdc42p staining.","label":0}
{"pair_id":"BioInfer.d782.s0.p13","sentence":"Unexpectedly, treatment with the @PROTEIN1$-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the @PROTEIN2$ tropomyosin and profilin also did not exhibit medial GFP-Cdc42p staining.","label":0}
{"pair_id":"BioInfer.d782.s0.p14","sentence":"Unexpectedly, treatment with the actin-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the @PROTEIN2$ tropomyosin and profilin also did not exhibit medial @PROTEIN1$-Cdc42p staining.","label":0}
{"pair_id":"AIMed.d143.s1215.p0","sentence":"These results demonstrate that @PROTEIN1$ and @PROTEIN2$ utilize different ligand binding proteins, but share common signal transducer, gp130, in TF-1 cells.","label":0}
{"pair_id":"AIMed.d143.s1215.p1","sentence":"These results demonstrate that @PROTEIN1$ and IL-6 utilize different ligand binding proteins, but share common signal transducer, @PROTEIN2$, in TF-1 cells.","label":0}
{"pair_id":"AIMed.d143.s1215.p2","sentence":"These results demonstrate that IL-11 and @PROTEIN1$ utilize different ligand binding proteins, but share common signal transducer, @PROTEIN2$, in TF-1 cells.","label":0}
{"pair_id":"AIMed.d51.s458.p0","sentence":"The structure of the @PROTEIN1$-@PROTEIN2$-heparin ternary complex provides a structural basis for the essential role of heparan sulphate in FGF signalling.","label":1}
{"pair_id":"BioInfer.d226.s1.p0","sentence":"Immunofluorescence microscopy of cells grown on fibronectin confirmed the presence of paxillin, talin, and @PROTEIN2$ at the ends of @PROTEIN1$ stress fibers at presumptive focal contacts in melanocytes.","label":1}
{"pair_id":"BioInfer.d226.s1.p1","sentence":"Immunofluorescence microscopy of cells grown on @PROTEIN2$ confirmed the presence of paxillin, talin, and vinculin at the ends of @PROTEIN1$ stress fibers at presumptive focal contacts in melanocytes.","label":0}
{"pair_id":"BioInfer.d226.s1.p2","sentence":"Immunofluorescence microscopy of cells grown on fibronectin confirmed the presence of @PROTEIN2$, talin, and vinculin at the ends of @PROTEIN1$ stress fibers at presumptive focal contacts in melanocytes.","label":1}
{"pair_id":"BioInfer.d226.s1.p3","sentence":"Immunofluorescence microscopy of cells grown on fibronectin confirmed the presence of paxillin, @PROTEIN2$, and vinculin at the ends of @PROTEIN1$ stress fibers at presumptive focal contacts in melanocytes.","label":1}
{"pair_id":"BioInfer.d226.s1.p4","sentence":"Immunofluorescence microscopy of cells grown on @PROTEIN2$ confirmed the presence of paxillin, talin, and @PROTEIN1$ at the ends of actin stress fibers at presumptive focal contacts in melanocytes.","label":0}
{"pair_id":"BioInfer.d226.s1.p5","sentence":"Immunofluorescence microscopy of cells grown on fibronectin confirmed the presence of @PROTEIN2$, talin, and @PROTEIN1$ at the ends of actin stress fibers at presumptive focal contacts in melanocytes.","label":0}
{"pair_id":"BioInfer.d226.s1.p6","sentence":"Immunofluorescence microscopy of cells grown on fibronectin confirmed the presence of paxillin, @PROTEIN2$, and @PROTEIN1$ at the ends of actin stress fibers at presumptive focal contacts in melanocytes.","label":0}
{"pair_id":"BioInfer.d226.s1.p7","sentence":"Immunofluorescence microscopy of cells grown on @PROTEIN1$ confirmed the presence of @PROTEIN2$, talin, and vinculin at the ends of actin stress fibers at presumptive focal contacts in melanocytes.","label":0}
{"pair_id":"BioInfer.d226.s1.p8","sentence":"Immunofluorescence microscopy of cells grown on @PROTEIN1$ confirmed the presence of paxillin, @PROTEIN2$, and vinculin at the ends of actin stress fibers at presumptive focal contacts in melanocytes.","label":0}
{"pair_id":"BioInfer.d226.s1.p9","sentence":"Immunofluorescence microscopy of cells grown on fibronectin confirmed the presence of @PROTEIN1$, @PROTEIN2$, and vinculin at the ends of actin stress fibers at presumptive focal contacts in melanocytes.","label":0}
{"pair_id":"BioInfer.d302.s0.p0","sentence":"Immunoreactivity for @PROTEIN2$, E-cadherin, @PROTEIN1$, beta-catenin, and p120 was observed in all 15 specimens.","label":0}
{"pair_id":"BioInfer.d302.s0.p1","sentence":"Immunoreactivity for pan-cadherin, E-cadherin, @PROTEIN1$, beta-catenin, and @PROTEIN2$ was observed in all 15 specimens.","label":0}
{"pair_id":"BioInfer.d302.s0.p2","sentence":"Immunoreactivity for pan-cadherin, @PROTEIN2$, @PROTEIN1$, beta-catenin, and p120 was observed in all 15 specimens.","label":0}
{"pair_id":"BioInfer.d302.s0.p3","sentence":"Immunoreactivity for pan-cadherin, E-cadherin, @PROTEIN1$, @PROTEIN2$, and p120 was observed in all 15 specimens.","label":0}
{"pair_id":"BioInfer.d302.s0.p4","sentence":"Immunoreactivity for @PROTEIN1$, E-cadherin, alpha-catenin, beta-catenin, and @PROTEIN2$ was observed in all 15 specimens.","label":0}
{"pair_id":"BioInfer.d302.s0.p5","sentence":"Immunoreactivity for @PROTEIN1$, @PROTEIN2$, alpha-catenin, beta-catenin, and p120 was observed in all 15 specimens.","label":0}
{"pair_id":"BioInfer.d302.s0.p6","sentence":"Immunoreactivity for @PROTEIN1$, E-cadherin, alpha-catenin, @PROTEIN2$, and p120 was observed in all 15 specimens.","label":0}
{"pair_id":"BioInfer.d302.s0.p7","sentence":"Immunoreactivity for pan-cadherin, @PROTEIN2$, alpha-catenin, beta-catenin, and @PROTEIN1$ was observed in all 15 specimens.","label":0}
{"pair_id":"BioInfer.d302.s0.p8","sentence":"Immunoreactivity for pan-cadherin, E-cadherin, alpha-catenin, @PROTEIN2$, and @PROTEIN1$ was observed in all 15 specimens.","label":0}
{"pair_id":"BioInfer.d302.s0.p9","sentence":"Immunoreactivity for pan-cadherin, @PROTEIN1$, alpha-catenin, @PROTEIN2$, and p120 was observed in all 15 specimens.","label":0}
{"pair_id":"AIMed.d41.s352.p0","sentence":"Crystal structure of the hereditary haemochromatosis protein @PROTEIN1$ complexed with @PROTEIN2$ receptor.","label":0}
{"pair_id":"AIMed.d41.s352.p1","sentence":"Crystal structure of the hereditary haemochromatosis protein @PROTEIN1$ complexed with @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d41.s352.p2","sentence":"Crystal structure of the hereditary haemochromatosis protein HFE complexed with @PROTEIN1$@PROTEIN2$.","label":0}
{"pair_id":"AIMed.d91.s779.p0","sentence":"Here we report the cloning, expression, and biochemical characterization of the 32-kDa subunit of human (h) @PROTEIN1$, termed @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d177.s1503.p0","sentence":"We have selected such mutations in the transcription factor @PROTEIN1$ that affect its ability to heterodimerize with @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d379.s0.p0","sentence":"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the @PROTEIN1$ protein and the MSH3 and @PROTEIN2$ proteins.","label":1}
{"pair_id":"BioInfer.d379.s0.p1","sentence":"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the @PROTEIN1$ protein and the @PROTEIN2$ and MSH6 proteins.","label":1}
{"pair_id":"BioInfer.d379.s0.p2","sentence":"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, @PROTEIN2$, and msh6 mutations and by studying the physical interaction between the @PROTEIN1$ protein and the MSH3 and MSH6 proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p3","sentence":"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of @PROTEIN2$, msh3, and msh6 mutations and by studying the physical interaction between the @PROTEIN1$ protein and the MSH3 and MSH6 proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p4","sentence":"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and @PROTEIN2$ mutations and by studying the physical interaction between the @PROTEIN1$ protein and the MSH3 and MSH6 proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p5","sentence":"In this study the role of @PROTEIN2$, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the @PROTEIN1$ protein and the MSH3 and MSH6 proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p6","sentence":"In this study the role of MSH2, MSH3, and @PROTEIN2$ in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the @PROTEIN1$ protein and the MSH3 and MSH6 proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p7","sentence":"In this study the role of MSH2, @PROTEIN2$, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the @PROTEIN1$ protein and the MSH3 and MSH6 proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p8","sentence":"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the @PROTEIN2$ and @PROTEIN1$ proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p9","sentence":"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, @PROTEIN2$, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and @PROTEIN1$ proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p10","sentence":"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of @PROTEIN2$, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and @PROTEIN1$ proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p11","sentence":"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and @PROTEIN2$ mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and @PROTEIN1$ proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p12","sentence":"In this study the role of @PROTEIN2$, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and @PROTEIN1$ proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p13","sentence":"In this study the role of MSH2, MSH3, and @PROTEIN2$ in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and @PROTEIN1$ proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p14","sentence":"In this study the role of MSH2, @PROTEIN2$, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and @PROTEIN1$ proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p15","sentence":"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, @PROTEIN2$, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the @PROTEIN1$ and MSH6 proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p16","sentence":"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of @PROTEIN2$, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the @PROTEIN1$ and MSH6 proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p17","sentence":"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and @PROTEIN2$ mutations and by studying the physical interaction between the MSH2 protein and the @PROTEIN1$ and MSH6 proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p18","sentence":"In this study the role of @PROTEIN2$, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the @PROTEIN1$ and MSH6 proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p19","sentence":"In this study the role of MSH2, MSH3, and @PROTEIN2$ in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the @PROTEIN1$ and MSH6 proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p20","sentence":"In this study the role of MSH2, @PROTEIN2$, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the @PROTEIN1$ and MSH6 proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p21","sentence":"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of @PROTEIN2$, @PROTEIN1$, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p22","sentence":"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, @PROTEIN1$, and @PROTEIN2$ mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p23","sentence":"In this study the role of @PROTEIN2$, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, @PROTEIN1$, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p24","sentence":"In this study the role of MSH2, MSH3, and @PROTEIN2$ in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, @PROTEIN1$, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p25","sentence":"In this study the role of MSH2, @PROTEIN2$, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, @PROTEIN1$, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p26","sentence":"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of @PROTEIN1$, msh3, and @PROTEIN2$ mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p27","sentence":"In this study the role of @PROTEIN2$, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of @PROTEIN1$, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p28","sentence":"In this study the role of MSH2, MSH3, and @PROTEIN2$ in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of @PROTEIN1$, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p29","sentence":"In this study the role of MSH2, @PROTEIN2$, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of @PROTEIN1$, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p30","sentence":"In this study the role of @PROTEIN2$, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and @PROTEIN1$ mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p31","sentence":"In this study the role of MSH2, MSH3, and @PROTEIN2$ in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and @PROTEIN1$ mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p32","sentence":"In this study the role of MSH2, @PROTEIN2$, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and @PROTEIN1$ mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p33","sentence":"In this study the role of @PROTEIN1$, MSH3, and @PROTEIN2$ in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p34","sentence":"In this study the role of @PROTEIN1$, @PROTEIN2$, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p35","sentence":"In this study the role of MSH2, @PROTEIN2$, and @PROTEIN1$ in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.","label":0}
{"pair_id":"BioInfer.d390.s0.p0","sentence":"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD\/@PROTEIN2$, RIP) and @PROTEIN1$ domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p1","sentence":"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, @PROTEIN2$\/MORT-1, RIP) and @PROTEIN1$ domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p2","sentence":"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD\/MORT-1, RIP) and @PROTEIN1$ domain-containing proteins (TRAF-1, @PROTEIN2$, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p3","sentence":"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD\/MORT-1, RIP) and @PROTEIN1$ domain-containing proteins (@PROTEIN2$, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p4","sentence":"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD\/MORT-1, RIP) and @PROTEIN1$ domain-containing proteins (TRAF-1, TRAF-2, @PROTEIN2$) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p5","sentence":"Isolation and characterization of death domain (@PROTEIN2$, Fas, TRADD, FADD\/MORT-1, RIP) and @PROTEIN1$ domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p6","sentence":"Isolation and characterization of death domain (TNF-RI, Fas, @PROTEIN2$, FADD\/MORT-1, RIP) and @PROTEIN1$ domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p7","sentence":"Isolation and characterization of death domain (TNF-RI, @PROTEIN2$, TRADD, FADD\/MORT-1, RIP) and @PROTEIN1$ domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p8","sentence":"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD\/MORT-1, @PROTEIN2$) and @PROTEIN1$ domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p9","sentence":"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, @PROTEIN2$\/@PROTEIN1$, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p10","sentence":"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD\/@PROTEIN1$, RIP) and TRAF domain-containing proteins (TRAF-1, @PROTEIN2$, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p11","sentence":"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD\/@PROTEIN1$, RIP) and TRAF domain-containing proteins (@PROTEIN2$, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p12","sentence":"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD\/@PROTEIN1$, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, @PROTEIN2$) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p13","sentence":"Isolation and characterization of death domain (@PROTEIN2$, Fas, TRADD, FADD\/@PROTEIN1$, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p14","sentence":"Isolation and characterization of death domain (TNF-RI, Fas, @PROTEIN2$, FADD\/@PROTEIN1$, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p15","sentence":"Isolation and characterization of death domain (TNF-RI, @PROTEIN2$, TRADD, FADD\/@PROTEIN1$, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p16","sentence":"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD\/@PROTEIN1$, @PROTEIN2$) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p17","sentence":"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, @PROTEIN1$\/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, @PROTEIN2$, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p18","sentence":"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, @PROTEIN1$\/MORT-1, RIP) and TRAF domain-containing proteins (@PROTEIN2$, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p19","sentence":"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, @PROTEIN1$\/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, @PROTEIN2$) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p20","sentence":"Isolation and characterization of death domain (@PROTEIN2$, Fas, TRADD, @PROTEIN1$\/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p21","sentence":"Isolation and characterization of death domain (TNF-RI, Fas, @PROTEIN2$, @PROTEIN1$\/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p22","sentence":"Isolation and characterization of death domain (TNF-RI, @PROTEIN2$, TRADD, @PROTEIN1$\/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p23","sentence":"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, @PROTEIN1$\/MORT-1, @PROTEIN2$) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p24","sentence":"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD\/MORT-1, RIP) and TRAF domain-containing proteins (@PROTEIN2$, @PROTEIN1$, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p25","sentence":"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD\/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, @PROTEIN1$, @PROTEIN2$) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p26","sentence":"Isolation and characterization of death domain (@PROTEIN2$, Fas, TRADD, FADD\/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, @PROTEIN1$, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p27","sentence":"Isolation and characterization of death domain (TNF-RI, Fas, @PROTEIN2$, FADD\/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, @PROTEIN1$, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p28","sentence":"Isolation and characterization of death domain (TNF-RI, @PROTEIN2$, TRADD, FADD\/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, @PROTEIN1$, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p29","sentence":"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD\/MORT-1, @PROTEIN2$) and TRAF domain-containing proteins (TRAF-1, @PROTEIN1$, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p30","sentence":"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD\/MORT-1, RIP) and TRAF domain-containing proteins (@PROTEIN1$, TRAF-2, @PROTEIN2$) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p31","sentence":"Isolation and characterization of death domain (@PROTEIN2$, Fas, TRADD, FADD\/MORT-1, RIP) and TRAF domain-containing proteins (@PROTEIN1$, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p32","sentence":"Isolation and characterization of death domain (TNF-RI, Fas, @PROTEIN2$, FADD\/MORT-1, RIP) and TRAF domain-containing proteins (@PROTEIN1$, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p33","sentence":"Isolation and characterization of death domain (TNF-RI, @PROTEIN2$, TRADD, FADD\/MORT-1, RIP) and TRAF domain-containing proteins (@PROTEIN1$, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p34","sentence":"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD\/MORT-1, @PROTEIN2$) and TRAF domain-containing proteins (@PROTEIN1$, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p35","sentence":"Isolation and characterization of death domain (@PROTEIN2$, Fas, TRADD, FADD\/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, @PROTEIN1$) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p36","sentence":"Isolation and characterization of death domain (TNF-RI, Fas, @PROTEIN2$, FADD\/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, @PROTEIN1$) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p37","sentence":"Isolation and characterization of death domain (TNF-RI, @PROTEIN2$, TRADD, FADD\/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, @PROTEIN1$) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p38","sentence":"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD\/MORT-1, @PROTEIN2$) and TRAF domain-containing proteins (TRAF-1, TRAF-2, @PROTEIN1$) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p39","sentence":"Isolation and characterization of death domain (@PROTEIN1$, Fas, @PROTEIN2$, FADD\/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p40","sentence":"Isolation and characterization of death domain (@PROTEIN1$, @PROTEIN2$, TRADD, FADD\/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p41","sentence":"Isolation and characterization of death domain (@PROTEIN1$, Fas, TRADD, FADD\/MORT-1, @PROTEIN2$) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p42","sentence":"Isolation and characterization of death domain (TNF-RI, @PROTEIN2$, @PROTEIN1$, FADD\/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p43","sentence":"Isolation and characterization of death domain (TNF-RI, Fas, @PROTEIN1$, FADD\/MORT-1, @PROTEIN2$) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p44","sentence":"Isolation and characterization of death domain (TNF-RI, @PROTEIN1$, TRADD, FADD\/MORT-1, @PROTEIN2$) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d317.s0.p0","sentence":"In addition, we report that radiation induced transient activation of @PROTEIN1$\/@PROTEIN2$ (JNK\/SAPK) activation and the transcription factor, AP-1.","label":0}
{"pair_id":"BioInfer.d317.s0.p1","sentence":"In addition, we report that radiation induced transient activation of @PROTEIN1$\/stress-activated protein kinase (JNK\/SAPK) activation and the transcription factor, @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d317.s0.p2","sentence":"In addition, we report that radiation induced transient activation of @PROTEIN1$\/stress-activated protein kinase (@PROTEIN2$\/SAPK) activation and the transcription factor, AP-1.","label":0}
{"pair_id":"BioInfer.d317.s0.p3","sentence":"In addition, we report that radiation induced transient activation of @PROTEIN1$\/stress-activated protein kinase (JNK\/@PROTEIN2$) activation and the transcription factor, AP-1.","label":0}
{"pair_id":"BioInfer.d317.s0.p4","sentence":"In addition, we report that radiation induced transient activation of c-Jun N-terminal kinase\/@PROTEIN1$ (JNK\/SAPK) activation and the transcription factor, @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d317.s0.p5","sentence":"In addition, we report that radiation induced transient activation of c-Jun N-terminal kinase\/@PROTEIN1$ (@PROTEIN2$\/SAPK) activation and the transcription factor, AP-1.","label":0}
{"pair_id":"BioInfer.d317.s0.p6","sentence":"In addition, we report that radiation induced transient activation of c-Jun N-terminal kinase\/@PROTEIN1$ (JNK\/@PROTEIN2$) activation and the transcription factor, AP-1.","label":0}
{"pair_id":"BioInfer.d317.s0.p7","sentence":"In addition, we report that radiation induced transient activation of c-Jun N-terminal kinase\/stress-activated protein kinase (@PROTEIN2$\/SAPK) activation and the transcription factor, @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d317.s0.p8","sentence":"In addition, we report that radiation induced transient activation of c-Jun N-terminal kinase\/stress-activated protein kinase (JNK\/@PROTEIN2$) activation and the transcription factor, @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d317.s0.p9","sentence":"In addition, we report that radiation induced transient activation of c-Jun N-terminal kinase\/stress-activated protein kinase (@PROTEIN1$\/@PROTEIN2$) activation and the transcription factor, AP-1.","label":0}
{"pair_id":"BioInfer.d259.s0.p0","sentence":"Herpes simplex virus type 1 (HSV-1) encodes a helicase-primase that consists of the products of the UL5, @PROTEIN1$, and @PROTEIN2$ genes (Crute, J. J., Tsurumi, T., Zhu, L., Weller, S. K., Olivo, P. D., Challberg, M. D., Mocarski, E. S. and Lehman, I. R. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 2186-2189).","label":1}
{"pair_id":"BioInfer.d259.s0.p1","sentence":"Herpes simplex virus type 1 (HSV-1) encodes a @PROTEIN2$ that consists of the products of the UL5, @PROTEIN1$, and UL52 genes (Crute, J. J., Tsurumi, T., Zhu, L., Weller, S. K., Olivo, P. D., Challberg, M. D., Mocarski, E. S. and Lehman, I. R. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 2186-2189).","label":1}
{"pair_id":"BioInfer.d259.s0.p2","sentence":"Herpes simplex virus type 1 (HSV-1) encodes a helicase-primase that consists of the products of the @PROTEIN2$, @PROTEIN1$, and UL52 genes (Crute, J. J., Tsurumi, T., Zhu, L., Weller, S. K., Olivo, P. D., Challberg, M. D., Mocarski, E. S. and Lehman, I. R. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 2186-2189).","label":1}
{"pair_id":"BioInfer.d259.s0.p3","sentence":"Herpes simplex virus type 1 (HSV-1) encodes a @PROTEIN2$ that consists of the products of the UL5, UL8, and @PROTEIN1$ genes (Crute, J. J., Tsurumi, T., Zhu, L., Weller, S. K., Olivo, P. D., Challberg, M. D., Mocarski, E. S. and Lehman, I. R. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 2186-2189).","label":1}
{"pair_id":"BioInfer.d259.s0.p4","sentence":"Herpes simplex virus type 1 (HSV-1) encodes a helicase-primase that consists of the products of the @PROTEIN2$, UL8, and @PROTEIN1$ genes (Crute, J. J., Tsurumi, T., Zhu, L., Weller, S. K., Olivo, P. D., Challberg, M. D., Mocarski, E. S. and Lehman, I. R. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 2186-2189).","label":1}
{"pair_id":"BioInfer.d259.s0.p5","sentence":"Herpes simplex virus type 1 (HSV-1) encodes a @PROTEIN1$ that consists of the products of the @PROTEIN2$, UL8, and UL52 genes (Crute, J. J., Tsurumi, T., Zhu, L., Weller, S. K., Olivo, P. D., Challberg, M. D., Mocarski, E. S. and Lehman, I. R. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 2186-2189).","label":1}
{"pair_id":"AIMed.d137.s1163.p0","sentence":"The interaction can also be observed in vivo, as @PROTEIN1$ can be co-precipitated with @PROTEIN2$ from co-transfected Cos1 cells and TBP co-immunoprecipitates with the endogenous Oct1 from HeLa cells.","label":1}
{"pair_id":"AIMed.d137.s1163.p1","sentence":"The interaction can also be observed in vivo, as @PROTEIN1$ can be co-precipitated with Oct2 from co-transfected Cos1 cells and @PROTEIN2$ co-immunoprecipitates with the endogenous Oct1 from HeLa cells.","label":0}
{"pair_id":"AIMed.d137.s1163.p2","sentence":"The interaction can also be observed in vivo, as @PROTEIN1$ can be co-precipitated with Oct2 from co-transfected Cos1 cells and TBP co-immunoprecipitates with the endogenous @PROTEIN2$ from HeLa cells.","label":0}
{"pair_id":"AIMed.d137.s1163.p3","sentence":"The interaction can also be observed in vivo, as TBP can be co-precipitated with @PROTEIN1$ from co-transfected Cos1 cells and @PROTEIN2$ co-immunoprecipitates with the endogenous Oct1 from HeLa cells.","label":0}
{"pair_id":"AIMed.d137.s1163.p4","sentence":"The interaction can also be observed in vivo, as TBP can be co-precipitated with @PROTEIN1$ from co-transfected Cos1 cells and TBP co-immunoprecipitates with the endogenous @PROTEIN2$ from HeLa cells.","label":0}
{"pair_id":"AIMed.d137.s1163.p5","sentence":"The interaction can also be observed in vivo, as TBP can be co-precipitated with Oct2 from co-transfected Cos1 cells and @PROTEIN1$ co-immunoprecipitates with the endogenous @PROTEIN2$ from HeLa cells.","label":1}
{"pair_id":"BioInfer.d225.s0.p0","sentence":"Further, PRP incubated with IL-6 showed a dose dependent increase in TXB2 and @PROTEIN1$ secretion as measured by RIA and an increased incorporation of actin binding protein, talin, and @PROTEIN2$ into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.","label":0}
{"pair_id":"BioInfer.d225.s0.p1","sentence":"Further, PRP incubated with IL-6 showed a dose dependent increase in @PROTEIN2$ and @PROTEIN1$ secretion as measured by RIA and an increased incorporation of actin binding protein, talin, and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.","label":0}
{"pair_id":"BioInfer.d225.s0.p2","sentence":"Further, PRP incubated with IL-6 showed a dose dependent increase in TXB2 and @PROTEIN1$ secretion as measured by RIA and an increased incorporation of actin binding protein, @PROTEIN2$, and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.","label":0}
{"pair_id":"BioInfer.d225.s0.p3","sentence":"Further, PRP incubated with IL-6 showed a dose dependent increase in TXB2 and @PROTEIN1$ secretion as measured by RIA and an increased incorporation of @PROTEIN2$, talin, and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.","label":0}
{"pair_id":"BioInfer.d225.s0.p4","sentence":"Further, PRP incubated with @PROTEIN2$ showed a dose dependent increase in TXB2 and @PROTEIN1$ secretion as measured by RIA and an increased incorporation of actin binding protein, talin, and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.","label":1}
{"pair_id":"BioInfer.d225.s0.p5","sentence":"Further, PRP incubated with IL-6 showed a dose dependent increase in @PROTEIN2$ and BTG secretion as measured by RIA and an increased incorporation of actin binding protein, talin, and @PROTEIN1$ into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.","label":0}
{"pair_id":"BioInfer.d225.s0.p6","sentence":"Further, PRP incubated with IL-6 showed a dose dependent increase in TXB2 and BTG secretion as measured by RIA and an increased incorporation of actin binding protein, @PROTEIN2$, and @PROTEIN1$ into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.","label":1}
{"pair_id":"BioInfer.d225.s0.p7","sentence":"Further, PRP incubated with IL-6 showed a dose dependent increase in TXB2 and BTG secretion as measured by RIA and an increased incorporation of @PROTEIN2$, talin, and @PROTEIN1$ into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.","label":1}
{"pair_id":"BioInfer.d225.s0.p8","sentence":"Further, PRP incubated with @PROTEIN2$ showed a dose dependent increase in TXB2 and BTG secretion as measured by RIA and an increased incorporation of actin binding protein, talin, and @PROTEIN1$ into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.","label":0}
{"pair_id":"BioInfer.d225.s0.p9","sentence":"Further, PRP incubated with IL-6 showed a dose dependent increase in @PROTEIN1$ and BTG secretion as measured by RIA and an increased incorporation of actin binding protein, @PROTEIN2$, and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.","label":0}
{"pair_id":"BioInfer.d225.s0.p10","sentence":"Further, PRP incubated with IL-6 showed a dose dependent increase in @PROTEIN1$ and BTG secretion as measured by RIA and an increased incorporation of @PROTEIN2$, talin, and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.","label":0}
{"pair_id":"BioInfer.d225.s0.p11","sentence":"Further, PRP incubated with @PROTEIN2$ showed a dose dependent increase in @PROTEIN1$ and BTG secretion as measured by RIA and an increased incorporation of actin binding protein, talin, and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.","label":1}
{"pair_id":"BioInfer.d225.s0.p12","sentence":"Further, PRP incubated with IL-6 showed a dose dependent increase in TXB2 and BTG secretion as measured by RIA and an increased incorporation of @PROTEIN2$, @PROTEIN1$, and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.","label":1}
{"pair_id":"BioInfer.d225.s0.p13","sentence":"Further, PRP incubated with @PROTEIN2$ showed a dose dependent increase in TXB2 and BTG secretion as measured by RIA and an increased incorporation of actin binding protein, @PROTEIN1$, and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.","label":0}
{"pair_id":"BioInfer.d225.s0.p14","sentence":"Further, PRP incubated with @PROTEIN2$ showed a dose dependent increase in TXB2 and BTG secretion as measured by RIA and an increased incorporation of @PROTEIN1$, talin, and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.","label":0}
{"pair_id":"BioInfer.d810.s0.p0","sentence":"We have cloned a Saccharomyces cerevisiae gene (@PROTEIN2$) encoding a low-M(r) actin-binding protein of 143 amino acid (aa) residues (yeast @PROTEIN1$; Cof); its aa sequence is 35% identical to porcine Cof.","label":1}
{"pair_id":"BioInfer.d810.s0.p1","sentence":"We have cloned a Saccharomyces cerevisiae gene (COF1) encoding a low-M(r) actin-binding protein of 143 amino acid (aa) residues (yeast @PROTEIN1$; @PROTEIN2$); its aa sequence is 35% identical to porcine Cof.","label":0}
{"pair_id":"BioInfer.d810.s0.p2","sentence":"We have cloned a Saccharomyces cerevisiae gene (COF1) encoding a low-M(r) @PROTEIN2$ of 143 amino acid (aa) residues (yeast @PROTEIN1$; Cof); its aa sequence is 35% identical to porcine Cof.","label":1}
{"pair_id":"BioInfer.d810.s0.p3","sentence":"We have cloned a Saccharomyces cerevisiae gene (COF1) encoding a low-M(r) actin-binding protein of 143 amino acid (aa) residues (yeast @PROTEIN1$; Cof); its aa sequence is 35% identical to porcine @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d810.s0.p4","sentence":"We have cloned a Saccharomyces cerevisiae gene (@PROTEIN1$) encoding a low-M(r) actin-binding protein of 143 amino acid (aa) residues (yeast cofilin; @PROTEIN2$); its aa sequence is 35% identical to porcine Cof.","label":1}
{"pair_id":"BioInfer.d810.s0.p5","sentence":"We have cloned a Saccharomyces cerevisiae gene (@PROTEIN1$) encoding a low-M(r) @PROTEIN2$ of 143 amino acid (aa) residues (yeast cofilin; Cof); its aa sequence is 35% identical to porcine Cof.","label":0}
{"pair_id":"BioInfer.d810.s0.p6","sentence":"We have cloned a Saccharomyces cerevisiae gene (@PROTEIN1$) encoding a low-M(r) actin-binding protein of 143 amino acid (aa) residues (yeast cofilin; Cof); its aa sequence is 35% identical to porcine @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d810.s0.p7","sentence":"We have cloned a Saccharomyces cerevisiae gene (COF1) encoding a low-M(r) @PROTEIN2$ of 143 amino acid (aa) residues (yeast cofilin; @PROTEIN1$); its aa sequence is 35% identical to porcine Cof.","label":1}
{"pair_id":"BioInfer.d810.s0.p8","sentence":"We have cloned a Saccharomyces cerevisiae gene (COF1) encoding a low-M(r) actin-binding protein of 143 amino acid (aa) residues (yeast cofilin; @PROTEIN1$); its aa sequence is 35% identical to porcine @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d810.s0.p9","sentence":"We have cloned a Saccharomyces cerevisiae gene (COF1) encoding a low-M(r) @PROTEIN1$ of 143 amino acid (aa) residues (yeast cofilin; Cof); its aa sequence is 35% identical to porcine @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d50.s442.p0","sentence":"Here, we quantitatively mapped the complete binding region of @PROTEIN1$ on @PROTEIN2$ by 35 individual mutations to alanine and isosteric residues.","label":1}
{"pair_id":"AIMed.d98.s834.p0","sentence":"Instead, 14-3-3 may facilitate the association of @PROTEIN1$ with @PROTEIN2$ in vivo, participating in the linkage between mitogenic signaling and the cell cycle machinery.","label":1}
{"pair_id":"AIMed.d108.s911.p0","sentence":"The multisubunit @PROTEIN1$ (@PROTEIN2$) is thought to be a primary target for site-specific activators of transcription.","label":0}
{"pair_id":"AIMed.d56.s500.p0","sentence":"Expressed in a murine myeloma, @PROTEIN1$ was identified as a ligand for @PROTEIN2$ by binding to a soluble CD40 construct.","label":1}
{"pair_id":"AIMed.d56.s500.p1","sentence":"Expressed in a murine myeloma, @PROTEIN1$ was identified as a ligand for CD40 by binding to a soluble @PROTEIN2$ construct.","label":1}
{"pair_id":"AIMed.d56.s500.p2","sentence":"Expressed in a murine myeloma, TRAP was identified as a ligand for @PROTEIN1$ by binding to a soluble @PROTEIN2$ construct.","label":0}
{"pair_id":"BioInfer.d834.s0.p0","sentence":"Within the sieve-tube exudate, @PROTEIN1$ was present in 15-fold molar excess to @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d127.s0.p0","sentence":"Calpain activity in vivo was determined by observing proteolysis of @PROTEIN2$ and @PROTEIN1$, two known substrates of calpain.","label":0}
{"pair_id":"BioInfer.d127.s0.p1","sentence":"Calpain activity in vivo was determined by observing proteolysis of actin-binding protein and @PROTEIN1$, two known substrates of @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d127.s0.p2","sentence":"@PROTEIN2$ activity in vivo was determined by observing proteolysis of actin-binding protein and @PROTEIN1$, two known substrates of calpain.","label":0}
{"pair_id":"BioInfer.d127.s0.p3","sentence":"Calpain activity in vivo was determined by observing proteolysis of @PROTEIN1$ and talin, two known substrates of @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d127.s0.p4","sentence":"@PROTEIN2$ activity in vivo was determined by observing proteolysis of @PROTEIN1$ and talin, two known substrates of calpain.","label":0}
{"pair_id":"BioInfer.d127.s0.p5","sentence":"@PROTEIN2$ activity in vivo was determined by observing proteolysis of actin-binding protein and talin, two known substrates of @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d726.s0.p0","sentence":"The Tetrahymena @PROTEIN2$ has two actin-binding domains, but lacks the EF-hand Ca(2+)-binding motif, suggesting that Tetrahymena fimbrin probably cross-links @PROTEIN1$ filaments in a Ca(2+)- insensitive manner during cytokinesis.","label":0}
{"pair_id":"BioInfer.d726.s0.p1","sentence":"The Tetrahymena fimbrin has two actin-binding domains, but lacks the EF-hand Ca(2+)-binding motif, suggesting that Tetrahymena @PROTEIN2$ probably cross-links @PROTEIN1$ filaments in a Ca(2+)- insensitive manner during cytokinesis.","label":1}
{"pair_id":"BioInfer.d726.s0.p2","sentence":"The Tetrahymena fimbrin has two @PROTEIN2$-binding domains, but lacks the EF-hand Ca(2+)-binding motif, suggesting that Tetrahymena fimbrin probably cross-links @PROTEIN1$ filaments in a Ca(2+)- insensitive manner during cytokinesis.","label":0}
{"pair_id":"BioInfer.d726.s0.p3","sentence":"The Tetrahymena @PROTEIN1$ has two actin-binding domains, but lacks the EF-hand Ca(2+)-binding motif, suggesting that Tetrahymena @PROTEIN2$ probably cross-links actin filaments in a Ca(2+)- insensitive manner during cytokinesis.","label":0}
{"pair_id":"BioInfer.d726.s0.p4","sentence":"The Tetrahymena @PROTEIN1$ has two @PROTEIN2$-binding domains, but lacks the EF-hand Ca(2+)-binding motif, suggesting that Tetrahymena fimbrin probably cross-links actin filaments in a Ca(2+)- insensitive manner during cytokinesis.","label":1}
{"pair_id":"BioInfer.d726.s0.p5","sentence":"The Tetrahymena fimbrin has two @PROTEIN2$-binding domains, but lacks the EF-hand Ca(2+)-binding motif, suggesting that Tetrahymena @PROTEIN1$ probably cross-links actin filaments in a Ca(2+)- insensitive manner during cytokinesis.","label":0}
{"pair_id":"AIMed.d224.s1951.p0","sentence":"In addition, @PROTEIN1$ dissociates from @PROTEIN2$ upon binding of MHC class I leader sequence peptides.","label":1}
{"pair_id":"AIMed.d108.s915.p0","sentence":"Together, these results suggest that @PROTEIN1$ and @PROTEIN2$ are important targets for transmitting activation signals between p53 and the initiation complex.","label":0}
{"pair_id":"AIMed.d108.s915.p1","sentence":"Together, these results suggest that @PROTEIN1$ and TAFII60 are important targets for transmitting activation signals between @PROTEIN2$ and the initiation complex.","label":1}
{"pair_id":"AIMed.d108.s915.p2","sentence":"Together, these results suggest that TAFII40 and @PROTEIN1$ are important targets for transmitting activation signals between @PROTEIN2$ and the initiation complex.","label":1}
{"pair_id":"BioInfer.d387.s0.p0","sentence":"In vitro studies indicated that suramin completely blocked @PROTEIN1$ activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) mitogen (@PROTEIN2$1\/@PROTEIN2$) and ERK1\/E, and abrogated transcription factor AP-1 DNA-binding activity.","label":0}
{"pair_id":"BioInfer.d387.s0.p1","sentence":"In vitro studies indicated that suramin completely blocked @PROTEIN1$ activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) mitogen (MEK1\/M) and ERK1\/E, and abrogated transcription factor @PROTEIN2$ DNA-binding activity.","label":0}
{"pair_id":"BioInfer.d387.s0.p2","sentence":"In vitro studies indicated that suramin completely blocked @PROTEIN1$ activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (@PROTEIN2$) mitogen (MEK1\/M) and ERK1\/E, and abrogated transcription factor AP-1 DNA-binding activity.","label":0}
{"pair_id":"BioInfer.d387.s0.p3","sentence":"In vitro studies indicated that suramin completely blocked @PROTEIN1$ activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) mitogen (MEK1\/M) and @PROTEIN2$1\/@PROTEIN2$, and abrogated transcription factor AP-1 DNA-binding activity.","label":0}
{"pair_id":"BioInfer.d387.s0.p4","sentence":"In vitro studies indicated that suramin completely blocked @PROTEIN1$ activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) mitogen (@PROTEIN2$\/M) and ERK1\/E, and abrogated transcription factor AP-1 DNA-binding activity.","label":0}
{"pair_id":"BioInfer.d387.s0.p5","sentence":"In vitro studies indicated that suramin completely blocked @PROTEIN1$ activation or phosphorylation stimulated by @PROTEIN2$, inhibited activation of mitogen-activated protein kinase (ERK) mitogen (MEK1\/M) and ERK1\/E, and abrogated transcription factor AP-1 DNA-binding activity.","label":1}
{"pair_id":"BioInfer.d387.s0.p6","sentence":"In vitro studies indicated that suramin completely blocked @PROTEIN1$ activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) mitogen (MEK1\/M) and @PROTEIN2$\/E, and abrogated transcription factor AP-1 DNA-binding activity.","label":0}
{"pair_id":"BioInfer.d387.s0.p7","sentence":"In vitro studies indicated that suramin completely blocked @PROTEIN1$ activation or phosphorylation stimulated by PDGF-AB, inhibited activation of @PROTEIN2$ (ERK) @PROTEIN2$ (MEK1\/M) and ERK1\/E, and abrogated transcription factor AP-1 DNA-binding activity.","label":0}
{"pair_id":"BioInfer.d387.s0.p8","sentence":"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) mitogen (@PROTEIN1$1\/@PROTEIN1$) and ERK1\/E, and abrogated transcription factor @PROTEIN2$ DNA-binding activity.","label":0}
{"pair_id":"BioInfer.d387.s0.p9","sentence":"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (@PROTEIN2$) mitogen (@PROTEIN1$1\/@PROTEIN1$) and ERK1\/E, and abrogated transcription factor AP-1 DNA-binding activity.","label":0}
{"pair_id":"BioInfer.d387.s0.p10","sentence":"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) mitogen (@PROTEIN1$1\/@PROTEIN1$) and @PROTEIN2$1\/@PROTEIN2$, and abrogated transcription factor AP-1 DNA-binding activity.","label":0}
{"pair_id":"BioInfer.d387.s0.p11","sentence":"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) mitogen (@PROTEIN1$@PROTEIN2$\/@PROTEIN1$) and ERK1\/E, and abrogated transcription factor AP-1 DNA-binding activity.","label":0}
{"pair_id":"BioInfer.d387.s0.p12","sentence":"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by @PROTEIN2$, inhibited activation of mitogen-activated protein kinase (ERK) mitogen (@PROTEIN1$1\/@PROTEIN1$) and ERK1\/E, and abrogated transcription factor AP-1 DNA-binding activity.","label":0}
{"pair_id":"BioInfer.d387.s0.p13","sentence":"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) mitogen (@PROTEIN1$1\/@PROTEIN1$) and @PROTEIN2$\/E, and abrogated transcription factor AP-1 DNA-binding activity.","label":0}
{"pair_id":"BioInfer.d387.s0.p14","sentence":"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of @PROTEIN2$ (ERK) @PROTEIN2$ (@PROTEIN1$1\/@PROTEIN1$) and ERK1\/E, and abrogated transcription factor AP-1 DNA-binding activity.","label":1}
{"pair_id":"BioInfer.d387.s0.p15","sentence":"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (@PROTEIN2$) mitogen (MEK1\/M) and ERK1\/E, and abrogated transcription factor @PROTEIN1$ DNA-binding activity.","label":0}
{"pair_id":"BioInfer.d387.s0.p16","sentence":"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) mitogen (MEK1\/M) and @PROTEIN2$1\/@PROTEIN2$, and abrogated transcription factor @PROTEIN1$ DNA-binding activity.","label":0}
{"pair_id":"BioInfer.d387.s0.p17","sentence":"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) mitogen (@PROTEIN2$\/M) and ERK1\/E, and abrogated transcription factor @PROTEIN1$ DNA-binding activity.","label":0}
{"pair_id":"BioInfer.d387.s0.p18","sentence":"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by @PROTEIN2$, inhibited activation of mitogen-activated protein kinase (ERK) mitogen (MEK1\/M) and ERK1\/E, and abrogated transcription factor @PROTEIN1$ DNA-binding activity.","label":0}
{"pair_id":"BioInfer.d387.s0.p19","sentence":"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) mitogen (MEK1\/M) and @PROTEIN2$\/E, and abrogated transcription factor @PROTEIN1$ DNA-binding activity.","label":0}
{"pair_id":"BioInfer.d387.s0.p20","sentence":"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of @PROTEIN2$ (ERK) @PROTEIN2$ (MEK1\/M) and ERK1\/E, and abrogated transcription factor @PROTEIN1$ DNA-binding activity.","label":0}
{"pair_id":"BioInfer.d387.s0.p21","sentence":"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (@PROTEIN1$) mitogen (MEK1\/M) and @PROTEIN2$1\/@PROTEIN2$, and abrogated transcription factor AP-1 DNA-binding activity.","label":0}
{"pair_id":"BioInfer.d387.s0.p22","sentence":"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (@PROTEIN1$) mitogen (@PROTEIN2$\/M) and ERK1\/E, and abrogated transcription factor AP-1 DNA-binding activity.","label":0}
{"pair_id":"BioInfer.d387.s0.p23","sentence":"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by @PROTEIN2$, inhibited activation of mitogen-activated protein kinase (@PROTEIN1$) mitogen (MEK1\/M) and ERK1\/E, and abrogated transcription factor AP-1 DNA-binding activity.","label":0}
{"pair_id":"BioInfer.d387.s0.p24","sentence":"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (@PROTEIN1$) mitogen (MEK1\/M) and @PROTEIN2$\/E, and abrogated transcription factor AP-1 DNA-binding activity.","label":0}
{"pair_id":"BioInfer.d387.s0.p25","sentence":"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of @PROTEIN2$ (@PROTEIN1$) @PROTEIN2$ (MEK1\/M) and ERK1\/E, and abrogated transcription factor AP-1 DNA-binding activity.","label":0}
{"pair_id":"BioInfer.d387.s0.p26","sentence":"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) mitogen (@PROTEIN2$\/M) and @PROTEIN1$1\/@PROTEIN1$, and abrogated transcription factor AP-1 DNA-binding activity.","label":0}
{"pair_id":"BioInfer.d387.s0.p27","sentence":"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by @PROTEIN2$, inhibited activation of mitogen-activated protein kinase (ERK) mitogen (MEK1\/M) and @PROTEIN1$1\/@PROTEIN1$, and abrogated transcription factor AP-1 DNA-binding activity.","label":0}
{"pair_id":"BioInfer.d387.s0.p28","sentence":"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) mitogen (MEK1\/M) and @PROTEIN1$@PROTEIN2$\/@PROTEIN1$, and abrogated transcription factor AP-1 DNA-binding activity.","label":0}
{"pair_id":"BioInfer.d387.s0.p29","sentence":"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of @PROTEIN2$ (ERK) @PROTEIN2$ (MEK1\/M) and @PROTEIN1$1\/@PROTEIN1$, and abrogated transcription factor AP-1 DNA-binding activity.","label":0}
{"pair_id":"BioInfer.d387.s0.p30","sentence":"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by @PROTEIN2$, inhibited activation of mitogen-activated protein kinase (ERK) mitogen (@PROTEIN1$\/M) and ERK1\/E, and abrogated transcription factor AP-1 DNA-binding activity.","label":0}
{"pair_id":"BioInfer.d387.s0.p31","sentence":"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) mitogen (@PROTEIN1$\/M) and @PROTEIN2$\/E, and abrogated transcription factor AP-1 DNA-binding activity.","label":0}
{"pair_id":"BioInfer.d387.s0.p32","sentence":"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of @PROTEIN2$ (ERK) @PROTEIN2$ (@PROTEIN1$\/M) and ERK1\/E, and abrogated transcription factor AP-1 DNA-binding activity.","label":1}
{"pair_id":"BioInfer.d387.s0.p33","sentence":"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by @PROTEIN1$, inhibited activation of mitogen-activated protein kinase (ERK) mitogen (MEK1\/M) and @PROTEIN2$\/E, and abrogated transcription factor AP-1 DNA-binding activity.","label":0}
{"pair_id":"BioInfer.d387.s0.p34","sentence":"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by @PROTEIN1$, inhibited activation of @PROTEIN2$ (ERK) @PROTEIN2$ (MEK1\/M) and ERK1\/E, and abrogated transcription factor AP-1 DNA-binding activity.","label":0}
{"pair_id":"BioInfer.d387.s0.p35","sentence":"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of @PROTEIN2$ (ERK) @PROTEIN2$ (MEK1\/M) and @PROTEIN1$\/E, and abrogated transcription factor AP-1 DNA-binding activity.","label":0}
{"pair_id":"AIMed.d175.s1476.p0","sentence":"Physical interaction of mammalian @PROTEIN1$ with @PROTEIN2$","label":1}
{"pair_id":"BioInfer.d102.s1.p0","sentence":"In this study, @PROTEIN1$ is identified as an @PROTEIN2$ in higher plants which is present in monocot and dicot angiosperms.","label":1}
{"pair_id":"AIMed.d150.s1276.p0","sentence":"In this report, it is demonstrated that @PROTEIN1$ contains a sequence motif that is highly related to the @PROTEIN2$ binding sites of several viral oncoproteins and binds to the pocket region of Rb both in vitro and in vivo.","label":0}
{"pair_id":"AIMed.d150.s1276.p1","sentence":"In this report, it is demonstrated that @PROTEIN1$ contains a sequence motif that is highly related to the Rb binding sites of several viral oncoproteins and binds to the pocket region of @PROTEIN2$ both in vitro and in vivo.","label":1}
{"pair_id":"AIMed.d150.s1276.p2","sentence":"In this report, it is demonstrated that Elf-1 contains a sequence motif that is highly related to the @PROTEIN1$ binding sites of several viral oncoproteins and binds to the pocket region of @PROTEIN2$ both in vitro and in vivo.","label":0}
{"pair_id":"BioInfer.d144.s2.p0","sentence":"We found that the 34- and 45-kDa polypeptides encoded by vaccinia virus ORFs @PROTEIN1$ and @PROTEIN2$, respectively, were necessary to reconstitute transcription of a template with an intermediate stage promoter.","label":0}
{"pair_id":"AIMed.d126.s1081.p0","sentence":"This suggests that @PROTEIN1$ must interact with @PROTEIN2$ throughout most of its folding reaction before it acquires a folding competent (groE independent) state.","label":1}
{"pair_id":"BioInfer.d285.s1.p0","sentence":"alpha-Catenin was not associated with these complexes after synthesis, but a subpopulation of @PROTEIN2$ joined the complex at a time coincident with the arrival of @PROTEIN1$ at the plasma membrane.","label":1}
{"pair_id":"BioInfer.d285.s1.p1","sentence":"@PROTEIN2$ was not associated with these complexes after synthesis, but a subpopulation of alpha-catenin joined the complex at a time coincident with the arrival of @PROTEIN1$ at the plasma membrane.","label":0}
{"pair_id":"BioInfer.d285.s1.p2","sentence":"@PROTEIN2$ was not associated with these complexes after synthesis, but a subpopulation of @PROTEIN1$ joined the complex at a time coincident with the arrival of E-cadherin at the plasma membrane.","label":0}
{"pair_id":"BioInfer.d496.s0.p0","sentence":"@PROTEIN2$ binds actin with a similar affinity to that of @PROTEIN1$, although it inhibits actin polymerization more strongly than profilin I under non-equilibrium conditions.","label":0}
{"pair_id":"BioInfer.d496.s0.p1","sentence":"Profilin II binds actin with a similar affinity to that of @PROTEIN1$, although it inhibits actin polymerization more strongly than @PROTEIN2$ under non-equilibrium conditions.","label":0}
{"pair_id":"BioInfer.d496.s0.p2","sentence":"Profilin II binds @PROTEIN2$ with a similar affinity to that of @PROTEIN1$, although it inhibits actin polymerization more strongly than profilin I under non-equilibrium conditions.","label":1}
{"pair_id":"BioInfer.d496.s0.p3","sentence":"Profilin II binds actin with a similar affinity to that of @PROTEIN1$, although it inhibits @PROTEIN2$ polymerization more strongly than profilin I under non-equilibrium conditions.","label":0}
{"pair_id":"BioInfer.d496.s0.p4","sentence":"@PROTEIN1$ binds actin with a similar affinity to that of profilin I, although it inhibits actin polymerization more strongly than @PROTEIN2$ under non-equilibrium conditions.","label":0}
{"pair_id":"BioInfer.d496.s0.p5","sentence":"@PROTEIN1$ binds @PROTEIN2$ with a similar affinity to that of profilin I, although it inhibits actin polymerization more strongly than profilin I under non-equilibrium conditions.","label":1}
{"pair_id":"BioInfer.d496.s0.p6","sentence":"@PROTEIN1$ binds actin with a similar affinity to that of profilin I, although it inhibits @PROTEIN2$ polymerization more strongly than profilin I under non-equilibrium conditions.","label":1}
{"pair_id":"BioInfer.d496.s0.p7","sentence":"Profilin II binds @PROTEIN2$ with a similar affinity to that of profilin I, although it inhibits actin polymerization more strongly than @PROTEIN1$ under non-equilibrium conditions.","label":0}
{"pair_id":"BioInfer.d496.s0.p8","sentence":"Profilin II binds actin with a similar affinity to that of profilin I, although it inhibits @PROTEIN2$ polymerization more strongly than @PROTEIN1$ under non-equilibrium conditions.","label":1}
{"pair_id":"BioInfer.d496.s0.p9","sentence":"Profilin II binds @PROTEIN1$ with a similar affinity to that of profilin I, although it inhibits @PROTEIN2$ polymerization more strongly than profilin I under non-equilibrium conditions.","label":0}
{"pair_id":"BioInfer.d63.s0.p0","sentence":"An association was seen between E-cadherin and @PROTEIN2$ expression, in both effusions and solid tumours, and for @PROTEIN1$ in solid tumours (range p<0. 001 to p=0.014).","label":0}
{"pair_id":"BioInfer.d63.s0.p1","sentence":"An association was seen between @PROTEIN2$ and alpha-catenin expression, in both effusions and solid tumours, and for @PROTEIN1$ in solid tumours (range p<0. 001 to p=0.014).","label":0}
{"pair_id":"BioInfer.d63.s0.p2","sentence":"An association was seen between @PROTEIN2$ and @PROTEIN1$ expression, in both effusions and solid tumours, and for beta-catenin in solid tumours (range p<0. 001 to p=0.014).","label":1}
{"pair_id":"AIMed.d102.s865.p0","sentence":"Furthermore, we demonstrate that @PROTEIN1$ binds directly to @PROTEIN2$ in vitro and in vivo.","label":1}
{"pair_id":"BioInfer.d160.s0.p0","sentence":"Cytoplasmic staining included stress fibers that colocalized with @PROTEIN1$, probably as a consequence of the @PROTEIN2$ component of the fusion protein.","label":1}
{"pair_id":"BioInfer.d399.s0.p0","sentence":"Kinetic studies on the effect of yeast @PROTEIN1$ on yeast @PROTEIN2$ polymerization.","label":1}
{"pair_id":"BioInfer.d56.s0.p0","sentence":"Analysis of changes in state suggests that SIR1 protein has a role in the establishment but not the maintenance of repression of silent mating type genes, whereas @PROTEIN1$, SIR3, and @PROTEIN2$ are required for maintenance.","label":0}
{"pair_id":"BioInfer.d56.s0.p1","sentence":"Analysis of changes in state suggests that @PROTEIN2$ protein has a role in the establishment but not the maintenance of repression of silent mating type genes, whereas @PROTEIN1$, SIR3, and SIR4 are required for maintenance.","label":0}
{"pair_id":"BioInfer.d56.s0.p2","sentence":"Analysis of changes in state suggests that SIR1 protein has a role in the establishment but not the maintenance of repression of silent mating type genes, whereas @PROTEIN1$, @PROTEIN2$, and SIR4 are required for maintenance.","label":0}
{"pair_id":"BioInfer.d56.s0.p3","sentence":"Analysis of changes in state suggests that @PROTEIN2$ protein has a role in the establishment but not the maintenance of repression of silent mating type genes, whereas SIR2, SIR3, and @PROTEIN1$ are required for maintenance.","label":0}
{"pair_id":"BioInfer.d56.s0.p4","sentence":"Analysis of changes in state suggests that SIR1 protein has a role in the establishment but not the maintenance of repression of silent mating type genes, whereas SIR2, @PROTEIN2$, and @PROTEIN1$ are required for maintenance.","label":0}
{"pair_id":"BioInfer.d56.s0.p5","sentence":"Analysis of changes in state suggests that @PROTEIN1$ protein has a role in the establishment but not the maintenance of repression of silent mating type genes, whereas SIR2, @PROTEIN2$, and SIR4 are required for maintenance.","label":0}
{"pair_id":"BioInfer.d116.s0.p0","sentence":"Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: @PROTEIN1$\/RSR1, BUD2, @PROTEIN2$, BUD4 and BUD5.","label":0}
{"pair_id":"BioInfer.d116.s0.p1","sentence":"Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: @PROTEIN1$\/RSR1, @PROTEIN2$, BUD3, BUD4 and BUD5.","label":0}
{"pair_id":"BioInfer.d116.s0.p2","sentence":"Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: @PROTEIN1$\/RSR1, BUD2, BUD3, BUD4 and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d116.s0.p3","sentence":"Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: @PROTEIN1$\/RSR1, BUD2, BUD3, @PROTEIN2$ and BUD5.","label":0}
{"pair_id":"BioInfer.d116.s0.p4","sentence":"Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: @PROTEIN1$\/@PROTEIN2$, BUD2, BUD3, BUD4 and BUD5.","label":0}
{"pair_id":"BioInfer.d116.s0.p5","sentence":"Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: BUD1\/RSR1, @PROTEIN2$, @PROTEIN1$, BUD4 and BUD5.","label":0}
{"pair_id":"BioInfer.d116.s0.p6","sentence":"Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: BUD1\/RSR1, BUD2, @PROTEIN1$, BUD4 and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d116.s0.p7","sentence":"Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: BUD1\/RSR1, BUD2, @PROTEIN1$, @PROTEIN2$ and BUD5.","label":0}
{"pair_id":"BioInfer.d116.s0.p8","sentence":"Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: BUD1\/@PROTEIN2$, BUD2, @PROTEIN1$, BUD4 and BUD5.","label":0}
{"pair_id":"BioInfer.d116.s0.p9","sentence":"Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: BUD1\/RSR1, @PROTEIN1$, BUD3, BUD4 and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d116.s0.p10","sentence":"Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: BUD1\/RSR1, @PROTEIN1$, BUD3, @PROTEIN2$ and BUD5.","label":0}
{"pair_id":"BioInfer.d116.s0.p11","sentence":"Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: BUD1\/@PROTEIN2$, @PROTEIN1$, BUD3, BUD4 and BUD5.","label":0}
{"pair_id":"BioInfer.d116.s0.p12","sentence":"Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: BUD1\/RSR1, BUD2, BUD3, @PROTEIN2$ and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d116.s0.p13","sentence":"Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: BUD1\/@PROTEIN2$, BUD2, BUD3, BUD4 and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d116.s0.p14","sentence":"Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: BUD1\/@PROTEIN2$, BUD2, BUD3, @PROTEIN1$ and BUD5.","label":0}
{"pair_id":"AIMed.d64.s549.p0","sentence":"We have isolated and characterized a cDNA clone, @PROTEIN1$, encoding a human fibroblast growth factor (FGF) receptor. @PROTEIN2$ contains an open reading frame which encodes an 820 amino acid polypeptide with three immunoglobulin-like domains in the extracellular part and an intracellular split tyrosine kinase domain.","label":0}
{"pair_id":"BioInfer.d278.s0.p0","sentence":"However, these rod structures were not observed in response to TSH, forskolin, or TPA, suggesting that dephosphorylation of cofilin correlates with the reorganization of @PROTEIN1$ microfilaments but not with the nuclear transport of @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d278.s0.p1","sentence":"However, these rod structures were not observed in response to @PROTEIN2$, forskolin, or TPA, suggesting that dephosphorylation of cofilin correlates with the reorganization of @PROTEIN1$ microfilaments but not with the nuclear transport of cofilin.","label":0}
{"pair_id":"BioInfer.d278.s0.p2","sentence":"However, these rod structures were not observed in response to TSH, forskolin, or TPA, suggesting that dephosphorylation of @PROTEIN2$ correlates with the reorganization of @PROTEIN1$ microfilaments but not with the nuclear transport of cofilin.","label":1}
{"pair_id":"BioInfer.d278.s0.p3","sentence":"However, these rod structures were not observed in response to @PROTEIN2$, forskolin, or TPA, suggesting that dephosphorylation of cofilin correlates with the reorganization of actin microfilaments but not with the nuclear transport of @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d278.s0.p4","sentence":"However, these rod structures were not observed in response to TSH, forskolin, or TPA, suggesting that dephosphorylation of @PROTEIN2$ correlates with the reorganization of actin microfilaments but not with the nuclear transport of @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d278.s0.p5","sentence":"However, these rod structures were not observed in response to @PROTEIN1$, forskolin, or TPA, suggesting that dephosphorylation of @PROTEIN2$ correlates with the reorganization of actin microfilaments but not with the nuclear transport of cofilin.","label":0}
{"pair_id":"AIMed.d2.s18.p0","sentence":"OBJECTIVE: To assess the usefulness of the molar ratio of serum @PROTEIN1$ (@PROTEIN2$) to transthyretin (TTR) to determine vitamin A (VA) status during infection.","label":0}
{"pair_id":"AIMed.d2.s18.p1","sentence":"OBJECTIVE: To assess the usefulness of the molar ratio of serum @PROTEIN1$ (RBP) to @PROTEIN2$ (TTR) to determine vitamin A (VA) status during infection.","label":0}
{"pair_id":"AIMed.d2.s18.p2","sentence":"OBJECTIVE: To assess the usefulness of the molar ratio of serum @PROTEIN1$ (RBP) to transthyretin (@PROTEIN2$) to determine vitamin A (VA) status during infection.","label":0}
{"pair_id":"AIMed.d2.s18.p3","sentence":"OBJECTIVE: To assess the usefulness of the molar ratio of serum retinol-binding protein (@PROTEIN1$) to @PROTEIN2$ (TTR) to determine vitamin A (VA) status during infection.","label":0}
{"pair_id":"AIMed.d2.s18.p4","sentence":"OBJECTIVE: To assess the usefulness of the molar ratio of serum retinol-binding protein (@PROTEIN1$) to transthyretin (@PROTEIN2$) to determine vitamin A (VA) status during infection.","label":0}
{"pair_id":"AIMed.d2.s18.p5","sentence":"OBJECTIVE: To assess the usefulness of the molar ratio of serum retinol-binding protein (RBP) to @PROTEIN1$ (@PROTEIN2$) to determine vitamin A (VA) status during infection.","label":0}
{"pair_id":"AIMed.d91.s777.p0","sentence":"Transcription factor @PROTEIN1$ consists of @PROTEIN2$ (TBP) and at least eight TBP-associated factors (TAFs).","label":0}
{"pair_id":"AIMed.d91.s777.p1","sentence":"Transcription factor @PROTEIN1$ consists of TATA binding protein (@PROTEIN2$) and at least eight TBP-associated factors (TAFs).","label":0}
{"pair_id":"AIMed.d91.s777.p2","sentence":"Transcription factor @PROTEIN1$ consists of TATA binding protein (TBP) and at least eight @PROTEIN2$-associated factors (TAFs).","label":0}
{"pair_id":"AIMed.d91.s777.p3","sentence":"Transcription factor TFIID consists of @PROTEIN1$ (@PROTEIN2$) and at least eight TBP-associated factors (TAFs).","label":0}
{"pair_id":"AIMed.d91.s777.p4","sentence":"Transcription factor TFIID consists of @PROTEIN1$ (TBP) and at least eight @PROTEIN2$-associated factors (TAFs).","label":0}
{"pair_id":"AIMed.d91.s777.p5","sentence":"Transcription factor TFIID consists of TATA binding protein (@PROTEIN1$) and at least eight @PROTEIN2$-associated factors (TAFs).","label":0}
{"pair_id":"BioInfer.d298.s0.p0","sentence":"Immunoprecipitation of metabolically labeled proteins with HECD-1 revealed three bands corresponding to E-cadherin, alpha-catenin, and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal @PROTEIN2$, indicating truncated @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d298.s0.p1","sentence":"Immunoprecipitation of metabolically labeled proteins with @PROTEIN2$ revealed three bands corresponding to E-cadherin, alpha-catenin, and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d298.s0.p2","sentence":"Immunoprecipitation of metabolically labeled proteins with HECD-1 revealed three bands corresponding to @PROTEIN2$, alpha-catenin, and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d298.s0.p3","sentence":"Immunoprecipitation of metabolically labeled proteins with HECD-1 revealed three bands corresponding to E-cadherin, @PROTEIN2$, and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d298.s0.p4","sentence":"Immunoprecipitation of metabolically labeled proteins with HECD-1 revealed three bands corresponding to E-cadherin, alpha-catenin, and @PROTEIN2$ and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d298.s0.p5","sentence":"Immunoprecipitation of metabolically labeled proteins with @PROTEIN2$ revealed three bands corresponding to E-cadherin, alpha-catenin, and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal @PROTEIN1$, indicating truncated beta-catenin.","label":0}
{"pair_id":"BioInfer.d298.s0.p6","sentence":"Immunoprecipitation of metabolically labeled proteins with HECD-1 revealed three bands corresponding to @PROTEIN2$, alpha-catenin, and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal @PROTEIN1$, indicating truncated beta-catenin.","label":0}
{"pair_id":"BioInfer.d298.s0.p7","sentence":"Immunoprecipitation of metabolically labeled proteins with HECD-1 revealed three bands corresponding to E-cadherin, @PROTEIN2$, and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal @PROTEIN1$, indicating truncated beta-catenin.","label":0}
{"pair_id":"BioInfer.d298.s0.p8","sentence":"Immunoprecipitation of metabolically labeled proteins with HECD-1 revealed three bands corresponding to E-cadherin, alpha-catenin, and @PROTEIN2$ and a 79-kDa band which was apparently smaller than that of normal @PROTEIN1$, indicating truncated beta-catenin.","label":0}
{"pair_id":"BioInfer.d298.s0.p9","sentence":"Immunoprecipitation of metabolically labeled proteins with @PROTEIN1$ revealed three bands corresponding to @PROTEIN2$, alpha-catenin, and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated beta-catenin.","label":1}
{"pair_id":"BioInfer.d298.s0.p10","sentence":"Immunoprecipitation of metabolically labeled proteins with @PROTEIN1$ revealed three bands corresponding to E-cadherin, @PROTEIN2$, and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated beta-catenin.","label":1}
{"pair_id":"BioInfer.d298.s0.p11","sentence":"Immunoprecipitation of metabolically labeled proteins with @PROTEIN1$ revealed three bands corresponding to E-cadherin, alpha-catenin, and @PROTEIN2$ and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated beta-catenin.","label":1}
{"pair_id":"BioInfer.d298.s0.p12","sentence":"Immunoprecipitation of metabolically labeled proteins with HECD-1 revealed three bands corresponding to @PROTEIN1$, @PROTEIN2$, and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated beta-catenin.","label":0}
{"pair_id":"BioInfer.d298.s0.p13","sentence":"Immunoprecipitation of metabolically labeled proteins with HECD-1 revealed three bands corresponding to @PROTEIN1$, alpha-catenin, and @PROTEIN2$ and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated beta-catenin.","label":0}
{"pair_id":"BioInfer.d298.s0.p14","sentence":"Immunoprecipitation of metabolically labeled proteins with HECD-1 revealed three bands corresponding to E-cadherin, @PROTEIN1$, and @PROTEIN2$ and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated beta-catenin.","label":0}
{"pair_id":"AIMed.d207.s1794.p0","sentence":"Thus, during myogenic differentiation, formation of @PROTEIN1$ and @PROTEIN2$\/p130 containing complexes is an early event, but not enough on its own to prevent the reactivation of DNA synthesis.","label":1}
{"pair_id":"AIMed.d207.s1794.p1","sentence":"Thus, during myogenic differentiation, formation of @PROTEIN1$ and pRb2\/@PROTEIN2$ containing complexes is an early event, but not enough on its own to prevent the reactivation of DNA synthesis.","label":1}
{"pair_id":"AIMed.d207.s1794.p2","sentence":"Thus, during myogenic differentiation, formation of E2F4 and @PROTEIN1$\/@PROTEIN2$ containing complexes is an early event, but not enough on its own to prevent the reactivation of DNA synthesis.","label":0}
{"pair_id":"BioInfer.d178.s1.p0","sentence":"We attribute these effects to potential sequestration of @PROTEIN2$ monomers by @PROTEIN1$, when present in excess.","label":1}
{"pair_id":"BioInfer.d639.s0.p0","sentence":"The main inhibitory action of p27, a cyclin-dependent kinase inhibitor (@PROTEIN1$), arises from its binding with the cyclin E\/@PROTEIN2$ (Cdk2) complex that results in G(1)-S arrest.","label":0}
{"pair_id":"BioInfer.d639.s0.p1","sentence":"The main inhibitory action of @PROTEIN2$, a cyclin-dependent kinase inhibitor (@PROTEIN1$), arises from its binding with the cyclin E\/cyclin-dependent kinase 2 (Cdk2) complex that results in G(1)-S arrest.","label":1}
{"pair_id":"BioInfer.d639.s0.p2","sentence":"The main inhibitory action of p27, a cyclin-dependent kinase inhibitor (@PROTEIN1$), arises from its binding with the cyclin E\/cyclin-dependent kinase 2 (@PROTEIN2$) complex that results in G(1)-S arrest.","label":0}
{"pair_id":"BioInfer.d639.s0.p3","sentence":"The main inhibitory action of p27, a @PROTEIN2$ (@PROTEIN1$), arises from its binding with the cyclin E\/cyclin-dependent kinase 2 (Cdk2) complex that results in G(1)-S arrest.","label":0}
{"pair_id":"BioInfer.d639.s0.p4","sentence":"The main inhibitory action of p27, a cyclin-dependent kinase inhibitor (@PROTEIN1$), arises from its binding with the @PROTEIN2$\/cyclin-dependent kinase 2 (Cdk2) complex that results in G(1)-S arrest.","label":0}
{"pair_id":"BioInfer.d639.s0.p5","sentence":"The main inhibitory action of @PROTEIN2$, a cyclin-dependent kinase inhibitor (CDKI), arises from its binding with the cyclin E\/@PROTEIN1$ (Cdk2) complex that results in G(1)-S arrest.","label":1}
{"pair_id":"BioInfer.d639.s0.p6","sentence":"The main inhibitory action of p27, a cyclin-dependent kinase inhibitor (CDKI), arises from its binding with the cyclin E\/@PROTEIN1$ (@PROTEIN2$) complex that results in G(1)-S arrest.","label":1}
{"pair_id":"BioInfer.d639.s0.p7","sentence":"The main inhibitory action of p27, a @PROTEIN2$ (CDKI), arises from its binding with the cyclin E\/@PROTEIN1$ (Cdk2) complex that results in G(1)-S arrest.","label":0}
{"pair_id":"BioInfer.d639.s0.p8","sentence":"The main inhibitory action of p27, a cyclin-dependent kinase inhibitor (CDKI), arises from its binding with the @PROTEIN2$\/@PROTEIN1$ (Cdk2) complex that results in G(1)-S arrest.","label":1}
{"pair_id":"BioInfer.d639.s0.p9","sentence":"The main inhibitory action of @PROTEIN1$, a cyclin-dependent kinase inhibitor (CDKI), arises from its binding with the cyclin E\/cyclin-dependent kinase 2 (@PROTEIN2$) complex that results in G(1)-S arrest.","label":1}
{"pair_id":"BioInfer.d639.s0.p10","sentence":"The main inhibitory action of @PROTEIN1$, a @PROTEIN2$ (CDKI), arises from its binding with the cyclin E\/cyclin-dependent kinase 2 (Cdk2) complex that results in G(1)-S arrest.","label":1}
{"pair_id":"BioInfer.d639.s0.p11","sentence":"The main inhibitory action of @PROTEIN1$, a cyclin-dependent kinase inhibitor (CDKI), arises from its binding with the @PROTEIN2$\/cyclin-dependent kinase 2 (Cdk2) complex that results in G(1)-S arrest.","label":1}
{"pair_id":"BioInfer.d639.s0.p12","sentence":"The main inhibitory action of p27, a @PROTEIN2$ (CDKI), arises from its binding with the cyclin E\/cyclin-dependent kinase 2 (@PROTEIN1$) complex that results in G(1)-S arrest.","label":0}
{"pair_id":"BioInfer.d639.s0.p13","sentence":"The main inhibitory action of p27, a cyclin-dependent kinase inhibitor (CDKI), arises from its binding with the @PROTEIN2$\/cyclin-dependent kinase 2 (@PROTEIN1$) complex that results in G(1)-S arrest.","label":1}
{"pair_id":"BioInfer.d639.s0.p14","sentence":"The main inhibitory action of p27, a @PROTEIN1$ (CDKI), arises from its binding with the @PROTEIN2$\/cyclin-dependent kinase 2 (Cdk2) complex that results in G(1)-S arrest.","label":0}
{"pair_id":"BioInfer.d0.s0.p0","sentence":"@PROTEIN2$ inhibits beta-catenin signaling by preventing formation of a beta-catenin*@PROTEIN1$*DNA complex.","label":1}
{"pair_id":"BioInfer.d0.s0.p1","sentence":"alpha-catenin inhibits @PROTEIN2$ signaling by preventing formation of a beta-catenin*@PROTEIN1$*DNA complex.","label":1}
{"pair_id":"BioInfer.d0.s0.p2","sentence":"alpha-catenin inhibits beta-catenin signaling by preventing formation of a @PROTEIN2$*@PROTEIN1$*DNA complex.","label":1}
{"pair_id":"BioInfer.d0.s0.p3","sentence":"@PROTEIN1$ inhibits @PROTEIN2$ signaling by preventing formation of a beta-catenin*T-cell factor*DNA complex.","label":1}
{"pair_id":"BioInfer.d0.s0.p4","sentence":"@PROTEIN1$ inhibits beta-catenin signaling by preventing formation of a @PROTEIN2$*T-cell factor*DNA complex.","label":1}
{"pair_id":"BioInfer.d0.s0.p5","sentence":"alpha-catenin inhibits @PROTEIN1$ signaling by preventing formation of a @PROTEIN2$*T-cell factor*DNA complex.","label":1}
{"pair_id":"BioInfer.d767.s0.p0","sentence":"To determine whether alpha 1-adrenergic stimulation produced similar effects on the turnover of myofibrillar proteins, rates of synthesis and degradation were estimated for a myofibrillar-enriched protein fraction and for @PROTEIN1$ and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d61.s535.p0","sentence":"Immunoprecipitation of @PROTEIN1$ from 32P-labeled 293\/@PROTEIN2$ cells demonstrated that the receptor is phosphorylated.","label":0}
{"pair_id":"AIMed.d193.s1644.p0","sentence":"As expected, overexpression of either @PROTEIN1$\/@PROTEIN2$ or ITF-2b effectively inhibited the activation of the muscle-specific creatine kinase promoter by the myogenic transcription factor MyoD.","label":0}
{"pair_id":"AIMed.d193.s1644.p1","sentence":"As expected, overexpression of either @PROTEIN1$\/HLH462 or @PROTEIN2$ effectively inhibited the activation of the muscle-specific creatine kinase promoter by the myogenic transcription factor MyoD.","label":0}
{"pair_id":"AIMed.d193.s1644.p2","sentence":"As expected, overexpression of either @PROTEIN1$\/HLH462 or ITF-2b effectively inhibited the activation of the muscle-specific @PROTEIN2$ promoter by the myogenic transcription factor MyoD.","label":0}
{"pair_id":"AIMed.d193.s1644.p3","sentence":"As expected, overexpression of either @PROTEIN1$\/HLH462 or ITF-2b effectively inhibited the activation of the muscle-specific creatine kinase promoter by the myogenic transcription factor @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d193.s1644.p4","sentence":"As expected, overexpression of either Id3\/@PROTEIN1$ or @PROTEIN2$ effectively inhibited the activation of the muscle-specific creatine kinase promoter by the myogenic transcription factor MyoD.","label":0}
{"pair_id":"AIMed.d193.s1644.p5","sentence":"As expected, overexpression of either Id3\/@PROTEIN1$ or ITF-2b effectively inhibited the activation of the muscle-specific @PROTEIN2$ promoter by the myogenic transcription factor MyoD.","label":0}
{"pair_id":"AIMed.d193.s1644.p6","sentence":"As expected, overexpression of either Id3\/@PROTEIN1$ or ITF-2b effectively inhibited the activation of the muscle-specific creatine kinase promoter by the myogenic transcription factor @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d193.s1644.p7","sentence":"As expected, overexpression of either Id3\/HLH462 or @PROTEIN1$ effectively inhibited the activation of the muscle-specific @PROTEIN2$ promoter by the myogenic transcription factor MyoD.","label":0}
{"pair_id":"AIMed.d193.s1644.p8","sentence":"As expected, overexpression of either Id3\/HLH462 or @PROTEIN1$ effectively inhibited the activation of the muscle-specific creatine kinase promoter by the myogenic transcription factor @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d193.s1644.p9","sentence":"As expected, overexpression of either Id3\/HLH462 or ITF-2b effectively inhibited the activation of the muscle-specific @PROTEIN1$ promoter by the myogenic transcription factor @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d161.s0.p0","sentence":"Data from affinity chromatography, analytical ultracentrifugation, covalent cross-linking, and fluorescence anisotropy show that profilin, @PROTEIN1$, and @PROTEIN2$ form a ternary complex.","label":1}
{"pair_id":"BioInfer.d161.s0.p1","sentence":"Data from affinity chromatography, analytical ultracentrifugation, covalent cross-linking, and fluorescence anisotropy show that @PROTEIN2$, @PROTEIN1$, and actin form a ternary complex.","label":1}
{"pair_id":"BioInfer.d161.s0.p2","sentence":"Data from affinity chromatography, analytical ultracentrifugation, covalent cross-linking, and fluorescence anisotropy show that @PROTEIN2$, thymosin beta(4), and @PROTEIN1$ form a ternary complex.","label":1}
{"pair_id":"AIMed.d187.s1591.p0","sentence":"Endogenous @PROTEIN1$-@PROTEIN2$ complexes were detected in human CSF by immunoprecipitation.","label":1}
{"pair_id":"AIMed.d146.s1241.p0","sentence":"In addition, PCR analysis of @PROTEIN1$-expressing cells could not detect splicing of the extracellular domain of the cloned @PROTEIN2$, thereby excluding the possibility that the p76 IL-7R is a previously undescribed splice variant of the cloned IL-7R.","label":0}
{"pair_id":"AIMed.d146.s1241.p1","sentence":"In addition, PCR analysis of @PROTEIN1$-expressing cells could not detect splicing of the extracellular domain of the cloned IL-7R, thereby excluding the possibility that the @PROTEIN2$ IL-7R is a previously undescribed splice variant of the cloned IL-7R.","label":0}
{"pair_id":"AIMed.d146.s1241.p2","sentence":"In addition, PCR analysis of @PROTEIN1$-expressing cells could not detect splicing of the extracellular domain of the cloned IL-7R, thereby excluding the possibility that the p76 @PROTEIN2$ is a previously undescribed splice variant of the cloned IL-7R.","label":0}
{"pair_id":"AIMed.d146.s1241.p3","sentence":"In addition, PCR analysis of @PROTEIN1$-expressing cells could not detect splicing of the extracellular domain of the cloned IL-7R, thereby excluding the possibility that the p76 IL-7R is a previously undescribed splice variant of the cloned @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d146.s1241.p4","sentence":"In addition, PCR analysis of p76-expressing cells could not detect splicing of the extracellular domain of the cloned @PROTEIN1$, thereby excluding the possibility that the @PROTEIN2$ IL-7R is a previously undescribed splice variant of the cloned IL-7R.","label":0}
{"pair_id":"AIMed.d146.s1241.p5","sentence":"In addition, PCR analysis of p76-expressing cells could not detect splicing of the extracellular domain of the cloned @PROTEIN1$, thereby excluding the possibility that the p76 @PROTEIN2$ is a previously undescribed splice variant of the cloned IL-7R.","label":0}
{"pair_id":"AIMed.d146.s1241.p6","sentence":"In addition, PCR analysis of p76-expressing cells could not detect splicing of the extracellular domain of the cloned @PROTEIN1$, thereby excluding the possibility that the p76 IL-7R is a previously undescribed splice variant of the cloned @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d146.s1241.p7","sentence":"In addition, PCR analysis of p76-expressing cells could not detect splicing of the extracellular domain of the cloned IL-7R, thereby excluding the possibility that the @PROTEIN1$ @PROTEIN2$ is a previously undescribed splice variant of the cloned IL-7R.","label":0}
{"pair_id":"AIMed.d146.s1241.p8","sentence":"In addition, PCR analysis of p76-expressing cells could not detect splicing of the extracellular domain of the cloned IL-7R, thereby excluding the possibility that the @PROTEIN1$ IL-7R is a previously undescribed splice variant of the cloned @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d146.s1241.p9","sentence":"In addition, PCR analysis of p76-expressing cells could not detect splicing of the extracellular domain of the cloned IL-7R, thereby excluding the possibility that the p76 @PROTEIN1$ is a previously undescribed splice variant of the cloned @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d146.s1236.p0","sentence":"These analyses showed that the ability of PBMC to proliferate to @PROTEIN1$ correlated with expression of the @PROTEIN2$ IL-7R, and not with expression of the p90 IL-7R.","label":0}
{"pair_id":"AIMed.d146.s1236.p1","sentence":"These analyses showed that the ability of PBMC to proliferate to @PROTEIN1$ correlated with expression of the p76 @PROTEIN2$, and not with expression of the p90 IL-7R.","label":0}
{"pair_id":"AIMed.d146.s1236.p2","sentence":"These analyses showed that the ability of PBMC to proliferate to @PROTEIN1$ correlated with expression of the p76 IL-7R, and not with expression of the @PROTEIN2$ IL-7R.","label":0}
{"pair_id":"AIMed.d146.s1236.p3","sentence":"These analyses showed that the ability of PBMC to proliferate to @PROTEIN1$ correlated with expression of the p76 IL-7R, and not with expression of the p90 @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d146.s1236.p4","sentence":"These analyses showed that the ability of PBMC to proliferate to IL-7 correlated with expression of the @PROTEIN1$ @PROTEIN2$, and not with expression of the p90 IL-7R.","label":0}
{"pair_id":"AIMed.d146.s1236.p5","sentence":"These analyses showed that the ability of PBMC to proliferate to IL-7 correlated with expression of the @PROTEIN1$ IL-7R, and not with expression of the @PROTEIN2$ IL-7R.","label":0}
{"pair_id":"AIMed.d146.s1236.p6","sentence":"These analyses showed that the ability of PBMC to proliferate to IL-7 correlated with expression of the @PROTEIN1$ IL-7R, and not with expression of the p90 @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d146.s1236.p7","sentence":"These analyses showed that the ability of PBMC to proliferate to IL-7 correlated with expression of the p76 @PROTEIN1$, and not with expression of the @PROTEIN2$ IL-7R.","label":0}
{"pair_id":"AIMed.d146.s1236.p8","sentence":"These analyses showed that the ability of PBMC to proliferate to IL-7 correlated with expression of the p76 @PROTEIN1$, and not with expression of the p90 @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d146.s1236.p9","sentence":"These analyses showed that the ability of PBMC to proliferate to IL-7 correlated with expression of the p76 IL-7R, and not with expression of the @PROTEIN1$ @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d183.s1556.p0","sentence":"Under these conditions, a ternary complex of @PROTEIN1$, @PROTEIN2$, and Raf-1 was observed.","label":1}
{"pair_id":"AIMed.d183.s1556.p1","sentence":"Under these conditions, a ternary complex of @PROTEIN1$, JAK2, and @PROTEIN2$ was observed.","label":0}
{"pair_id":"AIMed.d183.s1556.p2","sentence":"Under these conditions, a ternary complex of p21ras, @PROTEIN1$, and @PROTEIN2$ was observed.","label":0}
{"pair_id":"BioInfer.d67.s0.p0","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (@PROTEIN2$), Abp1p (ABP1), and capping protein (CAP1 and @PROTEIN1$) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p1","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), @PROTEIN2$ (SAC6), Abp1p (ABP1), and capping protein (CAP1 and @PROTEIN1$) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p2","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the @PROTEIN2$ (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and @PROTEIN1$) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p3","sentence":"A null mutation of the @PROTEIN2$ gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and @PROTEIN1$) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p4","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (@PROTEIN2$ and @PROTEIN1$) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p5","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), @PROTEIN2$ (ABP1), and capping protein (CAP1 and @PROTEIN1$) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p6","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and @PROTEIN2$ (CAP1 and @PROTEIN1$) genes have relatively mild or no effects.","label":1}
{"pair_id":"BioInfer.d67.s0.p7","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (@PROTEIN2$), and capping protein (CAP1 and @PROTEIN1$) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p8","sentence":"A null mutation of the actin gene (@PROTEIN2$) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and @PROTEIN1$) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p9","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (@PROTEIN2$), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and @PROTEIN1$) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p10","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), @PROTEIN2$ (@PROTEIN1$), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p11","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the @PROTEIN2$ (TPM1), fimbrin (@PROTEIN1$), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p12","sentence":"A null mutation of the @PROTEIN2$ gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (@PROTEIN1$), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p13","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (@PROTEIN1$), Abp1p (ABP1), and capping protein (@PROTEIN2$ and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p14","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (@PROTEIN1$), @PROTEIN2$ (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p15","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (@PROTEIN1$), Abp1p (ABP1), and @PROTEIN2$ (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p16","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (@PROTEIN1$), Abp1p (@PROTEIN2$), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p17","sentence":"A null mutation of the actin gene (@PROTEIN2$) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (@PROTEIN1$), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p18","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (@PROTEIN2$), fimbrin (@PROTEIN1$), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p19","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the @PROTEIN2$ (TPM1), @PROTEIN1$ (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p20","sentence":"A null mutation of the @PROTEIN2$ gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), @PROTEIN1$ (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p21","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), @PROTEIN1$ (SAC6), Abp1p (ABP1), and capping protein (@PROTEIN2$ and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p22","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), @PROTEIN1$ (SAC6), @PROTEIN2$ (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p23","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), @PROTEIN1$ (SAC6), Abp1p (ABP1), and @PROTEIN2$ (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p24","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), @PROTEIN1$ (SAC6), Abp1p (@PROTEIN2$), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p25","sentence":"A null mutation of the actin gene (@PROTEIN2$) is lethal, but null mutations in the tropomyosin (TPM1), @PROTEIN1$ (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p26","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (@PROTEIN2$), @PROTEIN1$ (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p27","sentence":"A null mutation of the @PROTEIN2$ gene (ACT1) is lethal, but null mutations in the @PROTEIN1$ (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p28","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the @PROTEIN1$ (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (@PROTEIN2$ and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p29","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the @PROTEIN1$ (TPM1), fimbrin (SAC6), @PROTEIN2$ (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p30","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the @PROTEIN1$ (TPM1), fimbrin (SAC6), Abp1p (ABP1), and @PROTEIN2$ (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p31","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the @PROTEIN1$ (TPM1), fimbrin (SAC6), Abp1p (@PROTEIN2$), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p32","sentence":"A null mutation of the actin gene (@PROTEIN2$) is lethal, but null mutations in the @PROTEIN1$ (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p33","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the @PROTEIN1$ (@PROTEIN2$), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p34","sentence":"A null mutation of the @PROTEIN1$ gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (@PROTEIN2$ and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p35","sentence":"A null mutation of the @PROTEIN1$ gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), @PROTEIN2$ (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p36","sentence":"A null mutation of the @PROTEIN1$ gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and @PROTEIN2$ (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p37","sentence":"A null mutation of the @PROTEIN1$ gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (@PROTEIN2$), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p38","sentence":"A null mutation of the @PROTEIN1$ gene (@PROTEIN2$) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p39","sentence":"A null mutation of the @PROTEIN1$ gene (ACT1) is lethal, but null mutations in the tropomyosin (@PROTEIN2$), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p40","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), @PROTEIN2$ (ABP1), and capping protein (@PROTEIN1$ and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p41","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and @PROTEIN2$ (@PROTEIN1$ and CAP2) genes have relatively mild or no effects.","label":1}
{"pair_id":"BioInfer.d67.s0.p42","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (@PROTEIN2$), and capping protein (@PROTEIN1$ and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p43","sentence":"A null mutation of the actin gene (@PROTEIN2$) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (@PROTEIN1$ and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p44","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (@PROTEIN2$), fimbrin (SAC6), Abp1p (ABP1), and capping protein (@PROTEIN1$ and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p45","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), @PROTEIN1$ (ABP1), and @PROTEIN2$ (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p46","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), @PROTEIN1$ (@PROTEIN2$), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p47","sentence":"A null mutation of the actin gene (@PROTEIN2$) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), @PROTEIN1$ (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p48","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (@PROTEIN2$), fimbrin (SAC6), @PROTEIN1$ (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p49","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (@PROTEIN2$), and @PROTEIN1$ (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p50","sentence":"A null mutation of the actin gene (@PROTEIN2$) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and @PROTEIN1$ (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p51","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (@PROTEIN2$), fimbrin (SAC6), Abp1p (ABP1), and @PROTEIN1$ (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p52","sentence":"A null mutation of the actin gene (@PROTEIN2$) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (@PROTEIN1$), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p53","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (@PROTEIN2$), fimbrin (SAC6), Abp1p (@PROTEIN1$), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p54","sentence":"A null mutation of the actin gene (@PROTEIN1$) is lethal, but null mutations in the tropomyosin (@PROTEIN2$), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"AIMed.d224.s1950.p0","sentence":"Further studies on the interaction of @PROTEIN1$ with molecules in the endoplasmic reticulum revealed that @PROTEIN2$ associates with the transporter associated with antigen processing (TAP) and calreticulin, and that HLA-E expression is TAP-dependent and tapasin-dependent.","label":0}
{"pair_id":"AIMed.d224.s1950.p1","sentence":"Further studies on the interaction of @PROTEIN1$ with molecules in the endoplasmic reticulum revealed that HLA-E associates with the @PROTEIN2$ (TAP) and calreticulin, and that HLA-E expression is TAP-dependent and tapasin-dependent.","label":0}
{"pair_id":"AIMed.d224.s1950.p2","sentence":"Further studies on the interaction of @PROTEIN1$ with molecules in the endoplasmic reticulum revealed that HLA-E associates with the transporter associated with antigen processing (@PROTEIN2$) and calreticulin, and that HLA-E expression is TAP-dependent and tapasin-dependent.","label":0}
{"pair_id":"AIMed.d224.s1950.p3","sentence":"Further studies on the interaction of @PROTEIN1$ with molecules in the endoplasmic reticulum revealed that HLA-E associates with the transporter associated with antigen processing (TAP) and @PROTEIN2$, and that HLA-E expression is TAP-dependent and tapasin-dependent.","label":0}
{"pair_id":"AIMed.d224.s1950.p4","sentence":"Further studies on the interaction of @PROTEIN1$ with molecules in the endoplasmic reticulum revealed that HLA-E associates with the transporter associated with antigen processing (TAP) and calreticulin, and that @PROTEIN2$ expression is TAP-dependent and tapasin-dependent.","label":0}
{"pair_id":"AIMed.d224.s1950.p5","sentence":"Further studies on the interaction of @PROTEIN1$ with molecules in the endoplasmic reticulum revealed that HLA-E associates with the transporter associated with antigen processing (TAP) and calreticulin, and that HLA-E expression is @PROTEIN2$-dependent and tapasin-dependent.","label":0}
{"pair_id":"AIMed.d224.s1950.p6","sentence":"Further studies on the interaction of HLA-E with molecules in the endoplasmic reticulum revealed that @PROTEIN1$ associates with the @PROTEIN2$ (TAP) and calreticulin, and that HLA-E expression is TAP-dependent and tapasin-dependent.","label":1}
{"pair_id":"AIMed.d224.s1950.p7","sentence":"Further studies on the interaction of HLA-E with molecules in the endoplasmic reticulum revealed that @PROTEIN1$ associates with the transporter associated with antigen processing (@PROTEIN2$) and calreticulin, and that HLA-E expression is TAP-dependent and tapasin-dependent.","label":1}
{"pair_id":"AIMed.d224.s1950.p8","sentence":"Further studies on the interaction of HLA-E with molecules in the endoplasmic reticulum revealed that @PROTEIN1$ associates with the transporter associated with antigen processing (TAP) and @PROTEIN2$, and that HLA-E expression is TAP-dependent and tapasin-dependent.","label":1}
{"pair_id":"AIMed.d224.s1950.p9","sentence":"Further studies on the interaction of HLA-E with molecules in the endoplasmic reticulum revealed that @PROTEIN1$ associates with the transporter associated with antigen processing (TAP) and calreticulin, and that @PROTEIN2$ expression is TAP-dependent and tapasin-dependent.","label":0}
{"pair_id":"AIMed.d224.s1950.p10","sentence":"Further studies on the interaction of HLA-E with molecules in the endoplasmic reticulum revealed that @PROTEIN1$ associates with the transporter associated with antigen processing (TAP) and calreticulin, and that HLA-E expression is @PROTEIN2$-dependent and tapasin-dependent.","label":0}
{"pair_id":"AIMed.d224.s1950.p11","sentence":"Further studies on the interaction of HLA-E with molecules in the endoplasmic reticulum revealed that HLA-E associates with the @PROTEIN1$ (@PROTEIN2$) and calreticulin, and that HLA-E expression is TAP-dependent and tapasin-dependent.","label":0}
{"pair_id":"AIMed.d224.s1950.p12","sentence":"Further studies on the interaction of HLA-E with molecules in the endoplasmic reticulum revealed that HLA-E associates with the @PROTEIN1$ (TAP) and @PROTEIN2$, and that HLA-E expression is TAP-dependent and tapasin-dependent.","label":0}
{"pair_id":"AIMed.d224.s1950.p13","sentence":"Further studies on the interaction of HLA-E with molecules in the endoplasmic reticulum revealed that HLA-E associates with the @PROTEIN1$ (TAP) and calreticulin, and that @PROTEIN2$ expression is TAP-dependent and tapasin-dependent.","label":0}
{"pair_id":"AIMed.d224.s1950.p14","sentence":"Further studies on the interaction of HLA-E with molecules in the endoplasmic reticulum revealed that HLA-E associates with the @PROTEIN1$ (TAP) and calreticulin, and that HLA-E expression is @PROTEIN2$-dependent and tapasin-dependent.","label":0}
{"pair_id":"AIMed.d224.s1950.p15","sentence":"Further studies on the interaction of HLA-E with molecules in the endoplasmic reticulum revealed that HLA-E associates with the transporter associated with antigen processing (@PROTEIN1$) and @PROTEIN2$, and that HLA-E expression is TAP-dependent and tapasin-dependent.","label":0}
{"pair_id":"AIMed.d224.s1950.p16","sentence":"Further studies on the interaction of HLA-E with molecules in the endoplasmic reticulum revealed that HLA-E associates with the transporter associated with antigen processing (@PROTEIN1$) and calreticulin, and that @PROTEIN2$ expression is TAP-dependent and tapasin-dependent.","label":0}
{"pair_id":"AIMed.d224.s1950.p17","sentence":"Further studies on the interaction of HLA-E with molecules in the endoplasmic reticulum revealed that HLA-E associates with the transporter associated with antigen processing (@PROTEIN1$) and calreticulin, and that HLA-E expression is @PROTEIN2$-dependent and tapasin-dependent.","label":0}
{"pair_id":"AIMed.d224.s1950.p18","sentence":"Further studies on the interaction of HLA-E with molecules in the endoplasmic reticulum revealed that HLA-E associates with the transporter associated with antigen processing (TAP) and @PROTEIN1$, and that @PROTEIN2$ expression is TAP-dependent and tapasin-dependent.","label":0}
{"pair_id":"AIMed.d224.s1950.p19","sentence":"Further studies on the interaction of HLA-E with molecules in the endoplasmic reticulum revealed that HLA-E associates with the transporter associated with antigen processing (TAP) and @PROTEIN1$, and that HLA-E expression is @PROTEIN2$-dependent and tapasin-dependent.","label":0}
{"pair_id":"AIMed.d224.s1950.p20","sentence":"Further studies on the interaction of HLA-E with molecules in the endoplasmic reticulum revealed that HLA-E associates with the transporter associated with antigen processing (TAP) and calreticulin, and that @PROTEIN1$ expression is @PROTEIN2$-dependent and tapasin-dependent.","label":0}
{"pair_id":"BioInfer.d342.s0.p0","sentence":"Inhibition of the interactions of @PROTEIN1$, destrin, and @PROTEIN2$ with actin by phosphoinositides.","label":0}
{"pair_id":"BioInfer.d342.s0.p1","sentence":"Inhibition of the interactions of @PROTEIN1$, destrin, and deoxyribonuclease I with @PROTEIN2$ by phosphoinositides.","label":1}
{"pair_id":"BioInfer.d342.s0.p2","sentence":"Inhibition of the interactions of @PROTEIN1$, @PROTEIN2$, and deoxyribonuclease I with actin by phosphoinositides.","label":0}
{"pair_id":"BioInfer.d342.s0.p3","sentence":"Inhibition of the interactions of cofilin, destrin, and @PROTEIN1$ with @PROTEIN2$ by phosphoinositides.","label":1}
{"pair_id":"BioInfer.d342.s0.p4","sentence":"Inhibition of the interactions of cofilin, @PROTEIN2$, and @PROTEIN1$ with actin by phosphoinositides.","label":0}
{"pair_id":"BioInfer.d342.s0.p5","sentence":"Inhibition of the interactions of cofilin, @PROTEIN2$, and deoxyribonuclease I with @PROTEIN1$ by phosphoinositides.","label":1}
{"pair_id":"AIMed.d98.s833.p0","sentence":"14-3-3 protein, however, has no effect on the @PROTEIN1$-kinase activity of @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d87.s0.p0","sentence":"A truncated @PROTEIN2$ disrupts the interaction between @PROTEIN1$ and alpha-catenin: a cause of loss of intercellular adhesiveness in human cancer cell lines.","label":1}
{"pair_id":"BioInfer.d87.s0.p1","sentence":"A truncated beta-catenin disrupts the interaction between @PROTEIN1$ and @PROTEIN2$: a cause of loss of intercellular adhesiveness in human cancer cell lines.","label":1}
{"pair_id":"BioInfer.d87.s0.p2","sentence":"A truncated @PROTEIN1$ disrupts the interaction between E-cadherin and @PROTEIN2$: a cause of loss of intercellular adhesiveness in human cancer cell lines.","label":1}
{"pair_id":"AIMed.d151.s1289.p0","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant @PROTEIN1$ gamma and @PROTEIN2$ delta with TBP, consistent either with the natural association of TBP with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p1","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant @PROTEIN1$ gamma and PTF delta with @PROTEIN2$, consistent either with the natural association of TBP with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p2","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant @PROTEIN1$ gamma and PTF delta with TBP, consistent either with the natural association of @PROTEIN2$ with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p3","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant @PROTEIN1$ gamma and PTF delta with TBP, consistent either with the natural association of TBP with @PROTEIN2$ in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p4","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant @PROTEIN1$ gamma and PTF delta with TBP, consistent either with the natural association of TBP with PTF in a semistable @PROTEIN2$-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p5","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant @PROTEIN1$ gamma and PTF delta with TBP, consistent either with the natural association of TBP with PTF in a semistable TBP-@PROTEIN2$-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p6","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant @PROTEIN1$ gamma and PTF delta with TBP, consistent either with the natural association of TBP with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound @PROTEIN2$ and TATA-bound TBP during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p7","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant @PROTEIN1$ gamma and PTF delta with TBP, consistent either with the natural association of TBP with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound @PROTEIN2$ during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p8","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and @PROTEIN1$ delta with @PROTEIN2$, consistent either with the natural association of TBP with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p9","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and @PROTEIN1$ delta with TBP, consistent either with the natural association of @PROTEIN2$ with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p10","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and @PROTEIN1$ delta with TBP, consistent either with the natural association of TBP with @PROTEIN2$ in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p11","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and @PROTEIN1$ delta with TBP, consistent either with the natural association of TBP with PTF in a semistable @PROTEIN2$-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p12","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and @PROTEIN1$ delta with TBP, consistent either with the natural association of TBP with PTF in a semistable TBP-@PROTEIN2$-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p13","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and @PROTEIN1$ delta with TBP, consistent either with the natural association of TBP with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound @PROTEIN2$ and TATA-bound TBP during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p14","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and @PROTEIN1$ delta with TBP, consistent either with the natural association of TBP with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound @PROTEIN2$ during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p15","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with @PROTEIN1$, consistent either with the natural association of @PROTEIN2$ with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p16","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with @PROTEIN1$, consistent either with the natural association of TBP with @PROTEIN2$ in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p17","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with @PROTEIN1$, consistent either with the natural association of TBP with PTF in a semistable @PROTEIN2$-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p18","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with @PROTEIN1$, consistent either with the natural association of TBP with PTF in a semistable TBP-@PROTEIN2$-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p19","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with @PROTEIN1$, consistent either with the natural association of TBP with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound @PROTEIN2$ and TATA-bound TBP during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p20","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with @PROTEIN1$, consistent either with the natural association of TBP with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound @PROTEIN2$ during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p21","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with TBP, consistent either with the natural association of @PROTEIN1$ with @PROTEIN2$ in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p22","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with TBP, consistent either with the natural association of @PROTEIN1$ with PTF in a semistable @PROTEIN2$-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p23","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with TBP, consistent either with the natural association of @PROTEIN1$ with PTF in a semistable TBP-@PROTEIN2$-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p24","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with TBP, consistent either with the natural association of @PROTEIN1$ with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound @PROTEIN2$ and TATA-bound TBP during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p25","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with TBP, consistent either with the natural association of @PROTEIN1$ with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound @PROTEIN2$ during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p26","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with TBP, consistent either with the natural association of TBP with @PROTEIN1$ in a semistable @PROTEIN2$-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p27","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with TBP, consistent either with the natural association of TBP with @PROTEIN1$ in a semistable TBP-@PROTEIN2$-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p28","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with TBP, consistent either with the natural association of TBP with @PROTEIN1$ in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound @PROTEIN2$ and TATA-bound TBP during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p29","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with TBP, consistent either with the natural association of TBP with @PROTEIN1$ in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound @PROTEIN2$ during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p30","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with TBP, consistent either with the natural association of TBP with PTF in a semistable @PROTEIN1$-@PROTEIN2$-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p31","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with TBP, consistent either with the natural association of TBP with PTF in a semistable @PROTEIN1$-TBP-associated factor complex or with possible functional interactions between PSE-bound @PROTEIN2$ and TATA-bound TBP during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p32","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with TBP, consistent either with the natural association of TBP with PTF in a semistable @PROTEIN1$-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound @PROTEIN2$ during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p33","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with TBP, consistent either with the natural association of TBP with PTF in a semistable TBP-@PROTEIN1$-associated factor complex or with possible functional interactions between PSE-bound @PROTEIN2$ and TATA-bound TBP during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p34","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with TBP, consistent either with the natural association of TBP with PTF in a semistable TBP-@PROTEIN1$-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound @PROTEIN2$ during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p35","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with TBP, consistent either with the natural association of TBP with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound @PROTEIN1$ and TATA-bound @PROTEIN2$ during promoter activation.","label":0}
{"pair_id":"BioInfer.d400.s0.p0","sentence":"Lack of detection in these preparations of a constituent that binds RBC alpha-spectrin antibody plus the presence of significant quantities of @PROTEIN2$, further suggests that the principal membrane skeletal element is actin with perhaps smaller quantities of a 240-kd component, identified by others as the protein @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d400.s0.p1","sentence":"Lack of detection in these preparations of a constituent that binds RBC alpha-spectrin antibody plus the presence of significant quantities of actin, further suggests that the principal membrane skeletal element is @PROTEIN2$ with perhaps smaller quantities of a 240-kd component, identified by others as the protein @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d400.s0.p2","sentence":"Lack of detection in these preparations of a constituent that binds RBC @PROTEIN2$ antibody plus the presence of significant quantities of actin, further suggests that the principal membrane skeletal element is actin with perhaps smaller quantities of a 240-kd component, identified by others as the protein @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d400.s0.p3","sentence":"Lack of detection in these preparations of a constituent that binds RBC alpha-spectrin antibody plus the presence of significant quantities of @PROTEIN1$, further suggests that the principal membrane skeletal element is @PROTEIN2$ with perhaps smaller quantities of a 240-kd component, identified by others as the protein talin.","label":0}
{"pair_id":"BioInfer.d400.s0.p4","sentence":"Lack of detection in these preparations of a constituent that binds RBC @PROTEIN2$ antibody plus the presence of significant quantities of @PROTEIN1$, further suggests that the principal membrane skeletal element is actin with perhaps smaller quantities of a 240-kd component, identified by others as the protein talin.","label":0}
{"pair_id":"BioInfer.d400.s0.p5","sentence":"Lack of detection in these preparations of a constituent that binds RBC @PROTEIN2$ antibody plus the presence of significant quantities of actin, further suggests that the principal membrane skeletal element is @PROTEIN1$ with perhaps smaller quantities of a 240-kd component, identified by others as the protein talin.","label":0}
{"pair_id":"BioInfer.d29.s0.p0","sentence":"After digestion of the 60 kDa fragment with cyanogen bromide, the N-terminal 21-amino acid sequence of one of the resulting peptides was found to show sequence similarity to a region near the @PROTEIN2$-binding site (amino acid residues 260-281) of yeast @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d276.s0.p0","sentence":"However, some proteins (e.g., @PROTEIN1$) and other agents (e.g., cytochalasin D) that bind to actin are affected by the presence of fluorescent labels, making @PROTEIN2$ intrinsic fluorescence potentially useful in investigating the interaction of these agents with actin, and in validating data obtained using labeled actin.","label":0}
{"pair_id":"BioInfer.d276.s0.p1","sentence":"However, some proteins (e.g., @PROTEIN1$) and other agents (e.g., cytochalasin D) that bind to actin are affected by the presence of fluorescent labels, making actin intrinsic fluorescence potentially useful in investigating the interaction of these agents with actin, and in validating data obtained using labeled @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d276.s0.p2","sentence":"However, some proteins (e.g., @PROTEIN1$) and other agents (e.g., cytochalasin D) that bind to actin are affected by the presence of fluorescent labels, making actin intrinsic fluorescence potentially useful in investigating the interaction of these agents with @PROTEIN2$, and in validating data obtained using labeled actin.","label":1}
{"pair_id":"BioInfer.d276.s0.p3","sentence":"However, some proteins (e.g., @PROTEIN1$) and other agents (e.g., cytochalasin D) that bind to @PROTEIN2$ are affected by the presence of fluorescent labels, making actin intrinsic fluorescence potentially useful in investigating the interaction of these agents with actin, and in validating data obtained using labeled actin.","label":1}
{"pair_id":"BioInfer.d276.s0.p4","sentence":"However, some proteins (e.g., profilin) and other agents (e.g., cytochalasin D) that bind to actin are affected by the presence of fluorescent labels, making @PROTEIN1$ intrinsic fluorescence potentially useful in investigating the interaction of these agents with actin, and in validating data obtained using labeled @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d276.s0.p5","sentence":"However, some proteins (e.g., profilin) and other agents (e.g., cytochalasin D) that bind to actin are affected by the presence of fluorescent labels, making @PROTEIN1$ intrinsic fluorescence potentially useful in investigating the interaction of these agents with @PROTEIN2$, and in validating data obtained using labeled actin.","label":0}
{"pair_id":"BioInfer.d276.s0.p6","sentence":"However, some proteins (e.g., profilin) and other agents (e.g., cytochalasin D) that bind to @PROTEIN2$ are affected by the presence of fluorescent labels, making @PROTEIN1$ intrinsic fluorescence potentially useful in investigating the interaction of these agents with actin, and in validating data obtained using labeled actin.","label":0}
{"pair_id":"BioInfer.d276.s0.p7","sentence":"However, some proteins (e.g., profilin) and other agents (e.g., cytochalasin D) that bind to actin are affected by the presence of fluorescent labels, making actin intrinsic fluorescence potentially useful in investigating the interaction of these agents with @PROTEIN2$, and in validating data obtained using labeled @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d276.s0.p8","sentence":"However, some proteins (e.g., profilin) and other agents (e.g., cytochalasin D) that bind to @PROTEIN2$ are affected by the presence of fluorescent labels, making actin intrinsic fluorescence potentially useful in investigating the interaction of these agents with actin, and in validating data obtained using labeled @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d276.s0.p9","sentence":"However, some proteins (e.g., profilin) and other agents (e.g., cytochalasin D) that bind to @PROTEIN2$ are affected by the presence of fluorescent labels, making actin intrinsic fluorescence potentially useful in investigating the interaction of these agents with @PROTEIN1$, and in validating data obtained using labeled actin.","label":0}
{"pair_id":"AIMed.d179.s1526.p0","sentence":"In addition, activation of @PROTEIN1$ was detected in anti-@PROTEIN2$ immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate PI 3-kinase.","label":0}
{"pair_id":"AIMed.d179.s1526.p1","sentence":"In addition, activation of @PROTEIN1$ was detected in anti-IRS-1 immunoprecipitates from @PROTEIN2$-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate PI 3-kinase.","label":0}
{"pair_id":"AIMed.d179.s1526.p2","sentence":"In addition, activation of @PROTEIN1$ was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of @PROTEIN2$, which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate PI 3-kinase.","label":0}
{"pair_id":"AIMed.d179.s1526.p3","sentence":"In addition, activation of @PROTEIN1$ was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of @PROTEIN2$, might be one mechanism used by gastrin to activate PI 3-kinase.","label":0}
{"pair_id":"AIMed.d179.s1526.p4","sentence":"In addition, activation of @PROTEIN1$ was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by @PROTEIN2$ to activate PI 3-kinase.","label":0}
{"pair_id":"AIMed.d179.s1526.p5","sentence":"In addition, activation of @PROTEIN1$ was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d179.s1526.p6","sentence":"In addition, activation of PI 3-kinase was detected in anti-@PROTEIN1$ immunoprecipitates from @PROTEIN2$-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate PI 3-kinase.","label":0}
{"pair_id":"AIMed.d179.s1526.p7","sentence":"In addition, activation of PI 3-kinase was detected in anti-@PROTEIN1$ immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of @PROTEIN2$, which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate PI 3-kinase.","label":0}
{"pair_id":"AIMed.d179.s1526.p8","sentence":"In addition, activation of PI 3-kinase was detected in anti-@PROTEIN1$ immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of @PROTEIN2$, might be one mechanism used by gastrin to activate PI 3-kinase.","label":0}
{"pair_id":"AIMed.d179.s1526.p9","sentence":"In addition, activation of PI 3-kinase was detected in anti-@PROTEIN1$ immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by @PROTEIN2$ to activate PI 3-kinase.","label":0}
{"pair_id":"AIMed.d179.s1526.p10","sentence":"In addition, activation of PI 3-kinase was detected in anti-@PROTEIN1$ immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d179.s1526.p11","sentence":"In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from @PROTEIN1$-treated cells, suggesting that tyrosine phosphorylation of @PROTEIN2$, which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate PI 3-kinase.","label":0}
{"pair_id":"AIMed.d179.s1526.p12","sentence":"In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from @PROTEIN1$-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of @PROTEIN2$, might be one mechanism used by gastrin to activate PI 3-kinase.","label":0}
{"pair_id":"AIMed.d179.s1526.p13","sentence":"In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from @PROTEIN1$-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by @PROTEIN2$ to activate PI 3-kinase.","label":0}
{"pair_id":"AIMed.d179.s1526.p14","sentence":"In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from @PROTEIN1$-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d179.s1526.p15","sentence":"In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of @PROTEIN1$, which leads to the rapid recruitment of @PROTEIN2$, might be one mechanism used by gastrin to activate PI 3-kinase.","label":0}
{"pair_id":"AIMed.d179.s1526.p16","sentence":"In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of @PROTEIN1$, which leads to the rapid recruitment of p85, might be one mechanism used by @PROTEIN2$ to activate PI 3-kinase.","label":0}
{"pair_id":"AIMed.d179.s1526.p17","sentence":"In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of @PROTEIN1$, which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d179.s1526.p18","sentence":"In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of @PROTEIN1$, might be one mechanism used by @PROTEIN2$ to activate PI 3-kinase.","label":0}
{"pair_id":"AIMed.d179.s1526.p19","sentence":"In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of @PROTEIN1$, might be one mechanism used by gastrin to activate @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d179.s1526.p20","sentence":"In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by @PROTEIN1$ to activate @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d777.s0.p0","sentence":"Treatment with HNE resulted in activation of extracellular signal-regulated protein kinases @PROTEIN1$ and @PROTEIN2$, induction of c-fos and c-jun protein expression, and an increase in transcription factor AP-1 DNA binding activity.","label":0}
{"pair_id":"BioInfer.d777.s0.p1","sentence":"Treatment with HNE resulted in activation of extracellular signal-regulated protein kinases @PROTEIN1$ and ERK2, induction of c-fos and c-jun protein expression, and an increase in transcription factor @PROTEIN2$ DNA binding activity.","label":0}
{"pair_id":"BioInfer.d777.s0.p2","sentence":"Treatment with HNE resulted in activation of extracellular signal-regulated protein kinases @PROTEIN1$ and ERK2, induction of c-fos and @PROTEIN2$ protein expression, and an increase in transcription factor AP-1 DNA binding activity.","label":0}
{"pair_id":"BioInfer.d777.s0.p3","sentence":"Treatment with HNE resulted in activation of extracellular signal-regulated protein kinases @PROTEIN1$ and ERK2, induction of @PROTEIN2$ and c-jun protein expression, and an increase in transcription factor AP-1 DNA binding activity.","label":0}
{"pair_id":"BioInfer.d777.s0.p4","sentence":"Treatment with HNE resulted in activation of @PROTEIN2$ @PROTEIN1$ and ERK2, induction of c-fos and c-jun protein expression, and an increase in transcription factor AP-1 DNA binding activity.","label":1}
{"pair_id":"BioInfer.d777.s0.p5","sentence":"Treatment with HNE resulted in activation of extracellular signal-regulated protein kinases ERK1 and @PROTEIN1$, induction of c-fos and c-jun protein expression, and an increase in transcription factor @PROTEIN2$ DNA binding activity.","label":0}
{"pair_id":"BioInfer.d777.s0.p6","sentence":"Treatment with HNE resulted in activation of extracellular signal-regulated protein kinases ERK1 and @PROTEIN1$, induction of c-fos and @PROTEIN2$ protein expression, and an increase in transcription factor AP-1 DNA binding activity.","label":0}
{"pair_id":"BioInfer.d777.s0.p7","sentence":"Treatment with HNE resulted in activation of extracellular signal-regulated protein kinases ERK1 and @PROTEIN1$, induction of @PROTEIN2$ and c-jun protein expression, and an increase in transcription factor AP-1 DNA binding activity.","label":0}
{"pair_id":"BioInfer.d777.s0.p8","sentence":"Treatment with HNE resulted in activation of @PROTEIN2$ ERK1 and @PROTEIN1$, induction of c-fos and c-jun protein expression, and an increase in transcription factor AP-1 DNA binding activity.","label":1}
{"pair_id":"BioInfer.d777.s0.p9","sentence":"Treatment with HNE resulted in activation of extracellular signal-regulated protein kinases ERK1 and ERK2, induction of c-fos and @PROTEIN2$ protein expression, and an increase in transcription factor @PROTEIN1$ DNA binding activity.","label":0}
{"pair_id":"BioInfer.d777.s0.p10","sentence":"Treatment with HNE resulted in activation of extracellular signal-regulated protein kinases ERK1 and ERK2, induction of @PROTEIN2$ and c-jun protein expression, and an increase in transcription factor @PROTEIN1$ DNA binding activity.","label":0}
{"pair_id":"BioInfer.d777.s0.p11","sentence":"Treatment with HNE resulted in activation of @PROTEIN2$ ERK1 and ERK2, induction of c-fos and c-jun protein expression, and an increase in transcription factor @PROTEIN1$ DNA binding activity.","label":0}
{"pair_id":"BioInfer.d777.s0.p12","sentence":"Treatment with HNE resulted in activation of extracellular signal-regulated protein kinases ERK1 and ERK2, induction of @PROTEIN2$ and @PROTEIN1$ protein expression, and an increase in transcription factor AP-1 DNA binding activity.","label":0}
{"pair_id":"BioInfer.d777.s0.p13","sentence":"Treatment with HNE resulted in activation of @PROTEIN2$ ERK1 and ERK2, induction of c-fos and @PROTEIN1$ protein expression, and an increase in transcription factor AP-1 DNA binding activity.","label":0}
{"pair_id":"BioInfer.d777.s0.p14","sentence":"Treatment with HNE resulted in activation of @PROTEIN2$ ERK1 and ERK2, induction of @PROTEIN1$ and c-jun protein expression, and an increase in transcription factor AP-1 DNA binding activity.","label":0}
{"pair_id":"BioInfer.d73.s2.p0","sentence":"Here we use physical monitoring of DNA to show that MAT switching is completely blocked at an early step in recombination in strains deleted for the DNA repair genes RAD51, @PROTEIN2$, RAD54, @PROTEIN1$ or RAD57.","label":0}
{"pair_id":"BioInfer.d73.s2.p1","sentence":"Here we use physical monitoring of DNA to show that MAT switching is completely blocked at an early step in recombination in strains deleted for the DNA repair genes RAD51, RAD52, RAD54, @PROTEIN1$ or @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d73.s2.p2","sentence":"Here we use physical monitoring of DNA to show that MAT switching is completely blocked at an early step in recombination in strains deleted for the DNA repair genes @PROTEIN2$, RAD52, RAD54, @PROTEIN1$ or RAD57.","label":0}
{"pair_id":"BioInfer.d73.s2.p3","sentence":"Here we use physical monitoring of DNA to show that MAT switching is completely blocked at an early step in recombination in strains deleted for the DNA repair genes RAD51, RAD52, @PROTEIN2$, @PROTEIN1$ or RAD57.","label":0}
{"pair_id":"BioInfer.d73.s2.p4","sentence":"Here we use physical monitoring of DNA to show that MAT switching is completely blocked at an early step in recombination in strains deleted for the DNA repair genes RAD51, @PROTEIN1$, RAD54, RAD55 or @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d73.s2.p5","sentence":"Here we use physical monitoring of DNA to show that MAT switching is completely blocked at an early step in recombination in strains deleted for the DNA repair genes @PROTEIN2$, @PROTEIN1$, RAD54, RAD55 or RAD57.","label":0}
{"pair_id":"BioInfer.d73.s2.p6","sentence":"Here we use physical monitoring of DNA to show that MAT switching is completely blocked at an early step in recombination in strains deleted for the DNA repair genes RAD51, @PROTEIN1$, @PROTEIN2$, RAD55 or RAD57.","label":0}
{"pair_id":"BioInfer.d73.s2.p7","sentence":"Here we use physical monitoring of DNA to show that MAT switching is completely blocked at an early step in recombination in strains deleted for the DNA repair genes @PROTEIN2$, RAD52, RAD54, RAD55 or @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d73.s2.p8","sentence":"Here we use physical monitoring of DNA to show that MAT switching is completely blocked at an early step in recombination in strains deleted for the DNA repair genes RAD51, RAD52, @PROTEIN2$, RAD55 or @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d73.s2.p9","sentence":"Here we use physical monitoring of DNA to show that MAT switching is completely blocked at an early step in recombination in strains deleted for the DNA repair genes @PROTEIN1$, RAD52, @PROTEIN2$, RAD55 or RAD57.","label":0}
{"pair_id":"AIMed.d65.s558.p0","sentence":"Although @PROTEIN1$\/@PROTEIN2$ and ATF\/CREB were previously thought to interact preferentially with different DNA regulatory elements (the AP-1\/TRE and ATF\/CRE sites, respectively), we find that members of these two families form selective cross-family heterodimers.","label":0}
{"pair_id":"AIMed.d65.s558.p1","sentence":"Although @PROTEIN1$\/Jun and @PROTEIN2$\/CREB were previously thought to interact preferentially with different DNA regulatory elements (the AP-1\/TRE and ATF\/CRE sites, respectively), we find that members of these two families form selective cross-family heterodimers.","label":0}
{"pair_id":"AIMed.d65.s558.p2","sentence":"Although @PROTEIN1$\/Jun and ATF\/@PROTEIN2$ were previously thought to interact preferentially with different DNA regulatory elements (the AP-1\/TRE and ATF\/CRE sites, respectively), we find that members of these two families form selective cross-family heterodimers.","label":0}
{"pair_id":"AIMed.d65.s558.p3","sentence":"Although Fos\/@PROTEIN1$ and @PROTEIN2$\/CREB were previously thought to interact preferentially with different DNA regulatory elements (the AP-1\/TRE and ATF\/CRE sites, respectively), we find that members of these two families form selective cross-family heterodimers.","label":0}
{"pair_id":"AIMed.d65.s558.p4","sentence":"Although Fos\/@PROTEIN1$ and ATF\/@PROTEIN2$ were previously thought to interact preferentially with different DNA regulatory elements (the AP-1\/TRE and ATF\/CRE sites, respectively), we find that members of these two families form selective cross-family heterodimers.","label":0}
{"pair_id":"AIMed.d65.s558.p5","sentence":"Although Fos\/Jun and @PROTEIN1$\/@PROTEIN2$ were previously thought to interact preferentially with different DNA regulatory elements (the AP-1\/TRE and ATF\/CRE sites, respectively), we find that members of these two families form selective cross-family heterodimers.","label":0}
{"pair_id":"BioInfer.d632.s0.p0","sentence":"The interactions of @PROTEIN1$ with thymosin beta 4, @PROTEIN2$ and profilin are compared.","label":1}
{"pair_id":"BioInfer.d632.s0.p1","sentence":"The interactions of @PROTEIN1$ with @PROTEIN2$, actobindin and profilin are compared.","label":1}
{"pair_id":"BioInfer.d632.s0.p2","sentence":"The interactions of @PROTEIN1$ with thymosin beta 4, actobindin and @PROTEIN2$ are compared.","label":1}
{"pair_id":"BioInfer.d632.s0.p3","sentence":"The interactions of actin with @PROTEIN2$, @PROTEIN1$ and profilin are compared.","label":0}
{"pair_id":"BioInfer.d632.s0.p4","sentence":"The interactions of actin with thymosin beta 4, @PROTEIN1$ and @PROTEIN2$ are compared.","label":0}
{"pair_id":"BioInfer.d632.s0.p5","sentence":"The interactions of actin with @PROTEIN1$, actobindin and @PROTEIN2$ are compared.","label":0}
{"pair_id":"BioInfer.d809.s1.p0","sentence":"Yeast @PROTEIN1$ can sequester yeast @PROTEIN2$ monomers and thereby reduce the ability of yeast actin to polymerize, whereas it has little effect on the degree of polymerization of rabbit skeletal muscle actin.","label":1}
{"pair_id":"BioInfer.d809.s1.p1","sentence":"Yeast @PROTEIN1$ can sequester yeast actin monomers and thereby reduce the ability of yeast @PROTEIN2$ to polymerize, whereas it has little effect on the degree of polymerization of rabbit skeletal muscle actin.","label":1}
{"pair_id":"BioInfer.d809.s1.p2","sentence":"Yeast @PROTEIN1$ can sequester yeast actin monomers and thereby reduce the ability of yeast actin to polymerize, whereas it has little effect on the degree of polymerization of rabbit @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d809.s1.p3","sentence":"Yeast profilin can sequester yeast @PROTEIN1$ monomers and thereby reduce the ability of yeast @PROTEIN2$ to polymerize, whereas it has little effect on the degree of polymerization of rabbit skeletal muscle actin.","label":0}
{"pair_id":"BioInfer.d809.s1.p4","sentence":"Yeast profilin can sequester yeast @PROTEIN1$ monomers and thereby reduce the ability of yeast actin to polymerize, whereas it has little effect on the degree of polymerization of rabbit @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d809.s1.p5","sentence":"Yeast profilin can sequester yeast actin monomers and thereby reduce the ability of yeast @PROTEIN1$ to polymerize, whereas it has little effect on the degree of polymerization of rabbit @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d185.s1575.p0","sentence":"Twelve amino acid peptides encompassing either of these two tyrosine residues in phosphorylated form coprecipitated @PROTEIN1$ but not @PROTEIN2$ and blocked IL-10-induced Stat3 phosphorylation in a cell-free system.","label":0}
{"pair_id":"AIMed.d185.s1575.p1","sentence":"Twelve amino acid peptides encompassing either of these two tyrosine residues in phosphorylated form coprecipitated @PROTEIN1$ but not Stat1 and blocked @PROTEIN2$-induced Stat3 phosphorylation in a cell-free system.","label":0}
{"pair_id":"AIMed.d185.s1575.p2","sentence":"Twelve amino acid peptides encompassing either of these two tyrosine residues in phosphorylated form coprecipitated @PROTEIN1$ but not Stat1 and blocked IL-10-induced @PROTEIN2$ phosphorylation in a cell-free system.","label":0}
{"pair_id":"AIMed.d185.s1575.p3","sentence":"Twelve amino acid peptides encompassing either of these two tyrosine residues in phosphorylated form coprecipitated Stat3 but not @PROTEIN1$ and blocked @PROTEIN2$-induced Stat3 phosphorylation in a cell-free system.","label":0}
{"pair_id":"AIMed.d185.s1575.p4","sentence":"Twelve amino acid peptides encompassing either of these two tyrosine residues in phosphorylated form coprecipitated Stat3 but not @PROTEIN1$ and blocked IL-10-induced @PROTEIN2$ phosphorylation in a cell-free system.","label":0}
{"pair_id":"AIMed.d185.s1575.p5","sentence":"Twelve amino acid peptides encompassing either of these two tyrosine residues in phosphorylated form coprecipitated Stat3 but not Stat1 and blocked @PROTEIN1$-induced @PROTEIN2$ phosphorylation in a cell-free system.","label":0}
{"pair_id":"BioInfer.d223.s0.p0","sentence":"Furthermore, the deletion of SJL1 suppresses the temperature-sensitive growth defect of @PROTEIN2$, a mutant in yeast fimbrin, supporting a role for @PROTEIN1$ family members in actin function.","label":0}
{"pair_id":"BioInfer.d223.s0.p1","sentence":"Furthermore, the deletion of SJL1 suppresses the temperature-sensitive growth defect of sac6, a mutant in yeast fimbrin, supporting a role for @PROTEIN1$ family members in @PROTEIN2$ function.","label":1}
{"pair_id":"BioInfer.d223.s0.p2","sentence":"Furthermore, the deletion of SJL1 suppresses the temperature-sensitive growth defect of sac6, a mutant in yeast @PROTEIN2$, supporting a role for @PROTEIN1$ family members in actin function.","label":0}
{"pair_id":"BioInfer.d223.s0.p3","sentence":"Furthermore, the deletion of @PROTEIN2$ suppresses the temperature-sensitive growth defect of sac6, a mutant in yeast fimbrin, supporting a role for @PROTEIN1$ family members in actin function.","label":0}
{"pair_id":"BioInfer.d223.s0.p4","sentence":"Furthermore, the deletion of SJL1 suppresses the temperature-sensitive growth defect of @PROTEIN1$, a mutant in yeast fimbrin, supporting a role for synaptojanin family members in @PROTEIN2$ function.","label":0}
{"pair_id":"BioInfer.d223.s0.p5","sentence":"Furthermore, the deletion of SJL1 suppresses the temperature-sensitive growth defect of @PROTEIN1$, a mutant in yeast @PROTEIN2$, supporting a role for synaptojanin family members in actin function.","label":0}
{"pair_id":"BioInfer.d223.s0.p6","sentence":"Furthermore, the deletion of @PROTEIN2$ suppresses the temperature-sensitive growth defect of @PROTEIN1$, a mutant in yeast fimbrin, supporting a role for synaptojanin family members in actin function.","label":1}
{"pair_id":"BioInfer.d223.s0.p7","sentence":"Furthermore, the deletion of SJL1 suppresses the temperature-sensitive growth defect of sac6, a mutant in yeast @PROTEIN2$, supporting a role for synaptojanin family members in @PROTEIN1$ function.","label":0}
{"pair_id":"BioInfer.d223.s0.p8","sentence":"Furthermore, the deletion of @PROTEIN2$ suppresses the temperature-sensitive growth defect of sac6, a mutant in yeast fimbrin, supporting a role for synaptojanin family members in @PROTEIN1$ function.","label":0}
{"pair_id":"BioInfer.d223.s0.p9","sentence":"Furthermore, the deletion of @PROTEIN2$ suppresses the temperature-sensitive growth defect of sac6, a mutant in yeast @PROTEIN1$, supporting a role for synaptojanin family members in actin function.","label":0}
{"pair_id":"AIMed.d213.s1853.p0","sentence":"Repression of @PROTEIN1$-directed transcription may be accomplished through direct physical interaction between @PROTEIN2$ and this activator.","label":0}
{"pair_id":"AIMed.d182.s1548.p0","sentence":"The crystal structure of the 109-residue amino-terminal domain of @PROTEIN1$ bound to a 15-residue transactivation domain peptide of @PROTEIN2$ revealed that MDM2 has a deep hydrophobic cleft on which the p53 peptide binds as an amphipathic alpha helix.","label":1}
{"pair_id":"AIMed.d182.s1548.p1","sentence":"The crystal structure of the 109-residue amino-terminal domain of @PROTEIN1$ bound to a 15-residue transactivation domain peptide of p53 revealed that @PROTEIN2$ has a deep hydrophobic cleft on which the p53 peptide binds as an amphipathic alpha helix.","label":0}
{"pair_id":"AIMed.d182.s1548.p2","sentence":"The crystal structure of the 109-residue amino-terminal domain of @PROTEIN1$ bound to a 15-residue transactivation domain peptide of p53 revealed that MDM2 has a deep hydrophobic cleft on which the @PROTEIN2$ peptide binds as an amphipathic alpha helix.","label":0}
{"pair_id":"AIMed.d182.s1548.p3","sentence":"The crystal structure of the 109-residue amino-terminal domain of MDM2 bound to a 15-residue transactivation domain peptide of @PROTEIN1$ revealed that @PROTEIN2$ has a deep hydrophobic cleft on which the p53 peptide binds as an amphipathic alpha helix.","label":0}
{"pair_id":"AIMed.d182.s1548.p4","sentence":"The crystal structure of the 109-residue amino-terminal domain of MDM2 bound to a 15-residue transactivation domain peptide of @PROTEIN1$ revealed that MDM2 has a deep hydrophobic cleft on which the @PROTEIN2$ peptide binds as an amphipathic alpha helix.","label":0}
{"pair_id":"AIMed.d182.s1548.p5","sentence":"The crystal structure of the 109-residue amino-terminal domain of MDM2 bound to a 15-residue transactivation domain peptide of p53 revealed that @PROTEIN1$ has a deep hydrophobic cleft on which the @PROTEIN2$ peptide binds as an amphipathic alpha helix.","label":1}
{"pair_id":"BioInfer.d171.s1.p0","sentence":"LOH was found in the RAD51 region in 32% of tumours, in the @PROTEIN2$ region in 16%, in RAD54 in 20% and in the BRCA1 and @PROTEIN1$ regions in 49% and 44% respectively.","label":0}
{"pair_id":"BioInfer.d171.s1.p1","sentence":"LOH was found in the RAD51 region in 32% of tumours, in the RAD52 region in 16%, in @PROTEIN2$ in 20% and in the BRCA1 and @PROTEIN1$ regions in 49% and 44% respectively.","label":0}
{"pair_id":"BioInfer.d171.s1.p2","sentence":"LOH was found in the @PROTEIN2$ region in 32% of tumours, in the RAD52 region in 16%, in RAD54 in 20% and in the BRCA1 and @PROTEIN1$ regions in 49% and 44% respectively.","label":0}
{"pair_id":"BioInfer.d171.s1.p3","sentence":"LOH was found in the RAD51 region in 32% of tumours, in the RAD52 region in 16%, in RAD54 in 20% and in the @PROTEIN2$ and @PROTEIN1$ regions in 49% and 44% respectively.","label":0}
{"pair_id":"BioInfer.d171.s1.p4","sentence":"LOH was found in the RAD51 region in 32% of tumours, in the @PROTEIN1$ region in 16%, in @PROTEIN2$ in 20% and in the BRCA1 and BRCA2 regions in 49% and 44% respectively.","label":0}
{"pair_id":"BioInfer.d171.s1.p5","sentence":"LOH was found in the @PROTEIN2$ region in 32% of tumours, in the @PROTEIN1$ region in 16%, in RAD54 in 20% and in the BRCA1 and BRCA2 regions in 49% and 44% respectively.","label":0}
{"pair_id":"BioInfer.d171.s1.p6","sentence":"LOH was found in the RAD51 region in 32% of tumours, in the @PROTEIN1$ region in 16%, in RAD54 in 20% and in the @PROTEIN2$ and BRCA2 regions in 49% and 44% respectively.","label":0}
{"pair_id":"BioInfer.d171.s1.p7","sentence":"LOH was found in the @PROTEIN2$ region in 32% of tumours, in the RAD52 region in 16%, in @PROTEIN1$ in 20% and in the BRCA1 and BRCA2 regions in 49% and 44% respectively.","label":0}
{"pair_id":"BioInfer.d171.s1.p8","sentence":"LOH was found in the RAD51 region in 32% of tumours, in the RAD52 region in 16%, in @PROTEIN1$ in 20% and in the @PROTEIN2$ and BRCA2 regions in 49% and 44% respectively.","label":0}
{"pair_id":"BioInfer.d171.s1.p9","sentence":"LOH was found in the @PROTEIN1$ region in 32% of tumours, in the RAD52 region in 16%, in RAD54 in 20% and in the @PROTEIN2$ and BRCA2 regions in 49% and 44% respectively.","label":0}
{"pair_id":"BioInfer.d26.s0.p0","sentence":"A distinct modulating domain in @PROTEIN2$ monomers in the repression of activity of the transcription factor @PROTEIN1$.","label":1}
{"pair_id":"AIMed.d160.s1346.p0","sentence":"Alanine-scanning mutagenesis was used to identify a positively charged surface in @PROTEIN1$ that mediates binding to @PROTEIN2$\/Flk-1.","label":0}
{"pair_id":"AIMed.d160.s1346.p1","sentence":"Alanine-scanning mutagenesis was used to identify a positively charged surface in @PROTEIN1$ that mediates binding to KDR\/@PROTEIN2$.","label":0}
{"pair_id":"AIMed.d160.s1346.p2","sentence":"Alanine-scanning mutagenesis was used to identify a positively charged surface in VEGF that mediates binding to @PROTEIN1$\/@PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d675.s0.p0","sentence":"The proteins encoded by @PROTEIN1$ and @PROTEIN2$, which display 35%, sequence identity are both located in the mitochondrial intermembrane space.","label":1}
{"pair_id":"AIMed.d33.s280.p0","sentence":"Suramin induced high-affinity trimerization of @PROTEIN1$ (Kd = 0.10 microM at 20 degrees C) and dimerization of @PROTEIN2$ (Kd = 0.86 microM at 20 degrees C).","label":0}
{"pair_id":"BioInfer.d24.s0.p0","sentence":"Addition of EGTA (3 mM) to the extracellular media completely inhibited the cleavage of @PROTEIN2$, talin, and @PROTEIN1$ in response to A23187 (1 microM).","label":0}
{"pair_id":"BioInfer.d24.s0.p1","sentence":"Addition of EGTA (3 mM) to the extracellular media completely inhibited the cleavage of actin-binding protein, @PROTEIN2$, and @PROTEIN1$ in response to A23187 (1 microM).","label":0}
{"pair_id":"BioInfer.d24.s0.p2","sentence":"Addition of EGTA (3 mM) to the extracellular media completely inhibited the cleavage of @PROTEIN1$, @PROTEIN2$, and pp60src in response to A23187 (1 microM).","label":0}
{"pair_id":"BioInfer.d650.s1.p0","sentence":"The role of @PROTEIN2$ in @PROTEIN1$ polymerization and nucleotide exchange.","label":1}
{"pair_id":"AIMed.d40.s347.p0","sentence":"We have crystallized a complex between human @PROTEIN1$ and a two-domain extracellular fragment of human @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d39.s341.p0","sentence":"By monitoring fluorescent recombinant protein and by gel mobility shift assays, @PROTEIN1$ was shown to accelerate the translocation of @PROTEIN2$ from the cytoplasm to the nucleus and to thereby suppress the binding of c-Jun homodimer to 12-O-tetradecanoylphorbol-13- acetate (TPA)-responsive element (TRE).","label":0}
{"pair_id":"AIMed.d39.s341.p1","sentence":"By monitoring fluorescent recombinant protein and by gel mobility shift assays, @PROTEIN1$ was shown to accelerate the translocation of QM from the cytoplasm to the nucleus and to thereby suppress the binding of @PROTEIN2$ homodimer to 12-O-tetradecanoylphorbol-13- acetate (TPA)-responsive element (TRE).","label":0}
{"pair_id":"AIMed.d39.s341.p2","sentence":"By monitoring fluorescent recombinant protein and by gel mobility shift assays, PS1 was shown to accelerate the translocation of @PROTEIN1$ from the cytoplasm to the nucleus and to thereby suppress the binding of @PROTEIN2$ homodimer to 12-O-tetradecanoylphorbol-13- acetate (TPA)-responsive element (TRE).","label":0}
{"pair_id":"BioInfer.d111.s0.p0","sentence":"Both pathway cells and superior tarsal smooth muscle cells expressed @PROTEIN2$ and @PROTEIN1$ throughout development.","label":0}
{"pair_id":"BioInfer.d569.s0.p0","sentence":"The adventitial tissue underlying PTCA-induced lesions temporarily expressed alpha-SM actin, @PROTEIN2$, and SM myosin heavy chain isoforms, but not @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d569.s0.p1","sentence":"The adventitial tissue underlying PTCA-induced lesions temporarily expressed alpha-SM actin, desmin, and @PROTEIN2$ isoforms, but not @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d569.s0.p2","sentence":"The adventitial tissue underlying PTCA-induced lesions temporarily expressed @PROTEIN2$, desmin, and SM myosin heavy chain isoforms, but not @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d569.s0.p3","sentence":"The adventitial tissue underlying PTCA-induced lesions temporarily expressed alpha-SM actin, @PROTEIN1$, and @PROTEIN2$ isoforms, but not smoothelin.","label":0}
{"pair_id":"BioInfer.d569.s0.p4","sentence":"The adventitial tissue underlying PTCA-induced lesions temporarily expressed @PROTEIN2$, @PROTEIN1$, and SM myosin heavy chain isoforms, but not smoothelin.","label":0}
{"pair_id":"BioInfer.d569.s0.p5","sentence":"The adventitial tissue underlying PTCA-induced lesions temporarily expressed @PROTEIN2$, desmin, and @PROTEIN1$ isoforms, but not smoothelin.","label":0}
{"pair_id":"BioInfer.d175.s0.p0","sentence":"Discrete segments (70-150 amino acids) of @PROTEIN1$ and TIF35 were found to be responsible for their binding to @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d175.s0.p1","sentence":"Discrete segments (70-150 amino acids) of @PROTEIN1$ and @PROTEIN2$ were found to be responsible for their binding to TIF34.","label":0}
{"pair_id":"BioInfer.d175.s0.p2","sentence":"Discrete segments (70-150 amino acids) of PRT1 and @PROTEIN2$ were found to be responsible for their binding to @PROTEIN1$.","label":1}
{"pair_id":"AIMed.d49.s436.p0","sentence":"Replacement of this loop with the homologous loop from @PROTEIN1$ dramatically reduced both the affinity of @PROTEIN2$ for KGFR and its biological potency but did not result in the ability to bind FGFR1.","label":0}
{"pair_id":"AIMed.d49.s436.p1","sentence":"Replacement of this loop with the homologous loop from @PROTEIN1$ dramatically reduced both the affinity of FGF-7 for @PROTEIN2$ and its biological potency but did not result in the ability to bind FGFR1.","label":0}
{"pair_id":"AIMed.d49.s436.p2","sentence":"Replacement of this loop with the homologous loop from @PROTEIN1$ dramatically reduced both the affinity of FGF-7 for KGFR and its biological potency but did not result in the ability to bind @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d49.s436.p3","sentence":"Replacement of this loop with the homologous loop from FGF-2 dramatically reduced both the affinity of @PROTEIN1$ for @PROTEIN2$ and its biological potency but did not result in the ability to bind FGFR1.","label":1}
{"pair_id":"AIMed.d49.s436.p4","sentence":"Replacement of this loop with the homologous loop from FGF-2 dramatically reduced both the affinity of @PROTEIN1$ for KGFR and its biological potency but did not result in the ability to bind @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d49.s436.p5","sentence":"Replacement of this loop with the homologous loop from FGF-2 dramatically reduced both the affinity of FGF-7 for @PROTEIN1$ and its biological potency but did not result in the ability to bind @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d417.s0.p0","sentence":"Mechanism of regulation of @PROTEIN2$ polymerization by Physarum @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d114.s0.p0","sentence":"@PROTEIN1$ or @PROTEIN2$ recombination-deficient yeast strains stabilize otherwise unstable YACs containing ribosomal DNA or the human color vision locus (Kohno et al., 1994).","label":0}
{"pair_id":"AIMed.d209.s1807.p0","sentence":"We now show that full-length @PROTEIN1$ interacts with activated @PROTEIN2$ in mammalian cells and defines a minimum region of 434 aa required for efficient RAS binding.","label":1}
{"pair_id":"AIMed.d209.s1807.p1","sentence":"We now show that full-length @PROTEIN1$ interacts with activated RAS in mammalian cells and defines a minimum region of 434 aa required for efficient @PROTEIN2$ binding.","label":0}
{"pair_id":"AIMed.d209.s1807.p2","sentence":"We now show that full-length RIN1 interacts with activated @PROTEIN1$ in mammalian cells and defines a minimum region of 434 aa required for efficient @PROTEIN2$ binding.","label":0}
{"pair_id":"BioInfer.d226.s0.p0","sentence":"Further, we show that talin, a high molecular weight structural protein that links @PROTEIN1$ to the @PROTEIN2$ cytoskeleton, is proteolytically cleaved in fetal, but not in neonatal melanocytes.","label":1}
{"pair_id":"BioInfer.d226.s0.p1","sentence":"Further, we show that @PROTEIN2$, a high molecular weight structural protein that links @PROTEIN1$ to the actin cytoskeleton, is proteolytically cleaved in fetal, but not in neonatal melanocytes.","label":1}
{"pair_id":"BioInfer.d226.s0.p2","sentence":"Further, we show that @PROTEIN2$, a high molecular weight structural protein that links integrins to the @PROTEIN1$ cytoskeleton, is proteolytically cleaved in fetal, but not in neonatal melanocytes.","label":1}
{"pair_id":"AIMed.d193.s1648.p0","sentence":"Additional analysis revealed the presence of transcripts for both the activating (@PROTEIN1$) and inhibitory (@PROTEIN2$) isoforms in differentiating C2C12 cultures, suggesting that both isoforms might participate in regulating the differentiation process.","label":0}
{"pair_id":"AIMed.d175.s1477.p0","sentence":"@PROTEIN1$ was originally identified as a Start gene in budding yeast and has been shown to be required for association of @PROTEIN2$ with cyclins.","label":0}
{"pair_id":"AIMed.d41.s354.p0","sentence":"@PROTEIN1$ binds to the @PROTEIN2$ receptor (TfR), a receptor by which cells acquire iron-loaded transferrin.","label":0}
{"pair_id":"AIMed.d41.s354.p1","sentence":"@PROTEIN1$ binds to the @PROTEIN2$ (TfR), a receptor by which cells acquire iron-loaded transferrin.","label":1}
{"pair_id":"AIMed.d41.s354.p2","sentence":"@PROTEIN1$ binds to the transferrin receptor (@PROTEIN2$), a receptor by which cells acquire iron-loaded transferrin.","label":1}
{"pair_id":"AIMed.d41.s354.p3","sentence":"@PROTEIN1$ binds to the transferrin receptor (TfR), a receptor by which cells acquire iron-loaded @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d41.s354.p4","sentence":"HFE binds to the @PROTEIN1$@PROTEIN2$ (TfR), a receptor by which cells acquire iron-loaded transferrin.","label":0}
{"pair_id":"AIMed.d41.s354.p5","sentence":"HFE binds to the @PROTEIN1$ receptor (@PROTEIN2$), a receptor by which cells acquire iron-loaded transferrin.","label":0}
{"pair_id":"AIMed.d41.s354.p6","sentence":"HFE binds to the @PROTEIN1$ receptor (TfR), a receptor by which cells acquire iron-loaded @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d41.s354.p7","sentence":"HFE binds to the @PROTEIN1$ (@PROTEIN2$), a receptor by which cells acquire iron-loaded transferrin.","label":0}
{"pair_id":"AIMed.d41.s354.p8","sentence":"HFE binds to the @PROTEIN1$ (TfR), a receptor by which cells acquire iron-loaded @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d41.s354.p9","sentence":"HFE binds to the transferrin receptor (@PROTEIN1$), a receptor by which cells acquire iron-loaded @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d607.s0.p0","sentence":"The drastic effects of the exogenous @PROTEIN2$ on @PROTEIN1$ assembly were suppressed by phosphatidylinositol 4,5-bisphosphate (PIP2).","label":1}
{"pair_id":"BioInfer.d683.s0.p0","sentence":"The recombinant material is similar to authentic human @PROTEIN2$ based on the measured Kd for rabbit @PROTEIN1$.","label":1}
{"pair_id":"AIMed.d204.s1756.p0","sentence":"The catalytic domain of activated @PROTEIN1$ (@PROTEIN2$) is absolutely required for interaction with its specific inhibitor, tissue inhibitor of metalloproteinases-1 (TIMP-1).","label":0}
{"pair_id":"AIMed.d204.s1756.p1","sentence":"The catalytic domain of activated @PROTEIN1$ (MMP-1) is absolutely required for interaction with its specific inhibitor, @PROTEIN2$ (TIMP-1).","label":0}
{"pair_id":"AIMed.d204.s1756.p2","sentence":"The catalytic domain of activated @PROTEIN1$ (MMP-1) is absolutely required for interaction with its specific inhibitor, tissue inhibitor of metalloproteinases-1 (@PROTEIN2$).","label":0}
{"pair_id":"AIMed.d204.s1756.p3","sentence":"The catalytic domain of activated collagenase I (@PROTEIN1$) is absolutely required for interaction with its specific inhibitor, @PROTEIN2$ (TIMP-1).","label":1}
{"pair_id":"AIMed.d204.s1756.p4","sentence":"The catalytic domain of activated collagenase I (@PROTEIN1$) is absolutely required for interaction with its specific inhibitor, tissue inhibitor of metalloproteinases-1 (@PROTEIN2$).","label":1}
{"pair_id":"AIMed.d204.s1756.p5","sentence":"The catalytic domain of activated collagenase I (MMP-1) is absolutely required for interaction with its specific inhibitor, @PROTEIN1$ (@PROTEIN2$).","label":0}
{"pair_id":"BioInfer.d295.s0.p0","sentence":"Immunohistochemistry revealed that arteries had three distinct populations of cells in respect to @PROTEIN1$, smooth muscle myosin heavy chain and @PROTEIN2$ (staining intensities '-', '+' or '++' for each protein), but only two populations in respect to desmin ('-' and '+').","label":0}
{"pair_id":"BioInfer.d295.s0.p1","sentence":"Immunohistochemistry revealed that arteries had three distinct populations of cells in respect to @PROTEIN1$, @PROTEIN2$ and vimentin (staining intensities '-', '+' or '++' for each protein), but only two populations in respect to desmin ('-' and '+').","label":0}
{"pair_id":"BioInfer.d295.s0.p2","sentence":"Immunohistochemistry revealed that arteries had three distinct populations of cells in respect to @PROTEIN1$, smooth muscle myosin heavy chain and vimentin (staining intensities '-', '+' or '++' for each protein), but only two populations in respect to @PROTEIN2$ ('-' and '+').","label":0}
{"pair_id":"BioInfer.d295.s0.p3","sentence":"Immunohistochemistry revealed that arteries had three distinct populations of cells in respect to alpha-smooth muscle actin, @PROTEIN2$ and @PROTEIN1$ (staining intensities '-', '+' or '++' for each protein), but only two populations in respect to desmin ('-' and '+').","label":0}
{"pair_id":"BioInfer.d295.s0.p4","sentence":"Immunohistochemistry revealed that arteries had three distinct populations of cells in respect to alpha-smooth muscle actin, smooth muscle myosin heavy chain and @PROTEIN1$ (staining intensities '-', '+' or '++' for each protein), but only two populations in respect to @PROTEIN2$ ('-' and '+').","label":0}
{"pair_id":"BioInfer.d295.s0.p5","sentence":"Immunohistochemistry revealed that arteries had three distinct populations of cells in respect to alpha-smooth muscle actin, @PROTEIN1$ and vimentin (staining intensities '-', '+' or '++' for each protein), but only two populations in respect to @PROTEIN2$ ('-' and '+').","label":0}
{"pair_id":"AIMed.d128.s1098.p0","sentence":"We present here the crystal structure of the 1:1 complex of @PROTEIN1$ bound to the extracellular domain of the @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d131.s1119.p0","sentence":"Expression cloning and characterization of a human @PROTEIN1$@PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d268.s1.p0","sentence":"Using the two-hybrid system, we show that @PROTEIN1$ binds @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d537.s1.p0","sentence":"These findings suggest a role of @PROTEIN1$ in stimulus-dependent @PROTEIN2$ remodeling in motile neutrophils.","label":1}
{"pair_id":"AIMed.d37.s314.p0","sentence":"All CC-chemokines currently available were tested for their ability to compete with [(125)I]-@PROTEIN1$ binding on a stable cell line expressing recombinant @PROTEIN2$, and\/or to induce a functional response in these cells.","label":0}
{"pair_id":"BioInfer.d787.s0.p0","sentence":"Using ITP (a substrate for myosin II @PROTEIN2$) and\/or ATP gamma S (a substrate for myosin II heavy-chain kinase [@PROTEIN1$]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.","label":0}
{"pair_id":"BioInfer.d787.s0.p1","sentence":"Using ITP (a substrate for @PROTEIN2$ ATPase) and\/or ATP gamma S (a substrate for myosin II heavy-chain kinase [@PROTEIN1$]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.","label":0}
{"pair_id":"BioInfer.d787.s0.p2","sentence":"Using ITP (a substrate for myosin II ATPase) and\/or ATP gamma S (a substrate for myosin II heavy-chain kinase [@PROTEIN1$]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that @PROTEIN2$ was localized at the foci.","label":0}
{"pair_id":"BioInfer.d787.s0.p3","sentence":"Using ITP (a substrate for myosin II ATPase) and\/or ATP gamma S (a substrate for @PROTEIN2$ [@PROTEIN1$]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.","label":0}
{"pair_id":"BioInfer.d787.s0.p4","sentence":"Using ITP (a substrate for myosin II ATPase) and\/or ATP gamma S (a substrate for myosin II heavy-chain kinase [@PROTEIN1$]), we demonstrated that phosphorylation of @PROTEIN2$ occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.","label":0}
{"pair_id":"BioInfer.d787.s0.p5","sentence":"Using ITP (a substrate for myosin II ATPase) and\/or ATP gamma S (a substrate for myosin II heavy-chain kinase [@PROTEIN1$]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the @PROTEIN2$ network, a result that suggests that MHCK was localized at the foci.","label":0}
{"pair_id":"BioInfer.d787.s0.p6","sentence":"Using ITP (a substrate for @PROTEIN2$ @PROTEIN1$) and\/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.","label":1}
{"pair_id":"BioInfer.d787.s0.p7","sentence":"Using ITP (a substrate for myosin II @PROTEIN1$) and\/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that @PROTEIN2$ was localized at the foci.","label":0}
{"pair_id":"BioInfer.d787.s0.p8","sentence":"Using ITP (a substrate for myosin II @PROTEIN1$) and\/or ATP gamma S (a substrate for @PROTEIN2$ [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.","label":0}
{"pair_id":"BioInfer.d787.s0.p9","sentence":"Using ITP (a substrate for myosin II @PROTEIN1$) and\/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of @PROTEIN2$ occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.","label":0}
{"pair_id":"BioInfer.d787.s0.p10","sentence":"Using ITP (a substrate for myosin II @PROTEIN1$) and\/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the @PROTEIN2$ network, a result that suggests that MHCK was localized at the foci.","label":0}
{"pair_id":"BioInfer.d787.s0.p11","sentence":"Using ITP (a substrate for @PROTEIN1$ ATPase) and\/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that @PROTEIN2$ was localized at the foci.","label":0}
{"pair_id":"BioInfer.d787.s0.p12","sentence":"Using ITP (a substrate for @PROTEIN1$ ATPase) and\/or ATP gamma S (a substrate for @PROTEIN2$ [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.","label":0}
{"pair_id":"BioInfer.d787.s0.p13","sentence":"Using ITP (a substrate for @PROTEIN1$ ATPase) and\/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of @PROTEIN2$ occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.","label":0}
{"pair_id":"BioInfer.d787.s0.p14","sentence":"Using ITP (a substrate for @PROTEIN1$ ATPase) and\/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the @PROTEIN2$ network, a result that suggests that MHCK was localized at the foci.","label":0}
{"pair_id":"BioInfer.d787.s0.p15","sentence":"Using ITP (a substrate for myosin II ATPase) and\/or ATP gamma S (a substrate for @PROTEIN2$ [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that @PROTEIN1$ was localized at the foci.","label":0}
{"pair_id":"BioInfer.d787.s0.p16","sentence":"Using ITP (a substrate for myosin II ATPase) and\/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of @PROTEIN2$ occurred at the foci within the actin network, a result that suggests that @PROTEIN1$ was localized at the foci.","label":0}
{"pair_id":"BioInfer.d787.s0.p17","sentence":"Using ITP (a substrate for myosin II ATPase) and\/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the @PROTEIN2$ network, a result that suggests that @PROTEIN1$ was localized at the foci.","label":0}
{"pair_id":"BioInfer.d787.s0.p18","sentence":"Using ITP (a substrate for myosin II ATPase) and\/or ATP gamma S (a substrate for @PROTEIN1$ [MHCK]), we demonstrated that phosphorylation of @PROTEIN2$ occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.","label":0}
{"pair_id":"BioInfer.d787.s0.p19","sentence":"Using ITP (a substrate for myosin II ATPase) and\/or ATP gamma S (a substrate for @PROTEIN1$ [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the @PROTEIN2$ network, a result that suggests that MHCK was localized at the foci.","label":0}
{"pair_id":"BioInfer.d787.s0.p20","sentence":"Using ITP (a substrate for myosin II ATPase) and\/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of @PROTEIN1$ occurred at the foci within the @PROTEIN2$ network, a result that suggests that MHCK was localized at the foci.","label":0}
{"pair_id":"AIMed.d220.s1909.p0","sentence":"Interactions between @PROTEIN1$ and the @PROTEIN2$ receptor. Identification of two ligand binding domains in soluble TRKB by affinity separation and chemical cross-linking.","label":0}
{"pair_id":"AIMed.d220.s1909.p1","sentence":"Interactions between @PROTEIN1$ and the @PROTEIN2$. Identification of two ligand binding domains in soluble TRKB by affinity separation and chemical cross-linking.","label":1}
{"pair_id":"AIMed.d220.s1909.p2","sentence":"Interactions between @PROTEIN1$ and the TRKB receptor. Identification of two ligand binding domains in soluble @PROTEIN2$ by affinity separation and chemical cross-linking.","label":0}
{"pair_id":"AIMed.d220.s1909.p3","sentence":"Interactions between brain-derived neurotrophic factor and the @PROTEIN1$@PROTEIN2$. Identification of two ligand binding domains in soluble TRKB by affinity separation and chemical cross-linking.","label":0}
{"pair_id":"AIMed.d220.s1909.p4","sentence":"Interactions between brain-derived neurotrophic factor and the @PROTEIN1$ receptor. Identification of two ligand binding domains in soluble @PROTEIN2$ by affinity separation and chemical cross-linking.","label":0}
{"pair_id":"AIMed.d220.s1909.p5","sentence":"Interactions between brain-derived neurotrophic factor and the @PROTEIN1$. Identification of two ligand binding domains in soluble @PROTEIN2$ by affinity separation and chemical cross-linking.","label":0}
{"pair_id":"BioInfer.d49.s2.p0","sentence":"How profilin promotes @PROTEIN1$ filament assembly in the presence of @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d49.s2.p1","sentence":"How @PROTEIN2$ promotes @PROTEIN1$ filament assembly in the presence of thymosin beta 4.","label":1}
{"pair_id":"BioInfer.d49.s2.p2","sentence":"How @PROTEIN2$ promotes actin filament assembly in the presence of @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d274.s0.p0","sentence":"However, similar to utrophin, @PROTEIN1$ is only present at the neuromuscular junction in mdx mouse muscle in which @PROTEIN2$ is absent.","label":0}
{"pair_id":"BioInfer.d274.s0.p1","sentence":"However, similar to @PROTEIN2$, @PROTEIN1$ is only present at the neuromuscular junction in mdx mouse muscle in which dystrophin is absent.","label":1}
{"pair_id":"BioInfer.d274.s0.p2","sentence":"However, similar to @PROTEIN2$, alpha-syntrophin is only present at the neuromuscular junction in mdx mouse muscle in which @PROTEIN1$ is absent.","label":0}
{"pair_id":"BioInfer.d174.s1.p0","sentence":"Recently, two mammalian proteins previously shown to regulate the actin cytoskeleton, Wiskott-Aldrich Syndrome Protein (@PROTEIN1$) and its homolog expressed in neurons (N-WASP), were found to possess short peptide motifs homologous to one part of @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d174.s1.p1","sentence":"Recently, two mammalian proteins previously shown to regulate the actin cytoskeleton, Wiskott-Aldrich Syndrome Protein (@PROTEIN1$) and its homolog expressed in neurons (@PROTEIN2$), were found to possess short peptide motifs homologous to one part of verprolin.","label":1}
{"pair_id":"BioInfer.d174.s1.p2","sentence":"Recently, two mammalian proteins previously shown to regulate the @PROTEIN2$ cytoskeleton, Wiskott-Aldrich Syndrome Protein (@PROTEIN1$) and its homolog expressed in neurons (N-WASP), were found to possess short peptide motifs homologous to one part of verprolin.","label":1}
{"pair_id":"BioInfer.d174.s1.p3","sentence":"Recently, two mammalian proteins previously shown to regulate the actin cytoskeleton, @PROTEIN2$ (@PROTEIN1$) and its homolog expressed in neurons (N-WASP), were found to possess short peptide motifs homologous to one part of verprolin.","label":0}
{"pair_id":"BioInfer.d174.s1.p4","sentence":"Recently, two mammalian proteins previously shown to regulate the actin cytoskeleton, Wiskott-Aldrich Syndrome Protein (WASP) and its homolog expressed in neurons (@PROTEIN2$), were found to possess short peptide motifs homologous to one part of @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d174.s1.p5","sentence":"Recently, two mammalian proteins previously shown to regulate the @PROTEIN2$ cytoskeleton, Wiskott-Aldrich Syndrome Protein (WASP) and its homolog expressed in neurons (N-WASP), were found to possess short peptide motifs homologous to one part of @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d174.s1.p6","sentence":"Recently, two mammalian proteins previously shown to regulate the actin cytoskeleton, @PROTEIN2$ (WASP) and its homolog expressed in neurons (N-WASP), were found to possess short peptide motifs homologous to one part of @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d174.s1.p7","sentence":"Recently, two mammalian proteins previously shown to regulate the @PROTEIN2$ cytoskeleton, Wiskott-Aldrich Syndrome Protein (WASP) and its homolog expressed in neurons (@PROTEIN1$), were found to possess short peptide motifs homologous to one part of verprolin.","label":1}
{"pair_id":"BioInfer.d174.s1.p8","sentence":"Recently, two mammalian proteins previously shown to regulate the actin cytoskeleton, @PROTEIN2$ (WASP) and its homolog expressed in neurons (@PROTEIN1$), were found to possess short peptide motifs homologous to one part of verprolin.","label":1}
{"pair_id":"BioInfer.d174.s1.p9","sentence":"Recently, two mammalian proteins previously shown to regulate the @PROTEIN1$ cytoskeleton, @PROTEIN2$ (WASP) and its homolog expressed in neurons (N-WASP), were found to possess short peptide motifs homologous to one part of verprolin.","label":1}
{"pair_id":"BioInfer.d737.s0.p0","sentence":"This arrest can be suppressed by mutations in RAD51, RAD52, and RAD57, suggesting that the cell cycle defect in @PROTEIN1$ @PROTEIN2$ mutants results from inappropriate homologous recombination.","label":0}
{"pair_id":"BioInfer.d737.s0.p1","sentence":"This arrest can be suppressed by mutations in RAD51, @PROTEIN2$, and RAD57, suggesting that the cell cycle defect in @PROTEIN1$ srs2 mutants results from inappropriate homologous recombination.","label":0}
{"pair_id":"BioInfer.d737.s0.p2","sentence":"This arrest can be suppressed by mutations in RAD51, RAD52, and @PROTEIN2$, suggesting that the cell cycle defect in @PROTEIN1$ srs2 mutants results from inappropriate homologous recombination.","label":0}
{"pair_id":"BioInfer.d737.s0.p3","sentence":"This arrest can be suppressed by mutations in @PROTEIN2$, RAD52, and RAD57, suggesting that the cell cycle defect in @PROTEIN1$ srs2 mutants results from inappropriate homologous recombination.","label":0}
{"pair_id":"BioInfer.d737.s0.p4","sentence":"This arrest can be suppressed by mutations in RAD51, @PROTEIN2$, and RAD57, suggesting that the cell cycle defect in sgs1 @PROTEIN1$ mutants results from inappropriate homologous recombination.","label":0}
{"pair_id":"BioInfer.d737.s0.p5","sentence":"This arrest can be suppressed by mutations in RAD51, RAD52, and @PROTEIN2$, suggesting that the cell cycle defect in sgs1 @PROTEIN1$ mutants results from inappropriate homologous recombination.","label":0}
{"pair_id":"BioInfer.d737.s0.p6","sentence":"This arrest can be suppressed by mutations in @PROTEIN2$, RAD52, and RAD57, suggesting that the cell cycle defect in sgs1 @PROTEIN1$ mutants results from inappropriate homologous recombination.","label":0}
{"pair_id":"BioInfer.d737.s0.p7","sentence":"This arrest can be suppressed by mutations in RAD51, @PROTEIN1$, and @PROTEIN2$, suggesting that the cell cycle defect in sgs1 srs2 mutants results from inappropriate homologous recombination.","label":0}
{"pair_id":"BioInfer.d737.s0.p8","sentence":"This arrest can be suppressed by mutations in @PROTEIN2$, @PROTEIN1$, and RAD57, suggesting that the cell cycle defect in sgs1 srs2 mutants results from inappropriate homologous recombination.","label":0}
{"pair_id":"BioInfer.d737.s0.p9","sentence":"This arrest can be suppressed by mutations in @PROTEIN2$, RAD52, and @PROTEIN1$, suggesting that the cell cycle defect in sgs1 srs2 mutants results from inappropriate homologous recombination.","label":0}
{"pair_id":"BioInfer.d471.s3.p0","sentence":"We used biochemical fractionation, immunoassays and microscopy of live and fixed Acanthamoeba to determine how much @PROTEIN2$ is bound to its known ligands: actin, membrane PIP(2), @PROTEIN1$\/A complex and polyproline sequences.","label":1}
{"pair_id":"BioInfer.d471.s3.p1","sentence":"We used biochemical fractionation, immunoassays and microscopy of live and fixed Acanthamoeba to determine how much profilin is bound to its known ligands: @PROTEIN2$, membrane PIP(2), @PROTEIN1$\/A complex and polyproline sequences.","label":0}
{"pair_id":"BioInfer.d471.s3.p2","sentence":"We used biochemical fractionation, immunoassays and microscopy of live and fixed Acanthamoeba to determine how much profilin is bound to its known ligands: actin, membrane PIP(2), @PROTEIN1$@PROTEIN2$2\/@PROTEIN2$ complex and polyproline sequences.","label":1}
{"pair_id":"BioInfer.d471.s3.p3","sentence":"We used biochemical fractionation, immunoassays and microscopy of live and fixed Acanthamoeba to determine how much @PROTEIN1$ is bound to its known ligands: @PROTEIN2$, membrane PIP(2), Arp2\/A complex and polyproline sequences.","label":1}
{"pair_id":"BioInfer.d471.s3.p4","sentence":"We used biochemical fractionation, immunoassays and microscopy of live and fixed Acanthamoeba to determine how much @PROTEIN1$ is bound to its known ligands: actin, membrane PIP(2), @PROTEIN2$2\/@PROTEIN2$ complex and polyproline sequences.","label":1}
{"pair_id":"BioInfer.d471.s3.p5","sentence":"We used biochemical fractionation, immunoassays and microscopy of live and fixed Acanthamoeba to determine how much profilin is bound to its known ligands: @PROTEIN1$, membrane PIP(2), @PROTEIN2$2\/@PROTEIN2$ complex and polyproline sequences.","label":0}
{"pair_id":"BioInfer.d35.s3.p0","sentence":"Here, we report that Aip1p also interacts with the ubiquitous @PROTEIN1$ @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d35.s3.p1","sentence":"Here, we report that @PROTEIN2$ also interacts with the ubiquitous @PROTEIN1$ cofilin.","label":0}
{"pair_id":"BioInfer.d35.s3.p2","sentence":"Here, we report that @PROTEIN2$ also interacts with the ubiquitous actin depolymerizing factor @PROTEIN1$.","label":1}
{"pair_id":"AIMed.d103.s872.p0","sentence":"Deletion analysis indicates that @PROTEIN1$ and @PROTEIN2$ bind to distinct domains of hTAFII28. hTAFII18 also interacts with TBP, but it interacts more strongly with hTAFII28 and hTAFII30.","label":0}
{"pair_id":"AIMed.d103.s872.p1","sentence":"Deletion analysis indicates that @PROTEIN1$ and hTAFII18 bind to distinct domains of @PROTEIN2$. hTAFII18 also interacts with TBP, but it interacts more strongly with hTAFII28 and hTAFII30.","label":1}
{"pair_id":"AIMed.d103.s872.p2","sentence":"Deletion analysis indicates that @PROTEIN1$ and hTAFII18 bind to distinct domains of hTAFII28. @PROTEIN2$ also interacts with TBP, but it interacts more strongly with hTAFII28 and hTAFII30.","label":0}
{"pair_id":"AIMed.d103.s872.p3","sentence":"Deletion analysis indicates that @PROTEIN1$ and hTAFII18 bind to distinct domains of hTAFII28. hTAFII18 also interacts with @PROTEIN2$, but it interacts more strongly with hTAFII28 and hTAFII30.","label":0}
{"pair_id":"AIMed.d103.s872.p4","sentence":"Deletion analysis indicates that @PROTEIN1$ and hTAFII18 bind to distinct domains of hTAFII28. hTAFII18 also interacts with TBP, but it interacts more strongly with @PROTEIN2$ and hTAFII30.","label":0}
{"pair_id":"AIMed.d103.s872.p5","sentence":"Deletion analysis indicates that @PROTEIN1$ and hTAFII18 bind to distinct domains of hTAFII28. hTAFII18 also interacts with TBP, but it interacts more strongly with hTAFII28 and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d103.s872.p6","sentence":"Deletion analysis indicates that TBP and @PROTEIN1$ bind to distinct domains of @PROTEIN2$. hTAFII18 also interacts with TBP, but it interacts more strongly with hTAFII28 and hTAFII30.","label":1}
{"pair_id":"AIMed.d103.s872.p7","sentence":"Deletion analysis indicates that TBP and @PROTEIN1$ bind to distinct domains of hTAFII28. @PROTEIN2$ also interacts with TBP, but it interacts more strongly with hTAFII28 and hTAFII30.","label":0}
{"pair_id":"AIMed.d103.s872.p8","sentence":"Deletion analysis indicates that TBP and @PROTEIN1$ bind to distinct domains of hTAFII28. hTAFII18 also interacts with @PROTEIN2$, but it interacts more strongly with hTAFII28 and hTAFII30.","label":0}
{"pair_id":"AIMed.d103.s872.p9","sentence":"Deletion analysis indicates that TBP and @PROTEIN1$ bind to distinct domains of hTAFII28. hTAFII18 also interacts with TBP, but it interacts more strongly with @PROTEIN2$ and hTAFII30.","label":0}
{"pair_id":"AIMed.d103.s872.p10","sentence":"Deletion analysis indicates that TBP and @PROTEIN1$ bind to distinct domains of hTAFII28. hTAFII18 also interacts with TBP, but it interacts more strongly with hTAFII28 and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d103.s872.p11","sentence":"Deletion analysis indicates that TBP and hTAFII18 bind to distinct domains of @PROTEIN1$. @PROTEIN2$ also interacts with TBP, but it interacts more strongly with hTAFII28 and hTAFII30.","label":0}
{"pair_id":"AIMed.d103.s872.p12","sentence":"Deletion analysis indicates that TBP and hTAFII18 bind to distinct domains of @PROTEIN1$. hTAFII18 also interacts with @PROTEIN2$, but it interacts more strongly with hTAFII28 and hTAFII30.","label":0}
{"pair_id":"AIMed.d103.s872.p13","sentence":"Deletion analysis indicates that TBP and hTAFII18 bind to distinct domains of @PROTEIN1$. hTAFII18 also interacts with TBP, but it interacts more strongly with @PROTEIN2$ and hTAFII30.","label":0}
{"pair_id":"AIMed.d103.s872.p14","sentence":"Deletion analysis indicates that TBP and hTAFII18 bind to distinct domains of @PROTEIN1$. hTAFII18 also interacts with TBP, but it interacts more strongly with hTAFII28 and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d103.s872.p15","sentence":"Deletion analysis indicates that TBP and hTAFII18 bind to distinct domains of hTAFII28. @PROTEIN1$ also interacts with @PROTEIN2$, but it interacts more strongly with hTAFII28 and hTAFII30.","label":1}
{"pair_id":"AIMed.d103.s872.p16","sentence":"Deletion analysis indicates that TBP and hTAFII18 bind to distinct domains of hTAFII28. @PROTEIN1$ also interacts with TBP, but it interacts more strongly with @PROTEIN2$ and hTAFII30.","label":1}
{"pair_id":"AIMed.d103.s872.p17","sentence":"Deletion analysis indicates that TBP and hTAFII18 bind to distinct domains of hTAFII28. @PROTEIN1$ also interacts with TBP, but it interacts more strongly with hTAFII28 and @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d103.s872.p18","sentence":"Deletion analysis indicates that TBP and hTAFII18 bind to distinct domains of hTAFII28. hTAFII18 also interacts with @PROTEIN1$, but it interacts more strongly with @PROTEIN2$ and hTAFII30.","label":0}
{"pair_id":"AIMed.d103.s872.p19","sentence":"Deletion analysis indicates that TBP and hTAFII18 bind to distinct domains of hTAFII28. hTAFII18 also interacts with @PROTEIN1$, but it interacts more strongly with hTAFII28 and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d103.s872.p20","sentence":"Deletion analysis indicates that TBP and hTAFII18 bind to distinct domains of hTAFII28. hTAFII18 also interacts with TBP, but it interacts more strongly with @PROTEIN1$ and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d575.s2.p0","sentence":"Thus, APC forms distinct heteromeric complexes containing combinations of @PROTEIN2$, @PROTEIN1$, and plakoglobin which are independent from the cadherin-catenin complexes.","label":1}
{"pair_id":"BioInfer.d575.s2.p1","sentence":"Thus, APC forms distinct heteromeric complexes containing combinations of alpha-catenin, @PROTEIN1$, and @PROTEIN2$ which are independent from the cadherin-catenin complexes.","label":1}
{"pair_id":"BioInfer.d575.s2.p2","sentence":"Thus, APC forms distinct heteromeric complexes containing combinations of alpha-catenin, @PROTEIN1$, and plakoglobin which are independent from the @PROTEIN2$-catenin complexes.","label":1}
{"pair_id":"BioInfer.d575.s2.p3","sentence":"Thus, @PROTEIN2$ forms distinct heteromeric complexes containing combinations of alpha-catenin, @PROTEIN1$, and plakoglobin which are independent from the cadherin-catenin complexes.","label":1}
{"pair_id":"BioInfer.d575.s2.p4","sentence":"Thus, APC forms distinct heteromeric complexes containing combinations of alpha-catenin, @PROTEIN1$, and plakoglobin which are independent from the cadherin-@PROTEIN2$ complexes.","label":1}
{"pair_id":"BioInfer.d575.s2.p5","sentence":"Thus, APC forms distinct heteromeric complexes containing combinations of @PROTEIN1$, beta-catenin, and @PROTEIN2$ which are independent from the cadherin-catenin complexes.","label":1}
{"pair_id":"BioInfer.d575.s2.p6","sentence":"Thus, APC forms distinct heteromeric complexes containing combinations of @PROTEIN1$, beta-catenin, and plakoglobin which are independent from the @PROTEIN2$-catenin complexes.","label":1}
{"pair_id":"BioInfer.d575.s2.p7","sentence":"Thus, @PROTEIN2$ forms distinct heteromeric complexes containing combinations of @PROTEIN1$, beta-catenin, and plakoglobin which are independent from the cadherin-catenin complexes.","label":1}
{"pair_id":"BioInfer.d575.s2.p8","sentence":"Thus, APC forms distinct heteromeric complexes containing combinations of @PROTEIN1$, beta-catenin, and plakoglobin which are independent from the cadherin-@PROTEIN2$ complexes.","label":1}
{"pair_id":"BioInfer.d575.s2.p9","sentence":"Thus, APC forms distinct heteromeric complexes containing combinations of alpha-catenin, beta-catenin, and @PROTEIN1$ which are independent from the @PROTEIN2$-catenin complexes.","label":1}
{"pair_id":"BioInfer.d575.s2.p10","sentence":"Thus, @PROTEIN2$ forms distinct heteromeric complexes containing combinations of alpha-catenin, beta-catenin, and @PROTEIN1$ which are independent from the cadherin-catenin complexes.","label":1}
{"pair_id":"BioInfer.d575.s2.p11","sentence":"Thus, APC forms distinct heteromeric complexes containing combinations of alpha-catenin, beta-catenin, and @PROTEIN1$ which are independent from the cadherin-@PROTEIN2$ complexes.","label":1}
{"pair_id":"BioInfer.d575.s2.p12","sentence":"Thus, @PROTEIN2$ forms distinct heteromeric complexes containing combinations of alpha-catenin, beta-catenin, and plakoglobin which are independent from the @PROTEIN1$-catenin complexes.","label":1}
{"pair_id":"BioInfer.d575.s2.p13","sentence":"Thus, APC forms distinct heteromeric complexes containing combinations of alpha-catenin, beta-catenin, and plakoglobin which are independent from the @PROTEIN1$-@PROTEIN2$ complexes.","label":1}
{"pair_id":"BioInfer.d575.s2.p14","sentence":"Thus, @PROTEIN1$ forms distinct heteromeric complexes containing combinations of alpha-catenin, beta-catenin, and plakoglobin which are independent from the cadherin-@PROTEIN2$ complexes.","label":1}
{"pair_id":"AIMed.d49.s438.p0","sentence":"The reciprocal loop replacement mutant (@PROTEIN1$-L4\/7) retained @PROTEIN2$ like affinity for FGFR1 and for KGFR.","label":0}
{"pair_id":"AIMed.d49.s438.p1","sentence":"The reciprocal loop replacement mutant (@PROTEIN1$-L4\/7) retained FGF-2 like affinity for @PROTEIN2$ and for KGFR.","label":0}
{"pair_id":"AIMed.d49.s438.p2","sentence":"The reciprocal loop replacement mutant (@PROTEIN1$-L4\/7) retained FGF-2 like affinity for FGFR1 and for @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d49.s438.p3","sentence":"The reciprocal loop replacement mutant (FGF2-L4\/7) retained @PROTEIN1$ like affinity for @PROTEIN2$ and for KGFR.","label":1}
{"pair_id":"AIMed.d49.s438.p4","sentence":"The reciprocal loop replacement mutant (FGF2-L4\/7) retained @PROTEIN1$ like affinity for FGFR1 and for @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d49.s438.p5","sentence":"The reciprocal loop replacement mutant (FGF2-L4\/7) retained FGF-2 like affinity for @PROTEIN1$ and for @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d166.s0.p0","sentence":"Deletion of both RAD50 and @PROTEIN1$ produces a phenotype similar to that produced by deletion of @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d166.s0.p1","sentence":"Deletion of both @PROTEIN2$ and @PROTEIN1$ produces a phenotype similar to that produced by deletion of RAD52.","label":0}
{"pair_id":"BioInfer.d166.s0.p2","sentence":"Deletion of both @PROTEIN2$ and RAD51 produces a phenotype similar to that produced by deletion of @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d171.s0.p0","sentence":"Detection of loss of heterozygosity at RAD51, @PROTEIN2$, RAD54 and BRCA1 and @PROTEIN1$ loci in breast cancer: pathological correlations.","label":0}
{"pair_id":"BioInfer.d171.s0.p1","sentence":"Detection of loss of heterozygosity at RAD51, RAD52, @PROTEIN2$ and BRCA1 and @PROTEIN1$ loci in breast cancer: pathological correlations.","label":0}
{"pair_id":"BioInfer.d171.s0.p2","sentence":"Detection of loss of heterozygosity at @PROTEIN2$, RAD52, RAD54 and BRCA1 and @PROTEIN1$ loci in breast cancer: pathological correlations.","label":0}
{"pair_id":"BioInfer.d171.s0.p3","sentence":"Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and @PROTEIN2$ and @PROTEIN1$ loci in breast cancer: pathological correlations.","label":0}
{"pair_id":"BioInfer.d171.s0.p4","sentence":"Detection of loss of heterozygosity at RAD51, @PROTEIN1$, @PROTEIN2$ and BRCA1 and BRCA2 loci in breast cancer: pathological correlations.","label":0}
{"pair_id":"BioInfer.d171.s0.p5","sentence":"Detection of loss of heterozygosity at @PROTEIN2$, @PROTEIN1$, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations.","label":0}
{"pair_id":"BioInfer.d171.s0.p6","sentence":"Detection of loss of heterozygosity at RAD51, @PROTEIN1$, RAD54 and @PROTEIN2$ and BRCA2 loci in breast cancer: pathological correlations.","label":0}
{"pair_id":"BioInfer.d171.s0.p7","sentence":"Detection of loss of heterozygosity at @PROTEIN2$, RAD52, @PROTEIN1$ and BRCA1 and BRCA2 loci in breast cancer: pathological correlations.","label":0}
{"pair_id":"BioInfer.d171.s0.p8","sentence":"Detection of loss of heterozygosity at RAD51, RAD52, @PROTEIN1$ and @PROTEIN2$ and BRCA2 loci in breast cancer: pathological correlations.","label":0}
{"pair_id":"BioInfer.d171.s0.p9","sentence":"Detection of loss of heterozygosity at @PROTEIN1$, RAD52, RAD54 and @PROTEIN2$ and BRCA2 loci in breast cancer: pathological correlations.","label":0}
{"pair_id":"BioInfer.d119.s0.p0","sentence":"By site-directed mutagenesis of @PROTEIN1$ from Dictyostelium discoideum the point mutations K114E and W3N were generated by PCR thus changing @PROTEIN2$ and poly-(L)-proline-binding activity respectively.","label":1}
{"pair_id":"AIMed.d36.s303.p0","sentence":"We further demonstrated that @PROTEIN1$ and E3 but not @PROTEIN2$ can decrease the fusogenic activity of Abeta(29-42) via a direct interaction.","label":0}
{"pair_id":"AIMed.d36.s303.p1","sentence":"We further demonstrated that @PROTEIN1$ and E3 but not apolipoprotein E4 can decrease the fusogenic activity of @PROTEIN2$(29-42) via a direct interaction.","label":1}
{"pair_id":"AIMed.d36.s303.p2","sentence":"We further demonstrated that apolipoprotein E2 and E3 but not @PROTEIN1$ can decrease the fusogenic activity of @PROTEIN2$(29-42) via a direct interaction.","label":0}
{"pair_id":"BioInfer.d404.s0.p0","sentence":"Like the @PROTEIN2$, the major central part of the @PROTEIN1$ is made up of repeat units of 106 amino-acids.","label":0}
{"pair_id":"AIMed.d214.s1865.p0","sentence":"These data imply that @PROTEIN1$ is a molecular adapter that regulates the function of @PROTEIN2$ in thymocytes and peripheral T cells.","label":0}
{"pair_id":"AIMed.d90.s764.p0","sentence":"Multiple proteins physically interact with @PROTEIN1$. Transcriptional synergy with @PROTEIN2$ (C\/EBP delta, CRP3).","label":0}
{"pair_id":"AIMed.d90.s764.p1","sentence":"Multiple proteins physically interact with @PROTEIN1$. Transcriptional synergy with NF-IL6 beta (C\/@PROTEIN2$, CRP3).","label":0}
{"pair_id":"AIMed.d90.s764.p2","sentence":"Multiple proteins physically interact with @PROTEIN1$. Transcriptional synergy with NF-IL6 beta (C\/EBP delta, @PROTEIN2$).","label":0}
{"pair_id":"AIMed.d90.s764.p3","sentence":"Multiple proteins physically interact with PU.1. Transcriptional synergy with @PROTEIN1$ (C\/@PROTEIN2$, CRP3).","label":0}
{"pair_id":"AIMed.d90.s764.p4","sentence":"Multiple proteins physically interact with PU.1. Transcriptional synergy with @PROTEIN1$ (C\/EBP delta, @PROTEIN2$).","label":0}
{"pair_id":"AIMed.d90.s764.p5","sentence":"Multiple proteins physically interact with PU.1. Transcriptional synergy with NF-IL6 beta (C\/@PROTEIN1$, @PROTEIN2$).","label":0}
{"pair_id":"AIMed.d74.s631.p0","sentence":"When transfected into COS cells the cloned cDNA directed the expression of a @PROTEIN1$ showing a single class of affinity (KD = 2(-8) nM) and specificity for human @PROTEIN2$ but not interleukin-3.","label":1}
{"pair_id":"AIMed.d74.s631.p1","sentence":"When transfected into COS cells the cloned cDNA directed the expression of a @PROTEIN1$ showing a single class of affinity (KD = 2(-8) nM) and specificity for human GM-CSF but not @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d74.s631.p2","sentence":"When transfected into COS cells the cloned cDNA directed the expression of a GM-CSF-R showing a single class of affinity (KD = 2(-8) nM) and specificity for human @PROTEIN1$ but not @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d103.s868.p0","sentence":"We have cloned cDNAs encoding three novel TAFIIs [@PROTEIN1$ (@PROTEIN2$)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p1","sentence":"We have cloned cDNAs encoding three novel TAFIIs [@PROTEIN1$ (TBP)-associated factors] from the human (h) HeLa cell @PROTEIN2$ complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p2","sentence":"We have cloned cDNAs encoding three novel TAFIIs [@PROTEIN1$ (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes @PROTEIN2$, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p3","sentence":"We have cloned cDNAs encoding three novel TAFIIs [@PROTEIN1$ (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, @PROTEIN2$ and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p4","sentence":"We have cloned cDNAs encoding three novel TAFIIs [@PROTEIN1$ (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and @PROTEIN2$. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p5","sentence":"We have cloned cDNAs encoding three novel TAFIIs [@PROTEIN1$ (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. @PROTEIN2$ is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p6","sentence":"We have cloned cDNAs encoding three novel TAFIIs [@PROTEIN1$ (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core @PROTEIN2$ present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p7","sentence":"We have cloned cDNAs encoding three novel TAFIIs [@PROTEIN1$ (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described @PROTEIN2$ species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p8","sentence":"We have cloned cDNAs encoding three novel TAFIIs [@PROTEIN1$ (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain @PROTEIN2$ (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p9","sentence":"We have cloned cDNAs encoding three novel TAFIIs [@PROTEIN1$ (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (@PROTEIN2$ alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p10","sentence":"We have cloned cDNAs encoding three novel TAFIIs [@PROTEIN1$ (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (@PROTEIN2$ and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p11","sentence":"We have cloned cDNAs encoding three novel TAFIIs [@PROTEIN1$ (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and @PROTEIN2$ beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p12","sentence":"We have cloned cDNAs encoding three novel TAFIIs [@PROTEIN1$ (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and @PROTEIN2$ respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p13","sentence":"We have cloned cDNAs encoding three novel TAFIIs [@PROTEIN1$ (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)@PROTEIN2$. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p14","sentence":"We have cloned cDNAs encoding three novel TAFIIs [@PROTEIN1$ (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. @PROTEIN2$ is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p15","sentence":"We have cloned cDNAs encoding three novel TAFIIs [@PROTEIN1$ (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel @PROTEIN2$ which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p16","sentence":"We have cloned cDNAs encoding three novel TAFIIs [@PROTEIN1$ (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast @PROTEIN2$, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p17","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (@PROTEIN1$)-associated factors] from the human (h) HeLa cell @PROTEIN2$ complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p18","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (@PROTEIN1$)-associated factors] from the human (h) HeLa cell TFIID complexes @PROTEIN2$, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p19","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (@PROTEIN1$)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, @PROTEIN2$ and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p20","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (@PROTEIN1$)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and @PROTEIN2$. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p21","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (@PROTEIN1$)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. @PROTEIN2$ is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p22","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (@PROTEIN1$)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core @PROTEIN2$ present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p23","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (@PROTEIN1$)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described @PROTEIN2$ species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p24","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (@PROTEIN1$)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain @PROTEIN2$ (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p25","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (@PROTEIN1$)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (@PROTEIN2$ alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p26","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (@PROTEIN1$)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (@PROTEIN2$ and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p27","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (@PROTEIN1$)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and @PROTEIN2$ beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p28","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (@PROTEIN1$)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and @PROTEIN2$ respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p29","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (@PROTEIN1$)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)@PROTEIN2$. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p30","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (@PROTEIN1$)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. @PROTEIN2$ is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p31","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (@PROTEIN1$)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel @PROTEIN2$ which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p32","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (@PROTEIN1$)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast @PROTEIN2$, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p33","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell @PROTEIN1$ complexes @PROTEIN2$, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p34","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell @PROTEIN1$ complexes hTAFII28, @PROTEIN2$ and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p35","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell @PROTEIN1$ complexes hTAFII28, hTAFII20 and @PROTEIN2$. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p36","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell @PROTEIN1$ complexes hTAFII28, hTAFII20 and hTAFII18. @PROTEIN2$ is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p37","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell @PROTEIN1$ complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core @PROTEIN2$ present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p38","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell @PROTEIN1$ complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described @PROTEIN2$ species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p39","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell @PROTEIN1$ complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain @PROTEIN2$ (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p40","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell @PROTEIN1$ complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (@PROTEIN2$ alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p41","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell @PROTEIN1$ complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (@PROTEIN2$ and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p42","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell @PROTEIN1$ complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and @PROTEIN2$ beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p43","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell @PROTEIN1$ complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and @PROTEIN2$ respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p44","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell @PROTEIN1$ complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)@PROTEIN2$. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p45","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell @PROTEIN1$ complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. @PROTEIN2$ is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p46","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell @PROTEIN1$ complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel @PROTEIN2$ which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p47","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell @PROTEIN1$ complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast @PROTEIN2$, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p48","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes @PROTEIN1$, @PROTEIN2$ and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p49","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes @PROTEIN1$, hTAFII20 and @PROTEIN2$. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p50","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes @PROTEIN1$, hTAFII20 and hTAFII18. @PROTEIN2$ is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p51","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes @PROTEIN1$, hTAFII20 and hTAFII18. hTAFII28 is a core @PROTEIN2$ present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p52","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes @PROTEIN1$, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described @PROTEIN2$ species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p53","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes @PROTEIN1$, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain @PROTEIN2$ (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p54","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes @PROTEIN1$, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (@PROTEIN2$ alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p55","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes @PROTEIN1$, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (@PROTEIN2$ and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p56","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes @PROTEIN1$, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and @PROTEIN2$ beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p57","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes @PROTEIN1$, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and @PROTEIN2$ respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p58","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes @PROTEIN1$, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)@PROTEIN2$. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p59","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes @PROTEIN1$, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. @PROTEIN2$ is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p60","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes @PROTEIN1$, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel @PROTEIN2$ which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p61","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes @PROTEIN1$, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast @PROTEIN2$, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p62","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, @PROTEIN1$ and @PROTEIN2$. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p63","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, @PROTEIN1$ and hTAFII18. @PROTEIN2$ is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p64","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, @PROTEIN1$ and hTAFII18. hTAFII28 is a core @PROTEIN2$ present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p65","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, @PROTEIN1$ and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described @PROTEIN2$ species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p66","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, @PROTEIN1$ and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain @PROTEIN2$ (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p67","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, @PROTEIN1$ and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (@PROTEIN2$ alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p68","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, @PROTEIN1$ and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (@PROTEIN2$ and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p69","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, @PROTEIN1$ and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and @PROTEIN2$ beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p70","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, @PROTEIN1$ and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and @PROTEIN2$ respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p71","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, @PROTEIN1$ and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)@PROTEIN2$. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p72","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, @PROTEIN1$ and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. @PROTEIN2$ is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p73","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, @PROTEIN1$ and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel @PROTEIN2$ which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p74","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, @PROTEIN1$ and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast @PROTEIN2$, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p75","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and @PROTEIN1$. @PROTEIN2$ is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p76","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and @PROTEIN1$. hTAFII28 is a core @PROTEIN2$ present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p77","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and @PROTEIN1$. hTAFII28 is a core hTAFII present in both of the previously described @PROTEIN2$ species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p78","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and @PROTEIN1$. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain @PROTEIN2$ (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p79","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and @PROTEIN1$. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (@PROTEIN2$ alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p80","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and @PROTEIN1$. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (@PROTEIN2$ and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p81","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and @PROTEIN1$. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and @PROTEIN2$ beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p82","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and @PROTEIN1$. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and @PROTEIN2$ respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p83","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and @PROTEIN1$. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)@PROTEIN2$. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p84","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and @PROTEIN1$. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. @PROTEIN2$ is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p85","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and @PROTEIN1$. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel @PROTEIN2$ which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p86","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and @PROTEIN1$. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast @PROTEIN2$, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p87","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. @PROTEIN1$ is a core @PROTEIN2$ present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p88","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. @PROTEIN1$ is a core hTAFII present in both of the previously described @PROTEIN2$ species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p89","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. @PROTEIN1$ is a core hTAFII present in both of the previously described hTFIID species which either lack or contain @PROTEIN2$ (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p90","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. @PROTEIN1$ is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (@PROTEIN2$ alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p91","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. @PROTEIN1$ is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (@PROTEIN2$ and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p92","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. @PROTEIN1$ is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and @PROTEIN2$ beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p93","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. @PROTEIN1$ is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and @PROTEIN2$ respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p94","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. @PROTEIN1$ is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)@PROTEIN2$. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p95","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. @PROTEIN1$ is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. @PROTEIN2$ is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p96","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. @PROTEIN1$ is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel @PROTEIN2$ which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p97","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. @PROTEIN1$ is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast @PROTEIN2$, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p98","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core @PROTEIN1$ present in both of the previously described @PROTEIN2$ species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p99","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core @PROTEIN1$ present in both of the previously described hTFIID species which either lack or contain @PROTEIN2$ (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p100","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core @PROTEIN1$ present in both of the previously described hTFIID species which either lack or contain hTAFII30 (@PROTEIN2$ alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p101","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core @PROTEIN1$ present in both of the previously described hTFIID species which either lack or contain hTAFII30 (@PROTEIN2$ and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p102","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core @PROTEIN1$ present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and @PROTEIN2$ beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p103","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core @PROTEIN1$ present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and @PROTEIN2$ respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p104","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core @PROTEIN1$ present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)@PROTEIN2$. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p105","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core @PROTEIN1$ present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. @PROTEIN2$ is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p106","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core @PROTEIN1$ present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel @PROTEIN2$ which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p107","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core @PROTEIN1$ present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast @PROTEIN2$, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p108","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described @PROTEIN1$ species which either lack or contain @PROTEIN2$ (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p109","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described @PROTEIN1$ species which either lack or contain hTAFII30 (@PROTEIN2$ alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p110","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described @PROTEIN1$ species which either lack or contain hTAFII30 (@PROTEIN2$ and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p111","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described @PROTEIN1$ species which either lack or contain hTAFII30 (hTFIID alpha and @PROTEIN2$ beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p112","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described @PROTEIN1$ species which either lack or contain hTAFII30 (hTFIID alpha and @PROTEIN2$ respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p113","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described @PROTEIN1$ species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)@PROTEIN2$. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p114","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described @PROTEIN1$ species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. @PROTEIN2$ is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p115","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described @PROTEIN1$ species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel @PROTEIN2$ which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p116","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described @PROTEIN1$ species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast @PROTEIN2$, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p117","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain @PROTEIN1$ (@PROTEIN2$ alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p118","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain @PROTEIN1$ (@PROTEIN2$ and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p119","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain @PROTEIN1$ (hTFIID alpha and @PROTEIN2$ beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p120","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain @PROTEIN1$ (hTFIID alpha and @PROTEIN2$ respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p121","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain @PROTEIN1$ (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)@PROTEIN2$. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p122","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain @PROTEIN1$ (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. @PROTEIN2$ is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p123","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain @PROTEIN1$ (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel @PROTEIN2$ which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p124","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain @PROTEIN1$ (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast @PROTEIN2$, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p125","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (@PROTEIN1$@PROTEIN2$ and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p126","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (@PROTEIN1$ alpha and @PROTEIN2$ beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p127","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (@PROTEIN1$ alpha and @PROTEIN2$ respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p128","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (@PROTEIN1$ alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)@PROTEIN2$. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p129","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (@PROTEIN1$ alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. @PROTEIN2$ is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p130","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (@PROTEIN1$ alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel @PROTEIN2$ which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p131","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (@PROTEIN1$ alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast @PROTEIN2$, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p132","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (@PROTEIN1$ and @PROTEIN2$ beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p133","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (@PROTEIN1$ and @PROTEIN2$ respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p134","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (@PROTEIN1$ and hTFIID beta respectively), and is the homologue of Drosophila (d)@PROTEIN2$. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p135","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (@PROTEIN1$ and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. @PROTEIN2$ is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p136","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (@PROTEIN1$ and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel @PROTEIN2$ which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p137","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (@PROTEIN1$ and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast @PROTEIN2$, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p138","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and @PROTEIN1$@PROTEIN2$ respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p139","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and @PROTEIN1$ beta respectively), and is the homologue of Drosophila (d)@PROTEIN2$. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p140","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and @PROTEIN1$ beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. @PROTEIN2$ is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p141","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and @PROTEIN1$ beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel @PROTEIN2$ which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p142","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and @PROTEIN1$ beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast @PROTEIN2$, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p143","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and @PROTEIN1$ respectively), and is the homologue of Drosophila (d)@PROTEIN2$. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p144","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and @PROTEIN1$ respectively), and is the homologue of Drosophila (d)TAFII30 beta. @PROTEIN2$ is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p145","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and @PROTEIN1$ respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel @PROTEIN2$ which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p146","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and @PROTEIN1$ respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast @PROTEIN2$, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p147","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)@PROTEIN1$. @PROTEIN2$ is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p148","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)@PROTEIN1$. hTAFII18 is a novel @PROTEIN2$ which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p149","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)@PROTEIN1$. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast @PROTEIN2$, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p150","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. @PROTEIN1$ is a novel @PROTEIN2$ which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p151","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. @PROTEIN1$ is a novel hTAFII which shows homology to the N-terminal region of the yeast @PROTEIN2$, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p152","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel @PROTEIN1$ which shows homology to the N-terminal region of the yeast @PROTEIN2$, but has no known Drosophila counterpart.","label":0}
{"pair_id":"BioInfer.d528.s0.p0","sentence":"SDS-PAGE analysis of growth cone cytoskeletons revealed the presence of several major bands, identified by their mobility as @PROTEIN2$ (43 kDa Mr), myosin heavy chain (195 kDa Mr), @PROTEIN1$ (235 and 240 kDa Mr), and tubulin (51-54 kDa Mr).","label":0}
{"pair_id":"BioInfer.d528.s0.p1","sentence":"SDS-PAGE analysis of growth cone cytoskeletons revealed the presence of several major bands, identified by their mobility as actin (43 kDa Mr), myosin heavy chain (195 kDa Mr), @PROTEIN1$ (235 and 240 kDa Mr), and @PROTEIN2$ (51-54 kDa Mr).","label":0}
{"pair_id":"BioInfer.d528.s0.p2","sentence":"SDS-PAGE analysis of growth cone cytoskeletons revealed the presence of several major bands, identified by their mobility as actin (43 kDa Mr), @PROTEIN2$ (195 kDa Mr), @PROTEIN1$ (235 and 240 kDa Mr), and tubulin (51-54 kDa Mr).","label":0}
{"pair_id":"BioInfer.d528.s0.p3","sentence":"SDS-PAGE analysis of growth cone cytoskeletons revealed the presence of several major bands, identified by their mobility as @PROTEIN1$ (43 kDa Mr), myosin heavy chain (195 kDa Mr), spectrin (235 and 240 kDa Mr), and @PROTEIN2$ (51-54 kDa Mr).","label":0}
{"pair_id":"BioInfer.d528.s0.p4","sentence":"SDS-PAGE analysis of growth cone cytoskeletons revealed the presence of several major bands, identified by their mobility as @PROTEIN1$ (43 kDa Mr), @PROTEIN2$ (195 kDa Mr), spectrin (235 and 240 kDa Mr), and tubulin (51-54 kDa Mr).","label":0}
{"pair_id":"BioInfer.d528.s0.p5","sentence":"SDS-PAGE analysis of growth cone cytoskeletons revealed the presence of several major bands, identified by their mobility as actin (43 kDa Mr), @PROTEIN2$ (195 kDa Mr), spectrin (235 and 240 kDa Mr), and @PROTEIN1$ (51-54 kDa Mr).","label":0}
{"pair_id":"BioInfer.d815.s0.p0","sentence":"We have shown that these proteins are indeed @PROTEIN1$: the 14 kd is the histone H4, the 19 kd is the @PROTEIN2$ H3, and the 25 kd is the sperm-specific protein SP2.","label":0}
{"pair_id":"BioInfer.d815.s0.p1","sentence":"We have shown that these proteins are indeed @PROTEIN1$: the 14 kd is the @PROTEIN2$ H4, the 19 kd is the histone H3, and the 25 kd is the sperm-specific protein SP2.","label":0}
{"pair_id":"BioInfer.d815.s0.p2","sentence":"We have shown that these proteins are indeed @PROTEIN1$: the 14 kd is the histone @PROTEIN2$, the 19 kd is the histone H3, and the 25 kd is the sperm-specific protein SP2.","label":1}
{"pair_id":"BioInfer.d815.s0.p3","sentence":"We have shown that these proteins are indeed @PROTEIN1$: the 14 kd is the histone H4, the 19 kd is the histone H3, and the 25 kd is the sperm-specific protein @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d815.s0.p4","sentence":"We have shown that these proteins are indeed @PROTEIN1$: the 14 kd is the histone H4, the 19 kd is the histone @PROTEIN2$, and the 25 kd is the sperm-specific protein SP2.","label":1}
{"pair_id":"BioInfer.d815.s0.p5","sentence":"We have shown that these proteins are indeed nuclear basic proteins: the 14 kd is the @PROTEIN2$ H4, the 19 kd is the @PROTEIN1$ H3, and the 25 kd is the sperm-specific protein SP2.","label":0}
{"pair_id":"BioInfer.d815.s0.p6","sentence":"We have shown that these proteins are indeed nuclear basic proteins: the 14 kd is the histone @PROTEIN2$, the 19 kd is the @PROTEIN1$ H3, and the 25 kd is the sperm-specific protein SP2.","label":0}
{"pair_id":"BioInfer.d815.s0.p7","sentence":"We have shown that these proteins are indeed nuclear basic proteins: the 14 kd is the histone H4, the 19 kd is the @PROTEIN1$ H3, and the 25 kd is the sperm-specific protein @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d815.s0.p8","sentence":"We have shown that these proteins are indeed nuclear basic proteins: the 14 kd is the histone H4, the 19 kd is the @PROTEIN1$ @PROTEIN2$, and the 25 kd is the sperm-specific protein SP2.","label":1}
{"pair_id":"BioInfer.d815.s0.p9","sentence":"We have shown that these proteins are indeed nuclear basic proteins: the 14 kd is the @PROTEIN1$ @PROTEIN2$, the 19 kd is the histone H3, and the 25 kd is the sperm-specific protein SP2.","label":1}
{"pair_id":"BioInfer.d815.s0.p10","sentence":"We have shown that these proteins are indeed nuclear basic proteins: the 14 kd is the @PROTEIN1$ H4, the 19 kd is the histone H3, and the 25 kd is the sperm-specific protein @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d815.s0.p11","sentence":"We have shown that these proteins are indeed nuclear basic proteins: the 14 kd is the @PROTEIN1$ H4, the 19 kd is the histone @PROTEIN2$, and the 25 kd is the sperm-specific protein SP2.","label":0}
{"pair_id":"BioInfer.d815.s0.p12","sentence":"We have shown that these proteins are indeed nuclear basic proteins: the 14 kd is the histone @PROTEIN1$, the 19 kd is the histone H3, and the 25 kd is the sperm-specific protein @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d815.s0.p13","sentence":"We have shown that these proteins are indeed nuclear basic proteins: the 14 kd is the histone @PROTEIN1$, the 19 kd is the histone @PROTEIN2$, and the 25 kd is the sperm-specific protein SP2.","label":0}
{"pair_id":"BioInfer.d815.s0.p14","sentence":"We have shown that these proteins are indeed nuclear basic proteins: the 14 kd is the histone H4, the 19 kd is the histone @PROTEIN2$, and the 25 kd is the sperm-specific protein @PROTEIN1$.","label":0}
{"pair_id":"AIMed.d30.s255.p0","sentence":"We also found another @PROTEIN1$, @PROTEIN2$, interacted with PS1.","label":0}
{"pair_id":"AIMed.d30.s255.p1","sentence":"We also found another @PROTEIN1$, p0071, interacted with @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d30.s255.p2","sentence":"We also found another armadillo-protein, @PROTEIN1$, interacted with @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d474.s0.p0","sentence":"Our in vitro recombinant protein-protein interaction studies demonstrated that @PROTEIN1$ could directly interact with TNFR1 and @PROTEIN2$ but not with FADD.","label":1}
{"pair_id":"BioInfer.d474.s0.p1","sentence":"Our in vitro recombinant protein-protein interaction studies demonstrated that @PROTEIN1$ could directly interact with @PROTEIN2$ and TRADD but not with FADD.","label":1}
{"pair_id":"BioInfer.d474.s0.p2","sentence":"Our in vitro recombinant protein-protein interaction studies demonstrated that @PROTEIN1$ could directly interact with TNFR1 and TRADD but not with @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d474.s0.p3","sentence":"Our in vitro recombinant protein-protein interaction studies demonstrated that Stat1 could directly interact with @PROTEIN2$ and @PROTEIN1$ but not with FADD.","label":0}
{"pair_id":"BioInfer.d474.s0.p4","sentence":"Our in vitro recombinant protein-protein interaction studies demonstrated that Stat1 could directly interact with TNFR1 and @PROTEIN1$ but not with @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d474.s0.p5","sentence":"Our in vitro recombinant protein-protein interaction studies demonstrated that Stat1 could directly interact with @PROTEIN1$ and TRADD but not with @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d451.s0.p0","sentence":"Newly disclosed interactions between gephyrin, exchange factors for @PROTEIN2$ of the @PROTEIN1$ and Rac families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.","label":0}
{"pair_id":"BioInfer.d451.s0.p1","sentence":"Newly disclosed interactions between gephyrin, exchange factors for @PROTEIN2$ of the @PROTEIN1$ and Rac families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.","label":1}
{"pair_id":"BioInfer.d451.s0.p2","sentence":"Newly disclosed interactions between gephyrin, exchange factors for G proteins of the @PROTEIN1$ and Rac families, the translational regulator @PROTEIN2$, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.","label":0}
{"pair_id":"BioInfer.d451.s0.p3","sentence":"Newly disclosed interactions between gephyrin, exchange factors for G proteins of the @PROTEIN1$ and Rac families, the translational regulator RAFT1, and actin-binding proteins like @PROTEIN2$ might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.","label":0}
{"pair_id":"BioInfer.d451.s0.p4","sentence":"Newly disclosed interactions between gephyrin, exchange factors for G proteins of the @PROTEIN1$ and Rac families, the translational regulator RAFT1, and @PROTEIN2$ like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.","label":0}
{"pair_id":"BioInfer.d451.s0.p5","sentence":"Newly disclosed interactions between @PROTEIN2$, exchange factors for G proteins of the @PROTEIN1$ and Rac families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.","label":0}
{"pair_id":"BioInfer.d451.s0.p6","sentence":"Newly disclosed interactions between gephyrin, exchange factors for G proteins of the @PROTEIN1$ and @PROTEIN2$ families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.","label":0}
{"pair_id":"BioInfer.d451.s0.p7","sentence":"Newly disclosed interactions between gephyrin, exchange factors for @PROTEIN1$@PROTEIN2$ of the Rho and Rac families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.","label":0}
{"pair_id":"BioInfer.d451.s0.p8","sentence":"Newly disclosed interactions between gephyrin, exchange factors for @PROTEIN1$ of the Rho and Rac families, the translational regulator @PROTEIN2$, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.","label":0}
{"pair_id":"BioInfer.d451.s0.p9","sentence":"Newly disclosed interactions between gephyrin, exchange factors for @PROTEIN1$ of the Rho and Rac families, the translational regulator RAFT1, and actin-binding proteins like @PROTEIN2$ might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.","label":0}
{"pair_id":"BioInfer.d451.s0.p10","sentence":"Newly disclosed interactions between gephyrin, exchange factors for @PROTEIN1$ of the Rho and Rac families, the translational regulator RAFT1, and @PROTEIN2$ like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.","label":0}
{"pair_id":"BioInfer.d451.s0.p11","sentence":"Newly disclosed interactions between @PROTEIN2$, exchange factors for @PROTEIN1$ of the Rho and Rac families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.","label":0}
{"pair_id":"BioInfer.d451.s0.p12","sentence":"Newly disclosed interactions between gephyrin, exchange factors for @PROTEIN1$ of the Rho and @PROTEIN2$ families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.","label":0}
{"pair_id":"BioInfer.d451.s0.p13","sentence":"Newly disclosed interactions between gephyrin, exchange factors for @PROTEIN1$ of the Rho and Rac families, the translational regulator @PROTEIN2$, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.","label":1}
{"pair_id":"BioInfer.d451.s0.p14","sentence":"Newly disclosed interactions between gephyrin, exchange factors for @PROTEIN1$ of the Rho and Rac families, the translational regulator RAFT1, and actin-binding proteins like @PROTEIN2$ might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.","label":0}
{"pair_id":"BioInfer.d451.s0.p15","sentence":"Newly disclosed interactions between gephyrin, exchange factors for @PROTEIN1$ of the Rho and Rac families, the translational regulator RAFT1, and @PROTEIN2$ like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.","label":1}
{"pair_id":"BioInfer.d451.s0.p16","sentence":"Newly disclosed interactions between @PROTEIN2$, exchange factors for @PROTEIN1$ of the Rho and Rac families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.","label":1}
{"pair_id":"BioInfer.d451.s0.p17","sentence":"Newly disclosed interactions between gephyrin, exchange factors for @PROTEIN1$ of the Rho and @PROTEIN2$ families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.","label":1}
{"pair_id":"BioInfer.d451.s0.p18","sentence":"Newly disclosed interactions between gephyrin, exchange factors for G proteins of the Rho and Rac families, the translational regulator @PROTEIN1$, and actin-binding proteins like @PROTEIN2$ might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.","label":0}
{"pair_id":"BioInfer.d451.s0.p19","sentence":"Newly disclosed interactions between gephyrin, exchange factors for G proteins of the Rho and Rac families, the translational regulator @PROTEIN1$, and @PROTEIN2$ like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.","label":1}
{"pair_id":"BioInfer.d451.s0.p20","sentence":"Newly disclosed interactions between @PROTEIN2$, exchange factors for G proteins of the Rho and Rac families, the translational regulator @PROTEIN1$, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.","label":1}
{"pair_id":"BioInfer.d451.s0.p21","sentence":"Newly disclosed interactions between gephyrin, exchange factors for G proteins of the Rho and @PROTEIN2$ families, the translational regulator @PROTEIN1$, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.","label":0}
{"pair_id":"BioInfer.d451.s0.p22","sentence":"Newly disclosed interactions between gephyrin, exchange factors for G proteins of the Rho and Rac families, the translational regulator RAFT1, and @PROTEIN2$ like @PROTEIN1$ might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.","label":1}
{"pair_id":"BioInfer.d451.s0.p23","sentence":"Newly disclosed interactions between @PROTEIN2$, exchange factors for G proteins of the Rho and Rac families, the translational regulator RAFT1, and actin-binding proteins like @PROTEIN1$ might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.","label":0}
{"pair_id":"BioInfer.d451.s0.p24","sentence":"Newly disclosed interactions between gephyrin, exchange factors for G proteins of the Rho and @PROTEIN2$ families, the translational regulator RAFT1, and actin-binding proteins like @PROTEIN1$ might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.","label":0}
{"pair_id":"BioInfer.d451.s0.p25","sentence":"Newly disclosed interactions between @PROTEIN2$, exchange factors for G proteins of the Rho and Rac families, the translational regulator RAFT1, and @PROTEIN1$ like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.","label":1}
{"pair_id":"BioInfer.d451.s0.p26","sentence":"Newly disclosed interactions between gephyrin, exchange factors for G proteins of the Rho and @PROTEIN2$ families, the translational regulator RAFT1, and @PROTEIN1$ like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.","label":0}
{"pair_id":"BioInfer.d451.s0.p27","sentence":"Newly disclosed interactions between @PROTEIN1$, exchange factors for G proteins of the Rho and @PROTEIN2$ families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.","label":0}
{"pair_id":"BioInfer.d596.s0.p0","sentence":"The comparison of @PROTEIN1$ proteins synthesized by E62 and E24 cell lines revealed no structural or functional differences because both localized at cell-cell contacts and associated with alpha-catenin, beta-catenin, and @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d596.s0.p1","sentence":"The comparison of @PROTEIN1$ proteins synthesized by E62 and E24 cell lines revealed no structural or functional differences because both localized at cell-cell contacts and associated with alpha-catenin, @PROTEIN2$, and plakoglobin.","label":1}
{"pair_id":"BioInfer.d596.s0.p2","sentence":"The comparison of @PROTEIN1$ proteins synthesized by E62 and E24 cell lines revealed no structural or functional differences because both localized at cell-cell contacts and associated with @PROTEIN2$, beta-catenin, and plakoglobin.","label":1}
{"pair_id":"BioInfer.d596.s0.p3","sentence":"The comparison of E-CD proteins synthesized by E62 and E24 cell lines revealed no structural or functional differences because both localized at cell-cell contacts and associated with alpha-catenin, @PROTEIN2$, and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d596.s0.p4","sentence":"The comparison of E-CD proteins synthesized by E62 and E24 cell lines revealed no structural or functional differences because both localized at cell-cell contacts and associated with @PROTEIN2$, beta-catenin, and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d596.s0.p5","sentence":"The comparison of E-CD proteins synthesized by E62 and E24 cell lines revealed no structural or functional differences because both localized at cell-cell contacts and associated with @PROTEIN2$, @PROTEIN1$, and plakoglobin.","label":0}
{"pair_id":"AIMed.d118.s997.p0","sentence":"The @PROTEIN1$ tumour-suppressor protein controls the expression of a gene encoding the @PROTEIN2$ cyclin-dependent protein kinase (CDK) regulator.","label":0}
{"pair_id":"AIMed.d70.s601.p0","sentence":"These data suggest that anchoring proteins interact with @PROTEIN1$@PROTEIN2$ via an amphipathic helix binding motif.","label":0}
{"pair_id":"AIMed.d44.s383.p0","sentence":"Using a soluble @PROTEIN1$\/@PROTEIN2$ chimeric protein, we assessed the ability of anti-CD30 MAb to inhibit the binding of CD30L to CD30 expressed by the CD30+ Karpas 299 cell line.","label":0}
{"pair_id":"AIMed.d44.s383.p1","sentence":"Using a soluble @PROTEIN1$\/CD8alpha chimeric protein, we assessed the ability of anti-@PROTEIN2$ MAb to inhibit the binding of CD30L to CD30 expressed by the CD30+ Karpas 299 cell line.","label":0}
{"pair_id":"AIMed.d44.s383.p2","sentence":"Using a soluble @PROTEIN1$\/CD8alpha chimeric protein, we assessed the ability of anti-CD30 MAb to inhibit the binding of @PROTEIN2$ to CD30 expressed by the CD30+ Karpas 299 cell line.","label":0}
{"pair_id":"AIMed.d44.s383.p3","sentence":"Using a soluble @PROTEIN1$\/CD8alpha chimeric protein, we assessed the ability of anti-CD30 MAb to inhibit the binding of CD30L to @PROTEIN2$ expressed by the CD30+ Karpas 299 cell line.","label":0}
{"pair_id":"AIMed.d44.s383.p4","sentence":"Using a soluble CD30L\/@PROTEIN1$ chimeric protein, we assessed the ability of anti-@PROTEIN2$ MAb to inhibit the binding of CD30L to CD30 expressed by the CD30+ Karpas 299 cell line.","label":0}
{"pair_id":"AIMed.d44.s383.p5","sentence":"Using a soluble CD30L\/@PROTEIN1$ chimeric protein, we assessed the ability of anti-CD30 MAb to inhibit the binding of @PROTEIN2$ to CD30 expressed by the CD30+ Karpas 299 cell line.","label":0}
{"pair_id":"AIMed.d44.s383.p6","sentence":"Using a soluble CD30L\/@PROTEIN1$ chimeric protein, we assessed the ability of anti-CD30 MAb to inhibit the binding of CD30L to @PROTEIN2$ expressed by the CD30+ Karpas 299 cell line.","label":0}
{"pair_id":"AIMed.d44.s383.p7","sentence":"Using a soluble CD30L\/CD8alpha chimeric protein, we assessed the ability of anti-@PROTEIN1$ MAb to inhibit the binding of @PROTEIN2$ to CD30 expressed by the CD30+ Karpas 299 cell line.","label":0}
{"pair_id":"AIMed.d44.s383.p8","sentence":"Using a soluble CD30L\/CD8alpha chimeric protein, we assessed the ability of anti-@PROTEIN1$ MAb to inhibit the binding of CD30L to @PROTEIN2$ expressed by the CD30+ Karpas 299 cell line.","label":0}
{"pair_id":"AIMed.d44.s383.p9","sentence":"Using a soluble CD30L\/CD8alpha chimeric protein, we assessed the ability of anti-CD30 MAb to inhibit the binding of @PROTEIN1$ to @PROTEIN2$ expressed by the CD30+ Karpas 299 cell line.","label":1}
{"pair_id":"AIMed.d161.s1355.p0","sentence":"@PROTEIN1$ associates with the @PROTEIN2$ (PDGF) receptor after ligand stimulation, and binding of SHPTP2 to this receptor promotes tyrosine phosphorylation of SHPTP2.","label":0}
{"pair_id":"AIMed.d161.s1355.p1","sentence":"@PROTEIN1$ associates with the platelet-derived growth factor (@PROTEIN2$) receptor after ligand stimulation, and binding of SHPTP2 to this receptor promotes tyrosine phosphorylation of SHPTP2.","label":0}
{"pair_id":"AIMed.d161.s1355.p2","sentence":"@PROTEIN1$ associates with the @PROTEIN2$ after ligand stimulation, and binding of SHPTP2 to this receptor promotes tyrosine phosphorylation of SHPTP2.","label":1}
{"pair_id":"AIMed.d161.s1355.p3","sentence":"@PROTEIN1$ associates with the platelet-derived growth factor (PDGF) receptor after ligand stimulation, and binding of @PROTEIN2$ to this receptor promotes tyrosine phosphorylation of SHPTP2.","label":0}
{"pair_id":"AIMed.d161.s1355.p4","sentence":"@PROTEIN1$ associates with the platelet-derived growth factor (PDGF) receptor after ligand stimulation, and binding of SHPTP2 to this receptor promotes tyrosine phosphorylation of @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d161.s1355.p5","sentence":"SHPTP2 associates with the @PROTEIN1$ (@PROTEIN2$) receptor after ligand stimulation, and binding of SHPTP2 to this receptor promotes tyrosine phosphorylation of SHPTP2.","label":0}
{"pair_id":"AIMed.d161.s1355.p6","sentence":"SHPTP2 associates with the @PROTEIN1$@PROTEIN2$ after ligand stimulation, and binding of SHPTP2 to this receptor promotes tyrosine phosphorylation of SHPTP2.","label":0}
{"pair_id":"AIMed.d161.s1355.p7","sentence":"SHPTP2 associates with the @PROTEIN1$ (PDGF) receptor after ligand stimulation, and binding of @PROTEIN2$ to this receptor promotes tyrosine phosphorylation of SHPTP2.","label":0}
{"pair_id":"AIMed.d161.s1355.p8","sentence":"SHPTP2 associates with the @PROTEIN1$ (PDGF) receptor after ligand stimulation, and binding of SHPTP2 to this receptor promotes tyrosine phosphorylation of @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d161.s1355.p9","sentence":"SHPTP2 associates with the @PROTEIN2$@PROTEIN1$) receptor after ligand stimulation, and binding of SHPTP2 to this receptor promotes tyrosine phosphorylation of SHPTP2.","label":0}
{"pair_id":"AIMed.d161.s1355.p10","sentence":"SHPTP2 associates with the platelet-derived growth factor (@PROTEIN1$) receptor after ligand stimulation, and binding of @PROTEIN2$ to this receptor promotes tyrosine phosphorylation of SHPTP2.","label":0}
{"pair_id":"AIMed.d161.s1355.p11","sentence":"SHPTP2 associates with the platelet-derived growth factor (@PROTEIN1$) receptor after ligand stimulation, and binding of SHPTP2 to this receptor promotes tyrosine phosphorylation of @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d161.s1355.p12","sentence":"SHPTP2 associates with the @PROTEIN1$ after ligand stimulation, and binding of @PROTEIN2$ to this receptor promotes tyrosine phosphorylation of SHPTP2.","label":0}
{"pair_id":"AIMed.d161.s1355.p13","sentence":"SHPTP2 associates with the @PROTEIN1$ after ligand stimulation, and binding of SHPTP2 to this receptor promotes tyrosine phosphorylation of @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d161.s1355.p14","sentence":"SHPTP2 associates with the platelet-derived growth factor (PDGF) receptor after ligand stimulation, and binding of @PROTEIN1$ to this receptor promotes tyrosine phosphorylation of @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d60.s525.p0","sentence":"Activation of @PROTEIN1$@PROTEIN2$ by v-Raf in NIH 3T3 cells and in vitro.","label":0}
{"pair_id":"AIMed.d60.s525.p1","sentence":"Activation of @PROTEIN1$ kinase by @PROTEIN2$ in NIH 3T3 cells and in vitro.","label":0}
{"pair_id":"AIMed.d60.s525.p2","sentence":"Activation of @PROTEIN1$ by @PROTEIN2$ in NIH 3T3 cells and in vitro.","label":1}
{"pair_id":"BioInfer.d256.s0.p0","sentence":"Here, we sought to determine the spatial distributions of @PROTEIN2$, alpha-catenin, @PROTEIN1$, and plakoglobin, and whether different complexes of these proteins accumulate at steady state in polarized Madin-Darby canine kidney cells.","label":0}
{"pair_id":"BioInfer.d256.s0.p1","sentence":"Here, we sought to determine the spatial distributions of E-cadherin, @PROTEIN2$, @PROTEIN1$, and plakoglobin, and whether different complexes of these proteins accumulate at steady state in polarized Madin-Darby canine kidney cells.","label":0}
{"pair_id":"BioInfer.d256.s0.p2","sentence":"Here, we sought to determine the spatial distributions of E-cadherin, alpha-catenin, @PROTEIN1$, and @PROTEIN2$, and whether different complexes of these proteins accumulate at steady state in polarized Madin-Darby canine kidney cells.","label":0}
{"pair_id":"BioInfer.d256.s0.p3","sentence":"Here, we sought to determine the spatial distributions of @PROTEIN1$, @PROTEIN2$, beta-catenin, and plakoglobin, and whether different complexes of these proteins accumulate at steady state in polarized Madin-Darby canine kidney cells.","label":0}
{"pair_id":"BioInfer.d256.s0.p4","sentence":"Here, we sought to determine the spatial distributions of @PROTEIN1$, alpha-catenin, beta-catenin, and @PROTEIN2$, and whether different complexes of these proteins accumulate at steady state in polarized Madin-Darby canine kidney cells.","label":0}
{"pair_id":"BioInfer.d256.s0.p5","sentence":"Here, we sought to determine the spatial distributions of E-cadherin, @PROTEIN1$, beta-catenin, and @PROTEIN2$, and whether different complexes of these proteins accumulate at steady state in polarized Madin-Darby canine kidney cells.","label":0}
{"pair_id":"AIMed.d69.s587.p0","sentence":"In resting human epithelial and fibroblastic cells, @PROTEIN1$ is phosphorylated on serine and threonine at five sites, three of which are phosphorylated in vitro by @PROTEIN2$ (GSK-3).","label":1}
{"pair_id":"AIMed.d69.s587.p1","sentence":"In resting human epithelial and fibroblastic cells, @PROTEIN1$ is phosphorylated on serine and threonine at five sites, three of which are phosphorylated in vitro by glycogen synthase kinase 3 (@PROTEIN2$).","label":1}
{"pair_id":"AIMed.d69.s587.p2","sentence":"In resting human epithelial and fibroblastic cells, c-Jun is phosphorylated on serine and threonine at five sites, three of which are phosphorylated in vitro by @PROTEIN1$ (@PROTEIN2$).","label":0}
{"pair_id":"BioInfer.d43.s2.p0","sentence":"Co-localization of @PROTEIN2$ with @PROTEIN1$ filaments.","label":1}
{"pair_id":"AIMed.d224.s1954.p0","sentence":"Our results also show that, although these @PROTEIN1$ binding peptides are derived from signal sequences, they may be released back into the cytosol and subsequently translocated by the @PROTEIN2$ complex and loaded onto HLA-E molecules.","label":0}
{"pair_id":"AIMed.d224.s1954.p1","sentence":"Our results also show that, although these @PROTEIN1$ binding peptides are derived from signal sequences, they may be released back into the cytosol and subsequently translocated by the TAP complex and loaded onto @PROTEIN2$ molecules.","label":0}
{"pair_id":"AIMed.d224.s1954.p2","sentence":"Our results also show that, although these HLA-E binding peptides are derived from signal sequences, they may be released back into the cytosol and subsequently translocated by the @PROTEIN1$ complex and loaded onto @PROTEIN2$ molecules.","label":0}
{"pair_id":"BioInfer.d285.s0.p0","sentence":"Immediately after synthesis, E-cadherin, @PROTEIN1$, and @PROTEIN2$ cosedimented as complexes.","label":1}
{"pair_id":"BioInfer.d285.s0.p1","sentence":"Immediately after synthesis, @PROTEIN2$, @PROTEIN1$, and plakoglobin cosedimented as complexes.","label":1}
{"pair_id":"BioInfer.d285.s0.p2","sentence":"Immediately after synthesis, @PROTEIN2$, beta-catenin, and @PROTEIN1$ cosedimented as complexes.","label":1}
{"pair_id":"AIMed.d142.s1203.p0","sentence":"The physical interaction between @PROTEIN1$ and @PROTEIN2$ may thus form the basis for the functional interplay observed previously.","label":1}
{"pair_id":"BioInfer.d153.s0.p0","sentence":"Confluent calf pulmonary artery endothelial monolayers exposed to 95% oxygen for 1, 2, or 3 days exhibit a time-dependent increase in adherence to substratum, which closely parallels changes in @PROTEIN1$ cytoarchitecture and the distribution of focal contact proteins vinculin and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d153.s0.p1","sentence":"Confluent calf pulmonary artery endothelial monolayers exposed to 95% oxygen for 1, 2, or 3 days exhibit a time-dependent increase in adherence to substratum, which closely parallels changes in @PROTEIN1$ cytoarchitecture and the distribution of focal contact proteins @PROTEIN2$ and talin.","label":0}
{"pair_id":"BioInfer.d153.s0.p2","sentence":"Confluent calf pulmonary artery endothelial monolayers exposed to 95% oxygen for 1, 2, or 3 days exhibit a time-dependent increase in adherence to substratum, which closely parallels changes in actin cytoarchitecture and the distribution of focal contact proteins @PROTEIN2$ and @PROTEIN1$.","label":0}
{"pair_id":"AIMed.d205.s1771.p0","sentence":"We investigated whether @PROTEIN1$, which binds to tyrosine-phosphorylated @PROTEIN2$, interacts with CD5 following T cell activation.","label":1}
{"pair_id":"AIMed.d205.s1771.p1","sentence":"We investigated whether @PROTEIN1$, which binds to tyrosine-phosphorylated ITAM, interacts with @PROTEIN2$ following T cell activation.","label":0}
{"pair_id":"AIMed.d205.s1771.p2","sentence":"We investigated whether phosphatidylinositol (PI) 3-kinase, which binds to tyrosine-phosphorylated @PROTEIN1$, interacts with @PROTEIN2$ following T cell activation.","label":0}
{"pair_id":"AIMed.d198.s1688.p0","sentence":"We employed both random and site-specific mutagenesis to determine the function of amino acid residues in the extracellular domain (referred to as @PROTEIN1$@PROTEIN2$, EBP) of the EPOR.","label":0}
{"pair_id":"AIMed.d198.s1688.p1","sentence":"We employed both random and site-specific mutagenesis to determine the function of amino acid residues in the extracellular domain (referred to as @PROTEIN1$ binding protein, @PROTEIN2$) of the EPOR.","label":1}
{"pair_id":"AIMed.d198.s1688.p2","sentence":"We employed both random and site-specific mutagenesis to determine the function of amino acid residues in the extracellular domain (referred to as @PROTEIN1$ binding protein, EBP) of the @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d198.s1688.p3","sentence":"We employed both random and site-specific mutagenesis to determine the function of amino acid residues in the extracellular domain (referred to as @PROTEIN1$, @PROTEIN2$) of the EPOR.","label":0}
{"pair_id":"AIMed.d198.s1688.p4","sentence":"We employed both random and site-specific mutagenesis to determine the function of amino acid residues in the extracellular domain (referred to as @PROTEIN1$, EBP) of the @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d198.s1688.p5","sentence":"We employed both random and site-specific mutagenesis to determine the function of amino acid residues in the extracellular domain (referred to as EPO binding protein, @PROTEIN1$) of the @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d25.s212.p0","sentence":"Determination of @PROTEIN1$, complement factors @PROTEIN2$ and C4, and alpha1AT may be a significant parameter in the differential diagnosis of serous effusions, particularly in those patients with malignant disease.","label":0}
{"pair_id":"AIMed.d25.s212.p1","sentence":"Determination of @PROTEIN1$, complement factors C3 and @PROTEIN2$, and alpha1AT may be a significant parameter in the differential diagnosis of serous effusions, particularly in those patients with malignant disease.","label":0}
{"pair_id":"AIMed.d25.s212.p2","sentence":"Determination of @PROTEIN1$, complement factors C3 and C4, and @PROTEIN2$ may be a significant parameter in the differential diagnosis of serous effusions, particularly in those patients with malignant disease.","label":0}
{"pair_id":"AIMed.d25.s212.p3","sentence":"Determination of TNFalpha, complement factors @PROTEIN1$ and @PROTEIN2$, and alpha1AT may be a significant parameter in the differential diagnosis of serous effusions, particularly in those patients with malignant disease.","label":0}
{"pair_id":"AIMed.d25.s212.p4","sentence":"Determination of TNFalpha, complement factors @PROTEIN1$ and C4, and @PROTEIN2$ may be a significant parameter in the differential diagnosis of serous effusions, particularly in those patients with malignant disease.","label":0}
{"pair_id":"AIMed.d25.s212.p5","sentence":"Determination of TNFalpha, complement factors C3 and @PROTEIN1$, and @PROTEIN2$ may be a significant parameter in the differential diagnosis of serous effusions, particularly in those patients with malignant disease.","label":0}
{"pair_id":"AIMed.d217.s1882.p0","sentence":"Based on the structure of the closely related @PROTEIN1$-@PROTEIN2$ complex, a molecular model of the FasL homotrimer bound to three Fas molecules was generated using knowledge-based protein modeling methods.","label":1}
{"pair_id":"AIMed.d217.s1882.p1","sentence":"Based on the structure of the closely related @PROTEIN1$-tumor necrosis factor receptor I complex, a molecular model of the @PROTEIN2$ homotrimer bound to three Fas molecules was generated using knowledge-based protein modeling methods.","label":0}
{"pair_id":"AIMed.d217.s1882.p2","sentence":"Based on the structure of the closely related @PROTEIN1$-tumor necrosis factor receptor I complex, a molecular model of the FasL homotrimer bound to three @PROTEIN2$ molecules was generated using knowledge-based protein modeling methods.","label":0}
{"pair_id":"AIMed.d217.s1882.p3","sentence":"Based on the structure of the closely related lymphotoxin alpha-@PROTEIN1$ complex, a molecular model of the @PROTEIN2$ homotrimer bound to three Fas molecules was generated using knowledge-based protein modeling methods.","label":0}
{"pair_id":"AIMed.d217.s1882.p4","sentence":"Based on the structure of the closely related lymphotoxin alpha-@PROTEIN1$ complex, a molecular model of the FasL homotrimer bound to three @PROTEIN2$ molecules was generated using knowledge-based protein modeling methods.","label":0}
{"pair_id":"AIMed.d217.s1882.p5","sentence":"Based on the structure of the closely related lymphotoxin alpha-tumor necrosis factor receptor I complex, a molecular model of the @PROTEIN1$ homotrimer bound to three @PROTEIN2$ molecules was generated using knowledge-based protein modeling methods.","label":1}
{"pair_id":"AIMed.d120.s1020.p0","sentence":"Immunoblotting studies were used to confirm the binding of @PROTEIN1$ from fresh platelet lysates to the @PROTEIN2$ fusion protein.","label":1}
{"pair_id":"BioInfer.d85.s0.p0","sentence":"Associations of UBE2I with RAD52, @PROTEIN1$, p53, and @PROTEIN2$ proteins in a yeast two-hybrid system.","label":0}
{"pair_id":"BioInfer.d85.s0.p1","sentence":"Associations of UBE2I with @PROTEIN2$, @PROTEIN1$, p53, and RAD51 proteins in a yeast two-hybrid system.","label":0}
{"pair_id":"BioInfer.d85.s0.p2","sentence":"Associations of @PROTEIN2$ with RAD52, @PROTEIN1$, p53, and RAD51 proteins in a yeast two-hybrid system.","label":1}
{"pair_id":"BioInfer.d85.s0.p3","sentence":"Associations of UBE2I with RAD52, @PROTEIN1$, @PROTEIN2$, and RAD51 proteins in a yeast two-hybrid system.","label":0}
{"pair_id":"BioInfer.d85.s0.p4","sentence":"Associations of UBE2I with @PROTEIN2$, UBL1, p53, and @PROTEIN1$ proteins in a yeast two-hybrid system.","label":0}
{"pair_id":"BioInfer.d85.s0.p5","sentence":"Associations of @PROTEIN2$ with RAD52, UBL1, p53, and @PROTEIN1$ proteins in a yeast two-hybrid system.","label":1}
{"pair_id":"BioInfer.d85.s0.p6","sentence":"Associations of UBE2I with RAD52, UBL1, @PROTEIN2$, and @PROTEIN1$ proteins in a yeast two-hybrid system.","label":0}
{"pair_id":"BioInfer.d85.s0.p7","sentence":"Associations of @PROTEIN2$ with @PROTEIN1$, UBL1, p53, and RAD51 proteins in a yeast two-hybrid system.","label":1}
{"pair_id":"BioInfer.d85.s0.p8","sentence":"Associations of UBE2I with @PROTEIN1$, UBL1, @PROTEIN2$, and RAD51 proteins in a yeast two-hybrid system.","label":0}
{"pair_id":"BioInfer.d85.s0.p9","sentence":"Associations of @PROTEIN1$ with RAD52, UBL1, @PROTEIN2$, and RAD51 proteins in a yeast two-hybrid system.","label":1}
{"pair_id":"AIMed.d180.s1532.p0","sentence":"@PROTEIN1$ (@PROTEIN2$, B-50, F1), a protein kinase C (PKC) substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.","label":0}
{"pair_id":"AIMed.d180.s1532.p1","sentence":"@PROTEIN1$ (neuromodulin, @PROTEIN2$, F1), a protein kinase C (PKC) substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.","label":0}
{"pair_id":"AIMed.d180.s1532.p2","sentence":"@PROTEIN1$ (neuromodulin, B-50, @PROTEIN2$), a protein kinase C (PKC) substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.","label":0}
{"pair_id":"AIMed.d180.s1532.p3","sentence":"@PROTEIN1$ (neuromodulin, B-50, F1), a @PROTEIN2$ (PKC) substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.","label":1}
{"pair_id":"AIMed.d180.s1532.p4","sentence":"@PROTEIN1$ (neuromodulin, B-50, F1), a protein kinase C (@PROTEIN2$) substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.","label":1}
{"pair_id":"AIMed.d180.s1532.p5","sentence":"GAP-43 (@PROTEIN1$, @PROTEIN2$, F1), a protein kinase C (PKC) substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.","label":0}
{"pair_id":"AIMed.d180.s1532.p6","sentence":"GAP-43 (@PROTEIN1$, B-50, @PROTEIN2$), a protein kinase C (PKC) substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.","label":0}
{"pair_id":"AIMed.d180.s1532.p7","sentence":"GAP-43 (@PROTEIN1$, B-50, F1), a @PROTEIN2$ (PKC) substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.","label":1}
{"pair_id":"AIMed.d180.s1532.p8","sentence":"GAP-43 (@PROTEIN1$, B-50, F1), a protein kinase C (@PROTEIN2$) substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.","label":1}
{"pair_id":"AIMed.d180.s1532.p9","sentence":"GAP-43 (neuromodulin, @PROTEIN1$, @PROTEIN2$), a protein kinase C (PKC) substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.","label":0}
{"pair_id":"AIMed.d180.s1532.p10","sentence":"GAP-43 (neuromodulin, @PROTEIN1$, F1), a @PROTEIN2$ (PKC) substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.","label":1}
{"pair_id":"AIMed.d180.s1532.p11","sentence":"GAP-43 (neuromodulin, @PROTEIN1$, F1), a protein kinase C (@PROTEIN2$) substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.","label":1}
{"pair_id":"AIMed.d180.s1532.p12","sentence":"GAP-43 (neuromodulin, B-50, @PROTEIN1$), a @PROTEIN2$ (PKC) substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.","label":1}
{"pair_id":"AIMed.d180.s1532.p13","sentence":"GAP-43 (neuromodulin, B-50, @PROTEIN1$), a protein kinase C (@PROTEIN2$) substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.","label":1}
{"pair_id":"AIMed.d180.s1532.p14","sentence":"GAP-43 (neuromodulin, B-50, F1), a @PROTEIN1$ (@PROTEIN2$) substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.","label":0}
{"pair_id":"BioInfer.d77.s0.p0","sentence":"@PROTEIN2$\/A complex from Acanthamoeba binds @PROTEIN1$ and cross-links actin filaments.","label":1}
{"pair_id":"BioInfer.d77.s0.p1","sentence":"@PROTEIN2$2\/@PROTEIN2$ complex from Acanthamoeba binds @PROTEIN1$ and cross-links actin filaments.","label":1}
{"pair_id":"BioInfer.d77.s0.p2","sentence":"Arp2\/A complex from Acanthamoeba binds @PROTEIN1$ and cross-links @PROTEIN2$ filaments.","label":0}
{"pair_id":"BioInfer.d77.s0.p3","sentence":"@PROTEIN1$@PROTEIN2$2\/@PROTEIN2$ complex from Acanthamoeba binds profilin and cross-links actin filaments.","label":1}
{"pair_id":"BioInfer.d77.s0.p4","sentence":"@PROTEIN1$\/A complex from Acanthamoeba binds profilin and cross-links @PROTEIN2$ filaments.","label":1}
{"pair_id":"BioInfer.d77.s0.p5","sentence":"@PROTEIN1$2\/@PROTEIN1$ complex from Acanthamoeba binds profilin and cross-links @PROTEIN2$ filaments.","label":1}
{"pair_id":"AIMed.d46.s403.p0","sentence":"@PROTEIN1$ (@PROTEIN2$) induces bone formation and regeneration in adult vertebrates and regulates important developmental processes in all animals.","label":0}
{"pair_id":"AIMed.d132.s1128.p0","sentence":"Functional participation of the @PROTEIN1$@PROTEIN2$ chain in IL-7 receptor complexes.","label":0}
{"pair_id":"AIMed.d132.s1128.p1","sentence":"Functional participation of the @PROTEIN1$ receptor gamma chain in @PROTEIN2$ receptor complexes.","label":0}
{"pair_id":"AIMed.d132.s1128.p2","sentence":"Functional participation of the @PROTEIN1$ receptor gamma chain in @PROTEIN2$ complexes.","label":0}
{"pair_id":"AIMed.d132.s1128.p3","sentence":"Functional participation of the @PROTEIN1$ chain in @PROTEIN2$ receptor complexes.","label":0}
{"pair_id":"AIMed.d132.s1128.p4","sentence":"Functional participation of the @PROTEIN1$ chain in @PROTEIN2$ complexes.","label":0}
{"pair_id":"AIMed.d132.s1128.p5","sentence":"Functional participation of the IL-2 receptor gamma chain in @PROTEIN1$@PROTEIN2$ complexes.","label":0}
{"pair_id":"BioInfer.d134.s0.p0","sentence":"Changes in beta-catenin binding to @PROTEIN1$ or APC protein, and the ensuing effects on cell morphology and adhesion, are independent of beta-catenin binding to @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d134.s0.p1","sentence":"Changes in @PROTEIN2$ binding to @PROTEIN1$ or APC protein, and the ensuing effects on cell morphology and adhesion, are independent of beta-catenin binding to alpha-catenin.","label":1}
{"pair_id":"BioInfer.d134.s0.p2","sentence":"Changes in beta-catenin binding to @PROTEIN1$ or APC protein, and the ensuing effects on cell morphology and adhesion, are independent of @PROTEIN2$ binding to alpha-catenin.","label":0}
{"pair_id":"BioInfer.d134.s0.p3","sentence":"Changes in beta-catenin binding to @PROTEIN1$ or @PROTEIN2$ protein, and the ensuing effects on cell morphology and adhesion, are independent of beta-catenin binding to alpha-catenin.","label":0}
{"pair_id":"BioInfer.d134.s0.p4","sentence":"Changes in @PROTEIN2$ binding to cadherin or APC protein, and the ensuing effects on cell morphology and adhesion, are independent of beta-catenin binding to @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d134.s0.p5","sentence":"Changes in beta-catenin binding to cadherin or APC protein, and the ensuing effects on cell morphology and adhesion, are independent of @PROTEIN2$ binding to @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d134.s0.p6","sentence":"Changes in beta-catenin binding to cadherin or @PROTEIN2$ protein, and the ensuing effects on cell morphology and adhesion, are independent of beta-catenin binding to @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d134.s0.p7","sentence":"Changes in @PROTEIN1$ binding to cadherin or APC protein, and the ensuing effects on cell morphology and adhesion, are independent of @PROTEIN2$ binding to alpha-catenin.","label":1}
{"pair_id":"BioInfer.d134.s0.p8","sentence":"Changes in @PROTEIN1$ binding to cadherin or @PROTEIN2$ protein, and the ensuing effects on cell morphology and adhesion, are independent of beta-catenin binding to alpha-catenin.","label":1}
{"pair_id":"BioInfer.d134.s0.p9","sentence":"Changes in beta-catenin binding to cadherin or @PROTEIN2$ protein, and the ensuing effects on cell morphology and adhesion, are independent of @PROTEIN1$ binding to alpha-catenin.","label":0}
{"pair_id":"BioInfer.d245.s0.p0","sentence":"Here we have now identified the reciprocal complementary binding site in @PROTEIN1$ which mediates its interaction with @PROTEIN2$ and plakoglobin.","label":1}
{"pair_id":"BioInfer.d245.s0.p1","sentence":"Here we have now identified the reciprocal complementary binding site in @PROTEIN1$ which mediates its interaction with beta-catenin and @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d245.s0.p2","sentence":"Here we have now identified the reciprocal complementary binding site in alpha-catenin which mediates its interaction with @PROTEIN1$ and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d116.s981.p0","sentence":"This last observation was confirmed by affinity chromatography and immunoprecipitation, which demonstrated an interaction between @PROTEIN1$ and @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d807.s0.p0","sentence":"We have analyzed the expression levels of the genes encoding @PROTEIN1$, beta-catenin and @PROTEIN2$ in correlation to the E-cadherin expression levels in cell lines derived from human cervical carcinomas.","label":0}
{"pair_id":"BioInfer.d807.s0.p1","sentence":"We have analyzed the expression levels of the genes encoding @PROTEIN1$, @PROTEIN2$ and plakoglobin in correlation to the E-cadherin expression levels in cell lines derived from human cervical carcinomas.","label":0}
{"pair_id":"BioInfer.d807.s0.p2","sentence":"We have analyzed the expression levels of the genes encoding @PROTEIN1$, beta-catenin and plakoglobin in correlation to the @PROTEIN2$ expression levels in cell lines derived from human cervical carcinomas.","label":0}
{"pair_id":"BioInfer.d807.s0.p3","sentence":"We have analyzed the expression levels of the genes encoding alpha-catenin, @PROTEIN2$ and @PROTEIN1$ in correlation to the E-cadherin expression levels in cell lines derived from human cervical carcinomas.","label":0}
{"pair_id":"BioInfer.d807.s0.p4","sentence":"We have analyzed the expression levels of the genes encoding alpha-catenin, beta-catenin and @PROTEIN1$ in correlation to the @PROTEIN2$ expression levels in cell lines derived from human cervical carcinomas.","label":0}
{"pair_id":"BioInfer.d807.s0.p5","sentence":"We have analyzed the expression levels of the genes encoding alpha-catenin, @PROTEIN1$ and plakoglobin in correlation to the @PROTEIN2$ expression levels in cell lines derived from human cervical carcinomas.","label":0}
{"pair_id":"AIMed.d206.s1781.p0","sentence":"There was extensive co-localisation of @PROTEIN1$ and beta 1 integrins on microvilli and at cell-cell borders of basal keratinocytes; however, in contrast to the integrins, @PROTEIN2$ was not found in focal adhesions.","label":0}
{"pair_id":"BioInfer.d183.s0.p0","sentence":"Dynamic @PROTEIN1$ structures stabilized by @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d176.s1483.p0","sentence":"Interactions of @PROTEIN1$, a mediator of @PROTEIN2$ assembly, with heat shock proteins hsp90 and hsp70.","label":0}
{"pair_id":"AIMed.d176.s1483.p1","sentence":"Interactions of @PROTEIN1$, a mediator of progesterone receptor assembly, with heat shock proteins @PROTEIN2$ and hsp70.","label":1}
{"pair_id":"AIMed.d176.s1483.p2","sentence":"Interactions of @PROTEIN1$, a mediator of progesterone receptor assembly, with heat shock proteins hsp90 and @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d176.s1483.p3","sentence":"Interactions of p60, a mediator of @PROTEIN1$ assembly, with heat shock proteins @PROTEIN2$ and hsp70.","label":0}
{"pair_id":"AIMed.d176.s1483.p4","sentence":"Interactions of p60, a mediator of @PROTEIN1$ assembly, with heat shock proteins hsp90 and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d176.s1483.p5","sentence":"Interactions of p60, a mediator of progesterone receptor assembly, with heat shock proteins @PROTEIN1$ and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d764.s0.p0","sentence":"To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two antimuscle actin antibodies, @PROTEIN1$ and CGA7, and two anti-SMC myosin heavy chain markers, anti-@PROTEIN2$ and anti-SM2 antibodies and related antibodies.","label":0}
{"pair_id":"BioInfer.d764.s0.p1","sentence":"To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two antimuscle actin antibodies, @PROTEIN1$ and CGA7, and two anti-@PROTEIN2$ markers, anti-SM1 and anti-SM2 antibodies and related antibodies.","label":0}
{"pair_id":"BioInfer.d764.s0.p2","sentence":"To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two antimuscle actin antibodies, @PROTEIN1$ and CGA7, and two anti-SMC myosin heavy chain markers, anti-SM1 and anti-@PROTEIN2$ antibodies and related antibodies.","label":0}
{"pair_id":"BioInfer.d764.s0.p3","sentence":"To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two antimuscle actin antibodies, @PROTEIN1$ and @PROTEIN2$, and two anti-SMC myosin heavy chain markers, anti-SM1 and anti-SM2 antibodies and related antibodies.","label":0}
{"pair_id":"BioInfer.d764.s0.p4","sentence":"To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two anti@PROTEIN2$ antibodies, @PROTEIN1$ and CGA7, and two anti-SMC myosin heavy chain markers, anti-SM1 and anti-SM2 antibodies and related antibodies.","label":1}
{"pair_id":"BioInfer.d764.s0.p5","sentence":"To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two antimuscle actin antibodies, HHF35 and CGA7, and two anti-@PROTEIN2$ markers, anti-@PROTEIN1$ and anti-SM2 antibodies and related antibodies.","label":0}
{"pair_id":"BioInfer.d764.s0.p6","sentence":"To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two antimuscle actin antibodies, HHF35 and CGA7, and two anti-SMC myosin heavy chain markers, anti-@PROTEIN1$ and anti-@PROTEIN2$ antibodies and related antibodies.","label":0}
{"pair_id":"BioInfer.d764.s0.p7","sentence":"To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two antimuscle actin antibodies, HHF35 and @PROTEIN2$, and two anti-SMC myosin heavy chain markers, anti-@PROTEIN1$ and anti-SM2 antibodies and related antibodies.","label":0}
{"pair_id":"BioInfer.d764.s0.p8","sentence":"To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two anti@PROTEIN2$ antibodies, HHF35 and CGA7, and two anti-SMC myosin heavy chain markers, anti-@PROTEIN1$ and anti-SM2 antibodies and related antibodies.","label":0}
{"pair_id":"BioInfer.d764.s0.p9","sentence":"To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two antimuscle actin antibodies, HHF35 and CGA7, and two anti-@PROTEIN1$ markers, anti-SM1 and anti-@PROTEIN2$ antibodies and related antibodies.","label":0}
{"pair_id":"BioInfer.d764.s0.p10","sentence":"To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two antimuscle actin antibodies, HHF35 and @PROTEIN2$, and two anti-@PROTEIN1$ markers, anti-SM1 and anti-SM2 antibodies and related antibodies.","label":0}
{"pair_id":"BioInfer.d764.s0.p11","sentence":"To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two anti@PROTEIN2$ antibodies, HHF35 and CGA7, and two anti-@PROTEIN1$ markers, anti-SM1 and anti-SM2 antibodies and related antibodies.","label":0}
{"pair_id":"BioInfer.d764.s0.p12","sentence":"To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two antimuscle actin antibodies, HHF35 and @PROTEIN2$, and two anti-SMC myosin heavy chain markers, anti-SM1 and anti-@PROTEIN1$ antibodies and related antibodies.","label":0}
{"pair_id":"BioInfer.d764.s0.p13","sentence":"To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two anti@PROTEIN2$ antibodies, HHF35 and CGA7, and two anti-SMC myosin heavy chain markers, anti-SM1 and anti-@PROTEIN1$ antibodies and related antibodies.","label":0}
{"pair_id":"BioInfer.d764.s0.p14","sentence":"To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two anti@PROTEIN2$ antibodies, HHF35 and @PROTEIN1$, and two anti-SMC myosin heavy chain markers, anti-SM1 and anti-SM2 antibodies and related antibodies.","label":1}
{"pair_id":"AIMed.d171.s1442.p0","sentence":"The crystal structure of the human @PROTEIN1$ inhibitory domain bound to the phosphorylated @PROTEIN2$-cyclin-dependent kinase 2 (Cdk2) complex has been determined at 2.3 angstrom.","label":1}
{"pair_id":"AIMed.d171.s1442.p1","sentence":"The crystal structure of the human @PROTEIN1$ inhibitory domain bound to the phosphorylated cyclin A-@PROTEIN2$ (Cdk2) complex has been determined at 2.3 angstrom.","label":0}
{"pair_id":"AIMed.d171.s1442.p2","sentence":"The crystal structure of the human @PROTEIN1$ inhibitory domain bound to the phosphorylated cyclin A-cyclin-dependent kinase 2 (@PROTEIN2$) complex has been determined at 2.3 angstrom.","label":1}
{"pair_id":"AIMed.d171.s1442.p3","sentence":"The crystal structure of the human p27Kip1 kinase inhibitory domain bound to the phosphorylated @PROTEIN1$-@PROTEIN2$ (Cdk2) complex has been determined at 2.3 angstrom.","label":0}
{"pair_id":"AIMed.d171.s1442.p4","sentence":"The crystal structure of the human p27Kip1 kinase inhibitory domain bound to the phosphorylated @PROTEIN1$-cyclin-dependent kinase 2 (@PROTEIN2$) complex has been determined at 2.3 angstrom.","label":1}
{"pair_id":"AIMed.d171.s1442.p5","sentence":"The crystal structure of the human p27Kip1 kinase inhibitory domain bound to the phosphorylated cyclin A-@PROTEIN1$ (@PROTEIN2$) complex has been determined at 2.3 angstrom.","label":0}
{"pair_id":"BioInfer.d674.s0.p0","sentence":"The protein has the two conserved domains identified as @PROTEIN2$ and phosphatidylinositol 4,5-biphosphate (PIP2) binding sites found in members of the @PROTEIN1$ family.","label":1}
{"pair_id":"BioInfer.d195.s0.p0","sentence":"Evidence for a conformational change in actin induced by @PROTEIN1$ (@PROTEIN2$) binding.","label":1}
{"pair_id":"BioInfer.d195.s0.p1","sentence":"Evidence for a conformational change in @PROTEIN2$ induced by @PROTEIN1$ (N375) binding.","label":0}
{"pair_id":"BioInfer.d195.s0.p2","sentence":"Evidence for a conformational change in @PROTEIN2$ induced by fimbrin (@PROTEIN1$) binding.","label":1}
{"pair_id":"AIMed.d153.s1306.p0","sentence":"These data suggest that @PROTEIN1$ on the cell surface is involved in an important immunoregulatory mechanism by which released @PROTEIN2$ binds to cell surface CD26, and this complex is capable of reducing the local concentration of adenosine.","label":0}
{"pair_id":"AIMed.d153.s1306.p1","sentence":"These data suggest that @PROTEIN1$ on the cell surface is involved in an important immunoregulatory mechanism by which released ADA binds to cell surface @PROTEIN2$, and this complex is capable of reducing the local concentration of adenosine.","label":0}
{"pair_id":"AIMed.d153.s1306.p2","sentence":"These data suggest that ADA on the cell surface is involved in an important immunoregulatory mechanism by which released @PROTEIN1$ binds to cell surface @PROTEIN2$, and this complex is capable of reducing the local concentration of adenosine.","label":1}
{"pair_id":"AIMed.d143.s1211.p0","sentence":"We next tested whether @PROTEIN1$ induced signaling can be inhibited by anti-@PROTEIN2$ antibodies which blocked IL-6-mediated functions.","label":0}
{"pair_id":"AIMed.d143.s1211.p1","sentence":"We next tested whether @PROTEIN1$ induced signaling can be inhibited by anti-gp130 antibodies which blocked @PROTEIN2$-mediated functions.","label":0}
{"pair_id":"AIMed.d143.s1211.p2","sentence":"We next tested whether IL-11 induced signaling can be inhibited by anti-@PROTEIN1$ antibodies which blocked @PROTEIN2$-mediated functions.","label":0}
{"pair_id":"BioInfer.d157.s0.p0","sentence":"Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV @PROTEIN1$ complex (UL5, UL8, UL52) and the major DNA-binding protein (@PROTEIN2$), was already sufficient to mediate the helper effect.","label":0}
{"pair_id":"BioInfer.d157.s0.p1","sentence":"Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV @PROTEIN1$ complex (UL5, UL8, @PROTEIN2$) and the major DNA-binding protein (UL29), was already sufficient to mediate the helper effect.","label":1}
{"pair_id":"BioInfer.d157.s0.p2","sentence":"Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV @PROTEIN1$ complex (UL5, UL8, UL52) and the @PROTEIN2$ (UL29), was already sufficient to mediate the helper effect.","label":0}
{"pair_id":"BioInfer.d157.s0.p3","sentence":"Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV @PROTEIN1$ complex (@PROTEIN2$, UL8, UL52) and the major DNA-binding protein (UL29), was already sufficient to mediate the helper effect.","label":1}
{"pair_id":"BioInfer.d157.s0.p4","sentence":"Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV @PROTEIN1$ complex (UL5, @PROTEIN2$, UL52) and the major DNA-binding protein (UL29), was already sufficient to mediate the helper effect.","label":1}
{"pair_id":"BioInfer.d157.s0.p5","sentence":"Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV helicase-primase complex (UL5, UL8, @PROTEIN2$) and the major DNA-binding protein (@PROTEIN1$), was already sufficient to mediate the helper effect.","label":0}
{"pair_id":"BioInfer.d157.s0.p6","sentence":"Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV helicase-primase complex (UL5, UL8, UL52) and the @PROTEIN2$ (@PROTEIN1$), was already sufficient to mediate the helper effect.","label":0}
{"pair_id":"BioInfer.d157.s0.p7","sentence":"Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV helicase-primase complex (@PROTEIN2$, UL8, UL52) and the major DNA-binding protein (@PROTEIN1$), was already sufficient to mediate the helper effect.","label":0}
{"pair_id":"BioInfer.d157.s0.p8","sentence":"Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV helicase-primase complex (UL5, @PROTEIN2$, UL52) and the major DNA-binding protein (@PROTEIN1$), was already sufficient to mediate the helper effect.","label":0}
{"pair_id":"BioInfer.d157.s0.p9","sentence":"Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV helicase-primase complex (UL5, UL8, @PROTEIN1$) and the @PROTEIN2$ (UL29), was already sufficient to mediate the helper effect.","label":0}
{"pair_id":"BioInfer.d157.s0.p10","sentence":"Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV helicase-primase complex (@PROTEIN2$, UL8, @PROTEIN1$) and the major DNA-binding protein (UL29), was already sufficient to mediate the helper effect.","label":1}
{"pair_id":"BioInfer.d157.s0.p11","sentence":"Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV helicase-primase complex (UL5, @PROTEIN2$, @PROTEIN1$) and the major DNA-binding protein (UL29), was already sufficient to mediate the helper effect.","label":1}
{"pair_id":"BioInfer.d157.s0.p12","sentence":"Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV helicase-primase complex (@PROTEIN2$, UL8, UL52) and the @PROTEIN1$ (UL29), was already sufficient to mediate the helper effect.","label":0}
{"pair_id":"BioInfer.d157.s0.p13","sentence":"Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV helicase-primase complex (UL5, @PROTEIN2$, UL52) and the @PROTEIN1$ (UL29), was already sufficient to mediate the helper effect.","label":0}
{"pair_id":"BioInfer.d157.s0.p14","sentence":"Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV helicase-primase complex (@PROTEIN1$, @PROTEIN2$, UL52) and the major DNA-binding protein (UL29), was already sufficient to mediate the helper effect.","label":1}
{"pair_id":"AIMed.d65.s554.p0","sentence":"Cross-family dimerization of transcription factors @PROTEIN1$\/@PROTEIN2$ and ATF\/CREB alters DNA binding specificity.","label":1}
{"pair_id":"AIMed.d65.s554.p1","sentence":"Cross-family dimerization of transcription factors @PROTEIN1$\/Jun and @PROTEIN2$\/CREB alters DNA binding specificity.","label":0}
{"pair_id":"AIMed.d65.s554.p2","sentence":"Cross-family dimerization of transcription factors @PROTEIN1$\/Jun and ATF\/@PROTEIN2$ alters DNA binding specificity.","label":0}
{"pair_id":"AIMed.d65.s554.p3","sentence":"Cross-family dimerization of transcription factors Fos\/@PROTEIN1$ and @PROTEIN2$\/CREB alters DNA binding specificity.","label":0}
{"pair_id":"AIMed.d65.s554.p4","sentence":"Cross-family dimerization of transcription factors Fos\/@PROTEIN1$ and ATF\/@PROTEIN2$ alters DNA binding specificity.","label":0}
{"pair_id":"AIMed.d65.s554.p5","sentence":"Cross-family dimerization of transcription factors Fos\/Jun and @PROTEIN1$\/@PROTEIN2$ alters DNA binding specificity.","label":1}
{"pair_id":"AIMed.d135.s1150.p0","sentence":"A receptor specific for human @PROTEIN1$ was identified, which suggests that cell surface LT may have functions that are distinct from those of secreted @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d54.s479.p0","sentence":"Analysis of @PROTEIN1$ in vivo in a diabetic mouse model of delayed wound healing showed that @PROTEIN2$ significantly enhanced repair of a full-thickness skin excision.","label":0}
{"pair_id":"BioInfer.d722.s0.p0","sentence":"The Src homology domain 3 (SH3) of a yeast type I myosin, @PROTEIN2$, binds to @PROTEIN1$ and is required for targeting to sites of actin polarization.","label":1}
{"pair_id":"BioInfer.d722.s0.p1","sentence":"The Src homology domain 3 (SH3) of a yeast @PROTEIN2$, Myo5p, binds to @PROTEIN1$ and is required for targeting to sites of actin polarization.","label":0}
{"pair_id":"BioInfer.d722.s0.p2","sentence":"The Src homology domain 3 (SH3) of a yeast type I myosin, Myo5p, binds to @PROTEIN1$ and is required for targeting to sites of @PROTEIN2$ polarization.","label":0}
{"pair_id":"BioInfer.d722.s0.p3","sentence":"The @PROTEIN2$ homology domain 3 (SH3) of a yeast type I myosin, Myo5p, binds to @PROTEIN1$ and is required for targeting to sites of actin polarization.","label":0}
{"pair_id":"BioInfer.d722.s0.p4","sentence":"The Src homology domain 3 (SH3) of a yeast @PROTEIN2$, @PROTEIN1$, binds to verprolin and is required for targeting to sites of actin polarization.","label":1}
{"pair_id":"BioInfer.d722.s0.p5","sentence":"The Src homology domain 3 (SH3) of a yeast type I myosin, @PROTEIN1$, binds to verprolin and is required for targeting to sites of @PROTEIN2$ polarization.","label":0}
{"pair_id":"BioInfer.d722.s0.p6","sentence":"The @PROTEIN2$ homology domain 3 (SH3) of a yeast type I myosin, @PROTEIN1$, binds to verprolin and is required for targeting to sites of actin polarization.","label":1}
{"pair_id":"BioInfer.d722.s0.p7","sentence":"The Src homology domain 3 (SH3) of a yeast @PROTEIN1$, Myo5p, binds to verprolin and is required for targeting to sites of @PROTEIN2$ polarization.","label":0}
{"pair_id":"BioInfer.d722.s0.p8","sentence":"The @PROTEIN2$ homology domain 3 (SH3) of a yeast @PROTEIN1$, Myo5p, binds to verprolin and is required for targeting to sites of actin polarization.","label":0}
{"pair_id":"BioInfer.d722.s0.p9","sentence":"The @PROTEIN2$ homology domain 3 (SH3) of a yeast type I myosin, Myo5p, binds to verprolin and is required for targeting to sites of @PROTEIN1$ polarization.","label":0}
{"pair_id":"BioInfer.d498.s0.p0","sentence":"Profilins also bind polyphosphoinositides, which can disrupt the @PROTEIN2$-@PROTEIN1$ complex, and proline-rich ligands which localize profilin to sites requiring extensive actin filament accumulation.","label":1}
{"pair_id":"BioInfer.d498.s0.p1","sentence":"Profilins also bind polyphosphoinositides, which can disrupt the profilin-@PROTEIN1$ complex, and proline-rich ligands which localize profilin to sites requiring extensive @PROTEIN2$ filament accumulation.","label":0}
{"pair_id":"BioInfer.d498.s0.p2","sentence":"@PROTEIN2$ also bind polyphosphoinositides, which can disrupt the profilin-@PROTEIN1$ complex, and proline-rich ligands which localize profilin to sites requiring extensive actin filament accumulation.","label":1}
{"pair_id":"BioInfer.d498.s0.p3","sentence":"Profilins also bind polyphosphoinositides, which can disrupt the profilin-@PROTEIN1$ complex, and proline-rich ligands which localize @PROTEIN2$ to sites requiring extensive actin filament accumulation.","label":0}
{"pair_id":"BioInfer.d498.s0.p4","sentence":"Profilins also bind polyphosphoinositides, which can disrupt the @PROTEIN1$-actin complex, and proline-rich ligands which localize profilin to sites requiring extensive @PROTEIN2$ filament accumulation.","label":0}
{"pair_id":"BioInfer.d498.s0.p5","sentence":"@PROTEIN2$ also bind polyphosphoinositides, which can disrupt the @PROTEIN1$-actin complex, and proline-rich ligands which localize profilin to sites requiring extensive actin filament accumulation.","label":1}
{"pair_id":"BioInfer.d498.s0.p6","sentence":"Profilins also bind polyphosphoinositides, which can disrupt the @PROTEIN1$-actin complex, and proline-rich ligands which localize @PROTEIN2$ to sites requiring extensive actin filament accumulation.","label":0}
{"pair_id":"BioInfer.d498.s0.p7","sentence":"@PROTEIN2$ also bind polyphosphoinositides, which can disrupt the profilin-actin complex, and proline-rich ligands which localize profilin to sites requiring extensive @PROTEIN1$ filament accumulation.","label":0}
{"pair_id":"BioInfer.d498.s0.p8","sentence":"Profilins also bind polyphosphoinositides, which can disrupt the profilin-actin complex, and proline-rich ligands which localize @PROTEIN2$ to sites requiring extensive @PROTEIN1$ filament accumulation.","label":0}
{"pair_id":"BioInfer.d498.s0.p9","sentence":"@PROTEIN1$ also bind polyphosphoinositides, which can disrupt the profilin-actin complex, and proline-rich ligands which localize @PROTEIN2$ to sites requiring extensive actin filament accumulation.","label":0}
{"pair_id":"AIMed.d105.s889.p0","sentence":"We demonstrate here that both the site 2 and site 3 @PROTEIN1$ variants complexed with @PROTEIN2$ bind a single gp130 molecule but are unable to dimerize it, whereas the combined site 2\/3 variants lose the ability to interact with gp130.","label":1}
{"pair_id":"AIMed.d105.s889.p1","sentence":"We demonstrate here that both the site 2 and site 3 @PROTEIN1$ variants complexed with IL-6R alpha bind a single @PROTEIN2$ molecule but are unable to dimerize it, whereas the combined site 2\/3 variants lose the ability to interact with gp130.","label":1}
{"pair_id":"AIMed.d105.s889.p2","sentence":"We demonstrate here that both the site 2 and site 3 @PROTEIN1$ variants complexed with IL-6R alpha bind a single gp130 molecule but are unable to dimerize it, whereas the combined site 2\/3 variants lose the ability to interact with @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d105.s889.p3","sentence":"We demonstrate here that both the site 2 and site 3 IL-6 variants complexed with @PROTEIN1$ bind a single @PROTEIN2$ molecule but are unable to dimerize it, whereas the combined site 2\/3 variants lose the ability to interact with gp130.","label":1}
{"pair_id":"AIMed.d105.s889.p4","sentence":"We demonstrate here that both the site 2 and site 3 IL-6 variants complexed with @PROTEIN1$ bind a single gp130 molecule but are unable to dimerize it, whereas the combined site 2\/3 variants lose the ability to interact with @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d105.s889.p5","sentence":"We demonstrate here that both the site 2 and site 3 IL-6 variants complexed with IL-6R alpha bind a single @PROTEIN1$ molecule but are unable to dimerize it, whereas the combined site 2\/3 variants lose the ability to interact with @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d542.s0.p0","sentence":"Since @PROTEIN2$ is a recombinational protein associated with @PROTEIN1$, this is the first genetic evidence that cancer arises from a defect in repair processes involving homologous recombination.","label":1}
{"pair_id":"AIMed.d163.s1374.p0","sentence":"A protein, @PROTEIN1$ (@PROTEIN2$), was identified in a human cell line that bound to a region of the epidermal growth factor receptor (EGFR) containing the lysosomal targeting code.","label":0}
{"pair_id":"AIMed.d163.s1374.p1","sentence":"A protein, @PROTEIN1$ (SNX1), was identified in a human cell line that bound to a region of the @PROTEIN2$ (EGFR) containing the lysosomal targeting code.","label":1}
{"pair_id":"AIMed.d163.s1374.p2","sentence":"A protein, @PROTEIN1$ (SNX1), was identified in a human cell line that bound to a region of the epidermal growth factor receptor (@PROTEIN2$) containing the lysosomal targeting code.","label":1}
{"pair_id":"AIMed.d163.s1374.p3","sentence":"A protein, sorting nexin-1 (@PROTEIN1$), was identified in a human cell line that bound to a region of the @PROTEIN2$ (EGFR) containing the lysosomal targeting code.","label":1}
{"pair_id":"AIMed.d163.s1374.p4","sentence":"A protein, sorting nexin-1 (@PROTEIN1$), was identified in a human cell line that bound to a region of the epidermal growth factor receptor (@PROTEIN2$) containing the lysosomal targeting code.","label":1}
{"pair_id":"AIMed.d163.s1374.p5","sentence":"A protein, sorting nexin-1 (SNX1), was identified in a human cell line that bound to a region of the @PROTEIN1$ (@PROTEIN2$) containing the lysosomal targeting code.","label":0}
{"pair_id":"AIMed.d174.s1467.p0","sentence":"The high affinity @PROTEIN1$ (@PROTEIN2$) signaling complex consists of IL-6 and two membrane-associated receptor components: a low affinity but specific IL-6 receptor and the affinity converter\/signal transducing protein gp130.","label":0}
{"pair_id":"AIMed.d174.s1467.p1","sentence":"The high affinity @PROTEIN1$ (IL-6) signaling complex consists of @PROTEIN2$ and two membrane-associated receptor components: a low affinity but specific IL-6 receptor and the affinity converter\/signal transducing protein gp130.","label":0}
{"pair_id":"AIMed.d174.s1467.p2","sentence":"The high affinity @PROTEIN1$ (IL-6) signaling complex consists of IL-6 and two membrane-associated receptor components: a low affinity but specific @PROTEIN2$ receptor and the affinity converter\/signal transducing protein gp130.","label":0}
{"pair_id":"AIMed.d174.s1467.p3","sentence":"The high affinity @PROTEIN1$ (IL-6) signaling complex consists of IL-6 and two membrane-associated receptor components: a low affinity but specific @PROTEIN2$ and the affinity converter\/signal transducing protein gp130.","label":0}
{"pair_id":"AIMed.d174.s1467.p4","sentence":"The high affinity @PROTEIN1$ (IL-6) signaling complex consists of IL-6 and two membrane-associated receptor components: a low affinity but specific IL-6 receptor and the affinity converter\/signal transducing protein @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d174.s1467.p5","sentence":"The high affinity interleukin-6 (@PROTEIN1$) signaling complex consists of @PROTEIN2$ and two membrane-associated receptor components: a low affinity but specific IL-6 receptor and the affinity converter\/signal transducing protein gp130.","label":0}
{"pair_id":"AIMed.d174.s1467.p6","sentence":"The high affinity interleukin-6 (@PROTEIN1$) signaling complex consists of IL-6 and two membrane-associated receptor components: a low affinity but specific @PROTEIN2$ receptor and the affinity converter\/signal transducing protein gp130.","label":0}
{"pair_id":"AIMed.d174.s1467.p7","sentence":"The high affinity interleukin-6 (@PROTEIN1$) signaling complex consists of IL-6 and two membrane-associated receptor components: a low affinity but specific @PROTEIN2$ and the affinity converter\/signal transducing protein gp130.","label":0}
{"pair_id":"AIMed.d174.s1467.p8","sentence":"The high affinity interleukin-6 (@PROTEIN1$) signaling complex consists of IL-6 and two membrane-associated receptor components: a low affinity but specific IL-6 receptor and the affinity converter\/signal transducing protein @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d174.s1467.p9","sentence":"The high affinity interleukin-6 (IL-6) signaling complex consists of @PROTEIN1$ and two membrane-associated receptor components: a low affinity but specific @PROTEIN2$ receptor and the affinity converter\/signal transducing protein gp130.","label":0}
{"pair_id":"AIMed.d174.s1467.p10","sentence":"The high affinity interleukin-6 (IL-6) signaling complex consists of @PROTEIN1$ and two membrane-associated receptor components: a low affinity but specific @PROTEIN2$ and the affinity converter\/signal transducing protein gp130.","label":1}
{"pair_id":"AIMed.d174.s1467.p11","sentence":"The high affinity interleukin-6 (IL-6) signaling complex consists of @PROTEIN1$ and two membrane-associated receptor components: a low affinity but specific IL-6 receptor and the affinity converter\/signal transducing protein @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d174.s1467.p12","sentence":"The high affinity interleukin-6 (IL-6) signaling complex consists of IL-6 and two membrane-associated receptor components: a low affinity but specific @PROTEIN1$@PROTEIN2$ and the affinity converter\/signal transducing protein gp130.","label":0}
{"pair_id":"AIMed.d174.s1467.p13","sentence":"The high affinity interleukin-6 (IL-6) signaling complex consists of IL-6 and two membrane-associated receptor components: a low affinity but specific @PROTEIN1$ receptor and the affinity converter\/signal transducing protein @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d174.s1467.p14","sentence":"The high affinity interleukin-6 (IL-6) signaling complex consists of IL-6 and two membrane-associated receptor components: a low affinity but specific @PROTEIN1$ and the affinity converter\/signal transducing protein @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d575.s1.p0","sentence":"The @PROTEIN2$ protein and @PROTEIN1$ form similar but independent complexes with alpha-catenin, beta-catenin, and plakoglobin.","label":1}
{"pair_id":"BioInfer.d575.s1.p1","sentence":"The APC protein and @PROTEIN1$ form similar but independent complexes with alpha-catenin, beta-catenin, and @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d575.s1.p2","sentence":"The APC protein and @PROTEIN1$ form similar but independent complexes with @PROTEIN2$, beta-catenin, and plakoglobin.","label":1}
{"pair_id":"BioInfer.d575.s1.p3","sentence":"The APC protein and @PROTEIN1$ form similar but independent complexes with alpha-catenin, @PROTEIN2$, and plakoglobin.","label":1}
{"pair_id":"BioInfer.d575.s1.p4","sentence":"The @PROTEIN1$ protein and E-cadherin form similar but independent complexes with alpha-catenin, beta-catenin, and @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d575.s1.p5","sentence":"The @PROTEIN1$ protein and E-cadherin form similar but independent complexes with @PROTEIN2$, beta-catenin, and plakoglobin.","label":1}
{"pair_id":"BioInfer.d575.s1.p6","sentence":"The @PROTEIN1$ protein and E-cadherin form similar but independent complexes with alpha-catenin, @PROTEIN2$, and plakoglobin.","label":1}
{"pair_id":"BioInfer.d575.s1.p7","sentence":"The APC protein and E-cadherin form similar but independent complexes with @PROTEIN2$, beta-catenin, and @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d575.s1.p8","sentence":"The APC protein and E-cadherin form similar but independent complexes with alpha-catenin, @PROTEIN2$, and @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d575.s1.p9","sentence":"The APC protein and E-cadherin form similar but independent complexes with @PROTEIN1$, @PROTEIN2$, and plakoglobin.","label":1}
{"pair_id":"BioInfer.d287.s0.p0","sentence":"Immunocytochemical localisation of @PROTEIN1$ and @PROTEIN2$ in the generative cell of angiosperm pollen: TEM studies on high-pressure frozen and freeze-substituted Ledebouria socialis Roth (Hyacinthaceae).","label":0}
{"pair_id":"BioInfer.d279.s0.p0","sentence":"However, upon treatment with DMSO, cytoplasmic actin filaments were disrupted and intranuclear rod structures containing @PROTEIN2$ and actin were apparently larger and thicker in cells overexpressing @PROTEIN1$ than in normal cells.","label":0}
{"pair_id":"BioInfer.d279.s0.p1","sentence":"However, upon treatment with DMSO, cytoplasmic actin filaments were disrupted and intranuclear rod structures containing cofilin and @PROTEIN2$ were apparently larger and thicker in cells overexpressing @PROTEIN1$ than in normal cells.","label":0}
{"pair_id":"BioInfer.d279.s0.p2","sentence":"However, upon treatment with DMSO, cytoplasmic @PROTEIN2$ filaments were disrupted and intranuclear rod structures containing cofilin and actin were apparently larger and thicker in cells overexpressing @PROTEIN1$ than in normal cells.","label":0}
{"pair_id":"BioInfer.d279.s0.p3","sentence":"However, upon treatment with DMSO, cytoplasmic actin filaments were disrupted and intranuclear rod structures containing @PROTEIN1$ and @PROTEIN2$ were apparently larger and thicker in cells overexpressing cofilin than in normal cells.","label":1}
{"pair_id":"BioInfer.d279.s0.p4","sentence":"However, upon treatment with DMSO, cytoplasmic @PROTEIN2$ filaments were disrupted and intranuclear rod structures containing @PROTEIN1$ and actin were apparently larger and thicker in cells overexpressing cofilin than in normal cells.","label":0}
{"pair_id":"BioInfer.d279.s0.p5","sentence":"However, upon treatment with DMSO, cytoplasmic @PROTEIN2$ filaments were disrupted and intranuclear rod structures containing cofilin and @PROTEIN1$ were apparently larger and thicker in cells overexpressing cofilin than in normal cells.","label":0}
{"pair_id":"BioInfer.d456.s0.p0","sentence":"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of @PROTEIN1$ (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and @PROTEIN2$ expression, and to determine which receptors mediate these effects.","label":1}
{"pair_id":"BioInfer.d456.s0.p1","sentence":"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding @PROTEIN2$ can mimic the effects of @PROTEIN1$ (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.","label":0}
{"pair_id":"BioInfer.d456.s0.p2","sentence":"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of @PROTEIN1$ (OSM) in acting synergistically with @PROTEIN2$ (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.","label":1}
{"pair_id":"BioInfer.d456.s0.p3","sentence":"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of @PROTEIN1$ (OSM) in acting synergistically with interleukin-1alpha (@PROTEIN2$) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.","label":1}
{"pair_id":"BioInfer.d456.s0.p4","sentence":"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of @PROTEIN1$ (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage @PROTEIN2$ breakdown and collagenase expression, and to determine which receptors mediate these effects.","label":1}
{"pair_id":"BioInfer.d456.s0.p5","sentence":"OBJECTIVE: To determine whether other @PROTEIN2$ (gp130) binding cytokines can mimic the effects of @PROTEIN1$ (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.","label":0}
{"pair_id":"BioInfer.d456.s0.p6","sentence":"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of @PROTEIN1$ (@PROTEIN2$) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.","label":0}
{"pair_id":"BioInfer.d456.s0.p7","sentence":"OBJECTIVE: To determine whether other glycoprotein 130 (@PROTEIN2$) binding cytokines can mimic the effects of @PROTEIN1$ (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.","label":0}
{"pair_id":"BioInfer.d456.s0.p8","sentence":"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding @PROTEIN2$ can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and @PROTEIN1$ expression, and to determine which receptors mediate these effects.","label":1}
{"pair_id":"BioInfer.d456.s0.p9","sentence":"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with @PROTEIN2$ (IL-1alpha) to induce cartilage collagen breakdown and @PROTEIN1$ expression, and to determine which receptors mediate these effects.","label":1}
{"pair_id":"BioInfer.d456.s0.p10","sentence":"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (@PROTEIN2$) to induce cartilage collagen breakdown and @PROTEIN1$ expression, and to determine which receptors mediate these effects.","label":1}
{"pair_id":"BioInfer.d456.s0.p11","sentence":"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage @PROTEIN2$ breakdown and @PROTEIN1$ expression, and to determine which receptors mediate these effects.","label":0}
{"pair_id":"BioInfer.d456.s0.p12","sentence":"OBJECTIVE: To determine whether other @PROTEIN2$ (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and @PROTEIN1$ expression, and to determine which receptors mediate these effects.","label":0}
{"pair_id":"BioInfer.d456.s0.p13","sentence":"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (@PROTEIN2$) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and @PROTEIN1$ expression, and to determine which receptors mediate these effects.","label":1}
{"pair_id":"BioInfer.d456.s0.p14","sentence":"OBJECTIVE: To determine whether other glycoprotein 130 (@PROTEIN2$) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and @PROTEIN1$ expression, and to determine which receptors mediate these effects.","label":0}
{"pair_id":"BioInfer.d456.s0.p15","sentence":"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding @PROTEIN1$ can mimic the effects of oncostatin M (OSM) in acting synergistically with @PROTEIN2$ (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.","label":1}
{"pair_id":"BioInfer.d456.s0.p16","sentence":"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding @PROTEIN1$ can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (@PROTEIN2$) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.","label":1}
{"pair_id":"BioInfer.d456.s0.p17","sentence":"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding @PROTEIN1$ can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage @PROTEIN2$ breakdown and collagenase expression, and to determine which receptors mediate these effects.","label":1}
{"pair_id":"BioInfer.d456.s0.p18","sentence":"OBJECTIVE: To determine whether other @PROTEIN2$ (gp130) binding @PROTEIN1$ can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.","label":1}
{"pair_id":"BioInfer.d456.s0.p19","sentence":"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding @PROTEIN1$ can mimic the effects of oncostatin M (@PROTEIN2$) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.","label":0}
{"pair_id":"BioInfer.d456.s0.p20","sentence":"OBJECTIVE: To determine whether other glycoprotein 130 (@PROTEIN2$) binding @PROTEIN1$ can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.","label":1}
{"pair_id":"BioInfer.d456.s0.p21","sentence":"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with @PROTEIN1$ (@PROTEIN2$) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.","label":0}
{"pair_id":"BioInfer.d456.s0.p22","sentence":"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with @PROTEIN1$ (IL-1alpha) to induce cartilage @PROTEIN2$ breakdown and collagenase expression, and to determine which receptors mediate these effects.","label":1}
{"pair_id":"BioInfer.d456.s0.p23","sentence":"OBJECTIVE: To determine whether other @PROTEIN2$ (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with @PROTEIN1$ (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.","label":0}
{"pair_id":"BioInfer.d456.s0.p24","sentence":"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (@PROTEIN2$) in acting synergistically with @PROTEIN1$ (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.","label":1}
{"pair_id":"BioInfer.d456.s0.p25","sentence":"OBJECTIVE: To determine whether other glycoprotein 130 (@PROTEIN2$) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with @PROTEIN1$ (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.","label":0}
{"pair_id":"BioInfer.d456.s0.p26","sentence":"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (@PROTEIN1$) to induce cartilage @PROTEIN2$ breakdown and collagenase expression, and to determine which receptors mediate these effects.","label":1}
{"pair_id":"BioInfer.d456.s0.p27","sentence":"OBJECTIVE: To determine whether other @PROTEIN2$ (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (@PROTEIN1$) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.","label":0}
{"pair_id":"BioInfer.d456.s0.p28","sentence":"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (@PROTEIN2$) in acting synergistically with interleukin-1alpha (@PROTEIN1$) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.","label":1}
{"pair_id":"BioInfer.d456.s0.p29","sentence":"OBJECTIVE: To determine whether other glycoprotein 130 (@PROTEIN2$) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (@PROTEIN1$) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.","label":0}
{"pair_id":"BioInfer.d456.s0.p30","sentence":"OBJECTIVE: To determine whether other @PROTEIN2$ (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage @PROTEIN1$ breakdown and collagenase expression, and to determine which receptors mediate these effects.","label":0}
{"pair_id":"BioInfer.d456.s0.p31","sentence":"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (@PROTEIN2$) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage @PROTEIN1$ breakdown and collagenase expression, and to determine which receptors mediate these effects.","label":1}
{"pair_id":"BioInfer.d456.s0.p32","sentence":"OBJECTIVE: To determine whether other glycoprotein 130 (@PROTEIN2$) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage @PROTEIN1$ breakdown and collagenase expression, and to determine which receptors mediate these effects.","label":0}
{"pair_id":"BioInfer.d456.s0.p33","sentence":"OBJECTIVE: To determine whether other @PROTEIN1$ (gp130) binding cytokines can mimic the effects of oncostatin M (@PROTEIN2$) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.","label":0}
{"pair_id":"BioInfer.d456.s0.p34","sentence":"OBJECTIVE: To determine whether other @PROTEIN1$ (@PROTEIN2$) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.","label":0}
{"pair_id":"BioInfer.d456.s0.p35","sentence":"OBJECTIVE: To determine whether other glycoprotein 130 (@PROTEIN2$) binding cytokines can mimic the effects of oncostatin M (@PROTEIN1$) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.","label":0}
{"pair_id":"AIMed.d142.s1201.p0","sentence":"We found that @PROTEIN1$ and @PROTEIN2$ can form a physical complex.","label":1}
{"pair_id":"BioInfer.d218.s0.p0","sentence":"From these observations it is concluded that (i) @PROTEIN1$ is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that @PROTEIN2$ and RAD52 have different functions, or that RAD52 has functions in addition to those of the Rad51\/Rad52 protein complex.","label":0}
{"pair_id":"BioInfer.d218.s0.p1","sentence":"From these observations it is concluded that (i) @PROTEIN1$ is required for high levels of both gene conversions and reciprocal crossovers, (ii) that @PROTEIN2$ is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that RAD52 has functions in addition to those of the Rad51\/Rad52 protein complex.","label":0}
{"pair_id":"BioInfer.d218.s0.p2","sentence":"From these observations it is concluded that (i) @PROTEIN1$ is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and @PROTEIN2$ have different functions, or that RAD52 has functions in addition to those of the Rad51\/Rad52 protein complex.","label":0}
{"pair_id":"BioInfer.d218.s0.p3","sentence":"From these observations it is concluded that (i) @PROTEIN1$ is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that RAD52 has functions in addition to those of the Rad51\/@PROTEIN2$ protein complex.","label":0}
{"pair_id":"BioInfer.d218.s0.p4","sentence":"From these observations it is concluded that (i) @PROTEIN1$ is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that @PROTEIN2$ has functions in addition to those of the Rad51\/Rad52 protein complex.","label":0}
{"pair_id":"BioInfer.d218.s0.p5","sentence":"From these observations it is concluded that (i) @PROTEIN1$ is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that RAD52 has functions in addition to those of the @PROTEIN2$\/Rad52 protein complex.","label":0}
{"pair_id":"BioInfer.d218.s0.p6","sentence":"From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that @PROTEIN2$ is not required for intrachromosomal crossovers, and (iii) that @PROTEIN1$ and RAD52 have different functions, or that RAD52 has functions in addition to those of the Rad51\/Rad52 protein complex.","label":0}
{"pair_id":"BioInfer.d218.s0.p7","sentence":"From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that @PROTEIN1$ and @PROTEIN2$ have different functions, or that RAD52 has functions in addition to those of the Rad51\/Rad52 protein complex.","label":1}
{"pair_id":"BioInfer.d218.s0.p8","sentence":"From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that @PROTEIN1$ and RAD52 have different functions, or that RAD52 has functions in addition to those of the Rad51\/@PROTEIN2$ protein complex.","label":0}
{"pair_id":"BioInfer.d218.s0.p9","sentence":"From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that @PROTEIN1$ and RAD52 have different functions, or that @PROTEIN2$ has functions in addition to those of the Rad51\/Rad52 protein complex.","label":0}
{"pair_id":"BioInfer.d218.s0.p10","sentence":"From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that @PROTEIN1$ and RAD52 have different functions, or that RAD52 has functions in addition to those of the @PROTEIN2$\/Rad52 protein complex.","label":0}
{"pair_id":"BioInfer.d218.s0.p11","sentence":"From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that @PROTEIN1$ is not required for intrachromosomal crossovers, and (iii) that RAD51 and @PROTEIN2$ have different functions, or that RAD52 has functions in addition to those of the Rad51\/Rad52 protein complex.","label":0}
{"pair_id":"BioInfer.d218.s0.p12","sentence":"From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that @PROTEIN1$ is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that RAD52 has functions in addition to those of the Rad51\/@PROTEIN2$ protein complex.","label":0}
{"pair_id":"BioInfer.d218.s0.p13","sentence":"From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that @PROTEIN1$ is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that @PROTEIN2$ has functions in addition to those of the Rad51\/Rad52 protein complex.","label":0}
{"pair_id":"BioInfer.d218.s0.p14","sentence":"From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that @PROTEIN1$ is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that RAD52 has functions in addition to those of the @PROTEIN2$\/Rad52 protein complex.","label":0}
{"pair_id":"BioInfer.d218.s0.p15","sentence":"From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and @PROTEIN1$ have different functions, or that RAD52 has functions in addition to those of the Rad51\/@PROTEIN2$ protein complex.","label":0}
{"pair_id":"BioInfer.d218.s0.p16","sentence":"From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and @PROTEIN1$ have different functions, or that @PROTEIN2$ has functions in addition to those of the Rad51\/Rad52 protein complex.","label":0}
{"pair_id":"BioInfer.d218.s0.p17","sentence":"From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and @PROTEIN1$ have different functions, or that RAD52 has functions in addition to those of the @PROTEIN2$\/Rad52 protein complex.","label":0}
{"pair_id":"BioInfer.d218.s0.p18","sentence":"From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that @PROTEIN2$ has functions in addition to those of the Rad51\/@PROTEIN1$ protein complex.","label":0}
{"pair_id":"BioInfer.d218.s0.p19","sentence":"From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that RAD52 has functions in addition to those of the @PROTEIN2$\/@PROTEIN1$ protein complex.","label":1}
{"pair_id":"BioInfer.d218.s0.p20","sentence":"From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that @PROTEIN1$ has functions in addition to those of the @PROTEIN2$\/Rad52 protein complex.","label":0}
{"pair_id":"BioInfer.d576.s0.p0","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, @PROTEIN1$, and @PROTEIN2$ (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p1","sentence":"The @PROTEIN2$\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, @PROTEIN1$, and p14 (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p2","sentence":"The @PROTEIN2$2\/@PROTEIN2$ complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, @PROTEIN1$, and p14 (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p3","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, @PROTEIN2$, p19, @PROTEIN1$, and p14 (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p4","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and @PROTEIN2$; and five apparently novel proteins, p40, p35, p19, @PROTEIN1$, and p14 (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p5","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, @PROTEIN2$, p35, p19, @PROTEIN1$, and p14 (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p6","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two @PROTEIN2$-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, @PROTEIN1$, and p14 (Machesky et al., 1994).","label":0}
{"pair_id":"BioInfer.d576.s0.p7","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on @PROTEIN2$, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, @PROTEIN1$, and p14 (Machesky et al., 1994).","label":0}
{"pair_id":"BioInfer.d576.s0.p8","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, @PROTEIN2$, @PROTEIN1$, and p14 (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p9","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, @PROTEIN2$ and Arp3; and five apparently novel proteins, p40, p35, p19, @PROTEIN1$, and p14 (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p10","sentence":"The @PROTEIN2$\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and @PROTEIN1$ (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p11","sentence":"The @PROTEIN2$2\/@PROTEIN2$ complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and @PROTEIN1$ (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p12","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, @PROTEIN2$, p19, p18, and @PROTEIN1$ (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p13","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and @PROTEIN2$; and five apparently novel proteins, p40, p35, p19, p18, and @PROTEIN1$ (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p14","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, @PROTEIN2$, p35, p19, p18, and @PROTEIN1$ (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p15","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two @PROTEIN2$-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and @PROTEIN1$ (Machesky et al., 1994).","label":0}
{"pair_id":"BioInfer.d576.s0.p16","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on @PROTEIN2$, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and @PROTEIN1$ (Machesky et al., 1994).","label":0}
{"pair_id":"BioInfer.d576.s0.p17","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, @PROTEIN2$, p18, and @PROTEIN1$ (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p18","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, @PROTEIN2$ and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and @PROTEIN1$ (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p19","sentence":"The @PROTEIN1$@PROTEIN2$2\/@PROTEIN2$ complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p20","sentence":"The @PROTEIN1$\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, @PROTEIN2$, p19, p18, and p14 (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p21","sentence":"The @PROTEIN1$\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and @PROTEIN2$; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p22","sentence":"The @PROTEIN1$\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, @PROTEIN2$, p35, p19, p18, and p14 (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p23","sentence":"The @PROTEIN1$\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two @PROTEIN2$-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).","label":0}
{"pair_id":"BioInfer.d576.s0.p24","sentence":"The @PROTEIN1$\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on @PROTEIN2$, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).","label":0}
{"pair_id":"BioInfer.d576.s0.p25","sentence":"The @PROTEIN1$\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, @PROTEIN2$, p18, and p14 (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p26","sentence":"The @PROTEIN1$\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, @PROTEIN2$ and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p27","sentence":"The @PROTEIN1$2\/@PROTEIN1$ complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, @PROTEIN2$, p19, p18, and p14 (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p28","sentence":"The @PROTEIN1$2\/@PROTEIN1$ complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and @PROTEIN2$; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p29","sentence":"The @PROTEIN1$2\/@PROTEIN1$ complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, @PROTEIN2$, p35, p19, p18, and p14 (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p30","sentence":"The @PROTEIN1$2\/@PROTEIN1$ complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two @PROTEIN2$-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).","label":0}
{"pair_id":"BioInfer.d576.s0.p31","sentence":"The @PROTEIN1$2\/@PROTEIN1$ complex, first isolated from Acanthamoeba castellani by affinity chromatography on @PROTEIN2$, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).","label":0}
{"pair_id":"BioInfer.d576.s0.p32","sentence":"The @PROTEIN1$2\/@PROTEIN1$ complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, @PROTEIN2$, p18, and p14 (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p33","sentence":"The @PROTEIN1$2\/@PROTEIN1$ complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, @PROTEIN2$ and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p34","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and @PROTEIN2$; and five apparently novel proteins, p40, @PROTEIN1$, p19, p18, and p14 (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p35","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, @PROTEIN2$, @PROTEIN1$, p19, p18, and p14 (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p36","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two @PROTEIN2$-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, @PROTEIN1$, p19, p18, and p14 (Machesky et al., 1994).","label":0}
{"pair_id":"BioInfer.d576.s0.p37","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on @PROTEIN2$, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, @PROTEIN1$, p19, p18, and p14 (Machesky et al., 1994).","label":0}
{"pair_id":"BioInfer.d576.s0.p38","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, @PROTEIN1$, @PROTEIN2$, p18, and p14 (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p39","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, @PROTEIN2$ and Arp3; and five apparently novel proteins, p40, @PROTEIN1$, p19, p18, and p14 (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p40","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and @PROTEIN1$; and five apparently novel proteins, @PROTEIN2$, p35, p19, p18, and p14 (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p41","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two @PROTEIN2$-related proteins, Arp2 and @PROTEIN1$; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p42","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on @PROTEIN2$, consists of seven polypeptides; two actin-related proteins, Arp2 and @PROTEIN1$; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).","label":0}
{"pair_id":"BioInfer.d576.s0.p43","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and @PROTEIN1$; and five apparently novel proteins, p40, p35, @PROTEIN2$, p18, and p14 (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p44","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, @PROTEIN2$ and @PROTEIN1$; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p45","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two @PROTEIN2$-related proteins, Arp2 and Arp3; and five apparently novel proteins, @PROTEIN1$, p35, p19, p18, and p14 (Machesky et al., 1994).","label":0}
{"pair_id":"BioInfer.d576.s0.p46","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on @PROTEIN2$, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, @PROTEIN1$, p35, p19, p18, and p14 (Machesky et al., 1994).","label":0}
{"pair_id":"BioInfer.d576.s0.p47","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, @PROTEIN1$, p35, @PROTEIN2$, p18, and p14 (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p48","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, @PROTEIN2$ and Arp3; and five apparently novel proteins, @PROTEIN1$, p35, p19, p18, and p14 (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p49","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on @PROTEIN2$, consists of seven polypeptides; two @PROTEIN1$-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).","label":0}
{"pair_id":"BioInfer.d576.s0.p50","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two @PROTEIN1$-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, @PROTEIN2$, p18, and p14 (Machesky et al., 1994).","label":0}
{"pair_id":"BioInfer.d576.s0.p51","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two @PROTEIN1$-related proteins, @PROTEIN2$ and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p52","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on @PROTEIN1$, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, @PROTEIN2$, p18, and p14 (Machesky et al., 1994).","label":0}
{"pair_id":"BioInfer.d576.s0.p53","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on @PROTEIN1$, consists of seven polypeptides; two actin-related proteins, @PROTEIN2$ and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).","label":0}
{"pair_id":"BioInfer.d576.s0.p54","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, @PROTEIN2$ and Arp3; and five apparently novel proteins, p40, p35, @PROTEIN1$, p18, and p14 (Machesky et al., 1994).","label":1}
{"pair_id":"AIMed.d146.s1243.p0","sentence":"Taken together these data suggest that the 76-kDa receptor is a novel high affinity @PROTEIN1$ that may be necessary for @PROTEIN2$ driven proliferation in human T cells.","label":0}
{"pair_id":"AIMed.d80.s685.p0","sentence":"A point mutation in @PROTEIN1$, analogous to the lpr mutation of @PROTEIN2$, abolishes its ability to bind Fas, suggesting a death domain to death domain interaction.","label":0}
{"pair_id":"AIMed.d80.s685.p1","sentence":"A point mutation in @PROTEIN1$, analogous to the lpr mutation of Fas, abolishes its ability to bind @PROTEIN2$, suggesting a death domain to death domain interaction.","label":1}
{"pair_id":"AIMed.d80.s685.p2","sentence":"A point mutation in FADD, analogous to the lpr mutation of @PROTEIN1$, abolishes its ability to bind @PROTEIN2$, suggesting a death domain to death domain interaction.","label":0}
{"pair_id":"AIMed.d73.s623.p0","sentence":"Unlabeled @PROTEIN1$ and @PROTEIN2$ were equally effective at displacing the binding of labeled TNF-alpha to TNF-R expressing cells.","label":0}
{"pair_id":"AIMed.d73.s623.p1","sentence":"Unlabeled @PROTEIN1$ and TNF-beta were equally effective at displacing the binding of labeled @PROTEIN2$ to TNF-R expressing cells.","label":0}
{"pair_id":"AIMed.d73.s623.p2","sentence":"Unlabeled TNF-alpha and @PROTEIN1$ were equally effective at displacing the binding of labeled @PROTEIN2$ to TNF-R expressing cells.","label":0}
{"pair_id":"AIMed.d146.s1239.p0","sentence":"In agreement, mAb to the previously cloned @PROTEIN1$ were found to stain unstimulated T cells that express only the @PROTEIN2$ IL-7R but not T-cell clones that express predominantly the p76 IL-7R.","label":0}
{"pair_id":"AIMed.d146.s1239.p1","sentence":"In agreement, mAb to the previously cloned @PROTEIN1$ were found to stain unstimulated T cells that express only the p90 @PROTEIN2$ but not T-cell clones that express predominantly the p76 IL-7R.","label":0}
{"pair_id":"AIMed.d146.s1239.p2","sentence":"In agreement, mAb to the previously cloned @PROTEIN1$ were found to stain unstimulated T cells that express only the p90 IL-7R but not T-cell clones that express predominantly the @PROTEIN2$ IL-7R.","label":0}
{"pair_id":"AIMed.d146.s1239.p3","sentence":"In agreement, mAb to the previously cloned @PROTEIN1$ were found to stain unstimulated T cells that express only the p90 IL-7R but not T-cell clones that express predominantly the p76 @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d146.s1239.p4","sentence":"In agreement, mAb to the previously cloned IL-7R were found to stain unstimulated T cells that express only the @PROTEIN1$ @PROTEIN2$ but not T-cell clones that express predominantly the p76 IL-7R.","label":0}
{"pair_id":"AIMed.d146.s1239.p5","sentence":"In agreement, mAb to the previously cloned IL-7R were found to stain unstimulated T cells that express only the @PROTEIN1$ IL-7R but not T-cell clones that express predominantly the @PROTEIN2$ IL-7R.","label":0}
{"pair_id":"AIMed.d146.s1239.p6","sentence":"In agreement, mAb to the previously cloned IL-7R were found to stain unstimulated T cells that express only the @PROTEIN1$ IL-7R but not T-cell clones that express predominantly the p76 @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d146.s1239.p7","sentence":"In agreement, mAb to the previously cloned IL-7R were found to stain unstimulated T cells that express only the p90 @PROTEIN1$ but not T-cell clones that express predominantly the @PROTEIN2$ IL-7R.","label":0}
{"pair_id":"AIMed.d146.s1239.p8","sentence":"In agreement, mAb to the previously cloned IL-7R were found to stain unstimulated T cells that express only the p90 @PROTEIN1$ but not T-cell clones that express predominantly the p76 @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d146.s1239.p9","sentence":"In agreement, mAb to the previously cloned IL-7R were found to stain unstimulated T cells that express only the p90 IL-7R but not T-cell clones that express predominantly the @PROTEIN1$ @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d154.s1309.p0","sentence":"We have cloned and characterized human @PROTEIN1$ and a second isoform of human @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d141.s1193.p0","sentence":"Cotransfection experiments indicate that @PROTEIN1$ and @PROTEIN2$ function in a mutually antagonistic manner to control cell cycle progression.","label":0}
{"pair_id":"BioInfer.d545.s0.p0","sentence":"@PROTEIN1$ prepared from chicken gizzard binds to @PROTEIN2$ in vitro.","label":1}
{"pair_id":"BioInfer.d553.s0.p0","sentence":"Studies on the interaction between @PROTEIN1$ and @PROTEIN2$ purified by a new method.","label":1}
{"pair_id":"BioInfer.d182.s0.p0","sentence":"During incubation of whole myofibrils at 37 degrees C, @PROTEIN1$, alpha actinin, @PROTEIN2$ and troponin T suffered degradation.","label":0}
{"pair_id":"BioInfer.d182.s0.p1","sentence":"During incubation of whole myofibrils at 37 degrees C, @PROTEIN1$, @PROTEIN2$, actin and troponin T suffered degradation.","label":0}
{"pair_id":"BioInfer.d182.s0.p2","sentence":"During incubation of whole myofibrils at 37 degrees C, @PROTEIN1$, alpha actinin, actin and @PROTEIN2$ suffered degradation.","label":0}
{"pair_id":"BioInfer.d182.s0.p3","sentence":"During incubation of whole myofibrils at 37 degrees C, myosin heavy chain, @PROTEIN2$, @PROTEIN1$ and troponin T suffered degradation.","label":0}
{"pair_id":"BioInfer.d182.s0.p4","sentence":"During incubation of whole myofibrils at 37 degrees C, myosin heavy chain, alpha actinin, @PROTEIN1$ and @PROTEIN2$ suffered degradation.","label":0}
{"pair_id":"BioInfer.d182.s0.p5","sentence":"During incubation of whole myofibrils at 37 degrees C, myosin heavy chain, @PROTEIN1$, actin and @PROTEIN2$ suffered degradation.","label":0}
{"pair_id":"AIMed.d174.s1469.p0","sentence":"Although @PROTEIN1$ has a higher binding affinity for immobilized @PROTEIN2$, as determined by biosensor analysis employing surface plasmon resonance detection, IL-6M is more potent than IL-6D in a STAT3 phosphorylation assay.","label":1}
{"pair_id":"AIMed.d174.s1469.p1","sentence":"Although @PROTEIN1$ has a higher binding affinity for immobilized sIL-6R, as determined by biosensor analysis employing surface plasmon resonance detection, @PROTEIN2$ is more potent than IL-6D in a STAT3 phosphorylation assay.","label":0}
{"pair_id":"AIMed.d174.s1469.p2","sentence":"Although @PROTEIN1$ has a higher binding affinity for immobilized sIL-6R, as determined by biosensor analysis employing surface plasmon resonance detection, IL-6M is more potent than @PROTEIN2$ in a STAT3 phosphorylation assay.","label":0}
{"pair_id":"AIMed.d174.s1469.p3","sentence":"Although IL-6D has a higher binding affinity for immobilized @PROTEIN1$, as determined by biosensor analysis employing surface plasmon resonance detection, @PROTEIN2$ is more potent than IL-6D in a STAT3 phosphorylation assay.","label":0}
{"pair_id":"AIMed.d174.s1469.p4","sentence":"Although IL-6D has a higher binding affinity for immobilized @PROTEIN1$, as determined by biosensor analysis employing surface plasmon resonance detection, IL-6M is more potent than @PROTEIN2$ in a STAT3 phosphorylation assay.","label":0}
{"pair_id":"AIMed.d174.s1469.p5","sentence":"Although IL-6D has a higher binding affinity for immobilized sIL-6R, as determined by biosensor analysis employing surface plasmon resonance detection, @PROTEIN1$ is more potent than @PROTEIN2$ in a STAT3 phosphorylation assay.","label":0}
{"pair_id":"AIMed.d137.s1155.p0","sentence":"The POU domains of the @PROTEIN1$ and @PROTEIN2$ transcription factors mediate specific interaction with TBP.","label":0}
{"pair_id":"AIMed.d137.s1155.p1","sentence":"The POU domains of the @PROTEIN1$ and Oct2 transcription factors mediate specific interaction with @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d137.s1155.p2","sentence":"The POU domains of the Oct1 and @PROTEIN1$ transcription factors mediate specific interaction with @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d58.s511.p0","sentence":"A cDNA clone encoding a novel, widely expressed protein (called @PROTEIN1$ or @PROTEIN2$) containing one src homology 2 (SH2) domain and two SH3 domains was isolated.","label":0}
{"pair_id":"AIMed.d128.s1091.p0","sentence":"The X-ray structure of a @PROTEIN1$-@PROTEIN2$ receptor complex.","label":0}
{"pair_id":"BioInfer.d749.s0.p0","sentence":"Three actin-associated proteins, @PROTEIN2$, @PROTEIN1$, and profilin, influence gelation, solation, and polymerization, respectively, of actin in vitro.","label":0}
{"pair_id":"BioInfer.d749.s0.p1","sentence":"Three @PROTEIN2$-associated proteins, actin-binding protein, @PROTEIN1$, and profilin, influence gelation, solation, and polymerization, respectively, of actin in vitro.","label":1}
{"pair_id":"BioInfer.d749.s0.p2","sentence":"Three actin-associated proteins, actin-binding protein, @PROTEIN1$, and profilin, influence gelation, solation, and polymerization, respectively, of @PROTEIN2$ in vitro.","label":0}
{"pair_id":"BioInfer.d749.s0.p3","sentence":"Three actin-associated proteins, actin-binding protein, @PROTEIN1$, and @PROTEIN2$, influence gelation, solation, and polymerization, respectively, of actin in vitro.","label":0}
{"pair_id":"BioInfer.d749.s0.p4","sentence":"Three @PROTEIN2$-associated proteins, @PROTEIN1$, gelsolin, and profilin, influence gelation, solation, and polymerization, respectively, of actin in vitro.","label":1}
{"pair_id":"BioInfer.d749.s0.p5","sentence":"Three actin-associated proteins, @PROTEIN1$, gelsolin, and profilin, influence gelation, solation, and polymerization, respectively, of @PROTEIN2$ in vitro.","label":0}
{"pair_id":"BioInfer.d749.s0.p6","sentence":"Three actin-associated proteins, @PROTEIN1$, gelsolin, and @PROTEIN2$, influence gelation, solation, and polymerization, respectively, of actin in vitro.","label":0}
{"pair_id":"BioInfer.d749.s0.p7","sentence":"Three @PROTEIN1$-associated proteins, actin-binding protein, gelsolin, and profilin, influence gelation, solation, and polymerization, respectively, of @PROTEIN2$ in vitro.","label":0}
{"pair_id":"BioInfer.d749.s0.p8","sentence":"Three @PROTEIN1$-associated proteins, actin-binding protein, gelsolin, and @PROTEIN2$, influence gelation, solation, and polymerization, respectively, of actin in vitro.","label":1}
{"pair_id":"BioInfer.d749.s0.p9","sentence":"Three actin-associated proteins, actin-binding protein, gelsolin, and @PROTEIN2$, influence gelation, solation, and polymerization, respectively, of @PROTEIN1$ in vitro.","label":1}
{"pair_id":"BioInfer.d87.s2.p0","sentence":"These results suggest that the dysfunction of @PROTEIN2$ in these cell lines is due primarily to its failure to interact with alpha-catenin, and that this defect results from the mutation in @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d87.s2.p1","sentence":"These results suggest that the dysfunction of E-cadherin in these cell lines is due primarily to its failure to interact with @PROTEIN2$, and that this defect results from the mutation in @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d87.s2.p2","sentence":"These results suggest that the dysfunction of @PROTEIN1$ in these cell lines is due primarily to its failure to interact with @PROTEIN2$, and that this defect results from the mutation in beta-catenin.","label":1}
{"pair_id":"AIMed.d168.s1414.p0","sentence":"We have used site-specific mutagenesis within the extracellular domain of the @PROTEIN1$ to search for amino acid residues involved in @PROTEIN2$ (EPO) binding.","label":1}
{"pair_id":"AIMed.d168.s1414.p1","sentence":"We have used site-specific mutagenesis within the extracellular domain of the @PROTEIN1$ to search for amino acid residues involved in erythropoietin (@PROTEIN2$) binding.","label":1}
{"pair_id":"AIMed.d168.s1414.p2","sentence":"We have used site-specific mutagenesis within the extracellular domain of the EPOR to search for amino acid residues involved in @PROTEIN1$ (@PROTEIN2$) binding.","label":0}
{"pair_id":"BioInfer.d1.s0.p0","sentence":"A binary complex of birch @PROTEIN1$ and @PROTEIN2$ could be isolated by gel chromatography.","label":1}
{"pair_id":"AIMed.d222.s1928.p0","sentence":"The protein product of @PROTEIN1$ proto-oncogene is known to interact with several proteins, including @PROTEIN2$, Crk and PI3 kinase, and is thought to regulate signalling by many cell surface receptors.","label":1}
{"pair_id":"AIMed.d222.s1928.p1","sentence":"The protein product of @PROTEIN1$ proto-oncogene is known to interact with several proteins, including Grb2, @PROTEIN2$ and PI3 kinase, and is thought to regulate signalling by many cell surface receptors.","label":1}
{"pair_id":"AIMed.d222.s1928.p2","sentence":"The protein product of @PROTEIN1$ proto-oncogene is known to interact with several proteins, including Grb2, Crk and @PROTEIN2$, and is thought to regulate signalling by many cell surface receptors.","label":1}
{"pair_id":"AIMed.d222.s1928.p3","sentence":"The protein product of c-cbl proto-oncogene is known to interact with several proteins, including @PROTEIN1$, @PROTEIN2$ and PI3 kinase, and is thought to regulate signalling by many cell surface receptors.","label":0}
{"pair_id":"AIMed.d222.s1928.p4","sentence":"The protein product of c-cbl proto-oncogene is known to interact with several proteins, including @PROTEIN1$, Crk and @PROTEIN2$, and is thought to regulate signalling by many cell surface receptors.","label":0}
{"pair_id":"AIMed.d222.s1928.p5","sentence":"The protein product of c-cbl proto-oncogene is known to interact with several proteins, including Grb2, @PROTEIN1$ and @PROTEIN2$, and is thought to regulate signalling by many cell surface receptors.","label":0}
{"pair_id":"AIMed.d131.s1127.p0","sentence":"Because @PROTEIN1$ inhibits macrophage activation by @PROTEIN2$, this relationship suggests possible shared receptor or signal transduction pathway components.","label":0}
{"pair_id":"BioInfer.d688.s0.p0","sentence":"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with @PROTEIN2$ and vinculin; (b) @PROTEIN1$-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":0}
{"pair_id":"BioInfer.d688.s0.p1","sentence":"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) @PROTEIN1$-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and @PROTEIN2$, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":0}
{"pair_id":"BioInfer.d688.s0.p2","sentence":"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) @PROTEIN1$-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of @PROTEIN2$, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":0}
{"pair_id":"BioInfer.d688.s0.p3","sentence":"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and @PROTEIN2$; (b) @PROTEIN1$-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":0}
{"pair_id":"BioInfer.d688.s0.p4","sentence":"The results indicate that (a) @PROTEIN2$ and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) @PROTEIN1$-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":0}
{"pair_id":"BioInfer.d688.s0.p5","sentence":"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) @PROTEIN1$-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, @PROTEIN2$ and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":0}
{"pair_id":"BioInfer.d688.s0.p6","sentence":"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) @PROTEIN1$-dependent transactivation is preferentially driven by @PROTEIN2$; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":0}
{"pair_id":"BioInfer.d688.s0.p7","sentence":"The results indicate that (a) plakoglobin and @PROTEIN2$ differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) @PROTEIN1$-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":0}
{"pair_id":"BioInfer.d688.s0.p8","sentence":"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with @PROTEIN1$ and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and @PROTEIN2$, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":0}
{"pair_id":"BioInfer.d688.s0.p9","sentence":"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with @PROTEIN1$ and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of @PROTEIN2$, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":0}
{"pair_id":"BioInfer.d688.s0.p10","sentence":"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with @PROTEIN1$ and @PROTEIN2$; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":0}
{"pair_id":"BioInfer.d688.s0.p11","sentence":"The results indicate that (a) @PROTEIN2$ and beta-catenin differ in their nuclear translocation and complexing with @PROTEIN1$ and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":1}
{"pair_id":"BioInfer.d688.s0.p12","sentence":"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with @PROTEIN1$ and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, @PROTEIN2$ and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":0}
{"pair_id":"BioInfer.d688.s0.p13","sentence":"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with @PROTEIN1$ and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by @PROTEIN2$; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":0}
{"pair_id":"BioInfer.d688.s0.p14","sentence":"The results indicate that (a) plakoglobin and @PROTEIN2$ differ in their nuclear translocation and complexing with @PROTEIN1$ and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":1}
{"pair_id":"BioInfer.d688.s0.p15","sentence":"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of @PROTEIN2$, cadherin and @PROTEIN1$, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":1}
{"pair_id":"BioInfer.d688.s0.p16","sentence":"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and @PROTEIN2$; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and @PROTEIN1$, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":0}
{"pair_id":"BioInfer.d688.s0.p17","sentence":"The results indicate that (a) @PROTEIN2$ and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and @PROTEIN1$, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":0}
{"pair_id":"BioInfer.d688.s0.p18","sentence":"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, @PROTEIN2$ and @PROTEIN1$, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":0}
{"pair_id":"BioInfer.d688.s0.p19","sentence":"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by @PROTEIN2$; and (c) the cytoplasmic partners of beta-catenin, cadherin and @PROTEIN1$, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":0}
{"pair_id":"BioInfer.d688.s0.p20","sentence":"The results indicate that (a) plakoglobin and @PROTEIN2$ differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and @PROTEIN1$, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":0}
{"pair_id":"BioInfer.d688.s0.p21","sentence":"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and @PROTEIN2$; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of @PROTEIN1$, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":0}
{"pair_id":"BioInfer.d688.s0.p22","sentence":"The results indicate that (a) @PROTEIN2$ and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of @PROTEIN1$, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":0}
{"pair_id":"BioInfer.d688.s0.p23","sentence":"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of @PROTEIN1$, @PROTEIN2$ and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":1}
{"pair_id":"BioInfer.d688.s0.p24","sentence":"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by @PROTEIN2$; and (c) the cytoplasmic partners of @PROTEIN1$, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":0}
{"pair_id":"BioInfer.d688.s0.p25","sentence":"The results indicate that (a) plakoglobin and @PROTEIN2$ differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of @PROTEIN1$, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":0}
{"pair_id":"BioInfer.d688.s0.p26","sentence":"The results indicate that (a) @PROTEIN2$ and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and @PROTEIN1$; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":1}
{"pair_id":"BioInfer.d688.s0.p27","sentence":"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and @PROTEIN1$; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, @PROTEIN2$ and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":0}
{"pair_id":"BioInfer.d688.s0.p28","sentence":"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and @PROTEIN1$; (b) LEF-1-dependent transactivation is preferentially driven by @PROTEIN2$; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":0}
{"pair_id":"BioInfer.d688.s0.p29","sentence":"The results indicate that (a) plakoglobin and @PROTEIN2$ differ in their nuclear translocation and complexing with LEF-1 and @PROTEIN1$; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":1}
{"pair_id":"BioInfer.d688.s0.p30","sentence":"The results indicate that (a) @PROTEIN1$ and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, @PROTEIN2$ and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":0}
{"pair_id":"BioInfer.d688.s0.p31","sentence":"The results indicate that (a) @PROTEIN1$ and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by @PROTEIN2$; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":0}
{"pair_id":"BioInfer.d688.s0.p32","sentence":"The results indicate that (a) @PROTEIN1$ and @PROTEIN2$ differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":1}
{"pair_id":"BioInfer.d688.s0.p33","sentence":"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by @PROTEIN2$; and (c) the cytoplasmic partners of beta-catenin, @PROTEIN1$ and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":0}
{"pair_id":"BioInfer.d688.s0.p34","sentence":"The results indicate that (a) plakoglobin and @PROTEIN2$ differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, @PROTEIN1$ and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":0}
{"pair_id":"BioInfer.d688.s0.p35","sentence":"The results indicate that (a) plakoglobin and @PROTEIN2$ differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by @PROTEIN1$; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":0}
{"pair_id":"BioInfer.d784.s0.p0","sentence":"Unmasking of this site serves as a molecular switch that initiates assembly of an @PROTEIN2$-based motility complex containing @PROTEIN1$ and profilin.","label":1}
{"pair_id":"BioInfer.d784.s0.p1","sentence":"Unmasking of this site serves as a molecular switch that initiates assembly of an actin-based motility complex containing @PROTEIN1$ and @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d784.s0.p2","sentence":"Unmasking of this site serves as a molecular switch that initiates assembly of an @PROTEIN1$-based motility complex containing VASP and @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d157.s1328.p0","sentence":"Similarly, in mammalian cells the cyclic adenosine 3',5'-monophosphate-dependent protein kinase (@PROTEIN1$) and @PROTEIN2$ [calcineurin (CaN)] are complexed by an A kinase anchoring protein, AKAP79.","label":0}
{"pair_id":"AIMed.d157.s1328.p1","sentence":"Similarly, in mammalian cells the cyclic adenosine 3',5'-monophosphate-dependent protein kinase (@PROTEIN1$) and phosphatase 2B [@PROTEIN2$ (CaN)] are complexed by an A kinase anchoring protein, AKAP79.","label":0}
{"pair_id":"AIMed.d157.s1328.p2","sentence":"Similarly, in mammalian cells the cyclic adenosine 3',5'-monophosphate-dependent protein kinase (@PROTEIN1$) and phosphatase 2B [calcineurin (@PROTEIN2$)] are complexed by an A kinase anchoring protein, AKAP79.","label":0}
{"pair_id":"AIMed.d157.s1328.p3","sentence":"Similarly, in mammalian cells the cyclic adenosine 3',5'-monophosphate-dependent protein kinase (@PROTEIN1$) and phosphatase 2B [calcineurin (CaN)] are complexed by an @PROTEIN2$, AKAP79.","label":0}
{"pair_id":"AIMed.d157.s1328.p4","sentence":"Similarly, in mammalian cells the cyclic adenosine 3',5'-monophosphate-dependent protein kinase (@PROTEIN1$) and phosphatase 2B [calcineurin (CaN)] are complexed by an A kinase anchoring protein, @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d157.s1328.p5","sentence":"Similarly, in mammalian cells the cyclic adenosine 3',5'-monophosphate-dependent protein kinase (PKA) and @PROTEIN1$ [@PROTEIN2$ (CaN)] are complexed by an A kinase anchoring protein, AKAP79.","label":0}
{"pair_id":"AIMed.d157.s1328.p6","sentence":"Similarly, in mammalian cells the cyclic adenosine 3',5'-monophosphate-dependent protein kinase (PKA) and @PROTEIN1$ [calcineurin (@PROTEIN2$)] are complexed by an A kinase anchoring protein, AKAP79.","label":0}
{"pair_id":"AIMed.d157.s1328.p7","sentence":"Similarly, in mammalian cells the cyclic adenosine 3',5'-monophosphate-dependent protein kinase (PKA) and @PROTEIN1$ [calcineurin (CaN)] are complexed by an @PROTEIN2$, AKAP79.","label":0}
{"pair_id":"AIMed.d157.s1328.p8","sentence":"Similarly, in mammalian cells the cyclic adenosine 3',5'-monophosphate-dependent protein kinase (PKA) and @PROTEIN1$ [calcineurin (CaN)] are complexed by an A kinase anchoring protein, @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d157.s1328.p9","sentence":"Similarly, in mammalian cells the cyclic adenosine 3',5'-monophosphate-dependent protein kinase (PKA) and phosphatase 2B [@PROTEIN1$ (@PROTEIN2$)] are complexed by an A kinase anchoring protein, AKAP79.","label":0}
{"pair_id":"AIMed.d157.s1328.p10","sentence":"Similarly, in mammalian cells the cyclic adenosine 3',5'-monophosphate-dependent protein kinase (PKA) and phosphatase 2B [@PROTEIN1$ (CaN)] are complexed by an @PROTEIN2$, AKAP79.","label":0}
{"pair_id":"AIMed.d157.s1328.p11","sentence":"Similarly, in mammalian cells the cyclic adenosine 3',5'-monophosphate-dependent protein kinase (PKA) and phosphatase 2B [@PROTEIN1$ (CaN)] are complexed by an A kinase anchoring protein, @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d157.s1328.p12","sentence":"Similarly, in mammalian cells the cyclic adenosine 3',5'-monophosphate-dependent protein kinase (PKA) and phosphatase 2B [calcineurin (@PROTEIN1$)] are complexed by an @PROTEIN2$, AKAP79.","label":0}
{"pair_id":"AIMed.d157.s1328.p13","sentence":"Similarly, in mammalian cells the cyclic adenosine 3',5'-monophosphate-dependent protein kinase (PKA) and phosphatase 2B [calcineurin (@PROTEIN1$)] are complexed by an A kinase anchoring protein, @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d157.s1328.p14","sentence":"Similarly, in mammalian cells the cyclic adenosine 3',5'-monophosphate-dependent protein kinase (PKA) and phosphatase 2B [calcineurin (CaN)] are complexed by an @PROTEIN1$, @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d118.s999.p0","sentence":"In normal human cells, but not in many tumour cells, @PROTEIN1$ exists in a quaternary complex with a cyclin, a CDK, and the @PROTEIN2$ (PCNA).","label":1}
{"pair_id":"AIMed.d118.s999.p1","sentence":"In normal human cells, but not in many tumour cells, @PROTEIN1$ exists in a quaternary complex with a cyclin, a CDK, and the proliferating-cell nuclear antigen (@PROTEIN2$).","label":1}
{"pair_id":"AIMed.d118.s999.p2","sentence":"In normal human cells, but not in many tumour cells, p21 exists in a quaternary complex with a cyclin, a CDK, and the @PROTEIN1$ (@PROTEIN2$).","label":0}
{"pair_id":"BioInfer.d623.s1.p0","sentence":"We expressed in Escherichia coli the vaccinia virus gene for a protein similar to vertebrate @PROTEIN2$, purified the recombinant viral @PROTEIN1$, and characterized its interactions with actin and polyphosphoinositides.","label":0}
{"pair_id":"BioInfer.d623.s1.p1","sentence":"We expressed in Escherichia coli the vaccinia virus gene for a protein similar to vertebrate profilins, purified the recombinant viral @PROTEIN1$, and characterized its interactions with @PROTEIN2$ and polyphosphoinositides.","label":1}
{"pair_id":"BioInfer.d623.s1.p2","sentence":"We expressed in Escherichia coli the vaccinia virus gene for a protein similar to vertebrate @PROTEIN1$, purified the recombinant viral profilin, and characterized its interactions with @PROTEIN2$ and polyphosphoinositides.","label":0}
{"pair_id":"BioInfer.d192.s0.p0","sentence":"Essential domains of the @PROTEIN1$ splicing factor are implicated in the binding to @PROTEIN2$ and PRP11 proteins and are conserved through evolution.","label":1}
{"pair_id":"BioInfer.d192.s0.p1","sentence":"Essential domains of the @PROTEIN1$ splicing factor are implicated in the binding to PRP9 and @PROTEIN2$ proteins and are conserved through evolution.","label":1}
{"pair_id":"BioInfer.d192.s0.p2","sentence":"Essential domains of the PRP21 splicing factor are implicated in the binding to @PROTEIN1$ and @PROTEIN2$ proteins and are conserved through evolution.","label":0}
{"pair_id":"BioInfer.d534.s0.p0","sentence":"Several intracellular proteins termed catenins, including alpha-catenin, beta-catenin, and @PROTEIN2$, are tightly associated with these @PROTEIN1$ and serve to link them to the cytoskeleton.","label":0}
{"pair_id":"BioInfer.d534.s0.p1","sentence":"Several intracellular proteins termed @PROTEIN2$, including alpha-catenin, beta-catenin, and plakoglobin, are tightly associated with these @PROTEIN1$ and serve to link them to the cytoskeleton.","label":1}
{"pair_id":"BioInfer.d534.s0.p2","sentence":"Several intracellular proteins termed catenins, including @PROTEIN2$, beta-catenin, and plakoglobin, are tightly associated with these @PROTEIN1$ and serve to link them to the cytoskeleton.","label":0}
{"pair_id":"BioInfer.d534.s0.p3","sentence":"Several intracellular proteins termed catenins, including alpha-catenin, @PROTEIN2$, and plakoglobin, are tightly associated with these @PROTEIN1$ and serve to link them to the cytoskeleton.","label":0}
{"pair_id":"BioInfer.d534.s0.p4","sentence":"Several intracellular proteins termed @PROTEIN2$, including alpha-catenin, beta-catenin, and @PROTEIN1$, are tightly associated with these cadherins and serve to link them to the cytoskeleton.","label":1}
{"pair_id":"BioInfer.d534.s0.p5","sentence":"Several intracellular proteins termed catenins, including @PROTEIN2$, beta-catenin, and @PROTEIN1$, are tightly associated with these cadherins and serve to link them to the cytoskeleton.","label":0}
{"pair_id":"BioInfer.d534.s0.p6","sentence":"Several intracellular proteins termed catenins, including alpha-catenin, @PROTEIN2$, and @PROTEIN1$, are tightly associated with these cadherins and serve to link them to the cytoskeleton.","label":0}
{"pair_id":"BioInfer.d534.s0.p7","sentence":"Several intracellular proteins termed @PROTEIN1$, including @PROTEIN2$, beta-catenin, and plakoglobin, are tightly associated with these cadherins and serve to link them to the cytoskeleton.","label":1}
{"pair_id":"BioInfer.d534.s0.p8","sentence":"Several intracellular proteins termed @PROTEIN1$, including alpha-catenin, @PROTEIN2$, and plakoglobin, are tightly associated with these cadherins and serve to link them to the cytoskeleton.","label":1}
{"pair_id":"BioInfer.d534.s0.p9","sentence":"Several intracellular proteins termed catenins, including @PROTEIN1$, @PROTEIN2$, and plakoglobin, are tightly associated with these cadherins and serve to link them to the cytoskeleton.","label":0}
{"pair_id":"BioInfer.d325.s0.p0","sentence":"In contrast, talin, another putative actin-membrane linker protein, could not be detected in significant amounts in human neutrophils using a polyclonal antibody raised against chicken gizzard talin, which reacted with human @PROTEIN2$ and @PROTEIN1$@PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d325.s0.p1","sentence":"In contrast, @PROTEIN2$, another putative actin-membrane linker protein, could not be detected in significant amounts in human neutrophils using a polyclonal antibody raised against chicken gizzard talin, which reacted with human platelet and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d325.s0.p2","sentence":"In contrast, talin, another putative @PROTEIN2$-membrane linker protein, could not be detected in significant amounts in human neutrophils using a polyclonal antibody raised against chicken gizzard talin, which reacted with human platelet and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d325.s0.p3","sentence":"In contrast, talin, another putative actin-membrane linker protein, could not be detected in significant amounts in human neutrophils using a polyclonal antibody raised against chicken @PROTEIN2$, which reacted with human platelet and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d325.s0.p4","sentence":"In contrast, @PROTEIN2$, another putative actin-membrane linker protein, could not be detected in significant amounts in human neutrophils using a polyclonal antibody raised against chicken gizzard talin, which reacted with human @PROTEIN1$ and lymphocyte @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d325.s0.p5","sentence":"In contrast, talin, another putative @PROTEIN2$-membrane linker protein, could not be detected in significant amounts in human neutrophils using a polyclonal antibody raised against chicken gizzard talin, which reacted with human @PROTEIN1$ and lymphocyte @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d325.s0.p6","sentence":"In contrast, talin, another putative actin-membrane linker protein, could not be detected in significant amounts in human neutrophils using a polyclonal antibody raised against chicken @PROTEIN2$, which reacted with human @PROTEIN1$ and lymphocyte @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d325.s0.p7","sentence":"In contrast, @PROTEIN1$, another putative @PROTEIN2$-membrane linker protein, could not be detected in significant amounts in human neutrophils using a polyclonal antibody raised against chicken gizzard talin, which reacted with human platelet and lymphocyte plate.","label":1}
{"pair_id":"BioInfer.d325.s0.p8","sentence":"In contrast, @PROTEIN1$, another putative actin-membrane linker protein, could not be detected in significant amounts in human neutrophils using a polyclonal antibody raised against chicken @PROTEIN2$, which reacted with human platelet and lymphocyte plate.","label":0}
{"pair_id":"BioInfer.d325.s0.p9","sentence":"In contrast, talin, another putative @PROTEIN1$-membrane linker protein, could not be detected in significant amounts in human neutrophils using a polyclonal antibody raised against chicken @PROTEIN2$, which reacted with human platelet and lymphocyte plate.","label":0}
{"pair_id":"AIMed.d102.s862.p0","sentence":"Here we report that stimulation of @PROTEIN1$-mediated transcription by @PROTEIN2$ is partially abrogated at the nonpermissive temperature in ts13 cells.","label":0}
{"pair_id":"BioInfer.d407.s0.p0","sentence":"Live dynamics of Dictyostelium @PROTEIN2$ suggests a role in remodeling @PROTEIN1$ latticework into bundles.","label":1}
{"pair_id":"AIMed.d114.s964.p0","sentence":"We expressed the cDNA of human @PROTEIN1$ and the COOH terminus of human @PROTEIN2$ in reticulocyte lysates using an in vitro transcription\/translation system.","label":0}
{"pair_id":"BioInfer.d709.s0.p0","sentence":"These results indicate that phosphorylation of @PROTEIN1$ by ROCK and consequently increased phosphorylation of cofilin by @PROTEIN2$ contribute to Rho-induced reorganization of the actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d709.s0.p1","sentence":"These results indicate that phosphorylation of @PROTEIN1$ by ROCK and consequently increased phosphorylation of @PROTEIN2$ by LIM-kinase contribute to Rho-induced reorganization of the actin cytoskeleton.","label":1}
{"pair_id":"BioInfer.d709.s0.p2","sentence":"These results indicate that phosphorylation of @PROTEIN1$ by ROCK and consequently increased phosphorylation of cofilin by LIM-kinase contribute to Rho-induced reorganization of the @PROTEIN2$ cytoskeleton.","label":1}
{"pair_id":"BioInfer.d709.s0.p3","sentence":"These results indicate that phosphorylation of @PROTEIN1$ by ROCK and consequently increased phosphorylation of cofilin by LIM-kinase contribute to @PROTEIN2$-induced reorganization of the actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d709.s0.p4","sentence":"These results indicate that phosphorylation of @PROTEIN1$ by @PROTEIN2$ and consequently increased phosphorylation of cofilin by LIM-kinase contribute to Rho-induced reorganization of the actin cytoskeleton.","label":1}
{"pair_id":"BioInfer.d709.s0.p5","sentence":"These results indicate that phosphorylation of LIM-kinase by ROCK and consequently increased phosphorylation of @PROTEIN2$ by @PROTEIN1$ contribute to Rho-induced reorganization of the actin cytoskeleton.","label":1}
{"pair_id":"BioInfer.d709.s0.p6","sentence":"These results indicate that phosphorylation of LIM-kinase by ROCK and consequently increased phosphorylation of cofilin by @PROTEIN1$ contribute to Rho-induced reorganization of the @PROTEIN2$ cytoskeleton.","label":1}
{"pair_id":"BioInfer.d709.s0.p7","sentence":"These results indicate that phosphorylation of LIM-kinase by ROCK and consequently increased phosphorylation of cofilin by @PROTEIN1$ contribute to @PROTEIN2$-induced reorganization of the actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d709.s0.p8","sentence":"These results indicate that phosphorylation of LIM-kinase by @PROTEIN2$ and consequently increased phosphorylation of cofilin by @PROTEIN1$ contribute to Rho-induced reorganization of the actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d709.s0.p9","sentence":"These results indicate that phosphorylation of LIM-kinase by ROCK and consequently increased phosphorylation of @PROTEIN1$ by LIM-kinase contribute to Rho-induced reorganization of the @PROTEIN2$ cytoskeleton.","label":1}
{"pair_id":"BioInfer.d709.s0.p10","sentence":"These results indicate that phosphorylation of LIM-kinase by ROCK and consequently increased phosphorylation of @PROTEIN1$ by LIM-kinase contribute to @PROTEIN2$-induced reorganization of the actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d709.s0.p11","sentence":"These results indicate that phosphorylation of LIM-kinase by @PROTEIN2$ and consequently increased phosphorylation of @PROTEIN1$ by LIM-kinase contribute to Rho-induced reorganization of the actin cytoskeleton.","label":1}
{"pair_id":"BioInfer.d709.s0.p12","sentence":"These results indicate that phosphorylation of LIM-kinase by ROCK and consequently increased phosphorylation of cofilin by LIM-kinase contribute to @PROTEIN2$-induced reorganization of the @PROTEIN1$ cytoskeleton.","label":1}
{"pair_id":"BioInfer.d709.s0.p13","sentence":"These results indicate that phosphorylation of LIM-kinase by @PROTEIN2$ and consequently increased phosphorylation of cofilin by LIM-kinase contribute to Rho-induced reorganization of the @PROTEIN1$ cytoskeleton.","label":1}
{"pair_id":"BioInfer.d709.s0.p14","sentence":"These results indicate that phosphorylation of LIM-kinase by @PROTEIN2$ and consequently increased phosphorylation of cofilin by LIM-kinase contribute to @PROTEIN1$-induced reorganization of the actin cytoskeleton.","label":0}
{"pair_id":"AIMed.d114.s968.p0","sentence":"In this recombinant expression system, the @PROTEIN1$ relatives, human @PROTEIN2$ related protein (DRP or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.","label":0}
{"pair_id":"AIMed.d114.s968.p1","sentence":"In this recombinant expression system, the @PROTEIN1$ relatives, human @PROTEIN2$ (DRP or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.","label":0}
{"pair_id":"AIMed.d114.s968.p2","sentence":"In this recombinant expression system, the @PROTEIN1$ relatives, human dystrophin related protein (@PROTEIN2$ or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.","label":0}
{"pair_id":"AIMed.d114.s968.p3","sentence":"In this recombinant expression system, the @PROTEIN1$ relatives, human dystrophin related protein (DRP or @PROTEIN2$) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.","label":0}
{"pair_id":"AIMed.d114.s968.p4","sentence":"In this recombinant expression system, the @PROTEIN1$ relatives, human dystrophin related protein (DRP or utrophin) and the @PROTEIN2$ from Torpedo electric organ, also bind to translated beta 1-syntrophin.","label":0}
{"pair_id":"AIMed.d114.s968.p5","sentence":"In this recombinant expression system, the @PROTEIN1$ relatives, human dystrophin related protein (DRP or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d114.s968.p6","sentence":"In this recombinant expression system, the dystrophin relatives, human @PROTEIN1$@PROTEIN2$ (DRP or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.","label":0}
{"pair_id":"AIMed.d114.s968.p7","sentence":"In this recombinant expression system, the dystrophin relatives, human @PROTEIN1$ related protein (@PROTEIN2$ or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.","label":0}
{"pair_id":"AIMed.d114.s968.p8","sentence":"In this recombinant expression system, the dystrophin relatives, human @PROTEIN1$ related protein (DRP or @PROTEIN2$) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.","label":0}
{"pair_id":"AIMed.d114.s968.p9","sentence":"In this recombinant expression system, the dystrophin relatives, human @PROTEIN1$ related protein (DRP or utrophin) and the @PROTEIN2$ from Torpedo electric organ, also bind to translated beta 1-syntrophin.","label":0}
{"pair_id":"AIMed.d114.s968.p10","sentence":"In this recombinant expression system, the dystrophin relatives, human @PROTEIN1$ related protein (DRP or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d114.s968.p11","sentence":"In this recombinant expression system, the dystrophin relatives, human @PROTEIN1$ (@PROTEIN2$ or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.","label":0}
{"pair_id":"AIMed.d114.s968.p12","sentence":"In this recombinant expression system, the dystrophin relatives, human @PROTEIN1$ (DRP or @PROTEIN2$) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.","label":0}
{"pair_id":"AIMed.d114.s968.p13","sentence":"In this recombinant expression system, the dystrophin relatives, human @PROTEIN1$ (DRP or utrophin) and the @PROTEIN2$ from Torpedo electric organ, also bind to translated beta 1-syntrophin.","label":0}
{"pair_id":"AIMed.d114.s968.p14","sentence":"In this recombinant expression system, the dystrophin relatives, human @PROTEIN1$ (DRP or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d114.s968.p15","sentence":"In this recombinant expression system, the dystrophin relatives, human dystrophin related protein (@PROTEIN1$ or @PROTEIN2$) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.","label":0}
{"pair_id":"AIMed.d114.s968.p16","sentence":"In this recombinant expression system, the dystrophin relatives, human dystrophin related protein (@PROTEIN1$ or utrophin) and the @PROTEIN2$ from Torpedo electric organ, also bind to translated beta 1-syntrophin.","label":0}
{"pair_id":"AIMed.d114.s968.p17","sentence":"In this recombinant expression system, the dystrophin relatives, human dystrophin related protein (@PROTEIN1$ or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d114.s968.p18","sentence":"In this recombinant expression system, the dystrophin relatives, human dystrophin related protein (DRP or @PROTEIN1$) and the @PROTEIN2$ from Torpedo electric organ, also bind to translated beta 1-syntrophin.","label":0}
{"pair_id":"AIMed.d114.s968.p19","sentence":"In this recombinant expression system, the dystrophin relatives, human dystrophin related protein (DRP or @PROTEIN1$) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d114.s968.p20","sentence":"In this recombinant expression system, the dystrophin relatives, human dystrophin related protein (DRP or utrophin) and the @PROTEIN1$ from Torpedo electric organ, also bind to translated @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d523.s0.p0","sentence":"RIPc, one of the cleavage products, enhanced interaction between TRADD and @PROTEIN2$\/MORT1 and increased cells' sensitivity to @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d523.s0.p1","sentence":"@PROTEIN2$, one of the cleavage products, enhanced interaction between TRADD and FADD\/MORT1 and increased cells' sensitivity to @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d523.s0.p2","sentence":"RIPc, one of the cleavage products, enhanced interaction between TRADD and FADD\/@PROTEIN2$ and increased cells' sensitivity to @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d523.s0.p3","sentence":"RIPc, one of the cleavage products, enhanced interaction between @PROTEIN2$ and FADD\/MORT1 and increased cells' sensitivity to @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d523.s0.p4","sentence":"@PROTEIN2$, one of the cleavage products, enhanced interaction between TRADD and @PROTEIN1$\/MORT1 and increased cells' sensitivity to TNF.","label":1}
{"pair_id":"BioInfer.d523.s0.p5","sentence":"RIPc, one of the cleavage products, enhanced interaction between TRADD and @PROTEIN1$\/@PROTEIN2$ and increased cells' sensitivity to TNF.","label":0}
{"pair_id":"BioInfer.d523.s0.p6","sentence":"RIPc, one of the cleavage products, enhanced interaction between @PROTEIN2$ and @PROTEIN1$\/MORT1 and increased cells' sensitivity to TNF.","label":1}
{"pair_id":"BioInfer.d523.s0.p7","sentence":"@PROTEIN1$, one of the cleavage products, enhanced interaction between TRADD and FADD\/@PROTEIN2$ and increased cells' sensitivity to TNF.","label":1}
{"pair_id":"BioInfer.d523.s0.p8","sentence":"@PROTEIN1$, one of the cleavage products, enhanced interaction between @PROTEIN2$ and FADD\/MORT1 and increased cells' sensitivity to TNF.","label":1}
{"pair_id":"BioInfer.d523.s0.p9","sentence":"RIPc, one of the cleavage products, enhanced interaction between @PROTEIN2$ and FADD\/@PROTEIN1$ and increased cells' sensitivity to TNF.","label":1}
{"pair_id":"BioInfer.d640.s0.p0","sentence":"The majority of cortical thymomas showed diffuse and homogenous membrane immunoreactivity for these molecules (88 per cent for @PROTEIN2$; 86 per cent for @PROTEIN1$; 91 per cent for beta-catenin) and the remaining cases showed heterogeneous immunoreactivity, whereas almost all mixed and medullary thymomas revealed decreased expression or were negative.","label":0}
{"pair_id":"BioInfer.d640.s0.p1","sentence":"The majority of cortical thymomas showed diffuse and homogenous membrane immunoreactivity for these molecules (88 per cent for E-CD; 86 per cent for @PROTEIN1$; 91 per cent for @PROTEIN2$) and the remaining cases showed heterogeneous immunoreactivity, whereas almost all mixed and medullary thymomas revealed decreased expression or were negative.","label":0}
{"pair_id":"BioInfer.d640.s0.p2","sentence":"The majority of cortical thymomas showed diffuse and homogenous membrane immunoreactivity for these molecules (88 per cent for @PROTEIN1$; 86 per cent for alpha-catenin; 91 per cent for @PROTEIN2$) and the remaining cases showed heterogeneous immunoreactivity, whereas almost all mixed and medullary thymomas revealed decreased expression or were negative.","label":0}
{"pair_id":"BioInfer.d1.s4.p0","sentence":"These data indicate that the @PROTEIN2$-binding domains in plant and animal @PROTEIN1$ are functionally highly conserved, although the overall sequence similarity is less than 25%.","label":1}
{"pair_id":"BioInfer.d169.s1.p0","sentence":"In the presence of magnesium ions birch profilin promoted the polymerization of @PROTEIN2$ from @PROTEIN1$:Tbeta4.","label":1}
{"pair_id":"BioInfer.d169.s1.p1","sentence":"In the presence of magnesium ions birch @PROTEIN2$ promoted the polymerization of actin from @PROTEIN1$:Tbeta4.","label":0}
{"pair_id":"BioInfer.d169.s1.p2","sentence":"In the presence of magnesium ions birch profilin promoted the polymerization of actin from @PROTEIN1$:@PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d169.s1.p3","sentence":"In the presence of magnesium ions birch @PROTEIN2$ promoted the polymerization of @PROTEIN1$ from A:Tbeta4.","label":1}
{"pair_id":"BioInfer.d169.s1.p4","sentence":"In the presence of magnesium ions birch profilin promoted the polymerization of @PROTEIN1$ from A:@PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d169.s1.p5","sentence":"In the presence of magnesium ions birch @PROTEIN1$ promoted the polymerization of actin from A:@PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d307.s0.p0","sentence":"In Acanthamoeba actin polymerization is regulated, at least in part, by profilin, which binds to @PROTEIN2$ monomers, and by @PROTEIN1$, which both nucleates polymerization and blocks monomer addition at the 'barbed' end of the filament.","label":0}
{"pair_id":"BioInfer.d307.s0.p1","sentence":"In Acanthamoeba actin polymerization is regulated, at least in part, by @PROTEIN2$, which binds to actin monomers, and by @PROTEIN1$, which both nucleates polymerization and blocks monomer addition at the 'barbed' end of the filament.","label":0}
{"pair_id":"BioInfer.d307.s0.p2","sentence":"In Acanthamoeba @PROTEIN2$ polymerization is regulated, at least in part, by profilin, which binds to actin monomers, and by @PROTEIN1$, which both nucleates polymerization and blocks monomer addition at the 'barbed' end of the filament.","label":1}
{"pair_id":"BioInfer.d307.s0.p3","sentence":"In Acanthamoeba actin polymerization is regulated, at least in part, by @PROTEIN2$, which binds to @PROTEIN1$ monomers, and by capping protein, which both nucleates polymerization and blocks monomer addition at the 'barbed' end of the filament.","label":1}
{"pair_id":"BioInfer.d307.s0.p4","sentence":"In Acanthamoeba @PROTEIN2$ polymerization is regulated, at least in part, by profilin, which binds to @PROTEIN1$ monomers, and by capping protein, which both nucleates polymerization and blocks monomer addition at the 'barbed' end of the filament.","label":0}
{"pair_id":"BioInfer.d307.s0.p5","sentence":"In Acanthamoeba @PROTEIN2$ polymerization is regulated, at least in part, by @PROTEIN1$, which binds to actin monomers, and by capping protein, which both nucleates polymerization and blocks monomer addition at the 'barbed' end of the filament.","label":1}
{"pair_id":"BioInfer.d653.s0.p0","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, @PROTEIN2$: 1751-2190, M: 3571-4057, @PROTEIN1$: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p1","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, @PROTEIN1$: 6621-7210, @PROTEIN2$: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p2","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (@PROTEIN2$) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, @PROTEIN1$: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p3","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, @PROTEIN2$: 3571-4057, @PROTEIN1$: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p4","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), @PROTEIN2$ (F), and large @PROTEIN2$ (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, @PROTEIN1$: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p5","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (@PROTEIN2$), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, @PROTEIN1$: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p6","sentence":"The nucleotide sequences of nucleocapsid (@PROTEIN2$), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, @PROTEIN1$: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p7","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (@PROTEIN2$), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, @PROTEIN1$: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p8","sentence":"The nucleotide sequences of @PROTEIN2$ (N), phosphoprotein (P), matrix (M), fusion (F), and large @PROTEIN2$ (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, @PROTEIN1$: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p9","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), @PROTEIN2$ (M), fusion (F), and large @PROTEIN2$ (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, @PROTEIN1$: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p10","sentence":"The nucleotide sequences of nucleocapsid (N), @PROTEIN2$ (P), matrix (M), fusion (F), and large @PROTEIN2$ (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, @PROTEIN1$: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p11","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and @PROTEIN2$ (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, @PROTEIN1$: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p12","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (@PROTEIN2$), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, @PROTEIN1$: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p13","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position @PROTEIN2$: 1301-1700, P: 1751-2190, M: 3571-4057, @PROTEIN1$: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p14","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, @PROTEIN1$: 1751-2190, M: 3571-4057, F: 6621-7210, @PROTEIN2$: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p15","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (@PROTEIN2$) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, @PROTEIN1$: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p16","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, @PROTEIN1$: 1751-2190, @PROTEIN2$: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p17","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), @PROTEIN2$ (F), and large @PROTEIN2$ (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, @PROTEIN1$: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p18","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (@PROTEIN2$), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, @PROTEIN1$: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p19","sentence":"The nucleotide sequences of nucleocapsid (@PROTEIN2$), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, @PROTEIN1$: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p20","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (@PROTEIN2$), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, @PROTEIN1$: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p21","sentence":"The nucleotide sequences of @PROTEIN2$ (N), phosphoprotein (P), matrix (M), fusion (F), and large @PROTEIN2$ (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, @PROTEIN1$: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p22","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), @PROTEIN2$ (M), fusion (F), and large @PROTEIN2$ (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, @PROTEIN1$: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p23","sentence":"The nucleotide sequences of nucleocapsid (N), @PROTEIN2$ (P), matrix (M), fusion (F), and large @PROTEIN2$ (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, @PROTEIN1$: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p24","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and @PROTEIN2$ (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, @PROTEIN1$: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p25","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (@PROTEIN2$), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, @PROTEIN1$: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p26","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position @PROTEIN2$: 1301-1700, @PROTEIN1$: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p27","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (@PROTEIN2$) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, @PROTEIN1$: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p28","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, @PROTEIN2$: 3571-4057, F: 6621-7210, @PROTEIN1$: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p29","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), @PROTEIN2$ (F), and large @PROTEIN2$ (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, @PROTEIN1$: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p30","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (@PROTEIN2$), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, @PROTEIN1$: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p31","sentence":"The nucleotide sequences of nucleocapsid (@PROTEIN2$), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, @PROTEIN1$: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p32","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (@PROTEIN2$), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, @PROTEIN1$: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p33","sentence":"The nucleotide sequences of @PROTEIN2$ (N), phosphoprotein (P), matrix (M), fusion (F), and large @PROTEIN2$ (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, @PROTEIN1$: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p34","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), @PROTEIN2$ (M), fusion (F), and large @PROTEIN2$ (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, @PROTEIN1$: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p35","sentence":"The nucleotide sequences of nucleocapsid (N), @PROTEIN2$ (P), matrix (M), fusion (F), and large @PROTEIN2$ (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, @PROTEIN1$: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p36","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and @PROTEIN2$ (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, @PROTEIN1$: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p37","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (@PROTEIN2$), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, @PROTEIN1$: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p38","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position @PROTEIN2$: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, @PROTEIN1$: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p39","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (@PROTEIN1$) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, @PROTEIN2$: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p40","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), @PROTEIN2$ (F), and large @PROTEIN2$ (@PROTEIN1$) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p41","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (@PROTEIN2$), matrix (M), fusion (F), and large protein (@PROTEIN1$) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p42","sentence":"The nucleotide sequences of nucleocapsid (@PROTEIN2$), phosphoprotein (P), matrix (M), fusion (F), and large protein (@PROTEIN1$) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p43","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (@PROTEIN2$), and large protein (@PROTEIN1$) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p44","sentence":"The nucleotide sequences of @PROTEIN2$ (N), phosphoprotein (P), matrix (M), fusion (F), and large @PROTEIN2$ (@PROTEIN1$) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p45","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), @PROTEIN2$ (M), fusion (F), and large @PROTEIN2$ (@PROTEIN1$) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p46","sentence":"The nucleotide sequences of nucleocapsid (N), @PROTEIN2$ (P), matrix (M), fusion (F), and large @PROTEIN2$ (@PROTEIN1$) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p47","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and @PROTEIN2$ (@PROTEIN1$) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p48","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (@PROTEIN2$), fusion (F), and large protein (@PROTEIN1$) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p49","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (@PROTEIN1$) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position @PROTEIN2$: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p50","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), @PROTEIN2$ (F), and large @PROTEIN2$ (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, @PROTEIN1$: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p51","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (@PROTEIN2$), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, @PROTEIN1$: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p52","sentence":"The nucleotide sequences of nucleocapsid (@PROTEIN2$), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, @PROTEIN1$: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p53","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (@PROTEIN2$), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, @PROTEIN1$: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p54","sentence":"The nucleotide sequences of @PROTEIN2$ (N), phosphoprotein (P), matrix (M), fusion (F), and large @PROTEIN2$ (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, @PROTEIN1$: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p55","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), @PROTEIN2$ (M), fusion (F), and large @PROTEIN2$ (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, @PROTEIN1$: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p56","sentence":"The nucleotide sequences of nucleocapsid (N), @PROTEIN2$ (P), matrix (M), fusion (F), and large @PROTEIN2$ (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, @PROTEIN1$: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p57","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and @PROTEIN2$ (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, @PROTEIN1$: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p58","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (@PROTEIN2$), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, @PROTEIN1$: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p59","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position @PROTEIN2$: 1301-1700, P: 1751-2190, @PROTEIN1$: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p60","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (@PROTEIN2$), matrix (M), @PROTEIN1$ (F), and large @PROTEIN1$ (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p61","sentence":"The nucleotide sequences of nucleocapsid (@PROTEIN2$), phosphoprotein (P), matrix (M), @PROTEIN1$ (F), and large @PROTEIN1$ (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p62","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), @PROTEIN1$ (@PROTEIN2$), and large @PROTEIN1$ (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p63","sentence":"The nucleotide sequences of @PROTEIN2$ (N), phosphoprotein (P), matrix (M), @PROTEIN1$ (F), and large @PROTEIN1$@PROTEIN2$ (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p64","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), @PROTEIN2$ (M), @PROTEIN1$ (F), and large @PROTEIN1$@PROTEIN2$ (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p65","sentence":"The nucleotide sequences of nucleocapsid (N), @PROTEIN2$ (P), matrix (M), @PROTEIN1$ (F), and large @PROTEIN1$@PROTEIN2$ (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p66","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), @PROTEIN1$ (F), and @PROTEIN2$@PROTEIN1$ (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p67","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (@PROTEIN2$), @PROTEIN1$ (F), and large @PROTEIN1$ (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p68","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), @PROTEIN1$ (F), and large @PROTEIN1$ (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position @PROTEIN2$: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p69","sentence":"The nucleotide sequences of nucleocapsid (@PROTEIN2$), phosphoprotein (@PROTEIN1$), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p70","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (@PROTEIN1$), matrix (M), fusion (@PROTEIN2$), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p71","sentence":"The nucleotide sequences of @PROTEIN2$ (N), phosphoprotein (@PROTEIN1$), matrix (M), fusion (F), and large @PROTEIN2$ (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p72","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (@PROTEIN1$), @PROTEIN2$ (M), fusion (F), and large @PROTEIN2$ (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p73","sentence":"The nucleotide sequences of nucleocapsid (N), @PROTEIN2$ (@PROTEIN1$), matrix (M), fusion (F), and large @PROTEIN2$ (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p74","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (@PROTEIN1$), matrix (M), fusion (F), and @PROTEIN2$ (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p75","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (@PROTEIN1$), matrix (@PROTEIN2$), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p76","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (@PROTEIN1$), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position @PROTEIN2$: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p77","sentence":"The nucleotide sequences of nucleocapsid (@PROTEIN1$), phosphoprotein (P), matrix (M), fusion (@PROTEIN2$), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p78","sentence":"The nucleotide sequences of @PROTEIN2$ (@PROTEIN1$), phosphoprotein (P), matrix (M), fusion (F), and large @PROTEIN2$ (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p79","sentence":"The nucleotide sequences of nucleocapsid (@PROTEIN1$), phosphoprotein (P), @PROTEIN2$ (M), fusion (F), and large @PROTEIN2$ (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p80","sentence":"The nucleotide sequences of nucleocapsid (@PROTEIN1$), @PROTEIN2$ (P), matrix (M), fusion (F), and large @PROTEIN2$ (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p81","sentence":"The nucleotide sequences of nucleocapsid (@PROTEIN1$), phosphoprotein (P), matrix (M), fusion (F), and @PROTEIN2$ (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p82","sentence":"The nucleotide sequences of nucleocapsid (@PROTEIN1$), phosphoprotein (P), matrix (@PROTEIN2$), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p83","sentence":"The nucleotide sequences of nucleocapsid (@PROTEIN1$), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position @PROTEIN2$: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p84","sentence":"The nucleotide sequences of @PROTEIN2$ (N), phosphoprotein (P), matrix (M), fusion (@PROTEIN1$), and large @PROTEIN2$ (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p85","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), @PROTEIN2$ (M), fusion (@PROTEIN1$), and large @PROTEIN2$ (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p86","sentence":"The nucleotide sequences of nucleocapsid (N), @PROTEIN2$ (P), matrix (M), fusion (@PROTEIN1$), and large @PROTEIN2$ (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p87","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (@PROTEIN1$), and @PROTEIN2$ (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p88","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (@PROTEIN2$), fusion (@PROTEIN1$), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p89","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (@PROTEIN1$), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position @PROTEIN2$: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p90","sentence":"The nucleotide sequences of @PROTEIN1$ (N), phosphoprotein (P), @PROTEIN2$ (M), fusion (F), and large @PROTEIN1$@PROTEIN2$ (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p91","sentence":"The nucleotide sequences of @PROTEIN1$ (N), @PROTEIN2$ (P), matrix (M), fusion (F), and large @PROTEIN1$@PROTEIN2$ (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p92","sentence":"The nucleotide sequences of @PROTEIN1$ (N), phosphoprotein (P), matrix (M), fusion (F), and @PROTEIN2$@PROTEIN1$ (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p93","sentence":"The nucleotide sequences of @PROTEIN1$ (N), phosphoprotein (P), matrix (@PROTEIN2$), fusion (F), and large @PROTEIN1$ (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p94","sentence":"The nucleotide sequences of @PROTEIN1$ (N), phosphoprotein (P), matrix (M), fusion (F), and large @PROTEIN1$ (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position @PROTEIN2$: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p95","sentence":"The nucleotide sequences of nucleocapsid (N), @PROTEIN2$ (P), @PROTEIN1$ (M), fusion (F), and large @PROTEIN1$@PROTEIN2$ (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p96","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), @PROTEIN1$ (M), fusion (F), and @PROTEIN2$@PROTEIN1$ (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p97","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), @PROTEIN1$ (@PROTEIN2$), fusion (F), and large @PROTEIN1$ (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p98","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), @PROTEIN1$ (M), fusion (F), and large @PROTEIN1$ (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position @PROTEIN2$: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p99","sentence":"The nucleotide sequences of nucleocapsid (N), @PROTEIN1$ (P), matrix (M), fusion (F), and @PROTEIN2$@PROTEIN1$ (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p100","sentence":"The nucleotide sequences of nucleocapsid (N), @PROTEIN1$ (P), matrix (@PROTEIN2$), fusion (F), and large @PROTEIN1$ (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p101","sentence":"The nucleotide sequences of nucleocapsid (N), @PROTEIN1$ (P), matrix (M), fusion (F), and large @PROTEIN1$ (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position @PROTEIN2$: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p102","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (@PROTEIN2$), fusion (F), and @PROTEIN1$ (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p103","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and @PROTEIN1$ (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position @PROTEIN2$: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p104","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (@PROTEIN1$), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position @PROTEIN2$: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"AIMed.d83.s704.p0","sentence":"By rational mutagenesis, receptor-specific functional analysis, and visualization of complex formation in solution, we identified individual amino acid side chains involved specifically in the interaction of @PROTEIN1$ (@PROTEIN2$) with CNTFR alpha and not with the beta-components, gp130 and LIFR.","label":0}
{"pair_id":"AIMed.d83.s704.p1","sentence":"By rational mutagenesis, receptor-specific functional analysis, and visualization of complex formation in solution, we identified individual amino acid side chains involved specifically in the interaction of @PROTEIN1$ (CNTF) with @PROTEIN2$ and not with the beta-components, gp130 and LIFR.","label":1}
{"pair_id":"AIMed.d83.s704.p2","sentence":"By rational mutagenesis, receptor-specific functional analysis, and visualization of complex formation in solution, we identified individual amino acid side chains involved specifically in the interaction of @PROTEIN1$ (CNTF) with CNTFR alpha and not with the beta-components, @PROTEIN2$ and LIFR.","label":0}
{"pair_id":"AIMed.d83.s704.p3","sentence":"By rational mutagenesis, receptor-specific functional analysis, and visualization of complex formation in solution, we identified individual amino acid side chains involved specifically in the interaction of @PROTEIN1$ (CNTF) with CNTFR alpha and not with the beta-components, gp130 and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d83.s704.p4","sentence":"By rational mutagenesis, receptor-specific functional analysis, and visualization of complex formation in solution, we identified individual amino acid side chains involved specifically in the interaction of ciliary neurotrophic factor (@PROTEIN1$) with @PROTEIN2$ and not with the beta-components, gp130 and LIFR.","label":1}
{"pair_id":"AIMed.d83.s704.p5","sentence":"By rational mutagenesis, receptor-specific functional analysis, and visualization of complex formation in solution, we identified individual amino acid side chains involved specifically in the interaction of ciliary neurotrophic factor (@PROTEIN1$) with CNTFR alpha and not with the beta-components, @PROTEIN2$ and LIFR.","label":0}
{"pair_id":"AIMed.d83.s704.p6","sentence":"By rational mutagenesis, receptor-specific functional analysis, and visualization of complex formation in solution, we identified individual amino acid side chains involved specifically in the interaction of ciliary neurotrophic factor (@PROTEIN1$) with CNTFR alpha and not with the beta-components, gp130 and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d83.s704.p7","sentence":"By rational mutagenesis, receptor-specific functional analysis, and visualization of complex formation in solution, we identified individual amino acid side chains involved specifically in the interaction of ciliary neurotrophic factor (CNTF) with @PROTEIN1$ and not with the beta-components, @PROTEIN2$ and LIFR.","label":0}
{"pair_id":"AIMed.d83.s704.p8","sentence":"By rational mutagenesis, receptor-specific functional analysis, and visualization of complex formation in solution, we identified individual amino acid side chains involved specifically in the interaction of ciliary neurotrophic factor (CNTF) with @PROTEIN1$ and not with the beta-components, gp130 and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d83.s704.p9","sentence":"By rational mutagenesis, receptor-specific functional analysis, and visualization of complex formation in solution, we identified individual amino acid side chains involved specifically in the interaction of ciliary neurotrophic factor (CNTF) with CNTFR alpha and not with the beta-components, @PROTEIN1$ and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d564.s0.p0","sentence":"The alpha-catenin molecule links E-cadherin\/ @PROTEIN2$ or @PROTEIN1$\/plakoglobin complexes to the actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d564.s0.p1","sentence":"The alpha-catenin molecule links @PROTEIN2$\/ beta-catenin or @PROTEIN1$\/plakoglobin complexes to the actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d564.s0.p2","sentence":"The alpha-catenin molecule links E-cadherin\/ beta-catenin or @PROTEIN1$\/@PROTEIN2$ complexes to the actin cytoskeleton.","label":1}
{"pair_id":"BioInfer.d564.s0.p3","sentence":"The @PROTEIN2$ molecule links E-cadherin\/ beta-catenin or @PROTEIN1$\/plakoglobin complexes to the actin cytoskeleton.","label":1}
{"pair_id":"BioInfer.d564.s0.p4","sentence":"The alpha-catenin molecule links E-cadherin\/ beta-catenin or @PROTEIN1$\/plakoglobin complexes to the @PROTEIN2$ cytoskeleton.","label":1}
{"pair_id":"BioInfer.d564.s0.p5","sentence":"The alpha-catenin molecule links @PROTEIN2$\/ @PROTEIN1$ or E-cadherin\/plakoglobin complexes to the actin cytoskeleton.","label":1}
{"pair_id":"BioInfer.d564.s0.p6","sentence":"The alpha-catenin molecule links E-cadherin\/ @PROTEIN1$ or E-cadherin\/@PROTEIN2$ complexes to the actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d564.s0.p7","sentence":"The @PROTEIN2$ molecule links E-cadherin\/ @PROTEIN1$ or E-cadherin\/plakoglobin complexes to the actin cytoskeleton.","label":1}
{"pair_id":"BioInfer.d564.s0.p8","sentence":"The alpha-catenin molecule links E-cadherin\/ @PROTEIN1$ or E-cadherin\/plakoglobin complexes to the @PROTEIN2$ cytoskeleton.","label":1}
{"pair_id":"BioInfer.d564.s0.p9","sentence":"The alpha-catenin molecule links @PROTEIN1$\/ beta-catenin or E-cadherin\/@PROTEIN2$ complexes to the actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d564.s0.p10","sentence":"The @PROTEIN2$ molecule links @PROTEIN1$\/ beta-catenin or E-cadherin\/plakoglobin complexes to the actin cytoskeleton.","label":1}
{"pair_id":"BioInfer.d564.s0.p11","sentence":"The alpha-catenin molecule links @PROTEIN1$\/ beta-catenin or E-cadherin\/plakoglobin complexes to the @PROTEIN2$ cytoskeleton.","label":1}
{"pair_id":"BioInfer.d564.s0.p12","sentence":"The @PROTEIN2$ molecule links E-cadherin\/ beta-catenin or E-cadherin\/@PROTEIN1$ complexes to the actin cytoskeleton.","label":1}
{"pair_id":"BioInfer.d564.s0.p13","sentence":"The alpha-catenin molecule links E-cadherin\/ beta-catenin or E-cadherin\/@PROTEIN1$ complexes to the @PROTEIN2$ cytoskeleton.","label":1}
{"pair_id":"BioInfer.d564.s0.p14","sentence":"The @PROTEIN1$ molecule links E-cadherin\/ beta-catenin or E-cadherin\/plakoglobin complexes to the @PROTEIN2$ cytoskeleton.","label":1}
{"pair_id":"AIMed.d36.s306.p0","sentence":"In this study, we simulated interactions of all amphipathic helices of @PROTEIN1$ and A-I with @PROTEIN2$ and simian immunodeficiency virus (SIV) fusogenic fragments by molecular modeling.","label":0}
{"pair_id":"BioInfer.d129.s0.p0","sentence":"@PROTEIN1$, a T cell activation Ag, also known as @PROTEIN2$, is directly associated with adenosine deaminase (ADA) on the surface of T cells and T cell lines.","label":0}
{"pair_id":"BioInfer.d129.s0.p1","sentence":"@PROTEIN1$, a T cell activation Ag, also known as dipeptidyl peptidase IV, is directly associated with adenosine deaminase (@PROTEIN2$) on the surface of T cells and T cell lines.","label":1}
{"pair_id":"BioInfer.d129.s0.p2","sentence":"@PROTEIN1$, a T cell activation Ag, also known as dipeptidyl peptidase IV, is directly associated with @PROTEIN2$ (ADA) on the surface of T cells and T cell lines.","label":1}
{"pair_id":"BioInfer.d129.s0.p3","sentence":"CD26, a T cell activation Ag, also known as @PROTEIN1$, is directly associated with adenosine deaminase (@PROTEIN2$) on the surface of T cells and T cell lines.","label":1}
{"pair_id":"BioInfer.d129.s0.p4","sentence":"CD26, a T cell activation Ag, also known as @PROTEIN1$, is directly associated with @PROTEIN2$ (ADA) on the surface of T cells and T cell lines.","label":1}
{"pair_id":"BioInfer.d129.s0.p5","sentence":"CD26, a T cell activation Ag, also known as dipeptidyl peptidase IV, is directly associated with @PROTEIN2$ (@PROTEIN1$) on the surface of T cells and T cell lines.","label":0}
{"pair_id":"AIMed.d105.s891.p0","sentence":"Immunoprecipitation experiments further reveal that the fully assembled receptor complex is composed of two @PROTEIN1$, two @PROTEIN2$ and two gp130 molecules.","label":1}
{"pair_id":"AIMed.d105.s891.p1","sentence":"Immunoprecipitation experiments further reveal that the fully assembled receptor complex is composed of two @PROTEIN1$, two IL-6R alpha and two @PROTEIN2$ molecules.","label":1}
{"pair_id":"AIMed.d105.s891.p2","sentence":"Immunoprecipitation experiments further reveal that the fully assembled receptor complex is composed of two IL-6, two @PROTEIN1$ and two @PROTEIN2$ molecules.","label":1}
{"pair_id":"AIMed.d77.s654.p0","sentence":"We show that the carboxy terminal \"tail\" of @PROTEIN1$ associates directly with the amino terminal \"head\" of type II epidermal keratins, including @PROTEIN2$, K2, K5, and K6.","label":1}
{"pair_id":"AIMed.d77.s654.p1","sentence":"We show that the carboxy terminal \"tail\" of @PROTEIN1$ associates directly with the amino terminal \"head\" of type II epidermal keratins, including K1, @PROTEIN2$, K5, and K6.","label":1}
{"pair_id":"AIMed.d77.s654.p2","sentence":"We show that the carboxy terminal \"tail\" of @PROTEIN1$ associates directly with the amino terminal \"head\" of type II epidermal keratins, including K1, K2, @PROTEIN2$, and K6.","label":1}
{"pair_id":"AIMed.d77.s654.p3","sentence":"We show that the carboxy terminal \"tail\" of @PROTEIN1$ associates directly with the amino terminal \"head\" of type II epidermal keratins, including K1, K2, K5, and @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d77.s654.p4","sentence":"We show that the carboxy terminal \"tail\" of DPI associates directly with the amino terminal \"head\" of type II epidermal keratins, including @PROTEIN1$, @PROTEIN2$, K5, and K6.","label":0}
{"pair_id":"AIMed.d77.s654.p5","sentence":"We show that the carboxy terminal \"tail\" of DPI associates directly with the amino terminal \"head\" of type II epidermal keratins, including @PROTEIN1$, K2, @PROTEIN2$, and K6.","label":0}
{"pair_id":"AIMed.d77.s654.p6","sentence":"We show that the carboxy terminal \"tail\" of DPI associates directly with the amino terminal \"head\" of type II epidermal keratins, including @PROTEIN1$, K2, K5, and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d77.s654.p7","sentence":"We show that the carboxy terminal \"tail\" of DPI associates directly with the amino terminal \"head\" of type II epidermal keratins, including K1, @PROTEIN1$, @PROTEIN2$, and K6.","label":0}
{"pair_id":"AIMed.d77.s654.p8","sentence":"We show that the carboxy terminal \"tail\" of DPI associates directly with the amino terminal \"head\" of type II epidermal keratins, including K1, @PROTEIN1$, K5, and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d77.s654.p9","sentence":"We show that the carboxy terminal \"tail\" of DPI associates directly with the amino terminal \"head\" of type II epidermal keratins, including K1, K2, @PROTEIN1$, and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d197.s1675.p0","sentence":"Analysis of the human @PROTEIN1$\/human @PROTEIN2$ receptor binding interface at the amino acid level: proposed mechanism of interaction.","label":0}
{"pair_id":"AIMed.d197.s1675.p1","sentence":"Analysis of the human @PROTEIN1$\/human @PROTEIN2$ binding interface at the amino acid level: proposed mechanism of interaction.","label":1}
{"pair_id":"AIMed.d197.s1675.p2","sentence":"Analysis of the human interleukin-6\/human @PROTEIN1$@PROTEIN2$ binding interface at the amino acid level: proposed mechanism of interaction.","label":0}
{"pair_id":"BioInfer.d384.s0.p0","sentence":"In three of the cell lines with CTNNB1 mutations, complexes of beta-catenin with @PROTEIN2$ and @PROTEIN1$ were detectable.","label":0}
{"pair_id":"BioInfer.d384.s0.p1","sentence":"In three of the cell lines with CTNNB1 mutations, complexes of @PROTEIN2$ with alpha-catenin and @PROTEIN1$ were detectable.","label":1}
{"pair_id":"BioInfer.d384.s0.p2","sentence":"In three of the cell lines with @PROTEIN2$ mutations, complexes of beta-catenin with alpha-catenin and @PROTEIN1$ were detectable.","label":0}
{"pair_id":"BioInfer.d384.s0.p3","sentence":"In three of the cell lines with CTNNB1 mutations, complexes of @PROTEIN2$ with @PROTEIN1$ and APC were detectable.","label":1}
{"pair_id":"BioInfer.d384.s0.p4","sentence":"In three of the cell lines with @PROTEIN2$ mutations, complexes of beta-catenin with @PROTEIN1$ and APC were detectable.","label":0}
{"pair_id":"BioInfer.d384.s0.p5","sentence":"In three of the cell lines with @PROTEIN2$ mutations, complexes of @PROTEIN1$ with alpha-catenin and APC were detectable.","label":0}
{"pair_id":"BioInfer.d730.s0.p0","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or @PROTEIN1$ stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble @PROTEIN2$-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p1","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or @PROTEIN1$ stress fibers on fibronectin, whereas @PROTEIN2$ (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p2","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble @PROTEIN2$ or paxillin-containing focal adhesions or @PROTEIN1$ stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p3","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or @PROTEIN1$ stress fibers on @PROTEIN2$, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p4","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or @PROTEIN2$ and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or @PROTEIN1$ stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p5","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not @PROTEIN2$ (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or @PROTEIN1$ stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p6","sentence":"The undifferentiated cells (a) were unable to spread on @PROTEIN2$ or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or @PROTEIN1$ stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p7","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on @PROTEIN2$ (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or @PROTEIN1$ stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p8","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of @PROTEIN2$, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or @PROTEIN1$ stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p9","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or @PROTEIN2$-containing focal adhesions or @PROTEIN1$ stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p10","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to @PROTEIN2$, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or @PROTEIN1$ stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p11","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a @PROTEIN2$ (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or @PROTEIN1$ stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p12","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas @PROTEIN2$ (-\/-) ES cells were able to assemble @PROTEIN1$-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p13","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble @PROTEIN2$ or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble @PROTEIN1$-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p14","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on @PROTEIN2$, whereas vinculin (-\/-) ES cells were able to assemble @PROTEIN1$-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p15","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or @PROTEIN2$ and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble @PROTEIN1$-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p16","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not @PROTEIN2$ (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble @PROTEIN1$-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p17","sentence":"The undifferentiated cells (a) were unable to spread on @PROTEIN2$ or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble @PROTEIN1$-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p18","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on @PROTEIN2$ (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble @PROTEIN1$-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p19","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of @PROTEIN2$, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble @PROTEIN1$-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p20","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or @PROTEIN2$-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble @PROTEIN1$-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p21","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to @PROTEIN2$, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble @PROTEIN1$-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p22","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a @PROTEIN2$ (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble @PROTEIN1$-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p23","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble @PROTEIN2$ or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas @PROTEIN1$ (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p24","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on @PROTEIN2$, whereas @PROTEIN1$ (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p25","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or @PROTEIN2$ and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas @PROTEIN1$ (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p26","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not @PROTEIN2$ (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas @PROTEIN1$ (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p27","sentence":"The undifferentiated cells (a) were unable to spread on @PROTEIN2$ or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas @PROTEIN1$ (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p28","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on @PROTEIN2$ (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas @PROTEIN1$ (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p29","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of @PROTEIN2$, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas @PROTEIN1$ (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p30","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or @PROTEIN2$-containing focal adhesions or actin stress fibers on fibronectin, whereas @PROTEIN1$ (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p31","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to @PROTEIN2$, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas @PROTEIN1$ (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p32","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a @PROTEIN2$ (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas @PROTEIN1$ (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p33","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble @PROTEIN1$ or paxillin-containing focal adhesions or actin stress fibers on @PROTEIN2$, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p34","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or @PROTEIN2$ and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble @PROTEIN1$ or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p35","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not @PROTEIN2$ (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble @PROTEIN1$ or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p36","sentence":"The undifferentiated cells (a) were unable to spread on @PROTEIN2$ or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble @PROTEIN1$ or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p37","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on @PROTEIN2$ (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble @PROTEIN1$ or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p38","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of @PROTEIN2$, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble @PROTEIN1$ or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p39","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble @PROTEIN1$ or @PROTEIN2$-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p40","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to @PROTEIN2$, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble @PROTEIN1$ or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p41","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a @PROTEIN2$ (-\/-) ES cell mutant (e) were unable to assemble @PROTEIN1$ or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p42","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or @PROTEIN2$ and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on @PROTEIN1$, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p43","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not @PROTEIN2$ (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on @PROTEIN1$, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p44","sentence":"The undifferentiated cells (a) were unable to spread on @PROTEIN2$ or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on @PROTEIN1$, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p45","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on @PROTEIN2$ (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on @PROTEIN1$, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p46","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of @PROTEIN2$, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on @PROTEIN1$, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p47","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or @PROTEIN2$-containing focal adhesions or actin stress fibers on @PROTEIN1$, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p48","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to @PROTEIN2$, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on @PROTEIN1$, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p49","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a @PROTEIN2$ (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on @PROTEIN1$, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p50","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or @PROTEIN1$ and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not @PROTEIN2$ (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p51","sentence":"The undifferentiated cells (a) were unable to spread on @PROTEIN2$ or @PROTEIN1$ and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p52","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or @PROTEIN1$ and grew as rounded colonies, although they were able to spread on @PROTEIN2$ (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p53","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or @PROTEIN1$ and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of @PROTEIN2$, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p54","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or @PROTEIN1$ and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or @PROTEIN2$-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p55","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or @PROTEIN1$ and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to @PROTEIN2$, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p56","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or @PROTEIN1$ and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a @PROTEIN2$ (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p57","sentence":"The undifferentiated cells (a) were unable to spread on @PROTEIN2$ or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not @PROTEIN1$ (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p58","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on @PROTEIN2$ (b) showed reduced adhesion to laminin, but not @PROTEIN1$ (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p59","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not @PROTEIN1$ (c) expressed much reduced levels of @PROTEIN2$, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p60","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not @PROTEIN1$ (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or @PROTEIN2$-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p61","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to @PROTEIN2$, but not @PROTEIN1$ (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p62","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not @PROTEIN1$ (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a @PROTEIN2$ (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p63","sentence":"The undifferentiated cells (a) were unable to spread on @PROTEIN1$ or laminin and grew as rounded colonies, although they were able to spread on @PROTEIN2$ (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p64","sentence":"The undifferentiated cells (a) were unable to spread on @PROTEIN1$ or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of @PROTEIN2$, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p65","sentence":"The undifferentiated cells (a) were unable to spread on @PROTEIN1$ or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or @PROTEIN2$-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p66","sentence":"The undifferentiated cells (a) were unable to spread on @PROTEIN1$ or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to @PROTEIN2$, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p67","sentence":"The undifferentiated cells (a) were unable to spread on @PROTEIN1$ or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a @PROTEIN2$ (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p68","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on @PROTEIN1$ (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of @PROTEIN2$, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p69","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on @PROTEIN1$ (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or @PROTEIN2$-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p70","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on @PROTEIN1$ (b) showed reduced adhesion to @PROTEIN2$, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p71","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on @PROTEIN1$ (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a @PROTEIN2$ (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p72","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of @PROTEIN1$, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or @PROTEIN2$-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p73","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to @PROTEIN2$, but not fibronectin (c) expressed much reduced levels of @PROTEIN1$, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p74","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of @PROTEIN1$, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a @PROTEIN2$ (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p75","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to @PROTEIN2$, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or @PROTEIN1$-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p76","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a @PROTEIN2$ (-\/-) ES cell mutant (e) were unable to assemble vinculin or @PROTEIN1$-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p77","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to @PROTEIN1$, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a @PROTEIN2$ (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d652.s1.p0","sentence":"The Pro1176 to Thr substitution found in @PROTEIN2$ from Wistar-Furth rats does not destroy the capacity of this region of the protein to bind @PROTEIN1$ or vinculin.","label":1}
{"pair_id":"BioInfer.d652.s1.p1","sentence":"The Pro1176 to Thr substitution found in talin from Wistar-Furth rats does not destroy the capacity of this region of the protein to bind @PROTEIN1$ or @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d652.s1.p2","sentence":"The Pro1176 to Thr substitution found in @PROTEIN1$ from Wistar-Furth rats does not destroy the capacity of this region of the protein to bind actin or @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d407.s1.p0","sentence":"These results demonstrate that @PROTEIN2$ plays a crucial role in vivo in rapid remodeling of the cortical @PROTEIN1$ meshwork into bundles.","label":1}
{"pair_id":"AIMed.d70.s595.p0","sentence":"Computer-aided analysis of secondary structure, performed on four @PROTEIN1$-anchoring protein sequences (the @PROTEIN2$, P150, and two thyroid proteins Ht 21 and Ht 31), has identified common regions of approximately 14 residues which display high probabilities of forming amphipathic helices.","label":0}
{"pair_id":"AIMed.d70.s595.p1","sentence":"Computer-aided analysis of secondary structure, performed on four @PROTEIN1$-anchoring protein sequences (the microtubule-associated protein 2, @PROTEIN2$, and two thyroid proteins Ht 21 and Ht 31), has identified common regions of approximately 14 residues which display high probabilities of forming amphipathic helices.","label":0}
{"pair_id":"AIMed.d70.s595.p2","sentence":"Computer-aided analysis of secondary structure, performed on four @PROTEIN1$-anchoring protein sequences (the microtubule-associated protein 2, P150, and two thyroid proteins @PROTEIN2$ and Ht 31), has identified common regions of approximately 14 residues which display high probabilities of forming amphipathic helices.","label":0}
{"pair_id":"AIMed.d70.s595.p3","sentence":"Computer-aided analysis of secondary structure, performed on four @PROTEIN1$-anchoring protein sequences (the microtubule-associated protein 2, P150, and two thyroid proteins Ht 21 and @PROTEIN2$), has identified common regions of approximately 14 residues which display high probabilities of forming amphipathic helices.","label":0}
{"pair_id":"AIMed.d70.s595.p4","sentence":"Computer-aided analysis of secondary structure, performed on four RII-anchoring protein sequences (the @PROTEIN1$, @PROTEIN2$, and two thyroid proteins Ht 21 and Ht 31), has identified common regions of approximately 14 residues which display high probabilities of forming amphipathic helices.","label":0}
{"pair_id":"AIMed.d70.s595.p5","sentence":"Computer-aided analysis of secondary structure, performed on four RII-anchoring protein sequences (the @PROTEIN1$, P150, and two thyroid proteins @PROTEIN2$ and Ht 31), has identified common regions of approximately 14 residues which display high probabilities of forming amphipathic helices.","label":0}
{"pair_id":"AIMed.d70.s595.p6","sentence":"Computer-aided analysis of secondary structure, performed on four RII-anchoring protein sequences (the @PROTEIN1$, P150, and two thyroid proteins Ht 21 and @PROTEIN2$), has identified common regions of approximately 14 residues which display high probabilities of forming amphipathic helices.","label":0}
{"pair_id":"AIMed.d70.s595.p7","sentence":"Computer-aided analysis of secondary structure, performed on four RII-anchoring protein sequences (the microtubule-associated protein 2, @PROTEIN1$, and two thyroid proteins @PROTEIN2$ and Ht 31), has identified common regions of approximately 14 residues which display high probabilities of forming amphipathic helices.","label":0}
{"pair_id":"AIMed.d70.s595.p8","sentence":"Computer-aided analysis of secondary structure, performed on four RII-anchoring protein sequences (the microtubule-associated protein 2, @PROTEIN1$, and two thyroid proteins Ht 21 and @PROTEIN2$), has identified common regions of approximately 14 residues which display high probabilities of forming amphipathic helices.","label":0}
{"pair_id":"AIMed.d70.s595.p9","sentence":"Computer-aided analysis of secondary structure, performed on four RII-anchoring protein sequences (the microtubule-associated protein 2, P150, and two thyroid proteins @PROTEIN1$ and @PROTEIN2$), has identified common regions of approximately 14 residues which display high probabilities of forming amphipathic helices.","label":0}
{"pair_id":"BioInfer.d291.s0.p0","sentence":"Immunohistochemical identification and localization of @PROTEIN1$ and @PROTEIN2$ in vestibular hair cells in the normal guinea pig and in a strain of the waltzing guinea pig.","label":0}
{"pair_id":"AIMed.d165.s1390.p0","sentence":"Additionally we have examined interactions between @PROTEIN1$ components, the human NER protein @PROTEIN2$, and the CSB protein which is implicated in Cockayne syndrome (CS).","label":0}
{"pair_id":"AIMed.d165.s1390.p1","sentence":"Additionally we have examined interactions between @PROTEIN1$ components, the human NER protein XPG, and the @PROTEIN2$ protein which is implicated in Cockayne syndrome (CS).","label":0}
{"pair_id":"AIMed.d165.s1390.p2","sentence":"Additionally we have examined interactions between TFIIH components, the human NER protein @PROTEIN1$, and the @PROTEIN2$ protein which is implicated in Cockayne syndrome (CS).","label":0}
{"pair_id":"BioInfer.d773.s0.p0","sentence":"Transcriptional regulation in the galactose regulon of yeast is determined by an interplay between a positive regulatory protein, @PROTEIN1$, and a negative regulatory protein, @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d68.s581.p0","sentence":"Association between @PROTEIN1$ and @PROTEIN2$\/cdc2 was detected in the HeLa cells.","label":1}
{"pair_id":"AIMed.d68.s581.p1","sentence":"Association between @PROTEIN1$ and cyclin B1\/@PROTEIN2$ was detected in the HeLa cells.","label":1}
{"pair_id":"AIMed.d68.s581.p2","sentence":"Association between cdc25A and @PROTEIN1$\/@PROTEIN2$ was detected in the HeLa cells.","label":0}
{"pair_id":"BioInfer.d351.s0.p0","sentence":"In reconstitution experiments, @PROTEIN2$ filaments incubated in EGTA with purified @PROTEIN1$ and villin form smooth-sided bundles containing an apparently random number of filaments.","label":1}
{"pair_id":"BioInfer.d351.s0.p1","sentence":"In reconstitution experiments, actin filaments incubated in EGTA with purified @PROTEIN1$ and @PROTEIN2$ form smooth-sided bundles containing an apparently random number of filaments.","label":0}
{"pair_id":"BioInfer.d351.s0.p2","sentence":"In reconstitution experiments, @PROTEIN1$ filaments incubated in EGTA with purified fimbrin and @PROTEIN2$ form smooth-sided bundles containing an apparently random number of filaments.","label":1}
{"pair_id":"BioInfer.d237.s1.p0","sentence":"Interaction of the yeast @PROTEIN1$ and @PROTEIN2$ proteins plays a crucial role in yeast DNA homologous recombination and DNA double-strand break repair.","label":1}
{"pair_id":"AIMed.d141.s1189.p0","sentence":"The cyclin-dependent kinase @PROTEIN1$ associates with @PROTEIN2$, D, and E and has been implicated in the control of the G1 to S phase transition in mammals.","label":0}
{"pair_id":"BioInfer.d750.s0.p0","sentence":"Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: @PROTEIN2$ (homolog of beta-catenin), Drosophila @PROTEIN1$ (DE-cadherin), and alpha-catenin.","label":0}
{"pair_id":"BioInfer.d750.s0.p1","sentence":"Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: Armadillo (homolog of beta-catenin), Drosophila @PROTEIN1$ (DE-cadherin), and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d750.s0.p2","sentence":"Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: Armadillo (homolog of @PROTEIN2$), Drosophila @PROTEIN1$ (DE-cadherin), and alpha-catenin.","label":0}
{"pair_id":"BioInfer.d750.s0.p3","sentence":"Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: Armadillo (homolog of beta-catenin), Drosophila @PROTEIN1$ (@PROTEIN2$), and alpha-catenin.","label":0}
{"pair_id":"BioInfer.d750.s0.p4","sentence":"Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: @PROTEIN1$ (homolog of beta-catenin), Drosophila E-cadherin (DE-cadherin), and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d750.s0.p5","sentence":"Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: @PROTEIN1$ (homolog of @PROTEIN2$), Drosophila E-cadherin (DE-cadherin), and alpha-catenin.","label":1}
{"pair_id":"BioInfer.d750.s0.p6","sentence":"Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: @PROTEIN1$ (homolog of beta-catenin), Drosophila E-cadherin (@PROTEIN2$), and alpha-catenin.","label":0}
{"pair_id":"BioInfer.d750.s0.p7","sentence":"Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: Armadillo (homolog of @PROTEIN2$), Drosophila E-cadherin (DE-cadherin), and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d750.s0.p8","sentence":"Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: Armadillo (homolog of beta-catenin), Drosophila E-cadherin (@PROTEIN2$), and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d750.s0.p9","sentence":"Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: Armadillo (homolog of @PROTEIN1$), Drosophila E-cadherin (@PROTEIN2$), and alpha-catenin.","label":0}
{"pair_id":"BioInfer.d694.s0.p0","sentence":"These data strongly suggest that the head, neck, and tail domains of all myosin heavy chains, and light chains at least of @PROTEIN1$, have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated actin-dependent MgATPase activity of Dictyostelium @PROTEIN2$ requires isoform specific interactions between the heavy chain head and tail and light chains.","label":1}
{"pair_id":"BioInfer.d694.s0.p1","sentence":"These data strongly suggest that the head, neck, and tail domains of all myosin heavy chains, and light chains at least of @PROTEIN1$, have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated @PROTEIN2$-dependent MgATPase activity of Dictyostelium myosin II requires isoform specific interactions between the heavy chain head and tail and light chains.","label":0}
{"pair_id":"BioInfer.d694.s0.p2","sentence":"These data strongly suggest that the head, neck, and tail domains of all myosin heavy chains, and light chains at least of @PROTEIN1$, have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated actin-dependent @PROTEIN2$ activity of Dictyostelium myosin II requires isoform specific interactions between the heavy chain head and tail and light chains.","label":0}
{"pair_id":"BioInfer.d694.s0.p3","sentence":"These data strongly suggest that the head, neck, and tail domains of all @PROTEIN2$, and light chains at least of @PROTEIN1$, have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated actin-dependent MgATPase activity of Dictyostelium myosin II requires isoform specific interactions between the heavy chain head and tail and light chains.","label":1}
{"pair_id":"BioInfer.d694.s0.p4","sentence":"These data strongly suggest that the head, neck, and tail domains of all myosin heavy chains, and light chains at least of class II myosins, have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated @PROTEIN2$-dependent MgATPase activity of Dictyostelium @PROTEIN1$ requires isoform specific interactions between the heavy chain head and tail and light chains.","label":1}
{"pair_id":"BioInfer.d694.s0.p5","sentence":"These data strongly suggest that the head, neck, and tail domains of all myosin heavy chains, and light chains at least of class II myosins, have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated actin-dependent @PROTEIN2$ activity of Dictyostelium @PROTEIN1$ requires isoform specific interactions between the heavy chain head and tail and light chains.","label":1}
{"pair_id":"BioInfer.d694.s0.p6","sentence":"These data strongly suggest that the head, neck, and tail domains of all @PROTEIN2$, and light chains at least of class II myosins, have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated actin-dependent MgATPase activity of Dictyostelium @PROTEIN1$ requires isoform specific interactions between the heavy chain head and tail and light chains.","label":1}
{"pair_id":"BioInfer.d694.s0.p7","sentence":"These data strongly suggest that the head, neck, and tail domains of all myosin heavy chains, and light chains at least of class II myosins, have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated @PROTEIN1$-dependent @PROTEIN2$ activity of Dictyostelium myosin II requires isoform specific interactions between the heavy chain head and tail and light chains.","label":0}
{"pair_id":"BioInfer.d694.s0.p8","sentence":"These data strongly suggest that the head, neck, and tail domains of all @PROTEIN2$, and light chains at least of class II myosins, have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated @PROTEIN1$-dependent MgATPase activity of Dictyostelium myosin II requires isoform specific interactions between the heavy chain head and tail and light chains.","label":0}
{"pair_id":"BioInfer.d694.s0.p9","sentence":"These data strongly suggest that the head, neck, and tail domains of all @PROTEIN2$, and light chains at least of class II myosins, have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated actin-dependent @PROTEIN1$ activity of Dictyostelium myosin II requires isoform specific interactions between the heavy chain head and tail and light chains.","label":0}
{"pair_id":"BioInfer.d299.s0.p0","sentence":"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- @PROTEIN2$ complexes, one composed of E-cadherin, alpha-catenin and @PROTEIN1$, and the other of E-cadherin, alpha-catenin and plakoglobin.","label":0}
{"pair_id":"BioInfer.d299.s0.p1","sentence":"Immunoprecipitations showed in both cell lines the presence of two different @PROTEIN2$- catenin complexes, one composed of E-cadherin, alpha-catenin and @PROTEIN1$, and the other of E-cadherin, alpha-catenin and plakoglobin.","label":0}
{"pair_id":"BioInfer.d299.s0.p2","sentence":"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, alpha-catenin and @PROTEIN1$, and the other of @PROTEIN2$, alpha-catenin and plakoglobin.","label":0}
{"pair_id":"BioInfer.d299.s0.p3","sentence":"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, alpha-catenin and @PROTEIN1$, and the other of E-cadherin, alpha-catenin and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d299.s0.p4","sentence":"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, alpha-catenin and @PROTEIN1$, and the other of E-cadherin, @PROTEIN2$ and plakoglobin.","label":0}
{"pair_id":"BioInfer.d299.s0.p5","sentence":"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of @PROTEIN2$, alpha-catenin and @PROTEIN1$, and the other of E-cadherin, alpha-catenin and plakoglobin.","label":1}
{"pair_id":"BioInfer.d299.s0.p6","sentence":"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, @PROTEIN2$ and @PROTEIN1$, and the other of E-cadherin, alpha-catenin and plakoglobin.","label":1}
{"pair_id":"BioInfer.d299.s0.p7","sentence":"Immunoprecipitations showed in both cell lines the presence of two different @PROTEIN2$- @PROTEIN1$ complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of E-cadherin, alpha-catenin and plakoglobin.","label":1}
{"pair_id":"BioInfer.d299.s0.p8","sentence":"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- @PROTEIN1$ complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of @PROTEIN2$, alpha-catenin and plakoglobin.","label":0}
{"pair_id":"BioInfer.d299.s0.p9","sentence":"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- @PROTEIN1$ complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of E-cadherin, alpha-catenin and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d299.s0.p10","sentence":"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- @PROTEIN1$ complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of E-cadherin, @PROTEIN2$ and plakoglobin.","label":0}
{"pair_id":"BioInfer.d299.s0.p11","sentence":"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- @PROTEIN1$ complexes, one composed of @PROTEIN2$, alpha-catenin and beta-catenin, and the other of E-cadherin, alpha-catenin and plakoglobin.","label":0}
{"pair_id":"BioInfer.d299.s0.p12","sentence":"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- @PROTEIN1$ complexes, one composed of E-cadherin, @PROTEIN2$ and beta-catenin, and the other of E-cadherin, alpha-catenin and plakoglobin.","label":0}
{"pair_id":"BioInfer.d299.s0.p13","sentence":"Immunoprecipitations showed in both cell lines the presence of two different @PROTEIN1$- catenin complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of @PROTEIN2$, alpha-catenin and plakoglobin.","label":0}
{"pair_id":"BioInfer.d299.s0.p14","sentence":"Immunoprecipitations showed in both cell lines the presence of two different @PROTEIN1$- catenin complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of E-cadherin, alpha-catenin and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d299.s0.p15","sentence":"Immunoprecipitations showed in both cell lines the presence of two different @PROTEIN1$- catenin complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of E-cadherin, @PROTEIN2$ and plakoglobin.","label":0}
{"pair_id":"BioInfer.d299.s0.p16","sentence":"Immunoprecipitations showed in both cell lines the presence of two different @PROTEIN1$- catenin complexes, one composed of @PROTEIN2$, alpha-catenin and beta-catenin, and the other of E-cadherin, alpha-catenin and plakoglobin.","label":0}
{"pair_id":"BioInfer.d299.s0.p17","sentence":"Immunoprecipitations showed in both cell lines the presence of two different @PROTEIN1$- catenin complexes, one composed of E-cadherin, @PROTEIN2$ and beta-catenin, and the other of E-cadherin, alpha-catenin and plakoglobin.","label":0}
{"pair_id":"BioInfer.d299.s0.p18","sentence":"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of @PROTEIN1$, alpha-catenin and @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d299.s0.p19","sentence":"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of @PROTEIN1$, @PROTEIN2$ and plakoglobin.","label":1}
{"pair_id":"BioInfer.d299.s0.p20","sentence":"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of @PROTEIN2$, alpha-catenin and beta-catenin, and the other of @PROTEIN1$, alpha-catenin and plakoglobin.","label":0}
{"pair_id":"BioInfer.d299.s0.p21","sentence":"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, @PROTEIN2$ and beta-catenin, and the other of @PROTEIN1$, alpha-catenin and plakoglobin.","label":0}
{"pair_id":"BioInfer.d299.s0.p22","sentence":"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of E-cadherin, @PROTEIN2$ and @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d299.s0.p23","sentence":"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of @PROTEIN2$, alpha-catenin and beta-catenin, and the other of E-cadherin, alpha-catenin and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d299.s0.p24","sentence":"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, @PROTEIN2$ and beta-catenin, and the other of E-cadherin, alpha-catenin and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d299.s0.p25","sentence":"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of @PROTEIN2$, alpha-catenin and beta-catenin, and the other of E-cadherin, @PROTEIN1$ and plakoglobin.","label":0}
{"pair_id":"BioInfer.d299.s0.p26","sentence":"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, @PROTEIN2$ and beta-catenin, and the other of E-cadherin, @PROTEIN1$ and plakoglobin.","label":0}
{"pair_id":"BioInfer.d299.s0.p27","sentence":"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of @PROTEIN1$, @PROTEIN2$ and beta-catenin, and the other of E-cadherin, alpha-catenin and plakoglobin.","label":1}
{"pair_id":"AIMed.d183.s1559.p0","sentence":"In mammalian cells treated with either erythropoietin or interferon-gamma, a small fraction of @PROTEIN1$ coimmunoprecipitated with @PROTEIN2$ in lysates of cells in which JAK2 was activated as judged by its state of tyrosine phosphorylation.","label":1}
{"pair_id":"AIMed.d183.s1559.p1","sentence":"In mammalian cells treated with either erythropoietin or interferon-gamma, a small fraction of @PROTEIN1$ coimmunoprecipitated with JAK2 in lysates of cells in which @PROTEIN2$ was activated as judged by its state of tyrosine phosphorylation.","label":0}
{"pair_id":"AIMed.d183.s1559.p2","sentence":"In mammalian cells treated with either erythropoietin or interferon-gamma, a small fraction of Raf-1 coimmunoprecipitated with @PROTEIN1$ in lysates of cells in which @PROTEIN2$ was activated as judged by its state of tyrosine phosphorylation.","label":0}
{"pair_id":"AIMed.d37.s316.p0","sentence":"Among these ligands, @PROTEIN1$ had the remarkable property of binding @PROTEIN2$ with high affinity without eliciting a functional response, MCP-3 could also inhibit the activation of CCR5 by MIP-1beta and may therefore be considered as a natural antagonist for CCR5.","label":1}
{"pair_id":"AIMed.d37.s316.p1","sentence":"Among these ligands, @PROTEIN1$ had the remarkable property of binding CCR5 with high affinity without eliciting a functional response, @PROTEIN2$ could also inhibit the activation of CCR5 by MIP-1beta and may therefore be considered as a natural antagonist for CCR5.","label":0}
{"pair_id":"AIMed.d37.s316.p2","sentence":"Among these ligands, @PROTEIN1$ had the remarkable property of binding CCR5 with high affinity without eliciting a functional response, MCP-3 could also inhibit the activation of @PROTEIN2$ by MIP-1beta and may therefore be considered as a natural antagonist for CCR5.","label":0}
{"pair_id":"AIMed.d37.s316.p3","sentence":"Among these ligands, @PROTEIN1$ had the remarkable property of binding CCR5 with high affinity without eliciting a functional response, MCP-3 could also inhibit the activation of CCR5 by @PROTEIN2$ and may therefore be considered as a natural antagonist for CCR5.","label":0}
{"pair_id":"AIMed.d37.s316.p4","sentence":"Among these ligands, @PROTEIN1$ had the remarkable property of binding CCR5 with high affinity without eliciting a functional response, MCP-3 could also inhibit the activation of CCR5 by MIP-1beta and may therefore be considered as a natural antagonist for @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d37.s316.p5","sentence":"Among these ligands, MCP-3 had the remarkable property of binding @PROTEIN1$ with high affinity without eliciting a functional response, @PROTEIN2$ could also inhibit the activation of CCR5 by MIP-1beta and may therefore be considered as a natural antagonist for CCR5.","label":0}
{"pair_id":"AIMed.d37.s316.p6","sentence":"Among these ligands, MCP-3 had the remarkable property of binding @PROTEIN1$ with high affinity without eliciting a functional response, MCP-3 could also inhibit the activation of @PROTEIN2$ by MIP-1beta and may therefore be considered as a natural antagonist for CCR5.","label":0}
{"pair_id":"AIMed.d37.s316.p7","sentence":"Among these ligands, MCP-3 had the remarkable property of binding @PROTEIN1$ with high affinity without eliciting a functional response, MCP-3 could also inhibit the activation of CCR5 by @PROTEIN2$ and may therefore be considered as a natural antagonist for CCR5.","label":0}
{"pair_id":"AIMed.d37.s316.p8","sentence":"Among these ligands, MCP-3 had the remarkable property of binding @PROTEIN1$ with high affinity without eliciting a functional response, MCP-3 could also inhibit the activation of CCR5 by MIP-1beta and may therefore be considered as a natural antagonist for @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d37.s316.p9","sentence":"Among these ligands, MCP-3 had the remarkable property of binding CCR5 with high affinity without eliciting a functional response, @PROTEIN1$ could also inhibit the activation of @PROTEIN2$ by MIP-1beta and may therefore be considered as a natural antagonist for CCR5.","label":0}
{"pair_id":"AIMed.d37.s316.p10","sentence":"Among these ligands, MCP-3 had the remarkable property of binding CCR5 with high affinity without eliciting a functional response, @PROTEIN1$ could also inhibit the activation of CCR5 by @PROTEIN2$ and may therefore be considered as a natural antagonist for CCR5.","label":0}
{"pair_id":"AIMed.d37.s316.p11","sentence":"Among these ligands, MCP-3 had the remarkable property of binding CCR5 with high affinity without eliciting a functional response, @PROTEIN1$ could also inhibit the activation of CCR5 by MIP-1beta and may therefore be considered as a natural antagonist for @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d37.s316.p12","sentence":"Among these ligands, MCP-3 had the remarkable property of binding CCR5 with high affinity without eliciting a functional response, MCP-3 could also inhibit the activation of @PROTEIN1$ by @PROTEIN2$ and may therefore be considered as a natural antagonist for CCR5.","label":1}
{"pair_id":"AIMed.d37.s316.p13","sentence":"Among these ligands, MCP-3 had the remarkable property of binding CCR5 with high affinity without eliciting a functional response, MCP-3 could also inhibit the activation of @PROTEIN1$ by MIP-1beta and may therefore be considered as a natural antagonist for @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d37.s316.p14","sentence":"Among these ligands, MCP-3 had the remarkable property of binding CCR5 with high affinity without eliciting a functional response, MCP-3 could also inhibit the activation of CCR5 by @PROTEIN1$ and may therefore be considered as a natural antagonist for @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d207.s1788.p0","sentence":"Withdrawal from the cell cycle of differentiating myocytes is regulated by the @PROTEIN1$ (@PROTEIN2$) protein MyoD and the pocket proteins pRb, p107 and pRb2\/p130.","label":0}
{"pair_id":"AIMed.d207.s1788.p1","sentence":"Withdrawal from the cell cycle of differentiating myocytes is regulated by the @PROTEIN1$ (bHLH) protein @PROTEIN2$ and the pocket proteins pRb, p107 and pRb2\/p130.","label":0}
{"pair_id":"AIMed.d207.s1788.p2","sentence":"Withdrawal from the cell cycle of differentiating myocytes is regulated by the @PROTEIN1$ (bHLH) protein MyoD and the pocket proteins @PROTEIN2$, p107 and pRb2\/p130.","label":0}
{"pair_id":"AIMed.d207.s1788.p3","sentence":"Withdrawal from the cell cycle of differentiating myocytes is regulated by the @PROTEIN1$ (bHLH) protein MyoD and the pocket proteins pRb, @PROTEIN2$ and pRb2\/p130.","label":0}
{"pair_id":"AIMed.d207.s1788.p4","sentence":"Withdrawal from the cell cycle of differentiating myocytes is regulated by the @PROTEIN1$ (bHLH) protein MyoD and the pocket proteins pRb, p107 and @PROTEIN2$\/p130.","label":0}
{"pair_id":"AIMed.d207.s1788.p5","sentence":"Withdrawal from the cell cycle of differentiating myocytes is regulated by the @PROTEIN1$ (bHLH) protein MyoD and the pocket proteins pRb, p107 and pRb2\/@PROTEIN2$.","label":0}
{"pair_id":"AIMed.d207.s1788.p6","sentence":"Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (@PROTEIN1$) protein @PROTEIN2$ and the pocket proteins pRb, p107 and pRb2\/p130.","label":0}
{"pair_id":"AIMed.d207.s1788.p7","sentence":"Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (@PROTEIN1$) protein MyoD and the pocket proteins @PROTEIN2$, p107 and pRb2\/p130.","label":0}
{"pair_id":"AIMed.d207.s1788.p8","sentence":"Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (@PROTEIN1$) protein MyoD and the pocket proteins pRb, @PROTEIN2$ and pRb2\/p130.","label":0}
{"pair_id":"AIMed.d207.s1788.p9","sentence":"Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (@PROTEIN1$) protein MyoD and the pocket proteins pRb, p107 and @PROTEIN2$\/p130.","label":0}
{"pair_id":"AIMed.d207.s1788.p10","sentence":"Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (@PROTEIN1$) protein MyoD and the pocket proteins pRb, p107 and pRb2\/@PROTEIN2$.","label":0}
{"pair_id":"AIMed.d207.s1788.p11","sentence":"Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein @PROTEIN1$ and the pocket proteins @PROTEIN2$, p107 and pRb2\/p130.","label":0}
{"pair_id":"AIMed.d207.s1788.p12","sentence":"Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein @PROTEIN1$ and the pocket proteins pRb, @PROTEIN2$ and pRb2\/p130.","label":0}
{"pair_id":"AIMed.d207.s1788.p13","sentence":"Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein @PROTEIN1$ and the pocket proteins pRb, p107 and @PROTEIN2$\/p130.","label":0}
{"pair_id":"AIMed.d207.s1788.p14","sentence":"Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein @PROTEIN1$ and the pocket proteins pRb, p107 and pRb2\/@PROTEIN2$.","label":0}
{"pair_id":"AIMed.d207.s1788.p15","sentence":"Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein MyoD and the pocket proteins @PROTEIN1$, @PROTEIN2$ and pRb2\/p130.","label":0}
{"pair_id":"AIMed.d207.s1788.p16","sentence":"Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein MyoD and the pocket proteins @PROTEIN1$, p107 and @PROTEIN2$\/p130.","label":0}
{"pair_id":"AIMed.d207.s1788.p17","sentence":"Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein MyoD and the pocket proteins @PROTEIN1$, p107 and pRb2\/@PROTEIN2$.","label":0}
{"pair_id":"AIMed.d207.s1788.p18","sentence":"Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein MyoD and the pocket proteins pRb, @PROTEIN1$ and @PROTEIN2$\/p130.","label":0}
{"pair_id":"AIMed.d207.s1788.p19","sentence":"Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein MyoD and the pocket proteins pRb, @PROTEIN1$ and pRb2\/@PROTEIN2$.","label":0}
{"pair_id":"AIMed.d207.s1788.p20","sentence":"Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein MyoD and the pocket proteins pRb, p107 and @PROTEIN1$\/@PROTEIN2$.","label":0}
{"pair_id":"AIMed.d81.s688.p0","sentence":"@PROTEIN1$: a novel protein containing a death domain that interacts with @PROTEIN2$\/APO-1 (CD95) in yeast and causes cell death.","label":1}
{"pair_id":"AIMed.d81.s688.p1","sentence":"@PROTEIN1$: a novel protein containing a death domain that interacts with Fas\/@PROTEIN2$ (CD95) in yeast and causes cell death.","label":1}
{"pair_id":"AIMed.d81.s688.p2","sentence":"@PROTEIN1$: a novel protein containing a death domain that interacts with Fas\/APO-1 (@PROTEIN2$) in yeast and causes cell death.","label":1}
{"pair_id":"AIMed.d81.s688.p3","sentence":"RIP: a novel protein containing a death domain that interacts with @PROTEIN1$\/@PROTEIN2$ (CD95) in yeast and causes cell death.","label":0}
{"pair_id":"AIMed.d81.s688.p4","sentence":"RIP: a novel protein containing a death domain that interacts with @PROTEIN1$\/APO-1 (@PROTEIN2$) in yeast and causes cell death.","label":0}
{"pair_id":"AIMed.d81.s688.p5","sentence":"RIP: a novel protein containing a death domain that interacts with Fas\/@PROTEIN1$ (@PROTEIN2$) in yeast and causes cell death.","label":0}
{"pair_id":"AIMed.d103.s869.p0","sentence":"In contrast to @PROTEIN1$, @PROTEIN2$ is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).","label":0}
{"pair_id":"AIMed.d103.s869.p1","sentence":"In contrast to @PROTEIN1$, hTAFII18 is a @PROTEIN2$ beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).","label":0}
{"pair_id":"AIMed.d103.s869.p2","sentence":"In contrast to @PROTEIN1$, hTAFII18 is a @PROTEIN2$-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).","label":0}
{"pair_id":"AIMed.d103.s869.p3","sentence":"In contrast to @PROTEIN1$, hTAFII18 is a TFIID beta-specific @PROTEIN2$. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).","label":0}
{"pair_id":"AIMed.d103.s869.p4","sentence":"In contrast to @PROTEIN1$, hTAFII18 is a TFIID beta-specific hTAFII. @PROTEIN2$ is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).","label":0}
{"pair_id":"AIMed.d103.s869.p5","sentence":"In contrast to @PROTEIN1$, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of @PROTEIN2$, an alternatively spliced form of dTAFII30 alpha (p32).","label":0}
{"pair_id":"AIMed.d103.s869.p6","sentence":"In contrast to @PROTEIN1$, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of d@PROTEIN2$ (p32).","label":0}
{"pair_id":"AIMed.d103.s869.p7","sentence":"In contrast to @PROTEIN1$, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (@PROTEIN2$).","label":0}
{"pair_id":"AIMed.d103.s869.p8","sentence":"In contrast to hTAFII28, @PROTEIN1$ is a @PROTEIN2$ beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).","label":0}
{"pair_id":"AIMed.d103.s869.p9","sentence":"In contrast to hTAFII28, @PROTEIN1$ is a @PROTEIN2$-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).","label":0}
{"pair_id":"AIMed.d103.s869.p10","sentence":"In contrast to hTAFII28, @PROTEIN1$ is a TFIID beta-specific @PROTEIN2$. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).","label":0}
{"pair_id":"AIMed.d103.s869.p11","sentence":"In contrast to hTAFII28, @PROTEIN1$ is a TFIID beta-specific hTAFII. @PROTEIN2$ is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).","label":0}
{"pair_id":"AIMed.d103.s869.p12","sentence":"In contrast to hTAFII28, @PROTEIN1$ is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of @PROTEIN2$, an alternatively spliced form of dTAFII30 alpha (p32).","label":0}
{"pair_id":"AIMed.d103.s869.p13","sentence":"In contrast to hTAFII28, @PROTEIN1$ is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of d@PROTEIN2$ (p32).","label":0}
{"pair_id":"AIMed.d103.s869.p14","sentence":"In contrast to hTAFII28, @PROTEIN1$ is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (@PROTEIN2$).","label":0}
{"pair_id":"AIMed.d103.s869.p15","sentence":"In contrast to hTAFII28, hTAFII18 is a @PROTEIN1$@PROTEIN2$-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).","label":0}
{"pair_id":"AIMed.d103.s869.p16","sentence":"In contrast to hTAFII28, hTAFII18 is a @PROTEIN1$ beta-specific @PROTEIN2$. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).","label":0}
{"pair_id":"AIMed.d103.s869.p17","sentence":"In contrast to hTAFII28, hTAFII18 is a @PROTEIN1$ beta-specific hTAFII. @PROTEIN2$ is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).","label":0}
{"pair_id":"AIMed.d103.s869.p18","sentence":"In contrast to hTAFII28, hTAFII18 is a @PROTEIN1$ beta-specific hTAFII. hTAFII20 is the homologue of @PROTEIN2$, an alternatively spliced form of dTAFII30 alpha (p32).","label":0}
{"pair_id":"AIMed.d103.s869.p19","sentence":"In contrast to hTAFII28, hTAFII18 is a @PROTEIN1$ beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of d@PROTEIN2$ (p32).","label":0}
{"pair_id":"AIMed.d103.s869.p20","sentence":"In contrast to hTAFII28, hTAFII18 is a @PROTEIN1$ beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (@PROTEIN2$).","label":0}
{"pair_id":"AIMed.d103.s869.p21","sentence":"In contrast to hTAFII28, hTAFII18 is a @PROTEIN1$-specific @PROTEIN2$. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).","label":0}
{"pair_id":"AIMed.d103.s869.p22","sentence":"In contrast to hTAFII28, hTAFII18 is a @PROTEIN1$-specific hTAFII. @PROTEIN2$ is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).","label":0}
{"pair_id":"AIMed.d103.s869.p23","sentence":"In contrast to hTAFII28, hTAFII18 is a @PROTEIN1$-specific hTAFII. hTAFII20 is the homologue of @PROTEIN2$, an alternatively spliced form of dTAFII30 alpha (p32).","label":0}
{"pair_id":"AIMed.d103.s869.p24","sentence":"In contrast to hTAFII28, hTAFII18 is a @PROTEIN1$-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of d@PROTEIN2$ (p32).","label":0}
{"pair_id":"AIMed.d103.s869.p25","sentence":"In contrast to hTAFII28, hTAFII18 is a @PROTEIN1$-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (@PROTEIN2$).","label":0}
{"pair_id":"AIMed.d103.s869.p26","sentence":"In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific @PROTEIN1$. @PROTEIN2$ is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).","label":0}
{"pair_id":"AIMed.d103.s869.p27","sentence":"In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific @PROTEIN1$. hTAFII20 is the homologue of @PROTEIN2$, an alternatively spliced form of dTAFII30 alpha (p32).","label":0}
{"pair_id":"AIMed.d103.s869.p28","sentence":"In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific @PROTEIN1$. hTAFII20 is the homologue of p22, an alternatively spliced form of d@PROTEIN2$ (p32).","label":0}
{"pair_id":"AIMed.d103.s869.p29","sentence":"In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific @PROTEIN1$. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (@PROTEIN2$).","label":0}
{"pair_id":"AIMed.d103.s869.p30","sentence":"In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. @PROTEIN1$ is the homologue of @PROTEIN2$, an alternatively spliced form of dTAFII30 alpha (p32).","label":0}
{"pair_id":"AIMed.d103.s869.p31","sentence":"In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. @PROTEIN1$ is the homologue of p22, an alternatively spliced form of d@PROTEIN2$ (p32).","label":0}
{"pair_id":"AIMed.d103.s869.p32","sentence":"In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. @PROTEIN1$ is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (@PROTEIN2$).","label":0}
{"pair_id":"AIMed.d103.s869.p33","sentence":"In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of @PROTEIN1$, an alternatively spliced form of d@PROTEIN2$ (p32).","label":0}
{"pair_id":"AIMed.d103.s869.p34","sentence":"In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of @PROTEIN1$, an alternatively spliced form of dTAFII30 alpha (@PROTEIN2$).","label":0}
{"pair_id":"AIMed.d103.s869.p35","sentence":"In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of d@PROTEIN1$ (@PROTEIN2$).","label":0}
{"pair_id":"AIMed.d41.s358.p0","sentence":"The @PROTEIN1$-@PROTEIN2$ complex suggests a binding site for transferrin on TfR and sheds light upon the function of HFE in regulating iron homeostasis.","label":1}
{"pair_id":"AIMed.d41.s358.p1","sentence":"The @PROTEIN1$-TfR complex suggests a binding site for transferrin on @PROTEIN2$ and sheds light upon the function of HFE in regulating iron homeostasis.","label":0}
{"pair_id":"AIMed.d41.s358.p2","sentence":"The @PROTEIN1$-TfR complex suggests a binding site for transferrin on TfR and sheds light upon the function of @PROTEIN2$ in regulating iron homeostasis.","label":0}
{"pair_id":"AIMed.d41.s358.p3","sentence":"The HFE-@PROTEIN1$ complex suggests a binding site for transferrin on @PROTEIN2$ and sheds light upon the function of HFE in regulating iron homeostasis.","label":0}
{"pair_id":"AIMed.d41.s358.p4","sentence":"The HFE-@PROTEIN1$ complex suggests a binding site for transferrin on TfR and sheds light upon the function of @PROTEIN2$ in regulating iron homeostasis.","label":0}
{"pair_id":"AIMed.d41.s358.p5","sentence":"The HFE-TfR complex suggests a binding site for transferrin on @PROTEIN1$ and sheds light upon the function of @PROTEIN2$ in regulating iron homeostasis.","label":0}
{"pair_id":"BioInfer.d519.s0.p0","sentence":"Requirement of the yeast MSH3 and @PROTEIN2$ genes for @PROTEIN1$-dependent genomic stability.","label":1}
{"pair_id":"BioInfer.d519.s0.p1","sentence":"Requirement of the yeast @PROTEIN2$ and MSH6 genes for @PROTEIN1$-dependent genomic stability.","label":1}
{"pair_id":"BioInfer.d519.s0.p2","sentence":"Requirement of the yeast @PROTEIN2$ and @PROTEIN1$ genes for MSH2-dependent genomic stability.","label":0}
{"pair_id":"AIMed.d46.s405.p0","sentence":"The binding epitopes of @PROTEIN1$ for @PROTEIN2$ (type I) and BMPR-II or ActR-II (type II) were characterized using BMP-2 mutant proteins for analysis of interactions with receptor ectodomains.","label":1}
{"pair_id":"AIMed.d46.s405.p1","sentence":"The binding epitopes of @PROTEIN1$ for BMPR-IA (type I) and @PROTEIN2$ or ActR-II (type II) were characterized using BMP-2 mutant proteins for analysis of interactions with receptor ectodomains.","label":1}
{"pair_id":"AIMed.d46.s405.p2","sentence":"The binding epitopes of @PROTEIN1$ for BMPR-IA (type I) and BMPR-II or @PROTEIN2$ (type II) were characterized using BMP-2 mutant proteins for analysis of interactions with receptor ectodomains.","label":1}
{"pair_id":"AIMed.d46.s405.p3","sentence":"The binding epitopes of @PROTEIN1$ for BMPR-IA (type I) and BMPR-II or ActR-II (type II) were characterized using @PROTEIN2$ mutant proteins for analysis of interactions with receptor ectodomains.","label":0}
{"pair_id":"AIMed.d46.s405.p4","sentence":"The binding epitopes of BMP-2 for @PROTEIN1$ (type I) and @PROTEIN2$ or ActR-II (type II) were characterized using BMP-2 mutant proteins for analysis of interactions with receptor ectodomains.","label":0}
{"pair_id":"AIMed.d46.s405.p5","sentence":"The binding epitopes of BMP-2 for @PROTEIN1$ (type I) and BMPR-II or @PROTEIN2$ (type II) were characterized using BMP-2 mutant proteins for analysis of interactions with receptor ectodomains.","label":0}
{"pair_id":"AIMed.d46.s405.p6","sentence":"The binding epitopes of BMP-2 for @PROTEIN1$ (type I) and BMPR-II or ActR-II (type II) were characterized using @PROTEIN2$ mutant proteins for analysis of interactions with receptor ectodomains.","label":0}
{"pair_id":"AIMed.d46.s405.p7","sentence":"The binding epitopes of BMP-2 for BMPR-IA (type I) and @PROTEIN1$ or @PROTEIN2$ (type II) were characterized using BMP-2 mutant proteins for analysis of interactions with receptor ectodomains.","label":0}
{"pair_id":"AIMed.d46.s405.p8","sentence":"The binding epitopes of BMP-2 for BMPR-IA (type I) and @PROTEIN1$ or ActR-II (type II) were characterized using @PROTEIN2$ mutant proteins for analysis of interactions with receptor ectodomains.","label":0}
{"pair_id":"AIMed.d46.s405.p9","sentence":"The binding epitopes of BMP-2 for BMPR-IA (type I) and BMPR-II or @PROTEIN1$ (type II) were characterized using @PROTEIN2$ mutant proteins for analysis of interactions with receptor ectodomains.","label":0}
{"pair_id":"BioInfer.d7.s4.p0","sentence":"MgCl2 strongly inhibits these effects of @PROTEIN2$, most likely by binding to the high-affinity divalent cation site on the @PROTEIN1$.","label":1}
{"pair_id":"AIMed.d32.s274.p0","sentence":"Thus, Phe93 and Phe205 are important binding determinants for both @PROTEIN1$ and @PROTEIN2$, even though these ligands share no sequence or structural homology, suggesting that these residues may represent a minimum epitope on the EPOR for productive ligand binding.","label":0}
{"pair_id":"AIMed.d32.s274.p1","sentence":"Thus, Phe93 and Phe205 are important binding determinants for both @PROTEIN1$ and EMP1, even though these ligands share no sequence or structural homology, suggesting that these residues may represent a minimum epitope on the @PROTEIN2$ for productive ligand binding.","label":1}
{"pair_id":"AIMed.d32.s274.p2","sentence":"Thus, Phe93 and Phe205 are important binding determinants for both EPO and @PROTEIN1$, even though these ligands share no sequence or structural homology, suggesting that these residues may represent a minimum epitope on the @PROTEIN2$ for productive ligand binding.","label":1}
{"pair_id":"AIMed.d209.s1808.p0","sentence":"@PROTEIN1$ interacts with the \"effector domain\" of @PROTEIN2$ and employs some RAS determinants that are common to, and others that are distinct from, those required for the binding of RAF1, a known RAS effector.","label":1}
{"pair_id":"AIMed.d209.s1808.p1","sentence":"@PROTEIN1$ interacts with the \"effector domain\" of RAS and employs some @PROTEIN2$ determinants that are common to, and others that are distinct from, those required for the binding of RAF1, a known RAS effector.","label":0}
{"pair_id":"AIMed.d209.s1808.p2","sentence":"@PROTEIN1$ interacts with the \"effector domain\" of RAS and employs some RAS determinants that are common to, and others that are distinct from, those required for the binding of @PROTEIN2$, a known RAS effector.","label":0}
{"pair_id":"AIMed.d209.s1808.p3","sentence":"@PROTEIN1$ interacts with the \"effector domain\" of RAS and employs some RAS determinants that are common to, and others that are distinct from, those required for the binding of RAF1, a known @PROTEIN2$ effector.","label":0}
{"pair_id":"AIMed.d209.s1808.p4","sentence":"RIN1 interacts with the \"effector domain\" of @PROTEIN1$ and employs some @PROTEIN2$ determinants that are common to, and others that are distinct from, those required for the binding of RAF1, a known RAS effector.","label":0}
{"pair_id":"AIMed.d209.s1808.p5","sentence":"RIN1 interacts with the \"effector domain\" of @PROTEIN1$ and employs some RAS determinants that are common to, and others that are distinct from, those required for the binding of @PROTEIN2$, a known RAS effector.","label":0}
{"pair_id":"AIMed.d209.s1808.p6","sentence":"RIN1 interacts with the \"effector domain\" of @PROTEIN1$ and employs some RAS determinants that are common to, and others that are distinct from, those required for the binding of RAF1, a known @PROTEIN2$ effector.","label":0}
{"pair_id":"AIMed.d209.s1808.p7","sentence":"RIN1 interacts with the \"effector domain\" of RAS and employs some @PROTEIN1$ determinants that are common to, and others that are distinct from, those required for the binding of @PROTEIN2$, a known RAS effector.","label":0}
{"pair_id":"AIMed.d209.s1808.p8","sentence":"RIN1 interacts with the \"effector domain\" of RAS and employs some @PROTEIN1$ determinants that are common to, and others that are distinct from, those required for the binding of RAF1, a known @PROTEIN2$ effector.","label":0}
{"pair_id":"AIMed.d209.s1808.p9","sentence":"RIN1 interacts with the \"effector domain\" of RAS and employs some RAS determinants that are common to, and others that are distinct from, those required for the binding of @PROTEIN1$, a known @PROTEIN2$ effector.","label":1}
{"pair_id":"AIMed.d199.s1699.p0","sentence":"@PROTEIN1$ utilizes two different pools of adapter protein @PROTEIN2$ to link to Ras.","label":0}
{"pair_id":"AIMed.d199.s1699.p1","sentence":"@PROTEIN1$ utilizes two different pools of adapter protein GRB2 to link to @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d199.s1699.p2","sentence":"FGFR3 utilizes two different pools of adapter protein @PROTEIN1$ to link to @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d94.s799.p0","sentence":"When [Ca2+]i changes were monitored in stably transfected human embryonic kidney 293 cells, @PROTEIN1$ @PROTEIN2$ and RANTES were both potent agonists for CC CKR3 and CC CKR1.","label":0}
{"pair_id":"AIMed.d94.s799.p1","sentence":"When [Ca2+]i changes were monitored in stably transfected human embryonic kidney 293 cells, @PROTEIN1$ MIP and @PROTEIN2$ were both potent agonists for CC CKR3 and CC CKR1.","label":0}
{"pair_id":"AIMed.d94.s799.p2","sentence":"When [Ca2+]i changes were monitored in stably transfected human embryonic kidney 293 cells, @PROTEIN1$ MIP and RANTES were both potent agonists for @PROTEIN2$ and CC CKR1.","label":1}
{"pair_id":"AIMed.d94.s799.p3","sentence":"When [Ca2+]i changes were monitored in stably transfected human embryonic kidney 293 cells, @PROTEIN1$ MIP and RANTES were both potent agonists for CC CKR3 and @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d94.s799.p4","sentence":"When [Ca2+]i changes were monitored in stably transfected human embryonic kidney 293 cells, (MIP)-1 alpha @PROTEIN1$ and @PROTEIN2$ were both potent agonists for CC CKR3 and CC CKR1.","label":0}
{"pair_id":"AIMed.d94.s799.p5","sentence":"When [Ca2+]i changes were monitored in stably transfected human embryonic kidney 293 cells, (MIP)-1 alpha @PROTEIN1$ and RANTES were both potent agonists for @PROTEIN2$ and CC CKR1.","label":0}
{"pair_id":"AIMed.d94.s799.p6","sentence":"When [Ca2+]i changes were monitored in stably transfected human embryonic kidney 293 cells, (MIP)-1 alpha @PROTEIN1$ and RANTES were both potent agonists for CC CKR3 and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d94.s799.p7","sentence":"When [Ca2+]i changes were monitored in stably transfected human embryonic kidney 293 cells, (MIP)-1 alpha MIP and @PROTEIN1$ were both potent agonists for @PROTEIN2$ and CC CKR1.","label":1}
{"pair_id":"AIMed.d94.s799.p8","sentence":"When [Ca2+]i changes were monitored in stably transfected human embryonic kidney 293 cells, (MIP)-1 alpha MIP and @PROTEIN1$ were both potent agonists for CC CKR3 and @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d94.s799.p9","sentence":"When [Ca2+]i changes were monitored in stably transfected human embryonic kidney 293 cells, (MIP)-1 alpha MIP and RANTES were both potent agonists for @PROTEIN1$ and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d199.s1700.p0","sentence":"Activated @PROTEIN1$ predominantly interacts with @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d5.s1.p0","sentence":"Acanthamoeba @PROTEIN1$ was cross-linked to @PROTEIN2$ via a zero-length isopeptide bond using carbodiimide.","label":1}
{"pair_id":"BioInfer.d723.s0.p0","sentence":"The structural homology between cofilin and @PROTEIN2$ segment-1 binding to @PROTEIN1$ was confirmed experimentally by two types of competitive binding assays.","label":1}
{"pair_id":"BioInfer.d723.s0.p1","sentence":"The structural homology between @PROTEIN2$ and gelsolin segment-1 binding to @PROTEIN1$ was confirmed experimentally by two types of competitive binding assays.","label":1}
{"pair_id":"BioInfer.d723.s0.p2","sentence":"The structural homology between @PROTEIN2$ and @PROTEIN1$ segment-1 binding to actin was confirmed experimentally by two types of competitive binding assays.","label":1}
{"pair_id":"BioInfer.d241.s0.p0","sentence":"Here, we describe proline-rich proteins involved in regulating @PROTEIN1$ polymerization and classify them according to their role in recruiting @PROTEIN2$ to the membrane.","label":0}
{"pair_id":"BioInfer.d261.s0.p0","sentence":"Herpes simplex virus type 1 (HSV-1) encodes a heterotrimeric @PROTEIN2$ composed of the products of the three DNA replication-specific genes UL5, @PROTEIN1$, and UL52 (Crute, J. J., and Lehman, I. R. (1991) J. Biol. Chem. 266, 4484-4488).","label":1}
{"pair_id":"BioInfer.d261.s0.p1","sentence":"Herpes simplex virus type 1 (HSV-1) encodes a heterotrimeric helicase-primase composed of the products of the three DNA replication-specific genes @PROTEIN2$, @PROTEIN1$, and UL52 (Crute, J. J., and Lehman, I. R. (1991) J. Biol. Chem. 266, 4484-4488).","label":1}
{"pair_id":"BioInfer.d261.s0.p2","sentence":"Herpes simplex virus type 1 (HSV-1) encodes a heterotrimeric helicase-primase composed of the products of the three DNA replication-specific genes UL5, @PROTEIN1$, and @PROTEIN2$ (Crute, J. J., and Lehman, I. R. (1991) J. Biol. Chem. 266, 4484-4488).","label":1}
{"pair_id":"BioInfer.d261.s0.p3","sentence":"Herpes simplex virus type 1 (HSV-1) encodes a heterotrimeric @PROTEIN1$ composed of the products of the three DNA replication-specific genes @PROTEIN2$, UL8, and UL52 (Crute, J. J., and Lehman, I. R. (1991) J. Biol. Chem. 266, 4484-4488).","label":1}
{"pair_id":"BioInfer.d261.s0.p4","sentence":"Herpes simplex virus type 1 (HSV-1) encodes a heterotrimeric @PROTEIN1$ composed of the products of the three DNA replication-specific genes UL5, UL8, and @PROTEIN2$ (Crute, J. J., and Lehman, I. R. (1991) J. Biol. Chem. 266, 4484-4488).","label":1}
{"pair_id":"BioInfer.d261.s0.p5","sentence":"Herpes simplex virus type 1 (HSV-1) encodes a heterotrimeric helicase-primase composed of the products of the three DNA replication-specific genes @PROTEIN1$, UL8, and @PROTEIN2$ (Crute, J. J., and Lehman, I. R. (1991) J. Biol. Chem. 266, 4484-4488).","label":1}
{"pair_id":"AIMed.d199.s1715.p0","sentence":"Finally, activated @PROTEIN1$ was also found to result in phosphorylation of @PROTEIN2$ but reduced phosphorylation of c-Src.","label":0}
{"pair_id":"AIMed.d199.s1715.p1","sentence":"Finally, activated @PROTEIN1$ was also found to result in phosphorylation of phospholipase C-gamma but reduced phosphorylation of @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d199.s1715.p2","sentence":"Finally, activated FGFR3 was also found to result in phosphorylation of @PROTEIN1$ but reduced phosphorylation of @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d161.s1353.p0","sentence":"Use of the two hybrid system to detect the association of the protein-tyrosine-phosphatase, @PROTEIN1$, with another SH2-containing protein, @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d92.s785.p0","sentence":"@PROTEIN1$ binds independently to two transmembrane receptors, the @PROTEIN2$ neurotrophin receptor and the p140trk (trkA) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to NGF.","label":0}
{"pair_id":"AIMed.d92.s785.p1","sentence":"@PROTEIN1$ binds independently to two transmembrane receptors, the @PROTEIN2$ and the p140trk (trkA) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to NGF.","label":1}
{"pair_id":"AIMed.d92.s785.p2","sentence":"@PROTEIN1$ binds independently to two transmembrane receptors, the p75 neurotrophin receptor and the @PROTEIN2$ (trkA) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to NGF.","label":0}
{"pair_id":"AIMed.d92.s785.p3","sentence":"@PROTEIN1$ binds independently to two transmembrane receptors, the p75 neurotrophin receptor and the p140trk (@PROTEIN2$) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to NGF.","label":0}
{"pair_id":"AIMed.d92.s785.p4","sentence":"@PROTEIN1$ binds independently to two transmembrane receptors, the p75 neurotrophin receptor and the @PROTEIN2$, which are both co-expressed in the majority of neuronal cells that respond to NGF.","label":1}
{"pair_id":"AIMed.d92.s785.p5","sentence":"@PROTEIN1$ binds independently to two transmembrane receptors, the p75 neurotrophin receptor and the p140trk (trkA) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d92.s785.p6","sentence":"Nerve growth factor binds independently to two transmembrane receptors, the @PROTEIN1$@PROTEIN2$ and the p140trk (trkA) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to NGF.","label":0}
{"pair_id":"AIMed.d92.s785.p7","sentence":"Nerve growth factor binds independently to two transmembrane receptors, the @PROTEIN1$ neurotrophin receptor and the @PROTEIN2$ (trkA) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to NGF.","label":0}
{"pair_id":"AIMed.d92.s785.p8","sentence":"Nerve growth factor binds independently to two transmembrane receptors, the @PROTEIN1$ neurotrophin receptor and the p140trk (@PROTEIN2$) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to NGF.","label":0}
{"pair_id":"AIMed.d92.s785.p9","sentence":"Nerve growth factor binds independently to two transmembrane receptors, the @PROTEIN1$ neurotrophin receptor and the @PROTEIN2$, which are both co-expressed in the majority of neuronal cells that respond to NGF.","label":0}
{"pair_id":"AIMed.d92.s785.p10","sentence":"Nerve growth factor binds independently to two transmembrane receptors, the @PROTEIN1$ neurotrophin receptor and the p140trk (trkA) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d92.s785.p11","sentence":"Nerve growth factor binds independently to two transmembrane receptors, the @PROTEIN1$ and the @PROTEIN2$ (trkA) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to NGF.","label":0}
{"pair_id":"AIMed.d92.s785.p12","sentence":"Nerve growth factor binds independently to two transmembrane receptors, the @PROTEIN1$ and the p140trk (@PROTEIN2$) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to NGF.","label":0}
{"pair_id":"AIMed.d92.s785.p13","sentence":"Nerve growth factor binds independently to two transmembrane receptors, the @PROTEIN1$ and the @PROTEIN2$, which are both co-expressed in the majority of neuronal cells that respond to NGF.","label":0}
{"pair_id":"AIMed.d92.s785.p14","sentence":"Nerve growth factor binds independently to two transmembrane receptors, the @PROTEIN1$ and the p140trk (trkA) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d92.s785.p15","sentence":"Nerve growth factor binds independently to two transmembrane receptors, the p75 neurotrophin receptor and the @PROTEIN1$ (@PROTEIN2$) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to NGF.","label":0}
{"pair_id":"AIMed.d92.s785.p16","sentence":"Nerve growth factor binds independently to two transmembrane receptors, the p75 neurotrophin receptor and the @PROTEIN1$@PROTEIN2$, which are both co-expressed in the majority of neuronal cells that respond to NGF.","label":0}
{"pair_id":"AIMed.d92.s785.p17","sentence":"Nerve growth factor binds independently to two transmembrane receptors, the p75 neurotrophin receptor and the @PROTEIN1$ (trkA) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d92.s785.p18","sentence":"Nerve growth factor binds independently to two transmembrane receptors, the p75 neurotrophin receptor and the @PROTEIN2$@PROTEIN1$) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to NGF.","label":0}
{"pair_id":"AIMed.d92.s785.p19","sentence":"Nerve growth factor binds independently to two transmembrane receptors, the p75 neurotrophin receptor and the p140trk (@PROTEIN1$) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d92.s785.p20","sentence":"Nerve growth factor binds independently to two transmembrane receptors, the p75 neurotrophin receptor and the @PROTEIN1$, which are both co-expressed in the majority of neuronal cells that respond to @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d44.s380.p0","sentence":"@PROTEIN1$ and its counter-receptor @PROTEIN2$ ligand (CD30L) are members of the TNF-receptor\/TNFalpha superfamily and function to regulate lymphocyte survival and differentiation.","label":0}
{"pair_id":"AIMed.d44.s380.p1","sentence":"@PROTEIN1$ and its counter-receptor @PROTEIN2$ (CD30L) are members of the TNF-receptor\/TNFalpha superfamily and function to regulate lymphocyte survival and differentiation.","label":1}
{"pair_id":"AIMed.d44.s380.p2","sentence":"@PROTEIN1$ and its counter-receptor CD30 ligand (@PROTEIN2$) are members of the TNF-receptor\/TNFalpha superfamily and function to regulate lymphocyte survival and differentiation.","label":1}
{"pair_id":"AIMed.d44.s380.p3","sentence":"@PROTEIN1$ and its counter-receptor CD30 ligand (CD30L) are members of the TNF-receptor\/@PROTEIN2$ superfamily and function to regulate lymphocyte survival and differentiation.","label":0}
{"pair_id":"AIMed.d44.s380.p4","sentence":"CD30 and its counter-receptor @PROTEIN1$@PROTEIN2$ (CD30L) are members of the TNF-receptor\/TNFalpha superfamily and function to regulate lymphocyte survival and differentiation.","label":0}
{"pair_id":"AIMed.d44.s380.p5","sentence":"CD30 and its counter-receptor @PROTEIN1$ ligand (@PROTEIN2$) are members of the TNF-receptor\/TNFalpha superfamily and function to regulate lymphocyte survival and differentiation.","label":0}
{"pair_id":"AIMed.d44.s380.p6","sentence":"CD30 and its counter-receptor @PROTEIN1$ ligand (CD30L) are members of the TNF-receptor\/@PROTEIN2$ superfamily and function to regulate lymphocyte survival and differentiation.","label":0}
{"pair_id":"AIMed.d44.s380.p7","sentence":"CD30 and its counter-receptor @PROTEIN1$ (@PROTEIN2$) are members of the TNF-receptor\/TNFalpha superfamily and function to regulate lymphocyte survival and differentiation.","label":0}
{"pair_id":"AIMed.d44.s380.p8","sentence":"CD30 and its counter-receptor @PROTEIN1$ (CD30L) are members of the TNF-receptor\/@PROTEIN2$ superfamily and function to regulate lymphocyte survival and differentiation.","label":0}
{"pair_id":"AIMed.d44.s380.p9","sentence":"CD30 and its counter-receptor CD30 ligand (@PROTEIN1$) are members of the TNF-receptor\/@PROTEIN2$ superfamily and function to regulate lymphocyte survival and differentiation.","label":0}
{"pair_id":"BioInfer.d232.s1.p0","sentence":"We find that heterozygotes for actin (Act88F) or myosin heavy chain (@PROTEIN2$) null alleles have complex myofibrillar defects, whereas Mhc36B-\/+; @PROTEIN1$-\/+ double heterozygotes have nearly normal myofibrils.","label":0}
{"pair_id":"BioInfer.d232.s1.p1","sentence":"We find that heterozygotes for actin (Act88F) or @PROTEIN2$ (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-\/+; @PROTEIN1$-\/+ double heterozygotes have nearly normal myofibrils.","label":0}
{"pair_id":"BioInfer.d232.s1.p2","sentence":"We find that heterozygotes for actin (@PROTEIN2$) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-\/+; @PROTEIN1$-\/+ double heterozygotes have nearly normal myofibrils.","label":0}
{"pair_id":"BioInfer.d232.s1.p3","sentence":"We find that heterozygotes for @PROTEIN2$ (Act88F) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-\/+; @PROTEIN1$-\/+ double heterozygotes have nearly normal myofibrils.","label":0}
{"pair_id":"BioInfer.d232.s1.p4","sentence":"We find that heterozygotes for actin (Act88F) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas @PROTEIN2$-\/+; @PROTEIN1$-\/+ double heterozygotes have nearly normal myofibrils.","label":0}
{"pair_id":"BioInfer.d232.s1.p5","sentence":"We find that heterozygotes for actin (Act88F) or @PROTEIN2$ (@PROTEIN1$) null alleles have complex myofibrillar defects, whereas Mhc36B-\/+; Act88F-\/+ double heterozygotes have nearly normal myofibrils.","label":0}
{"pair_id":"BioInfer.d232.s1.p6","sentence":"We find that heterozygotes for actin (@PROTEIN2$) or myosin heavy chain (@PROTEIN1$) null alleles have complex myofibrillar defects, whereas Mhc36B-\/+; Act88F-\/+ double heterozygotes have nearly normal myofibrils.","label":0}
{"pair_id":"BioInfer.d232.s1.p7","sentence":"We find that heterozygotes for @PROTEIN2$ (Act88F) or myosin heavy chain (@PROTEIN1$) null alleles have complex myofibrillar defects, whereas Mhc36B-\/+; Act88F-\/+ double heterozygotes have nearly normal myofibrils.","label":0}
{"pair_id":"BioInfer.d232.s1.p8","sentence":"We find that heterozygotes for actin (Act88F) or myosin heavy chain (@PROTEIN1$) null alleles have complex myofibrillar defects, whereas @PROTEIN2$-\/+; Act88F-\/+ double heterozygotes have nearly normal myofibrils.","label":0}
{"pair_id":"BioInfer.d232.s1.p9","sentence":"We find that heterozygotes for actin (@PROTEIN2$) or @PROTEIN1$ (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-\/+; Act88F-\/+ double heterozygotes have nearly normal myofibrils.","label":0}
{"pair_id":"BioInfer.d232.s1.p10","sentence":"We find that heterozygotes for @PROTEIN2$ (Act88F) or @PROTEIN1$ (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-\/+; Act88F-\/+ double heterozygotes have nearly normal myofibrils.","label":0}
{"pair_id":"BioInfer.d232.s1.p11","sentence":"We find that heterozygotes for actin (Act88F) or @PROTEIN1$ (Mhc36B) null alleles have complex myofibrillar defects, whereas @PROTEIN2$-\/+; Act88F-\/+ double heterozygotes have nearly normal myofibrils.","label":0}
{"pair_id":"BioInfer.d232.s1.p12","sentence":"We find that heterozygotes for @PROTEIN2$ (@PROTEIN1$) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-\/+; Act88F-\/+ double heterozygotes have nearly normal myofibrils.","label":0}
{"pair_id":"BioInfer.d232.s1.p13","sentence":"We find that heterozygotes for actin (@PROTEIN1$) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas @PROTEIN2$-\/+; Act88F-\/+ double heterozygotes have nearly normal myofibrils.","label":0}
{"pair_id":"BioInfer.d232.s1.p14","sentence":"We find that heterozygotes for @PROTEIN1$ (Act88F) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas @PROTEIN2$-\/+; Act88F-\/+ double heterozygotes have nearly normal myofibrils.","label":0}
{"pair_id":"BioInfer.d43.s3.p0","sentence":"When liver- or @PROTEIN1$ was transiently expressed in COS-7 cells, the expressed @PROTEIN2$ was also co-localized with actin filaments in the cytoplasm of these transfected cells.","label":0}
{"pair_id":"BioInfer.d43.s3.p1","sentence":"When @PROTEIN2$ or @PROTEIN1$@PROTEIN2$ was transiently expressed in COS-7 cells, the expressed glucokinase was also co-localized with actin filaments in the cytoplasm of these transfected cells.","label":0}
{"pair_id":"BioInfer.d43.s3.p2","sentence":"When liver- or @PROTEIN1$ was transiently expressed in COS-7 cells, the expressed glucokinase was also co-localized with @PROTEIN2$ filaments in the cytoplasm of these transfected cells.","label":0}
{"pair_id":"BioInfer.d43.s3.p3","sentence":"When @PROTEIN2$ or islet-@PROTEIN2$ was transiently expressed in COS-7 cells, the expressed @PROTEIN1$ was also co-localized with actin filaments in the cytoplasm of these transfected cells.","label":0}
{"pair_id":"BioInfer.d43.s3.p4","sentence":"When liver- or islet-liver- type gluc was transiently expressed in COS-7 cells, the expressed @PROTEIN1$ was also co-localized with @PROTEIN2$ filaments in the cytoplasm of these transfected cells.","label":1}
{"pair_id":"BioInfer.d43.s3.p5","sentence":"When @PROTEIN1$ or islet-@PROTEIN1$ was transiently expressed in COS-7 cells, the expressed glucokinase was also co-localized with @PROTEIN2$ filaments in the cytoplasm of these transfected cells.","label":0}
{"pair_id":"BioInfer.d789.s0.p0","sentence":"Using the 'nuclear displacement assay' as a measure of the integrity of the actin cytoskeleton in living stamen hair cells, we demonstrated that AtFim1 protects @PROTEIN2$ filaments in these cells from Z. mays @PROTEIN1$ (ZmPRO5)-induced depolymerization, in a dose-dependent manner.","label":1}
{"pair_id":"BioInfer.d789.s0.p1","sentence":"Using the 'nuclear displacement assay' as a measure of the integrity of the actin cytoskeleton in living stamen hair cells, we demonstrated that @PROTEIN2$ protects actin filaments in these cells from Z. mays @PROTEIN1$ (ZmPRO5)-induced depolymerization, in a dose-dependent manner.","label":0}
{"pair_id":"BioInfer.d789.s0.p2","sentence":"Using the 'nuclear displacement assay' as a measure of the integrity of the actin cytoskeleton in living stamen hair cells, we demonstrated that AtFim1 protects actin filaments in these cells from Z. mays @PROTEIN1$ (@PROTEIN2$)-induced depolymerization, in a dose-dependent manner.","label":0}
{"pair_id":"BioInfer.d789.s0.p3","sentence":"Using the 'nuclear displacement assay' as a measure of the integrity of the @PROTEIN2$ cytoskeleton in living stamen hair cells, we demonstrated that AtFim1 protects actin filaments in these cells from Z. mays @PROTEIN1$ (ZmPRO5)-induced depolymerization, in a dose-dependent manner.","label":0}
{"pair_id":"BioInfer.d789.s0.p4","sentence":"Using the 'nuclear displacement assay' as a measure of the integrity of the actin cytoskeleton in living stamen hair cells, we demonstrated that @PROTEIN2$ protects @PROTEIN1$ filaments in these cells from Z. mays profilin (ZmPRO5)-induced depolymerization, in a dose-dependent manner.","label":1}
{"pair_id":"BioInfer.d789.s0.p5","sentence":"Using the 'nuclear displacement assay' as a measure of the integrity of the actin cytoskeleton in living stamen hair cells, we demonstrated that AtFim1 protects @PROTEIN1$ filaments in these cells from Z. mays profilin (@PROTEIN2$)-induced depolymerization, in a dose-dependent manner.","label":1}
{"pair_id":"BioInfer.d789.s0.p6","sentence":"Using the 'nuclear displacement assay' as a measure of the integrity of the @PROTEIN2$ cytoskeleton in living stamen hair cells, we demonstrated that AtFim1 protects @PROTEIN1$ filaments in these cells from Z. mays profilin (ZmPRO5)-induced depolymerization, in a dose-dependent manner.","label":0}
{"pair_id":"BioInfer.d789.s0.p7","sentence":"Using the 'nuclear displacement assay' as a measure of the integrity of the actin cytoskeleton in living stamen hair cells, we demonstrated that @PROTEIN1$ protects actin filaments in these cells from Z. mays profilin (@PROTEIN2$)-induced depolymerization, in a dose-dependent manner.","label":0}
{"pair_id":"BioInfer.d789.s0.p8","sentence":"Using the 'nuclear displacement assay' as a measure of the integrity of the @PROTEIN2$ cytoskeleton in living stamen hair cells, we demonstrated that @PROTEIN1$ protects actin filaments in these cells from Z. mays profilin (ZmPRO5)-induced depolymerization, in a dose-dependent manner.","label":0}
{"pair_id":"BioInfer.d789.s0.p9","sentence":"Using the 'nuclear displacement assay' as a measure of the integrity of the @PROTEIN2$ cytoskeleton in living stamen hair cells, we demonstrated that AtFim1 protects actin filaments in these cells from Z. mays profilin (@PROTEIN1$)-induced depolymerization, in a dose-dependent manner.","label":0}
{"pair_id":"AIMed.d145.s1229.p0","sentence":"The novel fold of the TNF receptor structure is likely to be representative of the @PROTEIN1$ (@PROTEIN2$)\/TNF receptor family as a whole.","label":0}
{"pair_id":"BioInfer.d79.s1.p0","sentence":"Since our earlier studies of Acanthamoeba profilins suggested the importance of PIP2 binding for suppression, we conclude that both activities are implicated and that an interplay between PIP2 binding and @PROTEIN2$ binding may be important for @PROTEIN1$ function.","label":1}
{"pair_id":"BioInfer.d79.s1.p1","sentence":"Since our earlier studies of Acanthamoeba @PROTEIN2$ suggested the importance of PIP2 binding for suppression, we conclude that both activities are implicated and that an interplay between PIP2 binding and actin binding may be important for @PROTEIN1$ function.","label":0}
{"pair_id":"BioInfer.d79.s1.p2","sentence":"Since our earlier studies of Acanthamoeba @PROTEIN2$ suggested the importance of PIP2 binding for suppression, we conclude that both activities are implicated and that an interplay between PIP2 binding and @PROTEIN1$ binding may be important for profilin function.","label":0}
{"pair_id":"AIMed.d120.s1022.p0","sentence":"The data thus demonstrate specific binding of platelet @PROTEIN1$ to @PROTEIN2$ and suggest that HSP27 may participate in the cellular localization and\/or enzymatic regulation of platelet FXIII.","label":1}
{"pair_id":"AIMed.d120.s1022.p1","sentence":"The data thus demonstrate specific binding of platelet @PROTEIN1$ to HSP27 and suggest that @PROTEIN2$ may participate in the cellular localization and\/or enzymatic regulation of platelet FXIII.","label":0}
{"pair_id":"AIMed.d120.s1022.p2","sentence":"The data thus demonstrate specific binding of platelet @PROTEIN1$ to HSP27 and suggest that HSP27 may participate in the cellular localization and\/or enzymatic regulation of platelet @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d120.s1022.p3","sentence":"The data thus demonstrate specific binding of platelet FXIII to @PROTEIN1$ and suggest that @PROTEIN2$ may participate in the cellular localization and\/or enzymatic regulation of platelet FXIII.","label":0}
{"pair_id":"AIMed.d120.s1022.p4","sentence":"The data thus demonstrate specific binding of platelet FXIII to @PROTEIN1$ and suggest that HSP27 may participate in the cellular localization and\/or enzymatic regulation of platelet @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d120.s1022.p5","sentence":"The data thus demonstrate specific binding of platelet FXIII to HSP27 and suggest that @PROTEIN1$ may participate in the cellular localization and\/or enzymatic regulation of platelet @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d104.s883.p0","sentence":"However, the various @PROTEIN1$\/DP complexes display strong differences in the ability to bind to either @PROTEIN2$ or p107 in vivo, and the specificity of pRB or p107 binding is mediated by the E2F subunit.","label":0}
{"pair_id":"AIMed.d104.s883.p1","sentence":"However, the various @PROTEIN1$\/DP complexes display strong differences in the ability to bind to either pRB or @PROTEIN2$ in vivo, and the specificity of pRB or p107 binding is mediated by the E2F subunit.","label":0}
{"pair_id":"AIMed.d104.s883.p2","sentence":"However, the various @PROTEIN1$\/DP complexes display strong differences in the ability to bind to either pRB or p107 in vivo, and the specificity of @PROTEIN2$ or p107 binding is mediated by the E2F subunit.","label":0}
{"pair_id":"AIMed.d104.s883.p3","sentence":"However, the various @PROTEIN1$\/DP complexes display strong differences in the ability to bind to either pRB or p107 in vivo, and the specificity of pRB or @PROTEIN2$ binding is mediated by the E2F subunit.","label":0}
{"pair_id":"AIMed.d104.s883.p4","sentence":"However, the various @PROTEIN1$\/DP complexes display strong differences in the ability to bind to either pRB or p107 in vivo, and the specificity of pRB or p107 binding is mediated by the @PROTEIN2$ subunit.","label":0}
{"pair_id":"AIMed.d104.s883.p5","sentence":"However, the various E2F\/DP complexes display strong differences in the ability to bind to either @PROTEIN1$ or @PROTEIN2$ in vivo, and the specificity of pRB or p107 binding is mediated by the E2F subunit.","label":0}
{"pair_id":"AIMed.d104.s883.p6","sentence":"However, the various E2F\/DP complexes display strong differences in the ability to bind to either @PROTEIN1$ or p107 in vivo, and the specificity of @PROTEIN2$ or p107 binding is mediated by the E2F subunit.","label":0}
{"pair_id":"AIMed.d104.s883.p7","sentence":"However, the various E2F\/DP complexes display strong differences in the ability to bind to either @PROTEIN1$ or p107 in vivo, and the specificity of pRB or @PROTEIN2$ binding is mediated by the E2F subunit.","label":0}
{"pair_id":"AIMed.d104.s883.p8","sentence":"However, the various E2F\/DP complexes display strong differences in the ability to bind to either @PROTEIN1$ or p107 in vivo, and the specificity of pRB or p107 binding is mediated by the @PROTEIN2$ subunit.","label":0}
{"pair_id":"AIMed.d104.s883.p9","sentence":"However, the various E2F\/DP complexes display strong differences in the ability to bind to either pRB or @PROTEIN1$ in vivo, and the specificity of @PROTEIN2$ or p107 binding is mediated by the E2F subunit.","label":0}
{"pair_id":"AIMed.d104.s883.p10","sentence":"However, the various E2F\/DP complexes display strong differences in the ability to bind to either pRB or @PROTEIN1$ in vivo, and the specificity of pRB or @PROTEIN2$ binding is mediated by the E2F subunit.","label":0}
{"pair_id":"AIMed.d104.s883.p11","sentence":"However, the various E2F\/DP complexes display strong differences in the ability to bind to either pRB or @PROTEIN1$ in vivo, and the specificity of pRB or p107 binding is mediated by the @PROTEIN2$ subunit.","label":0}
{"pair_id":"AIMed.d104.s883.p12","sentence":"However, the various E2F\/DP complexes display strong differences in the ability to bind to either pRB or p107 in vivo, and the specificity of @PROTEIN1$ or @PROTEIN2$ binding is mediated by the E2F subunit.","label":0}
{"pair_id":"AIMed.d104.s883.p13","sentence":"However, the various E2F\/DP complexes display strong differences in the ability to bind to either pRB or p107 in vivo, and the specificity of @PROTEIN1$ or p107 binding is mediated by the @PROTEIN2$ subunit.","label":0}
{"pair_id":"AIMed.d104.s883.p14","sentence":"However, the various E2F\/DP complexes display strong differences in the ability to bind to either pRB or p107 in vivo, and the specificity of pRB or @PROTEIN1$ binding is mediated by the @PROTEIN2$ subunit.","label":0}
{"pair_id":"AIMed.d146.s1233.p0","sentence":"We have previously demonstrated such changes by affinity cross-linking studies, and have shown that unstimulated human T cells express a single @PROTEIN1$ of 90 kDa, whereas activated T cells express an additional 76-kDa @PROTEIN2$ binding protein.","label":0}
{"pair_id":"AIMed.d29.s245.p0","sentence":"These Ala mutants triggered neutrophil degranulation and induced calcium responses mediated by @PROTEIN1$ and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d166.s1395.p0","sentence":"The region of @PROTEIN1$ most important for binding to the @PROTEIN2$ is composed of residues from the amino terminus of the D-helix, carboxyl terminus of the B-helix, and C-D loop.","label":1}
{"pair_id":"BioInfer.d210.s0.p0","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor @PROTEIN1$, and have determined that histone @PROTEIN2$ is significantly preferred over the histone H4 and p53 substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p1","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor @PROTEIN1$, and have determined that histone H3 is significantly preferred over the histone @PROTEIN2$ and p53 substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p2","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor @PROTEIN1$, and have determined that @PROTEIN2$ H3 is significantly preferred over the histone H4 and p53 substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p3","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and @PROTEIN2$ and the transcription factor @PROTEIN1$, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p4","sentence":"Finally, we evaluated the acetylation of three putative @PROTEIN2$ substrates, histones H3 and H4 and the transcription factor @PROTEIN1$, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.","label":1}
{"pair_id":"BioInfer.d210.s0.p5","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, histones @PROTEIN2$ and H4 and the transcription factor @PROTEIN1$, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p6","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, @PROTEIN2$ H3 and H4 and the transcription factor @PROTEIN1$, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p7","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor @PROTEIN1$, and have determined that histone H3 is significantly preferred over the @PROTEIN2$ H4 and p53 substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p8","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor @PROTEIN1$, and have determined that histone H3 is significantly preferred over the histone H4 and @PROTEIN2$ substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p9","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone @PROTEIN1$ is significantly preferred over the histone @PROTEIN2$ and p53 substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p10","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that @PROTEIN2$ @PROTEIN1$ is significantly preferred over the histone H4 and p53 substrates.","label":1}
{"pair_id":"BioInfer.d210.s0.p11","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and @PROTEIN2$ and the transcription factor p53, and have determined that histone @PROTEIN1$ is significantly preferred over the histone H4 and p53 substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p12","sentence":"Finally, we evaluated the acetylation of three putative @PROTEIN2$ substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone @PROTEIN1$ is significantly preferred over the histone H4 and p53 substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p13","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, histones @PROTEIN2$ and H4 and the transcription factor p53, and have determined that histone @PROTEIN1$ is significantly preferred over the histone H4 and p53 substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p14","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, @PROTEIN2$ H3 and H4 and the transcription factor p53, and have determined that histone @PROTEIN1$ is significantly preferred over the histone H4 and p53 substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p15","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone @PROTEIN1$ is significantly preferred over the @PROTEIN2$ H4 and p53 substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p16","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone @PROTEIN1$ is significantly preferred over the histone H4 and @PROTEIN2$ substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p17","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that @PROTEIN2$ H3 is significantly preferred over the histone @PROTEIN1$ and p53 substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p18","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and @PROTEIN2$ and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone @PROTEIN1$ and p53 substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p19","sentence":"Finally, we evaluated the acetylation of three putative @PROTEIN2$ substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone @PROTEIN1$ and p53 substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p20","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, histones @PROTEIN2$ and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone @PROTEIN1$ and p53 substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p21","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, @PROTEIN2$ H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone @PROTEIN1$ and p53 substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p22","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the @PROTEIN2$ @PROTEIN1$ and p53 substrates.","label":1}
{"pair_id":"BioInfer.d210.s0.p23","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone @PROTEIN1$ and @PROTEIN2$ substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p24","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and @PROTEIN2$ and the transcription factor p53, and have determined that @PROTEIN1$ H3 is significantly preferred over the histone H4 and p53 substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p25","sentence":"Finally, we evaluated the acetylation of three putative @PROTEIN2$ substrates, histones H3 and H4 and the transcription factor p53, and have determined that @PROTEIN1$ H3 is significantly preferred over the histone H4 and p53 substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p26","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, histones @PROTEIN2$ and H4 and the transcription factor p53, and have determined that @PROTEIN1$ H3 is significantly preferred over the histone H4 and p53 substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p27","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, @PROTEIN2$ H3 and H4 and the transcription factor p53, and have determined that @PROTEIN1$ H3 is significantly preferred over the histone H4 and p53 substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p28","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that @PROTEIN1$ H3 is significantly preferred over the @PROTEIN2$ H4 and p53 substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p29","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that @PROTEIN1$ H3 is significantly preferred over the histone H4 and @PROTEIN2$ substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p30","sentence":"Finally, we evaluated the acetylation of three putative @PROTEIN2$ substrates, histones H3 and @PROTEIN1$ and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.","label":1}
{"pair_id":"BioInfer.d210.s0.p31","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, histones @PROTEIN2$ and @PROTEIN1$ and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p32","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, @PROTEIN2$ H3 and @PROTEIN1$ and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.","label":1}
{"pair_id":"BioInfer.d210.s0.p33","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and @PROTEIN1$ and the transcription factor p53, and have determined that histone H3 is significantly preferred over the @PROTEIN2$ H4 and p53 substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p34","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and @PROTEIN1$ and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and @PROTEIN2$ substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p35","sentence":"Finally, we evaluated the acetylation of three putative @PROTEIN1$ substrates, histones @PROTEIN2$ and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.","label":1}
{"pair_id":"BioInfer.d210.s0.p36","sentence":"Finally, we evaluated the acetylation of three putative @PROTEIN1$ substrates, @PROTEIN2$ H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p37","sentence":"Finally, we evaluated the acetylation of three putative @PROTEIN1$ substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the @PROTEIN2$ H4 and p53 substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p38","sentence":"Finally, we evaluated the acetylation of three putative @PROTEIN1$ substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and @PROTEIN2$ substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p39","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, @PROTEIN2$ @PROTEIN1$ and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.","label":1}
{"pair_id":"BioInfer.d210.s0.p40","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, histones @PROTEIN1$ and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the @PROTEIN2$ H4 and p53 substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p41","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, histones @PROTEIN1$ and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and @PROTEIN2$ substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p42","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, @PROTEIN1$ H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the @PROTEIN2$ H4 and p53 substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p43","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, @PROTEIN1$ H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and @PROTEIN2$ substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p44","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the @PROTEIN1$ H4 and @PROTEIN2$ substrates.","label":0}
{"pair_id":"AIMed.d142.s1197.p0","sentence":"The recently cloned @PROTEIN1$ is such an @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d833.s0.p0","sentence":"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, @PROTEIN2$, @PROTEIN1$, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p1","sentence":"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, @PROTEIN1$, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, @PROTEIN2$ and talin, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p2","sentence":"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, @PROTEIN1$, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and @PROTEIN2$, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p3","sentence":"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, @PROTEIN1$, @PROTEIN2$, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p4","sentence":"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, @PROTEIN1$, plakoglobin, vinculin and @PROTEIN2$ appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p5","sentence":"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, @PROTEIN1$, plakoglobin, @PROTEIN2$ and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p6","sentence":"Within 1 hour of raising the concentration of calcium ions, integrins, @PROTEIN2$, alpha-catenin, @PROTEIN1$, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p7","sentence":"Within 1 hour of raising the concentration of calcium ions, @PROTEIN2$, cadherins, alpha-catenin, @PROTEIN1$, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p8","sentence":"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, @PROTEIN1$, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, @PROTEIN2$ and talin, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p9","sentence":"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, @PROTEIN1$, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and @PROTEIN2$, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p10","sentence":"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, @PROTEIN1$, beta-catenin, @PROTEIN2$, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p11","sentence":"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, @PROTEIN1$, beta-catenin, plakoglobin, vinculin and @PROTEIN2$ appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p12","sentence":"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, @PROTEIN1$, beta-catenin, plakoglobin, @PROTEIN2$ and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p13","sentence":"Within 1 hour of raising the concentration of calcium ions, integrins, @PROTEIN2$, @PROTEIN1$, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p14","sentence":"Within 1 hour of raising the concentration of calcium ions, @PROTEIN2$, cadherins, @PROTEIN1$, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p15","sentence":"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, @PROTEIN1$ and @PROTEIN2$, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p16","sentence":"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, @PROTEIN2$, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, @PROTEIN1$ and talin, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p17","sentence":"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and @PROTEIN2$ appeared to accumulate at cell-cell borders, whereas the focal contact proteins, @PROTEIN1$ and talin, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p18","sentence":"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, @PROTEIN2$ and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, @PROTEIN1$ and talin, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p19","sentence":"Within 1 hour of raising the concentration of calcium ions, integrins, @PROTEIN2$, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, @PROTEIN1$ and talin, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p20","sentence":"Within 1 hour of raising the concentration of calcium ions, @PROTEIN2$, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, @PROTEIN1$ and talin, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p21","sentence":"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, @PROTEIN2$, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and @PROTEIN1$, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p22","sentence":"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and @PROTEIN2$ appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and @PROTEIN1$, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p23","sentence":"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, @PROTEIN2$ and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and @PROTEIN1$, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p24","sentence":"Within 1 hour of raising the concentration of calcium ions, integrins, @PROTEIN2$, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and @PROTEIN1$, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p25","sentence":"Within 1 hour of raising the concentration of calcium ions, @PROTEIN2$, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and @PROTEIN1$, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p26","sentence":"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, @PROTEIN1$, vinculin and @PROTEIN2$ appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p27","sentence":"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, @PROTEIN1$, @PROTEIN2$ and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p28","sentence":"Within 1 hour of raising the concentration of calcium ions, integrins, @PROTEIN2$, alpha-catenin, beta-catenin, @PROTEIN1$, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p29","sentence":"Within 1 hour of raising the concentration of calcium ions, @PROTEIN2$, cadherins, alpha-catenin, beta-catenin, @PROTEIN1$, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p30","sentence":"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, @PROTEIN2$ and @PROTEIN1$ appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p31","sentence":"Within 1 hour of raising the concentration of calcium ions, integrins, @PROTEIN2$, alpha-catenin, beta-catenin, plakoglobin, vinculin and @PROTEIN1$ appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p32","sentence":"Within 1 hour of raising the concentration of calcium ions, @PROTEIN2$, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and @PROTEIN1$ appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p33","sentence":"Within 1 hour of raising the concentration of calcium ions, integrins, @PROTEIN2$, alpha-catenin, beta-catenin, plakoglobin, @PROTEIN1$ and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p34","sentence":"Within 1 hour of raising the concentration of calcium ions, @PROTEIN2$, cadherins, alpha-catenin, beta-catenin, plakoglobin, @PROTEIN1$ and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p35","sentence":"Within 1 hour of raising the concentration of calcium ions, @PROTEIN2$, @PROTEIN1$, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.","label":1}
{"pair_id":"AIMed.d185.s1577.p0","sentence":"These data demonstrate that @PROTEIN1$ but not @PROTEIN2$ or Stat5 is directly recruited to the ligand-activated IL-10 receptor by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.","label":0}
{"pair_id":"AIMed.d185.s1577.p1","sentence":"These data demonstrate that @PROTEIN1$ but not Stat1 or @PROTEIN2$ is directly recruited to the ligand-activated IL-10 receptor by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.","label":0}
{"pair_id":"AIMed.d185.s1577.p2","sentence":"These data demonstrate that @PROTEIN1$ but not Stat1 or Stat5 is directly recruited to the ligand-activated @PROTEIN2$ receptor by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.","label":0}
{"pair_id":"AIMed.d185.s1577.p3","sentence":"These data demonstrate that @PROTEIN1$ but not Stat1 or Stat5 is directly recruited to the ligand-activated @PROTEIN2$ by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.","label":1}
{"pair_id":"AIMed.d185.s1577.p4","sentence":"These data demonstrate that Stat3 but not @PROTEIN1$ or @PROTEIN2$ is directly recruited to the ligand-activated IL-10 receptor by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.","label":0}
{"pair_id":"AIMed.d185.s1577.p5","sentence":"These data demonstrate that Stat3 but not @PROTEIN1$ or Stat5 is directly recruited to the ligand-activated @PROTEIN2$ receptor by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.","label":0}
{"pair_id":"AIMed.d185.s1577.p6","sentence":"These data demonstrate that Stat3 but not @PROTEIN1$ or Stat5 is directly recruited to the ligand-activated @PROTEIN2$ by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.","label":0}
{"pair_id":"AIMed.d185.s1577.p7","sentence":"These data demonstrate that Stat3 but not Stat1 or @PROTEIN1$ is directly recruited to the ligand-activated @PROTEIN2$ receptor by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.","label":0}
{"pair_id":"AIMed.d185.s1577.p8","sentence":"These data demonstrate that Stat3 but not Stat1 or @PROTEIN1$ is directly recruited to the ligand-activated @PROTEIN2$ by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.","label":0}
{"pair_id":"AIMed.d185.s1577.p9","sentence":"These data demonstrate that Stat3 but not Stat1 or Stat5 is directly recruited to the ligand-activated @PROTEIN1$@PROTEIN2$ by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.","label":0}
{"pair_id":"AIMed.d202.s1739.p0","sentence":"The @PROTEIN1$ family currently consists of two agonists, @PROTEIN2$ and IL-1beta, and one antagonist, IL-1ra.","label":0}
{"pair_id":"AIMed.d202.s1739.p1","sentence":"The @PROTEIN1$ family currently consists of two agonists, IL-1alpha and @PROTEIN2$, and one antagonist, IL-1ra.","label":0}
{"pair_id":"AIMed.d202.s1739.p2","sentence":"The @PROTEIN1$ family currently consists of two agonists, IL-1alpha and IL-1beta, and one antagonist, @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d202.s1739.p3","sentence":"The IL-1 family currently consists of two agonists, @PROTEIN1$ and @PROTEIN2$, and one antagonist, IL-1ra.","label":0}
{"pair_id":"AIMed.d202.s1739.p4","sentence":"The IL-1 family currently consists of two agonists, @PROTEIN1$ and IL-1beta, and one antagonist, @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d202.s1739.p5","sentence":"The IL-1 family currently consists of two agonists, IL-1alpha and @PROTEIN1$, and one antagonist, @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d124.s1059.p0","sentence":"Expression of 14-3-3 proteins in Xenopus oocytes enhanced @PROTEIN1$ activity and promoted @PROTEIN2$-dependent oocyte maturation.","label":0}
{"pair_id":"BioInfer.d539.s0.p0","sentence":"Silencing mediated by @PROTEIN2$-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, @PROTEIN1$, and histone H4.","label":0}
{"pair_id":"BioInfer.d539.s0.p1","sentence":"Silencing mediated by GBD-@PROTEIN2$ requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, @PROTEIN1$, and histone H4.","label":0}
{"pair_id":"BioInfer.d539.s0.p2","sentence":"Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, @PROTEIN2$, @PROTEIN1$, and histone H4.","label":0}
{"pair_id":"BioInfer.d539.s0.p3","sentence":"Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, @PROTEIN1$, and histone @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d539.s0.p4","sentence":"Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, @PROTEIN2$, SIR3, @PROTEIN1$, and histone H4.","label":0}
{"pair_id":"BioInfer.d539.s0.p5","sentence":"Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, @PROTEIN1$, and @PROTEIN2$ H4.","label":0}
{"pair_id":"BioInfer.d539.s0.p6","sentence":"Silencing mediated by @PROTEIN1$-@PROTEIN2$ requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and histone H4.","label":1}
{"pair_id":"BioInfer.d539.s0.p7","sentence":"Silencing mediated by @PROTEIN1$-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, @PROTEIN2$, SIR4, and histone H4.","label":0}
{"pair_id":"BioInfer.d539.s0.p8","sentence":"Silencing mediated by @PROTEIN1$-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and histone @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d539.s0.p9","sentence":"Silencing mediated by @PROTEIN1$-SIR1 requires the trans-acting factors that normally participate in repression, namely, @PROTEIN2$, SIR3, SIR4, and histone H4.","label":0}
{"pair_id":"BioInfer.d539.s0.p10","sentence":"Silencing mediated by @PROTEIN1$-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and @PROTEIN2$ H4.","label":0}
{"pair_id":"BioInfer.d539.s0.p11","sentence":"Silencing mediated by GBD-@PROTEIN1$ requires the trans-acting factors that normally participate in repression, namely, SIR2, @PROTEIN2$, SIR4, and histone H4.","label":0}
{"pair_id":"BioInfer.d539.s0.p12","sentence":"Silencing mediated by GBD-@PROTEIN1$ requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and histone @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d539.s0.p13","sentence":"Silencing mediated by GBD-@PROTEIN1$ requires the trans-acting factors that normally participate in repression, namely, @PROTEIN2$, SIR3, SIR4, and histone H4.","label":0}
{"pair_id":"BioInfer.d539.s0.p14","sentence":"Silencing mediated by GBD-@PROTEIN1$ requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and @PROTEIN2$ H4.","label":0}
{"pair_id":"BioInfer.d539.s0.p15","sentence":"Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, @PROTEIN1$, SIR4, and histone @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d539.s0.p16","sentence":"Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, @PROTEIN2$, @PROTEIN1$, SIR4, and histone H4.","label":0}
{"pair_id":"BioInfer.d539.s0.p17","sentence":"Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, @PROTEIN1$, SIR4, and @PROTEIN2$ H4.","label":0}
{"pair_id":"BioInfer.d539.s0.p18","sentence":"Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, @PROTEIN2$, SIR3, SIR4, and histone @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d539.s0.p19","sentence":"Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and @PROTEIN2$ @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d539.s0.p20","sentence":"Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, @PROTEIN1$, SIR3, SIR4, and @PROTEIN2$ H4.","label":0}
{"pair_id":"BioInfer.d468.s0.p0","sentence":"Opposite effects of cofilin and @PROTEIN1$ from porcine brain on rate of exchange of @PROTEIN2$-bound adenosine 5'-triphosphate.","label":0}
{"pair_id":"BioInfer.d468.s0.p1","sentence":"Opposite effects of @PROTEIN2$ and @PROTEIN1$ from porcine brain on rate of exchange of actin-bound adenosine 5'-triphosphate.","label":0}
{"pair_id":"BioInfer.d468.s0.p2","sentence":"Opposite effects of @PROTEIN2$ and profilin from porcine brain on rate of exchange of @PROTEIN1$-bound adenosine 5'-triphosphate.","label":0}
{"pair_id":"BioInfer.d78.s0.p0","sentence":"As a nuclear transport signal sequence exists in cofilin and ADF but not in @PROTEIN2$, ADF and\/or @PROTEIN1$ may be responsible for the nuclear import of actin in myogenic cells under certain conditions.","label":0}
{"pair_id":"BioInfer.d78.s0.p1","sentence":"As a nuclear transport signal sequence exists in @PROTEIN2$ and ADF but not in actin, ADF and\/or @PROTEIN1$ may be responsible for the nuclear import of actin in myogenic cells under certain conditions.","label":0}
{"pair_id":"BioInfer.d78.s0.p2","sentence":"As a nuclear transport signal sequence exists in cofilin and ADF but not in actin, ADF and\/or @PROTEIN1$ may be responsible for the nuclear import of @PROTEIN2$ in myogenic cells under certain conditions.","label":1}
{"pair_id":"BioInfer.d78.s0.p3","sentence":"As a nuclear transport signal sequence exists in cofilin and ADF but not in actin, @PROTEIN2$ and\/or @PROTEIN1$ may be responsible for the nuclear import of actin in myogenic cells under certain conditions.","label":0}
{"pair_id":"BioInfer.d78.s0.p4","sentence":"As a nuclear transport signal sequence exists in cofilin and @PROTEIN2$ but not in actin, ADF and\/or @PROTEIN1$ may be responsible for the nuclear import of actin in myogenic cells under certain conditions.","label":0}
{"pair_id":"BioInfer.d78.s0.p5","sentence":"As a nuclear transport signal sequence exists in @PROTEIN2$ and ADF but not in @PROTEIN1$, ADF and\/or cofilin may be responsible for the nuclear import of actin in myogenic cells under certain conditions.","label":0}
{"pair_id":"BioInfer.d78.s0.p6","sentence":"As a nuclear transport signal sequence exists in cofilin and ADF but not in @PROTEIN1$, ADF and\/or cofilin may be responsible for the nuclear import of @PROTEIN2$ in myogenic cells under certain conditions.","label":0}
{"pair_id":"BioInfer.d78.s0.p7","sentence":"As a nuclear transport signal sequence exists in cofilin and ADF but not in @PROTEIN1$, @PROTEIN2$ and\/or cofilin may be responsible for the nuclear import of actin in myogenic cells under certain conditions.","label":0}
{"pair_id":"BioInfer.d78.s0.p8","sentence":"As a nuclear transport signal sequence exists in cofilin and @PROTEIN2$ but not in @PROTEIN1$, ADF and\/or cofilin may be responsible for the nuclear import of actin in myogenic cells under certain conditions.","label":0}
{"pair_id":"BioInfer.d78.s0.p9","sentence":"As a nuclear transport signal sequence exists in @PROTEIN1$ and ADF but not in actin, ADF and\/or cofilin may be responsible for the nuclear import of @PROTEIN2$ in myogenic cells under certain conditions.","label":0}
{"pair_id":"BioInfer.d78.s0.p10","sentence":"As a nuclear transport signal sequence exists in @PROTEIN1$ and ADF but not in actin, @PROTEIN2$ and\/or cofilin may be responsible for the nuclear import of actin in myogenic cells under certain conditions.","label":0}
{"pair_id":"BioInfer.d78.s0.p11","sentence":"As a nuclear transport signal sequence exists in @PROTEIN1$ and @PROTEIN2$ but not in actin, ADF and\/or cofilin may be responsible for the nuclear import of actin in myogenic cells under certain conditions.","label":0}
{"pair_id":"BioInfer.d78.s0.p12","sentence":"As a nuclear transport signal sequence exists in cofilin and ADF but not in actin, @PROTEIN2$ and\/or cofilin may be responsible for the nuclear import of @PROTEIN1$ in myogenic cells under certain conditions.","label":1}
{"pair_id":"BioInfer.d78.s0.p13","sentence":"As a nuclear transport signal sequence exists in cofilin and @PROTEIN2$ but not in actin, ADF and\/or cofilin may be responsible for the nuclear import of @PROTEIN1$ in myogenic cells under certain conditions.","label":0}
{"pair_id":"BioInfer.d78.s0.p14","sentence":"As a nuclear transport signal sequence exists in cofilin and @PROTEIN2$ but not in actin, @PROTEIN1$ and\/or cofilin may be responsible for the nuclear import of actin in myogenic cells under certain conditions.","label":0}
{"pair_id":"BioInfer.d417.s1.p0","sentence":"The apparent critical concentration for polymerization of @PROTEIN1$ is increased by the addition of @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d334.s2.p0","sentence":"Our findings strongly suggest that in brain profilin I and profilin II complexes link the actin cytoskeleton and endocytic membrane flow, directing @PROTEIN1$ and @PROTEIN2$ assembly to distinct membrane domains.","label":0}
{"pair_id":"BioInfer.d334.s2.p1","sentence":"Our findings strongly suggest that in brain profilin I and profilin II complexes link the @PROTEIN2$ cytoskeleton and endocytic membrane flow, directing @PROTEIN1$ and clathrin assembly to distinct membrane domains.","label":1}
{"pair_id":"BioInfer.d334.s2.p2","sentence":"Our findings strongly suggest that in brain profilin I and @PROTEIN2$ complexes link the actin cytoskeleton and endocytic membrane flow, directing @PROTEIN1$ and clathrin assembly to distinct membrane domains.","label":1}
{"pair_id":"BioInfer.d334.s2.p3","sentence":"Our findings strongly suggest that in brain @PROTEIN2$ and profilin II complexes link the actin cytoskeleton and endocytic membrane flow, directing @PROTEIN1$ and clathrin assembly to distinct membrane domains.","label":1}
{"pair_id":"BioInfer.d334.s2.p4","sentence":"Our findings strongly suggest that in brain profilin I and profilin II complexes link the @PROTEIN2$ cytoskeleton and endocytic membrane flow, directing actin and @PROTEIN1$ assembly to distinct membrane domains.","label":1}
{"pair_id":"BioInfer.d334.s2.p5","sentence":"Our findings strongly suggest that in brain profilin I and @PROTEIN2$ complexes link the actin cytoskeleton and endocytic membrane flow, directing actin and @PROTEIN1$ assembly to distinct membrane domains.","label":1}
{"pair_id":"BioInfer.d334.s2.p6","sentence":"Our findings strongly suggest that in brain @PROTEIN2$ and profilin II complexes link the actin cytoskeleton and endocytic membrane flow, directing actin and @PROTEIN1$ assembly to distinct membrane domains.","label":1}
{"pair_id":"BioInfer.d334.s2.p7","sentence":"Our findings strongly suggest that in brain profilin I and @PROTEIN2$ complexes link the @PROTEIN1$ cytoskeleton and endocytic membrane flow, directing actin and clathrin assembly to distinct membrane domains.","label":1}
{"pair_id":"BioInfer.d334.s2.p8","sentence":"Our findings strongly suggest that in brain @PROTEIN2$ and profilin II complexes link the @PROTEIN1$ cytoskeleton and endocytic membrane flow, directing actin and clathrin assembly to distinct membrane domains.","label":1}
{"pair_id":"BioInfer.d334.s2.p9","sentence":"Our findings strongly suggest that in brain @PROTEIN2$ and @PROTEIN1$ complexes link the actin cytoskeleton and endocytic membrane flow, directing actin and clathrin assembly to distinct membrane domains.","label":0}
{"pair_id":"BioInfer.d30.s0.p0","sentence":"After elution of the three actin-binding proteins, @PROTEIN1$ and profilin were recovered from the @PROTEIN2$ column with 2 M urea solution.","label":0}
{"pair_id":"BioInfer.d30.s0.p1","sentence":"After elution of the three @PROTEIN2$, @PROTEIN1$ and profilin were recovered from the DNase I column with 2 M urea solution.","label":0}
{"pair_id":"BioInfer.d30.s0.p2","sentence":"After elution of the three actin-binding proteins, @PROTEIN1$ and @PROTEIN2$ were recovered from the DNase I column with 2 M urea solution.","label":0}
{"pair_id":"BioInfer.d30.s0.p3","sentence":"After elution of the three @PROTEIN2$, actin and profilin were recovered from the @PROTEIN1$ column with 2 M urea solution.","label":0}
{"pair_id":"BioInfer.d30.s0.p4","sentence":"After elution of the three actin-binding proteins, actin and @PROTEIN2$ were recovered from the @PROTEIN1$ column with 2 M urea solution.","label":0}
{"pair_id":"BioInfer.d30.s0.p5","sentence":"After elution of the three @PROTEIN1$, actin and @PROTEIN2$ were recovered from the DNase I column with 2 M urea solution.","label":0}
{"pair_id":"AIMed.d80.s684.p0","sentence":"@PROTEIN1$ contains a death domain homologous to the death domains of @PROTEIN2$ and TNFR-1.","label":0}
{"pair_id":"AIMed.d80.s684.p1","sentence":"@PROTEIN1$ contains a death domain homologous to the death domains of Fas and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d80.s684.p2","sentence":"FADD contains a death domain homologous to the death domains of @PROTEIN1$ and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d108.s914.p0","sentence":"Furthermore, a partial @PROTEIN1$ complex containing Drosophila @PROTEIN2$ (dTBP), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.","label":0}
{"pair_id":"AIMed.d108.s914.p1","sentence":"Furthermore, a partial @PROTEIN1$ complex containing Drosophila TATA binding protein (@PROTEIN2$), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.","label":0}
{"pair_id":"AIMed.d108.s914.p2","sentence":"Furthermore, a partial @PROTEIN1$ complex containing Drosophila TATA binding protein (dTBP), human @PROTEIN2$, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.","label":0}
{"pair_id":"AIMed.d108.s914.p3","sentence":"Furthermore, a partial @PROTEIN1$ complex containing Drosophila TATA binding protein (dTBP), human TAFII250, @PROTEIN2$, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.","label":0}
{"pair_id":"AIMed.d108.s914.p4","sentence":"Furthermore, a partial @PROTEIN1$ complex containing Drosophila TATA binding protein (dTBP), human TAFII250, dTAFII60, and @PROTEIN2$ supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.","label":0}
{"pair_id":"AIMed.d108.s914.p5","sentence":"Furthermore, a partial @PROTEIN1$ complex containing Drosophila TATA binding protein (dTBP), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas @PROTEIN2$ or a subcomplex lacking TAFII40 and TAFII60 did not.","label":0}
{"pair_id":"AIMed.d108.s914.p6","sentence":"Furthermore, a partial @PROTEIN1$ complex containing Drosophila TATA binding protein (dTBP), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking @PROTEIN2$ and TAFII60 did not.","label":0}
{"pair_id":"AIMed.d108.s914.p7","sentence":"Furthermore, a partial @PROTEIN1$ complex containing Drosophila TATA binding protein (dTBP), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and @PROTEIN2$ did not.","label":0}
{"pair_id":"AIMed.d108.s914.p8","sentence":"Furthermore, a partial TFIID complex containing Drosophila @PROTEIN1$ (@PROTEIN2$), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.","label":0}
{"pair_id":"AIMed.d108.s914.p9","sentence":"Furthermore, a partial TFIID complex containing Drosophila @PROTEIN1$ (dTBP), human @PROTEIN2$, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.","label":0}
{"pair_id":"AIMed.d108.s914.p10","sentence":"Furthermore, a partial TFIID complex containing Drosophila @PROTEIN1$ (dTBP), human TAFII250, @PROTEIN2$, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.","label":0}
{"pair_id":"AIMed.d108.s914.p11","sentence":"Furthermore, a partial TFIID complex containing Drosophila @PROTEIN1$ (dTBP), human TAFII250, dTAFII60, and @PROTEIN2$ supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.","label":0}
{"pair_id":"AIMed.d108.s914.p12","sentence":"Furthermore, a partial TFIID complex containing Drosophila @PROTEIN1$ (dTBP), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas @PROTEIN2$ or a subcomplex lacking TAFII40 and TAFII60 did not.","label":0}
{"pair_id":"AIMed.d108.s914.p13","sentence":"Furthermore, a partial TFIID complex containing Drosophila @PROTEIN1$ (dTBP), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking @PROTEIN2$ and TAFII60 did not.","label":0}
{"pair_id":"AIMed.d108.s914.p14","sentence":"Furthermore, a partial TFIID complex containing Drosophila @PROTEIN1$ (dTBP), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and @PROTEIN2$ did not.","label":0}
{"pair_id":"AIMed.d108.s914.p15","sentence":"Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (@PROTEIN1$), human @PROTEIN2$, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.","label":0}
{"pair_id":"AIMed.d108.s914.p16","sentence":"Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (@PROTEIN1$), human TAFII250, @PROTEIN2$, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.","label":0}
{"pair_id":"AIMed.d108.s914.p17","sentence":"Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (@PROTEIN1$), human TAFII250, dTAFII60, and @PROTEIN2$ supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.","label":0}
{"pair_id":"AIMed.d108.s914.p18","sentence":"Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (@PROTEIN1$), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas @PROTEIN2$ or a subcomplex lacking TAFII40 and TAFII60 did not.","label":0}
{"pair_id":"AIMed.d108.s914.p19","sentence":"Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (@PROTEIN1$), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking @PROTEIN2$ and TAFII60 did not.","label":0}
{"pair_id":"AIMed.d108.s914.p20","sentence":"Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (@PROTEIN1$), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and @PROTEIN2$ did not.","label":0}
{"pair_id":"AIMed.d108.s914.p21","sentence":"Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (dTBP), human @PROTEIN1$, @PROTEIN2$, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.","label":0}
{"pair_id":"AIMed.d108.s914.p22","sentence":"Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (dTBP), human @PROTEIN1$, dTAFII60, and @PROTEIN2$ supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.","label":0}
{"pair_id":"AIMed.d108.s914.p23","sentence":"Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (dTBP), human @PROTEIN1$, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas @PROTEIN2$ or a subcomplex lacking TAFII40 and TAFII60 did not.","label":0}
{"pair_id":"AIMed.d108.s914.p24","sentence":"Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (dTBP), human @PROTEIN1$, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking @PROTEIN2$ and TAFII60 did not.","label":0}
{"pair_id":"AIMed.d108.s914.p25","sentence":"Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (dTBP), human @PROTEIN1$, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and @PROTEIN2$ did not.","label":0}
{"pair_id":"AIMed.d108.s914.p26","sentence":"Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (dTBP), human TAFII250, @PROTEIN1$, and @PROTEIN2$ supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.","label":0}
{"pair_id":"AIMed.d108.s914.p27","sentence":"Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (dTBP), human TAFII250, @PROTEIN1$, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas @PROTEIN2$ or a subcomplex lacking TAFII40 and TAFII60 did not.","label":0}
{"pair_id":"AIMed.d108.s914.p28","sentence":"Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (dTBP), human TAFII250, @PROTEIN1$, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking @PROTEIN2$ and TAFII60 did not.","label":0}
{"pair_id":"AIMed.d108.s914.p29","sentence":"Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (dTBP), human TAFII250, @PROTEIN1$, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and @PROTEIN2$ did not.","label":0}
{"pair_id":"AIMed.d108.s914.p30","sentence":"Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (dTBP), human TAFII250, dTAFII60, and @PROTEIN1$ supported activation by a Gal4-p53 fusion protein in vitro, whereas @PROTEIN2$ or a subcomplex lacking TAFII40 and TAFII60 did not.","label":0}
{"pair_id":"AIMed.d108.s914.p31","sentence":"Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (dTBP), human TAFII250, dTAFII60, and @PROTEIN1$ supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking @PROTEIN2$ and TAFII60 did not.","label":0}
{"pair_id":"AIMed.d108.s914.p32","sentence":"Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (dTBP), human TAFII250, dTAFII60, and @PROTEIN1$ supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and @PROTEIN2$ did not.","label":0}
{"pair_id":"AIMed.d108.s914.p33","sentence":"Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (dTBP), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas @PROTEIN1$ or a subcomplex lacking @PROTEIN2$ and TAFII60 did not.","label":0}
{"pair_id":"AIMed.d108.s914.p34","sentence":"Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (dTBP), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas @PROTEIN1$ or a subcomplex lacking TAFII40 and @PROTEIN2$ did not.","label":0}
{"pair_id":"AIMed.d108.s914.p35","sentence":"Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (dTBP), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking @PROTEIN1$ and @PROTEIN2$ did not.","label":0}
{"pair_id":"AIMed.d109.s916.p0","sentence":"Crystal structure of the heterodimeric bZIP transcription factor @PROTEIN1$-@PROTEIN2$ bound to DNA.","label":1}
{"pair_id":"BioInfer.d100.s1.p0","sentence":"Four yeast spliceosomal proteins (@PROTEIN1$, PRP9, PRP11, and PRP21) interact to promote @PROTEIN2$ binding to pre-mRNA.","label":1}
{"pair_id":"BioInfer.d100.s1.p1","sentence":"Four yeast spliceosomal proteins (@PROTEIN1$, PRP9, PRP11, and @PROTEIN2$) interact to promote U2 snRNP binding to pre-mRNA.","label":1}
{"pair_id":"BioInfer.d100.s1.p2","sentence":"Four yeast spliceosomal proteins (@PROTEIN1$, @PROTEIN2$, PRP11, and PRP21) interact to promote U2 snRNP binding to pre-mRNA.","label":1}
{"pair_id":"BioInfer.d100.s1.p3","sentence":"Four yeast spliceosomal proteins (@PROTEIN1$, PRP9, @PROTEIN2$, and PRP21) interact to promote U2 snRNP binding to pre-mRNA.","label":1}
{"pair_id":"BioInfer.d100.s1.p4","sentence":"Four yeast spliceosomal proteins (PRP5, PRP9, PRP11, and @PROTEIN2$) interact to promote @PROTEIN1$ binding to pre-mRNA.","label":1}
{"pair_id":"BioInfer.d100.s1.p5","sentence":"Four yeast spliceosomal proteins (PRP5, @PROTEIN2$, PRP11, and PRP21) interact to promote @PROTEIN1$ binding to pre-mRNA.","label":1}
{"pair_id":"BioInfer.d100.s1.p6","sentence":"Four yeast spliceosomal proteins (PRP5, PRP9, @PROTEIN2$, and PRP21) interact to promote @PROTEIN1$ binding to pre-mRNA.","label":1}
{"pair_id":"BioInfer.d100.s1.p7","sentence":"Four yeast spliceosomal proteins (PRP5, @PROTEIN2$, PRP11, and @PROTEIN1$) interact to promote U2 snRNP binding to pre-mRNA.","label":1}
{"pair_id":"BioInfer.d100.s1.p8","sentence":"Four yeast spliceosomal proteins (PRP5, PRP9, @PROTEIN2$, and @PROTEIN1$) interact to promote U2 snRNP binding to pre-mRNA.","label":1}
{"pair_id":"BioInfer.d100.s1.p9","sentence":"Four yeast spliceosomal proteins (PRP5, @PROTEIN1$, @PROTEIN2$, and PRP21) interact to promote U2 snRNP binding to pre-mRNA.","label":1}
{"pair_id":"AIMed.d219.s1900.p0","sentence":"Although @PROTEIN1$ is a critical effector of @PROTEIN2$ signaling and transformation, the mechanism by which Ras promotes Raf-1 activation is complex and remains poorly understood.","label":0}
{"pair_id":"AIMed.d219.s1900.p1","sentence":"Although @PROTEIN1$ is a critical effector of Ras signaling and transformation, the mechanism by which @PROTEIN2$ promotes Raf-1 activation is complex and remains poorly understood.","label":0}
{"pair_id":"AIMed.d219.s1900.p2","sentence":"Although @PROTEIN1$ is a critical effector of Ras signaling and transformation, the mechanism by which Ras promotes @PROTEIN2$ activation is complex and remains poorly understood.","label":0}
{"pair_id":"AIMed.d219.s1900.p3","sentence":"Although Raf-1 is a critical effector of @PROTEIN1$ signaling and transformation, the mechanism by which @PROTEIN2$ promotes Raf-1 activation is complex and remains poorly understood.","label":0}
{"pair_id":"AIMed.d219.s1900.p4","sentence":"Although Raf-1 is a critical effector of @PROTEIN1$ signaling and transformation, the mechanism by which Ras promotes @PROTEIN2$ activation is complex and remains poorly understood.","label":0}
{"pair_id":"AIMed.d219.s1900.p5","sentence":"Although Raf-1 is a critical effector of Ras signaling and transformation, the mechanism by which @PROTEIN1$ promotes @PROTEIN2$ activation is complex and remains poorly understood.","label":0}
{"pair_id":"AIMed.d198.s1686.p0","sentence":"Mutagenesis studies of the human @PROTEIN1$@PROTEIN2$. Establishment of structure-function relationships.","label":0}
{"pair_id":"BioInfer.d309.s0.p0","sentence":"Inactivation of the Rb pathway in non-small cell lung carcinoma (NSCLC) occurs mostly through inactivation of the cyclin-dependent kinase inhibitor p16(@PROTEIN1$) and\/or up-regulation of @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d309.s0.p1","sentence":"Inactivation of the Rb pathway in non-small cell lung carcinoma (NSCLC) occurs mostly through inactivation of the @PROTEIN2$ p16(@PROTEIN1$) and\/or up-regulation of cyclin D1.","label":1}
{"pair_id":"BioInfer.d309.s0.p2","sentence":"Inactivation of the Rb pathway in non-small cell lung carcinoma (NSCLC) occurs mostly through inactivation of the cyclin-dependent kinase inhibitor @PROTEIN2$(@PROTEIN1$) and\/or up-regulation of cyclin D1.","label":0}
{"pair_id":"BioInfer.d309.s0.p3","sentence":"Inactivation of the @PROTEIN2$ pathway in non-small cell lung carcinoma (NSCLC) occurs mostly through inactivation of the cyclin-dependent kinase inhibitor p16(@PROTEIN1$) and\/or up-regulation of cyclin D1.","label":1}
{"pair_id":"BioInfer.d309.s0.p4","sentence":"Inactivation of the Rb pathway in non-small cell lung carcinoma (NSCLC) occurs mostly through inactivation of the @PROTEIN2$ p16(INK4A) and\/or up-regulation of @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d309.s0.p5","sentence":"Inactivation of the Rb pathway in non-small cell lung carcinoma (NSCLC) occurs mostly through inactivation of the cyclin-dependent kinase inhibitor @PROTEIN2$(INK4A) and\/or up-regulation of @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d309.s0.p6","sentence":"Inactivation of the @PROTEIN2$ pathway in non-small cell lung carcinoma (NSCLC) occurs mostly through inactivation of the cyclin-dependent kinase inhibitor p16(INK4A) and\/or up-regulation of @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d309.s0.p7","sentence":"Inactivation of the Rb pathway in non-small cell lung carcinoma (NSCLC) occurs mostly through inactivation of the @PROTEIN1$ @PROTEIN2$(INK4A) and\/or up-regulation of cyclin D1.","label":1}
{"pair_id":"BioInfer.d309.s0.p8","sentence":"Inactivation of the @PROTEIN2$ pathway in non-small cell lung carcinoma (NSCLC) occurs mostly through inactivation of the @PROTEIN1$ p16(INK4A) and\/or up-regulation of cyclin D1.","label":0}
{"pair_id":"BioInfer.d309.s0.p9","sentence":"Inactivation of the @PROTEIN2$ pathway in non-small cell lung carcinoma (NSCLC) occurs mostly through inactivation of the cyclin-dependent kinase inhibitor @PROTEIN1$(INK4A) and\/or up-regulation of cyclin D1.","label":1}
{"pair_id":"AIMed.d137.s1157.p0","sentence":"We have therefore investigated whether the octamer binding proteins might physically interact with @PROTEIN1$, the @PROTEIN2$ component of the TFIID factor.","label":0}
{"pair_id":"AIMed.d137.s1157.p1","sentence":"We have therefore investigated whether the octamer binding proteins might physically interact with @PROTEIN1$, the TATA box binding protein component of the @PROTEIN2$ factor.","label":0}
{"pair_id":"AIMed.d137.s1157.p2","sentence":"We have therefore investigated whether the octamer binding proteins might physically interact with TBP, the @PROTEIN1$ component of the @PROTEIN2$ factor.","label":0}
{"pair_id":"BioInfer.d244.s0.p0","sentence":"Here, we have detected a polypeptide in rat rod outer segments that is recognized by @PROTEIN2$ antibodies and was found to possess other characteristics of conventional non-muscle myosin heavy chain: it comigrates in SDS-PAGE with @PROTEIN1$; it associates with the cytoskeleton of rod outer segments in an ATP-sensitive manner; and it binds to purified actin filaments in the absence of ATP.","label":0}
{"pair_id":"BioInfer.d244.s0.p1","sentence":"Here, we have detected a polypeptide in rat rod outer segments that is recognized by myosin heavy chain antibodies and was found to possess other characteristics of conventional @PROTEIN2$: it comigrates in SDS-PAGE with @PROTEIN1$; it associates with the cytoskeleton of rod outer segments in an ATP-sensitive manner; and it binds to purified actin filaments in the absence of ATP.","label":0}
{"pair_id":"BioInfer.d244.s0.p2","sentence":"Here, we have detected a polypeptide in rat rod outer segments that is recognized by myosin heavy chain antibodies and was found to possess other characteristics of conventional non-muscle myosin heavy chain: it comigrates in SDS-PAGE with @PROTEIN1$; it associates with the cytoskeleton of rod outer segments in an ATP-sensitive manner; and it binds to purified @PROTEIN2$ filaments in the absence of ATP.","label":0}
{"pair_id":"BioInfer.d244.s0.p3","sentence":"Here, we have detected a polypeptide in rat rod outer segments that is recognized by @PROTEIN1$ antibodies and was found to possess other characteristics of conventional @PROTEIN2$: it comigrates in SDS-PAGE with non-muscle myosin heavy chain; it associates with the cytoskeleton of rod outer segments in an ATP-sensitive manner; and it binds to purified actin filaments in the absence of ATP.","label":0}
{"pair_id":"BioInfer.d244.s0.p4","sentence":"Here, we have detected a polypeptide in rat rod outer segments that is recognized by @PROTEIN1$ antibodies and was found to possess other characteristics of conventional non-muscle myosin heavy chain: it comigrates in SDS-PAGE with non-muscle myosin heavy chain; it associates with the cytoskeleton of rod outer segments in an ATP-sensitive manner; and it binds to purified @PROTEIN2$ filaments in the absence of ATP.","label":0}
{"pair_id":"BioInfer.d244.s0.p5","sentence":"Here, we have detected a polypeptide in rat rod outer segments that is recognized by myosin heavy chain antibodies and was found to possess other characteristics of conventional @PROTEIN1$: it comigrates in SDS-PAGE with non-muscle myosin heavy chain; it associates with the cytoskeleton of rod outer segments in an ATP-sensitive manner; and it binds to purified @PROTEIN2$ filaments in the absence of ATP.","label":1}
{"pair_id":"AIMed.d44.s386.p0","sentence":"The pattern of @PROTEIN1$ binding inhibition shows only limited correspondence to the functional capacity of some anti-@PROTEIN2$ MAb to trigger CD30 signaling.","label":0}
{"pair_id":"AIMed.d44.s386.p1","sentence":"The pattern of @PROTEIN1$ binding inhibition shows only limited correspondence to the functional capacity of some anti-CD30 MAb to trigger @PROTEIN2$ signaling.","label":0}
{"pair_id":"AIMed.d44.s386.p2","sentence":"The pattern of CD30L binding inhibition shows only limited correspondence to the functional capacity of some anti-@PROTEIN1$ MAb to trigger @PROTEIN2$ signaling.","label":0}
{"pair_id":"AIMed.d117.s987.p0","sentence":"Activin type I receptors, @PROTEIN1$ and @PROTEIN2$, were first cloned from well differentiated human hepatoma cells (HepG2).","label":0}
{"pair_id":"AIMed.d184.s1567.p0","sentence":"Neutralizing antibodies directed against either @PROTEIN1$-induced or V3 epitopes on @PROTEIN2$ blocked the interaction of gp12O-CD4 complexes with CCR-5.","label":0}
{"pair_id":"AIMed.d184.s1567.p1","sentence":"Neutralizing antibodies directed against either @PROTEIN1$-induced or V3 epitopes on gp120 blocked the interaction of @PROTEIN2$-CD4 complexes with CCR-5.","label":0}
{"pair_id":"AIMed.d184.s1567.p2","sentence":"Neutralizing antibodies directed against either @PROTEIN1$-induced or V3 epitopes on gp120 blocked the interaction of gp12O-@PROTEIN2$ complexes with CCR-5.","label":0}
{"pair_id":"AIMed.d184.s1567.p3","sentence":"Neutralizing antibodies directed against either @PROTEIN1$-induced or V3 epitopes on gp120 blocked the interaction of gp12O-CD4 complexes with @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d184.s1567.p4","sentence":"Neutralizing antibodies directed against either CD4-induced or V3 epitopes on @PROTEIN1$ blocked the interaction of @PROTEIN2$-CD4 complexes with CCR-5.","label":0}
{"pair_id":"AIMed.d184.s1567.p5","sentence":"Neutralizing antibodies directed against either CD4-induced or V3 epitopes on @PROTEIN1$ blocked the interaction of gp12O-@PROTEIN2$ complexes with CCR-5.","label":0}
{"pair_id":"AIMed.d184.s1567.p6","sentence":"Neutralizing antibodies directed against either CD4-induced or V3 epitopes on @PROTEIN1$ blocked the interaction of gp12O-CD4 complexes with @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d184.s1567.p7","sentence":"Neutralizing antibodies directed against either CD4-induced or V3 epitopes on gp120 blocked the interaction of @PROTEIN1$-@PROTEIN2$ complexes with CCR-5.","label":1}
{"pair_id":"AIMed.d184.s1567.p8","sentence":"Neutralizing antibodies directed against either CD4-induced or V3 epitopes on gp120 blocked the interaction of @PROTEIN1$-CD4 complexes with @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d184.s1567.p9","sentence":"Neutralizing antibodies directed against either CD4-induced or V3 epitopes on gp120 blocked the interaction of gp12O-@PROTEIN1$ complexes with @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d105.s886.p0","sentence":"We expressed differently tagged forms of @PROTEIN1$ and used them in solution-phase binding assays to show that the soluble extracellular domains of @PROTEIN2$ undergo dimerization in the absence of membranes.","label":0}
{"pair_id":"BioInfer.d11.s0.p0","sentence":"A common feature of these @PROTEIN2$-positive domains is the deep membrane infoldings, where bundles of @PROTEIN1$ filaments are inserted into the membrane.","label":0}
{"pair_id":"AIMed.d23.s189.p0","sentence":"In the present study, we examined the presence of glucocorticoid receptors (GRs) and @PROTEIN1$ (@PROTEIN2$) in the nasal polyps of nonallergic patients as compared with normal controls.","label":0}
{"pair_id":"AIMed.d104.s882.p0","sentence":"Both @PROTEIN1$ and @PROTEIN2$ bind to all E2F family members in vivo, and each complex is capable of activating transcription.","label":0}
{"pair_id":"AIMed.d104.s882.p1","sentence":"Both @PROTEIN1$ and hDP-2 bind to all @PROTEIN2$ family members in vivo, and each complex is capable of activating transcription.","label":0}
{"pair_id":"AIMed.d104.s882.p2","sentence":"Both hDP-1 and @PROTEIN1$ bind to all @PROTEIN2$ family members in vivo, and each complex is capable of activating transcription.","label":0}
{"pair_id":"BioInfer.d305.s0.p0","sentence":"In 50 mM KCl, high concentrations of Acanthamoeba @PROTEIN1$ inhibit the elongation rate of @PROTEIN2$ filaments measured directly by electron microscopy, but the effect is minimal in KCl with 2 MgCl2.","label":1}
{"pair_id":"AIMed.d198.s1692.p0","sentence":"Using these methods, we have identified residues that appear to be involved in @PROTEIN1$ binding as well as other residues, most of which are conserved in receptors of the cytokine receptor family, that appear to be necessary for the proper folding and\/or stability of the @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d179.s1525.p0","sentence":"Following @PROTEIN1$ stimulation, we observed a time- and dose-dependent association of @PROTEIN2$ with the p85 regulatory subunit of phosphatidylinositol 3-kinase (PI 3-kinase).","label":0}
{"pair_id":"AIMed.d179.s1525.p1","sentence":"Following @PROTEIN1$ stimulation, we observed a time- and dose-dependent association of IRS-1 with the @PROTEIN2$ regulatory subunit of phosphatidylinositol 3-kinase (PI 3-kinase).","label":0}
{"pair_id":"AIMed.d179.s1525.p2","sentence":"Following @PROTEIN1$ stimulation, we observed a time- and dose-dependent association of IRS-1 with the p85 regulatory subunit of @PROTEIN2$ (PI 3-kinase).","label":0}
{"pair_id":"AIMed.d179.s1525.p3","sentence":"Following @PROTEIN1$ stimulation, we observed a time- and dose-dependent association of IRS-1 with the p85 regulatory subunit of phosphatidylinositol 3-kinase (@PROTEIN2$).","label":0}
{"pair_id":"AIMed.d179.s1525.p4","sentence":"Following gastrin stimulation, we observed a time- and dose-dependent association of @PROTEIN1$ with the @PROTEIN2$ regulatory subunit of phosphatidylinositol 3-kinase (PI 3-kinase).","label":0}
{"pair_id":"AIMed.d179.s1525.p5","sentence":"Following gastrin stimulation, we observed a time- and dose-dependent association of @PROTEIN1$ with the p85 regulatory subunit of @PROTEIN2$ (PI 3-kinase).","label":1}
{"pair_id":"AIMed.d179.s1525.p6","sentence":"Following gastrin stimulation, we observed a time- and dose-dependent association of @PROTEIN1$ with the p85 regulatory subunit of phosphatidylinositol 3-kinase (@PROTEIN2$).","label":1}
{"pair_id":"AIMed.d179.s1525.p7","sentence":"Following gastrin stimulation, we observed a time- and dose-dependent association of IRS-1 with the @PROTEIN1$ regulatory subunit of @PROTEIN2$ (PI 3-kinase).","label":0}
{"pair_id":"AIMed.d179.s1525.p8","sentence":"Following gastrin stimulation, we observed a time- and dose-dependent association of IRS-1 with the @PROTEIN1$ regulatory subunit of phosphatidylinositol 3-kinase (@PROTEIN2$).","label":0}
{"pair_id":"AIMed.d179.s1525.p9","sentence":"Following gastrin stimulation, we observed a time- and dose-dependent association of IRS-1 with the p85 regulatory subunit of @PROTEIN1$ (@PROTEIN2$).","label":0}
{"pair_id":"BioInfer.d437.s0.p0","sentence":"Moreover, in the presence of @PROTEIN2$, rapid interconversion of monomeric and polymeric forms of @PROTEIN1$ can be induced by simply changing the pH of the medium.","label":0}
{"pair_id":"AIMed.d143.s1214.p0","sentence":"Finally, anti-@PROTEIN1$ antibody inhibited the ability of @PROTEIN2$, but not IL-11, to transduce early signals in TF-1 cells.","label":0}
{"pair_id":"AIMed.d143.s1214.p1","sentence":"Finally, anti-@PROTEIN1$ antibody inhibited the ability of IL-6, but not @PROTEIN2$, to transduce early signals in TF-1 cells.","label":0}
{"pair_id":"AIMed.d143.s1214.p2","sentence":"Finally, anti-IL-6R antibody inhibited the ability of @PROTEIN1$, but not @PROTEIN2$, to transduce early signals in TF-1 cells.","label":0}
{"pair_id":"AIMed.d176.s1491.p0","sentence":"Mutational analysis of @PROTEIN1$ indicates that the N terminus is required for @PROTEIN2$ binding, and a central region containing tetratricopeptide repeat motifs is necessary for binding hsp90 and hsp70.","label":1}
{"pair_id":"AIMed.d176.s1491.p1","sentence":"Mutational analysis of @PROTEIN1$ indicates that the N terminus is required for hsp70 binding, and a central region containing tetratricopeptide repeat motifs is necessary for binding @PROTEIN2$ and hsp70.","label":1}
{"pair_id":"AIMed.d176.s1491.p2","sentence":"Mutational analysis of @PROTEIN1$ indicates that the N terminus is required for hsp70 binding, and a central region containing tetratricopeptide repeat motifs is necessary for binding hsp90 and @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d176.s1491.p3","sentence":"Mutational analysis of p60 indicates that the N terminus is required for @PROTEIN1$ binding, and a central region containing tetratricopeptide repeat motifs is necessary for binding @PROTEIN2$ and hsp70.","label":0}
{"pair_id":"AIMed.d176.s1491.p4","sentence":"Mutational analysis of p60 indicates that the N terminus is required for @PROTEIN1$ binding, and a central region containing tetratricopeptide repeat motifs is necessary for binding hsp90 and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d176.s1491.p5","sentence":"Mutational analysis of p60 indicates that the N terminus is required for hsp70 binding, and a central region containing tetratricopeptide repeat motifs is necessary for binding @PROTEIN1$ and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d90.s768.p0","sentence":"Three of these clones encode DNA binding proteins (@PROTEIN1$, @PROTEIN2$, and SSRP), one clone encodes a chaperone protein, and another clone encodes a multifunctional phosphatase.","label":0}
{"pair_id":"AIMed.d90.s768.p1","sentence":"Three of these clones encode DNA binding proteins (@PROTEIN1$, HMG I\/Y, and @PROTEIN2$), one clone encodes a chaperone protein, and another clone encodes a multifunctional phosphatase.","label":0}
{"pair_id":"AIMed.d90.s768.p2","sentence":"Three of these clones encode DNA binding proteins (NF-IL6 beta, @PROTEIN1$, and @PROTEIN2$), one clone encodes a chaperone protein, and another clone encodes a multifunctional phosphatase.","label":0}
{"pair_id":"AIMed.d209.s1806.p0","sentence":"Human @PROTEIN1$ was first characterized as a @PROTEIN2$ binding protein based on the properties of its carboxyl-terminal domain.","label":1}
{"pair_id":"AIMed.d209.s1806.p1","sentence":"Human @PROTEIN1$ was first characterized as a @PROTEIN2$ based on the properties of its carboxyl-terminal domain.","label":0}
{"pair_id":"AIMed.d209.s1806.p2","sentence":"Human RIN1 was first characterized as a @PROTEIN1$@PROTEIN2$ based on the properties of its carboxyl-terminal domain.","label":0}
{"pair_id":"AIMed.d141.s1191.p0","sentence":"@PROTEIN1$ encodes a novel 21 kd protein that is found in @PROTEIN2$, cyclin D1, cyclin E, and Cdk2 immunoprecipitates.","label":0}
{"pair_id":"AIMed.d141.s1191.p1","sentence":"@PROTEIN1$ encodes a novel 21 kd protein that is found in cyclin A, @PROTEIN2$, cyclin E, and Cdk2 immunoprecipitates.","label":0}
{"pair_id":"AIMed.d141.s1191.p2","sentence":"@PROTEIN1$ encodes a novel 21 kd protein that is found in cyclin A, cyclin D1, @PROTEIN2$, and Cdk2 immunoprecipitates.","label":0}
{"pair_id":"AIMed.d141.s1191.p3","sentence":"@PROTEIN1$ encodes a novel 21 kd protein that is found in cyclin A, cyclin D1, cyclin E, and @PROTEIN2$ immunoprecipitates.","label":0}
{"pair_id":"AIMed.d141.s1191.p4","sentence":"CIP1 encodes a novel 21 kd protein that is found in @PROTEIN1$, @PROTEIN2$, cyclin E, and Cdk2 immunoprecipitates.","label":0}
{"pair_id":"AIMed.d141.s1191.p5","sentence":"CIP1 encodes a novel 21 kd protein that is found in @PROTEIN1$, cyclin D1, @PROTEIN2$, and Cdk2 immunoprecipitates.","label":0}
{"pair_id":"AIMed.d141.s1191.p6","sentence":"CIP1 encodes a novel 21 kd protein that is found in @PROTEIN1$, cyclin D1, cyclin E, and @PROTEIN2$ immunoprecipitates.","label":0}
{"pair_id":"AIMed.d141.s1191.p7","sentence":"CIP1 encodes a novel 21 kd protein that is found in cyclin A, @PROTEIN1$, @PROTEIN2$, and Cdk2 immunoprecipitates.","label":0}
{"pair_id":"AIMed.d141.s1191.p8","sentence":"CIP1 encodes a novel 21 kd protein that is found in cyclin A, @PROTEIN1$, cyclin E, and @PROTEIN2$ immunoprecipitates.","label":0}
{"pair_id":"AIMed.d141.s1191.p9","sentence":"CIP1 encodes a novel 21 kd protein that is found in cyclin A, cyclin D1, @PROTEIN1$, and @PROTEIN2$ immunoprecipitates.","label":0}
{"pair_id":"AIMed.d160.s1349.p0","sentence":"Mutations within the @PROTEIN1$ site had minimal effect on @PROTEIN2$ binding, and mutants deficient in FLT-1 binding did not affect KDR binding.","label":0}
{"pair_id":"AIMed.d160.s1349.p1","sentence":"Mutations within the @PROTEIN1$ site had minimal effect on FLT-1 binding, and mutants deficient in @PROTEIN2$ binding did not affect KDR binding.","label":0}
{"pair_id":"AIMed.d160.s1349.p2","sentence":"Mutations within the @PROTEIN1$ site had minimal effect on FLT-1 binding, and mutants deficient in FLT-1 binding did not affect @PROTEIN2$ binding.","label":0}
{"pair_id":"AIMed.d160.s1349.p3","sentence":"Mutations within the KDR site had minimal effect on @PROTEIN1$ binding, and mutants deficient in @PROTEIN2$ binding did not affect KDR binding.","label":0}
{"pair_id":"AIMed.d160.s1349.p4","sentence":"Mutations within the KDR site had minimal effect on @PROTEIN1$ binding, and mutants deficient in FLT-1 binding did not affect @PROTEIN2$ binding.","label":0}
{"pair_id":"AIMed.d160.s1349.p5","sentence":"Mutations within the KDR site had minimal effect on FLT-1 binding, and mutants deficient in @PROTEIN1$ binding did not affect @PROTEIN2$ binding.","label":0}
{"pair_id":"BioInfer.d522.s0.p0","sentence":"Reversible binding of @PROTEIN2$ to gelsolin and @PROTEIN1$ in human platelet extracts.","label":1}
{"pair_id":"BioInfer.d522.s0.p1","sentence":"Reversible binding of actin to @PROTEIN2$ and @PROTEIN1$ in human platelet extracts.","label":0}
{"pair_id":"BioInfer.d522.s0.p2","sentence":"Reversible binding of @PROTEIN1$ to @PROTEIN2$ and profilin in human platelet extracts.","label":1}
{"pair_id":"BioInfer.d186.s0.p0","sentence":"Effects of mutations of @PROTEIN1$, RAD51, @PROTEIN2$, and related genes on illegitimate recombination in Saccharomyces cerevisiae.","label":0}
{"pair_id":"BioInfer.d186.s0.p1","sentence":"Effects of mutations of @PROTEIN1$, @PROTEIN2$, RAD52, and related genes on illegitimate recombination in Saccharomyces cerevisiae.","label":0}
{"pair_id":"BioInfer.d186.s0.p2","sentence":"Effects of mutations of RAD50, @PROTEIN2$, @PROTEIN1$, and related genes on illegitimate recombination in Saccharomyces cerevisiae.","label":0}
{"pair_id":"AIMed.d173.s1463.p0","sentence":"Specificity was further shown by the finding that no significant interaction was observed in yeast expressing @PROTEIN1$-@PROTEIN2$ bait when the B42 transactivation domain was fused to an Abeta fragment with Phe-Phe at residues 19 and 20 replaced by Thr-Thr (AbetaTT), a finding that is consistent with in vitro observations made by others.","label":0}
{"pair_id":"AIMed.d173.s1463.p1","sentence":"Specificity was further shown by the finding that no significant interaction was observed in yeast expressing @PROTEIN1$-Abeta bait when the @PROTEIN2$ transactivation domain was fused to an Abeta fragment with Phe-Phe at residues 19 and 20 replaced by Thr-Thr (AbetaTT), a finding that is consistent with in vitro observations made by others.","label":0}
{"pair_id":"AIMed.d173.s1463.p2","sentence":"Specificity was further shown by the finding that no significant interaction was observed in yeast expressing @PROTEIN1$-Abeta bait when the B42 transactivation domain was fused to an @PROTEIN2$ fragment with Phe-Phe at residues 19 and 20 replaced by Thr-Thr (AbetaTT), a finding that is consistent with in vitro observations made by others.","label":0}
{"pair_id":"AIMed.d173.s1463.p3","sentence":"Specificity was further shown by the finding that no significant interaction was observed in yeast expressing LexA-@PROTEIN1$ bait when the @PROTEIN2$ transactivation domain was fused to an Abeta fragment with Phe-Phe at residues 19 and 20 replaced by Thr-Thr (AbetaTT), a finding that is consistent with in vitro observations made by others.","label":0}
{"pair_id":"AIMed.d173.s1463.p4","sentence":"Specificity was further shown by the finding that no significant interaction was observed in yeast expressing LexA-@PROTEIN1$ bait when the B42 transactivation domain was fused to an @PROTEIN2$ fragment with Phe-Phe at residues 19 and 20 replaced by Thr-Thr (AbetaTT), a finding that is consistent with in vitro observations made by others.","label":0}
{"pair_id":"AIMed.d173.s1463.p5","sentence":"Specificity was further shown by the finding that no significant interaction was observed in yeast expressing LexA-Abeta bait when the @PROTEIN1$ transactivation domain was fused to an @PROTEIN2$ fragment with Phe-Phe at residues 19 and 20 replaced by Thr-Thr (AbetaTT), a finding that is consistent with in vitro observations made by others.","label":0}
{"pair_id":"BioInfer.d78.s1.p0","sentence":"Immunofluorescence microscopy revealed that two actin-binding proteins of low molecular weight with different functional activity, @PROTEIN2$ and @PROTEIN1$, are transported into nuclei of cultured myogenic cells to form rod structures there together with actin, when the cells were incubated in medium containing dimethylsulfoxide.","label":0}
{"pair_id":"BioInfer.d78.s1.p1","sentence":"Immunofluorescence microscopy revealed that two actin-binding proteins of low molecular weight with different functional activity, ADF and @PROTEIN1$, are transported into nuclei of cultured myogenic cells to form rod structures there together with @PROTEIN2$, when the cells were incubated in medium containing dimethylsulfoxide.","label":1}
{"pair_id":"BioInfer.d78.s1.p2","sentence":"Immunofluorescence microscopy revealed that two @PROTEIN2$ of low molecular weight with different functional activity, ADF and @PROTEIN1$, are transported into nuclei of cultured myogenic cells to form rod structures there together with actin, when the cells were incubated in medium containing dimethylsulfoxide.","label":1}
{"pair_id":"BioInfer.d78.s1.p3","sentence":"Immunofluorescence microscopy revealed that two actin-binding proteins of low molecular weight with different functional activity, @PROTEIN1$ and cofilin, are transported into nuclei of cultured myogenic cells to form rod structures there together with @PROTEIN2$, when the cells were incubated in medium containing dimethylsulfoxide.","label":1}
{"pair_id":"BioInfer.d78.s1.p4","sentence":"Immunofluorescence microscopy revealed that two @PROTEIN2$ of low molecular weight with different functional activity, @PROTEIN1$ and cofilin, are transported into nuclei of cultured myogenic cells to form rod structures there together with actin, when the cells were incubated in medium containing dimethylsulfoxide.","label":1}
{"pair_id":"BioInfer.d78.s1.p5","sentence":"Immunofluorescence microscopy revealed that two @PROTEIN2$ of low molecular weight with different functional activity, ADF and cofilin, are transported into nuclei of cultured myogenic cells to form rod structures there together with @PROTEIN1$, when the cells were incubated in medium containing dimethylsulfoxide.","label":0}
{"pair_id":"AIMed.d68.s585.p0","sentence":"The motif may represent an activating domain that has to be provided to @PROTEIN1$ by intermolecular interaction with @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d122.s1041.p0","sentence":"Measurement of @PROTEIN1$ I3A,I5A interaction with the human @PROTEIN2$, Ht 31, by two independent methods suggests that mutation of isoleucines 3 and 5 decreases affinity by at least 6-fold.","label":1}
{"pair_id":"AIMed.d122.s1041.p1","sentence":"Measurement of @PROTEIN1$ I3A,I5A interaction with the human thyroid AKAP, @PROTEIN2$, by two independent methods suggests that mutation of isoleucines 3 and 5 decreases affinity by at least 6-fold.","label":1}
{"pair_id":"AIMed.d122.s1041.p2","sentence":"Measurement of RII alpha I3A,I5A interaction with the human @PROTEIN1$, @PROTEIN2$, by two independent methods suggests that mutation of isoleucines 3 and 5 decreases affinity by at least 6-fold.","label":0}
{"pair_id":"AIMed.d113.s957.p0","sentence":"The @PROTEIN1$ protein shares no significant homology with @PROTEIN2$ or other Bcl-2 family proteins, which can form homo- and heterodimers.","label":0}
{"pair_id":"AIMed.d113.s957.p1","sentence":"The @PROTEIN1$ protein shares no significant homology with Bcl-2 or other @PROTEIN2$ family proteins, which can form homo- and heterodimers.","label":0}
{"pair_id":"AIMed.d113.s957.p2","sentence":"The BAG-1 protein shares no significant homology with @PROTEIN1$ or other @PROTEIN2$ family proteins, which can form homo- and heterodimers.","label":0}
{"pair_id":"AIMed.d101.s858.p0","sentence":"We propose that @PROTEIN1$ and @PROTEIN2$ proteins function as transcriptional activators, in part by recruiting TBP to form complexes to initiate RNA synthesis.","label":0}
{"pair_id":"AIMed.d101.s858.p1","sentence":"We propose that @PROTEIN1$ and c-Jun proteins function as transcriptional activators, in part by recruiting @PROTEIN2$ to form complexes to initiate RNA synthesis.","label":1}
{"pair_id":"AIMed.d101.s858.p2","sentence":"We propose that c-Fos and @PROTEIN1$ proteins function as transcriptional activators, in part by recruiting @PROTEIN2$ to form complexes to initiate RNA synthesis.","label":1}
{"pair_id":"BioInfer.d331.s0.p0","sentence":"Increased interaction of @PROTEIN2$ with the actin cytoskeleton is consistent with and might be mediated by its enhanced binding to @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d331.s0.p1","sentence":"Increased interaction of beta1D integrin with the @PROTEIN2$ cytoskeleton is consistent with and might be mediated by its enhanced binding to @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d331.s0.p2","sentence":"Increased interaction of @PROTEIN1$ with the @PROTEIN2$ cytoskeleton is consistent with and might be mediated by its enhanced binding to talin.","label":1}
{"pair_id":"AIMed.d158.s1336.p0","sentence":"Overexpression of the intact @PROTEIN1$ protein induces both @PROTEIN2$ activation and apoptosis.","label":0}
{"pair_id":"BioInfer.d397.s2.p0","sentence":"The @PROTEIN2$ phenotype is developmentally and hormonally regulated, but less is known concerning the @PROTEIN1$ phenotype.","label":0}
{"pair_id":"AIMed.d118.s998.p0","sentence":"Levels of @PROTEIN1$ protein are increased in senescent cells and @PROTEIN2$ overexpression blocks the growth of tumour cells.","label":0}
{"pair_id":"AIMed.d112.s944.p0","sentence":"Human spleen tyrosine kinase @PROTEIN1$ associates with the Src-family kinase @PROTEIN2$\/56Lyn and a 120-kDa phosphoprotein.","label":1}
{"pair_id":"AIMed.d112.s944.p1","sentence":"Human spleen tyrosine kinase @PROTEIN1$ associates with the Src-family kinase p53\/@PROTEIN2$ and a 120-kDa phosphoprotein.","label":1}
{"pair_id":"AIMed.d112.s944.p2","sentence":"Human spleen tyrosine kinase @PROTEIN1$ associates with the Src-family kinase p53\/56Lyn and a @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d112.s944.p3","sentence":"Human spleen tyrosine kinase p72Syk associates with the Src-family kinase @PROTEIN1$\/@PROTEIN2$ and a 120-kDa phosphoprotein.","label":0}
{"pair_id":"AIMed.d112.s944.p4","sentence":"Human spleen tyrosine kinase p72Syk associates with the Src-family kinase @PROTEIN1$\/56Lyn and a @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d112.s944.p5","sentence":"Human spleen tyrosine kinase p72Syk associates with the Src-family kinase p53\/@PROTEIN1$ and a @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d184.s1565.p0","sentence":"Additionally, in the absence of @PROTEIN1$, an interaction between a two-domain @PROTEIN2$ fragment and CCR-5 was observed.","label":0}
{"pair_id":"AIMed.d184.s1565.p1","sentence":"Additionally, in the absence of @PROTEIN1$, an interaction between a two-domain CD4 fragment and @PROTEIN2$ was observed.","label":0}
{"pair_id":"AIMed.d184.s1565.p2","sentence":"Additionally, in the absence of gp120, an interaction between a two-domain @PROTEIN1$ fragment and @PROTEIN2$ was observed.","label":1}
{"pair_id":"AIMed.d209.s1813.p0","sentence":"Moreover, the amino-terminal domain of @PROTEIN1$ directly associates with, and is tyrosine phosphorylated by, @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d769.s0.p0","sentence":"To improve our ability to study these proteins, we have expressed @PROTEIN1$, UL8, @PROTEIN2$, and UL52 in insect cells by using the baculovirus expression system.","label":0}
{"pair_id":"BioInfer.d769.s0.p1","sentence":"To improve our ability to study these proteins, we have expressed @PROTEIN1$, @PROTEIN2$, UL9, and UL52 in insect cells by using the baculovirus expression system.","label":0}
{"pair_id":"BioInfer.d769.s0.p2","sentence":"To improve our ability to study these proteins, we have expressed @PROTEIN1$, UL8, UL9, and @PROTEIN2$ in insect cells by using the baculovirus expression system.","label":0}
{"pair_id":"BioInfer.d769.s0.p3","sentence":"To improve our ability to study these proteins, we have expressed UL5, @PROTEIN2$, @PROTEIN1$, and UL52 in insect cells by using the baculovirus expression system.","label":0}
{"pair_id":"BioInfer.d769.s0.p4","sentence":"To improve our ability to study these proteins, we have expressed UL5, UL8, @PROTEIN1$, and @PROTEIN2$ in insect cells by using the baculovirus expression system.","label":0}
{"pair_id":"BioInfer.d769.s0.p5","sentence":"To improve our ability to study these proteins, we have expressed UL5, @PROTEIN1$, UL9, and @PROTEIN2$ in insect cells by using the baculovirus expression system.","label":0}
{"pair_id":"BioInfer.d667.s0.p0","sentence":"The primary purpose of this study was to determine the relationship between myosin heavy chain (@PROTEIN2$) and @PROTEIN1$ contents and maximum isometric tetanic force (Po) in mouse extensor digitorum longus (EDL) muscles following eccentric contraction-induced injury.","label":0}
{"pair_id":"BioInfer.d667.s0.p1","sentence":"The primary purpose of this study was to determine the relationship between @PROTEIN2$ (MHC) and @PROTEIN1$ contents and maximum isometric tetanic force (Po) in mouse extensor digitorum longus (EDL) muscles following eccentric contraction-induced injury.","label":0}
{"pair_id":"BioInfer.d667.s0.p2","sentence":"The primary purpose of this study was to determine the relationship between @PROTEIN2$ (@PROTEIN1$) and actin contents and maximum isometric tetanic force (Po) in mouse extensor digitorum longus (EDL) muscles following eccentric contraction-induced injury.","label":0}
{"pair_id":"AIMed.d71.s607.p0","sentence":"The @PROTEIN1$ enzymes @PROTEIN2$ and pp42\/44 are regulated by tyrosine as well as serine\/threonine phosphorylation.","label":0}
{"pair_id":"AIMed.d71.s607.p1","sentence":"The @PROTEIN1$ enzymes pp54 and @PROTEIN2$\/44 are regulated by tyrosine as well as serine\/threonine phosphorylation.","label":0}
{"pair_id":"AIMed.d71.s607.p2","sentence":"The MAP kinase enzymes @PROTEIN1$ and @PROTEIN2$\/44 are regulated by tyrosine as well as serine\/threonine phosphorylation.","label":0}
{"pair_id":"AIMed.d199.s1714.p0","sentence":"@PROTEIN1$; these two complexes may alternatively link @PROTEIN2$ to mitogen-activated protein kinase.","label":0}
{"pair_id":"AIMed.d199.s1714.p1","sentence":"@PROTEIN1$; these two complexes may alternatively link FGFG3 to @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d199.s1714.p2","sentence":"Sos; these two complexes may alternatively link @PROTEIN1$ to @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d611.s0.p0","sentence":"The existence of this pathway helps to explain some of the effects of @PROTEIN1$ and @PROTEIN2$ in the control of actin dynamics.","label":0}
{"pair_id":"BioInfer.d611.s0.p1","sentence":"The existence of this pathway helps to explain some of the effects of @PROTEIN1$ and cofilin in the control of @PROTEIN2$ dynamics.","label":1}
{"pair_id":"BioInfer.d611.s0.p2","sentence":"The existence of this pathway helps to explain some of the effects of LIM kinase and @PROTEIN1$ in the control of @PROTEIN2$ dynamics.","label":1}
{"pair_id":"AIMed.d174.s1472.p0","sentence":"Studies of the @PROTEIN1$ ternary complex formation demonstrated that the reduced biological potency of @PROTEIN2$ resulted from a decreased ability of the IL-6D (sIL-6R)2 complex to couple with the soluble portion of gp130.","label":0}
{"pair_id":"AIMed.d174.s1472.p1","sentence":"Studies of the @PROTEIN1$ ternary complex formation demonstrated that the reduced biological potency of IL-6D resulted from a decreased ability of the @PROTEIN2$ (sIL-6R)2 complex to couple with the soluble portion of gp130.","label":0}
{"pair_id":"AIMed.d174.s1472.p2","sentence":"Studies of the @PROTEIN1$ ternary complex formation demonstrated that the reduced biological potency of IL-6D resulted from a decreased ability of the IL-6D (@PROTEIN2$)2 complex to couple with the soluble portion of gp130.","label":0}
{"pair_id":"AIMed.d174.s1472.p3","sentence":"Studies of the @PROTEIN1$ ternary complex formation demonstrated that the reduced biological potency of IL-6D resulted from a decreased ability of the IL-6D (sIL-6R)2 complex to couple with the soluble portion of @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d174.s1472.p4","sentence":"Studies of the IL-6 ternary complex formation demonstrated that the reduced biological potency of @PROTEIN1$ resulted from a decreased ability of the @PROTEIN2$ (sIL-6R)2 complex to couple with the soluble portion of gp130.","label":0}
{"pair_id":"AIMed.d174.s1472.p5","sentence":"Studies of the IL-6 ternary complex formation demonstrated that the reduced biological potency of @PROTEIN1$ resulted from a decreased ability of the IL-6D (@PROTEIN2$)2 complex to couple with the soluble portion of gp130.","label":0}
{"pair_id":"AIMed.d174.s1472.p6","sentence":"Studies of the IL-6 ternary complex formation demonstrated that the reduced biological potency of @PROTEIN1$ resulted from a decreased ability of the IL-6D (sIL-6R)2 complex to couple with the soluble portion of @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d174.s1472.p7","sentence":"Studies of the IL-6 ternary complex formation demonstrated that the reduced biological potency of IL-6D resulted from a decreased ability of the @PROTEIN1$ (@PROTEIN2$)2 complex to couple with the soluble portion of gp130.","label":1}
{"pair_id":"AIMed.d174.s1472.p8","sentence":"Studies of the IL-6 ternary complex formation demonstrated that the reduced biological potency of IL-6D resulted from a decreased ability of the @PROTEIN1$ (sIL-6R)2 complex to couple with the soluble portion of @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d174.s1472.p9","sentence":"Studies of the IL-6 ternary complex formation demonstrated that the reduced biological potency of IL-6D resulted from a decreased ability of the IL-6D (@PROTEIN1$)2 complex to couple with the soluble portion of @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d123.s0.p0","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone @PROTEIN1$, and not histone H3, was acetylated from the endogenous @PROTEIN2$\/waf1 promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":1}
{"pair_id":"BioInfer.d123.s0.p1","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone @PROTEIN1$, and not histone @PROTEIN2$, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p2","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone @PROTEIN1$, and not histone H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that @PROTEIN2$\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p3","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone @PROTEIN1$, and not histone H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/p300, and not the @PROTEIN2$ complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p4","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone @PROTEIN1$, and not histone H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/@PROTEIN2$, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p5","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone @PROTEIN1$, and not histone H3, was acetylated from the endogenous p21\/@PROTEIN2$ promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":1}
{"pair_id":"BioInfer.d123.s0.p6","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone @PROTEIN1$, and not histone H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/@PROTEIN2$ in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p7","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone @PROTEIN1$, and not histone H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of @PROTEIN2$\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p8","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone @PROTEIN1$, and not @PROTEIN2$ H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p9","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone @PROTEIN1$, and not histone H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with @PROTEIN2$ in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p10","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that @PROTEIN2$ @PROTEIN1$, and not histone H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":1}
{"pair_id":"BioInfer.d123.s0.p11","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone @PROTEIN2$, was acetylated from the endogenous @PROTEIN1$\/waf1 promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":1}
{"pair_id":"BioInfer.d123.s0.p12","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous @PROTEIN1$\/waf1 promoter in vivo, implying that @PROTEIN2$\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":1}
{"pair_id":"BioInfer.d123.s0.p13","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous @PROTEIN1$\/waf1 promoter in vivo, implying that CBP\/p300, and not the @PROTEIN2$ complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":1}
{"pair_id":"BioInfer.d123.s0.p14","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous @PROTEIN1$\/waf1 promoter in vivo, implying that CBP\/@PROTEIN2$, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":1}
{"pair_id":"BioInfer.d123.s0.p15","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous @PROTEIN1$\/@PROTEIN2$ promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":1}
{"pair_id":"BioInfer.d123.s0.p16","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous @PROTEIN1$\/waf1 promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/@PROTEIN2$ in HTLV-1-infected cells.","label":1}
{"pair_id":"BioInfer.d123.s0.p17","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous @PROTEIN1$\/waf1 promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of @PROTEIN2$\/waf1 in HTLV-1-infected cells.","label":1}
{"pair_id":"BioInfer.d123.s0.p18","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not @PROTEIN2$ H3, was acetylated from the endogenous @PROTEIN1$\/waf1 promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p19","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous @PROTEIN1$\/waf1 promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with @PROTEIN2$ in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":1}
{"pair_id":"BioInfer.d123.s0.p20","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that @PROTEIN2$ H4, and not histone H3, was acetylated from the endogenous @PROTEIN1$\/waf1 promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p21","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone @PROTEIN1$, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that @PROTEIN2$\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p22","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone @PROTEIN1$, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/p300, and not the @PROTEIN2$ complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p23","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone @PROTEIN1$, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/@PROTEIN2$, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p24","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone @PROTEIN1$, was acetylated from the endogenous p21\/@PROTEIN2$ promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":1}
{"pair_id":"BioInfer.d123.s0.p25","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone @PROTEIN1$, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/@PROTEIN2$ in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p26","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone @PROTEIN1$, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of @PROTEIN2$\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p27","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not @PROTEIN2$ @PROTEIN1$, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":1}
{"pair_id":"BioInfer.d123.s0.p28","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone @PROTEIN1$, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with @PROTEIN2$ in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p29","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that @PROTEIN2$ H4, and not histone @PROTEIN1$, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p30","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that @PROTEIN1$\/p300, and not the @PROTEIN2$ complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p31","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that @PROTEIN1$\/@PROTEIN2$, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p32","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21\/@PROTEIN2$ promoter in vivo, implying that @PROTEIN1$\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":1}
{"pair_id":"BioInfer.d123.s0.p33","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that @PROTEIN1$\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/@PROTEIN2$ in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p34","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that @PROTEIN1$\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of @PROTEIN2$\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p35","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not @PROTEIN2$ H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that @PROTEIN1$\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p36","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that @PROTEIN1$\/p300, and not the SAGA complex, was critical in complexing with @PROTEIN2$ in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":1}
{"pair_id":"BioInfer.d123.s0.p37","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that @PROTEIN2$ H4, and not histone H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that @PROTEIN1$\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p38","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/@PROTEIN2$, and not the @PROTEIN1$ complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p39","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21\/@PROTEIN2$ promoter in vivo, implying that CBP\/p300, and not the @PROTEIN1$ complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":1}
{"pair_id":"BioInfer.d123.s0.p40","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/p300, and not the @PROTEIN1$ complex, was critical in complexing with E2A in up-regulation of p21\/@PROTEIN2$ in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p41","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/p300, and not the @PROTEIN1$ complex, was critical in complexing with E2A in up-regulation of @PROTEIN2$\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p42","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not @PROTEIN2$ H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/p300, and not the @PROTEIN1$ complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p43","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/p300, and not the @PROTEIN1$ complex, was critical in complexing with @PROTEIN2$ in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":1}
{"pair_id":"BioInfer.d123.s0.p44","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that @PROTEIN2$ H4, and not histone H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/p300, and not the @PROTEIN1$ complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p45","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21\/@PROTEIN2$ promoter in vivo, implying that CBP\/@PROTEIN1$, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":1}
{"pair_id":"BioInfer.d123.s0.p46","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/@PROTEIN1$, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/@PROTEIN2$ in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p47","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/@PROTEIN1$, and not the SAGA complex, was critical in complexing with E2A in up-regulation of @PROTEIN2$\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p48","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not @PROTEIN2$ H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/@PROTEIN1$, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p49","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/@PROTEIN1$, and not the SAGA complex, was critical in complexing with @PROTEIN2$ in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":1}
{"pair_id":"BioInfer.d123.s0.p50","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that @PROTEIN2$ H4, and not histone H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/@PROTEIN1$, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p51","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21\/@PROTEIN1$ promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/@PROTEIN2$ in HTLV-1-infected cells.","label":1}
{"pair_id":"BioInfer.d123.s0.p52","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21\/@PROTEIN1$ promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of @PROTEIN2$\/waf1 in HTLV-1-infected cells.","label":1}
{"pair_id":"BioInfer.d123.s0.p53","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not @PROTEIN2$ H3, was acetylated from the endogenous p21\/@PROTEIN1$ promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p54","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21\/@PROTEIN1$ promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with @PROTEIN2$ in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":1}
{"pair_id":"BioInfer.d123.s0.p55","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that @PROTEIN2$ H4, and not histone H3, was acetylated from the endogenous p21\/@PROTEIN1$ promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p56","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of @PROTEIN2$\/@PROTEIN1$ in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p57","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not @PROTEIN2$ H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/@PROTEIN1$ in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p58","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with @PROTEIN2$ in up-regulation of p21\/@PROTEIN1$ in HTLV-1-infected cells.","label":1}
{"pair_id":"BioInfer.d123.s0.p59","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that @PROTEIN2$ H4, and not histone H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/@PROTEIN1$ in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p60","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not @PROTEIN2$ H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of @PROTEIN1$\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p61","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with @PROTEIN2$ in up-regulation of @PROTEIN1$\/waf1 in HTLV-1-infected cells.","label":1}
{"pair_id":"BioInfer.d123.s0.p62","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that @PROTEIN2$ H4, and not histone H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of @PROTEIN1$\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p63","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not @PROTEIN1$ H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with @PROTEIN2$ in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p64","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that @PROTEIN2$ H4, and not @PROTEIN1$ H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p65","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that @PROTEIN2$ H4, and not histone H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with @PROTEIN1$ in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d790.s0.p0","sentence":"Using these methods, we confirm previous reports that intact @PROTEIN1$ induces cross-linking as well as filament shortening on @PROTEIN2$ networks.","label":1}
{"pair_id":"BioInfer.d84.s0.p0","sentence":"As shown by in situ hybridization with cloned probes and analysis of in vitro translation products, M. occulta embryos do not accumulate high levels of @PROTEIN2$ or @PROTEIN1$ mRNA.","label":0}
{"pair_id":"AIMed.d182.s1550.p0","sentence":"These same @PROTEIN1$ residues are also involved in transactivation, supporting the hypothesis that @PROTEIN2$ inactivates p53 by concealing its transactivation domain.","label":0}
{"pair_id":"AIMed.d182.s1550.p1","sentence":"These same @PROTEIN1$ residues are also involved in transactivation, supporting the hypothesis that MDM2 inactivates @PROTEIN2$ by concealing its transactivation domain.","label":0}
{"pair_id":"AIMed.d182.s1550.p2","sentence":"These same p53 residues are also involved in transactivation, supporting the hypothesis that @PROTEIN1$ inactivates @PROTEIN2$ by concealing its transactivation domain.","label":1}
{"pair_id":"AIMed.d68.s582.p0","sentence":"These findings indicate that B-type cyclins are multifunctional proteins that not only act as M phase regulatory subunits of the @PROTEIN1$ protein kinase, but also activate the @PROTEIN2$ tyrosine phosphatase, of which cdc2 is the physiological substrate.","label":0}
{"pair_id":"AIMed.d68.s582.p1","sentence":"These findings indicate that B-type cyclins are multifunctional proteins that not only act as M phase regulatory subunits of the @PROTEIN1$ protein kinase, but also activate the cdc25 tyrosine phosphatase, of which @PROTEIN2$ is the physiological substrate.","label":0}
{"pair_id":"AIMed.d68.s582.p2","sentence":"These findings indicate that B-type cyclins are multifunctional proteins that not only act as M phase regulatory subunits of the cdc2 protein kinase, but also activate the @PROTEIN1$ tyrosine phosphatase, of which @PROTEIN2$ is the physiological substrate.","label":0}
{"pair_id":"AIMed.d23.s195.p0","sentence":"Therefore, 1) the presence of GRs and @PROTEIN1$ in nasal polyps from nonallergic patients, as well as upregulation of @PROTEIN2$ expression, suggests that inflammation may play an important role in the pathophysiology of nasal polyps; and 2) glucocorticoid could be a potential treatment method for suppressing inflammatory processes.","label":0}
{"pair_id":"AIMed.d116.s978.p0","sentence":"The protein encoded by the @PROTEIN1$ (@PROTEIN2$) functions as a tumour suppressor and negative growth regulator.","label":0}
{"pair_id":"BioInfer.d494.s0.p0","sentence":"Production of PIP and PIP2 may be important downstream signals since these polyphosphoinositides are able to regulate the interaction of @PROTEIN2$ and profilin with @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d494.s0.p1","sentence":"Production of PIP and PIP2 may be important downstream signals since these polyphosphoinositides are able to regulate the interaction of gelsolin and @PROTEIN2$ with @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d494.s0.p2","sentence":"Production of PIP and PIP2 may be important downstream signals since these polyphosphoinositides are able to regulate the interaction of @PROTEIN1$ and @PROTEIN2$ with actin.","label":0}
{"pair_id":"AIMed.d65.s560.p0","sentence":"These findings indicate that the @PROTEIN1$\/@PROTEIN2$ and ATF\/CREB families of transcription factors are not as distinct as was previously thought.","label":0}
{"pair_id":"AIMed.d65.s560.p1","sentence":"These findings indicate that the @PROTEIN1$\/Jun and @PROTEIN2$\/CREB families of transcription factors are not as distinct as was previously thought.","label":0}
{"pair_id":"AIMed.d65.s560.p2","sentence":"These findings indicate that the @PROTEIN1$\/Jun and ATF\/@PROTEIN2$ families of transcription factors are not as distinct as was previously thought.","label":0}
{"pair_id":"AIMed.d65.s560.p3","sentence":"These findings indicate that the Fos\/@PROTEIN1$ and @PROTEIN2$\/CREB families of transcription factors are not as distinct as was previously thought.","label":0}
{"pair_id":"AIMed.d65.s560.p4","sentence":"These findings indicate that the Fos\/@PROTEIN1$ and ATF\/@PROTEIN2$ families of transcription factors are not as distinct as was previously thought.","label":0}
{"pair_id":"AIMed.d65.s560.p5","sentence":"These findings indicate that the Fos\/Jun and @PROTEIN1$\/@PROTEIN2$ families of transcription factors are not as distinct as was previously thought.","label":0}
{"pair_id":"AIMed.d41.s356.p0","sentence":"On a cell membrane containing both proteins, @PROTEIN1$ would 'lie down' parallel to the membrane, such that the @PROTEIN2$ helices that delineate the counterpart of the MHC peptide-binding groove make extensive contacts with helices in the TfR dimerization domain.","label":0}
{"pair_id":"AIMed.d41.s356.p1","sentence":"On a cell membrane containing both proteins, @PROTEIN1$ would 'lie down' parallel to the membrane, such that the HFE helices that delineate the counterpart of the MHC peptide-binding groove make extensive contacts with helices in the @PROTEIN2$ dimerization domain.","label":0}
{"pair_id":"AIMed.d41.s356.p2","sentence":"On a cell membrane containing both proteins, HFE would 'lie down' parallel to the membrane, such that the @PROTEIN1$ helices that delineate the counterpart of the MHC peptide-binding groove make extensive contacts with helices in the @PROTEIN2$ dimerization domain.","label":1}
{"pair_id":"BioInfer.d161.s1.p0","sentence":"Experiments using a peptide that corresponds to the N-terminus of thymosin beta(4) (residues 6-22) confirm the presence of an extensive binding surface between actin and thymosin beta(4), and explain why @PROTEIN2$ and profilin can bind simultaneously to @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d161.s1.p1","sentence":"Experiments using a peptide that corresponds to the N-terminus of thymosin beta(4) (residues 6-22) confirm the presence of an extensive binding surface between @PROTEIN2$ and thymosin beta(4), and explain why thymosin beta(4) and profilin can bind simultaneously to @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d161.s1.p2","sentence":"Experiments using a peptide that corresponds to the N-terminus of @PROTEIN2$ (residues 6-22) confirm the presence of an extensive binding surface between actin and thymosin beta(4), and explain why thymosin beta(4) and profilin can bind simultaneously to @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d161.s1.p3","sentence":"Experiments using a peptide that corresponds to the N-terminus of thymosin beta(4) (residues 6-22) confirm the presence of an extensive binding surface between actin and @PROTEIN2$, and explain why thymosin beta(4) and profilin can bind simultaneously to @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d161.s1.p4","sentence":"Experiments using a peptide that corresponds to the N-terminus of thymosin beta(4) (residues 6-22) confirm the presence of an extensive binding surface between actin and thymosin beta(4), and explain why thymosin beta(4) and @PROTEIN2$ can bind simultaneously to @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d161.s1.p5","sentence":"Experiments using a peptide that corresponds to the N-terminus of thymosin beta(4) (residues 6-22) confirm the presence of an extensive binding surface between @PROTEIN2$ and thymosin beta(4), and explain why @PROTEIN1$ and profilin can bind simultaneously to actin.","label":0}
{"pair_id":"BioInfer.d161.s1.p6","sentence":"Experiments using a peptide that corresponds to the N-terminus of @PROTEIN2$ (residues 6-22) confirm the presence of an extensive binding surface between actin and thymosin beta(4), and explain why @PROTEIN1$ and profilin can bind simultaneously to actin.","label":0}
{"pair_id":"BioInfer.d161.s1.p7","sentence":"Experiments using a peptide that corresponds to the N-terminus of thymosin beta(4) (residues 6-22) confirm the presence of an extensive binding surface between actin and @PROTEIN2$, and explain why @PROTEIN1$ and profilin can bind simultaneously to actin.","label":0}
{"pair_id":"BioInfer.d161.s1.p8","sentence":"Experiments using a peptide that corresponds to the N-terminus of thymosin beta(4) (residues 6-22) confirm the presence of an extensive binding surface between actin and thymosin beta(4), and explain why @PROTEIN1$ and @PROTEIN2$ can bind simultaneously to actin.","label":1}
{"pair_id":"BioInfer.d161.s1.p9","sentence":"Experiments using a peptide that corresponds to the N-terminus of @PROTEIN2$ (residues 6-22) confirm the presence of an extensive binding surface between @PROTEIN1$ and thymosin beta(4), and explain why thymosin beta(4) and profilin can bind simultaneously to actin.","label":0}
{"pair_id":"BioInfer.d161.s1.p10","sentence":"Experiments using a peptide that corresponds to the N-terminus of thymosin beta(4) (residues 6-22) confirm the presence of an extensive binding surface between @PROTEIN1$ and @PROTEIN2$, and explain why thymosin beta(4) and profilin can bind simultaneously to actin.","label":1}
{"pair_id":"BioInfer.d161.s1.p11","sentence":"Experiments using a peptide that corresponds to the N-terminus of thymosin beta(4) (residues 6-22) confirm the presence of an extensive binding surface between @PROTEIN1$ and thymosin beta(4), and explain why thymosin beta(4) and @PROTEIN2$ can bind simultaneously to actin.","label":0}
{"pair_id":"BioInfer.d161.s1.p12","sentence":"Experiments using a peptide that corresponds to the N-terminus of @PROTEIN1$ (residues 6-22) confirm the presence of an extensive binding surface between actin and @PROTEIN2$, and explain why thymosin beta(4) and profilin can bind simultaneously to actin.","label":0}
{"pair_id":"BioInfer.d161.s1.p13","sentence":"Experiments using a peptide that corresponds to the N-terminus of @PROTEIN1$ (residues 6-22) confirm the presence of an extensive binding surface between actin and thymosin beta(4), and explain why thymosin beta(4) and @PROTEIN2$ can bind simultaneously to actin.","label":0}
{"pair_id":"BioInfer.d161.s1.p14","sentence":"Experiments using a peptide that corresponds to the N-terminus of thymosin beta(4) (residues 6-22) confirm the presence of an extensive binding surface between actin and @PROTEIN1$, and explain why thymosin beta(4) and @PROTEIN2$ can bind simultaneously to actin.","label":0}
{"pair_id":"BioInfer.d340.s0.p0","sentence":"Inhibition of @PROTEIN1$ subfragment 1 ATPase activity by analog peptides of the @PROTEIN2$-binding site around the Cys(SH1) of myosin heavy chain.","label":0}
{"pair_id":"BioInfer.d340.s0.p1","sentence":"Inhibition of @PROTEIN1$ subfragment 1 @PROTEIN2$ activity by analog peptides of the actin-binding site around the Cys(SH1) of myosin heavy chain.","label":1}
{"pair_id":"BioInfer.d340.s0.p2","sentence":"Inhibition of @PROTEIN1$ subfragment 1 ATPase activity by analog peptides of the actin-binding site around the Cys(SH1) of @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d340.s0.p3","sentence":"Inhibition of actomyosin subfragment 1 @PROTEIN2$ activity by analog peptides of the @PROTEIN1$-binding site around the Cys(SH1) of myosin heavy chain.","label":0}
{"pair_id":"BioInfer.d340.s0.p4","sentence":"Inhibition of actomyosin subfragment 1 ATPase activity by analog peptides of the @PROTEIN1$-binding site around the Cys(SH1) of @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d340.s0.p5","sentence":"Inhibition of actomyosin subfragment 1 @PROTEIN1$ activity by analog peptides of the actin-binding site around the Cys(SH1) of @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d121.s0.p0","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains @PROTEIN2$ (NP) and phosphoprotein (P) gene sequences; another, @PROTEIN1$ and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p1","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, @PROTEIN1$ and membrane protein (M) gene sequences; another, @PROTEIN2$ and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p2","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and @PROTEIN2$ (P) gene sequences; another, @PROTEIN1$ and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p3","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (@PROTEIN2$) and phosphoprotein (P) gene sequences; another, @PROTEIN1$ and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p4","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, @PROTEIN1$ and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, @PROTEIN2$ and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p5","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, @PROTEIN1$ and membrane protein (@PROTEIN2$) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p6","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (@PROTEIN2$) gene sequences; another, @PROTEIN1$ and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p7","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, @PROTEIN1$ and @PROTEIN2$ (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p8","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, @PROTEIN1$ and membrane protein (M) gene sequences; another, M and fusion protein (@PROTEIN2$) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p9","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, @PROTEIN1$ and membrane protein (M) gene sequences; another, M and @PROTEIN2$ (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p10","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, @PROTEIN1$ and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (@PROTEIN2$) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p11","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, @PROTEIN1$ and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and @PROTEIN2$ (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p12","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains @PROTEIN1$ (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, @PROTEIN2$ and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p13","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains @PROTEIN1$ (NP) and @PROTEIN2$ (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p14","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains @PROTEIN1$ (@PROTEIN2$) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p15","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains @PROTEIN1$ (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, @PROTEIN2$ and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p16","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains @PROTEIN1$ (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (@PROTEIN2$) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p17","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains @PROTEIN1$ (NP) and phosphoprotein (@PROTEIN2$) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p18","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains @PROTEIN1$ (NP) and phosphoprotein (P) gene sequences; another, P and @PROTEIN2$ (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p19","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains @PROTEIN1$ (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (@PROTEIN2$) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p20","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains @PROTEIN1$ (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and @PROTEIN2$ (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p21","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains @PROTEIN1$ (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (@PROTEIN2$) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p22","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains @PROTEIN1$ (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and @PROTEIN2$ (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p23","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and @PROTEIN2$ (P) gene sequences; another, P and membrane protein (M) gene sequences; another, @PROTEIN1$ and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p24","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (@PROTEIN2$) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, @PROTEIN1$ and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p25","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, @PROTEIN1$ and fusion protein (F0) gene sequences; and another, @PROTEIN2$ and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p26","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (@PROTEIN2$) gene sequences; another, @PROTEIN1$ and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p27","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (@PROTEIN2$) gene sequences; another, P and membrane protein (M) gene sequences; another, @PROTEIN1$ and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p28","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and @PROTEIN2$ (M) gene sequences; another, @PROTEIN1$ and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p29","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, @PROTEIN1$ and fusion protein (@PROTEIN2$) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p30","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, @PROTEIN1$ and @PROTEIN2$ (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p31","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, @PROTEIN1$ and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (@PROTEIN2$) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p32","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, @PROTEIN1$ and fusion protein (F0) gene sequences; and another, F0 and @PROTEIN2$ (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p33","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (@PROTEIN2$) and @PROTEIN1$ (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p34","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and @PROTEIN1$ (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, @PROTEIN2$ and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p35","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and @PROTEIN1$ (P) gene sequences; another, P and membrane protein (@PROTEIN2$) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p36","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and @PROTEIN1$ (@PROTEIN2$) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p37","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and @PROTEIN1$ (P) gene sequences; another, P and @PROTEIN2$ (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p38","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and @PROTEIN1$ (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (@PROTEIN2$) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p39","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and @PROTEIN1$ (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and @PROTEIN2$ (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p40","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and @PROTEIN1$ (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (@PROTEIN2$) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p41","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and @PROTEIN1$ (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and @PROTEIN2$ (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p42","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (@PROTEIN1$) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, @PROTEIN2$ and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p43","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (@PROTEIN1$) and phosphoprotein (P) gene sequences; another, P and membrane protein (@PROTEIN2$) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p44","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (@PROTEIN1$) and phosphoprotein (@PROTEIN2$) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p45","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (@PROTEIN1$) and phosphoprotein (P) gene sequences; another, P and @PROTEIN2$ (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p46","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (@PROTEIN1$) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (@PROTEIN2$) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p47","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (@PROTEIN1$) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and @PROTEIN2$ (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p48","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (@PROTEIN1$) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (@PROTEIN2$) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p49","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (@PROTEIN1$) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and @PROTEIN2$ (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p50","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (@PROTEIN2$) gene sequences; another, M and fusion protein (F0) gene sequences; and another, @PROTEIN1$ and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p51","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (@PROTEIN2$) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, @PROTEIN1$ and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p52","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and @PROTEIN2$ (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, @PROTEIN1$ and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p53","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (@PROTEIN2$) gene sequences; and another, @PROTEIN1$ and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p54","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and @PROTEIN2$ (F0) gene sequences; and another, @PROTEIN1$ and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p55","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, @PROTEIN1$ and hemagglutinin-neuraminidase protein (@PROTEIN2$) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p56","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, @PROTEIN1$ and @PROTEIN2$ (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p57","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (@PROTEIN2$) gene sequences; another, P and membrane protein (@PROTEIN1$) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p58","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and @PROTEIN2$ (@PROTEIN1$) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p59","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (@PROTEIN1$) gene sequences; another, M and fusion protein (@PROTEIN2$) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p60","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (@PROTEIN1$) gene sequences; another, M and @PROTEIN2$ (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p61","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (@PROTEIN1$) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (@PROTEIN2$) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p62","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (@PROTEIN1$) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and @PROTEIN2$ (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p63","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (@PROTEIN1$) gene sequences; another, P and @PROTEIN2$ (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p64","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (@PROTEIN1$) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (@PROTEIN2$) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p65","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (@PROTEIN1$) gene sequences; another, P and membrane protein (M) gene sequences; another, M and @PROTEIN2$ (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p66","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (@PROTEIN1$) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (@PROTEIN2$) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p67","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (@PROTEIN1$) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and @PROTEIN2$ (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p68","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and @PROTEIN1$ (M) gene sequences; another, M and fusion protein (@PROTEIN2$) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p69","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and @PROTEIN1$ (M) gene sequences; another, M and @PROTEIN2$ (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p70","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and @PROTEIN1$ (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (@PROTEIN2$) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p71","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and @PROTEIN1$ (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and @PROTEIN2$ (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p72","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and @PROTEIN2$ (@PROTEIN1$) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p73","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (@PROTEIN1$) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (@PROTEIN2$) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p74","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (@PROTEIN1$) gene sequences; and another, F0 and @PROTEIN2$ (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p75","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and @PROTEIN1$ (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (@PROTEIN2$) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p76","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and @PROTEIN1$ (F0) gene sequences; and another, F0 and @PROTEIN2$ (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p77","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and @PROTEIN2$ (@PROTEIN1$) gene sequences.","label":0}
{"pair_id":"BioInfer.d156.s0.p0","sentence":"Coprecipitations revealed that transfected cadherin molecules are complexed with @PROTEIN2$ and @PROTEIN1$ at plasma membranes.","label":1}
{"pair_id":"BioInfer.d156.s0.p1","sentence":"Coprecipitations revealed that transfected @PROTEIN2$ molecules are complexed with alpha-catenin and @PROTEIN1$ at plasma membranes.","label":1}
{"pair_id":"BioInfer.d156.s0.p2","sentence":"Coprecipitations revealed that transfected @PROTEIN2$ molecules are complexed with @PROTEIN1$ and beta-catenin at plasma membranes.","label":1}
{"pair_id":"BioInfer.d62.s1.p0","sentence":"Deletion mutants of the herpes simplex virus type 1 UL8 protein: effect on DNA synthesis and ability to interact with and influence the intracellular localization of the @PROTEIN2$ and @PROTEIN1$ proteins.","label":0}
{"pair_id":"BioInfer.d62.s1.p1","sentence":"Deletion mutants of the herpes simplex virus type 1 @PROTEIN2$ protein: effect on DNA synthesis and ability to interact with and influence the intracellular localization of the UL5 and @PROTEIN1$ proteins.","label":1}
{"pair_id":"BioInfer.d62.s1.p2","sentence":"Deletion mutants of the herpes simplex virus type 1 @PROTEIN2$ protein: effect on DNA synthesis and ability to interact with and influence the intracellular localization of the @PROTEIN1$ and UL52 proteins.","label":1}
{"pair_id":"BioInfer.d501.s0.p0","sentence":"@PROTEIN1$ fragments form complexes with E-cadherin, @PROTEIN2$, and alpha-catenin, all components of adherens junctions.","label":1}
{"pair_id":"BioInfer.d501.s0.p1","sentence":"@PROTEIN1$ fragments form complexes with @PROTEIN2$, beta-catenin, and alpha-catenin, all components of adherens junctions.","label":1}
{"pair_id":"BioInfer.d501.s0.p2","sentence":"@PROTEIN1$ fragments form complexes with E-cadherin, beta-catenin, and @PROTEIN2$, all components of adherens junctions.","label":1}
{"pair_id":"BioInfer.d501.s0.p3","sentence":"PS1 fragments form complexes with @PROTEIN2$, @PROTEIN1$, and alpha-catenin, all components of adherens junctions.","label":1}
{"pair_id":"BioInfer.d501.s0.p4","sentence":"PS1 fragments form complexes with E-cadherin, @PROTEIN1$, and @PROTEIN2$, all components of adherens junctions.","label":1}
{"pair_id":"BioInfer.d501.s0.p5","sentence":"PS1 fragments form complexes with @PROTEIN1$, beta-catenin, and @PROTEIN2$, all components of adherens junctions.","label":1}
{"pair_id":"AIMed.d174.s1475.p0","sentence":"Due to its increased affinity for the @PROTEIN1$ but its decreased ability to couple with @PROTEIN2$, we suggest that a stable IL-6 dimer may be an efficient IL-6 antagonist.","label":0}
{"pair_id":"AIMed.d174.s1475.p1","sentence":"Due to its increased affinity for the @PROTEIN1$ but its decreased ability to couple with gp130, we suggest that a stable @PROTEIN2$ dimer may be an efficient IL-6 antagonist.","label":1}
{"pair_id":"AIMed.d174.s1475.p2","sentence":"Due to its increased affinity for the @PROTEIN1$ but its decreased ability to couple with gp130, we suggest that a stable IL-6 dimer may be an efficient @PROTEIN2$ antagonist.","label":0}
{"pair_id":"AIMed.d174.s1475.p3","sentence":"Due to its increased affinity for the IL-6R but its decreased ability to couple with @PROTEIN1$, we suggest that a stable @PROTEIN2$ dimer may be an efficient IL-6 antagonist.","label":1}
{"pair_id":"AIMed.d174.s1475.p4","sentence":"Due to its increased affinity for the IL-6R but its decreased ability to couple with @PROTEIN1$, we suggest that a stable IL-6 dimer may be an efficient @PROTEIN2$ antagonist.","label":0}
{"pair_id":"AIMed.d174.s1475.p5","sentence":"Due to its increased affinity for the IL-6R but its decreased ability to couple with gp130, we suggest that a stable @PROTEIN1$ dimer may be an efficient @PROTEIN2$ antagonist.","label":0}
{"pair_id":"BioInfer.d714.s0.p0","sentence":"These results suggest that the heptapeptide sequence is specific for the interaction with @PROTEIN1$ and, therefore, may constitute part of the actin-binding domain of @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d714.s0.p1","sentence":"These results suggest that the heptapeptide sequence is specific for the interaction with @PROTEIN1$ and, therefore, may constitute part of the @PROTEIN2$-binding domain of cofilin.","label":0}
{"pair_id":"BioInfer.d714.s0.p2","sentence":"These results suggest that the heptapeptide sequence is specific for the interaction with actin and, therefore, may constitute part of the @PROTEIN2$-binding domain of @PROTEIN1$.","label":1}
{"pair_id":"AIMed.d147.s1249.p0","sentence":"The products of the @PROTEIN1$ and @PROTEIN2$ genes are ubiquitously expressed, large (200 kDa for RBP1 and 195 kDa for RBP2) nuclear phosphoproteins with structural motifs that suggest a role in transcriptional regulation.","label":0}
{"pair_id":"AIMed.d147.s1249.p1","sentence":"The products of the @PROTEIN1$ and RBP2 genes are ubiquitously expressed, large (200 kDa for @PROTEIN2$ and 195 kDa for RBP2) nuclear phosphoproteins with structural motifs that suggest a role in transcriptional regulation.","label":0}
{"pair_id":"AIMed.d147.s1249.p2","sentence":"The products of the @PROTEIN1$ and RBP2 genes are ubiquitously expressed, large (200 kDa for RBP1 and 195 kDa for @PROTEIN2$) nuclear phosphoproteins with structural motifs that suggest a role in transcriptional regulation.","label":0}
{"pair_id":"AIMed.d147.s1249.p3","sentence":"The products of the RBP1 and @PROTEIN1$ genes are ubiquitously expressed, large (200 kDa for @PROTEIN2$ and 195 kDa for RBP2) nuclear phosphoproteins with structural motifs that suggest a role in transcriptional regulation.","label":0}
{"pair_id":"AIMed.d147.s1249.p4","sentence":"The products of the RBP1 and @PROTEIN1$ genes are ubiquitously expressed, large (200 kDa for RBP1 and 195 kDa for @PROTEIN2$) nuclear phosphoproteins with structural motifs that suggest a role in transcriptional regulation.","label":0}
{"pair_id":"AIMed.d147.s1249.p5","sentence":"The products of the RBP1 and RBP2 genes are ubiquitously expressed, large (200 kDa for @PROTEIN1$ and 195 kDa for @PROTEIN2$) nuclear phosphoproteins with structural motifs that suggest a role in transcriptional regulation.","label":0}
{"pair_id":"AIMed.d49.s435.p0","sentence":"By utilizing domain swapping and site-directed mutagenesis we have found that the loop connecting the beta4-beta5 strands of @PROTEIN1$ contributes to high affinity receptor binding and is critical for @PROTEIN2$ recognition.","label":1}
{"pair_id":"BioInfer.d804.s0.p0","sentence":"We find that @PROTEIN1$ contributes in several ways to Cdc42-induced nucleation of @PROTEIN2$ filaments in high speed supernatant of lysed neutrophils.","label":1}
{"pair_id":"BioInfer.d804.s0.p1","sentence":"We find that @PROTEIN1$ contributes in several ways to @PROTEIN2$-induced nucleation of actin filaments in high speed supernatant of lysed neutrophils.","label":0}
{"pair_id":"BioInfer.d804.s0.p2","sentence":"We find that profilin contributes in several ways to @PROTEIN2$-induced nucleation of @PROTEIN1$ filaments in high speed supernatant of lysed neutrophils.","label":1}
{"pair_id":"BioInfer.d174.s0.p0","sentence":"Direct binding of the @PROTEIN1$-homology domain in N-WASP to @PROTEIN2$ is essential for cytoskeletal reorganization.","label":0}
{"pair_id":"BioInfer.d174.s0.p1","sentence":"Direct binding of the @PROTEIN1$-homology domain in @PROTEIN2$ to actin is essential for cytoskeletal reorganization.","label":1}
{"pair_id":"BioInfer.d174.s0.p2","sentence":"Direct binding of the verprolin-homology domain in @PROTEIN2$ to @PROTEIN1$ is essential for cytoskeletal reorganization.","label":1}
{"pair_id":"BioInfer.d106.s0.p0","sentence":"@PROTEIN1$ is expressed by endothelial and tumor cells as an isoform-specific receptor for @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d493.s0.p0","sentence":"Previous studies have yielded conflicting results concerning the physiological role of @PROTEIN1$, a 12-15-kD @PROTEIN2$- and phosphoinositide-binding protein, as a regulator of actin polymerization.","label":1}
{"pair_id":"BioInfer.d493.s0.p1","sentence":"Previous studies have yielded conflicting results concerning the physiological role of @PROTEIN1$, a 12-15-kD actin- and phosphoinositide-binding protein, as a regulator of @PROTEIN2$ polymerization.","label":1}
{"pair_id":"BioInfer.d493.s0.p2","sentence":"Previous studies have yielded conflicting results concerning the physiological role of profilin, a 12-15-kD @PROTEIN1$- and phosphoinositide-binding protein, as a regulator of @PROTEIN2$ polymerization.","label":0}
{"pair_id":"BioInfer.d237.s3.p0","sentence":"The RAD51-interacting region (amino acids 291-330) of the human @PROTEIN2$ protein shows no homology with the yeast @PROTEIN1$ protein, indicating that the interaction between RAD51 and RAD52 is species-specific.","label":1}
{"pair_id":"BioInfer.d237.s3.p1","sentence":"The RAD51-interacting region (amino acids 291-330) of the human RAD52 protein shows no homology with the yeast @PROTEIN1$ protein, indicating that the interaction between @PROTEIN2$ and RAD52 is species-specific.","label":0}
{"pair_id":"BioInfer.d237.s3.p2","sentence":"The RAD51-interacting region (amino acids 291-330) of the human RAD52 protein shows no homology with the yeast @PROTEIN1$ protein, indicating that the interaction between RAD51 and @PROTEIN2$ is species-specific.","label":0}
{"pair_id":"BioInfer.d237.s3.p3","sentence":"The @PROTEIN2$-interacting region (amino acids 291-330) of the human RAD52 protein shows no homology with the yeast @PROTEIN1$ protein, indicating that the interaction between RAD51 and RAD52 is species-specific.","label":0}
{"pair_id":"BioInfer.d237.s3.p4","sentence":"The RAD51-interacting region (amino acids 291-330) of the human @PROTEIN1$ protein shows no homology with the yeast RAD52 protein, indicating that the interaction between @PROTEIN2$ and RAD52 is species-specific.","label":0}
{"pair_id":"BioInfer.d237.s3.p5","sentence":"The RAD51-interacting region (amino acids 291-330) of the human @PROTEIN1$ protein shows no homology with the yeast RAD52 protein, indicating that the interaction between RAD51 and @PROTEIN2$ is species-specific.","label":0}
{"pair_id":"BioInfer.d237.s3.p6","sentence":"The @PROTEIN2$-interacting region (amino acids 291-330) of the human @PROTEIN1$ protein shows no homology with the yeast RAD52 protein, indicating that the interaction between RAD51 and RAD52 is species-specific.","label":1}
{"pair_id":"BioInfer.d237.s3.p7","sentence":"The RAD51-interacting region (amino acids 291-330) of the human RAD52 protein shows no homology with the yeast RAD52 protein, indicating that the interaction between @PROTEIN1$ and @PROTEIN2$ is species-specific.","label":1}
{"pair_id":"BioInfer.d237.s3.p8","sentence":"The @PROTEIN2$-interacting region (amino acids 291-330) of the human RAD52 protein shows no homology with the yeast RAD52 protein, indicating that the interaction between @PROTEIN1$ and RAD52 is species-specific.","label":0}
{"pair_id":"BioInfer.d237.s3.p9","sentence":"The @PROTEIN2$-interacting region (amino acids 291-330) of the human RAD52 protein shows no homology with the yeast RAD52 protein, indicating that the interaction between RAD51 and @PROTEIN1$ is species-specific.","label":0}
{"pair_id":"BioInfer.d115.s1.p0","sentence":"SNF11 interacts with @PROTEIN2$ in vitro and copurifies with the SNF-@PROTEIN1$ complex from yeast cells.","label":0}
{"pair_id":"BioInfer.d115.s1.p1","sentence":"@PROTEIN2$ interacts with SNF2 in vitro and copurifies with the SNF-@PROTEIN1$ complex from yeast cells.","label":1}
{"pair_id":"BioInfer.d115.s1.p2","sentence":"SNF11 interacts with SNF2 in vitro and copurifies with the @PROTEIN2$-@PROTEIN1$ complex from yeast cells.","label":1}
{"pair_id":"BioInfer.d115.s1.p3","sentence":"@PROTEIN2$ interacts with @PROTEIN1$ in vitro and copurifies with the SNF-SWI complex from yeast cells.","label":1}
{"pair_id":"BioInfer.d115.s1.p4","sentence":"SNF11 interacts with @PROTEIN1$ in vitro and copurifies with the @PROTEIN2$-SWI complex from yeast cells.","label":0}
{"pair_id":"BioInfer.d115.s1.p5","sentence":"@PROTEIN1$ interacts with SNF2 in vitro and copurifies with the @PROTEIN2$-SWI complex from yeast cells.","label":1}
{"pair_id":"AIMed.d219.s1906.p0","sentence":"Moreover, mutation of @PROTEIN1$ residues 143-145 impairs binding of 14-3-3, but not @PROTEIN2$, to the Raf-CRD.","label":1}
{"pair_id":"AIMed.d219.s1906.p1","sentence":"Moreover, mutation of @PROTEIN1$ residues 143-145 impairs binding of 14-3-3, but not Ras, to the @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d219.s1906.p2","sentence":"Moreover, mutation of Raf-1 residues 143-145 impairs binding of 14-3-3, but not @PROTEIN1$, to the @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d102.s866.p0","sentence":"These results suggest that @PROTEIN1$ can confer transcriptional regulation and possibly cell cycle control and tumor suppression through an interaction with @PROTEIN2$, in particular with TAFII250.","label":0}
{"pair_id":"AIMed.d102.s866.p1","sentence":"These results suggest that @PROTEIN1$ can confer transcriptional regulation and possibly cell cycle control and tumor suppression through an interaction with TFIID, in particular with @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d102.s866.p2","sentence":"These results suggest that RB can confer transcriptional regulation and possibly cell cycle control and tumor suppression through an interaction with @PROTEIN1$, in particular with @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d214.s1864.p0","sentence":"In addition, we show that the conserved motif Y699 MTP present in @PROTEIN1$ is the binding site for the @PROTEIN2$ SH2 domain in vitro.","label":1}
{"pair_id":"BioInfer.d164.s0.p0","sentence":"@PROTEIN1$ belong to the TNF receptor family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as TRADD and FADD and cysteine proteases such as @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d164.s0.p1","sentence":"@PROTEIN1$ belong to the TNF receptor family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as @PROTEIN2$ and FADD and cysteine proteases such as Caspase-8.","label":1}
{"pair_id":"BioInfer.d164.s0.p2","sentence":"@PROTEIN1$ belong to the TNF receptor family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as TRADD and @PROTEIN2$ and cysteine proteases such as Caspase-8.","label":1}
{"pair_id":"BioInfer.d164.s0.p3","sentence":"@PROTEIN1$ belong to the TNF receptor family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as TRADD and FADD and @PROTEIN2$ such as Caspase-8.","label":1}
{"pair_id":"BioInfer.d164.s0.p4","sentence":"@PROTEIN1$ belong to the @PROTEIN2$ family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as TRADD and FADD and cysteine proteases such as Caspase-8.","label":1}
{"pair_id":"BioInfer.d164.s0.p5","sentence":"Death receptors belong to the TNF receptor family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as @PROTEIN2$ and FADD and cysteine proteases such as @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d164.s0.p6","sentence":"Death receptors belong to the TNF receptor family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as TRADD and @PROTEIN2$ and cysteine proteases such as @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d164.s0.p7","sentence":"Death receptors belong to the TNF receptor family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as TRADD and FADD and @PROTEIN2$ such as @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d164.s0.p8","sentence":"Death receptors belong to the @PROTEIN2$ family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as TRADD and FADD and cysteine proteases such as @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d164.s0.p9","sentence":"Death receptors belong to the TNF receptor family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as @PROTEIN1$ and @PROTEIN2$ and cysteine proteases such as Caspase-8.","label":0}
{"pair_id":"BioInfer.d164.s0.p10","sentence":"Death receptors belong to the TNF receptor family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as @PROTEIN1$ and FADD and @PROTEIN2$ such as Caspase-8.","label":0}
{"pair_id":"BioInfer.d164.s0.p11","sentence":"Death receptors belong to the @PROTEIN2$ family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as @PROTEIN1$ and FADD and cysteine proteases such as Caspase-8.","label":0}
{"pair_id":"BioInfer.d164.s0.p12","sentence":"Death receptors belong to the TNF receptor family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as TRADD and @PROTEIN1$ and @PROTEIN2$ such as Caspase-8.","label":0}
{"pair_id":"BioInfer.d164.s0.p13","sentence":"Death receptors belong to the @PROTEIN2$ family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as TRADD and @PROTEIN1$ and cysteine proteases such as Caspase-8.","label":0}
{"pair_id":"BioInfer.d164.s0.p14","sentence":"Death receptors belong to the @PROTEIN2$ family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as TRADD and FADD and @PROTEIN1$ such as Caspase-8.","label":0}
{"pair_id":"BioInfer.d617.s0.p0","sentence":"The head domain of @PROTEIN2$ thus binds to @PROTEIN1$ to form a link to the actin cytoskeleton and can thus regulate integrin function.","label":1}
{"pair_id":"BioInfer.d617.s0.p1","sentence":"The head domain of talin thus binds to @PROTEIN1$ to form a link to the actin cytoskeleton and can thus regulate @PROTEIN2$ function.","label":0}
{"pair_id":"BioInfer.d617.s0.p2","sentence":"The head domain of talin thus binds to @PROTEIN1$ to form a link to the @PROTEIN2$ cytoskeleton and can thus regulate integrin function.","label":1}
{"pair_id":"BioInfer.d617.s0.p3","sentence":"The head domain of @PROTEIN1$ thus binds to integrins to form a link to the actin cytoskeleton and can thus regulate @PROTEIN2$ function.","label":1}
{"pair_id":"BioInfer.d617.s0.p4","sentence":"The head domain of @PROTEIN1$ thus binds to integrins to form a link to the @PROTEIN2$ cytoskeleton and can thus regulate integrin function.","label":1}
{"pair_id":"BioInfer.d617.s0.p5","sentence":"The head domain of talin thus binds to integrins to form a link to the @PROTEIN2$ cytoskeleton and can thus regulate @PROTEIN1$ function.","label":0}
{"pair_id":"AIMed.d143.s1212.p0","sentence":"It was observed that anti-@PROTEIN1$ antibodies abolished cell proliferation, protein tyrosine phosphorylation, and @PROTEIN2$ gene expression elicited by IL-11 or IL-6 in TF-1 cells.","label":0}
{"pair_id":"AIMed.d143.s1212.p1","sentence":"It was observed that anti-@PROTEIN1$ antibodies abolished cell proliferation, protein tyrosine phosphorylation, and junB gene expression elicited by @PROTEIN2$ or IL-6 in TF-1 cells.","label":0}
{"pair_id":"AIMed.d143.s1212.p2","sentence":"It was observed that anti-@PROTEIN1$ antibodies abolished cell proliferation, protein tyrosine phosphorylation, and junB gene expression elicited by IL-11 or @PROTEIN2$ in TF-1 cells.","label":0}
{"pair_id":"AIMed.d143.s1212.p3","sentence":"It was observed that anti-gp130 antibodies abolished cell proliferation, protein tyrosine phosphorylation, and @PROTEIN1$ gene expression elicited by @PROTEIN2$ or IL-6 in TF-1 cells.","label":0}
{"pair_id":"AIMed.d143.s1212.p4","sentence":"It was observed that anti-gp130 antibodies abolished cell proliferation, protein tyrosine phosphorylation, and @PROTEIN1$ gene expression elicited by IL-11 or @PROTEIN2$ in TF-1 cells.","label":0}
{"pair_id":"AIMed.d143.s1212.p5","sentence":"It was observed that anti-gp130 antibodies abolished cell proliferation, protein tyrosine phosphorylation, and junB gene expression elicited by @PROTEIN1$ or @PROTEIN2$ in TF-1 cells.","label":0}
{"pair_id":"BioInfer.d113.s0.p0","sentence":"Both tyrosine phosphorylation and association of beta-catenin with @PROTEIN1$ were inhibited by tyrphostin, a specific inhibitor of the EGFR tyrosine kinase, whereas dissociation of alpha-catenin from @PROTEIN2$ was not.","label":0}
{"pair_id":"BioInfer.d113.s0.p1","sentence":"Both tyrosine phosphorylation and association of beta-catenin with @PROTEIN1$ were inhibited by tyrphostin, a specific inhibitor of the @PROTEIN2$ tyrosine kinase, whereas dissociation of alpha-catenin from E-cadherin was not.","label":0}
{"pair_id":"BioInfer.d113.s0.p2","sentence":"Both tyrosine phosphorylation and association of beta-catenin with @PROTEIN1$ were inhibited by tyrphostin, a specific inhibitor of the EGFR @PROTEIN2$, whereas dissociation of alpha-catenin from E-cadherin was not.","label":0}
{"pair_id":"BioInfer.d113.s0.p3","sentence":"Both tyrosine phosphorylation and association of beta-catenin with @PROTEIN1$ were inhibited by tyrphostin, a specific inhibitor of the EGFR tyrosine kinase, whereas dissociation of @PROTEIN2$ from E-cadherin was not.","label":0}
{"pair_id":"BioInfer.d113.s0.p4","sentence":"Both tyrosine phosphorylation and association of @PROTEIN2$ with @PROTEIN1$ were inhibited by tyrphostin, a specific inhibitor of the EGFR tyrosine kinase, whereas dissociation of alpha-catenin from E-cadherin was not.","label":1}
{"pair_id":"BioInfer.d113.s0.p5","sentence":"Both tyrosine phosphorylation and association of beta-catenin with EGFR were inhibited by tyrphostin, a specific inhibitor of the @PROTEIN2$ tyrosine kinase, whereas dissociation of alpha-catenin from @PROTEIN1$ was not.","label":0}
{"pair_id":"BioInfer.d113.s0.p6","sentence":"Both tyrosine phosphorylation and association of beta-catenin with EGFR were inhibited by tyrphostin, a specific inhibitor of the EGFR @PROTEIN2$, whereas dissociation of alpha-catenin from @PROTEIN1$ was not.","label":0}
{"pair_id":"BioInfer.d113.s0.p7","sentence":"Both tyrosine phosphorylation and association of beta-catenin with EGFR were inhibited by tyrphostin, a specific inhibitor of the EGFR tyrosine kinase, whereas dissociation of @PROTEIN2$ from @PROTEIN1$ was not.","label":1}
{"pair_id":"BioInfer.d113.s0.p8","sentence":"Both tyrosine phosphorylation and association of @PROTEIN2$ with EGFR were inhibited by tyrphostin, a specific inhibitor of the EGFR tyrosine kinase, whereas dissociation of alpha-catenin from @PROTEIN1$ was not.","label":0}
{"pair_id":"BioInfer.d113.s0.p9","sentence":"Both tyrosine phosphorylation and association of beta-catenin with EGFR were inhibited by tyrphostin, a specific inhibitor of the @PROTEIN1$ @PROTEIN2$, whereas dissociation of alpha-catenin from E-cadherin was not.","label":1}
{"pair_id":"BioInfer.d113.s0.p10","sentence":"Both tyrosine phosphorylation and association of beta-catenin with EGFR were inhibited by tyrphostin, a specific inhibitor of the @PROTEIN1$ tyrosine kinase, whereas dissociation of @PROTEIN2$ from E-cadherin was not.","label":0}
{"pair_id":"BioInfer.d113.s0.p11","sentence":"Both tyrosine phosphorylation and association of @PROTEIN2$ with EGFR were inhibited by tyrphostin, a specific inhibitor of the @PROTEIN1$ tyrosine kinase, whereas dissociation of alpha-catenin from E-cadherin was not.","label":0}
{"pair_id":"BioInfer.d113.s0.p12","sentence":"Both tyrosine phosphorylation and association of beta-catenin with EGFR were inhibited by tyrphostin, a specific inhibitor of the EGFR @PROTEIN1$, whereas dissociation of @PROTEIN2$ from E-cadherin was not.","label":0}
{"pair_id":"BioInfer.d113.s0.p13","sentence":"Both tyrosine phosphorylation and association of @PROTEIN2$ with EGFR were inhibited by tyrphostin, a specific inhibitor of the EGFR @PROTEIN1$, whereas dissociation of alpha-catenin from E-cadherin was not.","label":0}
{"pair_id":"BioInfer.d113.s0.p14","sentence":"Both tyrosine phosphorylation and association of @PROTEIN2$ with EGFR were inhibited by tyrphostin, a specific inhibitor of the EGFR tyrosine kinase, whereas dissociation of @PROTEIN1$ from E-cadherin was not.","label":0}
{"pair_id":"AIMed.d199.s1701.p0","sentence":"@PROTEIN1$ in complex with a previously identified 90-kDa protein and designated protein @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d142.s1194.p0","sentence":"Evidence for physical interaction between the zinc-finger transcription factors @PROTEIN1$ and @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d209.s0.p0","sentence":"Finally it was shown that the two isoforms of @PROTEIN1$ can be separated from each other in the absence of @PROTEIN2$ also by chromatography on hydroxyapatite.","label":0}
{"pair_id":"BioInfer.d215.s0.p0","sentence":"For example, it is associated with alpha-catenin and @PROTEIN1$ (@PROTEIN2$), and protected from trypsin digestion only in the presence of Ca2+, as is the case for many of classic cadherins.","label":0}
{"pair_id":"BioInfer.d215.s0.p1","sentence":"For example, it is associated with alpha-catenin and @PROTEIN1$ (Armadillo), and protected from trypsin digestion only in the presence of Ca2+, as is the case for many of classic @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d215.s0.p2","sentence":"For example, it is associated with @PROTEIN2$ and @PROTEIN1$ (Armadillo), and protected from trypsin digestion only in the presence of Ca2+, as is the case for many of classic cadherins.","label":0}
{"pair_id":"BioInfer.d215.s0.p3","sentence":"For example, it is associated with alpha-catenin and @PROTEIN1$ (Armadillo), and protected from @PROTEIN2$ digestion only in the presence of Ca2+, as is the case for many of classic cadherins.","label":0}
{"pair_id":"BioInfer.d215.s0.p4","sentence":"For example, it is associated with alpha-catenin and beta-catenin (@PROTEIN1$), and protected from trypsin digestion only in the presence of Ca2+, as is the case for many of classic @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d215.s0.p5","sentence":"For example, it is associated with @PROTEIN2$ and beta-catenin (@PROTEIN1$), and protected from trypsin digestion only in the presence of Ca2+, as is the case for many of classic cadherins.","label":0}
{"pair_id":"BioInfer.d215.s0.p6","sentence":"For example, it is associated with alpha-catenin and beta-catenin (@PROTEIN1$), and protected from @PROTEIN2$ digestion only in the presence of Ca2+, as is the case for many of classic cadherins.","label":0}
{"pair_id":"BioInfer.d215.s0.p7","sentence":"For example, it is associated with @PROTEIN2$ and beta-catenin (Armadillo), and protected from trypsin digestion only in the presence of Ca2+, as is the case for many of classic @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d215.s0.p8","sentence":"For example, it is associated with alpha-catenin and beta-catenin (Armadillo), and protected from @PROTEIN2$ digestion only in the presence of Ca2+, as is the case for many of classic @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d215.s0.p9","sentence":"For example, it is associated with @PROTEIN1$ and beta-catenin (Armadillo), and protected from @PROTEIN2$ digestion only in the presence of Ca2+, as is the case for many of classic cadherins.","label":0}
{"pair_id":"AIMed.d152.s1292.p0","sentence":"Tumor necrosis factor (TNF) can induce apoptosis and activate @PROTEIN1$ through signaling cascades emanating from @PROTEIN2$ (TNFR1).","label":0}
{"pair_id":"AIMed.d152.s1292.p1","sentence":"Tumor necrosis factor (TNF) can induce apoptosis and activate @PROTEIN1$ through signaling cascades emanating from TNF receptor 1 (@PROTEIN2$).","label":0}
{"pair_id":"AIMed.d152.s1292.p2","sentence":"Tumor necrosis factor (TNF) can induce apoptosis and activate NF-kappa B through signaling cascades emanating from @PROTEIN1$ (@PROTEIN2$).","label":0}
{"pair_id":"AIMed.d73.s621.p0","sentence":"The extracellular cysteine-rich domain of the TNF-R is homologous to the nerve growth factor receptor and the @PROTEIN1$ @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d592.s0.p0","sentence":"The cellular transcription co-activators p300 and the @PROTEIN1$ @PROTEIN2$ are cellular targets for transformation by the E1A proteins of non-oncogenic adenovirus 5 (Ad5).","label":1}
{"pair_id":"BioInfer.d592.s0.p1","sentence":"The cellular transcription co-activators @PROTEIN2$ and the @PROTEIN1$ CBP are cellular targets for transformation by the E1A proteins of non-oncogenic adenovirus 5 (Ad5).","label":0}
{"pair_id":"BioInfer.d592.s0.p2","sentence":"The cellular transcription co-activators p300 and the @PROTEIN1$ CBP are cellular targets for transformation by the @PROTEIN2$ proteins of non-oncogenic adenovirus 5 (Ad5).","label":0}
{"pair_id":"BioInfer.d592.s0.p3","sentence":"The cellular transcription co-activators @PROTEIN2$ and the CREB-binding protein @PROTEIN1$ are cellular targets for transformation by the E1A proteins of non-oncogenic adenovirus 5 (Ad5).","label":0}
{"pair_id":"BioInfer.d592.s0.p4","sentence":"The cellular transcription co-activators p300 and the CREB-binding protein @PROTEIN1$ are cellular targets for transformation by the @PROTEIN2$ proteins of non-oncogenic adenovirus 5 (Ad5).","label":1}
{"pair_id":"BioInfer.d592.s0.p5","sentence":"The cellular transcription co-activators @PROTEIN1$ and the CREB-binding protein CBP are cellular targets for transformation by the @PROTEIN2$ proteins of non-oncogenic adenovirus 5 (Ad5).","label":1}
{"pair_id":"BioInfer.d140.s1.p0","sentence":"In this study we have used the yeast two-hybrid system to map the domains on @PROTEIN2$ that allow it to associate with beta-catenin\/@PROTEIN1$ and with alpha-actinin.","label":1}
{"pair_id":"BioInfer.d140.s1.p1","sentence":"In this study we have used the yeast two-hybrid system to map the domains on alpha-catenin that allow it to associate with @PROTEIN2$\/@PROTEIN1$ and with alpha-actinin.","label":0}
{"pair_id":"BioInfer.d140.s1.p2","sentence":"In this study we have used the yeast two-hybrid system to map the domains on alpha-catenin that allow it to associate with beta-catenin\/@PROTEIN1$ and with @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d140.s1.p3","sentence":"In this study we have used the yeast two-hybrid system to map the domains on @PROTEIN1$ that allow it to associate with @PROTEIN2$\/plakoglobin and with alpha-actinin.","label":1}
{"pair_id":"BioInfer.d140.s1.p4","sentence":"In this study we have used the yeast two-hybrid system to map the domains on @PROTEIN1$ that allow it to associate with beta-catenin\/plakoglobin and with @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d140.s1.p5","sentence":"In this study we have used the yeast two-hybrid system to map the domains on alpha-catenin that allow it to associate with @PROTEIN1$\/plakoglobin and with @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d507.s0.p0","sentence":"Recently it has been established, through a detailed biochemical analysis, that recombinant Arabidopsis thaliana fimbrin 1 (AtFim1) is a member of the @PROTEIN1$ family of @PROTEIN2$ filament bundling or cross-linking proteins [D.R. Kovar et al. (2000) Plant J 24:625-636].","label":1}
{"pair_id":"BioInfer.d507.s0.p1","sentence":"Recently it has been established, through a detailed biochemical analysis, that recombinant Arabidopsis thaliana @PROTEIN2$ (AtFim1) is a member of the @PROTEIN1$ family of actin filament bundling or cross-linking proteins [D.R. Kovar et al. (2000) Plant J 24:625-636].","label":1}
{"pair_id":"BioInfer.d507.s0.p2","sentence":"Recently it has been established, through a detailed biochemical analysis, that recombinant Arabidopsis thaliana fimbrin 1 (@PROTEIN2$) is a member of the @PROTEIN1$ family of actin filament bundling or cross-linking proteins [D.R. Kovar et al. (2000) Plant J 24:625-636].","label":1}
{"pair_id":"BioInfer.d507.s0.p3","sentence":"Recently it has been established, through a detailed biochemical analysis, that recombinant Arabidopsis thaliana @PROTEIN2$ (AtFim1) is a member of the fimbrin\/plastin family of @PROTEIN1$ filament bundling or cross-linking proteins [D.R. Kovar et al. (2000) Plant J 24:625-636].","label":0}
{"pair_id":"BioInfer.d507.s0.p4","sentence":"Recently it has been established, through a detailed biochemical analysis, that recombinant Arabidopsis thaliana fimbrin 1 (@PROTEIN2$) is a member of the fimbrin\/plastin family of @PROTEIN1$ filament bundling or cross-linking proteins [D.R. Kovar et al. (2000) Plant J 24:625-636].","label":0}
{"pair_id":"BioInfer.d507.s0.p5","sentence":"Recently it has been established, through a detailed biochemical analysis, that recombinant Arabidopsis thaliana @PROTEIN1$ (@PROTEIN2$) is a member of the fimbrin\/plastin family of actin filament bundling or cross-linking proteins [D.R. Kovar et al. (2000) Plant J 24:625-636].","label":0}
{"pair_id":"AIMed.d169.s1431.p0","sentence":"COS-7 cells transfected with the @PROTEIN1$ cDNA bind @PROTEIN2$ with high affinity but do not bind IL-4.","label":1}
{"pair_id":"AIMed.d169.s1431.p1","sentence":"COS-7 cells transfected with the @PROTEIN1$ cDNA bind IL-13 with high affinity but do not bind @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d169.s1431.p2","sentence":"COS-7 cells transfected with the IL-13R cDNA bind @PROTEIN1$ with high affinity but do not bind @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d377.s0.p0","sentence":"In this study, by immunoprecipitation and affinity chromatography it is shown that @PROTEIN2$ and @PROTEIN1$ interact in pig brain cortical membranes.","label":1}
{"pair_id":"BioInfer.d654.s1.p0","sentence":"This study details the expression patterns of @PROTEIN1$, beta-catenin, and @PROTEIN2$, during definition of the cardiac cell population as distinct compartments in the anterior regions of the chick embryo between stages 5 and 9.","label":0}
{"pair_id":"BioInfer.d654.s1.p1","sentence":"This study details the expression patterns of @PROTEIN1$, @PROTEIN2$, and gamma-catenin, during definition of the cardiac cell population as distinct compartments in the anterior regions of the chick embryo between stages 5 and 9.","label":0}
{"pair_id":"BioInfer.d654.s1.p2","sentence":"This study details the expression patterns of alpha-catenin, @PROTEIN2$, and @PROTEIN1$, during definition of the cardiac cell population as distinct compartments in the anterior regions of the chick embryo between stages 5 and 9.","label":0}
{"pair_id":"AIMed.d26.s214.p0","sentence":"Differential expression of @PROTEIN1$ and @PROTEIN2$ by NK cells in cancer patients and correlation of impaired granulysin expression withprogression of cancer.","label":0}
{"pair_id":"AIMed.d26.s214.p1","sentence":"Differential expression of @PROTEIN1$ and perforin by NK cells in cancer patients and correlation of impaired @PROTEIN2$ expression withprogression of cancer.","label":0}
{"pair_id":"AIMed.d26.s214.p2","sentence":"Differential expression of granulysin and @PROTEIN1$ by NK cells in cancer patients and correlation of impaired @PROTEIN2$ expression withprogression of cancer.","label":0}
{"pair_id":"AIMed.d162.s1368.p0","sentence":"As a result of this physical interaction, binding of @PROTEIN1$ to its hormone response elements either as homodimer or as a heterodimer with the @PROTEIN2$ was inhibited by p53 in a concentration-dependent manner.","label":1}
{"pair_id":"AIMed.d162.s1368.p1","sentence":"As a result of this physical interaction, binding of @PROTEIN1$ to its hormone response elements either as homodimer or as a heterodimer with the retinoic X receptor was inhibited by @PROTEIN2$ in a concentration-dependent manner.","label":0}
{"pair_id":"AIMed.d162.s1368.p2","sentence":"As a result of this physical interaction, binding of h-TR beta 1 to its hormone response elements either as homodimer or as a heterodimer with the @PROTEIN1$ was inhibited by @PROTEIN2$ in a concentration-dependent manner.","label":0}
{"pair_id":"AIMed.d193.s1646.p0","sentence":"Moreover, while @PROTEIN1$ inhibited the @PROTEIN2$ promoter, it acted as a weak transactivator on an artificial promoter consisting of three tandem copies of the consensus myogenic factor DNA binding site.","label":0}
{"pair_id":"AIMed.d184.s1561.p0","sentence":"@PROTEIN1$-induced interaction of primary HIV-1 @PROTEIN2$ glycoproteins with the chemokine receptor CCR-5.","label":1}
{"pair_id":"AIMed.d184.s1561.p1","sentence":"@PROTEIN1$-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d184.s1561.p2","sentence":"CD4-induced interaction of primary HIV-1 @PROTEIN1$ glycoproteins with the chemokine receptor @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d37.s1.p0","sentence":"The interaction of Acanthamoeba @PROTEIN1$ and Acanthamoeba @PROTEIN2$ was evaluated as a function of ionic conditions.","label":1}
{"pair_id":"AIMed.d18.s157.p0","sentence":"We established a strong correlation between chromatin activity of lymphocytes and the serum concentration of @PROTEIN1$, @PROTEIN2$, and IL-10, which are the active participants in the pro- and anti-inflammatory program in atherogenesis.","label":0}
{"pair_id":"AIMed.d18.s157.p1","sentence":"We established a strong correlation between chromatin activity of lymphocytes and the serum concentration of @PROTEIN1$, IL-6, and @PROTEIN2$, which are the active participants in the pro- and anti-inflammatory program in atherogenesis.","label":0}
{"pair_id":"AIMed.d18.s157.p2","sentence":"We established a strong correlation between chromatin activity of lymphocytes and the serum concentration of IL-1beta, @PROTEIN1$, and @PROTEIN2$, which are the active participants in the pro- and anti-inflammatory program in atherogenesis.","label":0}
{"pair_id":"AIMed.d141.s1192.p0","sentence":"@PROTEIN1$ is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of @PROTEIN2$ by cyclin A-Cdk2, cyclin E-Cdk2, cyclin D1-Cdk4, and cyclin D2-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p1","sentence":"@PROTEIN1$ is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by @PROTEIN2$-Cdk2, cyclin E-Cdk2, cyclin D1-Cdk4, and cyclin D2-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p2","sentence":"@PROTEIN1$ is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-@PROTEIN2$, cyclin E-Cdk2, cyclin D1-Cdk4, and cyclin D2-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p3","sentence":"@PROTEIN1$ is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, @PROTEIN2$-Cdk2, cyclin D1-Cdk4, and cyclin D2-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p4","sentence":"@PROTEIN1$ is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, cyclin E-@PROTEIN2$, cyclin D1-Cdk4, and cyclin D2-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p5","sentence":"@PROTEIN1$ is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, cyclin E-Cdk2, @PROTEIN2$-Cdk4, and cyclin D2-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p6","sentence":"@PROTEIN1$ is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, cyclin E-Cdk2, cyclin D1-@PROTEIN2$, and cyclin D2-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p7","sentence":"@PROTEIN1$ is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, cyclin E-Cdk2, cyclin D1-Cdk4, and @PROTEIN2$-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p8","sentence":"@PROTEIN1$ is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, cyclin E-Cdk2, cyclin D1-Cdk4, and cyclin D2-@PROTEIN2$ complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p9","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of @PROTEIN1$ by @PROTEIN2$-Cdk2, cyclin E-Cdk2, cyclin D1-Cdk4, and cyclin D2-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p10","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of @PROTEIN1$ by cyclin A-@PROTEIN2$, cyclin E-Cdk2, cyclin D1-Cdk4, and cyclin D2-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p11","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of @PROTEIN1$ by cyclin A-Cdk2, @PROTEIN2$-Cdk2, cyclin D1-Cdk4, and cyclin D2-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p12","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of @PROTEIN1$ by cyclin A-Cdk2, cyclin E-@PROTEIN2$, cyclin D1-Cdk4, and cyclin D2-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p13","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of @PROTEIN1$ by cyclin A-Cdk2, cyclin E-Cdk2, @PROTEIN2$-Cdk4, and cyclin D2-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p14","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of @PROTEIN1$ by cyclin A-Cdk2, cyclin E-Cdk2, cyclin D1-@PROTEIN2$, and cyclin D2-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p15","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of @PROTEIN1$ by cyclin A-Cdk2, cyclin E-Cdk2, cyclin D1-Cdk4, and @PROTEIN2$-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p16","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of @PROTEIN1$ by cyclin A-Cdk2, cyclin E-Cdk2, cyclin D1-Cdk4, and cyclin D2-@PROTEIN2$ complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p17","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by @PROTEIN1$-@PROTEIN2$, cyclin E-Cdk2, cyclin D1-Cdk4, and cyclin D2-Cdk4 complexes.","label":1}
{"pair_id":"AIMed.d141.s1192.p18","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by @PROTEIN1$-Cdk2, @PROTEIN2$-Cdk2, cyclin D1-Cdk4, and cyclin D2-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p19","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by @PROTEIN1$-Cdk2, cyclin E-@PROTEIN2$, cyclin D1-Cdk4, and cyclin D2-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p20","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by @PROTEIN1$-Cdk2, cyclin E-Cdk2, @PROTEIN2$-Cdk4, and cyclin D2-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p21","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by @PROTEIN1$-Cdk2, cyclin E-Cdk2, cyclin D1-@PROTEIN2$, and cyclin D2-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p22","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by @PROTEIN1$-Cdk2, cyclin E-Cdk2, cyclin D1-Cdk4, and @PROTEIN2$-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p23","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by @PROTEIN1$-Cdk2, cyclin E-Cdk2, cyclin D1-Cdk4, and cyclin D2-@PROTEIN2$ complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p24","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-@PROTEIN1$, @PROTEIN2$-Cdk2, cyclin D1-Cdk4, and cyclin D2-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p25","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-@PROTEIN1$, cyclin E-@PROTEIN2$, cyclin D1-Cdk4, and cyclin D2-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p26","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-@PROTEIN1$, cyclin E-Cdk2, @PROTEIN2$-Cdk4, and cyclin D2-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p27","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-@PROTEIN1$, cyclin E-Cdk2, cyclin D1-@PROTEIN2$, and cyclin D2-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p28","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-@PROTEIN1$, cyclin E-Cdk2, cyclin D1-Cdk4, and @PROTEIN2$-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p29","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-@PROTEIN1$, cyclin E-Cdk2, cyclin D1-Cdk4, and cyclin D2-@PROTEIN2$ complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p30","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, @PROTEIN1$-@PROTEIN2$, cyclin D1-Cdk4, and cyclin D2-Cdk4 complexes.","label":1}
{"pair_id":"AIMed.d141.s1192.p31","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, @PROTEIN1$-Cdk2, @PROTEIN2$-Cdk4, and cyclin D2-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p32","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, @PROTEIN1$-Cdk2, cyclin D1-@PROTEIN2$, and cyclin D2-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p33","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, @PROTEIN1$-Cdk2, cyclin D1-Cdk4, and @PROTEIN2$-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p34","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, @PROTEIN1$-Cdk2, cyclin D1-Cdk4, and cyclin D2-@PROTEIN2$ complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p35","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, cyclin E-@PROTEIN1$, @PROTEIN2$-Cdk4, and cyclin D2-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p36","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, cyclin E-@PROTEIN1$, cyclin D1-@PROTEIN2$, and cyclin D2-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p37","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, cyclin E-@PROTEIN1$, cyclin D1-Cdk4, and @PROTEIN2$-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p38","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, cyclin E-@PROTEIN1$, cyclin D1-Cdk4, and cyclin D2-@PROTEIN2$ complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p39","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, cyclin E-Cdk2, @PROTEIN1$-@PROTEIN2$, and cyclin D2-Cdk4 complexes.","label":1}
{"pair_id":"AIMed.d141.s1192.p40","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, cyclin E-Cdk2, @PROTEIN1$-Cdk4, and @PROTEIN2$-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p41","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, cyclin E-Cdk2, @PROTEIN1$-Cdk4, and cyclin D2-@PROTEIN2$ complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p42","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, cyclin E-Cdk2, cyclin D1-@PROTEIN1$, and @PROTEIN2$-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p43","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, cyclin E-Cdk2, cyclin D1-@PROTEIN1$, and cyclin D2-@PROTEIN2$ complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p44","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, cyclin E-Cdk2, cyclin D1-Cdk4, and @PROTEIN1$-@PROTEIN2$ complexes.","label":1}
{"pair_id":"AIMed.d74.s630.p0","sentence":"It does not contain a tyrosine kinase domain nor show homology with members of the immunoglobulin super gene family, but does show some significant sequence homologies with receptors for several other haemopoietic growth factors, including those for @PROTEIN1$, @PROTEIN2$ and interleukin-2 (beta-chain) and also to the prolactin receptor.","label":0}
{"pair_id":"AIMed.d74.s630.p1","sentence":"It does not contain a tyrosine kinase domain nor show homology with members of the immunoglobulin super gene family, but does show some significant sequence homologies with receptors for several other haemopoietic growth factors, including those for @PROTEIN1$, erythropoietin and @PROTEIN2$ (beta-chain) and also to the prolactin receptor.","label":0}
{"pair_id":"AIMed.d74.s630.p2","sentence":"It does not contain a tyrosine kinase domain nor show homology with members of the immunoglobulin super gene family, but does show some significant sequence homologies with receptors for several other haemopoietic growth factors, including those for interleukin-6, @PROTEIN1$ and @PROTEIN2$ (beta-chain) and also to the prolactin receptor.","label":0}
{"pair_id":"BioInfer.d786.s0.p0","sentence":"Using a complementary sequence or antipeptide to selectively neutralize the stretch of residues 633-642 of @PROTEIN1$, we recently demonstrated that this segment is an @PROTEIN2$ binding site operating in the absence as in the presence of nucleotide and that this stretch 633-642 is not part of the nucleotide binding site [Chaussepied & Morales (1988) Proc. Natl. Acad. Sci. U.S.A. 85, 7471-7475].","label":1}
{"pair_id":"AIMed.d220.s1920.p0","sentence":"These results, obtained from a variety of experimental techniques, highlight the importance of two distinct regions of the extracellular domain of the @PROTEIN1$@PROTEIN2$ in binding BDNF.","label":0}
{"pair_id":"AIMed.d220.s1920.p1","sentence":"These results, obtained from a variety of experimental techniques, highlight the importance of two distinct regions of the extracellular domain of the @PROTEIN1$ receptor in binding @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d220.s1920.p2","sentence":"These results, obtained from a variety of experimental techniques, highlight the importance of two distinct regions of the extracellular domain of the @PROTEIN1$ in binding @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d167.s1402.p0","sentence":"The @PROTEIN1$ glucose transporter interacts with @PROTEIN2$ and calreticulin.","label":1}
{"pair_id":"AIMed.d167.s1402.p1","sentence":"The @PROTEIN1$ glucose transporter interacts with calnexin and @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d167.s1402.p2","sentence":"The glut 1 glucose transporter interacts with @PROTEIN1$ and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d71.s608.p0","sentence":"@PROTEIN1$ activation of @PROTEIN2$ may underlie the common stimulation of this transcription factor by mitogens, growth factors and oncogenes.","label":0}
{"pair_id":"AIMed.d142.s1200.p0","sentence":"To study the mechanism underlying the apparent functional cooperation between @PROTEIN1$ and @PROTEIN2$, we explored the possibility of protein-protein interactions between these two transcription factors.","label":0}
{"pair_id":"AIMed.d179.s1522.p0","sentence":"In the present study, we demonstrate that @PROTEIN1$ stimulates tyrosine phosphorylation of @PROTEIN2$ receptor substrate 1 (IRS-1), the major cytoplasmic substrate of the insulin receptor.","label":0}
{"pair_id":"AIMed.d179.s1522.p1","sentence":"In the present study, we demonstrate that @PROTEIN1$ stimulates tyrosine phosphorylation of @PROTEIN2$ (IRS-1), the major cytoplasmic substrate of the insulin receptor.","label":1}
{"pair_id":"AIMed.d179.s1522.p2","sentence":"In the present study, we demonstrate that @PROTEIN1$ stimulates tyrosine phosphorylation of insulin receptor substrate 1 (@PROTEIN2$), the major cytoplasmic substrate of the insulin receptor.","label":1}
{"pair_id":"AIMed.d179.s1522.p3","sentence":"In the present study, we demonstrate that @PROTEIN1$ stimulates tyrosine phosphorylation of insulin receptor substrate 1 (IRS-1), the major cytoplasmic substrate of the @PROTEIN2$ receptor.","label":0}
{"pair_id":"AIMed.d179.s1522.p4","sentence":"In the present study, we demonstrate that @PROTEIN1$ stimulates tyrosine phosphorylation of insulin receptor substrate 1 (IRS-1), the major cytoplasmic substrate of the @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d179.s1522.p5","sentence":"In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of @PROTEIN1$@PROTEIN2$ (IRS-1), the major cytoplasmic substrate of the insulin receptor.","label":0}
{"pair_id":"AIMed.d179.s1522.p6","sentence":"In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of @PROTEIN1$ receptor substrate 1 (@PROTEIN2$), the major cytoplasmic substrate of the insulin receptor.","label":0}
{"pair_id":"AIMed.d179.s1522.p7","sentence":"In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of @PROTEIN1$ receptor substrate 1 (IRS-1), the major cytoplasmic substrate of the @PROTEIN2$ receptor.","label":0}
{"pair_id":"AIMed.d179.s1522.p8","sentence":"In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of @PROTEIN1$ receptor substrate 1 (IRS-1), the major cytoplasmic substrate of the @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d179.s1522.p9","sentence":"In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of @PROTEIN1$ (@PROTEIN2$), the major cytoplasmic substrate of the insulin receptor.","label":0}
{"pair_id":"AIMed.d179.s1522.p10","sentence":"In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of @PROTEIN1$ (IRS-1), the major cytoplasmic substrate of the @PROTEIN2$ receptor.","label":0}
{"pair_id":"AIMed.d179.s1522.p11","sentence":"In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of @PROTEIN1$ (IRS-1), the major cytoplasmic substrate of the @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d179.s1522.p12","sentence":"In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 (@PROTEIN1$), the major cytoplasmic substrate of the @PROTEIN2$ receptor.","label":0}
{"pair_id":"AIMed.d179.s1522.p13","sentence":"In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 (@PROTEIN1$), the major cytoplasmic substrate of the @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d179.s1522.p14","sentence":"In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 (IRS-1), the major cytoplasmic substrate of the @PROTEIN1$@PROTEIN2$.","label":0}
{"pair_id":"AIMed.d193.s1641.p0","sentence":"Physical and functional interactions between the transcriptional inhibitors @PROTEIN1$ and @PROTEIN2$. Evidence toward a novel mechanism regulating muscle-specific gene expression.","label":1}
{"pair_id":"AIMed.d23.s194.p0","sentence":"In contrast, in normal nasal tissues, @PROTEIN1$ labeling was only found in the vascular wall, and the expression was weaker--a finding demonstrating that @PROTEIN2$ is upregulated in nasal polyps.","label":0}
{"pair_id":"AIMed.d37.s311.p0","sentence":"@PROTEIN1$ was first characterized as a receptor for @PROTEIN2$, MIP-1beta, and RANTES, and was rapidly shown to be the main coreceptor for M-tropic human immunodeficiency virus (HIV)-1 strains and simian immunodeficiency virus (SIV).","label":1}
{"pair_id":"AIMed.d37.s311.p1","sentence":"@PROTEIN1$ was first characterized as a receptor for MIP-1alpha, @PROTEIN2$, and RANTES, and was rapidly shown to be the main coreceptor for M-tropic human immunodeficiency virus (HIV)-1 strains and simian immunodeficiency virus (SIV).","label":1}
{"pair_id":"AIMed.d37.s311.p2","sentence":"@PROTEIN1$ was first characterized as a receptor for MIP-1alpha, MIP-1beta, and @PROTEIN2$, and was rapidly shown to be the main coreceptor for M-tropic human immunodeficiency virus (HIV)-1 strains and simian immunodeficiency virus (SIV).","label":1}
{"pair_id":"AIMed.d37.s311.p3","sentence":"CCR5 was first characterized as a receptor for @PROTEIN1$, @PROTEIN2$, and RANTES, and was rapidly shown to be the main coreceptor for M-tropic human immunodeficiency virus (HIV)-1 strains and simian immunodeficiency virus (SIV).","label":0}
{"pair_id":"AIMed.d37.s311.p4","sentence":"CCR5 was first characterized as a receptor for @PROTEIN1$, MIP-1beta, and @PROTEIN2$, and was rapidly shown to be the main coreceptor for M-tropic human immunodeficiency virus (HIV)-1 strains and simian immunodeficiency virus (SIV).","label":0}
{"pair_id":"AIMed.d37.s311.p5","sentence":"CCR5 was first characterized as a receptor for MIP-1alpha, @PROTEIN1$, and @PROTEIN2$, and was rapidly shown to be the main coreceptor for M-tropic human immunodeficiency virus (HIV)-1 strains and simian immunodeficiency virus (SIV).","label":0}
{"pair_id":"BioInfer.d473.s0.p0","sentence":"Our data, which suggest that pollen @PROTEIN2$ can regulate @PROTEIN1$-based cytoskeletal protein assembly and protein kinase or protein pho activity, indicate a possible role for the involvement of profilin in signaling pathways that may regulate pollen tube growth.","label":0}
{"pair_id":"BioInfer.d473.s0.p1","sentence":"Our data, which suggest that pollen profilin can regulate @PROTEIN1$-based cytoskeletal protein assembly and protein kinase or protein pho activity, indicate a possible role for the involvement of @PROTEIN2$ in signaling pathways that may regulate pollen tube growth.","label":0}
{"pair_id":"BioInfer.d473.s0.p2","sentence":"Our data, which suggest that pollen profilin can regulate @PROTEIN1$-based cytoskeletal protein assembly and @PROTEIN2$ or protein pho activity, indicate a possible role for the involvement of profilin in signaling pathways that may regulate pollen tube growth.","label":0}
{"pair_id":"BioInfer.d473.s0.p3","sentence":"Our data, which suggest that pollen profilin can regulate @PROTEIN1$-based cytoskeletal protein assembly and @PROTEIN2$ kinase or @PROTEIN2$ activity, indicate a possible role for the involvement of profilin in signaling pathways that may regulate pollen tube growth.","label":0}
{"pair_id":"BioInfer.d473.s0.p4","sentence":"Our data, which suggest that pollen @PROTEIN1$ can regulate actin-based cytoskeletal protein assembly and protein kinase or protein pho activity, indicate a possible role for the involvement of @PROTEIN2$ in signaling pathways that may regulate pollen tube growth.","label":0}
{"pair_id":"BioInfer.d473.s0.p5","sentence":"Our data, which suggest that pollen @PROTEIN1$ can regulate actin-based cytoskeletal protein assembly and @PROTEIN2$ or protein pho activity, indicate a possible role for the involvement of profilin in signaling pathways that may regulate pollen tube growth.","label":1}
{"pair_id":"BioInfer.d473.s0.p6","sentence":"Our data, which suggest that pollen @PROTEIN1$ can regulate actin-based cytoskeletal protein assembly and @PROTEIN2$ kinase or @PROTEIN2$ activity, indicate a possible role for the involvement of profilin in signaling pathways that may regulate pollen tube growth.","label":1}
{"pair_id":"BioInfer.d473.s0.p7","sentence":"Our data, which suggest that pollen profilin can regulate actin-based cytoskeletal protein assembly and @PROTEIN2$ or protein pho activity, indicate a possible role for the involvement of @PROTEIN1$ in signaling pathways that may regulate pollen tube growth.","label":0}
{"pair_id":"BioInfer.d473.s0.p8","sentence":"Our data, which suggest that pollen profilin can regulate actin-based cytoskeletal protein assembly and @PROTEIN2$ kinase or @PROTEIN2$ activity, indicate a possible role for the involvement of @PROTEIN1$ in signaling pathways that may regulate pollen tube growth.","label":0}
{"pair_id":"BioInfer.d473.s0.p9","sentence":"Our data, which suggest that pollen profilin can regulate actin-based cytoskeletal protein assembly and @PROTEIN1$@PROTEIN2$ kinase or @PROTEIN2$ activity, indicate a possible role for the involvement of profilin in signaling pathways that may regulate pollen tube growth.","label":0}
{"pair_id":"BioInfer.d87.s4.p0","sentence":"While @PROTEIN2$ has been demonstrated to be crucial for @PROTEIN1$ function, the role of beta-catenin is not yet fully understood.","label":1}
{"pair_id":"BioInfer.d87.s4.p1","sentence":"While alpha-catenin has been demonstrated to be crucial for @PROTEIN1$ function, the role of @PROTEIN2$ is not yet fully understood.","label":0}
{"pair_id":"BioInfer.d87.s4.p2","sentence":"While @PROTEIN1$ has been demonstrated to be crucial for cadherin function, the role of @PROTEIN2$ is not yet fully understood.","label":0}
{"pair_id":"BioInfer.d544.s0.p0","sentence":"@PROTEIN1$@PROTEIN2$ alpha actin and @PROTEIN2$ expression in the vascular smooth muscle cells surrounding human endometrial arterioles.","label":0}
{"pair_id":"BioInfer.d628.s0.p0","sentence":"The inhibitory effects of rapamycin on bombesin-stimulated cell cycle progression did not involve accumulation of the @PROTEIN1$ p27(kip1) but a striking inhibition of the expression of @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d628.s0.p1","sentence":"The inhibitory effects of rapamycin on bombesin-stimulated cell cycle progression did not involve accumulation of the @PROTEIN1$ p27(@PROTEIN2$) but a striking inhibition of the expression of cyclin D1.","label":1}
{"pair_id":"BioInfer.d628.s0.p2","sentence":"The inhibitory effects of rapamycin on bombesin-stimulated cell cycle progression did not involve accumulation of the @PROTEIN1$ @PROTEIN2$(kip1) but a striking inhibition of the expression of cyclin D1.","label":1}
{"pair_id":"BioInfer.d628.s0.p3","sentence":"The inhibitory effects of rapamycin on bombesin-stimulated cell cycle progression did not involve accumulation of the cyclin-dependent kinase inhibitor p27(@PROTEIN2$) but a striking inhibition of the expression of @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d628.s0.p4","sentence":"The inhibitory effects of rapamycin on bombesin-stimulated cell cycle progression did not involve accumulation of the cyclin-dependent kinase inhibitor @PROTEIN2$(kip1) but a striking inhibition of the expression of @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d628.s0.p5","sentence":"The inhibitory effects of rapamycin on bombesin-stimulated cell cycle progression did not involve accumulation of the cyclin-dependent kinase inhibitor @PROTEIN2$(@PROTEIN1$) but a striking inhibition of the expression of cyclin D1.","label":0}
{"pair_id":"AIMed.d185.s1574.p0","sentence":"Using a structure-function mutagenesis approach, two tyrosine residues (Tyr427 and Tyr477) in the intracellular domain of the murine @PROTEIN1$@PROTEIN2$ were found to be redundantly required for receptor function and for activation of Stat3 but not for Stat1 or Stat5.","label":0}
{"pair_id":"AIMed.d185.s1574.p1","sentence":"Using a structure-function mutagenesis approach, two tyrosine residues (Tyr427 and Tyr477) in the intracellular domain of the murine @PROTEIN1$ receptor were found to be redundantly required for receptor function and for activation of @PROTEIN2$ but not for Stat1 or Stat5.","label":0}
{"pair_id":"AIMed.d185.s1574.p2","sentence":"Using a structure-function mutagenesis approach, two tyrosine residues (Tyr427 and Tyr477) in the intracellular domain of the murine @PROTEIN1$ receptor were found to be redundantly required for receptor function and for activation of Stat3 but not for @PROTEIN2$ or Stat5.","label":0}
{"pair_id":"AIMed.d185.s1574.p3","sentence":"Using a structure-function mutagenesis approach, two tyrosine residues (Tyr427 and Tyr477) in the intracellular domain of the murine @PROTEIN1$ were found to be redundantly required for receptor function and for activation of @PROTEIN2$ but not for Stat1 or Stat5.","label":1}
{"pair_id":"AIMed.d185.s1574.p4","sentence":"Using a structure-function mutagenesis approach, two tyrosine residues (Tyr427 and Tyr477) in the intracellular domain of the murine @PROTEIN1$ were found to be redundantly required for receptor function and for activation of Stat3 but not for @PROTEIN2$ or Stat5.","label":0}
{"pair_id":"AIMed.d185.s1574.p5","sentence":"Using a structure-function mutagenesis approach, two tyrosine residues (Tyr427 and Tyr477) in the intracellular domain of the murine IL-10 receptor were found to be redundantly required for receptor function and for activation of @PROTEIN1$ but not for @PROTEIN2$ or Stat5.","label":0}